{"docstore/metadata": {"1b3b6816-1958-458c-8149-78fdc732e3ed": {"doc_hash": "c00c27a1559ccaec054ad482db4cb929cd37777b0cc674f6bb2cbe784d37503d"}, "d765e96f-17af-4a9c-8058-b8b9b9d6de43": {"doc_hash": "d316a1ca2cc204c2d72ce81facd8184df253d9f99950f80c38f745938bff32b8"}, "b7955333-7e0f-451d-a6d3-3aacbbfb34c6": {"doc_hash": "ecfae4829282337ea3c89ecd60700e980197f2884caf7619c65ab94d78e1bf87"}, "b77b174e-6c7d-4c0b-8c62-66003c42a5bf": {"doc_hash": "0f44761c202184e793a87ca5f3e9a44ffec3571cd0a1c8804baacba1841031ec"}, "070446a3-3da9-42f0-954c-a635b168ddd7": {"doc_hash": "a3427b575a52490bb54e484986bb484eff592d422ead41174b645f8e1145f410"}, "e91e3e68-57cf-4e78-ac15-9b987f356d6c": {"doc_hash": "dfb93140841e8bc19f742c7178e55cae599ca05f2e09598eb03b995d82ebb204"}, "e8f2fe11-fb74-4d04-95b5-b10985c269aa": {"doc_hash": "b3bc8b6fe6aa126a1159acfa762c4942c2ab4bc1552a09f7a53431f2ec28261d"}, "431a22b7-b77a-49e3-b468-da4406cd9369": {"doc_hash": "7ce0a37a74fdad62e759a4510449179e888efee4984f37f3cc3ce8d81ee73ae3"}, "9ee5af03-ad45-4d50-badb-990e0c2a9fdd": {"doc_hash": "0d13b50a9e7321037cf837473908d3d5ee5bdf477757e60a02be5e9b6e433d99"}, "c0b96265-ec2e-495a-a56e-5d30cb2be073": {"doc_hash": "4454b313f06be91c1dd1c534d0b6028e38e172599b08367c26de0def5fbca340"}, "58038d3c-d0cb-4127-b0a6-c6c43d4e3e61": {"doc_hash": "178aa8d78aa4b66bd009df2ddc8452f620a0c982f55d372a0b2cdf42684c302f"}, "c8f396ef-0baa-4633-9b38-a0eb9a243cee": {"doc_hash": "9eb9744f0aee7c9fef96a6bec9c4ce25edb6eeedad6d6334a3d41f391277245a"}, "7ef34fde-d145-4415-a33a-c810b2b0a5bb": {"doc_hash": "8e64971bae3c64dea64f10459d5f367d5acb2c4201661c432eeacdb9952661d0"}, "47f8485b-9dcd-4b69-87bb-8fd38f8f4b01": {"doc_hash": "3b639e92aef0fff2aaaabca9546263144fee8a1873d92f7e1ee74d8bda996c55"}, "ab00847a-2717-4357-a270-8c37399d3c3e": {"doc_hash": "44df94dabe106bb4c39819cb8b69ebb3ba4d70fdfdbae85425c57756004a0565"}, "e506c5dc-b575-4b7f-b2bb-6a5405548aac": {"doc_hash": "04cac956b408995655bb182c5fc08e0a81a994451c58866a134b35a12e945d0b"}, "825498ea-067a-47a3-be1a-ff41fd529cde": {"doc_hash": "a7c0405c2ccb89aa1fc6daedb780df35f50ce7c2ab9eb31a9f2c92b6a8651fce"}, "31b57863-aad5-4d81-8864-cfffe5731a95": {"doc_hash": "485a138fd558237823916f5fc1d0852c5575e1dba9e5448e91afd0bd18e560a5"}, "b42026b7-52ac-4c0d-9323-569519f16406": {"doc_hash": "56b1a2d94240b375874f782a323bf2ba8789bd5b585bfe9427e69f04714c5da6"}, "32f6faf4-f7b0-4b0b-b7ab-fa52e7b01eb2": {"doc_hash": "318e30fe6f77827fef240e8d05223f2004d6f2e039598a8e154dd973a86a9d38"}, "cac5159c-9ab7-41ee-9f10-ca69789a719f": {"doc_hash": "1e53d40119716d0453dd3a653361f46a2f23d5dafc853f743475c28ce2ea06eb"}, "86d31c25-af43-4738-8006-7731b59af8cd": {"doc_hash": "645f6f4ea22c3f76a41471380692ea8ae6a0d379a6aa18c01e88c2e5325da303"}, "9a1339b5-f26d-4c46-a509-9b1d4b9ccb77": {"doc_hash": "b94529f0bcfd175f4017559bf57bde62f1d878e5dd9a564f2fcae6475055ab38"}, "ae16cc8a-f01d-4f92-9cec-074f198aface": {"doc_hash": "62e1b6774328967a1fe181a59d4d5d9151e0c29e6b6ea736a5edbcdee35b2400"}, "c470acc8-f010-45e5-9eff-29457f42fadf": {"doc_hash": "b203ce834c424b01d2b0a4f65628e03324c715a910cd7b0e3683f830ce66534e"}, "95e1795d-5fe8-470e-81a9-fcd21e8dedb4": {"doc_hash": "a45155c9311bbe1ac90ea902f2dbe3cf9998c29deff33fe3edfa60c23a3dd492"}, "0d2b8727-73a6-4b72-b6e4-2049b1d0a154": {"doc_hash": "ecf5668b6b3d9052fb098f5e3ee7466dd212f8f6e350004af6df4998ebe1e356"}, "5b6bbc65-d3e4-44ef-a3c4-288f9e62e3d3": {"doc_hash": "60834d8e29a8edd68f69a5fa0aac6a5353bbbe82dc76d0106e575153eb7d95a4"}, "a21ae520-db05-4339-b8e5-d73dc7be5643": {"doc_hash": "c6599e816edf72d56481c8c4995016b201f0b2208c6c93254c4f9512368287e5"}, "780c1fca-724d-4026-b189-cbfc52c97dcb": {"doc_hash": "4ad6498ed1ef977535f2be036110d9e9ccb03bcb5961bc69125b5212362a0c1b"}, "2ebfab61-a517-4ee6-bae8-546e2001f300": {"doc_hash": "c9daa283295a3a110bf54cfd4d1ebdd720712167c48c0c2576bc342d047b8cab"}, "c66fca50-a58e-4dd5-a417-14f48fea9cc6": {"doc_hash": "fcc52294dc9c223b666d66711361aa4f5cacca9d2f16023758581324e9ceb2bc"}, "b2f16060-1afa-40f8-932a-bb865d50af76": {"doc_hash": "55b89056ce18cf3a9a3f05e2f35a2e08516f5221d459cdcbf5e753b63433b8f0"}, "2b72f4e9-f9bb-4d2e-920f-8e06d4dd5010": {"doc_hash": "40da2784dce9e1a79add97a53b259a0b99f5b9236cf1014642eca78935484bd6"}, "19f554eb-964b-4b07-a5d2-4f3cf82a24b0": {"doc_hash": "3fd349a61fee4a235b5381eaa510b06a34388ba474ce000cdc2729b7584172cd"}, "6854c36d-a946-4d8e-a11b-bebf003f9ec5": {"doc_hash": "578fa856f72706250932207b0b01716040f58216eaafe48a6d060ab7d7b29050"}, "a4a87fe2-1f30-415a-9677-847e034f0666": {"doc_hash": "b7e8b776595b6e634dbba199d910acf838962997d97d7ecc11482f904cf272c0"}, "e59f91fa-2038-442f-8de6-23891af8efa3": {"doc_hash": "b5bd5f6f81210aa9069691347eeaeeb177d794e22e2916cf20e40f22555acf58"}, "f3bc2f24-8dd8-4784-9ef5-17e958b016a3": {"doc_hash": "028447bf4cdb3ef918855efb206ef9533ee12246d54096fb8fa14b715dbd4050"}, "042268cc-9263-43f8-a77d-62af53d7870a": {"doc_hash": "6b3ef0c308ad56f23772695a9b75678c95afa589699002fa8a19da971f17aab3"}, "383c7093-d630-4481-841f-852df9cf73b3": {"doc_hash": "507abf447938f016d44ad8e9b8c91a4bd1d196b8b261afb804bfa67117c0ae56"}, "29358fce-80f0-4b9e-9c8e-9234fb2e4bd5": {"doc_hash": "96b174d172546ed7908b30caa2d380d2101da5b6406bdaa1d349bfbff6110655"}, "86981af9-7c65-4b79-b0e7-352378ac6265": {"doc_hash": "f8c3c8b421a504cc0ee8dc9c7418b68b0fa21ac33403a88a57e1908519ba2818"}, "bd179acc-67b8-499f-b779-94b4ed1b18ea": {"doc_hash": "31cab9d080fa04f7c01af33d48be80f239e9f554a2ccc11033890919cfadf022"}, "1bdce6de-3906-429d-83c6-8a2539dc7c57": {"doc_hash": "d087bfed59db4b6cfdc3e6e4e66556e17df95f24b5efc334ba1e42af9cef1e5f"}, "73d0cfbd-e0e7-4e6e-85d9-60a25cc4a1ac": {"doc_hash": "75522d593fb41a691738e423cb72798107835fa0278252f87d507337a1320268"}, "4c3236c3-c195-48a2-bc81-1df7e0d256c4": {"doc_hash": "bafe497dda647cf56cb80570339aaa4092f93e9dc227fd5d07a2951ecf39f030"}, "3a51123c-82ea-4873-ac46-b5dd77a387cb": {"doc_hash": "34510b00ef229cb67153f730c6d08db72baf73c01fb80ce2bc1e8615f8f5224a"}, "040e8e55-1b5e-423b-a61e-78b07c315c43": {"doc_hash": "b71acaf6398032ab05bb15654cf983e84def035be8cb7ea439164cfa20e94415"}, "2bfe3106-e487-4947-ac3c-9593794b4ec4": {"doc_hash": "d806dd977a004a452c57cc823636121e147844f9adf868970bcfa5584d44de24"}, "9f9e7857-8573-46b4-809f-39d62f873ae1": {"doc_hash": "e1a97043116872d595196011439d330707308507708c6bbe5c8bd49766a1b433"}, "476b5ee2-fa3c-475c-acde-2a856ca49598": {"doc_hash": "8d9cce2e5a93cc6ae8daf4f0154a92f7ce8a2e032f56a5ccbb23f953a31afac2"}, "aa35fe49-aa28-429c-a281-d4ff86262064": {"doc_hash": "02dc730626fa149b78e929d859e6267dcf4e9ab6c768c555d44440258afdb19c"}, "fc107e44-0f72-4a91-8a46-92f5643f6459": {"doc_hash": "11e5e4ced98c9751bb749347d7c9cafb286a6c3e30060fb625345eed92b98a46"}, "4ab30247-e869-407d-a643-01b3be87b5fc": {"doc_hash": "6cd2cb7857027e5b5cf441dbea50f68c500dd963f227f1c6c223890cb6fa0bd6"}, "030b6d96-a642-4a88-982b-45434086a4ad": {"doc_hash": "632740c9d6d680c0f224c61310229a7afa0c826a52f3174445b8646630dfdd99"}, "42889750-f2fa-4c3f-b9ce-32e8dad2b00c": {"doc_hash": "19f96742d8d5d0f7720e48d5df4240e954a70b2aa48093607ac51441ef88c554"}, "95591b9d-3ef3-475d-a93c-1fba79f156e5": {"doc_hash": "d28ded224b5a825a4aea98bae12e7c7f6f90a0db73916c3fca949161c225ad3d"}, "33da8422-6e5d-46da-9f8d-61ca983eb55e": {"doc_hash": "00a689a033917c67ee417dc34beb1d1caff5840fd48320fc6b37fe84d3aa6742"}, "964807da-f9b7-494f-9a11-4cd7c7c2594e": {"doc_hash": "5228f8e9545e2dfaf2a19e47246601bc6e83ea29e0ee4303b01057c742ead8ce"}, "42343088-7b3d-49e5-b163-cf8e7c21fa09": {"doc_hash": "63bebfe1ec8bf9544f206f58a3d0d79f63478cdc427a3d5b3c2dd098422d83d1"}, "632b7795-822b-41ac-936e-93ae876a7cf1": {"doc_hash": "bd95fea0deaf5e119945eb1c37dcceb4501c06453f41185ef38e3a79c4fca4c7"}, "16f8ca8f-fd14-40b1-a292-9fcd5c355da5": {"doc_hash": "9b035a6019fd3f8a7fba138b17f134205261bbe7107605bf987c75fc11784084"}, "e2941bf5-0505-4abb-a1ba-4a5eb057ea6f": {"doc_hash": "2111e9fca042ed7c3a3ed54d14248cb90262aea464084827b17083df0c4797d2"}, "840d3bf8-8a0e-4576-aead-dafa00fbe7a2": {"doc_hash": "07ca570b4eb04ca73fe11ed6e20324d373e49f12bb4a5593a94733255e627009"}, "c11986ca-e7a9-473c-bdb5-39b5ea6357d1": {"doc_hash": "21de230aa64f8662b13af020e9872c4797aa49421b816b380d902540b18d46ae"}, "465f8c44-113e-4abd-92ff-0edf5721d2f2": {"doc_hash": "0dcec63122176bd3fe94c2b607cb1411128a3d5720745c4908419cc27a2878f3"}, "a9ab4941-7cb5-41e2-9ba0-bce4729b3024": {"doc_hash": "5ba5741542145907342c4c393c4552ef23b0940e4e68a41933dd483f907133e5"}, "86c8d4eb-296b-4eb0-8807-cc4440408207": {"doc_hash": "73057260163c27d5ac80bbfab5fb32b98c24e6125058cf7fda7126280c9eb7f7"}, "c96ff112-0157-46d1-afc7-062945cee5e8": {"doc_hash": "cc931afa9a633c48bfcc79735d200d3721abe2c8104e00ec513c2c84358505d5"}, "ce9f5616-877a-44e5-8cb0-b4482925c8c2": {"doc_hash": "b0b7b0e447aa555379799ffc7c419172b183a0e2885a400f6f1f24bc24848f34"}, "7774eaf7-da5c-46eb-b4d8-ce492199a35d": {"doc_hash": "2ccd921ee6708c00133528ffaa928ce6d8d57002d835145ccd482e739de8565c"}, "f6c30827-2624-471c-9232-2255e5419ef0": {"doc_hash": "2183a4744d00df31976f02a153864cac5e4bdc616c73d15602eee4cc29680234"}, "cee73198-a1e9-45f2-886f-9438a1bd4941": {"doc_hash": "9215800e06396337860ff4853226aa26d3f6997fc0329d40679a1f3ad359fa7a"}, "1c5a8482-67dd-4f6f-ad77-0347e49cbd87": {"doc_hash": "7d66192afce8953e7c95c952fb032b0ff511ed82ad20ea154062cdc08334b819"}, "0c6386b0-e9fa-45fc-9979-461bcb548ca7": {"doc_hash": "bb863da3572ec8a37a1e21498eb4b20708e90a9420e6273899dd9864ecff685d"}, "2a9fffc5-cb4d-4256-bf15-3ae118b45cc6": {"doc_hash": "61bfa9f13bbfa96046cedac70dab70c7cf9c05fcf43e178057d155196bd360f2"}, "bf4ed3e7-72df-4708-b175-cfe7b30c6df6": {"doc_hash": "c0551279fc7fed058a2808cd1b9f75627e3db47af6f0e4b20f2870cde0ff03db"}, "7d793112-63e0-4df1-a230-2a88b2814a91": {"doc_hash": "84b14f8ee154124cb5d8df9364ad05f5398f3a10f24aaf0377ba7736afffa92a"}, "da1ae84b-def8-4b78-bc8c-3d7e923d352d": {"doc_hash": "8852f6de83b25170cfd9be9bef0ca6df0081b7688cb2f48ffbd581c2c7b206e2"}, "b2a8144f-e260-41ce-9862-13cb8a4f9d1b": {"doc_hash": "eac86e64011bf8838aaaa4991c467031919a4282ba2eed8b8ca89a7a97b0d660"}, "6d517ac0-ad80-48de-9fb0-6d941c193baf": {"doc_hash": "d50f9b056f11a12d6b3134477aa3958fbab868e503cedf5e9ee1732cbe8c6b03"}, "d5999fc5-6e91-4b03-a590-22bbb863d842": {"doc_hash": "36c57517e7b78afff558407303639901476d2c5d7ffd2bce4a0899519043d192"}, "1af20325-881e-40df-aa99-7173fcbc25c7": {"doc_hash": "9702499dcd271841c8f79b30b271eea8ec2762201f2d8e81980e40f447eeb2b8"}, "f09b998a-1082-4b58-afec-3686b619651f": {"doc_hash": "01e470d088330769126ea3a690306d4772e8c3a5f50fa7028e78e2b6a88c2792"}, "10e3b110-c6bd-4324-aeaf-8389002f32ed": {"doc_hash": "bf411a519b838d1d1d54cb86dffa5cec1640cdca2d86d0dd3dd204e68af39390"}, "1dbe0886-2bdb-4948-893a-8e1289135704": {"doc_hash": "b82fbd8e790248d28470f910b75084116968e146b695cdf4ae0803307ea24143"}, "4b8a3c67-6899-4add-b562-df68a9d3ec82": {"doc_hash": "b10c2c74ccd159919bcac9d18ed4d9b72d7711d103ab4d443c34e9f378810e19"}, "8e5b980b-174d-4b0a-b125-fc1edbc3e3f1": {"doc_hash": "c9e58759d3f14b3aa6b28c79676a979f7e83a45dd085dcc6e1a7a82f827b4c50"}, "1da45cb7-ec01-418b-9699-1d611a9eb1ea": {"doc_hash": "539df705a59035f89e491c47e506ba0eb2db21182110d249ba1da0d1f51bade3"}, "c4d62c21-fd18-44c7-8cae-887634363ed4": {"doc_hash": "fb0136697ebb32c463f11ffd13d02fbbe61b860ea76cb21198bc45136b5656b2"}, "9c07f040-46fc-410b-a8c6-3ffd10943c0f": {"doc_hash": "ddec4f4f7501245ec18fd44825fc3a230daaaccd212b041f1afb8b656f9a5c2c"}, "d3eda07a-cfaa-4dc5-8564-4909ff605fe4": {"doc_hash": "c2e28c071bd46cc50e0e61e4446d6120d0cf86bbde2bd95c94e89f6d819c1671"}, "923a94ef-af9f-42ac-b099-640e707f6931": {"doc_hash": "afcc03779af36b0a388628af50f2a052f97638df9bc7b45e37b184af09bfbe8e"}, "6ca606fd-0454-4a3c-8f6e-a99d1368dab4": {"doc_hash": "252f71dce2def4660af35a6d733a7263e3caa204c425bcccfaf7352569d02431"}, "0cedf0fa-abc8-4f72-b929-bb6af80badc5": {"doc_hash": "659bdb2bb3a044da65cb9c81f4d953a516c4f6ddc45b2f37aa01b8437e66dcf1"}, "3e6bd924-2c5f-459f-9318-9420a9e33ba3": {"doc_hash": "711e4fcc269c20d345633a6c86f749f5ec84f4e4d07d4e99092a5b600f08acaf"}, "66fefaef-6ba7-4df7-81ff-c072fe119879": {"doc_hash": "e8a5ec6c4fa724a001a8d8374c6e1494154994f93bd82a61ad5b777dc1446091"}, "bfde1ebb-63ba-4ac6-8622-c91fe12c3a89": {"doc_hash": "9fb3903134d6d7b5247faaed01837ec75169b1cdb9f41f2bfb1684256ef32163"}, "322a8bcf-c775-4b29-8426-bdfeaf0ad72b": {"doc_hash": "a421084883e90aba0ad1669458c48e5c8d1303d0b4c47a927fc4fd8585e19f80"}, "43f9ca28-4532-4a92-9c07-59013df56d1a": {"doc_hash": "56e2f48223eab72a03c586dc4f2594ef2bef879b72b13e685185cae5c6ca2661"}, "877bbf1f-5106-4894-a5e1-3285b410d669": {"doc_hash": "38e19614a8e645e763f3e8d5c61db9dcdc5a5a37f1da1a0698031ff4a04770ff"}, "52764204-8803-47f3-ad26-052cfabc7f84": {"doc_hash": "6151860c98543d9a1a3bde02e9862c1a17e4f59f593cab0b81bddb0af2edfaa9"}, "36132048-5b84-4c1f-9209-2abff9297b0b": {"doc_hash": "1039a97b3059433362abb96dc8e48649d4d11e4d6eedb6e31105ef3707247d23"}, "11bbdfb9-b55b-420b-893e-42c5b2be6732": {"doc_hash": "2fef7c940702b8efa00d3ed2ee7aa1acf3bd21a1cdfc2b97f82053955c1e57ec"}, "564be214-2fe9-4681-84be-93f26b887790": {"doc_hash": "f0971494f866f05377a25d01cab5640df97af2df17f57af403a13739f1cabf04"}, "a07c1f81-e112-4d24-b379-3173bda1f275": {"doc_hash": "354846497d492d9f6c60e545d68843f3dfe32d0996d394baedce2c7a913c0919"}, "24d748fb-a338-4061-b032-0466ee6697e8": {"doc_hash": "547a1c1d19073802813c98b4c62d330163dfcde31d47598e6e406693e4c3d4a8"}, "96613642-e63d-4b1e-8252-ecb4d4e26853": {"doc_hash": "ba174d57ceb0febb8ae056f28396e73f06817980b2b2bed3da830f0f74651a2a"}, "aafa609a-4cb3-42f7-8637-aa761dc4f733": {"doc_hash": "1a7ee453f78e2d6dda67284488d956265465841e38f28c07c5a3131199ba7722"}, "2edfb660-1efa-4517-b3d7-2c7c42053af2": {"doc_hash": "46ddd77afbb2a01ce15d8da0be74f66bffc6654b8f1d7f44268b62608cd3c42f"}, "4029a4e4-3c05-41b1-aab2-3512cb045dbd": {"doc_hash": "2dda1466baa1267f1a8b470ee695a4bfcea9fbb6ad8183e00dc76720d5b4729f"}, "4d4d8996-38b7-4922-a5a3-8d460bdcccdd": {"doc_hash": "6b028aa514ef1db23906b33ad859e2f4ed5feb56ba4b16a96ad8c3ec7aeba3ca"}, "22a72e50-3350-486e-897a-d10f1865f945": {"doc_hash": "98ee9f00ddddf809bde137759a4e110d8629ab4f9fe7aa87383b66289f1efc8f"}, "47f3f53c-3ea9-42d0-80da-1817d6feef8e": {"doc_hash": "476bd08e5b25d117ddd457c152855d9a7c7ad53dcb41f4387fdf063a2de70910"}, "f80344a4-f951-44f4-b562-cf9c2eafcd14": {"doc_hash": "d2d4552246342ea1754858007d24c480642e7fded344219e8fdd933babd9b607"}, "9985ffb1-0998-483b-8b2d-b3bf7665cc35": {"doc_hash": "47e7c4497fe944783b5f3285c3840dfbfb8c199d190ecb8f90660eb3274bf0f8"}, "65c43e63-3cad-4eea-8e2e-2eefdd741572": {"doc_hash": "4dd0c80cd2b269b77ac91eeded7fbb76a8c72a1ea23ede03e3dc48815218b2a4"}, "46715ff1-001c-42a3-b1c7-c5f9aafdcdba": {"doc_hash": "a6ed71733b393028a0acf407c12ac46ee8e6cf4d433faf0752c7b06c97531600"}, "065fd747-9054-4a38-aea8-0afc053c9abe": {"doc_hash": "e57d184a3f7a563347c6f762bf2ed14dd62ee700bff3f750419e37ad72b97931"}, "ba303aa1-ca51-4ca1-ab01-b46b11269478": {"doc_hash": "a20453949aafb835750d072e74e2d3b34f916c05986f68f1f0f8515775bacbc8"}, "eb6c427c-364e-4849-8a79-0e46f568a1f9": {"doc_hash": "8f3c2dadfc9fb40fe4baf5c0959e740c8ea78af09d541d69abd06d9790a1f6aa"}, "a69db317-69d6-4df8-87d3-3b67e5ef98ee": {"doc_hash": "851ea07f4312367611af49f1fdf1f10a93cf29b9b13ce4af0003285a041a857e"}, "557ebe60-20be-48ca-9271-cf6bd9e97759": {"doc_hash": "be6093d6037964924b35f2094cfffa7325c453af51b78134ca24dc4945fd0737"}, "0c365bc2-bcc0-40d8-8359-312d7db0ea2c": {"doc_hash": "96055c423bd030c13bce822c120e0d4b65ae1b9665b5e4fadc81f54647cf5183"}, "11760da2-6cb5-44a1-b8cb-24ec0da66b81": {"doc_hash": "8f64f5e1318b1935c27175bf47ca437a966de3906580603ce8b22b03b2778641"}, "2cd72a0a-e948-4ff7-9f40-dbc3b9d4ea8b": {"doc_hash": "b11154f8dd86a005fc24d03f67ceaf0cc57af5587429db3ea19ce9d3bd8934b5"}, "2231a9a6-e601-4296-ada5-8372b6438bca": {"doc_hash": "7fefeec552eb710ec0c827be406d75e9bfa4ab3801c52d7cc5e748ddf6f437bd"}, "454d8df7-3e4e-48db-afa0-93c1996ca420": {"doc_hash": "741e3b8bb96ca649f5ed476092e0f0f955647a1da8c9ab15d8ba99d51c2b2e51"}, "08b94b43-9af2-497c-bb3f-ebe575c982a7": {"doc_hash": "458ff3f5e86e92c2ac90998e7d8d4882461206114f873b5871e4428ce0503947"}, "fc50f281-55d5-4bca-8c0e-b00942990a56": {"doc_hash": "33c9eac5f0cfb8b8bc32eedb4c2209b3ecde60d150ce37fe7bb633a4bf684578"}, "7b190dc8-87f9-4544-ae07-5279ce3046df": {"doc_hash": "54a055e30ca30e96bd0c3896ccc269a51128f72a2a2b5cdb66297b8405735c2c"}, "d7dd4540-5a15-48fc-b18c-11de029555bf": {"doc_hash": "b93e92e988c356fdb6583980be38bc2af64299882a41126824d1ee15e2b6b988"}, "1fab887a-2cc2-448b-9138-3857e0701c2a": {"doc_hash": "f6af5c76e0775b952a54183d7630270502b6aef80bd109d9bf39fb843288fe0d"}, "8636484c-e14b-44dd-a251-e385c4fc294b": {"doc_hash": "c3800f2cc4296f8c231fecb2238af1d3776a295738c607ad086acfe9a97afb20"}, "62bbae2d-2a78-4e00-9e92-693cdbb875c3": {"doc_hash": "d4f5c4fadf9ba42311834853adf477002b71606dc35f0b37de604d80b9f6dbc1"}, "c73013c9-4787-41d0-9d00-34488ecc060d": {"doc_hash": "104237cd24b689b00824c254be48098ea3ef6aecbb7fbce1e916fdf1389e5046"}, "fc3608e5-730c-4c90-b7d1-7929f0c13535": {"doc_hash": "4ef02a8ec55df35be11d9aed1f999127ace13601e6e9bf4f0bcef0f34fb999c0"}, "4f11f617-4d24-45ad-b7d3-8d85bb8ce0ec": {"doc_hash": "a3ab8293e3aaff061fd7e54c633fead1b1c6940c9dba0365ad1fcc02293959d5"}, "164c284c-7d6e-406a-ab4a-01fe063f918a": {"doc_hash": "4baba4e78f8ee187236adbfe1c7cfa8fcc4433caaa82698a9ea8e9388baa40d0"}, "7551b48e-58a2-4aa1-9488-450efbb970bc": {"doc_hash": "2189e6e190e7d923bafd82de08c7fdfbd9a50c9c16bc7a3635e16370a1be1345"}, "6eb7cbf9-595d-4db0-9b59-a948ae86bc15": {"doc_hash": "84a5cfbb810fe63fd4f68423678f47e3a9192cb941f14d1446d26f8fe01e74e3"}, "4edb0ee4-816a-491d-b66e-d989f8566872": {"doc_hash": "80e90df7d3866409f209f8ab848e1690c0dd50bd57f00be568e3abfe5650677d"}, "0830e9d3-f18c-471f-8483-3041ab118bf3": {"doc_hash": "fc6547474b8ae33bff96200918f5af0b67359e53bf9e400e545922c17225a774"}, "6805abe0-1bef-47af-8148-626d40fda5a9": {"doc_hash": "154639e2cefd3614f7b89331746d77ad5718214b096c98f4c411a98b9cab6396"}, "b9740561-4cd0-4c2d-b92b-a2889e1c4ee9": {"doc_hash": "b0bfa8b71fb8741ee667b666205fa6433d94f9d6fd33d83dd0a4357c7fd2757f"}, "3023d401-35be-42ca-b3cb-cbf86baa1b62": {"doc_hash": "fd2f4ac0b67a4b45adcfa179a5c1e3a7128f9240e4b945826afa3860dfea0603"}, "abd74dc6-fe7d-4741-9b1c-86cf92e9dabf": {"doc_hash": "a184486d4b2c74d9124df5ebd194e2e33ef892b90819863af04ab7eb900f04d5"}, "4f3b0d9b-3d9c-4ecf-94d8-82ff1cae6797": {"doc_hash": "985ce7952551293f7cf2345a45649c322b9fe71f687f36588177ad733f769829"}, "45404661-bab7-4afc-b84f-ad80c34e64ef": {"doc_hash": "6c38caeb982dc318b2123be16a9f50ee5da9c5a86938405b668e38adca4feb1d"}, "7141c8aa-45df-4258-857b-3f22bede7a91": {"doc_hash": "2efd68ea84189343576fb305416f47ba4e284c2870dac6bcbb18f908abbf0ad9"}, "d1ad9bc5-6a79-4608-b573-62003c3ac7ea": {"doc_hash": "c02df4d1f63b176beb10555295471dcee5014621d43c24af240d11308026e16d"}, "af45694e-1feb-4877-bb4e-50acd4f43140": {"doc_hash": "e623aa9c52411f4b0ee7e6d1ca4ae010600019a8f8f109840ba16302c4b69644"}, "523b1e56-c39b-4a4a-8a56-ccd03adb8d44": {"doc_hash": "f83160a0484abbbb97db38281d842adad51d92b3a56df8fc383a0206ac4c1785"}, "82e70b4e-1015-49a6-b739-e34dd8156fab": {"doc_hash": "bb46a42290e852f6e1fe6c3dca6b436ccc2cc6c0a2b3da3a0c56d7a5610aac9f"}, "86778868-7bb3-4f49-9a26-c78b2494eade": {"doc_hash": "f35b8cf496fa3004ff0ba0221a9b9b28e2637501c4be0fb5ff211dbc11457ac3"}, "f4f60c32-d5f9-44d4-b601-312e24eff0b7": {"doc_hash": "168d875b84b28ec35b08ddbd99d7ddd539de7b8d7a6c35966a186f1c63a5ba88"}, "d60fb424-3065-4c56-97b2-f1cbd9afde27": {"doc_hash": "afd70c0609780344acc32f2ef1cb8f2b7bd8db500948f2a5751281e50b861e24"}, "be98ff6f-3e0b-4d15-b1e0-45cf596f670e": {"doc_hash": "0c9ce6b226951e8f47702077b6f7a2b12572f26b3efff7e90acd2af202084fc7"}, "d618ac31-f76b-4fb9-9f01-aeb7219e1f8c": {"doc_hash": "3dc5e89a95b1186620a94a8ed848faa2292ec568a0b4f767e574337c254da276"}, "a9c80840-7405-4c0d-8877-02e68e887912": {"doc_hash": "58b2d763d091a914f8fa5e518853ab922aefe3ac851b40490a85faf18397a057"}, "d17a71fa-869f-4b81-98d3-ff8349298260": {"doc_hash": "b5976e13fd10c7b437c239a37f57aa5dbb36b5af3b676e9e6a768c86ff7c717b"}, "73e33618-683d-4bc7-9faf-051ffc48cc4b": {"doc_hash": "4d40c0c7a908b741229c324c48fe45336ae2a3d55e41efa0fe59c56a22b3fc15"}, "320656b7-73a3-4842-b9c3-168530bde414": {"doc_hash": "e00ae308ff019abaf7d7ba3c3a3a9fa4e867ad5d755b17f61512d70f86f1c546"}, "e9428e8d-3031-4b47-ab08-aca218f40ef6": {"doc_hash": "1e2bdf6407b630bee2a0d0079a446a8a97622d0f59a20004fc471c774cf5714c"}, "20ad4412-10a8-4773-ac3d-ac540932b472": {"doc_hash": "8bcecbabc05cf18c5cfec9388a082de9ede4776cd1d42e2b84e464cb5414a9e8"}, "121b4028-703c-44b1-9338-f482f68f9e35": {"doc_hash": "bfd8118dedee8edea33de16347a23d6374bb12ad72bd1b956ca68e5663921d58"}, "3bc50e88-cce7-4421-805d-9e3007b2187e": {"doc_hash": "fbee78a218baf61aed2d60a9a1a6c5197153f8fb2f26ac37f4474a31beff0762"}, "d0646bfb-0b1d-4b34-b0df-5d5a7945cea2": {"doc_hash": "4fe51a9b82532624dcdb911a7d9b202bbcf56baa7d4bdd038f0b4fbe18fe928e"}, "00706bb0-b713-4b31-be38-a28d086dd506": {"doc_hash": "8cacecd7dbe86be41dac145197326ca46e2ba3b31c391aba9d448a519e7a263d"}, "5582fb45-e245-45e8-a48a-ef2e232df2ed": {"doc_hash": "89f989f2cd7fb08036d81b6ef31591f259e57c6425d3e34b3f616edfccc83e34"}, "1350de92-7f10-40f9-9c9e-febcc0126be8": {"doc_hash": "5fc01bb1c7045f4f780d87019b1e02c6a8b0efc747e5735d3716e68016cf3b23"}, "6590eeee-6173-4372-8040-49481b4dcd11": {"doc_hash": "308eb7a98b8c1a4254a685601985622deea831bff3cbbf2165e25acfb719ff0f"}, "267fddab-aaeb-4434-b1ca-f4883a1d767d": {"doc_hash": "7e43916df34f090353a977dab89e384176f95bc6d6c43fdf53ec9b2113a90a60"}, "61a98377-5bf1-4862-a502-94a14a74c755": {"doc_hash": "e377e887931a999d9aff064ae3dfac8e39fbb4dff6840372006d56785de01592"}, "aeb2cb41-13b7-44f1-b621-cf924cc08d97": {"doc_hash": "66cae1640fa6f48b2f6b9defd916d0dc997ce0d602428fc8d17eb7401f9b3391"}, "3769e52b-d842-45ac-8b7a-3c33f489dfef": {"doc_hash": "d23f754dc10bdd008692924d67713e8d2411b9f8fb98f8e7bf6dbc6c901f1ec5"}, "16fe3a9d-d8bb-4065-9958-448ae109fc6b": {"doc_hash": "0f4577da5c7be1a4f750f688fa2bfcbca14164e3f4563354d65abbe5defa933d"}, "30f5fc87-1a02-46f0-80e8-51751b8f5215": {"doc_hash": "8851b6f886dbef32ed01fd96ed0630fc4528ed3590f5a6c57abca0410ec49cc6"}, "d0c6b54c-3a08-49ee-bb80-d5364fb49707": {"doc_hash": "57aba1cb8d0edb456107cd21d4e0922a4af01b71dcdf9b6a3f3b5455aa52a14d"}, "fe9b8670-2917-4f81-b168-34eb07a0a8b5": {"doc_hash": "3194aa2ce993dd2e8b175779f587f14b8eb7864b216d79d9b1873c7ba5abe612"}, "cb162009-3a11-4c0a-aae3-23b0ec30497c": {"doc_hash": "4b26089756402675d739b2e7aa49791039de664f3ffe3a9cea59ed1d8241e943"}, "75d77322-5d9e-40d0-adcd-324b2274e3f0": {"doc_hash": "fd85d4e40434fc7207111dc5bf54be67838420303bd241cee0b8219b9afe2965"}, "3f498d54-3613-4c3c-aae9-1d2d8887754f": {"doc_hash": "b51d42af85f4e7014c34c29de933bbdb8698d7991166146359d6eca8b36b91c0"}, "55793051-95e5-4bc3-8f97-b1a7430c48cd": {"doc_hash": "2f44a1cbdc9b7adee1a344dfa96668cae4b0a30da3b5f662414fef555603c235"}, "76aa9e20-2532-45e3-8834-c6bf10f1c929": {"doc_hash": "d1a458bc5985898515d9475717d188fe017b68eedb7b8cfa8eb253d5ce4a4e9c"}, "c920ead1-8e97-4ee1-a373-bd138608e3f4": {"doc_hash": "e039b05b72d55c36cf831297e29b2a9b1ff9c760df84c7ff0959c5268cdf17d3"}, "706afe10-1d21-41e7-a56a-a9714dfa220d": {"doc_hash": "3dad99bc0de83e3afb3e040136f62c95a0ff2de68d67f159e5aec2047554d7a2"}, "a7fc0c2c-cfaf-4a3a-bb82-593ec92ba62b": {"doc_hash": "52effeccc5945193bda8ca032bf1b4d1b6da26981d920b17ca835d3e7fdabff3"}, "1ff26edc-6068-4418-87a6-5f6954af649e": {"doc_hash": "2d5dfec8b80a4c144df77186f779398642d7e0356890ece066f0c0023c5f097a"}, "50af3b9a-9078-4af7-9d3a-fcafc326ca7e": {"doc_hash": "72987cc03c857ff110c4d9bfd10b1c05cbb3b2e579b0fde92c4639669bf3ac4b"}, "dcf0a36f-cf81-405c-8222-597a4ab35fff": {"doc_hash": "b8efb19c139a443683c1678c6c6d53c37bdbfb00b8e1ba51ccc3c4116f2cc9b3"}, "2c4eee77-7889-4fd0-9b3c-5cf27e31e117": {"doc_hash": "48a24b4cde34546705bd2dcd2b80196209b609ac0794f596ac65a38f61f097f4"}, "b8040aff-46eb-4b9d-b564-38e42aa53bfc": {"doc_hash": "56e3d02dc9583f359812fd1a60e4bbfc61735f2c1d3d28d10e3dc2bb754674bc"}, "03a32e3a-9ec1-4327-99bf-588d27b47a52": {"doc_hash": "e9be3bb70f1358daeb24df906958e8c825d4a484111c41228d915bf552870403"}, "40048bb9-df3b-4ec7-bb92-de8f0695610c": {"doc_hash": "682bd6c65159c7296656f3d718552144710944ec06340278c77d51e383f12fb2"}, "b5077bf6-30b9-41af-9bf3-761cee8b9bad": {"doc_hash": "f387bbea5424df57f8f0ee14009460386c15a5b7c3d52fff34a2da3f04723ea5"}, "8174bae9-4522-4adc-bc8b-192a8f06cb11": {"doc_hash": "5f57b7109c0202b80664c15710fa58249e8330d3e341af2c735787d274cc67ac"}, "80e1dba3-3e11-4412-b88f-283d539a6a80": {"doc_hash": "3e06568b69388e866f6713e67b3f3cef8452d70e2be32ee76312bc16054680d8"}, "b2ac548d-5e76-40a5-b2b3-987488dcba02": {"doc_hash": "8bb98eb3a0038b560dbc06d2ac9612a9e036305eb2ab262972bbba62fc211009"}, "183de8bd-164f-43d1-ab3b-15a1589f21f5": {"doc_hash": "3caf0c91c2f5e42bceaf35bf6a256f65565604ac00840d9ecb1a0ccb087e016f"}, "36d87278-720a-4186-8abc-502e01c4c92c": {"doc_hash": "e7bb8c918060d9ef2630482d871271f3b32327e3d1016adaa9630c58d01d8558"}, "c6a3cd14-4f5d-4453-97d5-2c412c6b872f": {"doc_hash": "193e21005418f36053f72100ebf6ae0a1902c2a0649fad4d734fab42ce070813"}, "50bf6623-bca6-47b7-bafd-bcba7cd025dd": {"doc_hash": "7fe1bd971eaf5457ba53f79ed38d53126917826745c15bd5e9b6709c3839b446"}, "51184f76-ff7d-4635-a3fe-782c187e98ca": {"doc_hash": "d1dd3031c8a9488c58a93c1b7b801558d6ea0c1e6a65c38567ff424947037b29"}, "ed366a82-5a01-474e-9658-ea4995f6816f": {"doc_hash": "cfba2ab63f8829fe1a01af5327eafb514ed5bbacccb09b0d9f34ae90e9016ede"}, "e03429d5-b5b0-41f1-8298-da426c6d8cb1": {"doc_hash": "4382dc3acf419e8750c1470f19e73a26883d932ffd0bc2262718ae685f03cc9b"}, "592ef5db-5488-4678-bdcf-a395d808d1e7": {"doc_hash": "3403d086ccb8fb9bec698a5b4fa72bd09476c0d393b8a23a4c727f492559f360"}, "08e01526-25ca-40a7-b3dc-dcff6052c0bc": {"doc_hash": "363243074370c5de3ef442a439c4fcc2b702bbb8530818d3d6e601d69458358e"}, "d40a7492-e2e2-4de8-9478-08d112579e1e": {"doc_hash": "217622cb9589a4ad75e984da7ed1f43ba7195db341eca23f88b3a03e08b11e3b"}, "76092514-2027-4582-b797-e282c30074c5": {"doc_hash": "a77f7bf40e7f68325299544be8f81cb7cbdc4b7c968f1ec493a1791ed91dc435"}, "e84abbec-d22f-41ea-9b98-807ba9ecc40a": {"doc_hash": "48a24b4cde34546705bd2dcd2b80196209b609ac0794f596ac65a38f61f097f4"}, "18b64455-6332-49ab-9827-1f0737061d77": {"doc_hash": "725fc494bac74b71071a44ea6ab982cc7e0856eed0d582d97cf604100f9df006"}, "ba275713-5ed4-4998-ae30-e6c7c907d010": {"doc_hash": "7262faa76d78868a4fa1798228cf5f9ad9768e395d901656abdf11eacd5ce46a"}, "c29cde0f-500a-436d-b4cf-ba2cea602e2b": {"doc_hash": "27c4dc604a5a85300f2aa21c15d2bf3e86e72680d5c2661d06ab31028391fc54"}, "aefbd97e-0df7-492f-8b63-46cce30bbc67": {"doc_hash": "e9be3bb70f1358daeb24df906958e8c825d4a484111c41228d915bf552870403"}, "68bbc07e-2bff-444b-9669-da38603e38c3": {"doc_hash": "70487b421d075886699be386f87a854ead9683888d9ca7a5c135ac8d54c37ada"}, "1d329a1e-0703-4833-99fb-677b52c7c2df": {"doc_hash": "95b5d390a7d398f2c1ee705b65bc1a90daa6672973daddaf5d288d97318bed77"}, "f5f941f3-33c1-4129-b048-86958c4ce59f": {"doc_hash": "d7d3d84f29030d7419c9f7a97859a054d20a881d066b9a7489fc232d668806cc"}, "bd32f1cc-9490-4fdf-a7f9-af9c8727de96": {"doc_hash": "55585bb1bd67bed8df5c53341a5db409f4922dad07bac42f803be83781bfb5de"}, "889cd50e-629c-4ca0-a8d5-0fd3e5725da8": {"doc_hash": "f7e23e0d07091595b9babae415e74380c145189db11675a30c699c7dd382598c"}, "e4211359-7d89-4f16-a277-172fc2824132": {"doc_hash": "894f287891bf3843e272fd3eda6ffd762bc49019177dd2e7d340e406cf857137"}, "e18d9d14-5d55-4e48-9694-9c345ca4c553": {"doc_hash": "1d4402fa1a1f2d2e2b11e91717de1ad439b81db895f5729f4edfd30781cada58"}, "091ec803-2613-4a04-bd73-56767fd6700d": {"doc_hash": "533af6d345025a34986245cc054469520e6faf0e0ff174515aca46a908554766"}, "30a60ecd-2d11-43ae-b311-b812c138845d": {"doc_hash": "d597de737a2dbd89f8a1b13146f0681f3ed2a20313174b75cf1bcb902492174b"}, "665f4910-425a-4a19-80e3-3ee30f9af373": {"doc_hash": "088494e682c28be9dbc411a3cf4e6e76b8af884d79e8bfaaff3b40485f40859a"}, "8a98ee00-4caf-4f06-ae25-e4dbc0edd485": {"doc_hash": "94e233ed698752727fe1952b837c12febba354305294f4ec8e2d8d8e01bdd5f8"}, "751589dd-2e81-4c07-9036-3f2bd12521c8": {"doc_hash": "834b05797f2fc801b19be8093dfa5ed1d7fd4e598cf6774045730abc0ed1f4ee"}, "abd0c72c-4a87-47ca-bd66-66ba21d56103": {"doc_hash": "aaf17115ce40d2fd8a355fd2cc9befd9c7a14664db2c5cd1918579c31f5e20ea"}, "39d1ae6e-aa3d-499c-9e51-56bb223f7d48": {"doc_hash": "4382dc3acf419e8750c1470f19e73a26883d932ffd0bc2262718ae685f03cc9b"}, "1f4943a8-9181-4030-aed5-6d8c2537c119": {"doc_hash": "2291a645c21a4dda4dc7a55ba412307f2d54f9cce378851d0578be299701ee76"}, "d7f47c7f-3166-4fd7-be4a-0536779e410f": {"doc_hash": "48a24b4cde34546705bd2dcd2b80196209b609ac0794f596ac65a38f61f097f4"}, "5c855c94-1d62-4907-84c6-71f7a45fa42a": {"doc_hash": "708ffeb254a4c5a6eb621c6b12e49392306e5b7a0af24287a72f18a0950b5a52"}, "c75d8b1d-2bd0-4d16-97c2-86ddee171fcb": {"doc_hash": "a0387f7758bd0b8297fe6c8d56c59ec92d560f7c16dca2d08d7a29d4e8c8f9af"}, "403c7a90-f672-476a-805a-30ffcffc9ac4": {"doc_hash": "89445202579b00aed3d1f44dee83f7e55db56acea8ff2c74c9335ade3ff7c2ed"}, "4c7d94f0-0b39-4907-adf6-198ca9f103ef": {"doc_hash": "e91894908efdb802491284a128126d122173120ca535c78384a0b2452bb2bc59"}, "fd7c1274-1898-4c64-be35-3330e31dbd2d": {"doc_hash": "9f25b5dfa38bbd9fb286ab92a54fdecfe53a41509ad662fa5a78a060cadc0d5d"}, "53ec4ed4-b3c8-4993-a3bb-b1d829bcbbc5": {"doc_hash": "2fe2a1b7b5ca910f5588c34ebc40173ec7c20b725e344b88ebb23b6f02823ca1"}, "6ed45376-0993-4862-80ff-81bbc9430f32": {"doc_hash": "86d467d735f8d23a7ba9b3f08a9ab58e2c51b6e44b545052c4a02dd75b802f16"}, "662e1f61-bdc1-4564-b941-fd74ebfd115d": {"doc_hash": "8bed0f0cafb0a2492277993c4a1ed8efeb8db4ce0e812012cc9d7d7148759ba9"}, "27799c77-1c88-4b19-913a-be1a43e96d5e": {"doc_hash": "5f3a6a1fb9baed030d83787799ab3701902c4952bea9fee347890e31941ae134"}, "31932e3a-b7b8-41ec-8d9d-5733fd7da724": {"doc_hash": "38d46397158d866d56f0c94a0aaf4cff9e5020c1cbfc2bbee3592f3ba706143b"}, "84e7383c-40d5-443a-94a7-5a7bcf59e66c": {"doc_hash": "d55f0451279b2492e271a30e29c23f67dd3ecc84af30fd144a11b298e28735de"}, "2fe1d8c2-5a5c-4ead-91b0-051b3b1c6c9e": {"doc_hash": "73090eaa955135134b8081958ff8d2ca146c595896dff7d3ee852fe83b1812e8"}, "8bfcac68-b6a3-4f3f-aa57-c4871b18cd8e": {"doc_hash": "ddaade98320c299df693bc98c78d2d75b6755854d89d5b44ead83e726de4fdc6"}, "1de97efb-4656-4e94-95e6-478e452fe11b": {"doc_hash": "5655ba4b981294a0698539ac568514a598fc0536644dd56e5289f6303a999ee0"}, "a49a2160-6510-49d7-a44e-318221aa98eb": {"doc_hash": "ebf37add24cd0e49d6c5265c12c05d50520766f877fc4273b7f11b23ff182b2d"}, "2fe85357-3333-462e-8bfb-86fd13130c4c": {"doc_hash": "5c4a1eacdc50b757d33270a4c939735979d28ad878b439aed1113542f0e6e9ce"}, "2761301d-6f02-4aa5-be7a-e8f7ef1c9123": {"doc_hash": "3b4508201f4500778f85219e3b6ad479818e0f445b9237e6e541f0b6acd7060c"}, "5b01e8da-cdf8-498c-97be-d7fec3306a22": {"doc_hash": "98e6aef587d5024d984cac0ad20ec6bdb1f7ac913e815e8f0192656b54762d8f"}, "84db34e3-f7a7-40ea-aa21-a25df08d2118": {"doc_hash": "f1fd20989243f40b5fc25a9089e9e2f8f75020d80f0652fef4dc741a190552bb"}, "8c64ef8d-0cef-4420-b875-ed74ca20af63": {"doc_hash": "f6035251aafd43f9fc0129615f4a9338d7bede259d4087b0d6d509b678ebeb0c"}, "e1bc2c2b-2118-407b-bdbe-c5cebae82411": {"doc_hash": "48cd68957fd3839a47f1b3ae5fee2e43cd2822b7908ae036d442d3e1b51dedc6"}, "6faff7ed-f9fe-416d-b93b-66ff57602eea": {"doc_hash": "f11885197299eb0df978892fc4b10ea3731b2bdb51884bb39ff1649562aa9e2c"}, "5d51fdf4-b97f-4932-9aeb-12a44a11ad9e": {"doc_hash": "cbe3d7a2977929b5f34368620ad4757ae54cdc824dbfd9b924516bf6e287f3fb"}, "7b1bcf56-e8a1-4d60-858d-873a215c8797": {"doc_hash": "80931861d5bdcd8922c332e2b136e699fe91e11e534529ae282a642af3726052"}, "6f5f8819-8c97-4618-8c22-231e7a63b9e9": {"doc_hash": "f2d261af0a8728bee0498dd33c88a0727fc8579a5c84e13333cea25a4d76cb92"}, "6a9f4369-38b1-4b58-96c9-53477b30e0d0": {"doc_hash": "0b2153ec23130454484b42af7033a1be99a3f2783fbc713bd619ac01b72b697d"}, "0976cd84-8c3b-44fe-b76c-79d43a093462": {"doc_hash": "e3d36e6219363ffc0643fc1acdde68f884979c48bf65a3d1293b8d451aa4651e"}, "1632a9d5-d901-414b-9f23-4d288dcbe667": {"doc_hash": "3353947ff1ed2ce58892b12996cdb8d88cc5406d6c2c0f695c94c57bfdb05639"}, "cbc9625c-b832-4841-9f4a-79d7ef4eb00a": {"doc_hash": "5001356a739b8e79cd7e2a75bb68a481d3d6eecae26d825e234791eb1b607141"}, "53c38a42-adeb-4cba-9f02-fce031194822": {"doc_hash": "eb1f9c0cf5a9823eda7754669f22bc8ac6827047fe6ad1d8a4fb5eebb7fd75c8"}, "ab3afd9f-61b9-4672-a80f-7929b53381a5": {"doc_hash": "b53e579e773d5edd49a0a49b5e893dea6060adeea4b40ef212fa1dacefc32e0d"}, "8562775b-0cc5-4cfe-b91b-c570ebd28d69": {"doc_hash": "2e4a6efb5892d00dfc0d8adccaf44b8521bd628a2c326505f4dde24c408f07dd"}, "0f7cc04c-c62f-4a04-8b8e-5fcafe22108f": {"doc_hash": "2e4f3d3231043a0a4f42d852993a51dc6391fbce362e5cd0647b7a41649c5198"}, "6181ad41-099c-4f46-bc34-22c438fb9110": {"doc_hash": "5366adf4cf998e084420d14e52c7884194a799512cf05c2b52b4e77d20595330"}, "6bc4fb2e-ff80-4ba2-9cdb-c4b48fb96cc8": {"doc_hash": "4382dc3acf419e8750c1470f19e73a26883d932ffd0bc2262718ae685f03cc9b"}, "219dd4f0-169b-4eb3-aed1-a1c071bd2e81": {"doc_hash": "baa4dd3ddf33b3713c87260206410b02a27c0b02e8f754574c1540461456f94c"}, "8bdd227f-6d71-496d-beea-90ccbaf24cd1": {"doc_hash": "1f54685ead873938fc0fbc903877b92a83e18ebc01833435826a8849ed46b2ca"}, "6bcc1e8c-952b-4fe2-a07c-60f677d54836": {"doc_hash": "bc08542b1af04b0bf25b1c36361ee86ac5ac71783f095db4d1d99917c8226a3d"}, "814542d0-a943-45c8-8b7f-17312ea9f32c": {"doc_hash": "6ca0886ce7050ef02209b302422001240e397af797a9b2ea756ca555d764dba8"}, "d94d010b-1367-42f0-86a1-a31e8489c1d1": {"doc_hash": "cc9ff7157a8ca43e3c066a62c15eee1ed1b2c8379c2a0319f9957bf555755206"}, "56b566c1-7e01-4dad-8f70-08e80810707c": {"doc_hash": "15df3149f8bc8b2b761d6379e6001c18e5febd8b6bee7d85ae455d0ca6d25f03"}, "93f90cd7-76ce-468e-9609-829ed002d25a": {"doc_hash": "e20c9ef180b3f171ad513c5ddcae20b346f59019f62fcfd9adcdb71697265e9b"}, "c87ef109-5034-45a5-817b-5b7089cf2be8": {"doc_hash": "c9501d2793d2a7bfa90a03b3a6b8fa3d5918856305e021f63448d7b99049387d"}, "98a71733-3765-4d3f-941f-0d0c73e1436a": {"doc_hash": "87ebaf3e51855ffc3d8b37ad569b586bbffd756b6022824b8938a67517eea9c0"}, "026288bc-f373-4e0f-a2fc-fff67d7d0d65": {"doc_hash": "e7fcd24bbb086ee5feb33490c78bf571d11ee68763ceaa05429be1bf6a40a4e9"}, "0fa70009-c74f-452a-827d-e23cef0a4264": {"doc_hash": "d25a1ac1486728e96692806ccce1ef968764f9e8851fb4eb8ad14d6ee310e761"}, "a22d8d37-6647-4f99-905a-802fb2dada39": {"doc_hash": "1068e3e4e50aeb3d85d30b2c63243f5da72c44dfc6cd4be5a41828fb2e1643c7"}, "3f4f69cc-dbda-4249-8138-4b543a63dbe9": {"doc_hash": "6c80e9b2c13f550aabcaa771956d11b66b6e6b91cd3fde3399a95a1a675a574f"}, "b037187b-168e-47a0-a234-40424e837049": {"doc_hash": "63df13819e2e16425eea636aa615490fad9e8dec6bc70423faa8d8b3e6a871e6"}, "e190678b-93a7-4aba-bc84-dc2e3d026831": {"doc_hash": "e096e08c15351cc37c6cf3e623ad19ed3910b8426fa74cf96aa1204f59249fbd"}, "67dde4f9-e0a7-4bb0-b2d9-cacb212fad75": {"doc_hash": "e624bba8faa851f6e1ad8baaae168376c5c74b468b7fb9f74660e477a63b4e17"}, "e672f2b1-52e9-466d-b00e-8971b3239a2e": {"doc_hash": "d6c8430bfba1c37365fb83ead9d739370ff3c0ee71c32da6dd5f37c803ef9b7c"}, "cb1885e7-5557-4608-9163-5cf17eb20ac2": {"doc_hash": "910cb33b3e13f2641fa9db1d6cfa2d7d877886c486ad9562c2cc2604cf048f4e"}, "48e2f4cc-40df-435b-b25d-966a29140255": {"doc_hash": "bb1567804f8e70435347fb51c1d39b784604a652248fe9ab298c31cd1e367bdc"}, "8c924ce5-dbc9-47cc-85fa-b5415399c7bb": {"doc_hash": "93ca99d0839314bdf83058a7fd4efb7429d6c01cae0e357407ce4f3b056df2dd"}, "fa9d4ee3-efef-4660-969f-0e664b9e7965": {"doc_hash": "b91c13e7e5a3b2e21a1ff5c75cae1a5a024583addd3747d4350a78f40d094452"}, "8b664315-0da8-477f-b771-ded25b832a1f": {"doc_hash": "ddd503704d56ee2abf95e380aa94a76edd8497a495ff577893188215e45d9269"}, "43d0a6c4-1751-43c4-9a86-0081f573b732": {"doc_hash": "1762f72cea1e5902ec4c782ee607de9c190ca9eb141daeeb9ec388301f80f915"}, "08ca0299-2d3b-4d06-a6e4-e38785018b19": {"doc_hash": "6b50fc9df86eea08b32bc1c9a576482dc11a2f1c07c22c670fcb12995ae5bcf3"}, "41760108-e91e-4910-a3b0-abd0a5074054": {"doc_hash": "5e95bb23be42080cccab02ccc6416e9a7726b7cc47cfef2edc943037be670702"}, "b4fd54f1-65b3-4753-b6bb-ba929903a383": {"doc_hash": "bf7f1f4a497dfdde9621101d9b701c104e7e05d645d86b107d1838cae534a7f0"}, "5091eaca-5116-4288-a894-e579c77ce2f2": {"doc_hash": "534c23fc54366ecd4d837d26704eec8efb07f307d5ebdd9742e814389cc6160c"}, "b495504f-99f2-4f00-8289-e132287648eb": {"doc_hash": "45b42e9be17685302c8e5b9f6ba3e76f269fc45be604637d9e085d9b5fdfddb3"}, "ce38c990-8ff4-48cc-ad74-b1716523ee85": {"doc_hash": "d7fca937390da4cc808d40233f9c6c70ce358cd0f6954543e5ab81deb2872d5a"}, "54ab014f-1bc1-4451-967a-3a09aa3d6682": {"doc_hash": "217959e43fb1e28b191125ff1d9e5921436d365a34d023ec1eb120bc5ef34f80"}, "1e93cd10-201f-4094-bbce-8f55d589895c": {"doc_hash": "1bbe6874dc4bf58efdb946ffd41a92a32da75a7d6ba71996419a319ab849dc14"}, "d8a38b2a-6d9d-4ab1-9448-8bc2d106f785": {"doc_hash": "8ebd8617e0311cbed4c12540cdb3d447b9ca31099e35ece7995df068ada8de63"}, "c54999e7-a083-46f1-8977-cba0591d7b82": {"doc_hash": "a6425d0d9418e9768bf8befb14a1b82d83827d6d030fc8d1af5591ea8ac72876"}, "08ba7508-b6cc-4a57-9273-e78e7bc33d38": {"doc_hash": "b3bf8a2cdb676b2f824c4473dd0bf10971338b4ed51bddc6311e8128118d817c"}, "3ca03a1f-4216-4d0d-a111-7f9ac455d319": {"doc_hash": "edb0941ddca0583aa56cbfebd4fbe050082170215d44b401a9526dbe3aa85c0e"}, "9c0dc66a-4a2f-4e60-bc3b-55ffa499c387": {"doc_hash": "4eeae9083e46a95eacd7f30889e0f81fa07216940beec55ee8a3811cb1500680"}, "e49a5757-2aaa-42ca-9ecc-92280809f8f9": {"doc_hash": "a508c987f8828d178302b235bb60b4ef51fb14490da5e4e2268dbd007c3c0fa8"}, "4b99f63e-c492-4cb2-b40e-72d8d78aa5e3": {"doc_hash": "c751161d2c4a2d06543746470aece70d3850755b2c05027508ddef27ee9a22f4"}, "a68ed2a5-faa4-4695-ad41-30c66ac6865e": {"doc_hash": "fb1a82275a9f8cc35bcc1693c85cbcce4c9f07171b6a58f2a81bca9aa537d403"}, "871c5359-e2cf-45f5-b029-325a1695579c": {"doc_hash": "d37dbe90d6d67b558dfcfde6939ec63df98bb0d96b2c6ad9efc2e32fc939d9a7"}, "0c17d98a-ad42-406e-ba96-b074716ece41": {"doc_hash": "16492301115fed4e4139c31b9a2aad9d37bb2d2ee832bb25e7a290af78580625"}, "396f56a4-7757-4959-adaf-5ce628011ea2": {"doc_hash": "48a24b4cde34546705bd2dcd2b80196209b609ac0794f596ac65a38f61f097f4"}, "28cb1650-ce1b-4752-bf3b-5374d5a0c862": {"doc_hash": "2a0d3ba9b7a22a0e1624d4830284a66c1ed87537acaaf9313a00433d1c0368a5"}, "b16f0d93-7d87-4f19-9ab2-efdc2f07508a": {"doc_hash": "a1f10dac50db6490a5a6271003442dc68cf0c440c3a35d9ccb3334b04de86276"}, "36606f32-0c53-471f-9449-c6c88bd25c55": {"doc_hash": "84016eb4c7a9b5bcbf2184464d839af461a6921a9a4458f7015e80ce91544739"}, "de452f0f-b7ca-4fef-9cb2-d1100b0820e1": {"doc_hash": "58368a4406a0dc4a69f8b31f54e35fc19dfd9bdd9231c6dbcb5e478f4cedae4f"}, "f96687e2-8b36-42ed-89aa-043031f280fb": {"doc_hash": "1eb9d095b64511c254e46b3535eaeb4d31ac8efcb268129ff6a7f72079924dc6"}, "114209dd-c3f0-4c23-952a-2eb3841c4e0f": {"doc_hash": "36734fe536498107e974e7796cedb3466d0534ab259f4cab400aa31e8364960e"}, "c92d7b7d-d307-40c5-9463-4201f68950c7": {"doc_hash": "ea9c9ac9dca546c22a707695f05ba2ecd5bf978a38fd32fc01f3c89a57740a04"}, "bb6c8e65-ce9c-4bcb-89f3-3fcbc085e6d9": {"doc_hash": "bf97d7e7f50509e417f29c21496035c0d46d4f5a14830a0c578d604f696a500d"}, "199dc43a-fa99-416f-9f9a-dca34492d54b": {"doc_hash": "328531c49ed55b3d7822092f63fcbfe0ec0ca308ea5c78cd765dcde84e8c9a0c"}, "a194c74a-dee7-4eb3-b608-20799ce20975": {"doc_hash": "9bc2774581253b2e3fb860be9cf33034bfd999b2bfd718650cdf754f9ef828b3"}, "5c480dc4-f289-4b8d-a582-b69db29fcbc6": {"doc_hash": "619951cda33a982784dd43c8588e3569a4e79584692cb5c45629a530691bcd34"}, "be16816a-89f7-4570-adb0-cb6bc4aa1929": {"doc_hash": "4bb2d35be0bc5d6848b9b261e6d4813477483946b59cb565168b6b25ee07f626"}, "eed48874-0ca6-4536-b38d-3ac2b5459f23": {"doc_hash": "ca4e747f3f0eda6a62bfe36ec469e93c59b4ce3249f35812ca875735f8f8e9b1"}, "bcaee994-c85e-4a0b-b683-c8650ef622bd": {"doc_hash": "1906ece24181b71e849615dada8a1770f27ff309da26f0e24b0076d9de6708d9"}, "fd74c8ba-c371-4b34-a41b-11dcd76beec1": {"doc_hash": "e0a5707076d524662cf587c6c08a3f6fcd67ef2b13cf308c02953954dcc28021"}, "aa1dc9d5-9637-4cad-8683-0d3b78b6a5f3": {"doc_hash": "e2d09ec5a99cda8e5fb4758d85f29560822ec8cbbdac8beeca45970b5a37a9fe"}, "29fed515-9919-45b0-b19f-c438861dd2c1": {"doc_hash": "f5d07f35db049c74114580a2667556284d3c19800df5cf4ac0ea72099e880f70"}, "06ba733b-9eb8-48f4-a13d-2712d158fbbc": {"doc_hash": "4d320728e141e032d0bc2a35e7ce55db0762b4b587cabeb41ab0f33fb507374e"}, "508f3977-f5b5-4d30-b48a-cd0b28b9648c": {"doc_hash": "a25e64a72d5953e8d1728bf58af51ba48a09804f9703b0d63af05602ddbe4a7b"}, "a6c54a9a-220e-4a7e-b4ba-db36984ed438": {"doc_hash": "2cf6217addd9a41f038ee1a689f0ae16e35679911b04c2deb3755588696d83fc"}, "75145522-13df-486d-9407-fcb25dbc61c9": {"doc_hash": "ab239d692ae0b82c7f74fbd66bb036ef4e9e4bdf0a16d9fa502efe4b8266d92f"}, "249e5398-ad37-4e63-b758-6ad6581a4ec1": {"doc_hash": "04341b7d4b7a460bf370244ceda2eab4cfadfb94f499293993c7b5245563a266"}, "1393e96d-5672-4c1f-964c-1bf711a54242": {"doc_hash": "4bc3654fa32635860fcbcc1b67957d6bc562b2919be7a2ce84f7ab56b3effbf9"}, "b5efe434-5d4a-4b07-863a-78270ede227a": {"doc_hash": "a318baef34f7d83e6143ee096ce780e8d1e3bdc878f7878e8c9e725f62cc7a27"}, "b68f706a-4896-4b7e-ab61-53d9c369c487": {"doc_hash": "caeb006993d953bb2e62e5d3c89afc8d99f5ae409f7bb6a7d1df3f1f02baa5eb"}, "d5fcdfed-41f5-4f2d-a2e2-1089c0fac632": {"doc_hash": "1255b8d174ae07b92185dbea29e2e2ca83aa5f6bcc3481ce9c76437b7d22760f"}, "cb1d5f08-8e88-4fa9-aba4-8f8914f57612": {"doc_hash": "e3061a28d89674ba6a4a32fbed1605d9dffbf62c4b0f1b156c10b947fa3b6f04"}, "2f875451-b71b-41f1-abab-d58e1f8b87f7": {"doc_hash": "8e332837518cab987e63c5ac8e69b7c564a9c728a2d5b335b0591fcae1c83fa3"}, "56154760-10c7-47a4-8a8c-1d1b2e68a24c": {"doc_hash": "3c7b326de4573dcc0fb5245d24377110211396b9999d0fe74b4843e07cc6fa44"}, "372234ac-74c6-4632-ac11-6d73f036cd2c": {"doc_hash": "6e7916a46c9e5c6e2cba2d368cf198679b21a0ddc0f535eb1d95747806d229fd"}, "e6d60321-b32b-46a7-9192-011c10f3b05a": {"doc_hash": "3016793145b61253c1c49412dc781b38023d56f442e5ca608f8cd4a6ec83f991"}, "7eac9f2b-9698-48b3-b65f-869b28114dd3": {"doc_hash": "2b07558cb0d3c9bc3bf7ebed2440076fb8b891169e6a8f6b23871b17877761f3"}, "030c4b85-035d-4b57-a196-dec5b10f3dc2": {"doc_hash": "ea943388e97fabc84917b70d56e1aaafe3100233a7fc4b34c1646f43d31b51dd"}, "02c64c2b-2d3a-4ff4-b647-6582aa1bd20d": {"doc_hash": "18fec1e268eae7b2adf847c03f8ec50a4c15b7452af4fca48cdf3ea8ec35c861"}, "bbf1da6a-2921-4a4e-955c-33ce1ef6f3ec": {"doc_hash": "409bc8f24cc7b2cdbb23f7a186fdfa95de004ac4817952f5bb5baadf9a7bf31f"}, "2ddd6854-53df-486c-b20c-9061691d57e6": {"doc_hash": "b33cfe24dc548a10162e8ad4e178996c9ff0cd335de18e77ef1894015d8fb794"}, "b35bf376-96d7-457a-8501-d8ab87a56741": {"doc_hash": "9056337a78bd6cd413584f6046cd0bf3cc77b6f1d85a612ca73939fc05c25fec"}, "7cea3a13-0def-4e49-bbed-d0df8dc4e13e": {"doc_hash": "151cae36a9f33750ef913cd88ad20bc25106be7e66255fa79875b56e514630aa"}, "4b32e8ce-2449-497e-8b28-3b08c60d4005": {"doc_hash": "bf8dca0827de504cc56de3095bca374fa30f0590977a7ccf1d972615616284c0"}, "2b3e6e4e-593b-4b70-9fc4-ff01a1cf338f": {"doc_hash": "c6799a38a967a9ade9ef8129811dc4a876d7ce873b5bb6b567c3d27b18c1b032"}, "2b2be256-a302-4ad1-97cd-3bf2f4e7157a": {"doc_hash": "df10432efe635ef617699c6bbdf02e67f25bb8fb85d566286ed477174ff21204"}, "9906c64e-7aa8-42cd-8ea6-4df35ba83ca9": {"doc_hash": "f353d0fe24e63569171dce7392406f236fe7ee91a94c17325f20fa80f77b93e2"}, "b34325f6-4d87-4ee5-918a-ab92adba3181": {"doc_hash": "a0fcf4af5d2cd6c0fe1fec93e251596326fb3708c09cbd42820fc69d13d13342"}, "e6494872-b79c-43bd-ad90-496a4276dc0f": {"doc_hash": "85e59f071c191154fe25246b5c0e07fb4603ae4df0c4cb01a45c1c98a8ff11e4"}, "1699a1e2-f7eb-4715-91b2-76171e32e8d9": {"doc_hash": "b738f30b38cf34a7337c66f8fbcc6f2b5ef2ea0e8313c9758188d44107779e5d"}, "2e89285d-cd67-438a-a1c6-cd37dad1ddaa": {"doc_hash": "bf2d6d10006b0c17b36769df02d92d1bf440785b09a648ac440f767140a4dcd2"}, "2177da75-a3c9-4dd7-91c7-396eff74e80e": {"doc_hash": "fad6ceae468b788a31f19cd13bd3b6c35783a4149d665562cf274e430d83df7c"}, "8acc95f1-80e7-4628-8f6e-f3a072acf140": {"doc_hash": "7a9ca3ea8079d5f39ccdb1d463d2155ec51a4f1fb9a67520b70b4159eae9aaab"}, "faed7418-4f49-477d-9c3e-6735993d8d1c": {"doc_hash": "dabab3d99e1b9306f216ec04c85d417ffe00b37f43eec1f2067c6742fa834caf"}, "aba80f52-0638-4bcd-ae24-ef59f7531a5a": {"doc_hash": "23559e37a8f853ab38a0c09f9ca98e629dcd075494083e952f854b92a0d9df5b"}, "0364ed87-108a-43a2-8955-ff5f81d645c9": {"doc_hash": "a825d5fb921eb8a4a45980ffd1fbcaaef5996338b300e4275a246f76c334cf86"}, "ebf888b7-020e-4ebc-8c44-4fa407b3ad71": {"doc_hash": "1f7d187491bd7c6b6d1e19561218f5a96b530cb84f51352da0fd84804b852e79"}, "c035b128-3007-4740-bdbd-52378a31b460": {"doc_hash": "c38f6422e54e2abf5f061b37ef7e2de938c397b61e25cc5831a607b8e8afa962"}, "d257ddfa-46b0-4265-ba8d-1e0ca181ff05": {"doc_hash": "142a5aa9968f7cde418002f11f65819f3b2f13b1d69f034a3d00ec5d27dca209"}, "4aa28399-d79d-4307-9ac0-887ee43f9917": {"doc_hash": "47ce4ccb2e2ab03cf96f12624c248621caa8b9000b67785883a8a8277b01f51a"}, "f4b1972e-8a52-466f-8256-3cc01a6214d3": {"doc_hash": "5d52cea7a0ae3639b5eecc4d5a2bdfcc2f025c7fe25f33db11f673a6d7f6d51e"}, "61654af1-2de7-4da1-b49f-1e66dc467aaa": {"doc_hash": "e7aa633363377b2c36ac6a097ea49642badbd04a4586e6afe50cc4d94caf112d"}, "8c3ae60d-c0bc-4932-ac62-f612bfe01745": {"doc_hash": "d4477925af0e29a451d98ba82b24312ad8327c6062ae2098a2875cc74cfd7d04"}, "502271a1-a919-4ec7-affa-60086b96a7ab": {"doc_hash": "8e920086d99005fb3d35aa0eb9ffcef1d2585d165ce621aa873ddb07370226cf"}, "a66bc89b-3d68-4032-9d33-844381ab7fc9": {"doc_hash": "a08dc7a6d0433a8805235c4c538491e8cbfa04e4236db537ea70c5864b24e27b"}, "af3149a5-22ae-4a37-ba9f-0daa7bbc7c9a": {"doc_hash": "dbe88df6e8810c1d033591b34ee265157f8f20277ff7d1299c8bed28cfd46cd8"}, "a927777f-51d0-4918-8821-d113c1d616d7": {"doc_hash": "17613e1131213e1e459978aee8e6bc93b197891d3e1d52fcafcbf8469f5b0194"}, "5f22d32e-7a05-4666-b5cc-c88670289cf3": {"doc_hash": "5a19709634fc628baf7cc42d61acf539f3b671664f70305d74e35092cf9809ca"}, "d47d6206-7aaa-4c46-8625-b71dccccdec8": {"doc_hash": "87d81b371c1f9425a85103b5ef96a81b31ff4d145317ad8a33be2f968ba45929"}, "0b5699da-3e53-4075-a884-940130781bb7": {"doc_hash": "f5165885f077b6a2664482ccc221ad940c0c3df1388188b067e2bdd8cd727fda"}, "20abdebd-3ed0-4cf4-9010-71bef0421e85": {"doc_hash": "f5e79cca2a8642cce359fda13906f1b59c09b6b2e1391aa762ab4a722b1088fe"}, "117e59b5-8898-494a-89fd-b035f81d68c3": {"doc_hash": "3ec1500b16708dd52ecc204c37fe6a11e1e6e80228a33db8db93d10832701a3b"}, "24ddcc1f-2a82-447b-98bd-29f38e00ba24": {"doc_hash": "023ca793cb62b4833bab694c2965b74e4f6cafc318631a1a7b4010c97f1e1af4"}, "db0c8ecf-f252-41fd-bf90-2a2f2f45d1b4": {"doc_hash": "f1f74d06f5acd5d3eddd633d0e02a173ab4a48c7d62108cbe6061f0716092ab9"}, "9d2c51f3-1f65-43c3-848d-7b8c9aaaae30": {"doc_hash": "cc392b363fd1199bae5da9ffbd447b4e283741492fafa676c528f759d5871edb"}, "6f332ede-25c7-4902-99ad-dde39eb3623a": {"doc_hash": "bc11d45b3d91a90100230b8eb60e66def73393be43304cee132dd39ecfd8b521"}, "de77d731-5d31-480e-9b02-e0a148e6f2fa": {"doc_hash": "369d961713730e3111f4d5c7ce1081086a341694abb1c3665f2fa64d4604f2e3"}, "c0a248b4-1429-412f-85a2-7cfb4f97a35b": {"doc_hash": "ce0671e4f20d45cd360641f99cc98770027e15b7da4a50f8f0a290cf03621df1"}, "8a8e756c-7d2f-4aef-acde-8abe31a85285": {"doc_hash": "fb718a36f1488fc3a16c8e8de0318db6ec0e0ad1ba9f658c7cdd2d67b2b09976"}, "7aae59f0-f6c5-4c31-b9d6-1818fe4caae7": {"doc_hash": "6866b9e1e4e70ac8d4d05779267af8eed3ae92ab66797deeaedf320a6141c5f5"}, "c3c57cfa-80cc-475a-873d-e9c090506352": {"doc_hash": "1dc4209822ae9217b70860b6a1bf849f98312ed2bac078e4b254bc67f08903d8"}, "c3f6d652-1d3a-4011-8345-7b43154d447b": {"doc_hash": "7e1aafbf0789e0fd3c9ad0a07211615a317cd92d0c38948279a3cfb324abae1a"}, "214c2c80-da52-4e5e-9eca-340ef182e59b": {"doc_hash": "8ed86d3825a5882a36b364d7ef2b2e3b004ff803a71a812507fa34ecfa967ab2"}, "0a5a8146-d989-43db-bd13-071849a61dc8": {"doc_hash": "8ce904af98697ded4913e4297d5ddf693319657de4cdb403d4e83947d68f68be"}, "7f614e04-4bd3-451c-b88f-18d4b1281776": {"doc_hash": "41987cf0f17c63a630334256375496cb7bdc124f14f5ccc106d881d65ffcdaeb"}, "8129796e-03bd-4f17-8048-43e90ad8ecdb": {"doc_hash": "9611e5ed9cc24ff9e3385e19ca513ab7502f411c3f852905667093801fdf22b3"}, "011d93b2-f660-4c2c-9eb3-4bff2c1c2889": {"doc_hash": "4e74494f67d4752cb46778d4a18741fc39f4fa427318524e87d2d1f681244bc9"}, "12a1ccb9-4cd9-401e-b78a-284992d075b3": {"doc_hash": "04f6ff1d897e99c35c4a0f26c6472f394015c7f040de5e5077d6f4533082ef07"}, "14633116-3be4-49c1-ac2a-af6833fb77e8": {"doc_hash": "409f0e6a5bbcdd5783ec9d25f3a2d588e22dec003bda6029f467ee21abcac5b7"}, "384ee793-8cfc-4eef-bb78-2279591ec169": {"doc_hash": "e3f8fed11e2f91283fdf7dfd30e6c36514b043669c62792fbf02fdd7920cc341"}, "8eacd4ca-96bd-4d7a-ae66-84fcfa82fecf": {"doc_hash": "2a90ac01dd99b6f1eb113a0ea20833e761d62b7f315f57b4569704c82dd12cff"}, "4cfc7e19-b986-47ac-8230-1fe5c89a1d7c": {"doc_hash": "b6cebb8a809a4ddd69d5c460b36e79d1ce815cbe737836300a4058433ab4d7f9"}, "e716e14b-1b53-4a73-a2b1-59a959495c1f": {"doc_hash": "8c852baafae725122d927ece0d915a6b1c11ba84623ba87655c0294eaf5c43d5"}, "f5decd1b-4ffa-446c-8671-1cb14dd17f5d": {"doc_hash": "ee09beae01873eb1ec101225af01877eee975bcf221b7f775560821d37d08721"}, "45ee9676-4042-413c-a5c2-9739ae78450c": {"doc_hash": "1b746c846b5d71d375882fd4107de96141a3c8a79e11838a5e156e905ae64639"}, "aa63fe36-66ab-4604-a512-1a24bf9efddf": {"doc_hash": "4c2feb87359baf86b0b3c30b48467866014b5581e6d09527cc3dbf83d579fd11"}, "7e66a00c-9e2b-43ba-9963-7d9dc0c0e8f0": {"doc_hash": "cebab36555f95b01c8b91a02253cf8babe8936ee57945ac92a58a27fceb4fc3e"}, "091195b6-77f7-4c41-9a95-d2e7458e1454": {"doc_hash": "e1c081e30d3bfdb651e4bcc2e5560cf1c38bdf658a1df1ad4ae82d4da6c17979"}, "b5c8f1fa-1d35-4434-aef9-5a73150765fc": {"doc_hash": "993764522384772f51f0fec10e97a40cfefb54ae261433ed669fda59162fdc3f"}, "8d8847a0-8a60-4d44-a48c-cfe9a329fced": {"doc_hash": "2f7bf8ebe5a497a7bf61b94a25278748fbd1ce770f198aa87d7ee04b98fb280c"}, "847cc523-ad0a-430e-9a4d-10c322d69765": {"doc_hash": "04c2c9bb0866d670c9bcaf9691a64d41dc6868d681ff305235916a49558f63ce"}, "806ed290-062f-49b7-babd-019a18c3718d": {"doc_hash": "cc341207fc630d904d611540cb49098ccf7021d33de6a2cdfbdc67ed0d73633e"}, "c43957d4-d1c4-483d-9617-f253fd4ce501": {"doc_hash": "0398d8c091110607b3b81c784431afe823ce4860ebb1efb211e641e84f09490e"}, "8cc7038e-4a92-4545-9eae-b44d918c4034": {"doc_hash": "e9e0619c6eb53577a18ca05be7358faa3ca3df4dbbd2b264d30ff15f9650576c"}, "2ba33c6f-138c-497a-8c34-2e26dcee99d8": {"doc_hash": "3176b63e65ef55bc6f4c92bc34e40c15ecbf41d0c58858df16583e30450734e2"}, "b6e75d96-528d-4876-98cb-3bb412d062e3": {"doc_hash": "1404045710350326c5010e4330e1d6942045127293056577b6ce83e2bd2e78aa"}, "2add9834-e099-46b5-92e6-1bf112a8c8e2": {"doc_hash": "53ef477bcd7889d4a093a9faad7234664768f158c9217245e5d8d39734aaf099"}, "558b39a2-a42c-49c9-8965-e91aeefb5e8c": {"doc_hash": "8395ee5b066a2603e60b5dfcdeaab757e96bbb71cbd32f3b38277d25db2fe675"}, "5b3cd6cc-74ab-4144-bd11-836d4294b1a1": {"doc_hash": "fd14fc52152fe20f789cf83905157ba20f10871d11a5534b60a1533a5572e53b"}, "76dd1dd1-a980-469c-929d-45be7af573fb": {"doc_hash": "1ce5ea466866013afc65ca9c319215a2f42d1691dfd2f9b76294e7d8eb68238c"}, "536ed06a-1bf1-4332-ab44-6a24ca0a70ab": {"doc_hash": "1349ccead5788ea05c0e396aab487b7ba8a6b047e9038e0fcbe67dd12e5438ae"}, "7056acff-81fd-4c47-ac1d-aa3d44039b2d": {"doc_hash": "e316d8eacbb768c10407308710d715c8e46fc0c6d398a2078be91fec03d30f62"}, "a5f75fd9-5e62-454d-a1e0-c530dda55998": {"doc_hash": "6e59e82c392b310c3df2bf144898b59ab3f30e387fe7002f0ae70e8ab483b5ce"}, "f89f877f-a5d2-4a17-9e73-55b60b4c07e5": {"doc_hash": "16cc34b68795096c1dc166c34bd9eff7da6e890a004887b38c45ba656bc58125"}, "f4773fad-1731-4484-9bfe-6c969b86c51f": {"doc_hash": "ba378f8756c3cbfa6220dcae114cfcaba97b9bbcbf18beb9be63fd7e6c2de0c3"}, "dad44534-f2f8-4299-8541-aac67e0adebb": {"doc_hash": "e474534efcc4d4322a7bbfef25fc9f0cfaa2f96be0b87e0a5d902ad4f5e32509"}, "dee24cd6-e25a-4e11-95cc-d1dd600fb258": {"doc_hash": "8bc47f9dc831efed788c88fe702f23233a1d24331ec15536ab22ef15e2772caa"}, "55e1203e-8d14-41b5-b519-96cfd53f1da0": {"doc_hash": "fbee45f7457d07c39ae9bc26fb04e62fb9e14d49fc9e875654c01a21435ca496"}, "7910c92b-e77a-4593-8e8e-c052461c22ff": {"doc_hash": "beaa19c20205a4fe90fadfc8f6efe0f8eba333bee15168ace5274a5db3c6977f"}, "4fb31344-41d5-491a-b3af-3c8cfb080810": {"doc_hash": "69125fe4e25ca21c1a50e77961c821528b875953f9fe58edb72ba0427578c2dd"}, "26c90f15-e994-4ac0-b794-ca112fa1dfde": {"doc_hash": "e0e9a4ec6bb0bd0f4ebaa6b605e10749f463c4111433387b6b1a1fe3837fc7af"}, "28eb9a33-5d63-4346-8782-6cc4c110c7ef": {"doc_hash": "079fa2b90a4cedb06095a380a5a467b6c2ac8d4beb4e16d77db6803878be7f9b"}, "a381e99d-428e-4584-b1d8-1f38875bb39d": {"doc_hash": "4dd22d0ba77d0e9b60031667422e8f857d0aab896ffea8e8dbef1b6c90bf1abb"}, "cfebc3f6-a515-426c-9fbe-8664a8d0a0f7": {"doc_hash": "870cd8ac67c3099424fe21c2c9c77ca826162f111232f5d01828afa00ea9108a"}, "73c156b3-4447-40cf-a167-5f3a9c734ba9": {"doc_hash": "b10eb66a40fe26d9ca2e3c7453c7eb86aa4d589df417d940f354330ed30bdba9"}, "0521c137-7569-46fb-a7f5-ec9863101883": {"doc_hash": "e8ab806a1f80029be0a1e48c068918ccaaea3124f51f9fde49e9b5b309321273"}, "59d266c8-e7ee-40b0-9bab-23daf7d679cc": {"doc_hash": "9931bc7fe6479da3de7f1a3aa2bfac3d5aaec146147f020ecb380654d17a4f6c"}, "93e4e1d4-2431-490e-9736-b0ee0c6a03d3": {"doc_hash": "ed57fa5749dbb44dc2427b430e6a46fcf9afdd99f8db9558543385ddf510ab62"}, "64b1958f-904f-4b8a-a68a-d910a22ec84f": {"doc_hash": "88bbcda22e1e34d1c8d4b8f5a29b4933082db28250c5fe25757232441683c991"}, "98736360-5799-4d99-a700-7eeef2383c98": {"doc_hash": "8f680531f74b08e4ad86039eefeb6404a06e99785cb2973cfa6bf5acf1198978"}, "7e08d210-08ca-4beb-a8c3-3164760a1faf": {"doc_hash": "a5d13b87405a95ca08cff2ea75f203c927f08cfb2dacd22b4c2f85b20de60540"}, "ff8420b1-db58-417b-a095-401a8ae6ceda": {"doc_hash": "7024c091a5695b43ed74e6503235473cedca3ac87daba36ef170cda5b2d4a9ae"}, "22f664b1-429f-464a-9ab5-8efd85bbe601": {"doc_hash": "9ab209e92a93bbbd7a1349cb831f679e39777c7ca54405eebf642996b3ae89f1"}, "e35c7e90-66e4-4f57-928e-807d4e44f915": {"doc_hash": "0ab6cb376966596a3795cbd72abebde34dfa30e0d0f83c4aae181f861071e3b7"}, "54866c51-7519-4431-9896-e77009cc1bd6": {"doc_hash": "1dec3ad7570f349f1a6da5c51b3553c19c84d48dabe8bac0011f3200b9088b41"}, "6e0cbbfa-923c-44db-83df-1be863618107": {"doc_hash": "e0a9d0a85aafb1e4198f402ea2d0ecaa9f71d695c7f874c4fbb5eedc6d57a862"}, "dc39979f-ab7f-4685-a505-4cb71d028e8d": {"doc_hash": "a43409693bb619bc1763d8fae2839fe6d265ddf6d458894ef441699d426c941a"}, "95bb94e0-96b5-48fc-b902-5519599b1622": {"doc_hash": "c8a5cbd0a12634417be35a80b6d6cd374b2ed5a2d7e8aa431d0924103be3021c"}, "262c71ad-8937-4d67-ae60-2a027cdcbc8b": {"doc_hash": "a997126deaedbb49a9e0c3da11e01e00cd5245fecd04c5868493b1a381047000"}, "18cb0e6d-7b31-4119-9d26-eba95623c599": {"doc_hash": "1d85030e0450d8044913e0a7f398cd82dc78fbac39bb8cccbaa716569c2c30a9"}, "b3203d08-981c-4ff2-b907-6a89028ef19b": {"doc_hash": "729080d746a13ef5599a124a272e83ebe1976ee1b6495e2a1a123a03348619f8"}, "601b2877-bd45-4a3a-9ea4-72e2c8a63667": {"doc_hash": "0efb72008003213cc302dc581c888272b5834ad473148c62c14b57e23afc345b"}, "bb4c07d3-82e0-4e31-b4fa-c472c09ddd56": {"doc_hash": "e8211131a41ec9799a99bde6891b764bd1f0fb8b27566561d3278dbc9482d16a"}, "89c917ad-9b8b-4b12-b468-535274738573": {"doc_hash": "78e86dd77951ddd552b97081f87255492ef0c6b508a86b3eac6284866b826426"}, "c2e3a3c4-f216-45f6-a45c-292a3e326572": {"doc_hash": "bd02057ae0fd610dbebdbcf1143ea331551635662f0b439fbeff59f37b0d9e58"}, "d0cf6711-65cc-4616-828b-6fb8297d7735": {"doc_hash": "b2210bad4a90da51816a765e0ec3ca61aff062259537d785052de1d46e373817"}, "e40940b5-496b-4c8a-b343-991dc5e15c1d": {"doc_hash": "0381fec04a9025ab7efdf5a12d102ac9ac7c3603b0d1bbc2f5b416f0403626d0"}, "0b707e58-b244-48a8-acae-3951a8a07440": {"doc_hash": "53fae4df44ed699189786836683c6fac8823c5dbe58c16504bb74be0801bde52"}, "c0d6491f-4e66-4870-916f-39ccd91893de": {"doc_hash": "a019f78c8fbd8847b6098f85900baeebd8c7c973cfeca311cada1b232f3c6306"}, "8e244258-ce82-48e4-ab09-b4985835d6ff": {"doc_hash": "3b7f1157126e7e80c88b415e269bce819aa7f97f4a0554a8e67ea5c44edaa45b"}, "05a21a83-38b5-4631-8527-b1e1be17a6a7": {"doc_hash": "452748bbb326c654c72423a444146ab7c6611ba2a4643c873e4e31d0cc70bed0"}, "8b07e036-a70a-4f5d-a8e1-bfe9c64c33dd": {"doc_hash": "67e04fe42cbed3319716be95ed49f04f1a9dd46ff521304aa06655b61d35de3b"}, "f123db96-bde5-4cf4-bf62-59c8ebabcfa2": {"doc_hash": "6607b97581764b28132e12c1b56854057108ab6d298f0b13a57ab216ca6aa8b0"}, "b9b4f284-6b1f-44be-8e63-1789dd16d0b0": {"doc_hash": "72b64df06409257e2431fdc1d074ef820f8996860813ec125198c6d2ae9213dd"}, "7ec26ca4-978d-428d-8853-3c19af52e1dc": {"doc_hash": "f3c5ddde07d862e51bce157c732b6c446939cf0f6c7fd4182af8116f6aa4bd68"}, "3fb390ab-5fe8-4517-ba8b-1aaf75651131": {"doc_hash": "bf5f760204cfe4fd27e4ef1c4de936c994523026fdd9382f53a8a8d6b3f3645e"}, "12d59e46-b053-4d4d-a2ef-9b55e9637041": {"doc_hash": "4a91b5bb1a79bd3c2b5aaf39838c0325dc8053c956e01e0942e4be1f1db537ab"}, "25996ae0-abbc-4a3e-94ed-2be6180ab372": {"doc_hash": "192afe7816e6ea593bca8a785dcef0a9e5f8f350af8a7b4a48e378de7b15d1d6"}, "e958eaac-faff-4d6d-b39a-de6b38bec378": {"doc_hash": "9f5d9f0c45936da06c3ef9a2b0f1a586dd1d552ef20f52488cbe05faa3fe105c"}, "e191e3d9-7ea5-4785-9d54-de14eaa891b1": {"doc_hash": "2a6a4a55c717cd4cc8c2ab3f292a5362ae66777a208c5da004558d58bc1e29fb"}, "20ba0f61-f859-4ee7-bb7c-43c8f133e7ea": {"doc_hash": "86013f1ceba1b15660830ccbcab16e5300b02047ec16b7215cbb6ae644c32613"}, "a328156d-2d2d-463f-83f7-89897fdd01b6": {"doc_hash": "6281cfcd5d9187c0f62a24a6e5b5845978a4ff4ba0c0da7ce027f2000e8ed916"}, "8b82c6ff-cfe1-43dd-bf17-47e22b82d1e7": {"doc_hash": "6f3c0b91675a0e43ad8714befc3d7affbe6832252ba83d1b31b23820d0fbbf08"}, "5ab9ab3a-ea89-4cf4-98be-79809b993d4d": {"doc_hash": "27287c0c5d04f5264fb4c6fd8ba3c903f7a4abd8c3729fdc9b19a92afcb18cb2"}, "74343b6a-befb-4945-83cd-8624afc21a78": {"doc_hash": "b8b3be8baf14a85d9e75b481723f881e16fbcf268bc4ebd7899ff09bb43c470b"}, "49773c2e-553c-438a-83e3-9ee8bff9dd02": {"doc_hash": "59151e41a64c1fc42388847c5d7d383660d1f13ff169b4bd116ec0cfe7ea3b16"}, "464f72df-ecc2-4e8c-bda7-ed6a9e48b3ce": {"doc_hash": "317bd3a99d2dcbe10fc6e782996c88b9833438fe1ea53bb331e79b1922e347d1"}, "c8895567-d7d3-41f0-af4d-323e66ca12a5": {"doc_hash": "9da98cdd2546ec32f76fbb008b1b8eaaed4d6ef84cc5a289590a9bc8bd044313"}, "b7cd3b05-b387-4e47-bd73-6332868d2f71": {"doc_hash": "675a2bff7d15e87dc5a35adb01bc89da003a1e567a6aa31307a39355567359c1"}, "80c09984-4352-4c08-9c7d-3849fe2af964": {"doc_hash": "2e9c8a6f51283ac70b1438d5f1eb601790e7450f5909031bd1303bf04e7b68f7"}, "2644ea91-18a5-492e-a493-618e2b18453c": {"doc_hash": "970b2165a5c22690f6bd861218deba81f4e624742bcc40f8b248c8f006ec6a03"}, "c9251f5f-1c6d-4e16-9134-2c2ac3c139b0": {"doc_hash": "c7fc545b63dbb99c5c1284216009ebfd66772fa23c10e0ac81cf32aef81f9c11"}, "b7906c76-a271-4abd-8076-4718b552463c": {"doc_hash": "a63f0163916a9bc9602bf4ba11d182e89773c977c15db348135be1dd418b4e3d"}, "83d64e1e-4dc1-44c6-ae1f-e10e751821c8": {"doc_hash": "5ea4fb8f06a008368ba12143a0647a5e7ec797f6f5ea83953bf73710ee4a981b"}, "8ccecdc0-a929-4abe-8711-764bcce21d46": {"doc_hash": "43f5fa812a6aac30d88b043ea16e3b86d28a0905ccd7f40f24fd416fc83e3085"}, "1c5ae921-d2d4-4638-bcea-3268b4f399a7": {"doc_hash": "a25a6cc7b9c23c1b7494235c41885d9ffeee91d349b49553e2fab0b90adc9ecb"}, "5b8f5770-46f0-4457-84ff-e4fead8b5ea8": {"doc_hash": "5798a6baa493d0e8275c064ec8ab6a851228c8951286fb49275e42353f79e979"}, "65609a37-f6f0-4cbf-af03-0560605f4151": {"doc_hash": "fe36ff0685d4b4ef2c8c3d8bb6742d6a74f00a669b48f9adcb9d210bdfb55728"}, "06485463-bed3-463d-9461-a3115a18a41c": {"doc_hash": "de7ed1cf4b69bf8f62617c0ee335618f5baa93da24b9e098ac3c73857de2b39b"}, "da5f1789-484f-4b37-a625-7224e9af9bc1": {"doc_hash": "ea7bdcf3fc0c26e04948a08f387b5025b4de5a1148d1de965c7107ac6bb1f962"}, "0c190c38-2aca-4303-9904-a9d9e2aff4ad": {"doc_hash": "7fb20c8f49746bb690f42ef4b76453e207b7c5ef2298e18df5b0406a602076af"}, "3fa27da2-95c6-4e2f-9908-8ad616c2ac93": {"doc_hash": "d9ff3d04e1a9b3d4aac9f343ec15fa69b954ee182df62c2edb60d66b040eefeb"}, "2b9c6b40-8ef1-4f1e-b712-a6618e6b2700": {"doc_hash": "37b2d446a381974c17c8662ab3a8569de4798e23fb3ef8aa2554c6f5bb57dd93"}, "25806191-6fae-4531-bc02-c0cc86cdf675": {"doc_hash": "b1aec5ba9bcc1bb59b9797049dc6fc044b3ffb921ae8fa6d13b1f6d6e452d75e"}, "4de1f6e0-fea2-4c63-8530-7f994b1dab01": {"doc_hash": "195011ffae36edc6290e96e86e7cc308cf58472d7cb1895f44b7d4e184447dfa"}, "e3c1da99-58cc-44f6-973f-ec416ff41ecb": {"doc_hash": "54ed69a39953aabe1bed7309c9eb34a770f000e6b6cced2c534436ef312fd8d8"}, "843db1e8-313f-4dcd-8a38-11fe49895ed2": {"doc_hash": "e93f7b45f2c04d352634c4da4ea7a464ec83ff3128120f3d862fedbbdea38ce3"}, "9b56996e-92f8-47a9-a2bb-aa13b6224d50": {"doc_hash": "140352464caf8a100573b192b1bb2b8a487043e77c2a31daace22a7530b65d51"}, "bae05820-b5ba-43cb-a997-a8f53c423ea8": {"doc_hash": "3b8ff60c14cc7f33083bd85e329d6b30ec90137ff9d2f8f25a49f64d2e522444"}, "f36e38dd-553c-4e0d-ac75-a5d7b713e845": {"doc_hash": "97351790e42a9007fb62941edddceedabbfb9387751b452a36819fae42f45d0a"}, "55162cc9-88dd-4f82-8993-ecde20fc8218": {"doc_hash": "943764d7f50ae00681c434065b2904f8e0e858391741089324f42f74c9a69a91"}, "c612144b-a346-49a7-9f89-812486da452d": {"doc_hash": "633aeb402e7c0317a0a9f20e1b420cd3af1e0f9164c1fa7d7d9751d84e96c542"}, "80a0c601-6aea-4d03-84e0-81719b61973f": {"doc_hash": "9a6e535897573174dec93efffb708af27c7179c7f052217037c242a1846bc89f"}, "4518e2dc-3831-4551-b49f-a5cf7eee3d7d": {"doc_hash": "1fc7cd5261594a715cb960761d7901a6d7e5bd7c340b8ddb8fd0ce23f42ffccb"}, "55bf603a-fd80-4849-89d7-9cde89fc6608": {"doc_hash": "185117bdaeffbafa9e8f080aa66e7a924cb48ba8f88787aeb19177f4cddc30d6"}, "8a50997a-ce41-40a4-af4b-51b7c36cd5d4": {"doc_hash": "0ca6381cb760f2cb0fde7ddc2d59802baaa0578360400c94e4f46a173ef6cbe2"}, "fd0096f8-c08c-4a89-9c46-4be58dd57aaf": {"doc_hash": "fe39fb2766614a732399d6fc92548f953dadbccb481b163d05ae7a51deda4dcc"}, "95c8c2e0-91c4-48e2-be73-551fe0c0faf4": {"doc_hash": "4016bce3be94787e3ac2c315cc59571a2872858f9d9f90d78f7662e9d680bea9"}, "e1458d9e-6811-4473-ba70-8d3f74ffedda": {"doc_hash": "8e19840aff8f571622859ba7e1d3d64b3307ea9517f6e7bb1e2ac7891ee217d8"}, "563b72de-8eb3-4255-a09c-e178e130a693": {"doc_hash": "94f347ed0999fb9e5ecb4c0ceed1ac4a52503add961d78af037a4b74e6e7b3b7"}, "7eeb2edb-fe43-4036-836d-7eef45d0310f": {"doc_hash": "0b5857ce0d7d19824fdecce1aa09517cc978ec1230ce1389cd32b2798ff07d4a"}, "f5cc37e0-8d0c-4e05-9497-9c8b22631e6e": {"doc_hash": "14f2e2186b336047d59f2db8932306d2fcce2e67e8f863f0f9475b494f897f62"}, "ca777b81-be46-4861-a040-2822409932fb": {"doc_hash": "186c79d694d44cd7fdbe5a25fa79127dc29cd69b3a8fd0b96eff80fae14cd351"}, "1ca83fb1-02b6-4557-8ebc-2a2b07acceb0": {"doc_hash": "3b36abcabea4a89225f41b3dd29dd2d0afa3eebc500f3b86e13bb277aa8d2ba4"}, "9c40b014-3149-41c4-99c4-fb5908945fcd": {"doc_hash": "b6b7ecde58eb2497722d0e3aa14dbb120bbc1b9392422583a35817820ed0891d"}, "7cbc7b66-a5f4-40bb-8507-e2c6ef1a1798": {"doc_hash": "b54f4a6a0de09bf6f4b4744b8374274c533e09a4ed24378372011f0beb785d59"}, "d13f967e-a94f-4f32-9efb-297fed8be716": {"doc_hash": "babd33ef59a2c40424454f1d9a1acf8c08b25f69b3aa65266b8f03985b20ed51"}, "3e450db7-6cce-456c-a366-296cc11772f7": {"doc_hash": "70396902d02a48aaf8cbdee719f979fe5d3a2c06964997b648417d639794e66f"}, "72f72bd8-581e-4857-bfcf-0d91ea609926": {"doc_hash": "42d111e118fd53c0710259225529a35744bb1b54038a6cfafaf20153165c2817"}, "a4ddecbc-db0a-4788-b640-2b0c48ab3dd1": {"doc_hash": "c4ad4bf4d7a41f7ea53bf2d721e1ca5299ebbe0a0d3979e4f140ec42f01f5ab4"}, "31be2bfa-63db-47ee-98bd-d895e19d1f79": {"doc_hash": "98e2dddaea9b329c8e407accb6b974eef49be2c399fcb27e13745ffdc9bbf906"}, "3eeb9251-1278-4cba-bca6-1228f5ef77a4": {"doc_hash": "b0e13520af52631b29fc914c6fc8dfa613139675f02a284536a84dbe5ac9c220"}, "85d9eaac-aece-4fb1-b21f-3fed29f5b1f9": {"doc_hash": "6637e1fd86fdc991984d8fb802429144678aa496010771b85ad6d7e3c3a36a97"}, "e1ac18f8-8c2b-4df6-a9e9-df3add5dff8d": {"doc_hash": "2762727fcb0c97c42e681737017cf5fe970bd79b070266a20f6c4613e408ca9a"}, "b43afcef-a70c-4de2-91bf-045894da8b85": {"doc_hash": "fecfa2db2b437e5754fcf6a55559fcbe3a48377315ace614c48825aad256ffe4"}, "68a515dc-0738-48af-b90e-865a07583aa1": {"doc_hash": "a43abf9711487dcc0eae462b552127645c67dbf8bf9a34cd55ce2c47df6ddddb"}, "58a63d7f-222b-45f7-9ba4-377c140c1257": {"doc_hash": "f9e80ddb4e7e241291041d5bbb277417d0a8fddddce713de52714ef1fd7dea77"}, "211d1d5e-b3a0-46a9-8293-5fa209172bff": {"doc_hash": "a73b6919604c5d1ce6470e71e477daa2c6441b4f74e9384e746c585f505e455c"}, "adda00cd-fd82-47bb-ab6f-65f8106c5cd6": {"doc_hash": "d6ae108a00ae8f15552d557b7879233148e1c230a579fa812d65c311c948ba28"}, "537c8940-b879-437c-af8c-e60eab39e36c": {"doc_hash": "fd79dc2537468953c590489b0ab96238a11be353d65fb9a7cbcc2e57dbc41066"}, "dd866226-6628-438f-9b32-fa5540433fcf": {"doc_hash": "7b1a8c10050098b4d31d00e111174d4fa364aa829d0ad53076e23b931a5f85b3"}, "3e535bc6-a0b6-4cc1-b23b-941a8f71cbca": {"doc_hash": "e5c06cb2e012e12f51495ba31e8c0c9c2a7baf2e93b182e037dd4a41bdb4c270"}, "6326781e-f2ad-4de6-8ddc-f8896584e187": {"doc_hash": "d3d9d63f289cb369d8d6988be0f99d9bf80cdca5e5d9051c0b1724890c0c3d9b"}, "5a52e576-ecca-46e5-abe8-afc9f8eaf98d": {"doc_hash": "7c34280b71fcf778c4af828f087d3aec4ebde79079db83f1066fce478bce169a"}, "8b0ee7db-f668-4ab9-b6f8-5eacef6ce66f": {"doc_hash": "4386d6344566f5af304ac97dc301a4ea48aa843781ee4af403fd138ddd4ce441"}, "e95ead9b-daef-43d5-a7c4-f65903599fdd": {"doc_hash": "276c42d227d60f9135afccc9424527f70b17c2d7dbe8c3acd526c0c69b11436d"}, "c0f99a7c-927e-4f3b-bf34-a7955338e211": {"doc_hash": "7f480569fe3e2ffe3b7a078cb63d0c905bf7eff0ae924f85ce25b16650dd2c6a"}, "11c68c32-5e28-409c-a38c-d23ed01226b0": {"doc_hash": "ae9df7d8a360d41d72dc8b1d7bfc5d930934cd8d37976224743a6ee508d2eb56"}, "5137f702-1993-4c47-865c-54be5a4e01aa": {"doc_hash": "18c0303f851036e472e6e04fdc18042ca23832805059230048b06273f04e0212"}, "f1197c4f-56cf-42b3-ae02-2edbaa4c12f3": {"doc_hash": "82c6b0a9281824a5d8708d80f48ac0b0e16d6b9ddedac7ee2b0a958b751c32fe"}, "8d1ca404-b26c-4e93-901a-5fd42e281f1b": {"doc_hash": "dc5774214dd8998b401b423c1c30056d75d6cb08d8b09c34f905fd51e7496a44"}, "8fc7f01f-eac6-4d4a-bc14-efd63530f1e6": {"doc_hash": "a6c6592782b356c84348548865e0cbb9a4840e6e3a4cf733858ca7d8508f83b1"}, "be20f6dd-0544-4400-81e9-90c49b9e1c87": {"doc_hash": "408bdad1b0524f846969cfb880402d42edf20183893ea3abb6c5cf0166965423"}, "8c38fd15-c3b7-4aa2-a5c3-43f232285574": {"doc_hash": "ffa9e42b6e83b533b33c234fa39758cee8d46bbdde1b433d7b633d1aa11c9edd"}, "9fbcc2bd-481f-4a49-94d1-a8fc053fde3c": {"doc_hash": "04230eb5e5cf457d6b97c54c7d1245106cf7a47ebfb699eb9c89e6d105ae2e0a"}, "fbca77c3-84fe-4cc6-9bd5-cde8b169a07d": {"doc_hash": "bc14b607d72cf14fe783e81008827296bdf1953d5377a5a1683ecba071fe1d10"}, "93f70f2d-ccfe-4e5a-87bd-4c8e04a2cc60": {"doc_hash": "3a1b2bd7987ed313775c4e7e8ac2878343d6c4b0fef9bc538920054b9e61aa3d"}, "4c95681c-666d-4d0b-a70e-58ad7f7d0c2e": {"doc_hash": "2b8deae704f23bc60de39055f387baca5d53d918457d93a40aa4f07789a053b1"}, "ab2759f0-3cdf-4eed-9b89-034c5a4df81b": {"doc_hash": "cb4ce12b85c4d477a30910a1bed2932ebcf604a58ae1f30b4053adfac469e24b"}, "b55ee70e-c31d-488b-ac5c-a58989c8a7d3": {"doc_hash": "060353a988c85c6fe437ee2443fc891e48c377fbfa469f98102f642b2509c7d8"}, "3a8bcb25-4f13-4666-818c-ef35089ac60c": {"doc_hash": "ff9647289508abd9901d6b02d1f4d1bbdaf2ef01bddcda77910e49a5b99c7681"}, "cbc32d79-dc69-4a2e-8c63-c9024836d8e1": {"doc_hash": "c791cbc9e914bd71507c91d17ace12024cc8b953f14558d8a264defc17d0a823"}, "b0b8a719-144f-4c58-91a4-3cdd04719217": {"doc_hash": "c8857da3bf699620ae2376be9885f72712666994e1dcf47f1d04e3199d77eb52"}, "b5e73bf4-899d-4b93-86e4-d06a64514f30": {"doc_hash": "f1e687d005cfaa374d81eff6737f7b1ad92816cf588f15142157372510333a46"}, "1d58fd78-3f25-41f1-b741-fbe5daf17545": {"doc_hash": "d1de02016aad3a3103faa414a1ac1bef9a318d677ad9599363e4f641fb889ddc"}, "be4c64c7-2ac6-4ff6-8315-424cadd800d0": {"doc_hash": "a71d768eb87e92c8e1371f0f74bf1c16927bf171ba0541102fb10358d0181c58"}, "2b1c3246-6cd1-460d-9f84-97eae6be59a8": {"doc_hash": "317a8efbada5c48233093f797eda9d5e483d6fb05f8b6f52e187c6bf1395be7f"}, "cc35bbe2-2f71-4bf7-805a-7aa04ccf3cec": {"doc_hash": "3c02fea2881c2382ab96152a2ce1f5a3eecfc7a8572b66d4f52953069aeb5500"}, "8f244968-058a-4b28-96c8-54231b836c86": {"doc_hash": "fe1d4ce8f87d4be2661b94e2d2218e0b1af41dff38646656f593aad68d21a24b"}, "a3cda906-642e-4693-b653-91e0e0930d44": {"doc_hash": "d0e7f8c7fac985267fbe1af0bad84e9c064bd26447c342d282a2c416548b4e64"}, "5d1aac2c-5dd0-400c-af4a-691963a335eb": {"doc_hash": "ca800ca46aa635fe5cdb79dc63bfe26f93daf47309e5b3b8831b564d4b8ab9a2"}, "b246a1ef-6c8d-412b-b7a6-8ebbbc2fa4fa": {"doc_hash": "76ca9d68a972ef90ba8589c98585ea47a29cc9732e64b883a39fd8c01af45a71"}, "48bb9627-0e93-4f1e-a663-882cbc8b48f1": {"doc_hash": "56d0d07a4b526663aa1ad3c819f1b411591aae3b8bcdc9e04faf41b0a33c27c3"}, "96ca9ee5-accc-4efb-a58b-cbea598e1853": {"doc_hash": "df5553415c75a993c5d5387d06df3a5c0a77b007ba652e38208cc18f698967c5"}, "bfb93aa3-909f-43da-8b36-35068775b2d5": {"doc_hash": "cf4bdcd1a32d981b5163ecebc061dfaa15fd39d363b1b1478bf969839447ba1e"}, "7ae3b18b-3148-48a1-93ff-f59a957801bf": {"doc_hash": "0caee3a958f715246265e8fc67a4486f260663e3a6c9dcb90fbe0abf4e6b366b"}, "bd069c61-8ffa-44a6-833a-376b260d943f": {"doc_hash": "d5dd5144730d449012e2560848e38c2cf279db3f9314d16aa8ecb432ec5fd489"}, "19d4a083-81f2-41cb-849b-0dfcdb2ba363": {"doc_hash": "d20c9a5a14d374f196efb084b4c305f28fd71f55b5c7d6473fb3ca3dfea58e6d"}, "326f35aa-b7fb-4b59-9e5f-686bf8da67cb": {"doc_hash": "5ce4e6ada3ade295b6b0b1a34aa0d85427caef3f39c7d3936fd6a003a5215206"}, "b3a984a1-cc76-4ebd-a2dd-b859dec5e178": {"doc_hash": "517616f50cde6814b7f921b6ce0adbb8189c376812f3c603ee50cacd25be7acc"}, "b1681497-bbdd-49c8-a168-681075e3ccb2": {"doc_hash": "99c93c49f67ff87c60d4816843b9868cb21fd6c43cc34a06d878ea5fd969217d"}, "0be31fe9-5b2b-482d-ae55-6a450a2fb3ce": {"doc_hash": "6b75d2828cccf9bc8d61629fa8cdb81d99de10c31a69f615babe96fbdf285e0e"}, "a773e1c7-e136-4a72-9181-3b5ae100a604": {"doc_hash": "63ddcad2156acc20583d10459616c7c4fc679d16b507db6a491399ff0a55ea45"}, "d5a57339-4cf2-4097-985b-78a2b4f77a8e": {"doc_hash": "ca68cbb1c80e5bdab889c8dfb885953a8f7a554850bfe59e7ca8638d416b38d1"}, "340602bd-fd52-4c47-a88a-f60b2a334379": {"doc_hash": "296c3b1ac4a090f4f9414d8f44b9463d7b3cad06042ae63a8628329f47cf99ed"}, "6cf3666e-c874-4a61-a829-fd4870acf4ad": {"doc_hash": "cd445bb922e7b1f6a8cca703090ee39fc07852527a8270db99023b83a4ffdcdb"}, "ffed7e98-724f-4ecd-abd5-82c1c936fca1": {"doc_hash": "278b11b294dfc0d5aa21a512ed021235406f711a00164dc1b1e6359da5ffc851"}, "25350984-feb6-4e1c-8866-ee5a7d062813": {"doc_hash": "21a249206eb771fb2b65aa95125d77230bce7e224df20bd91ac105de425effba"}, "0dbc89fb-1ed2-47b4-acd0-2fa69a22ab72": {"doc_hash": "91c82d32f0761f01348770ec04f4636672c7f3d33d7cabc251343ccb4d78fe27"}, "cbfe7b95-bc81-40fc-9ac3-367c16bf4b08": {"doc_hash": "1f0da39d3de0d5b49edb3a687fc68959ff8999667f543e55438abcbeae3fee6d"}, "c3321b95-e5f0-4876-82e8-1dfe9d205165": {"doc_hash": "48c146849dac9b07762b11b7d459026a96c8e2aec7c3f2aaea69cb336de43553"}, "40edf429-a462-41d0-b55f-5889cc3fdda1": {"doc_hash": "96cfe28f36699c3f37c38da97d844b9de3c6f34e9ea3a56505b25f4c29b2edf1"}, "e4ef913b-8fb2-43e1-8799-9372b7c41da2": {"doc_hash": "d0597db09645f2d4a7362709f9c533be1acf59c6619ebba6e69d4a0f3ac22011"}, "0db4f992-e1b5-4b2d-bb66-e2d857638072": {"doc_hash": "9ba723a2d247544e65b99a00559f9e14cddbdb4b792ad1f470d4b5b8cf790b00"}, "5028cfdc-74f2-46d6-967b-f91496342667": {"doc_hash": "858030c28dd46f4de8190d0260dbf2617979481b3f28cd06216e7d11ba5878e9"}, "4e2426af-23d9-4557-94ba-7c70b1075ea9": {"doc_hash": "93553ab5f1c302d57e84bed0a3b020fa0f8c0280f1c7f55e387a230695eb48be"}, "6baca1f2-5328-406d-8e50-faac2a4f3b23": {"doc_hash": "894be9431ceca2a723b501799ae59896bc591459fdb1aa79b1f766be0e287f37"}, "df728331-6a32-4c9b-b5e1-ff7abe42926a": {"doc_hash": "e7a3f08c8efaf3bdde717363e612d8c30193ff2f005b9c8bb067e3ae39e1e49d"}, "5400fae0-5fc5-4e30-ae1f-83d44dd5dd06": {"doc_hash": "a34e4f84f1291bd6b0cf7bb2d60bd7916f71b5e930fc9e31be6fddac7ee83acc"}, "3a902a5e-83a1-4fbd-b444-4d2816941a25": {"doc_hash": "df0b5ca513febe0c940728ad06132bdca3a98266e82a854c6af2770002276bc6"}, "dfe82da8-b5ee-470d-a706-d81394c80778": {"doc_hash": "b1ff80afbe0f28fa50a5ca8382dbf4b91d28870bd1a5dddc43fe634702b09993"}, "716b8d49-946d-4db0-97a7-980be76b4cd5": {"doc_hash": "b82244a61c319aa00316f7cab06d066b31a7f3ac62267d95bc759b5caa0e8103"}, "d984e73d-8443-4308-b6eb-ddc9c4475b3d": {"doc_hash": "79a5ae0e3549ec7cef3d1aee45810604e6d0b837be6594374a3153a7ee4964d0"}, "414e7d21-4569-4522-94cf-c6a7a4f97765": {"doc_hash": "0a3f68418e83fd06920f2447b5490a59c65ee0288a81640bfa0c83aaad754684"}, "74ed164e-b9dd-470c-a775-382f3165dec8": {"doc_hash": "899042dff0fb2340265d3bfeff908ca53f63c4c5f5aefc267cfe9e505601860f"}, "e593b6e7-c1db-482c-9523-d3b18c67dea0": {"doc_hash": "1ee778c0ac4bb2076f673d7f0476f70fa24fadc178a6dd6c696bb6890da30a0b"}, "56c936d7-0c72-4d5f-99c9-90851dfd3c4b": {"doc_hash": "5e374d3c977f913c7e34c63567b21e6f9671b3562b5fc79e8ecce3b5688c8662"}, "82aeaad1-c8bf-43d2-82dc-446c5beba1b8": {"doc_hash": "949f4da21d49c2bc1ca035697a0319c8b7b1ea08e488efb0b2d854a669065fb3"}, "dfccef0c-5266-48d4-9ac0-cba82680f8e2": {"doc_hash": "f6b95c5d775cca9407d97ca25480803357c212080d5fdfdfb4d909f5baf0f3dd"}, "d8f011d6-bdd1-4296-91d3-2212fd530a42": {"doc_hash": "bcc718180c136fe65fa9236bfe359b0aa2d2214774f77c25878087238bd2a36c"}, "61347e8b-48c7-4264-9306-9c7c54ba86d3": {"doc_hash": "4068ed12055239b6ce570cbd9570e4bb86eca737885ff98c0df4564b97866934"}, "80342e07-82a4-430f-b4d4-659d7582b928": {"doc_hash": "807c1a0c45a11fd6486faf5cb23ffe402f2967be17ca1e02e9b9f24270c7c4c1"}, "69b2d8eb-c43f-41cd-9936-c7591d645dde": {"doc_hash": "c858ec8f4fef0642c4b9db438a79441e4dc4ce4846da9e3ce54d1ced5c3e2adf"}, "f3f8b529-843d-4e57-be0b-999636c81b66": {"doc_hash": "ebb1ae4225f26ceb7d35fae453c450d3cc959f41e110e4a76193a828c5ad1a71"}, "aeb8ba79-baba-4ff6-af11-0b792ece2cd8": {"doc_hash": "fa70d4ab88f73fbad6659e6a69fc84e46eedee00e9dad8a3bfa1cc51b13eb306"}, "0d9e8793-6891-4aa7-9231-8f0425b74ada": {"doc_hash": "34546e2715aa4624a494ae8cad1be1f7e8327edfda9ca6f89c2a6b0f5cf6b6ab"}, "c516e149-81fe-4c9d-b33b-1cd9405d2a7f": {"doc_hash": "26b0fc26c1ddc20b6a1f0186cf38c359dc1b7fdc78af9cbd40851d3aef12db0a"}, "4bd96e82-36b4-4fa4-aeb3-73b90edde45e": {"doc_hash": "bac1a18527411b9b638c928e5425f9316bc11bba0fe3525021a6680fa61967d9"}, "b7872f07-08fb-41f6-bb4b-01043cdc3776": {"doc_hash": "cf31587c3babc88fc8535b789cacabfc50371d9222059e3917f82a00ab3a07d2"}, "70118c48-8006-4642-bdbc-650a44838811": {"doc_hash": "b495275e0ac2a48033aac40388dc9e8bab19b6af25192239c6050609e1d7e21f"}, "f5ab21c7-4a41-4218-83e8-8d9d0a0a9720": {"doc_hash": "229fd83012144e86a4c01cc280aea9901af492020f41946bb2f34a06870b8b79"}, "b9435c82-af16-419a-b1a4-d8dde3b52a61": {"doc_hash": "89f1f0cd436ef1e8cf74a33235706ed113fc0d69865c37537a93598ec192cfb7"}, "695e7042-7851-47be-9245-39cbb6e62990": {"doc_hash": "d743f398f6a08af07fbb33c9bf89c49130c68d1ca1895c20168a9126d51eb14f"}, "2f40d532-aa3b-4cec-9c92-b9b86ab2761a": {"doc_hash": "20d3393ef3599321002bc6b99e56e9ebb5c2a8d9f80abc283c392ae801edb7de"}, "ad2a7a4c-d6c0-4249-9727-20cedbfec3ad": {"doc_hash": "3d87254c425f8d0f1b05311a514afba82b07b6957951ffbc27827512c16f3591"}, "f4a588de-9a68-4282-9e49-24f8e0684dc9": {"doc_hash": "19e0914a45024b1332f2c2c03fdd0b1f2e98a225ab3d60d4cc328504083687d5"}, "7622fc68-037a-429a-8112-e6c7981b4385": {"doc_hash": "938ff9b86be13b03783063d8d8e6dad5000b918839c3b9a3b4b26003363399e6"}, "cfc0b404-7185-4d74-9a7f-c3779acdf1d0": {"doc_hash": "d4c43b7fb58967b9a243da989fd8b1d103662b3c28f3d85e33252476592b412b"}, "6d4adbf4-53ae-48f8-afa7-cb29e2b56221": {"doc_hash": "12d299197f43141618e80b1a900f2d27f62caf1abde241590c056c66415863a5"}, "f5171a67-45ed-4f46-87fa-e735da6bf8f5": {"doc_hash": "7896752cb4fc13cfe00f615e86dd6c2e8cfed71bc5559a28786357074b388530"}, "ab886341-ca4a-488f-b6c4-b8566cccb408": {"doc_hash": "10ea80e0f3ae4b6fb097510279224f8964f7fd1f770f5934b89f3f6ad100f31b"}, "e5142296-fb57-4d5d-8471-8a2429789238": {"doc_hash": "a8dbb4e5510d4005916f660f1f9056cfa9b3634dfd57eb6a4b803e27d718c28a"}, "88a79746-b3b1-4930-8de0-ef14e7bac47b": {"doc_hash": "69769bfb1b1b89e15de02138eadaa28d724264639c4f17ce35f3244ab26f5bed"}, "fefeb2e4-fa50-409b-b273-9a55d090854c": {"doc_hash": "bef538ed14b30698d7a7a3fc4a1377a24a7d426de4df9ad9d27ec8a5bade55b9"}, "dabfb1ec-1fec-423e-9e17-6a4a84193b0b": {"doc_hash": "499c48f60d465b4c092446139858e14ebcbfdcec1bf7953e2055b8f0f62c6517"}, "47d534d4-569f-4124-9961-a543051103ae": {"doc_hash": "d1056c3a8d41c5b28bc80e0736c1c73a2f00a6bc9f1d0645093625c463e92439"}, "9213abc8-699d-4d6a-b9b5-3c0d30d9c5e9": {"doc_hash": "64ed353de080d996b0a1d84d6340676cb82f5dfad6593dcb0d3868732d931e69"}, "bd124f09-adbe-436d-9c99-1a05470cc56d": {"doc_hash": "3b4830a1a1bbc697996e6df18abda76f61ae4fca461326563d6300be0ff4e385"}, "334260e0-0bc2-4ef8-8466-e6c09bf5c427": {"doc_hash": "a1383a62b183705341a7c8e854c351bb246d5826b4e3c945c7168435c8e44b0e"}, "a02d10cf-7961-4714-bca0-c2f0057e0be7": {"doc_hash": "44dbf244b1d7a0c547901d282258b7e96f34b745d67798aededdfa2b808f719b"}, "9ddabf22-f972-4a1a-87ea-f255e5d173f6": {"doc_hash": "421a254d0653a9293bd5d2f48c42bb919fb8d75a96789f801efe44b68a420777"}, "14dfcf1c-bfe0-435c-b92f-4d541b041a13": {"doc_hash": "27c5a55b3a17669b2fa9c68457bb32ab9d4358989d3b9d72fdf7d1835fc4bb8d"}, "aea476da-fc3b-4f90-973c-6ca78b1f3f4e": {"doc_hash": "af1e517a60a4179981ec557969cee4ced7069f0e324800a5a82e32c00303202b"}, "d80db5c4-9be7-49c9-b200-ef5ee39ae91f": {"doc_hash": "2b1be58f21c37f30a07e807dc360a100d33244c629829bf480a1aa78efd7827d"}, "f6ec7068-4cb1-4aeb-a6f6-3e063d9ecf22": {"doc_hash": "04340455c749be9736a2bb36c495f8852940e78b6f55b35b486a9e16aa87eecb"}, "eb69c7c3-889f-40d7-90a1-803c125e3873": {"doc_hash": "7f52b9ce96d323dd475889aedb17128931e582953a866068882de06f663fed72"}, "296186c2-9202-48c5-b70c-3294eaa81af6": {"doc_hash": "f39d4a36f5eea9f0db34d3c2d4fc8ae536b9dc2d95da7d6b9a2396e53ae343ea"}, "cfda448e-23be-4c3d-a72d-943b7ea328f7": {"doc_hash": "737fb5fa41efff1d516f8b184e87a1a305a1bc56cfb87b19930a883b3b55d2f9"}, "f1835085-b2b9-4909-a1a3-31bcb3460bdc": {"doc_hash": "b8d5900180aca81089d559ca7bef408fea33aa814c2edc07eca35a9ea1377a70"}, "2a86203e-4954-4c9a-bf58-886c2274a6f2": {"doc_hash": "5574f7e6c6e02c66b374defcdd20507c91c51c280a45edafe0a690c40e978fab"}, "440122c7-3b78-489d-904e-e0f94fda9e2c": {"doc_hash": "02696e0b0f065bba03a23f15e0911d656000f964abe10bcc49fc02791b1ec884"}, "65382a9d-f1b6-4134-9420-99e6e3515f21": {"doc_hash": "293e417faa956187c236f41d7e485fc75a74085fe1acce1ad0fcd5b222bd6531"}, "7c81ecd3-1852-4c8e-9e59-52c4cc960c88": {"doc_hash": "cf1bde2ef6faded70db9b9dafd670e6c93b7c0924173d2feb87f651fbafef5f6"}, "d13da3cb-9445-4e9f-bc4f-4086d3094aef": {"doc_hash": "be6906b657ca8b1c9a43bde3cccb29d7dff19bfdcbf7b76f36e55f1b93968cae"}, "f3e2be62-9905-4c69-bb8e-e82dacfb0172": {"doc_hash": "54062369d290cc5069f0ab46a9916af2cbbbcbc1bccb7ee4f28bc8543b8f523e"}, "fd117434-8cee-451c-ae80-6cdafb89ab36": {"doc_hash": "5ed0689d627e051a1ecf90022b32c6b4fdaebcb2326fe6872449a03d8c44f4bd"}, "46fab903-bd65-4bed-89fa-4215915b5a98": {"doc_hash": "458a2e4b59f4312f6688f7ae74f99505e69413ea75eade1520d2d709eb8d71ee"}, "53388152-0495-4488-b81f-a4f44c519302": {"doc_hash": "0e89c6b1ff6bde946374f93f8e100ebc5f18d5b070b1fbb277aec2085a78bf10"}, "969aa1b9-3650-4098-80cc-d4ff65a472c0": {"doc_hash": "6c3fe51029f6e970a9f2a5e1786e569669e7419d7f195a80243edbd27fed097d"}, "602a1312-e439-4400-9e75-7ebd57787044": {"doc_hash": "42ce25fd44cc2d70e238bcaa307783a0ca8d8f61a4745fcfde112fd2cc0fabe2"}, "6081da8e-5f59-4c95-8879-f2d8e6fdf693": {"doc_hash": "672b25ebda24b119fb1af51526b1b9625edf9a3a75906c0cb0b0b845e081cc4b"}, "09902bf0-884b-42b0-855b-0814e8e38eb3": {"doc_hash": "a8bc864f5aa6f4b4d52ce11d8ab2d7a85d388e82a7ebe7e88b14b70b963890dc"}, "4e5a221c-86af-4c7f-8ab6-fcc8923bbec8": {"doc_hash": "e9a7fec52d5b0e589b767a6bc0ee6efc32c33fbbb8b76786d5c6cf01b6f06eba"}, "b3de2038-fb5d-4cf4-92fb-c52b2d5053b5": {"doc_hash": "ef2589ccd551d25af9a2c2ffbfd8eec9445e3e9eb61b1e87595f87755afe72ea"}, "5d6094d6-5229-4fda-8bdf-5b54ba3281ad": {"doc_hash": "5210203bb3fcf47002d97ed2c4028c9f81d48171e94381a735de05f224fa7c78"}, "a375168c-7ef6-43d7-baec-d629602c2e61": {"doc_hash": "71e8aec7c0ff82f04aac7530f8d1bb96c43f6c4c18d3803a4b9407f930e811d2"}, "a873d01a-f583-45a5-9b1c-0acb4b421302": {"doc_hash": "438c1b4c5a5bb51806016cbc4f95a88ba82c6c7a6fd139ab806057ed441d41d2"}, "d4968a66-01e4-411f-ba47-88438d7131bd": {"doc_hash": "eb0883ad3773782f09071aea4a073018c3e50f2d3e73448b1eaab69f94af2419"}, "f198b2e5-6c47-4fec-8bd5-0f38a5b74b0b": {"doc_hash": "270f1c846543c3b8d43c22d90f6bccd79153eec2c55cf75a4bd74b88a26119c7"}, "98593757-a895-4036-a9ef-3ddc12cc96e3": {"doc_hash": "3bec2dd2f7357591c17415d34761a438ab9e9f4d10cc14041c6a01c915539490"}, "d78897c3-032a-40bf-b2ab-0788d48bdb8b": {"doc_hash": "1c6a57bea06cf5adbd6e8431accc0bad55fc971d41eff47a9be9ca5092eb3f73"}, "fedd5123-40eb-4b67-b80b-3d80ce3e3a8c": {"doc_hash": "29194cc425bbede9a57d7d15362dd1ab1a6d4c4fcc422cf7b4ac0625dd73235f"}, "5b853828-4e4e-460a-9d9c-adb26ecd020d": {"doc_hash": "600872c562cf499189711aa669f5072bf12510490b2a7dc20b7c69de6817ab12"}, "9e7d6bd3-f4d7-4f43-9080-fcd97e581879": {"doc_hash": "9ff8a6f407adaacf2a8c53d4fef645b9460b421e5f788fc49998c78c8f253f47"}, "de7af606-e05a-429e-82f6-46659b800759": {"doc_hash": "acb4077dee3b6f5ad3ac43b4647eb6967cceb5a51b10308e4b293e99a5882494"}, "48e56db1-a34f-47b0-85f7-f8e0d4a498c7": {"doc_hash": "7a23f444bf9b267e1153d0c3995b1466e2e3d3961444e37028b19aa2147c3a32"}, "8ec066e6-b23f-4efe-a5c0-1c29405acbd8": {"doc_hash": "bf5dd9842e3e16b602a60c9dd2d4331123494f32236fa9b7ae84e516e442d896"}, "eac67285-dde7-410e-a8bf-9ed7417ab0fd": {"doc_hash": "e118307de0330f9927bc4d83ec3148865e505c05766e527bf93fd5528f08ee6c"}, "240c6a92-ffb9-4379-8cc3-62c3b9bb6797": {"doc_hash": "784f63757d689a06f0232684fb01a6b097997b3e7ce6ded63bdb217a25cb0173"}, "7184ef01-821b-4940-8b97-77f57740fe36": {"doc_hash": "4349f7b5dec32a8f4c0ece0a7c4f1621a8c17dad2cb7cefced7c4de66bd329d2"}, "8fb51e8d-354b-4d0a-8022-495b3e061ab4": {"doc_hash": "8d92d9e06fe754ab81b91001c623b2a60a95268211f1deeb5398162b4cbc9c56"}, "ad167c10-fb09-49c5-b91b-5da9208ad6c9": {"doc_hash": "663667a29136c479cc9071f2e04f85b3f09bddcea631786e387beec442f8889a"}, "e9575dc0-b5d3-47ed-a1b1-53bd518d6b4d": {"doc_hash": "f8db856d8ea10d7c58b396c2b7b808ec9ef1a81036f24efd1fcf9db2641a7ca7"}, "be2cbe4e-7eca-4745-b27b-4833381f0ded": {"doc_hash": "d21ed24abf6fa4ae8d350ac4ba95ae537b0fc354a4901eb5cfc87f89f25de950"}, "f23a9b17-ee72-4a41-8883-2ee4f753d6b9": {"doc_hash": "9657e27dafbce8965f1544bbc4fc93df6cbf698801f15b811499b237f76bfffe"}, "2b9e1723-2543-4008-ad3d-e8256e862473": {"doc_hash": "d0c32b7431b732720c1b5c9a183236d39f362e0c68123d46ca70adc8b28667df"}, "8d266231-6d43-480f-a91b-3018a85f744d": {"doc_hash": "11fff993fb2d38c3db4025af71c2964cb2faf0cae38cfd17c0319e04627f8f7e"}, "168da124-b2a2-46a4-a21c-6756a475ad72": {"doc_hash": "56fd8bb094894776301b20762cee3bbb34169fc5a3d2eba2d022c2fade202561"}, "6372dea5-5c91-4cbc-b6c2-99db1f1ad824": {"doc_hash": "b559bec330e252807a0d58d3c7ef49dc7590cbf4014ea1a8180a11185e4e969b"}, "0dd9af1d-276f-4158-9316-24d70f4c2346": {"doc_hash": "5ea58755d1679b0e425ed6a396ef7146398322fcaa42307b452475fef3db5b30"}, "eed29472-a58a-4c50-bc20-6c10b3cf4b06": {"doc_hash": "4581cc53363d8075fafe1a912ec36cc97e2624c1101ea3960498091b254146b0"}, "e9618c84-17fb-4d63-afde-315af3ee7994": {"doc_hash": "a3136f8c388067b5035c08eb2eeeebe0e2bb6ed6f1daecb94d59fe82d47761f0"}, "766d11d7-0ee7-44ce-b991-66b9b044c35c": {"doc_hash": "23eab5ed8560c8f8e20b3123d1856370972bac0d89e07ffe3eda033e2a8aa4c2"}, "96e540cb-c8be-4391-b8db-a6e7362b8bed": {"doc_hash": "89edb186ab9d00c96315a0158495329a8444edcbdab080a9a6972b81d279de2a"}, "093142eb-5b44-41bd-a7e0-0fb9c67094fb": {"doc_hash": "be337bff05d249b813fcad7f69f007c54118da5d4e78ef24e51a9c9e8e95898c"}, "3c18afb4-9eea-4a32-ac32-fbe38fbe01cf": {"doc_hash": "eccfc79727a2ecc15e84cb25b9be60875927282ffc4c1fe0b7d79a7cbf19bf43"}, "47bf9623-b0cc-4780-b5f7-98913aa5676d": {"doc_hash": "a907efb93b7ed2642b31a1bbdf30ff170c1322cb4806f1a7edc20d45018e0979"}, "ca401f0c-1cb6-4a3e-b95b-d2af330266e4": {"doc_hash": "0c5dc1b54ef156f25ece9a02ba4897832f0cf73da700ca55b16fd6f4e220cc6e"}, "d8bebab5-ca08-43d9-9d34-99e7e7f34823": {"doc_hash": "0ca385a21434028bd7d6a36a52b916e13416629d50d1759b351e527adad1ec75"}, "647767e4-695d-4162-8221-bf123378c6c4": {"doc_hash": "4ce62f750a93b568664e924adb2b0f5979e453fc19205d234d8effadb319e015"}, "dc96b367-15db-4f18-841a-c9ac2e218273": {"doc_hash": "9fd838dd0cfbecdb999b14d8be0a6fa13ddfa19b9663829e6b4e3ab4ddb6a5b1"}, "0e3eb214-e972-4b8c-be82-d6fb73f45abb": {"doc_hash": "adec571ef864cee671dcd8ca0fe0eaafdc28e75ca5bc55008278c2b546b035bd"}, "c5fa34ec-2817-4c00-8bd0-70e42d676ac7": {"doc_hash": "5689d5aeea3664f6e3ffa6884458ff3e9c8c578b4500610d709f99784e2c103c"}, "47275007-5bd9-4bd2-a364-a46daf657f56": {"doc_hash": "736767d24054a7275449c102911b6731f967b48e1820183f35f78db480674d84"}, "f16e9867-3d7f-4ab4-b0a4-730aa8ff021b": {"doc_hash": "89d921f0c99ba5593d2c8f968f742a101612fd2139830e86e16355685d5d50da"}, "8efc1757-450a-4101-85a8-6a8ac8a7cdc8": {"doc_hash": "058e5cb8bb667847f38cf217cd1ea2c7929c6fdd7f770ba65652bdab3e7165a7"}, "b6eb5b1a-cf86-4208-af68-778b22528b3c": {"doc_hash": "c5c993a978146608a5040b101b8e8e6ab57f2de99931ba1ffc7e2eb3cd936e14"}, "17ce5a05-7749-4cad-94d0-e2a035a07589": {"doc_hash": "d6bd7783725d0683da4d105bf2e67fce865ab1df5e82643ec43ef7f32d97cff7"}, "865dfd3d-082a-4c13-ba8c-d3f94173a2e5": {"doc_hash": "e195fd22e1e7aaa1a513535c16d1d84f74471f52d69876b4a1af5a092ee48717"}, "41b42745-8e37-4c18-b9bb-f5546abc7ca8": {"doc_hash": "b7fe40cd32791db2bb4160b472b31f8527b83383c11eea818286de8ab7307418"}, "2c4b01fb-9624-4039-a5c3-b9601afc5505": {"doc_hash": "e04a235f1fa03ad32e8cd2d0b65a15fb03b7b80e0f93b67ccf0421f8246fbe05"}, "fcd73603-c506-4c9f-b171-88e41786b6fc": {"doc_hash": "97d66fc39ab9f5bdd756956c7df5688dfa9ceb5dda3c147d932371241a4188cd"}, "ace1e287-3f72-420a-925d-cb07dcffeb41": {"doc_hash": "3afd858b89772cd261ca5c428d729e4a0eafdc59d1fd436b711a06dec26523c9"}, "886dbe1a-cc89-4f6e-b87c-3cccc957e758": {"doc_hash": "7898c5d8eddc7b4a49f4fc64d5628b32792bd39854f74e757f915a95671948dc"}, "a15f0fdc-e685-4859-a340-c571e43268f6": {"doc_hash": "b86451d2b807435e243e1ba4e80fe9dec6f8afe9fdf7ad16df3f6b31968c2028"}, "8c6065d3-4518-4f9a-aac9-65c10b8e7326": {"doc_hash": "e6c2b7e1e85394356bbcc189d2c738abd1d765ae15e83c420443ea7bbea97af6"}, "eaff0afd-454f-45ee-b410-8a34b92ac9d1": {"doc_hash": "3baed1d67ee805d8d29ad7ecf48c5cfea2f3380064fa577ffc61cee8341de090"}, "c2c818c3-94f1-4d70-b757-e0308d0e6047": {"doc_hash": "020b80aebf94c6971dccede15e1dd6796764aefe2abcdf47d0eeb4472f08879f"}, "f39ad70b-4517-4cea-9847-c4c7b96bb20c": {"doc_hash": "b63aa5da7a7adaf4b345cc97d35b21237e5438f7a01b1c4aad75133428fa0ca1"}, "fd1444e9-ea1a-4603-8463-b4798bcf37c3": {"doc_hash": "2dbcb76fb721ce535bdfb47753fe290ba47980c37296e55eb046372a9b109985"}, "37ce8779-2b94-4b5c-b787-096077321904": {"doc_hash": "35577037b7863f7fe90d89ad6a0566d90f59db1d2326fa34780e66407bb8b331"}, "0b3d603b-6f5c-452d-9e94-5d690fc02fcb": {"doc_hash": "327ed7deddd92a0f225919323430f138414d59c9d95827708ab0be772b9453d3"}, "e16dd13f-d22a-4924-a5cd-e5fc41c962ae": {"doc_hash": "5084f38953cccc18015ad41b9d28094c35d2cef6f318d12db14adb53e8703c87"}, "c531c61b-6774-4e5f-af49-dcc479bf860e": {"doc_hash": "8543e8a218497a4dc7bf7bd99e3b0a636361a5c396c0075b3367c27bde7bf516"}, "5c89ec9e-8fe5-4fe6-8191-d55b40abb5d1": {"doc_hash": "4719235972a73cfb2a6f3cc0818e6cb5c03acadde0676fac938f06f74c65d0a6"}, "e97a6fee-0257-45a0-996b-e4003e08f436": {"doc_hash": "7fde0363363acebd7453c644a88af977f0b7dc742bfdc5a1c64e2545043077ee"}, "7b91c120-fd51-473a-8679-845e77d25a69": {"doc_hash": "924438f81821e5ca81a27053e31c1301cde04d6c837ef0fc56aa4f0037abe0e8"}, "ba7ed773-c004-4c35-aa17-c59e08eb4c60": {"doc_hash": "f293a6f80d678f09b4fc6e7fcc42be72a5add8966199377190ddd3fbff573222"}, "88955839-0cd6-4d3d-bc2a-7fe54da0f3df": {"doc_hash": "aad8438aa74c9677d1694a95910a76f4beb38307b174096dd615dfd22efc4850"}, "e731013e-7f10-4cb5-b8c0-4f7318d29fff": {"doc_hash": "18a2deab50e81e9bd4cc93096603ab5dcbb0ca3b80e855389dba207f0581abae"}, "2f233f50-8a7b-4f63-b2df-4700c9c393f0": {"doc_hash": "54fde4d8ae59bbab5bf9169889d4c976d5d8c353bc8b12cdf18748e35eb10c6d"}, "2fdcdc6f-e99b-407d-8448-cd14401c067c": {"doc_hash": "ccfff254a63d10b5493ad18197c705795d9a24c6f39494f76d0449ba72e7b6fa"}, "a74d80ed-3ec7-40ce-8fc4-fe0b57a36a93": {"doc_hash": "9bf658cbcc2813bcecc2c8ba5c708e60df7f969b7cffb66f88da885e056ff279"}, "530a8a2d-c5af-45a2-909e-0d0c560f25cb": {"doc_hash": "39cade9ba55a03188346c4e6f9cd764e857c7733ea320e7e561aa18ac561d58b"}, "46324956-7f0c-4aff-90cc-4a9e860548fe": {"doc_hash": "b5b23f8a6744a4f9d389a047a137fa2faab3676902a58e47de1845049f512596"}, "03ae296d-730a-4d29-b64f-32e9749a5cb9": {"doc_hash": "80176d2010829af712638625649d5e8849876f1dfdc42735d11c2795a8017512"}, "33b68a48-834d-4585-b39d-cb572c743ec9": {"doc_hash": "589e9282586f3951ecce26f0ea6cd7fc932bbedee542bacae311d4d6f36d639a"}, "af3394b1-e0ad-4c6f-8797-05f32e48917c": {"doc_hash": "c86367c5ebe22ced6dd4f4d105ff51e659dcd83d3f9e01f7a9b3c11d14092933"}, "71d387cf-b021-401a-a21e-1106fa502a10": {"doc_hash": "571c5ed73c186fe102f61d8277fa293e8ae82541e244e71f283e948a049a6b0f"}, "4c54b4e3-a104-43cb-a352-eb08ea20274b": {"doc_hash": "e166d5626b9e6445c80f0e2a17616bf33b9f2ded4714a624d11b70438e6878c8"}, "6fa06366-fd96-47da-99c5-2d88b429cb70": {"doc_hash": "8ec2bd0d05de11fb9bcbb8bfade91595d8cdd40b47f537202e9c560edc31ea2c"}, "4f6ef1ec-493d-4a04-8ea5-cf7b6c0c1c4f": {"doc_hash": "66c93a3e572288b3b507d5a118688cc21a228209a08c7f09c4706cc3c1e18840"}, "ec0964c0-7075-4fb5-8192-dbe44bbaac35": {"doc_hash": "de16c78513740592cc73764cf3b0229bc774b60e9851318ac308ccea314d3d2d"}, "179ad5e8-2168-42e5-9b4a-3fc25a4bacbe": {"doc_hash": "7074caea0f2420440c97e5045e807507995021660ae184ddbcf5551a3ca642eb"}, "7211b10d-5d49-428b-a6ac-c8e52e775ede": {"doc_hash": "f8c24fee861a34e66891d512787ee1c8a208772d2d14170775ec4900147d4f54"}, "6bbf4b1e-91d7-4e0e-8415-43a3e9facda7": {"doc_hash": "ef81d0a630128158cb29d9b727e6e69d20bbd7a426d67ba61fa42752b33fe3d9"}, "ed92c2c6-1d2b-4944-a66c-a3f178c78963": {"doc_hash": "a807669647fe15e92bcbc3a431cab25c4ec98940b5a9b6ce9a0720544e20464f"}, "6395f535-202c-40ae-af13-5cd0750064de": {"doc_hash": "047c6fe8d67318ed98488c9b766acfe48bdff5dda6052bea2891277c8cae0880"}, "25251940-a9aa-4a44-be2a-d6d182a6643c": {"doc_hash": "16391ce1c4eaad9a127648bfd62ae626ba5a0f37ba4bad6bc7302e4f37ae3e04"}, "c488adb3-85df-415f-b162-2059539bd9e1": {"doc_hash": "cac95608b6373192a38acca1ae1f54b7c4b764ae49ec84689080ad7354239587"}, "41620ec0-17d6-491d-b92e-f2feb3f5dafc": {"doc_hash": "bfbd4931dd3f82f7f4790d550f010a14f4b8ca45873dde69f877ef2b10359f66"}, "bd5276f9-8c4a-4cbf-8121-62c5f3188573": {"doc_hash": "5a0f5e833fe753896c27f332dfc58d6cdbb8b526bfa136a41cc65887492f1083"}, "77362737-2019-4275-b843-391f0f66c833": {"doc_hash": "c9732bbb1960bfecea26778838cc706460fb3a4316e9d6d9f44114216c3c1d9e"}, "d4f9f3d6-5264-403b-8ed9-b3f55debc262": {"doc_hash": "7f8ea45b280af8bb703701f2ee1b2479d7fa13536cceba875be1aae8422b7f9a"}, "d0124cc1-a30a-4d11-b057-b5cb518082ce": {"doc_hash": "109e951c8dd7253b98951237178993a4e453f4116bb82ba32c18b87b1ac30e21"}, "08ec5caf-db44-40e2-aa24-02749acf641f": {"doc_hash": "cb23bf514210b4d54fb2cf3a475a542f306725f11acb873793f3e54e16d9dd89"}, "9464a974-34ee-4592-9db7-80cee722a664": {"doc_hash": "52cd59a0ec47624e4ce905898eb222e5939e350b7aa7cf4e6aec1976732da73c"}, "81957cd5-b59d-4b41-bea7-cdce65fa0f74": {"doc_hash": "c2ae886fbb973bc02fccbd2d21853ef222fc94a3538ec21715b34a5f3845b41c"}, "978509c9-644c-4cce-8779-41b73b77d6df": {"doc_hash": "b2236c5068f8e0a7fa089a459def8e6bfc1c5f5b17dfd9e53094469abdbddf22"}, "8a4cee62-34ff-489a-b469-9008fdac7c6f": {"doc_hash": "b2267212a82605eb000200e7de1ad7511a78a71eb4432e7c9c7d1bfb315580a4"}, "10bb66b5-b2ae-4876-a56b-73b97d570b8e": {"doc_hash": "b37b9cb798e649825f189908b860272af1460b9feb631531f55b30448199a224"}, "2581dd4a-8231-4db4-a147-21247e3535e5": {"doc_hash": "d482b09844bc0304581fdaa944409c910abd8aa7d695a9fe055445b382701ab4"}, "c232d232-e884-4c69-b5c5-b9b5ac48dd6b": {"doc_hash": "5b52951914d2e122d833fc5a24d79e9d64af1edc79ca2c7adce65fe015036096"}, "dee528de-6897-40c7-90a8-ca2d316e0707": {"doc_hash": "6de4e1ffcf7ea2d19dada4cbdb12ab9aae73514e7351a422226d26b2e96ecae8"}, "3053c4a2-649f-4da0-8b26-58906bb1e2aa": {"doc_hash": "06654ef3e7216e57c72870f6274a8a4efe6922d6cb9177fae85a1edd70757042"}, "768e62b1-4fd0-47cf-868f-29f51dddc810": {"doc_hash": "5f6f4e651f511ad59bbd2fcfa974c91d31825292bed6f0fce4eb517629b2efa0"}, "f2fce29c-72c4-471c-9f2c-7aa2905e4800": {"doc_hash": "d7097195c3ae2f9d149d904e5d6c9a842e2a49956df25ab048be14ef19ddd423"}, "1a331528-9e76-438a-9b25-fecde62bfd6b": {"doc_hash": "c14a1b03862906144ba9e946e66588d0fa986d056cf68589e8e79f13e989c460"}, "64fdaecc-2262-45c5-837f-b1c02a2b04ec": {"doc_hash": "c44b216dbcb506d8f04dd19edbe847975ac4562334f6ac7c01964adccbe5c690"}, "bfa27bcb-2237-40a5-b9b8-66e737ad0bf3": {"doc_hash": "abf4c14041a25c927f82e0b219fd2b7d9a6c0b99bf15f5e1b45cf3843b0afe6a"}, "0438edf7-54b4-45fc-92ca-3e10b8691fd5": {"doc_hash": "6bbab592f856a48b8532295ebaf7934936dedb1fded79b23213b55514ca2e31e"}, "c1545690-c03d-429a-9824-919d39e1bb8b": {"doc_hash": "475597bc4acae83f79ddf76cf3244febf27d63dba235bb642316e625f8977906"}, "500dd663-ab10-49a3-ba66-1e29de46d7b8": {"doc_hash": "fb8bc4c0bc7f7a3d255544eef07c89e3113df845f5485e7ff80162c45fff3fd0"}, "19155338-de8b-47be-9b4f-923dbbd478f9": {"doc_hash": "411a1ca55cb79721e440dbd03e2ac1c3853a298282e8cf15e6be186fa95c6651"}, "8bfae649-ca7a-447e-b5ea-b4626bbc3cd8": {"doc_hash": "a97695487bc24717efce03b7aa9f5960f5a9b38df261cce1fae0c3438751805e"}, "9aa7c006-17e3-45fd-8f1a-3baa73580c3b": {"doc_hash": "8c2d2b49abcab45e16abe8808832fc4067ef002a6a1591a685ee303ff5b2bca8"}, "78881e17-c525-4eba-970f-7a041e68e21a": {"doc_hash": "69bf917d3bab1a4cdaa0e45d50e162718b45019eb4627cacfbeb5b9df9b6ee26"}, "50e71756-353c-4210-bed6-872cea03856a": {"doc_hash": "7a71b3e902c119d602b9a441323b6e9adafdc1c7f0727596fbe886fe47ddb873"}, "a03e446b-7c7b-4760-a388-d1f2f678d606": {"doc_hash": "e978f456475213d545534ccbcc04bc81f5e6c13746f2c2f5c16fabb2cea0ab43"}, "3376a34d-1a3f-45fb-9da2-184d1178df59": {"doc_hash": "1b90e8ced0dd57081abafe2b391d5759d794ce2a6afcc876546a42ad0b3c73b8"}, "a9568b26-ee9b-4411-87f9-2ec374d23452": {"doc_hash": "2470c6577152855abb9527c3f29da95dad25e6aa8f26e0f2a0c3fee712db3a36"}, "d6232089-f1fa-4846-99ab-d09259c97e72": {"doc_hash": "0690504b6a26e62da7e5b7070f54b6c4ca4f413e08157dbd9f7b6947042ea3fb"}, "6462ee0d-7760-434c-a7ad-bb2ab830e4cd": {"doc_hash": "1697f044940454f86ddd8d1071801985a7590fb6635afa0d68e45dc751cf4b2f"}, "26ccd585-ed8c-4540-b663-ca78d36b32b5": {"doc_hash": "9f726d355f44536c852d57712f635617eb3e4de8c9d2e5b5c3f71b38606d0c7f"}, "0872a95f-a12d-454b-8fb5-8fa8a8745c32": {"doc_hash": "bb59575fee8901feca2c923a621e0a577ebfa2059c165b6ebab300c98ef2a7dd"}, "6954f9ca-a7ec-493a-be4d-db893e3fb581": {"doc_hash": "3020267a4f92141ab4dc3ae527f87e6fb225cb0a105a5f8aac6a1da7b6923ea7"}, "01f8ccf6-c17b-444b-b86b-16ca2bd4519a": {"doc_hash": "7513840168fd77fd6f5687ff9c6c92ff4741345b8231098f4985cb1e5eff9c54"}, "b0573aee-04b4-4eb9-8aff-1b831ea7adee": {"doc_hash": "450f79c9d0e07ef3a3a5bbe6ca0fc54090c8f8a15cbfeee3f5f4f470ea3caaed"}, "04273a0d-2536-4665-9838-ba4be1315332": {"doc_hash": "4e7816f0c88f34ba4024ba042ee9eae4215d1394574fa1c6e633256b8b27961e"}, "cb9b74d6-c457-41ab-a698-be9e5117e15e": {"doc_hash": "6c44f1a3f0ac475a9d1c69b71d0005979c5189c2b03138863eccb10ed926188b"}, "abe218d5-7fbd-46bd-a5ea-4ae4541ccf0a": {"doc_hash": "ee4308a7bce245537979afeb14e5654c7ff0442365aa9a6f4b66da18aa5e2996"}, "69b2902c-0352-47bf-b8d1-18e8d3a80685": {"doc_hash": "8e76ac5c61baca43dd8a35ff9401f9b84d7142874d2bfbaea0a50c4c52c85f91"}, "e5be28c1-accb-4d2a-8d1a-a68a8317bab5": {"doc_hash": "cf0e1d93a75b47e725ee83826b0f6760f650b57c9491673790621afa41674fc9"}, "9c5f1562-e517-4a26-bf03-ca35368c5323": {"doc_hash": "d71a676bff6939396b88025f50011ee5fb7b22be369a47e29b1f329b22041cd4"}, "395498b6-3b64-48e8-a76f-7570241b9d7c": {"doc_hash": "dae2143d6f20974d2e00c5551bad57e950896f7641b752a1d803bcd219c81ded"}, "e22252c5-29e4-4c97-ab69-4d724bf10dda": {"doc_hash": "7f8c1e20c28d28b09c0bea474cb60ba31ee57bd3a5e8afa5f810e38fad3880fd"}, "d68ce0ac-4b94-4063-bb5e-1b26b9549a34": {"doc_hash": "97601edee6ef19aa22ee030c3b7c5c77c2c18c9d701c35b2d87fb7386e6bdb53"}, "f0bf4a6b-0bc9-4657-a02b-5f9928d52d02": {"doc_hash": "38171eb5a279d17a82e7c3e34f0be9189914812165cc75e9c13f6aa9b82343db"}, "f4d8fdda-7afb-42a4-b263-315c6759a080": {"doc_hash": "e24c9cf63171069b30e2dada39ce134096beada50bde4ae71a33fa3180d27add"}, "d3c06c8f-28b9-4ad2-9a41-3ea8061b8bb8": {"doc_hash": "50f9c84e3b028b9e238eb5c0832a75cc5b685b505bf9b615da9c2d597abdbd0c"}, "f8567d07-388e-45e6-8078-dfd315af2abf": {"doc_hash": "6cba303e95366ddd4b92def6dfaf748d620dae53ee24681e654e8c2d4142dbf5"}, "5a9186a3-c5b2-421e-bad9-52037ff8f147": {"doc_hash": "44d8e6308c1bb860cc7c20bcc933ec8de1d14edb50e7479bd9202896c673365f"}, "414c19d2-8dc2-430c-96da-8392067048f1": {"doc_hash": "031faa4e16b4b12a9fc883ea9113bc7bf4fe01326957e9cf008b63a80a1c2aac"}, "e634a94d-f01a-40c1-97a9-b40e98f81cc9": {"doc_hash": "d86ae800efcbe190918cdb187ce51b5779bc016554ff2b92666f229adcb5fbe3"}, "da6b46e2-a30f-42c9-b5df-409135888d47": {"doc_hash": "55f2e7947d627901f7f4cba50e86f76dc74a624b4dec491c21f47a92d5111e03"}, "285ac0c1-3190-4173-bbde-62197b34d2c9": {"doc_hash": "1e16657c9c9c371375aba4e29f49fb66d9b01915ffab6ae79756847ac0f0870d"}, "16fd00d8-ae5e-4807-877a-2779a8b43f3a": {"doc_hash": "0f42854f6e39c7edbb8ca9ca0d9e299e69bede018d246d80a741c6c438d16879"}, "37ad5fb6-fd88-4971-8d40-64f08ff770b3": {"doc_hash": "5252b98370390722509117bfb54315ead3698c43f455375eed43bea727dc0da8"}, "c5da2eea-0177-43bd-ab5f-96b6c181450d": {"doc_hash": "af5ce9b0c9b2910466fadbd972e6480cfaee838fa82756b711dbdf4bdc178a85"}, "9843dc54-2c66-4950-ae83-07365b0620c7": {"doc_hash": "b81dadb19997571b6b6f5a40f87be434d600e3e3eb7c3fcc8aa3c837cc1c73b4"}, "8539a61a-f8fd-4077-8507-154b939fd6b5": {"doc_hash": "4134fd0f4be42a7f10ee49607e0961f6e2a0536545446e74c2a540f3b522ccfe"}, "445010af-be61-47fa-96e3-7e3311ae92e5": {"doc_hash": "cde86f69711736bcf4ee85e6cb5ef1c9dc0cef0eb9fc3367454ecf421c2aacac"}, "78f83326-329d-4bba-9954-2e47fe4cdbde": {"doc_hash": "d17a8ec303a8cff603d04f0bb611e82480da5326e7e9da68bbb40e996bfde601"}, "ced2e015-d42d-44a6-9896-5d7d5b6b035e": {"doc_hash": "8d54cee5e3e27f479a7c4625d4d145b2756daf0344a06077bc92ae5cdc3904f3"}, "28f49267-5c6f-40a5-96c2-761c97e54565": {"doc_hash": "20e7d3ede98fd68b9770b05add18f261b0a164c05d1a68459fac89d667104995"}, "3a8e6836-91a9-4a45-8c51-467166017b5b": {"doc_hash": "73f563ca6a686db17c7cbfa81417d0d1bd6725eb7382bbe9e378a3fd0371c35b"}, "27d7d2e1-8b17-40b0-bc1a-6bf7d1d99f29": {"doc_hash": "1b0196f4a881fef61150afd1d940a9285086f590ec4853db4934803e4af47f19"}, "16196aef-a89a-4129-a589-8a59cacbe57b": {"doc_hash": "d6b1a5df1fd70484f5bd8595649713c6e19b966351198c225aa158328ee568bf"}, "2828cf88-22b2-4f21-b1ec-e3b687d57b4b": {"doc_hash": "f7018f20959accb06a49a9a2364b78ea0c3076356ab54e653f35fcec1f7b2abe"}, "dda42b98-4673-4f4c-b0a4-eb142ee475ae": {"doc_hash": "7c8eddf86281f8925551cb0c3fa273e835f232e656bc4b00973eafd723af76f9"}, "7b5f1e27-ce57-404b-b178-75462eac1191": {"doc_hash": "f3374d477560f5c07f03925ed82ab8c04d51627241b37c661efe318ced3038bd"}, "b30cca01-bca3-4cd6-8b28-ef040cdef698": {"doc_hash": "fbac300e08cb472664fee5162e79ed7a47f0c9512feda06fc2566b7ca1c42fbf"}, "3d41d941-e12f-4b03-8278-95934e666eef": {"doc_hash": "0a36a36aaaa5b0471cee5f3aee0e94f8c70819bd1a4bfc4fe45dd5fd6b4f3a39"}, "0222e3b8-2e99-409d-9dc9-325350e1368c": {"doc_hash": "3058cd9021d4aa5af8b2cdd0cb78abdda1382460fc4752ffff5dd6584b377b74"}, "da724003-f946-4e97-aab5-6723bf41167b": {"doc_hash": "99b6ba63c28b5922361f4f694a5820508bc7a2bab14aadb648c2e1eaed366e78"}, "6a23ed58-8ff0-44eb-84a5-86be2329939e": {"doc_hash": "11d39ee6195ddc223953045864f7e651b3a441a96c7454a941f050f385a5810e"}, "bb70d6a9-956a-42c7-a90e-340138353d6b": {"doc_hash": "8ad4bd4e9e826240b2f57bb020ca0cdbd770196d6aa575f827a7e38f5da3fd04"}, "c338b85b-5910-460f-8985-baf44b386a50": {"doc_hash": "8b482fe40d41efef097894fc37b7e389e8ae33412ad2b29f1b1ae3ebbc972663"}, "0cc39450-ffee-4e2a-a6fb-0cf4205ed138": {"doc_hash": "f56c8a77e48623d8111cae4cda7ac6a26f4935eb75c7d0b468c8b26a1cc2d2c4"}, "fa97cbc6-dca5-4588-b3e2-5ac343963e64": {"doc_hash": "aadff34f0c7889ca43776d1e6eafdf81960a0e08d3af985245ce90ddd3f79622"}, "e429dcd4-fc5f-47d4-afc5-091d24ecf087": {"doc_hash": "5e62ed6f1adf2cd32b1357aba8ec06e8696d005611cd4082ea123d22bbac6420"}, "9c5d9557-dc8f-4f83-a3e5-6482850caa45": {"doc_hash": "a60bfb7c527c4c99f0b3b4a05fe23b3b8e2822bb8b159cd47b0276c3df6f63a5"}, "096f6d0f-a1b9-4d89-a030-b614f13b0928": {"doc_hash": "ef007957c63f76c07b122e758da19f7f31b47190681fe935e717446fcbd3132f"}, "9e2cbbaa-a0e9-4982-b5b2-5032090d844d": {"doc_hash": "e6b57488463638656c36b33244a53c76ccfb484e3fded0158b1dd830e8d32bf1"}, "1642f712-6069-41a3-b668-f070c4fb1660": {"doc_hash": "e8c51bdfa3563e3d9bc7bbc70700a6d1d24aa3913a15b8bcc99f7da2a04a1e4f"}, "0221f21f-533e-499e-8a6c-9ab3371aba6c": {"doc_hash": "512c92bcf0b4e541ab7b6129388b2692e2e06298901e831a86548a62d887952c"}, "408c9afc-ae19-442e-b34e-6f4a968be1e9": {"doc_hash": "658f4526bbf9c55f7f7030100b04959efd0a66ceef6e4427e12f2a0cb6f97f9e"}, "7b198585-0651-4d18-9ad1-2c18c5384b89": {"doc_hash": "3802a8decd6b3132a1d91ef3d4a414f1d73f71baa16dc64d0d87f676df6c5fc4"}, "d18dbc97-899f-4591-9001-e9278a0d8ac2": {"doc_hash": "462995275305545aca5f9a7935190f5d53f747754281259e2856a995bd717452"}, "da0ccd8d-0ed8-4352-bada-fb542d16444e": {"doc_hash": "408d8f292e2d89d2218f9f17758219e104c00cae0e42b0b61fa2a7c6ed8773d9"}, "9030a411-2fe7-490e-bf54-98da9e614fea": {"doc_hash": "4ffd2d42aed353d791fab27239387a1c03a7b922b55b42e71184c380b0c2998a"}, "15ed4db5-c25c-4510-b40a-b888c83dde49": {"doc_hash": "1e30474004b91558e91f285de5dd70c26d83bc9b45e83fb877e9b3ddc8e2ca29"}, "7e9ce147-1d7d-46b0-926c-8d6c5b3236fc": {"doc_hash": "0714ef50a2874e64b91f83176605a50f862b9cb89f240d674a1cfe2549e3af9a"}, "5076c786-4113-46e6-af09-3c1065253e6b": {"doc_hash": "971fca375b8033a3687d436d5ab61e3d4872ff22d48005c08aa633750ec12409"}, "7b116cc3-b924-4681-80a0-6f2942899ae0": {"doc_hash": "4b869e56a38969245bacb4d472786dd01d2bec68dbe80eeb07ebc76173ff6f96"}, "c3da7ba5-9756-4bbc-88a9-04f2b9c1d47c": {"doc_hash": "718a10526e7bb21d02cb415e9e468c6aef4aff9c80465c67a78f5f9add26b12c"}, "6e3ef52f-d2a2-435c-a94e-e183aff702dc": {"doc_hash": "5854743fe376dd6ba6b13ee12b9451b77d8aa0bee93670f83a18e9d49601339f"}, "ad883cdb-5bc4-4b28-9b53-d45eae2c3dac": {"doc_hash": "d20dfa5fefbefa2a17485a96ee159429d6c7d5c0f5be461fbb40db3da1197c1f"}, "6544ec01-8856-411c-87c3-c9fdff15b75a": {"doc_hash": "ffa8b12f0147ae18c1ef1b48b80c5d7779bdf860d27d742093554eea4b8f4b71"}, "97adca19-548a-4ca8-8bdb-139e790d4474": {"doc_hash": "c5044e252266641025a147ea1c816784606e9c36ddea0b4b6141bfb4ae0bdcfd"}, "8d03a7f9-e960-4642-9e43-7e040e6cf608": {"doc_hash": "5c2a6e138819c376ea9277d9548abf3d7232542eb184073bfcb03b9aec12bc72"}, "80fdd1b4-fd4a-482c-b6bc-21072484a0aa": {"doc_hash": "88bd9b8ecf5107d4617fce00b1cc32d8ea5ae9c90076448d7f8335a0380d90c5"}, "ba0f64b0-60c7-4bb6-9eae-f330517d1527": {"doc_hash": "dea485a852c8aaa6958b8145ffb67342fbce888aefea31b410f9862501f07f30"}, "66236342-c64b-42a4-bd6a-21375720f8d2": {"doc_hash": "509b244dbcde7f3145f6479de92eb928ab7df5c69a3fec89804e57e132494dd6"}, "d1183035-04d1-4881-bbce-bdcc1f90d454": {"doc_hash": "d0e3197d432f3257ca583ae4e7287cd1a6b4a0d4e40eaa29470e7e06aacf3cb6"}, "d1d821a4-265f-424d-a1e9-ba9cd96749ef": {"doc_hash": "c53f4e9c8b81ef5d87dceeddf71e02a8b7eec80444bd44182f025c5d3d2bd843"}, "809252d7-09c1-45b4-8e0c-cd17abed0bc3": {"doc_hash": "657b14b641a5d657c9c9a18ef16648f3685f0512af76316c09c2e22bbc9e0089"}, "3efc3db5-f691-49b1-915a-d33eb89b5584": {"doc_hash": "d13f7ff9bf210c10214ba78a6f4f6d2fce2428114f9a2252113cfef97933a1ad"}, "3d7fb24b-545c-4805-b50e-cb64f3eefdb6": {"doc_hash": "d19d5b166d89f17b74428f316be9fce2184710132f321d778d259ebf3b81d0e5"}, "d5d8e73b-cdbb-4bb4-bd44-5d5061357f0b": {"doc_hash": "ac7e5d2c4f326450ef464c2cc581f7b331e741e94237893583cd51a37f489f1f"}, "ea015b4e-e9df-469c-8e4a-2540fd0ce2e2": {"doc_hash": "b28dd3d4bfa278ba857aebc08a5fc7ec61a623ea1e3aed88340227b06ec44783"}, "c0b9c18a-d7e8-41b4-9208-cd94722c46d0": {"doc_hash": "46a69ab64b94fdbb3dfd65e1446b1fe178f6057e897e92f12dafdf7de0ea99a4"}, "56536342-369d-4ac0-9b53-6a7d41ef9093": {"doc_hash": "ca833ed2566829eeb6006d30b10fc83e2131471a4cd3fe20f064a364ffde73c7"}, "94c39ae4-911b-486c-afb6-ce3b469ab99e": {"doc_hash": "31fcdd0b030fc4d82fda34c8592604dfa3a1e82bf554dadb3d472f385ab4c386"}, "6fa2d6e4-5d6d-4b07-a521-2eb3ec602aca": {"doc_hash": "de0fd26fb5f350e4b38fff6e98e67bae90005457698da574b14e58fee1c8d917"}, "6c6f8500-d42c-4ffd-9880-6bf8efb96eb5": {"doc_hash": "f6e976021ab43387f28b40afa4cf74d0b20310e8c40424585e86e700a3f784fe"}, "2b2afbcf-c5d2-4f9c-a31c-b0623cfa21a7": {"doc_hash": "239a3c19df37d476a79064f08c4b433da7245bf3a04947ca46f2e1df5e1df9ee"}, "db1aaa1a-25d0-423d-8d8a-867328927174": {"doc_hash": "ad1297449eee92145d01cef58849f27d9a8a7c040cf33dea615f8de0e1c6b67a"}, "9a87e606-489f-4eca-8b52-5930f9294ecd": {"doc_hash": "f4682c189326615eada01342780b79283a4f805f0cf4962c983b2009f218b5e1"}, "48e56091-4ff4-4414-a543-59fb3fcd44f6": {"doc_hash": "99c642643851e705ee1507fff4d45336e43a8de9049b60afe5a143c880e9cf3c"}, "f3819c57-c2ad-4fdf-9ee5-1a9cebc0094a": {"doc_hash": "7b4137b3a22436616bbb5f582b87f1c48a9a493f68464a662a124f26a38fd35e"}, "126e3063-fd17-40b2-9763-eb9ca89dd3ce": {"doc_hash": "56da5725afb4989d52cb19c0791fd8902022fca46c50d4e18676ffe7a81442c3"}, "4fd7aef3-8287-4b77-86e3-e302dd2e0e1d": {"doc_hash": "d7826e3bf197bf1b7501f0316bf14bec2474b1851fb63c9671667a45584f2500"}, "179f7de7-3417-4759-aea1-5af23e617098": {"doc_hash": "00a73f31f13de72f4a712f52a8298d86238d03c968e09cddfef48720ca0aafa9"}, "b4c15fdd-cade-41fa-898f-8ce1b3698eda": {"doc_hash": "bfe77c34aacb7d453b459a0a9405b96dd34fe0c8f034f9ed75cdc612ad9c202e"}, "c348d70a-c948-4bbb-adfa-cd8d0584c6bc": {"doc_hash": "10d995800527d9dcaa56f38bd2b98a0a5dea18c5950cad36eeea1953bc9cfc1a"}, "90f05822-ff9e-4dd6-a16f-74811208cea9": {"doc_hash": "ef574da628a06dbba4867f21a3eb60a8adc4814a4a7bd968c707e75288b22b93"}, "c2cb36ea-501c-4d7a-94d8-57e04e2abccb": {"doc_hash": "4242a1aa04902a78f2c5f8b951db404d78de7174ca0ebc82cd04530d699e9598"}, "bad1e53b-3f75-49da-9933-9dfa87803513": {"doc_hash": "ef73726f229d97f8e2009f53117821ae5dca7e1a623605cb41ab32b18cf80e85"}, "641565d9-5d94-42d9-8bf5-71065e432027": {"doc_hash": "cbe09d3efebbc9b1b15dfabfe45e79af27d39e17f0744eef196a652aa6fa4e41"}, "9e355033-4d36-4402-9ae1-91586cae39c5": {"doc_hash": "24208b63a804b77146ff96f14d15c43ca471b42087883d9cb360e8d1f7bffe47"}, "d844d938-d107-4133-8b6d-943c8f6882e1": {"doc_hash": "59c83146c38fc32c5b57ca13bc29d758a44c6d9b518eacc94caa964b2e3f5e93"}, "466948df-3193-49dd-aef9-5660f2d1b2f4": {"doc_hash": "d491aca4021c6eac3260db859e8c9d7ad1a1243805a613a15a91534a581c155b"}, "d4ebb80b-57c2-4212-ae89-b7d03fed5808": {"doc_hash": "10bc2774c52f67a060f199b77781535317d55766babf72b191fcb70e1898e1a8"}, "e986b28b-65f2-440c-9164-d1771d720e5b": {"doc_hash": "f5eed40d07e32360b1da73c617275c22a63eac661eda4ac82d65f89c367706c0"}, "b45fa1d8-31d2-4ace-9dbf-2985acbcc01e": {"doc_hash": "7f1eca43e99e5ab43a4a9d8170313fcc5475db2a3b24d0af7dd5972f45960244"}, "b0a102fd-edb9-4528-8813-817a66edb6ce": {"doc_hash": "65fddfdcaf2bb7b87865d6302bb63306cd7c7a703ae8108049fb32dae45b2ffe"}, "0d9ab629-dc3a-46f4-a4f1-b274c1d61ecc": {"doc_hash": "690d258f4106c1ac20da680d56c044895f8d988e74a318c8d0f1d029ade5b888"}, "bbb4e867-9c55-45b4-89a8-110d3cd81088": {"doc_hash": "7ae591be7f8583bf795b61f377e191ddd02a0e546dad234026b677eb690fb02f"}, "f76b4f24-17e7-49e3-af96-50f841fa4053": {"doc_hash": "8e6312565726fef6aaeefb4b744a77cb0eafce9a3ce9140ea6810d15dc59d8bb"}, "8b6161e9-28be-420c-9df5-e2cb8f3ddb00": {"doc_hash": "69e98fd3d3e7e606b1c8d6b14604a2207eac6f0d7c25570499813012f4928024"}, "6aaba0e6-6fc2-4137-9d93-f9e28f1a8f96": {"doc_hash": "52e914fdcb1d2355be183d2f21bea82e6f571df5a46883a75fa2d302df60a944"}, "8144624d-fe3b-430f-9b0b-cb7f09d22a3f": {"doc_hash": "c86aef899c5fc0e2d0fe6121ee220536abc7d58e105b19e32947e22d56add9d2"}, "dbbd87a3-3925-4eda-b0b4-f6b5997aa555": {"doc_hash": "3dcbec1d043d4cb5a04690203ee681f0aa3d623a5a1b6170c500e14c04482eb9"}, "be11db4e-3d43-4fe4-b75b-d6fd466fd959": {"doc_hash": "79f1296e1577f4f8dd814b8f77bded9cf4efbd2443ac9b3cceb4f48b0af2975b"}, "dce594c8-8c6f-46dd-ab57-c708e6af7f54": {"doc_hash": "3000dacf3967666eea50ab9d2a4f8c9ec0e13c5125861d3d851f004b001b2caf"}, "6fd743f9-6b2a-4993-a587-d1ebc3371876": {"doc_hash": "1a9e6a11b1dc545060c33bfc1693e385d125aeed4bc3d75868fd197b0a6aabb7"}, "73585aa2-0aa6-4c2b-a2cb-d3a7054912ea": {"doc_hash": "dd5e56d32dadcbb57c816eeb352a549518e6cdc59041f4e7d8a1b9b409cb1d8c"}, "1092826d-70a7-47fc-b815-a0fec2eca5a2": {"doc_hash": "f05981aa4c7ce0295daa459bffe3ee2bbf0a4da54f48e4af001d77909f95268d"}, "a5dcb2cd-9355-4083-8ce6-cdc64275d3b2": {"doc_hash": "441894e35f1d2954cd04063d8d1b74736ec3d5425c227a716a969f0022b15989"}, "38d2a0d1-c1e5-4181-a4c6-2483b114b7c4": {"doc_hash": "4793a5777e6516a6849bb4137a4f9eacbb4192588193be2fa4606ba1d0ed5c7f"}, "4d8006dc-bf0b-4e97-81fe-43f3818136f4": {"doc_hash": "a1170dfa17a28c88e21f44609a7a7ccac388c7d2c08bf1a48181d8b3cd026fa2"}, "ec1a898c-61f2-4f2d-aa85-9924745205c9": {"doc_hash": "7e48d1accf15f23908509547e32bd801e97e0d795c898fc3118248816cf8bbcc"}, "998a3f32-8c34-4aac-82ce-5e09116d7dc3": {"doc_hash": "58cdf18324dea9fb34e2ed0321d7016530e7d257feee0b91ea69b693effd36f4"}, "b0eb98a7-8078-4088-9626-0f0a1a73d54a": {"doc_hash": "458d0a0d135966e6221ca10a2e7cf84304da040430e7a27eb552ccaa12dbccd2"}, "8ac6b4ec-6c2c-4ce7-a6f3-09940035431a": {"doc_hash": "346169a0b08f6110261df93f58307808fd2c16e6066619f5d27aec04d3928d36"}, "11193413-5dfa-49ed-b554-659fb978048f": {"doc_hash": "f7288ef4614a29a2a25508db872a605b69d76b73ed1a7aa31b275656fc829b75"}, "ba6ae197-583e-41a3-acaa-e34f13ecd4a8": {"doc_hash": "e08f116ee7666e296c590cfe38865f26c9a2350c104d31a1a42921664c201404"}, "a86d8f41-431b-418a-876e-738034e77aa2": {"doc_hash": "bfc030c43521d51b2fd41e4a5ad9fb15edd3f20c4a796545348c682fb8ed0763"}, "087c9eb8-b802-478b-a328-100010ddae24": {"doc_hash": "4462f4a7bc32f688e9260e046f37e6ec3404d7d3890055ba59a0c260506280f4"}, "64c87987-c398-47fd-bdea-9ecb541e4b90": {"doc_hash": "5fa02928458f8455c7dd8faa9cd60a227a539a7e9e1ebfd7f3dea10401e7ad9b"}, "0507fe5c-5eb7-4339-88b6-c0851636e608": {"doc_hash": "7bffc83e6fa57e7885feaf78ab96f60521f854ddadaf67776149cfe6f8e72285"}, "f869ac5d-b608-49e6-b0ed-9106387e6c41": {"doc_hash": "8d50df0d6555a78a0f72a99a2c11e0884a446b46eae01ba9999b07f39734c9fc"}, "4030aae3-0365-443e-a794-e358776dd6f3": {"doc_hash": "7a18ac42d492a58d783375b3f237f338d5cb8ef3ecb782b0730be7c660a9777d"}, "941ae92a-ee2d-40a9-9000-7b2e00b061f6": {"doc_hash": "8926f648fa2599e09628fc8531012c509d2fcb1cd0baa622551fc41d3921eb80"}, "5bd77dd5-0f77-412c-a16e-8fe9bcbd4f25": {"doc_hash": "502b82893a3dba4237f2391574c9d808ce603e4be43f65714443a1a1dd8658e8"}, "21c5150f-ba65-4463-b9a4-7b6cc46774d1": {"doc_hash": "accb814e33441a0c4ca2aaa884d01c23054b73f5ed777c3d4b56fcea473b18a8"}, "acabbdc1-3dac-4cb0-a745-98ee92a31da5": {"doc_hash": "fe143ad143ab8c6499187404c0940bcbb26757a4453b9b90dd5180b9e64740e3"}, "880f2ccc-ce11-4f02-b940-ad9e5fbed360": {"doc_hash": "53cada3a28dc3efda5124d657208133ab0f1da11f986de2e81b24717495dc212"}, "c2286310-5d5e-456f-bc5f-07dd356f904f": {"doc_hash": "5001f2fce29ed2f69d4cfee11c6053f28465d68eb16127201274d6f73cb76cea"}, "b79e56cc-1fc9-4282-a83e-d131ee3df67a": {"doc_hash": "527dd879152175a46400cd759ae9e20b6ae930618d61a3acda97f39dea4a7ff6"}, "8fa06bdf-3135-4003-9bfd-fbe0dd9501e5": {"doc_hash": "72b5eceb43e437c0c913c02e501d4fe317b8829623df1b6e37fc9796f1d50d27"}, "8cbd348c-8e10-494e-b9a9-a36551bb66ca": {"doc_hash": "57c18b125c75ebfec22d7f7edfe95f30bec8533bc1dadd3ecda2c5b6f850a9f5"}, "6b692a4f-0b81-48ac-842b-07859deb3301": {"doc_hash": "ff17bbe69af57876db14e4d43938a19273cf60ce613b778e2d3e8c798cde8dc1"}, "da06ef5a-6c94-43a2-9347-b7d0f6280998": {"doc_hash": "8dcd567fe33c9e15808c8d7e232657b1b550caf7162c1ab8f78d720638c63472"}, "12171429-7444-4e97-b551-1ea5eed30f87": {"doc_hash": "323eefb78991c6cd3d12f95d944e8669ce15be50cf211b5572d8d868ecea4f7f"}, "73af4080-5016-4759-8e6d-3be2198c8d79": {"doc_hash": "24db5f9057abc1d62e076bee199d82a41c605c179c0392c3010e3707ba0c81bc"}, "e6eccb9b-6d24-4d40-8293-5c61181b2125": {"doc_hash": "48509e3ba5252a539c393a5878e5d48cd7a129258e09fbbd3e49cc6c9fa58ccd"}, "0dbe04b2-f662-47fa-9c46-046ae5317deb": {"doc_hash": "a50b80cc1f7ac65ad0eeccb4f3212298e185ffd1aa810400d45a7dc629b16386"}, "b60f1b52-33f8-4ccd-8ea7-e22a9ae6d854": {"doc_hash": "e8c4a82192752d93f9afb5dabe6db68361508ce8cbd906804204f6c0d3bc3269"}, "d463771d-cec1-46e0-ba77-f8c16ceefd07": {"doc_hash": "f3ca98c8fd15b79475c562a093fb97af75326885833a6590b5c94f5ec8a42914"}, "971eabe0-9fb2-4df5-abaf-ae9c5fd856ec": {"doc_hash": "dc2ba08c84196e2e6bcd51e95f92b52d52937a0210b809cc69d19241a19e489a"}, "c3f860a3-59d0-46a3-a1b9-353f455d3682": {"doc_hash": "a1d94164625f471e9c57b86f49f07f54b8e6f326643300cdbfe8f2f73f911873"}, "bcd7dbe4-c15c-4d37-87fd-b310d010f3fa": {"doc_hash": "35a403be4bdb438e331439544406da5283522d073c4ef7ed41682a13f1a204e7"}, "c42ee03b-6667-4501-9a88-4af636d9cc2b": {"doc_hash": "48c1b326c8c4ad4e465977cb0700d32297e6ac70b8c6591401ddb000ebd42e81"}, "70b83907-0f17-408f-9aa3-a41491f453a5": {"doc_hash": "bd4ddcdce6351da79fee8eeff33787fe4b915ed4d2eeb1f2e338c293e4d92daf"}, "c914b42c-19f9-448b-b2db-fd29d8a8c233": {"doc_hash": "32e4fb2247cb198577c73ac9d6d0b0b2efc8d99eff2ea284a107fddf99ad59c4"}, "685e5eb1-7d50-4d73-b03f-fabdde0ac592": {"doc_hash": "61a66fefc3701c9542ebe2c9dbb677d88158e27f6d2de0256bb2b82ffa0a43d8"}, "3f0eb595-68ed-4497-96ae-640aaf18e8e0": {"doc_hash": "e6ee177354cefbf9be0cb0d3ffa9bd39201f086e11d17ee700ec3ebaae09e8da"}, "18267c81-baae-42c1-95e9-78fcbf5d4339": {"doc_hash": "c54af16f7611fbafc177ebdca228ff4d666034bb94df5fa265fc4e682a430a76"}, "216e0901-5b01-449f-a115-69c5d483f0bb": {"doc_hash": "548342dabea3f2c3826c28656a914e6e04cee84350b7dc96b99eea4006407e23"}, "9a527a69-dddd-4795-b429-9cb00ec7a6aa": {"doc_hash": "5efd2f937f1b77f28c212c1a9d978bc48c58faebc836e6200a744a64362b5679"}, "1b7eed84-f5f9-42fb-ba83-14671a23490c": {"doc_hash": "2f437388ce20a9ab58bd2d1a3a4b49682042f42a55eb92fd789ab4b8093963e3"}, "29fd480d-1c2c-45c8-a54b-2eccf5b43215": {"doc_hash": "7f171948552e0fb9b93efea95776c58664409b15cc6f4a24a292e9b9b1a22d28"}, "26d3e909-9d51-40e0-b667-5c5fcd96ff4a": {"doc_hash": "d14be8764daa51757378f9c58ca268d41fe82e86faa1585c135dacce90e4dedc"}, "8fed0da7-633e-4634-906a-951d151ed94a": {"doc_hash": "d20f29914c1041738bc8331d40c49e348f0c2f50e07c5b5fdd9f4900f38791b0"}, "43c346ac-b7fc-47a6-8e70-96b70c4cf1b4": {"doc_hash": "c3828c4a51dac4978246f3bd1aeabbbf2f0b31bd78003d52ed3940337cec6604"}, "4e519bc3-29de-419c-9b5c-bdd4c91c2171": {"doc_hash": "c3828c4a51dac4978246f3bd1aeabbbf2f0b31bd78003d52ed3940337cec6604"}, "86de31a0-3140-46a2-b800-2c9a31c3ae82": {"doc_hash": "d272ff9cf3daee5345c1f9916dc7b356b7edd8f0f0f327d691346ba3797c4c57"}, "5399b3a5-3d94-432c-a51a-6ce1c4574045": {"doc_hash": "c389f685058607079444883419284c0ef3d6873e395508c2a1f449592bab3136"}, "90618f92-da87-45f1-97fd-4d8f8dacea0e": {"doc_hash": "569ab1660f4fb554b352014076bd52bb3e2d1214f8a2de8781843b5f7913aed2"}, "8cd49350-0a44-48cd-a337-cd75befa1bfd": {"doc_hash": "a216e1563634384d70d77df9327396fe23a21d7914ec1c9fc8877bfc3bf5e9a3"}, "c774fbac-eea3-4371-b879-8fc57e21f29d": {"doc_hash": "a216e1563634384d70d77df9327396fe23a21d7914ec1c9fc8877bfc3bf5e9a3"}, "2b91a97e-5696-4dd0-9927-abbe78bac3d9": {"doc_hash": "e33c399035a51d41c84daff8e4bec0284e01e1ab525947e580c6f2186bb05acb"}, "d969ddda-4720-4dc5-8a53-bd7869c811e5": {"doc_hash": "829088f1a8fce5996b4af4c62b0138eced9c5ac33896a6ae4b33a2ec6576f74f"}, "d6c177fa-cc81-4527-af07-593456035e28": {"doc_hash": "7c52ac080a54ea2d0e6fdf18e80cbbadf955becca02a1bb794f5673186990a76"}, "08c4aff6-0f02-4cda-8205-baa57b7e3a2d": {"doc_hash": "58722a40f1c82c6c0e31eec737d4f97fa883eedd382e09110682e25a84942c17"}, "c82a1ed2-6632-430b-b417-210bd6948512": {"doc_hash": "e53215b94047c6970219afe86f93cfdfb61d8780b862018aeed817fa37571123"}, "87724d6e-064b-4946-953c-75b95b8de25b": {"doc_hash": "acd643f122b454ae0ace667f4b5106ded5afa57f30123696d56110a5be840725"}, "2cc2148e-386e-4858-988f-a0b2f9913f96": {"doc_hash": "03a185f23441bc08d2b1d3ac9f4977c967da3d45c19ed751c8a5a7b9a3bf2ba5"}, "85380493-c4a7-4d2c-aad1-2c0293382887": {"doc_hash": "6fa8f0d8ec367c21ab9b43329874a31b87e727323af60d53ae64fa676ac989fc"}, "6d8cb138-f981-4deb-820c-639c01fb026f": {"doc_hash": "6fa8f0d8ec367c21ab9b43329874a31b87e727323af60d53ae64fa676ac989fc"}, "103bb39e-40c2-4130-aa26-363b570cd31a": {"doc_hash": "2161ad529087cf084a1ea9f3c910a0071acc06e515dbaa3c2316dd6d7f56e45b"}, "1ed3d51f-981e-4705-a19c-a6b6595a682e": {"doc_hash": "462c4b3570e5c5bca4dc91914eaaa3a9c168e047c1f4bbf015f7db9dbc035199"}, "99740c43-5487-407e-b6af-7bc8db6b74ef": {"doc_hash": "e82df2d04d2d90aed3d6662b58a9b5ef23af66a8f68fc492d910537fe0b4e71c"}, "e11470ea-6fff-4c68-872d-22efa4ba7278": {"doc_hash": "c508df1558feb1cbf3d5b70c627e5960fc2a325c9bec67c7997e54954dc4a0e4"}, "37e0d9be-2edc-412b-b35f-ad6724c9cc3d": {"doc_hash": "c508df1558feb1cbf3d5b70c627e5960fc2a325c9bec67c7997e54954dc4a0e4"}, "87a13fee-c559-408f-9ff7-ab37ea9e2517": {"doc_hash": "6ffb667aea7988efd9d60e5ee6ea012b97fcc9107a2ebf8f37d4ec5251ea7b67"}, "6ff5dfbd-4a2f-4a75-8936-486d9c797d3c": {"doc_hash": "f092827fe45bd70cd86a04c5fce4da33bd76a6c82b5030c8bd7eb5472608c82a"}, "b3e92f83-c6e9-48a1-917b-f90368028926": {"doc_hash": "66d200b5a358ca8118a8f6f494eedb6e2de6d8d320f3e2062e95ed28fabc6514"}, "9ea37fd5-c81e-48a5-bd3c-bae82986e816": {"doc_hash": "308907ce0542535898b3a474ff2ce05ceaf999e49bbfbba4710ba28a688655b7"}, "f8889e75-d27e-4f61-b0b6-ff36cab61945": {"doc_hash": "47feec6313d6bc6c9468d61e497a37273b5f245396819b488e1f19d3f335b5fe"}, "24ad982c-47d1-455c-952d-a31ae43a2c78": {"doc_hash": "a0ae25e54f66c0236eefc3ffa7c7b7df476622fd3b5ff72653ac87599bdbb5f4"}, "c1075af5-68cf-4abd-9166-1b8cdb36eadd": {"doc_hash": "65008acddc65e127f0090c7d7c884aec16df264bc5de470aa1803f424780acef"}, "823bc112-1294-4fe6-b2f5-3faf64dfbe18": {"doc_hash": "ba6bc6fe32b95e208b5c24bcafdc10e97f336e41d3177c6939b9bc040c0855bc"}, "8d5ad962-585b-4050-8998-b68b7d4f356a": {"doc_hash": "b2590ee8505ecc733641c1caffe1221a2efe27b5f0490a346a313e38fb56d33e"}, "53bd4554-9e4a-490e-a410-bbdbc26f5130": {"doc_hash": "7542ab2756817e53fef1ca7cc447d301f9f279cb9b950e7b8b1508ea1ee2adba"}, "27fbe2c8-e129-4395-a5a5-778eb7354f3e": {"doc_hash": "dd72093905aa920bc96a1854f61dcb3fc52c1d274556e8c61d30d2383d393710"}, "deebf027-27d2-47f0-8869-b4dd099c55bc": {"doc_hash": "fa82bfdea73b768adc13b63577a9a5eb9b2fc7f60353f3a322e85d59c0508c49"}, "2b13c655-fad3-45df-93ab-7fda4e85ca44": {"doc_hash": "55d6825b7174aa66fd4fe71706f58352ce163284a3cd9a80d17dd0d4700a95bc"}, "d88111c5-5c2d-4ca7-869c-50631e5383a3": {"doc_hash": "dd090f00560c38b58352ccf1f7779bbd01c1ccc9376f411eca92484cc37ae5df", "ref_doc_id": "1b3b6816-1958-458c-8149-78fdc732e3ed"}, "3a4bd5c4-d905-41af-8099-571093f86255": {"doc_hash": "e534756e92fb402fa5557746638d1f4c152817067d7bea6f89ad232800f9a84b", "ref_doc_id": "1b3b6816-1958-458c-8149-78fdc732e3ed"}, "7ed9d7be-60b1-4c85-80c3-90882184e672": {"doc_hash": "e094d928a1be83e4c38ce3037d4cb71df7d5b12f7fe13300e03329724ce9cc5c", "ref_doc_id": "d765e96f-17af-4a9c-8058-b8b9b9d6de43"}, "b20a0218-a06a-49a3-9bbf-67f59a81e2c8": {"doc_hash": "2f794374ef837815d5b200ded9c468492db823a4a13c802be26f32663a507cde", "ref_doc_id": "d765e96f-17af-4a9c-8058-b8b9b9d6de43"}, "e09fb4c5-4d77-460e-8d82-c8dd7cbb9372": {"doc_hash": "be44969ee118deef0591d8ce29389c37d8295cabd03f362f36849f734305be8b", "ref_doc_id": "b7955333-7e0f-451d-a6d3-3aacbbfb34c6"}, "419b6a02-1175-4c13-9f0f-c21710064c21": {"doc_hash": "5118d065df0fc65d945c48f8952480b7caa3a03e938179a3bf80775dc3d033bd", "ref_doc_id": "b7955333-7e0f-451d-a6d3-3aacbbfb34c6"}, "1f814178-2bdd-4f90-88b7-55ca606a272e": {"doc_hash": "6eff2e26cf0d0bff3b19cbb2937122bb46e646e7d0ddab9b3c24d9b3e76e43bf", "ref_doc_id": "b77b174e-6c7d-4c0b-8c62-66003c42a5bf"}, "a64ee598-7107-4ad5-8c57-d4e297c86b63": {"doc_hash": "3a034bcb1f971de232a5026e74ce238e1886c1946fdc177d04fcffb449fffa42", "ref_doc_id": "b77b174e-6c7d-4c0b-8c62-66003c42a5bf"}, "0ec52f52-02e5-49c7-80c2-d76e4f9d2f4e": {"doc_hash": "ccb65fc09110d8e89cdeb3baeefa41e02fbd973510c0360ba00b8c316d7df07e", "ref_doc_id": "070446a3-3da9-42f0-954c-a635b168ddd7"}, "03bbb1c3-07eb-453e-8428-ddc3faae2e7b": {"doc_hash": "21ef2839cd57cb6b85f3dfe249397fc56c1de9b51a57cc5a44bb1b16c85a71a4", "ref_doc_id": "070446a3-3da9-42f0-954c-a635b168ddd7"}, "c2f5e7d0-dd26-45f7-b93a-ddc1f7e72fc9": {"doc_hash": "e66e1789ad3a175b4a1ce5f347163bbad86498e2bd24c372c9ca36fa8e7f0e60", "ref_doc_id": "e91e3e68-57cf-4e78-ac15-9b987f356d6c"}, "914451a0-36d2-4930-be45-c1ee3537756a": {"doc_hash": "e5304913b23bc6dade89763a97c50953473080efe257ed9a897f6dddea73d610", "ref_doc_id": "e91e3e68-57cf-4e78-ac15-9b987f356d6c"}, "a3850e14-a154-4959-8959-b373b6945410": {"doc_hash": "d07213d08effee0c240a47553b90743fad2d1c2e982cd9b35522f3a7b2a4e2f3", "ref_doc_id": "e8f2fe11-fb74-4d04-95b5-b10985c269aa"}, "5ac68af3-5d43-4b4e-9b04-7c188c75a24e": {"doc_hash": "51f63f5852f227d5fe760c31abf63820b54f04e8668a4631b573dcec3e5767d4", "ref_doc_id": "e8f2fe11-fb74-4d04-95b5-b10985c269aa"}, "57e3bd1e-137a-475d-9903-129736fe13a1": {"doc_hash": "408ef1f9e8029f23b9a2287f6d5c509464c45e443d31aa4a0970ea75d4141ee5", "ref_doc_id": "e8f2fe11-fb74-4d04-95b5-b10985c269aa"}, "38ba013a-6609-4a0c-845d-9bad70fca7e2": {"doc_hash": "ce08d90fddecca70e8915b813310688f96079726055ab3d2a96441639d6508ad", "ref_doc_id": "431a22b7-b77a-49e3-b468-da4406cd9369"}, "91a1ac69-e01f-4cf1-97f1-b20f55216de1": {"doc_hash": "e1eb37dfa70965d1772f26bd70be84aed7391bf5e60701dda28c903a81390305", "ref_doc_id": "431a22b7-b77a-49e3-b468-da4406cd9369"}, "7822fe13-ccb6-4615-aa22-defc698bf8b5": {"doc_hash": "8e5fe4738ecab5cc7304ebbdcbda81e7ea27b0fa8699f0f2d04135cfc3fa1d58", "ref_doc_id": "431a22b7-b77a-49e3-b468-da4406cd9369"}, "03edea06-c124-407c-abad-7b173c36d1bf": {"doc_hash": "4e55597e6bfa75d9ff803bfcd057d225c7758704f6d94bccf8fdd49b118978f4", "ref_doc_id": "9ee5af03-ad45-4d50-badb-990e0c2a9fdd"}, "421b8b40-b015-436a-bee0-cce6db83fd58": {"doc_hash": "77c07735a02651c75bdd54fcc143af766050cf8ba7a9b3630c0b1ad76ce60443", "ref_doc_id": "9ee5af03-ad45-4d50-badb-990e0c2a9fdd"}, "e19f52dc-0427-4d13-9142-cf1265c38a5b": {"doc_hash": "c4bb86d81b79e861b69c419502b2cb02bda6920fe186aa80ec4d02916f385d9b", "ref_doc_id": "9ee5af03-ad45-4d50-badb-990e0c2a9fdd"}, "a2c4c8de-ebeb-407c-b16b-ca2aaa323899": {"doc_hash": "d7b58b91eb7043568967a1440dcb93cdd738fa2a49b43e9734696faee67357e3", "ref_doc_id": "9ee5af03-ad45-4d50-badb-990e0c2a9fdd"}, "2ef1cba7-494e-4372-b09d-4477f20768bd": {"doc_hash": "864801f51fa60f49e958317d8ab34b7fc9f198d3a73e27f8099a9c44f8224455", "ref_doc_id": "c0b96265-ec2e-495a-a56e-5d30cb2be073"}, "b7d331f8-0996-4965-a7cc-51e38e45bb9d": {"doc_hash": "0828e56521aa5456ab94ab760bda9de5ab0e11f7d205b28721f0e54a3850cc9a", "ref_doc_id": "58038d3c-d0cb-4127-b0a6-c6c43d4e3e61"}, "52eb706a-16b9-4ad3-a32d-309ff00212c6": {"doc_hash": "b179b8324b435a884cfa33bc0fd35ca63760fc71d7682811fbfeb000e8c3cae4", "ref_doc_id": "c8f396ef-0baa-4633-9b38-a0eb9a243cee"}, "b51a406d-d29a-4573-a6db-ea49cf8b096d": {"doc_hash": "c0a0bd0bd59e2a120f1cca7601102ff43d014e31e9acf8b549e303a31ad73c71", "ref_doc_id": "7ef34fde-d145-4415-a33a-c810b2b0a5bb"}, "80e0a98d-2999-4d0a-a6ac-7a0eed28a745": {"doc_hash": "f0ad04ea28d5e09a4858b4e99f9d871887beab5c67351ca35f881fce0ca48afb", "ref_doc_id": "47f8485b-9dcd-4b69-87bb-8fd38f8f4b01"}, "7a70b390-e152-453f-939b-c9abd4ef4de9": {"doc_hash": "38f2f37dea484b99bfe7ff45e014a5f236828ff83834762da81389d5faeb3996", "ref_doc_id": "ab00847a-2717-4357-a270-8c37399d3c3e"}, "c584229e-aeda-4a04-b52d-e8d3b73e52e9": {"doc_hash": "e553833aa4d58da569595eb20eefb4d12a38f7bf76867c01e58a5f7dd01fd860", "ref_doc_id": "e506c5dc-b575-4b7f-b2bb-6a5405548aac"}, "aa2c6917-796d-4808-8bd8-bfb35d4b4d79": {"doc_hash": "6868392124c140316eef1e7242a620ad125915440d5ee4a78505cc90fc4f10d4", "ref_doc_id": "825498ea-067a-47a3-be1a-ff41fd529cde"}, "0aeb9b04-bf9b-4e59-8f90-b4e427ac34b1": {"doc_hash": "594754b5ea39468bd1973eef77cd95f4c85c42e848ab3ec2f7554fcb6b039a5f", "ref_doc_id": "31b57863-aad5-4d81-8864-cfffe5731a95"}, "168962aa-34c0-4d80-b3e1-d5a2bee2f615": {"doc_hash": "eadac9325a357a627a42bdef125096aca43663801d52026179e88b73cb85cf8a", "ref_doc_id": "b42026b7-52ac-4c0d-9323-569519f16406"}, "ea439a48-6c02-45a4-8e67-14c10dbfcc01": {"doc_hash": "b379596b88c72d5938170e6b80f041068c09f0ad2b2ddcb6f10abc4b9a67dc27", "ref_doc_id": "32f6faf4-f7b0-4b0b-b7ab-fa52e7b01eb2"}, "48d17c72-bc9e-4ea8-9f86-e2188a8102c8": {"doc_hash": "91bd17d091f7e2475fbe7b7a1b78eab462cc590af2c3fbd8d0cae633ac1c8e95", "ref_doc_id": "cac5159c-9ab7-41ee-9f10-ca69789a719f"}, "9cb2cfc3-2ab8-4b29-a0e1-4253dbac5f55": {"doc_hash": "f2d6adf3231f2dd15509ef06878474047125fc0dee0d0b105b2435a44d88e256", "ref_doc_id": "86d31c25-af43-4738-8006-7731b59af8cd"}, "85b83824-3ce3-4c3e-9492-3cf97e4632b8": {"doc_hash": "c1b4d0a847f3c458051deaba1ecbf048201cc9dc3f39928703f11210f1ce23e5", "ref_doc_id": "9a1339b5-f26d-4c46-a509-9b1d4b9ccb77"}, "20312873-d71f-4e69-a174-fbf4cf841258": {"doc_hash": "154db0be775afbd257227322bfcff8e28fe33e035aeff27efad383d3e6876538", "ref_doc_id": "ae16cc8a-f01d-4f92-9cec-074f198aface"}, "d27c9f49-1eb1-42d1-9227-fbd9d211652a": {"doc_hash": "1890db6057eafcaf0031a79763d9798dd8060643a49916bfbf1445b9a497890c", "ref_doc_id": "c470acc8-f010-45e5-9eff-29457f42fadf"}, "77363321-b770-412e-81da-48d61c19b271": {"doc_hash": "4cacb4fea41cda7236c85648908e7f999794079d0f09b323999f9a650603f6dc", "ref_doc_id": "95e1795d-5fe8-470e-81a9-fcd21e8dedb4"}, "0542ecdf-d6dd-4f01-ae5d-bc3537611bdf": {"doc_hash": "1764cff717597b660a036770a7c459669414dadbd71339829fd2175ff9a11827", "ref_doc_id": "0d2b8727-73a6-4b72-b6e4-2049b1d0a154"}, "25a0cda0-7632-4bf1-9fdc-914bb6b30d59": {"doc_hash": "fcd6eff5d2144caf701d61589ee7fdc6a32e2f7b005a32080df2ce4caf6973c0", "ref_doc_id": "5b6bbc65-d3e4-44ef-a3c4-288f9e62e3d3"}, "228cc1ac-9712-41ee-b88d-54f2bd75f557": {"doc_hash": "c073ff13e7a7b1ad5167a7eadf2de3e4b3c2434d1c68596444a8aedbd151d008", "ref_doc_id": "a21ae520-db05-4339-b8e5-d73dc7be5643"}, "bef68375-5c6c-4e27-ab3b-ad87f3ce27cb": {"doc_hash": "4f7e8ecd3b1d3da8f53a9aa0e46db036e3bd11d1c19ad30fb7d449f197b55ebe", "ref_doc_id": "780c1fca-724d-4026-b189-cbfc52c97dcb"}, "f8175b62-fb63-4373-bd35-fdc183f3e5f9": {"doc_hash": "c568cdd79bb2bf5a2e686bd3ff1bfe57421711f09ad0777e6a9221e31ae25ac6", "ref_doc_id": "2ebfab61-a517-4ee6-bae8-546e2001f300"}, "79e5377f-3b53-4848-a76c-15836734bef1": {"doc_hash": "fc59607e75cefdc4055cc0e85352c0d79c746854eca3df3d02cff8840e84f6b5", "ref_doc_id": "c66fca50-a58e-4dd5-a417-14f48fea9cc6"}, "b050465a-a261-4913-878e-3ab98495483a": {"doc_hash": "e30e65f6af819506c6a0cfb7c5f607e12b22a0e7cfc7c3f5f27dce6a81fc7db1", "ref_doc_id": "b2f16060-1afa-40f8-932a-bb865d50af76"}, "da507684-d356-4a0c-9523-c3ffcb393e99": {"doc_hash": "e056413b20afed0aa5788028560a0e7e360d15b3deb619e2a28a0ff9f9cbac49", "ref_doc_id": "2b72f4e9-f9bb-4d2e-920f-8e06d4dd5010"}, "98b91c68-6590-49fe-bb09-c101b27f41b5": {"doc_hash": "2612bf398c7e692263e224291db8fec0389678433c0ae26a6591ff8f51b1c15b", "ref_doc_id": "19f554eb-964b-4b07-a5d2-4f3cf82a24b0"}, "86cbddaf-dd13-4727-aef8-532a00209c68": {"doc_hash": "bfe8bfb415c1942ac2d3875ce214c752f6733567a25d654ea1cdbfc407dfb993", "ref_doc_id": "6854c36d-a946-4d8e-a11b-bebf003f9ec5"}, "130da3d8-1cfb-4f63-a0ae-90c45e8335f9": {"doc_hash": "4e0307ef4cec4a6269ce9c48ec482143243a6bb01561d9c9bbdef327f10c197b", "ref_doc_id": "a4a87fe2-1f30-415a-9677-847e034f0666"}, "9d096cb7-bc83-4a73-a4e2-08b05082c628": {"doc_hash": "c06878c255b02da23d75caa02be47c7ecab73b880a83c2f00653e89d27820c9b", "ref_doc_id": "e59f91fa-2038-442f-8de6-23891af8efa3"}, "0f57c95a-1d01-49d4-9e7f-9ccf2ad2b0ae": {"doc_hash": "1e1c209f07d8bdd279d9bd8300bdba7830e1bc7ae004ba58ed0a556795e764a9", "ref_doc_id": "f3bc2f24-8dd8-4784-9ef5-17e958b016a3"}, "f8971cf5-726d-4310-9e4d-061a8a5f1682": {"doc_hash": "ec7095ef5f6b52ac4f2130eab8bd50df3954fd6422ff3e2aefd157752cd40e75", "ref_doc_id": "042268cc-9263-43f8-a77d-62af53d7870a"}, "81a599ce-1371-4f66-9309-ef753cb94d57": {"doc_hash": "1dbfc310a24f3c0d524f310074b4781b4c9f28a6b6208f9d9404e9f54377b9c4", "ref_doc_id": "042268cc-9263-43f8-a77d-62af53d7870a"}, "4a7282e4-2418-4bee-9550-dc279c89e654": {"doc_hash": "84e92f45b24593f5b15f88f01cb466f8945a90d0a07252d22bba54cf681d2b17", "ref_doc_id": "383c7093-d630-4481-841f-852df9cf73b3"}, "bfc4245f-5581-4203-8ddb-7c808b396d38": {"doc_hash": "da3b026ebe3d9edf4071ede7ccfa2ef235b311677c50eb55e5c8504b19e1863f", "ref_doc_id": "383c7093-d630-4481-841f-852df9cf73b3"}, "cdf182f7-a25b-40eb-8f34-79edebf4bac1": {"doc_hash": "994f3decea5fe943ae49a4ae737cc0fcf967004e8946b71ba86b24b7c02c920f", "ref_doc_id": "29358fce-80f0-4b9e-9c8e-9234fb2e4bd5"}, "8aa55827-446c-40d2-a135-0be6b9660789": {"doc_hash": "90017753cf1a2c687bf4759d6720bcafcab85ff8d87120f977a3a8bd0f405fa5", "ref_doc_id": "29358fce-80f0-4b9e-9c8e-9234fb2e4bd5"}, "5e4a93e9-9a49-4ec3-8226-1b725f6d27bf": {"doc_hash": "abf83fe51d3d46040886116c08b267aa9b303b3e586c430cfd04c9bc6c98573c", "ref_doc_id": "86981af9-7c65-4b79-b0e7-352378ac6265"}, "cf005b2f-9063-42fe-a0ef-e4e1add9531b": {"doc_hash": "dc6a9343d7447c1b4aae6ff37db41ffebf648503613893f4bf2ab0fd218b2916", "ref_doc_id": "86981af9-7c65-4b79-b0e7-352378ac6265"}, "9cfb6122-36b5-4648-b10e-f448ef9b716e": {"doc_hash": "637d4961eab0affe9bdec397b4a6c75467987836986641b93dbe3b321c0a642f", "ref_doc_id": "bd179acc-67b8-499f-b779-94b4ed1b18ea"}, "0a8d94e5-665f-4b6f-b2f4-b556c1423aa8": {"doc_hash": "69aadb6854d14963facde9509f0976db44988e0d535da05f0761b44332d6bc31", "ref_doc_id": "bd179acc-67b8-499f-b779-94b4ed1b18ea"}, "a99a5f2e-8f6d-4f97-8536-07018a7c7ab4": {"doc_hash": "3a7b96590de447dcbb5de88ada6ff4fa8f3f57edd0a5816a569c79d4ca0237e3", "ref_doc_id": "bd179acc-67b8-499f-b779-94b4ed1b18ea"}, "6a08adf3-1408-4008-9aa1-0906db922c83": {"doc_hash": "07f720d1b9850d2f0fcda229990decf79a2a709f329a4027263cd370fc09e9a0", "ref_doc_id": "1bdce6de-3906-429d-83c6-8a2539dc7c57"}, "10495a0d-57cc-42eb-9a04-0ec2e12ab6e6": {"doc_hash": "9a5485a5e470bb8ea4dc97ced7cf2094a2160434d269edf28f487dd33bd1ad94", "ref_doc_id": "1bdce6de-3906-429d-83c6-8a2539dc7c57"}, "7c9de5bd-7411-45f4-bd2f-d1857163a7a7": {"doc_hash": "027b769de69c71f11b5ce09b57577b542779bd583cab54b93ca164c0f772249c", "ref_doc_id": "1bdce6de-3906-429d-83c6-8a2539dc7c57"}, "b6e5ba86-17eb-4e63-a97b-0ed865d9d0b8": {"doc_hash": "07d67c01053d591e8b47795731398d29e98f64b5d2885faf7d39180e6ac0d730", "ref_doc_id": "1bdce6de-3906-429d-83c6-8a2539dc7c57"}, "71fc69a0-ce96-4466-8553-639b0af29f7a": {"doc_hash": "75522d593fb41a691738e423cb72798107835fa0278252f87d507337a1320268", "ref_doc_id": "73d0cfbd-e0e7-4e6e-85d9-60a25cc4a1ac"}, "70a96f1a-9292-4f55-8236-7078e612a96c": {"doc_hash": "8385ad6de4b3d2e3f83448547f4049612b054b3c809eb2863aac1a7a53f65439", "ref_doc_id": "040e8e55-1b5e-423b-a61e-78b07c315c43"}, "6ae90039-22e3-4f19-a45e-8ca3ad90e0d7": {"doc_hash": "d8b1dac183638a786a43dc2774aa2ddc7335a29168e1c20678b49aa5a7239830", "ref_doc_id": "040e8e55-1b5e-423b-a61e-78b07c315c43"}, "457f887c-421e-432f-a504-2f0d15e83052": {"doc_hash": "06637401423cf67783fd3a2c1c49a2becf3c4765ee65a6d3ffc15e0482f2c30f", "ref_doc_id": "2bfe3106-e487-4947-ac3c-9593794b4ec4"}, "ec10494a-8d7a-478c-868a-579082577571": {"doc_hash": "18c14db9376e1167f29c12d5ea55589a5cdb9764485f69a83824fe628b491138", "ref_doc_id": "2bfe3106-e487-4947-ac3c-9593794b4ec4"}, "c271753a-766b-40d1-985b-ab14a37c4555": {"doc_hash": "f57bb3c7829a9e8edab3acce89593bf7e10abe68ad2c5079320e051cfeb89460", "ref_doc_id": "9f9e7857-8573-46b4-809f-39d62f873ae1"}, "530410eb-fa93-46cd-9048-9db79d3e8387": {"doc_hash": "903806c2aee9050f125bf9df3e35a4efdad4b0ee46310a77bf1b73adbe30599c", "ref_doc_id": "9f9e7857-8573-46b4-809f-39d62f873ae1"}, "d6ff58f3-4120-47d6-8e97-696bbf6475e6": {"doc_hash": "b7019ef8588410ebe42639c81b831f82d1f74f7570ffa938acdff776b419dbc2", "ref_doc_id": "9f9e7857-8573-46b4-809f-39d62f873ae1"}, "f4ce544d-c2d3-41d7-a447-61ae5996c356": {"doc_hash": "f4003e824d17ad6bc5cb826c529d30d999b61efb349131fae060e392faa48e85", "ref_doc_id": "476b5ee2-fa3c-475c-acde-2a856ca49598"}, "c09b6a39-d94b-41cb-a1d2-fdf6f41e42a8": {"doc_hash": "fda66f2405575970a05c82ec2f27b918940fbced978e48212b3ce715c9e107de", "ref_doc_id": "476b5ee2-fa3c-475c-acde-2a856ca49598"}, "c6a902ce-ae8e-49be-b11e-d34edb665935": {"doc_hash": "d23c380d8dab201f9c9edad2f51fcf2712f1042254b2783ca65410ce7afbfe9e", "ref_doc_id": "476b5ee2-fa3c-475c-acde-2a856ca49598"}, "71fa0849-1390-468e-bbcf-1b9f5be80beb": {"doc_hash": "2be8c8022c3ee3799f49c5c57d5b06c680716558c32188269d5c3ff6aba9e07b", "ref_doc_id": "aa35fe49-aa28-429c-a281-d4ff86262064"}, "697c33a6-d80d-459c-ac10-0e1ba69cdc9e": {"doc_hash": "d9e61b136d2feacf69321f3918adc8a32a154b2b9ac5410f737a2bb29056fadb", "ref_doc_id": "aa35fe49-aa28-429c-a281-d4ff86262064"}, "0669bcbd-659c-4385-a744-c6a16128ef1d": {"doc_hash": "78280e775722c50b9c0b1031e953cf4171ddc01e3353925d33f2ebd887fd7938", "ref_doc_id": "fc107e44-0f72-4a91-8a46-92f5643f6459"}, "9c60ef29-f1fd-4628-919f-7757f702d2d8": {"doc_hash": "caa72baecd3f415b752cda4e526916a38b1d30b2c272d369295332d91818d8af", "ref_doc_id": "fc107e44-0f72-4a91-8a46-92f5643f6459"}, "09534c82-703c-44db-8e39-de05e7b252d2": {"doc_hash": "9f17c62c7c8b1feea346241cb92f9e6d0d219ff428bcdec97771a2462205e0c9", "ref_doc_id": "4ab30247-e869-407d-a643-01b3be87b5fc"}, "002ba8ec-84c4-4cc4-ac2e-9257c16d01bf": {"doc_hash": "0b42613bc8258994554afc5b560955646a1b48e0ae3a9f1f8a8ae7b8a94330c0", "ref_doc_id": "4ab30247-e869-407d-a643-01b3be87b5fc"}, "64b9eb5d-1218-4501-8388-943f19a57f75": {"doc_hash": "7b9317f0f8c828e722e4d18c67d8b75185e84bc2ac190d16615931bc771c7de4", "ref_doc_id": "4ab30247-e869-407d-a643-01b3be87b5fc"}, "6e6418f7-9754-4aa3-8ca4-30864191f408": {"doc_hash": "072fd286552005f1eda661561c9bb6a60179ec643cdd50ec94b037ce48d1e4ec", "ref_doc_id": "030b6d96-a642-4a88-982b-45434086a4ad"}, "19112842-e366-4f3d-8b58-c4bc05705217": {"doc_hash": "fc8b2862cfcce219b4952eb1bc931e8e8bd19c7345cd6867ed2882ffbc6adf5d", "ref_doc_id": "030b6d96-a642-4a88-982b-45434086a4ad"}, "ed90a57d-ea06-45c7-a4ee-86d518a2732f": {"doc_hash": "20b52b0f4fb8197d9dec3ff389b044f4d807257f240586c55fce2a57ef920af0", "ref_doc_id": "42889750-f2fa-4c3f-b9ce-32e8dad2b00c"}, "8a604d14-4e9a-4b11-8372-55320c813a84": {"doc_hash": "a640718c39856595092d41991fe5b93c34e3486da1df935d00b57a08e6de71c6", "ref_doc_id": "42889750-f2fa-4c3f-b9ce-32e8dad2b00c"}, "e7d29b03-6830-4b88-b8d0-030434ec2ef2": {"doc_hash": "011230094e33e192ce46cb888ff91b0011ed915f653cf9daa44a7a1304aca6d9", "ref_doc_id": "95591b9d-3ef3-475d-a93c-1fba79f156e5"}, "0351036d-6a80-4cf7-b9c4-6ec7cd46c65f": {"doc_hash": "51958a08ab6df3b19d3af195c99c6dee05cf61b7fe8a4a32fbb0e5dbc7369412", "ref_doc_id": "95591b9d-3ef3-475d-a93c-1fba79f156e5"}, "d1ad78a3-8f30-4d3e-8812-837966c9971a": {"doc_hash": "8f58813eb3a26fe759c86bcd16c4a368f611fba771344ac9f392b17ef5a783f2", "ref_doc_id": "95591b9d-3ef3-475d-a93c-1fba79f156e5"}, "f15e74fb-4d33-4809-9933-5143d50d9002": {"doc_hash": "ef75d6890eed9e266ff1381137f14d948fb1fafc0a80c63f65fc89c1f5878585", "ref_doc_id": "33da8422-6e5d-46da-9f8d-61ca983eb55e"}, "395fa888-85c3-4f26-a8ca-367756b1644e": {"doc_hash": "bdd875bc5cb81c01b67363f7c292e8ed31e83e62d84191bb5b9c7001865d1e19", "ref_doc_id": "33da8422-6e5d-46da-9f8d-61ca983eb55e"}, "6ef2dfc1-e86e-4653-af67-6f56dea89a53": {"doc_hash": "68931050bc355cccfbb097491211edffa8c16872af11e3ab4039e525140626e1", "ref_doc_id": "33da8422-6e5d-46da-9f8d-61ca983eb55e"}, "a8ca9e5c-7419-4773-a605-d97a651f73cf": {"doc_hash": "aeafc76523358b594da18223b6aeb90f3e329fea58101e8e98a096343882c0ce", "ref_doc_id": "33da8422-6e5d-46da-9f8d-61ca983eb55e"}, "edc0108c-3ea9-440a-9a86-a2d16c680724": {"doc_hash": "2d39ec79597a17d3d2478f6c8c53734a21c8bb007b98138e653792f613214774", "ref_doc_id": "33da8422-6e5d-46da-9f8d-61ca983eb55e"}, "1343b8e5-3f04-43b3-9cbc-395cb074ad5f": {"doc_hash": "1c04ce6650af1093e3855cbd7283d0e0c913f31fbf78fd4d6fc3d0666d0e0b70", "ref_doc_id": "964807da-f9b7-494f-9a11-4cd7c7c2594e"}, "b648d7ea-9149-458d-838c-050ed68be90b": {"doc_hash": "d429214e837dcb0dd064d7dfbc917e420c6677e4de912748845e23fa6260531c", "ref_doc_id": "964807da-f9b7-494f-9a11-4cd7c7c2594e"}, "3abf83c4-5435-4f9d-afcf-1980a45e3f9f": {"doc_hash": "5d56aa2f7ad4c6406bd06d9dbc09fd4ce5e6252ca4812638b29406f914b7d296", "ref_doc_id": "964807da-f9b7-494f-9a11-4cd7c7c2594e"}, "e3224ff9-c9c6-431c-ba7e-1bcc1dbdbf02": {"doc_hash": "de3c9c28495ca7a6a39de4a3ba1995ba3c4ba09df9a702528152a10b9802c104", "ref_doc_id": "964807da-f9b7-494f-9a11-4cd7c7c2594e"}, "6dab25d3-e35e-4c29-adc8-55ec0c26c866": {"doc_hash": "8421ac701b52f388d887d34cf083a65438f61e155f255677fb4ccafc734a68e3", "ref_doc_id": "964807da-f9b7-494f-9a11-4cd7c7c2594e"}, "4c94fac8-c7ab-434b-b526-cd9752eee1cb": {"doc_hash": "a00929468d23c568a43b64bcca4ced86c79619d6f3b5b9169f0d588fcf23ea34", "ref_doc_id": "42343088-7b3d-49e5-b163-cf8e7c21fa09"}, "701448be-994d-42dc-8342-f5f29cdaf514": {"doc_hash": "0f1cad02807414b7b8d015a3d2650f0a37caff75a2ee7168510deae51a6275a2", "ref_doc_id": "42343088-7b3d-49e5-b163-cf8e7c21fa09"}, "b1c8e77a-c3b5-4c48-a94e-f8eff1982f51": {"doc_hash": "b0afb04a16689efbac9f5ab8fe9fe802a76ef3f87ea71f93a474743de14914e4", "ref_doc_id": "632b7795-822b-41ac-936e-93ae876a7cf1"}, "bbb23c7e-2d78-4169-959e-7265c16ef7cb": {"doc_hash": "c232e7bb81be5e0a0ae7c6a9ba684bdb52847733bb53db52731d112e2aad2a08", "ref_doc_id": "16f8ca8f-fd14-40b1-a292-9fcd5c355da5"}, "aafb88d5-8fee-4551-a5ee-eb0a1f946965": {"doc_hash": "09e5ea32d72ef7b714b278d11c1c01b4f95d931677362cc1b254f4682579341a", "ref_doc_id": "e2941bf5-0505-4abb-a1ba-4a5eb057ea6f"}, "9829d300-e571-4447-bd65-9f0e4f0d8495": {"doc_hash": "33edb855ff1c64ad18f1371fb7a4c1e73146e7e66442a6ff14af1e1532511f33", "ref_doc_id": "840d3bf8-8a0e-4576-aead-dafa00fbe7a2"}, "ec6d8172-61a3-4422-8309-bcfc182f4640": {"doc_hash": "f1e784848623b32b626253b78c3330dcf4ea161a9521fe61f9a2eacd0a725a72", "ref_doc_id": "c11986ca-e7a9-473c-bdb5-39b5ea6357d1"}, "97d74e34-4890-4ab4-9e79-d84a3e759c4f": {"doc_hash": "9714f530db702a08fc1172625474bfdeae917e829c10ff02729ae98527ab9580", "ref_doc_id": "465f8c44-113e-4abd-92ff-0edf5721d2f2"}, "892ecbdc-d1fe-45c0-88a2-379273c21e52": {"doc_hash": "f771016a04d7af8b070b935e59c2e8b761c388baed43ec21de8593f1e0a31c74", "ref_doc_id": "a9ab4941-7cb5-41e2-9ba0-bce4729b3024"}, "56c54bf5-7980-4e4d-9f68-e52914443dd9": {"doc_hash": "2097599a0922f6dc92cfc34aa2264c72f9a11cc9c92becd6ffbd30dbc6a75f96", "ref_doc_id": "86c8d4eb-296b-4eb0-8807-cc4440408207"}, "53402e72-f71a-4ced-9c46-ff64d523dedb": {"doc_hash": "42346ff40cd39afbf86df3f6a117e76d30143202cbe8e2d267de8206335c2c65", "ref_doc_id": "c96ff112-0157-46d1-afc7-062945cee5e8"}, "9c0b2ebb-12fd-4c04-b898-8c3289a526df": {"doc_hash": "68b72b2959ab5e3b8bb6f20dec14f07e616e2e4abc491fef6f84c575c689886a", "ref_doc_id": "c96ff112-0157-46d1-afc7-062945cee5e8"}, "a56aaed1-27a8-4bbc-9762-e108a04fa6f2": {"doc_hash": "8a98030fe1b1dd93fd9e66bb8fe204b8ccb5b159816aa5568367653964e459c9", "ref_doc_id": "c96ff112-0157-46d1-afc7-062945cee5e8"}, "3105db04-163f-4bf0-a988-7f2ca81ca815": {"doc_hash": "eac2f37ca93ae83a75a97b0ec9f5c22f6fb1440a5887956e420cde495c2862bd", "ref_doc_id": "ce9f5616-877a-44e5-8cb0-b4482925c8c2"}, "7e75b686-87c7-44d5-a3dd-2cbf17eb321f": {"doc_hash": "b830b3016d86af90b97355133cdaa52e177ab3ee4a8c7d3f42c15af5bbcf4672", "ref_doc_id": "ce9f5616-877a-44e5-8cb0-b4482925c8c2"}, "35a6b9ca-7179-4509-b09f-d217c75a36c0": {"doc_hash": "536ea00bc0d9932ff10c78b8b9cc763afced5b9ae1a1af45d187c3f86fc2263e", "ref_doc_id": "7774eaf7-da5c-46eb-b4d8-ce492199a35d"}, "c012bfef-2960-4cb7-8e34-47995ef8ec49": {"doc_hash": "a4899996403e5be1e349af38a591a7e7c92e3ec7863f9ef6cb1698aec11d1fe4", "ref_doc_id": "7774eaf7-da5c-46eb-b4d8-ce492199a35d"}, "debde025-9bd9-4f58-a0c2-8fc4abebdf80": {"doc_hash": "3e70b7149208e56b6f48167f27999657f32eef257480b7f604eea251c71cea52", "ref_doc_id": "7774eaf7-da5c-46eb-b4d8-ce492199a35d"}, "177c2108-7b45-475c-bc09-a5e9eeef807d": {"doc_hash": "d24424f59cea67cd1636c7f0230f849ce16b7f7e466da9929a56a8ec97a60cf8", "ref_doc_id": "f6c30827-2624-471c-9232-2255e5419ef0"}, "3c780846-ade5-4f1f-b807-62cb9daa67e8": {"doc_hash": "1d1229350ff0f814d882720e44c10084440035fc26073a33bd07b34b02c3dce3", "ref_doc_id": "f6c30827-2624-471c-9232-2255e5419ef0"}, "b86dd750-0abe-461a-abf2-4031b04f2d78": {"doc_hash": "d893c81ddf222e3ba9235735fb244a5862fbf31325052c4cf58c731611863216", "ref_doc_id": "f6c30827-2624-471c-9232-2255e5419ef0"}, "594addd9-4526-41bc-8cb9-8f817f45f594": {"doc_hash": "c5ec2a7e78b92426dc7bea8028b8e7bc786f9eb9f0b265398abed5ca076ec1d2", "ref_doc_id": "cee73198-a1e9-45f2-886f-9438a1bd4941"}, "de043ff6-a667-45d4-bbc4-f59fe216fa2a": {"doc_hash": "a2ef09367edd874a41188b8d27d9a97b2463408906618cebfcc462a51554e432", "ref_doc_id": "cee73198-a1e9-45f2-886f-9438a1bd4941"}, "ef41ebd1-72e9-4c82-8d88-9ebf2c502ecd": {"doc_hash": "340fc697565cf653cd4a81b2621d93d0d27a5361c4b6dc1d148c8e6867ec2bf8", "ref_doc_id": "cee73198-a1e9-45f2-886f-9438a1bd4941"}, "0f166413-6027-43c7-8302-a7229b23273d": {"doc_hash": "da1cbae08a0b1dc0278e2fc0b20e070889ff9039bc3ef974e5fe09a90e98e2da", "ref_doc_id": "1c5a8482-67dd-4f6f-ad77-0347e49cbd87"}, "d735a31b-8d83-44b9-af23-6904d1cc9313": {"doc_hash": "28ec6591dc74faa198db2b7b3ef5e2f4fca904e6c403e552b88f3eab07c45dcc", "ref_doc_id": "1c5a8482-67dd-4f6f-ad77-0347e49cbd87"}, "3eb61476-9ed0-4c41-be89-c5008536f6c5": {"doc_hash": "bb58ac179db7baaebea05cdb3d7cb18138281b323307b1302d392020e877d938", "ref_doc_id": "1c5a8482-67dd-4f6f-ad77-0347e49cbd87"}, "627cff98-0935-460c-9c2c-86091d8fc95c": {"doc_hash": "989b1169bb429126d8c28f9dc44585c9066ee7e8bd82bc0b965ae4145a25bdb3", "ref_doc_id": "1c5a8482-67dd-4f6f-ad77-0347e49cbd87"}, "d443a53b-e2c1-4ea5-bf06-78e9e220ddbb": {"doc_hash": "9579cb1f8eec2fbcc145060222d59c842f33d25c61ca5e31059a48931f88f9d4", "ref_doc_id": "0c6386b0-e9fa-45fc-9979-461bcb548ca7"}, "38022e6d-f4c4-40b7-b696-0c01bdcf7b82": {"doc_hash": "98a5c15ee4b9c91be44d9040993cefa0c8d1c4361bf2e6ad6b2ff6356be7c675", "ref_doc_id": "0c6386b0-e9fa-45fc-9979-461bcb548ca7"}, "0bd6f479-1ed4-4c7d-bb87-2fcadf02f8f4": {"doc_hash": "d72817953bbb4eb1edf125c85cb4f43f6cf0d127e69b5914cf4147a7bca5fb91", "ref_doc_id": "2a9fffc5-cb4d-4256-bf15-3ae118b45cc6"}, "326f48af-3c8b-498d-8ba8-7eb9b0687d88": {"doc_hash": "90dd6c9d8af948bd9d7e97d3ee5fff11be931e8739316814c2746116a8d2f18f", "ref_doc_id": "2a9fffc5-cb4d-4256-bf15-3ae118b45cc6"}, "7e51c9a9-a114-4f7a-b47d-05fcdfccd3be": {"doc_hash": "cf3cc6f593465dbcc4d741eff36b062442cb482f9202d8b9500dc63fad0ab2bc", "ref_doc_id": "bf4ed3e7-72df-4708-b175-cfe7b30c6df6"}, "778b8b0d-0771-4ce5-89aa-a1f6954f483d": {"doc_hash": "60d201668cd2c18257746e6e954c47a3fce102d1fad54237773fa371a78b6ec8", "ref_doc_id": "bf4ed3e7-72df-4708-b175-cfe7b30c6df6"}, "7a504931-95d1-4c33-96f7-93655e7371a4": {"doc_hash": "b838df5f65dbcdfb51787af92e78a10a5c89327b0727411277678f944444e68d", "ref_doc_id": "7d793112-63e0-4df1-a230-2a88b2814a91"}, "d594a625-15f7-426d-a964-06a4c405e80e": {"doc_hash": "d5027124d95f04dffb176b0dcd2dc53d6b3049dae407a414e8d54c65dd68a65e", "ref_doc_id": "7d793112-63e0-4df1-a230-2a88b2814a91"}, "6ed7d1f8-06b4-4202-8442-8fb6a861e809": {"doc_hash": "f20ac1748482dfbece70fd626e927168a0cb695558e38a53614e7a4697e63c3b", "ref_doc_id": "7d793112-63e0-4df1-a230-2a88b2814a91"}, "15b86604-a610-46df-95e9-f4f391bac995": {"doc_hash": "b9d230c1d163ddb586405303b25ea9e1016ed62e0a93f39de6af7b9f31b7f688", "ref_doc_id": "da1ae84b-def8-4b78-bc8c-3d7e923d352d"}, "b3faf751-82a0-4ed9-ac47-40c0d5d99d0d": {"doc_hash": "9909be5ab2651d7b85d75879f978b18e35af79173f94f9f21cc55d636252fc5d", "ref_doc_id": "da1ae84b-def8-4b78-bc8c-3d7e923d352d"}, "95081197-c928-47b0-872c-a1a76b4fa6df": {"doc_hash": "dd29de47a10d45744a66f6eb03b99c38ca9f8cd8b8c4e3d2e7da1f5fa4df4920", "ref_doc_id": "da1ae84b-def8-4b78-bc8c-3d7e923d352d"}, "cff898c1-49b3-471c-8436-77ef467f0a0e": {"doc_hash": "eac86e64011bf8838aaaa4991c467031919a4282ba2eed8b8ca89a7a97b0d660", "ref_doc_id": "b2a8144f-e260-41ce-9862-13cb8a4f9d1b"}, "5ee2f055-d432-49c6-a2b4-816efc6f18e4": {"doc_hash": "90473791c5d276be7a39d74c9a871430e59a31d59e9fe13b15e346a8425ff62a", "ref_doc_id": "6d517ac0-ad80-48de-9fb0-6d941c193baf"}, "6383e10c-3f31-4a32-b4a7-ab1b65e1cd3a": {"doc_hash": "2c5bcbc94590ac39d717ded3a2feced30b9d4d0df538ee6833467268c1611921", "ref_doc_id": "6d517ac0-ad80-48de-9fb0-6d941c193baf"}, "93783ed7-dea3-4ba8-b9dd-0b6403ddec51": {"doc_hash": "3af2fa049e02acb5b04810a8432818596572145c0e3d41940a3ad28949f489d8", "ref_doc_id": "6d517ac0-ad80-48de-9fb0-6d941c193baf"}, "16c72702-0871-4a87-ad4d-9f26c7329045": {"doc_hash": "52aa62349b14d1e013465b0416cedf0b8b2b91357d2badc1b22df592e45c64f7", "ref_doc_id": "d5999fc5-6e91-4b03-a590-22bbb863d842"}, "47b8cce7-5baf-4743-a1e0-854e8523c399": {"doc_hash": "7aa4cc2da8f646e43ec41841323f28e1758c7aef422282115bb9d3684f3b2f0b", "ref_doc_id": "d5999fc5-6e91-4b03-a590-22bbb863d842"}, "4a63da66-e883-40d9-89d2-58b2431546cf": {"doc_hash": "68c9868415e6bfe84b824fae6573f900f7fdce75a1770358b4bbbc7afc435a87", "ref_doc_id": "d5999fc5-6e91-4b03-a590-22bbb863d842"}, "0a9f933a-93c1-4b31-a179-f17d05d92bdf": {"doc_hash": "2379ea8c2531825273b2b337e75cd3cdb15805d3125b8708d5a9a812ddabce33", "ref_doc_id": "1af20325-881e-40df-aa99-7173fcbc25c7"}, "feb8aa93-a1cf-4250-9a9a-b0d99c584026": {"doc_hash": "434664dea4b84142e2b95e57c93cfc7edde758065c93f7a21b6ed7602bdc22b0", "ref_doc_id": "1af20325-881e-40df-aa99-7173fcbc25c7"}, "754b8b70-29ff-4a25-99eb-97e0a9383ff3": {"doc_hash": "f31a6ba085bad0fde47216f5dbca0ea079241813181352e832b101637d313908", "ref_doc_id": "f09b998a-1082-4b58-afec-3686b619651f"}, "f15684df-522b-42b9-8490-1f0219d2c30c": {"doc_hash": "07386a7ccec599d48812a152a064d9c03f6f3a8e4464e8a4d9a3a2c2e10a80f1", "ref_doc_id": "f09b998a-1082-4b58-afec-3686b619651f"}, "09b00673-3361-47a6-afa9-10be2001c91e": {"doc_hash": "104ca9fe67d392cced6ba79fb7f2ce377206abe74e7af3368babd6a5e1b73802", "ref_doc_id": "10e3b110-c6bd-4324-aeaf-8389002f32ed"}, "3e092ae2-3e8a-4cec-be85-263c0c831924": {"doc_hash": "b3559d580d0d3ce3473f205a04e39b00d15ec92a5952e22c025db70e6824d0fe", "ref_doc_id": "10e3b110-c6bd-4324-aeaf-8389002f32ed"}, "30286db6-3820-4c30-896b-24a15d0bad99": {"doc_hash": "2cdc96c54d89634ed77e5c0cfd7054e754cf010b798d7b55a87b21cb801bd546", "ref_doc_id": "1dbe0886-2bdb-4948-893a-8e1289135704"}, "ae2d3c06-526a-445c-a533-0183b92ec72e": {"doc_hash": "0bd1a599e46f9d24866ac3b6a9b265daa3da07854e60977fbe003fd15827e4d9", "ref_doc_id": "1dbe0886-2bdb-4948-893a-8e1289135704"}, "ceb39412-e202-44ec-b691-f59091b70308": {"doc_hash": "61fb9046b5851b935509ae1ef9babe0f0311958a9c77a5cc5d30d8831c302f38", "ref_doc_id": "4b8a3c67-6899-4add-b562-df68a9d3ec82"}, "4dc9194d-24bf-4b02-aa7f-88362cd168da": {"doc_hash": "3e2bd0136e6e003e70461d9fe53e92826919e65e9f54ac794307692d90985c75", "ref_doc_id": "4b8a3c67-6899-4add-b562-df68a9d3ec82"}, "07341d95-7cd2-4c7d-8535-ad8d7922a35d": {"doc_hash": "995874d82f09dc59d1aecacfce99af3a86bac9b1a0c96360097fb62a875dc04b", "ref_doc_id": "8e5b980b-174d-4b0a-b125-fc1edbc3e3f1"}, "b14a46f7-90a2-4a98-9a90-dae4a681d3e4": {"doc_hash": "37c9a477c5e4be5a0fea1d89af95605d70ba2af94a0df57b062a5c2f4016c07e", "ref_doc_id": "8e5b980b-174d-4b0a-b125-fc1edbc3e3f1"}, "3a3df280-effb-488a-9877-348fc9eb5675": {"doc_hash": "523dd5b62f32fcc7941fc76738d90a6ea140dad23a83124921ef7b507f271ab7", "ref_doc_id": "1da45cb7-ec01-418b-9699-1d611a9eb1ea"}, "e0f4f9c9-3fc4-4f00-93cd-f13e28621d60": {"doc_hash": "83b4fef3bb61a28b23b94ac0b2d174c4243dea6926fc335eb77ed3c1f12cd04d", "ref_doc_id": "1da45cb7-ec01-418b-9699-1d611a9eb1ea"}, "ea160cf8-1bb7-4ea0-9668-65cc0062314d": {"doc_hash": "50589c62dc08916de1ad513215b5d804b7e48fa8414e4677f46373d244474e53", "ref_doc_id": "1da45cb7-ec01-418b-9699-1d611a9eb1ea"}, "b2b1abc5-e4a4-4fc3-90e7-a092a00250fb": {"doc_hash": "79882198c2d5b6664144899554848bb008d3a5c9a625435c3970caec7d976872", "ref_doc_id": "c4d62c21-fd18-44c7-8cae-887634363ed4"}, "c3891d57-6330-4e6c-ad04-bbc8ee57b996": {"doc_hash": "64f5f68f2d5831b02fd95cd456ef05922c728217c887990c751fa9f42e3d3f05", "ref_doc_id": "c4d62c21-fd18-44c7-8cae-887634363ed4"}, "692cab3c-7b0c-49b6-a137-0f8b7e11c60b": {"doc_hash": "07acf7f53cc98994efd04d0d15f0da2cf3bca346ee5479e84864777d59ba9c79", "ref_doc_id": "c4d62c21-fd18-44c7-8cae-887634363ed4"}, "41f86849-1423-4f47-843d-3a4189de53b4": {"doc_hash": "2451aedd2c3772e3b5dd6d839ec8db91e58e8d197ff7603ea4a9d3833256db7f", "ref_doc_id": "9c07f040-46fc-410b-a8c6-3ffd10943c0f"}, "9ed0940b-daf0-437b-b813-fea55fcbac5a": {"doc_hash": "7c12976ed6881519ddd3e8332fcbd56039bff5ff19dec828a554e7e04e1450af", "ref_doc_id": "9c07f040-46fc-410b-a8c6-3ffd10943c0f"}, "835b5bac-2732-4be4-95f4-d9b21d41d39e": {"doc_hash": "c47c53c8051e1a7b8f0445886b55acdf0f40e735d4a192bdb00070419dd0c59f", "ref_doc_id": "9c07f040-46fc-410b-a8c6-3ffd10943c0f"}, "2ae4bccc-0ecd-490b-b71f-011c5e3e7beb": {"doc_hash": "a33a49c396fd99bda01729cf0d40b77192f81a37cccf02cd808ae1a8190b3f52", "ref_doc_id": "9c07f040-46fc-410b-a8c6-3ffd10943c0f"}, "fcee602a-d1a8-4768-b530-579010d93ddb": {"doc_hash": "aac1186c21e967f754f6bc93a36f2a150b5d8ad28cc4f5f0a5750d2c5fb8c399", "ref_doc_id": "d3eda07a-cfaa-4dc5-8564-4909ff605fe4"}, "e951c7c0-aea0-4a8b-a86c-e4210701c0c8": {"doc_hash": "39eaaa35ae3029353a48d14d865e0a1a74a2f9e5e8ac94b4c6d084d3f56b9d16", "ref_doc_id": "923a94ef-af9f-42ac-b099-640e707f6931"}, "ea555bc5-96f4-499c-ae8f-dea28f846e18": {"doc_hash": "404fe352757cb1c35e08ff62762d373f88aca4d372c3684fa605c0587eba4d36", "ref_doc_id": "923a94ef-af9f-42ac-b099-640e707f6931"}, "4611531f-7be8-42ab-b0bd-724b85e40363": {"doc_hash": "4cd5538681c72afc1bf03eecdaa322566809cdc7ae2490c72f4a5f0179bf8e16", "ref_doc_id": "923a94ef-af9f-42ac-b099-640e707f6931"}, "8d3e7748-e1ec-4c66-aea5-3df8ab4258e4": {"doc_hash": "20423033bd60754ae2d36cfd0e0cec7975af1cd83e5b4808cb064a0718c0b31f", "ref_doc_id": "923a94ef-af9f-42ac-b099-640e707f6931"}, "30ed782e-28bd-470e-afaa-3c722c82d995": {"doc_hash": "f7b19b9510b0c25e55a50451762de3bb27bed75bde0c6e789506beb76ef5e0ee", "ref_doc_id": "923a94ef-af9f-42ac-b099-640e707f6931"}, "4131791d-6d8a-4620-a6e7-eb9d5a21d5cf": {"doc_hash": "de748e0915d09ed061a3fae6030021e4c953033a960864c614aa4aeee872f8ae", "ref_doc_id": "923a94ef-af9f-42ac-b099-640e707f6931"}, "d1d42f18-6022-409a-85b0-f996a77f8477": {"doc_hash": "34aa60acfed9d31f908ef663a511ce666b7a790dbd1a1ea0e11e680dc198f67e", "ref_doc_id": "923a94ef-af9f-42ac-b099-640e707f6931"}, "e8ec6d48-4535-4668-b392-e0d1bad9680a": {"doc_hash": "c67d13e6d588b72298664cb3131c5b95dc37fa87495c350875f54450ba45ee83", "ref_doc_id": "923a94ef-af9f-42ac-b099-640e707f6931"}, "c952cc82-ca2c-480f-8db2-1304a9099ccf": {"doc_hash": "97b1fa590d269f6f1d5f2df24cf4d08e530f1a13cd1a189fd1dba3843fc2f60d", "ref_doc_id": "6ca606fd-0454-4a3c-8f6e-a99d1368dab4"}, "9046d928-4cc2-41c6-a747-da6856fbe30c": {"doc_hash": "8a00a661649f33b2d125eb5abdd782014e2c88f81e210c48d013fff62e683a29", "ref_doc_id": "6ca606fd-0454-4a3c-8f6e-a99d1368dab4"}, "280cf2df-4e33-4e8b-b2a7-e09fbf21dfe0": {"doc_hash": "2ae4bfc711303cbb631337a0981cf59e8b2e03185539c4ea3a50ce7a97e83d7e", "ref_doc_id": "6ca606fd-0454-4a3c-8f6e-a99d1368dab4"}, "efca8c91-0add-4ef7-bf3d-737c4f8319a7": {"doc_hash": "9f6b97419b6d4d007066901eb1f138e274edad94b9d435be9459917f2ff5bbeb", "ref_doc_id": "6ca606fd-0454-4a3c-8f6e-a99d1368dab4"}, "46d74122-a40d-429b-a7dd-a289dc0bd2aa": {"doc_hash": "16cc56993427eaae27f5988b7742447597040be3716c738735fad69fe1346984", "ref_doc_id": "6ca606fd-0454-4a3c-8f6e-a99d1368dab4"}, "645b24d2-e0ce-43a9-9e08-b3bcfc0e5f75": {"doc_hash": "a86a369621657b703698779cf74ac9782b2c47232d009d64009cc3921a7e637a", "ref_doc_id": "6ca606fd-0454-4a3c-8f6e-a99d1368dab4"}, "2cefc23a-55c6-4ca7-9337-572cf128bf49": {"doc_hash": "b347ba434820f7b37e52b666f7fec2a1c872c0cdf19abd0e5f4ec8ee8dfafa7a", "ref_doc_id": "6ca606fd-0454-4a3c-8f6e-a99d1368dab4"}, "9c9c9e3e-72a1-4bc0-a733-ba77d7eae0d8": {"doc_hash": "d086d4d206383b5608a874b9f0c8fde8a46df09cdc048dfd687d4b5dd5a15eda", "ref_doc_id": "0cedf0fa-abc8-4f72-b929-bb6af80badc5"}, "eee3b41f-2b36-431f-9239-cc7b5db9b33b": {"doc_hash": "8bd83e4235c747cd2a886adf9bade559d822051480942873527cece51eba8987", "ref_doc_id": "0cedf0fa-abc8-4f72-b929-bb6af80badc5"}, "332e7a22-5ed5-420d-a269-89a7221df196": {"doc_hash": "533d1d208582e855d79800fe0216a5fd8a4525706a34fe78301bfd2419e01593", "ref_doc_id": "0cedf0fa-abc8-4f72-b929-bb6af80badc5"}, "7cc8e856-a0fd-4655-ba46-303968bdd965": {"doc_hash": "61958dfce3e09ff21140a90da64e827af7ca564f64d869ac951ee229d029f945", "ref_doc_id": "0cedf0fa-abc8-4f72-b929-bb6af80badc5"}, "c318d636-18e3-4f3d-ab84-26eb05c26352": {"doc_hash": "b6d738a4b498fbcebbeb9383d811b486f9dc0b84ec3330b27acdd209aa1682ea", "ref_doc_id": "0cedf0fa-abc8-4f72-b929-bb6af80badc5"}, "c678010c-fe8e-47a0-b15c-834f84e9c30d": {"doc_hash": "01a98a6bd9a75bc60c2e487320223ee4b27c5ddbfd53f3956600831da20a25e9", "ref_doc_id": "0cedf0fa-abc8-4f72-b929-bb6af80badc5"}, "3a144196-f49d-48fa-9472-a206a7b637db": {"doc_hash": "8d4e13c8d63e83629b2dbcc62bc5cd37a68c38da02bea7da469f6cd748f3fa04", "ref_doc_id": "0cedf0fa-abc8-4f72-b929-bb6af80badc5"}, "4737476f-7377-408b-ad53-3d3c71b408b3": {"doc_hash": "6206e8542d843ef274968ccbcf3b64c1eff886deae63b37d63f4b552884e3719", "ref_doc_id": "0cedf0fa-abc8-4f72-b929-bb6af80badc5"}, "6f2c9210-3779-4b74-9279-2560073d8734": {"doc_hash": "b47c05bb4b50b585586e32ee2e6419f8f3793d47502a7408cfd59506be584387", "ref_doc_id": "3e6bd924-2c5f-459f-9318-9420a9e33ba3"}, "835a6315-1e1c-40e0-9cb5-119335cf01d4": {"doc_hash": "624509af7d4c242b5e5be32c1e5895a6d99d15d8b8822564e26073d84db5aa1a", "ref_doc_id": "3e6bd924-2c5f-459f-9318-9420a9e33ba3"}, "5311c2f1-b538-44e3-9a3e-b07d609207d7": {"doc_hash": "4bb126308058f3f213cd665c795c64d61c7e30657ee3a2e61df4d7b10fe46fa6", "ref_doc_id": "3e6bd924-2c5f-459f-9318-9420a9e33ba3"}, "f588c98b-61fb-4b05-b4a4-ecf270bcbc89": {"doc_hash": "635f312a08449ffd92ae30dfdc759e93039c0e0e835da1b82fd5b2a74326b342", "ref_doc_id": "66fefaef-6ba7-4df7-81ff-c072fe119879"}, "93a5025b-9233-4750-b5a6-9011c81d15d6": {"doc_hash": "8e4de11d961403d9003780ce418ac6355b34bf2800952579ded7515065422952", "ref_doc_id": "66fefaef-6ba7-4df7-81ff-c072fe119879"}, "1f98cb1d-b748-4579-91b0-ac0d4536ee17": {"doc_hash": "2819fae4614f453098d719549bd666671c69c5e4d89da176db9292c7f0647e37", "ref_doc_id": "bfde1ebb-63ba-4ac6-8622-c91fe12c3a89"}, "95de104c-cd78-4f43-9edc-530a9abceebe": {"doc_hash": "fcc2b0446720bc99639c8c9536f17aef5fef511ea439d873d8d72a0263023be2", "ref_doc_id": "bfde1ebb-63ba-4ac6-8622-c91fe12c3a89"}, "53629363-3e58-4e13-a368-82f7ef1565d2": {"doc_hash": "4fd265a0bd61f10c3a9af81eaf0ee4f5b5709dd203cee57498f752b1a222a565", "ref_doc_id": "322a8bcf-c775-4b29-8426-bdfeaf0ad72b"}, "84318884-e5d5-4892-bb4b-d704a3f4d452": {"doc_hash": "2eac0bec7a133c8f2238478e8e2943ff5fa1bca0875b15a14130040f5c660298", "ref_doc_id": "322a8bcf-c775-4b29-8426-bdfeaf0ad72b"}, "fd5e26a7-bbbd-4404-884b-6a51055b8954": {"doc_hash": "c09f78a07ee390d4a910b66db2fb4e2f92219840ba757885dd792624ee0ff6f9", "ref_doc_id": "322a8bcf-c775-4b29-8426-bdfeaf0ad72b"}, "00166eef-598f-4437-95e1-b9402d28c055": {"doc_hash": "7c92b7c997c169726ae3d433370aa83c0bd35485c51ddee395edf82cee87c16f", "ref_doc_id": "43f9ca28-4532-4a92-9c07-59013df56d1a"}, "67393e03-69fb-4a8f-a671-07d440da96c8": {"doc_hash": "ed087cbfd21e071eb4e401433ea233045bc19fe02ca59407e8c03174b1e8745d", "ref_doc_id": "43f9ca28-4532-4a92-9c07-59013df56d1a"}, "e75788aa-d349-4147-912e-1ca0666c14b0": {"doc_hash": "9968609cb7f62f666a03e9beadad5762acbd2ea59db2d255f405d43f01f73ff6", "ref_doc_id": "43f9ca28-4532-4a92-9c07-59013df56d1a"}, "4a7a7e3f-997b-407f-9028-66c5aa865cd4": {"doc_hash": "4f9851f2e4aed61dfc60a9c16363fde10ca0424770f1a62ef8acb54f2d853c7e", "ref_doc_id": "877bbf1f-5106-4894-a5e1-3285b410d669"}, "bc209971-7e4e-45c3-ba1e-463ad943adf6": {"doc_hash": "e816aa447a459bfae169e0aea99423a3964457566bdeff787f1900f9e854f5df", "ref_doc_id": "877bbf1f-5106-4894-a5e1-3285b410d669"}, "7d13c077-5950-4f2b-ab27-94831f0c9f8b": {"doc_hash": "cac7a6ff26f2a5c24ee5e1474acad3651c3f2099150fcb4ac945b69af700c85c", "ref_doc_id": "877bbf1f-5106-4894-a5e1-3285b410d669"}, "f7a1d006-8fa7-4b9c-8c94-d0a5eba3c810": {"doc_hash": "fd81a17bdc5f094f0863135519c6a5e1cf600129d038f85dca6f3129ca6f5af2", "ref_doc_id": "877bbf1f-5106-4894-a5e1-3285b410d669"}, "ec1ee651-4b0c-47b7-9f98-0fdcacda9311": {"doc_hash": "c2becfe4f6d79273190875a8df33aac946e23f824b8e29da0482a5f7cd9da7a6", "ref_doc_id": "877bbf1f-5106-4894-a5e1-3285b410d669"}, "b272c3e0-9341-4072-9fea-6a1e71531d70": {"doc_hash": "f378e7bcc608334e6d6ca1c85316f2fe5a6f4cfd18a4d31c70955681618e210c", "ref_doc_id": "52764204-8803-47f3-ad26-052cfabc7f84"}, "1930f2b0-29d3-4b06-9846-619eaf1207f4": {"doc_hash": "bc592de0953929ac98fea1043d8bb7d81315000ab3aa49581030952a55f2b98a", "ref_doc_id": "52764204-8803-47f3-ad26-052cfabc7f84"}, "1776d018-bd97-44ce-9ec2-42e827e10b31": {"doc_hash": "822208bb58053ec2498c7652f77c5716255c092160d0364fba04e028a17a6928", "ref_doc_id": "52764204-8803-47f3-ad26-052cfabc7f84"}, "a91f861a-ba1e-48c6-ab49-ce861b1925b4": {"doc_hash": "1644c60dc04bd1b3b592a2b8dd3b32cdffebca6497db9ab67d17576205185757", "ref_doc_id": "52764204-8803-47f3-ad26-052cfabc7f84"}, "d6891c34-5c10-4b73-bad8-3764f7d150e9": {"doc_hash": "f579d405737ec45651d5ef8cb04c1c0a19b9f959a42262c3632672449bdab4ee", "ref_doc_id": "36132048-5b84-4c1f-9209-2abff9297b0b"}, "44f15c74-ff06-4684-bd29-179f36f1e075": {"doc_hash": "7e5c5a27ab6954cd8713ab736027526a2a32a3981d9c8de24850a8b761470941", "ref_doc_id": "36132048-5b84-4c1f-9209-2abff9297b0b"}, "8d94b934-4534-41e3-b277-15b52285367c": {"doc_hash": "260448813c97b2fc2b0b4abf2fb0c57f208b41e7817b5e1e60260961a201fef3", "ref_doc_id": "36132048-5b84-4c1f-9209-2abff9297b0b"}, "2ed823d7-d9d2-4399-8257-b987af381099": {"doc_hash": "d737a1bfb5ffb16e5360e7fb7e8e92c56878ffbb1671715a8a20ddc7fb84f927", "ref_doc_id": "36132048-5b84-4c1f-9209-2abff9297b0b"}, "beebd843-d8bd-4fd8-9476-662122f8326e": {"doc_hash": "d3806b17b081a4f26c79d9874abd4fa39da7e26a7ff1cb1a82b45512cdec0356", "ref_doc_id": "11bbdfb9-b55b-420b-893e-42c5b2be6732"}, "ffa77d7d-e5ed-4a05-9319-a59768aaf549": {"doc_hash": "c7e3879706fe2a1b72e9dff7355b233de0f07124bd9b3496e4de9b8c6e3aca4e", "ref_doc_id": "11bbdfb9-b55b-420b-893e-42c5b2be6732"}, "0a9fee56-a758-44ff-ade0-b89d8bd83863": {"doc_hash": "57c2390847b6cfe9c00d1a57aacedc0037a8ac1a1011b9ec7c177cb1c3768abc", "ref_doc_id": "564be214-2fe9-4681-84be-93f26b887790"}, "6b106609-5372-4d2a-a375-d0dc224cf81e": {"doc_hash": "dc4522a6dd639eab2c2da1bd9511f254b1050fe704454b16265bbc5be6882ba4", "ref_doc_id": "564be214-2fe9-4681-84be-93f26b887790"}, "ea066f63-8af9-43e5-968e-0e4212d94a71": {"doc_hash": "e277dc4107b1c9dfba02a2b3379ce949acae9e0f86e7fcdbe14ff06d8a9be8ee", "ref_doc_id": "a07c1f81-e112-4d24-b379-3173bda1f275"}, "45a5b192-fb73-4765-81e0-46ee07af9845": {"doc_hash": "75d89a97bbfced90901adeadde731ab4852642b4f86a9f148d0635a34fc4e2fb", "ref_doc_id": "a07c1f81-e112-4d24-b379-3173bda1f275"}, "2486d01e-60e9-4a64-b240-cb67eeed7690": {"doc_hash": "07286133d3505232f84d16770ffaa3543db0f49219393cd9249ab31c7b60fce4", "ref_doc_id": "a07c1f81-e112-4d24-b379-3173bda1f275"}, "84cad516-4adb-45aa-9ce0-d241ed187470": {"doc_hash": "8270d5f7c856d5da743dde0fecf5682619fed0dd8dc75610e0607354b5c9059f", "ref_doc_id": "a07c1f81-e112-4d24-b379-3173bda1f275"}, "0c6ab53d-cabd-4b4d-b7e8-ba6ffe96aee7": {"doc_hash": "f8f5de6f77f137509357865283e7f3b6a569bff7ea995abac7e56c15649acee5", "ref_doc_id": "a07c1f81-e112-4d24-b379-3173bda1f275"}, "5edf3f53-8c1a-484d-9172-b7f4f482fa4a": {"doc_hash": "45c9febad4210fae65c33ef819cf1f9dc14fd70973f49d9f47c0963a70b2245a", "ref_doc_id": "a07c1f81-e112-4d24-b379-3173bda1f275"}, "6f69f89c-9cd8-4aaf-a35d-5de457acae66": {"doc_hash": "6434599eff20ce6d49eaf95500741e02e11a71df026fbd8fb81b9d6a42b9351c", "ref_doc_id": "a07c1f81-e112-4d24-b379-3173bda1f275"}, "8a2fb072-28cd-4006-9676-89a8eb8434bb": {"doc_hash": "73fe6179eb38d3f61389e19a1e3dbc8cfd6f13325321b953667e55320d601e1a", "ref_doc_id": "a07c1f81-e112-4d24-b379-3173bda1f275"}, "a6f3cd15-fb77-4b97-9d4b-a5492ca8770c": {"doc_hash": "b718c477f02660c16b231666918bf34105bd6cc7038e63b4408bc6c4a5502c5c", "ref_doc_id": "a07c1f81-e112-4d24-b379-3173bda1f275"}, "b128157d-9f1a-4199-8dbd-4e4b35385ff8": {"doc_hash": "ae6dc3d26662aa913bc8e7b4588d659706def321ed56e5dd48d6134e21d25e87", "ref_doc_id": "24d748fb-a338-4061-b032-0466ee6697e8"}, "8d0e1396-8165-431d-b0ac-2f58a0952892": {"doc_hash": "9b515358b2f71f8762356bfad0edeb213696cd8bbb62ffec3c31a1add090284d", "ref_doc_id": "24d748fb-a338-4061-b032-0466ee6697e8"}, "5d44643a-88e5-4095-975e-0f373e9b38fe": {"doc_hash": "b71d3b3fc1ac71df19294f23a4c7a70d21535176b2edcb5ba10564aebd0ebba1", "ref_doc_id": "24d748fb-a338-4061-b032-0466ee6697e8"}, "9e9cecca-6015-44bd-96cf-3deb12ac24cc": {"doc_hash": "15e21cd165c6da634eb4f14e266fc212d979297cfd5bf7808d0b1d55c2bc3711", "ref_doc_id": "24d748fb-a338-4061-b032-0466ee6697e8"}, "3c2c4feb-38aa-4df3-9050-10c1c7da9c64": {"doc_hash": "6acd27885da7fd4b9d9fb421d2c78a16acee22c25b424eed7ab0a823ba4b1ed7", "ref_doc_id": "24d748fb-a338-4061-b032-0466ee6697e8"}, "d00a2be3-59f8-40ab-a2ad-d0f056b35294": {"doc_hash": "4c2a108c999f9e94999a19962fa28da5a39da3d3245e70384d317d1282a85f9c", "ref_doc_id": "24d748fb-a338-4061-b032-0466ee6697e8"}, "352c27a2-6598-434e-9c3b-4d75d2c9989c": {"doc_hash": "4e28b0eec7537ff1f7915870c7bc05cf75907fd214d256b4f5c8ec730865a290", "ref_doc_id": "24d748fb-a338-4061-b032-0466ee6697e8"}, "7f10eeb0-701d-4d63-9b9c-f29d74424d7e": {"doc_hash": "6c0b7bca569fe2a7994ec00f1f3b19c19744b8d8a902ce6a2a3cb0fb62af454a", "ref_doc_id": "24d748fb-a338-4061-b032-0466ee6697e8"}, "f1d6febf-03aa-4ef0-9507-02a8c1bb6f0e": {"doc_hash": "534b436c23f93d60526df19578a4b6bf02ab18792e9bf21f4fe3b1fe797d7ec2", "ref_doc_id": "96613642-e63d-4b1e-8252-ecb4d4e26853"}, "5ce8fa17-089a-4270-8ede-7b08fc823da5": {"doc_hash": "bbf261cc9d8c411fb5c679cc72488d46b2aa955436029858dd0c738c4fbb6061", "ref_doc_id": "96613642-e63d-4b1e-8252-ecb4d4e26853"}, "9dd45a83-1df4-48ad-a252-ee84ecab1741": {"doc_hash": "bfb70b7d40c501b4ec16048396bc8a7e97617c911e972a491437500baf1e9403", "ref_doc_id": "96613642-e63d-4b1e-8252-ecb4d4e26853"}, "5abc2c8e-e5b8-43c6-b732-985766fc22fb": {"doc_hash": "34cd28b9c51cf065610f70e9ce0c090f1f85672b68e01d4f0653b751851a22a3", "ref_doc_id": "96613642-e63d-4b1e-8252-ecb4d4e26853"}, "ffecce29-2cc7-474a-b89c-ad8e750e8111": {"doc_hash": "bfecb447f23ac9b2cefd9c4c69b0f3e62f63c4f7cd8f68a096d70364efd98eff", "ref_doc_id": "96613642-e63d-4b1e-8252-ecb4d4e26853"}, "929d9da9-c77e-4d30-9866-f5da79d36830": {"doc_hash": "de5b8a24785768bfdc3a6bb58ec6bd1bca965a70b348d0cf0d8d9fe56db58a84", "ref_doc_id": "96613642-e63d-4b1e-8252-ecb4d4e26853"}, "4a84a8a3-0b30-498f-af20-1bfe7b1fd16d": {"doc_hash": "3410fc5c40280a248f0878b3a0488f6a9e735189a29e27ee95afb7c15db70af8", "ref_doc_id": "96613642-e63d-4b1e-8252-ecb4d4e26853"}, "64084fbc-0d40-4ce2-bf17-f5dcd7232297": {"doc_hash": "71f86dbd010fbd8a96b3a97a1c95a4008d349c7e0566aca45f70d839be93a6bf", "ref_doc_id": "96613642-e63d-4b1e-8252-ecb4d4e26853"}, "6ee6fab6-6f36-4f8a-907e-97225c01d8f0": {"doc_hash": "900c93666b958248dc84e8c04e94bded0a4c32f9a0fb03091da6a554509d137e", "ref_doc_id": "96613642-e63d-4b1e-8252-ecb4d4e26853"}, "dd8aa3f5-cec3-4794-807d-10e726bf074c": {"doc_hash": "cc5fb3c0597eb185c2c222225d7b8adf4858a408e9d665ce775f78e0f1e7f95f", "ref_doc_id": "aafa609a-4cb3-42f7-8637-aa761dc4f733"}, "d7d40529-0952-4823-99b7-b571aecfd62b": {"doc_hash": "cb3e03996ce9461b70b337c3416f06b61a1c1f79ad13f6913ae53decfeeb96c1", "ref_doc_id": "aafa609a-4cb3-42f7-8637-aa761dc4f733"}, "16317337-af6a-47f3-9966-c28247926065": {"doc_hash": "ca8a5a4b313f2a9f7c9e6d3b5db310b3a13a3482524c5736b7df66bbcd16987f", "ref_doc_id": "aafa609a-4cb3-42f7-8637-aa761dc4f733"}, "e247ef33-5c3f-4884-a641-b9849175f7f0": {"doc_hash": "eb2248265f34fb5b3e5e01ebb8d65bfda96cff0671da5694984b8d05a9b2bb7a", "ref_doc_id": "aafa609a-4cb3-42f7-8637-aa761dc4f733"}, "c19dffdf-2bf6-4350-9f08-54a3a709f677": {"doc_hash": "e696d3caaae7a78da0b8eff0dddccc250e01d1581a8860ea9238d57b42548282", "ref_doc_id": "aafa609a-4cb3-42f7-8637-aa761dc4f733"}, "660755ea-048e-41a4-b58d-ea38c2776a26": {"doc_hash": "35a8ebaff817b3486c6f8512c0af876d9847fd2c45c7db3ff0205ba88c19332c", "ref_doc_id": "2edfb660-1efa-4517-b3d7-2c7c42053af2"}, "8b9bec50-67ce-4940-a5be-b99a7a838eaf": {"doc_hash": "47c74735233168f39036c30612973913bf37bd2aab4762135f500cfed2ee77b7", "ref_doc_id": "2edfb660-1efa-4517-b3d7-2c7c42053af2"}, "1fa23db0-433f-47b4-91fd-2fc81a00a227": {"doc_hash": "d10baa685ae677859d992f3ca1041268235c43ebc27c936309838101e7c39a9e", "ref_doc_id": "2edfb660-1efa-4517-b3d7-2c7c42053af2"}, "96f4fe87-4e21-4088-8381-6279675def54": {"doc_hash": "f6ff3bedb63e2debd9084b14330c47a8ee5f1e64444c0d25c5e9d24722355759", "ref_doc_id": "2edfb660-1efa-4517-b3d7-2c7c42053af2"}, "5937a12d-c359-47dc-b0e8-7d42ef8f6d69": {"doc_hash": "33a755a78d3ce05f4b814a5d20a85ccb936074c79cb6db9591b39a0041299941", "ref_doc_id": "2edfb660-1efa-4517-b3d7-2c7c42053af2"}, "0063b3ea-0801-4263-9c56-75cca5255a7b": {"doc_hash": "eab2e09ffac735f9d209470f24d99cba69d6cfc8b5f7bfaba2ae15708494cebd", "ref_doc_id": "2edfb660-1efa-4517-b3d7-2c7c42053af2"}, "99423ed5-0c4e-40d0-ac63-d76dd2ecaadd": {"doc_hash": "81ba5efadd52bbaa93cd0a169badde45113394316745a02fde9c5fc0203c6ec2", "ref_doc_id": "2edfb660-1efa-4517-b3d7-2c7c42053af2"}, "16529f6c-0a09-4e13-8fbd-9a602de72665": {"doc_hash": "dff339d9a88b37dd2c789b2beeb8a17910cd5a34ce01405321347eeb32cdfbd6", "ref_doc_id": "2edfb660-1efa-4517-b3d7-2c7c42053af2"}, "eeeb62d0-d13a-4581-84e2-e5fee3a5aaa5": {"doc_hash": "dec7f39a490a54d54b11bdd5d0218e9ba8dcc7d96723b968055242dcc18bee6e", "ref_doc_id": "2edfb660-1efa-4517-b3d7-2c7c42053af2"}, "4f1ff419-1c3b-4a6b-925f-e5a1062f2be1": {"doc_hash": "f110e5e82e780609b26e979d6d461a94322ef6d88c114fc682271e7254255f77", "ref_doc_id": "4029a4e4-3c05-41b1-aab2-3512cb045dbd"}, "f9c3f23d-e0c4-4758-a2ac-37eaf8f61d91": {"doc_hash": "f80edccbc6e5bf328a3e92ef6c594627e8209a0f019fa301cc605b0e1bf8b339", "ref_doc_id": "4029a4e4-3c05-41b1-aab2-3512cb045dbd"}, "67a91526-3d60-4a7b-a97f-4740da4a7fd7": {"doc_hash": "146dda9d63768edcfe52a4a433397b775f92d04f311ce710db748396c4915623", "ref_doc_id": "4029a4e4-3c05-41b1-aab2-3512cb045dbd"}, "bde6d71c-aed5-49d6-9b79-796edda986cc": {"doc_hash": "e79a5af788d419302d5df33ae7cc7f2380d1fcef6e6f0d07d3bfaa0aebed9d96", "ref_doc_id": "4029a4e4-3c05-41b1-aab2-3512cb045dbd"}, "96e63029-1f71-42fe-818c-58017536a9b5": {"doc_hash": "b190880c9ddc6394cabf310dd4078a47c57694202093004e73cf020166c7b798", "ref_doc_id": "4029a4e4-3c05-41b1-aab2-3512cb045dbd"}, "0a34bd99-0674-4038-b979-d20aa5c00460": {"doc_hash": "978a6ea15bb611b271d7d0369c693757fcf262466a6244960afc11a57815dc3e", "ref_doc_id": "4029a4e4-3c05-41b1-aab2-3512cb045dbd"}, "36442997-87ec-4cb2-b348-77450a7d15bd": {"doc_hash": "0c559297f1fc7944842d878423a50ccf15c13c9b341358c3867db6cb6159676e", "ref_doc_id": "4029a4e4-3c05-41b1-aab2-3512cb045dbd"}, "283d0512-492c-4e90-9b45-e2f585ccdf1a": {"doc_hash": "592b5fce32aeefea2485b0e6a3015982a1e9275bdddc9d5d9bcb8a1abb75ed6d", "ref_doc_id": "4029a4e4-3c05-41b1-aab2-3512cb045dbd"}, "ce33a154-1d5a-43a8-ab28-897485fb0942": {"doc_hash": "ba37b97effb2db3e304aeffcefeb5750e8d6c46f107db97885a3787783e57afa", "ref_doc_id": "4029a4e4-3c05-41b1-aab2-3512cb045dbd"}, "df42b3a9-20b8-4ec0-876f-9fc355bc1e02": {"doc_hash": "d247c4f44dbdda4143d9c96b1317bd943a1eddba29ab48a6620f98c8d829eb86", "ref_doc_id": "4029a4e4-3c05-41b1-aab2-3512cb045dbd"}, "ea639285-da04-477f-baf9-537e9d2196f7": {"doc_hash": "dafd0fe0f6df4b912370b25ef05b13a2a4de5efea8cfe5024a924e388f3a8878", "ref_doc_id": "4d4d8996-38b7-4922-a5a3-8d460bdcccdd"}, "0a46df26-0faa-4880-9cb0-a018de3ab880": {"doc_hash": "affbe47713376bc896a1a7e01c9772c24aee354a1057397812d1f1405371cee6", "ref_doc_id": "22a72e50-3350-486e-897a-d10f1865f945"}, "ba4865c4-44fb-41a3-b835-5dd528115af3": {"doc_hash": "0445da38fac77ae4f9c85085b7885bb09d5775f4d3fb5ac50a6e756fbd268fe8", "ref_doc_id": "47f3f53c-3ea9-42d0-80da-1817d6feef8e"}, "ede47257-aa3d-4826-b5b1-ed154d6ca766": {"doc_hash": "ada99048874310acfd6f38db3c2e8e1b151778b7478a9dbd690210d59d340e3a", "ref_doc_id": "f80344a4-f951-44f4-b562-cf9c2eafcd14"}, "933ae657-3341-4562-be4c-d3e5f9a17aab": {"doc_hash": "7953d7bf2048c7f101be9985802523102ef3ccb23d9954654791d621e4b05450", "ref_doc_id": "9985ffb1-0998-483b-8b2d-b3bf7665cc35"}, "b0e470e9-c52c-4b2e-bd79-b1d2bece0655": {"doc_hash": "8cb5e2283c0425c7c21a26333fefc10d520daf8abaa6138b7ba60cc8ed35d658", "ref_doc_id": "65c43e63-3cad-4eea-8e2e-2eefdd741572"}, "71ff9a68-a58e-480d-9cb9-7ba7bf4a5608": {"doc_hash": "9eb1a1aa21358a5532529ccb142a5dcc2735399066ae24f5e2464f7c2e7809d3", "ref_doc_id": "46715ff1-001c-42a3-b1c7-c5f9aafdcdba"}, "d7e4d261-5579-4cf2-b2c6-c0a67c07b2f4": {"doc_hash": "e5655db6ec821227851deed5d66347ab0fbe29b298a5c60528f707db7b17b130", "ref_doc_id": "065fd747-9054-4a38-aea8-0afc053c9abe"}, "ae5931d9-818f-4a26-91f3-a133fe31128b": {"doc_hash": "492f76bf994beb0d83d0076393f01e7736e052b1152cce3a576c49d77da2d61a", "ref_doc_id": "ba303aa1-ca51-4ca1-ab01-b46b11269478"}, "ab86afae-c3bc-4c8e-ac98-215c4efe1662": {"doc_hash": "ed98f19344eed83c42591cbdc4c32d451694e170abf422b4843fac35b4663055", "ref_doc_id": "eb6c427c-364e-4849-8a79-0e46f568a1f9"}, "fda80048-74b1-45b2-93f9-5a3a02f895f2": {"doc_hash": "4f7a1dc2258c688272834d0f51a319d5c6d2f296f082b59a927ae5e048466a25", "ref_doc_id": "a69db317-69d6-4df8-87d3-3b67e5ef98ee"}, "5b92a4e0-4b8c-4138-b2f7-9bb16179456e": {"doc_hash": "b3f076f53bbcbea5d92d17cb14463da2afcc6dc227416cc4a927b1533825c6c5", "ref_doc_id": "557ebe60-20be-48ca-9271-cf6bd9e97759"}, "f80d0539-2eaa-477f-a6a2-3d03911209c7": {"doc_hash": "0d612378544004c20eeb77a91209b5224c47556d6c8a9a3c1974fd80251f3b02", "ref_doc_id": "0c365bc2-bcc0-40d8-8359-312d7db0ea2c"}, "4ce29ceb-24c0-4b1d-a98d-be9dae95d663": {"doc_hash": "2bddba887fe4eb10a92a0e47bc8e29ebee75bfe5f0001e6edd9e681cf4fb26fc", "ref_doc_id": "11760da2-6cb5-44a1-b8cb-24ec0da66b81"}, "80625897-7eec-4d3c-9d2f-a61ac33a9975": {"doc_hash": "8989311930ff9756de262165adb2f522cd2a177555bf4f201f1a9aad56a83ba4", "ref_doc_id": "2cd72a0a-e948-4ff7-9f40-dbc3b9d4ea8b"}, "f8a1a392-b154-44f9-8bae-129585e85a3c": {"doc_hash": "cb5db584dca67abea6d5ec6772d9fc205a4ba4de95e4054664c5956b0cea5a5e", "ref_doc_id": "2231a9a6-e601-4296-ada5-8372b6438bca"}, "68abbf8e-d10b-405f-86c5-c8b768f25f12": {"doc_hash": "1411729c2f184c3ea2b57df3014510e4d75c0df42f971987cbdb702a391a14f6", "ref_doc_id": "454d8df7-3e4e-48db-afa0-93c1996ca420"}, "0e04afd8-0560-48ae-9243-bb105902157e": {"doc_hash": "267a382395a0d060f9acac6860d48042587849ae2dbd105a1926d8c25f48043e", "ref_doc_id": "08b94b43-9af2-497c-bb3f-ebe575c982a7"}, "d8c8d4a2-75c9-4cc6-8972-2ea9ec05b57e": {"doc_hash": "c9fc876d3651984a30a0ffec6bffe15f1170c81db26d9a8daaa2b915730bddce", "ref_doc_id": "fc50f281-55d5-4bca-8c0e-b00942990a56"}, "d819f5ef-910f-497c-8d79-f30abea08677": {"doc_hash": "eb20a1aa835755d72d5d8565c3cb2e1cabce83779ff120e923c0140f72b24a30", "ref_doc_id": "7b190dc8-87f9-4544-ae07-5279ce3046df"}, "7b29d162-82a2-4187-9091-d23cee72e09f": {"doc_hash": "ac997c78199ea780c66f2e0ca84677fa331f0cf335b076789cca6fdba2a23f7b", "ref_doc_id": "d7dd4540-5a15-48fc-b18c-11de029555bf"}, "037e4d8c-80e8-4e17-b8a1-a51ebdd4467e": {"doc_hash": "4e119ca0dc587144fe74b25eea69b35bdf1a11b3645362c6c5cc5dbfee55471c", "ref_doc_id": "1fab887a-2cc2-448b-9138-3857e0701c2a"}, "69afcf26-b0f3-487b-b5dc-f088976df4e0": {"doc_hash": "21fdd963a3dc91821b8d3acfbcd89a8bc5af47b3c3586bab8f97cef39033a9cc", "ref_doc_id": "8636484c-e14b-44dd-a251-e385c4fc294b"}, "547b89ac-a120-46ee-9499-6189be3d72e7": {"doc_hash": "75ad9c3378c0795931c49b76875e9ac9c4dc331981867f671d1660fc5d69b5ad", "ref_doc_id": "62bbae2d-2a78-4e00-9e92-693cdbb875c3"}, "3b93d38c-c0db-466d-92f9-00c12ba4f80a": {"doc_hash": "10899eed5b64dc801dc0d7620b65265956ccfbef13b2f980863dce151429318f", "ref_doc_id": "c73013c9-4787-41d0-9d00-34488ecc060d"}, "35dbaa95-d457-477d-a828-db6329496d1e": {"doc_hash": "bf53781b773893399df66bba0cff48a2dd842b68415a03bc1d99bfbadc1d6714", "ref_doc_id": "fc3608e5-730c-4c90-b7d1-7929f0c13535"}, "afc91496-fabd-4eea-83ca-3cf28945f4e3": {"doc_hash": "bc8239c901e5e45913ebdfbc7a5da946889e70dd2aa78733fcc4038d27f0958d", "ref_doc_id": "4f11f617-4d24-45ad-b7d3-8d85bb8ce0ec"}, "1931b393-296f-49d7-96a6-470cca4f8435": {"doc_hash": "4b15c2fabc023b66292745d3bd6ab1d8aadd7a3e297e29a4dc5eee2b71426be1", "ref_doc_id": "164c284c-7d6e-406a-ab4a-01fe063f918a"}, "8acd034d-14ef-4902-8b6c-6c612d3afe8e": {"doc_hash": "f53048eeb74ef0a7d8bb3f674a272c25996e831de2cb2c1faa3be984aaceb6a7", "ref_doc_id": "7551b48e-58a2-4aa1-9488-450efbb970bc"}, "217514ac-0302-4024-be7c-5c9c129f10fb": {"doc_hash": "b1d8fd3f9b54f78cc578f4994d62c80d8dce2db7b5db20403ddf9fd560239f4c", "ref_doc_id": "6eb7cbf9-595d-4db0-9b59-a948ae86bc15"}, "f9e5e153-602d-4b20-be33-63c5a27df942": {"doc_hash": "92c5b527f35f2a1e5fb8ef0f91488eb6771cd430ebacebae8a8f5cae77bbba74", "ref_doc_id": "4edb0ee4-816a-491d-b66e-d989f8566872"}, "5aebc125-9b5b-4cdc-9bb7-652a1baf1189": {"doc_hash": "90b384101c359036c7c3d1b35d024e61938805c2a2f2f74a15436e68fe7ef951", "ref_doc_id": "0830e9d3-f18c-471f-8483-3041ab118bf3"}, "74136630-c072-42e6-a157-1f74252eaf71": {"doc_hash": "c3641f47b90d3f10cdde7c5314c69318d79d819630ab63c83d19f7998ff52b7d", "ref_doc_id": "6805abe0-1bef-47af-8148-626d40fda5a9"}, "91b2c7cd-cdf3-4435-92ea-ca40473b5075": {"doc_hash": "bdf44dc086f7a20735bea25104ecc5510bacbf7884177abea55c47241327740f", "ref_doc_id": "b9740561-4cd0-4c2d-b92b-a2889e1c4ee9"}, "4a4ebe49-5c0d-47b9-8636-8704494eb3d6": {"doc_hash": "3558c5f88cc67586331f3ee74cf20cdb7216e72e83e5cda9b7de4b4de733267f", "ref_doc_id": "3023d401-35be-42ca-b3cb-cbf86baa1b62"}, "88f72e55-2042-4efd-8841-8e883a11aa05": {"doc_hash": "8572fbfd49a04aec7601292b3f4eca867bde956312b17cd429c6e958bbcbd8fc", "ref_doc_id": "abd74dc6-fe7d-4741-9b1c-86cf92e9dabf"}, "e0ba8016-d0d1-4755-ab00-0dabef4c6e16": {"doc_hash": "4fd94556fda74df20df03bb77e8dca0a04ac96c6b051b9769dd35674db361f28", "ref_doc_id": "4f3b0d9b-3d9c-4ecf-94d8-82ff1cae6797"}, "f3a92e71-4b5c-4585-b284-c141bcf3d68f": {"doc_hash": "eb225c7c8cce3493a7b5bf5b889ded5826956625d02d327c699c2196d7c56493", "ref_doc_id": "45404661-bab7-4afc-b84f-ad80c34e64ef"}, "3e99523d-5c41-42e2-b34e-49ca61162bcc": {"doc_hash": "18e22c14510ba578a7ecf4f0897d55ee228c0b2ca42ff7b405a9f713eea98fd0", "ref_doc_id": "7141c8aa-45df-4258-857b-3f22bede7a91"}, "2ba61e40-2efb-490e-b098-5e104b25402e": {"doc_hash": "b3d3e76aa158c41ea77247083217ac6a63244a41bd1ce13fffbc9cf73d01c950", "ref_doc_id": "d1ad9bc5-6a79-4608-b573-62003c3ac7ea"}, "00adc7df-e795-43b3-9281-3038e36fc896": {"doc_hash": "869e7b39ab1b67e8348eaada73802c3274477427b102fb6d9b539107b2fbf9ac", "ref_doc_id": "af45694e-1feb-4877-bb4e-50acd4f43140"}, "b8841d32-bfa2-498e-a6d2-2cc15e813f53": {"doc_hash": "23ec15e40bd5391b45ef4ce2807eee1dc1975eb42041c71c2792bc9359f59a00", "ref_doc_id": "523b1e56-c39b-4a4a-8a56-ccd03adb8d44"}, "5bf5ec7a-fac5-4130-a024-2404ca9d4755": {"doc_hash": "6a55edcfa0b2e7c9774f2c324cee2a0a436de7f9ae4d8ecb73c51c3848e66721", "ref_doc_id": "82e70b4e-1015-49a6-b739-e34dd8156fab"}, "8995be51-bc15-44fb-b62c-b7f3329ff100": {"doc_hash": "c8f0c0ae2fff05ad04e0908a270bfbe90ba8991331ea2a3630210fddf86b169d", "ref_doc_id": "86778868-7bb3-4f49-9a26-c78b2494eade"}, "0b2ebfac-3563-44bc-8800-e0fd2deefe6c": {"doc_hash": "570bcff01af04728f0f8662dbc3485c17a76f1b37981849bff22de1164ab4f8b", "ref_doc_id": "f4f60c32-d5f9-44d4-b601-312e24eff0b7"}, "67556386-09dd-4bd5-9b39-10802a53e8e0": {"doc_hash": "6f31c37c3c0400710e540eb26c26465250d38aaa64dc0ea60e9700f2351db1df", "ref_doc_id": "d60fb424-3065-4c56-97b2-f1cbd9afde27"}, "926d310a-3165-4ce6-99c7-db589da8c99f": {"doc_hash": "606a0116be78d1efef91bd899dab9e1c83e930a9e754ee1810aa967de724ccc5", "ref_doc_id": "be98ff6f-3e0b-4d15-b1e0-45cf596f670e"}, "f120ad7b-51ac-4619-8cbb-7391534f5c18": {"doc_hash": "f34500563b3ee4a9e398a6ebef98c244db20ea0a917bc5093fda6688b2d31a8a", "ref_doc_id": "d618ac31-f76b-4fb9-9f01-aeb7219e1f8c"}, "af72457b-c4c8-4ad6-9b38-cb9d41939956": {"doc_hash": "672367d6ae783a1b509c1ea94025e2f6791c593ac5e616b9d593e9462c42d2af", "ref_doc_id": "a9c80840-7405-4c0d-8877-02e68e887912"}, "a651bbec-9897-478d-a598-7aa2d99b79ef": {"doc_hash": "5863a2523085e633a0c17e291e38aa9d7a9cba77e3cf1b5d5544e09498158e7e", "ref_doc_id": "d17a71fa-869f-4b81-98d3-ff8349298260"}, "13275b11-c875-48c3-8737-a36bb3a43668": {"doc_hash": "f4cb98582f61d08ce3ced9713f8dc3fb94686c957c477739e9bf5504e9eed5c8", "ref_doc_id": "73e33618-683d-4bc7-9faf-051ffc48cc4b"}, "a6baf061-15fc-4a0c-aa59-1a9e919e880a": {"doc_hash": "2e1ffb3fb69f886a6071ea7c3d2b12b02bad6d4be1c832fbe69f587f46d6991f", "ref_doc_id": "320656b7-73a3-4842-b9c3-168530bde414"}, "14463634-2918-4934-aa20-bbc7e8fec7b1": {"doc_hash": "21836642f0e1592812c551fd2e83d5217057ce2d14792b5c78b0fc6e59b6ac74", "ref_doc_id": "320656b7-73a3-4842-b9c3-168530bde414"}, "945ff3e4-4a48-4595-9ca0-00f596c38f37": {"doc_hash": "8df18ce925a9405e3eb091c0aca1e37f8bf4458aa48b1a1854e28a5e148469ee", "ref_doc_id": "e9428e8d-3031-4b47-ab08-aca218f40ef6"}, "de4a92f0-e385-4258-8f07-8cf05dc11a33": {"doc_hash": "facc0b369e2e0a5eb4e17ea6bb07d49315407e226096ee2bb95db9be7e575b12", "ref_doc_id": "20ad4412-10a8-4773-ac3d-ac540932b472"}, "910029f0-9e4a-487a-9bb3-9be05d353706": {"doc_hash": "728d4a5ad385bb4ed48558dc1a5110f050c0b620519857a4d9d958af8de5d2ab", "ref_doc_id": "121b4028-703c-44b1-9338-f482f68f9e35"}, "52763446-f37b-4c10-8f3c-7e3f1aff0e0b": {"doc_hash": "209f0e1534aa928a75af5955ee55205101b9570940f1e5dc22a3a2007c108571", "ref_doc_id": "3bc50e88-cce7-4421-805d-9e3007b2187e"}, "e350a3a4-7d4f-4971-b7da-2921f83ab1f2": {"doc_hash": "1062873da12ed6e431458e86d90f1a713eb2d2d01e4a91d9b0f37347bc99484a", "ref_doc_id": "d0646bfb-0b1d-4b34-b0df-5d5a7945cea2"}, "e03cc3c3-c480-45f8-8d4a-a349fe103c89": {"doc_hash": "f5df91903549c55f83f3c861689a8d8734f599190aa5b10ad37cedd5d4f0e4e4", "ref_doc_id": "00706bb0-b713-4b31-be38-a28d086dd506"}, "299cdbad-23bb-4048-b8ff-4bac8d6bb318": {"doc_hash": "12d979bfcfe0f4536bc8be3ee2b4feeb2cd71e492c8ebe06acaea519f574bfcf", "ref_doc_id": "5582fb45-e245-45e8-a48a-ef2e232df2ed"}, "b75cfa21-4137-4e47-8fa6-e5ab52c15b86": {"doc_hash": "8496a0d95424ca4b9b725aa043367ca36471af6656791263771c2dc669a31edb", "ref_doc_id": "1350de92-7f10-40f9-9c9e-febcc0126be8"}, "d25f949c-b3f8-40a7-80d7-64aa92f76caa": {"doc_hash": "ca924b76d777d0774ade9672644f5ca6cc3538e9d63faa3466b76db10dc8befb", "ref_doc_id": "6590eeee-6173-4372-8040-49481b4dcd11"}, "384e8ffc-ab56-4f74-b8ae-2ed822ee3b98": {"doc_hash": "426746a72da3042ee1d163e1c9a3e8dea069aef17af3d2b7ba443c730e297cf4", "ref_doc_id": "6590eeee-6173-4372-8040-49481b4dcd11"}, "afe77b60-4255-4a25-8ed1-f526ff848693": {"doc_hash": "9cb59b915163ec84e44f4bb83db5f3b0b05f1f25cff54fb487abfbc4da58e6e8", "ref_doc_id": "267fddab-aaeb-4434-b1ca-f4883a1d767d"}, "91cfe710-79e6-4a28-9f6c-3f7cd5b6d353": {"doc_hash": "65ec08c1ba2eabd44dae4debad8ec4186933f1ef985717ff8674226bcb758c49", "ref_doc_id": "61a98377-5bf1-4862-a502-94a14a74c755"}, "335b5e7c-00e5-42f9-a3a3-cd2d9cfb78cd": {"doc_hash": "75b3cea947d413010861697b69349ef83eaecda5db985f7458060caf3092132b", "ref_doc_id": "aeb2cb41-13b7-44f1-b621-cf924cc08d97"}, "526e119b-9ca6-4d6f-92a1-3bb8e3c85683": {"doc_hash": "bf935bca5716e0bb27ad1676229f45d50e44e52da78a43de26cc5afe8bd463e9", "ref_doc_id": "3769e52b-d842-45ac-8b7a-3c33f489dfef"}, "265564f4-fb91-410f-9567-6b3eb05d4a09": {"doc_hash": "a561b7c8769060288c69d0df570d295f0bd57758642d3f0947555e4b6c0ef8aa", "ref_doc_id": "16fe3a9d-d8bb-4065-9958-448ae109fc6b"}, "0eceda12-9049-4396-a1b1-8d495580b8dd": {"doc_hash": "b8e33041dd5fd95f6bd0e8b5b8096a985a1ff49e3e44b5e650d3329eac1ceb85", "ref_doc_id": "30f5fc87-1a02-46f0-80e8-51751b8f5215"}, "2dcab1ec-8af2-44f5-a1ad-a8bca77eca2e": {"doc_hash": "bb2bb4b38bc47a05dca659518725e673c8bf78be7b41752b1db01e8da28d1c80", "ref_doc_id": "d0c6b54c-3a08-49ee-bb80-d5364fb49707"}, "a42feef0-0d08-4fc2-9af6-3a7b5a6c826e": {"doc_hash": "53c2f5c4959ba76cd93eeeb021228b80c5f799d96e8d0f28d842ce068acec62c", "ref_doc_id": "fe9b8670-2917-4f81-b168-34eb07a0a8b5"}, "5c2f61bd-f4ab-4bfa-873b-e247a07a1fdc": {"doc_hash": "c03d60db52459a2d4e5d7b45d9c788742ad26123295f93b26cf24ba8494edc14", "ref_doc_id": "cb162009-3a11-4c0a-aae3-23b0ec30497c"}, "c0966a18-53c6-46c8-b5a4-ed0965af8f06": {"doc_hash": "31e30b01b351e47ab66c58c93c7f043c3147056ed1789b710096c80f3c99f22b", "ref_doc_id": "75d77322-5d9e-40d0-adcd-324b2274e3f0"}, "66abc75b-1312-45de-ab81-19fd54d49ab3": {"doc_hash": "c7c14c5374b7593c4650c88a88ea861f1b1f547e80be0bab0ff994f05ac0d72c", "ref_doc_id": "3f498d54-3613-4c3c-aae9-1d2d8887754f"}, "600ce937-46d3-4b4a-9a87-aba1f4e14d70": {"doc_hash": "d5329ae5fd638c83f9e4e971f03238af9a47feea1bb77b83f33c193af8918017", "ref_doc_id": "55793051-95e5-4bc3-8f97-b1a7430c48cd"}, "f973e596-e39e-4f06-a675-9553a560d491": {"doc_hash": "11018fae173f26cfc34ea66d21b58fbecca79b40696bba76b1b7d6885fd49bce", "ref_doc_id": "76aa9e20-2532-45e3-8834-c6bf10f1c929"}, "928aa4d8-f827-46e5-a260-5824d5da7538": {"doc_hash": "2a5840800bff45adbb34c1de50ffa2fea8b576be56e3f1e9abf23e2db509d440", "ref_doc_id": "c920ead1-8e97-4ee1-a373-bd138608e3f4"}, "ba2f78bb-ffdf-4aee-8673-57fcc0246a3e": {"doc_hash": "0ba677078971e9f02febeca021aca159aabd581e828322408786ba7a1bcc40a1", "ref_doc_id": "706afe10-1d21-41e7-a56a-a9714dfa220d"}, "28f391d7-b209-44e1-b3eb-e9a373688552": {"doc_hash": "40dd39173c1835718eaeb56541520a327d0bfb51b2ecdd1537dacd53722403ef", "ref_doc_id": "a7fc0c2c-cfaf-4a3a-bb82-593ec92ba62b"}, "d9db22eb-bf05-4b6a-b9ac-19ab505a6a3f": {"doc_hash": "ebfd7e88573e6f58250f97c82350b5629a597f518c30319c4317b38e6dc924c3", "ref_doc_id": "1ff26edc-6068-4418-87a6-5f6954af649e"}, "0d291464-a5cb-45d3-aea0-a3d4fcf715e8": {"doc_hash": "7a8eecb04b44f563bb2c29fd62215b52879df0bff7d48100a2026153ac3d0ca3", "ref_doc_id": "50af3b9a-9078-4af7-9d3a-fcafc326ca7e"}, "6a1bb986-4981-41a5-8013-1c0ea2d830be": {"doc_hash": "1462ab86f8463badc244917aa127f9a68c2509c2efb56bccd2371e0749ba1210", "ref_doc_id": "dcf0a36f-cf81-405c-8222-597a4ab35fff"}, "23ac4044-81e5-4ae2-9e15-ad50dc9f9a62": {"doc_hash": "dc55dbbfe84937d9f652ff2bc70146ee31215fb9f98b94c46bc1628fb57290c9", "ref_doc_id": "2c4eee77-7889-4fd0-9b3c-5cf27e31e117"}, "9621eae2-edde-49ab-9404-5473ab25f901": {"doc_hash": "b0077c5027a35942ffac80103f390889f1aa4bc3ac05c6c7051278a205b4676c", "ref_doc_id": "b8040aff-46eb-4b9d-b564-38e42aa53bfc"}, "ab3b63f2-7083-4428-b7b8-219dbecba0ec": {"doc_hash": "f45aa709296b89493f08e0322fc81d1a53822e662ec8368a64ab562bfdce7c23", "ref_doc_id": "03a32e3a-9ec1-4327-99bf-588d27b47a52"}, "3b00b9e9-3fa9-4767-abda-3f5bedc2fca1": {"doc_hash": "7b44fca610d23b298e6dd8492e2b18071a39f4db1b9bd559857c7544afb0be11", "ref_doc_id": "40048bb9-df3b-4ec7-bb92-de8f0695610c"}, "74e668d9-6710-47ed-bd9e-ef1aeabca33c": {"doc_hash": "9abfeb28e694b041e8fb79d3b5d389f74644987c6bd1aaf600f49c5c48bcd045", "ref_doc_id": "b5077bf6-30b9-41af-9bf3-761cee8b9bad"}, "431de908-7ca4-46fe-93d7-5287dc3677ae": {"doc_hash": "4e389117ef8771c953aae39b88fe3faaf2f618c70835bf0b2eaaa946b9f3be4c", "ref_doc_id": "8174bae9-4522-4adc-bc8b-192a8f06cb11"}, "49a6317d-f8b8-45de-b0e5-0f7faaa41b45": {"doc_hash": "afc4b04bcecb818da529d027fb8f3b82f4505c9a4548506c791c4db2e4fe3a13", "ref_doc_id": "80e1dba3-3e11-4412-b88f-283d539a6a80"}, "faf54093-7e8a-4628-97f7-f034f0dcc6f0": {"doc_hash": "4ca76d33f82acf06b5cc79354eeee019282f8419fdb7ade431dcf0206259a599", "ref_doc_id": "b2ac548d-5e76-40a5-b2b3-987488dcba02"}, "81304499-aa85-4a57-b325-6d9a6478211c": {"doc_hash": "4c944f9656e7731e146fa2e326e06e25db4e1ae615d910d742b5f42b17b52ea0", "ref_doc_id": "183de8bd-164f-43d1-ab3b-15a1589f21f5"}, "4ce45d0e-5e6d-4f56-93b2-166e4a4cca9d": {"doc_hash": "5b8b399bc825af82d9780c523d9bc04dedaa58938d55bd056e8f673cce8b7384", "ref_doc_id": "36d87278-720a-4186-8abc-502e01c4c92c"}, "bf8b70de-44fc-4838-974c-0c4822b65e14": {"doc_hash": "781c98f7e59ee967f4fe66a6fd67824540fbc4943de77a12c342eb1e8b7960b6", "ref_doc_id": "c6a3cd14-4f5d-4453-97d5-2c412c6b872f"}, "6ff5a90b-45e3-4777-805c-d8377ea4c098": {"doc_hash": "f8d498e85ee37b79ce916b558f548bb9d2ca296ea1d2bc49b67513d632fe9dc9", "ref_doc_id": "50bf6623-bca6-47b7-bafd-bcba7cd025dd"}, "39d97ab4-a99d-463b-a950-eacfe53dd664": {"doc_hash": "751e4f5a7b1cc0488df39200dd32be68c93c489b749999976deebdafc2c85b5f", "ref_doc_id": "51184f76-ff7d-4635-a3fe-782c187e98ca"}, "42f114aa-529c-47e7-adc9-07910d150a62": {"doc_hash": "225831275dcada8b28f88b7a541244c967e90dc7e0625960ccbb9c1ed683d6a9", "ref_doc_id": "ed366a82-5a01-474e-9658-ea4995f6816f"}, "d3515af2-41fd-4f90-9415-8a3e37d92e24": {"doc_hash": "f6444c6b19a491726650d6a7dcc62c48c07e77ffefab10484cd911f4c68ae2aa", "ref_doc_id": "e03429d5-b5b0-41f1-8298-da426c6d8cb1"}, "7fe85003-e71f-496c-8ac2-7adf9a52086b": {"doc_hash": "7808d643cd2d25feee252233faddfb3c988888ca0d3218c7a4e9b42c6397d561", "ref_doc_id": "592ef5db-5488-4678-bdcf-a395d808d1e7"}, "3b8fa743-65f5-49dd-99cf-fd8cef6445b2": {"doc_hash": "2853c432a75f24f2b2dcacabeea106fae1e3645734fa16639146f0922bf5e40d", "ref_doc_id": "08e01526-25ca-40a7-b3dc-dcff6052c0bc"}, "8edfccdb-292f-43e0-bf79-83180b6b59b0": {"doc_hash": "d6205e21d9806e7f360143c53f702c3e54b166b4677259d2083e0b0428a5fbfc", "ref_doc_id": "d40a7492-e2e2-4de8-9478-08d112579e1e"}, "3739e152-4112-49cf-bff2-25ace0bbad70": {"doc_hash": "a67a5562f4f4fc7e55b3411784571aee12c4137352e1b704bb7b538ebc103e19", "ref_doc_id": "76092514-2027-4582-b797-e282c30074c5"}, "9eb98e97-1386-4a6a-a52d-29169a2849d1": {"doc_hash": "dc55dbbfe84937d9f652ff2bc70146ee31215fb9f98b94c46bc1628fb57290c9", "ref_doc_id": "e84abbec-d22f-41ea-9b98-807ba9ecc40a"}, "753f5604-f539-4b4b-b959-a54cf7ac9cbf": {"doc_hash": "071c3c2a95163851f9033e5a003d33d94a436d13a1138005741574f56aeb41c9", "ref_doc_id": "18b64455-6332-49ab-9827-1f0737061d77"}, "39a99b8b-7b07-465d-9ddf-bb1409012fa2": {"doc_hash": "4ed363ea5a17f94ef199ba19c0b2a67953ea90562d72f6e7019c3c7d4b319100", "ref_doc_id": "ba275713-5ed4-4998-ae30-e6c7c907d010"}, "51750201-7ff4-451f-bf12-45ea13fedc6b": {"doc_hash": "311e7df4acbdbd29b89c714d16d7b3159591416bf2b063d8296e641a72efa08e", "ref_doc_id": "c29cde0f-500a-436d-b4cf-ba2cea602e2b"}, "ca94cb58-b2bb-4582-a65b-0d2c632f5904": {"doc_hash": "f45aa709296b89493f08e0322fc81d1a53822e662ec8368a64ab562bfdce7c23", "ref_doc_id": "aefbd97e-0df7-492f-8b63-46cce30bbc67"}, "b9ca5db3-cc71-43ce-9f25-378f5a4e7efc": {"doc_hash": "9625c0ad163b16fb9b04eda477561cda64373fbd94cd9d569fa906a038688466", "ref_doc_id": "68bbc07e-2bff-444b-9669-da38603e38c3"}, "1cb2a82a-f5ab-45bd-9c0b-24bb350f57cc": {"doc_hash": "b9f70b56858306cfd9f540b8bbbf54182e87641fb0395819e26ecdb33b63aa4d", "ref_doc_id": "1d329a1e-0703-4833-99fb-677b52c7c2df"}, "ca72572a-d14e-49c0-9281-14cc6bc32135": {"doc_hash": "44dc55784b3d531d17dc8e6d6d083bf07cdeaa5b700494a78f58a89f60807cba", "ref_doc_id": "f5f941f3-33c1-4129-b048-86958c4ce59f"}, "a00bb63b-0ca0-4562-8a6a-02adbc8994b2": {"doc_hash": "c1d64b02458b1ad920435e0d183f36675fbbbf2e9c9b4be87524dc66f1d1731e", "ref_doc_id": "bd32f1cc-9490-4fdf-a7f9-af9c8727de96"}, "88adc248-6f71-434e-8ef6-7e3f3e62b82a": {"doc_hash": "f9bb1d92f6800283283e528d78e4bd25069c7c254c00abb7a0fa839bddb2dd72", "ref_doc_id": "889cd50e-629c-4ca0-a8d5-0fd3e5725da8"}, "67288be1-b886-4cd8-ba98-f6bd551db859": {"doc_hash": "c914d2f27ec51ce3fa5ed1d894ef8a51da73176dd00887f7e7731d9899f45418", "ref_doc_id": "e4211359-7d89-4f16-a277-172fc2824132"}, "9d6881f0-6667-4c21-94a7-9c63003f9cc7": {"doc_hash": "35090f52ec0b4975eacfefefc8f3dad1664cc21072d98b9de2e4b9d4059d0b0a", "ref_doc_id": "e18d9d14-5d55-4e48-9694-9c345ca4c553"}, "eb1868ee-381d-4a49-b76e-8f7e8da02e01": {"doc_hash": "f2647cd019ff70b27768ca3012f05d07dc4dbd587dbec570ce5945e511a126d9", "ref_doc_id": "091ec803-2613-4a04-bd73-56767fd6700d"}, "8ac18525-2496-4838-87c2-154537173ca3": {"doc_hash": "0714bfbed952303fff59b465a928c0b7b9da413e017fd256670db36e8bda0351", "ref_doc_id": "30a60ecd-2d11-43ae-b311-b812c138845d"}, "19faec39-55ed-4d84-95bf-027d54d4f2dd": {"doc_hash": "5cb2662c59a11728897d4d9154ab66a49931d375563841965a9f32bf239ecfd2", "ref_doc_id": "665f4910-425a-4a19-80e3-3ee30f9af373"}, "f0d53255-0bbd-404d-aba1-614f7a016feb": {"doc_hash": "a3e3465afbe894f30dccc4c0df4c159aa66589326cc639c263458fb19b4af73c", "ref_doc_id": "8a98ee00-4caf-4f06-ae25-e4dbc0edd485"}, "36dc1a2c-82e0-4305-8493-805b3ec5dc4f": {"doc_hash": "203d3d7b156e5246fafd142a9a781137715b364e3ca6f91332ef99392ec5ff82", "ref_doc_id": "751589dd-2e81-4c07-9036-3f2bd12521c8"}, "235f43b5-181a-4c46-946f-6157d339d318": {"doc_hash": "462137f30d260ec2d81c900dc4a63756fa272024c919a432c211fe42b362635a", "ref_doc_id": "abd0c72c-4a87-47ca-bd66-66ba21d56103"}, "f08699df-cfb2-400a-981b-391444220f25": {"doc_hash": "f6444c6b19a491726650d6a7dcc62c48c07e77ffefab10484cd911f4c68ae2aa", "ref_doc_id": "39d1ae6e-aa3d-499c-9e51-56bb223f7d48"}, "56e114b6-a3d8-4eca-8e8d-6979e368370e": {"doc_hash": "042ce2a44e6c844d6a1eae1e5a447814d284ed31b5578c7e155b25f140f771f1", "ref_doc_id": "1f4943a8-9181-4030-aed5-6d8c2537c119"}, "a9e9655c-f5a8-44a7-a033-2d8e4e25b1f5": {"doc_hash": "dc55dbbfe84937d9f652ff2bc70146ee31215fb9f98b94c46bc1628fb57290c9", "ref_doc_id": "d7f47c7f-3166-4fd7-be4a-0536779e410f"}, "e5077f7c-6d27-4fd7-82c5-0a2fc5bbbb6e": {"doc_hash": "ab50a17eb345b946b59eb2b12b003f484ccfd6fbfd3ac99c67fe48f7100b42fe", "ref_doc_id": "5c855c94-1d62-4907-84c6-71f7a45fa42a"}, "a861ccb5-a594-4f13-b903-bfc332ab5505": {"doc_hash": "0d95dc3452ee16da2e4487ed43f4783252cde11b36646670c5959e3d309c5e81", "ref_doc_id": "c75d8b1d-2bd0-4d16-97c2-86ddee171fcb"}, "d5eb1fe6-7042-43e3-b692-52210be9acb2": {"doc_hash": "e6dd3686d406ae6344934a0b20c93fa5e3b7931d46ce126d9749e596c760c9af", "ref_doc_id": "c75d8b1d-2bd0-4d16-97c2-86ddee171fcb"}, "b533ce53-6263-43bf-a3a8-1000d24f8971": {"doc_hash": "954650e91ad88aad3ba0ac03df755791dd94af41991029cdfa8dd34a95ffafcf", "ref_doc_id": "403c7a90-f672-476a-805a-30ffcffc9ac4"}, "e177f1a3-1c67-4f53-9a45-6ffddfa14ba6": {"doc_hash": "812fda96dd2c8b6e71182118bd6dcd51f3407e2648b1aafa587eabb54b3d1d99", "ref_doc_id": "4c7d94f0-0b39-4907-adf6-198ca9f103ef"}, "95c1194f-f587-4497-b357-2489eb58e3be": {"doc_hash": "cf2bbde190df4e0e0565dd600314e13a09b49242505856066b30c7ab5ebc3f1f", "ref_doc_id": "fd7c1274-1898-4c64-be35-3330e31dbd2d"}, "a88973d1-4a1d-4e13-9c84-a9012b798772": {"doc_hash": "4d07879f12692c0d9acb412f651af9ab702755c21f0caf3d2c90df0058c846a2", "ref_doc_id": "53ec4ed4-b3c8-4993-a3bb-b1d829bcbbc5"}, "69163d6d-5721-4ced-bc83-d7e6a1e5ff0e": {"doc_hash": "24f14cd89b946d2d36619f7caad0a299c15b9dc46bda32268cfc7c5a7e95c359", "ref_doc_id": "6ed45376-0993-4862-80ff-81bbc9430f32"}, "1ea99c6e-a7a9-47e4-b0a9-98ed10e4c8e5": {"doc_hash": "16de609834ead6533f307729d5a83cb5eb97f32cefd84e3f91b69e2301c849f1", "ref_doc_id": "662e1f61-bdc1-4564-b941-fd74ebfd115d"}, "979c9a0c-7fb8-47eb-8c63-5f929e43f5a2": {"doc_hash": "65002a312335f80fd7beefa49c27dba042e219089fa1f597174073960b93035a", "ref_doc_id": "27799c77-1c88-4b19-913a-be1a43e96d5e"}, "1b34bdc3-53d9-468b-9087-8156159ee081": {"doc_hash": "02b70b5b1f4525815e829274c07383b35ba59a0043a83a42731df27fb1a8b5df", "ref_doc_id": "31932e3a-b7b8-41ec-8d9d-5733fd7da724"}, "dbffbdc5-d447-4b7b-92f9-352fd7cfacc6": {"doc_hash": "9e749fae9893a3f0f5dba0ad339a4cf12a0942ac1bdd795baaf6f3d7bf3beceb", "ref_doc_id": "84e7383c-40d5-443a-94a7-5a7bcf59e66c"}, "f0ae845c-eb81-43da-a725-0f7492261826": {"doc_hash": "d50f9125c385a8c269576a23cf0a98c43d72cb92c6da02a105e8e0e80fb8c4dd", "ref_doc_id": "2fe1d8c2-5a5c-4ead-91b0-051b3b1c6c9e"}, "dfcbeaf4-e847-43c5-84ad-44cd8fe34ca2": {"doc_hash": "9725e849d9dbd07ac80a983e645e6cc4ec813252159faf43522f9b616d0c9173", "ref_doc_id": "8bfcac68-b6a3-4f3f-aa57-c4871b18cd8e"}, "cf102e4f-0665-40d4-9659-fda6aa99fbd3": {"doc_hash": "01c389cfd2513b8196dce216db97c8d1a3b6ea944e9251c4a897ed4681362b01", "ref_doc_id": "1de97efb-4656-4e94-95e6-478e452fe11b"}, "25a5b9be-ca88-4ffb-b1db-229a6f0ca12e": {"doc_hash": "4d0ecec46fdb47af696b923b6daa64e96b55e2eff350024c2846576bfabfb439", "ref_doc_id": "a49a2160-6510-49d7-a44e-318221aa98eb"}, "3cd1e1b2-13fa-4f7d-8575-9fc605ff3268": {"doc_hash": "c1bfb69ef47ae4c500ea040b737a90337b72ae85327d079ad34a785d4ade6fbd", "ref_doc_id": "2fe85357-3333-462e-8bfb-86fd13130c4c"}, "ff19db76-d9e9-49db-aef8-0945b94ea412": {"doc_hash": "69c3c7f9887847c277d188eeb364fa06b3059dd6224d2f96388edd8731dd0c0f", "ref_doc_id": "2761301d-6f02-4aa5-be7a-e8f7ef1c9123"}, "760cf1b0-416f-4022-bba0-7fa4f8c83eb1": {"doc_hash": "cf5dc080e9d4f8f7c85a292ce617c1cdc1158da3e9674436ad6bf1c3fc7f4b8e", "ref_doc_id": "5b01e8da-cdf8-498c-97be-d7fec3306a22"}, "3f3bd525-02b4-493f-a792-502ef3bdc737": {"doc_hash": "ba62a35955d4f024699c69e39aa0d07e03e35fbd2eb1656746aec9481a8838f3", "ref_doc_id": "84db34e3-f7a7-40ea-aa21-a25df08d2118"}, "efa85554-8b85-44cd-b46c-5cead059591a": {"doc_hash": "6f78e6bd05a294e97ce05f8c878e931eccc0fa538f73c5308a11db9fe842097f", "ref_doc_id": "8c64ef8d-0cef-4420-b875-ed74ca20af63"}, "f4241ec7-b9fb-4ff3-8c1f-7eff3436ac02": {"doc_hash": "f54c420312d17f9dc59459f4017da084bb3dbcb86f44dcbbfe1f012d3ca80ccf", "ref_doc_id": "e1bc2c2b-2118-407b-bdbe-c5cebae82411"}, "fc925d48-7a94-413c-b7c0-284bd3b65ec2": {"doc_hash": "0d19c9391e63dc998de8c6a0b84f5a6f84c95cffb9e03fbce31f27207e8f3321", "ref_doc_id": "6faff7ed-f9fe-416d-b93b-66ff57602eea"}, "8550ecc3-10be-47af-b379-a581cb908df9": {"doc_hash": "97d160f5550df5ce29336504c67956343dedfe29e891d839d61d935efdef730a", "ref_doc_id": "5d51fdf4-b97f-4932-9aeb-12a44a11ad9e"}, "451854f1-a9f9-4328-a8a7-d226f6b388e0": {"doc_hash": "f344323f50774b18053152c06781c5fbbf2f3c18cdbb8a010ae5f886c272ffdc", "ref_doc_id": "7b1bcf56-e8a1-4d60-858d-873a215c8797"}, "2dc3e64d-7418-4a7f-bcec-022df3923f8e": {"doc_hash": "4068eb4da4b04c52f053cda99b3d994a11bc5b63092dd456c5e6859b560fb30b", "ref_doc_id": "6f5f8819-8c97-4618-8c22-231e7a63b9e9"}, "5752e04a-09ea-4a59-a33c-55ad523ac00b": {"doc_hash": "13c72450b57928e4729edefc2f0435a054402dc9c78d6949ca6189b94ba8ab1e", "ref_doc_id": "6a9f4369-38b1-4b58-96c9-53477b30e0d0"}, "5916a9c6-7cd1-4921-9698-237d1ee568e9": {"doc_hash": "66805b3e42eb7543157cb74ebfd8fe5f387ac3f3f9c317c5c40dcca498328444", "ref_doc_id": "0976cd84-8c3b-44fe-b76c-79d43a093462"}, "37397fbc-e0f3-4db6-9442-2c976661e7a7": {"doc_hash": "3fee4a881a6d7f31e6a6564e5aee13c308a5ac6b3e7b2411c7915e2dba55af85", "ref_doc_id": "1632a9d5-d901-414b-9f23-4d288dcbe667"}, "12e0c405-2466-4d23-b7f7-0ea28c98e1d7": {"doc_hash": "cbfcd707d60da9026c1aad9cede9b949a5658831006f872db0a1d585f4bc65f5", "ref_doc_id": "cbc9625c-b832-4841-9f4a-79d7ef4eb00a"}, "2f10864b-b493-4ab9-863f-d5ef10c5cc0f": {"doc_hash": "1aeb78ac3c777cd025f66d36db5997a065178d578731ba8d94bd7c8ec6942e61", "ref_doc_id": "53c38a42-adeb-4cba-9f02-fce031194822"}, "f8de43e2-0837-4fee-9cf0-e0119786e8e1": {"doc_hash": "73a19225a6d3aa674616799053e3d8fb7fc7ad3d7e87cfd337fb1a11881a2a29", "ref_doc_id": "ab3afd9f-61b9-4672-a80f-7929b53381a5"}, "703cbfaf-bca3-4485-9868-0d5127984e32": {"doc_hash": "94761c5dd62dc32cb5d8ca2fd9055bca2e82f80928dd1b3817fe8238caad6d76", "ref_doc_id": "8562775b-0cc5-4cfe-b91b-c570ebd28d69"}, "cb404a40-6e9e-4dcd-b998-a2aa9c4f98e0": {"doc_hash": "ca2565c3e4f6a59948de24665a722e0f9acc0fa35a8074710120977bc33c8796", "ref_doc_id": "0f7cc04c-c62f-4a04-8b8e-5fcafe22108f"}, "6d910027-5cdc-42d6-913a-f12a30e4b91b": {"doc_hash": "31cbe0fea22cd81434c8f24fc38ae9c09c4a9409feed420b1750d13f64102a44", "ref_doc_id": "6181ad41-099c-4f46-bc34-22c438fb9110"}, "f99014cf-b613-40e1-82fd-a0c8e9728068": {"doc_hash": "f6444c6b19a491726650d6a7dcc62c48c07e77ffefab10484cd911f4c68ae2aa", "ref_doc_id": "6bc4fb2e-ff80-4ba2-9cdb-c4b48fb96cc8"}, "d4fffb0a-1351-4761-b023-1c6b0b19082d": {"doc_hash": "156014b3c63be784c583b0f3a2c82fb5a5df97f6e7735a4e9e0b92798f326183", "ref_doc_id": "219dd4f0-169b-4eb3-aed1-a1c071bd2e81"}, "3fb366e6-ee1f-4b2e-9780-8ee059c8d139": {"doc_hash": "156f1bce4ddd230ca5a6a1c7d6429fab076e9f09b561bb9e3c1b519678cf9aca", "ref_doc_id": "8bdd227f-6d71-496d-beea-90ccbaf24cd1"}, "c188c748-f7bd-4642-82cc-6fc14a674992": {"doc_hash": "96ba42b2e9a52606f372f22006befbafdcaed950145e9a39191983335189b0cc", "ref_doc_id": "6bcc1e8c-952b-4fe2-a07c-60f677d54836"}, "a2059d8b-ed25-4a40-ac5f-683610fbc349": {"doc_hash": "f2e3b4c8c7f5c735f15d6e859b27186570051924a869e8ab08c27e04f0d9b6b2", "ref_doc_id": "814542d0-a943-45c8-8b7f-17312ea9f32c"}, "3087930b-1e6e-4fef-a911-6bd6639b8166": {"doc_hash": "5133a0aa0bbc50205105c0e3a0dd0a8d9657d9632304f39d5f1fd2d0d836a460", "ref_doc_id": "d94d010b-1367-42f0-86a1-a31e8489c1d1"}, "4a2bb702-e7a6-4051-ad15-f5de720411e8": {"doc_hash": "c917d8c74afb82cdfbef87a735f07bc056209c57a283f749087520fa7084d535", "ref_doc_id": "56b566c1-7e01-4dad-8f70-08e80810707c"}, "fde02f39-122b-4659-b015-cdd88952b979": {"doc_hash": "d755f1deb9e09a065c85d7263e72ba7b7c35e95554c043e2306f8dadaae6bbdd", "ref_doc_id": "93f90cd7-76ce-468e-9609-829ed002d25a"}, "6cd1d26e-7baf-4750-b787-a94b0d1f44c0": {"doc_hash": "111250942a91c04860b19a759e47745583a30f44e753e06a1f7af3ec4d2c752b", "ref_doc_id": "c87ef109-5034-45a5-817b-5b7089cf2be8"}, "998824e0-c58c-4486-bfd9-d59833b68c54": {"doc_hash": "950b11c0c436b7aa622dc04bef44bcbfcd3e863768c32efb7dc1fd17f9504ff7", "ref_doc_id": "98a71733-3765-4d3f-941f-0d0c73e1436a"}, "12f6a891-3671-4ab3-885f-87ac1b63fe11": {"doc_hash": "5222237734305475a553505e202f29703d8c11a3797171b731a3dc2f87454ba1", "ref_doc_id": "026288bc-f373-4e0f-a2fc-fff67d7d0d65"}, "a66036bc-2b0d-4e66-97a8-bb08e113c087": {"doc_hash": "75d3a803cfefe43fb947d8b9a5d66a4cd280952b1c770ec66d98eecb33ebdd32", "ref_doc_id": "0fa70009-c74f-452a-827d-e23cef0a4264"}, "724c90cf-2ad0-4781-b684-cb29c7892327": {"doc_hash": "22afa6fbf7722f2567d7ca8bcbac9abbf07fae53cf17a0ef740daaf6dd6b1b39", "ref_doc_id": "a22d8d37-6647-4f99-905a-802fb2dada39"}, "f93180f4-09c3-41b3-b553-ed3a29ac7027": {"doc_hash": "3652032d4c718ca290bbcfcffdeba9a4063508a89c60b662ddede1cedf52d250", "ref_doc_id": "3f4f69cc-dbda-4249-8138-4b543a63dbe9"}, "6cf8a60b-6975-495c-8949-5971fc6582e0": {"doc_hash": "08b300a9793aaa3f88210760f2aa9900249589e39a6beb60f9f7786e435c648a", "ref_doc_id": "b037187b-168e-47a0-a234-40424e837049"}, "2a58c021-9886-4791-ba83-d7924108955b": {"doc_hash": "eec4457455c293e930c82d3540e924d448b94a6ae4c2891bbc5cee8556a1fa69", "ref_doc_id": "e190678b-93a7-4aba-bc84-dc2e3d026831"}, "da53c304-2bbf-4f7f-8142-ea573a71a157": {"doc_hash": "d6ae738512f0060286369dc75738031c3f026b5ebc62e219e8662c043f70778b", "ref_doc_id": "67dde4f9-e0a7-4bb0-b2d9-cacb212fad75"}, "693daaea-aa59-4eab-ba1e-a62ffd6d773e": {"doc_hash": "4f8cb40b2e656bcd36fd8db8a5699eb04e3e3a5c8f0a38ad50051db862c215ba", "ref_doc_id": "e672f2b1-52e9-466d-b00e-8971b3239a2e"}, "ab4a228e-3073-4453-bd4d-4101169cd9ee": {"doc_hash": "7a6cc420cfd076bfe05812336211ca63e8c6dce5ebf12ac2b59ab689ff936060", "ref_doc_id": "cb1885e7-5557-4608-9163-5cf17eb20ac2"}, "b6239cb8-38b7-4cbb-9561-9ebd848418aa": {"doc_hash": "9365eae824752cbe35ae58a013b0fb963bc165d9f9a9cf020d6bcccd7896b856", "ref_doc_id": "48e2f4cc-40df-435b-b25d-966a29140255"}, "e3b3ae4f-afee-450d-a113-7ef3370ec372": {"doc_hash": "596391e8b0754efd534df253205e4a120edee373353ef6769f0758190a99937f", "ref_doc_id": "8c924ce5-dbc9-47cc-85fa-b5415399c7bb"}, "162404ad-a136-4c43-bc17-6c3e0779acb3": {"doc_hash": "ace416f4b1a7436ad85ce5f6a5322330d7b8b1326bf7847b5e38d88e97682b08", "ref_doc_id": "fa9d4ee3-efef-4660-969f-0e664b9e7965"}, "0ad1bee6-bda9-4d64-9f1a-2c0f6d91b1b9": {"doc_hash": "4fe7599d989f383212e3068c8da3ab90db75f8e997ac68d81ed8f81ee1a32e8b", "ref_doc_id": "8b664315-0da8-477f-b771-ded25b832a1f"}, "7936686d-e216-40c2-8060-6c4395245639": {"doc_hash": "1a26e496eb2faffe92f3d93c0d774a3a8ef36dae24f272ccbbd3e5da8c1a7d0d", "ref_doc_id": "43d0a6c4-1751-43c4-9a86-0081f573b732"}, "3d1b75b6-db29-4951-aa6f-a9062c38e1d1": {"doc_hash": "d2ce432a3f08e330c0d95a52afbcb48839d7f9dcbfccbbece88c123897ce9632", "ref_doc_id": "08ca0299-2d3b-4d06-a6e4-e38785018b19"}, "43574f83-da1d-4bed-b832-840be1f0c44f": {"doc_hash": "53c0903613da775d9f48afcfc766b8aa759682ce3504a49858612c5796547849", "ref_doc_id": "41760108-e91e-4910-a3b0-abd0a5074054"}, "d94fa6c4-5ab2-42a4-9261-6444b8b7cbb6": {"doc_hash": "523af235b3f57670feee9019f587e2f1a21b41fab5ecf02d9f50e196189a58f1", "ref_doc_id": "b4fd54f1-65b3-4753-b6bb-ba929903a383"}, "6116d24f-d37e-450b-adc5-b0da78848a78": {"doc_hash": "7ea1cdcbca980d715d156ef2f4c0b0bf0000ad7135331759c09b48e7676ab68a", "ref_doc_id": "5091eaca-5116-4288-a894-e579c77ce2f2"}, "8dd463ec-c44b-4494-990e-13a29e55132a": {"doc_hash": "9fa45b6061b98ede8438d151611d7d7b6867f9173102e582513407d47007bed2", "ref_doc_id": "b495504f-99f2-4f00-8289-e132287648eb"}, "52018ce0-2f4e-453b-a81f-2a2a24accea9": {"doc_hash": "b36507a8831a20e780712cb3235f61731e8b31b55854e1d33f5b32dd0743b9d8", "ref_doc_id": "b495504f-99f2-4f00-8289-e132287648eb"}, "07674c8f-96eb-48fc-af03-4652c649af05": {"doc_hash": "4388a02a8dc861d9dac3de87d4474681af5db96dbfa47dd4b2c7fc28723be169", "ref_doc_id": "ce38c990-8ff4-48cc-ad74-b1716523ee85"}, "7a467993-8164-4434-834f-a26527bed0ed": {"doc_hash": "9cbb45597a7b33a140db964346380d08c0c73cd9a64e1e8f47df0998d8b949cb", "ref_doc_id": "54ab014f-1bc1-4451-967a-3a09aa3d6682"}, "c3984da4-6798-49f9-b181-049000963206": {"doc_hash": "73959556b7a7b04836150abee59e56b28a404b150f2aa3abee14e563762cc49a", "ref_doc_id": "1e93cd10-201f-4094-bbce-8f55d589895c"}, "5f1293be-9034-492d-a954-c9c165d6ab2f": {"doc_hash": "31887501b110adc0ce76f0476d7b825a812f6fadc0cd52afae065d56dc7e7a19", "ref_doc_id": "d8a38b2a-6d9d-4ab1-9448-8bc2d106f785"}, "5e7a5dd8-19b3-4f19-88ab-1b86fa7bfca3": {"doc_hash": "320ed74bad3555ffefbc989986118192f876df344e75cf6b2e1efe94eaaf1c44", "ref_doc_id": "c54999e7-a083-46f1-8977-cba0591d7b82"}, "517dbeb2-2672-4324-991a-918a22b7b3cb": {"doc_hash": "f572d8de6d421c8cf95fa317763e7774d128a0f0ff2881ce5742b62c31ece931", "ref_doc_id": "08ba7508-b6cc-4a57-9273-e78e7bc33d38"}, "e120fec8-1074-430f-bf4f-a10ddd946a88": {"doc_hash": "8bc6d1f7ff45662117fb6f1eaf038863fde1e1bc5d23aea3814af8bf0de317c8", "ref_doc_id": "3ca03a1f-4216-4d0d-a111-7f9ac455d319"}, "eec26144-b4e2-49fd-87e6-6b11519585ca": {"doc_hash": "7771e9c6bdaf5e4deeaace7952d4f6717302c11bb9e01128ccf15c9a7ea0296f", "ref_doc_id": "9c0dc66a-4a2f-4e60-bc3b-55ffa499c387"}, "a1f90c99-e4bf-4cd0-870c-6c8192953a5e": {"doc_hash": "afbb167fa943ec584ae4a6bdc77167318481be0f201ce29eefd65b461db7dad2", "ref_doc_id": "e49a5757-2aaa-42ca-9ecc-92280809f8f9"}, "ec6406b3-0f36-4f7b-8ca7-8137a363cc61": {"doc_hash": "3000a826692e2fbf0af063426de9aab20eaf39a5a960280973d4222cb8aa7d2e", "ref_doc_id": "4b99f63e-c492-4cb2-b40e-72d8d78aa5e3"}, "34e7d15a-d9e6-4d73-a5bf-5c99ada6e793": {"doc_hash": "3187babbc676a4b0c3049d80c77d43deaeea47cd89f31d53cf32b11b08acfff3", "ref_doc_id": "a68ed2a5-faa4-4695-ad41-30c66ac6865e"}, "e17aae44-dad8-4f49-bd63-bc92f421185c": {"doc_hash": "9ff7760e46fe5a7eaa112f196b9849e92ff43c2c2d6d050562b9d2f0cb7a1205", "ref_doc_id": "871c5359-e2cf-45f5-b029-325a1695579c"}, "e1dee07a-8a97-420a-95da-36762653bd04": {"doc_hash": "80e7e148ee3b87af5c2e68f5240432697eb167168ec4dc92b23f8479f951a700", "ref_doc_id": "0c17d98a-ad42-406e-ba96-b074716ece41"}, "29c0a0c3-c270-4e19-9038-2884cb8c1bbe": {"doc_hash": "dc55dbbfe84937d9f652ff2bc70146ee31215fb9f98b94c46bc1628fb57290c9", "ref_doc_id": "396f56a4-7757-4959-adaf-5ce628011ea2"}, "5e2536c0-e3a1-46be-aeb9-9333ef5234af": {"doc_hash": "22a416f1d72ffcad68b851594c5d292e30c6285c858a767f96683e91d75f8961", "ref_doc_id": "28cb1650-ce1b-4752-bf3b-5374d5a0c862"}, "dcb83664-0098-48d4-91f0-2434118747c0": {"doc_hash": "88b7d9e17b114c8b91887225648b7b128c62a0438067f486a445e2666d59b3ab", "ref_doc_id": "b16f0d93-7d87-4f19-9ab2-efdc2f07508a"}, "6cb78328-cbcd-4dc8-aa7a-8b080b17c331": {"doc_hash": "de9c6e502e97b5fc412698ffb4d74dc98d7f63fe97ed0f50a94833f86644e1f8", "ref_doc_id": "36606f32-0c53-471f-9449-c6c88bd25c55"}, "d527b497-fe27-4005-ae0c-e464617ea9b5": {"doc_hash": "4ffe256d26d52e52f9197ccf9c7e1245d34b11c236515e785c2dd5af5c6e030c", "ref_doc_id": "de452f0f-b7ca-4fef-9cb2-d1100b0820e1"}, "a181c69c-f0ab-4594-ad98-b845148eb48a": {"doc_hash": "83e57ee74c3a3e3c712175640442a707c94d9ea7ea7d6885aff54cdbe78cdcd5", "ref_doc_id": "f96687e2-8b36-42ed-89aa-043031f280fb"}, "b2838f06-7ebc-4ddf-83a3-171011bb15bf": {"doc_hash": "911b416467b72eda0d046681dc1d2a3cd8beddba70022f8694e199ca8ef33da1", "ref_doc_id": "114209dd-c3f0-4c23-952a-2eb3841c4e0f"}, "bf56bd92-3eb8-468c-a837-b738466906b4": {"doc_hash": "eabb09cca391e9c4f88642429dd28686ed683b0444dd9a55a8a6f577fe14eece", "ref_doc_id": "c92d7b7d-d307-40c5-9463-4201f68950c7"}, "54eb5e22-7122-4475-87cf-8a02fbbd084a": {"doc_hash": "ac4e3b815797cd9e17a59b5f5b16fdbd611efe68cdf0e027e41bcceb34b38e7e", "ref_doc_id": "bb6c8e65-ce9c-4bcb-89f3-3fcbc085e6d9"}, "e957f483-d986-4571-a571-18169bbae733": {"doc_hash": "eaa4d0efe552138b714aabdee03ee151f2a486aedab635963dd53d78e0d4e2bf", "ref_doc_id": "199dc43a-fa99-416f-9f9a-dca34492d54b"}, "92ab99f4-0247-4551-9193-600249d217a9": {"doc_hash": "0362ea51bd9267c1c6524b42c5fc684b3a0c7d7253984f459be8904231a1ab70", "ref_doc_id": "a194c74a-dee7-4eb3-b608-20799ce20975"}, "72efe6de-19af-4447-aae2-495fd629c2ac": {"doc_hash": "7b644237793e3c23b6e9711336deda6ff4eb61a9e6b08b2be36d43088c04608a", "ref_doc_id": "5c480dc4-f289-4b8d-a582-b69db29fcbc6"}, "28dc8eba-27fc-4085-b0fb-70338b9fb5db": {"doc_hash": "de67426c94c17d8d5e9accb866dcdc00ff72bab52b34a0903006da142641aa0a", "ref_doc_id": "5c480dc4-f289-4b8d-a582-b69db29fcbc6"}, "f767fc25-451a-4b9c-86d2-dccbfa9426ef": {"doc_hash": "e2799603facc6322a9cc42ca67e220aba5ae7b34c7ada871cc17da063dddb544", "ref_doc_id": "be16816a-89f7-4570-adb0-cb6bc4aa1929"}, "3020b8bb-de31-4d16-8094-a2416d352d5f": {"doc_hash": "1595c6e2a32d4e845e95220f0b050e4d58c66d85d9338519c6cc03524f63eaa1", "ref_doc_id": "eed48874-0ca6-4536-b38d-3ac2b5459f23"}, "0d4e5db9-ae9b-437a-8795-f9bcc90e0b84": {"doc_hash": "b9d7d32b91590fe3573ae3dedc8d848f36dba9d7c15639071823511a44a25397", "ref_doc_id": "bcaee994-c85e-4a0b-b683-c8650ef622bd"}, "1ee037e6-5c10-44f7-be67-2f47d502b3a2": {"doc_hash": "7d2b2f2fcb44e921f2750867d7170566d7ccece88a3a02882da40e2d4689c1b9", "ref_doc_id": "fd74c8ba-c371-4b34-a41b-11dcd76beec1"}, "8b41760e-e087-4f6c-accb-4799186f769b": {"doc_hash": "eb40e6ff14409acb990f226c3b399eb478a7d87233b1a0b5b14da467f1647fdb", "ref_doc_id": "aa1dc9d5-9637-4cad-8683-0d3b78b6a5f3"}, "7315d2d8-ee17-4929-9fe5-0cee967aa820": {"doc_hash": "5fc2357c9eaac6194680d2dfe807fb78c05819707624d1302387caf91fbb8677", "ref_doc_id": "29fed515-9919-45b0-b19f-c438861dd2c1"}, "b1145a33-5999-40ca-b7aa-4a355b78c23e": {"doc_hash": "c958ca8d6155ba84b1e19912dcaed12ce8f88348a3a68ab129eac138088e22c7", "ref_doc_id": "06ba733b-9eb8-48f4-a13d-2712d158fbbc"}, "2a3cd050-c677-4408-9eb3-5fb0ae196566": {"doc_hash": "681b6996dc9fa78786ad43fb77281450c2fc3a84ec84f226a67a353c2a05efd3", "ref_doc_id": "508f3977-f5b5-4d30-b48a-cd0b28b9648c"}, "525ddb01-fabb-4e5b-90fa-4b356e8b6cb9": {"doc_hash": "b3ba5c644e1e28a7f86123d0219c7f573e706e237869e2eb7f74885098b885ce", "ref_doc_id": "a6c54a9a-220e-4a7e-b4ba-db36984ed438"}, "132e1696-ae47-49cd-b1bd-63dd983a194a": {"doc_hash": "f4b2fe25c9da7958f1376e4cc9622f8ad33230d2fc027e8f237438e8a6746ba7", "ref_doc_id": "75145522-13df-486d-9407-fcb25dbc61c9"}, "2ad2424d-e85f-4020-a7a9-1f895b06b6f9": {"doc_hash": "74822d580451068d4ef395807613490c294f9d8464cc622bbf84868cce82f91e", "ref_doc_id": "249e5398-ad37-4e63-b758-6ad6581a4ec1"}, "9111114d-7007-4495-a3c4-ce006224eddd": {"doc_hash": "4bc3654fa32635860fcbcc1b67957d6bc562b2919be7a2ce84f7ab56b3effbf9", "ref_doc_id": "1393e96d-5672-4c1f-964c-1bf711a54242"}, "a56b2916-5c93-4b6b-973d-ddfefb3193bc": {"doc_hash": "a318baef34f7d83e6143ee096ce780e8d1e3bdc878f7878e8c9e725f62cc7a27", "ref_doc_id": "b5efe434-5d4a-4b07-863a-78270ede227a"}, "b7e4e73b-7d6e-48bc-8a1d-5281b21c1871": {"doc_hash": "caeb006993d953bb2e62e5d3c89afc8d99f5ae409f7bb6a7d1df3f1f02baa5eb", "ref_doc_id": "b68f706a-4896-4b7e-ab61-53d9c369c487"}, "a67b9481-40d3-491d-8dc3-08d81038bda5": {"doc_hash": "1255b8d174ae07b92185dbea29e2e2ca83aa5f6bcc3481ce9c76437b7d22760f", "ref_doc_id": "d5fcdfed-41f5-4f2d-a2e2-1089c0fac632"}, "ad2a2470-bfda-48db-829c-91683ef020c1": {"doc_hash": "e414256a51f1330f37976c565fd4471ca91e743dcaa6b1b6aaa533b9fa3e6d87", "ref_doc_id": "cb1d5f08-8e88-4fa9-aba4-8f8914f57612"}, "4bdb01bf-ea29-454e-939f-8e29a7f01a8a": {"doc_hash": "8e332837518cab987e63c5ac8e69b7c564a9c728a2d5b335b0591fcae1c83fa3", "ref_doc_id": "2f875451-b71b-41f1-abab-d58e1f8b87f7"}, "e643902d-e70e-40f8-a8cc-d2f18d100f8c": {"doc_hash": "3c7b326de4573dcc0fb5245d24377110211396b9999d0fe74b4843e07cc6fa44", "ref_doc_id": "56154760-10c7-47a4-8a8c-1d1b2e68a24c"}, "8dcd3a28-54f3-490d-8633-42d5710f2567": {"doc_hash": "6e7916a46c9e5c6e2cba2d368cf198679b21a0ddc0f535eb1d95747806d229fd", "ref_doc_id": "372234ac-74c6-4632-ac11-6d73f036cd2c"}, "a82075c7-fff8-4e83-bfbf-0c87bd40d5b2": {"doc_hash": "3016793145b61253c1c49412dc781b38023d56f442e5ca608f8cd4a6ec83f991", "ref_doc_id": "e6d60321-b32b-46a7-9192-011c10f3b05a"}, "b55cc126-485e-4c16-931b-5bf403ca028f": {"doc_hash": "2b07558cb0d3c9bc3bf7ebed2440076fb8b891169e6a8f6b23871b17877761f3", "ref_doc_id": "7eac9f2b-9698-48b3-b65f-869b28114dd3"}, "fbeb3bd7-a905-4c0f-84f1-ad921ad4d0e6": {"doc_hash": "297d385ab5befca41a672f0f1e7afdb8dea450d96e21e3a6d2cc8d0e59401088", "ref_doc_id": "030c4b85-035d-4b57-a196-dec5b10f3dc2"}, "b1a3237d-02ad-48d4-b09d-f99136b973a0": {"doc_hash": "18fec1e268eae7b2adf847c03f8ec50a4c15b7452af4fca48cdf3ea8ec35c861", "ref_doc_id": "02c64c2b-2d3a-4ff4-b647-6582aa1bd20d"}, "b0daa1ac-5efc-4614-b793-42178c895d39": {"doc_hash": "409bc8f24cc7b2cdbb23f7a186fdfa95de004ac4817952f5bb5baadf9a7bf31f", "ref_doc_id": "bbf1da6a-2921-4a4e-955c-33ce1ef6f3ec"}, "f2a9382d-a200-4481-a4c6-ac2ee0c47eca": {"doc_hash": "d534c029c89eef4f62129086e3f6292ef49a44481e8df7f83b0eed9b84d5291f", "ref_doc_id": "2ddd6854-53df-486c-b20c-9061691d57e6"}, "f34bb0c3-1819-425e-8c67-2201da1338cb": {"doc_hash": "9056337a78bd6cd413584f6046cd0bf3cc77b6f1d85a612ca73939fc05c25fec", "ref_doc_id": "b35bf376-96d7-457a-8501-d8ab87a56741"}, "232ef1e8-2993-4040-9432-ea652369d380": {"doc_hash": "151cae36a9f33750ef913cd88ad20bc25106be7e66255fa79875b56e514630aa", "ref_doc_id": "7cea3a13-0def-4e49-bbed-d0df8dc4e13e"}, "a289e731-9deb-490f-a9b9-f8d1f46c842d": {"doc_hash": "bf8dca0827de504cc56de3095bca374fa30f0590977a7ccf1d972615616284c0", "ref_doc_id": "4b32e8ce-2449-497e-8b28-3b08c60d4005"}, "a9118504-f382-41da-aea4-7ced17e70074": {"doc_hash": "c6799a38a967a9ade9ef8129811dc4a876d7ce873b5bb6b567c3d27b18c1b032", "ref_doc_id": "2b3e6e4e-593b-4b70-9fc4-ff01a1cf338f"}, "c2bd5547-c7af-425d-be59-b8c5449cae32": {"doc_hash": "785f58c017dea82ad2d927522ff9139776a2b3a848b2536befe9cd8a2d386409", "ref_doc_id": "2b2be256-a302-4ad1-97cd-3bf2f4e7157a"}, "3183e05d-a528-49b2-82c0-3bf1abf030ce": {"doc_hash": "f353d0fe24e63569171dce7392406f236fe7ee91a94c17325f20fa80f77b93e2", "ref_doc_id": "9906c64e-7aa8-42cd-8ea6-4df35ba83ca9"}, "306648fa-2bd9-4d0e-9cf1-74d4759c769b": {"doc_hash": "4bc7520f3e25776cd2ac2bfaa877d5cbe168684aacc7bd1c74c554e54409fdd5", "ref_doc_id": "b34325f6-4d87-4ee5-918a-ab92adba3181"}, "ce6f1050-e242-4dec-9595-5c8ce24aed2c": {"doc_hash": "85e59f071c191154fe25246b5c0e07fb4603ae4df0c4cb01a45c1c98a8ff11e4", "ref_doc_id": "e6494872-b79c-43bd-ad90-496a4276dc0f"}, "2fcd8041-02e6-4e96-a35d-801c2169a81b": {"doc_hash": "e88fbecd15f2ec95d28bd4eb6c7a6adfe182a0a493fa50aea090f53e24a84d11", "ref_doc_id": "1699a1e2-f7eb-4715-91b2-76171e32e8d9"}, "45e0528a-2bb9-40aa-9fa3-b6e6b04fdad8": {"doc_hash": "bf2d6d10006b0c17b36769df02d92d1bf440785b09a648ac440f767140a4dcd2", "ref_doc_id": "2e89285d-cd67-438a-a1c6-cd37dad1ddaa"}, "f83ea746-90c3-44b0-ab22-c56b782a20b6": {"doc_hash": "fad6ceae468b788a31f19cd13bd3b6c35783a4149d665562cf274e430d83df7c", "ref_doc_id": "2177da75-a3c9-4dd7-91c7-396eff74e80e"}, "189947f0-7d6b-4918-9666-58c239ebb017": {"doc_hash": "7a9ca3ea8079d5f39ccdb1d463d2155ec51a4f1fb9a67520b70b4159eae9aaab", "ref_doc_id": "8acc95f1-80e7-4628-8f6e-f3a072acf140"}, "366ff943-1a55-4abf-a2ca-0da61dc257bd": {"doc_hash": "dabab3d99e1b9306f216ec04c85d417ffe00b37f43eec1f2067c6742fa834caf", "ref_doc_id": "faed7418-4f49-477d-9c3e-6735993d8d1c"}, "fabaa199-2b29-4304-9293-ca23965ee003": {"doc_hash": "23559e37a8f853ab38a0c09f9ca98e629dcd075494083e952f854b92a0d9df5b", "ref_doc_id": "aba80f52-0638-4bcd-ae24-ef59f7531a5a"}, "b46ce821-b02b-477d-b474-3f1e16ae68e9": {"doc_hash": "a825d5fb921eb8a4a45980ffd1fbcaaef5996338b300e4275a246f76c334cf86", "ref_doc_id": "0364ed87-108a-43a2-8955-ff5f81d645c9"}, "977039c1-b9e7-4a92-b6d1-9549604bcaad": {"doc_hash": "1f7d187491bd7c6b6d1e19561218f5a96b530cb84f51352da0fd84804b852e79", "ref_doc_id": "ebf888b7-020e-4ebc-8c44-4fa407b3ad71"}, "6308d5d2-4f2b-4a87-806e-171df07e67df": {"doc_hash": "50a23c1e81df57370429af0dbd09a293607999cdfd42b75ab5bf61510b6390ce", "ref_doc_id": "c035b128-3007-4740-bdbd-52378a31b460"}, "1e0c8a40-7b35-4c2f-894e-9d35dc21e1a9": {"doc_hash": "8c7f77d377ba754b813b16f9210bfec7dd7800056dd4be99fb1b1735c06dc505", "ref_doc_id": "d257ddfa-46b0-4265-ba8d-1e0ca181ff05"}, "6b0f32a0-8e23-4d08-a6dc-48f0e5aa6ba1": {"doc_hash": "47ce4ccb2e2ab03cf96f12624c248621caa8b9000b67785883a8a8277b01f51a", "ref_doc_id": "4aa28399-d79d-4307-9ac0-887ee43f9917"}, "ee97dd64-c214-4a0a-b67d-0748c3fde2d1": {"doc_hash": "b85aa1ecf09840500cd3f841462dc90dd78ffc9ae900ed930c3b67f8e7c3b9f8", "ref_doc_id": "f4b1972e-8a52-466f-8256-3cc01a6214d3"}, "a4ea7b18-8d35-4489-b26c-244e1dea05ab": {"doc_hash": "dab0dabf715eca67c490ed3f4cc8fdcd971e16ff251b210331af42a6b376f924", "ref_doc_id": "61654af1-2de7-4da1-b49f-1e66dc467aaa"}, "cb946c0a-3453-46ac-b1c0-64a9413d77ad": {"doc_hash": "ed53c2ee001963916a184943775f11d69531b1f47395a1d6ece6a832a37be4b0", "ref_doc_id": "8c3ae60d-c0bc-4932-ac62-f612bfe01745"}, "5d23be60-5a7a-4422-b4b3-590f23ce0b23": {"doc_hash": "e95fcee2ba5337f500ad47f6eeb2d2b40a226cbb226155d9b5b47fd52c3acd91", "ref_doc_id": "502271a1-a919-4ec7-affa-60086b96a7ab"}, "5ed3e715-fff0-4ff2-bb7e-550a051678f1": {"doc_hash": "5857509460d2a0f05b6899da19ae43f2cf40432b9867fe57b92be203eb832b09", "ref_doc_id": "a66bc89b-3d68-4032-9d33-844381ab7fc9"}, "c0468e9c-d9f3-4bd4-b8bb-8c05b63370f0": {"doc_hash": "6585f21dad5a8060035814e65e5dc52e3aaa83aff68813f1f33fbf0753c78e2a", "ref_doc_id": "af3149a5-22ae-4a37-ba9f-0daa7bbc7c9a"}, "83f76be8-5781-45a3-bcca-9e75f840e5d5": {"doc_hash": "17613e1131213e1e459978aee8e6bc93b197891d3e1d52fcafcbf8469f5b0194", "ref_doc_id": "a927777f-51d0-4918-8821-d113c1d616d7"}, "f808eb8a-9d9f-4b9a-b123-90fb64f37d1a": {"doc_hash": "f1f74d06f5acd5d3eddd633d0e02a173ab4a48c7d62108cbe6061f0716092ab9", "ref_doc_id": "db0c8ecf-f252-41fd-bf90-2a2f2f45d1b4"}, "7c14baa3-cf9f-4b7b-bd9a-de0e8c933b80": {"doc_hash": "cc392b363fd1199bae5da9ffbd447b4e283741492fafa676c528f759d5871edb", "ref_doc_id": "9d2c51f3-1f65-43c3-848d-7b8c9aaaae30"}, "bfb98fbd-69f8-4a74-9bfc-1d5f3779a1b5": {"doc_hash": "369d961713730e3111f4d5c7ce1081086a341694abb1c3665f2fa64d4604f2e3", "ref_doc_id": "de77d731-5d31-480e-9b02-e0a148e6f2fa"}, "ac60a717-41fd-4e23-9a9c-8b3861548e85": {"doc_hash": "ce0671e4f20d45cd360641f99cc98770027e15b7da4a50f8f0a290cf03621df1", "ref_doc_id": "c0a248b4-1429-412f-85a2-7cfb4f97a35b"}, "fa6a722a-90a2-4baf-9482-68e72cdba3b9": {"doc_hash": "fb718a36f1488fc3a16c8e8de0318db6ec0e0ad1ba9f658c7cdd2d67b2b09976", "ref_doc_id": "8a8e756c-7d2f-4aef-acde-8abe31a85285"}, "fb5d495d-c999-4156-9d54-92b088813f42": {"doc_hash": "6866b9e1e4e70ac8d4d05779267af8eed3ae92ab66797deeaedf320a6141c5f5", "ref_doc_id": "7aae59f0-f6c5-4c31-b9d6-1818fe4caae7"}, "fa973945-4a4d-45b5-a690-4ccab4f2ee91": {"doc_hash": "7e1aafbf0789e0fd3c9ad0a07211615a317cd92d0c38948279a3cfb324abae1a", "ref_doc_id": "c3f6d652-1d3a-4011-8345-7b43154d447b"}, "342ae22d-56c2-4f88-b8fa-645ef98e84cf": {"doc_hash": "756f62ad4ea2f0ed456e78dd196eb80c155f965ce1e3ae04a0bcfc7eba7f0b9a", "ref_doc_id": "214c2c80-da52-4e5e-9eca-340ef182e59b"}, "f4097ff7-e5e2-4a95-ad80-a7b71922fbb0": {"doc_hash": "7f5dffc26465f2de6244faa8b9b5eb00435fbf1cd88180ea14c1713d0419c0d3", "ref_doc_id": "0a5a8146-d989-43db-bd13-071849a61dc8"}, "2ae0d4e8-0e4b-4a0c-9174-030aea9bad7c": {"doc_hash": "04f6ff1d897e99c35c4a0f26c6472f394015c7f040de5e5077d6f4533082ef07", "ref_doc_id": "12a1ccb9-4cd9-401e-b78a-284992d075b3"}, "7eb22c98-9365-42a0-94a4-5a5490a82774": {"doc_hash": "409f0e6a5bbcdd5783ec9d25f3a2d588e22dec003bda6029f467ee21abcac5b7", "ref_doc_id": "14633116-3be4-49c1-ac2a-af6833fb77e8"}, "b97cf4d7-39b5-4b33-aa25-2a3787dd278a": {"doc_hash": "6f024f3c43bb94eef2a0f2f567a671f4205b88e072baca53e74867114b6d912a", "ref_doc_id": "384ee793-8cfc-4eef-bb78-2279591ec169"}, "1384580d-2dca-437c-8a6e-ae3f49fa47d4": {"doc_hash": "2a90ac01dd99b6f1eb113a0ea20833e761d62b7f315f57b4569704c82dd12cff", "ref_doc_id": "8eacd4ca-96bd-4d7a-ae66-84fcfa82fecf"}, "a3e6426d-3c71-4323-9449-ced0a6857fe7": {"doc_hash": "b6cebb8a809a4ddd69d5c460b36e79d1ce815cbe737836300a4058433ab4d7f9", "ref_doc_id": "4cfc7e19-b986-47ac-8230-1fe5c89a1d7c"}, "e5542335-5114-4da7-bea6-e1acba868855": {"doc_hash": "ee09beae01873eb1ec101225af01877eee975bcf221b7f775560821d37d08721", "ref_doc_id": "f5decd1b-4ffa-446c-8671-1cb14dd17f5d"}, "ec884725-99c2-43fa-ba57-cc1125ab4593": {"doc_hash": "1b01b4dae2f351118f14672d1f859bea506b5c062f9c6dd463fa56a34af148d9", "ref_doc_id": "45ee9676-4042-413c-a5c2-9739ae78450c"}, "058a97e4-77f5-44fc-babc-e3ba976fc8fb": {"doc_hash": "4c2feb87359baf86b0b3c30b48467866014b5581e6d09527cc3dbf83d579fd11", "ref_doc_id": "aa63fe36-66ab-4604-a512-1a24bf9efddf"}, "5d6692b1-5bc8-4ef6-83fe-b6386f60c7d1": {"doc_hash": "db1d6c8a2a47ba01faf8663b4d6490be866abf10de75acbe13aff6e625d4751b", "ref_doc_id": "7e66a00c-9e2b-43ba-9963-7d9dc0c0e8f0"}, "c300f158-5d99-4fc2-b681-d41e3d26b222": {"doc_hash": "e1c081e30d3bfdb651e4bcc2e5560cf1c38bdf658a1df1ad4ae82d4da6c17979", "ref_doc_id": "091195b6-77f7-4c41-9a95-d2e7458e1454"}, "54447828-fb03-4280-8f44-cff96ea6b8c8": {"doc_hash": "a931400503b04c845c6761e0040def30113730aaba3db3c815d260cc65110ce8", "ref_doc_id": "b5c8f1fa-1d35-4434-aef9-5a73150765fc"}, "fc064960-13bd-4e43-a7de-84295a9e1336": {"doc_hash": "67b64c134643b8c9c25d4e5c375d1bdd9b4bf1cdaf4661f6254ff79d6afb1310", "ref_doc_id": "8d8847a0-8a60-4d44-a48c-cfe9a329fced"}, "9ecc34e4-d4c2-42ea-9044-2ed4b4532ebe": {"doc_hash": "064c778907961ff4498c7c7ff3542c2d3151fd295f53e7f4619c9b17e3248664", "ref_doc_id": "847cc523-ad0a-430e-9a4d-10c322d69765"}, "c0d8ce06-93ba-44a1-a160-b53a3ee45f2c": {"doc_hash": "0398d8c091110607b3b81c784431afe823ce4860ebb1efb211e641e84f09490e", "ref_doc_id": "c43957d4-d1c4-483d-9617-f253fd4ce501"}, "08cddb51-3849-4cea-aaf4-c0da244d1053": {"doc_hash": "e9e0619c6eb53577a18ca05be7358faa3ca3df4dbbd2b264d30ff15f9650576c", "ref_doc_id": "8cc7038e-4a92-4545-9eae-b44d918c4034"}, "1183b9b3-19f3-4429-93a4-c7f3c1e31590": {"doc_hash": "3176b63e65ef55bc6f4c92bc34e40c15ecbf41d0c58858df16583e30450734e2", "ref_doc_id": "2ba33c6f-138c-497a-8c34-2e26dcee99d8"}, "1c7b442b-2145-4df4-844c-80476f5a3c3e": {"doc_hash": "1404045710350326c5010e4330e1d6942045127293056577b6ce83e2bd2e78aa", "ref_doc_id": "b6e75d96-528d-4876-98cb-3bb412d062e3"}, "b32e5894-f76a-4de6-9a31-182d73c787e1": {"doc_hash": "044c49c252a99d40ba9471f308617dcabf649bdc07ea48a7f510108a15fa43ea", "ref_doc_id": "2add9834-e099-46b5-92e6-1bf112a8c8e2"}, "15f7d3da-a0d5-41bd-9199-de4c90444ef9": {"doc_hash": "8395ee5b066a2603e60b5dfcdeaab757e96bbb71cbd32f3b38277d25db2fe675", "ref_doc_id": "558b39a2-a42c-49c9-8965-e91aeefb5e8c"}, "08bca4d2-56a8-4342-97ac-2b24f0d780e6": {"doc_hash": "fd14fc52152fe20f789cf83905157ba20f10871d11a5534b60a1533a5572e53b", "ref_doc_id": "5b3cd6cc-74ab-4144-bd11-836d4294b1a1"}, "50949945-c3b3-4eab-888d-2678fd288602": {"doc_hash": "1ce5ea466866013afc65ca9c319215a2f42d1691dfd2f9b76294e7d8eb68238c", "ref_doc_id": "76dd1dd1-a980-469c-929d-45be7af573fb"}, "8561daae-3c82-4130-9618-5e68d14d35ec": {"doc_hash": "1349ccead5788ea05c0e396aab487b7ba8a6b047e9038e0fcbe67dd12e5438ae", "ref_doc_id": "536ed06a-1bf1-4332-ab44-6a24ca0a70ab"}, "8852690d-563a-4a1c-a387-543081112713": {"doc_hash": "e316d8eacbb768c10407308710d715c8e46fc0c6d398a2078be91fec03d30f62", "ref_doc_id": "7056acff-81fd-4c47-ac1d-aa3d44039b2d"}, "e2622b0e-c5f4-43b8-9d08-3fbde9ef4c2f": {"doc_hash": "84286ed09d23f9da3cfaf727f5dacb733c32e56be4946f7a802a29e1909c4a06", "ref_doc_id": "a5f75fd9-5e62-454d-a1e0-c530dda55998"}, "466b73ef-2ef1-4d7e-a903-5949c4f03dfb": {"doc_hash": "16cc34b68795096c1dc166c34bd9eff7da6e890a004887b38c45ba656bc58125", "ref_doc_id": "f89f877f-a5d2-4a17-9e73-55b60b4c07e5"}, "5bb8219a-03ce-4699-b13d-ddaf870c96a3": {"doc_hash": "ba378f8756c3cbfa6220dcae114cfcaba97b9bbcbf18beb9be63fd7e6c2de0c3", "ref_doc_id": "f4773fad-1731-4484-9bfe-6c969b86c51f"}, "93fc4c02-6c4e-4bb2-8383-6c74a5511f65": {"doc_hash": "e474534efcc4d4322a7bbfef25fc9f0cfaa2f96be0b87e0a5d902ad4f5e32509", "ref_doc_id": "dad44534-f2f8-4299-8541-aac67e0adebb"}, "0a829309-4572-4c18-9f2b-879a527394f1": {"doc_hash": "8bc47f9dc831efed788c88fe702f23233a1d24331ec15536ab22ef15e2772caa", "ref_doc_id": "dee24cd6-e25a-4e11-95cc-d1dd600fb258"}, "e417585b-1cca-459f-9fca-4669ede2b095": {"doc_hash": "beaa19c20205a4fe90fadfc8f6efe0f8eba333bee15168ace5274a5db3c6977f", "ref_doc_id": "7910c92b-e77a-4593-8e8e-c052461c22ff"}, "af597769-f624-48bf-9104-560849b54ccc": {"doc_hash": "5e56b887adb4432549930bc8ab3bb7b636234885ee40a22236fa02a296cd2372", "ref_doc_id": "4fb31344-41d5-491a-b3af-3c8cfb080810"}, "42720fb3-d2f7-4d1f-aa80-1ac0b3608158": {"doc_hash": "079fa2b90a4cedb06095a380a5a467b6c2ac8d4beb4e16d77db6803878be7f9b", "ref_doc_id": "28eb9a33-5d63-4346-8782-6cc4c110c7ef"}, "7e5a0b44-f57d-4ec8-914c-be80a6141d00": {"doc_hash": "4dd22d0ba77d0e9b60031667422e8f857d0aab896ffea8e8dbef1b6c90bf1abb", "ref_doc_id": "a381e99d-428e-4584-b1d8-1f38875bb39d"}, "cb9e95d1-1e47-4320-b97a-60eb34180a79": {"doc_hash": "870cd8ac67c3099424fe21c2c9c77ca826162f111232f5d01828afa00ea9108a", "ref_doc_id": "cfebc3f6-a515-426c-9fbe-8664a8d0a0f7"}, "d5e11156-e53e-4dd6-bfe5-ecf30222e4da": {"doc_hash": "b10eb66a40fe26d9ca2e3c7453c7eb86aa4d589df417d940f354330ed30bdba9", "ref_doc_id": "73c156b3-4447-40cf-a167-5f3a9c734ba9"}, "2821b06f-8e6b-475d-9da1-310ef9af7cd9": {"doc_hash": "e8ab806a1f80029be0a1e48c068918ccaaea3124f51f9fde49e9b5b309321273", "ref_doc_id": "0521c137-7569-46fb-a7f5-ec9863101883"}, "c2ee4bd6-dbbf-4991-99ba-0f8c5efe2485": {"doc_hash": "131e3bbdad5ad5f2d6c195a3dc8e52c2239a8637e5dbe51bde1e7c156e7a47d6", "ref_doc_id": "59d266c8-e7ee-40b0-9bab-23daf7d679cc"}, "9c2b8f81-ff0b-4942-a01f-ecea43702233": {"doc_hash": "ed57fa5749dbb44dc2427b430e6a46fcf9afdd99f8db9558543385ddf510ab62", "ref_doc_id": "93e4e1d4-2431-490e-9736-b0ee0c6a03d3"}, "d4f58d19-7c2c-4dcb-9f46-bf4556991918": {"doc_hash": "88bbcda22e1e34d1c8d4b8f5a29b4933082db28250c5fe25757232441683c991", "ref_doc_id": "64b1958f-904f-4b8a-a68a-d910a22ec84f"}, "2fae1aab-9948-49b7-a9b6-ef8ddbfb7c21": {"doc_hash": "8f680531f74b08e4ad86039eefeb6404a06e99785cb2973cfa6bf5acf1198978", "ref_doc_id": "98736360-5799-4d99-a700-7eeef2383c98"}, "27a7d603-f229-475d-87fc-07388bf0438b": {"doc_hash": "a5d13b87405a95ca08cff2ea75f203c927f08cfb2dacd22b4c2f85b20de60540", "ref_doc_id": "7e08d210-08ca-4beb-a8c3-3164760a1faf"}, "962660d0-984d-48fe-942e-6cdd7ae29d0a": {"doc_hash": "7024c091a5695b43ed74e6503235473cedca3ac87daba36ef170cda5b2d4a9ae", "ref_doc_id": "ff8420b1-db58-417b-a095-401a8ae6ceda"}, "19b0f0fb-067f-4a17-bf45-3cebd85574a7": {"doc_hash": "9ab209e92a93bbbd7a1349cb831f679e39777c7ca54405eebf642996b3ae89f1", "ref_doc_id": "22f664b1-429f-464a-9ab5-8efd85bbe601"}, "7fa03572-a33a-461c-8089-b191bdb97781": {"doc_hash": "0ab6cb376966596a3795cbd72abebde34dfa30e0d0f83c4aae181f861071e3b7", "ref_doc_id": "e35c7e90-66e4-4f57-928e-807d4e44f915"}, "47c39ab0-6e60-4512-8e2f-57f85979a3b8": {"doc_hash": "1dec3ad7570f349f1a6da5c51b3553c19c84d48dabe8bac0011f3200b9088b41", "ref_doc_id": "54866c51-7519-4431-9896-e77009cc1bd6"}, "49cf98e2-1feb-4ef5-b6b2-4b28af9cab5f": {"doc_hash": "e0a9d0a85aafb1e4198f402ea2d0ecaa9f71d695c7f874c4fbb5eedc6d57a862", "ref_doc_id": "6e0cbbfa-923c-44db-83df-1be863618107"}, "594bbe8e-8a41-4439-a579-faa90d873f41": {"doc_hash": "a43409693bb619bc1763d8fae2839fe6d265ddf6d458894ef441699d426c941a", "ref_doc_id": "dc39979f-ab7f-4685-a505-4cb71d028e8d"}, "c21d5739-2da0-4606-b6af-6b563d1a22c2": {"doc_hash": "c8a5cbd0a12634417be35a80b6d6cd374b2ed5a2d7e8aa431d0924103be3021c", "ref_doc_id": "95bb94e0-96b5-48fc-b902-5519599b1622"}, "c0cd86a2-d5b2-444c-ba15-74535398736e": {"doc_hash": "a997126deaedbb49a9e0c3da11e01e00cd5245fecd04c5868493b1a381047000", "ref_doc_id": "262c71ad-8937-4d67-ae60-2a027cdcbc8b"}, "7580d9ef-63e6-4060-aa4f-f37202224077": {"doc_hash": "1d85030e0450d8044913e0a7f398cd82dc78fbac39bb8cccbaa716569c2c30a9", "ref_doc_id": "18cb0e6d-7b31-4119-9d26-eba95623c599"}, "704129c3-ac87-4153-ba50-8cfe4ecce372": {"doc_hash": "729080d746a13ef5599a124a272e83ebe1976ee1b6495e2a1a123a03348619f8", "ref_doc_id": "b3203d08-981c-4ff2-b907-6a89028ef19b"}, "adf64a4d-8604-4f78-b045-8df47fd981a8": {"doc_hash": "0efb72008003213cc302dc581c888272b5834ad473148c62c14b57e23afc345b", "ref_doc_id": "601b2877-bd45-4a3a-9ea4-72e2c8a63667"}, "96772174-818c-4356-90e7-76bd0c7acc09": {"doc_hash": "e8211131a41ec9799a99bde6891b764bd1f0fb8b27566561d3278dbc9482d16a", "ref_doc_id": "bb4c07d3-82e0-4e31-b4fa-c472c09ddd56"}, "f6bc4646-1d26-49f9-870b-c3672966511c": {"doc_hash": "78e86dd77951ddd552b97081f87255492ef0c6b508a86b3eac6284866b826426", "ref_doc_id": "89c917ad-9b8b-4b12-b468-535274738573"}, "dd52a6fc-a68d-4e9c-8fc8-4c57c46027d4": {"doc_hash": "bd02057ae0fd610dbebdbcf1143ea331551635662f0b439fbeff59f37b0d9e58", "ref_doc_id": "c2e3a3c4-f216-45f6-a45c-292a3e326572"}, "b826317b-ad42-4f91-b10f-ae277e698e9d": {"doc_hash": "fa7dcc06bf325dbe88c48e2d552e5914cdaf33d92e574e54d0759988d73df4d5", "ref_doc_id": "d0cf6711-65cc-4616-828b-6fb8297d7735"}, "95dfbc90-cff5-4825-8126-7fe9734ea14e": {"doc_hash": "3f73844c30024d959ec343f42e5245d9197307741005a4a535cb9111cfd5b35b", "ref_doc_id": "d0cf6711-65cc-4616-828b-6fb8297d7735"}, "dfb0dfc3-fe73-4206-b304-0b11ae68fe97": {"doc_hash": "0381fec04a9025ab7efdf5a12d102ac9ac7c3603b0d1bbc2f5b416f0403626d0", "ref_doc_id": "e40940b5-496b-4c8a-b343-991dc5e15c1d"}, "d4a3cdf8-4635-4977-8f22-f5316353a1b6": {"doc_hash": "e2d86d0ebe24f6d53805f078283e470329ffb0c5cfa6fdbf67382fb42ea94fa3", "ref_doc_id": "0b707e58-b244-48a8-acae-3951a8a07440"}, "524633a4-370f-4299-8797-0d49b51adef6": {"doc_hash": "a019f78c8fbd8847b6098f85900baeebd8c7c973cfeca311cada1b232f3c6306", "ref_doc_id": "c0d6491f-4e66-4870-916f-39ccd91893de"}, "f2d9d198-36a0-42f2-9626-c05220a56a23": {"doc_hash": "5eddb1f5736474090cfdb16989bf7c1b1d44df8976c197e0b2ee710f38a98281", "ref_doc_id": "8e244258-ce82-48e4-ab09-b4985835d6ff"}, "10a13c11-5674-4ec9-9d79-4571487c4345": {"doc_hash": "6427549dcbd65676626f1d2687b80e9866519b608d77f6c5d527a7a9e4aca1d0", "ref_doc_id": "05a21a83-38b5-4631-8527-b1e1be17a6a7"}, "a2be7ffc-1b58-4756-bc92-e4a6b51ac21a": {"doc_hash": "ee0d0e66c6e41e106f5a2d981d14b95bfb69144dc67da941aa71eb0d1cb96b7f", "ref_doc_id": "8b07e036-a70a-4f5d-a8e1-bfe9c64c33dd"}, "10764762-bd24-42ea-bad6-3c66ed5d9a48": {"doc_hash": "315a93ed652a8c5d62e9502b8263e4b4ec92adc75178d51e4b6256ea2dc20b3d", "ref_doc_id": "f123db96-bde5-4cf4-bf62-59c8ebabcfa2"}, "b4a5fe1a-6153-4e11-91a6-aca748d54048": {"doc_hash": "295b869436ed24cdadaa08098d0b228dc77b02322f13ab8947ccf048d40dc8ce", "ref_doc_id": "b9b4f284-6b1f-44be-8e63-1789dd16d0b0"}, "9e4c2221-66c4-467b-bb9e-02f3af6173a0": {"doc_hash": "942e43398b2842301d135d6e3997b1273816df054274dfe8017d60c84c4155cb", "ref_doc_id": "7ec26ca4-978d-428d-8853-3c19af52e1dc"}, "ed64d3fc-08cf-4768-9129-8cad3602c35b": {"doc_hash": "b3ed0114f3a5bff4cddea261024ba65a249325e0eec97518f1e6b47c8d216f19", "ref_doc_id": "3fb390ab-5fe8-4517-ba8b-1aaf75651131"}, "d41a65c8-8fcf-4c7c-abfb-498c8e4cd5aa": {"doc_hash": "310086565ea866a570b956986a9b4cd8809026d6150797ef46415ff850bfbdb4", "ref_doc_id": "12d59e46-b053-4d4d-a2ef-9b55e9637041"}, "d8361ba6-42d7-406a-a3dd-283334f73b4e": {"doc_hash": "7895a2db355e339a0da36868765705398f11535cedd1e9fb31b35433499ba50b", "ref_doc_id": "25996ae0-abbc-4a3e-94ed-2be6180ab372"}, "b6da2fc8-3880-4cc2-9671-2ffd416e06a7": {"doc_hash": "be4fbc16680ea98e3acd3442b75979a4d298027147936ad2032bb865f1b37d36", "ref_doc_id": "e958eaac-faff-4d6d-b39a-de6b38bec378"}, "a232b068-7f5c-4f65-bd46-2c77b1d9f059": {"doc_hash": "6583f77dadd04f03f4e642e4b3e724c06a90b83c0b0283f23fd63fca6b6f82ac", "ref_doc_id": "e191e3d9-7ea5-4785-9d54-de14eaa891b1"}, "f35a511a-f5c3-4ff0-92a7-5ff211288cf5": {"doc_hash": "61ac4fe4028b549ee7df79b4d53c94c6eaee18a548b2e2035625bb4715c030a9", "ref_doc_id": "20ba0f61-f859-4ee7-bb7c-43c8f133e7ea"}, "fccedcba-ada4-49b5-9023-357f9c1446b9": {"doc_hash": "8f711a188523a1af852928f711fce1172db6e47726e6b08b0d865625e1df1593", "ref_doc_id": "a328156d-2d2d-463f-83f7-89897fdd01b6"}, "ce7b68fe-8fd8-49a7-8163-96f379212c70": {"doc_hash": "b878baca8caea776eb94a17b6ae4760086886e5511e6dc95ebddef31ac61e1cc", "ref_doc_id": "8b82c6ff-cfe1-43dd-bf17-47e22b82d1e7"}, "2617fae3-a51e-406a-9e31-1b7de76824cd": {"doc_hash": "5d9e795e1eb2c4d7c873bf817c9a139406bb250f37afc4294498e630469851c5", "ref_doc_id": "5ab9ab3a-ea89-4cf4-98be-79809b993d4d"}, "a5ca573b-4663-4278-a22d-4ea3c17c9b57": {"doc_hash": "76d73d89a8b7039b5dd9b4aaf04225cb9c77c3bfd68b04dba75438e84969c5cb", "ref_doc_id": "74343b6a-befb-4945-83cd-8624afc21a78"}, "a151a985-1f96-4900-b4d7-9dcf034bdab7": {"doc_hash": "76a0678f6b4839952566febda81167638f1d625c980bec497a5f1eb42257fd42", "ref_doc_id": "49773c2e-553c-438a-83e3-9ee8bff9dd02"}, "364712e9-39c8-45eb-80a1-1ab7a2d1d4d1": {"doc_hash": "f6180775ad0c2d1a71978f7a5471fc28b7949a1239eab62472ab528f869d4415", "ref_doc_id": "c8895567-d7d3-41f0-af4d-323e66ca12a5"}, "8e590a6f-ba5d-4613-91e7-64c095596c33": {"doc_hash": "675a2bff7d15e87dc5a35adb01bc89da003a1e567a6aa31307a39355567359c1", "ref_doc_id": "b7cd3b05-b387-4e47-bd73-6332868d2f71"}, "930cb0cd-dd9c-4cd5-9f7f-e242d6839570": {"doc_hash": "2e9c8a6f51283ac70b1438d5f1eb601790e7450f5909031bd1303bf04e7b68f7", "ref_doc_id": "80c09984-4352-4c08-9c7d-3849fe2af964"}, "52b4edfe-cccc-454b-830e-a12ba4a99ea1": {"doc_hash": "bee95c2f09547b854e0c73575b83bc4716ec0d3256fd5a66ce690e58bd7edb08", "ref_doc_id": "2644ea91-18a5-492e-a493-618e2b18453c"}, "bc9f0df5-2eab-4138-9c5e-8e4100e6adc0": {"doc_hash": "c7fc545b63dbb99c5c1284216009ebfd66772fa23c10e0ac81cf32aef81f9c11", "ref_doc_id": "c9251f5f-1c6d-4e16-9134-2c2ac3c139b0"}, "109f0e51-71bc-4ebc-ba5a-e2319f3bb773": {"doc_hash": "a63f0163916a9bc9602bf4ba11d182e89773c977c15db348135be1dd418b4e3d", "ref_doc_id": "b7906c76-a271-4abd-8076-4718b552463c"}, "9c2cce78-4759-4872-b117-933e7b398dbf": {"doc_hash": "783e1d400b2a7ac93b081c68a75501bf898bdecab2fe95d2f6751eaf6e8f856f", "ref_doc_id": "83d64e1e-4dc1-44c6-ae1f-e10e751821c8"}, "e39e42ea-a156-4776-a7a1-c059a2accfe7": {"doc_hash": "53c62855fb756a23eee5c6d80f59dccabbd024e2323898551492649720dc8f0f", "ref_doc_id": "8ccecdc0-a929-4abe-8711-764bcce21d46"}, "d8b5f0f2-b7bb-4a6b-9a9f-52d914f23d5b": {"doc_hash": "3c7123b49fd480790198cee4faa017fffad984ff7934312fbed2469d8bbce8de", "ref_doc_id": "1c5ae921-d2d4-4638-bcea-3268b4f399a7"}, "b7547afa-2f98-470f-a76f-23374157fa3f": {"doc_hash": "fa032ef68301e613054a3b15728f514fb3850c897f94d2329d0c9d19e903846c", "ref_doc_id": "5b8f5770-46f0-4457-84ff-e4fead8b5ea8"}, "859f5d15-8c4a-4150-9cd1-47834beae28a": {"doc_hash": "889653b65261eb96d08aa8a208903f45cd58e6f0234d08d35f76c8d1482c9dde", "ref_doc_id": "65609a37-f6f0-4cbf-af03-0560605f4151"}, "f2a63b53-3014-45a8-8d69-3f80a932522f": {"doc_hash": "de7ed1cf4b69bf8f62617c0ee335618f5baa93da24b9e098ac3c73857de2b39b", "ref_doc_id": "06485463-bed3-463d-9461-a3115a18a41c"}, "74e041a6-8e4f-4441-9fe7-e24717d60a8e": {"doc_hash": "ea7bdcf3fc0c26e04948a08f387b5025b4de5a1148d1de965c7107ac6bb1f962", "ref_doc_id": "da5f1789-484f-4b37-a625-7224e9af9bc1"}, "580d0859-9c51-419a-ad3d-e2ab68417e36": {"doc_hash": "7fb20c8f49746bb690f42ef4b76453e207b7c5ef2298e18df5b0406a602076af", "ref_doc_id": "0c190c38-2aca-4303-9904-a9d9e2aff4ad"}, "e9ee20f1-391b-40e6-b1b4-73377ae0a521": {"doc_hash": "d9ff3d04e1a9b3d4aac9f343ec15fa69b954ee182df62c2edb60d66b040eefeb", "ref_doc_id": "3fa27da2-95c6-4e2f-9908-8ad616c2ac93"}, "29a35073-a96d-4407-995d-398957872cd1": {"doc_hash": "37b2d446a381974c17c8662ab3a8569de4798e23fb3ef8aa2554c6f5bb57dd93", "ref_doc_id": "2b9c6b40-8ef1-4f1e-b712-a6618e6b2700"}, "4f066b06-1897-48f0-bb02-10a5941b8a00": {"doc_hash": "b1aec5ba9bcc1bb59b9797049dc6fc044b3ffb921ae8fa6d13b1f6d6e452d75e", "ref_doc_id": "25806191-6fae-4531-bc02-c0cc86cdf675"}, "8e4b1be8-d201-42ad-8b26-4fdba9bafd01": {"doc_hash": "195011ffae36edc6290e96e86e7cc308cf58472d7cb1895f44b7d4e184447dfa", "ref_doc_id": "4de1f6e0-fea2-4c63-8530-7f994b1dab01"}, "a0500740-20c2-4149-97a5-b5ae11417d78": {"doc_hash": "f81e74c5c97a86fe64c902bb3135f8e5739ebf3067bbe416e61ac7f83ce51085", "ref_doc_id": "e3c1da99-58cc-44f6-973f-ec416ff41ecb"}, "dea23ae2-1f8d-40a8-b9f7-23804a8fef7b": {"doc_hash": "410af0eed9f569abb8f3aaf0914e03a8cb69e481e85294d0bea497e7d92226d4", "ref_doc_id": "843db1e8-313f-4dcd-8a38-11fe49895ed2"}, "a0368a94-525b-4c1b-9ed0-504971c7be55": {"doc_hash": "944a7aece22727011dae258837b0e5d26e9fda8b41e352a898fbb2def827681f", "ref_doc_id": "9b56996e-92f8-47a9-a2bb-aa13b6224d50"}, "5efe383b-5b46-41ba-a015-0b926de97775": {"doc_hash": "2960c5c9e7770cf597fa9dab9f87c48a8ec69c1edc5dfed0817de7b2175b6f17", "ref_doc_id": "f36e38dd-553c-4e0d-ac75-a5d7b713e845"}, "943aa60e-b93d-40db-9249-83c64b26cac6": {"doc_hash": "2f0a9fcd5026f30064fc14758ebf2efa20806a9793ed864ebdeb3451cd05ed17", "ref_doc_id": "55162cc9-88dd-4f82-8993-ecde20fc8218"}, "46776e83-1fee-4526-81ac-4944be38ba54": {"doc_hash": "633aeb402e7c0317a0a9f20e1b420cd3af1e0f9164c1fa7d7d9751d84e96c542", "ref_doc_id": "c612144b-a346-49a7-9f89-812486da452d"}, "05254788-00b6-4611-87da-eb96cc536352": {"doc_hash": "185117bdaeffbafa9e8f080aa66e7a924cb48ba8f88787aeb19177f4cddc30d6", "ref_doc_id": "55bf603a-fd80-4849-89d7-9cde89fc6608"}, "31832931-b874-44f8-8210-ecfcba1db792": {"doc_hash": "0ca6381cb760f2cb0fde7ddc2d59802baaa0578360400c94e4f46a173ef6cbe2", "ref_doc_id": "8a50997a-ce41-40a4-af4b-51b7c36cd5d4"}, "7932b02b-7e76-43c2-b3c5-7e740aaeba49": {"doc_hash": "6a1981d0debf09c39f2aed7b6d2e9e6e72935c2a6fdc44fb282052a54e562613", "ref_doc_id": "fd0096f8-c08c-4a89-9c46-4be58dd57aaf"}, "aceef56b-786c-442a-b654-f7aa36576798": {"doc_hash": "ae0874e31eaa85a8907ed59f4bd6f8205a7547b0e5ba291dfabfa822bc6ba68a", "ref_doc_id": "95c8c2e0-91c4-48e2-be73-551fe0c0faf4"}, "c77571bc-ab79-4d50-9d7a-c896600f31b3": {"doc_hash": "8e19840aff8f571622859ba7e1d3d64b3307ea9517f6e7bb1e2ac7891ee217d8", "ref_doc_id": "e1458d9e-6811-4473-ba70-8d3f74ffedda"}, "72a289b7-6157-47ab-af06-04e4aad155e8": {"doc_hash": "94f347ed0999fb9e5ecb4c0ceed1ac4a52503add961d78af037a4b74e6e7b3b7", "ref_doc_id": "563b72de-8eb3-4255-a09c-e178e130a693"}, "f4daf9a6-e3fb-48dd-8b8b-2d39b579d758": {"doc_hash": "0b5857ce0d7d19824fdecce1aa09517cc978ec1230ce1389cd32b2798ff07d4a", "ref_doc_id": "7eeb2edb-fe43-4036-836d-7eef45d0310f"}, "e9e05026-871f-49d8-8f89-dd6339e5fc06": {"doc_hash": "d5588b58236c0e7941916b94a412c53722dfd59c1dc934b26d8fdfb09b07a6bb", "ref_doc_id": "f5cc37e0-8d0c-4e05-9497-9c8b22631e6e"}, "5e780672-7164-4ed3-9d9a-bedf6561a105": {"doc_hash": "54b88cfa4a22ba732f85b6028fe81039bc4aad919047997fb403a76295c9337b", "ref_doc_id": "ca777b81-be46-4861-a040-2822409932fb"}, "0497ea76-86cf-411a-9b0c-34c997f34e6d": {"doc_hash": "f8acf677123b4c2db1871807b8f5babd15b09e3d95cb84f61219016b49a7be37", "ref_doc_id": "1ca83fb1-02b6-4557-8ebc-2a2b07acceb0"}, "1e4dca50-ec02-41ad-b048-e1c71c53508d": {"doc_hash": "b25da34484e48ab523e0d075cf4f8aa87e7a626fefc2cefeaf270660668ff157", "ref_doc_id": "9c40b014-3149-41c4-99c4-fb5908945fcd"}, "1b4f3ba4-edcb-4c8d-b488-8a6f99eb78f4": {"doc_hash": "c7c963a0e26033666dbda39b4ac1d6158dffe17ebee533564277a8a53ba4d93f", "ref_doc_id": "7cbc7b66-a5f4-40bb-8507-e2c6ef1a1798"}, "7e9aa9ab-fc1f-4611-9c4c-bfcce0afd3e8": {"doc_hash": "babd33ef59a2c40424454f1d9a1acf8c08b25f69b3aa65266b8f03985b20ed51", "ref_doc_id": "d13f967e-a94f-4f32-9efb-297fed8be716"}, "07456e60-5c6e-4dfb-aacc-c4f7976ccdec": {"doc_hash": "70396902d02a48aaf8cbdee719f979fe5d3a2c06964997b648417d639794e66f", "ref_doc_id": "3e450db7-6cce-456c-a366-296cc11772f7"}, "9da110c3-f9d5-4dac-81e1-15ffebc73678": {"doc_hash": "7b0a610bd026d5ab49c89be241b5082039899f216349146c8bbc197bad00f867", "ref_doc_id": "72f72bd8-581e-4857-bfcf-0d91ea609926"}, "1bc25ce4-f0aa-4c0a-b604-bb314a15fa73": {"doc_hash": "30aa21d3523baac9118d79e652c861c69ff76237b1ad32c6d1fc61a5300dc1ef", "ref_doc_id": "a4ddecbc-db0a-4788-b640-2b0c48ab3dd1"}, "a5137f03-03f9-4c9e-bf99-1534cbd42abf": {"doc_hash": "98e2dddaea9b329c8e407accb6b974eef49be2c399fcb27e13745ffdc9bbf906", "ref_doc_id": "31be2bfa-63db-47ee-98bd-d895e19d1f79"}, "5a3afb0c-dcd3-4e0b-add1-879e1ee86cb2": {"doc_hash": "b0e13520af52631b29fc914c6fc8dfa613139675f02a284536a84dbe5ac9c220", "ref_doc_id": "3eeb9251-1278-4cba-bca6-1228f5ef77a4"}, "75031268-fe31-40a5-9cf0-ab51fb50ce36": {"doc_hash": "6637e1fd86fdc991984d8fb802429144678aa496010771b85ad6d7e3c3a36a97", "ref_doc_id": "85d9eaac-aece-4fb1-b21f-3fed29f5b1f9"}, "2093ff83-57a0-4cfb-a33f-b7d292576828": {"doc_hash": "2762727fcb0c97c42e681737017cf5fe970bd79b070266a20f6c4613e408ca9a", "ref_doc_id": "e1ac18f8-8c2b-4df6-a9e9-df3add5dff8d"}, "a04f252e-044c-4bfd-9b18-3b813645f5b5": {"doc_hash": "fecfa2db2b437e5754fcf6a55559fcbe3a48377315ace614c48825aad256ffe4", "ref_doc_id": "b43afcef-a70c-4de2-91bf-045894da8b85"}, "2e772f81-9bc3-45bd-a270-ca251b0c7b77": {"doc_hash": "a43abf9711487dcc0eae462b552127645c67dbf8bf9a34cd55ce2c47df6ddddb", "ref_doc_id": "68a515dc-0738-48af-b90e-865a07583aa1"}, "a899541c-31f4-4f35-ba52-15a92d1728ca": {"doc_hash": "d6ae108a00ae8f15552d557b7879233148e1c230a579fa812d65c311c948ba28", "ref_doc_id": "adda00cd-fd82-47bb-ab6f-65f8106c5cd6"}, "af4d4531-602f-400d-a7a4-c4a6dba858ed": {"doc_hash": "fd79dc2537468953c590489b0ab96238a11be353d65fb9a7cbcc2e57dbc41066", "ref_doc_id": "537c8940-b879-437c-af8c-e60eab39e36c"}, "059f2bb3-657e-4996-9c20-8a3ead9c7e9d": {"doc_hash": "e4b2537a20ac6e318c2952946c8187ae4efd458388a110f3875494b0d11295d0", "ref_doc_id": "dd866226-6628-438f-9b32-fa5540433fcf"}, "bf0e753e-2220-4fc4-814f-6e26dc7d00e3": {"doc_hash": "e5c06cb2e012e12f51495ba31e8c0c9c2a7baf2e93b182e037dd4a41bdb4c270", "ref_doc_id": "3e535bc6-a0b6-4cc1-b23b-941a8f71cbca"}, "ccc0ad08-e978-4763-b521-0eeb119a5433": {"doc_hash": "d3d9d63f289cb369d8d6988be0f99d9bf80cdca5e5d9051c0b1724890c0c3d9b", "ref_doc_id": "6326781e-f2ad-4de6-8ddc-f8896584e187"}, "d7ea3afc-6947-465c-bc7f-8d5a670fb4cb": {"doc_hash": "c5fe7b1f5c33b1b9c1e4de9d34f37861305e6e5789c17019ce9ccbc155d8e95b", "ref_doc_id": "5a52e576-ecca-46e5-abe8-afc9f8eaf98d"}, "36e5b6fa-a7b9-481d-96bc-3557b9f29bc5": {"doc_hash": "4386d6344566f5af304ac97dc301a4ea48aa843781ee4af403fd138ddd4ce441", "ref_doc_id": "8b0ee7db-f668-4ab9-b6f8-5eacef6ce66f"}, "e940c6e3-653b-46f1-86d5-5d43179e2fb7": {"doc_hash": "43af2c314b880afd06e7c093b5fdc02b02d96ffdef84f4d560e2a7dfe6368774", "ref_doc_id": "e95ead9b-daef-43d5-a7c4-f65903599fdd"}, "570bdca0-3dc5-43f1-affc-f1187bbbb0d9": {"doc_hash": "7f480569fe3e2ffe3b7a078cb63d0c905bf7eff0ae924f85ce25b16650dd2c6a", "ref_doc_id": "c0f99a7c-927e-4f3b-bf34-a7955338e211"}, "fa56dd15-b2e8-4aa2-a91c-c3bfc8effc73": {"doc_hash": "ae9df7d8a360d41d72dc8b1d7bfc5d930934cd8d37976224743a6ee508d2eb56", "ref_doc_id": "11c68c32-5e28-409c-a38c-d23ed01226b0"}, "05c11f84-da7b-495d-ac9c-3174f892815a": {"doc_hash": "013df9e69e9d56498fcb088198bd2aeead4ca0b9e5f34d9469ad4ff61930ed9d", "ref_doc_id": "5137f702-1993-4c47-865c-54be5a4e01aa"}, "92157c07-439c-4062-be9b-b8d3b250f703": {"doc_hash": "e9d0843e305bcd43179ef3ca6b82ea5d6fbe306189942f81412bb6348b031c56", "ref_doc_id": "f1197c4f-56cf-42b3-ae02-2edbaa4c12f3"}, "9b8cffa0-7d61-442d-add0-7ed6fd167c78": {"doc_hash": "dc5774214dd8998b401b423c1c30056d75d6cb08d8b09c34f905fd51e7496a44", "ref_doc_id": "8d1ca404-b26c-4e93-901a-5fd42e281f1b"}, "a629a532-730f-467a-b7a7-72b3e699abcf": {"doc_hash": "a6c6592782b356c84348548865e0cbb9a4840e6e3a4cf733858ca7d8508f83b1", "ref_doc_id": "8fc7f01f-eac6-4d4a-bc14-efd63530f1e6"}, "8d877530-15d5-4c4c-8102-676e80e9041d": {"doc_hash": "1055ff56941c2c8ca5c6d5a94b8944936e375565a56230ef6b69956455a7a5f8", "ref_doc_id": "be20f6dd-0544-4400-81e9-90c49b9e1c87"}, "35e5b796-1e58-4c78-9788-f0fffe02488f": {"doc_hash": "8da3e78eae2e86956e6dc445562d2ca9f1a20a2cf895c1c628c4f1e7d9bb1dea", "ref_doc_id": "8c38fd15-c3b7-4aa2-a5c3-43f232285574"}, "d866e2d8-1346-4793-a4aa-8e5f2afcd480": {"doc_hash": "04230eb5e5cf457d6b97c54c7d1245106cf7a47ebfb699eb9c89e6d105ae2e0a", "ref_doc_id": "9fbcc2bd-481f-4a49-94d1-a8fc053fde3c"}, "c4a2fcc3-d771-4b07-8078-55ff279f835d": {"doc_hash": "bc14b607d72cf14fe783e81008827296bdf1953d5377a5a1683ecba071fe1d10", "ref_doc_id": "fbca77c3-84fe-4cc6-9bd5-cde8b169a07d"}, "57dc438a-5746-4463-a2af-e3530221da08": {"doc_hash": "ec180527ae91a9e15422703901f0487c4772df35c7eb5fd274b95fc19fd2ab54", "ref_doc_id": "93f70f2d-ccfe-4e5a-87bd-4c8e04a2cc60"}, "01161378-09c7-4e3f-aa3d-dcf61e0599a9": {"doc_hash": "2b8deae704f23bc60de39055f387baca5d53d918457d93a40aa4f07789a053b1", "ref_doc_id": "4c95681c-666d-4d0b-a70e-58ad7f7d0c2e"}, "c95fcfa7-06d0-41e2-8385-0efbb1887855": {"doc_hash": "cb4ce12b85c4d477a30910a1bed2932ebcf604a58ae1f30b4053adfac469e24b", "ref_doc_id": "ab2759f0-3cdf-4eed-9b89-034c5a4df81b"}, "7ef83312-a150-44e5-b712-dd12be58d0e6": {"doc_hash": "060353a988c85c6fe437ee2443fc891e48c377fbfa469f98102f642b2509c7d8", "ref_doc_id": "b55ee70e-c31d-488b-ac5c-a58989c8a7d3"}, "72446381-df80-4ae6-a3c5-70742f5f9251": {"doc_hash": "0f53a67882b5f484bb190358cc4dffc1c4dca024e1a4a69e6d82aa25b941b939", "ref_doc_id": "3a8bcb25-4f13-4666-818c-ef35089ac60c"}, "fe3dd61e-0e93-4dfb-8859-c49bdb2750ad": {"doc_hash": "0caf86ea2370c2a8d7f7860f38778fde38cd26a7bb43ce9f237fe9f79dedb7e5", "ref_doc_id": "cbc32d79-dc69-4a2e-8c63-c9024836d8e1"}, "cefbde89-fc99-49a6-85ca-c221ed00235e": {"doc_hash": "0eb294995e4a4318c121025a8d13f6a342a141040341a4ddb19c1915a15c2a03", "ref_doc_id": "b0b8a719-144f-4c58-91a4-3cdd04719217"}, "34cfbc64-e909-4b85-8f38-df8974e96468": {"doc_hash": "f1e687d005cfaa374d81eff6737f7b1ad92816cf588f15142157372510333a46", "ref_doc_id": "b5e73bf4-899d-4b93-86e4-d06a64514f30"}, "b2b5db5d-6194-4952-955a-dd4bab48c19e": {"doc_hash": "d1de02016aad3a3103faa414a1ac1bef9a318d677ad9599363e4f641fb889ddc", "ref_doc_id": "1d58fd78-3f25-41f1-b741-fbe5daf17545"}, "cc23551e-21c4-4128-8312-f5d3c86c7e98": {"doc_hash": "e4a759f8504bb8dc8636c3fa631a8835a2ce546b13737a033507462459858ea7", "ref_doc_id": "be4c64c7-2ac6-4ff6-8315-424cadd800d0"}, "edcceba6-ada1-44ff-b3c0-954b6ebe5eff": {"doc_hash": "be12b5cc148d34b23d72217e394bbae7c19563365d5c13e263f63394a470a3de", "ref_doc_id": "2b1c3246-6cd1-460d-9f84-97eae6be59a8"}, "f5c19990-3452-4ef3-960d-eddd193e0f81": {"doc_hash": "33936363b502ceccfaf3090fe46129446d00b87c32d0de58e40f86652c7a2255", "ref_doc_id": "cc35bbe2-2f71-4bf7-805a-7aa04ccf3cec"}, "3b64ecad-15ff-4f20-87b5-798fec51a8ba": {"doc_hash": "fe1d4ce8f87d4be2661b94e2d2218e0b1af41dff38646656f593aad68d21a24b", "ref_doc_id": "8f244968-058a-4b28-96c8-54231b836c86"}, "5ecb1289-3517-4bda-a9d9-324d49d1e090": {"doc_hash": "d0e7f8c7fac985267fbe1af0bad84e9c064bd26447c342d282a2c416548b4e64", "ref_doc_id": "a3cda906-642e-4693-b653-91e0e0930d44"}, "28ef66a9-f638-47d6-a8f1-791cf8f5eda1": {"doc_hash": "fcc82c7a8be0c37df8da7333142b804b9fbd825dec7b0e6d5a64a3ceb9245f31", "ref_doc_id": "5d1aac2c-5dd0-400c-af4a-691963a335eb"}, "0f9562c4-e24c-42c4-9acd-7aa7d4fb878b": {"doc_hash": "b416b7cca6f1614bf77213a667aece06bb45e546aed93576f47db1befd80b5eb", "ref_doc_id": "b246a1ef-6c8d-412b-b7a6-8ebbbc2fa4fa"}, "7275e3a8-866a-417a-84e7-299188adf5bb": {"doc_hash": "c4de34337cb7ac2c7225a45e65fbe993995fc8e1d96557ed641d2ee659a2e629", "ref_doc_id": "48bb9627-0e93-4f1e-a663-882cbc8b48f1"}, "fa9efaa9-4b09-4721-98ad-5ce2784a0dad": {"doc_hash": "982bc04b55df7af07792e5562b594efaee85e32662eb3cc27751fde2f3d28b33", "ref_doc_id": "96ca9ee5-accc-4efb-a58b-cbea598e1853"}, "ec43a3d0-9dc4-4be1-b2b1-cbaf90932cec": {"doc_hash": "d76444793b913327911b8b99ec0f4ce0b4bd6d9c82c168e13c3f1b7971fc778b", "ref_doc_id": "bfb93aa3-909f-43da-8b36-35068775b2d5"}, "aadd0e4b-ab37-4ec9-85a1-1f00514439d4": {"doc_hash": "0caee3a958f715246265e8fc67a4486f260663e3a6c9dcb90fbe0abf4e6b366b", "ref_doc_id": "7ae3b18b-3148-48a1-93ff-f59a957801bf"}, "afc239eb-e9a2-4b74-a2f8-7521e64db9e3": {"doc_hash": "d5dd5144730d449012e2560848e38c2cf279db3f9314d16aa8ecb432ec5fd489", "ref_doc_id": "bd069c61-8ffa-44a6-833a-376b260d943f"}, "a0fd4cd5-b198-4182-9b53-37323ecded8c": {"doc_hash": "d20c9a5a14d374f196efb084b4c305f28fd71f55b5c7d6473fb3ca3dfea58e6d", "ref_doc_id": "19d4a083-81f2-41cb-849b-0dfcdb2ba363"}, "c8182f1e-7184-484a-97f5-b8136a46f03c": {"doc_hash": "56f52f5dcd10b866c6d3535d038f1976ee56fe38ba160f55bb7780f5c63b8a5b", "ref_doc_id": "326f35aa-b7fb-4b59-9e5f-686bf8da67cb"}, "a91d4993-3b9a-46ae-af45-b226ff9e4189": {"doc_hash": "517616f50cde6814b7f921b6ce0adbb8189c376812f3c603ee50cacd25be7acc", "ref_doc_id": "b3a984a1-cc76-4ebd-a2dd-b859dec5e178"}, "593e6482-2548-4455-9052-2c7243c6c2d1": {"doc_hash": "296c3b1ac4a090f4f9414d8f44b9463d7b3cad06042ae63a8628329f47cf99ed", "ref_doc_id": "340602bd-fd52-4c47-a88a-f60b2a334379"}, "cb7fe02f-2084-463a-b900-ab5fb7282e55": {"doc_hash": "cd445bb922e7b1f6a8cca703090ee39fc07852527a8270db99023b83a4ffdcdb", "ref_doc_id": "6cf3666e-c874-4a61-a829-fd4870acf4ad"}, "b715ce9b-d232-4d4d-99bc-95c3a2fdacc7": {"doc_hash": "278b11b294dfc0d5aa21a512ed021235406f711a00164dc1b1e6359da5ffc851", "ref_doc_id": "ffed7e98-724f-4ecd-abd5-82c1c936fca1"}, "fb80ed35-825a-492f-a748-a8458d94a5e5": {"doc_hash": "21a249206eb771fb2b65aa95125d77230bce7e224df20bd91ac105de425effba", "ref_doc_id": "25350984-feb6-4e1c-8866-ee5a7d062813"}, "b472e735-ce31-43fe-9efe-6b086b8e8593": {"doc_hash": "b31a8c9406baabab8fe21c1d431dbc692efe88a13b819b171c8cab6b2c3949fc", "ref_doc_id": "0dbc89fb-1ed2-47b4-acd0-2fa69a22ab72"}, "39f7f34b-3cc7-4a0f-9014-0961df352474": {"doc_hash": "1f0da39d3de0d5b49edb3a687fc68959ff8999667f543e55438abcbeae3fee6d", "ref_doc_id": "cbfe7b95-bc81-40fc-9ac3-367c16bf4b08"}, "1c7b4eee-ede3-49da-a1b5-53b6fb19dbc5": {"doc_hash": "96cfe28f36699c3f37c38da97d844b9de3c6f34e9ea3a56505b25f4c29b2edf1", "ref_doc_id": "40edf429-a462-41d0-b55f-5889cc3fdda1"}, "3bd3cacf-6ee3-43bb-8ae3-35ab8760c9a7": {"doc_hash": "d0597db09645f2d4a7362709f9c533be1acf59c6619ebba6e69d4a0f3ac22011", "ref_doc_id": "e4ef913b-8fb2-43e1-8799-9372b7c41da2"}, "29bd2599-ad0a-49d1-8d47-031341511b0a": {"doc_hash": "9ba723a2d247544e65b99a00559f9e14cddbdb4b792ad1f470d4b5b8cf790b00", "ref_doc_id": "0db4f992-e1b5-4b2d-bb66-e2d857638072"}, "1e9fec63-e3fc-41bc-ade7-8abd03e9b406": {"doc_hash": "9e79e85fe8fa499e78a44cb8bdf4f41bae8eb4652600cd51b764d7728da7d1a0", "ref_doc_id": "5028cfdc-74f2-46d6-967b-f91496342667"}, "61595e0b-bf98-47fa-b271-490ef7b1a2fa": {"doc_hash": "93553ab5f1c302d57e84bed0a3b020fa0f8c0280f1c7f55e387a230695eb48be", "ref_doc_id": "4e2426af-23d9-4557-94ba-7c70b1075ea9"}, "0a79cc6d-7432-4ffe-b2f3-418479d9c9a4": {"doc_hash": "7c5d9d586751e37542aa7b4aab48a68cd55f03a3a46b15a876587d7187ecd6e6", "ref_doc_id": "6baca1f2-5328-406d-8e50-faac2a4f3b23"}, "997e2e07-8cb2-47ef-9bc3-46ff8c0b13d3": {"doc_hash": "a4ee45de6b58458365f91a561a2f3aedcd58bcb9faacffbed36e67f82eb4be65", "ref_doc_id": "6baca1f2-5328-406d-8e50-faac2a4f3b23"}, "5d55b35b-4c36-499a-ac78-0e2dae56dbde": {"doc_hash": "e7a3f08c8efaf3bdde717363e612d8c30193ff2f005b9c8bb067e3ae39e1e49d", "ref_doc_id": "df728331-6a32-4c9b-b5e1-ff7abe42926a"}, "fad7ec60-2d03-4a9e-9c06-434889973b52": {"doc_hash": "a34e4f84f1291bd6b0cf7bb2d60bd7916f71b5e930fc9e31be6fddac7ee83acc", "ref_doc_id": "5400fae0-5fc5-4e30-ae1f-83d44dd5dd06"}, "9995d704-a341-4b54-9e54-c93f1de21d74": {"doc_hash": "4162ad372fe98f0f3914501e9968c0c249ee5101748b9fba3aaf331e114b9d36", "ref_doc_id": "3a902a5e-83a1-4fbd-b444-4d2816941a25"}, "df532cd8-936a-47ec-9464-c8c48ac2f010": {"doc_hash": "4aba410ad663ad8ea5da53abe163d9b3b5318c10bae9bd3ae1f5e1e3736ea481", "ref_doc_id": "dfe82da8-b5ee-470d-a706-d81394c80778"}, "32310663-18b5-4101-956a-4ef25fc9bc5a": {"doc_hash": "5595d020785167d0f107c991ea08de34c4a444bbcbcb22d22e5fdb69ba82b993", "ref_doc_id": "d984e73d-8443-4308-b6eb-ddc9c4475b3d"}, "f00e6f06-28d8-4eb6-ad66-df98a5959f35": {"doc_hash": "0a3f68418e83fd06920f2447b5490a59c65ee0288a81640bfa0c83aaad754684", "ref_doc_id": "414e7d21-4569-4522-94cf-c6a7a4f97765"}, "15e1bc63-62e7-4a70-b2f7-3c07e36901d0": {"doc_hash": "899042dff0fb2340265d3bfeff908ca53f63c4c5f5aefc267cfe9e505601860f", "ref_doc_id": "74ed164e-b9dd-470c-a775-382f3165dec8"}, "ec6f7101-2cfa-4663-9de4-f52a76f1cf65": {"doc_hash": "1cac3234c516cf34ac8f131e9cdf8362383d9e4f58c91e6f8f1503c9872c229f", "ref_doc_id": "e593b6e7-c1db-482c-9523-d3b18c67dea0"}, "cfc1b58a-2a3e-43fd-99cf-a25f5e799f75": {"doc_hash": "5e374d3c977f913c7e34c63567b21e6f9671b3562b5fc79e8ecce3b5688c8662", "ref_doc_id": "56c936d7-0c72-4d5f-99c9-90851dfd3c4b"}, "048a7971-7832-40cb-af48-846f1baa681e": {"doc_hash": "949f4da21d49c2bc1ca035697a0319c8b7b1ea08e488efb0b2d854a669065fb3", "ref_doc_id": "82aeaad1-c8bf-43d2-82dc-446c5beba1b8"}, "689f7407-4fbe-476f-99db-f4a564b130f9": {"doc_hash": "523420ff831d84d53c2112ed67766e643b68319d0398a8b77e2d026721e2a2f2", "ref_doc_id": "dfccef0c-5266-48d4-9ac0-cba82680f8e2"}, "2f878312-5dd0-49f6-b331-9022466b864e": {"doc_hash": "b2428c1d0a0ffe5f5f2a39643d519106b32f814f32f2b44f96a47deb092b1ae4", "ref_doc_id": "d8f011d6-bdd1-4296-91d3-2212fd530a42"}, "238ec9e9-5dbd-408c-81f8-491d6e9ad33d": {"doc_hash": "4068ed12055239b6ce570cbd9570e4bb86eca737885ff98c0df4564b97866934", "ref_doc_id": "61347e8b-48c7-4264-9306-9c7c54ba86d3"}, "a4f39c2e-f564-4b33-9a09-0e0900fac1d0": {"doc_hash": "4987d4116da4a1a53e18bd87d822d79b17db24ce8c39519457d26d29a769784b", "ref_doc_id": "80342e07-82a4-430f-b4d4-659d7582b928"}, "99d359e9-69c1-43dd-b96d-480f958166da": {"doc_hash": "8f497366a843864b0a800e5c058d864c0db6495366138d7769d7f0c63dde16dc", "ref_doc_id": "69b2d8eb-c43f-41cd-9936-c7591d645dde"}, "3ba100a0-44b6-43c2-aeeb-00ceabcd5ef9": {"doc_hash": "2098e6dcb4df088ce5ad29b760737e978489408bbb4b941418fb7f8edbf68b87", "ref_doc_id": "f3f8b529-843d-4e57-be0b-999636c81b66"}, "ab7fd245-e601-4a24-a0b8-def54ebd9210": {"doc_hash": "9e1a73391330cca89ac198bb27c5c1023be3cb3e9dc8ece7f043df34485d375a", "ref_doc_id": "aeb8ba79-baba-4ff6-af11-0b792ece2cd8"}, "175642c0-4626-4118-a744-305d372f9fe3": {"doc_hash": "ca438c6d32819b531df92f0f403d2001a67d29171d2feee294d3192ceaaebc91", "ref_doc_id": "0d9e8793-6891-4aa7-9231-8f0425b74ada"}, "e0a0efa0-5b9e-4882-b549-ad60f1eca4cf": {"doc_hash": "26b0fc26c1ddc20b6a1f0186cf38c359dc1b7fdc78af9cbd40851d3aef12db0a", "ref_doc_id": "c516e149-81fe-4c9d-b33b-1cd9405d2a7f"}, "1dcb0171-24f2-4b02-a7de-6fb004bb7f9f": {"doc_hash": "bac1a18527411b9b638c928e5425f9316bc11bba0fe3525021a6680fa61967d9", "ref_doc_id": "4bd96e82-36b4-4fa4-aeb3-73b90edde45e"}, "789d0713-1183-4351-ba77-c953fe2a1db2": {"doc_hash": "af629a22517e59e1c988164ee3a27ac9a2a980848af5016520c4edc1d1220fe4", "ref_doc_id": "b7872f07-08fb-41f6-bb4b-01043cdc3776"}, "d5d3a7f4-5aa2-4104-af7e-65512d0a9611": {"doc_hash": "3a31d3935341dd9061bcba6227f979d3bb1d373a4a263a84c3ab8f212be8326f", "ref_doc_id": "70118c48-8006-4642-bdbc-650a44838811"}, "4e6f42da-3bf1-4aca-92d3-e4829cdd2ef5": {"doc_hash": "13959277cfe755bcadf16d226c0f637e06a3dfff8f2add53187c9645b8364322", "ref_doc_id": "f5ab21c7-4a41-4218-83e8-8d9d0a0a9720"}, "183f8f70-4808-4829-83a0-384890479e57": {"doc_hash": "4e806c395ee4d23a6822549586d2d734351e632bc2f579181b4ee7ba20159f9c", "ref_doc_id": "b9435c82-af16-419a-b1a4-d8dde3b52a61"}, "9df3a1be-5cb8-41ae-857a-4ca3874a1fcc": {"doc_hash": "d743f398f6a08af07fbb33c9bf89c49130c68d1ca1895c20168a9126d51eb14f", "ref_doc_id": "695e7042-7851-47be-9245-39cbb6e62990"}, "2ca5fd7e-f431-442c-a080-e7b0e7aacb4a": {"doc_hash": "20d3393ef3599321002bc6b99e56e9ebb5c2a8d9f80abc283c392ae801edb7de", "ref_doc_id": "2f40d532-aa3b-4cec-9c92-b9b86ab2761a"}, "ab409f11-bc92-4a6b-bf15-dfc6c034299e": {"doc_hash": "3d87254c425f8d0f1b05311a514afba82b07b6957951ffbc27827512c16f3591", "ref_doc_id": "ad2a7a4c-d6c0-4249-9727-20cedbfec3ad"}, "3dfe89c7-ce20-49e6-8cac-d3775bb68220": {"doc_hash": "a337c28e1fe1ea660ed4149214cd075f439013c361fba2cfb6f77cb28064baf4", "ref_doc_id": "f4a588de-9a68-4282-9e49-24f8e0684dc9"}, "8ce5a58f-0e32-4be8-8b82-438f794750f8": {"doc_hash": "938ff9b86be13b03783063d8d8e6dad5000b918839c3b9a3b4b26003363399e6", "ref_doc_id": "7622fc68-037a-429a-8112-e6c7981b4385"}, "b0904091-99d2-4d1b-a59e-36d83819c48c": {"doc_hash": "0529f2f2ea1948a05422897bcb607119ce4d7441146b2d749b9e80ebbc5b9ad8", "ref_doc_id": "cfc0b404-7185-4d74-9a7f-c3779acdf1d0"}, "c5824f60-7629-4259-bf52-a475329a1eb3": {"doc_hash": "12d299197f43141618e80b1a900f2d27f62caf1abde241590c056c66415863a5", "ref_doc_id": "6d4adbf4-53ae-48f8-afa7-cb29e2b56221"}, "3e824c69-1d60-4623-8f9c-98e57f83839a": {"doc_hash": "7896752cb4fc13cfe00f615e86dd6c2e8cfed71bc5559a28786357074b388530", "ref_doc_id": "f5171a67-45ed-4f46-87fa-e735da6bf8f5"}, "96a05e0b-24ae-40a9-8246-d029a7fb792a": {"doc_hash": "10ea80e0f3ae4b6fb097510279224f8964f7fd1f770f5934b89f3f6ad100f31b", "ref_doc_id": "ab886341-ca4a-488f-b6c4-b8566cccb408"}, "8a46a8b3-7569-42ac-8ffa-268ab0c68b91": {"doc_hash": "04799dc87b50fe03ce9116b7f1c6453ba70d3644836d13c97d23c08f16e1db26", "ref_doc_id": "e5142296-fb57-4d5d-8471-8a2429789238"}, "0e9aee42-605b-41e8-aea3-1a2907092db6": {"doc_hash": "69769bfb1b1b89e15de02138eadaa28d724264639c4f17ce35f3244ab26f5bed", "ref_doc_id": "88a79746-b3b1-4930-8de0-ef14e7bac47b"}, "46e9c00b-1fd0-4cc7-b086-d271bfcdb8ad": {"doc_hash": "0e17644e6e27f6985f3978f782aad362c87972d62f7b26ef57819ea6c1a4ff53", "ref_doc_id": "fefeb2e4-fa50-409b-b273-9a55d090854c"}, "e7958613-e73b-426e-9cc8-a0daea64c468": {"doc_hash": "6dd2bd8ed2ce733b3967df7bd54d75eedf9499d7e07d9ad22364ee5fe6877f05", "ref_doc_id": "dabfb1ec-1fec-423e-9e17-6a4a84193b0b"}, "49a5b01c-eb79-4cf7-a53f-6f174629191c": {"doc_hash": "d1056c3a8d41c5b28bc80e0736c1c73a2f00a6bc9f1d0645093625c463e92439", "ref_doc_id": "47d534d4-569f-4124-9961-a543051103ae"}, "a8315963-f5c3-4921-b1fb-e1c3c85d06a9": {"doc_hash": "64ed353de080d996b0a1d84d6340676cb82f5dfad6593dcb0d3868732d931e69", "ref_doc_id": "9213abc8-699d-4d6a-b9b5-3c0d30d9c5e9"}, "a2399b5d-5707-4db9-8dfe-4fdae3981326": {"doc_hash": "35cdc07c69f173610c29ae043d6ebedc7316a87da5a28843c0ba1b50b94b24b8", "ref_doc_id": "bd124f09-adbe-436d-9c99-1a05470cc56d"}, "ee7f5154-c2e6-4a4e-87c5-8c2b1e39b3c3": {"doc_hash": "dd7f0c95ec5b08a030130cd9dd445b7640fef36e1b2d067cfa8915efcc28e5b9", "ref_doc_id": "334260e0-0bc2-4ef8-8466-e6c09bf5c427"}, "0f6dd000-5b1b-464b-a845-dd3eccfb6be6": {"doc_hash": "7958856b53fab9239d86324804498c51c7e66a0a399e7149372fead20dc0333c", "ref_doc_id": "a02d10cf-7961-4714-bca0-c2f0057e0be7"}, "7a1c1630-b72a-48d5-baf3-338ec7dcf53b": {"doc_hash": "031ae8cad97edb947758054b2537b8cf2f0a9b1a65ca951d27633fa0b94779af", "ref_doc_id": "9ddabf22-f972-4a1a-87ea-f255e5d173f6"}, "3bf1aa97-37d3-4994-9dd8-d13e884ce487": {"doc_hash": "0d50a5b835dd89e920de12e6d39021ba7c9835730dab3be9a07aeb47c88a426a", "ref_doc_id": "14dfcf1c-bfe0-435c-b92f-4d541b041a13"}, "3271bb74-d320-4319-b1bf-aa97724fb697": {"doc_hash": "af1e517a60a4179981ec557969cee4ced7069f0e324800a5a82e32c00303202b", "ref_doc_id": "aea476da-fc3b-4f90-973c-6ca78b1f3f4e"}, "231b76ca-87f9-4c38-bdf4-f2e4a390f8cf": {"doc_hash": "2b1be58f21c37f30a07e807dc360a100d33244c629829bf480a1aa78efd7827d", "ref_doc_id": "d80db5c4-9be7-49c9-b200-ef5ee39ae91f"}, "70873e6c-2c82-4328-8249-277958021442": {"doc_hash": "04340455c749be9736a2bb36c495f8852940e78b6f55b35b486a9e16aa87eecb", "ref_doc_id": "f6ec7068-4cb1-4aeb-a6f6-3e063d9ecf22"}, "e7911243-ec7c-44ab-a314-2ed64ded7910": {"doc_hash": "d28e6ed58cad25c92c1515d1e586fea0f57d7717d7a9bdd4672523bdf0fbaa71", "ref_doc_id": "eb69c7c3-889f-40d7-90a1-803c125e3873"}, "786219fa-d603-49bd-9527-0c901cbf5fd5": {"doc_hash": "f39d4a36f5eea9f0db34d3c2d4fc8ae536b9dc2d95da7d6b9a2396e53ae343ea", "ref_doc_id": "296186c2-9202-48c5-b70c-3294eaa81af6"}, "270db915-93a4-4aab-9a3a-091112acaf8b": {"doc_hash": "a462afe5bfa9f8b8cff9b253fa0d80e11dcf566f45f2e21f7cc24ff8d19dc640", "ref_doc_id": "cfda448e-23be-4c3d-a72d-943b7ea328f7"}, "53f57b99-b6ff-4d9a-89b3-ee6cb358ac82": {"doc_hash": "5574f7e6c6e02c66b374defcdd20507c91c51c280a45edafe0a690c40e978fab", "ref_doc_id": "2a86203e-4954-4c9a-bf58-886c2274a6f2"}, "e4ed45f1-3a53-4927-a26c-79070a591d8f": {"doc_hash": "293e417faa956187c236f41d7e485fc75a74085fe1acce1ad0fcd5b222bd6531", "ref_doc_id": "65382a9d-f1b6-4134-9420-99e6e3515f21"}, "decafcd9-a7ad-42af-b737-646cbcb31992": {"doc_hash": "cf1bde2ef6faded70db9b9dafd670e6c93b7c0924173d2feb87f651fbafef5f6", "ref_doc_id": "7c81ecd3-1852-4c8e-9e59-52c4cc960c88"}, "8c34cecd-595f-4fc8-9270-26719b594f91": {"doc_hash": "be6906b657ca8b1c9a43bde3cccb29d7dff19bfdcbf7b76f36e55f1b93968cae", "ref_doc_id": "d13da3cb-9445-4e9f-bc4f-4086d3094aef"}, "5d0d9326-2550-4a4d-89e9-c70e2fc39a8f": {"doc_hash": "54062369d290cc5069f0ab46a9916af2cbbbcbc1bccb7ee4f28bc8543b8f523e", "ref_doc_id": "f3e2be62-9905-4c69-bb8e-e82dacfb0172"}, "cee5bec1-7ae2-4523-8370-b0e3acb635d4": {"doc_hash": "869e8e694b11ac6c1c87f1ba0a542c85f20695fab2006995eb3c3e7e72c70400", "ref_doc_id": "fd117434-8cee-451c-ae80-6cdafb89ab36"}, "4c926c00-6f3d-4aaa-a306-98c7a214b943": {"doc_hash": "458a2e4b59f4312f6688f7ae74f99505e69413ea75eade1520d2d709eb8d71ee", "ref_doc_id": "46fab903-bd65-4bed-89fa-4215915b5a98"}, "de2c544f-368b-4d19-879b-930644291fe0": {"doc_hash": "0e89c6b1ff6bde946374f93f8e100ebc5f18d5b070b1fbb277aec2085a78bf10", "ref_doc_id": "53388152-0495-4488-b81f-a4f44c519302"}, "b34d8286-f02b-4765-aec4-e91982f1f0f1": {"doc_hash": "6c3fe51029f6e970a9f2a5e1786e569669e7419d7f195a80243edbd27fed097d", "ref_doc_id": "969aa1b9-3650-4098-80cc-d4ff65a472c0"}, "a98b9bf7-8fe5-41bc-a325-1073f7d138bb": {"doc_hash": "42ce25fd44cc2d70e238bcaa307783a0ca8d8f61a4745fcfde112fd2cc0fabe2", "ref_doc_id": "602a1312-e439-4400-9e75-7ebd57787044"}, "af1e9418-850b-4839-b21a-ad775d4b9ac8": {"doc_hash": "ae33c2efafb7511098adde3fbeb8da686e4cf39971db0faf0e8ffe67b13dc9e4", "ref_doc_id": "6081da8e-5f59-4c95-8879-f2d8e6fdf693"}, "5614989e-d57a-41a0-bbdf-95ba30b37926": {"doc_hash": "afc67abe85b1cb00e6150f4fbc7546a63229fead605763507db78de4c964b2dd", "ref_doc_id": "09902bf0-884b-42b0-855b-0814e8e38eb3"}, "f2e206dd-63d8-4640-92a5-407f2680c750": {"doc_hash": "a7d81d325e8c6ac31036ca47950d6fc1131ad39bd1a18ca5be88ac31fe05374e", "ref_doc_id": "4e5a221c-86af-4c7f-8ab6-fcc8923bbec8"}, "34b6c13b-019f-4b87-836c-23d06bdbef7d": {"doc_hash": "db9e64b12b4f35488de3e7bc37e5f9e0784d9ecf6a25cf2beea4dcaef0d69605", "ref_doc_id": "b3de2038-fb5d-4cf4-92fb-c52b2d5053b5"}, "f4cf3d1b-566c-4952-a176-f3166da36fd6": {"doc_hash": "5210203bb3fcf47002d97ed2c4028c9f81d48171e94381a735de05f224fa7c78", "ref_doc_id": "5d6094d6-5229-4fda-8bdf-5b54ba3281ad"}, "8d0cee87-b5a2-4417-b4fc-7558ffb81dc8": {"doc_hash": "3a6f96e2ebd1eb70ab2ef9c45201f62622811aea0a6d656104981f6f244c3f0c", "ref_doc_id": "a375168c-7ef6-43d7-baec-d629602c2e61"}, "cba00c07-eaa7-41a0-bf39-df29f8eddab8": {"doc_hash": "da33e42ecaf3aeb9e644065c7384b6444cee6f5b43e2e4678008e9ff40ce1099", "ref_doc_id": "a873d01a-f583-45a5-9b1c-0acb4b421302"}, "96c30dcc-d977-4855-ab19-9c693d625c97": {"doc_hash": "d46bb76fb897e8f146269b26f3952ced20e37c1692c2508d59c8e0f0732436d4", "ref_doc_id": "d4968a66-01e4-411f-ba47-88438d7131bd"}, "2b21fc6f-9259-48c3-b76d-71ecdc31ad80": {"doc_hash": "d2f39af8d5dd5c1a805089e8ba319e610a00e94e649a3a72d23c4864cb5c51f0", "ref_doc_id": "f198b2e5-6c47-4fec-8bd5-0f38a5b74b0b"}, "aa1b965b-7594-447d-8739-1fa0921944b4": {"doc_hash": "600872c562cf499189711aa669f5072bf12510490b2a7dc20b7c69de6817ab12", "ref_doc_id": "5b853828-4e4e-460a-9d9c-adb26ecd020d"}, "209b87ca-d3f4-4855-8c70-c3d0459a60d3": {"doc_hash": "5b9d826af98a92c5c9714872ee3c5ca394636014912213d73257a9a2c1ce407e", "ref_doc_id": "9e7d6bd3-f4d7-4f43-9080-fcd97e581879"}, "8702b66e-8c54-4c62-94d2-fc03909384a6": {"doc_hash": "d5074bf447503509ae387abf7eba723749f2f120a61fa41fd3521444a2387707", "ref_doc_id": "de7af606-e05a-429e-82f6-46659b800759"}, "d2c7809d-15d0-4810-bf2b-658e29f54d77": {"doc_hash": "88685dbb399fa692b6918c950ca6be05d60c96b42f0b5ecbd443b9cde08a8c03", "ref_doc_id": "48e56db1-a34f-47b0-85f7-f8e0d4a498c7"}, "f8b5e776-a7c7-44c6-b6b9-0b88ca2414ea": {"doc_hash": "72e0ba14f41e620696ea648e7fa072df76b5bbd12cbc938c4b68891cb39333e3", "ref_doc_id": "8ec066e6-b23f-4efe-a5c0-1c29405acbd8"}, "af706123-e945-4102-aac6-8d5c5acc0fb2": {"doc_hash": "a09924d7d562e0f46e2fd270afddcb2996de4eb89cb066de41c581589c75c525", "ref_doc_id": "eac67285-dde7-410e-a8bf-9ed7417ab0fd"}, "8e28b912-eb4f-44ee-98b6-c730092acf71": {"doc_hash": "78a66a58ccc0f94381562542171e22c40a6e807188dd01aaf979719a9c0fa0ed", "ref_doc_id": "240c6a92-ffb9-4379-8cc3-62c3b9bb6797"}, "f338f187-d88b-4867-b03f-cec8eb12f316": {"doc_hash": "ec115deee15c2d32e9a92af4075c6df005926eb06bfd2a591a742956a32092d3", "ref_doc_id": "7184ef01-821b-4940-8b97-77f57740fe36"}, "5bea6282-f6b4-401e-9664-710e05e3116d": {"doc_hash": "f8db856d8ea10d7c58b396c2b7b808ec9ef1a81036f24efd1fcf9db2641a7ca7", "ref_doc_id": "e9575dc0-b5d3-47ed-a1b1-53bd518d6b4d"}, "787dc2a2-10f3-4b51-9d45-68138174030a": {"doc_hash": "56fd8bb094894776301b20762cee3bbb34169fc5a3d2eba2d022c2fade202561", "ref_doc_id": "168da124-b2a2-46a4-a21c-6756a475ad72"}, "5ec06432-240a-4da9-8143-a0cd8d1a0c85": {"doc_hash": "b559bec330e252807a0d58d3c7ef49dc7590cbf4014ea1a8180a11185e4e969b", "ref_doc_id": "6372dea5-5c91-4cbc-b6c2-99db1f1ad824"}, "29ce71a9-59b5-4343-b873-662254de2f78": {"doc_hash": "4581cc53363d8075fafe1a912ec36cc97e2624c1101ea3960498091b254146b0", "ref_doc_id": "eed29472-a58a-4c50-bc20-6c10b3cf4b06"}, "1ba84ce9-5faf-450e-979b-b658ad6114d8": {"doc_hash": "a3136f8c388067b5035c08eb2eeeebe0e2bb6ed6f1daecb94d59fe82d47761f0", "ref_doc_id": "e9618c84-17fb-4d63-afde-315af3ee7994"}, "643c4898-3826-4ded-8a19-b9834a6d6b34": {"doc_hash": "23eab5ed8560c8f8e20b3123d1856370972bac0d89e07ffe3eda033e2a8aa4c2", "ref_doc_id": "766d11d7-0ee7-44ce-b991-66b9b044c35c"}, "a828ceab-c5c5-425e-ad47-179c14f6d5b4": {"doc_hash": "94ed7448865038694480c32139f2a922d7db0f56995a1e9066c89b1938340ca5", "ref_doc_id": "96e540cb-c8be-4391-b8db-a6e7362b8bed"}, "2e7055be-c0fd-46b1-accb-70dea0636a63": {"doc_hash": "be337bff05d249b813fcad7f69f007c54118da5d4e78ef24e51a9c9e8e95898c", "ref_doc_id": "093142eb-5b44-41bd-a7e0-0fb9c67094fb"}, "c5bfdf2f-0b87-4b46-9af3-33b88b64f94f": {"doc_hash": "692d6bfacd8b9d74a0d5abca84a7d4ecd32aed514320d4ba2819d7b8657e3d55", "ref_doc_id": "3c18afb4-9eea-4a32-ac32-fbe38fbe01cf"}, "8d762f62-ac38-4d08-8471-fe070575324f": {"doc_hash": "b35f34e910de10691453d0acf12fad63e04d902b59b36ca0611db8f68a9cbad2", "ref_doc_id": "47bf9623-b0cc-4780-b5f7-98913aa5676d"}, "eb6cfab6-bd4c-406f-8bcd-f324d90a7350": {"doc_hash": "736767d24054a7275449c102911b6731f967b48e1820183f35f78db480674d84", "ref_doc_id": "47275007-5bd9-4bd2-a364-a46daf657f56"}, "a8659176-32d2-49b1-bc2d-ec694be160fd": {"doc_hash": "89d921f0c99ba5593d2c8f968f742a101612fd2139830e86e16355685d5d50da", "ref_doc_id": "f16e9867-3d7f-4ab4-b0a4-730aa8ff021b"}, "c4e78711-331a-4361-8601-23fb9360a85f": {"doc_hash": "f0322ee8f0fba019fe7fbd6d0c3657cbd9603871873980c444b9f1429118955c", "ref_doc_id": "8efc1757-450a-4101-85a8-6a8ac8a7cdc8"}, "e347eb9d-6f30-445d-a891-1bc827ec9a39": {"doc_hash": "c5c993a978146608a5040b101b8e8e6ab57f2de99931ba1ffc7e2eb3cd936e14", "ref_doc_id": "b6eb5b1a-cf86-4208-af68-778b22528b3c"}, "0709621f-d709-460b-91cf-cced4007ec7a": {"doc_hash": "328d95d050514c9b6a768be187b79d2e5769c848ec0defaf64edf87b7347661f", "ref_doc_id": "17ce5a05-7749-4cad-94d0-e2a035a07589"}, "c287223f-b131-4946-930f-f79a72e07312": {"doc_hash": "5b56705a3766702c20ff00b8bb33de35784790b4e87ebd076b2656be42be45de", "ref_doc_id": "865dfd3d-082a-4c13-ba8c-d3f94173a2e5"}, "4c0c6d47-e60d-4e66-aa81-475d109c75ad": {"doc_hash": "b7fe40cd32791db2bb4160b472b31f8527b83383c11eea818286de8ab7307418", "ref_doc_id": "41b42745-8e37-4c18-b9bb-f5546abc7ca8"}, "17776516-d1c3-4f70-8502-47dbef9b7724": {"doc_hash": "e04a235f1fa03ad32e8cd2d0b65a15fb03b7b80e0f93b67ccf0421f8246fbe05", "ref_doc_id": "2c4b01fb-9624-4039-a5c3-b9601afc5505"}, "7d04c8bb-9181-4a53-bbb5-29fdc992a8eb": {"doc_hash": "bee00d569fb8240d30b248dbb81d8bacdfbc566f6f01434b0f7d2db4eeb0546f", "ref_doc_id": "fcd73603-c506-4c9f-b171-88e41786b6fc"}, "56e906c8-6ace-486c-bf8a-17fbcf8d44b0": {"doc_hash": "3afd858b89772cd261ca5c428d729e4a0eafdc59d1fd436b711a06dec26523c9", "ref_doc_id": "ace1e287-3f72-420a-925d-cb07dcffeb41"}, "0e2df1af-42da-49b6-aab1-ae19252779ed": {"doc_hash": "7898c5d8eddc7b4a49f4fc64d5628b32792bd39854f74e757f915a95671948dc", "ref_doc_id": "886dbe1a-cc89-4f6e-b87c-3cccc957e758"}, "d874027f-1aa8-4661-bef6-5bde8274ac6e": {"doc_hash": "b86451d2b807435e243e1ba4e80fe9dec6f8afe9fdf7ad16df3f6b31968c2028", "ref_doc_id": "a15f0fdc-e685-4859-a340-c571e43268f6"}, "2b81d68a-82dd-475a-8456-0d21ce25cae7": {"doc_hash": "e6c2b7e1e85394356bbcc189d2c738abd1d765ae15e83c420443ea7bbea97af6", "ref_doc_id": "8c6065d3-4518-4f9a-aac9-65c10b8e7326"}, "c64671a2-d2de-4c6f-acef-7e4086cde925": {"doc_hash": "3baed1d67ee805d8d29ad7ecf48c5cfea2f3380064fa577ffc61cee8341de090", "ref_doc_id": "eaff0afd-454f-45ee-b410-8a34b92ac9d1"}, "f141558e-a89e-4cd6-96f8-f4b718da8a9a": {"doc_hash": "020b80aebf94c6971dccede15e1dd6796764aefe2abcdf47d0eeb4472f08879f", "ref_doc_id": "c2c818c3-94f1-4d70-b757-e0308d0e6047"}, "b1900855-520d-4e59-a351-5586feea8160": {"doc_hash": "b63aa5da7a7adaf4b345cc97d35b21237e5438f7a01b1c4aad75133428fa0ca1", "ref_doc_id": "f39ad70b-4517-4cea-9847-c4c7b96bb20c"}, "35fdc611-628f-4d1c-a1de-d891d598b4ca": {"doc_hash": "327ed7deddd92a0f225919323430f138414d59c9d95827708ab0be772b9453d3", "ref_doc_id": "0b3d603b-6f5c-452d-9e94-5d690fc02fcb"}, "231b0a85-6f66-4535-ab14-f0e174d595b5": {"doc_hash": "06cc3c23a649236bd32fd1d751507ed5399b57526fe9a68aa40c948d10d9bf23", "ref_doc_id": "e16dd13f-d22a-4924-a5cd-e5fc41c962ae"}, "be6199aa-d4a8-47d9-a876-01b02a8383b9": {"doc_hash": "8543e8a218497a4dc7bf7bd99e3b0a636361a5c396c0075b3367c27bde7bf516", "ref_doc_id": "c531c61b-6774-4e5f-af49-dcc479bf860e"}, "c5a7f2bf-a06b-4225-a62c-20fccbea926c": {"doc_hash": "4719235972a73cfb2a6f3cc0818e6cb5c03acadde0676fac938f06f74c65d0a6", "ref_doc_id": "5c89ec9e-8fe5-4fe6-8191-d55b40abb5d1"}, "0376581d-45ca-455d-9379-5ecec6925d35": {"doc_hash": "7fde0363363acebd7453c644a88af977f0b7dc742bfdc5a1c64e2545043077ee", "ref_doc_id": "e97a6fee-0257-45a0-996b-e4003e08f436"}, "80bcdd99-2e69-4e1a-bc6b-2f573bc2df9d": {"doc_hash": "924438f81821e5ca81a27053e31c1301cde04d6c837ef0fc56aa4f0037abe0e8", "ref_doc_id": "7b91c120-fd51-473a-8679-845e77d25a69"}, "e2d3a483-0e37-4d4b-939d-493ac2c03a17": {"doc_hash": "c86367c5ebe22ced6dd4f4d105ff51e659dcd83d3f9e01f7a9b3c11d14092933", "ref_doc_id": "af3394b1-e0ad-4c6f-8797-05f32e48917c"}, "d3fdda39-c5de-4db1-8b1e-d2145af877b1": {"doc_hash": "f8c24fee861a34e66891d512787ee1c8a208772d2d14170775ec4900147d4f54", "ref_doc_id": "7211b10d-5d49-428b-a6ac-c8e52e775ede"}, "833692a4-8100-4efb-9a4c-7056060e3a7f": {"doc_hash": "fd08b5be255dead539d4ac4e5f15f248bbe169ad8563021db5895d01dda78f3f", "ref_doc_id": "6bbf4b1e-91d7-4e0e-8415-43a3e9facda7"}, "d9fda1a9-9628-4d4b-9de6-b658243a0736": {"doc_hash": "d982ce7c99cf53c2211077b06ee603cf6ad78ccab1e37f5a6f1b72252f24e4b6", "ref_doc_id": "ed92c2c6-1d2b-4944-a66c-a3f178c78963"}, "11fcf3af-6add-4d95-a300-416a2c445acd": {"doc_hash": "e9dd730c2aef9d3e39cd242ac223384a658c5f1f44b12c2fbc29f75da6a86ba1", "ref_doc_id": "6395f535-202c-40ae-af13-5cd0750064de"}, "0698bd11-935e-4ba2-acfb-ac38311abe5a": {"doc_hash": "16391ce1c4eaad9a127648bfd62ae626ba5a0f37ba4bad6bc7302e4f37ae3e04", "ref_doc_id": "25251940-a9aa-4a44-be2a-d6d182a6643c"}, "650d2d2f-d372-45ab-b589-fb68418f9bd8": {"doc_hash": "cac95608b6373192a38acca1ae1f54b7c4b764ae49ec84689080ad7354239587", "ref_doc_id": "c488adb3-85df-415f-b162-2059539bd9e1"}, "af222551-8ce6-461f-bab7-7c67511a34b6": {"doc_hash": "bfbd4931dd3f82f7f4790d550f010a14f4b8ca45873dde69f877ef2b10359f66", "ref_doc_id": "41620ec0-17d6-491d-b92e-f2feb3f5dafc"}, "9454e10f-7ead-4d88-ac36-144d9a8d7e52": {"doc_hash": "c9732bbb1960bfecea26778838cc706460fb3a4316e9d6d9f44114216c3c1d9e", "ref_doc_id": "77362737-2019-4275-b843-391f0f66c833"}, "201a64ab-b912-41bf-99e7-4509de01a59d": {"doc_hash": "7f8ea45b280af8bb703701f2ee1b2479d7fa13536cceba875be1aae8422b7f9a", "ref_doc_id": "d4f9f3d6-5264-403b-8ed9-b3f55debc262"}, "e1dff4df-3a33-4aba-b06a-ec7af357dde9": {"doc_hash": "109e951c8dd7253b98951237178993a4e453f4116bb82ba32c18b87b1ac30e21", "ref_doc_id": "d0124cc1-a30a-4d11-b057-b5cb518082ce"}, "f7a084b9-063b-409f-b607-e755f72e31fe": {"doc_hash": "cb23bf514210b4d54fb2cf3a475a542f306725f11acb873793f3e54e16d9dd89", "ref_doc_id": "08ec5caf-db44-40e2-aa24-02749acf641f"}, "e4f297b2-fef4-4f0e-abc5-628924830d1d": {"doc_hash": "52cd59a0ec47624e4ce905898eb222e5939e350b7aa7cf4e6aec1976732da73c", "ref_doc_id": "9464a974-34ee-4592-9db7-80cee722a664"}, "e5ba6a66-5a69-4aa3-8ff0-a7532a9fffa3": {"doc_hash": "890b24218848132cfc5a478a50aa0c8b43fb36c795f9984220d7c3eb68d602ef", "ref_doc_id": "81957cd5-b59d-4b41-bea7-cdce65fa0f74"}, "98cbd58e-da25-4501-8260-d01964be8381": {"doc_hash": "ad115e25d1237024c872cd1e65fe9dfc2b3fc3f6b0b52688942099ab022bd7d4", "ref_doc_id": "978509c9-644c-4cce-8779-41b73b77d6df"}, "305980e2-5d57-426c-9434-5eaf483ed047": {"doc_hash": "c9743d42d3bd486f187bdd00df37db15dd691b876c2132a2741ea14189079be0", "ref_doc_id": "8a4cee62-34ff-489a-b469-9008fdac7c6f"}, "cfa2bb4a-16d7-499b-845b-b6bc3cabe96a": {"doc_hash": "054bfb1627b71d914fe045637efc2df8d1763e54a41afb07a6816a0b52d15b72", "ref_doc_id": "10bb66b5-b2ae-4876-a56b-73b97d570b8e"}, "23ddf73b-7d49-4ed3-9770-b062a7fbafea": {"doc_hash": "f774a3a0051f9bedf2b8837cb3f35d4e7cf9b0dff1760f2c1b5a34abcf336281", "ref_doc_id": "2581dd4a-8231-4db4-a147-21247e3535e5"}, "4cc89f8b-43b1-4519-9045-5016aa95c4ec": {"doc_hash": "06654ef3e7216e57c72870f6274a8a4efe6922d6cb9177fae85a1edd70757042", "ref_doc_id": "3053c4a2-649f-4da0-8b26-58906bb1e2aa"}, "cc6bef92-7b63-4e78-ad4e-6c65a82717cb": {"doc_hash": "5f6f4e651f511ad59bbd2fcfa974c91d31825292bed6f0fce4eb517629b2efa0", "ref_doc_id": "768e62b1-4fd0-47cf-868f-29f51dddc810"}, "263d9f44-1efa-4a9e-9d7c-61a7f9990f43": {"doc_hash": "d7097195c3ae2f9d149d904e5d6c9a842e2a49956df25ab048be14ef19ddd423", "ref_doc_id": "f2fce29c-72c4-471c-9f2c-7aa2905e4800"}, "0f446209-c32c-4fda-8f2b-deea19440081": {"doc_hash": "c14a1b03862906144ba9e946e66588d0fa986d056cf68589e8e79f13e989c460", "ref_doc_id": "1a331528-9e76-438a-9b25-fecde62bfd6b"}, "87975171-4a91-4bc4-bc90-16bf6f4a2222": {"doc_hash": "c44b216dbcb506d8f04dd19edbe847975ac4562334f6ac7c01964adccbe5c690", "ref_doc_id": "64fdaecc-2262-45c5-837f-b1c02a2b04ec"}, "7520ba72-4be4-420a-b59e-316e61182481": {"doc_hash": "abf4c14041a25c927f82e0b219fd2b7d9a6c0b99bf15f5e1b45cf3843b0afe6a", "ref_doc_id": "bfa27bcb-2237-40a5-b9b8-66e737ad0bf3"}, "074883ab-2928-42f9-9b33-3c25018f1741": {"doc_hash": "6bbab592f856a48b8532295ebaf7934936dedb1fded79b23213b55514ca2e31e", "ref_doc_id": "0438edf7-54b4-45fc-92ca-3e10b8691fd5"}, "f4738d78-56f8-4815-90f5-4b367c4353e1": {"doc_hash": "475597bc4acae83f79ddf76cf3244febf27d63dba235bb642316e625f8977906", "ref_doc_id": "c1545690-c03d-429a-9824-919d39e1bb8b"}, "d955fbfe-9da1-4085-9435-a5982590fec3": {"doc_hash": "fb8bc4c0bc7f7a3d255544eef07c89e3113df845f5485e7ff80162c45fff3fd0", "ref_doc_id": "500dd663-ab10-49a3-ba66-1e29de46d7b8"}, "aa9173f8-801f-4b06-9bd4-8362c00e996a": {"doc_hash": "411a1ca55cb79721e440dbd03e2ac1c3853a298282e8cf15e6be186fa95c6651", "ref_doc_id": "19155338-de8b-47be-9b4f-923dbbd478f9"}, "e8567626-3484-4ac1-95ae-ee8f0abc4b62": {"doc_hash": "3ccb5dd3b62f41efdf5fd3283ae2d7804217809ba76afe17e2ac7fe9bc9f839d", "ref_doc_id": "8bfae649-ca7a-447e-b5ea-b4626bbc3cd8"}, "5c466c4c-97a9-4ee2-8816-3b6f4e758a82": {"doc_hash": "8c2d2b49abcab45e16abe8808832fc4067ef002a6a1591a685ee303ff5b2bca8", "ref_doc_id": "9aa7c006-17e3-45fd-8f1a-3baa73580c3b"}, "aba408d5-ac12-40a2-b823-7c3ccb8fd5ec": {"doc_hash": "69bf917d3bab1a4cdaa0e45d50e162718b45019eb4627cacfbeb5b9df9b6ee26", "ref_doc_id": "78881e17-c525-4eba-970f-7a041e68e21a"}, "f9171d4d-e27d-4ae9-9134-67609a4224a1": {"doc_hash": "1b90e8ced0dd57081abafe2b391d5759d794ce2a6afcc876546a42ad0b3c73b8", "ref_doc_id": "3376a34d-1a3f-45fb-9da2-184d1178df59"}, "53786129-583f-4c93-b873-012fcd616dba": {"doc_hash": "2470c6577152855abb9527c3f29da95dad25e6aa8f26e0f2a0c3fee712db3a36", "ref_doc_id": "a9568b26-ee9b-4411-87f9-2ec374d23452"}, "18137675-f1dd-40f4-8b35-f6706b353ee8": {"doc_hash": "8c1f771c612184a3f1fc82015ace07efc4fd9ae3282b2e26ceedf2efd8961995", "ref_doc_id": "d6232089-f1fa-4846-99ab-d09259c97e72"}, "6e1aebe7-e0f7-4695-9b44-8414928ecc18": {"doc_hash": "1697f044940454f86ddd8d1071801985a7590fb6635afa0d68e45dc751cf4b2f", "ref_doc_id": "6462ee0d-7760-434c-a7ad-bb2ab830e4cd"}, "497efb4d-a759-4ba6-b2c2-7b192205b2a8": {"doc_hash": "9f726d355f44536c852d57712f635617eb3e4de8c9d2e5b5c3f71b38606d0c7f", "ref_doc_id": "26ccd585-ed8c-4540-b663-ca78d36b32b5"}, "6b9f7abe-174d-480c-acca-85c9c4d0ace4": {"doc_hash": "bb59575fee8901feca2c923a621e0a577ebfa2059c165b6ebab300c98ef2a7dd", "ref_doc_id": "0872a95f-a12d-454b-8fb5-8fa8a8745c32"}, "c0c227d1-cec8-45be-b95f-0ea75b94a5df": {"doc_hash": "3020267a4f92141ab4dc3ae527f87e6fb225cb0a105a5f8aac6a1da7b6923ea7", "ref_doc_id": "6954f9ca-a7ec-493a-be4d-db893e3fb581"}, "6c494515-3af4-4f76-8349-36d62b63c072": {"doc_hash": "7513840168fd77fd6f5687ff9c6c92ff4741345b8231098f4985cb1e5eff9c54", "ref_doc_id": "01f8ccf6-c17b-444b-b86b-16ca2bd4519a"}, "f8414fc6-d65d-4c4a-992d-67510fa066e7": {"doc_hash": "23351d120e1cd35f484abd39b818f6066ccb5508e512a337c0a5ba442e7e1f3e", "ref_doc_id": "b0573aee-04b4-4eb9-8aff-1b831ea7adee"}, "05327225-a34f-42d9-a578-aba7c65d5074": {"doc_hash": "4e7816f0c88f34ba4024ba042ee9eae4215d1394574fa1c6e633256b8b27961e", "ref_doc_id": "04273a0d-2536-4665-9838-ba4be1315332"}, "3e239478-c7aa-49d8-8698-417595883121": {"doc_hash": "47c67e07c0b4f78a81c967a3658d418f09ce45af2b41234ecac5de4146b53f58", "ref_doc_id": "cb9b74d6-c457-41ab-a698-be9e5117e15e"}, "104d9cb6-83f6-4c8c-8c08-6db97fb6a85b": {"doc_hash": "a8b588eccf96521319401c18b31ef8e99af019f53cc6a78f3c153ef7d51f23c1", "ref_doc_id": "abe218d5-7fbd-46bd-a5ea-4ae4541ccf0a"}, "9d43e97a-feca-4c17-b52d-3b2b6ca5b7a0": {"doc_hash": "dae2143d6f20974d2e00c5551bad57e950896f7641b752a1d803bcd219c81ded", "ref_doc_id": "395498b6-3b64-48e8-a76f-7570241b9d7c"}, "413a90a1-f253-4827-b283-9247329ad9e6": {"doc_hash": "7f8c1e20c28d28b09c0bea474cb60ba31ee57bd3a5e8afa5f810e38fad3880fd", "ref_doc_id": "e22252c5-29e4-4c97-ab69-4d724bf10dda"}, "7edf93b9-48fe-4f62-b7a7-28b6bdb2aab3": {"doc_hash": "97601edee6ef19aa22ee030c3b7c5c77c2c18c9d701c35b2d87fb7386e6bdb53", "ref_doc_id": "d68ce0ac-4b94-4063-bb5e-1b26b9549a34"}, "79794603-0892-49d5-9c3e-10e4e2cebd15": {"doc_hash": "38171eb5a279d17a82e7c3e34f0be9189914812165cc75e9c13f6aa9b82343db", "ref_doc_id": "f0bf4a6b-0bc9-4657-a02b-5f9928d52d02"}, "7451e935-9d04-41a2-a84b-c6449ed72809": {"doc_hash": "e24c9cf63171069b30e2dada39ce134096beada50bde4ae71a33fa3180d27add", "ref_doc_id": "f4d8fdda-7afb-42a4-b263-315c6759a080"}, "bdf99cfc-f558-4d79-a3f8-0b73ce4a93ec": {"doc_hash": "38ae1031d95f59b5831c703b9100fd1258b4703a62e74c00201ad82687147edc", "ref_doc_id": "d3c06c8f-28b9-4ad2-9a41-3ea8061b8bb8"}, "5279ccad-e861-4718-8206-12395116270a": {"doc_hash": "44d8e6308c1bb860cc7c20bcc933ec8de1d14edb50e7479bd9202896c673365f", "ref_doc_id": "5a9186a3-c5b2-421e-bad9-52037ff8f147"}, "06b89863-1436-4597-a041-b380801f74f1": {"doc_hash": "031faa4e16b4b12a9fc883ea9113bc7bf4fe01326957e9cf008b63a80a1c2aac", "ref_doc_id": "414c19d2-8dc2-430c-96da-8392067048f1"}, "0b64ccb6-91b9-4e8d-b385-55c9dd01cdf6": {"doc_hash": "d86ae800efcbe190918cdb187ce51b5779bc016554ff2b92666f229adcb5fbe3", "ref_doc_id": "e634a94d-f01a-40c1-97a9-b40e98f81cc9"}, "ea76787f-43af-4055-86da-e1b6754468ca": {"doc_hash": "55f2e7947d627901f7f4cba50e86f76dc74a624b4dec491c21f47a92d5111e03", "ref_doc_id": "da6b46e2-a30f-42c9-b5df-409135888d47"}, "804fb2e2-48c2-43b7-8b45-a6234b18926e": {"doc_hash": "0f42854f6e39c7edbb8ca9ca0d9e299e69bede018d246d80a741c6c438d16879", "ref_doc_id": "16fd00d8-ae5e-4807-877a-2779a8b43f3a"}, "95f44770-de1d-48fc-8f2f-1664a00417b4": {"doc_hash": "5252b98370390722509117bfb54315ead3698c43f455375eed43bea727dc0da8", "ref_doc_id": "37ad5fb6-fd88-4971-8d40-64f08ff770b3"}, "27015a00-d915-494e-8ef2-f0ca78eb2c79": {"doc_hash": "af5ce9b0c9b2910466fadbd972e6480cfaee838fa82756b711dbdf4bdc178a85", "ref_doc_id": "c5da2eea-0177-43bd-ab5f-96b6c181450d"}, "5b60a166-cf63-4fdf-a385-33d12691b997": {"doc_hash": "b81dadb19997571b6b6f5a40f87be434d600e3e3eb7c3fcc8aa3c837cc1c73b4", "ref_doc_id": "9843dc54-2c66-4950-ae83-07365b0620c7"}, "a6848844-92e1-4451-8d10-2b808b05504e": {"doc_hash": "4134fd0f4be42a7f10ee49607e0961f6e2a0536545446e74c2a540f3b522ccfe", "ref_doc_id": "8539a61a-f8fd-4077-8507-154b939fd6b5"}, "25693c24-7cb9-424a-8ce8-264c489b5887": {"doc_hash": "cde86f69711736bcf4ee85e6cb5ef1c9dc0cef0eb9fc3367454ecf421c2aacac", "ref_doc_id": "445010af-be61-47fa-96e3-7e3311ae92e5"}, "39101dfe-3ca4-482a-8c22-d0162dd3f1e5": {"doc_hash": "d17a8ec303a8cff603d04f0bb611e82480da5326e7e9da68bbb40e996bfde601", "ref_doc_id": "78f83326-329d-4bba-9954-2e47fe4cdbde"}, "f00ad10b-c03b-48ab-9c95-0b97f1cd28b7": {"doc_hash": "8d54cee5e3e27f479a7c4625d4d145b2756daf0344a06077bc92ae5cdc3904f3", "ref_doc_id": "ced2e015-d42d-44a6-9896-5d7d5b6b035e"}, "4fa5e6b7-dfff-4977-8269-e9b61908841b": {"doc_hash": "20e7d3ede98fd68b9770b05add18f261b0a164c05d1a68459fac89d667104995", "ref_doc_id": "28f49267-5c6f-40a5-96c2-761c97e54565"}, "7a97ece0-372e-4199-b059-a7440ea2cc34": {"doc_hash": "1b0196f4a881fef61150afd1d940a9285086f590ec4853db4934803e4af47f19", "ref_doc_id": "27d7d2e1-8b17-40b0-bc1a-6bf7d1d99f29"}, "4f219c82-8d76-4444-b55c-364efed94728": {"doc_hash": "14b5d1c4ff3466f69cbc0e130277b8344bbe38ea7a8aac6d6f2c8ec20de7e227", "ref_doc_id": "16196aef-a89a-4129-a589-8a59cacbe57b"}, "014365ab-f9ee-4603-b821-0cda078428f4": {"doc_hash": "f7018f20959accb06a49a9a2364b78ea0c3076356ab54e653f35fcec1f7b2abe", "ref_doc_id": "2828cf88-22b2-4f21-b1ec-e3b687d57b4b"}, "9d44dd46-a4bc-4271-97db-13d254ce694b": {"doc_hash": "843a4d06f11771c9a0358001f27bf01be62122fb1ed75f25bd6645354a5c7a97", "ref_doc_id": "dda42b98-4673-4f4c-b0a4-eb142ee475ae"}, "65502f8d-7c5a-4f3f-be8e-010147f09366": {"doc_hash": "c9a46da281562cfd7901c9fcf6f48b4072185464297ca9af5ef6b93ac50682da", "ref_doc_id": "7b5f1e27-ce57-404b-b178-75462eac1191"}, "6a12453e-eb58-445a-8b79-805d81253dfd": {"doc_hash": "6e6d6bfcdf235eb094daa2b3bd3813005335ba1fa0290e6286aef85ce56888af", "ref_doc_id": "b30cca01-bca3-4cd6-8b28-ef040cdef698"}, "a326da56-f86b-43a5-9fd7-00e7f557f46f": {"doc_hash": "6289a6d4d99e43a12278144954bbd37d1a735e4da2acffa455c2914e7fda5bff", "ref_doc_id": "3d41d941-e12f-4b03-8278-95934e666eef"}, "7ca740ad-e2f8-4b0d-875d-e4138b0cb3a0": {"doc_hash": "6e6d4188c8292e3282ec799e4af9941b2b00b4c2a819b662a6bd4789e2b31b2c", "ref_doc_id": "0222e3b8-2e99-409d-9dc9-325350e1368c"}, "0b3eff4e-e048-4b88-9395-6f48afeaa67e": {"doc_hash": "99b6ba63c28b5922361f4f694a5820508bc7a2bab14aadb648c2e1eaed366e78", "ref_doc_id": "da724003-f946-4e97-aab5-6723bf41167b"}, "7b476d46-d041-427c-bb29-9f47f9f5d29c": {"doc_hash": "11d39ee6195ddc223953045864f7e651b3a441a96c7454a941f050f385a5810e", "ref_doc_id": "6a23ed58-8ff0-44eb-84a5-86be2329939e"}, "6db9ff3c-3614-4652-9752-1f3b3bb29049": {"doc_hash": "8ad4bd4e9e826240b2f57bb020ca0cdbd770196d6aa575f827a7e38f5da3fd04", "ref_doc_id": "bb70d6a9-956a-42c7-a90e-340138353d6b"}, "cf3113a9-ae5a-476c-804c-9aacab526913": {"doc_hash": "8b482fe40d41efef097894fc37b7e389e8ae33412ad2b29f1b1ae3ebbc972663", "ref_doc_id": "c338b85b-5910-460f-8985-baf44b386a50"}, "73cff873-8026-4bc1-a874-a82d3b155412": {"doc_hash": "f56c8a77e48623d8111cae4cda7ac6a26f4935eb75c7d0b468c8b26a1cc2d2c4", "ref_doc_id": "0cc39450-ffee-4e2a-a6fb-0cf4205ed138"}, "e612b570-77b6-4976-ba42-dbeb750dba06": {"doc_hash": "aadff34f0c7889ca43776d1e6eafdf81960a0e08d3af985245ce90ddd3f79622", "ref_doc_id": "fa97cbc6-dca5-4588-b3e2-5ac343963e64"}, "f139d746-8a5d-4e11-9f17-1061bb5f1147": {"doc_hash": "5e62ed6f1adf2cd32b1357aba8ec06e8696d005611cd4082ea123d22bbac6420", "ref_doc_id": "e429dcd4-fc5f-47d4-afc5-091d24ecf087"}, "80247227-393d-469d-b2b5-ca4c6973aa10": {"doc_hash": "a60bfb7c527c4c99f0b3b4a05fe23b3b8e2822bb8b159cd47b0276c3df6f63a5", "ref_doc_id": "9c5d9557-dc8f-4f83-a3e5-6482850caa45"}, "c186fbcf-baed-4224-9fd6-2b0ad9f57efd": {"doc_hash": "232b5fb091279b298683faab4c856b0cee77d9402a8b521b8e8470c98855aa5d", "ref_doc_id": "096f6d0f-a1b9-4d89-a030-b614f13b0928"}, "02e19e6a-bb63-4d71-a33d-8f5e21a65654": {"doc_hash": "53932b3adecaf8ca94fa650771e7a7b73f5b22c74a4deb072cf4266757e0541a", "ref_doc_id": "096f6d0f-a1b9-4d89-a030-b614f13b0928"}, "3e8e1c22-e135-4c56-9af2-1faadcd33940": {"doc_hash": "c72ac131390ecad57c34aa59aaa689da64ea0c2b044319931325d43da0387a3e", "ref_doc_id": "096f6d0f-a1b9-4d89-a030-b614f13b0928"}, "3fad2f19-46d1-4dbc-9c9e-3b2c1f480e4d": {"doc_hash": "f91ca9a2fa13bd13bd02d727b175a28f601afaf2ecca9c2f5b82b75bd828acee", "ref_doc_id": "0221f21f-533e-499e-8a6c-9ab3371aba6c"}, "9e1c85f5-9f5b-4f54-a43e-414b57b289d3": {"doc_hash": "ea410ce6bfd9eb0305ea364078e0b759f54dd66e2655a52885a0347f2f78d0da", "ref_doc_id": "408c9afc-ae19-442e-b34e-6f4a968be1e9"}, "5e95e6de-faed-446f-8903-adc75c4a2e65": {"doc_hash": "3802a8decd6b3132a1d91ef3d4a414f1d73f71baa16dc64d0d87f676df6c5fc4", "ref_doc_id": "7b198585-0651-4d18-9ad1-2c18c5384b89"}, "179f412f-6314-45f7-8c50-6295f11efb67": {"doc_hash": "5761fd4ebb165525d942b68f74d69ca1a284c4c71ee84361a6cbce1fceb64475", "ref_doc_id": "9030a411-2fe7-490e-bf54-98da9e614fea"}, "73d90f82-4eac-4ba2-a3d3-ace3c78d2437": {"doc_hash": "c6bb2d34406ab5ff844e66eb7af66390497df28f293a6fe375380dddc10329eb", "ref_doc_id": "15ed4db5-c25c-4510-b40a-b888c83dde49"}, "9b360ade-5e78-4247-90fa-fb06d11c8afa": {"doc_hash": "0714ef50a2874e64b91f83176605a50f862b9cb89f240d674a1cfe2549e3af9a", "ref_doc_id": "7e9ce147-1d7d-46b0-926c-8d6c5b3236fc"}, "9ae0081c-a23e-4ff8-9396-333ac53752bc": {"doc_hash": "971fca375b8033a3687d436d5ab61e3d4872ff22d48005c08aa633750ec12409", "ref_doc_id": "5076c786-4113-46e6-af09-3c1065253e6b"}, "d44a3be0-62ca-4398-8d96-5663689ab7bb": {"doc_hash": "4b869e56a38969245bacb4d472786dd01d2bec68dbe80eeb07ebc76173ff6f96", "ref_doc_id": "7b116cc3-b924-4681-80a0-6f2942899ae0"}, "4f4db405-36df-478e-bb34-2b9dbbb4db19": {"doc_hash": "718a10526e7bb21d02cb415e9e468c6aef4aff9c80465c67a78f5f9add26b12c", "ref_doc_id": "c3da7ba5-9756-4bbc-88a9-04f2b9c1d47c"}, "1819545b-84b5-4352-a907-4033433ddb4d": {"doc_hash": "5854743fe376dd6ba6b13ee12b9451b77d8aa0bee93670f83a18e9d49601339f", "ref_doc_id": "6e3ef52f-d2a2-435c-a94e-e183aff702dc"}, "326e2c56-4094-4678-a914-ad50f4a6ddcc": {"doc_hash": "d20dfa5fefbefa2a17485a96ee159429d6c7d5c0f5be461fbb40db3da1197c1f", "ref_doc_id": "ad883cdb-5bc4-4b28-9b53-d45eae2c3dac"}, "b397fecb-f4e5-4db7-8ede-52cc116d9bae": {"doc_hash": "ffa8b12f0147ae18c1ef1b48b80c5d7779bdf860d27d742093554eea4b8f4b71", "ref_doc_id": "6544ec01-8856-411c-87c3-c9fdff15b75a"}, "3c8f6f71-f61d-428e-98e2-ff40229d5197": {"doc_hash": "c5044e252266641025a147ea1c816784606e9c36ddea0b4b6141bfb4ae0bdcfd", "ref_doc_id": "97adca19-548a-4ca8-8bdb-139e790d4474"}, "a21cbc0e-599d-46c3-8e1e-1d708ebc2284": {"doc_hash": "5c2a6e138819c376ea9277d9548abf3d7232542eb184073bfcb03b9aec12bc72", "ref_doc_id": "8d03a7f9-e960-4642-9e43-7e040e6cf608"}, "fb552bba-cf38-4dc5-9ed5-3cc1758e6e7f": {"doc_hash": "88bd9b8ecf5107d4617fce00b1cc32d8ea5ae9c90076448d7f8335a0380d90c5", "ref_doc_id": "80fdd1b4-fd4a-482c-b6bc-21072484a0aa"}, "6bd82d4f-c603-469c-99ad-65b207169256": {"doc_hash": "de16ff39f2fba364f56e91a9c195bd3b4b577ae0a856218ddb6358db2f51afdd", "ref_doc_id": "ba0f64b0-60c7-4bb6-9eae-f330517d1527"}, "1653a7f3-0422-44ae-8c65-a5e0845a9c7f": {"doc_hash": "509b244dbcde7f3145f6479de92eb928ab7df5c69a3fec89804e57e132494dd6", "ref_doc_id": "66236342-c64b-42a4-bd6a-21375720f8d2"}, "f2f2c470-9e4c-4163-a3ac-52b07d62c2c7": {"doc_hash": "d0e3197d432f3257ca583ae4e7287cd1a6b4a0d4e40eaa29470e7e06aacf3cb6", "ref_doc_id": "d1183035-04d1-4881-bbce-bdcc1f90d454"}, "fa3ad50d-aa0b-4ada-8eec-d8ca6882f263": {"doc_hash": "18adf62079546aff1720bf49f4974f2d663351aa02fdbb1a61c87d9c2260dc26", "ref_doc_id": "d1d821a4-265f-424d-a1e9-ba9cd96749ef"}, "0915bb2c-0a10-4aa9-9c1d-0651ef0ec0f0": {"doc_hash": "ada6a9ed5d779a46052f95f32d32f74120dd17d54324f7551f9c1213e913e75b", "ref_doc_id": "d1d821a4-265f-424d-a1e9-ba9cd96749ef"}, "59c90a06-351e-4525-9283-c0eda045c29b": {"doc_hash": "0d6279c260216118bbf25d0fda37719a891468f4f6934c9ac970f98e208174db", "ref_doc_id": "d1d821a4-265f-424d-a1e9-ba9cd96749ef"}, "fa7c69b7-e356-4ea7-94d6-c1a643f2dd2a": {"doc_hash": "657b14b641a5d657c9c9a18ef16648f3685f0512af76316c09c2e22bbc9e0089", "ref_doc_id": "809252d7-09c1-45b4-8e0c-cd17abed0bc3"}, "73912734-e13e-4bbe-a30d-9dcf1db91563": {"doc_hash": "054c1ff95dd2ccea27cac99cdd785afd804c1ef1e466cb4f8bdf81331a3880c5", "ref_doc_id": "3efc3db5-f691-49b1-915a-d33eb89b5584"}, "ca45094f-cb2e-41cc-9270-3a487fc0637b": {"doc_hash": "9e3ca583b914aa6f0b005a8cf4153475227a280f19c69424fe10e36f18512623", "ref_doc_id": "3d7fb24b-545c-4805-b50e-cb64f3eefdb6"}, "8e2ce759-1fd1-475b-84bd-4e16e2674df0": {"doc_hash": "3b964d0b6642dbb6142d5105ca4bf67d12928473788b418831cf1f9decac5a8a", "ref_doc_id": "d5d8e73b-cdbb-4bb4-bd44-5d5061357f0b"}, "21ac7a76-22b8-41bd-a1d9-59fc31ff944d": {"doc_hash": "e643b62354f88e85d42ee4e98a65ab2b4995e8a615cfbee86943ca9381ea6089", "ref_doc_id": "d5d8e73b-cdbb-4bb4-bd44-5d5061357f0b"}, "d6f5c387-1516-40bc-90cd-8548ce468b16": {"doc_hash": "fce3c78a5f6366ea471361c099acdc2a779964f8b86fde4151a95507012cd0c0", "ref_doc_id": "d5d8e73b-cdbb-4bb4-bd44-5d5061357f0b"}, "ad38e77d-e63b-4cce-962d-560a43e7da1a": {"doc_hash": "fa89c53317b5ade65931042391e601022a90bd79b5cae74ac6b6f68c58b6007f", "ref_doc_id": "ea015b4e-e9df-469c-8e4a-2540fd0ce2e2"}, "e2704c23-a290-4d79-8de3-c2757ba9f213": {"doc_hash": "03e574ff9d56e234ba2dcf96712f7170d4106f76c1ca79b3cf8a6f8957b1961a", "ref_doc_id": "ea015b4e-e9df-469c-8e4a-2540fd0ce2e2"}, "c31913ef-e258-4037-bbe0-e848bc864b90": {"doc_hash": "0c558888f5172c0b8c1023436bc88e7d6880be5d7453687847b4775bad408529", "ref_doc_id": "ea015b4e-e9df-469c-8e4a-2540fd0ce2e2"}, "56742981-38be-4dcf-90fa-98533897779e": {"doc_hash": "46a69ab64b94fdbb3dfd65e1446b1fe178f6057e897e92f12dafdf7de0ea99a4", "ref_doc_id": "c0b9c18a-d7e8-41b4-9208-cd94722c46d0"}, "0d0156fe-6c03-40e8-9489-c6edbbb72c19": {"doc_hash": "ca833ed2566829eeb6006d30b10fc83e2131471a4cd3fe20f064a364ffde73c7", "ref_doc_id": "56536342-369d-4ac0-9b53-6a7d41ef9093"}, "d3cccacb-d0aa-4f54-9d35-d51a6f0e5b74": {"doc_hash": "0bb5232e526817073df91bf67bfa3152b44ab284f92c22ee10fa6bc18754926d", "ref_doc_id": "94c39ae4-911b-486c-afb6-ce3b469ab99e"}, "805cb416-9e03-408f-a2a7-708e174b719e": {"doc_hash": "0163fb1396e6f664c301682ea0dc3d723982fc2535279a6a8fc0e744d778fb43", "ref_doc_id": "6fa2d6e4-5d6d-4b07-a521-2eb3ec602aca"}, "7287c845-6be4-4d0e-b36d-68b2b3875699": {"doc_hash": "f6e976021ab43387f28b40afa4cf74d0b20310e8c40424585e86e700a3f784fe", "ref_doc_id": "6c6f8500-d42c-4ffd-9880-6bf8efb96eb5"}, "8dffb8bf-71f5-412d-9531-a16981cc0e86": {"doc_hash": "239a3c19df37d476a79064f08c4b433da7245bf3a04947ca46f2e1df5e1df9ee", "ref_doc_id": "2b2afbcf-c5d2-4f9c-a31c-b0623cfa21a7"}, "43848eed-d46d-44be-ace9-4af55a03b0f2": {"doc_hash": "f4682c189326615eada01342780b79283a4f805f0cf4962c983b2009f218b5e1", "ref_doc_id": "9a87e606-489f-4eca-8b52-5930f9294ecd"}, "6b3cc094-9dbc-4987-b06d-4482d4fa4187": {"doc_hash": "7b4137b3a22436616bbb5f582b87f1c48a9a493f68464a662a124f26a38fd35e", "ref_doc_id": "f3819c57-c2ad-4fdf-9ee5-1a9cebc0094a"}, "3e610083-4be7-4ec2-b526-c86c0f2866dc": {"doc_hash": "6ebe3bf4c16a59d26ee39f3f38dcc6d896e067a528415b3b621a05a1d61d2a58", "ref_doc_id": "126e3063-fd17-40b2-9763-eb9ca89dd3ce"}, "9af7bbcc-5cf0-420d-8925-0a0974b5c077": {"doc_hash": "d7826e3bf197bf1b7501f0316bf14bec2474b1851fb63c9671667a45584f2500", "ref_doc_id": "4fd7aef3-8287-4b77-86e3-e302dd2e0e1d"}, "7e808ec4-48c7-418c-9d1a-c6d7347df526": {"doc_hash": "00a73f31f13de72f4a712f52a8298d86238d03c968e09cddfef48720ca0aafa9", "ref_doc_id": "179f7de7-3417-4759-aea1-5af23e617098"}, "3cf6053b-7f68-4d51-b512-baab4d24abdd": {"doc_hash": "bfe77c34aacb7d453b459a0a9405b96dd34fe0c8f034f9ed75cdc612ad9c202e", "ref_doc_id": "b4c15fdd-cade-41fa-898f-8ce1b3698eda"}, "172c7029-52b2-4eca-a63e-160e141a45d0": {"doc_hash": "10d995800527d9dcaa56f38bd2b98a0a5dea18c5950cad36eeea1953bc9cfc1a", "ref_doc_id": "c348d70a-c948-4bbb-adfa-cd8d0584c6bc"}, "ea62c283-6ca9-4350-84b6-139597832f11": {"doc_hash": "ef574da628a06dbba4867f21a3eb60a8adc4814a4a7bd968c707e75288b22b93", "ref_doc_id": "90f05822-ff9e-4dd6-a16f-74811208cea9"}, "2b478724-1f73-4db3-a6c9-1e2fc3177fa8": {"doc_hash": "4242a1aa04902a78f2c5f8b951db404d78de7174ca0ebc82cd04530d699e9598", "ref_doc_id": "c2cb36ea-501c-4d7a-94d8-57e04e2abccb"}, "7c5b19ec-2c2f-4b2a-aa11-83af1ebb7380": {"doc_hash": "dc20d936e9e6e917a54fd7b006ad1438b7562b530330e27cd3ac43155b18c425", "ref_doc_id": "bad1e53b-3f75-49da-9933-9dfa87803513"}, "35b90f3d-cdc3-4b29-829d-761368747c7e": {"doc_hash": "cbe09d3efebbc9b1b15dfabfe45e79af27d39e17f0744eef196a652aa6fa4e41", "ref_doc_id": "641565d9-5d94-42d9-8bf5-71065e432027"}, "b907b3c6-c073-42a6-ac1d-d060bf159ab2": {"doc_hash": "24208b63a804b77146ff96f14d15c43ca471b42087883d9cb360e8d1f7bffe47", "ref_doc_id": "9e355033-4d36-4402-9ae1-91586cae39c5"}, "99cf3815-df30-4adf-ab85-b18527495274": {"doc_hash": "1e02f69944127439051ff6b869c15c0a7c798189155e4de677b23b7edf405aa0", "ref_doc_id": "d844d938-d107-4133-8b6d-943c8f6882e1"}, "ae12aafc-485a-4270-8cb6-7a6f99cc358f": {"doc_hash": "5336617ad4ec8fb768dc9b992a084aa582a784356786139db8705108d7cb8a18", "ref_doc_id": "466948df-3193-49dd-aef9-5660f2d1b2f4"}, "36535690-c3f3-4b18-be8d-6ef47c81284a": {"doc_hash": "10bc2774c52f67a060f199b77781535317d55766babf72b191fcb70e1898e1a8", "ref_doc_id": "d4ebb80b-57c2-4212-ae89-b7d03fed5808"}, "c6ae5842-961a-4e9e-a470-2430b4aa338d": {"doc_hash": "392cf150b1d6f04b81b7588c763937804edcc65f86b5537c8374f9a5fe7babc0", "ref_doc_id": "e986b28b-65f2-440c-9164-d1771d720e5b"}, "bc1441a6-9e2a-48a1-8112-65ef2f2b0daf": {"doc_hash": "82b57ff865710df3fbebdb75004bb65dce7cd90aa1083e417d4887eb4924badd", "ref_doc_id": "b45fa1d8-31d2-4ace-9dbf-2985acbcc01e"}, "fa4ff336-1a89-4e53-9026-c99c559ad65c": {"doc_hash": "65fddfdcaf2bb7b87865d6302bb63306cd7c7a703ae8108049fb32dae45b2ffe", "ref_doc_id": "b0a102fd-edb9-4528-8813-817a66edb6ce"}, "ad927f5d-f066-4176-9c71-b426db155b63": {"doc_hash": "690d258f4106c1ac20da680d56c044895f8d988e74a318c8d0f1d029ade5b888", "ref_doc_id": "0d9ab629-dc3a-46f4-a4f1-b274c1d61ecc"}, "ddadac37-e15e-4cc4-bbb8-e5edc94962c3": {"doc_hash": "7ae591be7f8583bf795b61f377e191ddd02a0e546dad234026b677eb690fb02f", "ref_doc_id": "bbb4e867-9c55-45b4-89a8-110d3cd81088"}, "28e52fc1-9b5b-4e3d-898d-b2dd09d58bbd": {"doc_hash": "8e6312565726fef6aaeefb4b744a77cb0eafce9a3ce9140ea6810d15dc59d8bb", "ref_doc_id": "f76b4f24-17e7-49e3-af96-50f841fa4053"}, "ce0cdc89-a26e-4b32-8bc7-c2f5e118814e": {"doc_hash": "69e98fd3d3e7e606b1c8d6b14604a2207eac6f0d7c25570499813012f4928024", "ref_doc_id": "8b6161e9-28be-420c-9df5-e2cb8f3ddb00"}, "296495c7-b609-4d02-abb6-a7ae55a0e686": {"doc_hash": "52e914fdcb1d2355be183d2f21bea82e6f571df5a46883a75fa2d302df60a944", "ref_doc_id": "6aaba0e6-6fc2-4137-9d93-f9e28f1a8f96"}, "2cd52b86-6fc6-4267-b032-284ac54f2bc5": {"doc_hash": "c86aef899c5fc0e2d0fe6121ee220536abc7d58e105b19e32947e22d56add9d2", "ref_doc_id": "8144624d-fe3b-430f-9b0b-cb7f09d22a3f"}, "33bca0c6-2906-448f-9b36-dcb088d7324d": {"doc_hash": "3dcbec1d043d4cb5a04690203ee681f0aa3d623a5a1b6170c500e14c04482eb9", "ref_doc_id": "dbbd87a3-3925-4eda-b0b4-f6b5997aa555"}, "d122aad4-558e-41f4-9dda-0cc293924b38": {"doc_hash": "79f1296e1577f4f8dd814b8f77bded9cf4efbd2443ac9b3cceb4f48b0af2975b", "ref_doc_id": "be11db4e-3d43-4fe4-b75b-d6fd466fd959"}, "55718dab-2871-4de2-9ac3-ef0eb30823c5": {"doc_hash": "3000dacf3967666eea50ab9d2a4f8c9ec0e13c5125861d3d851f004b001b2caf", "ref_doc_id": "dce594c8-8c6f-46dd-ab57-c708e6af7f54"}, "bcd1e528-6eb0-484e-b615-6e544246eac5": {"doc_hash": "552ff8ddab54d11165168a4f56ec0740f0346993d5bf39af4a2be171160e1c64", "ref_doc_id": "6fd743f9-6b2a-4993-a587-d1ebc3371876"}, "f5d9bf1e-e570-460c-9c14-93f169ec21fe": {"doc_hash": "6fe45a25166a3dd5c6111c93ecd40916f4a697cd358d47aaa379d309e34c3bd0", "ref_doc_id": "73585aa2-0aa6-4c2b-a2cb-d3a7054912ea"}, "33485320-eaea-44cf-93ee-2bcb91262453": {"doc_hash": "f05981aa4c7ce0295daa459bffe3ee2bbf0a4da54f48e4af001d77909f95268d", "ref_doc_id": "1092826d-70a7-47fc-b815-a0fec2eca5a2"}, "d9a0c41b-f874-4282-be09-8c0a144cb90d": {"doc_hash": "441894e35f1d2954cd04063d8d1b74736ec3d5425c227a716a969f0022b15989", "ref_doc_id": "a5dcb2cd-9355-4083-8ce6-cdc64275d3b2"}, "fc2c4993-3de8-4c3b-91a5-6399b0d501b7": {"doc_hash": "4793a5777e6516a6849bb4137a4f9eacbb4192588193be2fa4606ba1d0ed5c7f", "ref_doc_id": "38d2a0d1-c1e5-4181-a4c6-2483b114b7c4"}, "d9cdb572-14db-411d-b9f4-73d5d60af6fb": {"doc_hash": "a1170dfa17a28c88e21f44609a7a7ccac388c7d2c08bf1a48181d8b3cd026fa2", "ref_doc_id": "4d8006dc-bf0b-4e97-81fe-43f3818136f4"}, "34078a83-8527-4793-9161-e88fb1b446cd": {"doc_hash": "7e48d1accf15f23908509547e32bd801e97e0d795c898fc3118248816cf8bbcc", "ref_doc_id": "ec1a898c-61f2-4f2d-aa85-9924745205c9"}, "8e173b85-7fcf-448f-8945-38ea7f373dab": {"doc_hash": "d00e4da6108ef5cc6274cc6e2a935eafa04d9da301bc3263520daf1cdba55d01", "ref_doc_id": "998a3f32-8c34-4aac-82ce-5e09116d7dc3"}, "e5b05fb9-dc6e-4f95-a156-97b3de323d01": {"doc_hash": "8b8ceb20c1ae5d8a5a449c07bdf8f5eb0409009f7f76ec3708b5700767ff12fc", "ref_doc_id": "b0eb98a7-8078-4088-9626-0f0a1a73d54a"}, "4dc97208-bea2-4a78-9841-29ef78f7260f": {"doc_hash": "346169a0b08f6110261df93f58307808fd2c16e6066619f5d27aec04d3928d36", "ref_doc_id": "8ac6b4ec-6c2c-4ce7-a6f3-09940035431a"}, "9d8d3384-d30b-4823-8f86-7f615b3c725a": {"doc_hash": "f7288ef4614a29a2a25508db872a605b69d76b73ed1a7aa31b275656fc829b75", "ref_doc_id": "11193413-5dfa-49ed-b554-659fb978048f"}, "b44c52cc-9444-4da4-a9bb-fc25b0a86e45": {"doc_hash": "e08f116ee7666e296c590cfe38865f26c9a2350c104d31a1a42921664c201404", "ref_doc_id": "ba6ae197-583e-41a3-acaa-e34f13ecd4a8"}, "12ea6f5d-c178-44b8-8c1e-aba71d4e718b": {"doc_hash": "822453318b496f8bdd4f76183e5294f1aaf5cc335a054cac373300b3422cb5f7", "ref_doc_id": "a86d8f41-431b-418a-876e-738034e77aa2"}, "8118a288-8659-4620-ba33-666b97a3cb56": {"doc_hash": "4462f4a7bc32f688e9260e046f37e6ec3404d7d3890055ba59a0c260506280f4", "ref_doc_id": "087c9eb8-b802-478b-a328-100010ddae24"}, "6d6a2116-40c6-43d3-a908-837714912ed9": {"doc_hash": "0384698f1ff97ec414ec08d0ef9d5d793ccb25d56157df6d7e664c11f17de64a", "ref_doc_id": "64c87987-c398-47fd-bdea-9ecb541e4b90"}, "9bc9b730-2649-45ac-b008-0b74f44c5c9e": {"doc_hash": "ae24c33de3798b843b1e46598663f06f45843acfe88af4ec98855ac816569233", "ref_doc_id": "64c87987-c398-47fd-bdea-9ecb541e4b90"}, "ae4edda3-09d7-465d-9a98-18995fd68954": {"doc_hash": "54b1871bbf3d41792bb56acd337d855b0d4c6bc25a4b4d52de4b762195b246e4", "ref_doc_id": "0507fe5c-5eb7-4339-88b6-c0851636e608"}, "d6aed060-8f63-4d62-a893-6fe3e0e50feb": {"doc_hash": "fe1834cd9e686a32cfe85ea6ebebcae8893f81d357f787c299ff188e80b262eb", "ref_doc_id": "0507fe5c-5eb7-4339-88b6-c0851636e608"}, "3985d5b7-45ad-4fb1-a5e3-905b8d881841": {"doc_hash": "f83f03b60974b9836692af19dfef86d59c8f124e167944dd03a8c486ad842ea2", "ref_doc_id": "0507fe5c-5eb7-4339-88b6-c0851636e608"}, "2273510c-3b45-485e-aa6d-1fb84a4dfa8e": {"doc_hash": "e0ae80fd4ff625d9148380e7c37d046ccb077c296ee0e9dbefa28761b4befa68", "ref_doc_id": "0507fe5c-5eb7-4339-88b6-c0851636e608"}, "202b0011-9f12-4828-b7e7-351693fcd282": {"doc_hash": "8fc05c0b17be59ef5df8508ab6dd88445c81ccf1c96c40101a41bc32713c4c20", "ref_doc_id": "f869ac5d-b608-49e6-b0ed-9106387e6c41"}, "c0297a94-d151-40fb-891d-6df53182ecab": {"doc_hash": "1ee6d32b4d6872347809ea578006064a0a8440cc0382f12e6e3de2b62ad26625", "ref_doc_id": "f869ac5d-b608-49e6-b0ed-9106387e6c41"}, "e8a86fe0-30a4-49c8-9412-446acf5b604d": {"doc_hash": "050ba6da3cedd08679a9a4bbff6583738b6860dfc336c79caabac80fc2e30f93", "ref_doc_id": "f869ac5d-b608-49e6-b0ed-9106387e6c41"}, "7ebe1b2f-427e-456d-9d40-3cff421955a8": {"doc_hash": "efeb74b23ffc1f9a601fc61cb690ae26f2d64cc765ea74436e73f57fb46b4afe", "ref_doc_id": "f869ac5d-b608-49e6-b0ed-9106387e6c41"}, "0f2db9c3-2f91-443f-88f1-2b0d16896797": {"doc_hash": "0e9dc01671626ef63e6ec10c62e1a6b90b4af56489bb9dc9152717fe261383dd", "ref_doc_id": "f869ac5d-b608-49e6-b0ed-9106387e6c41"}, "054e0d4f-70d4-40d3-ad36-7470bd64a9cf": {"doc_hash": "d29a4fc111baede4fe8cbfe26f03cae55c80b66d6a46660d884c7bd7bf347c53", "ref_doc_id": "4030aae3-0365-443e-a794-e358776dd6f3"}, "645efdf3-f569-468e-a48b-2927439533a7": {"doc_hash": "6adb801efa14544de600361bb6151cce50e9a83ea91b95cc0ea728add1ab1d4b", "ref_doc_id": "4030aae3-0365-443e-a794-e358776dd6f3"}, "f0d3ec22-99c1-473a-be4a-23d3a4c69192": {"doc_hash": "9298d0ecbc7d73ef5d4ac6333ace7cbcd437bb7b794c6b4e030489635fe24c7f", "ref_doc_id": "4030aae3-0365-443e-a794-e358776dd6f3"}, "40809ff8-cdf4-4867-aa6d-7b1b2678b9a7": {"doc_hash": "81e5810b6a5ec1b99eb4352634f4732d2f6c2c2047e5d67b34720198faa9af50", "ref_doc_id": "4030aae3-0365-443e-a794-e358776dd6f3"}, "00240aa9-6b8e-46dc-8d0e-a06189100603": {"doc_hash": "82015f1e29bd1c101bafcc16e38d305109b27378970f520a4bda7c1a038df8f7", "ref_doc_id": "4030aae3-0365-443e-a794-e358776dd6f3"}, "3fe71f0b-3204-4378-a7f3-d2dc305bf1ba": {"doc_hash": "b0a54cb8773224902aa6c7b6b8482fb0d336833cd1a5332149e82913bac3a34e", "ref_doc_id": "941ae92a-ee2d-40a9-9000-7b2e00b061f6"}, "fc59229f-ac16-43e0-a0e1-7a1a41db7881": {"doc_hash": "effb0ae91f1c0dedc016bb74f1ce9924b0a620df872e4d1eec806e2875612450", "ref_doc_id": "941ae92a-ee2d-40a9-9000-7b2e00b061f6"}, "fe20bc37-aad7-4c0e-910f-e8f60e181fe5": {"doc_hash": "cca6e401c3fb28947a23099cd30a631241999ed1f488e0d55f54c4eb11538c54", "ref_doc_id": "941ae92a-ee2d-40a9-9000-7b2e00b061f6"}, "a4e3b13c-82b6-46f4-8b6b-c344fe41d9b0": {"doc_hash": "b7886e91024e3228856e7244abc8a821bedf785296508565291eb191334e4d1b", "ref_doc_id": "941ae92a-ee2d-40a9-9000-7b2e00b061f6"}, "d09bea1b-2b0e-4317-8539-871ebeeef697": {"doc_hash": "27a4074daa185dbbd08aee60f215d1f351aa252cddebe6818469e948a7b3ea04", "ref_doc_id": "5bd77dd5-0f77-412c-a16e-8fe9bcbd4f25"}, "63bf84cc-6bb7-4880-9da2-a97913db3808": {"doc_hash": "46cb0bbf880ec5b7805f52d56bf31b52f862de359a1228a828e629d9b9b0553b", "ref_doc_id": "5bd77dd5-0f77-412c-a16e-8fe9bcbd4f25"}, "c8a846f2-eb26-4021-8703-a413ba958dbd": {"doc_hash": "989236586333a55d34c455f34553b552c0fd7b5ab31de68c28b82812a7a085e5", "ref_doc_id": "5bd77dd5-0f77-412c-a16e-8fe9bcbd4f25"}, "9de35603-4cf4-4939-9bec-7d9360547d30": {"doc_hash": "a48d3eb71a0db342ccb61b9bed29edb238c3386493c8c62bce261065889f855a", "ref_doc_id": "5bd77dd5-0f77-412c-a16e-8fe9bcbd4f25"}, "af5587a6-2593-4bae-a1ee-5782ba363497": {"doc_hash": "983afd503f61fd52f751a39f44cc9d28487e793b6322c5de056d5b2762c49716", "ref_doc_id": "21c5150f-ba65-4463-b9a4-7b6cc46774d1"}, "18398298-b91a-4ea2-b7b0-f494e0e7babe": {"doc_hash": "91e05ab5cc2304bf3c5971b2b87b6199b4c3f89c21338471316f37f54f58e122", "ref_doc_id": "21c5150f-ba65-4463-b9a4-7b6cc46774d1"}, "fd241010-c07a-4b07-9399-d6a9d3fdcb11": {"doc_hash": "b7e82a23b41328a926dc2afa3041d8604abe7d1c6722c75238082e8bef84a2de", "ref_doc_id": "21c5150f-ba65-4463-b9a4-7b6cc46774d1"}, "0b8a87e9-0ef2-416b-981a-a36595da67be": {"doc_hash": "280aadc0f5f2eb941a4a43c93131529de289bf65fc11176e2935092246aa3540", "ref_doc_id": "21c5150f-ba65-4463-b9a4-7b6cc46774d1"}, "42ab1fd4-ae05-48a2-bb36-7deef6db7bbc": {"doc_hash": "37b0c7f68d241d3dd2c673f11c7bad931ea585ac357f3c43a54fc8b7ad3f7b9d", "ref_doc_id": "21c5150f-ba65-4463-b9a4-7b6cc46774d1"}, "8c9d0eab-2868-415f-b693-62327b8eb53f": {"doc_hash": "0677ca331493623ee23c0f09caa6cdc5bf3fb6825fd71b108e993bccac325edf", "ref_doc_id": "21c5150f-ba65-4463-b9a4-7b6cc46774d1"}, "eabb7bdd-f29d-47d0-98ff-e74dc16139a9": {"doc_hash": "0414d6ceecd7b055d0d97c574d8c4810f0470ea7def6344d1ab23ae0be94e969", "ref_doc_id": "acabbdc1-3dac-4cb0-a745-98ee92a31da5"}, "1753cbf6-6289-4dd5-8cc1-ec396c4e7998": {"doc_hash": "78c9dbdb4bcfbf2521e9348a113a0433967e95bad737c033c281208456f13e30", "ref_doc_id": "acabbdc1-3dac-4cb0-a745-98ee92a31da5"}, "57c742fc-029c-4a52-ac80-9bf123e909f5": {"doc_hash": "0d7bada09406590f9aa150e26105d5c81d2261134a70d0466dd6120264aa7adf", "ref_doc_id": "acabbdc1-3dac-4cb0-a745-98ee92a31da5"}, "6ca95c29-59d9-4177-aba8-976cba88b82d": {"doc_hash": "856c5b737877ab8a649efe993c79771d5656e640dc85b45793ca55d24064ac7b", "ref_doc_id": "acabbdc1-3dac-4cb0-a745-98ee92a31da5"}, "50ad5d94-7afb-433b-9d21-528ed8b432a6": {"doc_hash": "53cada3a28dc3efda5124d657208133ab0f1da11f986de2e81b24717495dc212", "ref_doc_id": "880f2ccc-ce11-4f02-b940-ad9e5fbed360"}, "8477a745-994c-4891-8706-e8cc46d58265": {"doc_hash": "da3c00944cd2a6c424c9481c685445ebec91821b68ac4e198880e4f66b6d4ddd", "ref_doc_id": "c2286310-5d5e-456f-bc5f-07dd356f904f"}, "a301b8b7-9fdd-44ba-affc-b1de97c7c404": {"doc_hash": "761ae2373fceed894529cb284b90c6564985748f86420f41dbe08fd8e89465e2", "ref_doc_id": "c2286310-5d5e-456f-bc5f-07dd356f904f"}, "2ad05135-f727-4fe8-aa0e-067d950d0fce": {"doc_hash": "0119a2e7c45d0c856ee4d4aa9008a8f5bf53665ed615056b7e70b27bf2d85b4b", "ref_doc_id": "c2286310-5d5e-456f-bc5f-07dd356f904f"}, "ae62338e-bd16-4de9-9f42-3fcabfe435b1": {"doc_hash": "0fec968d9be2a72329052ed1ba5bea99b6d348a7c6177efe0f38079e109e758d", "ref_doc_id": "b79e56cc-1fc9-4282-a83e-d131ee3df67a"}, "49e36f9c-baad-4000-870f-8636af293ce5": {"doc_hash": "876423f1168769593d1de42d83ab61c44373a6bdad754c77931591824712e247", "ref_doc_id": "b79e56cc-1fc9-4282-a83e-d131ee3df67a"}, "ac8f5290-543f-4c15-b42e-523d5168341d": {"doc_hash": "94ca47d2ab89850ecc2d93ce282aaedcab531f1378dc1080c73530b570faeec5", "ref_doc_id": "b79e56cc-1fc9-4282-a83e-d131ee3df67a"}, "4793a604-c914-470b-94a3-26f2175d1902": {"doc_hash": "dc4eaf4f366cfd75ecd4c1cfee8a7ecdde19c18dc3afa1488dfa1dfc9c59b36c", "ref_doc_id": "b79e56cc-1fc9-4282-a83e-d131ee3df67a"}, "fabd75d6-8aac-434c-80d5-3a1616424456": {"doc_hash": "1709cf21311410f414c209924ec36e314c802853da99c0bbf4bba19a4b09e710", "ref_doc_id": "b79e56cc-1fc9-4282-a83e-d131ee3df67a"}, "19f8625c-c143-4001-8bba-4b54b49b596d": {"doc_hash": "b495c4b71c9d6eb14bf4d870e88e3e015cb41de5e67643dd5ad51020e651c565", "ref_doc_id": "8fa06bdf-3135-4003-9bfd-fbe0dd9501e5"}, "0cecde41-e8bc-432b-aed0-2b0091456b56": {"doc_hash": "8eb87d08dcf7da9c6caa06f1d22c058869e8c439f67d4ad9defd15b820fa2ea9", "ref_doc_id": "8fa06bdf-3135-4003-9bfd-fbe0dd9501e5"}, "4feae115-4bd7-48b3-bfd2-2298e7460ee4": {"doc_hash": "351744855caf197f2a609e217c06f046edf9aa54f857e10a5a82ba88e664406c", "ref_doc_id": "8fa06bdf-3135-4003-9bfd-fbe0dd9501e5"}, "e00a6891-4adf-48bb-8728-2ed6e8978622": {"doc_hash": "311db32c3cd4cd9cd43c6d264f12f1af3b24df81bc3e784a1279a81d89d3f46f", "ref_doc_id": "8fa06bdf-3135-4003-9bfd-fbe0dd9501e5"}, "e341310d-56b1-4fcd-ad0f-39d4d77bcbc2": {"doc_hash": "a6690a25abc5c6da3e18c4964eb91d5d06024c47e946bd6fdf92d379355f2650", "ref_doc_id": "8fa06bdf-3135-4003-9bfd-fbe0dd9501e5"}, "33563af5-af3d-4204-a53b-24c90e45019b": {"doc_hash": "b9adea1c3f5de411b9d150b9577c5b693fc58655caaa0609178dceb4704c8e36", "ref_doc_id": "8fa06bdf-3135-4003-9bfd-fbe0dd9501e5"}, "4833f9f3-6a2a-45e0-bc29-77cd084ce264": {"doc_hash": "db81b70dc141afdb0b982ac4c91fdc3cda8a81eafd38af4b93a220f2c2d36f72", "ref_doc_id": "8cbd348c-8e10-494e-b9a9-a36551bb66ca"}, "f6e45b3c-5d26-4c74-b74c-4380b8fd2fb3": {"doc_hash": "c0caf03a563b2103aff7b831b7a0dee084e39b0631089c528ab11a569769e727", "ref_doc_id": "8cbd348c-8e10-494e-b9a9-a36551bb66ca"}, "630e35a9-f078-476c-a3b1-81f91bd4df25": {"doc_hash": "d0ac4dad3412b610ef223ee7d25261087d0dadc99b5352f49aa0369f043e6833", "ref_doc_id": "8cbd348c-8e10-494e-b9a9-a36551bb66ca"}, "b176a171-2e73-470c-b496-c03252252a63": {"doc_hash": "6c8a292b4c1cab5f3c49f38ad9187f81e723b37bbc09ca6ad8bff5c06106c5dc", "ref_doc_id": "8cbd348c-8e10-494e-b9a9-a36551bb66ca"}, "e881883f-2b12-450a-a6e2-e089dd7bcb2c": {"doc_hash": "8485d340503f27ba6336d38fa50c4730b8eb7de100836f013cd3fee3bffaeb0f", "ref_doc_id": "6b692a4f-0b81-48ac-842b-07859deb3301"}, "a965164f-649c-489e-b828-24f27b52242f": {"doc_hash": "21846f5bbde508181c667d62833443b5dd389da070cd642c375b2bd28f659988", "ref_doc_id": "6b692a4f-0b81-48ac-842b-07859deb3301"}, "be874afb-a9a4-4e8a-925c-4fb98912acef": {"doc_hash": "2e564e393e1754c40169f3405e1c4c6296f1c4efcfa27bced34088c203404d38", "ref_doc_id": "6b692a4f-0b81-48ac-842b-07859deb3301"}, "feb6da34-b679-4bf1-97e8-12e8068995e1": {"doc_hash": "e09c79c1f6f609f97df3b7d03a26991e122057af8974541aa81893955df8fc41", "ref_doc_id": "6b692a4f-0b81-48ac-842b-07859deb3301"}, "94b73e2c-db77-4fe7-88ed-fe3675652aab": {"doc_hash": "5fcddf65d14c14987910c813ebbfb4d9b5e4254dd440d3535bb828e68e12bb37", "ref_doc_id": "da06ef5a-6c94-43a2-9347-b7d0f6280998"}, "3e60d765-da5b-472a-a5b8-7d6892f092b9": {"doc_hash": "f9f79fbe86baed587691056cc8f02cdfa887238ed0cf31a34e98166796237d8a", "ref_doc_id": "da06ef5a-6c94-43a2-9347-b7d0f6280998"}, "b0df5462-4e19-41d0-9582-29730f587456": {"doc_hash": "f30b1682bef0252bb81a035488fde51c152db01e244d99655103cdaed10e5105", "ref_doc_id": "da06ef5a-6c94-43a2-9347-b7d0f6280998"}, "40d2dbad-fde0-490d-889e-ffa50bb1ee1e": {"doc_hash": "7edf89c9299c60824c6df224b58eb90149f1512e9930d70cffb7c539b09898a5", "ref_doc_id": "da06ef5a-6c94-43a2-9347-b7d0f6280998"}, "ebdc86de-e786-46c2-92af-2ee95a78ed5c": {"doc_hash": "4088307c1880f6bb3b0570d21d59e412cdff930d7e3239389a0e6706564cd9f8", "ref_doc_id": "da06ef5a-6c94-43a2-9347-b7d0f6280998"}, "8eda9e10-5a28-4399-83b6-bc34e233e286": {"doc_hash": "f9d17ea95becbe53d83526fb8e1483a7667ce1e52284027181674f76d1dd3964", "ref_doc_id": "da06ef5a-6c94-43a2-9347-b7d0f6280998"}, "225f51d1-82ac-472c-9009-31722b15eecb": {"doc_hash": "56bbf7232e7db6b21bd0ae568ea43002cdc54ee2569f29a2a135a2d1f0680194", "ref_doc_id": "12171429-7444-4e97-b551-1ea5eed30f87"}, "0d1eba7e-2175-4f27-befd-39e4b87d9e94": {"doc_hash": "9be521450375c22206c07258157a2aa9c3f5f3ca2f2d9548071b760a29c5c610", "ref_doc_id": "12171429-7444-4e97-b551-1ea5eed30f87"}, "691fc26a-704f-437d-89b4-ef01fc7c93ae": {"doc_hash": "28364c4af1cd52b9aabe3067ad9017297b38088f1912a7e413eaa5595516a569", "ref_doc_id": "12171429-7444-4e97-b551-1ea5eed30f87"}, "3d21d032-9889-4ff8-8c7f-0b9226a888fe": {"doc_hash": "ffd7d4f5540d80ac6b3b0a500537283dd97e6290de8baa295bb9a5471a69e60b", "ref_doc_id": "12171429-7444-4e97-b551-1ea5eed30f87"}, "485d5279-275c-4438-8e7e-c592032baeab": {"doc_hash": "8e212cda78ebf3f4773e1e69916251573451a2cd7883d0dc89d4466007536e15", "ref_doc_id": "12171429-7444-4e97-b551-1ea5eed30f87"}, "abd93524-e851-4886-be1f-933c2b83bc7f": {"doc_hash": "3a998acb7296aaa8c91c746abf822ae76ce0eae86511c4b0b4aa401b82c37c22", "ref_doc_id": "12171429-7444-4e97-b551-1ea5eed30f87"}, "87d84eb6-9091-4b08-9905-90d1f2f1b539": {"doc_hash": "2d255a3c0daa41db17f4bf14e43885b92bc82c36ea35dc01abec845872003883", "ref_doc_id": "12171429-7444-4e97-b551-1ea5eed30f87"}, "76b4e163-8ba7-4e42-8876-f388dfb49388": {"doc_hash": "34e2803334d20816e6a5982d8ad77e9dd1473583c333965c46891e216bd6120e", "ref_doc_id": "73af4080-5016-4759-8e6d-3be2198c8d79"}, "760438f2-9c61-435c-8579-363639e9d235": {"doc_hash": "3cb7d61277fe8839b900e89364222f892740e53f9a312db1c5ea512636b83dcf", "ref_doc_id": "73af4080-5016-4759-8e6d-3be2198c8d79"}, "59a87990-7c5b-48c7-b4ab-86cf6c106250": {"doc_hash": "fabcc8b4d627396717f9f27590c624a63e3db86846bd15b7f0b5b1b1af78e660", "ref_doc_id": "73af4080-5016-4759-8e6d-3be2198c8d79"}, "b96afea9-d62b-4fb8-9d11-c5c3a7424d8f": {"doc_hash": "a505166599ded9d7f8d540df7c3e9f052dde20ce71a77fabff4d89a1b924b98b", "ref_doc_id": "73af4080-5016-4759-8e6d-3be2198c8d79"}, "28232525-2e59-4d84-b615-2d94881df3f5": {"doc_hash": "832554511dea5633b1b0917ed55cd6fb2e42df638fd8ff837d634426e795af24", "ref_doc_id": "73af4080-5016-4759-8e6d-3be2198c8d79"}, "3984616d-c373-425b-9ebb-ce6f79bce0cb": {"doc_hash": "6e591bec6bce6ea124419ff9f59b6c4f87c71e9d05b402e0690df83410f0caf6", "ref_doc_id": "73af4080-5016-4759-8e6d-3be2198c8d79"}, "5e69d876-a216-4a69-8181-efc445aed1e5": {"doc_hash": "a7e80963e82e7582fc648361afeae0c92e7131a6718356944166691b9962a5bc", "ref_doc_id": "73af4080-5016-4759-8e6d-3be2198c8d79"}, "e0920a3f-17d9-4b88-8965-d662ec4802bb": {"doc_hash": "178d83235c264fcd07c2f39d718d06fb1a276d77247a874339e91b4f810c2073", "ref_doc_id": "73af4080-5016-4759-8e6d-3be2198c8d79"}, "5b9a3be4-8592-4ff0-9451-0460d9ab61c8": {"doc_hash": "1f91295b5e8394c2178fabbbdd8422fe277653ae8cd64b931ea034cfd1171a74", "ref_doc_id": "73af4080-5016-4759-8e6d-3be2198c8d79"}, "becfcfa7-0dda-47b8-91bc-84b5e1a8ab56": {"doc_hash": "8e4ec209de741c0c9b0afdd9eef688b8902018b6809b5dbca6ae83a8fc75b878", "ref_doc_id": "e6eccb9b-6d24-4d40-8293-5c61181b2125"}, "60779efd-497f-4922-9625-1d656f6b81b7": {"doc_hash": "c377631c88eb78172e04d5c1096389c691e90ea6c7027466819d2f4aabdbe44d", "ref_doc_id": "e6eccb9b-6d24-4d40-8293-5c61181b2125"}, "9de9ccdb-c81d-49e1-a507-d9fad0994f42": {"doc_hash": "a50b80cc1f7ac65ad0eeccb4f3212298e185ffd1aa810400d45a7dc629b16386", "ref_doc_id": "0dbe04b2-f662-47fa-9c46-046ae5317deb"}, "8050142c-8722-4568-b4d6-f075300a8db7": {"doc_hash": "d465e122260fab5c479f3d87e6895634775f8caf8b71733f223cabf5de47908f", "ref_doc_id": "b60f1b52-33f8-4ccd-8ea7-e22a9ae6d854"}, "0243a1f0-9573-41d6-82f6-87ffffb970e0": {"doc_hash": "0ba352ad526ea4f3bb911a9d610fbe6bf6738e9596c3c98f3396fb43a930256e", "ref_doc_id": "b60f1b52-33f8-4ccd-8ea7-e22a9ae6d854"}, "a6463906-f946-419d-b291-997d71031aa1": {"doc_hash": "faed98102835925a4951fa1b63c800547864a79665cdeeb74867f937b94f3537", "ref_doc_id": "b60f1b52-33f8-4ccd-8ea7-e22a9ae6d854"}, "6b77a12b-b2fc-4328-8949-5d144fa93043": {"doc_hash": "c42bfd9fa335dbb1b556499004b7288bf7a46077e15f03f13f5afaf985153cfb", "ref_doc_id": "b60f1b52-33f8-4ccd-8ea7-e22a9ae6d854"}, "1370e093-be41-4dbc-9c82-c39cb96a434e": {"doc_hash": "db3bccc428c71db22636bf62cb49f76ded5f62d073b46c9f22a8630200fd662c", "ref_doc_id": "b60f1b52-33f8-4ccd-8ea7-e22a9ae6d854"}, "0c8684b8-00a6-4ef3-ae0f-1b05b52d470b": {"doc_hash": "558b1e2823f7c8d39d44f05f2d8c97f05bd7db5930628df864d2848fee50fd1d", "ref_doc_id": "d463771d-cec1-46e0-ba77-f8c16ceefd07"}, "d7e14ba6-2054-4637-b894-1908cd5c5598": {"doc_hash": "4bb1e9817ab1567b2ba56bce4182bb8467971b72a827bd8b31d51f5ff46b9ae0", "ref_doc_id": "d463771d-cec1-46e0-ba77-f8c16ceefd07"}, "9575f03a-6cb2-4724-885b-d745dcc629f6": {"doc_hash": "4e4e08f28da8697422ae756c533025ed94c7da28b13cb7da514a14735434406f", "ref_doc_id": "d463771d-cec1-46e0-ba77-f8c16ceefd07"}, "9fc1dd50-d11d-4488-851c-2c9260fc8330": {"doc_hash": "174828a9daf62b36568c6cb51f765351786f3ea05dd7e74cab98629e3e25e05f", "ref_doc_id": "971eabe0-9fb2-4df5-abaf-ae9c5fd856ec"}, "5ba439ab-1d57-496f-96f8-99a0b37820aa": {"doc_hash": "c90a3a042f7a9a820ab1f6d8a5706f3b4fdd014aa75c393420de11d46ccf6a18", "ref_doc_id": "971eabe0-9fb2-4df5-abaf-ae9c5fd856ec"}, "ea04c89a-504f-445b-b7e9-7991fd25915d": {"doc_hash": "8defdf1e92fad6056cd4672261dd721e8e937b185049bd0a451ab46d3d028f93", "ref_doc_id": "971eabe0-9fb2-4df5-abaf-ae9c5fd856ec"}, "7c0e4f7e-c4d3-4524-9024-7a75d2171787": {"doc_hash": "e741619d1e014d6a59ab05805043f5d161b9c2842f633529c619a947af90942e", "ref_doc_id": "971eabe0-9fb2-4df5-abaf-ae9c5fd856ec"}, "34a72aec-770e-44b8-a5e3-97b6df8da356": {"doc_hash": "38c46de02ae7089f5d8326476c1dde480a812afc78cab9ef70793022b6b74b8d", "ref_doc_id": "971eabe0-9fb2-4df5-abaf-ae9c5fd856ec"}, "0306edde-6966-4bab-b44d-22e07b4e3dab": {"doc_hash": "9d266ec7f8a69b08ee16be8d0c42d6c13d6267394e2f69f8274e71a9f18c8ad9", "ref_doc_id": "c3f860a3-59d0-46a3-a1b9-353f455d3682"}, "c57c6886-ab85-441c-ba63-7643aa2485f0": {"doc_hash": "b54dc6714127adaba0a2bbdc67f150ec1e6eb2781d49130f06dea857d19ef7ca", "ref_doc_id": "c3f860a3-59d0-46a3-a1b9-353f455d3682"}, "7719dde6-cb23-40e2-90e1-9c69e67d626f": {"doc_hash": "fbd6e517a8e8751f92784f609302035e63c24d81e07a58e0c8e75089463ad5f4", "ref_doc_id": "c3f860a3-59d0-46a3-a1b9-353f455d3682"}, "9defa700-8b12-4126-b38c-5e61ff36d53e": {"doc_hash": "d2ab69cee0250db4417f7acfb1ad17fb02636c794a770010db8f136000021676", "ref_doc_id": "c3f860a3-59d0-46a3-a1b9-353f455d3682"}, "2f08617b-5325-48a7-b484-22f0c0f4cfa5": {"doc_hash": "fa26bc59953b71e902f78ffba877dad44831294a7424728749126a9f1a167164", "ref_doc_id": "c3f860a3-59d0-46a3-a1b9-353f455d3682"}, "744bd50a-37da-4afb-a05a-44d998562bfc": {"doc_hash": "f01cfe42e5ded0536727b2c0793ee344649bc59661f66f475f9e0399440b93d4", "ref_doc_id": "bcd7dbe4-c15c-4d37-87fd-b310d010f3fa"}, "e426ca88-1144-43cc-a553-fe7fde22a7e6": {"doc_hash": "7fdb4b5ce4de08462911b241f8e46d71bfe0549947102ea45e2dae7fc03e1328", "ref_doc_id": "bcd7dbe4-c15c-4d37-87fd-b310d010f3fa"}, "40a5cd8c-c47e-4f64-b49d-e43d2e3d9620": {"doc_hash": "0d6bcc8cc216a0dd0c642be477be02721d56e79c64208af3d3348c55175e2891", "ref_doc_id": "bcd7dbe4-c15c-4d37-87fd-b310d010f3fa"}, "c05a0bc9-aa7d-45ca-a3be-cfa10cd0806d": {"doc_hash": "3026206a893850f016e747d58591eedeba0267ca097d4855c22702cdb7fab7ad", "ref_doc_id": "c42ee03b-6667-4501-9a88-4af636d9cc2b"}, "48caa830-bf9e-4aca-a414-10fa5328b91f": {"doc_hash": "ac756ac95cd59f72e84949afb3a34e3d8ccdb6e81637f608a42f9107c6ace962", "ref_doc_id": "c42ee03b-6667-4501-9a88-4af636d9cc2b"}, "269984ef-07b1-4ab0-99c1-27ee937095f3": {"doc_hash": "77cfe58203e16169adf638c289184d0ffa36a5630d23f21e7f575cf8121841e7", "ref_doc_id": "70b83907-0f17-408f-9aa3-a41491f453a5"}, "6cbbfdb9-ebf3-4d72-bf3e-a4e48a04a431": {"doc_hash": "6b2fdd8e34f1deadbda7bc98b8f6f292f57f6ef86928ce147a1e58aeabb8ab29", "ref_doc_id": "70b83907-0f17-408f-9aa3-a41491f453a5"}, "d36c1149-f10f-4955-b8f0-2b4bd3971aaf": {"doc_hash": "847e7af936b5ba8cad5d045e2827c940af3809e4f0ad297f5d316facabf1b9f5", "ref_doc_id": "70b83907-0f17-408f-9aa3-a41491f453a5"}, "e388c546-05f5-449f-b03c-92a154aa13e2": {"doc_hash": "1e1fff46deeaf0674944c1beb310f73667ba707d476ba5df42467be6d02cbd2f", "ref_doc_id": "70b83907-0f17-408f-9aa3-a41491f453a5"}, "0c94b2cf-6ba2-4621-96bc-a0c797db27d5": {"doc_hash": "5d7250e13dbc06d7d69a2358b4c84d26c477bea2d6897698e29cc882eeac004f", "ref_doc_id": "70b83907-0f17-408f-9aa3-a41491f453a5"}, "adc45dde-0169-4ab4-a329-d415575ad099": {"doc_hash": "02a90d77e6b45ad23f09fffb3ccb799937a7c953f06849a451626ea9e5f97b04", "ref_doc_id": "c914b42c-19f9-448b-b2db-fd29d8a8c233"}, "4c3eebfe-08b0-4bd7-94f8-e745f336092e": {"doc_hash": "23dc29ba282487ca9008ee206cba030f1935b762b96bab2647284d694609e005", "ref_doc_id": "c914b42c-19f9-448b-b2db-fd29d8a8c233"}, "b1355554-c476-411f-b6be-5948a0604314": {"doc_hash": "6afff22d67b855c70c4eda2a92ba1097fb7ef0440bd985a1df43f3c40acea1be", "ref_doc_id": "685e5eb1-7d50-4d73-b03f-fabdde0ac592"}, "dc19e830-9fd0-4513-a2db-54195b1d8da0": {"doc_hash": "0fe5454728b703aeb7ef4083cffa1d89e4e2f4925bef47cadcb36817e02b09e1", "ref_doc_id": "685e5eb1-7d50-4d73-b03f-fabdde0ac592"}, "a0a99ffa-c7a8-438d-983e-618067a1eded": {"doc_hash": "bd0c222b638a881c8bbfe71ffd9e6354188543919b98d2d7d4aad369ba7bfc83", "ref_doc_id": "685e5eb1-7d50-4d73-b03f-fabdde0ac592"}, "b3c3c55b-56d2-406d-9af0-9f3c92de24bf": {"doc_hash": "7781947ff19470b6146d91c0e59bffb6821e9d8e930576a92d207200dc70340a", "ref_doc_id": "685e5eb1-7d50-4d73-b03f-fabdde0ac592"}, "184f6b8e-6fcd-428a-9519-7969baf5384a": {"doc_hash": "8e36370fa3ba21bdc453d976f8db3558bfc2059d29f724f11506dc02acee311c", "ref_doc_id": "3f0eb595-68ed-4497-96ae-640aaf18e8e0"}, "13094e2a-8b61-4ece-9098-f4c899041f04": {"doc_hash": "6620450116c0fd744dcca3dc037c158557bd1abdb084a03204cef3158f2c6831", "ref_doc_id": "3f0eb595-68ed-4497-96ae-640aaf18e8e0"}, "c8c6991c-4774-4be4-884b-90d9331119a6": {"doc_hash": "237622736ec4758cf4c882c86688dc9e37a9d83ca1d7f845862b52f8d954a98d", "ref_doc_id": "18267c81-baae-42c1-95e9-78fcbf5d4339"}, "5ebdc624-894b-4ea3-b94e-b5c0e6d46556": {"doc_hash": "83ef7d77a7d6ea67570232c615992d1fbe1e91fcca59bdb37573ff1fdd1be190", "ref_doc_id": "18267c81-baae-42c1-95e9-78fcbf5d4339"}, "22e8a381-e726-46dd-b0d9-02c3e1a1496c": {"doc_hash": "0f48e3ae2c7819dc97b0a30a4106090192cc5d8f21161a0c723326358743337f", "ref_doc_id": "18267c81-baae-42c1-95e9-78fcbf5d4339"}, "391620cb-7dcb-4af3-8e84-7c2a8dfe2d83": {"doc_hash": "a570afd8356de05da6665022c93637f964fcea4abed407d29419f1baf50524a7", "ref_doc_id": "216e0901-5b01-449f-a115-69c5d483f0bb"}, "0541350f-072e-4d47-9079-21cdeb46d7bb": {"doc_hash": "ce46bd6d1d92d47bae1029bd728b3287764ef3bb5d94a5e6ab14d3fbd74255c6", "ref_doc_id": "216e0901-5b01-449f-a115-69c5d483f0bb"}, "d905e483-6aa7-453c-b94d-ad35b9b2441c": {"doc_hash": "b77ea0e4c4d18307ca0a39922268ebe008c4314a3b060f8b4ef6d1cd016df5f6", "ref_doc_id": "216e0901-5b01-449f-a115-69c5d483f0bb"}, "24528f9b-a319-4dcd-9d06-aa89f24583f8": {"doc_hash": "5c1e398d78693daa881c59cd0d3b75415690f25d045be397994102999f7c394c", "ref_doc_id": "216e0901-5b01-449f-a115-69c5d483f0bb"}, "1b519fd2-2173-4024-b130-87968de1d36a": {"doc_hash": "7ddfb0054a9aadbf878f603835a8e33134976af5dfa49980ad8eb3f0d59ddc42", "ref_doc_id": "9a527a69-dddd-4795-b429-9cb00ec7a6aa"}, "ba9e114e-bc74-444a-9973-17a4b1c3daf3": {"doc_hash": "627d469506cdc5ab491e9ea8dbdb7d994833174b6cecfe5cac86e3de5aa5c733", "ref_doc_id": "9a527a69-dddd-4795-b429-9cb00ec7a6aa"}, "074f11d1-8deb-4fc7-b98b-49e8dce03f01": {"doc_hash": "36b1e5dbbfc4290dd259217f649eda1e88b5d15ecaeee591ff2a8a6f78a35381", "ref_doc_id": "1b7eed84-f5f9-42fb-ba83-14671a23490c"}, "9edaebc1-94a2-4eb6-9dbe-2c5a732bc7dc": {"doc_hash": "d066e2aae6eea8eb27ffdf277da4c6f150ca502f7c747a8a677bef4647103f2c", "ref_doc_id": "1b7eed84-f5f9-42fb-ba83-14671a23490c"}, "f626a660-fbd9-40ac-9670-bfd406c6183a": {"doc_hash": "4bd37d9ed19937b5cc0c2531f865a4d11de9d9ed206eb736b8c5cd9eeb5ea10f", "ref_doc_id": "1b7eed84-f5f9-42fb-ba83-14671a23490c"}, "51b8894d-47e5-4693-a08f-8d56de1464f1": {"doc_hash": "21503088cdfd347dc817efcd54bb490581387983a5af2ea43e30383a8b39a0b1", "ref_doc_id": "1b7eed84-f5f9-42fb-ba83-14671a23490c"}, "c094a7e3-a2f6-42b9-8a07-dbaa9f343bb6": {"doc_hash": "c7fb469fb039db68a2e7218a4f0a4d6500fe09df705e65128a760dfaa70f18ed", "ref_doc_id": "1b7eed84-f5f9-42fb-ba83-14671a23490c"}, "8611eb7c-86ff-48b2-912a-a070f28af374": {"doc_hash": "230eaf6a8888a2cb5f58650d06929fe6cad33bdf6c2c4aa0e5630bef0259a91e", "ref_doc_id": "29fd480d-1c2c-45c8-a54b-2eccf5b43215"}, "e7f86d3b-cec6-443e-8ce1-4786cbc065e2": {"doc_hash": "0fef49dfe638aa35c18b6b3d4cf8af197fc5f87cf95c7b7215bd9e421c71afd1", "ref_doc_id": "29fd480d-1c2c-45c8-a54b-2eccf5b43215"}, "5ccd14ca-9de1-4de9-9160-33e7e8cda112": {"doc_hash": "9e23d28e125d8bd11f19805e958a0b0e02b7195f98e7149efd1399e0d3c46022", "ref_doc_id": "29fd480d-1c2c-45c8-a54b-2eccf5b43215"}, "a2513c57-cb40-4ac1-b124-eef20af14e7b": {"doc_hash": "5641a5634d001f92d6eeeb0a212a2cdd2037ba32d9ce1b437803b5515d69351b", "ref_doc_id": "29fd480d-1c2c-45c8-a54b-2eccf5b43215"}, "ae982e83-4f2e-4db7-89e5-6993a8bc1ab7": {"doc_hash": "90be4cad9b57765e30bd7e1a2bcbff01ae1195b45ee4eeb639b3a551fcab9b4e", "ref_doc_id": "26d3e909-9d51-40e0-b667-5c5fcd96ff4a"}, "f03f2ddc-4c32-413e-855a-e078f8ed6b97": {"doc_hash": "a896494b1b527af1cc34baeb2d7318ede774d7e93bf709b4d819381c237baef3", "ref_doc_id": "26d3e909-9d51-40e0-b667-5c5fcd96ff4a"}, "f34bd321-25f9-454b-b74b-7689762c97e7": {"doc_hash": "010ef8c293f2aa9405b67add1e77b52cbd6e6d932f42103dea64003b52fb4379", "ref_doc_id": "26d3e909-9d51-40e0-b667-5c5fcd96ff4a"}, "7dd70d5b-5099-4dab-8458-3c51b446b3e8": {"doc_hash": "1c161d438dcef7c48574fff9fdfa55a7b503cf9e077c11a9220bb03609600b00", "ref_doc_id": "26d3e909-9d51-40e0-b667-5c5fcd96ff4a"}, "2b9aa816-d439-4c7f-a219-c717d10011c4": {"doc_hash": "19b093b4602aa7b46747f8eb843d6e944fd1d693c6d72272f7e2f2d4751b674c", "ref_doc_id": "26d3e909-9d51-40e0-b667-5c5fcd96ff4a"}, "3a8dbf9c-f982-4fea-a1f2-b3f8a6bbbb67": {"doc_hash": "2e8fd5f84f1fd727844b6dc300bce1ed716d1ba6cb391e972c056b9ec5701aaa", "ref_doc_id": "8fed0da7-633e-4634-906a-951d151ed94a"}, "a381f8a9-76fb-4fda-b1fd-bae0f2f579b8": {"doc_hash": "6b64e944e7921ec0824c6fdcb2909ed83fc3545c9b395f01ef26d3233be55dce", "ref_doc_id": "8fed0da7-633e-4634-906a-951d151ed94a"}, "7ef2159d-801f-4c0b-8f25-53087d9159f3": {"doc_hash": "0693246b92af607048ecda04a4b4e02108392457db69b6a19e0050aead7a702e", "ref_doc_id": "43c346ac-b7fc-47a6-8e70-96b70c4cf1b4"}, "8db24b60-a857-4c7c-8283-76b17d221c9f": {"doc_hash": "c04c38a45b334fde765f82dcf65780bda68a614e11b6274cf534ea012c5b482b", "ref_doc_id": "43c346ac-b7fc-47a6-8e70-96b70c4cf1b4"}, "7515b8fd-a5e7-43d7-8249-fd4ada1a00c6": {"doc_hash": "4227026aded388a2f9cabb9512229be465435865bc7f78115c1504d75d19c242", "ref_doc_id": "43c346ac-b7fc-47a6-8e70-96b70c4cf1b4"}, "8c236949-804a-41d5-83ec-d1342b030777": {"doc_hash": "7c107265515de6dc9ae3e0b7e2bf48037a030650265763f4dfc38dd2d6910766", "ref_doc_id": "43c346ac-b7fc-47a6-8e70-96b70c4cf1b4"}, "93e4b592-79cb-4281-8034-00cdfb78f2c5": {"doc_hash": "ff63c27f599f3e36f7d159cb1524f2272134d2ef53462ff01bfb4fdc929cc5df", "ref_doc_id": "43c346ac-b7fc-47a6-8e70-96b70c4cf1b4"}, "70e82283-9cf8-427d-bfdb-e1c7393ac047": {"doc_hash": "0693246b92af607048ecda04a4b4e02108392457db69b6a19e0050aead7a702e", "ref_doc_id": "4e519bc3-29de-419c-9b5c-bdd4c91c2171"}, "d6e5d46a-2200-48c1-893c-a6ce5ca80274": {"doc_hash": "c04c38a45b334fde765f82dcf65780bda68a614e11b6274cf534ea012c5b482b", "ref_doc_id": "4e519bc3-29de-419c-9b5c-bdd4c91c2171"}, "c21e9466-59b7-4fef-8323-90eeb9bce0b1": {"doc_hash": "4227026aded388a2f9cabb9512229be465435865bc7f78115c1504d75d19c242", "ref_doc_id": "4e519bc3-29de-419c-9b5c-bdd4c91c2171"}, "e8b15746-d669-471b-b0fa-dea5c264e590": {"doc_hash": "7c107265515de6dc9ae3e0b7e2bf48037a030650265763f4dfc38dd2d6910766", "ref_doc_id": "4e519bc3-29de-419c-9b5c-bdd4c91c2171"}, "6303af92-3080-4860-bb76-a2ec847b7cc8": {"doc_hash": "ff63c27f599f3e36f7d159cb1524f2272134d2ef53462ff01bfb4fdc929cc5df", "ref_doc_id": "4e519bc3-29de-419c-9b5c-bdd4c91c2171"}, "a333f89f-9549-4d66-acfe-0a20c418e2b8": {"doc_hash": "b3e533838f9452be4552787d41597b4d0bd3ccd98c909f4db15671b05d03bf0d", "ref_doc_id": "86de31a0-3140-46a2-b800-2c9a31c3ae82"}, "fcb681a5-a55c-4097-8834-bb1c93f524da": {"doc_hash": "94ece4c039b956b04ecc74b8e21a3f5e1f4416a57fd3f52ddc58a86116b21192", "ref_doc_id": "86de31a0-3140-46a2-b800-2c9a31c3ae82"}, "21c257dd-0ca5-4966-8874-c6cafcd2fc6a": {"doc_hash": "fae4b0a1b3b51f41e54f77a81e605bf738392808a4107fdc8b235323d69adacf", "ref_doc_id": "86de31a0-3140-46a2-b800-2c9a31c3ae82"}, "9837547e-91cd-492c-88f6-0ea1c5b9625e": {"doc_hash": "7ebfaede4a7b4e0f4d49b5da8f9d5799624960ddbc9267de8355233d544cd81f", "ref_doc_id": "86de31a0-3140-46a2-b800-2c9a31c3ae82"}, "f83078de-19e5-4b26-8890-7794f34d9d27": {"doc_hash": "3cf189881c3a827b1fd79496ba17b57ebee59bc7f9e4ffda36337dfec866c083", "ref_doc_id": "86de31a0-3140-46a2-b800-2c9a31c3ae82"}, "2f3aa23c-8afb-463c-9690-062f35513d50": {"doc_hash": "a96471916ae2cdae9502f298f9e0fbe94b5aefb713ba90f0c340e69f02fde813", "ref_doc_id": "5399b3a5-3d94-432c-a51a-6ce1c4574045"}, "87dafef3-d727-4219-ae85-8cc563f3e7e2": {"doc_hash": "1b9f84c7ec8f7b059031e61b75e57ad8f91c161070dd504bdc0b1ec68f4451a9", "ref_doc_id": "5399b3a5-3d94-432c-a51a-6ce1c4574045"}, "f9d820d3-7e2a-4df3-ac94-109a77ffb589": {"doc_hash": "2b40ccb966e2bfbc27dc79086ece6c79daebc810cd0f189567b83508cd2e3772", "ref_doc_id": "90618f92-da87-45f1-97fd-4d8f8dacea0e"}, "28fa33e7-47ac-4dfa-bbbc-7d9b84fcacb0": {"doc_hash": "666baf6918afac152c274e3ee172b11ffbfe5149dfbd74be0da7699b7ed309d3", "ref_doc_id": "90618f92-da87-45f1-97fd-4d8f8dacea0e"}, "1e5be4b9-d434-4692-bcda-f468de0d2908": {"doc_hash": "1678dd9bb33cd91e7cd3de01b1b49c0de068a478edbab1dd822663e903acc9ea", "ref_doc_id": "90618f92-da87-45f1-97fd-4d8f8dacea0e"}, "d1727f3d-941d-4663-8f11-abb822ab3bae": {"doc_hash": "701e6c68ab0de6659282de247ae1847ab2ca38bcd0c1a17f6fa2f528017b03bd", "ref_doc_id": "90618f92-da87-45f1-97fd-4d8f8dacea0e"}, "a4fc4f7a-be61-44d5-965d-b5cf70b91baa": {"doc_hash": "1fff08a40deb86bcf686a6e6f32b66aca74801bedb376f0f26ddb45b962d31fb", "ref_doc_id": "90618f92-da87-45f1-97fd-4d8f8dacea0e"}, "4b14c783-3edc-4958-be8b-c0c0673c11ac": {"doc_hash": "5ad940ecc8a12ecccdd5b9388cf4c592786959ee455d1166c82a35b144dc1ed3", "ref_doc_id": "8cd49350-0a44-48cd-a337-cd75befa1bfd"}, "304d48c4-000f-47f8-b5d1-0bf48bdbdee6": {"doc_hash": "26fc2ccd73716ae094e0e9ccaa7725a1eefd071e6be8dce72c157e0b0def6b02", "ref_doc_id": "8cd49350-0a44-48cd-a337-cd75befa1bfd"}, "00cd7fcf-1025-4207-bdc6-c3134a69fb44": {"doc_hash": "5ad940ecc8a12ecccdd5b9388cf4c592786959ee455d1166c82a35b144dc1ed3", "ref_doc_id": "c774fbac-eea3-4371-b879-8fc57e21f29d"}, "b17811f6-9e14-459c-8b77-88c8e3ca4225": {"doc_hash": "26fc2ccd73716ae094e0e9ccaa7725a1eefd071e6be8dce72c157e0b0def6b02", "ref_doc_id": "c774fbac-eea3-4371-b879-8fc57e21f29d"}, "1e445500-3faa-4c6e-b90f-59c6f6569949": {"doc_hash": "4644cd22122beec52a80fd632af1d2d520b6ae7001b17be4b889eeae46ff5e0c", "ref_doc_id": "2b91a97e-5696-4dd0-9927-abbe78bac3d9"}, "b84f36f0-bc9c-4f2a-a9a8-5efe17f0e80a": {"doc_hash": "6b7c7f490d7ea4fb10af32bb79fada82d0ad448c2299bb6d2fa3171917a58568", "ref_doc_id": "2b91a97e-5696-4dd0-9927-abbe78bac3d9"}, "e4d3bc90-8249-4e00-b573-6da7986761df": {"doc_hash": "691d83c74f2425d518eb5eb5bb79fc93dfea221dc2211935ad5565922058d472", "ref_doc_id": "2b91a97e-5696-4dd0-9927-abbe78bac3d9"}, "b7d32e3b-62af-4d64-ac5f-bbd90412ecfa": {"doc_hash": "3c66216ac632f89e27c1a9f78834a6b449b523a23b1d0cbc962f58c65936594c", "ref_doc_id": "2b91a97e-5696-4dd0-9927-abbe78bac3d9"}, "a5dc620d-b86d-468f-9a1b-b78ac11e7028": {"doc_hash": "261905c8d4ff7f329b8cec1d7326a6d0d062432ede1d776c2b1d81264d697273", "ref_doc_id": "d969ddda-4720-4dc5-8a53-bd7869c811e5"}, "c253acc0-49dc-4f11-afa9-63ac42fa04dd": {"doc_hash": "643239648ad875503d82c496659822d90976c36472897efe71f8ceb8523b170c", "ref_doc_id": "d969ddda-4720-4dc5-8a53-bd7869c811e5"}, "87adaa89-8516-4ef9-8876-81bacdec4486": {"doc_hash": "07adbf73421ff91d093baa28f3b29977d4d3d3e5871068722009cb09a3b1c87d", "ref_doc_id": "d969ddda-4720-4dc5-8a53-bd7869c811e5"}, "e9815643-171d-46c3-88de-7ee783f013ee": {"doc_hash": "b469484ca4ae3754cb656ec16d286705ef16bc01e37ca5aecee51f4f049fb9df", "ref_doc_id": "d969ddda-4720-4dc5-8a53-bd7869c811e5"}, "b52d16a3-356a-4722-b844-d1774e03fe86": {"doc_hash": "e9dfb88dce2b4047f9eb7e035efb6fbd4c2b5f65bf766577253562f0a5df94d4", "ref_doc_id": "d969ddda-4720-4dc5-8a53-bd7869c811e5"}, "f49fa140-5cd7-42cd-bfb7-248860e7b89f": {"doc_hash": "e6ce80188e1f0c8c4b6020bddf2adfa2cbd930fe6df9803ec65d8d4bd11233d4", "ref_doc_id": "d6c177fa-cc81-4527-af07-593456035e28"}, "5458e084-2ef8-44a5-a725-1461edf91e33": {"doc_hash": "05d0fdd1433f818d123f18488cef6304e6de97815af946a2e01a1e5a2ca894e2", "ref_doc_id": "d6c177fa-cc81-4527-af07-593456035e28"}, "863d8eac-b462-40af-a987-2779fed1a8c4": {"doc_hash": "51de7c70f832a3c27253a42c2bfc4da060e3b95f518535ccd5d06a1a1a6e48a1", "ref_doc_id": "d6c177fa-cc81-4527-af07-593456035e28"}, "239defe6-6377-4907-abc7-d8a24b7173b8": {"doc_hash": "3cde9e0e0f9ba6213518c7552d3f90c52ed407e2769b7399ce98fdeac4f77307", "ref_doc_id": "d6c177fa-cc81-4527-af07-593456035e28"}, "4db018ba-81db-4534-9b9b-477c51bf212b": {"doc_hash": "d57667d6e0d745be342f8d93f54b8ac9332cf1b376b7390090e77ccbabbd8a0d", "ref_doc_id": "08c4aff6-0f02-4cda-8205-baa57b7e3a2d"}, "506b85c2-0fb8-40bd-bbc1-54f09c1ff2da": {"doc_hash": "f6b48c88ac4723a974e4c1e1c2fdf8570afc2c21c47741e184509eb1df65c0ed", "ref_doc_id": "08c4aff6-0f02-4cda-8205-baa57b7e3a2d"}, "53649073-64a3-4212-be15-410ebe793d30": {"doc_hash": "7c97df361668c9a1ba591fa81239e4ec7be2c92aa5308185673a10348cc0546b", "ref_doc_id": "08c4aff6-0f02-4cda-8205-baa57b7e3a2d"}, "4eddc232-e312-47fd-9997-e24bfda3fc0d": {"doc_hash": "fbd563da4302445ccda0e7ab59f73e7ece331c6329f05b20d04494fef3590fb5", "ref_doc_id": "08c4aff6-0f02-4cda-8205-baa57b7e3a2d"}, "f439deee-c13b-4205-93cb-60459eae36f3": {"doc_hash": "2320a524b902fa6d16e22ab11b04e8b827da7c759b7c27d9d46c08002ce865f8", "ref_doc_id": "c82a1ed2-6632-430b-b417-210bd6948512"}, "29ddf5fd-85b8-427a-98e2-a78d732c88c8": {"doc_hash": "c1ed29546abf68681af444c0e310899531ab3e40f75abf40379b7224b4d07b12", "ref_doc_id": "c82a1ed2-6632-430b-b417-210bd6948512"}, "ec7c26c5-6ef3-40f8-87e6-94e6381ce7bb": {"doc_hash": "884f11d0cf4047a3af12309469f9d5953d3bfe7e5e72758383b30cd9b38f00bb", "ref_doc_id": "c82a1ed2-6632-430b-b417-210bd6948512"}, "f4f7ddac-3a7e-403f-a290-012bb65ff987": {"doc_hash": "d086a899c4079b0edfa260ed553304e6e24bce54fe8af7c1739294d74372be5d", "ref_doc_id": "c82a1ed2-6632-430b-b417-210bd6948512"}, "fefe3df9-9a4c-452d-9802-68885fc6e173": {"doc_hash": "fe219ccdb76df08ac67e5299eb6174de43170ae69e93a88f94fb71b70d09fd75", "ref_doc_id": "c82a1ed2-6632-430b-b417-210bd6948512"}, "dc3eb136-10c8-4243-a0af-e7f54d6c322a": {"doc_hash": "d6fa77ef066b3e28f67e189ae83d1f42490b287c447dfcdf3f3c59b8934cb0e1", "ref_doc_id": "87724d6e-064b-4946-953c-75b95b8de25b"}, "4076f231-110d-4a3d-a268-26812d3e5d3f": {"doc_hash": "16c1e734d6152236efa447696e268e724c452232e15c1137eefe2500810d4358", "ref_doc_id": "87724d6e-064b-4946-953c-75b95b8de25b"}, "24176a38-ac1d-4748-8356-338621794216": {"doc_hash": "05d598f90cabd0ac9e5e056a443b5dc5b29a2e06bd88ab9e32cd79ccfcf5ccb8", "ref_doc_id": "87724d6e-064b-4946-953c-75b95b8de25b"}, "6dcbc230-3487-472d-9cd2-594c5a9474ea": {"doc_hash": "f5497c2a9022cce6ff35558f8185706bdc9d81ad43fa0d2d0ce626d682097ee0", "ref_doc_id": "87724d6e-064b-4946-953c-75b95b8de25b"}, "5ae1e491-f920-4d5b-98f2-95297851c440": {"doc_hash": "801c58426432e0b16398cd4d1fa592af70824b6844c375f050e6a5798a8b5427", "ref_doc_id": "2cc2148e-386e-4858-988f-a0b2f9913f96"}, "fcbd2ef8-e4ab-41f0-be3e-318470c535c7": {"doc_hash": "8ec97deeeb81117018711b23ca5b970740e55a00835d0c93fa21428f7fc8958a", "ref_doc_id": "2cc2148e-386e-4858-988f-a0b2f9913f96"}, "d0086d60-c0a6-499e-82a7-b1312a74e3fa": {"doc_hash": "0c973f8ce719a82d45dfa35cb6a5d7f9079b1f0e8a39ea754cfc8768edf6b827", "ref_doc_id": "2cc2148e-386e-4858-988f-a0b2f9913f96"}, "da7396c2-56f6-4c94-b042-4c7f67b63a0f": {"doc_hash": "90ec36819bf96db6a61bbfcc3ac7a3fa05f66036f8e521faa07634a6b5edbaa1", "ref_doc_id": "2cc2148e-386e-4858-988f-a0b2f9913f96"}, "a29ad700-8c5f-4e04-b345-de4cafc1b99c": {"doc_hash": "6884d79ca1303a9c63300ff394e4924b937a07a7e7039c3c3b76100e926d70e4", "ref_doc_id": "2cc2148e-386e-4858-988f-a0b2f9913f96"}, "87755d0d-37c7-464a-81ef-55a04e57fb7b": {"doc_hash": "b606c4400e2e44ce5a39658d1a8de8d8eaa76cfd50ecd7214c8ee998d2ba8590", "ref_doc_id": "85380493-c4a7-4d2c-aad1-2c0293382887"}, "5f1c789f-09d9-49a7-a87a-98035c896d3c": {"doc_hash": "00019f653317c71b072f2e37cfbcf1651d6e2ccf1c88ad81b5e83e2f2956141f", "ref_doc_id": "85380493-c4a7-4d2c-aad1-2c0293382887"}, "18546f5a-9fd5-4635-9914-28b7aef75e9a": {"doc_hash": "b606c4400e2e44ce5a39658d1a8de8d8eaa76cfd50ecd7214c8ee998d2ba8590", "ref_doc_id": "6d8cb138-f981-4deb-820c-639c01fb026f"}, "5041258c-3dc2-4db9-9747-b310ea24de15": {"doc_hash": "00019f653317c71b072f2e37cfbcf1651d6e2ccf1c88ad81b5e83e2f2956141f", "ref_doc_id": "6d8cb138-f981-4deb-820c-639c01fb026f"}, "63d487e3-aa6b-4af4-b569-cbb0e225b8cb": {"doc_hash": "0f9d1ebaa1d01286ec0b7eacf9e129899cd8b345635f910ff202f7e4cc47f09b", "ref_doc_id": "103bb39e-40c2-4130-aa26-363b570cd31a"}, "fde57304-2ecb-4e4b-98e2-b6b2c08f5864": {"doc_hash": "01431dce29938606cd721541fc81228bec4a50cae788d18849e06a0e01dc0e80", "ref_doc_id": "103bb39e-40c2-4130-aa26-363b570cd31a"}, "ac4db4a3-aa1e-4b11-84c1-bff7877a4302": {"doc_hash": "eba184b4772207234208a560ad687efa0b139709707a069af30d48bf429b7897", "ref_doc_id": "103bb39e-40c2-4130-aa26-363b570cd31a"}, "1c186c8a-58d8-4e86-bcf0-8efb865ac00b": {"doc_hash": "6c7a31f390389ba8dbf6d83a7d9a47d705cf028ffc6580f4fd22c976dcd5523a", "ref_doc_id": "103bb39e-40c2-4130-aa26-363b570cd31a"}, "0fbda229-3938-4573-a11a-98f6f458fafc": {"doc_hash": "cd2cfa9fc9af062041da4823fdbe51e128d48b9a99e149209478ec2aa37aa913", "ref_doc_id": "103bb39e-40c2-4130-aa26-363b570cd31a"}, "aac3782e-57e5-40a8-9111-f1a50b2455ed": {"doc_hash": "23b89dca8fe69d6e2ebcef87328f145489881193145627971f039ef37b27bdfe", "ref_doc_id": "1ed3d51f-981e-4705-a19c-a6b6595a682e"}, "c83e851d-ffe1-4ce4-93a9-2800ed0984c2": {"doc_hash": "c6195021f32ebf1b72262e614ef0a8954238fb244f97e216396d3ba6af5f3eb5", "ref_doc_id": "1ed3d51f-981e-4705-a19c-a6b6595a682e"}, "5dc6b10a-20b2-4e5b-9677-f76ed0feb21c": {"doc_hash": "d5fa17af02f07e3d97da429fe91ad9379129441a65f5308a1be48700f9010b4a", "ref_doc_id": "1ed3d51f-981e-4705-a19c-a6b6595a682e"}, "abaee270-e759-4ad1-90b0-23817060b571": {"doc_hash": "6de41d56a13479e9846ce854d93426f8c6fdaec18328482fa27ab809b0d647be", "ref_doc_id": "99740c43-5487-407e-b6af-7bc8db6b74ef"}, "95038553-3f67-4a30-81a2-ddf557b1cce8": {"doc_hash": "db343a4d93aeb8ad680c595d963a0cc722b35d09cf8bb8a4305a5d83fb76e047", "ref_doc_id": "99740c43-5487-407e-b6af-7bc8db6b74ef"}, "1ab70d1d-ffd6-4cfb-9446-18ba41361e1c": {"doc_hash": "fca63dba8b231b7dcde622a7540985930b8b2afa7331304f8c6d8255b7487446", "ref_doc_id": "99740c43-5487-407e-b6af-7bc8db6b74ef"}, "f5587619-42ba-4ab9-8349-b4bffcc1a52d": {"doc_hash": "71fef0c212d4d95381e8e2a5cc6cf9aa6f099fa993ad8318c6c6c14e3c657539", "ref_doc_id": "99740c43-5487-407e-b6af-7bc8db6b74ef"}, "47c59203-6b25-4890-b2fa-75cada4a5c62": {"doc_hash": "66559baf84b01057dd629e815886c854037a53e1999028c1be89ec319864fc87", "ref_doc_id": "e11470ea-6fff-4c68-872d-22efa4ba7278"}, "5f6edfe4-dc85-4641-80a5-516d5c2af3fe": {"doc_hash": "d5320aa59c7fa2b91eb21894b1ceb493c4c2fe2156d25740855dcabfccc5c629", "ref_doc_id": "e11470ea-6fff-4c68-872d-22efa4ba7278"}, "91d01f93-9e3d-4bf9-9bd2-cb31118d4f79": {"doc_hash": "66559baf84b01057dd629e815886c854037a53e1999028c1be89ec319864fc87", "ref_doc_id": "37e0d9be-2edc-412b-b35f-ad6724c9cc3d"}, "5f0c7dee-04c8-4045-b7b5-2ed35278a8a3": {"doc_hash": "d5320aa59c7fa2b91eb21894b1ceb493c4c2fe2156d25740855dcabfccc5c629", "ref_doc_id": "37e0d9be-2edc-412b-b35f-ad6724c9cc3d"}, "e1568e93-ce08-4b5b-b176-0098d8b620d2": {"doc_hash": "370c2a18c00fc2a3c66aaa216199c1b70a9935aec456f1db468b5ddded8b68d2", "ref_doc_id": "87a13fee-c559-408f-9ff7-ab37ea9e2517"}, "24d4a904-90a7-48e3-99bb-cfce73c337d2": {"doc_hash": "5d83b646d9b7b5d3b342d790a0fe8897922651c80e695247050841b3c4ce8317", "ref_doc_id": "87a13fee-c559-408f-9ff7-ab37ea9e2517"}, "d23b5fa2-c982-4a9f-bb7f-4cca942bf869": {"doc_hash": "7bfab3203cf0c61a045e5dd7142ee9a44f6ed13c5a11eb38437148399b814d72", "ref_doc_id": "87a13fee-c559-408f-9ff7-ab37ea9e2517"}, "a55b5ead-c163-4763-8f42-e192b2cd9ec1": {"doc_hash": "2b558c4cf73b0b825a6a8f87eac9e8755e4a5e6af832c1227ea96ce2e9ce29b3", "ref_doc_id": "87a13fee-c559-408f-9ff7-ab37ea9e2517"}, "2afc6927-fa37-4256-b9c0-6f16a6e60a21": {"doc_hash": "430f862ca63989cf21542b09b3205721f5e7181cb9b7105cefb51463ae00ff53", "ref_doc_id": "87a13fee-c559-408f-9ff7-ab37ea9e2517"}, "818fff00-7cf2-4411-b9df-dd7125fa71bd": {"doc_hash": "40ef7c1f9909ef24b7584c061f42200a561c553c99ab67e9566455727c8e12b7", "ref_doc_id": "6ff5dfbd-4a2f-4a75-8936-486d9c797d3c"}, "5710083f-e829-4223-b149-006b8e2cc37a": {"doc_hash": "93420653353514a0d5aae2a991483dfe00d3e49b6eb63dac487cf4b8bb8290c0", "ref_doc_id": "6ff5dfbd-4a2f-4a75-8936-486d9c797d3c"}, "0fb2014c-0d4d-42c4-8a73-2c7ac73de9f1": {"doc_hash": "304fb10c2a8f6ba47f7c9c0768e642c3969ccfd9f9829835566243a75efadafd", "ref_doc_id": "6ff5dfbd-4a2f-4a75-8936-486d9c797d3c"}, "693e9899-8695-4938-9cfa-b4d9cb2fed1a": {"doc_hash": "a965930f9ae7318d11d020b8de247e239d412fc6cb3b394b17aee347bc441bad", "ref_doc_id": "b3e92f83-c6e9-48a1-917b-f90368028926"}, "0d8b786c-b5f8-4501-8a4a-f265cb7512aa": {"doc_hash": "715db60618ddd7435c850e1b7694fc98b2ff97451fa319c65d43817e148da584", "ref_doc_id": "b3e92f83-c6e9-48a1-917b-f90368028926"}, "963d8af9-d4af-4975-9aeb-2963913b1ebd": {"doc_hash": "40cb5ceb5b9d80c9517dba76a034f051b1a731bf2937d65cfd160fe0322076a8", "ref_doc_id": "b3e92f83-c6e9-48a1-917b-f90368028926"}, "05caf1ff-530f-440d-b419-1447e82ff532": {"doc_hash": "7fdd0a7281dd12a36e48789ac92f633a4f9a1ab7f847c31538e9490eb1911326", "ref_doc_id": "b3e92f83-c6e9-48a1-917b-f90368028926"}, "e081b850-e694-4694-bfa1-198347b7c91a": {"doc_hash": "fcd7d53c1b38497810fb2d5bff66a43b9ba51693413f0bfb26a3989f59ab8001", "ref_doc_id": "b3e92f83-c6e9-48a1-917b-f90368028926"}, "8c314373-158c-4809-aa1e-e62cac28267a": {"doc_hash": "6ae2d5ee87044c16931c3cbf8429a3483d26113a2a02fed0f710cd2c8499e10f", "ref_doc_id": "9ea37fd5-c81e-48a5-bd3c-bae82986e816"}, "764a415e-1965-43e7-9e14-8bd22b8d4570": {"doc_hash": "121490ac21ac68392a1a016d53da9bb425e7566d660574959049d418c92585e0", "ref_doc_id": "9ea37fd5-c81e-48a5-bd3c-bae82986e816"}, "71f26691-4420-4346-9629-2f4360782977": {"doc_hash": "918a87da067193cc98f1ac3cc992c2dd77317a30b3c46c14187e9f4f73b8e10c", "ref_doc_id": "9ea37fd5-c81e-48a5-bd3c-bae82986e816"}, "ce98c793-a083-469f-b2c5-e08f9aa48da3": {"doc_hash": "e7c4b84b4f1bbb78d07fa6405dc812caaad1b6bd5b877fe9bba89cda5072fd35", "ref_doc_id": "f8889e75-d27e-4f61-b0b6-ff36cab61945"}, "84ed673b-1d18-4bff-8e69-0252ebd0ffa8": {"doc_hash": "ab31cd94d94d72acb12b6a88ebcae6e8aa687c4986ad63ffd0efa92cdf0e9b75", "ref_doc_id": "f8889e75-d27e-4f61-b0b6-ff36cab61945"}, "5987bcd2-04aa-40c4-8949-a25177e9db7a": {"doc_hash": "bbe1bb6a5040008d5e5498fa220e4ddf8fceefd274b08774c6e9d6d43e82458c", "ref_doc_id": "f8889e75-d27e-4f61-b0b6-ff36cab61945"}, "cb8cf659-62c7-45ad-9b31-0f25b6239658": {"doc_hash": "ac3aaad2e8659a817697726d9ae5999b7abab82da74d90f444515cb2fbc6417c", "ref_doc_id": "f8889e75-d27e-4f61-b0b6-ff36cab61945"}, "4abb23eb-b9ae-4d65-b5ee-8892ac8c51cf": {"doc_hash": "835364ccfe27560b05bbff73fdd2fcf02322866dabf553b54ccd5903ab5e31cc", "ref_doc_id": "24ad982c-47d1-455c-952d-a31ae43a2c78"}, "b490697e-511d-4a71-aa09-3a660cc77090": {"doc_hash": "819ddd2556eea6362ea6c7d55c457007abf6832f3e7f32a4204332ea40fc3322", "ref_doc_id": "24ad982c-47d1-455c-952d-a31ae43a2c78"}, "9c170077-5710-4100-8fe6-b7fc617f5103": {"doc_hash": "e30ea9de3d99db0c800219f17f7cea6e25f433b54e94af4f0e0613f6731b175a", "ref_doc_id": "24ad982c-47d1-455c-952d-a31ae43a2c78"}, "485fd1f9-1cb7-4db7-b9e5-9d8b16f068f5": {"doc_hash": "c6aac06f4ceb8086b93a95053c3beb5e9eb345a3369710172858034c51dd20c0", "ref_doc_id": "24ad982c-47d1-455c-952d-a31ae43a2c78"}, "354d3032-6499-4dc3-850a-274f6bfac20c": {"doc_hash": "66d7cc542874ddef122b8251d18603dcc39ade540787950020f6861f670d808a", "ref_doc_id": "c1075af5-68cf-4abd-9166-1b8cdb36eadd"}, "6fe5b514-8788-4c8c-b9bb-e92bdef9d8eb": {"doc_hash": "a7965f3be15ad7983701849fef8f26918a6384bbaa5c19ec2726bd5263cc97f6", "ref_doc_id": "c1075af5-68cf-4abd-9166-1b8cdb36eadd"}, "e65461c4-d1ed-4d26-9013-c16773a0da8e": {"doc_hash": "8fdb325028f994a7f223022946d3f17264c923d22c5c302dbd995a5213e1e0f9", "ref_doc_id": "c1075af5-68cf-4abd-9166-1b8cdb36eadd"}, "b6f0456d-79ad-4b02-a825-b91b0ce03725": {"doc_hash": "7289d39bf7cb84082ac640d931199f9030b50dd637ba1e6f5ce2e921cededf89", "ref_doc_id": "c1075af5-68cf-4abd-9166-1b8cdb36eadd"}, "d6747943-9398-44c0-aac7-99ef809c5847": {"doc_hash": "0bb029cd428ea95a67956a2082bdb5071b9ef2d5bbb04def3b3a8b200693cbab", "ref_doc_id": "823bc112-1294-4fe6-b2f5-3faf64dfbe18"}, "6133f04f-cff1-43d7-9429-027ae1d0720a": {"doc_hash": "79d0dc8222bb11d95d85632386423dbb8724d79e174f05cdc826e340edb129ac", "ref_doc_id": "823bc112-1294-4fe6-b2f5-3faf64dfbe18"}, "bbe5ca41-84f9-4aa3-9e2b-c9510899515e": {"doc_hash": "3218bae10526ae184c19a8a6cc6f8636314b52974590c4e64dd2da70d39b4fd1", "ref_doc_id": "823bc112-1294-4fe6-b2f5-3faf64dfbe18"}, "02650291-184b-4a68-b8e5-5f211912159a": {"doc_hash": "b3ae47d058d04ed877add8ecb60410ff055351ae6840081606bd09f62fe756ba", "ref_doc_id": "823bc112-1294-4fe6-b2f5-3faf64dfbe18"}, "47931fe8-deb8-4f76-b5c4-f727e574ae07": {"doc_hash": "e7a02214b9c8382ccc198f0481935a00aabebdfabd9a1dffc37ac3ad8469d7e0", "ref_doc_id": "8d5ad962-585b-4050-8998-b68b7d4f356a"}, "725b54c8-090f-46fb-9fcf-5b7d1d3ceb73": {"doc_hash": "9451852d1a18723b55c74375f00c8a317baba0a90c79d63c90a4e507dfa56cd3", "ref_doc_id": "8d5ad962-585b-4050-8998-b68b7d4f356a"}, "d29b08c4-3165-4509-b5fc-69167c2df5b4": {"doc_hash": "4e252c5d0a079bebfdcabe342e174d44c0406f20f253fa9e301860d7bee8c835", "ref_doc_id": "8d5ad962-585b-4050-8998-b68b7d4f356a"}, "25440e66-f9c5-47b7-a8b2-4f916352bd33": {"doc_hash": "05580cb51e01db0e665982fbbb6ab613884522b6cd5ee34b532cdc7522213f84", "ref_doc_id": "8d5ad962-585b-4050-8998-b68b7d4f356a"}, "2eec2970-4623-4c74-bbbf-c3a209896641": {"doc_hash": "e7808c166800a0082f1f285754188d29a1c5a91c1f0ce8d9e9fd7d34712564ad", "ref_doc_id": "8d5ad962-585b-4050-8998-b68b7d4f356a"}, "ad60890b-2625-4e4c-a380-d3384e5d4b67": {"doc_hash": "46a4e3bb728a7465d39f88cf4ee77872a768a769d3e88c6e938b7c36c8c0c29b", "ref_doc_id": "53bd4554-9e4a-490e-a410-bbdbc26f5130"}, "10a6cd87-4ef5-473a-80e2-773a4edbb8a5": {"doc_hash": "77a92a00532a8c12796937ac0c43a680612c8d34ffe4a09135aba78f322e8aa3", "ref_doc_id": "53bd4554-9e4a-490e-a410-bbdbc26f5130"}, "ebf94cfa-7a0a-4fab-b377-1e956a88e06b": {"doc_hash": "c56e7810cbfb14c2eefb66563ae864ecce987fe9fdcc09f033ece1912146beb2", "ref_doc_id": "27fbe2c8-e129-4395-a5a5-778eb7354f3e"}, "b4bb383e-d719-4d2a-ac03-b0abf1845785": {"doc_hash": "0cd32e1a2911b4e1ae990166f6e76ac17cfd0905c751f0b0b3e64df9c8df1e17", "ref_doc_id": "27fbe2c8-e129-4395-a5a5-778eb7354f3e"}, "f2aa6b1c-1ae4-47d5-944f-113f26a67784": {"doc_hash": "6ab2163dd9a356ba897f69cbc308c40ed407bb8228db32289fc64e58a495af33", "ref_doc_id": "27fbe2c8-e129-4395-a5a5-778eb7354f3e"}, "5d4433de-3bb9-4c4d-a37e-470e46c75a6a": {"doc_hash": "c5db734ac6f0098c3cba4be51d7c28d0577c8cd5748c16c565e59ec4586141d6", "ref_doc_id": "27fbe2c8-e129-4395-a5a5-778eb7354f3e"}, "ec1a0ccd-1a92-427c-b890-a704e121f820": {"doc_hash": "5aafada92d88b32dcd2924918ab9b38c3c5eeb8163c0caadcd627b202daebdb2", "ref_doc_id": "27fbe2c8-e129-4395-a5a5-778eb7354f3e"}, "e7a18b09-5e05-472f-9fd3-19ae204de705": {"doc_hash": "627945186c30bb71346404d3e7fc72fbb7f77f2741d2c365076a23b245519e70", "ref_doc_id": "deebf027-27d2-47f0-8869-b4dd099c55bc"}, "e21613ce-28e5-4126-a97c-fb100f34571a": {"doc_hash": "ebdaf80234e586865dd11799b1a32a8ca9bd90d748360938feb284afbc22d32d", "ref_doc_id": "deebf027-27d2-47f0-8869-b4dd099c55bc"}, "aba609f2-3914-4104-93a1-1792afa729cf": {"doc_hash": "43bf0e45ab620651bbe84c20f80bdd24e8a1fa9d4c7ee33ddbca18fe3e1d9810", "ref_doc_id": "deebf027-27d2-47f0-8869-b4dd099c55bc"}, "277cfaa5-adec-4de8-89bb-f882cd8963be": {"doc_hash": "884f216f82c2a46e66a9fb5b1f7df713b1b6054f6096be809f9996529943b523", "ref_doc_id": "2b13c655-fad3-45df-93ab-7fda4e85ca44"}, "459bd1ac-bdc4-4c5d-a1fb-a6ba3f29581b": {"doc_hash": "93a39149ec7ae4d1dce7b4752a862d21b5b44220759a798637663d86664f692e", "ref_doc_id": "2b13c655-fad3-45df-93ab-7fda4e85ca44"}}, "docstore/data": {"d88111c5-5c2d-4ca7-869c-50631e5383a3": {"__data__": {"id_": "d88111c5-5c2d-4ca7-869c-50631e5383a3", "embedding": null, "metadata": {"page_label": "1", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1b3b6816-1958-458c-8149-78fdc732e3ed", "node_type": null, "metadata": {"page_label": "1", "file_name": "1_PhoenixVirus.pdf"}, "hash": "c00c27a1559ccaec054ad482db4cb929cd37777b0cc674f6bb2cbe784d37503d"}, "3": {"node_id": "3a4bd5c4-d905-41af-8099-571093f86255", "node_type": null, "metadata": {"page_label": "1", "file_name": "1_PhoenixVirus.pdf"}, "hash": "e534756e92fb402fa5557746638d1f4c152817067d7bea6f89ad232800f9a84b"}}, "hash": "dd090f00560c38b58352ccf1f7779bbd01c1ccc9376f411eca92484cc37ae5df", "text": "Identification of an infectious progenitor\nfor the multiple-copy HERV-K humanendogenous retroelements\nMarie Dewannieux,1,3Francis Harper,2,4Aur\u00e9lien Richaud,1,4Claire Letzelter,1\nDavid Ribet,1G\u00e9rard Pierron,2and Thierry Heidmann1,5\n1Unit\u00e9 des R\u00e9trovirus Endog\u00e8nes et El\u00e9ments R\u00e9tro\u00efdes des Eucaryotes Sup\u00e9rieurs, UMR 8122 CNRS, Institut Gustave Roussy,\n94805 Villejuif Cedex, France;2Laboratoire de R\u00e9plication de l\u2019ADN et Ultrastructure du Noyau, UPR1983 Institut Andr\u00e9 Lwoff,\n94801 Villejuif Cedex, France\nHuman Endogenous Retroviruses are expected to be the remnants of ancestral infections of primates by active\nretroviruses that have thereafter been transmitted in a Mendelian fashion. Here, we derived in silico the sequence ofthe putative ancestral \u201cprogenitor\u201d element of one of the most recently amplified family\u2014the HERV-K family\u2014andconstructed it. This element, Phoenix, produces viral particles that disclose all of the structural and functional\nproperties of a bona-fide retrovirus, can infect mammalian, including human, cells, and integrate with the exactsignature of the presently found endogenous HERV-K progeny. We also show that this element amplifies via anextracellular pathway involving reinfection, at variance with the non-LTR-retrotransposons (LINEs, SINEs) orLTR-retrotransposons, thus recapitulating ex vivo the molecular events responsible for its dissemination in the hostgenomes. We also show that in vitro recombinations among present-day human HERV-K (also known as ERVK) loci\ncan similarly generate functional HERV-K elements, indicating that human cells still have the potential to produceinfectious retroviruses.\n[Supplemental material is available online at www.genome.org.]\nNearly 8% of the human genome is composed of sequences of\nretroviral origin. Most of them are degenerate, either due to re-combination between the two provirus LTRs or to mutations in-terrupting the retroviral ORFs. The envgene seems to be best\nconserved, with 18 intact genes retaining a full coding capacityin the human genome (Benit et al. 2001; de Parseval et al. 2003;Villesen et al. 2004), possibly because of its potential role in hu-man physiology. The HERV-K(HML2) family of endogenous ret-roviruses is an exception to this general rule, since some copiesstill contain complete ORFs for the other retroviral genes (L\u00f6weret al. 1996; for review, see Bannert and Kurth 2004). This familyincludes the most recently amplified endogenous retroviruses,most of which have integrated into the genome <5 million yearsago, with a few insertions showing polymorphism within thehuman population (Steinhuber et al. 1995; Medstrand and Mager1998; Barbulescu et al. 1999; Turner et al. 2001; Hughes andCoffin 2004; Belshaw et al. 2005). Some of these recently inte-grated proviruses are responsible for the synthesis of retroviralparticles that can be observed in teratocarcinoma and mela-noma-derived cell lines (Boller et al. 1993; L\u00f6wer et al. 1993;Bieda et al. 2001; Muster et al. 2003; Buscher et al. 2005), andpossibly in human placenta (Kalter et al. 1973; Dirksen and Levy1977; Wilkinson et al. 1994). Because of this \u201cactivity,\u201d theHERV-K(HML2) family has been the subject of numerous studiesin the past years, with the description of alleles with nearly intactproviruses and complete coding capacity (Mayer et al. 1999; Reuset al. 2001; Turner et", "start_char_idx": 0, "end_char_idx": 3361, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3a4bd5c4-d905-41af-8099-571093f86255": {"__data__": {"id_": "3a4bd5c4-d905-41af-8099-571093f86255", "embedding": null, "metadata": {"page_label": "1", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1b3b6816-1958-458c-8149-78fdc732e3ed", "node_type": null, "metadata": {"page_label": "1", "file_name": "1_PhoenixVirus.pdf"}, "hash": "c00c27a1559ccaec054ad482db4cb929cd37777b0cc674f6bb2cbe784d37503d"}, "2": {"node_id": "d88111c5-5c2d-4ca7-869c-50631e5383a3", "node_type": null, "metadata": {"page_label": "1", "file_name": "1_PhoenixVirus.pdf"}, "hash": "dd090f00560c38b58352ccf1f7779bbd01c1ccc9376f411eca92484cc37ae5df"}}, "hash": "e534756e92fb402fa5557746638d1f4c152817067d7bea6f89ad232800f9a84b", "text": "capacity (Mayer et al. 1999; Reuset al. 2001; Turner et al. 2001). Despite these efforts, no func-tional provirus able to produce infectious particles has yet beendescribed. Even if several loci containing complete ORFs havebeen identified, and in spite of the availability of the completesequence of the human genome, the search for a functional pro-virus is hampered by the significant polymorphism that can bedetected at each HERV-K(HML2) locus within the human popu-\nlation. To overcome this limitation, we used a reverse strategyand generated a consensus HERV-K(HML2) provirus, thus \u201cresus-citating\u201d Phoenix, the likely progenitor of the last, human-\nspecific HERV-K(HML2) amplification burst. This allowed a defi-nite characterization of the structure and life cycle of an \u201cances-tral\u201d retroviral element and recapitulation of the molecularevents responsible for its amplification.\nResults\nPhoenix, the ancestral HERV-K(HML2) retrovirus\nTo construct a consensus HERV-K(HML2) provirus, we assembledall of the complete copies of the 9.4-kb proviruses that are humanspecific (excluding those with the 292-nt deletion at the begin-ning of the envgene) and aligned their nucleotide sequence to\ngenerate the consensus in silico, taking for each position themost frequent nucleotide. The resulting provirus sequence con-tains, as expected, ORFs for all of the HERV-K(HML2)-encodedproteins (Gag, Pro, Pol, Env, and the accessory Rec protein), withgag,pro, and polseparated by /H115021 frameshifts. Noteworthily, this\nconsensus provirus is distinct from each of the sequences used togenerate it, with at least 20 amino acid changes on the overallsequences (Fig. 1).\nBased on this in silico reconstruction, we then generated a\n3Present address: Department of Immunology and Molecular Pa-\nthology, University College of London, Windeyer Institute, London\nW1T 4JF, UK.\n4These authors contributed equally to this work.\n5Corresponding author.\nE-mail heidmann@igr.fr; fax 33-1-42-11-53-42.Article published online before print. Article and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.5565706.Letter\n1548 Genome Research\nwww.genome.org16:1548\u20131556 \u00a92006 by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/06; www.genome.org Cold Spring Harbor Laboratory Press  on April 10, 2020 - Published by genome.cshlp.org Downloaded from", "start_char_idx": 3306, "end_char_idx": 5647, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7ed9d7be-60b1-4c85-80c3-90882184e672": {"__data__": {"id_": "7ed9d7be-60b1-4c85-80c3-90882184e672", "embedding": null, "metadata": {"page_label": "2", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d765e96f-17af-4a9c-8058-b8b9b9d6de43", "node_type": null, "metadata": {"page_label": "2", "file_name": "1_PhoenixVirus.pdf"}, "hash": "d316a1ca2cc204c2d72ce81facd8184df253d9f99950f80c38f745938bff32b8"}, "3": {"node_id": "b20a0218-a06a-49a3-9bbf-67f59a81e2c8", "node_type": null, "metadata": {"page_label": "2", "file_name": "1_PhoenixVirus.pdf"}, "hash": "2f794374ef837815d5b200ded9c468492db823a4a13c802be26f32663a507cde"}}, "hash": "e094d928a1be83e4c38ce3037d4cb71df7d5b12f7fe13300e03329724ce9cc5c", "text": "molecular clone corresponding to the consensus DNA proviral\nsequence that we named Phoenix, using the related K108 and\nK109 proviruses (which we had previously cloned from a com-mercial human BAC library) as a backbone, and a commercial kitto introduce single nucleotide mutations at each position re-quired to match the consensus. As the HERV-K(HML2) LTRs arenot functional in every cell line (Ruda et al. 2004; Lavie et al.2005), we also replaced the U3 part of the 5 /H11032LTR by the CMVpromoter, with its start site positionedso as to conserve the expected nucleo-tide sequence of the native retroviraltranscript. We also introduced a cloningsite downstream of the envgene into the\nnoncoding U3 region of the 3/H11032 LTR to\npossibly tag (with the neogene) the ret-\nroviral transcript without altering itscoding capacity.\nPhoenix codes for bona-fide\nretroviral particles\nIn a first assay, we introduced the Phoe-\nnixexpression vector into human 293T\ncells, and looked for retroviral particlesby transmission electron microscopy. Asillustrated in Figure 2, A and B, this re-sulted in the synthesis of particles bud-ding from the plasma membrane (notobserved with a control vector), as clas-sically observed with /H9253- (type-C) or /H9254-\n(HTLV) retroviruses, or even lentiviruses(HIV). No preassembled particles weredetected within the cytoplasm, althoughHERV-K(HML2) elements are moreclosely related to /H9252- (type-B/D) retrovi-\nruses based on their polgene (but this is\nconsistent with viral particle morphol-ogy and site of assembly being essen-tially dependent on the gagrather than\nthepolgene). In the extracellular space,\ntwo classes of particles could be ob-served, either with a hollow interior sur-rounded by a dense ring of stain corre-sponding to immature particles or with acondensed hexagonal core correspond-ing most probably to the mature form ofthe virus (Fig. 2C), in which the polypro-teins are cleaved into the final products.Consistently, a provirus with a mutationintroduced into the active site of theprotease (Pro) also produces particles,but all of them disclose the immaturemorphology (Fig. 2F). The particles aresurrounded by prominent spikes (Fig.2D) that can be marked in immuno-electron microscopy experiments withan antibody directed against the SU sub-unit of the HERV-K(HML2) envelopeprotein (Fig. 2E). As expected, thesespikes are absent when the provirus con-tains a premature Stop codon in the env\ngene (Fig. 2G). Altogether, these features\nsuggest that Phoenix can direct the synthesis of complete retro-\nviral particles.\nAs a confirmation, we performed immunoblot analyses of\nthe 293T cells transfected with the proviral vector. As illustratedin Figure 3A, Phoenix, as well as its promutant, promotes the\nsynthesis of a Gag precursor of \u223c80 kDa in cell lysates, as well as\nsome cleaved products (not observed with the promutant).\nCleavage products could also be observed in the supernatant of\nFigure 1. HERV-K(HML2) \u201cendogenization\u201d and present-day human proviruses. (A) Evolutionary\nscheme for HERV-K(HML2) entry into and invasion of the genome of primates. (B) Map of the full-\nlength 9.4-kb long human-specific HERV-K(HML2) proviruses and comparison with the in silico-engineered consensus sequence. Each provirus is represented by a solid dark line, with the amino acidsubstitutions in Gag, Pro, Pol, and Env as compared with the consensus element indicated below", "start_char_idx": 0, "end_char_idx": 3412, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b20a0218-a06a-49a3-9bbf-67f59a81e2c8": {"__data__": {"id_": "b20a0218-a06a-49a3-9bbf-67f59a81e2c8", "embedding": null, "metadata": {"page_label": "2", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d765e96f-17af-4a9c-8058-b8b9b9d6de43", "node_type": null, "metadata": {"page_label": "2", "file_name": "1_PhoenixVirus.pdf"}, "hash": "d316a1ca2cc204c2d72ce81facd8184df253d9f99950f80c38f745938bff32b8"}, "2": {"node_id": "7ed9d7be-60b1-4c85-80c3-90882184e672", "node_type": null, "metadata": {"page_label": "2", "file_name": "1_PhoenixVirus.pdf"}, "hash": "e094d928a1be83e4c38ce3037d4cb71df7d5b12f7fe13300e03329724ce9cc5c"}}, "hash": "2f794374ef837815d5b200ded9c468492db823a4a13c802be26f32663a507cde", "text": "Pro, Pol, and Env as compared with the consensus element indicated below the\nline, and the insertions/deletions (ins//H9004) and premature Stop codons (red stars) indicated above the\nline. The ORF map of the consensus provirus is shown, with gagin green, proin pink, polin blue, env\nin orange and yellow, the bipartite recin orange, and the two LTRs as gray boxes. (Note that the first\ncoding exon of recbelongs to the envORF). The transcripts responsible for the expression of the viral\nproteins, with the corresponding spliced out domains (dotted lines), are schematized below the ORF map.A functional HERV-K human endogenous retrovirus\nGenome Research 1549\nwww.genome.org Cold Spring Harbor Laboratory Press  on April 10, 2020 - Published by genome.cshlp.org Downloaded from", "start_char_idx": 3340, "end_char_idx": 4117, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e09fb4c5-4d77-460e-8d82-c8dd7cbb9372": {"__data__": {"id_": "e09fb4c5-4d77-460e-8d82-c8dd7cbb9372", "embedding": null, "metadata": {"page_label": "3", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b7955333-7e0f-451d-a6d3-3aacbbfb34c6", "node_type": null, "metadata": {"page_label": "3", "file_name": "1_PhoenixVirus.pdf"}, "hash": "ecfae4829282337ea3c89ecd60700e980197f2884caf7619c65ab94d78e1bf87"}, "3": {"node_id": "419b6a02-1175-4c13-9f0f-c21710064c21", "node_type": null, "metadata": {"page_label": "3", "file_name": "1_PhoenixVirus.pdf"}, "hash": "5118d065df0fc65d945c48f8952480b7caa3a03e938179a3bf80775dc3d033bd"}}, "hash": "be44969ee118deef0591d8ce29389c37d8295cabd03f362f36849f734305be8b", "text": "the transfected cells, except for the promutant that only ex-\npresses the Gag precursor. Similarly, using an antibody directed\nagainst the SU component of the HERV-K(HML2) envelope pro-tein, we detected, in the supernatants, a protein of a size (55 kDa)consistent with that of the processed SU subunit, but we wereunable to detect the Env protein in cell lysates, most probablybecause of a too-low expression level. Notwithstanding, expres-sion of the envelope protein could be observed by immunofluo-rescence analysis using HeLa and 293T cells transiently trans-fected with Phoenix (Fig. 3B). In these cells, it can further be\nobserved that Gag and Env colocalize to some common subcel-lular domains including, as expected, the plasma membrane.\nPhoenix is an infectious retrovirus\nTo get insight into the functionality of this ancestral virus, wethen looked for a reverse-transcriptase activity in the supernatantof the transfected cells. Using the previously described sensitiveproduct-enhanced reverse transcriptase (PERT) assay (Pyra et al.1994; see Methods), an RT activity could indeed be detected inthe supernatant of cells transfected with Phoenix, not observed\nwith a provirus in which we had introduced a mutation withinthe catalytic site of the RT domain (Fig. 3C). To further study theinfectivity potential of Phoenix-derived particles, we then in-\nfected a panel of mammalian cell lines with the supernatant of293T cells transfected with a neo-marked Phoenix provirus, and\nsubjected them to G418 selection. G418\nRclones were obtained\nfor several target cells including hamster BHK21 cells, felineG355.5 cells, and, noteworthily, the human SH-SY5Y and 293cells, indicating that Phoenix is fully functional and infectious\n(Fig. 4A). In the same assay, the human HeLa cells and the mu-rine WOP cells seemed to be resistant to infection, most probablydue to the absence of the appropriate receptor for the Env proteinat the cell surface. We then ensured that the G418\nRclones that\nwere obtained are the result of bona-fide infection. Their occur-rence actually depends on the presence of intact gag,pro,pol, and\nenvgenes, since the inactivation of any of the encoded proteins\nrenders Phoenix noninfectious without decreasing the amount of\nviral particles produced, except for the gagmutant, as assessed by\nWestern Blot (Fig. 4A; data not shown). In these experiments, theapparent titer of Phoenix is quite low even for the cell lines per-\nmissive for infection. A quantitative assay by real-time PCR onthe genomic DNA from BHK21 cells infected with particles gen-erated by Phoenix, marked, or not, by the neogene (see Methods),\nindicated that the presence of neowithin the provirus contributes\nonly to a limited extent to this low titer. A possible explanationis that infection with Phoenix occurs more efficiently via cell\u2013cell\ninteraction, as observed for HTLV and in some cases HIV (seeDiscussion), consistent with some images obtained by electronmicroscopy where budding particles appear to be directly cap-tured by a recipient cell (Fig. 4B).\nNext, we characterized further the G418\nRclones that we\nisolated and determined the provirus insertion sites using an in-verse PCR strategy. Identification of the target loci of these newinsertions was further asserted by direct PCR reactions betweenthe identified flanking sequences and the neogene of the marked\nproviruses (see Methods). In all cases, we found complete LTRswith short target-site duplications (TSDs) bordering the newlyinserted proviruses (Fig. 5), thus confirming that the infectionprocess is canonical. Rather surprisingly, the TSDs were of a vari-able length (one of 5 bp and two of 6 bp), which was unexpectedsince well-characterized retroviral integrases", "start_char_idx": 0, "end_char_idx": 3735, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "419b6a02-1175-4c13-9f0f-c21710064c21": {"__data__": {"id_": "419b6a02-1175-4c13-9f0f-c21710064c21", "embedding": null, "metadata": {"page_label": "3", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b7955333-7e0f-451d-a6d3-3aacbbfb34c6", "node_type": null, "metadata": {"page_label": "3", "file_name": "1_PhoenixVirus.pdf"}, "hash": "ecfae4829282337ea3c89ecd60700e980197f2884caf7619c65ab94d78e1bf87"}, "2": {"node_id": "e09fb4c5-4d77-460e-8d82-c8dd7cbb9372", "node_type": null, "metadata": {"page_label": "3", "file_name": "1_PhoenixVirus.pdf"}, "hash": "be44969ee118deef0591d8ce29389c37d8295cabd03f362f36849f734305be8b"}}, "hash": "5118d065df0fc65d945c48f8952480b7caa3a03e938179a3bf80775dc3d033bd", "text": "6 bp), which was unexpectedsince well-characterized retroviral integrases yield TSDs of a fixedlength (for review, see Brown 1997). However, our data are con-sistent with the structures observed for the HERV-K(HML2) en-dogenous copies of the human genome, since, even if the mostcommon length of the endogenous HERV-K proviruses TSD is 6bp, we could identify, both in the literature (Barbulescu et al.1999; Turner et al. 2001) and databases (our unpublished obser-vation), a few elements (three of 15 full-length proviruses) bor-dered by perfect TSD of only 5 bp (see the endogenous K115\nFigure 2. Electron microscopy of the viral-like particles generated by the Phoenix provirus. Human 293T cells were transfected with an expression\nvector for Phoenix (A\u2013E), or mutants (F,G), and observed 48 h post-transfection. (A) Low magnification of particles assembled at the cell membrane. (B)\nRepresentative image of particles budding from the plasma membrane. ( C) High magnification of two particles, one of which (bottom) discloses a mature\n(M) morphology with a condensed core, while the other appears to be still immature (IM) with two dark peripheral rings surrounding an electron-lucent\ncore. (D) High magnification of a particle with prominent spikes, corresponding to the Env protein. (E) Image of a particle after labeling with an antibody\nspecific for the HERV-K envelope protein and a secondary antibody linked to gold beads, obtained by immuno-electron microscopy. Quantification ofthe labeling on 11 independent fields demonstrates association of the gold beads with the viral particles: 307 /H11506121 gold beads/\u00b5m\n2for the viral\nparticles, versus 4.9 /H115063.2 and 1.1 /H115061.5 gold beads/\u00b5m2for the cytoplasm and particle-free extracellular space, respectively (P < 0.001 between viral\nparticles and any of the two other compartments, Student\u2019s t-test). (F) Image of representative particles obtained after transfection with an expression\nvector for the Phoenix pro mutant. All of them disclosed an immature morphology (41 of 41 identified \u201cfree\u201d particles, i.e., no more in the budding\nprocess, for the promutant, vs. 15 of 37 for Phoenix WT). (G) High magnification of a particle obtained after transfection with an expression vector for\nthePhoenix env mutant. The membrane surrounding the particle is clearly detectable, without any spike. Scale bars: (A): 200 nm, (B\u2013G):100 nm.Dewannieux et al.\n1550 Genome Research\nwww.genome.org Cold Spring Harbor Laboratory Press  on April 10, 2020 - Published by genome.cshlp.org Downloaded from", "start_char_idx": 3662, "end_char_idx": 6213, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1f814178-2bdd-4f90-88b7-55ca606a272e": {"__data__": {"id_": "1f814178-2bdd-4f90-88b7-55ca606a272e", "embedding": null, "metadata": {"page_label": "4", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b77b174e-6c7d-4c0b-8c62-66003c42a5bf", "node_type": null, "metadata": {"page_label": "4", "file_name": "1_PhoenixVirus.pdf"}, "hash": "0f44761c202184e793a87ca5f3e9a44ffec3571cd0a1c8804baacba1841031ec"}, "3": {"node_id": "a64ee598-7107-4ad5-8c57-d4e297c86b63", "node_type": null, "metadata": {"page_label": "4", "file_name": "1_PhoenixVirus.pdf"}, "hash": "3a034bcb1f971de232a5026e74ce238e1886c1946fdc177d04fcffb449fffa42"}}, "hash": "6eff2e26cf0d0bff3b19cbb2937122bb46e646e7d0ddab9b3c24d9b3e76e43bf", "text": "provirus in the lower part of Fig. 5 for an illustration). Finally, we\nmapped the three Phoenix insertion sites using the UCSC Ge-\nnome Browser and found that integration occurred within (fortwo of three) or close to (<20 kb, for one of three) genes. Al-though the number of target sites that we characterized is low,and thus cannot reveal subtle insertion site preferences, the iden-tified loci are consistent with the preferences observed for clas-sical retroviruses that favor insertion in transcribed regions (forreview, see Bushman 2003). Interestingly, the characterization ofthe insertion sites of 11 (nearly) full-length HERV-K(HML2) en-dogenous elements gave a rather different result, with five ofthem found far from known human genes (>100 kb on eachside), four being in the vicinity (<20 kb) of genes, and only twoinserted within genes (M. Dewannieux, unpubl.). This discrep-ancy is probably due to the strong counter-selection that shouldoperate in vivo against insertions within genes, which are mostprobably deleterious for the proper expression of the targetedgenes.HERV-K(HML2) provirus amplification via reinfection\nNext, to get an insight into the possible physiological mecha-nism responsible for the amplification of the HERV-K(HML2)family of endogenous retroviruses, we analyzed the relative effi-ciency of intracellular retrotransposition versus reinfection byPhoenix. To do so, we marked Phoenix with a specific neoindicator\ngene (neo\nTNF), in which neobecomes active only after the marked\nelement has been transcribed, reverse-transcribed, and integrated(Esnault et al. 2002). The marked element was introduced bytransfection into various cell lines, permissive or not, for infec-\nFigure 3. Characterization of Phoenix.( A) Immunoblot analysis of the\nPhoenix products present in the lysates of transiently transfected 293T\ncells, or in the concentrated supernatant. Cells were transfected with (1)\na control plasmid (pCMV-/H9252), (2) an expression vector for Phoenix,o r( 3 )\nan expression vector for a promutant. The membranes were hybridized\nwith an antibody directed against the Gag protein (left) or the Env protein(right). (B ) Immunofluorescence study of 293T cells transfected with\nPhoenix. Gag is marked in red, Env in green, and the nuclei are stained inblue. Note the colocalization of the two proteins, especially at the mem-brane that separates the two adjacent marked cells. (C) Detection of RTactivity in the concentrated supernatant of 293T cells transfected withPhoenix and a series of proviral and control vectors. Concentrated virions\nwere used as a source of RT activity to reverse transcribe synthetic MS2RNA. Presence of cDNA was revealed via a PCR amplification using ap-propriate primers. (1) pCMV-/H9252;( 2)Phoenix;( 3)Phoenix mutated in RT;\n(4) chimera K109-K115; (5) chimera K109-K113; (6) chimera K109-K108;\n(7) MLV core proteins).\nFigure 4. Infectious properties of Phoenix encoded particles. (A) Infec-\ntivity of the HERV-K retroviral particles. The apparent viral titer observedwith the neo-marked HERV-K(HML2) provirus is indicated for a panel of\ntarget cell lines (the quantitative results for the 293 cell line is not shownsince their restricted adherence impaired the proper quantification ofindividual G418\nRclones), together with that obtained with a mutant for\nthe RT domain tested in the same conditions (no clone observed); dataare the results from three to eight independent experiments, with thestandard deviation indicated. The other mutants (gag, pro, and env) gave\nthe same, negative, results when assayed, with no clone observed in", "start_char_idx": 0, "end_char_idx": 3603, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a64ee598-7107-4ad5-8c57-d4e297c86b63": {"__data__": {"id_": "a64ee598-7107-4ad5-8c57-d4e297c86b63", "embedding": null, "metadata": {"page_label": "4", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b77b174e-6c7d-4c0b-8c62-66003c42a5bf", "node_type": null, "metadata": {"page_label": "4", "file_name": "1_PhoenixVirus.pdf"}, "hash": "0f44761c202184e793a87ca5f3e9a44ffec3571cd0a1c8804baacba1841031ec"}, "2": {"node_id": "1f814178-2bdd-4f90-88b7-55ca606a272e", "node_type": null, "metadata": {"page_label": "4", "file_name": "1_PhoenixVirus.pdf"}, "hash": "6eff2e26cf0d0bff3b19cbb2937122bb46e646e7d0ddab9b3c24d9b3e76e43bf"}}, "hash": "3a034bcb1f971de232a5026e74ce238e1886c1946fdc177d04fcffb449fffa42", "text": "gave\nthe same, negative, results when assayed, with no clone observed in threeindependent experiments (difference measured between Phoenix WT and\nmutants significant with P<0.001 for G355.5 and BHK21 cells and P\n<0.01 for SH-SY5Y cells, Student\u2019s t-test). The rationale of the assay is\nschematized at top.( B) Infection of cells by Phoenix particles. On the left,\ntwo mature particles appear to interact with the cell membrane of theclosest cell, with a thickening of the membrane at the exact point ofinteraction with the particle. In the middle and on the right, two images\nsuggestive of a cell-to-cell infection are presented, with a particle stillbudding from its progenitor cell already in contact with the neighboringcell.A functional HERV-K human endogenous retrovirus\nGenome Research 1551\nwww.genome.org Cold Spring Harbor Laboratory Press  on April 10, 2020 - Published by genome.cshlp.org Downloaded from", "start_char_idx": 3531, "end_char_idx": 4445, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0ec52f52-02e5-49c7-80c2-d76e4f9d2f4e": {"__data__": {"id_": "0ec52f52-02e5-49c7-80c2-d76e4f9d2f4e", "embedding": null, "metadata": {"page_label": "5", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "070446a3-3da9-42f0-954c-a635b168ddd7", "node_type": null, "metadata": {"page_label": "5", "file_name": "1_PhoenixVirus.pdf"}, "hash": "a3427b575a52490bb54e484986bb484eff592d422ead41174b645f8e1145f410"}, "3": {"node_id": "03bbb1c3-07eb-453e-8428-ddc3faae2e7b", "node_type": null, "metadata": {"page_label": "5", "file_name": "1_PhoenixVirus.pdf"}, "hash": "21ef2839cd57cb6b85f3dfe249397fc56c1de9b51a57cc5a44bb1b16c85a71a4"}}, "hash": "ccb65fc09110d8e89cdeb3baeefa41e02fbd973510c0360ba00b8c316d7df07e", "text": "tion. Under these conditions, we reproductively obtained G418R\nclones only with the cell lines permissive for infection (i.e., the\nfeline G355.5 cells, the hamster BHK21 cells, and the humanSH-SY5Y cells) (Fig. 6; data not shown). This suggests that theamplification process must, at some stage, get the envelope pro-tein receptor involved, and thus should occur via an extracellularreinfection process. To confirm this hypothesis, we performedthe same experiment as above, but with the provirus defective fortheenvgene (see Methods), using SH-SY5Y permissive cells. Un-\nder these conditions, no amplification of the marked mutantprovirus was observed. As a control, addition of a CMV-drivenexpression vector for the envelope protein restored, at least par-tially, the mobility of the env-defective provirus (Fig. 6) (partial\nrestoration might be due, indirectly, to an identified cytotoxiceffect of Env overexpression, as commonly observed with thisclass of retroviral transmembrane proteins). Altogether, the re-sults strongly support the hypothesis that HERV-K(HML2) am-plification in the human genome took place via a reinfectionprocess, possibly in the germ line of the developing embryo, aprocess consistent both with evolutionary data indicating thatthe HERV-K(HML2) envgene has been subjected to the same\npurifying selection as the other retroviral genes during amplifi-cation of this family (Belshaw et al. 2004) and with the presenceof retroviral particles in human placenta and in germ-line tumorsmorphologically similar to those produced by Phoenix (Kalter et\nal. 1973; Dirksen and Levy 1977; Boller et al. 1993; L\u00f6wer et al.1993; Wilkinson et al. 1994).\n\u201cRecombination\u201d of human endogenous HERV-K(HML2) loci\ncan generate an infectious retrovirus\nFinally, taking advantage of our present knowledge on the \u201can-\ncestor\u201d of the HERV-K(HML2) family, we asked whether an \u201cav-\nerage human genome\u201d would still be able to generate fully infec-\ntious retroviral particles. With the proviruses that were used toassemble the consensus sequence, we constructed a set of chi-meric elements that could spontaneously emerge via recombina-tion between definite human alleles and were able to express allof the retroviral genes. As described in the Methods, the 5/H11032 part\nwas\u201cborrowed\u201d from the HERV-K109 element, the 3/H11032 end from\nK108, K113, or K115 (Fig. 7), and the heterologous CMV pro-moter was introduced, as for Phoenix, in place of the U3 part of\nthe 5/H11032 LTR. We assayed these three proviruses for a virion-\nassociated RT activity in the supernatant of human 293T cellsfollowing their transient transfection and, remarkably, foundthat the K109/K115 chimera was positive (Figs. 3C, 7). However,this construct is not infectious on its own, most probably becauseof defects in the HERV-K115 envgene (which is noninfectious in\nFigure 6. Assay for Phoenix \u201cretrotransposition.\u201d (Top) Rationale of the\nassay. Phoenix was marked with the neoTNFindicator gene for retrotrans-\nposition (Esnault et al. 2002), in which neobecomes active only after a\ncomplete retrotransposition cycle (i.e., transcription, reverse transcrip-\ntion, and integration), and the marked element was introduced by trans-fection into SH-SY5Y human cells permissive for Phoenix infection. The\ncells were then amplified and subjected to G418 selection for 2 wk; thenumber of G418\nRclones (several of which were assayed by PCR to dem-\nonstrate splicing out of the intron within the neoindicator", "start_char_idx": 0, "end_char_idx": 3472, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "03bbb1c3-07eb-453e-8428-ddc3faae2e7b": {"__data__": {"id_": "03bbb1c3-07eb-453e-8428-ddc3faae2e7b", "embedding": null, "metadata": {"page_label": "5", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "070446a3-3da9-42f0-954c-a635b168ddd7", "node_type": null, "metadata": {"page_label": "5", "file_name": "1_PhoenixVirus.pdf"}, "hash": "a3427b575a52490bb54e484986bb484eff592d422ead41174b645f8e1145f410"}, "2": {"node_id": "0ec52f52-02e5-49c7-80c2-d76e4f9d2f4e", "node_type": null, "metadata": {"page_label": "5", "file_name": "1_PhoenixVirus.pdf"}, "hash": "ccb65fc09110d8e89cdeb3baeefa41e02fbd973510c0360ba00b8c316d7df07e"}}, "hash": "21ef2839cd57cb6b85f3dfe249397fc56c1de9b51a57cc5a44bb1b16c85a71a4", "text": "to dem-\nonstrate splicing out of the intron within the neoindicator gene) yielded\nthe frequency of retrotransposition of the marked elements. (Bottom)\u201cRetrotransposition\u201d is dependent on the presence of a functional env\ngene, either present within the native Phoenix provirus (Phoenix WT) or\nadded in trans to an env-mutated Phoenix provirus (Phoenix Stop Env) by\ncotransfection of the cells with an envexpression vector (CMV Env). The\nresults presented here correspond to three independent experiments,performed with 5\u201310 /H1150310\n6cells, and are given as relative transposition\nfrequencies as compared to neoTNF-marked Phoenix (whose transposition\nfrequency is 2 /H1150310/H115025clone/seeded cell under these conditions).\nFigure 5. Structure of three de novo integration sites of Phoenix pro-\nvirus, and comparison with the structure of natural HERV-K provirus in-sertions. The complete characterization of inserted Phoenix elements and\ninsertion sites was performed using individual clones from human SH-SY5Y cells after infection and G418 selection. A provirus insertion and thecorresponding empty site are schematized at the top. The sequences of\nthree characterized Phoenix de novo insertions are shown below, with the\nflanking DNA in uppercase and the proviral sequences in lowercase; tar-get-site duplications of 5/6 bp (TSD, yellow) are found in all cases, asso-ciated with full-length LTRs. For comparison, the corresponding struc-tures of two resident HERV-K proviruses with a polymorphic insertion inhumans (Turner et al. 2001) are presented in the lower part, one with a\n5-bp TSD and one with a 6-bp TSD.Dewannieux et al.\n1552 Genome Research\nwww.genome.org Cold Spring Harbor Laboratory Press  on April 10, 2020 - Published by genome.cshlp.org Downloaded from", "start_char_idx": 3405, "end_char_idx": 5180, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c2f5e7d0-dd26-45f7-b93a-ddc1f7e72fc9": {"__data__": {"id_": "c2f5e7d0-dd26-45f7-b93a-ddc1f7e72fc9", "embedding": null, "metadata": {"page_label": "6", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e91e3e68-57cf-4e78-ac15-9b987f356d6c", "node_type": null, "metadata": {"page_label": "6", "file_name": "1_PhoenixVirus.pdf"}, "hash": "dfb93140841e8bc19f742c7178e55cae599ca05f2e09598eb03b995d82ebb204"}, "3": {"node_id": "914451a0-36d2-4930-be45-c1ee3537756a", "node_type": null, "metadata": {"page_label": "6", "file_name": "1_PhoenixVirus.pdf"}, "hash": "e5304913b23bc6dade89763a97c50953473080efe257ed9a897f6dddea73d610"}}, "hash": "e66e1789ad3a175b4a1ce5f347163bbad86498e2bd24c372c9ca36fa8e7f0e60", "text": "pseudotype experiments, at variance with the K108 envgene)\n(Dewannieux et al. 2005). Therefore we generated a \u201ctriple chi-\nmera\u201d by replacing the envregion in the above construct with\nthat from K108 and assayed it for infection. With this element,\nspecific integration of the provirus (i.e., not observed with Phoe-\nnixmutated in the RT domain used as a control) could be de-\ntected in the BHK21 cells by quantitative PCR (see Methods) at alevel only five- to 10-fold lower than that observed with Phoenix\n(Fig. 7). This indicates that, as observed in AKR mice where amultistep recombination process reproductively generates newinfectious retroviruses (Stoye et al. 1991; Boeke and Stoye 1997),some individuals could reconstitute functional HERV-K(HML2)proviruses either via a three-fragment recombination event, ormore likely via a single recombination event between 2 HERV-Kcopies (e.g., K109 and K115) with complementation in trans by\nan intact envelope protein (e.g., K108). Recombination eventshave indeed occurred frequently between HERV-K(HML2) provi-ruses (Hughes and Coffin 2005). In this way, or even using func-tional (but still uncharacterized) alleles that might be present insome individuals, the HERV-K(HML2) family could repeat its lifecycle and regenerate functional elements that could, in turn, bethe initiators of amplification events to come.\nDiscussion\nIn the present investigation, the reconstruction of an activeHERV-K(HML2) provirus gives access de facto to the first identi-fied human retrovirus of endogenous origin that can conse-quently be characterized at both the structural and functionallevel. Actually, following \u201cendogenization,\u201d which transformed\nits retroviral status into that of a host genomic locus and thusdramatically reduced its evolutionary rate, this element has beenfrozen in time in its ancestral state, which we have recoveredhere. The essential attributes of Phoenix are those of a type-C\nretrovirus, with assembly and budding at the cell membrane,release in the cell supernatant of particles disclosing protrudingspikes that can be unambiguously identified as envelope pro-teins, morphological maturation of the core structure upon viralprotease processing, and finally, infectivity of the particles for arange of target cells. Furthermore, analysis of the integrated pro-viruses associated with infection discloses the specific structuralfeatures of retroviral integration, with precise opening of the tar-get sites, insertion of complete proviral structures with reconsti-tuted LTR, and target-site duplications of a few base pairs. Ofnote, the target-site duplications are not of a fixed length, butvary from 5 to 6 bp. Although this is not common for present-dayinfectious retroviruses, where the target site duplications are offixed lengths (for review, see Brown 1997), this peculiarity is alsoobserved for the endogenous proviral HERV-K loci, as illustrated\nin Figure 5. Possibly, this unusual feature might reflect the \u201cage\u201d\nofPhoenix and be a specific characteristic of its ancestral inte-\ngrase.\nAnother particular trait of Phoenix is its low infectious titer.\nOne possible interpretation could be that this results from itssensitivity to one or more of the multiple cellular defense mecha-nisms that have evolved to counteract the amplification of ret-roelements, thus guarding their hosts against the potentiallyharmful consequences of retrotransposition. The replication ofPhoenix could be limited by RNA interference-mediated gene si-\nlencing, as well as by the action of a variety of host gene-encodedrestriction factors, such as members of the AID/APOBEC cytosinedeaminase family or of the TRIM protein family (for review, seeGoff 2004; Harris and Liddament 2004). Another possible inter-pretation", "start_char_idx": 0, "end_char_idx": 3763, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "914451a0-36d2-4930-be45-c1ee3537756a": {"__data__": {"id_": "914451a0-36d2-4930-be45-c1ee3537756a", "embedding": null, "metadata": {"page_label": "6", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e91e3e68-57cf-4e78-ac15-9b987f356d6c", "node_type": null, "metadata": {"page_label": "6", "file_name": "1_PhoenixVirus.pdf"}, "hash": "dfb93140841e8bc19f742c7178e55cae599ca05f2e09598eb03b995d82ebb204"}, "2": {"node_id": "c2f5e7d0-dd26-45f7-b93a-ddc1f7e72fc9", "node_type": null, "metadata": {"page_label": "6", "file_name": "1_PhoenixVirus.pdf"}, "hash": "e66e1789ad3a175b4a1ce5f347163bbad86498e2bd24c372c9ca36fa8e7f0e60"}}, "hash": "e5304913b23bc6dade89763a97c50953473080efe257ed9a897f6dddea73d610", "text": "seeGoff 2004; Harris and Liddament 2004). Another possible inter-pretation could be that the still not-identified receptor for thisancestral retrovirus has diverged since its entry into the primategenome and is no more adapted to Phoenix, and could even have\nbeen positively selected for this divergence for the sake of thehost. However, a more likely interpretation, consistent with thefrequently observed images shown in Figure 4B, is that its modeof transmission is more closely related to that of retroviruses suchas human HTLV, where virions are poorly infectious and spreadessentially via cell\u2013cell contacts, most probably at the level ofdedicated \u201cvirological synapses\u201d (for review, see Jolly and Satten-\ntau 2004). Similar structures might exist for Phoenix, also consis-\ntent with its relative phylogenetic proximity to delta- (HTLV) andlenti- (HIV) viruses (Tristem 2000; Benit et al. 2001), and shouldactually be particularly well suited to optimize cell reinfectionand proviral amplification. As a matter of fact, despite its lowinfectious titer, another important and related outcome of thepresent investigation is the demonstration that past amplifica-tion of HERV-K has most probably involved an extracellular\npathway and cell reinfection: Indeed, using an appropriate ret-rotransposition assay, we demonstrate that amplification re-quires the presence of a functional envgene, and is only observed\nwith cells that are permissive for infection. Accordingly, themode of amplification of Phoenix is clearly distinct from that\nprevailing for most retroelements naturally present in eukaryotegenomes, which amplify via a strictly intracellular pathway.These elements include the highly reiterated LINE and SINE se-quences, which are non-LTR retrotransposons that replicate alsoby a copy-and-paste mechanism but are not infectious, and theclassical LTR retrotransposons, such as the yeast Ty1 and theDrosophila copia elements, which are closely related to retrovi-\nruses, of which they are most probably the evolutionary precur-sors but do not possess an envgene and transpose intracellularly\n(for review, see Boeke and Stoye 1997; Kazazian Jr. 2004; Dewan-nieux and Heidmann 2005). In this respect, the HERV-K family ofelements has a distinct and specific mode of amplification, whichvery likely also applies to most of the so-called \u201cendogenous\nretroviruses,\u201d and Phoenix, being actually the first infectious\nFigure 7. An infectious HERV-K(HML2) retrovirus can be generated by\nin vitro recombination from cloned HERV-K loci. Structure of the cloned\nHERV-K(HML2) proviruses and of the in vitro constructed chimera (see\nMethods), with the RT activities in the supernatant of 293T cells trans-fected with the corresponding plasmids measured as in Figure 3C, andthe associated infection efficiencies measured by quantitative PCR on thetarget cell genomic DNA (BHK21 cells, see Methods).A functional HERV-K human endogenous retrovirus\nGenome Research 1553\nwww.genome.org Cold Spring Harbor Laboratory Press  on April 10, 2020 - Published by genome.cshlp.org Downloaded from", "start_char_idx": 3689, "end_char_idx": 6769, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a3850e14-a154-4959-8959-b373b6945410": {"__data__": {"id_": "a3850e14-a154-4959-8959-b373b6945410", "embedding": null, "metadata": {"page_label": "7", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e8f2fe11-fb74-4d04-95b5-b10985c269aa", "node_type": null, "metadata": {"page_label": "7", "file_name": "1_PhoenixVirus.pdf"}, "hash": "b3bc8b6fe6aa126a1159acfa762c4942c2ab4bc1552a09f7a53431f2ec28261d"}, "3": {"node_id": "5ac68af3-5d43-4b4e-9b04-7c188c75a24e", "node_type": null, "metadata": {"page_label": "7", "file_name": "1_PhoenixVirus.pdf"}, "hash": "51f63f5852f227d5fe760c31abf63820b54f04e8668a4631b573dcec3e5767d4"}}, "hash": "d07213d08effee0c240a47553b90743fad2d1c2e982cd9b35522f3a7b2a4e2f3", "text": "HERV available to date, can therefore be considered as a model\nelement to characterize the life cycle of these invaders of allmammalian genomes.\nFinally, the present active cloned element provides a potent\ntool to appraise the role of elements of the HERV-K family in arange of diseases where related particles and viral proteins havebeen detected. These include essentially, but not exclusively, hu-man tumors such as germ-line tumors and melanomas, wheresuch elements have been suggested to play a role (Boller et al.1993; L\u00f6wer et al. 1993, 1996; Bieda et al. 2001; Muster et al.2003; Buscher et al. 2005) (for review, see Bannert and Kurth2004). Taking into account their retroviral origin, firmly estab-lished by the present investigation, it is indeed legitimate to hy-pothesize that HERV-K elements have conserved some of thepathological potency of infectious retroviruses, which could ariseupon their transcriptional activation. Clearly, most present-dayinfectious retroviruses are pathogenic and mediate such effectsvia both insertional mutagenesis and the activity of the viralproteins they encode. The present study clearly shows that Phoe-\nnixis a complex retrovirus that can insert into new genomic\nlocations, and that most probably, human cells can generate ac-tive retroviruses by recombination between genomic loci. Asshown in the Results section, in vitro recombination betweencloned HERV-K copies indeed generate a functional element (andactive when further placed under the control of the strong CMVpromoter) and it is likely, taking into account the polymorphismof such elements in the human population, that some allelesmight still be functional and even become fully active in somedefinite circumstances. Search for such alleles, possibly amongindividuals with specific tumors where HERV-K elements are ex-pressed and viral particles detected, should now be performedusing Phoenix as a functional \u201creference\u201d element together with\nthe presently devised infectivity assay.\nAltogether, the present results have allowed the structural\nand functional characterization of the oldest active retrovirusisolated to date and the unraveling of the molecular scenarioresponsible for its successful amplification in primate genomes.They also provide tools for elucidating the role of its \u201cgenomic\noffspring\u201d in human diseases, in particular in some tumors that\nhave primarily been qualified as of genetic origin, but could ul-timately turn out to have a bona-fide retroviral basis. In thisrespect, this study also suggests that more appropriate safety con-ditions should be considered for the manipulation of such tissuesand tumor cell lines.\nMethods\nIn silico engineering and in vitro reconstruction\nof the HERV-K(HML2) consensus provirus\nTo generate the consensus HERV-K(HML2) provirus sequence, we\ntook the nucleotide sequences of the nine full-length, human-specific, 9.4-kb class proviruses that can be found in sequencedatabases and publications and aligned them using ClustalW togenerate the consensus sequence (see Supplemental Fig. 1;Supplemental Table 1). To obtain a backbone for the Phoenix\nprovirus expression vector, we subcloned the K108 and K109proviruses by digesting commercial BAC clones RP11-33P21 andRP11-152J15 (BACPAC Resources), and generated chimeric con-structs to get closer to the consensus sequence. Fragments fromthese chimeric constructs were placed in pALTER-1 plasmid (Pro-mega) and subjected to successive rounds of site-directed muta-genesis using the Altered Sites II in vitro Mutagenesis System(Promega) and appropriate primers. When all expected muta-tions had been introduced, the Phoenix provirus was reassembled\nin the pBluescript plasmid and we checked the whole constructby sequencing. To generate the CMV expression vector, the CMVpromoter region was isolated from pCMV\u00df", "start_char_idx": 0, "end_char_idx": 3824, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5ac68af3-5d43-4b4e-9b04-7c188c75a24e": {"__data__": {"id_": "5ac68af3-5d43-4b4e-9b04-7c188c75a24e", "embedding": null, "metadata": {"page_label": "7", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e8f2fe11-fb74-4d04-95b5-b10985c269aa", "node_type": null, "metadata": {"page_label": "7", "file_name": "1_PhoenixVirus.pdf"}, "hash": "b3bc8b6fe6aa126a1159acfa762c4942c2ab4bc1552a09f7a53431f2ec28261d"}, "2": {"node_id": "a3850e14-a154-4959-8959-b373b6945410", "node_type": null, "metadata": {"page_label": "7", "file_name": "1_PhoenixVirus.pdf"}, "hash": "d07213d08effee0c240a47553b90743fad2d1c2e982cd9b35522f3a7b2a4e2f3"}, "3": {"node_id": "57e3bd1e-137a-475d-9903-129736fe13a1", "node_type": null, "metadata": {"page_label": "7", "file_name": "1_PhoenixVirus.pdf"}, "hash": "408ef1f9e8029f23b9a2287f6d5c509464c45e443d31aa4a0970ea75d4141ee5"}}, "hash": "51f63f5852f227d5fe760c31abf63820b54f04e8668a4631b573dcec3e5767d4", "text": "the CMV expression vector, the CMVpromoter region was isolated from pCMV\u00df (Clontech, EcoRI\u2013\nSacI fragment) and used it to replace the U3 part of the 5/H11032 LTR,\nusing PCR, so as to keep the transcription start site unchanged.\nPoint mutations within the protease and RT motifs (from\nLVDTGA to LVaaaA and from YIDD to aIaa, respectively) wereintroduced using the Altered Sites II in vitro Mutagenesis System(Promega) and appropriate primers. Inactivation of the gaggene\nwas achieved via an in-phase deletion between the SfoI andPshAI unique sites, and the envgene was disrupted by inserting a\nsmall synthetic linker containing Stop codons in all six frames atthe unique StuI site (located at the end of the SU subunit, posi-tion 7784 in the sequence provided in Supplemental Fig. 1).\nThis series of expression vectors was marked with the SV neo\nresistance gene or SV neo\nTNFretrotransposition indicator gene by\ninserting fragments taken from pSVneo* and pSVneoTNFplas-\nmids (Esnault et al. 2002), respectively, at position 8662 of theconsensus sequence (position according to the sequence pro-vided in Supplemental Fig. 1).\nConstruction of chimeric HERV-K proviruses\nTo generate the chimeric HERV-K proviruses, we first constructedan expression vector for the HERV-K109 copy by replacing theU3 part of its 5/H11032 LTR by the CMV promoter region. The 3/H11032 part of\nthis provirus was replaced by the corresponding sequences ofK113 and K115 proviruses (from the unique SexAI site to the end)or K108-1 (from the SacI site to the end). For the triple chimeraK109-K115-K108, the 3/H11032 domain of K109-K115 was replaced by\nthe corresponding part of the K108-1 provirus (from the XbaI siteto the end).\nProduction of antibodies: Western blot analysis\nand immunofluorescence studies\nWe developed a polyclonal anti-HERV-K Gag antiserum by im-\nmunizing rabbits with a mix of purified recombinant proteinsproduced in bacteria, covering the complete HERV-K113 Gagprotein. The resulting sera were checked by Immunoblot analysesand affinity-purified before use (Agrobio). The monoclonal anti-body directed against the SU subunit of the HERV-K envelopeprotein has already been described (Dewannieux et al. 2005). Wealso raised a rabbit antiserum specific for the HERV-K envelopeprotein using a recombinant protein produced in bacteria, cor-responding to aa 223\u2013437 of the K109 Env protein.\nFor analysis of retroviral protein expression and cleavage,\n293T cells transiently transfected with the provirus expressionvectors (using Lipofectamine and +Reagent; Invitrogen) werelysed in Laemmli buffer 48 h post-transfection and lysate pro-teins directly separated by SDS-PAGE, followed by transfer ontonitrocellulose membranes (Schleicher and Schuell) and incuba-tion with the appropriate antibody and with a secondary anti-body linked to Horseradish peroxidase. For analysis of cell super-natants, 293T cells were transfected by the Calcium Phosphatemethod using the MBS commercial kit (Stratagene). Particulatematerial in the medium was concentrated by ultracentrifugationon a 20% sucrose cushion 48 h post-transfection, and the virionswere lysed in Laemmli buffer before viral protein analysis bySDS-PAGE and immunoblotting.\nImmunofluorescence analysis of the intracellular localiza-\ntion of Gag and Env was carried out on 293T cells transientlytransfected with the Phoenix expression vector. Cells were fixed\n30 h", "start_char_idx": 3762, "end_char_idx": 7163, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "57e3bd1e-137a-475d-9903-129736fe13a1": {"__data__": {"id_": "57e3bd1e-137a-475d-9903-129736fe13a1", "embedding": null, "metadata": {"page_label": "7", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e8f2fe11-fb74-4d04-95b5-b10985c269aa", "node_type": null, "metadata": {"page_label": "7", "file_name": "1_PhoenixVirus.pdf"}, "hash": "b3bc8b6fe6aa126a1159acfa762c4942c2ab4bc1552a09f7a53431f2ec28261d"}, "2": {"node_id": "5ac68af3-5d43-4b4e-9b04-7c188c75a24e", "node_type": null, "metadata": {"page_label": "7", "file_name": "1_PhoenixVirus.pdf"}, "hash": "51f63f5852f227d5fe760c31abf63820b54f04e8668a4631b573dcec3e5767d4"}}, "hash": "408ef1f9e8029f23b9a2287f6d5c509464c45e443d31aa4a0970ea75d4141ee5", "text": "cells transientlytransfected with the Phoenix expression vector. Cells were fixed\n30 h post-transfection, permeabilized, and stained with a rabbitDewannieux et al.\n1554 Genome Research\nwww.genome.org Cold Spring Harbor Laboratory Press  on April 10, 2020 - Published by genome.cshlp.org Downloaded from", "start_char_idx": 7140, "end_char_idx": 7442, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "38ba013a-6609-4a0c-845d-9bad70fca7e2": {"__data__": {"id_": "38ba013a-6609-4a0c-845d-9bad70fca7e2", "embedding": null, "metadata": {"page_label": "8", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "431a22b7-b77a-49e3-b468-da4406cd9369", "node_type": null, "metadata": {"page_label": "8", "file_name": "1_PhoenixVirus.pdf"}, "hash": "7ce0a37a74fdad62e759a4510449179e888efee4984f37f3cc3ce8d81ee73ae3"}, "3": {"node_id": "91a1ac69-e01f-4cf1-97f1-b20f55216de1", "node_type": null, "metadata": {"page_label": "8", "file_name": "1_PhoenixVirus.pdf"}, "hash": "e1eb37dfa70965d1772f26bd70be84aed7391bf5e60701dda28c903a81390305"}}, "hash": "ce08d90fddecca70e8915b813310688f96079726055ab3d2a96441639d6508ad", "text": "polyclonal anti-Gag serum and a mouse monoclonal anti-Env\nantibody. Alexa 546-conjugated goat anti-rabbit IgG and Alexa488-conjugated goat anti-mouse IgG were used as secondary an-tibodies (Molecular Probes); nuclei were stained with Dapi andTopro3 (Molecular Probes).\nElectron microscopy\nFor morphological studies, cells were fixed in phosphate buffer(pH 7.2), 3% glutaraldehyde for 1 h, and post-fixed in 0.1 Mcacodylate buffer, 1% osmium tetroxyde for 2 h. After beingrinsed for 5 min in water and 15 min in 0.1 M cacodylate buffer,cells were transferred to 0.2 M cacodylate buffer for 30 min. Cellswere washed in 30% methanol for 10 min, stained in 2% uranylacetate in 0.1 M cacodylate buffer , 30% methanol for 1 h, andwashed in 30% methanol. Cells were then dehydrated through agraded ethanol-propylene oxide series and embedded in Epon812. Ultrathin sections were collected on formvar-carbon-coatedgold grids (200-mesh), stained with 4% uranyl acetate and leadcitrate, and examined with a Zeiss 902 microscope at 80 Kv.\nFor immuno-electron microscopy experiments, transfected\ncells were fixed for1ha t4 \u00b0C with either 4% formaldehyde or\n1.6% glutaraldehyde in 0.1 M phosphate buffer (pH 7.3). Duringfixation, the cells were scraped from the plates and centrifuged.Pellets were dehydrated in increasing concentrations of metha-nol and embedded in Lowicryl K4M at low temperature. Poly-merization was carried out for5da t\u2013 30\u00b0C under long-\nwavelength UV light. Ultrathin sections of Lowicryl-embeddedmaterial were collected on formvar-carbon-coated gold grids(200-mesh) and used for labeling with a rabbit antiserum specificfor the SU subunit of the HERV-K envelope protein, followed byincubation with a goat anti-rabbit IgG conjugated to gold par-ticles, 10 nm in diameter. Sections were contrasted as above. Thespecificity of the association between the gold beads and the viralparticles was performed by counting, in 11 independent fields,the number of gold particles/\u00b5m\n2within three \u201ccompartments\u201d\n(viral particles, cytoplasm, and particle-free extracellular space).\nRT assay\nAssays for the presence of RT activity in cell supernatants wereperformed using transiently transfected 293T cells. At day 2 post-transfection, the medium was harvested, filtered through 0.45-\u00b5m pore-sized membranes, and particulate material concentratedby ultracentrifugation on a 20% sucrose cushion. The virionswere lysed in Buffer A (25 mM Tris, 0.25 mM EDTA, 50 mM KCl,5 mM DTT, 0.025% Triton X-100, 50% glycerol) and used as areverse-transcriptase source for reverse transcription of commer-cial MS2 RNA (adapted from the PERT assay described in Pyra etal. 1994). Briefly, 300 ng of MS2 RNA were annealed to 16 pmolof RT-1 primer and incubated with viral lysate corresponding to1\u20132 mL of cell supernatant. cDNA synthesis was then assayedusing 1/25 of the RT reaction as a template for a 25 cycle PCRreaction conducted with RT-1 and RT-2 primers (Pyra et al. 1994).In these assays, expression vectors for the MLV and HIV coreproteins were used as positive controls and CMV-/H9252 (Clontech)\nas a negative control.\nInfection and retrotransposition assays\nFor infection assays, 293T cells were used as producer cells,", "start_char_idx": 0, "end_char_idx": 3206, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "91a1ac69-e01f-4cf1-97f1-b20f55216de1": {"__data__": {"id_": "91a1ac69-e01f-4cf1-97f1-b20f55216de1", "embedding": null, "metadata": {"page_label": "8", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "431a22b7-b77a-49e3-b468-da4406cd9369", "node_type": null, "metadata": {"page_label": "8", "file_name": "1_PhoenixVirus.pdf"}, "hash": "7ce0a37a74fdad62e759a4510449179e888efee4984f37f3cc3ce8d81ee73ae3"}, "2": {"node_id": "38ba013a-6609-4a0c-845d-9bad70fca7e2", "node_type": null, "metadata": {"page_label": "8", "file_name": "1_PhoenixVirus.pdf"}, "hash": "ce08d90fddecca70e8915b813310688f96079726055ab3d2a96441639d6508ad"}, "3": {"node_id": "7822fe13-ccb6-4615-aa22-defc698bf8b5", "node_type": null, "metadata": {"page_label": "8", "file_name": "1_PhoenixVirus.pdf"}, "hash": "8e5fe4738ecab5cc7304ebbdcbda81e7ea27b0fa8699f0f2d04135cfc3fa1d58"}}, "hash": "e1eb37dfa70965d1772f26bd70be84aed7391bf5e60701dda28c903a81390305", "text": "assays\nFor infection assays, 293T cells were used as producer cells, fol-lowing transient transfection with the consensus provirus by theCalcium Phosphate method (Stratagene MBS commercial kit).Target cell lines (SH-SY5Y, BHK21, G355.5, HeLa, and WOP) wereseeded the day before infection in 6-well plates. The day of in-fection, the supernatants of 293T cells were harvested, filteredthrough 0.45-\u00b5m pore-sized membranes, and added to targetcells (1 mL per well, with 4 \u00b5g/mL polybrene). To increase thesensitivity of the assay, the target cells were then subjected to\u201cspinoculation\u201d (centrifugation at 1200g for 2.5 h) and incubated\novernight at 37\u00b0C before medium change. For detection of infec-tion events, target cells were split into 10-cm plates (\u223c5 /H1150310\n5\ncells per plate) at day 3 post infection and subjected to G418selection 24 h later. For infection assays using quantitative PCR,10\n5BHK21 cells were seeded in 6-well plates and used as target\ncells. At day 2 post-infection, the cells were washed with DNaseIto remove residual DNA and split, and genomic DNA was recov-ered at days 5\u20136 post-infection. DNA purification was performedvia two successive phenol/chloroform extractions followed byethanol precipitation. Integration events were detected with theTaqman technology using a 5/H11032 -FAM MGB probe (6FAM-\nATAGTGTATGGGTACCTGGC-MGBNFQ, Applied Biosystems)and primers specific for the HERV-K(HML2) family (5/H11032-GCCTTTCCCGCCCTTAATT-3/H11032 and 5/H11032 -GCAGGGCAGCGATCATCTA-3/H11032 ),\nand 500 ng of genomic DNA as a template. The infectious titerswere estimated by comparison with a standard obtained by mix-ing genomic DNAs extracted from naive BHK21 cells and from aclone containing a single inserted provirus in varying propor-tions. In this assay, the titer of Phoenix WT was in the 10\n3in-\nfectious particles/milliliter range. BHK21 cells were chosen as thetarget cell line, since their genomic DNA generates only verylimited background with the HERV-K-specific primers and probe\nused in this assay; genomic DNA of BHK21 cells infected withPhoenix particles deficient for the RT was used as a negative con-\ntrol to rule out contamination by residual DNA that could origi-nate from the transfected plasmid or genomic DNA of the pro-ducer cells.\nFor retrotransposition assays, 7.5 /H1150310\n5SH-SY5Y cells were\nseeded in 60-mm dishes the day prior to transfection. Transfec-tion was performed using 8 \u00b5L of Plus Reagent (Invitrogen), 12 \u00b5Lof Lipofectamine (Invitrogen), and 3 \u00b5g of DNA (2.5 \u00b5g of Phoe-\nnix-derived expression vector and 0.5 \u00b5g of envexpression plas-\nmid or control plasmid). Cells were grown for 1 wk before platingon 10-cm plates and subsequent selection with G418. The resultspresented here correspond to three independent experimentsperformed with 5\u201310 /H1150310\n6cells and are given as relative trans-\nposition frequencies as compared with neoTNF-marked Phoenix\n(whose absolute transposition frequency is 2 /H1150310/H115025clone/\nseeded cell under these conditions).\nCharacterization of HERV-K(HML2) de novo insertion sites\nIntegration sites were analyzed by inverse PCR using individualG418\nRclones essentially as described (Dewannieux et al. 2003).\nBriefly, 5 \u00b5g of DNA from each clone was digested with PvuII andeither (1)", "start_char_idx": 3148, "end_char_idx": 6424, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7822fe13-ccb6-4615-aa22-defc698bf8b5": {"__data__": {"id_": "7822fe13-ccb6-4615-aa22-defc698bf8b5", "embedding": null, "metadata": {"page_label": "8", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "431a22b7-b77a-49e3-b468-da4406cd9369", "node_type": null, "metadata": {"page_label": "8", "file_name": "1_PhoenixVirus.pdf"}, "hash": "7ce0a37a74fdad62e759a4510449179e888efee4984f37f3cc3ce8d81ee73ae3"}, "2": {"node_id": "91a1ac69-e01f-4cf1-97f1-b20f55216de1", "node_type": null, "metadata": {"page_label": "8", "file_name": "1_PhoenixVirus.pdf"}, "hash": "e1eb37dfa70965d1772f26bd70be84aed7391bf5e60701dda28c903a81390305"}}, "hash": "8e5fe4738ecab5cc7304ebbdcbda81e7ea27b0fa8699f0f2d04135cfc3fa1d58", "text": "\u00b5g of DNA from each clone was digested with PvuII andeither (1) DraI, (2) SspI, or (3) with a mix of XbaI, AvrII, and SpeI,or (4) with ApoI alone. After enzyme removal, DNA was dilutedand self-ligated overnight. It was ethanol-precipitated, dissolvedin 20 \u00b5L of Tris 10 mM, and subjected to one (or in some casestwo) round of PCR with sets of divergent primers located withintheneogene and designed for the amplification of the 5/H11032 or 3/H11032\nend and flanking sequences of the newly inserted proviruses. Theamplified DNAs were gel-purified, cloned, and sequenced, thusyielding the target-site sequences. The identification of these in-sertion sites was further confirmed by PCR reactions allowingdirect amplification of both left and right junctions between thenewly inserted proviruses and the identified loci, using for eachreaction a primer specific for the identified insertion locus and aninternal primer located in the neogene. In each case, we checked\nthat the same reactions performed on the naive, noninfectedtarget cells did not yield any specific amplification. Primer se-quences are available on request.A functional HERV-K human endogenous retrovirus\nGenome Research 1555\nwww.genome.org Cold Spring Harbor Laboratory Press  on April 10, 2020 - Published by genome.cshlp.org Downloaded from", "start_char_idx": 6420, "end_char_idx": 7728, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "03edea06-c124-407c-abad-7b173c36d1bf": {"__data__": {"id_": "03edea06-c124-407c-abad-7b173c36d1bf", "embedding": null, "metadata": {"page_label": "9", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9ee5af03-ad45-4d50-badb-990e0c2a9fdd", "node_type": null, "metadata": {"page_label": "9", "file_name": "1_PhoenixVirus.pdf"}, "hash": "0d13b50a9e7321037cf837473908d3d5ee5bdf477757e60a02be5e9b6e433d99"}, "3": {"node_id": "421b8b40-b015-436a-bee0-cce6db83fd58", "node_type": null, "metadata": {"page_label": "9", "file_name": "1_PhoenixVirus.pdf"}, "hash": "77c07735a02651c75bdd54fcc143af766050cf8ba7a9b3630c0b1ad76ce60443"}}, "hash": "4e55597e6bfa75d9ff803bfcd057d225c7758704f6d94bccf8fdd49b118978f4", "text": "Safety precautions\nAll manipulations involving the reconstructed HERV-K were car-\nried out in our lab according to the rules established by the\u201cCommission de G\u00e9nie G\u00e9n\u00e9tique\u201d from the \u201cMinist\u00e8re d\u00e9l\u00e9gu\u00e9\n\u00e0l\u2019Enseignement sup\u00e9rieur et \u00e0la Recherche\u201d French authority\nthat regulates handling of genetically modified organisms in allresearch institutions in France.\nAlbeit the HERV-K virus has a very low infectivity and does\nnot sustain multiple-cycle infection, at least in all the cells tested,Phoenix is a retrovirus, and as such, is a priori eligible to BL3\nconditions for manipulation. Accordingly, the material will onlybe sent to other labs in appropriate sealed containers in the formof small amounts of plasmid DNA that will require it to be am-plified before use as a transfection vector to produce viral par-ticles. At the present time and as a precautionary principle, it willonly be distributed under a material transfer agreement specify-ing the commitment of the recipient labs to carry out every ex-periment using the material under BL3 conditions and accompa-nied by a duly signed authorization form from the BiosafetyCommittee responsible for genetic manipulations in their coun-try of origin.\nAcknowledgments\nWe thank A. Jalil for assistance with confocal microscopy, E.Pichard for technical assistance, and C. Lavialle for critical read-ing of the manuscript. This work was supported by the CNRS andby grants from the Ligue Nationale contre Le Cancer (EquipeLabellis\u00e9e).\nReferences\nBannert, N. and Kurth, R. 2004. Retroelements and the human genome:\nNew perspectives on an old relation. Proc. Natl. Acad. Sci.\n101: 14572\u201314579.\nBarbulescu, M., Turner, G., Seaman, M.I., Deinard, A.S., Kidd, K.K., and\nLenz, J. 1999. Many human endogenous retrovirus K (HERV-K)\nproviruses are unique to humans. Curr. Biol. 9:861\u2013868.\nBelshaw, R., Pereira, V., Katzourakis, A., Talbot, G., Paces, J., Burt, A.,\nand Tristem, M. 2004. Long-term reinfection of the human genomeby endogenous retroviruses. Proc. Natl. Acad. Sci. 25:25.\nBelshaw, R., Dawson, A.L., Woolven-Allen, J., Redding, J., Burt, A., and\nTristem, M. 2005. Genomewide screening reveals high levels ofinsertional polymorphism in the human endogenous retrovirusfamily HERV-K(HML2): Implications for present-day activity. J. Virol.\n79:12507\u201312514.\nBenit, L., Dessen, P., and Heidmann, T. 2001. Identification, phylogeny,\nand evolution of retroviral elements based on their envelope genes.J. Virol. 75:11709\u201311719.\nBieda, K., Hoffmann, A., and Boller, K. 2001. Phenotypic heterogeneity\nof human endogenous retrovirus particles produced byteratocarcinoma cell lines. J. Gen. Virol. 82:591\u2013596.\nBoeke, J.D. and Stoye, J.P. 1997. Retrotransposons, endogenous\nretroviruses, and the evolution of retroelements. In Retroviruses (eds.\nJ.M. Coffin et al.), pp. 343\u2013435. Cold Spring Harbor LaboratoryPress, Cold Spring Harbor, NY.\nBoller, K., K\u00f6nig, H., Sauter, M., Mueller-Lantzsch, N., L\u00f6wer, R., L\u00f6wer,\nJ., and Kurth, R. 1993. Evidence that HERV-K is the endogenousretrovirus sequence that codes for the humanteratocarcinoma-derived retrovirus HTDV.", "start_char_idx": 0, "end_char_idx": 3102, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "421b8b40-b015-436a-bee0-cce6db83fd58": {"__data__": {"id_": "421b8b40-b015-436a-bee0-cce6db83fd58", "embedding": null, "metadata": {"page_label": "9", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9ee5af03-ad45-4d50-badb-990e0c2a9fdd", "node_type": null, "metadata": {"page_label": "9", "file_name": "1_PhoenixVirus.pdf"}, "hash": "0d13b50a9e7321037cf837473908d3d5ee5bdf477757e60a02be5e9b6e433d99"}, "2": {"node_id": "03edea06-c124-407c-abad-7b173c36d1bf", "node_type": null, "metadata": {"page_label": "9", "file_name": "1_PhoenixVirus.pdf"}, "hash": "4e55597e6bfa75d9ff803bfcd057d225c7758704f6d94bccf8fdd49b118978f4"}, "3": {"node_id": "e19f52dc-0427-4d13-9142-cf1265c38a5b", "node_type": null, "metadata": {"page_label": "9", "file_name": "1_PhoenixVirus.pdf"}, "hash": "c4bb86d81b79e861b69c419502b2cb02bda6920fe186aa80ec4d02916f385d9b"}}, "hash": "77c07735a02651c75bdd54fcc143af766050cf8ba7a9b3630c0b1ad76ce60443", "text": "that codes for the humanteratocarcinoma-derived retrovirus HTDV. Virology 196: 349\u2013353.\nBrown, P.O. 1997. Integration. In Retroviruses (eds. J.M. Coffin et al.),\npp. 161\u2013204. Cold Spring Harbor Laboratory Press, Cold SpringHarbor, NY.\nBuscher, K., Trefzer, U., Hofmann, M., Sterry, W., Kurth, R., and\nDenner, J. 2005. Expression of human endogenous retrovirus K inmelanomas and melanoma cell lines. Cancer Res. 65:4172\u20134180.\nBushman, F.D. 2003. Targeting survival. Integration site selection by\nretroviruses and LTR-retrotransposons. Cell115: 135\u2013138.\nde Parseval, N., Lazar, V., B\u00e9nit, L., Casella, J., and Heidmann, T. 2003.\nSurvey of human genes of retroviral origin: Identification andtranscriptome of the genes with coding capacity for completeenvelope proteins. J. Virol. 77:10414\u201310422.Dewannieux, M. and Heidmann, T. 2005. LINEs, SINEs and processed\npseudogenes: Parasitic strategies for genome modeling. Cytogenet.\nGenome Res. 110: 35\u201348.\nDewannieux, M., Esnault, C., and Heidmann, T. 2003. LINE-mediated\nretrotransposition of marked Alusequences. Nat. Genet. 35:41\u201348.\nDewannieux, M., Blaise, S., and Heidmann, T. 2005. Identification of a\nfunctional envelope protein from the HERV-K family of humanendogenous retroviruses. J. Virol. 79:15573\u201315577.\nDirksen, E. and Levy, J. 1977. Virus-like particles in placentas from\nnormal individuals and patients with systemic lupus erythematosus.J. Natl. Cancer Inst. 59:1187\u20131192.\nEsnault, C., Casella, J.F., and Heidmann, T. 2002. A Tetrahymena\nthermophila ribozyme-based indicator gene to detect transpositionof marked retroelements in mammalian cells. Nucleic Acids Res. 30:e49.\nGoff, S. 2004. Retrovirus restriction factors. Mol. Cell 16:849\u2013859.\nHarris, R.S. and Liddament, M.T. 2004. Retroviral restriction by APOBEC\nproteins. Nat. Rev. Immunol. 4:868\u2013877.\nHughes, J.F. and Coffin, J.M. 2004. Human endogenous retrovirus K\nsolo-LTR formation and insertional polymorphisms: Implications forhuman and viral evolution. Proc. Natl. Acad. Sci. 101: 1668\u20131672.\nHughes, J.F. and Coffin, J.M. 2005. Human endogenous retroviral\nelements as indicators of ectopic recombination events in theprimate genome. Genetics 12:12.\nJolly, C. and Sattentau, Q.J. 2004. Retroviral spread by induction of\nvirological synapses. Traffic 5:643\u2013650.\nKalter, S.S., Helmke, R.J., Heberling, R.L., Panigel, M., Fowler, A.K.,\nStrickland, J.E., and Hellman, A. 1973. C-Type particles in normalhuman placentas. J. Natl. Cancer Inst. 50:1081\u20131084.\nKazazian Jr., H.H. 2004. Mobile elements: Drivers of genome evolution.\nScience 303: 1626\u20131632.\nLavie, L., Kitova, M., Maldener, E., Meese, E., and Mayer, J. 2005. CpG\nmethylation directly regulates transcriptional activity of the humanendogenous retrovirus family HERV-K(HML-2). J. Virol.", "start_char_idx": 3045, "end_char_idx": 5804, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e19f52dc-0427-4d13-9142-cf1265c38a5b": {"__data__": {"id_": "e19f52dc-0427-4d13-9142-cf1265c38a5b", "embedding": null, "metadata": {"page_label": "9", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9ee5af03-ad45-4d50-badb-990e0c2a9fdd", "node_type": null, "metadata": {"page_label": "9", "file_name": "1_PhoenixVirus.pdf"}, "hash": "0d13b50a9e7321037cf837473908d3d5ee5bdf477757e60a02be5e9b6e433d99"}, "2": {"node_id": "421b8b40-b015-436a-bee0-cce6db83fd58", "node_type": null, "metadata": {"page_label": "9", "file_name": "1_PhoenixVirus.pdf"}, "hash": "77c07735a02651c75bdd54fcc143af766050cf8ba7a9b3630c0b1ad76ce60443"}, "3": {"node_id": "a2c4c8de-ebeb-407c-b16b-ca2aaa323899", "node_type": null, "metadata": {"page_label": "9", "file_name": "1_PhoenixVirus.pdf"}, "hash": "d7b58b91eb7043568967a1440dcb93cdd738fa2a49b43e9734696faee67357e3"}}, "hash": "c4bb86d81b79e861b69c419502b2cb02bda6920fe186aa80ec4d02916f385d9b", "text": "retrovirus family HERV-K(HML-2). J. Virol. 79:876\u2013883.\nL\u00f6wer, R., Boller, K., Hasenmaier, B., Korbmacher, C., Mueller-Lantzsch,\nN., L\u00f6wer, J., and Kurth, R. 1993. Identification of humanendogenous retroviruses with complex mRNA expression andparticle formation. Proc. Natl. Acad. Sci. 90:4480\u20134484.\nL\u00f6wer, R., L\u00f6wer, J., and Kurth, R. 1996. The viruses in all of us:\nCharacteristics and biological significance of human endogenousretrovirus sequences. Proc. Natl. Acad. Sci. 93:5177\u20135184.\nMayer, J., Sauter, M., Racz, A., Scherer, D., Mueller-Lantzsch, N., and\nMeese, E. 1999. An almost-intact human endogenous retrovirus K onhuman chromosome 7. Nat. Genet. 21:257\u2013258.\nMedstrand, P. and Mager, D.L. 1998. Human-specific integrations of the\nHERV-K endogenous retrovirus family. J. Virol. 72:9782\u20139787.\nMuster, T., Waltenberger, A., Grassauer, A., Hirschl, S., Caucig, P.,\nRomirer, I., Fodinger, D., Seppele, H., Schanab, O.,Magin-Lachmann, C., et al. 2003. An endogenous retrovirus derivedfrom human melanoma cells. Cancer Res. 63:8735\u20138741.\nPyra, H., Boni, J., and Schupbach, J. 1994. Ultrasensitive retrovirus\ndetection by a reverse transcriptase assay based on productenhancement. Proc. Natl. Acad. Sci. 91:1544\u20131548.\nReus, K., Mayer, J., Sauter, M., Scherer, D., Muller-Lantzsch, N., and\nMeese, E. 2001. Genomic organization of the human endogenousretrovirus HERV-K(HML-2.HOM) (ERVK6) on chromosome 7.Genomics 72:314\u2013320.\nRuda, V.M., Akopov, S.B., Trubetskoy, D.O., Manuylov, N.L.,\nVetchinova, A.S., Zavalova, L.L., Nikolaev, L.G., and Sverdlov, E.D.2004. Tissue specificity of enhancer and promoter activities of aHERV-K(HML-2) LTR. Virus Res. 104: 11\u201316.\nSteinhuber, S., Brack, M., Hunsmann, G., Schwelberger, H., Dierich,\nM.P., and Vogetseder, W. 1995. Distribution of human endogenousretrovirus HERV-K genomes in humans and different primates. Hum.\nGenet. 96:188\u2013192.\nStoye, J.P., Moroni, C., and Coffin, J.M. 1991. Virological events leading\nto spontaneous AKR thymomas. J. Virol. 65:1273\u20131285.\nTristem, M. 2000. Identification and characterization of novel human\nendogenous retrovirus families by phylogenetic screening of thehuman genome mapping project database. J. Virol. 74:3715\u20133730.\nTurner, G., Barbulescu, M., Su, M., Jensen-Seaman, M.I., Kidd, K.K., and\nLenz, J. 2001. Insertional polymorphisms of full-length endogenousretroviruses in humans. Curr. Biol. 11:1531\u20131535.\nVillesen, P., Aagaard, L., Wiuf, C., and Pedersen, F.S. 2004. Identification\nof endogenous retroviral reading frames in the human genome.Retrovirology 1:32.\nWilkinson, D.A., Mager, D.L., and Leong, J.A.C. 1994.", "start_char_idx": 5825, "end_char_idx": 8423, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a2c4c8de-ebeb-407c-b16b-ca2aaa323899": {"__data__": {"id_": "a2c4c8de-ebeb-407c-b16b-ca2aaa323899", "embedding": null, "metadata": {"page_label": "9", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9ee5af03-ad45-4d50-badb-990e0c2a9fdd", "node_type": null, "metadata": {"page_label": "9", "file_name": "1_PhoenixVirus.pdf"}, "hash": "0d13b50a9e7321037cf837473908d3d5ee5bdf477757e60a02be5e9b6e433d99"}, "2": {"node_id": "e19f52dc-0427-4d13-9142-cf1265c38a5b", "node_type": null, "metadata": {"page_label": "9", "file_name": "1_PhoenixVirus.pdf"}, "hash": "c4bb86d81b79e861b69c419502b2cb02bda6920fe186aa80ec4d02916f385d9b"}}, "hash": "d7b58b91eb7043568967a1440dcb93cdd738fa2a49b43e9734696faee67357e3", "text": "Mager, D.L., and Leong, J.A.C. 1994. Endogenous\nhuman retroviruses. In The retroviridae (ed. J.A. Levy), pp. 465\u2013535.\nPlenum Press, New York.\nReceived May 28, 2006; accepted in revised form August 30, 2006.Dewannieux et al.\n1556 Genome Research\nwww.genome.org Cold Spring Harbor Laboratory Press  on April 10, 2020 - Published by genome.cshlp.org Downloaded from", "start_char_idx": 8425, "end_char_idx": 8787, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2ef1cba7-494e-4372-b09d-4477f20768bd": {"__data__": {"id_": "2ef1cba7-494e-4372-b09d-4477f20768bd", "embedding": null, "metadata": {"page_label": "10", "file_name": "1_PhoenixVirus.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c0b96265-ec2e-495a-a56e-5d30cb2be073", "node_type": null, "metadata": {"page_label": "10", "file_name": "1_PhoenixVirus.pdf"}, "hash": "4454b313f06be91c1dd1c534d0b6028e38e172599b08367c26de0def5fbca340"}}, "hash": "864801f51fa60f49e958317d8ab34b7fc9f198d3a73e27f8099a9c44f8224455", "text": "10.1101/gr.5565706 Access the most recent version at doi:2006 16: 1548-1556 originally published online October 31, 2006 Genome Res.\u00a0\u00a0 Marie Dewannieux, Francis Harper, Aur\u00e9lien Richaud, et al. \u00a0 HERV-K human endogenous retroelementsIdentification of an infectious progenitor for the multiple-copy\n\u00a0 MaterialSupplemental\n\u00a0  http://genome.cshlp.org/content/suppl/2006/11/06/gr.5565706.DC1\n\u00a0 References\n\u00a0  http://genome.cshlp.org/content/16/12/1548.full.html#ref-list-1This article cites 34 articles, 16 of which can be accessed free at:\n\u00a0 License\nServiceEmail Alerting\n\u00a0  click here. top right corner of the article or Receive free email alerts when new articles cite this article - sign up in the box at the\n http://genome.cshlp.org/subscriptionsgo to: Genome Research To subscribe to \nCopyright \u00a9 2006, Cold Spring Harbor Laboratory Press Cold Spring Harbor Laboratory Press  on April 10, 2020 - Published by genome.cshlp.org Downloaded from", "start_char_idx": 0, "end_char_idx": 942, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b7d331f8-0996-4965-a7cc-51e38e45bb9d": {"__data__": {"id_": "b7d331f8-0996-4965-a7cc-51e38e45bb9d", "embedding": null, "metadata": {"page_label": "1", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "58038d3c-d0cb-4127-b0a6-c6c43d4e3e61", "node_type": null, "metadata": {"page_label": "1", "file_name": "3_Covid.pdf"}, "hash": "178aa8d78aa4b66bd009df2ddc8452f620a0c982f55d372a0b2cdf42684c302f"}}, "hash": "0828e56521aa5456ab94ab760bda9de5ab0e11f7d205b28721f0e54a3850cc9a", "text": "1Title: Rapid reconstruction of SARS-CoV -2 using a synthetic genomics platform 1 \nShort title: In yeast genome engineering of RNA viruses 2 \nTran Thi Nhu Thao\u00b6, 1,2,3, Fabien Labroussaa\u00b6, 2,4, Nadine Ebert \u00b6, 1,2, Philip V\u2019kovski1,2, 3 \nHanspeter Stalder1,2, Jasmine Portmann1,2, Jenna Kelly1,2, Silvio Steiner1,2,3, Melle 4 \nHolwerda1,2,3,5,  Annika Kratzel1,2,3, Mitra Gultom1,2,3,5, Laura Laloli1,2,3,5, Linda H\u00fcsser1,2, 5 \nManon Wider5, Stephanie Pfaender1,2, Dagny Hirt1,2, Valentina Cipp\u00e02,4, Silvia Crespo- 6 \nPomar2,4, Simon Schr\u00f6der6, Doreen Muth6,7, Daniela Niemeyer6,7, Marcel A. M\u00fcller6,7,8, 7 \nChristian Drosten6,7, Ronald Dijkman1,2,5, Joerg Jores\u00a7,*, 2,4, Volker Thiel\u00a7,*, 1,2 8 \n1Institute of Virology and Immunology (IVI), Bern, Switzerland 9 \n2Department of Infectious Diseases and Pathobi ology, Vetsuisse Faculty, University of Bern, 10 \nBern, Switzerland 11 \n3Graduate School for Biomedical Science, Un iversity of Bern, Bern, Switzerland 12 \n4Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern, Bern, Switzerland 13 \n5Insitute for Infectious Diseases, University of Bern, Bern, Switzerland 14 \n6Institute of Virology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, corporate member of Freie 15 \nUniversit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, 16 \nGermany  17 \n7German Centre for Infection Research, asso ciated partner Charit\u00e9, Berlin, Germany. 18 \n8Martsinovsky Institute of Medical Parasitology, Tropical and Vector Borne Diseases, 19 \nSechenov University, Moscow, Russia. 20 \n 21 \n\u00b6, \u00a7: equally contributed 22 \n*corresponding authors:  23 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 1842, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "52eb706a-16b9-4ad3-a32d-309ff00212c6": {"__data__": {"id_": "52eb706a-16b9-4ad3-a32d-309ff00212c6", "embedding": null, "metadata": {"page_label": "2", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c8f396ef-0baa-4633-9b38-a0eb9a243cee", "node_type": null, "metadata": {"page_label": "2", "file_name": "3_Covid.pdf"}, "hash": "9eb9744f0aee7c9fef96a6bec9c4ce25edb6eeedad6d6334a3d41f391277245a"}}, "hash": "b179b8324b435a884cfa33bc0fd35ca63760fc71d7682811fbfeb000e8c3cae4", "text": "2Volker Thiel; e-mail: volker.thiel@vetsuisse.unibe.ch ; phone: +41-31-6312413 24 \nJoerg Jores; e-mail: joerg.jores@vetsuisse.unibe.ch ;  phone: +41-31-6312414 25 \nAbstract : 207 words ; main text : 2373 words. 26 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 433, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b51a406d-d29a-4573-a6db-ea49cf8b096d": {"__data__": {"id_": "b51a406d-d29a-4573-a6db-ea49cf8b096d", "embedding": null, "metadata": {"page_label": "3", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7ef34fde-d145-4415-a33a-c810b2b0a5bb", "node_type": null, "metadata": {"page_label": "3", "file_name": "3_Covid.pdf"}, "hash": "8e64971bae3c64dea64f10459d5f367d5acb2c4201661c432eeacdb9952661d0"}}, "hash": "c0a0bd0bd59e2a120f1cca7601102ff43d014e31e9acf8b549e303a31ad73c71", "text": "3Abstract 27 \nReverse genetics has been an indispensable tool revolutionising our insights into viral 28 \npathogenesis and vaccine development. Large RNA virus genomes, such as from 29 \nCoronaviruses, are cumbersome to clone and to manipulate in E. coli  hosts due to size and 30 \noccasional instability1-3. Therefore, an alternative rapid and robust reverse genetics platform 31 \nfor RNA viruses would benefit the research community. Here we show the full functionality 32 \nof a yeast-based synthetic genomics platform for the genetic reconstruction of diverse RNA 33 \nviruses, including members of the Coronaviridae , Flaviviridae  and Paramyxoviridae  families. 34 \nViral subgenomic fragments were  generated using viral isolates, cloned viral DNA, clinical 35 \nsamples, or synthetic DNA, and reassembled in one step in Saccharomyces cerevisiae  using 36 \ntransformation associated recombination (TAR) cloning to maintain the genome as a yeast 37 \nartificial chromosome (YAC). T7-RNA polymerase has been used to generate infectious 38 \nRNA, which was then used to rescue viable virus. Based on this platform we have been able 39 \nto engineer and resurrect chemically-synthetized clones of the recent epidemic SARS-CoV-24 40 \nin only a week after receipt of the synt hetic DNA fragments. The technical advance we 41 \ndescribe here allows to rapidly responding to  emerging viruses as it enables the generation 42 \nand functional characterization of evolving RNA virus variants - in real-time - during an 43 \noutbreak.  44 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 1743, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "80e0a98d-2999-4d0a-a6ac-7a0eed28a745": {"__data__": {"id_": "80e0a98d-2999-4d0a-a6ac-7a0eed28a745", "embedding": null, "metadata": {"page_label": "4", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "47f8485b-9dcd-4b69-87bb-8fd38f8f4b01", "node_type": null, "metadata": {"page_label": "4", "file_name": "3_Covid.pdf"}, "hash": "3b639e92aef0fff2aaaabca9546263144fee8a1873d92f7e1ee74d8bda996c55"}}, "hash": "f0ad04ea28d5e09a4858b4e99f9d871887beab5c67351ca35f881fce0ca48afb", "text": "4Main Text 45 \nPopulation growth, increased travel and climate change foster epidemic and pandemic threats 46 \nby (re)emerging RNA viruses. Although black swan events cannot be predicted, our medical 47 \nsector should be ready to use th e latest advancements in science to combat emerging viruses. 48 \nWithin the past decade we have seen outbreaks of Middle-East Respiratory Syndrome 49 \ncoronavirus (MERS-CoV)5, ZIKA virus (ZIKV)6, Ebola virus7, and at the end of 2019, 50 \nSARS-CoV-2 that was first detected in Wuhan, Hubei province, China4, but meanwhile 51 \nspread throughout China and beyond. Until now SARS-CoV-2 isolates from China have not 52 \nbeen shared with health authorities and the sc ientific community, although they are urgently 53 \nneeded to build up serological diagnostics, to develop and assess antivirals and vaccines, and 54 \nto establish appropriate in vivo  models. Generation of SARS-CoV-2 from chemically 55 \nsynthesized DNA could bypass the limited availability of virus isolates and would 56 \nfurthermore allow genetic modifications and func tional characterization of individual genes. 57 \nHowever, although the workhorse E. coli  did prove very useful for cloning many viral 58 \ngenomes, it has drawbacks for a number of emerging RNA viruses, including coronaviruses, 59 \nin terms of assembling and stably maintaining full-length molecular clones.  60 \nSynthetic genomics is a field that was fuelled by the efforts to create a bacterial cell that is 61 \ncontrolled by a synthetic genome 8. Genome-wide reassembly of the ~1.1Mb Mycoplasma  62 \ngenome was first attempted using E. coli  as an intermediate host 8, but the maintenance of 63 \nthese 100-kbp DNA fragments appeared to be very difficult in this host. Therefore, the yeast 64 \nSaccharomyces cerevisiae  was chosen to clone, assemble and even mutagenize entire 65 \nMycoplasma genomes 9,10. This ultimately led to the construction of the Mycoplasma JCVI 66 \nSyn3.0, a cell carrying the minimal set of genes allowing its autonomous replication in 67 \nauxotrophic medium 11. The rationale for using a yeast cloning system is the ability of yeast to 68 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 2357, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7a70b390-e152-453f-939b-c9abd4ef4de9": {"__data__": {"id_": "7a70b390-e152-453f-939b-c9abd4ef4de9", "embedding": null, "metadata": {"page_label": "5", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab00847a-2717-4357-a270-8c37399d3c3e", "node_type": null, "metadata": {"page_label": "5", "file_name": "3_Covid.pdf"}, "hash": "44df94dabe106bb4c39819cb8b69ebb3ba4d70fdfdbae85425c57756004a0565"}}, "hash": "38f2f37dea484b99bfe7ff45e014a5f236828ff83834762da81389d5faeb3996", "text": "5recombine overlapping DNA fragments in cellulo, which led to the development of a 69 \ntechnique called \u201ctransformation-associated recombination\u201d (TAR) cloning12. 70 \nMore recently, TAR cloning was successfully applied for the assembly, genetic engineering 71 \nand rescue of large DNA viruses such as cytomegalovirus and herpes simplex virus 113,14. 72 \nWhile large DNA viruses such as herpesviruses can be rescued by transfecting the entire viral 73 \nDNA genome into eukaryotic cells, the rescue of RNA viruses requires the transcription of a 74 \nviral genomic RNA from the cloned DNA template. For coronaviruses that belong to a family 75 \nof positive-stranded RNA viruses termed Coronaviridae , the generation of full-length 76 \nmolecular clones has long been hampered by the extraordinary genome size (27-31 kb) and 77 \noccasional instability of cloned DNA in E. coli. It took until 2000/2001 before unconventional 78 \napproaches, such as cloning in low copy bacterial artificial chromosomes (BACs) or vaccinia 79 \nvirus, or cloning of subgenomic DNA fragments followed by in-vitro  ligation, were 80 \nsuccessful1-3. However, each system has caveats leaving the generation of recombinant 81 \ncoronaviruses cumbersome. We therefore aimed to assess the use of the yeast S. cerevisiae  to 82 \nassemble and maintain genomes of diverse RNA viruses in order to establish a rapid, stable, 83 \nand universal reverse genetic s pipeline for RNA viruses. 84 \nIn an effort to adopt a yeast-based reverse geneti cs platform to RNA viru ses we first tested the 85 \nMurine hepatitis virus strain A59 containing the gene for the green fluorescent protein (MHV- 86 \nGFP), which is routinely used in our laboratory and has an established vaccinia virus-based 87 \nreverse genetics platform15,16. The overall strategy is shown in Fig. 1a. Viral RNA was 88 \nprepared from MHV-GFP-infected murine 17Cl-1 cells and used to amplify 7 overlapping 89 \nDNA fragments by RT-PCR together spanning the MHV-GFP genome from nt 2024 to nt 90 \n29672. Fragments containing the 5\u2019- and 3\u2019-termini were PCR-amplified from the vaccinia 91 \nvirus-cloned genome to include a T7-RNA polymerase promoter and a cleavage site ( PacI) 92 \nfollowing the polyA sequence. Overlaps to the TAR vector pVC604 were included in the 93 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 2505, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c584229e-aeda-4a04-b52d-e8d3b73e52e9": {"__data__": {"id_": "c584229e-aeda-4a04-b52d-e8d3b73e52e9", "embedding": null, "metadata": {"page_label": "6", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e506c5dc-b575-4b7f-b2bb-6a5405548aac", "node_type": null, "metadata": {"page_label": "6", "file_name": "3_Covid.pdf"}, "hash": "04cac956b408995655bb182c5fc08e0a81a994451c58866a134b35a12e945d0b"}}, "hash": "e553833aa4d58da569595eb20eefb4d12a38f7bf76867c01e58a5f7dd01fd860", "text": "6primers used to amplify the 5\u2019- and 3\u2019-terminal fragments and the pVC604 backbone that was 94 \nalso generated by PCR (Fig. 1b, Table 1, Extend ed Data Table 1, Extended Data Figure 1a). 95 \nAll DNA fragments were used to transform Saccharomyces cerevisiae  (strain VL6-48N) and 96 \nresulting colonies were screened for corre ct assembly of the YAC containing the MHV 97 \ngenome by multiplex PCRs that covered the junctions of the different fragments. This screen 98 \nrevealed that > 90 % of the clones tested were positive indicating a highly efficient assembly 99 \nin yeast (Extended Data Figure 1a). To rescue MHV-GFP we randomly chose two clones, 100 \npurified the YAC, linearized the plas mid using the restriction endonuclease PacI (Extended 101 \nData Table 2) and subjected it to T7 RNA polymerase-based in vitro  transcription to generate 102 \ncapped viral genomic RNA. This RNA was transfected together with an in vitro  transcribed 103 \nmRNA encoding the MHV nucleocapsid (N) protein into BHK-MHV-N cells as previously 104 \ndescribed15. Transfected BHK-MHV-N cells were mixed with MHV-susceptible 17Cl-1 cells 105 \nand cytopathic effect (CPE), virus-induced sy ncytia, and GFP-expressing cells were readily 106 \ndetectable for both clones within 48 hours, indi cating successful recovery of infectious virus 107 \n(Fig. 1c). Finally, we assessed the replication kinetics of the recovered viruses, which were 108 \nindistinguishable compared to the parental MHV-GFP (Fig. 1d). 109 \nTo address if the synthetic genomics platform can be applied to other coronaviruses, and if it 110 \ncan be used for rapid mutagenesis, we used a molecular BAC clone of MERS-CoV17. We 111 \nPCR-amplified eight subgenomic overlapping DN A fragments covering the entire MERS- 112 \nCoV genome (Figure 2a, Extended Data Figure 1b, Extended Data Table 1). The 5\u2019- and 3\u2019- 113 \nterminal DNA fragments contai ned the T7-RNA polymerase promoter upstream the MERS- 114 \nCoV 5\u2019-end and a restriction endonuclease cleavage site MluI  downstream the polyA 115 \nsequence, and overlapping sequences with the TAR plasmid pVC604. To mutagenize the 116 \nMERS-CoV clone and introduce the GFP gene, fra gment 7 was modified to overlap with the 117 \nPCR-amplified GFP gene. Following transformation  almost all YAC clones were positive for 118 \nthe junctions indicating a successful assembly (Figure 2a, Extended Data Figure 1b). Virus 119 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 2626, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "aa2c6917-796d-4808-8bd8-bfb35d4b4d79": {"__data__": {"id_": "aa2c6917-796d-4808-8bd8-bfb35d4b4d79", "embedding": null, "metadata": {"page_label": "7", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "825498ea-067a-47a3-be1a-ff41fd529cde", "node_type": null, "metadata": {"page_label": "7", "file_name": "3_Covid.pdf"}, "hash": "a7c0405c2ccb89aa1fc6daedb780df35f50ce7c2ab9eb31a9f2c92b6a8651fce"}}, "hash": "6868392124c140316eef1e7242a620ad125915440d5ee4a78505cc90fc4f10d4", "text": "7rescue from cloned DNA was performed as described previously17 and virus-induced CPE 120 \nbecame apparent in VeroB4 cells inoculated with recovered recombinant MERS-CoV (Fig. 121 \n2b). Importantly, we could readily detect green fluorescent VeroB4 cells that had been 122 \ninfected with recovered MERS-CoV-GFP demonstr ating that the synthetic genomics platform 123 \nis suitable to genetically modify coronaviru s genomes (Fig. 2b). As expected replication 124 \nkinetics of recombinant MERS-CoV and MERS-C oV-GFP were slightly reduced compared to 125 \ncell-culture-adapted MERS-CoV-EMC (Fig. 2c). 126 \nHaving shown that the TAR cloning approach is robust and reproducible, we aimed to 127 \nthoroughly evaluate the system concerning stability of cloned sequences, the range of 128 \napplicability to other virus genomes, and if molecular clones can even be generated from 129 \nclinical samples. The yeast clones contai ning YACs encoding MHV-GFP and MERS-CoV 130 \nwere passaged 15-17 times followed  by re-sequencing. Results of this experiment were very 131 \nsupportive of the yeast-based platform (Extended Data Table 3), since the genomes could be 132 \nstably maintained and no mutations arose. We then embarked on cloning a number of other 133 \ncoronaviruses (HCoV-229E2, HCoV-HKU1; GenBank: NC_006577, MERS-CoV-Riyadh- 134 \n1734-2015; GenBank: MN481979) and viruses of other families, such as ZIKV (family 135 \nFlaviviridae , GenBank: KX377337) and human respiratory-syncytial-virus (hRSV; family 136 \nParamyxoviridae ) (Table 1) that are known to be difficult to clone and stably maintain in E. 137 \ncoli. As shown in Extended data Figure 1d-h, we  followed the same strategy to prepare the 138 \ngenome termini in cloned plasmids to include genetic elements that are later needed for virus 139 \nrescue (e.g. T7-RNA polymerase promoter, cleavages sites or ribozyme elements) and 140 \nproduced a set of overlapping DNA fragments covering the rest of the genome. This strategy 141 \nproved to be successful irrespectively of the source of virus or nucleic acid template or the 142 \nnumber of DNA fragments that were used for the one-step assembly in yeast. Of note, we 143 \nwere also able to clone hRSV-B, without any prior information on the virus genotype, directly 144 \nfrom a clinical sample (nasopharyngeal aspira te) by designing RSV consensus primers to 145 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 2584, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0aeb9b04-bf9b-4e59-8f90-b4e427ac34b1": {"__data__": {"id_": "0aeb9b04-bf9b-4e59-8f90-b4e427ac34b1", "embedding": null, "metadata": {"page_label": "8", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "31b57863-aad5-4d81-8864-cfffe5731a95", "node_type": null, "metadata": {"page_label": "8", "file_name": "3_Covid.pdf"}, "hash": "485a138fd558237823916f5fc1d0852c5575e1dba9e5448e91afd0bd18e560a5"}}, "hash": "594754b5ea39468bd1973eef77cd95f4c85c42e848ab3ec2f7554fcb6b039a5f", "text": "8amplify 4 overlapping DNA fragments (sequence submitted to GenBank).  Collectively, these 146 \nresults demonstrate the synthetic genomics platform provides the technical advance to rapidly 147 \ngenerate molecular clones of diverse RNA vi ruses by using viral isolates, cloned DNA, 148 \nsynthetic DNA, and even clinical samples as starting material. 149 \nThe appearance of a novel CoV in China at th e end of 2019 prompted us to go a step further 150 \nand to test the applicability of our synthetic ge nomics platform to reconstruct the virus based 151 \non its released genome sequence and chemically synthesized DNA fragments. Notably, at the 152 \ntime when the first genome sequences of  SARS-CoV-2 were released (Jan 10/11th, 2020) no 153 \nvirus isolate has been made available and it took until the end of January 2020 when 154 \nsuccessful isolation of SARS-CoV-2 was reported from patients in Australia 155 \n(https://www.the-scientist.com/news-opinion/australian-lab-cultures-new-coronavirus-as- 156 \ninfections-climb-67031). We fragmented the genome into 12 subgenomic DNA fragments 157 \nranging in size between 0.5-3.4 kbp (Fig. 3a, Ex tended Data Figure 1i, Extended Data Tables 158 \n1, 4). In parallel, we also aimed to generate  a SARS-CoV-2 expressing GFP that could be 159 \nvaluable to facilitate the establishment of se rological diagnostics (e.g. virus neutralization 160 \nassay) and detection in cell culture. To do this  we divided fragment 11  into 3 sub-fragments 161 \n(Fig. 3a, Extended Data Figure 1i, Extended Data Tables 1, 4) to include the GFP sequence, 162 \nwhich was inserted in frame within the ORF7a. We noticed at the 5\u2019 end of the reported 163 \nSARS-CoV-2 sequence that nucleotides 3-5 (5\u2019-AUUAAAGG; Genbank MN996528.1) were 164 \ndifferent compared to the closely re lated SARS-CoV (5\u2019-AUAUUAGG; GenBank 165 \nAY291315) and to the even more closely related bat SARS-related CoVs ZXC21 and ZC45 166 \n(5\u2019-AUAUUAGG)18, and that for all three the 5\u2019-end has been experimentally determined by 167 \n5\u2019-RACE4,18,19. Therefore, we designed three 5\u2019-end versions of fragment 1 containing the 168 \nreported SARS-CoV-2 sequence (fragment 1.3; 5\u2019-AUUAAAGG), a version modified by 3 169 \nnucleotides (fragment 1.1; 5\u2019-AUAUUAGG), and a version containing the 124 5\u2019-terminal 170 \nnucleotides spanning the first four 5\u2019-termina l stem-loop structures of SARS-CoV (fragment 171 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 2610, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "168962aa-34c0-4d80-b3e1-d5a2bee2f615": {"__data__": {"id_": "168962aa-34c0-4d80-b3e1-d5a2bee2f615", "embedding": null, "metadata": {"page_label": "9", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b42026b7-52ac-4c0d-9323-569519f16406", "node_type": null, "metadata": {"page_label": "9", "file_name": "3_Covid.pdf"}, "hash": "56b1a2d94240b375874f782a323bf2ba8789bd5b585bfe9427e69f04714c5da6"}}, "hash": "eadac9325a357a627a42bdef125096aca43663801d52026179e88b73cb85cf8a", "text": "91.2; Fig. 3b). Notably, nucleotide differenc es between SARS-CoV-2 and SARS-CoV within 172 \nthis region are in agreement with the predicted RNA secondary structures (Fig. 3b).  173 \nWe ordered the synthetic DNA constructs on January 14th (Fig. 3d, Extended data Table 4, 174 \nExtended Data Document 1), and until February 4th 12 of 14 constructs were delivered as 175 \nsequence-confirmed plasmids. However, fragments  5 and 7 turned out to be problematic to 176 \nclone in E. coli  and could not be delivered. Since we received at the same time SARS-CoV-2 177 \nviral RNA obtained from an isolate of a Munich patient (SARS-CoV-2/M\u00fcnchen- 178 \n1.1/2020/929), we decided to amplify the regions of fragments 5 and 7 by RT-PCR. TAR 179 \ncloning was immediately initiated, and for all 6 SARS-CoV-2 constructs we obtained 180 \ncorrectly assembled molecular clones (3 versio ns of the 5\u2019-end and each version with and 181 \nwithout GFP; Extended Data Fig. 2). Since sequence verification was not possible within this 182 \nshort time frame, we randomly selected two clones for each construct for rescuing 183 \nrecombinant rSARS-CoV-2 and rSARS-CoV-2-GFP. YAC DNA were isolated, in vitro  184 \ntranscribed and the resulting RNAs electropor ated together with an mRNA encoding the 185 \nSARS-CoV-2 N protein into BHK-21 and, in parallel, into BHK-SARS-N cells expressing the 186 \nSARS-CoV N protein20. The BHK-21 and BHK-SARS-N cells were seeded over VeroE6 187 \ncells and at two days post electroporation we ob served green fluorescent signals in cells that 188 \nreceived the GFP-encoding SARS-CoV-2 RNAs. Indeed supernatants transferred to fresh 189 \nVeroE6 cells contained infectious recombinant viruses for almost all recombinant rSARS- 190 \nCoV-2 and rSARS-CoV-GFP constructs (Extended Data Fig. 2). As shown in Figure 3c for 191 \nSARS-CoV-2 clones 1.1, 2.2, and 3.1, plaque s were detectable on VeroE6 cells that were 192 \ninoculated with supernatants containing th e RNA-electroporated ce lls, demonstrating the 193 \ninfectious virus has been recovered for r ecombinant rSARS-CoV-2 and for the variants 194 \ncontaining modified 5\u2019-termini. Similarly, we could detect green fluorescent cells on VeroE6 195 \nmonolayers that were inoculated with supernatants from RNA-electroporated cells of rSARS- 196 \nCoV-2-GFP clones 4.1, 5.2 and 6.1, demonstrating that recombinant GFP-expressing viruses 197 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 2607, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ea439a48-6c02-45a4-8e67-14c10dbfcc01": {"__data__": {"id_": "ea439a48-6c02-45a4-8e67-14c10dbfcc01", "embedding": null, "metadata": {"page_label": "10", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "32f6faf4-f7b0-4b0b-b7ab-fa52e7b01eb2", "node_type": null, "metadata": {"page_label": "10", "file_name": "3_Covid.pdf"}, "hash": "318e30fe6f77827fef240e8d05223f2004d6f2e039598a8e154dd973a86a9d38"}}, "hash": "b379596b88c72d5938170e6b80f041068c09f0ad2b2ddcb6f10abc4b9a67dc27", "text": "10have been recoverd for all 5\u2019-end variants. This result demonstrates the full functionality of 198 \nthe SARS-CoV-2 reverse genetics  system and also shows that the 5\u2019-ends of SARS-CoV and 199 \nbat SARS-related CoVs ZXC21 and ZC45 are compatible with the replication machinery of 200 \nSARS-CoV-2. 201 \nWe expect that the fast, robust and versatile synthetic genomics platform we describe here 202 \nwill provide new insights into the molecular biology and pathogenesis of a number of 203 \nemerging RNA viruses and will specifically facilitate the molecular characterization of the 204 \nnovel coronavirus SARS-CoV-2. Although homologous recombination in yeast has already 205 \nbeen used for the generation of a number of molecular virus clones in the past13,14,21, we 206 \npresent here a thorough evaluation of the feasibility of this approach to rapidly generate full- 207 \nlength cDNAs for large RNA viruses that have a known history of instability in E. coli . We 208 \nshow that one main advantage of the TAR cloning system is that the viral genomes can be 209 \nfragmented to at least 14 overlapping fragments and re-assembled with remarkable efficacy 210 \n(usually >90% of the clones are correct). This allowed us to complete the cloning and rescue 211 \nof rSARS-CoV-2 and rSARS-CoV-2-GFP within one week. It should also be noted that we 212 \nsee considerable potential to reduce the ti me of DNA synthesis. Currently, synthetic DNA 213 \nfragments are still routinely cloned in E. coli , which turned out to be problematic for SARS- 214 \nCoV-2 fragments 5 and 7. We could however use 4 and 3 shorter dsDNA parts of fragments 5 215 \nand 7, respectively, that we received, to assemble the full-length fragments 5 and 7 by TAR 216 \ncloning which is an additional proof of the s uperior cloning efficiency of our yeast system 217 \nversus E. coli -based systems. This allowed us to ge nerate a molecular clone of SARS-CoV-2 218 \nby using exclusively chemically synthesized DNA,  and the rescue of this version is currently 219 \nin progress.  220 \nThe appearance of SARS-CoV-2 emphasizes the need for preparedness to rapidly respond to 221 \nemerging virus threats. While the availability of SARS-CoV-2 isolates is still limited, full 222 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 2454, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "48d17c72-bc9e-4ea8-9f86-e2188a8102c8": {"__data__": {"id_": "48d17c72-bc9e-4ea8-9f86-e2188a8102c8", "embedding": null, "metadata": {"page_label": "11", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cac5159c-9ab7-41ee-9f10-ca69789a719f", "node_type": null, "metadata": {"page_label": "11", "file_name": "3_Covid.pdf"}, "hash": "1e53d40119716d0453dd3a653361f46a2f23d5dafc853f743475c28ce2ea06eb"}}, "hash": "91bd17d091f7e2475fbe7b7a1b78eab462cc590af2c3fbd8d0cae633ac1c8e95", "text": "11virus genome sequences were disclosed very early during the outbreak. The rapidity of our 223 \nsynthetic genomics approach to generate SARS-CoV-2 and the applicability to other 224 \nemerging RNA viruses make this system an attractive alternative to provide infectious virus 225 \nto health authorities and diagnostic laboratories without the need to have access to clinical 226 \nsamples. Finally, as the SARS-CoV-2 outbreak is ongoing, we expect to see sequence 227 \nvariations and possibly phenotypic changes of evolving SARS-CoV-2 in the human host. 228 \nWith the synthetic genomics platform it is now  possible to introduce such sequence variations 229 \ninto the infectious clone and to functionally ch aracterize SARS-CoV-2 evolution in real-time. 230 \n 231 \n  232 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 989, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9cb2cfc3-2ab8-4b29-a0e1-4253dbac5f55": {"__data__": {"id_": "9cb2cfc3-2ab8-4b29-a0e1-4253dbac5f55", "embedding": null, "metadata": {"page_label": "12", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "86d31c25-af43-4738-8006-7731b59af8cd", "node_type": null, "metadata": {"page_label": "12", "file_name": "3_Covid.pdf"}, "hash": "645f6f4ea22c3f76a41471380692ea8ae6a0d379a6aa18c01e88c2e5325da303"}}, "hash": "f2d6adf3231f2dd15509ef06878474047125fc0dee0d0b105b2435a44d88e256", "text": "12References 233 \n1 Almazan, F.  et al.  Engineering the largest RNA virus genome as an infectious 234 \nbacterial artificial chromosome. Proc Natl Acad Sci U S A  97, 5516-5521, 235 \ndoi:10.1073/pnas.97.10.5516 (2000). 236 \n2 Thiel, V., Herold, J., Schelle, B. & Siddell, S. G. Infectious RNA transcribed in vitro 237 \nfrom a cDNA copy of the human coronavirus genome cloned in vaccinia virus. J Gen 238 \nVirol  82, 1273\u20131281 (2001). 239 \n3 Yount, B., Curtis, K. M. & Baric, R. S. Strategy for systematic assembly of large RNA 240 \nand DNA genomes: transmissible gastroenteritis virus model. J Virol 74, 10600- 241 \n10611, doi:10.1128/jvi.74.22.10600-10611.2000 (2000). 242 \n4 Zhu, N.  et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019. N 243 \nEngl J Med , doi:10.1056/NEJMoa2001017 (2020). 244 \n5 Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. & Fouchier, R. A. 245 \nIsolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl 246 \nJ Med  367, 1814-1820, doi:10.1056/NEJMoa1211721 (2012). 247 \n6 Cao-Lormeau, V. M.  et al.  Zika virus, French polynesia, South pacific, 2013. Emerg 248 \nInfect Dis  20, 1085-1086, doi:10.3201/eid2006.140138 (2014). 249 \n7 Baize, S.  et al.  Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 371, 250 \n1418-1425, doi:10.1056/NEJMoa1404505 (2014). 251 \n8 Gibson, D. G.  et al.  Creation of a Bacterial Cell Controlled by a Chemically 252 \nSynthesized Genome. Science  329, 52-56, doi:science.1190719 [pii] 253 \n10.1126/science.1190719 (2010). 254 \n9 Lartigue, C.  et al.  Creating bacterial strains from genomes that have been cloned and 255 \nengineered in yeast. Science  325, 1693-1696, doi:1173759 [pii] 256 \n10.1126/science.1173759 (2009). 257 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 1977, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "85b83824-3ce3-4c3e-9492-3cf97e4632b8": {"__data__": {"id_": "85b83824-3ce3-4c3e-9492-3cf97e4632b8", "embedding": null, "metadata": {"page_label": "13", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9a1339b5-f26d-4c46-a509-9b1d4b9ccb77", "node_type": null, "metadata": {"page_label": "13", "file_name": "3_Covid.pdf"}, "hash": "b94529f0bcfd175f4017559bf57bde62f1d878e5dd9a564f2fcae6475055ab38"}}, "hash": "c1b4d0a847f3c458051deaba1ecbf048201cc9dc3f39928703f11210f1ce23e5", "text": "1310 Benders, G. A. et al.  Cloning whole bacterial genomes in yeast. Nucleic Acids Res  38, 258 \n2558-2569, doi:10.1093/nar/gkq119 (2010). 259 \n11 Hutchison, C. A., 3rd  et al.  Design and synthesis of a minimal bacterial genome. 260 \nScience  351, aad6253, doi:10.1126/science.aad6253 (2016). 261 \n12 Kouprina, N. & Larionov, V. Selective isolation of genomic loci from complex 262 \ngenomes by transformation-associated recombination cloning in the yeast 263 \nSaccharomyces cerevisiae. Nat Protoc 3, 371-377, doi:10.1038/nprot.2008.5 (2008). 264 \n13 Vashee, S.  et al.  Cloning, Assembly, and Modification of the Primary Human 265 \nCytomegalovirus Isolate Toledo by Yeast-Based Transformation-Associated 266 \nRecombination. mSphere  2, doi:10.1128/mSphereDirect.00331-17 (2017). 267 \n14 Oldfield, L. M.  et al.  Genome-wide engineering of an infectious clone of herpes 268 \nsimplex virus type 1 using synthetic genomics assembly methods. Proc Natl Acad Sci 269 \nU S A 114, E8885-E8894, doi:10.1073/pnas.1700534114 (2017). 270 \n15 Coley, S. E.  et al.  Recombinant mouse hepatitis virus strain A59 from cloned, full- 271 \nlength cDNA replicates to high titers in vitro and is fully pathogenic in vivo. J Virol 272 \n79, 3097-3106, doi:10.1128/JVI.79.5.3097-3106.2005 (2005). 273 \n16 Zust, R.  et al.  Coronavirus non-structural protein 1 is a major pathogenicity factor: 274 \nimplications for the rational design of coronavirus vaccines. PLoS Pathog 3, e109, 275 \ndoi:10.1371/journal.ppat.0030109 (2007). 276 \n17 Muth, D.  et al.  Transgene expression in the genome of Middle East respiratory 277 \nsyndrome coronavirus based on a novel reverse genetics system utilizing Red- 278 \nmediated recombination cloning. J Gen Virol  98, 2461-2469, 279 \ndoi:10.1099/jgv.0.000919 (2017). 280 \n18 Hu, D. et al.  Genomic characterization and infectivity of a novel SARS-like 281 \ncoronavirus in Chinese bats. Emerg Microbes Infect  7, 154, doi:10.1038/s41426-018- 282 \n0155-5 (2018). 283 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 2195, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "20312873-d71f-4e69-a174-fbf4cf841258": {"__data__": {"id_": "20312873-d71f-4e69-a174-fbf4cf841258", "embedding": null, "metadata": {"page_label": "14", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ae16cc8a-f01d-4f92-9cec-074f198aface", "node_type": null, "metadata": {"page_label": "14", "file_name": "3_Covid.pdf"}, "hash": "62e1b6774328967a1fe181a59d4d5d9151e0c29e6b6ea736a5edbcdee35b2400"}}, "hash": "154db0be775afbd257227322bfcff8e28fe33e035aeff27efad383d3e6876538", "text": "1419 Thiel, V.  et al.  Mechanisms and enzymes involved in SARS coronavirus genome 284 \nexpression. J Gen Virol 84, 2305-2315, doi:10.1099/vir.0.19424-0 (2003). 285 \n20 van den Worm, S. H.  et al. Reverse genetics of SARS-related coronavirus using 286 \nvaccinia virus-based recombination. PLoS One  7, e32857, 287 \ndoi:10.1371/journal.pone.0032857 (2012). 288 \n21 Polo, S., Ketner, G., Levis, R. & Falgout, B. Infectious RNA transcripts from full- 289 \nlength dengue virus type 2 cDNA clones made in yeast. J Virol  71, 5366-5374 (1997). 290 \n22 Chan, J. F.  et al.  Genomic characterization of the 2019 novel human-pathogenic 291 \ncoronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. 292 \nEmerg Microbes Infect  9, 221-236, doi:10.1080/22221751.2020.1719902 (2020). 293 \n 294 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 1025, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d27c9f49-1eb1-42d1-9227-fbd9d211652a": {"__data__": {"id_": "d27c9f49-1eb1-42d1-9227-fbd9d211652a", "embedding": null, "metadata": {"page_label": "15", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c470acc8-f010-45e5-9eff-29457f42fadf", "node_type": null, "metadata": {"page_label": "15", "file_name": "3_Covid.pdf"}, "hash": "b203ce834c424b01d2b0a4f65628e03324c715a910cd7b0e3683f830ce66534e"}}, "hash": "1890db6057eafcaf0031a79763d9798dd8060643a49916bfbf1445b9a497890c", "text": "15Acknowledgements 295 \nThis work was supported by the European Commission (Marie Sklodowska-Curie Innovative 296 \nTraining Network \u201cHONOURS\u201d; grant agreement No 721367), the Swiss National Science 297 \nFoundation (SNF; grants CRSII3_160780, and 310030_173085), the German Research 298 \nCouncil (DFG; grants SFB-TR84 (TRR 84/3, A07), and DR 772/7-2), the Federal Ministry of 299 \nEducation and Research (BMBF; grant RAPID, #01KI1723A) and by core funds of the 300 \nUniversity of Bern. We thank the J. Craig Ve nter Institute (JCVI) for provision of the TAR 301 \nvectors. We thank specifically Eric Sun and Tibbers Zhang and are grateful for the timely 302 \nprovision of the synthetic DNA fragments from GenScript. We thank Jeanne Peters Zocher 303 \nfrom VETCOM Z\u00fcrich for her a dvice in generating the figures and we thank Franziska Suter- 304 \nRiniker and Pascal Bittel, Institu te for Infectious Diseases, Un iversity of Bern, for providing 305 \nclinical samples. We thank Philippe Plattet, Markus Gerber, Martina Friesland, Marco Alves, 306 \nNathalie Vielle, Beatrice Zumkehr, Melanie Br\u00fcgger, Daniel Brechb\u00fchl for reagents, 307 \ntechnical advise and helpful discussions. 308 \nAuthors contributions 309 \nVT and JJ conceived the study. TT, NE and FL performed most of the experiments. PV, HS, 310 \nJP, SSt, MH, AK, MG, LL, LH, MW, SP, DH, VC, SC, SSch, DM, DN, MM, CD, RD, did 311 \nexperimental work and/or provided essential experimental systems and reagents. TT, NE, FL, 312 \nHS, JK, and RD performed sequencing including computational analyses. VT, JJ, TT, FL, NE 313 \nwrote the manuscript and made the figures. All authors read and approved the final 314 \nmanuscript. 315 \nEthical statement 316 \nThe authors are aware that this work contains aspects of Dual Use Research of Concern 317 \n(DURC). The benefits were carefully balanced against the risks and the benefits outweigh the 318 \nrisks. Permission to generate and work w ith recombinant SARS-CoV-2 and SARS-CoV-2- 319 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 2198, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "77363321-b770-412e-81da-48d61c19b271": {"__data__": {"id_": "77363321-b770-412e-81da-48d61c19b271", "embedding": null, "metadata": {"page_label": "16", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "95e1795d-5fe8-470e-81a9-fcd21e8dedb4", "node_type": null, "metadata": {"page_label": "16", "file_name": "3_Covid.pdf"}, "hash": "a45155c9311bbe1ac90ea902f2dbe3cf9998c29deff33fe3edfa60c23a3dd492"}}, "hash": "4cacb4fea41cda7236c85648908e7f999794079d0f09b323999f9a650603f6dc", "text": "16GFP was granted by the Swiss Federal Office of Public Health (#A131191/3) with 320 \nconsultation of the Federal Office for Environment, Federal Food Safety and Veterinary 321 \nOffice, and the Swiss Expert Committee for Biosafety.  322 \nCompeting interests  323 \nThe authors declare no competing interests 324 \nAdditional information 325 \nCorrespondence and requests for material should be addressed to V.T. or J.J. 326 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 640, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0542ecdf-d6dd-4f01-ae5d-bc3537611bdf": {"__data__": {"id_": "0542ecdf-d6dd-4f01-ae5d-bc3537611bdf", "embedding": null, "metadata": {"page_label": "17", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0d2b8727-73a6-4b72-b6e4-2049b1d0a154", "node_type": null, "metadata": {"page_label": "17", "file_name": "3_Covid.pdf"}, "hash": "ecf5668b6b3d9052fb098f5e3ee7466dd212f8f6e350004af6df4998ebe1e356"}}, "hash": "1764cff717597b660a036770a7c459669414dadbd71339829fd2175ff9a11827", "text": "17Figure Legends 327 \nFigure 1. Application of yeast-based TAR cloning to generate viral cDNA clones and the 328 \nrecovery of recombinant MHV-GFP. 329 \na, Schematic representation of the general work flow of TAR cloning and virus rescue. In- 330 \nyeast assembly require the delivery of over lapping DNA fragments covering the viral genome 331 \nand a TAR vector into yeast in one transformation event. Transformed DNA fragments are 332 \njoined by homologous recombination in yeast generating a YAC-cloned full-length viral 333 \ngenomic cDNA. The in vitro production of infectious capped viral RNA starts with the 334 \nisolation of the YAC, followed by plasmid linearization to provide DNA template for run-off 335 \nT7 polymerase-based transcription. Virus rescue starts with electroporation of BHK-21 and/or 336 \nBHK-21 cells expressing the corresponding coronavirus N protein, followed by co-cultivation 337 \nof electroporated cells with susceptible cell line for virus production and amplification. b, 338 \nSchematic representation of MHV-GFP genome  organisation with 9 viral subgenomic 339 \noverlapping cDNA fragments used for TAR cloning. pT7, T7 RNA polymerase promoter; 340 \nUTR, untranslated region; An, poly (A) tail; J represents assembly junction between two 341 \noverlapping DNA fragments. c, Recovery of infectious recombinant MHV-GFP. Cell culture 342 \nsupernatants containing viruses produced afte r virus rescue from two MHV-GFP YAC clones 343 \n(Clone1, Clone 2) were used to infect 17Cl-1 cells. At 48 hours post-infection, infected cells 344 \nwere visualised for GFP expression (left panels) and by bright field microscopy (right panels). 345 \nMock represents 17Cl-1 cells inoculated with supernatant from BHK-MHV-N cells 346 \nelectroporated without viral RNAs. d, Replication kinetics of parental MHV-GFP and 347 \nrecombinant MHV-GFP Clone 1 and Clone 2. L929 cells were infected at an MOI of 0.1. Cell 348 \nculture supernatants were harvested at indicated time points post-infection and titrated by 349 \nplaque assay. Data are representative of three independent experiments with two replicates per 350 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 2341, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "25a0cda0-7632-4bf1-9fdc-914bb6b30d59": {"__data__": {"id_": "25a0cda0-7632-4bf1-9fdc-914bb6b30d59", "embedding": null, "metadata": {"page_label": "18", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5b6bbc65-d3e4-44ef-a3c4-288f9e62e3d3", "node_type": null, "metadata": {"page_label": "18", "file_name": "3_Covid.pdf"}, "hash": "60834d8e29a8edd68f69a5fa0aac6a5353bbbe82dc76d0106e575153eb7d95a4"}}, "hash": "fcd6eff5d2144caf701d61589ee7fdc6a32e2f7b005a32080df2ce4caf6973c0", "text": "18virus in each experiment. Error bars show sta ndard deviation (SD) from the mean. pfu/ml, 351 \nplaque forming units per millilitre. 352 \n 353 \nFigure 2.  Generation of viral cDNA clones and recovery of recombinant MERS-CoV 354 \nand MERS-CoV-GFP.  355 \na, Schematic representation of MERS-CoV (upp er panel) and MERS-CoV-GFP (lower panel) 356 \ngenome organization with 8 and 10 viral subgenomic overlapping cDNA fragments, 357 \nrespectively, used for TAR cloning. pT7, T7 RNA polymerase promoter; UTR, untranslated 358 \nregion; An, poly (A) tail; J represents as sembly junction between two overlapping DNA 359 \nfragments. b, Rescue of recombinant MERS-CoV and MERS-CoV-GFP.  Following delivery 360 \nof viral RNAs into BHK-21 cells via electropora tion the cells were co-cultivated with VeroB4 361 \ncells and supernatants containing recombinant viruses produced were used to infect new 362 \nVeroB4 cells. Infected cells were visualised by bright field microscopy for recombinant 363 \nMERS-CoV (upper panel; 5 days post infecti on), and for GFP expression for recombinant 364 \nMERS-CoV-GFP (lower panel, 3 days post infection). Mock represents VeroB4 cells 365 \ninoculated with supernatant from BHK-21 cells electroporated without viral RNAs. c, 366 \nReplication kinetics of the ME RS-CoV-EMC (laboratory adapted isolate), rMERS-CoV and 367 \nrMERS-CoV-GFP. VeroB4 cells were infected at an MOI of 0.01. Cell culture supernatants 368 \nwere harvested at indicated time points post infe ction and titrated by TCID50 assay. Data are 369 \nrepresentative of three independent experime nts with two replicates per virus in each 370 \nexperiment. Error bars show standard deviation (SD) from the mean. TCID50/ml, 50% tissue 371 \nculture infectious dose per millilitre. 372 \n 373 \nFigure 3. Generation of viral cDNA clones and recovery of recombinant SARS-CoV-2 374 \nand SARS-CoV-2-GFP. a, Schematic representation of SARS-CoV-2 (upper panel) and 375 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 2160, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "228cc1ac-9712-41ee-b88d-54f2bd75f557": {"__data__": {"id_": "228cc1ac-9712-41ee-b88d-54f2bd75f557", "embedding": null, "metadata": {"page_label": "19", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a21ae520-db05-4339-b8e5-d73dc7be5643", "node_type": null, "metadata": {"page_label": "19", "file_name": "3_Covid.pdf"}, "hash": "c6599e816edf72d56481c8c4995016b201f0b2208c6c93254c4f9512368287e5"}}, "hash": "c073ff13e7a7b1ad5167a7eadf2de3e4b3c2434d1c68596444a8aedbd151d008", "text": "19SARS-CoV-2-GFP (lower panel) genome orga nisation with 12 and 14 viral subgenomic 376 \noverlapping cDNA fragments, respectively, used for TAR cloning. pT7, T7 RNA polymerase 377 \npromoter; UTR, untranslated region; An, poly (A) tail; J represents assembly junction 378 \nbetween two overlapping DNA fragments. b, Representation of predicted RNA stem-loop 379 \n(SL) secondary structures formed in the 5'-UTR of SARS-CoV-2. The SARS-CoV-2 RNA 380 \nsecondary structures were manually adjusted based on RNA structure predictions by Chan et 381 \nal.22. Black letters and numbering represents the SARS-CoV-2 5\u2019-terminal sequence. Red 382 \nletters depict nucleotides that are different within the SARS-CoV 5\u2019-terminal sequence ( \u201c-\u201c 383 \nindicates nucleotide deletion in SARS-CoV versus SARS-CoV-2). N20 indicates 20 384 \nnucleotides. SL structures 1, 2, and 4 are shown according to Chan et al.22. Note that 385 \nrecombinant virus construct 1 (rSARS-CoV-2 clone 1) and construct 4 (rSARS-CoV-GFP 386 \nclone 4) contain the SARS-CoV-2 5\u2019-terminus with nucleotides 3-5 (UAA) exchanged by 387 \nnucleotides 3-5 (AUU) of SARS-CoV; recombin ant virus construct 2 (rSARS-CoV-2 clone 2) 388 \nand construct 5 (rSARS-CoV-2-GFP clone 5) contain a 5\u2019-terminus with the first 124 389 \nnucleotides from SARS-CoV; and recombinant virus construct 3 (rSARS-CoV-2 clone 3) and 390 \nconstruct 6 (rSARS-CoV-GFP clone 6) contain the authentic SARS-CoV-2 5\u2019-terminus. c, 391 \nRescue of recombinant rSARS-CoV-2 and rSARS-CoV-2-GFP. The experimental setting is 392 \nillustrated in the upper panel. Two clones of each construct 1-6 were used to prepare YAC 393 \nDNAs and in-vitro transcribed viral genome RNAs we re electroporated into BHK-21 cells 394 \nand/or BHK-SARS-N together with an mRNA encoding the SARS-CoV-2 N protein. 395 \nElectroporated cells were co-cultivated with Ve roE6 cells in a T25 flask and cell culture 396 \nsupernatants were transferred to 12-well plates to perform plaque assay for rSARS-CoV-2 397 \nconstructs 1-3 and fluorescence microscopy fo r rSARS-CoV-2-GFP constructs 4-6. Plaque 398 \nassays are shown in the lower panel for SARS-CoV-2 clones 1.1, 2.2, and 3.1. VeroE6 cells 399 \nwere infected with 10-1, 10-2, and 10-3 dilutions of 1 ml supernatant from the individual rescue 400 \nexperiments and are compared to non-infected cells (Mock). The expression of GFP in SARS- 401 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 2594, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "bef68375-5c6c-4e27-ab3b-ad87f3ce27cb": {"__data__": {"id_": "bef68375-5c6c-4e27-ab3b-ad87f3ce27cb", "embedding": null, "metadata": {"page_label": "20", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "780c1fca-724d-4026-b189-cbfc52c97dcb", "node_type": null, "metadata": {"page_label": "20", "file_name": "3_Covid.pdf"}, "hash": "4ad6498ed1ef977535f2be036110d9e9ccb03bcb5961bc69125b5212362a0c1b"}}, "hash": "4f7e8ecd3b1d3da8f53a9aa0e46db036e3bd11d1c19ad30fb7d449f197b55ebe", "text": "20CoV-2-GFP infected VeroE6 cells is shown for clones 4.1, 5.2, and 6.1. Mock represents non- 402 \ninfected VeroE6 cells. d, Summary of the timeline of events of the SARS-CoV-2 outbreak 403 \nand the work leading to the reconstruction and recovery of rSARS-CoV-2. 404 \n 405 \nExtended Data Figure 1  406 \na, Schematic representation of the MHV-GFP ge nome organisation (upper panel) and nine 407 \nviral subgenomic cDNA fragments (F1-9) used for TAR cloning. Viral open reading frames 408 \n(ORFs), the ORF for GFP and sequence elements at the 5\u2019- and 3\u2019-untranslated regions 409 \n(UTRs) are indicated. Primers used to generate the fragments are listed in Extended Data 410 \nTable 1. J2-9 represent the junctions, i.e. overlapping regions, between the subgenomic cDNA 411 \nfragments. J1 and J10 represent junctions with the TAR vector. Gel images show results from 412 \ntwo multiplex PCRs that were designed to detect the presence of correctly recombined 413 \njunctions J1-10, confirming the proper assembly of the YAC containing the viral genome in 414 \n12 out of 12 clones. kb, kilobases; pT7, T7 RNA polymerase promoter; An, poly (A) tail.  415 \n 416 \nb, Schematic representation of the MERS-CoV genome organisation (upper panel) and eight 417 \nviral subgenomic cDNA fragments (F1-8) used for TAR cloning. Viral open reading frames 418 \n(ORFs) and sequence elements at the 5\u2019- and 3 \u2019-untranslated regions (UTRs) are indicated. 419 \nPrimers used to generate the fragments are listed in Extended Data Table 1. J2-8 represent the 420 \njunctions, i.e. overlapping regions, between the subgenomic cDNA fragments. J1 and J9 421 \nrepresent junctions with the TAR vector. Gel image shows results from a multiplex PCR that 422 \nwas designed to detect the presence of corre ctly recombined junctions J1-9, confirming the 423 \nproper assembly of the YAC containing the viral genome in 6 out of 8 clones. kb, kilobases; 424 \npT7, T7 RNA polymerase promoter; An, poly (A) tail. 425 \n 426 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 2194, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f8175b62-fb63-4373-bd35-fdc183f3e5f9": {"__data__": {"id_": "f8175b62-fb63-4373-bd35-fdc183f3e5f9", "embedding": null, "metadata": {"page_label": "21", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2ebfab61-a517-4ee6-bae8-546e2001f300", "node_type": null, "metadata": {"page_label": "21", "file_name": "3_Covid.pdf"}, "hash": "c9daa283295a3a110bf54cfd4d1ebdd720712167c48c0c2576bc342d047b8cab"}}, "hash": "c568cdd79bb2bf5a2e686bd3ff1bfe57421711f09ad0777e6a9221e31ae25ac6", "text": "21c, Schematic representation of the MERS-CoV-G FP genome organisation (upper panel) and 427 \nten viral subgenomic cDNA fragments (F1-10 a nd F13) used for TAR cloning. Viral open 428 \nreading frames (ORFs), ORF for GFP and sequence  elements at the 5\u2019- and 3\u2019-untranslated 429 \nregions (UTRs) are indicated. Primers used to generate the fragments are listed in Extended 430 \nData Table 1. J2-8 and J10-11 represent the junctions, i.e. overlapping regions, between the 431 \nsubgenomic cDNA fragments. J1 and J9 represent junctions with the TAR vector. Gel images 432 \nshow results from two multiplex PCRs that were designed to detect the presence of correctly 433 \nrecombined junctions J1-11, confirming the proper assembly of the YAC containing the viral 434 \ngenome in 5 out of 8 clones. kb, kilobases; pT7, T7 RNA polymerase promoter; An, poly (A) 435 \ntail. 436 \n 437 \nd, Schematic representation of the HCoV-229E genome organisation (upper panel) and 438 \nthirteen viral subgenomic cDNA fragments (F1-13) used for TAR cloning. Viral open reading 439 \nframes (ORFs) and sequence elements at the 5\u2019- and 3\u2019-untranslated regions (UTRs) are 440 \nindicated. Primers used to generate the fragments are listed in Extended Data Table 1. J2-13 441 \nrepresent the junctions, i.e. overlapping regions, between the subgenomic cDNA fragments. 442 \nJ1 and J14 represent junctions with the TAR vector. Gel images show results from two 443 \nmultiplex PCRs that were designed to detect the presence of correctly recombined junctions 444 \nJ1-14, confirming the proper assembly of the YAC containing the viral genome in 7 out of 10 445 \nclones. kb, kilobases; pT7, T7 RNA polymerase promoter; An, poly (A) tail. 446 \n 447 \nd, Schematic representation of the HCoV-HKU1 genome organisation (upper panel) and 448 \neleven viral subgenomic cDNA fragments (F1-11) used for TAR cloning. Viral open reading 449 \nframes (ORFs) and sequence elements at the 5\u2019- and 3\u2019-untranslated regions (UTRs) are 450 \nindicated. Primers used to generate the fragments are listed in Extended Data Table 1. J2-11 451 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 2297, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "79e5377f-3b53-4848-a76c-15836734bef1": {"__data__": {"id_": "79e5377f-3b53-4848-a76c-15836734bef1", "embedding": null, "metadata": {"page_label": "22", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c66fca50-a58e-4dd5-a417-14f48fea9cc6", "node_type": null, "metadata": {"page_label": "22", "file_name": "3_Covid.pdf"}, "hash": "fcc52294dc9c223b666d66711361aa4f5cacca9d2f16023758581324e9ceb2bc"}}, "hash": "fc59607e75cefdc4055cc0e85352c0d79c746854eca3df3d02cff8840e84f6b5", "text": "22represent the junctions, i.e. overlapping regions, between the subgenomic cDNA fragments. 452 \nJ1 and J12 represent junctions with the TAR vector. Gel images show results from two 453 \nmultiplex PCRs that were designed to detect the presence of correctly recombined junctions 454 \nJ1-12, confirming the proper assembly of the YAC containing the viral genome in 14 out of 455 \n14 clones. kb, kilobases; pT7, T7 RNA polymerase promoter; An, poly (A) tail. 456 \ne, Schematic representation of the MERS-CoV-Riadh-1734-2015 genome organisation (upper 457 \npanel) and eight viral subgenomic cDNA fragment s (F1-8) used for TAR cloning. Viral open 458 \nreading frames (ORFs) and sequence elements at  the 5\u2019- and 3\u2019-untranslated regions (UTRs) 459 \nare indicated. Primers used to generate the fragments are listed in Extended Data Table 1. J2-8 460 \nrepresent the junctions, i.e. overlapping regions, between the subgenomic cDNA fragments. 461 \nJ1 and J9 represent junctions with the TAR vector. Gel images show results from a multiplex 462 \nPCR and a simplex PCR, both of which were designed to detect the presence of correctly 463 \nrecombined junctions J1-9, confirming the proper assembly of the YAC containing the viral 464 \ngenome in 5 out of 8 clones. kb, kilobases; pT7, T7 RNA polymerase promoter; An, poly (A) 465 \ntail. 466 \n 467 \nf, Schematic representation of the ZIKA virus geno me organisation (upper panel) and six viral 468 \nsubgenomic cDNA fragments (F1-6) used for TAR cloning. Viral open reading frames 469 \n(ORFs) and sequence elements at the 5\u2019- and 3 \u2019-untranslated regions (UTRs) are indicated. 470 \nPrimers used to generate the fragments are listed in Extended Data Table 1. J2-5 represent the 471 \njunctions, i.e. overlapping regions, between the subgenomic cDNA fragments. J1 and J6 472 \nrepresent junctions with the TAR vector. Gel image shows results from a multiplex PCR that 473 \nwas designed to detect the presence of corre ctly recombined junctions J1-6, confirming the 474 \nproper assembly of the YAC containing the viral genome in 3 out of 15 clones. kb, kilobases; 475 \npT7, T7 RNA polymerase promoter; HDR, hepatitis delta virus ribozyme. 476 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 2393, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b050465a-a261-4913-878e-3ab98495483a": {"__data__": {"id_": "b050465a-a261-4913-878e-3ab98495483a", "embedding": null, "metadata": {"page_label": "23", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b2f16060-1afa-40f8-932a-bb865d50af76", "node_type": null, "metadata": {"page_label": "23", "file_name": "3_Covid.pdf"}, "hash": "55b89056ce18cf3a9a3f05e2f35a2e08516f5221d459cdcbf5e753b63433b8f0"}}, "hash": "e30e65f6af819506c6a0cfb7c5f607e12b22a0e7cfc7c3f5f27dce6a81fc7db1", "text": "23 477 \ng, Schematic representation of the human RSV-B virus genome organisation (upper panel) 478 \nand six viral subgenomic cDNA fragments (F1-6) used for TAR cloning. Viral open reading 479 \nframes (ORFs) and sequence elements at the 5\u2019- and 3\u2019-untranslated regions (UTRs) are 480 \nindicated. Primers used to generate the fragments are listed in Extended Data Table 1. J1-5 481 \nrepresent the junctions, i.e. overlapping regions, between the subgenomic cDNA fragments. 482 \nJ1 and J5 contain junctions with the TAR vector. Gel image shows results from a multiplex 483 \nPCR that was designed to detect the presence of correctly recombined junctions J1-5, 484 \nconfirming the proper assembly of the YAC containing the viral genome in 7 out of 8 clones. 485 \nkb, kilobases; pT7, T7 RNA polymerase promoter; HHrb, hammerhead ribozyme, Rb-T7ter, 486 \nRibozyme and T7 RNA polymerase terminator seqeunce. 487 \n 488 \nh, Schematic representation of the SARS-CoV-2 genome organisation (upper panel) and 489 \ntwelve viral subgenomic cDNA fragments (F1-12) used for TAR cloning. Viral open reading 490 \nframes (ORFs) and sequence elements at the 5\u2019- and 3\u2019-untranslated regions (UTRs) are 491 \nindicated. Primers used to generate the fragments are listed in Extended Data Table 1. J2-12 492 \nrepresent the junctions, i.e. overlapping regions, between the subgenomic cDNA fragments. 493 \nJ1 and J13 represent junctions with the TAR vector. Gel images show results from two 494 \nmultiplex PCRs that were designed to detect the presence of correctly recombined junctions 495 \nJ1-13, confirming the proper assembly of the YAC containing the viral genome in 6 out of 6 496 \nclones. kb, kilobases; pT7, T7 RNA polymerase promoter; An, poly (A) tail. 497 \n 498 \ni, Schematic representation of the SARS-CoV-2 genome organisation (upper panel) and 499 \nfourteen viral subgenomic cDNA fragments (F1-10 and F12-15) used for TAR cloning. Viral 500 \nopen reading frames (ORFs), ORF for GFP and sequence elements at the 5\u2019- and 3\u2019- 501 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 2231, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "da507684-d356-4a0c-9523-c3ffcb393e99": {"__data__": {"id_": "da507684-d356-4a0c-9523-c3ffcb393e99", "embedding": null, "metadata": {"page_label": "24", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2b72f4e9-f9bb-4d2e-920f-8e06d4dd5010", "node_type": null, "metadata": {"page_label": "24", "file_name": "3_Covid.pdf"}, "hash": "40da2784dce9e1a79add97a53b259a0b99f5b9236cf1014642eca78935484bd6"}}, "hash": "e056413b20afed0aa5788028560a0e7e360d15b3deb619e2a28a0ff9f9cbac49", "text": "24untranslated regions (UTRs) are indicated. Primers used to generate the fragments are listed in 502 \nExtended Data Table 1. J2-12 and J14 represent the junctions, i.e. overlapping regions, 503 \nbetween the subgenomic cDNA fragments. J1 and J13 represent junctions with the TAR 504 \nvector. Gel images show results from two multiplex PCRs and a simplex PCR, all of which 505 \nwere designed to detect the presence of correctly recombined junctions J1-13 and J14 506 \nrespectively, confirming the proper assembly of the YAC containing the viral genome in 6 out 507 \nof 6 clones. kb, kilobases; pT7, T7 RNA polymerase promoter; An, poly (A) tail. 508 \n 509 \nExtended Data Figure 2 510 \na, Six constructs were initially designed base d on 3 different 5\u2019-UTR regions. These regions 511 \ncontain i) a modified sequence of the 5\u2019-UTR region of the SARS-CoV-2 (5\u2019- ATAUUAGG; 512 \n5\u2019-terminal 8 nucleotides are shown, modified nucleotides underlined) were nucleotides 3-5 513 \n(UAA) of SARS-CoV-2 were changed to AU U to match the SARS-CoV nucleotides 3-5 514 \n(synthetic fragment 1.1 for constructs 1 and 4) , ii) a SARS-CoV-2 5\u2019-terminus with the first 515 \n124 nucleotides exchanged by the corresponding 5\u2019-terminal sequence of SARS-CoV 516 \n(synthetic fragment 1.2; construct 2 and 5) and iii) the reported sequence of the SARS-CoV-2 517 \n(GISAID: EPI_ISL_402119) (synthetic fragmen t 1.3; constructs 3 and 6). After yeast 518 \ntransformation, 10 colonies were randomly picked for each of the six constructs and all the 519 \njunctions bridging the overlapping fragments we re verified by multiplex PCR. For each 520 \nconstruct, two clones (x.1 and x.2) were ran domly selected and YAC DNAs were isolated (12 521 \nclones in total). RNAs were generated by in vitro  transcription and electroporated together 522 \nwith an mRNA encoding the SARS-CoV-2 N protein either into BHK-21 cells (12 clones) or 523 \nBHK-SARS-N cells (cells expressing the SARS -CoV N protein) (6 clones). Electroporated 524 \ncells were then co-cultivated with susceptible VeroE6 cells to rescue the recombinant viruses. 525 \nP.0 supernatants were collected at different time points afte r electroporation (from 2 dpe to 5 526 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 2411, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "98b91c68-6590-49fe-bb09-c101b27f41b5": {"__data__": {"id_": "98b91c68-6590-49fe-bb09-c101b27f41b5", "embedding": null, "metadata": {"page_label": "25", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "19f554eb-964b-4b07-a5d2-4f3cf82a24b0", "node_type": null, "metadata": {"page_label": "25", "file_name": "3_Covid.pdf"}, "hash": "3fd349a61fee4a235b5381eaa510b06a34388ba474ce000cdc2729b7584172cd"}}, "hash": "2612bf398c7e692263e224291db8fec0389678433c0ae26a6591ff8f51b1c15b", "text": "25dpe) and transferred to VeroE6 cells to gene rate P.1 virus stocks, and in parallel to 527 \ndemonstrate presence of infectious virus by plaque assay (virus clones that do not encode 528 \nGFP) or fluorescence microscopy (GFP-encoding virus clones). YAC, yeast artificial 529 \nchromosome; h.p.e, hours post-electroporation;  d.p.e, days post-electroporation; CPE, 530 \ncytopathic effects; GFP, green fluorescent protein; pfu/ml, plaque forming units per millilitre. 531 \n 532 \n 533 . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 701, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "86cbddaf-dd13-4727-aef8-532a00209c68": {"__data__": {"id_": "86cbddaf-dd13-4727-aef8-532a00209c68", "embedding": null, "metadata": {"page_label": "26", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6854c36d-a946-4d8e-a11b-bebf003f9ec5", "node_type": null, "metadata": {"page_label": "26", "file_name": "3_Covid.pdf"}, "hash": "578fa856f72706250932207b0b01716040f58216eaafe48a6d060ab7d7b29050"}}, "hash": "bfe8bfb415c1942ac2d3875ce214c752f6733567a25d654ea1cdbfc407dfb993", "text": ". CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 219, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "130da3d8-1cfb-4f63-a0ae-90c45e8335f9": {"__data__": {"id_": "130da3d8-1cfb-4f63-a0ae-90c45e8335f9", "embedding": null, "metadata": {"page_label": "27", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a4a87fe2-1f30-415a-9677-847e034f0666", "node_type": null, "metadata": {"page_label": "27", "file_name": "3_Covid.pdf"}, "hash": "b7e8b776595b6e634dbba199d910acf838962997d97d7ecc11482f904cf272c0"}}, "hash": "4e0307ef4cec4a6269ce9c48ec482143243a6bb01561d9c9bbdef327f10c197b", "text": ". CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 219, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9d096cb7-bc83-4a73-a4e2-08b05082c628": {"__data__": {"id_": "9d096cb7-bc83-4a73-a4e2-08b05082c628", "embedding": null, "metadata": {"page_label": "28", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e59f91fa-2038-442f-8de6-23891af8efa3", "node_type": null, "metadata": {"page_label": "28", "file_name": "3_Covid.pdf"}, "hash": "b5bd5f6f81210aa9069691347eeaeeb177d794e22e2916cf20e40f22555acf58"}}, "hash": "c06878c255b02da23d75caa02be47c7ecab73b880a83c2f00653e89d27820c9b", "text": ". CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 219, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0f57c95a-1d01-49d4-9e7f-9ccf2ad2b0ae": {"__data__": {"id_": "0f57c95a-1d01-49d4-9e7f-9ccf2ad2b0ae", "embedding": null, "metadata": {"page_label": "29", "file_name": "3_Covid.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f3bc2f24-8dd8-4784-9ef5-17e958b016a3", "node_type": null, "metadata": {"page_label": "29", "file_name": "3_Covid.pdf"}, "hash": "028447bf4cdb3ef918855efb206ef9533ee12246d54096fb8fa14b715dbd4050"}}, "hash": "1e1c209f07d8bdd279d9bd8300bdba7830e1bc7ae004ba58ed0a556795e764a9", "text": "Table 1: RNA virus genomes cloned us ing the synthetic genomics platform \nVirus Family RNA \ntype Size \n(kbp) Template Fragment \ngeneration Number of assembled fra\ngments*Virus rescue \nMHV-GFP Coronaviridae (+)RNA 31.9 Viral RNA (laboratory \nvirus); DNA clone  \n(vaccinia virus) RT-PCR/PCR 9 yes \nMERS-CoV Coronaviridae (+)RNA 30.1 DNA clone (BAC) PCR 8 yes\nMERS-CoV-GFP Coronaviridae (+)RNA 30.7 DNA clone (BAC) \nGFP plasmid DNA PCR 10 yes \nHCoV-229E Coronaviridae (+)RNA 27.3 Viral RNA (laboratory \nvirus); DNA clone  (vaccinia virus) RT-PCR/PCR 13 in progress \nHCoV-HKU1 Coronaviridae (+)RNA 29.9 Synthetic DNA \nviral RNA (virus isolate) PCR/RT-PCR 11 in progress \nMERS-CoV-Riyadh-1734-2015 Coronaviridae (+)RNA (30) Viral RNA (virus isolate) RT-PCR 8 in progress \nZIKA virus Flaviviridae (+)RNA 10.8 Viral RNA (isolate) RT-PCR 6 in progress \nHuman RSV-B Paramyxoviridae (-)RNA 15 Clinical sample RT-PCR 4 in progress \nSARS-CoV-2 Coronaviridae (+)RNA 30 Synthetic DNA/viral RNA plasmid DNA \nrestriction/ RT-PCR 12 yes \nSARS-CoV-2-GFP Coronaviridae (+)RNA 30.5 Synthetic DNA/viral RNA plasmid DNA \nrestriction/RT-PCR/PCR 14 yes \n*excluding the TAR vector fragment . CC-BY-ND 4.0 International license author/funder. It is made available under aThe copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.02.21.959817doi: bioRxiv preprint", "start_char_idx": 0, "end_char_idx": 1384, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f8971cf5-726d-4310-9e4d-061a8a5f1682": {"__data__": {"id_": "f8971cf5-726d-4310-9e4d-061a8a5f1682", "embedding": null, "metadata": {"page_label": "39", "file_name": "4_DNA_of_things.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "042268cc-9263-43f8-a77d-62af53d7870a", "node_type": null, "metadata": {"page_label": "39", "file_name": "4_DNA_of_things.pdf"}, "hash": "6b3ef0c308ad56f23772695a9b75678c95afa589699002fa8a19da971f17aab3"}, "3": {"node_id": "81a599ce-1371-4f66-9309-ef753cb94d57", "node_type": null, "metadata": {"page_label": "39", "file_name": "4_DNA_of_things.pdf"}, "hash": "1dbfc310a24f3c0d524f310074b4781b4c9f28a6b6208f9d9404e9f54377b9c4"}}, "hash": "ec7095ef5f6b52ac4f2130eab8bd50df3954fd6422ff3e2aefd157752cd40e75", "text": "Letters\nhttps:/ / doi.org/10.1038/s41587-019-0356-z1Functional Materials Laboratory, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland. 2Complex Materials, Department  \nof Materials, ETH Zurich, Zurich, Switzerland. 3Erlich Lab LLC, Raanana, Israel. 4These authors contributed equally: Yaniv Erlich, Robert N. Grass.  \n*e-mail: erlichya@gmail.com; robert.grass@chem.ethz.chDNA storage offers substantial information density1\u20137 and \nexceptional half-life3. We devised a \u2018DNA-of-things\u2019 (DoT) \nstorage architecture to produce materials with immutable \nmemory. In a DoT framework, DNA molecules record the data, \nand these molecules are then encapsulated in nanometer silica beads\n8, which are fused into various materials that are \nused to print or cast objects in any shape. First, we applied \nDoT to three-dimensionally print a Stanford Bunny9 that con-\ntained a 45\u2009kB digital DNA blueprint for its synthesis. We syn-thesized five generations of the bunny, each from the memory \nof the previous generation without additional DNA synthesis or degradation of information. T o test the scalability of DoT, \nwe stored a 1.4\u2009MB video in DNA in plexiglass spectacle lenses \nand retrieved it by excising a tiny piece of the plexiglass and sequencing the embedded DNA. DoT could be applied to store \nelectronic health records in medical implants, to hide data in \neveryday objects (steganography) and to manufacture objects containing their own blueprint. It may also facilitate the devel-opment of self-replicating machines.\nThe world\u2019s data are growing at exponential rates in today\u2019s  \ninformation age5. However, attempts to further miniaturize tradi -\ntional storage architectures, such as hard-drives and magnetic tapes, \nare becoming increasingly difficult10,11. These devices are reaching \ntheir physical limitations and can hardly keep pace with digital  \nstorage requirements. Due to these challenges, there is great inter -\nest in the potential of using DNA molecules as an architecture for  \nlong-term cold storage. Previous studies have reported that DNA storage can reach 215 PB g\n\u22121, orders of magnitude higher physical \ndensities than traditional devices1,5, and can have a half-life of thou -\nsands of years3,12.\nBeyond exceptional density and endurance, DNA storage is vir -\ntually the only storage architecture that can take any shape. This stands in stark contrast to traditional storage architectures such as tapes and hard-drives, where the actual shape of the device is often \ncritical to its functionality. Previous studies of DNA storage have \nlargely overlooked the virtue of the absence of shape constraints. However, this property allows the realization of new storage archi\n-\ntectures beyond today\u2019s conventional designs.\nHere, we explored a storage architecture, dubbed DoT, in which \nDNA molecules are fused to a functional material to create objects \nwith immutable memory. The DoT architecture starts with encod -\ning the data in DNA molecules in a manner that is robust to errors. \nDue to the low density of the DNA molecules in the embedding material, we expect that some DNA fragments will not be recov\n-\nered from the object, creating fragment dropouts. To ameliorate that, we used DNA Fountain5 as our encoding scheme. This scheme \nprovides high flexibility in setting virtually any redundancy level that can correct dropout errors and has been shown to perfectly \nretrieve data from minute quantities of material\n5. One challenge for \nthe DoT architecture is that simply mixing the DNA with the func -\ntional material results in quickly degraded DNA due to hydrolysis \nstress and elevated temperatures during the preparation of the mix -\nture", "start_char_idx": 0, "end_char_idx": 3703, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "81a599ce-1371-4f66-9309-ef753cb94d57": {"__data__": {"id_": "81a599ce-1371-4f66-9309-ef753cb94d57", "embedding": null, "metadata": {"page_label": "39", "file_name": "4_DNA_of_things.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "042268cc-9263-43f8-a77d-62af53d7870a", "node_type": null, "metadata": {"page_label": "39", "file_name": "4_DNA_of_things.pdf"}, "hash": "6b3ef0c308ad56f23772695a9b75678c95afa589699002fa8a19da971f17aab3"}, "2": {"node_id": "f8971cf5-726d-4310-9e4d-061a8a5f1682", "node_type": null, "metadata": {"page_label": "39", "file_name": "4_DNA_of_things.pdf"}, "hash": "ec7095ef5f6b52ac4f2130eab8bd50df3954fd6422ff3e2aefd157752cd40e75"}}, "hash": "1dbfc310a24f3c0d524f310074b4781b4c9f28a6b6208f9d9404e9f54377b9c4", "text": "and elevated temperatures during the preparation of the mix -\nture (Supplementary Fig. 1). To mitigate this, the DoT architecture first encapsulates the DNA in\u00a0silica nanoparticles\n8, resulting in\u00a0silica \nparticle-encapsulated DNA (SPED). The SPED shell sequesters the DNA molecules, prolonging their half-life and facilitating the mix\n-\ning of DNA with the embedding material. Finally, we mix the SPED with the desired material and shape it using either three-dimen\n-\nsional (3D) printing or casting techniques.\nTo empirically test data storage using the DoT architecture, we \ncreated a 3D object that embeds DNA that encodes the blueprint \nfor creating itself (Fig. 1a and Supplementary Video 1). This con -\nfiguration is reminiscent of biological organisms, in which the \ninstructions for making an object reside within the matter itself. As for the object, we selected the Stanford Bunny\n9, which is a common \ncomputer graphics 3D test model. First, we compressed the binary stereolithography (stl) file of the bunny from 100 kB to 45 kB. Next, \nwe used DNA Fountain to encode the file in 12,000 DNA oligo\n-\nnucleotides (oligos), which is the maximal number of oligos pro -\nduced by a single CustomArray chip (Supplementary Note 1). With this number of oligos compared with the file size, DNA Fountain encoding yields a redundancy level of 5.2\u00d7, meaning that we can \ntolerate a dropout of even 80% of the DNA oligos and still correctly \ndecode the file. The length of the oligos was 145 nucleotides (nt), \nconsisting of 104 nt of payload and 41 nt for PCR annealing sites \n(Supplementary Fig. 2). Next, we loaded the PCR-amplified oligos \ninto SPED beads (Supplementary Fig. 3 and Supplementary Note 2) \n \nand embedded the beads in polycaprolactone (PCL). PCL is a bio -\ndegradable thermoplastic polyester that offers low melting tempera -\nture and high solubility in various organic solvents, making it an \nideal material for blending and printing under mild conditions. To prepare 3D-printing filaments, we mixed the SPED capsules with \ndissolved PCL and extruded the mix into a 2.85 mm filament com\n-\npatible with desktop 3D printers. Notably, the filament contained \nSPED beads in a concentration of 100 mg kg\u22121 (100 ppm), which \ndid not create any detectable changes to the mechanical properties, weight or color of the filament\n13. The DNA loading within SPED \nwas 2 mg of DNA per gram of SPED beads, which translates to a \nDNA concentration of 0.2 mg kg\u22121 (0.2 ppm) of the PCL filament \n(Fig. 1b and Supplementary Note 3), well below the concentration A DNA-of-things storage architecture to create \nmaterials with embedded memory\nJulian Koch1, Silvan Gantenbein\u200a \u200a2, Kunal Masania\u200a \u200a2, Wendelin J. Stark1, Yaniv Erlich\u200a \u200a3,4* and \nRobert N. Grass\u200a \u200a1,4*\nNAtuRE BiotE chNoloGY | VOL 38 | JANu ARY 2020 | 39\u201343 | www.nature.com/naturebiotechnology 39", "start_char_idx": 3637, "end_char_idx": 6497, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4a7282e4-2418-4bee-9550-dc279c89e654": {"__data__": {"id_": "4a7282e4-2418-4bee-9550-dc279c89e654", "embedding": null, "metadata": {"page_label": "40", "file_name": "4_DNA_of_things.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "383c7093-d630-4481-841f-852df9cf73b3", "node_type": null, "metadata": {"page_label": "40", "file_name": "4_DNA_of_things.pdf"}, "hash": "507abf447938f016d44ad8e9b8c91a4bd1d196b8b261afb804bfa67117c0ae56"}, "3": {"node_id": "bfc4245f-5581-4203-8ddb-7c808b396d38", "node_type": null, "metadata": {"page_label": "40", "file_name": "4_DNA_of_things.pdf"}, "hash": "da3b026ebe3d9edf4071ede7ccfa2ef235b311677c50eb55e5c8504b19e1863f"}}, "hash": "84e92f45b24593f5b15f88f01cb466f8945a90d0a07252d22bba54cf681d2b17", "text": "Letters Nature BiotechNologyof DNA in biological organisms compared with their body weight \n(~1,000 ppm in Escherichia coli ). Finally, we proceeded with 3D \nprinting of the Stanford Bunny using the same file as stored in the \nDNA-containing PCL filament.\nOur results show that the data can be perfectly and rapidly \nretrieved from the 3D object by consuming a minute quantity of \nmaterial using a portable sequencer. We clipped ~10 mg of the \nprinted PCL from the ear of the bunny, which is 0.3% of the total material of the bunny that weighed 3.2 g (Fig. 2a). Next, we released \nthe SPED beads from the embedding PCL using tetrahydrofuran (THF), extracted the DNA from the SPED beads using buffered oxide etch (BOE) and purified the library using a standard PCR \ncleaning kit. The recovered DNA library weighed 25 pg in 50 \u00b5l \nvolume, corresponding to about 14,000 copies of the encoded \nfile, including the 5.4\u00d7 redundancy (Supplementary Note 4). This entire process took 4 h end-to-end. We then amplified 1 \u00b5l of the \nrecovered DNA, equivalent to 1/50 of the recovered DNA, using ten PCR cycles and sequenced the library using an iSeq, a portable Illumina sequencer (Supplementary Note 5). This process took 17 h \nand yielded 1,046,118 reads. Finally, we processed the data using the DNA Fountain decoder and perfectly retrieved the stored .stl \nfile despite missing 5.9% of the original oligos and being subject to sequencing errors. This took a few minutes on a standard laptop \n(Supplementary Fig. 4).\nEncouraged by these results, we conducted multi-round replica\n-\ntion experiments using the DoT architecture. In the first replication round, we fused the PCR-amplified DNA from the parent Stanford Bunny (dubbed \u2018P\u2019 following the common notation in genetics) to \na nascent PCL filament using the DoT procedure. Next, we created \nthree offspring 3D structures (F1) using the PCL filament and the retrieved .stl file (Fig. 2b). Subsequently, we clipped about 10 mg \nfrom one of the F1 bunnies, extracted the DNA, sequenced the \nlibrary with iSeq to retrieve the .stl file and 3D printed the next gen\n-\neration. We repeated the same procedure for a total of five genera -\ntions (Fig. 2c), where in each generation a new PCL filament was \ncreated by fusing the PCR-amplified DNA molecules of the pre -\nvious experiment. Finally, to demonstrate the ability to store the DNA long term, we sequenced the F4 9 months after its synthesis, \nsequenced the information and used it to generate a further product \ngeneration, F5.\nWe were able to perfectly retrieve the file from all five genera\n-\ntions of progeny, including the retrieval of information 9 months \nafter synthesis. In nearly every replication round, we saw an increase  \nin the fraction of dropout molecules, from a level of 5.9% for the \n1001100011\n1010100010\n1110110100\n1110100100\n1001001001Binary stl  fileDNA code stl file\nDNA \nencapsulationEncode\nwith DNA fountain\nFilament extrusion\nPrinting of 3D object DNA extractionSequencing and decoding\nwith DNA fountain\nPCR\n0110010\n1110100SiO2\nSiO2\n100 ppm particles in PCL 0.2 wt% DNA loading 105 bunny file units per g PCLDNA library:\n12,000 oligos \u00d7 145 nt\nstl file size: 100 kBa\nb\nFig. 1 | Dot workflow and proof-of-principle 3D printing of a Stanford Bunny. a, The digital file is encoded into a DNA oligo library using DNA Fountain \nencoding. The synthesized library is encapsulated by a sol-gel synthesis method", "start_char_idx": 0, "end_char_idx": 3425, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "bfc4245f-5581-4203-8ddb-7c808b396d38": {"__data__": {"id_": "bfc4245f-5581-4203-8ddb-7c808b396d38", "embedding": null, "metadata": {"page_label": "40", "file_name": "4_DNA_of_things.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "383c7093-d630-4481-841f-852df9cf73b3", "node_type": null, "metadata": {"page_label": "40", "file_name": "4_DNA_of_things.pdf"}, "hash": "507abf447938f016d44ad8e9b8c91a4bd1d196b8b261afb804bfa67117c0ae56"}, "2": {"node_id": "4a7282e4-2418-4bee-9550-dc279c89e654", "node_type": null, "metadata": {"page_label": "40", "file_name": "4_DNA_of_things.pdf"}, "hash": "84e92f45b24593f5b15f88f01cb466f8945a90d0a07252d22bba54cf681d2b17"}}, "hash": "da3b026ebe3d9edf4071ede7ccfa2ef235b311677c50eb55e5c8504b19e1863f", "text": "The synthesized library is encapsulated by a sol-gel synthesis method into small glass particles and blended into PCL, which is then extruded into a standard 3D-printing filament. The object, as defined by the initial digital file, is printed with the PCL filament that contains DNA. The DNA library can be extracted from any part of the printed object and amplified by PCR. By sequencing the DNA and decoding the DNA Fountain, the original .stl file can be retrieved to 3D-print new objects. b, Schematic of the hierarchical architecture of the 3D-printed Stanford Bunny, which contains all the instructions needed to reprint the object. Scale bar, 1\u2009cm. \nNAtuRE BiotE chNoloGY | VOL 38 | JANu ARY 2020 | 39\u201343 | www.nature.com/naturebiotechnology 40", "start_char_idx": 3356, "end_char_idx": 4107, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "cdf182f7-a25b-40eb-8f34-79edebf4bac1": {"__data__": {"id_": "cdf182f7-a25b-40eb-8f34-79edebf4bac1", "embedding": null, "metadata": {"page_label": "41", "file_name": "4_DNA_of_things.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "29358fce-80f0-4b9e-9c8e-9234fb2e4bd5", "node_type": null, "metadata": {"page_label": "41", "file_name": "4_DNA_of_things.pdf"}, "hash": "96b174d172546ed7908b30caa2d380d2101da5b6406bdaa1d349bfbff6110655"}, "3": {"node_id": "8aa55827-446c-40d2-a135-0be6b9660789", "node_type": null, "metadata": {"page_label": "41", "file_name": "4_DNA_of_things.pdf"}, "hash": "90017753cf1a2c687bf4759d6720bcafcab85ff8d87120f977a3a8bd0f405fa5"}}, "hash": "994f3decea5fe943ae49a4ae737cc0fcf967004e8946b71ba86b24b7c02c920f", "text": "Letters Nature BiotechNologyoriginal library before inserting the DNA into the PCL filament to a \nlevel of over 20% in the final generations (Fig. 2c and Supplementary Table 1). To better understand the effect of replication on the library \ncomposition, we also modeled the number of correct sequence \nreads per oligo using a negative binomial distribution. This analy\n-\nsis showed an escalation in the negative binomial over-dispersion parameter from 1.0 in original library to 2.95 in F5 (Fig. 2d,e). This increase in over-dispersion means that the oligos are becoming less \nequally represented, which may be ascribed to the added thermal \nstress during polymer extrusion/printing and increasing numbers of PCR rounds\n5,14. In addition, we observed a significant increase \n(Spearman \u03c1 = 0.24, n = 600,000, P < 10\u22129) in the rate of substitution \nerrors as a function of the generation and a significant but modest decrease in the rate of deletions and increase in the rate of insertions \n(Spearman \u03c1\ndeletion  = \u22120.05, Spearman \u03c1insertion  = 0.008, n = 600,000, \nP < 10\u22129) (Supplementary Fig. 5). The length distribution of the \nDNA oligos was quite similar and we did not observe a clear trend \n(Supplementary Fig. 6). However, we did find a slight underrepre -\nsentation in later generations (Pearson r = \u22120.0375, n = 4.9 \u00d7 106, \nP < 10\u22129) of DNA oligos with higher numbers of guanine nucleo -\ntides (Supplementary Fig. 7), which are known to be sensitive for extrinsic stressors\n15. Despite these myriad imperfections, the DNA \nFountain strategy retrieved the file correctly for all generations, showing the robustness of our strategy.\nThe economy of the DoT architecture is consistent with mass \nproduction of goods with memory at negligible per-unit costs. Each replication consumes only 0.3% from each bunny and yields suffi\n-\ncient DNA material to create 29 offspring bunnies. Therefore, even if we restrict the number of replications to five generations, it is theoretically possible to create at least (29/0.003)\n5 = 8.44 \u00d7 1019 bun -\nnies without resynthesizing the DNA library. These results indicate that despite the relatively high upfront costs to synthesize the file for the first time ($2,500 in our case), the per-unit costs of synthesis \nare likely to be negligible as mass production will require only one \n \nsynthesis event. To better understand the total costs per unit, we  conducted an analysis that also includes the costs of the other molec -\nular procedures, such as SPED preparation and PCR, using current \nlaboratory costs and an industrial scale (Supplementary Note 6). Our results show that with the industrial scale costs, manufacturing \nover 1,000 units of the same item, the cost of 1 MB DoT is smaller \nthan the cost of the polymer filament (Supplementary Fig. 8).\nWe envisage that the DoT architecture could be compatible with \na wide range of embedding materials. For such compatibility, the DNA library should be miscible with the final material and sur\n-\nvive the melting temperature of the embedding material and the \nmaterial formation chemistry, which may include radical oxygen species (RoS) or other types of aggressive chemical reactions (for \nexample, radical polymerization). Since DNA is not dissolvable in \nmost organic solvents, or polymeric systems, the encapsulation of the DNA library into a dispersible carrier enables the mixing of the DNA with such materials. As silica particles have a long use history \nas a polymer filler\n16, the usage of SPEDs is advantageous17.\nWe sought to empirically test the robustness of our architecture \nfor various polymer preparation techniques. We first used quantita -\ntive PCR (qPCR) to measure", "start_char_idx": 0, "end_char_idx": 3684, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8aa55827-446c-40d2-a135-0be6b9660789": {"__data__": {"id_": "8aa55827-446c-40d2-a135-0be6b9660789", "embedding": null, "metadata": {"page_label": "41", "file_name": "4_DNA_of_things.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "29358fce-80f0-4b9e-9c8e-9234fb2e4bd5", "node_type": null, "metadata": {"page_label": "41", "file_name": "4_DNA_of_things.pdf"}, "hash": "96b174d172546ed7908b30caa2d380d2101da5b6406bdaa1d349bfbff6110655"}, "2": {"node_id": "cdf182f7-a25b-40eb-8f34-79edebf4bac1", "node_type": null, "metadata": {"page_label": "41", "file_name": "4_DNA_of_things.pdf"}, "hash": "994f3decea5fe943ae49a4ae737cc0fcf967004e8946b71ba86b24b7c02c920f"}}, "hash": "90017753cf1a2c687bf4759d6720bcafcab85ff8d87120f977a3a8bd0f405fa5", "text": "We first used quantita -\ntive PCR (qPCR) to measure the amount of DNA retrieved from the \nSPED beads in PCL using various extrusion and 3D-printing tem -\nperatures (Supplementary Fig. 9 and Supplementary Note 7). We found that the amount of recovered DNA follows Arrhenius expres\n-\nsion trends (Supplementary Note 8). For the extrusion process, for each 30 \u00b0C increase in temperature, there is a drop of approxi\n-\nmately one order of magnitude in the recovered DNA. On the other hand, we observed only a relatively slow decline in the recovered DNA with the increase of the 3D-printing temperature, which is \nexpected, as this process is much faster than extrusion and therefore \nexposes the library to high heat only for a short amount of time. The results also indicate that it is possible to use elevated tempera\n-\ntures for short cycle times during polymer processing, while suffer -\ning some losses of DNA13, which could be compensated by loading \nmore DNA into the polymer preforms. Such temperatures will allow the use of DoT for selected polymer injection molding processes, \n00.10.20.30.40.50.60.70.80.9\nMP F1 F2 F3 F4 F5Frequency\nPerfect calls per oligo per million readsab\nMaximum restorable drop-out rate  \nOverdispersion: 1.04\nMean = 16.3d0.01 g 3.2 gParent\nIdentical Progenyc\nDrop-out rate9 months\n05 10 15 2000.050.100.150.20Mean = 8.5Overdispersion: 2.95FrequencyF5\n02 04 06 08 010000.010.020.030.040.050.06\nPerfect calls per oligo per million readsMastrer library\nFig. 2 | Dot objects can be replicated for multiple generations. a, Just 10\u2009mg of the parent 3D-printed object was sufficient to recover enough DNA \nwith accurate building instructions (.stl file) to generate identical progeny. Scale bar, 1\u2009cm. b, The initial bunny and three \u2018children\u2019 printed with the DNA instructions embedded in the parent DNA. The progeny also hold DNA instructions using the original DNA library. Scale bar, 1\u2009cm. c, For every new generation, the file corruption rate increased, yet for the six experimentally implemented generations, it remained well below the file corruption rate that the Fountain error correction code allowed. d, Oligo coverage frequency distribution for the master library before embedding the DNA and the fifth descendant generation (F5). M, master library; P, parent.\nNAtuRE BiotE chNoloGY | VOL 38 | JANu ARY 2020 | 39\u201343 | www.nature.com/naturebiotechnology 41", "start_char_idx": 3633, "end_char_idx": 6024, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5e4a93e9-9a49-4ec3-8226-1b725f6d27bf": {"__data__": {"id_": "5e4a93e9-9a49-4ec3-8226-1b725f6d27bf", "embedding": null, "metadata": {"page_label": "42", "file_name": "4_DNA_of_things.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "86981af9-7c65-4b79-b0e7-352378ac6265", "node_type": null, "metadata": {"page_label": "42", "file_name": "4_DNA_of_things.pdf"}, "hash": "f8c3c8b421a504cc0ee8dc9c7418b68b0fa21ac33403a88a57e1908519ba2818"}, "3": {"node_id": "cf005b2f-9063-42fe-a0ef-e4e1add9531b", "node_type": null, "metadata": {"page_label": "42", "file_name": "4_DNA_of_things.pdf"}, "hash": "dc6a9343d7447c1b4aae6ff37db41ffebf648503613893f4bf2ab0fd218b2916"}}, "hash": "abf83fe51d3d46040886116c08b267aa9b303b3e586c430cfd04c9bc6c98573c", "text": "Letters Nature BiotechNologyand pre-impregnated carbon fiber composite autoclaving. Next, \nwe also evaluated the robustness of our library to RoS8 using the \nFenton-like copper reaction18 and bleach oxidation (Supplementary \nNote 9). We found that the encapsulation of the DNA is sufficient to protect against these extreme conditions without any detect\n-\nable change in the amount of DNA. As such, this robustness to  \nRoS and oxidation agents should enable DoT to be embedded in materials manufactured by radical polymerization, such as polysty\n-\nrene, polyacrylates and acrylamides. Taken together, these results suggest that a wider range of materials can be used to embed the DNA library.\nNext, we conducted a larger scale DoT architecture experiment \nin a distinct setting, using a different material, DNA synthesis method, material shaping technique and application (Fig. 3a). We started by encoding in DNA a 2 min video (1.4 MB) about the Oneg \nShabbat archive, a collection of documents from the Warsaw Ghetto that were concealed during the Holocaust in milk cans; they are now part of the UNESCO (United Nations Educational, Scientific and Cultural Organization) Memory of the World Register and are a prime example of physical steganography\n19. Next, we used DNA \nFountain to encode the file in 300,000 DNA oligos of 104 nt, yield -\ning a redundancy level of 4.2\u00d7, and synthesized these oligos with Twist Biosciences. We then fused them to SPED beads and loaded them at a concentration of 100 ppm to methyl methacrylate, which \nwas polymerized using dicumyl peroxide as initiator at room tem\n-\nperature to polymethyl methacrylate (PMMA, plexiglass), a widely used transparent plastic material (Fig. 3b). As we were interested in testing our approach to conceal data, we cast the plexiglass in \nthe shape of a lens and mounted it on a glasses frame. The plexi\n-\nglass with the concealed data had highly similar optical properties \nas ordinary plexiglass with a similar transmittance pattern between 400 nm and 700 nm (Fig. 3c). While DNA absorbs light of shorter \nwavelengths (230\u2013260 nm), even ordinary plexiglass has virtually \nzero transmittance20 in UV and therefore cannot expose the pres -\nence of DNA. The end result was a pair of ordinary-looking glasses with ordinary-transmittance lenses (Fig. 3a) that secretly stored a video message.\nThe DoT architecture could easily retrieve the video message \nconcealed in the glasses. We collected a small piece of 10 mg from \none lens and isolated the SPED beads by dissolving the plexiglass in acetone. We then harnessed the ability to spin-down the SPED \nparticles by centrifugation to recover them from the dissolved \npolymer solution. We then followed our standard extraction pro\n-\ncedure, yielding 0.4 ng of DNA, corresponding to about 6,000 cop -\nies of the encoded file. Sequencing the library with an iSeq resulted in 5.7 million paired-end reads (Supplementary Note 10). The \naverage coverage was about 11 reads per correct oligo, the over-\n \ndispersion parameter was 0.7 and 288,253 of the 300,000 oligos  \nwere detected in the library at least once (96.0%) (Fig. 3d). We applied the sequence reads to the DNA Fountain decoder and \n \nwere able to correctly recover the library after processing the first 73,512 oligos. All lines of evidence suggest that larger file sizes can be stored with the DoT architecture, as future experiments can \nreduce either the logical redundancy from 4.2\u00d7 to closer to the \nShannon limit or the physical redundancy from 6,000 copies to a much smaller number.\nWe posit that the DoT architecture is useful in applications where \nblueprint level information is required to be accessible, either in a personalized item or a", "start_char_idx": 0, "end_char_idx": 3720, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "cf005b2f-9063-42fe-a0ef-e4e1add9531b": {"__data__": {"id_": "cf005b2f-9063-42fe-a0ef-e4e1add9531b", "embedding": null, "metadata": {"page_label": "42", "file_name": "4_DNA_of_things.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "86981af9-7c65-4b79-b0e7-352378ac6265", "node_type": null, "metadata": {"page_label": "42", "file_name": "4_DNA_of_things.pdf"}, "hash": "f8c3c8b421a504cc0ee8dc9c7418b68b0fa21ac33403a88a57e1908519ba2818"}, "2": {"node_id": "5e4a93e9-9a49-4ec3-8226-1b725f6d27bf", "node_type": null, "metadata": {"page_label": "42", "file_name": "4_DNA_of_things.pdf"}, "hash": "abf83fe51d3d46040886116c08b267aa9b303b3e586c430cfd04c9bc6c98573c"}}, "hash": "dc6a9343d7447c1b4aae6ff37db41ffebf648503613893f4bf2ab0fd218b2916", "text": "where \nblueprint level information is required to be accessible, either in a personalized item or a mass-manufactured object. For example, in the field of 3D medical or dental implants, each structure is unique and customized for the precise anatomical structure of the patient. As SPED beads are nontoxic, DoT allows storage of the design of \nDNA synthesis\n300,000 oligos\n145 nta\nDNA encapsulation\nbDigital data file in DNA\nhidden in PMMA \nYouTube video (1.4 MB)\nc d\nPMMA\nPMMA + videoIncorporation\nin PMMA\n300 400 500 600 700 8000102030405060708090100Transmittance (%)\nWavelength (nm)O O\nO O\nn\nMMA PMMARadical \npolymerization\nin moldO\nOO O\nO\nOI.\nO\nO\nOPMFrequency\n05 10 15 2000.010.020.030.040.050.06Mean per million reads = 2.2\nOverdispersion: 0.7\nFig. 3 | A video is concealed in reading glasses. a, The Oneg Shabbat video file is encoded into a DNA oligo library using DNA Fountain encoding. The \nDNA library is encapsulated in SPED and incorporated into transparent PMMA glasses. b, For the formation of the information-bearing polymer, the monomer methyl methacrylate (MMA) is premixed with SPED and radical initiator and poured into a mold. Polymerization at room temperature yields solid and transparent objects. c, The transparency of the DoT glasses was measured with uV\u2013visible spectroscopy and compared with the transparency of PMMA glasses without SPED. Mean values and error bars (s.d.) from n\u2009=\u20093 independent experiments; three different spots on the same glass. d, Oligo coverage frequency distribution of the video file after extraction from the PMMA glasses.\nNAtuRE BiotE chNoloGY | VOL 38 | JANu ARY 2020 | 39\u201343 | www.nature.com/naturebiotechnology 42", "start_char_idx": 3621, "end_char_idx": 5291, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9cfb6122-36b5-4648-b10e-f448ef9b716e": {"__data__": {"id_": "9cfb6122-36b5-4648-b10e-f448ef9b716e", "embedding": null, "metadata": {"page_label": "43", "file_name": "4_DNA_of_things.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bd179acc-67b8-499f-b779-94b4ed1b18ea", "node_type": null, "metadata": {"page_label": "43", "file_name": "4_DNA_of_things.pdf"}, "hash": "31cab9d080fa04f7c01af33d48be80f239e9f554a2ccc11033890919cfadf022"}, "3": {"node_id": "0a8d94e5-665f-4b6f-b2f4-b556c1423aa8", "node_type": null, "metadata": {"page_label": "43", "file_name": "4_DNA_of_things.pdf"}, "hash": "69aadb6854d14963facde9509f0976db44988e0d535da05f0761b44332d6bc31"}}, "hash": "637d4961eab0affe9bdec397b4a6c75467987836986641b93dbe3b321c0a642f", "text": "Letters Nature BiotechNologythe implant together with other medical background information \nin the implant, offering a long-range back-up alternative to tradi -\ntional electronic medical records, which are usually required to be kept only for 5\u201310 yr. Similarly, DoT might be applicable for build\n-\ning materials, pharmaceutical products and electronic components. All of these are areas that require product control information, which currently is not available at the point of usage. While for per\n-\nsonalized items the cost of DNA synthesis may still currently be a limiting factor, for mass-manufactured objects the cost of synthesiz\n-\ning the DNA library becomes marginal as the number of devices increases (Supplementary Fig. 8). Having relevant information directly integrated via DoT into the product in an invisible, distrib\n-\nuted and nonremovable manner will consequently allow tighter and better controlled product quality measures. Of course, this vision will require faster DoT retrieval protocols and ubiquitous DNA \nsequencers, which may be available in the future\n21.\nAnother area of interest for the DoT architecture is information \nsteganography. Previous studies have suggested hiding data in DNA as a form of microdot\n22. The DoT architecture extends this concept \nand enables a wide range of everyday objects, from a keychain to \na bottle lid, to be turned into concealed storage devices that can \nsecretly carry data. An adversary trying to intercept the data will \nface multiple barriers: first, the SPED beads do not change the prop -\nerties of the material, meaning that the adversary will have to test multiple objects to reveal the concealing object. Second, the DNA is sequestered in the SPED, so common DNA-sensing techniques such \nas UV light will not be helpful. Third, even if the library is recov\n-\nered, the adversary will have to know the annealing sites to amplify \nthe message by PCR. Taken together, these properties suggest that DoT is highly resistant to malicious interception, but more research \nis needed to test various scenarios to detect and hide the data.\nFinally, a more futuristic application of DoT could be in the area \nof self-replicating devices. Our results suggest that one DoT library \nhas sufficient replicating capacity to produce storage material for \na virtually unlimited supply of objects. This can simplify blueprint \ntransmission in self-replicating devices. More generally, the increas\n-\ning data flow leads to increased dependency on delocalized data storage and large-scale data centers. The DoT approach provides a powerful alternative for localized and off-the-grid storage tech\n-\nnology, capable of storing sensitive and precious data for multiple generations. It could also be used for integrating fabrication plans and conditions into complex products such as houses and art instal\n-\nlations, as a way of preserving information for later generations.\nonline content\nAny methods, additional references, Nature Research reporting summaries, source data, extended data, supplementary informa\n-\ntion, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available at https://doi.org/10.1038/s41587-\n019-0356-z.Received: 27 February 2019; Accepted: 11 November 2019;  \nPublished online: 9 December 2019\nReferences\n 1. Church, G. M., Gao, Y . & Kosuri, S. Next-generation digital information \nstorage in DNA. Science  337, 1628\u20131628 (2012).\n 2. Goldman, N. et\u00a0al. Towards practical, high-capacity, low-maintenance information storage in synthesized DNA. Nature  494, 77\u201380 (2013).\n 3. Grass, R. N., Heckel, R., Puddu, M., Paunescu, D. & Stark, W . J. Robust chemical preservation of digital information on DNA in\u00a0silica with error-correcting codes. Angew. Chem. Int. Ed. 54, 2552\u20132555 (2015).\n 4. Y azdi, S. M. H. T.,", "start_char_idx": 0, "end_char_idx": 3880, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0a8d94e5-665f-4b6f-b2f4-b556c1423aa8": {"__data__": {"id_": "0a8d94e5-665f-4b6f-b2f4-b556c1423aa8", "embedding": null, "metadata": {"page_label": "43", "file_name": "4_DNA_of_things.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bd179acc-67b8-499f-b779-94b4ed1b18ea", "node_type": null, "metadata": {"page_label": "43", "file_name": "4_DNA_of_things.pdf"}, "hash": "31cab9d080fa04f7c01af33d48be80f239e9f554a2ccc11033890919cfadf022"}, "2": {"node_id": "9cfb6122-36b5-4648-b10e-f448ef9b716e", "node_type": null, "metadata": {"page_label": "43", "file_name": "4_DNA_of_things.pdf"}, "hash": "637d4961eab0affe9bdec397b4a6c75467987836986641b93dbe3b321c0a642f"}, "3": {"node_id": "a99a5f2e-8f6d-4f97-8536-07018a7c7ab4", "node_type": null, "metadata": {"page_label": "43", "file_name": "4_DNA_of_things.pdf"}, "hash": "3a7b96590de447dcbb5de88ada6ff4fa8f3f57edd0a5816a569c79d4ca0237e3"}}, "hash": "69aadb6854d14963facde9509f0976db44988e0d535da05f0761b44332d6bc31", "text": "(2015).\n 4. Y azdi, S. M. H. T., Gabrys, R. & Milenkovic, O. Portable and error-free DNA-based data storage. Sci. Rep. 7, 5011 (2017).\n 5. Erlich, Y . & Zielinski, D. DNA fountain enables a robust and efficient storage architecture. Science  355, 950\u2013954 (2017).\n 6. Organick, L. et\u00a0al. Random access in large-scale DNA data storage.  Nat. Biotechnol.  36, 242\u2013248 (2018).\n 7. Carmean, D. et\u00a0al. DNA data storage and hybrid molecular\u2013electronic computing. Proc. IEEE 107, 63\u201372 (2019).\n 8. Paunescu, D., Puddu, M., Soellner, J. O. B., Stoessel, P . R. & Grass, R. N. Reversible DNA encapsulation in\u00a0silica to produce ROS-resistant and heat-resistant synthetic DNA \u2018fossils\u2019 . Nat. Protoc.  8, 2440\u20132448 (2013).\n 9. Turk, G. & Levoy, M. Zippered polygon meshes from range images. in Proc. 21st Annual Conference on Computer Graphics and Interactive Techniques 311\u2013318 (ACM, 1994).\n 10. Evans, R. F. L., Chantrell, R. W ., Nowak, U., Lyberatos, A. & Richter, H. J. Thermally induced error: density limit for magnetic data storage. Appl. Phys. Lett.  100, 102402 (2012).\n 11. Charap, S. H., Lu, P .-L. & He, Y . Thermal stability of recorded information at high densities. IEEE Trans. Magn. 33, 978\u2013983 (1997).\n 12. Zhirnov, V ., Zadegan, R. M., Sandhu, G. S., Church, G. M. & Hughes, W . L. Nucleic acid memory. Nat. Mater.  15, 366\u2013370 (2016).\n 13. Paunescu, D., Fuhrer, R. & Grass, R. N. Protection and deprotection of DNA\u2014high-temperature stability of nucleic acid barcodes for polymer labeling. Angew. Chem. Int. Ed. 52, 4269\u20134272 (2013).\n 14. Heckel, R., Mikutis, G. & Grass, R. N. A characterization of the DNA data storage channel. Sci. Rep. 9, 9663 (2019).\n 15. Bonnet, J. et\u00a0al. Chain and conformation stability of solid-state DNA: implications for room temperature storage. Nucleic Acids Res. 38,  \n1531\u20131546 (2010).\n 16. Bandyopadhyay, A., de Sarkar, M. & Bhowmick, A. K. Polymer\u2013filler interactions in sol\u2013gel derived polymer/silica hybrid nanocomposites.  J. Polym. Sci. B 43, 2399\u20132412 (2005).\n 17. Paunescu, D., Stark, W . J. & Grass, R. N. Particles with an identity: tracking and tracing in commodity products. Powder Technol. 291, 344\u2013350 (2016).\n 18. Pham, A. N., Xing, G., Miller, C. J. & Waite, T. D. Fenton-like copper redox chemistry revisited: hydrogen peroxide and superoxide mediation of copper-catalyzed oxidant production. J. Catal. 301, 54\u201364 (2013).\n 19. Schmeh, K. Versteckte Botschaften: Die faszinierende Geschichte der \nSteganografie (Heise Verlag, 2017).\n 20. Abramoff, B. & Covino, J. Transmittance and mechanical properties of PMMA-fumed silica composites. J. Appl. Polym. Sci. 46, 1785\u20131791 (1992).\n 21. Erlich, Y . A vision for ubiquitous sequencing. Genome Res. 25,  \n1411\u20131416 (2015).\n", "start_char_idx": 3856, "end_char_idx": 6580, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a99a5f2e-8f6d-4f97-8536-07018a7c7ab4": {"__data__": {"id_": "a99a5f2e-8f6d-4f97-8536-07018a7c7ab4", "embedding": null, "metadata": {"page_label": "43", "file_name": "4_DNA_of_things.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bd179acc-67b8-499f-b779-94b4ed1b18ea", "node_type": null, "metadata": {"page_label": "43", "file_name": "4_DNA_of_things.pdf"}, "hash": "31cab9d080fa04f7c01af33d48be80f239e9f554a2ccc11033890919cfadf022"}, "2": {"node_id": "0a8d94e5-665f-4b6f-b2f4-b556c1423aa8", "node_type": null, "metadata": {"page_label": "43", "file_name": "4_DNA_of_things.pdf"}, "hash": "69aadb6854d14963facde9509f0976db44988e0d535da05f0761b44332d6bc31"}}, "hash": "3a7b96590de447dcbb5de88ada6ff4fa8f3f57edd0a5816a569c79d4ca0237e3", "text": "sequencing. Genome Res. 25,  \n1411\u20131416 (2015).\n 22. Clelland, C. T., Risca, V . & Bancroft, C. Hiding messages in DNA microdots. Nature  399, 533\u2013534 (1999).\nPublisher\u2019s note Springer Nature remains neutral with regard to jurisdictional claims in \npublished maps and institutional affiliations.\n\u00a9 The Author(s), under exclusive licence to Springer Nature America, Inc. 2019\nNAtuRE BiotE chNoloGY | VOL 38 | JANu ARY 2020 | 39\u201343 | www.nature.com/naturebiotechnology 43", "start_char_idx": 6557, "end_char_idx": 7026, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6a08adf3-1408-4008-9aa1-0906db922c83": {"__data__": {"id_": "6a08adf3-1408-4008-9aa1-0906db922c83", "embedding": null, "metadata": {"page_label": "44", "file_name": "4_DNA_of_things.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1bdce6de-3906-429d-83c6-8a2539dc7c57", "node_type": null, "metadata": {"page_label": "44", "file_name": "4_DNA_of_things.pdf"}, "hash": "d087bfed59db4b6cfdc3e6e4e66556e17df95f24b5efc334ba1e42af9cef1e5f"}, "3": {"node_id": "10495a0d-57cc-42eb-9a04-0ec2e12ab6e6", "node_type": null, "metadata": {"page_label": "44", "file_name": "4_DNA_of_things.pdf"}, "hash": "9a5485a5e470bb8ea4dc97ced7cf2094a2160434d269edf28f487dd33bd1ad94"}}, "hash": "07f720d1b9850d2f0fcda229990decf79a2a709f329a4027263cd370fc09e9a0", "text": "Letters Nature BiotechNologyMethods\nDNA encoding for the bunny experiment. The original binary stl file was \ndownloaded from http://graphics.stanford.edu/pub/3Dscanrep/bunny.tar.gz and was reduced in resolution from 22 MB to 100 kB by reducing the vertex count  \nof the mesh with Blender 2.79b (Blender Foundation). Next, we compressed the  file using gzip and encoded the data using DNA Fountain software with the following parameters: --max_homopolymer 3 --gc 0.05 --rs 2 --size 20 --delta  0.001 --c_dist 0.025. These parameters correspond to a maximal homopolymer of three nucleotides, a GC content of 50 \u00b1 5%, 2 B of Reed\u2013Solomon error-correcting \ncode, 20 B of data in each oligo and robust soliton distribution\n23.\nLibrary synthesis for the bunny experiment. The DNA Fountain output was a  library with 12,000 oligos of length 104 nt. We added the following PCR annealing \nsequences to flank each oligo: 5\u2019-ACACGACGCTCTTCCGATCT-3\u2019 (20 nt) and  \n5\u2019-AGATCGGAAGAGCACACGTCT-3\u2019 (21 nt), so the resulting oligos were of  \nlength 145 nt. We synthesized the oligos with CustomArray. From the synthesized  \nlibrary, 47 ng was PCR amplified using the following primers: 5\u2019-ACACGACGCT \nCTTCCGATCT-3\u2019 and 5\u2019-AGACGTGTGCTCTTCCGATCT-3\u2019 , and KAPA SYBR FAST qPCR Master Mix (KAPA Biosystems) using the following cycling parameters: 95 \u00b0C for 15 s, 54 \u00b0C for 30 s, 72 \u00b0C for 30 s for 30 cycles. We then loaded \n12.2 \u03bcg of DNA onto 1.75 mg of silica nanoparticles (Supplementary Fig. 10), \nfunctionalized with N-trimethoxysilylpropyl-N,N,N-trimethylammonium chloride and subsequently coated with an additional silica layer by adding tetraethoxysilane using a protocol described by Paunescu et\u00a0al.\n8.\nIncorporation into PCL and 3D printing. First, 2 mg of SPED was centrifuged \nat 15,000 r.p.m. for 3 min and the supernatant was removed. The particles were \nthen washed and centrifuged twice in 2-ml Eppendorf tubes with 2 ml of acetone \n(>99.8%, ProLabo). The particles were then suspended in 2 ml of THF (VWR, \n>99.5%) and added to THF-dissolved PCL (MakerBot, 20 wt% PCL in THF). To \ndistribute the particles in the polymer, the suspension was mixed with a high-speed mixer (SpeedMixer DAC 150 FVZ). After solvent evaporation under a fume hood, the solid polymer was extruded (Filastruder) at 60 \u00b0C to form a 2.85 mm \nfilament. Objects were then printed with a commercial 3D printer (Ultimaker 2+, Ultimaker) modified with a geared direct drive extruder and a V6 hotend (E3D). The parts were printed onto a heated build-plate (45 \u00b0C) that was coated with a \nlayer of adhesive spray (3DLac) at a speed of 20 mm s\n\u22121 and forced convection \nwas applied to cool the extrudate. The Stanford Bunny was printed with a nozzle temperature of 100 \u00b0C. An open-source fused deposition modeling slicer (Cura, \nUltimaker) was used to generate the print paths.\nSequencing and product cycle generation for the bunny experiments. We \nclipped ~10 mg from the bunny ear using a scalpel. This piece was dissolved in \n250 \u03bcl of THF (VWR) before adding 10 \u03bcl of BOE solution. The BOE was added to", "start_char_idx": 0, "end_char_idx": 3065, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "10495a0d-57cc-42eb-9a04-0ec2e12ab6e6": {"__data__": {"id_": "10495a0d-57cc-42eb-9a04-0ec2e12ab6e6", "embedding": null, "metadata": {"page_label": "44", "file_name": "4_DNA_of_things.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1bdce6de-3906-429d-83c6-8a2539dc7c57", "node_type": null, "metadata": {"page_label": "44", "file_name": "4_DNA_of_things.pdf"}, "hash": "d087bfed59db4b6cfdc3e6e4e66556e17df95f24b5efc334ba1e42af9cef1e5f"}, "2": {"node_id": "6a08adf3-1408-4008-9aa1-0906db922c83", "node_type": null, "metadata": {"page_label": "44", "file_name": "4_DNA_of_things.pdf"}, "hash": "07f720d1b9850d2f0fcda229990decf79a2a709f329a4027263cd370fc09e9a0"}, "3": {"node_id": "7c9de5bd-7411-45f4-bd2f-d1857163a7a7", "node_type": null, "metadata": {"page_label": "44", "file_name": "4_DNA_of_things.pdf"}, "hash": "027b769de69c71f11b5ce09b57577b542779bd583cab54b93ca164c0f772249c"}}, "hash": "9a5485a5e470bb8ea4dc97ced7cf2094a2160434d269edf28f487dd33bd1ad94", "text": "before adding 10 \u03bcl of BOE solution. The BOE was added to \nrelease the DNA molecules from the SPED beads. The DNA was then purified by PCR Purification Kit (Qiagen) and PCR using the same qPCR protocol as for the library synthesis. The different DNA samples from each generation were pooled and diluted to 1 nM and mixed with an additional 2% spike of PhiX added for base \ndiversity. Finally, the DNA pool was sequenced with Illumina iSeq100 using the 150 nt paired-end protocol. A detailed procedure for sequencing preparation can \nbe found in Supporting Note 5.\nDecoding for the bunny experiments. For each generation, the paired-end \nsequencing data were stitched together using Pear\n24. We then removed sequence \nreads whose length was not equal to the original design length 104 nt using awk. \nNext, we continued with a decoding strategy similar to the original DNA Fountain scheme\n5. In short, reads were first collapsed and sorted based on their appearance \nfrom the most abundant to the least abundant, breaking ties lexicographically. Then, we decoded the file back using DNA Fountain, which employs a message-passing algorithm scheme. We compared the input SHA256 of the compressed stl file (314d00155dcbc259683cfc02fbe9edbbf205a978f573569c79ab2d1b5e6bdc53) with the SHA256 of the retrieved file for each generation. In all cases, the SHA256 signatures were identical. Subsequently, the extracted file was printed as described in the previous section. Fitting of the negative binomial distribution was done in R using the tdistr command. For the analysis of the number of errors as a function of generation time, we scanned each sequence read against all possible 12,000 designed oligos. To this end, we started by splitting the 12,000 oligos into k -mers and associating each \nunique k-mer with a list of the original oligos. Then, we took each sequence read, spilt \ninto 1-base pair overlapping k -mers and enumerating all possible oligos. In practice, \nwe used k  = 9. The best-matching oligo had to have at least two more matching k -mers \nthan the second best and at least four distinct k -mer matches. After finding the best-\nmatching oligo, we performed an alignment between the read and the best-matching oligo using muscle v.3.8.31 (ref. \n25) to find insertions, deletions and substitutions. \nWe used the following alignment parameters: match = 1, mismatch =  \u22121, gap_\nopening = \u22121, gap_extension = \u22120.5. Statistical analyses were carried out with Python \nSciPy and P  values smaller than 10\u20139 were reported as P  < 10\u22129 in the main text.\nStorage and retrieval of the Oneg Shabbat video. The video published by UNESCO on Y ouTube was entitled \u2018The incredible and moving story of Oneg Shabbat\u2019 ( https://www.youtube.com/watch?v=yqcLlTbSXUg). It was accessed \n14 May 2019 and was reformatted (AAC, H.264) to a resolution of 240 pixels at \n12 frames per\u00a0second with 60 kilobase mono audio yielding an mp4 video file of \n1.4 MB. The digital bitstream was encoded in DNA using DNA Fountain software \nwith the same parameters as for the bunny experiment with two exceptions: first, we let the DNA Fountain software generate 300,000 DNA oligos. Second, we allowed a slightly larger GC content of 50 \u00b1 20%. After appending adapter \ninformation, 300,000 DNA sequences (length 145 nt) were ordered from Twist \nBioscience. The DNA sample (6 \u00b5g) was dissolved in 120 \u03bcl of Milli-Q grade water \nto reach a concentration of 50 ng \u03bcl\n\u22121 and stored at \u221220 \u00b0C.\nIncorporation of Oneg Shabbat library into a PMMA cast. SPED (2 mg),", "start_char_idx": 3020, "end_char_idx": 6551, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7c9de5bd-7411-45f4-bd2f-d1857163a7a7": {"__data__": {"id_": "7c9de5bd-7411-45f4-bd2f-d1857163a7a7", "embedding": null, "metadata": {"page_label": "44", "file_name": "4_DNA_of_things.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1bdce6de-3906-429d-83c6-8a2539dc7c57", "node_type": null, "metadata": {"page_label": "44", "file_name": "4_DNA_of_things.pdf"}, "hash": "d087bfed59db4b6cfdc3e6e4e66556e17df95f24b5efc334ba1e42af9cef1e5f"}, "2": {"node_id": "10495a0d-57cc-42eb-9a04-0ec2e12ab6e6", "node_type": null, "metadata": {"page_label": "44", "file_name": "4_DNA_of_things.pdf"}, "hash": "9a5485a5e470bb8ea4dc97ced7cf2094a2160434d269edf28f487dd33bd1ad94"}, "3": {"node_id": "b6e5ba86-17eb-4e63-a97b-0ed865d9d0b8", "node_type": null, "metadata": {"page_label": "44", "file_name": "4_DNA_of_things.pdf"}, "hash": "07d67c01053d591e8b47795731398d29e98f64b5d2885faf7d39180e6ac0d730"}}, "hash": "027b769de69c71f11b5ce09b57577b542779bd583cab54b93ca164c0f772249c", "text": "of Oneg Shabbat library into a PMMA cast. SPED (2 mg), \nwhich was manufactured from the DNA library using published methods8, was \ncentrifuged at 15,000 r.p.m. for 3 min and the supernatant aqueous solution was \nremoved. The particles were then washed and centrifuged twice in 2-ml Eppendorf tubes with 2 ml of acetone (>99.8%, ProLabo). The particles were then suspended \nin 2 ml of acetone by ultrasonication. For casting one pair of PMMA glasses, \n0.66 mg of particles were added to 7 ml of methyl methacrylate (SKresin 1702,  \nS u. K Hock). The suspension was mixed in a 150-ml polypropylene beaker with a high-speed mixer (SpeedMixer DAC 150 FVZ) for 30 s at 3,500 r.p.m. To initiate \nthe radical polymerization, 70 mg of Peroxan (PM25S, S u. K Hock) was added \nbefore mixing again for 30 s at 3,500 r.p.m. with the high-speed mixer. The reaction \nmixture was left overnight in the beaker, resulting in a transparent PMMA disk. With a scalpel, the form of the glasses lens was cut out of the disk and inserted into the eyeglass frame. For comparing the visibility of PMMA with and without SPED, the same procedure was used to produce a PMMA glass without adding SPED.\nDecoding of the Oneg Shabbat video. We used very similar steps to those used \nfor decoding the bunny experiment to decode the Oneg Shabbat video. The only exception was that during the first round of decoding we noticed that a large number of oligos were sequenced from both their forward and reverse strands. The source of this issue remained unclear but might have stemmed from a parsing error in obtaining the reverse and forward strands from the sequencer. To overcome this issue and to find the correct orientation for each read, we reverse-complemented each sequence read and generated a tandem of two reads sorted lexicographically. For example, if the original read was TTTA then we created the reverse complement, which is AAAT, and then stitched the two reads together in a lexicographical order, resulting in the tandem read AAAT\u2013TTTA. We carried out this process for all reads in the file after the stitching step. Then, we continued with the normal preprocessing steps of collapsing the tandem reads and sorting them based on their appearances. Next, we took each part of the tandem read and evaluated the Reed\u2013Solomon code. We then moved the part that showed zero errors based on the Reed\u2013Solomon code to the decoder. If both parts showed zero errors, it signified that we could not distinguish the orientation and so we discarded the entire tandem read. If none of the parts showed zero errors, we also discarded the entire tandem read. For example, if AAAT showed zero errors based on the Reed\u2013Solomon code and TTTA showed one error, we progressed the AAAT to the decoder and discarded the TTTA. This process resulted in 287,344 unique oligos for decoding. Finally, we decoded the file back using the 287,344 oligos. We compared the input SHA256 of the video (ef819b4f0fe855becb53a3a39183d6b8544f24c9c5963f474ec019bbdffe913c) with the SHA256 of the retrieved file, which was identical. We could also play the video using QuickTime player on a standard Mac laptop.\nThermal and chemical stability assays. DNA-infused PCL was extruded and \n3D printed at temperatures ranging from 60 \u00b0C to 120 \u00b0C. Assessing long-term \nstability, dried pure and SPED DNA libraries were stored at 60 \u00b0C for 10 d and then \nre-suspended and quantified by qPCR. Chemical stability was tested by a radical treatment stability assay, where a combination of ascorbic acid, H\n2O2 and CuCl2 \nproduced reactive oxidative species and tested the", "start_char_idx": 6554, "end_char_idx": 10155, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b6e5ba86-17eb-4e63-a97b-0ed865d9d0b8": {"__data__": {"id_": "b6e5ba86-17eb-4e63-a97b-0ed865d9d0b8", "embedding": null, "metadata": {"page_label": "44", "file_name": "4_DNA_of_things.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1bdce6de-3906-429d-83c6-8a2539dc7c57", "node_type": null, "metadata": {"page_label": "44", "file_name": "4_DNA_of_things.pdf"}, "hash": "d087bfed59db4b6cfdc3e6e4e66556e17df95f24b5efc334ba1e42af9cef1e5f"}, "2": {"node_id": "7c9de5bd-7411-45f4-bd2f-d1857163a7a7", "node_type": null, "metadata": {"page_label": "44", "file_name": "4_DNA_of_things.pdf"}, "hash": "027b769de69c71f11b5ce09b57577b542779bd583cab54b93ca164c0f772249c"}}, "hash": "07d67c01053d591e8b47795731398d29e98f64b5d2885faf7d39180e6ac0d730", "text": "H\n2O2 and CuCl2 \nproduced reactive oxidative species and tested the protective properties of SPED (see Supporting Notes 7 and 8 for details).\nReporting Summary. Further information on research design is available in the \nNature Research Reporting Summary linked to this article.\nData availability\nThe input files are available at https://figshare.com/s/283543df2b734b7988c6.The sequencing files are available on the European Nucleotide Archive website, under accession code PRJEB35217.\ncode availability\nDNA Fountain is available at https://github.com/TeamErlich/dna-fountain.\nReferences\n 23. Luby, M. LT codes. in Symposium on Foundations of Computer Science 2002 271\u2013280 (IEEE, 2002).\n 24. Zhang, J., Kobert, K., Flouri, T. & Stamatakis, A. PEAR: a fast and accurate illumina Paired-End reAd mergeR. Bioinformatics  30, 614\u2013620 (2013).\nNAtuRE BiotE chNoloGY | www.nature.com/naturebiotechnology", "start_char_idx": 10132, "end_char_idx": 11028, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "71fc69a0-ce96-4466-8553-639b0af29f7a": {"__data__": {"id_": "71fc69a0-ce96-4466-8553-639b0af29f7a", "embedding": null, "metadata": {"page_label": "45", "file_name": "4_DNA_of_things.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "73d0cfbd-e0e7-4e6e-85d9-60a25cc4a1ac", "node_type": null, "metadata": {"page_label": "45", "file_name": "4_DNA_of_things.pdf"}, "hash": "75522d593fb41a691738e423cb72798107835fa0278252f87d507337a1320268"}}, "hash": "75522d593fb41a691738e423cb72798107835fa0278252f87d507337a1320268", "text": "Letters Nature BiotechNology 25. Edgar, R. C. MUSCLE: a multiple sequence alignment method  \nwith reduced time and space complexity. BMC Bioinformatics  5,  \n113\u2013113 (2004).\nAcknowledgements\nThe authors thank the Christen group at ETH for giving access to the iSeq 100 \nsequencing device. Y .E thank B. Zaks for helpful discussions. Financial support by the ETH Zurich is kindly acknowledged.\nAuthor contributions\nThe idea for the study was by conceived by Y .E. and R.N.G. The study was \nconceptualized by R.N.G., Y .E., W .J.S. and K.M. Coding was done by Y .E. Experimental \nwork was performed by J.K. 3D printing was carried out by S.G. Visualization was performed by J.K. and R.N.G. The first draft was written by Y .E. All authors contributed to reviewing, editing and providing additional text for the manuscript. The order of the \nfirst two authors, who contributed equally, was determined lexigraphically.\ncompeting interests\nY .E. is an employee of MyHeritage, owner of Erlich Lab LLC, and holds patents in the \narea of DNA storage. ETH Zurich holds patents on DNA encapsulation. Y .E. and R.N.G are listed as inventors on a patent application in the field of DNA of things.\nAdditional information\nSupplementary information is available for this paper at https://doi.org/10.1038/\ns41587-019-0356-z.\nCorrespondence and requests for materials should be addressed to Y .E. or R.N.G.Reprints and permissions information is available at www.nature.com/reprints.\nNAtuRE BiotE chNoloGY | www.nature.com/naturebiotechnology", "start_char_idx": 0, "end_char_idx": 1525, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "70a96f1a-9292-4f55-8236-7078e612a96c": {"__data__": {"id_": "70a96f1a-9292-4f55-8236-7078e612a96c", "embedding": null, "metadata": {"page_label": "1", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "040e8e55-1b5e-423b-a61e-78b07c315c43", "node_type": null, "metadata": {"page_label": "1", "file_name": "5_COVID_Medicine.pdf"}, "hash": "b71acaf6398032ab05bb15654cf983e84def035be8cb7ea439164cfa20e94415"}, "3": {"node_id": "6ae90039-22e3-4f19-a45e-8ca3ad90e0d7", "node_type": null, "metadata": {"page_label": "1", "file_name": "5_COVID_Medicine.pdf"}, "hash": "d8b1dac183638a786a43dc2774aa2ddc7335a29168e1c20678b49aa5a7239830"}}, "hash": "8385ad6de4b3d2e3f83448547f4049612b054b3c809eb2863aac1a7a53f65439", "text": "Cite as:T. P. Sheahan et al., Sci. Transl. Med.  \n10.1126/scitranslmed.abb5883 (2020).    \n \n \n  RESEARCH ARTICLES  \n \nFirst release: 6 April 2020    stm.sciencemag.org   ( Page numbers not final at time of first  release ) 1\n   \n \nINTRODUCTION  \nThe genetically diverse Orthocoronavirinae  (coronavirus, \nCoV) family circulates in many avian and mammalian  spe-\ncies. Phylogenetically, CoVs are divided into 4 genera: alpha (group 1), beta (group 2), gamma (group 3) and delta (group 4). Three new human CoV have emerged in the past 20 years with severe acute respiratory syndrome CoV (SARS -CoV) in \n2002, Middle Ea st respiratory syndrome CoV (MERS -CoV) in \n2012, and now SARS -CoV-2 in 2019 (1-3 ). In fact, all human \nCoV are thought to have emerged originally as zoonoses ( 4-\n6). The ongoing SARS -CoV-2 pandemic (referred to as \nCOVID -19, Coronavirus disease 2019) has caused over \n500,000 infections and over 25,000 deaths in 199 countries. Like SARS- and MERS -CoV, the respiratory disease caused by \nSARS- CoV-2 can progress to acute lung injury (ALI), an end \nstage lung disease with limited treatment options and very poor prognoses( 3, 7, 8 ). This emergence paradigm is not lim-\nited to humans. A novel group 1 CoV called swine acute diar-rhea syndrome CoV (SADS -CoV) recently emerged from bats \ncausing the loss of over 20,000 pigs in Guangdong Province, China (9 ). More alarmingly, m any group 2 SARS -like and \nMERS- like coronaviruses are circulating in bat reservoir spe-\ncies that can use human receptors and replicate efficiently in primary human lung cells without adaptation( 9-12). The \npresence of these \u201cpre -epidemic\u201d zoonotic strains fo reshadow \nthe emergence and epidemic potential of additional SARS -CORONAVIRUS  \nAn orally bioavailable broad -spectrum antiviral inhibits \nSARS -CoV -2 in human airway epithelial cell cultures and \nmultiple coronaviruses in mice \nTimothy P. Sheahan1*\u2020, Amy C. Sims1$*, Shuntai Zhou2, Rachel L. Graham1, Andrea J. Pruijssers3, Maria L. \nAgostini3, Sarah R. Leist1, Alexandra Sch\u00e4fer1, Kenneth H. Dinnon III1,4, Laura J. Stevens3, James D. Chappell3, \nXiaotao Lu3, Tia M. Hughes3, Amelia S. George3, Collin S. Hill2, Stephanie A. Montgomery5, Ariane J. Brown1, \nGregory R. Bluemling6,7, Michael G. Natchus6, Manohar Saindane6, Alexander A. Kolykhalov6,7, George \nPainter6,7,8, Jennifer Harcourt9, Azaibi Tamin9, Natalie J. Thornburg9, Ronald Swanstrom2,10, Mark R. Denison3, \nRalph S. Baric1,4\u2020 \n1Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. 2Lineberger Comprehensive Cancer Center, University of North \nCarolina at Chapel Hill, Chapel Hill, NC, 27599, USA. 3Department of Pediatrics, Vanderbilt U niversity Medical Center, Nashville, TN, TN, 37232,USA 4Department of \nMicrobiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 5Department of Pathology & Laboratory Medicine, University of North", "start_char_idx": 0, "end_char_idx": 2952, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6ae90039-22e3-4f19-a45e-8ca3ad90e0d7": {"__data__": {"id_": "6ae90039-22e3-4f19-a45e-8ca3ad90e0d7", "embedding": null, "metadata": {"page_label": "1", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "040e8e55-1b5e-423b-a61e-78b07c315c43", "node_type": null, "metadata": {"page_label": "1", "file_name": "5_COVID_Medicine.pdf"}, "hash": "b71acaf6398032ab05bb15654cf983e84def035be8cb7ea439164cfa20e94415"}, "2": {"node_id": "70a96f1a-9292-4f55-8236-7078e612a96c", "node_type": null, "metadata": {"page_label": "1", "file_name": "5_COVID_Medicine.pdf"}, "hash": "8385ad6de4b3d2e3f83448547f4049612b054b3c809eb2863aac1a7a53f65439"}}, "hash": "d8b1dac183638a786a43dc2774aa2ddc7335a29168e1c20678b49aa5a7239830", "text": "Chapel Hill, NC 5Department of Pathology & Laboratory Medicine, University of North Carolina, \nChapel Hill, NC, 2 7599, USA. 6Emory Institute of Drug Development (EIDD), Emory University, Atlanta, GA, 30322, USA. 7Drug Innovation Ventures at Emory (DRIVE), \nAtlanta, GA, 30322, USA. 8Department of Pharmacology and Chemical Biology, Emory University, Atlanta, GA, 30322, USA. 9Centers for Disease Control and Prevention, \nDivision of Viral Diseases Atlanta GA 10Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC  \n*Authors contributed equally.  \n$ Current address for A.C.S. is Chemical and Biological Signature Sciences, National Security Division, Pacific Northwest National Laboratory, Richland, WA 9 9352, USA.  \n\u2020Corresponding author. Email:  Timothy P. Sheahan sheahan@email.unc.edu and Ralph S. Baric rbaric@email.unc.edu  \nCoronavir uses (CoVs) traffic frequently between species resulting in novel disease outbreaks, most \nrecently exemplified by the newly emerged SARS -CoV -2, the causative agent of COVID- 19. Herein, we show \nthat the ribonucleoside analog \u03b2 -D-N4-hydroxycytidine (NHC, EIDD- 1931) has broad spectrum antiviral \nactivity against SARS -CoV -2, MERS -CoV, SARS- CoV, and related zoonotic group 2b or 2c Bat -CoVs, as well \nas increased potency against a coronavirus bearing resistance mutations to the nucleoside analog inhibitor remdesivi r. In mice infected with SARS -CoV or MERS -CoV, both prophylactic and therapeutic \nadministration of EIDD- 2801, an orally bioavailable NHC -prodrug ( \u03b2-D-N\n4-hydroxycytidine -5\u2032-isopropyl \nester), improved pulmonary function, and reduced virus titer and body weig ht loss. Decreased MERS -CoV \nyields in vitro and in vivo were associated with increased transition mutation frequency in viral but not host cell RNA, supporting a mechanism of lethal mutagenesis in CoV. The potency of NHC/EIDD -2801 against \nmultiple coronavi ruses and oral bioavailability highlight its potential utility as an effective antiviral against \nSARS -CoV -2 and other future zoonotic coronaviruses.   at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 2869, "end_char_idx": 5055, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "457f887c-421e-432f-a504-2f0d15e83052": {"__data__": {"id_": "457f887c-421e-432f-a504-2f0d15e83052", "embedding": null, "metadata": {"page_label": "2", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2bfe3106-e487-4947-ac3c-9593794b4ec4", "node_type": null, "metadata": {"page_label": "2", "file_name": "5_COVID_Medicine.pdf"}, "hash": "d806dd977a004a452c57cc823636121e147844f9adf868970bcfa5584d44de24"}, "3": {"node_id": "ec10494a-8d7a-478c-868a-579082577571", "node_type": null, "metadata": {"page_label": "2", "file_name": "5_COVID_Medicine.pdf"}, "hash": "18c14db9376e1167f29c12d5ea55589a5cdb9764485f69a83824fe628b491138"}}, "hash": "06637401423cf67783fd3a2c1c49a2becf3c4765ee65a6d3ffc15e0482f2c30f", "text": "First release: 6 April 2020   stm.sciencemag.org   ( Page numbers not final at time of first  release ) 2 \n like and MERS -like viruses in the future. Given the diversity \nof CoV strains in zoonotic reservoirs and a penchant for \nemergence, broadly active antivirals are clearly needed for rapid respon se to new CoV outbreaks in humans and domes-\nticated animals.  \nCurrently, there are no approved therapies specific for any \nhuman CoV. \u03b2 -D-N4-hydroxycytidine (NHC, EIDD -1931) is \norally bioavailable ribonucleoside analog with broad -spec-\ntrum antiviral activity a gainst various unrelated RNA viruses \nincluding influenza, Ebola, CoV, and Venezuelan equine en-cephalitis virus (VEEV)( 13-16). For VEEV, the mechanism of \naction (MOA) for NHC has been shown to be through lethal mutagenesis where deleterious transition mutations accumu-late in viral RNA( 14, 17 ). Thus, we sought to determine NHC\u2019s \nbreadth of antiviral activity against multiple emerging CoV, its mechanism of action for CoV and its efficacy in mouse models of CoV pathogenesis.  \nRESULTS \nNHC potently inhibits MERS -CoV and newly emerging \nSARS -CoV -2 replication  \nTo determine whether NHC blocks the replication of highly pathogenic human CoV, we performed antiviral assays in cell lines with MERS -CoV and the newly emerging SARS -CoV-2. \nWe first assessed the a ntiviral activity of NHC against MERS -\nCoV in the human lung epithelial cell line Calu -3 2B4 (\u201cCalu3\u201d \ncells). Using a recombinant MERS -CoV expressing nanolucif-\nerase (MERS -nLUC)( 18), we measured virus replication in \ncultures exposed to a dose range of drug f or 48hr. NHC was \npotently antiviral with an average half -maximum effective \nconcentration (IC\n50) of 0.15 \u03bc M and no observed cytoxicity in \nsimilarly treated uninfected cultures across the dose range (50% cytotoxic concentration, CC\n50, >10 \u03bc M) (Fig. 1A). The \ntherapeutic index for NHC was >100. Using a clinical isolate of SARS- CoV2 (2019 -nCoV/USA -WA1/2020), we performed \nantiviral assays in African green monkey kidney (Vero) cells and found NHC was potently antiviral with an IC\n50 of 0.3 \u03bc M \nand CC 50 of >10 \u03bc M (Fi g. 1B). We then determined the antivi-\nral activity of NHC against SARS -CoV-2 in the Calu- 3 cells \nthrough the measurement of infectious virus production and viral genomes. We observed a dose -dependent reduction in \nvirus titers (Fig. 1C) with an IC\n50 of 0.08 \u03bc M. Viral genomic \nRNA was quantitated in clarified supernatants by qRT -PCR \n(Fig. 1D). Like the effect on infectious titers, we found a dose -\ndependent reduction in viral genomic RNA and a similar cal-culated IC\n50 of 0.09 \u03bc M. Collectively, these data demonstr ate \nthat NHC is potently antiviral against two genetically distinct emerging CoV.  \nNHC is highly active against SARS -CoV -2, MERS -CoV, \nand SARS -CoV in primary human airway epithelial cell \ncultures  \nTo determine if NHC would be similarly antiviral in primary human cells, we performed a series of studies in primary air-\nway epithelial (HAE) cell cultures. HAE model the architec-ture and cellular complexity of the conducting airway and are readily infected by multiple human and zoonotic CoV, includ-ing SARS - and MERS- CoV ( 19).", "start_char_idx": 0, "end_char_idx": 3213, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ec10494a-8d7a-478c-868a-579082577571": {"__data__": {"id_": "ec10494a-8d7a-478c-868a-579082577571", "embedding": null, "metadata": {"page_label": "2", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2bfe3106-e487-4947-ac3c-9593794b4ec4", "node_type": null, "metadata": {"page_label": "2", "file_name": "5_COVID_Medicine.pdf"}, "hash": "d806dd977a004a452c57cc823636121e147844f9adf868970bcfa5584d44de24"}, "2": {"node_id": "457f887c-421e-432f-a504-2f0d15e83052", "node_type": null, "metadata": {"page_label": "2", "file_name": "5_COVID_Medicine.pdf"}, "hash": "06637401423cf67783fd3a2c1c49a2becf3c4765ee65a6d3ffc15e0482f2c30f"}}, "hash": "18c14db9376e1167f29c12d5ea55589a5cdb9764485f69a83824fe628b491138", "text": "CoV, includ-ing SARS - and MERS- CoV ( 19). We first assessed cytotoxicity \nof NHC in HAE treated with an extended dose range for 48hr using quantitative PCR of cell death -related gene transcripts \nas our metric. NHC treatment did not appreciably alter gene expression even at doses up to 10 0 \u03bcM (fig. S1). We then \nsought to determine if NHC would inhibit clinical isolate SARS- CoV-2 replication in HAE. We observed a dose depend-\nent reduction in SARS -CoV-2 infectious virus production (Fig. \n2A). In MERS -CoV infected HAE, NHC substantially reduced  \nvirus production with maximal titer reduction of > 5 logs at 10 \u03bcM (average IC\n50 = 0.024 \u03bcM), which correlated with re-\nduced genomic (ORF1) and subgenomic (ORFN) RNA in paired samples (Fig. 2B). We observed similar trends in titer reduction (> 3 log at 10 \u03bc M, average IC\n50 = 0.14 \u03bcM) and in \ncopies of genomic and subgenomic RNA in SARS -CoV- in-\nfected HAE (Fig. 2C). Thus, NHC was potently antiviral \nagainst SARS -CoV-2, MERS -CoV and SARS- CoV in primary \nhuman epithelial cell cultures without cytotoxicity.  \nNHC is effective against remdesivir (RDV)- resistant vi-\nrus and multiple distinct zoonotic CoV  \nCoV are taxonomically divided into multiple genogroups (al-pha, beta, gamma, delta) but human -infecting CoV are found \nin only the alpha and beta subgroups thus far (Fig. 3A). There is high sequence conservation in the RNA -dependent RNA \npolymerase (RdRp, nsp12) ac ross CoV (Fig. 3A). For example, \nthe RdRp of SARS- CoV-2 has 99.1% similarity and 96% amino \nacid identity to that of SARS -CoV (Fig. 3A). To gain insight \ninto structural conservation of RdRp across the CoV family, we modeled the variation reflected in the RdRp dendrogram in Fig. 3A onto the structure of the SARS -CoV RdRp ( 20) (Fig. \n3B). The core of the RdRp molecule and main structural mo-tifs that all RdRp harbor (Fig. 3B and fig. S2) are highly con-served among CoV including SARS -CoV-2. We previously \nreported  that CoV resistance to another broad spectrum nu-\ncleoside analog, RDV, was mediated by RdRp residues F480L and V557L in a model coronavirus mouse hepatitis virus (MHV) and in SARS -CoV, resulting in a 5 -fold shift in IC\n50 \n(Fig. 3C)(21 ). Consequently, we tes ted whether RDV re-\nsistance mutations in MHV conferred cross -resistance to \nNHC. In fact, the two RDV resistance mutations, alone or to-gether, conferred increased sensitivity to inhibition by NHC (Fig. 3D). As our previous studies have demonstrated a high genetic barrier to NHC for VEEV, influenza and CoV (14 -16), \nthe lack of cross -resistance further suggests that NHC and \nRDV may select for exclusive and mutually sensitizing re-sistance pathways.  \nTo explore the breadth of antiviral efficacy against zoono-\ntic CoV, we performed antiviral assays in HAE with three  at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 3170, "end_char_idx": 6064, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c271753a-766b-40d1-985b-ab14a37c4555": {"__data__": {"id_": "c271753a-766b-40d1-985b-ab14a37c4555", "embedding": null, "metadata": {"page_label": "3", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9f9e7857-8573-46b4-809f-39d62f873ae1", "node_type": null, "metadata": {"page_label": "3", "file_name": "5_COVID_Medicine.pdf"}, "hash": "e1a97043116872d595196011439d330707308507708c6bbe5c8bd49766a1b433"}, "3": {"node_id": "530410eb-fa93-46cd-9048-9db79d3e8387", "node_type": null, "metadata": {"page_label": "3", "file_name": "5_COVID_Medicine.pdf"}, "hash": "903806c2aee9050f125bf9df3e35a4efdad4b0ee46310a77bf1b73adbe30599c"}}, "hash": "f57bb3c7829a9e8edab3acce89593bf7e10abe68ad2c5079320e051cfeb89460", "text": "First release: 6 April 2020   stm.sciencemag.org   ( Page numbers not final at time of first  release ) 3 \n zoonotic Bat -CoV: SHC014, HKU3, and HKU5. Closely related \nto the beta 2b SARS -CoV, Bat -CoV SHC014 is capable of rep-\nlicating in human cells without adaptation( 11), suggesting its \npotential for zoonotic emergence into humans. The more dis-\ntantly related SARS -like beta 2b CoV, recombinant Bat -CoV \nHKU3, has a modified receptor binding domain to facilitate growth in cell culture ( 22). Lastly, Bat -CoV HKU5 is a MERS -\nlike beta 2c CoV ( 23). NHC diminished infectious  virus pro-\nduction and the levels of genomic/subgenomic viral RNA in HAE in a dose -dependent manner for all three Bat -CoVs (Fig. \n4). Therefore, the antiviral activity of NHC was not limited by natural amino acid variation in the RdRp, which among the group 2b and group 2c CoV can vary by almost 20%. Moreo-\nver, these data suggest that if another SARS - or MERS -like \nvirus were to spillover into humans in the future, they would likely be susceptible to the antiviral activity of NHC.  \nNHC antiviral activity is asso ciated with increased viral \nmutation rates  \nIt has recently been shown that NHC treatment increases the mutation rate in viral genomic RNA of RSV ( 24), VEEV ( 14), \ninfluenza (24 ), and our previous study used RNA seq to show \nthat overall transition mutation f requency is increased dur-\ning NHC treatment of MHV and MERS -CoV during infection \nin continuous cell lines( 16). We sought to determine if NHC \nwould increase the mutation frequency during MERS -CoV in-\nfection in human primary HAE. Using MERS -CoV-infected \nHAE treated with either vehicle or a dose range of NHC or RDV, we show that both drugs reduced virus titers in a dose -\ndependent manner (Fig. 5A). We then used a highly -sensitive \nhigh-fidelity deep sequencing approach (Primer ID NGS), \nwhich uses barcoded degenera te primers and Illumina in-\ndexed libraries to determine accurate mutation rates on viral RNA production (25 ). Using this approach, we analyzed a 538 \nbp region of viral genomic RNA in nonstructural protein 15 (nsp15). The error rates (#mutations/10,000 bases) in vehicle - \n(0.01) or RDV - (0.01) treated cultures were very low. RDV is \nreported to act via chain termination of nascent viral RNA, and thus the low error rates in RDV- treated cultures are in \nline with the proposed MOA ( 26). In contrast, the error rate \nwas significantly increased in NHC -treated MERS -CoV RNA \nin a dose -dependent manner (Two -way ANOVA with Dun-\nnett\u2019s multiple comparison test; 10 -fold increase at 10 \u03bc M, P \n< 0.0001 at 24 and 48 hpi; 5 -fold increase at 1 \u03bcM, P < 0.0001 \nat 24 hpi and P = 0.0015 a t 48 hpi) (Fig. 5C). The magnitude \nof the error rate in NHC -treated cultures correlated with vi-\nrus titer reduction. At 48 hpi the respective error rate and virus titer was 0.015 and 3.96E+06 pfu/mL for vehicle treat-ment, 0.045 and 2.86E+04 pfu/mL with 1 \u03bc M NHC; and 0.090 \nand 1.5E+02 pfu/mL 10 \u03bc M NHC. Thus, with 1 \u03bc M NHC a 3 -\nfold increase in error rate resulted in a 138 -fold decrease in \nvirus titer, while with 10 \u03bc M NHC a 6 -fold increase in error \nrate resulted in a 26,000 -fold decrease in virus", "start_char_idx": 0, "end_char_idx": 3216, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "530410eb-fa93-46cd-9048-9db79d3e8387": {"__data__": {"id_": "530410eb-fa93-46cd-9048-9db79d3e8387", "embedding": null, "metadata": {"page_label": "3", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9f9e7857-8573-46b4-809f-39d62f873ae1", "node_type": null, "metadata": {"page_label": "3", "file_name": "5_COVID_Medicine.pdf"}, "hash": "e1a97043116872d595196011439d330707308507708c6bbe5c8bd49766a1b433"}, "2": {"node_id": "c271753a-766b-40d1-985b-ab14a37c4555", "node_type": null, "metadata": {"page_label": "3", "file_name": "5_COVID_Medicine.pdf"}, "hash": "f57bb3c7829a9e8edab3acce89593bf7e10abe68ad2c5079320e051cfeb89460"}, "3": {"node_id": "d6ff58f3-4120-47d6-8e97-696bbf6475e6", "node_type": null, "metadata": {"page_label": "3", "file_name": "5_COVID_Medicine.pdf"}, "hash": "b7019ef8588410ebe42639c81b831f82d1f74f7570ffa938acdff776b419dbc2"}}, "hash": "903806c2aee9050f125bf9df3e35a4efdad4b0ee46310a77bf1b73adbe30599c", "text": "in error \nrate resulted in a 26,000 -fold decrease in virus titer.  We the n examined the mutational spectra induced by \nNHC, which can be incorporated into viral RNA as a substi-tution for either cytosine (C) or uracil (U). RNA -mutagenic \nantivirals may incorporate in both nascent negative and pos-itive sense RNA during genome repli cation (Fig. 5D). Ade-\nnine-to-guanine (A -to-G) and uracil -to-cytosine (U -to-C) \ntransitions were enriched in MERS -CoV genomic RNA in an \nNHC dose -dependent manner (Fig. 5E). Collectively, these \ndata used high -fidelity sequence analysis to demonstrate a \nspecif ic enrichment for A:G and C:U transitions in MERS -\nCoV RNA after NHC treatment of primary HAE cell cultures.  \nTherapeutic EIDD -2801 reduces SARS -CoV replication \nand pathogenesis  \nGiven the promising antiviral activity of NHC in vitro, we next evaluated its in  vivo efficacy using EIDD -2801, an orally \nbioavailable prodrug of NHC (\u03b2 -D-N\n4-hydroxycytidine -5\u2032-iso-\npropyl ester), designed for improved in vivo pharmacokinet-ics and oral bioavailability in humans and non -human \nprimates ( 15). Importantly, the plasma profiles of NHC and \nEIDD -2801 are similar in mice following oral delivery ( 15). We \nfirst performed a prophylactic dose escalation study in C57BL/6 mice where we orally administered vehicle (10% PEG, 2.5% Cremophor RH40 in water) or 50, 150, or 500 mg/kg EIDD -2801 2hr prior to intranasal infection with \n5E+04 PFU of mouse -adapted SARS -CoV (SARS- MA15), and \nthen vehicle or drug every 12 hours thereafter. Beginning on 3 days post -infection (dpi) and through the end of the study, \nbody weight loss compared to vehicle treatment was signifi-cantly diminished (50 mg/kg) or prevented (150, 500 mg/kg) with EIDD -2801 prophylaxis (Two -way ANOVA with Dun-\nnett\u2019s multiple comparison test, P < 0.0001) (fig. S3A). Lung hemorrhage was also significantly reduced 5 dpi with 500 mg/kg EID D-2801 treatment (Kruskal -Wallis Test, P = 0.010, \nfig. S3B). Interestingly, there was a dose -dependent reduction \nin SARS- CoV lung titer (median titers: 50 mg/kg = 7E+03 \npfu/mL, 150 mg/kg = 2.5E+03 pfu/mL, 500 mg/kg = 50 pfu/mL, vehicle = 6.5E+04 pfu/mL) wi th significant differ-\nences (Kruskal -Wallis with Dunn\u2019s multiple comparisons \ntest) among the vehicle, 150 mg/kg (P = 0.03) and 500 mg/kg (P = 0.006) groups. Thus, prophylactic orally administered EIDD -2801 was robustly antiviral and able to prevent SARS -\nCoV replication and disease.  \nSince only the 500 mg/kg group significantly diminished \nweight loss, hemorrhage and reduced lung titer to near un-detectable levels, we tested this dose under therapeutic treat-ment conditions to determine if EIDD -2801 could improve  \nthe outcomes of an ongoing CoV infection. As a control, we initiated oral vehicle or EIDD -2801 2 hours prior to infection \nwith 1E+04 pfu SARS- MA15. For therapeutic conditions, we \ninitiated EIDD -2801 treatment 12, 24, or 48 hours after infec-\ntion. After initiating treatment, dosing for all groups was", "start_char_idx": 3168, "end_char_idx": 6190, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d6ff58f3-4120-47d6-8e97-696bbf6475e6": {"__data__": {"id_": "d6ff58f3-4120-47d6-8e97-696bbf6475e6", "embedding": null, "metadata": {"page_label": "3", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9f9e7857-8573-46b4-809f-39d62f873ae1", "node_type": null, "metadata": {"page_label": "3", "file_name": "5_COVID_Medicine.pdf"}, "hash": "e1a97043116872d595196011439d330707308507708c6bbe5c8bd49766a1b433"}, "2": {"node_id": "530410eb-fa93-46cd-9048-9db79d3e8387", "node_type": null, "metadata": {"page_label": "3", "file_name": "5_COVID_Medicine.pdf"}, "hash": "903806c2aee9050f125bf9df3e35a4efdad4b0ee46310a77bf1b73adbe30599c"}}, "hash": "b7019ef8588410ebe42639c81b831f82d1f74f7570ffa938acdff776b419dbc2", "text": "hours after infec-\ntion. After initiating treatment, dosing for all groups was per-formed every 12 hours for the duration of the study. Both  at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 6161, "end_char_idx": 6386, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f4ce544d-c2d3-41d7-a447-61ae5996c356": {"__data__": {"id_": "f4ce544d-c2d3-41d7-a447-61ae5996c356", "embedding": null, "metadata": {"page_label": "4", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "476b5ee2-fa3c-475c-acde-2a856ca49598", "node_type": null, "metadata": {"page_label": "4", "file_name": "5_COVID_Medicine.pdf"}, "hash": "8d9cce2e5a93cc6ae8daf4f0154a92f7ce8a2e032f56a5ccbb23f953a31afac2"}, "3": {"node_id": "c09b6a39-d94b-41cb-a1d2-fdf6f41e42a8", "node_type": null, "metadata": {"page_label": "4", "file_name": "5_COVID_Medicine.pdf"}, "hash": "fda66f2405575970a05c82ec2f27b918940fbced978e48212b3ce715c9e107de"}}, "hash": "f4003e824d17ad6bc5cb826c529d30d999b61efb349131fae060e392faa48e85", "text": "First release: 6 April 2020   stm.sciencemag.org   ( Page numbers not final at time of first  release ) 4 \n prophylactic treatment initiated 2 hours prior to infection \nand therapeutic treatment initiated 12 hours after infection significantly (Two -way ANOVA with Tukey\u2019s multiple com-\nparison test) prevented body weight loss following SARS -CoV \ninfection on 2 dpi and thereafter ( -2 hours: P = 0.0002 to \n<0.0001; +12 hours: P = 0.0289 to <0.0001) as compared to vehicle treated animals (Fig. 6A). Treatment initiated  24 hpi \nalso significantly reduced body weight loss (3 -5 dpi, P = 0.01 \nto <0.0001) although not to the same degree as the earlier treatment initiation groups. When initiated 48 hpi, body weight loss was only different from vehicle on 4 dpi (P = 0.037, Fig.  6A). Therapeutic EIDD -2801 significantly (Krus-\nkal-Wallis with Dunnett\u2019s multiple comparison test) reduced \nlung hemorrhage when initiated up to 24 hours after infec-tion ( -2, +12, and +24 hours P < 0.0001) mirroring the body \nweight loss phenotypes (Fig. 6B) . Interestingly, all EIDD -2801 \ntreated mice had significantly (Kruskal -Wallis with Dunnett\u2019s \nmultiple comparison test) reduced viral loads in the lungs even in the +48 hours group (All P < 0.0001, Fig. 6C), which experienced the least protection from body weight loss and lung hemorrhage. We also measured pulmonary function via whole body plethysmography (WBP). In Fig. 6D, we show the WBP enhanced pause (PenH) metric, which is a surrogate marker for bronchoconstriction or pulmonary obstruction (27), was sign ificantly (Two -way ANOVA with Dunnett\u2019s mul-\ntiple comparison test) improved throughout the course of the study if treatment was initiated up to 12 hours after infection (-2 hours: 2d pi to 5 dpi, P < 0.0001 to 0.019, +12 hours: 2 dpi \nto 5 dpi, P < 0.0001 to  0.0192) although the +24 hours group \nshowed sporadic improvement as well (3 dpi P = 0.002) (Fig. 6D). Lastly, we blindly evaluated hematoxylin and eosin -\nstained lung tissue sections for histological features of ALI using two different and complementary sc oring tools (18 ), \nwhich show that treatment initiated up to +12 hours signifi-cantly reduced ALI (Kruskal- Wallis with Dunn\u2019s multiple \ncomparison test) (American Thoracic Society (ATS) Lung In-jury Score: -2 hours P = 0.0004, +12 hours P = 0.0053, Diffuse \nalveolar damage (DAD) Score: -2 hours P = 0.0015, +12 hours \nP = 0.0004, Fig. 6E). Altogether, therapeutic EIDD -2801 was \npotently antiviral against SARS -CoV in vivo but the degree of \nclinical benefit was dependent on the time of initiation post -\ninfection.  \nEIDD -2801 prophylactic and therapeutic efficacy corre-\nlates with increased MERS -CoV mutation rate  \nAfter obtaining promising in vivo efficacy data with SARS -\nCoV, we investigated whether EIDD -2801 would be effective \nagainst MERS -CoV. As the murine ortholog of the MERS -CoV \nreceptor, dipeptidyl peptidase 4 (DPP4), does not support vi-ral binding and entry, all in vivo studies were performed in genetically modified mice encoding a murine DPP4 receptor encoding two human residues at positions 288 and 330 (hDPP4 288/330 mice)( 18, 28 ). Similar to our SARS -CoV", "start_char_idx": 0, "end_char_idx": 3181, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c09b6a39-d94b-41cb-a1d2-fdf6f41e42a8": {"__data__": {"id_": "c09b6a39-d94b-41cb-a1d2-fdf6f41e42a8", "embedding": null, "metadata": {"page_label": "4", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "476b5ee2-fa3c-475c-acde-2a856ca49598", "node_type": null, "metadata": {"page_label": "4", "file_name": "5_COVID_Medicine.pdf"}, "hash": "8d9cce2e5a93cc6ae8daf4f0154a92f7ce8a2e032f56a5ccbb23f953a31afac2"}, "2": {"node_id": "f4ce544d-c2d3-41d7-a447-61ae5996c356", "node_type": null, "metadata": {"page_label": "4", "file_name": "5_COVID_Medicine.pdf"}, "hash": "f4003e824d17ad6bc5cb826c529d30d999b61efb349131fae060e392faa48e85"}, "3": {"node_id": "c6a902ce-ae8e-49be-b11e-d34edb665935", "node_type": null, "metadata": {"page_label": "4", "file_name": "5_COVID_Medicine.pdf"}, "hash": "d23c380d8dab201f9c9edad2f51fcf2712f1042254b2783ca65410ce7afbfe9e"}}, "hash": "fda66f2405575970a05c82ec2f27b918940fbced978e48212b3ce715c9e107de", "text": "288/330 mice)( 18, 28 ). Similar to our SARS -CoV data, all doses of prophylactic EIDD -2801 (50, 150 and 500 mg/kg) \nprotected hDPP4 288/330 mice (fig. S4) from significant body weight loss (Two -way ANOVA with Dunnett\u2019s multiple com-\nparison test, P = 0.03 to < 0.0001), lung hemorrhage (Kruskal -\nWallis with Dunn\u2019s multiple comparison test, P = 0.01 to <0.0001), and virus replication which was undetectable (Kruskal -Wallis with Dunn\u2019s multiple comparison test, P < \n0.0001) regardless of drug dose following intran asal infection \nwith 5E+04 PFU mouse -adapted MERS- CoV (fig. S4).  \nWe then evaluated the therapeutic efficacy EIDD -2801 fol-\nlowing the promising results of our prophylactic studies. Sim-ilar to our SARS -CoV study, EIDD -2801 treatment \nadministered before or 12 h ours after intranasal mouse -\nadapted MERS -CoV infection (5E+04 PFU) prevented body \nweight loss from 2 through 6 dpi (Two -way ANOVA with \nTukey\u2019s multiple comparison test, Fig. 7A, P = 0.02 to <0.0001) and lung hemorrhage on 6 dpi (Kruskal -Wallis with \nDunn\u2019s multiple comparison test, P = 0.0004 to < 0.0001, Fig. \n7B), but treatment initiated 24 or 48 hours did not offer sim-ilar protection. Unlike body weight loss and lung hemorrhage data which varied by treatment initiation time, virus lung ti-ter on 6 dpi was significantly reduced to the limit of detection in all treatment groups (Kruskal -Wallis with Dunn\u2019s multiple \ncomparison test, Fig. 7C, P < 0.0001). Interestingly, when vi-ral genomic RNA was quantified in paired samples of lung tissue, EIDD -2801 significantly reduced quantities of viral \nRNA (One -way ANOVA with Dunnett\u2019s multiple comparison \ntest, P <0.0001 to 0.017) in an initiation time -dependent man-\nner for all groups except for +48 hours (Fig. 7D). The discrep-ancy among infectious titers and viral RNA sugges ts that \naccumulated mutations render the particles non -infectious \nand undetectable by plaque assay, consistent with the MOA. To gauge the effect of EIDD- 2801 treatment on lung function, \nwe assessed pulmonary function by WBP. Mirroring the body weight loss data, normal pulmonary function was only ob-served in groups where treatment was initiated prior to or 12 hours after infection (Two- way ANOVA with Tukey\u2019s multiple \ncomparison test, - 2hr: P < 0.0001 3 dpi, P = 0.0002 4 dpi, \n+12hr: P < 0.0001 3 dpi, P = 0.00 08 4 dpi, Fig. 7E). Collec-\ntively, these data demonstrate that NHC prodrug, EIDD -2801, \nrobustly reduces MERS -CoV infectious titers, viral RNA, and \npathogenesis under both prophylactic and early therapeutic conditions. \nTo study the molecular mechanisms assoc iated with drug \nperformance in vivo, we investigated the correlation between infectious virus production and EIDD -2801-mediated muta-\ngenesis of MERS -CoV RNA under therapeutic treatment con-\nditions. Using Primer ID NGS, we measured the mutation rates of both viral genomic RNA (non -structural protein 10, \nnsp10) and host interferon stimulated gene 15 (ISG15 ) mRNA, \na highly up -regulated innate immune -related gene after \nMERS- CoV infection (Fig. 7F). Primer ID NGS measures the  at Stanford University on April 10,", "start_char_idx": 3142, "end_char_idx": 6291, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c6a902ce-ae8e-49be-b11e-d34edb665935": {"__data__": {"id_": "c6a902ce-ae8e-49be-b11e-d34edb665935", "embedding": null, "metadata": {"page_label": "4", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "476b5ee2-fa3c-475c-acde-2a856ca49598", "node_type": null, "metadata": {"page_label": "4", "file_name": "5_COVID_Medicine.pdf"}, "hash": "8d9cce2e5a93cc6ae8daf4f0154a92f7ce8a2e032f56a5ccbb23f953a31afac2"}, "2": {"node_id": "c09b6a39-d94b-41cb-a1d2-fdf6f41e42a8", "node_type": null, "metadata": {"page_label": "4", "file_name": "5_COVID_Medicine.pdf"}, "hash": "fda66f2405575970a05c82ec2f27b918940fbced978e48212b3ce715c9e107de"}}, "hash": "d23c380d8dab201f9c9edad2f51fcf2712f1042254b2783ca65410ce7afbfe9e", "text": "7F). Primer ID NGS measures the  at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 6263, "end_char_idx": 6379, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "71fa0849-1390-468e-bbcf-1b9f5be80beb": {"__data__": {"id_": "71fa0849-1390-468e-bbcf-1b9f5be80beb", "embedding": null, "metadata": {"page_label": "5", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa35fe49-aa28-429c-a281-d4ff86262064", "node_type": null, "metadata": {"page_label": "5", "file_name": "5_COVID_Medicine.pdf"}, "hash": "02dc730626fa149b78e929d859e6267dcf4e9ab6c768c555d44440258afdb19c"}, "3": {"node_id": "697c33a6-d80d-459c-ac10-0e1ba69cdc9e", "node_type": null, "metadata": {"page_label": "5", "file_name": "5_COVID_Medicine.pdf"}, "hash": "d9e61b136d2feacf69321f3918adc8a32a154b2b9ac5410f737a2bb29056fadb"}}, "hash": "2be8c8022c3ee3799f49c5c57d5b06c680716558c32188269d5c3ff6aba9e07b", "text": "First release: 6 April 2020   stm.sciencemag.org   ( Page numbers not final at time of first  release ) 5 \n mutational frequency in single RNA molecules, each of which \nare represented by a single template consensus sequence (TCS) (25 ). Viral TCS were significantly reduced (Two -way \nANOVA with Tukey\u2019s multiple comparison test, -2 hours P \n<0.0001, +12 hours P = 0.0001, +24 hours P = 0.02) in a treat-ment initiation time -dependent manner (Fig. 7G) similar to \nviral genomic RNA measured by qRT -PCR. In contrast, the \nnumbers of ISG15 TCS were similar (P = 0.2 to 0.8) for all groups indicating that neither vehicle nor drug treatment sig-nificantly affected the levels of or mutated ISG15 mRNA tran-scripts (Fig. 7G). Similar to our TCS data in Fig. 6G, the total error rate in viral nsp10 was significantly increased (Two -way \nANOVA with Tukey\u2019s multiple comparison test) in groups where treatment was initiated prior t o (-2 hours, median er-\nror rate = 10.5 errors/10,000 bases, P < 0.0001) and up to 24 hours post infection (12 hours, median error rate = 8.2 er-rors/10,000 bases, P < 0.0001 ; +24 hours, median error rate = 5.4 errors/10,000 bases, P = 0.0003) but the error rates in \nISG15 remained at baseline for all groups (Fig. 7H). In addi-tion, nucleotide transitions observed in MERS -CoV genomes \nin vitro, were also observed in vivo in groups where treatment was initiated prior to and up to 12 hours post infection (Two -\nway ANOVA with Tukey\u2019s multiple comparison test, P = \n0.0003 to < 0.0001) (Fig. 7I). Importantly, these transitions were not observed in host ISG15 mRNA (Fig. 7I). Lastly, the EIDD -2801 dose -dependent mutagenesis of viral RNA corre-\nlated with an increase in codo n change frequency, including \nstop codons, in mice where treatment was initiated 12 hours or before (Two- way ANOVA with Tukey\u2019s multiple compari-\nson test, vehicle median = 3.4; -2hr median = 22.8, P = 0.0035; \n+12 hours median = 20.0, P = 0.0004, Fig. 7J). Thus, approxi-mately 20% of the mutations observed in the -2 hours and \n+12 hours groups resulted in a codon change and alteration of the nsp10 protein sequence. When extrapolating our re-sults from nsp10 to the entirety of the 30kb MERS -CoV ge-\nnome, EIDD -2801 likely causes between 15 (+24 hours \ntreatment) and 30 (- 2 hours treatment) mutations per ge-\nnome, 10- 20% of which result in amino acid coding changes. \nAltogether, our data demonstrates that EIDD -2801-driven \nmutagenesis correlates well with the reductions in  viral load, \nstrongly suggestive of an error catastrophe -driven mecha-\nnism of action under therapeutic conditions.  \nDISCUSSION  \nIn the past 20 years, three novel human coronaviruses have emerged ( 29, 30 ). The group 2b SARS -like CoV represent an \nexistential an d future threat to global health as evidenced by \nthe emergence of SARS -CoV and SARS- CoV-2. Zoonotic \nSARS- like bat CoV strains can use human angiotensin- con-\nverting enzyme 2 (ACE2) receptors, grow well in primary hu-man airway cells, and vary by as much as 25 % in key \ntherapeutic and vaccine gene targets ( 11, 31 ). Thus, to address the current public health emergency of COVID- 19 and to max-\nimize pandemic", "start_char_idx": 0, "end_char_idx": 3187, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "697c33a6-d80d-459c-ac10-0e1ba69cdc9e": {"__data__": {"id_": "697c33a6-d80d-459c-ac10-0e1ba69cdc9e", "embedding": null, "metadata": {"page_label": "5", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa35fe49-aa28-429c-a281-d4ff86262064", "node_type": null, "metadata": {"page_label": "5", "file_name": "5_COVID_Medicine.pdf"}, "hash": "02dc730626fa149b78e929d859e6267dcf4e9ab6c768c555d44440258afdb19c"}, "2": {"node_id": "71fa0849-1390-468e-bbcf-1b9f5be80beb", "node_type": null, "metadata": {"page_label": "5", "file_name": "5_COVID_Medicine.pdf"}, "hash": "2be8c8022c3ee3799f49c5c57d5b06c680716558c32188269d5c3ff6aba9e07b"}}, "hash": "d9e61b136d2feacf69321f3918adc8a32a154b2b9ac5410f737a2bb29056fadb", "text": "the current public health emergency of COVID- 19 and to max-\nimize pandemic preparedness in the future, broad -based vac-\ncines and therapeutics, which are active against the higher risk RNA virus families prone to emergence, are desperately needed. \nSmall molecule antivirals can exert their antiviral effect \nthrough multiple mechanisms including blocking viral entry, inhibiting a virally encoded enzyme, blocking virus particle formation, or t argeting a host factor required for replication \n(32). Multiple direct acting antivirals are currently under \nevaluation in randomized control trials to treat COVID -19 in-\ncluding hydroxychloroquine, remdesivir, lopinavir/ri-tonavir( 33-35). Here, we report the broad -spectrum antiviral \nactivity of NHC and its orally bioavailable prodrug EIDD -\n2801, against SARS -CoV, MERS- CoV, and the current pan-\ndemic strain SARS -CoV-2 in primary human airway epithelial \ncells. In addition to CoV, NHC is broadly active against mul-tiple genetically distinct viruses including VEE, influenza A \nand B, Ebola, and Chikungunya viruses ( 13-16, 19, 21, 24, 36 -\n38). Here, we show that prophylactic and therapeutic EIDD -\n2801 significantly reduced lung viral loads and improved pul-monary function i n mouse models of both SARS - and MERS-\nCoV pathogenesis. Although the improvement in both SARS - \nand MERS -CoV outcomes diminished with the delay of treat-\nment initiation time, it is important to note that the kinetics of disease in mice are compressed as comp ared to that in hu-\nmans. Whereas SARS - and MERS- CoV lung titers peak on 1 -2 \ndpi in mice concurrent with the onset of clinical signs and notable damage to the lung epithelium, in humans this oc-curs 7 -10 days after the onset of symptoms ( 19, 28, 39, 40 ). \nThus , in mice, the window within which to treat emerging \nCoV infection prior to peak replication is compressed (e.g., 24-48 hours). As with oseltamivir treatment for influenza \nwhich fails to provide a protective effect if administered >5 days after the onset o f symptoms, the window in which to \ntreat COVID -19 patients prior to peak virus replication is \nlikely during the first week of symptoms when pharyngeal shedding is at its highest( 41, 42 ). However, virus replication \nand shedding may continue for several week s in the most se-\nvere COVID -19 patients( 34). Thus, early intervention with an \nantiviral like EIDD -2801 is likely to provide the most clinical \nbenefit although there may opportunities in severe patients where the duration of virus replication may be extended . Our \ncurrent study is clearly limited by the lack of in vivo efficacy testing with SARS -CoV-2. Currently, robust mouse models \nthat recapitulate the SARS -CoV-2 pathogenesis observed in \nhumans do not yet exist due to a noted virus spike glycopro-tein and mouse ACE2 receptor incompatibility complicating the evaluation of medical countermeasures( 43, 44). In addi-\ntion, SARS -CoV and MERS -CoV, SARS -CoV-2 disease severity \nincreases with increasing age. Our studies are limited by the lack of drug efficacy testing in CoV aged mouse models that  at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 3112, "end_char_idx": 6308, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0669bcbd-659c-4385-a744-c6a16128ef1d": {"__data__": {"id_": "0669bcbd-659c-4385-a744-c6a16128ef1d", "embedding": null, "metadata": {"page_label": "6", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fc107e44-0f72-4a91-8a46-92f5643f6459", "node_type": null, "metadata": {"page_label": "6", "file_name": "5_COVID_Medicine.pdf"}, "hash": "11e5e4ced98c9751bb749347d7c9cafb286a6c3e30060fb625345eed92b98a46"}, "3": {"node_id": "9c60ef29-f1fd-4628-919f-7757f702d2d8", "node_type": null, "metadata": {"page_label": "6", "file_name": "5_COVID_Medicine.pdf"}, "hash": "caa72baecd3f415b752cda4e526916a38b1d30b2c272d369295332d91818d8af"}}, "hash": "78280e775722c50b9c0b1031e953cf4171ddc01e3353925d33f2ebd887fd7938", "text": "First release: 6 April 2020   stm.sciencemag.org   ( Page numbers not final at time of first  release ) 6 \n recapitulate the age -related increase in pathogenesis ob-\nserved in humans( 45). The data provided in this manuscript \nsuggest that EIDD -2801 should be quickly evaluated in pri-\nmate models of human disease, using immediate models for \nMERS- CoV and SARS- CoV pathogenesis or newly described \ncynomolgus and rhesus macaque models for SARS -CoV-2 (46-\n49). \nFor VEE and influenza, NHC/EIDD -2801 exerts its antivi-\nral activity on the RNA -dependent RNA polymerase leading \nto error catastrophe by induci ng an error rate of replication \nthat surpasses the error threshold allowed to sustain a virus population (14, 15 ). This process occurs when NHC is incor-\nporated during RNA synthesis then subsequently misread thus increasing mutation rates. Therefore, for CoV, the NHC MOA would appear less likely to be affected by the RNA proofreading activity encoded by the nsp14 exonuclease func-tion that otherwise limits misincorperation ( 50). Here, we \npresent data using Primer ID NGS to quantitate the fre-quency and identit y of the mutational spectra in the MERS -\nCoV genome in both drug -treated primary human airway \ncells and in mice at single genome resolution. As CoV are pos-itive sense RNA viruses that replicate through a negative sense RNA intermediate, NHC incorporation as  a C or a U \ncan occur in both polarities of RNA. We found increased nu-cleotide transitions (A to G, G to A, C to U, U to C) consistent with those reported after influenza and VEE infections ( 14, \n15). Under identical conditions, RDV did not alter the muta-\ntion rate in MERS -CoV genomic RNA, supporting its reported \nmechanism of action as a chain terminator of viral RNA syn-thesis ( 26). In primary human lung cell cultures and mice in-\nfected with MERS -CoV, the NHC mutation rates inversely \ncorrelated with a reductio n in infectious virus. In addition, \nwe found a positive correlation between increased mutation rates and the frequency of nonsynonymous mutations and the degree of therapeutic efficacy in mice. To explore the po-tential off -target effect in host mRNA which may contribute \nto drug toxicity, we also examined the impact of NHC treat-ment on ISG15  transcripts, a gene highly induced following \nMERS- CoV infection. Although ISG15 transcripts are present \nin great abundance, an accumulation of mutations was not observed  in ISG15  in this model even at 500 mg/kg dosing. \nThese data also support previous studies using RNAseq to demonstrate that the model coronavirus MHV displayed in-creased mutation frequencies following NHC treatment in vitro (16 ). With regard to nucleic acid specificity, ribonucleo-\ntides are efficiently removed from eukaryotic cell DNA; there-fore, treating a viral infection with a mutagenic ribonucleoside analog should show a selectivity for incorpo-ration into the viral genome and not be efficient at being in-corporated into and inducing mutations into host cell DNA (51). All together, these data strongly support the notion that \nEIDD -2801 and its active nucleoside analog NHC exert their antiviral effect through the induction of error catastrophe in the targeted  virus. While our data suggest that the MERS -CoV \nnsp14 proofreading activity appeared ineffective against NHC in vitro and EIDD -2801 in vivo, future studies should investi-\ngate the antiviral activity of NHC in the presence or absence of the nsp14 proofreading activity, as loss of this activity in-creased the sensitivity of MHV and SARS -CoV replication to \nRDV treatment ( 50).", "start_char_idx": 0, "end_char_idx": 3609, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9c60ef29-f1fd-4628-919f-7757f702d2d8": {"__data__": {"id_": "9c60ef29-f1fd-4628-919f-7757f702d2d8", "embedding": null, "metadata": {"page_label": "6", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fc107e44-0f72-4a91-8a46-92f5643f6459", "node_type": null, "metadata": {"page_label": "6", "file_name": "5_COVID_Medicine.pdf"}, "hash": "11e5e4ced98c9751bb749347d7c9cafb286a6c3e30060fb625345eed92b98a46"}, "2": {"node_id": "0669bcbd-659c-4385-a744-c6a16128ef1d", "node_type": null, "metadata": {"page_label": "6", "file_name": "5_COVID_Medicine.pdf"}, "hash": "78280e775722c50b9c0b1031e953cf4171ddc01e3353925d33f2ebd887fd7938"}}, "hash": "caa72baecd3f415b752cda4e526916a38b1d30b2c272d369295332d91818d8af", "text": "of MHV and SARS -CoV replication to \nRDV treatment ( 50). \nTogether, our data support the continued development of \nEIDD -2801 as a potent broad spectrum antiviral that could \nbe useful in treating c ontemporary, newly emerged and \nemerging coronavirus infections of the future.  \nMATERIALS AND METHODS  \nStudy Design  \nThe primary goal of this study was to determine the antiviral activity of the nucleoside analog NHC (EIDD -1931) against \nmultiple emerging CoV in vitro and antiviral efficacy of its \nprodrug, EIDD -2801, in mouse models of CoV pathogenesis. \nCoupling cell lines and primary HAE cell cultures, we evalu-ated the antiviral activity of NHC against the three most re-cently emerged human CoV: SA RS-CoV, MERS -CoV, and \nSARS- CoV-2. For both SARS -CoV and MERS -CoV, the data \npresented for HAE studies are representative of those from 2 -\n3 separate human donors. For SARS -CoV-2, the HAE were \nfrom a single human donor. We evaluated drug cytotoxicity in both Calu-3 2B4 and HAE cell cultures. Calu -3 and the \nSARS- CoV and MERS- CoV HAE studies were performed in \nbiological triplicate. HAE studies with SARS -CoV-2 and the \nSARS- and MERS -like bat CoV were performed with two wells \nper condition. Drug effects were measu red relative to vehicle \ncontrols in vitro and comparisons in vivo were performed to vehicle controls. We also aimed to determine the antiviral ef-ficacy of EIDD -2801 in mouse models of CoV pathogenesis. \nThese studies were intended to provide the preclinical data \nto justify nonhuman primate studies and human clinical tri-als. Mice were age- and sex- matched and randomly assigned \ninto groups before infection and treatment. Pathology was scored blinded by a board -certified veterinary pathologist. \nPrimary data for  all studies are provided in data file S1.  \nEthics regulation of laboratory animals  \nEfficacy studies were performed in animal biosafety level 3 facilities at UNC Chapel Hill. All work was conducted under protocols approved by the Institutional Animal Care a nd Use \nCommittee at UNC Chapel Hill (IACUC protocol #16- 284) ac-\ncording to guidelines set by the Association for the Assess-ment and Accreditation of Laboratory Animal Care and the U.S. Department of Agriculture.  \nCompounds  \nThe parental compound \u03b2 \u2212D\u2212N\n4-hydroxycytidine (NHC, all \nin vitro studies) and its prodrug EIDD -2801 (all in vivo stud-\nies) was supplied by Emory University Institute for Drug  at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 3552, "end_char_idx": 6074, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "09534c82-703c-44db-8e39-de05e7b252d2": {"__data__": {"id_": "09534c82-703c-44db-8e39-de05e7b252d2", "embedding": null, "metadata": {"page_label": "7", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4ab30247-e869-407d-a643-01b3be87b5fc", "node_type": null, "metadata": {"page_label": "7", "file_name": "5_COVID_Medicine.pdf"}, "hash": "6cd2cb7857027e5b5cf441dbea50f68c500dd963f227f1c6c223890cb6fa0bd6"}, "3": {"node_id": "002ba8ec-84c4-4cc4-ac2e-9257c16d01bf", "node_type": null, "metadata": {"page_label": "7", "file_name": "5_COVID_Medicine.pdf"}, "hash": "0b42613bc8258994554afc5b560955646a1b48e0ae3a9f1f8a8ae7b8a94330c0"}}, "hash": "9f17c62c7c8b1feea346241cb92f9e6d0d219ff428bcdec97771a2462205e0c9", "text": "First release: 6 April 2020   stm.sciencemag.org   ( Page numbers not final at time of first  release ) 7 \n Discovery (EIDD). NHC was supplied as a 10 mM stock in \nDMSO and EIDD -2801 as a solid and solubilized in vehicle  \ncontaining 10% PEG400, 2.5% Cremophor RH40 in water (10/2.5/87.5%, all v/v) prior to use. RDV was solubilized in 100% DMSO and provided by Gilead Sciences, Inc as previ-ously described ( 18, 19 ). \nCell cultures  \nAt UNC, the human lung epithelial cell line Calu- 3 2B4 cells \nwas maintained in Dulbecco\u2019s modified Eagle\u2019s medium (DMEM, Gibco), 20% fetal bovine serum (Hyclone) and 1x an-tibiotic/antimycotic (Gibco). At Vanderbilt University Medi-cal Center (VUMC), Calu -3 2B4 were propagated in DMEM \nsupplemented with 2 0% FBS (Gibco), 100 U/ml penicillin and \nstreptomycin (Gibco), and 0.25 \u03bcM amphotericin B (Corn-\ning). At VUMC, VeroE6 cells were cultured in DMEM supple-mented with 10% FBS (Gibco), 100 U/ml penicillin and streptomycin (Gibco), and 0.25 \u03bcM amphotericin B (Cor n-\ning). At UNC, VeroE6 cells were cultured in DMEM supple-mented with 10% Fetal Clone II (Hyclone) and 1x antibiotic/antimycotic (Gibco). Murine delayed brain tumor (DBT) cells were maintained in DMEM supplemented with 10% FBS (Gibco), 100 U/ml penicillin an d streptomycin \n(Gibco), and 0.25 \u03bc M amphotericin B (Corning). Primary hu-\nman airway epithelial (HAE) cell cultures were obtained from the Tissue Procurement and Cell Culture Core Laboratory in the Marsico Lung Institute/Cystic Fibrosis Research Center at UN C and are described more thoroughly below ( 52). \nVirus strains  \nExcept for SARS -CoV-2, all viruses used for these studies were \nderived from infectious clones and isolated as previously de-scribed ( 53). SARS- CoV-2 clinical isolate was obtained at \nVUMC and UNC from the CDC (2019 -nCoV/USA- WA1/2020 \nstrain, GenBank accession no. MN985325.1) and passaged twice in Vero E6 cells at each respective institution to create a passage 5 working stock ( 54). Virus strains for in vitro ex-\nperiments include SARS -CoV expressing the green fluores-\ncent protein (GFP) in place of open reading frames 7a/b (ORF7a/b, SARS- GFP)( 53), bat -spike receptor binding do-\nmain (Bat -SRBD)( 22), a chimeric CoV strain derived from the \nHKU3 SARS- like bat coronavirus genomic sequence that has \nthe wild type  (Urbani SARS -CoV strain) RBD in the HKU3 \nspike gene to allow for virus replication in non -human pri-\nmate cell lines and HAE cultures, SHC014 SARS -like bat coro-\nnavirus (11 ), MERS -CoV expressing nanoluciferase in the \nplace of ORF3 (MERS- nLUC)( 19), and MERS -CoV expressing \nthe red fluorescent protein gene in the place of ORF 5 (RFP, MERS- RFP)( 55). The virus stock utilized for MERS -CoV in \nvivo studies was derived from a plaque -purified isolate of the \nmouse -adapted MERS -CoV p35C4 strain (56 ). The virus stock \nutilized for SARS -CoV in vivo studies was derived from the", "start_char_idx": 0, "end_char_idx": 2920, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "002ba8ec-84c4-4cc4-ac2e-9257c16d01bf": {"__data__": {"id_": "002ba8ec-84c4-4cc4-ac2e-9257c16d01bf", "embedding": null, "metadata": {"page_label": "7", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4ab30247-e869-407d-a643-01b3be87b5fc", "node_type": null, "metadata": {"page_label": "7", "file_name": "5_COVID_Medicine.pdf"}, "hash": "6cd2cb7857027e5b5cf441dbea50f68c500dd963f227f1c6c223890cb6fa0bd6"}, "2": {"node_id": "09534c82-703c-44db-8e39-de05e7b252d2", "node_type": null, "metadata": {"page_label": "7", "file_name": "5_COVID_Medicine.pdf"}, "hash": "9f17c62c7c8b1feea346241cb92f9e6d0d219ff428bcdec97771a2462205e0c9"}, "3": {"node_id": "64b9eb5d-1218-4501-8388-943f19a57f75", "node_type": null, "metadata": {"page_label": "7", "file_name": "5_COVID_Medicine.pdf"}, "hash": "7b9317f0f8c828e722e4d18c67d8b75185e84bc2ac190d16615931bc771c7de4"}}, "hash": "0b42613bc8258994554afc5b560955646a1b48e0ae3a9f1f8a8ae7b8a94330c0", "text": "stock \nutilized for SARS -CoV in vivo studies was derived from the \ninfectious clone of the mouse -adapted SARS -CoV MA15 \n(MA15) strain ( 57). All work with MHV was performed using the recombinant WT strain MHV -A59 (GenBank accession \nno. AY910861)( 58). \nIn vitro antiviral activity experiments  \nMERS -CoV nLUC in Calu -3: At 48 hours prior to infection, \nCalu-3 2B4 cells were plated in a 96-well black -walled clear \nbottom plate at 5x10\n4 cells/well. A 10 mM stock of NHC was \nserially diluted in 100% DMSO in 3 -fold increments to obta in \na ten -point dilution series. MERS -nLUC was diluted in \nDMEM supplemented with 10% FBS, and 1% Antibiotic -Anti-\nmycotic to achieve a multiplicity of infection (MOI) of 0.08. Cells were infected and concurrently treated with NHC in triplicate per drug dilution for 1hr, after which viral inoculum was aspirated, cultures were rinsed once and fresh medium containing drug or vehicle was added. At 48 hours post infec-tion, nanoluciferase expression as a surrogate for virus repli-cation was quantitated on a Spectramax plate reader (Molecular Devices) according to the manufacturer\u2019s instruc-tions (Promega, NanoGlo). For the 100% inhibition control, diluted MERS -nLUC was exposed to short -wave UV light \n(UVP, LLC) for 6 min to inhibit the ability of the virus to rep-licate.  For the 0% inhibition control, cells were infected in the \npresence of vehicle only. DMSO was kept constant in all con-ditions at 0.05%. Values from triplicate wells per condition were averaged and compared to controls to generate a per-cent inhibition value  for each drug dilution. The IC\n50 value \nwas defined as the concentration at which there was a 50% decrease in luciferase expression. Data were analyzed using GraphPad Prism 8.0. The IC\n50 values were calculated by non -\nlinear regression analysis using the do se-response (variable \nslope) equation (four parameter logistic equation): Y = Bot-tom + (Top -Bottom)/(1+10^((LogIC50 -X)*HillSlope)). To \nmeasure cell viability to determine if there was any NHC -\ninduced cytotoxicity, Calu -3 2B4 cells were plated and treated \nwith NHC only as described above. Cells were exposed to the \nsame ten -point dilution series created for the in vitro efficacy \nstudies. As above, 0.05% DMSO- treated cells served as the 0% \ncytotoxicity control. Wells without cells served as the 100% cytotoxic positive control. After 48 hours, cell viability was \nmeasured on a Spectramax (Molecular Devices) via Cell -Titer \nGlo Assay (Promega) according to the manufacturer\u2019s proto-col. Similar data were obtained in three independent experi-ments.  \nSARS -CoV-2 in Calu -3: Calu-3 2B4 cells were adsorbed \nwith MOI 0.1 PFU/cell of SARS -CoV-2 (2019 -nCoV/USA -\nWA1/2020 strain) at 37\u00b0C. Plates were manually rocked every 10 min to redistribute the inoculum. After 30 min, virus inoc-ulum was removed, cells were washed with Phosphate buff-ered saline (PBS) once to remove unbound virus, medium containing NHC or vehicle control (DMSO) was added back onto the cells, and cells were incubated for 72 hours at 37\u00b0C.  \nSARS -CoV-2 in Vero E6: Vero E6 cells were plated at \n20,000 cells/well in a 96 -well plate. 24hr later, medium  at Stanford University on April 10, 2020", "start_char_idx": 2866, "end_char_idx": 6102, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "64b9eb5d-1218-4501-8388-943f19a57f75": {"__data__": {"id_": "64b9eb5d-1218-4501-8388-943f19a57f75", "embedding": null, "metadata": {"page_label": "7", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4ab30247-e869-407d-a643-01b3be87b5fc", "node_type": null, "metadata": {"page_label": "7", "file_name": "5_COVID_Medicine.pdf"}, "hash": "6cd2cb7857027e5b5cf441dbea50f68c500dd963f227f1c6c223890cb6fa0bd6"}, "2": {"node_id": "002ba8ec-84c4-4cc4-ac2e-9257c16d01bf", "node_type": null, "metadata": {"page_label": "7", "file_name": "5_COVID_Medicine.pdf"}, "hash": "0b42613bc8258994554afc5b560955646a1b48e0ae3a9f1f8a8ae7b8a94330c0"}}, "hash": "7b9317f0f8c828e722e4d18c67d8b75185e84bc2ac190d16615931bc771c7de4", "text": "96 -well plate. 24hr later, medium  at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 6081, "end_char_idx": 6200, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6e6418f7-9754-4aa3-8ca4-30864191f408": {"__data__": {"id_": "6e6418f7-9754-4aa3-8ca4-30864191f408", "embedding": null, "metadata": {"page_label": "8", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "030b6d96-a642-4a88-982b-45434086a4ad", "node_type": null, "metadata": {"page_label": "8", "file_name": "5_COVID_Medicine.pdf"}, "hash": "632740c9d6d680c0f224c61310229a7afa0c826a52f3174445b8646630dfdd99"}, "3": {"node_id": "19112842-e366-4f3d-8b58-c4bc05705217", "node_type": null, "metadata": {"page_label": "8", "file_name": "5_COVID_Medicine.pdf"}, "hash": "fc8b2862cfcce219b4952eb1bc931e8e8bd19c7345cd6867ed2882ffbc6adf5d"}}, "hash": "072fd286552005f1eda661561c9bb6a60179ec643cdd50ec94b037ce48d1e4ec", "text": "First release: 6 April 2020   stm.sciencemag.org   ( Page numbers not final at time of first  release ) 8 \n containing a dose response of NHC was added concurrent \nwith SARS- CoV-2 (2019 -nCoV/USA -WA1/2020 strain) at an \nMOI of 0.05. 48 hours post infection, cell viability was mea s-\nured by CellTiter Glo assay.  \nSARS -CoV, MERS -CoV, and SARS -CoV-2 in HAE:  Human \ntracheobronchial epithelial cells provided by Dr. Scott Ran-dell were obtained from airway specimens resected from pa-tients undergoing surgery under University of North Carolina Institutional Review Board- approved protocols (#03 -1396) by \nthe Cystic Fibrosis Center Tissue Culture Core. Primary cells were expanded to generate passage 1 cells and passage 2 cells were plated at a density of 250,000 cells per well on Transwell- COL (12m m diameter) supports (Corning). Human \nairway epithelium cultures (HAE) were generated by provi-sion of an air- liquid interface for 6 to 8 weeks to form well -\ndifferentiated, polarized cultures that resembled in vivo pseu-dostratified mucociliary epithelium (59 ).\u00b7 At 48 hours prior \nto infection the apical surface of the culture was washed with 500 \u03bcL PBS for 1.5 hours at 37 \u00b0C and the cultures moved into \nfresh air liquid interface (ALI) media. Immediately prior to infection, apical surfaces were washed twice to remove accu-mulated mucus with 500 \u03bc L of PBS with each wash lasting \n30 min at 37 \u00b0C and HAE cultures were moved into ALI media \ncontaining various concentrations of NHC ranging from 10 \u03bcM to 0.0016 \u03bc M as indicated for each experiment (final % \nDMSO < 0.05%). Upon removing the second PBS wash, 200 \u03bcL of viral inoculum (SARS -GFP, MERS -RFP or 2019 -\nnCoV/USA- WA1/2020 strain) at an MOI of 0.5 was added to \nthe apical surface and HAE cultures were incubated for 2 hours at 37\u00b0C. Viral inoculum was then removed, and the ap-ical surface of the cultures were washed three times with 500\u03bc L PBS and then incubated at 37 \u00b0C until 48 hours post \ninfection (hpi). For all HAE cultures, infectious virus pro-duced was collected by washing the apical surface of the cul-ture with 100 \u03bc L PBS . Apical washes were stored at - 80\u00b0C \nuntil analysis and titered by plaque assay as previously de-scribed ( 19). \nqRT -PCR approach to assess cytotoxicity  \nTotal RNA was isolated using the Zymo Direct- zol RNA Min-\niPrep Kit (Zymo Research Corp.) according to the m anufac-\nturer\u2019s directions. Cells were treated with 1 \u03bcM staurosporine \n(Sigma -Aldrich) as a positive control. First -strand cDNA was \ngenerated using Superscript III reverse transcriptase (Life Technologies). For quantification of cellular markers of tox-icity/a poptosis, real -time PCR was performed using commer-\ncially validated TaqMan -based primer- probe sets ( table S1 ) \nand TaqMan Universal PCR Mix (Life Technologies). Results were then normalized as described above.  \nMERS -CoV genomic RNA qRT -PCR \nMouse lungs were st ored in RNAlater (ThermoFisher) at -\n80\u00b0C until processed via homogenization in TRIzol (Invitro-gen). Total RNA was isolated using Direct -zol RNA MiniPrep kit (Zymo Research). Previously published TaqMan primers were synthesized by Integrated DNA Technologies (IDT) to quantify MERS genomic RNA (targeting orf1a: Forward: 5 \u2032- \nGCACATCTGTGGTTCTCCTCTCT-3 \u2032, Probe", "start_char_idx": 0, "end_char_idx": 3288, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "19112842-e366-4f3d-8b58-c4bc05705217": {"__data__": {"id_": "19112842-e366-4f3d-8b58-c4bc05705217", "embedding": null, "metadata": {"page_label": "8", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "030b6d96-a642-4a88-982b-45434086a4ad", "node_type": null, "metadata": {"page_label": "8", "file_name": "5_COVID_Medicine.pdf"}, "hash": "632740c9d6d680c0f224c61310229a7afa0c826a52f3174445b8646630dfdd99"}, "2": {"node_id": "6e6418f7-9754-4aa3-8ca4-30864191f408", "node_type": null, "metadata": {"page_label": "8", "file_name": "5_COVID_Medicine.pdf"}, "hash": "072fd286552005f1eda661561c9bb6a60179ec643cdd50ec94b037ce48d1e4ec"}}, "hash": "fc8b2862cfcce219b4952eb1bc931e8e8bd19c7345cd6867ed2882ffbc6adf5d", "text": "\nGCACATCTGTGGTTCTCCTCTCT-3 \u2032, Probe (6 -\nFAM/ZEN/IBFQ): 5 \u2032- TGCTCCAACAGTTACAC -3\u2032, Reverse: \n5\u2032-AAGCCCAGGCCCTACTATTAGC)( 60). qRT -PCR was per-\nformed using 100ng total RNA compared to an RNA standa rd \ncurve using TaqMan Fast Virus 1 -Step Master Mix (Ther-\nmoFisher) on a Quant Studio 3 (Applied Biosystems). \nQuantification of SARS -CoV -2 viral RNA genome copy \nnumber by qRT -PCR \nCell supernatants were harvested in TRIzol LS reagent (Invi-\ntrogen), and RNA was  purified following phase separation by \nchloroform as recommended by the manufacturer. The RNA in the aqueous phase was collected and further purified using PureLink RNA Mini Kits (Invitrogen) according to the man-ufacturer\u2019s protocol. Viral RNA was quantified using one -step \nquantitative reverse transcription PCR (qRT -PCR) on a \nStepOnePlus Real -Time PCR system (Applied Biosystems) by \nTaqMan Fast Virus 1 -Step Master Mix chemistry (Applied Bi-\nosystems). SARS -CoV-2 N gene RNA was amplified using for-\nward (5\u2032-GACC CCAAAATCAGCGAAAT) and reverse (5 \u2032-\nTCTGGTTACTGCCAGTTGAATCTG) primers and probe (5 \u2032- \nFAM -ACCCCGCATTACGTTTGGTGGACC -BHQ1) designed by \nthe United States Centers for Disease Control and Prevention (oligonucleotides produced by IDT, cat# 10006606). Copy numbers were interpolated from a standard curve produced with dilutions of N gene RNA. Briefly, SARS -CoV-2-N positive \ncontrol plasmid DNA (IDT, cat# 10006625) was amplified us-ing forward (5 \u2032-\nTAATACGACTCACTATAGGGATGTCTGATAATGGACCCCA) and reverse (5 \u2032- TTAGGCCTGAGTTGA GTCAG) primers, re-\nsulting in a 1280 nucleotide fragment containing a T7 pro-moter. The PCR product was purified by column (Promega) and in vitro transcribed using the mMESSAGE mMACHINE T7 Transcription Kit (Invitrogen) according to the manufac-turer\u2019s protocol. Transcribed RNA was purified using RNeasy mini kit (Qiagen) according to the manufacturer\u2019s protocol, and serial 10 -fold dilutions were quantified as described \nabove.  \nPrimer ID and deep sequencing  \nPrimer ID NGS is designed to specifically identify and remove \nRT-PCR mutations, while facilitating highly accurate se-\nquence determination of single RNA molecules, because each cDNA is created with a barcoded degenerate primer (N10, 4\n10 \ncombinations) from which Illumina indexed libraries are made. We used a multiplexed Primer ID library prep ap-proach and MiSeq sequencing to investigate the presence of mutations in the viral genomes and murine mRNA. We de-signed cDNA primers targeting multiple regions on the viral genome and murine mRNA, each with a block of random  at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 3253, "end_char_idx": 5902, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ed90a57d-ea06-45c7-a4ee-86d518a2732f": {"__data__": {"id_": "ed90a57d-ea06-45c7-a4ee-86d518a2732f", "embedding": null, "metadata": {"page_label": "9", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "42889750-f2fa-4c3f-b9ce-32e8dad2b00c", "node_type": null, "metadata": {"page_label": "9", "file_name": "5_COVID_Medicine.pdf"}, "hash": "19f96742d8d5d0f7720e48d5df4240e954a70b2aa48093607ac51441ef88c554"}, "3": {"node_id": "8a604d14-4e9a-4b11-8372-55320c813a84", "node_type": null, "metadata": {"page_label": "9", "file_name": "5_COVID_Medicine.pdf"}, "hash": "a640718c39856595092d41991fe5b93c34e3486da1df935d00b57a08e6de71c6"}}, "hash": "20b52b0f4fb8197d9dec3ff389b044f4d807257f240586c55fce2a57ef920af0", "text": "First release: 6 April 2020   stm.sciencemag.org   ( Page numbers not final at time of first  release ) 9 \n nucleotides (11 bp long) as the Primer ID (25, 61 ) (table S2 ). \nViral RNA was extracted using QIAamp viral RNA kit. A pre -\namplification titration of templates was performed to esti-\nmate the amount of template to use. We used SuperScript III to make cDNA with multiplexed cDNA primers based on the regions to be sequenced. We used 41R_PID11 for the pilot se-quencing and titration determination. For the MERS -CoV se-\nquencing, we multiplexed nsp10_PID11, nsp12_PID11 and nsp14_PID11 for the cDNA reaction; for the murine mRNA sequencing, we used mixed primers of nsp10_PID11, ifit3_PID11, isg15_PID11. After bead purification, we ampli-fied the cDNA with a mixture of forward primers (based on the described schemes) and a universal reverse primer, fol-\nlowed by another round of PCR to incorporate Illumina se-quencing adaptors and barcodes in the amplicons. After gel -\npurification and quantification, we pooled 24 libraries for MiSeq 300 base paired -end sequencing. The TCS pipeline ver-\nsion 1.38 (https://github.com/SwanstromLab/PID\n) was used \nto process the Primer ID sequencing data and construct tem-plate consensus sequences (TCSs) to represent each indivi d-\nual input templates, and the sequences of each region in the pool was de -multiplexed. The RUBY package viral_seq ver-\nsion 1.0.6 (\nhttps://rubygems.org/gems/viral_seq ) was used to \ncalculate the mutation rate at each position. NCBI SRA Ac-cession numbers for sequence data are as follows: PRJNA613261 (Fig. 5) and PRJNA613454 (Fig. 7).  \nIn vivo experiments  \nWe performed 4 mouse studies to evaluate the in vivo efficacy of the NHC prodrug (EIDD -2801). First, we performed \nprophylactic dose escalation studies for both SARS - and \nMERS- CoV to determine the most efficacious dose of EIDD -\n2801 per virus. For SARS -CoV, in cohorts of equivalent num-\nbers of male and female 20 -29 week old SPF C57BL/6J (Stock \n000664 Jackson La bs) mice (n = 10/dose group), we admin-\nistered vehicle (10% PEG, 2.5% Cremophor RH40 in water) or 50, 150 or 500 mg/kg EIDD- 2801 by oral gavage 2 hours prior \nto intranasal infection with 1E+04 PFU mouse -adapted \nSARS- CoV strain MA15 in 50 \u03bcl. Mice were anaest hetized with \na mixture of ketamine/xylazine prior to intranasal infection. Vehicle or drug was administered every 12hr for the remain-der of the study. Body weight and pulmonary function by whole body plethysmography were measured daily. On 5 dpi, animals w ere sacrificed by isoflurane overdose, lungs were \nscored for lung hemorrhage, and the inferior right lobe was frozen at \u221280\u00b0C for viral titration via plaque assay. Briefly, 500,000 Vero E6 cells/well were seeded in 6 -well plates. The \nfollowing day, medium was removed and serial dilutions of clarified lung homogenate were added per plate (10\n\u22121 to 10\u22126 \ndilutions) and incubated at 37\u00b0C for 1hr after which wells were overlaid with 1X DMEM, 5% Fetal Clone 2 serum, 1X antibiotic/antimycotic, 0.8% agarose. Two day s after, plaques", "start_char_idx": 0, "end_char_idx": 3078, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8a604d14-4e9a-4b11-8372-55320c813a84": {"__data__": {"id_": "8a604d14-4e9a-4b11-8372-55320c813a84", "embedding": null, "metadata": {"page_label": "9", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "42889750-f2fa-4c3f-b9ce-32e8dad2b00c", "node_type": null, "metadata": {"page_label": "9", "file_name": "5_COVID_Medicine.pdf"}, "hash": "19f96742d8d5d0f7720e48d5df4240e954a70b2aa48093607ac51441ef88c554"}, "2": {"node_id": "ed90a57d-ea06-45c7-a4ee-86d518a2732f", "node_type": null, "metadata": {"page_label": "9", "file_name": "5_COVID_Medicine.pdf"}, "hash": "20b52b0f4fb8197d9dec3ff389b044f4d807257f240586c55fce2a57ef920af0"}}, "hash": "a640718c39856595092d41991fe5b93c34e3486da1df935d00b57a08e6de71c6", "text": "0.8% agarose. Two day s after, plaques \nwere enumerated to generate a plaque/ml value. Lung hemorrhage is a gross pathological phenotype readily ob-served by the naked eye driven by the degree of virus replica-tion where the coloration of the lung changes from pink to dark red ( 62, 63). The large left lobe was placed in 10% buff-\nered formalin and stored at 4\u00b0C for 1 -3 weeks until histologi-\ncal sectioning and analysis. For MERS -CoV, the prophylactic \ndose escalation studies we performed similarly as done for SARS- CoV with our recently developed a mouse model for \nMERS- CoV, which has a humanized DPP4 receptor (hDPP4) \n(28). We performed all in vivo studies with EIDD -2801 in \nequivalent numbers of 10 -14 week old female and male \nC57BL/6J hDPP4 mice. Second, we intranasally infected mice with 5E+04 PFU mouse -adapted MERS- CoV strain M35C4 in \n50\u03bcl. Third, to titer lungs by plaque assay, Vero CCL81 cells \nwere used and plaques were enumerated 3 dpi.  \nTo determine the time at which therapeutic administra-\ntion of EIDD -2801 would fail to improve outcome s with \nSARS- CoV or MERS -CoV infection, we performed therapeutic \nefficacy studies in mice where we initiated treatment 2 hours prior to infection or 12, 24 or 48 hours after infection. As 500 mg/kg provided the most complete protection from disease in prophylactic SARS -CoV studies, this dose was used for both \ntherapeutic efficacy studies. Vehicle or EIDD -2801 was given \nvia oral gavage twice daily following initiation of treatment. For both SARS -CoV and MERS -CoV, the infectious dose for \nthe therapeutic studie s and the mouse strains were the same \nas that used in the prophylactic studies. The numbers of mice per group for the SARS- CoV studies were as follows: Vehicle \n(n = 10), -2 hours (n = 10), +12 hours (n = 10), +24 hours (n = \n10), +48 hours (n = 10). The num bers of mice per group for \nthe MERS- CoV therapeutic studies were as follows: Vehicle \n(n = 9), -2 hours (n = 9), +12 hours (n = 9), +24 hours (n = 7), \n+48 hours (n = 10). As described above, each day mouse body weight and pulmonary function were quantitated . On 5 dpi \nfor SARS -CoV and 6 dpi for MERS -CoV, animals were hu-\nmanely sacrificed and tissues were harvested and analyzed as described above. In addition, for the MERS -CoV study, lung \ntissue was harvested and stored in RNAlater (Thermo Fisher) at -80\u00b0C and then thawed, homogenized in Trizol reagent \n(Invitrogen) and total RNA was isolated using a Direct- zol \nRNA MiniPrep kit (Zymo Research). This total RNA was then used for Primer ID and qRT -PCR.  \nWhole body plethysmography  \nPulmonary function was monitored once  daily via whole -\nbody plethysmography (Buxco Respiratory Solutions, DSI Inc.). Mice intended for this analysis were randomly chosen prior to the initiation of the study. Briefly, after a 30 -min ac-\nclimation time in the plethysmograph, data for 11 parameters  \nwas recorded every 2 s for 5 min.  \nAcute lung injury histological assessment tools  \nTwo different and complementary quantitative histologic tools were used to determine if antiviral treatments  at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 3040, "end_char_idx": 6232, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e7d29b03-6830-4b88-b8d0-030434ec2ef2": {"__data__": {"id_": "e7d29b03-6830-4b88-b8d0-030434ec2ef2", "embedding": null, "metadata": {"page_label": "10", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "95591b9d-3ef3-475d-a93c-1fba79f156e5", "node_type": null, "metadata": {"page_label": "10", "file_name": "5_COVID_Medicine.pdf"}, "hash": "d28ded224b5a825a4aea98bae12e7c7f6f90a0db73916c3fca949161c225ad3d"}, "3": {"node_id": "0351036d-6a80-4cf7-b9c4-6ec7cd46c65f", "node_type": null, "metadata": {"page_label": "10", "file_name": "5_COVID_Medicine.pdf"}, "hash": "51958a08ab6df3b19d3af195c99c6dee05cf61b7fe8a4a32fbb0e5dbc7369412"}}, "hash": "011230094e33e192ce46cb888ff91b0011ed915f653cf9daa44a7a1304aca6d9", "text": "First release: 6 April 2020   stm.sciencemag.org   ( Page numbers not final at time of first  release ) 10 \n diminished the histopathologic features associated with lung \ninjury. Both analyses and scoring were performed by a Board \nCertified Veterinary Pathologist who was blinded to the treat-ment groups.  \nAmerican Thoracic Society lung injury scoring tool.  In or-\nder to help quantitate histological features of ALI observed in mous e models and increase their translation to the human \ncondition, we used the ATS scoring tool ( 63). In a blinded \nmanner, we chose three random diseased fields of lung tissue at high power (60 \u00d7), which were scored for the following: (A) neutrophils in the a lveolar space (none = 0, 1 \u20135 cells = 1, \n> 5 cells = 2), (B) neutrophils in the interstitial space/ septae (none = 0, 1 \u20135 cells = 1, > 5 cells = 2), (C) hyaline membranes \n(none = 0, one membrane = 1, > 1 membrane = 2), (D) Pro-teinaceous debris in air spaces  (none = 0, one instance = 1, > \n1 instance = 2), (E) alveolar septal thickening (< 2\u00d7 mock thickness = 0, 2 \u20134\u00d7 mock thickness = 1, > 4\u00d7 mock thickness \n= 2). To obtain a lung injury score per field, the scores for A \u2013\nE were then put into the following formula, which contains multipliers that assign varying levels of importance for each phenotype of the disease state.: score = [(20x A) + (14 x B) + (7 x C) + (7 x D) + (2 x E)]/100. The scores for the three fields per mouse were averaged to obtain a final score  ranging from \n0 to and including 1.  \nDiffuse Alveolar Damage (DAD) tool. The second histolog-\nical tool to quantitate lung injury was reported by Schmidt et al.(64). DAD is the pathological hallmark of ALI ( 63, 64 ). \nThree random diseased fields of lung tissue  were scored at \nhigh power (60 \u00d7) for the following in a blinded manner: 1 = absence of cellular sloughing and necrosis, 2 = Uncommon solitary cell sloughing and necrosis (1 \u20132 foci/field), 3 = mul-\ntifocal (3 + foci) cellular sloughing and necrosis with uncom-mon septal wall hyalinization, or 4 = multifocal (>75% of field) cellular sloughing and necrosis with common and/or prominent hyaline membranes. The scores for the three fields per mouse were averaged to get a final DAD score per mouse.  \nnsp12 phylogenetic analysis and conservation modeling  \nCoronavirus RdRp (nsp12) protein sequence alignments and phylogenetic trees were generated using Geneious Tree Builder in Geneious Prime (version 2020.0.5) and visualized using Evolview ( https://www.evolgenius.info/evolview/\n). \nProtein similarity scores were calculated using Blosom62 ma-trix. The accession numbers used were: PDCoV (KR265858), AIBV (NC_001451), HCoV -229E (JX503060), PEDV \n(NC_003436), MHV (AY700211), HCoV -HKU1 (DQ415904), \nHCoV -NL63 (JX504050), HCOV -OC43 (AY903460), HKU5 -1 \n(NC_009020), MERS -CoV (JX869059), HKU9 -4 (EF065516), \n2019-nCoV (MN996528), HKU3 -1 (DQ022305), SHC014 \n(KC881005), WIV1 (KF367457), SARS -CoV (AY278741). Amino \nacid conservation scores of coronavirus RdRp were generated using ConSurf Server", "start_char_idx": 0, "end_char_idx": 3046, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0351036d-6a80-4cf7-b9c4-6ec7cd46c65f": {"__data__": {"id_": "0351036d-6a80-4cf7-b9c4-6ec7cd46c65f", "embedding": null, "metadata": {"page_label": "10", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "95591b9d-3ef3-475d-a93c-1fba79f156e5", "node_type": null, "metadata": {"page_label": "10", "file_name": "5_COVID_Medicine.pdf"}, "hash": "d28ded224b5a825a4aea98bae12e7c7f6f90a0db73916c3fca949161c225ad3d"}, "2": {"node_id": "e7d29b03-6830-4b88-b8d0-030434ec2ef2", "node_type": null, "metadata": {"page_label": "10", "file_name": "5_COVID_Medicine.pdf"}, "hash": "011230094e33e192ce46cb888ff91b0011ed915f653cf9daa44a7a1304aca6d9"}, "3": {"node_id": "d1ad78a3-8f30-4d3e-8812-837966c9971a", "node_type": null, "metadata": {"page_label": "10", "file_name": "5_COVID_Medicine.pdf"}, "hash": "8f58813eb3a26fe759c86bcd16c4a368f611fba771344ac9f392b17ef5a783f2"}}, "hash": "51958a08ab6df3b19d3af195c99c6dee05cf61b7fe8a4a32fbb0e5dbc7369412", "text": "conservation scores of coronavirus RdRp were generated using ConSurf Server (\nhttps://consurf.tau.ac.il/ ) using the \nprotein alignment described above and visualized on the SARS- CoV RdRp structure (PDB: 6NUR) in PyMol (version \n1.8.6.0)( 20, 6 5). \nStatistical analysis  \nAll statistical data analyses were performed in Graphpad Prism 8. Statistical significance for each endpoint was deter-mined with specific statistical tests. In general, for metrics with multiple treatment groups with longitudinal data (e.g., mouse weight loss or pulmonary function over time), two-way ANOVA was performed with the suggested multiple com-parison test as advised by Prism. For comparative data with for a single timepoint (e.g., lung titer) Kruskal -Wallis or one-\nway ANOVA was performed with the suggested multiple com-parison test. For each test, a p -value <0.05 was considered \nsignificant. Specific tests are noted in each figure legend. \n \nSUPPLEMENTARY MATERIALS  \nstm .sciencemag.org/cgi/content/full/scitranslmed .abb5883 /DC1  \nSupplementary Figure 1. Assessment of cytotoxicity of NHC in primary human epi-\nthelial cell cultures by qRT -PCR.  \nSupplementary Figure 2. High conservation of RdRp functional domains for SARS -\nCoV- 2. \nSupplementary Figure 3. Prophylactic EIDD -2801 re duces SARS -CoV replication and \npathogenesis.  \nSupplementary Figure 4. Prophylactic EIDD -2801 reduces MERS -CoV replication and \npathogenesis.  \nSupplementary Table 1. Real -time PCR primer/probe sets for indicators of cellular \napoptosis/toxicity.  \nSupplementary T able 2. Primers used for MiSeq library prep and sequencing.  \nData file S1. Primary data.  \nREFERENCES AND NOTES  \n1. World Health Organization, M iddle East respiratory syndrome coronavirus (MERS -\nCoV); www.who.int/emergencies/mers -cov/en/ .  \n2. E. de Wit, N. van Doremalen, D. Falzarano, V. J. Munster, SARS and MERS: Recent \ninsights into emerging coronaviruses. Nat. Rev. Microbiol.  14, 523 \u2013534 (2016). \ndoi:10.1038/nrmicro.2016.81 Medline  \n3. D. Wang, B. Hu, C. Hu, F. Zhu, X. Liu, J. Zhang, B. Wang, H. Xiang, Z. Cheng, Y. Xiong, \nY. Zhao, Y. Li, X. Wang, Z. Peng, Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus -Infected Pneumonia in Wuhan, China. \nJAMA \n323 , 1061 (2020). doi:10.1001/jama.2020.1585  Medline  \n4. S. J. Anthony, K. Gilardi, V. D. Menachery, T. Goldstein, B. Ssebide, R. Mbabazi, I. \nNavarrete -Macias, E. Liang, H. Wells, A. Hicks, A. Petrosov, D. K. Byarugaba, K. \nDebbink, K. H. Dinnon, T. Scobey, S. H. Randell, B. L. Yount, M. Cranfield, C. K. Johnson, R. S. Baric, W. I. Lipkin, J. A. Mazet, Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome  Coronavirus. mBio  \n8, \ne00373 -17 (2017). doi:10.1128/mBio.00373 -17 Medline  \n5. B. Hu , X. Ge, L. F. Wang, Z. Shi, Bat origin of human", "start_char_idx": 2981, "end_char_idx": 5827, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d1ad78a3-8f30-4d3e-8812-837966c9971a": {"__data__": {"id_": "d1ad78a3-8f30-4d3e-8812-837966c9971a", "embedding": null, "metadata": {"page_label": "10", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "95591b9d-3ef3-475d-a93c-1fba79f156e5", "node_type": null, "metadata": {"page_label": "10", "file_name": "5_COVID_Medicine.pdf"}, "hash": "d28ded224b5a825a4aea98bae12e7c7f6f90a0db73916c3fca949161c225ad3d"}, "2": {"node_id": "0351036d-6a80-4cf7-b9c4-6ec7cd46c65f", "node_type": null, "metadata": {"page_label": "10", "file_name": "5_COVID_Medicine.pdf"}, "hash": "51958a08ab6df3b19d3af195c99c6dee05cf61b7fe8a4a32fbb0e5dbc7369412"}}, "hash": "8f58813eb3a26fe759c86bcd16c4a368f611fba771344ac9f392b17ef5a783f2", "text": "X. Ge, L. F. Wang, Z. Shi, Bat origin of human coronaviruses. Virol. J.  12, 221 \n(2015). doi:10.1186/s12985 -015-0422 -1 Medline  \n6. J. Huynh, S. Li, B. Yount, A. Smith, L. Sturges, J. C. Olsen, J. Nagel, J. B. Johnson, S. \nAgnihothram, J. E. Gates, M. B. Frieman, R. S. Baric, E. F. Donaldson, Evidence supporting a zoonotic origin of human coronavirus strain NL63. J. Virol.  \n86, \n12816 \u201312825 (2012). doi:10.1128/JVI.00906 -12 Medline  \n7. A. M. Zaki, S. van Boheemen, T. M. Bestebroer, A. D. Osterhaus, R. A. Fouchier, \nIsolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. \nEngl. J. Med.  367 , 1814 \u20131820 (2012). doi:10.1056/NEJMoa1211721 Medline  \n8. L. Y. Hsu, C. C. Lee, J. A. Green, B. Ang, N. I. Paton, L. Lee, J. S. Villacian, P. L. L im, \nA. Earnest, Y. S. Leo, Severe acute respiratory syndrome (SARS) in Singapore: Clinical features of index patient and initial contacts. Emerg. Infect. Dis.  \n9, 713 \u2013\n717 (2003). doi:10.3201/eid0906.030264  Medline  \n9. P. Zhou, H. Fan, T. Lan, X. L. Yang, W. F. Shi, W. Zhang, Y. Zhu, Y. W. Zhang, Q. M. \nXie, S. Mani, X. S. Zheng, B. Li, J. M. Li, H. Guo, G. Q. Pei, X. P. An, J. W. Chen, L.  at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 5847, "end_char_idx": 7104, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f15e74fb-4d33-4809-9933-5143d50d9002": {"__data__": {"id_": "f15e74fb-4d33-4809-9933-5143d50d9002", "embedding": null, "metadata": {"page_label": "11", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "33da8422-6e5d-46da-9f8d-61ca983eb55e", "node_type": null, "metadata": {"page_label": "11", "file_name": "5_COVID_Medicine.pdf"}, "hash": "00a689a033917c67ee417dc34beb1d1caff5840fd48320fc6b37fe84d3aa6742"}, "3": {"node_id": "395fa888-85c3-4f26-a8ca-367756b1644e", "node_type": null, "metadata": {"page_label": "11", "file_name": "5_COVID_Medicine.pdf"}, "hash": "bdd875bc5cb81c01b67363f7c292e8ed31e83e62d84191bb5b9c7001865d1e19"}}, "hash": "ef75d6890eed9e266ff1381137f14d948fb1fafc0a80c63f65fc89c1f5878585", "text": "First release: 6 April 2020   stm.sciencemag.org   ( Page numbers not final at time of first  release ) 11 \n Zhou, K. J. Mai, Z. X. Wu, D. Li, D. E. Anderson, L. B. Zhang, S. Y. Li, Z. Q. Mi, T. T. \nHe, F. Cong, P. J. Guo, R. Huang, Y. Luo, X. L. Liu, J. Chen, Y. Huang, Q. Sun, X. L. Zhang, Y. Y. Wang, S. Z. Xing , Y. S. Chen, Y. Sun, J. Li, P. Daszak, L. F. Wang, Z. L. \nShi, Y. G. Tong, J. Y. Ma, Fatal swine acute diarrhoea syndrome caused by an HKU2 -related coronavirus of bat origin. Nature  \n556 , 255\u2013258 (2018). \ndoi:10.1038/s41586 -018-0010-9  Medline  \n10. P. C. Woo, S. K. Lau, K. S. Li, R. W. Poon, B. H. Wong, H. W. Tsoi, B. C. Yip, Y. Huang, \nK. H. Chan, K. Y. Yuen, Molecular diversity of coronaviruses in bats. Virology  351, \n180 \u2013187 (2006). doi:10.1016/j.virol.2006.02.041 Medline  \n11. V. D. Menachery, B. L. Yount Jr., K. Debbink, S. Agnihothram, L. E. Gralinski, J. A. \nPlante, R. L. Graham, T. Scobey, X. Y. Ge, E. F. Don aldson, S. H. Randell, A. \nLanzavecchia, W. A. Marasco, Z. L. Shi, R. S. Baric, A SARS -like cluster of \ncirculating bat coronaviruses shows potential for human emergence. Nat. Med.  \n21, 1508 \u20131513 (2015). doi:10.1038/nm.3985  Medline  \n12. V. D. Menachery, B. L. Yount Jr., A. C. Sims, K. Debbink, S. S. Agnihothram, L. E. \nGralinski, R. L. Graham, T. Scobey, J. A. Plante, S. R. Royal, J. Swanstrom, T. P. \nSheahan, R. J. Pickles, D. Corti, S. H. Randell, A. Lanzavecchia, W. A. Marasco, R. S. Baric, SARS -like WIV1 -CoV poised for human emergence. Proc. Natl. Acad. Sci. \nU.S.A. \n113, 3048\u2013 3053 (2016). doi:10.1073/pnas.1517719113  Medline  \n13. O. Reynard, X. N. Nguyen, N. Alazard- Dany, V. B arateau, A. Cimarelli, V. E. \nVolchkov, Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication. Viruses  \n7, 6233 \u20136240 (2015). doi:10.3390/v7122934  Medline  \n14. N. Urakova, V. Kuznetsova, D. K. Crossman, A. Sokratian, D. B. Guthrie, A. A. \nKolykhalov, M. A. Lockwood, M. G. Natchus, M. R. Crowley, G. R. Painter, E. I. \nFrolova, I. Frolov, \u03b2 -d-N4-Hydroxycytidine Is a Potent Anti- alphavirus Compound \nThat Induces a High Level of Mutations in the Viral Genome. J. Virol.  92, \u2022\u2022\u2022 \n(2018). Medline  \n15. M.", "start_char_idx": 0, "end_char_idx": 2180, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "395fa888-85c3-4f26-a8ca-367756b1644e": {"__data__": {"id_": "395fa888-85c3-4f26-a8ca-367756b1644e", "embedding": null, "metadata": {"page_label": "11", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "33da8422-6e5d-46da-9f8d-61ca983eb55e", "node_type": null, "metadata": {"page_label": "11", "file_name": "5_COVID_Medicine.pdf"}, "hash": "00a689a033917c67ee417dc34beb1d1caff5840fd48320fc6b37fe84d3aa6742"}, "2": {"node_id": "f15e74fb-4d33-4809-9933-5143d50d9002", "node_type": null, "metadata": {"page_label": "11", "file_name": "5_COVID_Medicine.pdf"}, "hash": "ef75d6890eed9e266ff1381137f14d948fb1fafc0a80c63f65fc89c1f5878585"}, "3": {"node_id": "6ef2dfc1-e86e-4653-af67-6f56dea89a53", "node_type": null, "metadata": {"page_label": "11", "file_name": "5_COVID_Medicine.pdf"}, "hash": "68931050bc355cccfbb097491211edffa8c16872af11e3ab4039e525140626e1"}}, "hash": "bdd875bc5cb81c01b67363f7c292e8ed31e83e62d84191bb5b9c7001865d1e19", "text": "Virol.  92, \u2022\u2022\u2022 \n(2018). Medline  \n15. M. Toots, J. J. Yoon, R. M. Cox, M. Hart, Z. M. Sticher, N. Makhsous, R. Plesker, A. \nH. Barrena, P. G. Reddy, D. G. Mitchell, R.  C. Shean, G. R. Bluemling, A. A. \nKolykhalov, A. L. Greninger, M. G. Natchus, G. R. Painter, R. K. Plemper, \nCharacterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia. Sci. Transl. Med.  \n11, eaax 5866 (2019). \ndoi:10.1126/scitranslmed.aax5866  Medline  \n16. M. L. Agostini, A . J. Pruijssers, J. D. Chappell, J. Gribble, X. Lu, E. L. Andres, G. R. \nBluemling, M. A. Lockwood, T. P. Sheahan, A. C. Sims, M. G. Natchus, M. Saindane, A. A. Kolykhalov, G. R. Painter, R. S. Baric, M. R. Denison, Small -Molecule Antiviral \n\u03b2-d-N\n4-Hydroxycytidine Inhibits a Proofreading -Intact Coronavirus with a High \nGenetic Barrier to Resistance. J. Virol.  93, e01348 -19 (2019). \ndoi:10.1128/JVI.01348 -19 Medline  \n17. P. C. Jordan, C. Liu, P. Raynaud, M. K. Lo, C. F. Spiropoulou, J. A. Symons, L. \nBeigelman, J. Deval, Initiation, extension, and termination of RNA synthesis by a paramyxovirus p olymerase. PLOS Pathog.  \n14, e1006889 (2018). \ndoi:10.1371/journal.ppat.1006889  Medline  \n18. T. P. Sheahan, A. C. Sims, S. R. Leist, A. Sch\u00e4fer, J. Won, A. J. Brown, S. A. \nMontgomery, A. Hogg, D. Babusis, M. O. Clarke, J. E. Spahn, L. Bauer, S. Sellers, D. Porter, J. Y. Feng, T. Cihlar, R. Jordan, M. R. Denison, R. S. Baric, Compara tive \ntherapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS -CoV. Nat. Commun.  \n11, 222 (2020). \ndoi:10.1038/s41467 -019-13940 -6 Medline  \n19. T. P. Sheahan, A. C. Sims, R. L. Graham, V. D. Menachery, L. E. Gralinski, J. B. Case, \nS. R. Leist, K. Pyrc, J. Y. Feng, I. Trantcheva, R. Bannis ter, Y. Park, D. Babusis, M. \nO. Clarke, R. L. Mackman, J. E. Spahn, C. A. Palmiotti, D. Siegel, A. S. Ray, T. Cihlar, R. Jordan, M. R. Denison, R. S. Baric, Broad -spectrum antiviral GS- 5734 inhibits \nboth epidemic and zoonotic coronaviruses. Sci. Transl. Me d. \n9, eaal3653 (2017). \ndoi:10.1126/scitranslmed.aal3653  Medline  \n20. R. N. Kirchdoerfer, A. B. Ward, Structure of the SARS -CoV nsp12 polymerase \nbound to nsp7 and nsp8 co -factors.", "start_char_idx": 2148, "end_char_idx": 4396, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6ef2dfc1-e86e-4653-af67-6f56dea89a53": {"__data__": {"id_": "6ef2dfc1-e86e-4653-af67-6f56dea89a53", "embedding": null, "metadata": {"page_label": "11", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "33da8422-6e5d-46da-9f8d-61ca983eb55e", "node_type": null, "metadata": {"page_label": "11", "file_name": "5_COVID_Medicine.pdf"}, "hash": "00a689a033917c67ee417dc34beb1d1caff5840fd48320fc6b37fe84d3aa6742"}, "2": {"node_id": "395fa888-85c3-4f26-a8ca-367756b1644e", "node_type": null, "metadata": {"page_label": "11", "file_name": "5_COVID_Medicine.pdf"}, "hash": "bdd875bc5cb81c01b67363f7c292e8ed31e83e62d84191bb5b9c7001865d1e19"}, "3": {"node_id": "a8ca9e5c-7419-4773-a605-d97a651f73cf", "node_type": null, "metadata": {"page_label": "11", "file_name": "5_COVID_Medicine.pdf"}, "hash": "aeafc76523358b594da18223b6aeb90f3e329fea58101e8e98a096343882c0ce"}}, "hash": "68931050bc355cccfbb097491211edffa8c16872af11e3ab4039e525140626e1", "text": "polymerase \nbound to nsp7 and nsp8 co -factors. Nat. Commun.  10, 2342 (2019). \ndoi:10.1038/s41467 -019-10280 -3 Medline  \n21. M. L. Agostini, E. L. Andres, A. C. Sims, R. L. Graham, T. P. Sheahan, X. Lu, E. C. \nSmith, J. B. Case, J. Y. Feng, R. Jordan, A. S. Ray, T. Cihlar, D. Siegel, R. L. Mackman, M. O. Clarke, R. S. Baric, M. R. Denison, Coronavirus Susceptibility to the Antiviral Remdesivir (GS -5734) Is Mediated by the Viral Polymerase and the \nProofreading Exoribonuclease. mBio  \n9, e00221 -18 (2018). \ndoi:10.1128/mBio.00221 -18 Medline  \n22. M. M. Becker, R. L. Graham, E. F. Donaldson, B. Rockx, A. C. Sims , T. Sheahan, R. J. Pickles, D. Corti, R. E. Johnston, R. S. Baric, M. R. Denison, Synthetic recombinant bat SARS -like coronavirus is infectious in cultured cells and in mice. \nProc. Natl. Acad. Sci. U.S.A. \n105 , 19944 \u201319949 (2008). \ndoi:10.1073/pnas.0808116105  Medline  \n23. S. Agnihothram, B. L. Yount Jr., E. F. Donaldson, J. Huynh, V. D. Menachery, L. E. \nGralinski, R. L. Graham, M. M. Becker, S. Tomar, T. D. Scobey, H. L. Osswald, A. Whitmore, R. Gopal, A. K. Ghosh, A. Mesecar, M. Zambon, M. Heise, M. R. Denison, R. S. Baric, A mouse model for Betacoronavirus subgroup 2c using a bat coron avirus strain HKU5 variant. mBio  \n5, e00047 \u2013e14 (2014). \ndoi:10.1128/mBio.00047 -14 Medline  \n24. J. J. Yoon, M. Toots, S. Lee, M. E. Lee, B. Ludeke, J. M. Luczo, K. Ganti, R. M. Cox, \nZ. M. Sticher, V. Edpuganti, D. G. Mitchell, M. A. Lockwood, A. A. Kolykhalov, A. L. Greninger, M. L. Moore, G. R. Painter, A. C. Lowen, S. M. Tompkins, R. Fearns, M. G. Natchus, R. K. Plemper, Orally Efficacious Broad -Spectrum Ribonucleoside \nAnalog Inhibitor of Influenza and Respiratory Syncytial Viruses. Antimicrob. Agents Chemother.  \n62, e00766 -18 (2018). doi:10.1128/AAC.00766 -18 Medline  \n25. S. Zhou, C. Jones, P. Mieczkowski, R. Swanstrom, Primer ID Validates Template \nSampling Depth and Greatly Reduces the Error Rate of Next -Generation \nSequencing of HIV -1 Genomic RNA Populations. J. Virol.  89, 8540 \u20138555 (2015). \ndoi:10.1128/JVI.00522 -15 Medline  \n26. E. P. Tchesnokov, J. Y. Feng, D. P. Porter, M. G\u00f6tte, Mechanism of Inhibition of \nEbola Virus RNA -Dependent RNA Polymerase by Remdesivir. Viruses  11, 326 \n(2019). doi:10.3390/v11040326  Medline  \n27. V. D. Menachery, L.", "start_char_idx": 4390, "end_char_idx": 6699, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a8ca9e5c-7419-4773-a605-d97a651f73cf": {"__data__": {"id_": "a8ca9e5c-7419-4773-a605-d97a651f73cf", "embedding": null, "metadata": {"page_label": "11", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "33da8422-6e5d-46da-9f8d-61ca983eb55e", "node_type": null, "metadata": {"page_label": "11", "file_name": "5_COVID_Medicine.pdf"}, "hash": "00a689a033917c67ee417dc34beb1d1caff5840fd48320fc6b37fe84d3aa6742"}, "2": {"node_id": "6ef2dfc1-e86e-4653-af67-6f56dea89a53", "node_type": null, "metadata": {"page_label": "11", "file_name": "5_COVID_Medicine.pdf"}, "hash": "68931050bc355cccfbb097491211edffa8c16872af11e3ab4039e525140626e1"}, "3": {"node_id": "edc0108c-3ea9-440a-9a86-a2d16c680724", "node_type": null, "metadata": {"page_label": "11", "file_name": "5_COVID_Medicine.pdf"}, "hash": "2d39ec79597a17d3d2478f6c8c53734a21c8bb007b98138e653792f613214774"}}, "hash": "aeafc76523358b594da18223b6aeb90f3e329fea58101e8e98a096343882c0ce", "text": " Medline  \n27. V. D. Menachery, L. E. Gralinski, R. S. Baric, M. T. Ferris, New Metrics for Evaluating \nViral Respiratory Pathogenesis. PLOS ONE  10, e0131451 (2015). \ndoi:10.1371/journal.pone.0131451 Medline  \n28. A. S. Cockrell, B. L. Yount, T. Scobey, K. Jensen, M. Douglas, A. Beall, X. C. Tang, \nW. A. Marasco, M. T. Heise, R. S. Baric, A mouse model for MERS coronavirus -\ninduced acute respiratory dis tress syndrome. Nat. Microbiol.  2, 16226 (2016). \ndoi:10.1038/nmicrobiol.2016.226  Medline  \n29. H. D. Marston, G. K. Folkers, D. M. Morens, A. S. Fauci, Emerging viral diseases: \nConfronting threats with new technologies. Sci. Transl. Med.  6, 253ps10 (2014). \ndoi:10.1126/scitranslmed.3009872  Medline  \n30. C. I. Paules, H. D. Marston, A. S. Fauci, Coronavirus Infections -More Than Just the \nCommon Cold. JAMA 323 , 707 (2020). doi:10.1001/jama.2020.0757  Medline  \n31. A. J. Brown, J. J. Won, R. L. Graham, K. H. Dinnon 3rd, A. C. Sims, J. Y. Feng, T. \nCihlar, M. R. Denison, R. S. Baric, T. P. Sheahan, Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase. Antivir al Res.  \n169 , 104541 (2019). \ndoi:10.1016/j.antiviral.2019.104541 Medline  \n32. A. Zumla, J. F. Chan, E. I. Azhar, D. S. Hui, K. Y. Yuen, Coronaviruses - drug \ndiscovery and therapeutic options. Nat. Rev. Drug Discov.  15, 327 \u2013347 (2016). \ndoi:10.1038/nrd.2015.37  Medline  \n33. A. Cortegiani, G. Ingoglia, M. Ippolito, A. Giarratano, S. Einav, A systematic review \non the efficacy and safety of chloroquine for the treatment of COVID -19. J. Crit. \nCare S0883 -9441(20)30390- 7 (2020). doi:10.1016/j.jcrc.2020.03.005  Medline  \n34. F. X. Lescure, L. Bouadma, D. Nguyen, M. Parisey, P. H. Wicky, S. Behillil, A. \nGaymard, M. Bouscambert -Duchamp, F. Donati, Q. Le Hingrat,  V. Enouf, N. \nHouhou -Fidouh, M. Valette, A. Mailles, J. C. Lucet, F. Mentre, X. Duval, D. \nDescamps, D. Malvy, J. F. Timsit, B. Lina, S. van -der-Werf, Y. Yazdanpanah, \nClinical and virological data of the first cases of COVID -19 in Europe: A case series. \nLancet Infect. Dis.  S1473 -3099(20)30200- 0 (2020). doi:10.1016/S1473 -\n3099(20)30200-0  Medline  \n35. B. Cao, Y. Wang, D. Wen, W. Liu, J. Wang, G. Fan, L. Ruan, B. Song, Y. Cai, M. Wei, \nX. Li, J. Xia,", "start_char_idx": 6713, "end_char_idx": 9024, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "edc0108c-3ea9-440a-9a86-a2d16c680724": {"__data__": {"id_": "edc0108c-3ea9-440a-9a86-a2d16c680724", "embedding": null, "metadata": {"page_label": "11", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "33da8422-6e5d-46da-9f8d-61ca983eb55e", "node_type": null, "metadata": {"page_label": "11", "file_name": "5_COVID_Medicine.pdf"}, "hash": "00a689a033917c67ee417dc34beb1d1caff5840fd48320fc6b37fe84d3aa6742"}, "2": {"node_id": "a8ca9e5c-7419-4773-a605-d97a651f73cf", "node_type": null, "metadata": {"page_label": "11", "file_name": "5_COVID_Medicine.pdf"}, "hash": "aeafc76523358b594da18223b6aeb90f3e329fea58101e8e98a096343882c0ce"}}, "hash": "2d39ec79597a17d3d2478f6c8c53734a21c8bb007b98138e653792f613214774", "text": "Y. Cai, M. Wei, \nX. Li, J. Xia, N. Chen, J. Xiang, T. Yu, T. Bai, X. Xie, L. Zhang, C. Li, Y. Yuan, H. Chen, H. Li, H. Huang, S. Tu, F. Gong, Y. Liu, Y. Wei, C. Dong, F. Zhou, X. Gu, J. Xu, Z. Liu, Y. Zhang, H. Li, L. Shang, K. Wang, K. Li, X. Zhou, X. Dong, Z. Qu, S. Lu, X. Hu, S. Ruan, S. Luo, J. Wu, L. Peng, F. Cheng, L. Pan, J. Zou, C. Jia, J. Wang, X. Liu, S. Wang, X. Wu, Q. Ge, J. He, H. Zhan, F. Qiu, L. Guo, C. Huang, T. Jaki, F. G. Hayden, P. W. Horby, D. Zhang, C. Wang, A Trial of Lopinavir -Ritonavir in Adults \nHospitalized with Severe Covid -19. N. Engl. J. Med.  NEJMoa2001282 (2020). \ndoi:10.1056/NEJMoa2001282  Medline\n \n36. M. Ehteshami, S. Tao, K. Zandi, H. M. Hsiao, Y. Jiang, E. Hammond, F. Amblard, O. \nO. Russell, A. Merits, R. F. Schinazi, Characterization of \u03b2 -d-N4-Hydroxycytidine \nas a Novel Inhibitor of Chikungunya Virus. Antimicrob. Agents Chemother.  61,  at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 9020, "end_char_idx": 9994, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1343b8e5-3f04-43b3-9cbc-395cb074ad5f": {"__data__": {"id_": "1343b8e5-3f04-43b3-9cbc-395cb074ad5f", "embedding": null, "metadata": {"page_label": "12", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "964807da-f9b7-494f-9a11-4cd7c7c2594e", "node_type": null, "metadata": {"page_label": "12", "file_name": "5_COVID_Medicine.pdf"}, "hash": "5228f8e9545e2dfaf2a19e47246601bc6e83ea29e0ee4303b01057c742ead8ce"}, "3": {"node_id": "b648d7ea-9149-458d-838c-050ed68be90b", "node_type": null, "metadata": {"page_label": "12", "file_name": "5_COVID_Medicine.pdf"}, "hash": "d429214e837dcb0dd064d7dfbc917e420c6677e4de912748845e23fa6260531c"}}, "hash": "1c04ce6650af1093e3855cbd7283d0e0c913f31fbf78fd4d6fc3d0666d0e0b70", "text": "First release: 6 April 2020   stm.sciencemag.org   ( Page numbers not final at time of first  release ) 12 \n e02395- 16 (2017). doi:10.1128/AAC.02395 -16 Medline  \n37. T. K. Warren, R. Jordan, M. K. Lo, A. S. Ray, R. L. Mackman, V. Soloveva, D. Siegel, \nM. Perron, R. Bannister, H. C. Hui, N. Larson, R. Strickley, J. Wells, K. S. Stuthman , \nS. A. Van Tongeren, N. L. Garza, G. Donnelly, A. C. Shurtleff, C. J. Retterer, D. \nGharaibeh, R. Zamani, T. Kenny, B. P. Eaton, E. Grimes, L. S. Welch, L. Gomba, C. L. Wilhelmsen, D. K. Nichols, J. E. Nuss, E. R. Nagle, J. R. Kugelman, G. Palacios, E. Doe rffler, S. Neville, E. Carra, M. O. Clarke, L. Zhang, W. Lew, B. Ross, Q. Wang, K. \nChun, L. Wolfe, D. Babusis, Y. Park, K. M. Stray, I. Trancheva, J. Y. Feng, O. Barauskas, Y. Xu, P. Wong, M. R. Braun, M. Flint, L. K. McMullan, S. S. Chen, R. Fearns, S. Swaminathan, D. L. Mayers, C. F. Spiropoulou, W. A. Lee, S. T. Nichol, T. Cihlar, S. Bavari, Therapeutic efficacy of the small molecule GS -5734 against \nEbola virus in rhesus monkeys. Nature  \n531, 381 \u2013385 (2016). \ndoi:10.1038/nature17180  Medline  \n38. M. K. Lo, R. Jordan, A. Arvey, J. Sudhamsu, P. Shrivastava -Ranjan, A. L. Hotard, M. \nFlint, L. K. McMullan, D. Siegel, M. O. Clarke, R. L. Mackman, H. C. Hui, M. Perron, A. S. Ray, T. Cihlar, S. T. Nichol, C. F. Spiropoulou, GS -5734 and its parent \nnucle oside analog inhibit Filo -, Pneumo -, and Paramyxoviruses. Sci. Rep.  \n7, 43395 \n(2017). doi:10.1038/srep43395  Medline  \n39. M. D. Oh, W. B. Park, P. G. Choe, S. J. Choi, J. I. Kim, J. Chae, S. S. Park, E. C. Kim, \nH. S. Oh, E. J. Kim, E. Y. Nam, S. H. Na, D. K. Kim, S. M. Lee, K. H. Song, J. H. Bang, E. S. Kim, H. B. Kim, S. W. Park, N. J. Kim, V iral Load Kinetics of MERS Coronavirus \nInfection. N. Engl. J. Med.  \n375 , 1303\u2013 1305 (2016). doi:10.1056/NEJMc1511695  \nMedline  \n40. J. S. Peiris, C. M. Chu, V. C. Cheng, K. S. Chan, I. F. Hung, L. L. Poon, K. I. Law, B. S. \nTang, T. Y. Hon, C. S. Chan, K. H. Chan, J. S. Ng, B. J. Zheng, W. L. Ng, R. W. Lai, Y. Guan, K. Y. Yuen; HKU/UCH SARS St udy Group, Clinical progression and", "start_char_idx": 0, "end_char_idx": 2104, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b648d7ea-9149-458d-838c-050ed68be90b": {"__data__": {"id_": "b648d7ea-9149-458d-838c-050ed68be90b", "embedding": null, "metadata": {"page_label": "12", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "964807da-f9b7-494f-9a11-4cd7c7c2594e", "node_type": null, "metadata": {"page_label": "12", "file_name": "5_COVID_Medicine.pdf"}, "hash": "5228f8e9545e2dfaf2a19e47246601bc6e83ea29e0ee4303b01057c742ead8ce"}, "2": {"node_id": "1343b8e5-3f04-43b3-9cbc-395cb074ad5f", "node_type": null, "metadata": {"page_label": "12", "file_name": "5_COVID_Medicine.pdf"}, "hash": "1c04ce6650af1093e3855cbd7283d0e0c913f31fbf78fd4d6fc3d0666d0e0b70"}, "3": {"node_id": "3abf83c4-5435-4f9d-afcf-1980a45e3f9f", "node_type": null, "metadata": {"page_label": "12", "file_name": "5_COVID_Medicine.pdf"}, "hash": "5d56aa2f7ad4c6406bd06d9dbc09fd4ce5e6252ca4812638b29406f914b7d296"}}, "hash": "d429214e837dcb0dd064d7dfbc917e420c6677e4de912748845e23fa6260531c", "text": "Yuen; HKU/UCH SARS St udy Group, Clinical progression and viral load \nin a community outbreak of coronavirus -associated SARS pneumonia: A \nprospective study. Lancet  \n361 , 1767\u20131772 (2003). doi:10.1016/S0140 -\n6736(03)13 412-5 Medline  \n41. R. W\u00f6lfel, V. M. Corman, W. Guggemos, M. Seilmaier, S. Zange, M. A. M\u00fcller, D. \nNiemeyer, T. C. Jones, P. Vollmar, C. Rot he, M. Hoelscher, T. Bleicker, S. Br\u00fcnink, \nJ. Schneider, R. Ehmann, K. Zwirglmaier, C. Drosten, C. Wendtner, Virological assessment of hospitalized patients with COVID -2019. Nature  (2020). \ndoi:10. 1038/s41586 -020 -2196 -x Medline\n \n42. H. Yu, Z. Feng, T. M. Uyeki, Q. Liao, L. Zhou, L. Feng, M. Ye, N. Xiang, Y. Huai, Y. \nYuan, H. Jiang, Y.  Zheng, P. Gargiullo, Z. Peng, Y. Feng, J. Zheng, C. Xu, Y. Zhang, \nY. Shu, Z. Gao, W. Yang, Y. Wang, Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clin. Infect. Dis.  \n52, 457 \u2013465 \n(2011). doi:10.1093/cid/ciq144  Medline  \n43. Y. Wan, J. Shang, R. Graham, R. S. Baric, F. Li, Receptor recognition by novel \ncoronavirus from Wuhan: An analysis based on decade -long structural studies of \nSARS coronavirus. J. Virol.  94, e00127 -20 (2020). doi:10.1128/JVI.00127 -20 \nMedline  \n44. P. Zhou, X. -L. Yang, X. -G. Wang, B. Hu, L. Zhang, W. Zhang, H. -R. Si, Y. Zhu, B. Li, \nC.-L. Huang, H. -D. Chen, J. Chen, Y. Luo, H. Guo, R.- D. Jiang, M. -Q. Liu, Y. Ch en, \nX.-R. Shen, X. Wang, X. -S. Zheng, K. Zhao, Q. -J. Chen, F. Deng, L. -L. Liu, B. Yan, F.-\nX. Zhan, Y. -Y. Wang, G. Xiao, Z.- L. Shi, Discovery of a novel coronavirus associated \nwith the recent pneumonia outbreak in humans and its potential bat origin. bioRxi v, 2020.2001.2022.914952 (2020).  \n45. T. Sheahan, A. Whitmore, K. Long, M. Ferris, B. Rockx, W. Funkhouser, E. \nDonaldson, L. Gralinski, M. Collier, M. Heise, N. Davis, R. Johnston, R. S. Baric, Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus. J. Virol.  \n85, 217 \u2013230 (2011). doi:10.1128/JVI.01805 -10 Medline  \n46. E. de Wit, A. L. Rasmussen, D. Falzarano, T. Bushmaker, F. Feldmann, D. L. Brining, \nE. R. Fischer, C. Martellaro, A. Okumura, J. Chang, D. Scott, A. G. Benecke, M. G. \nKatze, H. Feldmann,", "start_char_idx": 2056, "end_char_idx": 4358, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3abf83c4-5435-4f9d-afcf-1980a45e3f9f": {"__data__": {"id_": "3abf83c4-5435-4f9d-afcf-1980a45e3f9f", "embedding": null, "metadata": {"page_label": "12", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "964807da-f9b7-494f-9a11-4cd7c7c2594e", "node_type": null, "metadata": {"page_label": "12", "file_name": "5_COVID_Medicine.pdf"}, "hash": "5228f8e9545e2dfaf2a19e47246601bc6e83ea29e0ee4303b01057c742ead8ce"}, "2": {"node_id": "b648d7ea-9149-458d-838c-050ed68be90b", "node_type": null, "metadata": {"page_label": "12", "file_name": "5_COVID_Medicine.pdf"}, "hash": "d429214e837dcb0dd064d7dfbc917e420c6677e4de912748845e23fa6260531c"}, "3": {"node_id": "e3224ff9-c9c6-431c-ba7e-1bcc1dbdbf02", "node_type": null, "metadata": {"page_label": "12", "file_name": "5_COVID_Medicine.pdf"}, "hash": "de3c9c28495ca7a6a39de4a3ba1995ba3c4ba09df9a702528152a10b9802c104"}}, "hash": "5d56aa2f7ad4c6406bd06d9dbc09fd4ce5e6252ca4812638b29406f914b7d296", "text": "G. Benecke, M. G. \nKatze, H. Feldmann, V. J. Munster, Middle East respiratory syndrome coronavirus (MERS -CoV) causes transient lower respiratory tract infection in rhesus \nmacaques. Proc. Natl. Acad. Sci. U.S.A. \n110, 16598 \u201316603 (2013). \ndoi:10.1073/pnas.1310744110  Medline  \n47. J. McAuliffe, L. Vogel, A. Roberts, G. Fahle, S. Fischer, W. -J. Shieh, E. Butler, S. Zaki, \nM. St Claire, B. Murphy, K. Subbarao, Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys. Virology  \n330 , 8\u201315 (2004). doi:10.1016/j.virol.2004.09.030  Medline  \n48. V. J. Munster, F. Feldmann, B. N. Williamson, N. van Doremalen, L. P\u00e9rez -P\u00e9rez, J. Schulz, K. Meade -White, A. Okumura, J. Callison, B. Brumbaugh, V. A. Avanzato, \nR. Rosenke, P. W. Hanley, G. Saturday, D. Scott, E. R. Fischer, E. de Wit, Respiratory disease and virus shedding in rhesus macaques inoculated w ith \nSARS -CoV -2. bioRxiv , 2020.2003.2021.001628 (2020).  \n49. B. Rockx, T. Kuiken, S. Herfst, T. Bestebroer, M. M. Lamers, D. de Meulder, G. van \nAmerongen, J. van den Brand, N. M. A. Okba, D. Schipper, P. van Run, L. Leijten, E. Verschoor, B. Verstrepen, J. Langermans, C. Drosten, M. F. van Vlissingen, R. \nFouchier, R. de Swart, M. Koopmans, B. L. Haagmans, Comparative Pathogenesis Of COVID -19, MERS And SARS In A Non -Human Primate Model. bioRxiv , \n2020.2003.2017.995639 (2020).  \n50. E. C. Smith, H. Blanc, M. C. Surdel, M. Vignuzzi, M. R. Denison, Coronaviruses \nlacking exoribonuclease activity are susceptible to lethal mutagenesis: Evidence for proofreading and potential therapeutics. PLOS Pathog.  \n9, e1003565 (2013). \ndoi:10.1371/journal.ppat.1003565  Medline  \n51. T. Suzuki, K. Moriyama, C. Otsuka, D. Loakes, K. Negishi, Template properties  of \nmutagenic cytosine analogues in reverse transcription. Nucleic Acids Res.  34, \n6438 \u20136449 (2006). doi:10.1093/nar/gkl761 Medline  \n52. M. L. Fulcher, S. H. Randell, Human nasal and tracheo -bronchial respiratory \nepithelial cell culture. Methods Mol. Biol.  945 , 109 \u2013121 (2013). doi:10.1007/978 -\n1-62703 -125-7_8 Medline  \n53. A. C. Sims, R. S. Baric, B. Yount, S. E. Burkett, P. L. Collins, R. J. Pickles, Severe \nacute respiratory syndrome coronavirus infection of human ciliated airway epithelia: Role of ciliated cells in viral spread in the conducting airways of the lungs. J. Virol.  \n79, 15511 \u201315524 (2005). doi:10.1128/JVI.79.24.15511-", "start_char_idx": 4376, "end_char_idx": 6816, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e3224ff9-c9c6-431c-ba7e-1bcc1dbdbf02": {"__data__": {"id_": "e3224ff9-c9c6-431c-ba7e-1bcc1dbdbf02", "embedding": null, "metadata": {"page_label": "12", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "964807da-f9b7-494f-9a11-4cd7c7c2594e", "node_type": null, "metadata": {"page_label": "12", "file_name": "5_COVID_Medicine.pdf"}, "hash": "5228f8e9545e2dfaf2a19e47246601bc6e83ea29e0ee4303b01057c742ead8ce"}, "2": {"node_id": "3abf83c4-5435-4f9d-afcf-1980a45e3f9f", "node_type": null, "metadata": {"page_label": "12", "file_name": "5_COVID_Medicine.pdf"}, "hash": "5d56aa2f7ad4c6406bd06d9dbc09fd4ce5e6252ca4812638b29406f914b7d296"}, "3": {"node_id": "6dab25d3-e35e-4c29-adc8-55ec0c26c866", "node_type": null, "metadata": {"page_label": "12", "file_name": "5_COVID_Medicine.pdf"}, "hash": "8421ac701b52f388d887d34cf083a65438f61e155f255677fb4ccafc734a68e3"}}, "hash": "de3c9c28495ca7a6a39de4a3ba1995ba3c4ba09df9a702528152a10b9802c104", "text": "(2005). doi:10.1128/JVI.79.24.15511- 15524.2005  \nMedline  \n54. J. Harcourt, A. Tamin, X. Lu, S. Kamili, S. K. Sakthivel, J. Murray, K. Queen, Y. Tao, \nC. R. Paden, J. Zhang, Y. Li, A. Uehara, H. Wang, C. Goldsmith, H. A. Bullock, L. Wang, B. Whitaker, B. Lynch, R. Gautam, C. Schindewolf, K. G. Lokugamage , D. \nScharton, J. A. Plante, D. Mirchandani, S. G. Widen, K. Narayanan, S. Makino, T. G. Ksiazek, K. S. Plante, S. C. Weaver, S. Lindstrom, S. Tong, V. D. Menachery, N. J. Thornburg, Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 No vel Coronavirus Disease, United States. Emerg. Infect. Dis.  \n26, \u2022\u2022\u2022 \n(2020). doi:10.3201/eid2606.200516  Medline  \n55. T. Scobey, B. L. Yount, A. C. Sims, E. F. Donaldson, S. S. Agnihothram, V. D. \nMenachery, R. L. Graham, J. Swanstrom, P. F. Bove, J. D. Kim, S. Grego, S. H. Randell, R. S. Baric, Reverse genetics with a full- length infectious cDNA of the \nMiddle East res piratory syndrome coronavirus. Proc. Natl. Acad. Sci. U.S.A. \n110, \n16157 \u201316162 (2013). doi:10.1073/pnas.1311542110  Medline  \n56. M. G. Douglas, J. F. Kocher, T. Scobey, R. S. Baric, A. S. Cockrell, Adaptive evolution \ninfluences the infectious dose of MERS -CoV necessary to achieve severe \nrespiratory disease. Virology  517, 98 \u2013107 (2018). doi:10.1016/j.virol.2017.12.006  \nMedline  \n57. A. Roberts, D. Deming, C. D. Paddock, A. Cheng, B. Yount, L. Vogel, B. D. Herman, \nT. Sheahan, M. Heise, G. L. Genrich, S. R. Zaki, R. Baric, K. Subbarao, A mouse -\nadapted SARS -coronavirus causes disease and mortality in BALB/c mice. PLOS \nPathog.  3, e5 (2007). doi:10.1371/journal.ppat.0030005  Medline  \n58. B. Yount, M. R. Denison, S. R. Weiss, R. S. Baric, Systemati c assembly of a full-\nlength infectious cDNA of mouse hepatitis virus strain A59. J. Virol.  76, 11065 \u2013\n11078 (2002). doi:10.1128/JVI.76.21.11065 -11078.2002  Medline  \n59. M. L. Fulcher, S. Gabriel, K. A. Burns, J. R. Yankaskas, S. H. Randell, Well -\ndifferentiated human airway epithelial cell cultures. Methods Mol. Med.  107 , 183\u2013\n206 (2005). Medline  \n60. F. Almaz\u00e1n, M. L. DeDiego, I. Sola, S. Zu\u00f1iga, J. L. Nieto -Torres, S. Marquez -\nJurado, G. Andr\u00e9s, L. Enjuanes, Engineering a replication -competent, \npropagation- defective Middle East respiratory syndrome coronavirus as a vaccine \ncandidate. mBio  4,", "start_char_idx": 6814, "end_char_idx": 9140, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6dab25d3-e35e-4c29-adc8-55ec0c26c866": {"__data__": {"id_": "6dab25d3-e35e-4c29-adc8-55ec0c26c866", "embedding": null, "metadata": {"page_label": "12", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "964807da-f9b7-494f-9a11-4cd7c7c2594e", "node_type": null, "metadata": {"page_label": "12", "file_name": "5_COVID_Medicine.pdf"}, "hash": "5228f8e9545e2dfaf2a19e47246601bc6e83ea29e0ee4303b01057c742ead8ce"}, "2": {"node_id": "e3224ff9-c9c6-431c-ba7e-1bcc1dbdbf02", "node_type": null, "metadata": {"page_label": "12", "file_name": "5_COVID_Medicine.pdf"}, "hash": "de3c9c28495ca7a6a39de4a3ba1995ba3c4ba09df9a702528152a10b9802c104"}}, "hash": "8421ac701b52f388d887d34cf083a65438f61e155f255677fb4ccafc734a68e3", "text": "syndrome coronavirus as a vaccine \ncandidate. mBio  4, e00650\u2013e13 (2013). doi:10.1128/mBio.00650 -13 Medline  \n61. C. B. Jabara, C. D. Jones, J. Roach, J. A. Anderson, R. Swanstrom, Accurate \nsampling and deep sequencing of the HIV- 1 protease gene using a Pri mer ID. Proc. \nNatl. Acad. Sci. U.S.A.  108 , 20166 \u201320171 (2011). doi:10.1073/pnas.1110064108  \nMedline  \n62. M. Fukushi, T. Ito, T. Oka, T. Kitazawa, T. Miyoshi -Akiyama, T. Kirikae, M. \nYamashita, K. Kudo, Serial histopathological examination of the lungs of mice infected with influenza A virus PR8 strain. PLOS ONE  \n6, e21207 (2011). \ndoi:10.1371/journal.pone.0021207  Medline  \n63. G. Matute -Bello, G. Downey, B. B. Moore, S. D. Groshong, M. A. Matthay, A. S.  at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 9121, "end_char_idx": 9934, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4c94fac8-c7ab-434b-b526-cd9752eee1cb": {"__data__": {"id_": "4c94fac8-c7ab-434b-b526-cd9752eee1cb", "embedding": null, "metadata": {"page_label": "13", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "42343088-7b3d-49e5-b163-cf8e7c21fa09", "node_type": null, "metadata": {"page_label": "13", "file_name": "5_COVID_Medicine.pdf"}, "hash": "63bebfe1ec8bf9544f206f58a3d0d79f63478cdc427a3d5b3c2dd098422d83d1"}, "3": {"node_id": "701448be-994d-42dc-8342-f5f29cdaf514", "node_type": null, "metadata": {"page_label": "13", "file_name": "5_COVID_Medicine.pdf"}, "hash": "0f1cad02807414b7b8d015a3d2650f0a37caff75a2ee7168510deae51a6275a2"}}, "hash": "a00929468d23c568a43b64bcca4ced86c79619d6f3b5b9169f0d588fcf23ea34", "text": "First release: 6 April 2020   stm.sciencemag.org   ( Page numbers not final at time of first  release ) 13 \n Slutsky, W. M. Kuebler; Acute Lung Injury in Animals Study Group, An official \nAmerican Thoracic Society workshop report: Features and measurements of experimental acute lung injury in animals. Am. J. Respir. Cell Mol. Biol.  \n44, 725 \u2013\n738 (2011). doi:10.1165/rcmb.2009 -0210ST  Medline  \n64. M. E. Schm idt, C. J. Knudson, S. M. Hartwig, L. L. Pewe, D. K. Meyerholz, R. A. \nLanglois, J. T. Harty, S. M. Varga, Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection. PLOS Pathog.  \n14, e1006810 (2018). doi:10.1371/journal.ppat.1006810  Medline  \n65. H. Ashkenazy, S. Abadi, E. Martz, O. Chay, I. M ayrose, T. Pupko, N. Ben -Tal, \nConSurf 2016: An improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Res.  \n44 (W1), W344 \u2013W350 \n(2016). doi:10.1093/nar/gkw408  Medline  \n \nAcknowledgments:  Funding:  We would like to acknowledge the following funding \nsources, Antiviral Drug Disco very and Development Center (5U19AI109680 and \n(1U19AI142759) awarded to M.D. and R.S.B, a partnership grant from the National Institutes of Allergy and Infectious Disease (NIAID, 5R01AI132178) awarded to T.P.S. and R.S.B. and an NIAID R01 grant (AI108197) awarded to M.D. and R.S.B.. NIAID contract, HHSN272201500008C, was awarded to G.P. and The Emory institute for Drug Development and a subcontract from this was awarded to R.S.B. and M.R.D. M.L.A. was funded through training grants F31AI133952 and T32AI1125 41. The Marsico lung Institute Tissue Procurement and Cell Culture \nCore is supported by NIH grant DK065988 and Cystic Fibrosis Foundation grant BOUCHE15RO. \nAuthor contributions:  A.C.S., T.P.S, A.J.P. and M.L.A. designed in \nvitro efficacy studies. A.C.S., A .J.B., T.P.S., R.L.G. A.J.P., L.J.S., and M.L.A. \nexecuted and/or analyzed in vitro efficacy studies. X.L., T.M.H. and A.S.G. designed, optimized and/or executed the SARS -CoV- 2 qRT -PCR studies. J.H., \nA.T. and N.J.T. providing the clinical isolate of SARS -CoV- 2. T.P.S., A.A.K., \nM.G.N., G.P. and R.S.B. designed in vivo efficacy studies. T.P.S., A.C.S., S.Z., C.S.H, and R.S. designed, executed and/or analyzed the Primer ID NGS data. K.H.D 3\nrd performed structural modeling and phylogenetics and sequence \nalignments. M.L.A., A.J.P., J.D.C. and M.R.D. designed, performed and/or executed the construction of RDV resistant MHV and performed cross -\nresistance studies. T.P.S., A.S. and S.R.L. executed and analyzed in", "start_char_idx": 0, "end_char_idx": 2588, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "701448be-994d-42dc-8342-f5f29cdaf514": {"__data__": {"id_": "701448be-994d-42dc-8342-f5f29cdaf514", "embedding": null, "metadata": {"page_label": "13", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "42343088-7b3d-49e5-b163-cf8e7c21fa09", "node_type": null, "metadata": {"page_label": "13", "file_name": "5_COVID_Medicine.pdf"}, "hash": "63bebfe1ec8bf9544f206f58a3d0d79f63478cdc427a3d5b3c2dd098422d83d1"}, "2": {"node_id": "4c94fac8-c7ab-434b-b526-cd9752eee1cb", "node_type": null, "metadata": {"page_label": "13", "file_name": "5_COVID_Medicine.pdf"}, "hash": "a00929468d23c568a43b64bcca4ced86c79619d6f3b5b9169f0d588fcf23ea34"}}, "hash": "0f1cad02807414b7b8d015a3d2650f0a37caff75a2ee7168510deae51a6275a2", "text": "A.S. and S.R.L. executed and analyzed in vivo efficacy studies. A.S. and S.R.L. performed whole body plethysmography for in vivo studies. S.A.M. assessed all lung pathology. G.R.B., and M.S., were responsible for synthesis, and scale -up of small molecules. T.P.S., A.C.S., S.Z., S.R.L, A.S., \nK.H.D. 3\nrd, M.L.A., A.J.P., J.D.C, G.R.B., A.A.K., G.P., R.S ., M.R.D., and R.S.B., \nwrote the manuscript. Disclaimers:  The findings and conclusions in this report \nare those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Names of specific ven dors, \nmanufacturers, or products are included for public health and informational purposes; inclusion does not imply endorsement of the vendors, manufacturers, or products by the Centers for Disease Control and Prevention or the US Department of Health and  Human Services. \nCompeting financial interests:  UNC \nis pursuing IP protection for Primer ID and R.S. has received nominal royalties. G.R.R, M.G.N., and G.R.P hold patents 62096915, 62201140, 2015066144, 62306163, 2017021759, 16083177, 62595907, 62626998, 62760434, 2018064503, 62971559, and 62988133, \u201cN4 -Hydroxycytidine and Derivatives \nand Anti- Viral Uses Related Thereto,\u201d relating to this work. This study could \naffect their personal financial status. \nData and Materials Availability:  All data \nassociated with this study are present in the paper or Supplementary Materials. Sequence data are deposited to NCBI SRA as PRJNA613261 and PRJNA613454. This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit \nhttp://creativecommons.org/licenses/by/4.0/ . This \nlicen se does not apply to figures/photos/artwork or other content included in \nthe article that is credited to a third party; obtain authorization from the rights holder before using such material.  \n Submitted 5 March 2020  \nAccepted 2 April 2020  \nPublished First Re lease 6 April 2020  \n10.1126/scitranslmed .abb5883    at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 2548, "end_char_idx": 4801, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b1c8e77a-c3b5-4c48-a94e-f8eff1982f51": {"__data__": {"id_": "b1c8e77a-c3b5-4c48-a94e-f8eff1982f51", "embedding": null, "metadata": {"page_label": "14", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "632b7795-822b-41ac-936e-93ae876a7cf1", "node_type": null, "metadata": {"page_label": "14", "file_name": "5_COVID_Medicine.pdf"}, "hash": "bd95fea0deaf5e119945eb1c37dcceb4501c06453f41185ef38e3a79c4fca4c7"}}, "hash": "b0afb04a16689efbac9f5ab8fe9fe802a76ef3f87ea71f93a474743de14914e4", "text": "First release: 6 April 2020   stm.sciencemag.org   ( Page numbers not final at time of first  release ) 14 \n  \n \n \n \n  \n  \nFig. 1. NHC potently inhibits MERS -CoV and newly emerging SARS -CoV -2 replication. (A)  Percent \ninhibition of MERS -CoV replication and NHC cytotoxicity in Calu- 3 cells. Calu -3 cells were infected in \ntriplicate with MERS -CoV nanoluciferase (nLUC) at a multiplicity of infection (MOI) of 0.08 in the \npresence of a range of drug for 48 hours, after which replication was measured through quantitation \nof MERS -CoV\u2013 expressed nLUC. Cytotoxicity was measured in similarly treated but uninfected \ncultures via Cell -Titer -Glo assay. Data are combined from 3 independent experiments. (B) NHC \nantiviral activity and cytotoxicity in Vero E6 cells infected with SARS -CoV- 2. Vero E6 cells were \ninfected in duplicate  with SARS-CoV- 2 clinical isolate 2019 -nCoV/USA -WA1/2020 virus at an MOI \nof 0.05 in the presence of a range of drug for 48 hours, after which replication was measured through quantitation of cell viability by Cell -Titer -Glo assay. Cytotoxicity was measured  as in \nA. Data are \ncombined from 2 independent experiments. ( C) SARS-CoV- 2 titer reduction (left) and percent \ninhibition (right) in Calu- 3 cells. Cells were infected with at an MOI of 0.1 for 30 min, washed and \nexposed to a dose response of NHC in triplicate per condition. 72 hours post infection, virus production was  measured by plaque assay. \n(D) SARS-CoV- 2 genomic RNA reduction (left) and \npercent inhibition (right) in Calu -3 cells. Viral RNA was isolated from clarified supernatants from the \nstudy in panel C. Genome copy numbers were quantitated by qRT- PCR with primer /probes targeting \nthe N gene. For A-D, the symbol is at the mean and the error bars represent the standard deviation.  \n  at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 0, "end_char_idx": 1902, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "bbb23c7e-2d78-4169-959e-7265c16ef7cb": {"__data__": {"id_": "bbb23c7e-2d78-4169-959e-7265c16ef7cb", "embedding": null, "metadata": {"page_label": "15", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "16f8ca8f-fd14-40b1-a292-9fcd5c355da5", "node_type": null, "metadata": {"page_label": "15", "file_name": "5_COVID_Medicine.pdf"}, "hash": "9b035a6019fd3f8a7fba138b17f134205261bbe7107605bf987c75fc11784084"}}, "hash": "c232e7bb81be5e0a0ae7c6a9ba684bdb52847733bb53db52731d112e2aad2a08", "text": "First release: 6 April 2020   stm.sciencemag.org   ( Page numbers not final at time of first  release ) 15 \n  \n  \nFig. 2. NHC is highly active against SARS -CoV -2, MERS -CoV, and SARS -CoV in primary human \nairway epithelial cell cultures. (A)  HAE were infected at an MOI of 0.5 with clinical isolate SARS -CoV-\n2 for 2 hours in the presence of NHC in duplicate after which virus was removed and cultures were \nwashed in incubated in NHC for 48 hours when apical washes were collected for virus titration by plaque assay. The line is at the mean. Each symbol represents the titer from a single well. \n(B) HAE cells \nwere infected with MERS -CoV red fluorescent protein (RFP) at an MOI of 0.5 in triplicate and treated \nsimilarly to A. qRT- PCR for ME RS-CoV ORF1 and ORFN mRNA. Total RNA was isolated from cultures \nin C for qRT -PCR analysis. Representative data from three separate experiments with three different \ncell donors are displayed. PFU, plaque -forming units. (C) Studies performed as in A but with SARS-\nCoV green fluorescent protein (GFP). Representative data from two separate experiments with two different cell donors are displayed. Each symbol represents the data from one HAE culture, the line is at the mean and the error bars represent the standard deviation.  \n  at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 0, "end_char_idx": 1371, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "aafb88d5-8fee-4551-a5ee-eb0a1f946965": {"__data__": {"id_": "aafb88d5-8fee-4551-a5ee-eb0a1f946965", "embedding": null, "metadata": {"page_label": "16", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e2941bf5-0505-4abb-a1ba-4a5eb057ea6f", "node_type": null, "metadata": {"page_label": "16", "file_name": "5_COVID_Medicine.pdf"}, "hash": "2111e9fca042ed7c3a3ed54d14248cb90262aea464084827b17083df0c4797d2"}}, "hash": "09e5ea32d72ef7b714b278d11c1c01b4f95d931677362cc1b254f4682579341a", "text": "First release: 6 April 2020   stm.sciencemag.org   ( Page numbers not final at time of first  release ) 16 \n  \n \n \n \nFig. 3. Remdesivir (RDV) resistance mutations in the highly conserved RNA -dependent RNA polymerase \nincrease susceptibility to NHC. (A)  Neighbor -joining trees created with representatives from all four CoV \ngenogroups showing the genetic similarity of CoV nsp12 (RdRp) and CoV spike glycoprotein, which mediates \nhost tropism and entry into cells. Text color of the virus strain label corresponds to virus host species on the left. The heatmap adjacent to each neighbor -joining tree depicts percent amino acid identity (% A.A. similarity) \nagainst mouse hepatitis virus (MHV), SARS -CoV, or MERS -CoV. \n(B) The variation encompassed in panel A was \nmodel ed onto the RdRp structure of the SARS -CoV RdRp. (C) Amino acid sequence of CoV in panel A at known \nresistance alleles to antiviral drug RDV. (D) Virus titer reduction assay in DBT cells across a range of NHC with \nrecombinant MHV bearing resistance mutations to RDV. Data shown are combined from three independent experiments performed with biological duplicates or triplicates per condition. Asterisks indicate statistically significant differences by Mann- Whitney test as indicated on the graph.  at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 0, "end_char_idx": 1362, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9829d300-e571-4447-bd65-9f0e4f0d8495": {"__data__": {"id_": "9829d300-e571-4447-bd65-9f0e4f0d8495", "embedding": null, "metadata": {"page_label": "17", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "840d3bf8-8a0e-4576-aead-dafa00fbe7a2", "node_type": null, "metadata": {"page_label": "17", "file_name": "5_COVID_Medicine.pdf"}, "hash": "07ca570b4eb04ca73fe11ed6e20324d373e49f12bb4a5593a94733255e627009"}}, "hash": "33edb855ff1c64ad18f1371fb7a4c1e73146e7e66442a6ff14af1e1532511f33", "text": "First release: 6 April 2020   stm.sciencemag.org   ( Page numbers not final at time of first  release ) 17 \n  \n \n \n   \n  \nFig. 4. NHC is effective against multiple genetically distinct Bat -CoV.  Top: Antiviral efficacy of NHC \nin HAE cells against SARS -like (HKU3, SHC014, group 2b) and MERS -like (HKU5, group 2c) bat -CoV. \nHAE cells were infected at an MOI of 0.5 in the presence of NHC in duplicate. After 48 hours, virus \nproduced was titrated via plaque assay. Each data point represents the titer per culture. Bottom: qRT-PCR for CoV ORF1 and ORFN mRNA in total RNA from cultures in the top panel. Mock, mock -treated. \nRepresentative data from two separate experiments with two different cell donors are displayed.  \n  at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 0, "end_char_idx": 812, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ec6d8172-61a3-4422-8309-bcfc182f4640": {"__data__": {"id_": "ec6d8172-61a3-4422-8309-bcfc182f4640", "embedding": null, "metadata": {"page_label": "18", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c11986ca-e7a9-473c-bdb5-39b5ea6357d1", "node_type": null, "metadata": {"page_label": "18", "file_name": "5_COVID_Medicine.pdf"}, "hash": "21de230aa64f8662b13af020e9872c4797aa49421b816b380d902540b18d46ae"}}, "hash": "f1e784848623b32b626253b78c3330dcf4ea161a9521fe61f9a2eacd0a725a72", "text": "First release: 6 April 2020   stm.sciencemag.org   ( Page numbers not final at time of first  release ) 18 \n  \n \n \nFig. 5. NHC antiviral activity is associated with increased viral mutation rates . (A) HAE cultures were infected \nwith MERS -CoV red fluorescent protein (RFP) at an MOI of 0.5 in duplicate in the presence of vehicle, RDV, or \nNHC for 48 hours, after which apical washes were collected for virus titration. Data are combined from two \nindependent studies. The boxes encompass the 25th to 75th percentile, the line is at the median, while the whiskers represent the range. \n(B) Schematic of Primer ID deep sequencing for single RNA genomes of MERS -\nCoV. (C) The total error rate for MERS -CoV RNA isolated from cultures in panel A as determined by Primer ID. \nError rate values are # mutations per 10,000 bases. Asterisks indicate significant differences as compared to untreated group by two -way ANOVA with a Dunnett\u2019s multiple comparison test. \n(D) Description of potential \nNHC mutational spectra on both positive and negative sense viral RNA. (E) Nucleotide transitions in cDNA \nderived from MERS -CoV genomic RNA .  at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 0, "end_char_idx": 1220, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "97d74e34-4890-4ab4-9e79-d84a3e759c4f": {"__data__": {"id_": "97d74e34-4890-4ab4-9e79-d84a3e759c4f", "embedding": null, "metadata": {"page_label": "19", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "465f8c44-113e-4abd-92ff-0edf5721d2f2", "node_type": null, "metadata": {"page_label": "19", "file_name": "5_COVID_Medicine.pdf"}, "hash": "0dcec63122176bd3fe94c2b607cb1411128a3d5720745c4908419cc27a2878f3"}}, "hash": "9714f530db702a08fc1172625474bfdeae917e829c10ff02729ae98527ab9580", "text": "First release: 6 April 2020   stm.sciencemag.org   ( Page numbers not final at time of first  release ) 19 \n  \n \n \n \n  \n \n    \n  \nFig. 6. Prophylactic and therapeutic EIDD -2801 reduces SARS -CoV replication and pathogenesis . \nEquivalent numbers of 25 -29 week old male and female C57BL/6 mice were administered vehicle (10% PEG, \n2.5% Cremophor RH40 in water) or NHC prodrug EIDD -2801 beginning at - 2 hours, +12, +24 or +48 hours \npost infection and every 12 hours thereafter by oral gavage (n = 10/group). Mi ce were intranasally infected \nwith 1E+04 PFU mouse- adapted SARS -CoV MA15 strain. (A) Percent starting weight. Asterisks indicate \ndifferences from vehicle treated by two -way ANOVA with Tukey\u2019s multiple comparison test. ( B) Lung \nhemorrhage in mice from panel  A scored on a scale of 0 -4 where 0 is a normal pink healthy lung and 4 is a \ndiffusely discolored dark red lung. (C) Virus lung titer in mice from panel A as determined by plaque assay. \nAsterisks in both panel B and C indicate differences from vehicle by o ne-way ANOVA with a Dunnett\u2019s \nmultiple comparison test. ( D) Pulmonary function by whole body plethysmography was performed daily on \nfive animals per group. Asterisks indicate differences from vehicle by two -way ANOVA with a Dunnett\u2019s \nmultiple comparison te st. (E) The histological features of acute lung injury (ALI) were blindly scored using \nthe American Thoracic Society Lung Injury Scoring system and a Diffuse Alveolar Damage Scoring System. \nThree randomly chosen high power (60X) fields of diseased lung were assessed per mouse. The numbers of mice scored per group: Vehicle N = 7, - 2 hours N = 9, +12 hours N = 9, +24 hours N = 10, +48 hours N = 9. \nAsterisks indicate statistical significance compared to vehicle by Kruskal -Wallis with a Dunn\u2019s multiple \ncomparis on test. For all panels, the boxes encompass the 25th to 75th percentile, the line is at the median, \nwhile the whiskers represent the range. *, - 2 hours and +12 hours compared to vehicle; **, +24 hours \ncompared to vehicle; ***, +48 hours compared to vehicl e. \n  at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 0, "end_char_idx": 2168, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "892ecbdc-d1fe-45c0-88a2-379273c21e52": {"__data__": {"id_": "892ecbdc-d1fe-45c0-88a2-379273c21e52", "embedding": null, "metadata": {"page_label": "20", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a9ab4941-7cb5-41e2-9ba0-bce4729b3024", "node_type": null, "metadata": {"page_label": "20", "file_name": "5_COVID_Medicine.pdf"}, "hash": "5ba5741542145907342c4c393c4552ef23b0940e4e68a41933dd483f907133e5"}}, "hash": "f771016a04d7af8b070b935e59c2e8b761c388baed43ec21de8593f1e0a31c74", "text": "First release: 6 April 2020   stm.sciencemag.org   ( Page numbers not final at time of first  release ) 20 \n  \n \n \nFig. 7. Prophylactic and therapeutic EIDD -2801 reduces MERS -CoV replication and pathogenesis coincident \nwith increased viral mutation rates . Equivalent numbers of 10 -14 week old male and female C57BL/6 hDPP4 mice \nwere administered vehicle (10% PEG, 2.5% Cremophor RH40 in water) or NHC prodrug EIDD -2801 beginning at - 2 \nhours, +12, +24 or +48 hours post infection and every 12 hours thereafter by oral gavage (n = 10/group). Mice were \nintranasally infected with 5E+04 PFU mo use- adapted MERS -CoV M35C4 strain. ( A) Percent starting weight. \nAsterisks indicate differences between - 2 hours and +12 hours group from vehicle by two -way ANOVA with Tukey\u2019s \nmultiple comparison test. ( B) Lung hemorrhage in mice from panel A scored on a sc ale of 0 -4 where 0 is a normal \npink healthy lung and 4 is a diffusely discolored dark red lung. (C) Virus lung titer in mice from panel A as determined \nby plaque assay. Asterisks in both panel B and C indicate differences from vehicle by Kruskal -Wallis wit h Dunn\u2019s \nmultiple comparison test. (D) MERS -CoV genomic RNA in lung tissue by qRT- PCR. Asterisks indicate differences by \none- way ANOVA with a Dunnett\u2019s multiple comparison test. (E) Pulmonary function by whole body plethysmography \nwas performed daily on fo ur animals per group. Asterisks indicate differences from vehicle by two -way ANOVA with \nTukey\u2019s multiple comparison test. (F) Workflow to measure mutation rate in MERS -CoV RNA and host transcript \nISG15 by Primer ID in mouse lung tissue. (G) Number of templ ate consensus sequences (TCS) for MERS -CoV nsp10 \nand ISG15. (H) Total error rate in MERS -CoV nsp10 and ISG15. (I) The cytosine to uridine transition rate in MERS -\nCoV nsp10 and ISG15. In panels G-I, asterisks indicate differences from vehicle by two -way ANO VA with Tukey\u2019s \nmultiple comparison test. (J) Codon change frequency in MERS -CoV nsp10. Asterisks indicate differences from \nvehicle by Kruskal -Wallis with Dunn\u2019s multiple comparison test. For all panels, the boxes encompass the 25th to 75th \npercentile, the line is at the median, while the whiskers represent the range.  \n  at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 0, "end_char_idx": 2325, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "56c54bf5-7980-4e4d-9f68-e52914443dd9": {"__data__": {"id_": "56c54bf5-7980-4e4d-9f68-e52914443dd9", "embedding": null, "metadata": {"page_label": "21", "file_name": "5_COVID_Medicine.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "86c8d4eb-296b-4eb0-8807-cc4440408207", "node_type": null, "metadata": {"page_label": "21", "file_name": "5_COVID_Medicine.pdf"}, "hash": "73057260163c27d5ac80bbfab5fb32b98c24e6125058cf7fda7126280c9eb7f7"}}, "hash": "2097599a0922f6dc92cfc34aa2264c72f9a11cc9c92becd6ffbd30dbc6a75f96", "text": "epithelial cell cultures and multiple coronaviruses in miceAn orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway\nSwanstrom, Mark R. Denison and Ralph S. BaricSaindane, Alexander A. Kolykhalov, George Painter, Jennifer Harcourt, Azaibi Tamin, Natalie J. Thornburg, Ronald George, Collin S. Hill, Stephanie A. Montgomery, Ariane J. Brown, Gregory R. Bluemling, Michael G. Natchus, ManoharAlexandra Sch\u00e4fer, Kenneth H. Dinnon III, Laura J. Stevens, James D. Chappell, Xiaotao Lu, Tia M. Hughes, Amelia S. Timothy P. Sheahan, Amy C. Sims, Shuntai Zhou, Rachel L. Graham, Andrea J. Pruijssers, Maria L. Agostini, Sarah R. Leist,\npublished online 6 April 2020 Sci Transl Med \nARTICLE TOOLS http://stm.sciencemag.org/content/early/2020/04/03/scitranslmed.abb5883\nMATERIALSSUPPLEMENTARY http://stm.sciencemag.org/content/suppl/2020/04/03/scitranslmed.abb5883.DC1\nREFERENCES\nhttp://stm.sciencemag.org/content/early/2020/04/03/scitranslmed.abb5883#BIBLThis article cites 61 articles, 19 of which you can access for free\nPERMISSIONS http://www.sciencemag.org/help/reprints-and-permissions\nTerms of Service Use of this article is subject to the \ntrademark of AAAS. is a registered Science Translational Medicine Science, 1200 New York Avenue NW, Washington, DC 20005. The title (ISSN 1946-6242) is published by the American Association for the Advancement of Science Translational Medicine \nCopyright \u00a9 2020, American Association for the Advancement of Science at Stanford University on April 10, 2020 http://stm.sciencemag.org/ Downloaded from", "start_char_idx": 0, "end_char_idx": 1562, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "53402e72-f71a-4ced-9c46-ff64d523dedb": {"__data__": {"id_": "53402e72-f71a-4ced-9c46-ff64d523dedb", "embedding": null, "metadata": {"page_label": "3698", "file_name": "6_Bacterial_Lithography.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c96ff112-0157-46d1-afc7-062945cee5e8", "node_type": null, "metadata": {"page_label": "3698", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "cc931afa9a633c48bfcc79735d200d3721abe2c8104e00ec513c2c84358505d5"}, "3": {"node_id": "9c0b2ebb-12fd-4c04-b898-8c3289a526df", "node_type": null, "metadata": {"page_label": "3698", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "68b72b2959ab5e3b8bb6f20dec14f07e616e2e4abc491fef6f84c575c689886a"}}, "hash": "42346ff40cd39afbf86df3f6a117e76d30143202cbe8e2d267de8206335c2c65", "text": "Bio\ufb01lm Lithography enables high-resolution cell\npatterning via optogenetic adhesin expression\nXiaofan Jinaand Ingmar H. Riedel-Krusea,1\naDepartment of Bioengineering, Stanford University, Stanford, CA 94305\nEdited by Scott J. Hultgren, Washington University School of Medicine, St. Louis, MO, and approved February 23, 2018 (received for review November\n28, 2017)\nBacterial bio\ufb01lms represent a promising opportunity for engi-\nneering of microbial communities. However, our ability to con-\ntrol spatial structure in bio\ufb01lms remains limited. Here we engi-\nneer Escherichia coli with a light-activated transcriptional pro-\nmoter (pDawn) to optically regulate expression of an adhesin\ngene (Ag43). When illuminated with patterned blue light, long-\nterm viable bio\ufb01lms with spatial resolution down to 25 \u00b5m\ncan be formed on a variety of substrates and inside enclosed\nculture chambers without the need for surface pretreatment.\nA biophysical model suggests that the patterning mechanism\ninvolves stimulation of transiently surface-adsorbed cells, lend-\ning evidence to a previously proposed role of adhesin expres-\nsion during natural bio\ufb01lm maturation. Overall, this tool\u2014termed\n\u201cBio\ufb01lm Lithography\u201d\u2014has distinct advantages over existing cell-\ndepositing/patterning methods and provides the ability to grow\nstructured bio\ufb01lms, with applications toward an improved under-\nstanding of natural bio\ufb01lm communities, as well as the engineer-\ning of living biomaterials and bottom\u2013up approaches to microbial\nconsortia design.\nbio\ufb01lm|optogenetics|bacterial patterning |lithography|pDawn-Ag43\nBio\ufb01lms are surface-attached communities of microbes and\nrepresent the predominant mode of life for bacteria on earth\n(1). While well known for their role in biofouling and infections\n(2, 3), bio\ufb01lms can also be harnessed as biotechnological tools,\nsuch as those used in wastewater treatment (4). Recent research\nhas highlighted their potential as living biomaterials in appli-\ncations including the prevention of biofouling (5), nanoparticle\ntemplating, protein immobilization, and bioelectricity (6, 7), as\nwell as a promising platform upon which to engineer synthetic\nmicrobial communities (8, 9).\nA key feature of natural bio\ufb01lms is distinct spatial pattern-\ning coupled to ecological relationships within the microbial com-\nmunity, such as metabolic division of labor between colocalized\nstrains (10). In some cases, this type of structure allows simulta-\nneous biochemical reactions to occur that would be incompatible\nwithin single cells (11). Clearly, the full biotechnological capabil-\nities of engineered bene\ufb01cial bio\ufb01lms cannot be realized without\nreliable tools to control bio\ufb01lm structure.\nSuch patterning tools should ideally be able to structure sta-\nble/viable bio\ufb01lms with high spatial resolution, in a variety of\nenvironments without necessarily requiring substrate pretreat-\nment or directly exposed surfaces. Many techniques exist to\npattern cells to surfaces, including (but not limited to) inkjet\nprinting (12, 13), microcontact printing (14, 15), polydimethyl-\nsiloxane (PDMS) stenciling (16), patterned substrate modi\ufb01ca-\ntion (17\u201319), micro\ufb02uidics (20), photoactivated antibiotic (21),\nlight-switchable adhesion proteins (22), and optogenetic cyclic-di-\nGMP regulation (23, 24). Optogenetic approaches have also been\nused to control gene expression on preexisting bacterial", "start_char_idx": 0, "end_char_idx": 3379, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9c0b2ebb-12fd-4c04-b898-8c3289a526df": {"__data__": {"id_": "9c0b2ebb-12fd-4c04-b898-8c3289a526df", "embedding": null, "metadata": {"page_label": "3698", "file_name": "6_Bacterial_Lithography.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c96ff112-0157-46d1-afc7-062945cee5e8", "node_type": null, "metadata": {"page_label": "3698", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "cc931afa9a633c48bfcc79735d200d3721abe2c8104e00ec513c2c84358505d5"}, "2": {"node_id": "53402e72-f71a-4ced-9c46-ff64d523dedb", "node_type": null, "metadata": {"page_label": "3698", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "42346ff40cd39afbf86df3f6a117e76d30143202cbe8e2d267de8206335c2c65"}, "3": {"node_id": "a56aaed1-27a8-4bbc-9762-e108a04fa6f2", "node_type": null, "metadata": {"page_label": "3698", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "8a98030fe1b1dd93fd9e66bb8fe204b8ccb5b159816aa5568367653964e459c9"}}, "hash": "68b72b2959ab5e3b8bb6f20dec14f07e616e2e4abc491fef6f84c575c689886a", "text": "approaches have also been\nused to control gene expression on preexisting bacterial lawns\n(25). However, to our knowledge, no existing method comprehen-\nsively ful\ufb01lls the listed requirements for bio\ufb01lm patterning.\nHere we present a technique termed \u201cBio\ufb01lm Lithography\u201d\nto structure bacterial bio\ufb01lms by projecting optical patterns that\ninduce a planktonic-to-bio\ufb01lm phenotypic switch in engineeredbacteria. Our method rests on two key elements: (i) Light-\nregulated transcriptional elements have been developed for bac-\nteria, such as pDawn, which uses a light\u2013oxygen\u2013voltage domain\nto regulate gene expression according to blue light illumination\n(26). (ii) The switch from planktonic to bio\ufb01lm phenotype in\nbacteria can be controlled by the expression of membrane pro-\nteins that promote cell-substrate attachment, such as antigen 43\n(Ag43), a homodimerizing autotransporter adhesin that has been\ndemonstrated to induce both bio\ufb01lm formation as well as cell\u2013\ncell adhesion (27, 28). Here we bring Ag43 under the control of\npDawn, allowing us to pattern bio\ufb01lms with light.\nResults\npDawn-Ag43 Expression Drives Light-Regulated Bio\ufb01lm Formation in\nE. coli .We postulated that E. coli cells expressing Ag43 from the\nblue light-responsive promoter pDawn should transition from\na planktonic to bio\ufb01lm phenotype when illuminated by blue\nlight. To test our hypothesis, we designed a construct (termed\npDawn-Ag43) where a ribosomal binding site and the Ag43\ncoding sequence have been inserted downstream of the pDawn\ntranscriptional control element (Fig. 1A). We then transformed\npDawn-Ag43 into the MG1655 strain of E. coli, a weak native\nbio\ufb01lm former (29) that is known to form bio\ufb01lm with Ag43 over-\nexpression (28).\nWe seeded cultures of MG1655/pDawn-Ag43 inside a polysty-\nrene well plate with M63 growth media and used a portable LED\nSigni\ufb01cance\nBacteria live in surface-attached communities known as\nbio\ufb01lms, where spatial structure is tightly linked to com-\nmunity function. We have developed a genetically encoded\nbio\ufb01lm patterning tool (\u201cBio\ufb01lm Lithography\u201d) by engineering\nbacteria such that the expression of membrane adhesion pro-\nteins responsible for surface attachment is optically regulated.\nAccordingly, these bacteria only form bio\ufb01lm on illuminated\nsurface regions. With this tool, we are able to use blue light\nto pattern Escherichia coli bio\ufb01lms with 25 \u00b5m spatial res-\nolution. We present an accompanying biophysical model to\nunderstand the mechanism behind light-regulated bio\ufb01lm\nformation and to provide insight on related natural bio\ufb01lm\nprocesses. Overall, this bio\ufb01lm patterning tool can be applied\nto study natural microbial communities as well as to engineer\nliving biomaterials.\nAuthor contributions: X.J. and I.H.R.-K. designed research; X.J. performed research; X.J.\nand I.H.R.-K. analyzed data; and X.J. and I.H.R.-K. wrote the paper.\nThe authors declare no con\ufb02ict of interest.\nThis article is a PNAS Direct Submission.\nThis open access article is distributed under Creative Commons Attribution-\nNonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).\nData deposition: The sequences reported in this paper have been deposited in Addgene\n[ID codes 107741", "start_char_idx": 3308, "end_char_idx": 6490, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a56aaed1-27a8-4bbc-9762-e108a04fa6f2": {"__data__": {"id_": "a56aaed1-27a8-4bbc-9762-e108a04fa6f2", "embedding": null, "metadata": {"page_label": "3698", "file_name": "6_Bacterial_Lithography.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c96ff112-0157-46d1-afc7-062945cee5e8", "node_type": null, "metadata": {"page_label": "3698", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "cc931afa9a633c48bfcc79735d200d3721abe2c8104e00ec513c2c84358505d5"}, "2": {"node_id": "9c0b2ebb-12fd-4c04-b898-8c3289a526df", "node_type": null, "metadata": {"page_label": "3698", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "68b72b2959ab5e3b8bb6f20dec14f07e616e2e4abc491fef6f84c575c689886a"}}, "hash": "8a98030fe1b1dd93fd9e66bb8fe204b8ccb5b159816aa5568367653964e459c9", "text": "reported in this paper have been deposited in Addgene\n[ID codes 107741 (pBAD-Ag43), 107742 (pDawn-Ag43), and 107743 (pDawn-sfGFP)].\n1To whom correspondence should be addressed. Email: ingmar@stanford.edu.\nThis article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.\n1073/pnas.1720676115/-/DCSupplemental .\nPublished online March 19, 2018.\n3698\u20133703 |PNAS |April 3, 2018 |vol. 115 |no. 14 www.pnas.org/cgi/doi/10.1073/pnas.1720676115Downloaded at STANFORD UNIV MED CENTER on April 10, 2020", "start_char_idx": 6492, "end_char_idx": 7008, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3105db04-163f-4bf0-a988-7f2ca81ca815": {"__data__": {"id_": "3105db04-163f-4bf0-a988-7f2ca81ca815", "embedding": null, "metadata": {"page_label": "3699", "file_name": "6_Bacterial_Lithography.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ce9f5616-877a-44e5-8cb0-b4482925c8c2", "node_type": null, "metadata": {"page_label": "3699", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "b0b7b0e447aa555379799ffc7c419172b183a0e2885a400f6f1f24bc24848f34"}, "3": {"node_id": "7e75b686-87c7-44d5-a3dd-2cbf17eb321f", "node_type": null, "metadata": {"page_label": "3699", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "b830b3016d86af90b97355133cdaa52e177ab3ee4a8c7d3f42c15af5bbcf4672"}}, "hash": "eac2f37ca93ae83a75a97b0ec9f5c22f6fb1440a5887956e420cde495c2862bd", "text": "MICROBIOLOGY\nFig. 1. pDawn control of the adhesin Ag43 enables light-controlled deposition of bio\ufb01lm onto surfaces. (A) Ag43 was inserted downstream of pDawn\ncontrol. Escherichia coli with pDawn-Ag43 can be optically stimulated with a projector to express Ag43 and to form bio\ufb01lm at surfaces. (B) Cells engineered\nwith the pDawn-Ag43 construct form bio\ufb01lm contingent upon illumination (***P <0.001). Wild-type and pDawn controls fail to form signi\ufb01cant bio\ufb01lm,\nand pBAD-Ag43 expression forms bio\ufb01lm regardless of illumination. Representative 96-well crystal violet stains are shown below. (C ) Increasing illumination\nintensity increases bio\ufb01lm formation, saturating past \u223c41\u00b5W/cm2. Dashed curve, \ufb01t with Monod model. (D) Increasing illumination time increases bio\ufb01lm\nformation up to approximately 8 h. Dashed curve, linear \ufb01t. (B\u2013D, error bars represent SD, n= 4 wells.)\nprojector (Ivation Pro4) to provide blue light illumination during\nan overnight growth incubation (Fig. 1A). Using crystal violet\nstaining for quanti\ufb01cation (30), we found that MG1655 trans-\nformed with pDawn-Ag43 formed robust bio\ufb01lm when grown\nunder illumination, compared with weak bio\ufb01lm when grown in\nthe dark (Fig. 1B). We further veri\ufb01ed using qPCR that light\nstimulation of MG1655/pDawn-Ag43 increased Ag43 mRNA\ntranscript levels approximately 15-fold (Ag43 mRNA Transcript\nLevels Measured by qRT-PCR) and that this elevated gene expres-\nsion did not cause a growth rate defect (MG1655+pDawn-Ag43\nGrowth Curves: Dark vs. Illuminated).\nTo verify that the pDawn-regulated Ag43 expression is in\nfact responsible for this light-dependent phenotype, we ran a\nseries of controls: (i) untransformed MG1655; (ii) MG1655\ntransformed with pDawn-sfGFP\u2014a pDawn plasmid express-\ning superfolder green \ufb02uorescent protein (sfGFP) instead of\nAg43; and (iii) MG1655 transformed with pBAD-Ag43\u2014a plas-\nmid expressing Ag43 under the control of the pBAD promoter,\ninduced with 10 mM arabinose (Fig. 1B). As expected, native\nMG1655 and MG1655 transformed with pDawn-sfGFP both\nfailed to form strong bio\ufb01lm regardless of dark or illuminated\ngrowth conditions. This indicates that at the intensity used\n(40\u00b5W/cm2), blue light illumination on its own is unable to\nstimulate bio\ufb01lm growth in MG1655, even with stimulation of\nthe YF1/\ufb01xJ two-component sensor involved in pDawn. We ver-\ni\ufb01ed that pDawn works as expected in MG1655/pDawn-sfGFP\nby con\ufb01rming sfGFP expression (pDawn-sfGFP Control). On\nthe other hand, MG1655 transformed with pBAD-Ag43 induced\nwith arabinose formed bio\ufb01lm regardless of illumination inten-\nsity, indicating that Ag43 expression is suf\ufb01cient to induce bio\ufb01lmformation. We conclude that pDawn-regulated expression of\nAg43 is responsible for the light-dependent bio\ufb01lm phenotype\nin MG1655/pDawn-Ag43.\nBio\ufb01lm Formation Can Be Tuned by Illumination Intensity and Time.\nWe characterized the in\ufb02uence of illumination intensity and time\non the extent of", "start_char_idx": 0, "end_char_idx": 2928, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7e75b686-87c7-44d5-a3dd-2cbf17eb321f": {"__data__": {"id_": "7e75b686-87c7-44d5-a3dd-2cbf17eb321f", "embedding": null, "metadata": {"page_label": "3699", "file_name": "6_Bacterial_Lithography.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ce9f5616-877a-44e5-8cb0-b4482925c8c2", "node_type": null, "metadata": {"page_label": "3699", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "b0b7b0e447aa555379799ffc7c419172b183a0e2885a400f6f1f24bc24848f34"}, "2": {"node_id": "3105db04-163f-4bf0-a988-7f2ca81ca815", "node_type": null, "metadata": {"page_label": "3699", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "eac2f37ca93ae83a75a97b0ec9f5c22f6fb1440a5887956e420cde495c2862bd"}}, "hash": "b830b3016d86af90b97355133cdaa52e177ab3ee4a8c7d3f42c15af5bbcf4672", "text": "the in\ufb02uence of illumination intensity and time\non the extent of bio\ufb01lm formation. By stimulating cells overnight\nfor 16 h across a range of intensities from 0 to 115 \u00b5W/cm2,\nwe found that bio\ufb01lm formation increases with brighter illu-\nmination in a saturating manner with a characteristic illumina-\ntion intensity constant of 41 \u00b5W/cm2when \ufb01t with the Monod\nequation (Fig. 1C; see \ufb01t/model choice discussion in Fitting\nBio\ufb01lm Formation vs. Illumination Intensity/Time). When illu-\nminating with 40 \u00b5W/cm2, we found a linear increasing rela-\ntionship between bio\ufb01lm formation and illumination time up to\n\u223c8 h, beyond which bio\ufb01lm formation appears to slow down\n(Fig. 1D). For the remainder of this paper, we use standard\nillumination conditions of 40 \u00b5W/cm2for 16 h unless stated\notherwise.\nBio\ufb01lm Can Be Patterned Using Light in Various Environments. Next,\nwe developed a protocol to form and visualize patterned bio\ufb01lms\nbased on pDawn-Ag43. We cotransformed MG1655/pDawn-\nAg43 with a red \ufb02uorescent protein (mRFP) expression plas-\nmid. Applying the same culture conditions as before, we set\nup the projector using Microsoft Powerpoint to illuminate var-\nious patterns (e.g., stripes, polka dots, pictures) on bacterial cul-\ntures in polystyrene wells and subsequently veri\ufb01ed that the pat-\nterns were recapitulated as bacterial bio\ufb01lms using \ufb02uorescence\nmicroscopy (Fig. 2A).\nJin and Riedel-Kruse PNAS |April 3, 2018 |vol. 115 |no. 14 |3699Downloaded at STANFORD UNIV MED CENTER on April 10, 2020", "start_char_idx": 2864, "end_char_idx": 4362, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "35a6b9ca-7179-4509-b09f-d217c75a36c0": {"__data__": {"id_": "35a6b9ca-7179-4509-b09f-d217c75a36c0", "embedding": null, "metadata": {"page_label": "3700", "file_name": "6_Bacterial_Lithography.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7774eaf7-da5c-46eb-b4d8-ce492199a35d", "node_type": null, "metadata": {"page_label": "3700", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "2ccd921ee6708c00133528ffaa928ce6d8d57002d835145ccd482e739de8565c"}, "3": {"node_id": "c012bfef-2960-4cb7-8e34-47995ef8ec49", "node_type": null, "metadata": {"page_label": "3700", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "a4899996403e5be1e349af38a591a7e7c92e3ec7863f9ef6cb1698aec11d1fe4"}}, "hash": "536ea00bc0d9932ff10c78b8b9cc763afced5b9ae1a1af45d187c3f86fc2263e", "text": "Fig. 2. Bio\ufb01lm Lithography enables the structured patterning of viable bio\ufb01lms over multiple days and inside closed-culture chambers. (A) Various illumi-\nnation images (stripes, polka dots, pictures) are recapitulated as bio\ufb01lm patterns; patterns (shown on Left for reference) were illuminated from below using\na projector (Fig. 1A). (B) Patterned bio\ufb01lms remain stable for at least 3 d under ambient conditions in PBS buffer. (C ) In culture media, growth and eventual\ndetachment of viable bio\ufb01lm can be observed over 3 d. Growth regions with increased mRFP signal and instances of bio\ufb01lm detachment are marked by\nwhite rectangles and triangles, respectively. (D) Bio\ufb01lms can be patterned with light inside sealed, transparent culture chambers, without requiring direct\nphysical access to the substrate. Image contrast appears reduced compared with Band Cdue to a secondary bio\ufb01lm image that forms at the PDMS ceiling,\nand planktonic bacteria were harder to wash out from the chamber without perturbing the patterned bio\ufb01lm on the polystyrene.\nWe next investigated the long-term stability of the patterned\nbio\ufb01lms. After overnight incubation, samples were removed\nfrom optical illumination and rinsed with PBS, and subsequent\ndaily imaging demonstrated that the bio\ufb01lm pattern remained\nstable over a period of 3 d in PBS (Fig. 2B). When bio\ufb01lm was\nmaintained in M63 growth medium over the same time span, we\nobserved growth and shedding of viable bio\ufb01lm (Fig. 2 C), anal-\nogous to expansion and dispersal processes in natural bio\ufb01lms\n(29). Using qPCR, we con\ufb01rmed that Ag43 mRNA levels remain\nstable over the course of these long-term experiments (Ag43\nmRNA Transcript Levels Measured by qRT-PCR).\nNext, we tested this tool\u2019s ability to pattern other materials\nbesides polystyrene. Using glass coverslips and PDMS coupons\nplaced into well-plates, we con\ufb01rmed that our engineered cells\nare able to form patterned bio\ufb01lms on both glass and PDMS\n(Patterned Bio\ufb01lm Formation on Other Surfaces). For all tested\nsubstrates, no surface pretreatment or patterning was required.\nFurthermore, we tested whether our method works on sam-\nples inside completely enclosed environments. This is in con-\ntrast to the requirement of direct surface access for other pat-\nterning methods such as inkjet-based printers or microcontact\nprinting (12\u201315). We used molded PDMS cavities (31) bonded\nto polystyrene to create enclosed culture chambers with dimen-\nsions 19 mm \u00d713 mm \u00d71.5 mm (Fig. 2D). Bacteria were cul-\ntured in this chamber using the same illumination conditions as\nbefore. We found that patterned bio\ufb01lms form as expected on\nthe polystyrene substrate, with a faint secondary bio\ufb01lm image\npresent on the PDMS ceiling (Fig. 2D). Hence, our method can\npattern bio\ufb01lm inside enclosed environments.\nBio\ufb01lms Can Be Optically Patterned with 25 \u00b5m Resolution. To more\nquantitatively characterize pDawn-Ag43\u2013mediated bio\ufb01lm pat-\nterning, we collected volumetric bio\ufb01lm data via confocal laser\nscanning microscopy (Fig. 3A) and measured the bio\ufb01lm\u2019s aver-\nage thickness to be 14.4 \u00b5m (Quantifying Bio\ufb01lm Thickness and\nDensity from Confocal Bio\ufb01lm Images). Assuming an average\nE. coli cell volume of 1", "start_char_idx": 0, "end_char_idx": 3184, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c012bfef-2960-4cb7-8e34-47995ef8ec49": {"__data__": {"id_": "c012bfef-2960-4cb7-8e34-47995ef8ec49", "embedding": null, "metadata": {"page_label": "3700", "file_name": "6_Bacterial_Lithography.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7774eaf7-da5c-46eb-b4d8-ce492199a35d", "node_type": null, "metadata": {"page_label": "3700", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "2ccd921ee6708c00133528ffaa928ce6d8d57002d835145ccd482e739de8565c"}, "2": {"node_id": "35a6b9ca-7179-4509-b09f-d217c75a36c0", "node_type": null, "metadata": {"page_label": "3700", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "536ea00bc0d9932ff10c78b8b9cc763afced5b9ae1a1af45d187c3f86fc2263e"}, "3": {"node_id": "debde025-9bd9-4f58-a0c2-8fc4abebdf80", "node_type": null, "metadata": {"page_label": "3700", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "3e70b7149208e56b6f48167f27999657f32eef257480b7f604eea251c71cea52"}}, "hash": "a4899996403e5be1e349af38a591a7e7c92e3ec7863f9ef6cb1698aec11d1fe4", "text": "Bio\ufb01lm Images). Assuming an average\nE. coli cell volume of 1 \u00b5m3(32) and that cells constitute 10%\nof total bio\ufb01lm volume (33), this approximately corresponds to\nan average thickness of seven cells and a surface density of 1.4 \u00d7\n106cells per mm2. From this, we can estimate an average bio\ufb01lm\ndeposition rate on the order of 25 cells per mm2\u00b7s over the\ncourse of a 16 h incubation (Quantifying Bio\ufb01lm Thickness and\nDensity from Confocal Bio\ufb01lm Images).The confocal images also reveal that the bio\ufb01lm surface is not\nsmooth, and we determine a surface roughness coef\ufb01cient (34)\nof\u223c0.33 (Quantifying Bio\ufb01lm Roughness from Confocal Bio\ufb01lm\nImages). This is in general agreement with the value of 0.31 esti-\nmated by assuming bio\ufb01lm deposition to be a purely Poisson\nprocess (Quantifying Bio\ufb01lm Roughness from Confocal Bio\ufb01lm\nImages). Using autocorrelation analysis, we derive an approx-\nimate length scale for the surface roughness on the order of\n5.7\u00b5m (Quantifying Bio\ufb01lm Roughness from Confocal Bio\ufb01lm\nImages). We speculate that clustering on this length scale may\nbe a result of cell division and intercellular Ag43 homodimeriza-\ntion leading to a different effective af\ufb01nity for cell\u2013cell vs. cell\u2013\nsurface binding.\nNext, we determined the spatial resolution (smallest feature\nsize) that could be patterned with this method by measuring\nthe step response of the red \ufb02uorescence signal across a light\u2013\ndark illumination boundary. Using the striped illumination sam-\nple (Fig. 2A, Top), we estimate resolution of \u223c45\u00b5m (Fig. 3B and\nDetermining Width of Transition Region Between Dark and Illu-\nminated Regions). This is on the order of the optical resolution\nlimit of the projector setup, which has a pixel\u2013pixel distance of\n\u223c80\u00b5m; the effect is visible in corresponding periodic structural\nartifacts at this length scale (Fig. 3B, white triangles). To improve\nthis resolution, we applied electrical tape to the bottom of the\nwell plate to act as a \ufb01eld stop and repeated the step-response\nanalysis across the tape boundary. Based on this analysis, we esti-\nmate the spatial resolution to be 25 \u00b5m, measured as the width\nof the transition region across the light\u2013dark boundary (Fig. 3C\nand Determining Width of Transition Region Between Dark and\nIlluminated Regions).\nTo validate this point further, we taped a \ufb01lm photomask\n[originally designed for micro\ufb02uidic circuit fabrication (35)] to\nthe bottom of the culture chamber. This structure was faith-\nfully recapitulated over the area of multiple mm2(Fig. 3 D) with\nfeature sizes at the scale of 25 \u00b5m (Fig. 3E and Pro\ufb01le Plot of\nHigh-Resolution Bio\ufb01lm Patterning ). By comparing the peak RFP\nintensity in this image to basal RFP expression in nonillumi-\nnated regions, we estimate a contrast of 3.3 (Pro\ufb01le Plot of High-\nResolution Bio\ufb01lm Patterning ). We noted that the feature sizes of\nthe \ufb01nal patterned bio\ufb01lm are reduced compared with the under-\nlying photomask\u2014that is, 25 \u00b5m-wide stripes were observed in\nthe bio\ufb01lm corresponding to 75 \u00b5m transparent stripes in the\nphotomask (Images of Photomask). This reduction is roughly\n3700 |www.pnas.org/cgi/doi/10.1073/pnas.1720676115 Jin and Riedel-KruseDownloaded at STANFORD", "start_char_idx": 3134, "end_char_idx": 6308, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "debde025-9bd9-4f58-a0c2-8fc4abebdf80": {"__data__": {"id_": "debde025-9bd9-4f58-a0c2-8fc4abebdf80", "embedding": null, "metadata": {"page_label": "3700", "file_name": "6_Bacterial_Lithography.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7774eaf7-da5c-46eb-b4d8-ce492199a35d", "node_type": null, "metadata": {"page_label": "3700", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "2ccd921ee6708c00133528ffaa928ce6d8d57002d835145ccd482e739de8565c"}, "2": {"node_id": "c012bfef-2960-4cb7-8e34-47995ef8ec49", "node_type": null, "metadata": {"page_label": "3700", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "a4899996403e5be1e349af38a591a7e7c92e3ec7863f9ef6cb1698aec11d1fe4"}}, "hash": "3e70b7149208e56b6f48167f27999657f32eef257480b7f604eea251c71cea52", "text": "Jin and Riedel-KruseDownloaded at STANFORD UNIV MED CENTER on April 10, 2020", "start_char_idx": 6317, "end_char_idx": 6393, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "177c2108-7b45-475c-bc09-a5e9eeef807d": {"__data__": {"id_": "177c2108-7b45-475c-bc09-a5e9eeef807d", "embedding": null, "metadata": {"page_label": "3701", "file_name": "6_Bacterial_Lithography.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f6c30827-2624-471c-9232-2255e5419ef0", "node_type": null, "metadata": {"page_label": "3701", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "2183a4744d00df31976f02a153864cac5e4bdc616c73d15602eee4cc29680234"}, "3": {"node_id": "3c780846-ade5-4f1f-b807-62cb9daa67e8", "node_type": null, "metadata": {"page_label": "3701", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "1d1229350ff0f814d882720e44c10084440035fc26073a33bd07b34b02c3dce3"}}, "hash": "d24424f59cea67cd1636c7f0230f849ce16b7f7e466da9929a56a8ec97a60cf8", "text": "MICROBIOLOGY\nAB\nDE\nFG HCFig. 3. Bio\ufb01lm Lithography enables patterning with a lateral resolution\ndown to 25 \u00b5m, which is explained by transient, light-independent cell\u2013\nsurface attachment followed by light-activated adhesin expression. (A) Con-\nfocal microscopy reveals average bio\ufb01lm thickness of 15 \u00b5m, surface rough-\nness coef\ufb01cient of 0.33, and characteristic roughness length scale of 5.4 \u00b5m.\n(B) Step-response analysis across light\u2013dark boundary with high-resolution\nmicroscopy of striped illumination sample indicates \u223c45\u00b5m spatial reso-\nlution; white triangles point to artifacts due to projector pixels. (C ) Using\nelectrical tape as \ufb01eld stop (as opposed to a projector) enables a spatial res-\nolution of\u223c25\u00b5m. (D) Bio\ufb01lm patterned over large area and at high reso-\nlution are possible with photomask (shown example was originally designed\nfor patterning micro\ufb02uidic channels). (E ) Higher magni\ufb01cation imaging of\nDcon\ufb01rms feature sizes of \u223c25\u00b5m; white triangle points to an example of\na spurious individual cell. (F ) Schematic of Monte-Carlo simulation with cell\nswimming, adsorption/desorption, and light-regulated levels of adhesin A.\nIn model 1, adhesin level is directly proportional to the adsorption rate of\nplanktonic cells, whereas in model 2, adhesin level is inversely proportional\nto the desorption rate of adsorbed cells. ( G) No clear bio\ufb01lm boundary can\nbe observed at the light\u2013dark border in model 1 where optically regulated\nadhesin production increases adsorption rate ka. (H) Clear bio\ufb01lm bound-\nary can be observed in model 2 where optically regulated adhesin produc-\ntion decreases desorption rate kd. (For Gand H, adsorbed cells are labeled\nred, illuminated region is marked in blue, and histogram of cell positions\nplotted below.)\nconsistent with the 25 \u00b5m light\u2013dark transition region measured\nearlier and suggests that the transition region lies on the illumi-\nnated side of the light\u2013dark boundary. We also noted spurious\ncells attached to the surface (Fig. 3E, white triangle), which along\nwith the transition region and surface roughness length scales\nconstitute a spatial resolution limit for Bio\ufb01lm Lithography as\ncurrently implemented.\nBiophysical Modeling of Bio\ufb01lm Formation Explains High Spatial Res-\nolution. Finally, we sought to understand mechanistically how\nMG1655/pDawn-Ag43 bio\ufb01lm patterning can achieve high spa-\ntial resolution across illumination boundaries, given the inherent\nmotility of the MG1655 strain.\nOur initial working hypothesis (model 1, Fig. 3F ) was that\npDawn-Ag43 works by optically regulating Ag43 expression in\nfreely swimming planktonic cells. The expression of surfaceappendages on cell membranes can help overcome cell-substrate\nelectrostatic repulsion (36\u201338), which could lead to increased\nadsorption rate and higher levels of bio\ufb01lm formation in illu-\nminated regions. However, a back-of-the-envelope calculation\nsuggests that this model is inconsistent with the observed\n25\u00b5m spatial resolution. Motile E. coli have an effective diffu-\nsivity due to motility of De\ufb00\u223c200\u00b5m2/s (39), while a very con-\nservative lower bound on pDawn-Ag43 stimulation delay based\nonly on gene expression time can be estimated at Tdelay\u223c100s\n(40\u201342). Bacterial swimming during the time delay between stim-\nulation and attachment would then blur features below a", "start_char_idx": 0, "end_char_idx": 3319, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3c780846-ade5-4f1f-b807-62cb9daa67e8": {"__data__": {"id_": "3c780846-ade5-4f1f-b807-62cb9daa67e8", "embedding": null, "metadata": {"page_label": "3701", "file_name": "6_Bacterial_Lithography.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f6c30827-2624-471c-9232-2255e5419ef0", "node_type": null, "metadata": {"page_label": "3701", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "2183a4744d00df31976f02a153864cac5e4bdc616c73d15602eee4cc29680234"}, "2": {"node_id": "177c2108-7b45-475c-bc09-a5e9eeef807d", "node_type": null, "metadata": {"page_label": "3701", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "d24424f59cea67cd1636c7f0230f849ce16b7f7e466da9929a56a8ec97a60cf8"}, "3": {"node_id": "b86dd750-0abe-461a-abf2-4031b04f2d78", "node_type": null, "metadata": {"page_label": "3701", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "d893c81ddf222e3ba9235735fb244a5862fbf31325052c4cf58c731611863216"}}, "hash": "1d1229350ff0f814d882720e44c10084440035fc26073a33bd07b34b02c3dce3", "text": "during the time delay between stim-\nulation and attachment would then blur features below a length\nscale of at least lblur=\u221a\nTdelay\u00d7De\ufb00\u223c140\u00b5m. A realistic esti-\nmate for spatial resolution would be even larger due to addi-\ntional delays related to pDawn-signaling and protein accumu-\nlation/export, suggesting that model 1 is inconsistent with the\nobserved spatial resolution given cell motility (Estimating Spatial\nResolution Limits Due to Diffusion).\nFor another hypothesis (model 2, Fig. 3F ), we note that\npDawn-Ag43\u2013mediated patterning occurs within the context\nof other bio\ufb01lm-related processes\u2014in particular, bacteria at a\nliquid\u2013solid interface naturally exhibit reversible adsorption and\ndesorption (43), switching between planktonic and transiently\nadsorbed subpopulations. Instead of only stimulating the plank-\ntonic subpopulation (by increasing their adsorption, as discussed\nabove), pDawn-Ag43 could also have a signi\ufb01cant effect on the\ndesorption rate of transiently adsorbed cells. Left unstimulated\nin the dark, these cells readily desorb from the surface (43), but\nin illuminated regions, membrane-expressed Ag43 reduces the\ndesorption rate of adsorbed cells, effectively anchoring them to\nthe surface (38). Model 2 is consistent with high spatial resolu-\ntion patterning that is not limited by bacterial motility since the\nadsorbed cells are immotile.\nTo quantitatively con\ufb01rm these models, we developed a\nMonte-Carlo simulation of cell swimming and adsorption/de-\nsorption (Fig. 3F ; see also Monte-Carlo Modeling ). Individual\ncells are simulated to swim in a virtual culture chamber, one\nside of which is \u201cilluminated,\u201d causing increased production of\nadhesin A. Bacterial cells adsorb and desorb from the surface\nwith respective rates kaandkd, which are functions of their\nadhesin expression level A. We simulated model 1 by setting kd\nconstant and kaan increasing function of Aand observed no\nclear transition at the light\u2013dark boundary (Fig. 3G). We simu-\nlated model 2 by setting kaconstant and kda decreasing function\nofAand observed a clear increase in adsorbed cells in the illumi-\nnated region, with a sharp transition across the light\u2013dark bound-\nary (Fig. 3H ). Notably, this model did not need to incorporate\nadditional features such as increased adsorption, 3D cell\u2013cell\ninteractions, or a permanently attached cell state. Therefore, we\nestablish that a biophysical model with just two key features, (i)\noptically controlled adhesin expression and (ii) adhesin decreas-\ning desorption rate of adsorbed cells, is suf\ufb01cient to explain light-\nregulated bio\ufb01lm formation with high spatial resolution despite\nbacterial motility. Additionally, the light\u2013dark transition region\nin the simulations is less than 1 \u00b5m (Higher Resolution Analy-\nsis of Light\u2013Dark Boundary in Monte-Carlo Simulations)\u2014smaller\nthan the experimentally observed 25 \u00b5m transition region. This\ndiscrepancy points to unaccounted-for experimental sources of\nnoise such as colony growth/clustering, optical scattering, and 3D\neffects (e.g., cell stacking), which may inform future experimen-\ntal strategies to improve spatial resolution even further.\nDiscussion\nIn conclusion, we have developed a method (Bio\ufb01lm Lithog-\nraphy) that uses light-regulated adhesin expression (pDawn-\nAg43) to quantitatively control bio\ufb01lm formation and patterning\nwith high spatial resolution. Compared with existing cell depo-\nsition and patterning approaches such as inkjet printing (12,\n13), microcontact printing (14, 15), micro\ufb02uidics (20),", "start_char_idx": 3242, "end_char_idx": 6764, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b86dd750-0abe-461a-abf2-4031b04f2d78": {"__data__": {"id_": "b86dd750-0abe-461a-abf2-4031b04f2d78", "embedding": null, "metadata": {"page_label": "3701", "file_name": "6_Bacterial_Lithography.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f6c30827-2624-471c-9232-2255e5419ef0", "node_type": null, "metadata": {"page_label": "3701", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "2183a4744d00df31976f02a153864cac5e4bdc616c73d15602eee4cc29680234"}, "2": {"node_id": "3c780846-ade5-4f1f-b807-62cb9daa67e8", "node_type": null, "metadata": {"page_label": "3701", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "1d1229350ff0f814d882720e44c10084440035fc26073a33bd07b34b02c3dce3"}}, "hash": "d893c81ddf222e3ba9235735fb244a5862fbf31325052c4cf58c731611863216", "text": "microcontact printing (14, 15), micro\ufb02uidics (20), PDMS\nJin and Riedel-Kruse PNAS |April 3, 2018 |vol. 115 |no. 14 |3701Downloaded at STANFORD UNIV MED CENTER on April 10, 2020", "start_char_idx": 6792, "end_char_idx": 6968, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "594addd9-4526-41bc-8cb9-8f817f45f594": {"__data__": {"id_": "594addd9-4526-41bc-8cb9-8f817f45f594", "embedding": null, "metadata": {"page_label": "3702", "file_name": "6_Bacterial_Lithography.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cee73198-a1e9-45f2-886f-9438a1bd4941", "node_type": null, "metadata": {"page_label": "3702", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "9215800e06396337860ff4853226aa26d3f6997fc0329d40679a1f3ad359fa7a"}, "3": {"node_id": "de043ff6-a667-45d4-bbc4-f59fe216fa2a", "node_type": null, "metadata": {"page_label": "3702", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "a2ef09367edd874a41188b8d27d9a97b2463408906618cebfcc462a51554e432"}}, "hash": "c5ec2a7e78b92426dc7bea8028b8e7bc786f9eb9f0b265398abed5ca076ec1d2", "text": "stenciling (16), and patterned substrate modi\ufb01cation (17\u201319),\nthis method can pattern on a variety of surfaces, without the\nneed for surface prepatterning or pretreatment, within enclosed\nchambers, over large areas, and at high spatial resolution. Rapid\nprototyping of different bio\ufb01lm geometries is possible with low-\ncost digital projectors at resolutions of 45 \u00b5m; resolutions down\nto 25 \u00b5m can be reached with photomasks and likely also\nwith more advanced optical projector setups (44, 45). This res-\nolution represents an important step toward the engineering\nof bio\ufb01lm communities, as natural bio\ufb01lm microcolonies exist\naround this length scale (10). Our biophysical model suggests\nthat the pDawn-Ag43 patterning mechanism works alongside\nnatural surface adsorption/desorption in bacteria and involves\nthe stimulation of transiently adsorbed cells on the bio\ufb01lm sub-\nstrate toward a more permanently attached state. This insight\ngives additional support to the proposed role of Ag43 as an\nadhesin involved in bio\ufb01lm maturation as opposed to initial sur-\nface adsorption (46). Ultimately, optogenetic patterning tools\nsuch as pDawn-Ag43 can be applied toward an improved under-\nstanding of naturally existing bio\ufb01lms (47, 48), the design of\nsynthetic microbial consortia (8), distributed metabolic engineer-\ning (49), and new types of integrated diagnostic and micro\ufb02u-\nidic devices (50), with impact and trajectory that may potentially\nparallel that of silicon photolithography in the semiconductor\nindustry (51, 52).\nMaterials and Methods\nPlasmids and Bacterial Strains. MG1655 was obtained from the Coli Genetic\nStock Center (Yale University, New Haven, CT; CGSC strain #6300). pDawn-\nAg43 was constructed using standard cloning techniques using pDawn\n(a gift from Andreas Moeglich, Universit \u00a8at Bayreuth, Bayreuth, Germany;\nAddgene Plasmid #43796) plasmid as a starting point. First, Gibson Assem-\nbly was used to swap out the kanamycin marker for a less commonly used\nspectinomycin resistance marker. BamHI/XhoI restriction digest was then\nused to linearize the resulting plasmid at the multiple cloning site down-\nstream of the \u03bbpromoter to create the backbone for pDawn-Ag43.\nThe coding sequence for Ag43 was obtained from the BioBricks iGEM dis-\ntribution, part number BBa K346007 (iGEM Foundation, Cambridge, MA).\nWe noted during construction that several PstI restriction enzyme sites\nremained in the coding sequence, making the part incompatible with the\nBioBrick Standard. Using a combination of site-directed mutagenesis and\nDNA synthesis (IDT gBlock synthesis), these PstI sites were removed and\nreplaced with silent mutations so as to not alter the \ufb01nal amino acid\nsequence. Using this now BioBrick-compatible part, we used standard Bio-\nBrick pre\ufb01x/suf\ufb01x assembly to add a medium strength ribosomal binding\nsite (BBa B0031 rbs) upstream of the Ag43 coding sequence. We then used\nBamHI/XhoI digestion/ligation to insert rbs-Ag43 into the backbone pre-\npared earlier to create pDawn-Ag43.\nA similar protocol was used to create pDawn-sfGFP, with a superfold-\nerGFP coding sequence used in place of Ag43. pBAD-Ag43 was created by\nusing standard BioBrick pre\ufb01x/suf\ufb01x assembly to insert the Ag43 coding\nsequence downstream of an araC\u2013pBAD expression vector (BioBricks part\nBBa I0500). Sequences for pDawn-sfGFP,", "start_char_idx": 0, "end_char_idx": 3327, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "de043ff6-a667-45d4-bbc4-f59fe216fa2a": {"__data__": {"id_": "de043ff6-a667-45d4-bbc4-f59fe216fa2a", "embedding": null, "metadata": {"page_label": "3702", "file_name": "6_Bacterial_Lithography.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cee73198-a1e9-45f2-886f-9438a1bd4941", "node_type": null, "metadata": {"page_label": "3702", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "9215800e06396337860ff4853226aa26d3f6997fc0329d40679a1f3ad359fa7a"}, "2": {"node_id": "594addd9-4526-41bc-8cb9-8f817f45f594", "node_type": null, "metadata": {"page_label": "3702", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "c5ec2a7e78b92426dc7bea8028b8e7bc786f9eb9f0b265398abed5ca076ec1d2"}, "3": {"node_id": "ef41ebd1-72e9-4c82-8d88-9ebf2c502ecd", "node_type": null, "metadata": {"page_label": "3702", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "340fc697565cf653cd4a81b2621d93d0d27a5361c4b6dc1d148c8e6867ec2bf8"}}, "hash": "a2ef09367edd874a41188b8d27d9a97b2463408906618cebfcc462a51554e432", "text": "part\nBBa I0500). Sequences for pDawn-sfGFP, pDawn-Ag43, and pBAD-Ag43 are\navailable from Addgene.\nThe plasmid for red \ufb02uorescent protein expression was obtained from\nthe BioBricks iGEM distribution and expresses mRFP from the Lac promoter\n(BBa J04450\u2212pSB3T 5).\nBio\ufb01lm Formation and Patterning. E. coli strains were cultured to late log\nphase in LB broth under dark conditions (OD 6001.4,\u223c6 h with shaking at\n37\u25e6C after 1:1,000 dilution of overnight culture). Media was supplemented\nwith antibiotics as appropriate (50 \u00b5g/mL for kanamycin and spectinomycin,\n10\u00b5g/mL for tetracycline, and 100 \u00b5g/mL for ampicillin). These cultures\nwere then seeded onto non-tissue culture-treated polystyrene well plates at\n1:100 dilution into M63 media supplemented with 0.2 %w/v glucose and\n0.1%w/v casamino acids.\nFor assays characterizing bio\ufb01lm formation, 96-well black-walled plates\n(Corning Costar 3631) were used. Patterning assays were performed in 6- or\n12-well plates (Corning Falcon 351146/351143).\nWell plates containing the bio\ufb01lm cultures were taped to the ceiling\nof a 37\u25e6C incubator, ensuring the bottom surface of the well plates\nremained uncovered. An Ivation Pro4 Wireless Pocket Projector (IVPJPRO4)was secured below the ceiling of the incubator, pointing upward toward the\nwell plate on the incubator ceiling. The projector was connected via HDMI\ncable to a laptop through the incubator\u2019s side access port, and Microsoft\nPowerPoint software was used to project blue light patterns.\nGlobal illumination intensity was tuned by placing an adjustable neutral\ndensity \ufb01lter (K &Fconcept AMSKU0124) at the aperture of the projector.\nLocal illumination intensity was further tuned by taping thin neutral density\n\ufb01lters from the Lee\u2019s Filters Designer\u2019s Edition Swatchbook (Lee\u2019s Filters part\nSWB) to the bottom surface of the well plates over speci\ufb01c wells to subject\nbacterial samples to a wide range of illumination intensities. Intensity of\nthe projected pattern was measured using a Newport optical power meter\nwith UV-vis photodetector (Newport 840C/818-UV). Illumination time was\nadjusted on the software end through Microsoft PowerPoint.\nFor bio\ufb01lm characterization experiments, bio\ufb01lm cultures were placed in\nthe incubator overnight (16 h). Media was subsequently aspirated, and wells\nwere gently washed twice with PBS. Wells were then stained with 0.1 %\ncrystal violet (Acros Organics 212120250) for 10 min, before another 2\u00d7\nwash with PBS. Wells were then allowed to dry before imaging, followed\nby A550 nm quanti\ufb01cation using 30% acetic acid solubilization as previously\ndetailed (30).\nTo prepare samples for \ufb02uorescence microscopy, bio\ufb01lm cultures were\nprepared using bacteria cotransformed with the BBa J04450\u2212pSB3T 5 plas-\nmid for mRFP expression. To pattern optical illumination for bio\ufb01lm pat-\nterning experiments, various patterns were generated on the software end\nas PowerPoint illustrations, or alternatively, a \ufb01lm photomask was taped\ndirectly under the well plate. Cultures were incubated with patterned illumi-\nnation as described above and rinsed twice with PBS before imaging under\na wide-\ufb01eld \ufb02uorescence microscope. For the long-term culture experiments\nin PBS, cultures were prepared and", "start_char_idx": 3289, "end_char_idx": 6500, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ef41ebd1-72e9-4c82-8d88-9ebf2c502ecd": {"__data__": {"id_": "ef41ebd1-72e9-4c82-8d88-9ebf2c502ecd", "embedding": null, "metadata": {"page_label": "3702", "file_name": "6_Bacterial_Lithography.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cee73198-a1e9-45f2-886f-9438a1bd4941", "node_type": null, "metadata": {"page_label": "3702", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "9215800e06396337860ff4853226aa26d3f6997fc0329d40679a1f3ad359fa7a"}, "2": {"node_id": "de043ff6-a667-45d4-bbc4-f59fe216fa2a", "node_type": null, "metadata": {"page_label": "3702", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "a2ef09367edd874a41188b8d27d9a97b2463408906618cebfcc462a51554e432"}}, "hash": "340fc697565cf653cd4a81b2621d93d0d27a5361c4b6dc1d148c8e6867ec2bf8", "text": "For the long-term culture experiments\nin PBS, cultures were prepared and patterned overnight, before media was\naspirated, followed by PBS rinse. The sample was then imaged under a wide-\n\ufb01eld \ufb02uorescence microscope and left in PBS under ambient dark conditions\nfor 3 d with daily imaging. The same protocol was used for long culture\nexperiments in media, except cells were maintained in M63 media with daily\nPBS rinse.\nqRT-PCR. See Ag43 mRNA Transcript Levels Measured by qRT-PCR for\ndetails.\nConfocal Microscopy. To prepare cultures for confocal microscopy, a drop\nof self-hardening Shandon immunomount (Thermo Scienti\ufb01c 9990402) was\ndropped onto the cultured sample, before being covered with a glass cov-\nerslip (FisherScienti\ufb01c 12-545-81). The sample was then allowed to harden\novernight at room temperature in the dark. The following day, the sam-\nples were imaged through the glass coverslip using a Leica Upright confocal\nmicroscope (Leica DMRXE), using a 20\u00d7/0.50 water immersion objective with\nan excitation line at 543 nm for mRFP.\nMonte-Carlo Modeling. The Monte-Carlo bacterial adhesion simulation was\nimplemented in MATLAB using a forward Euler numerical approach, time\ndiscretized in dt = 100 ms timesteps (repeats run with dt = 50 ms timesteps\nproduced qualitatively identical results). Simulations were run for 16 h over\nan area of (600 \u00b5m)2. Within this area, a 400 \u00b5m-wide stripe on the left is\nilluminated with blue light. Bacterial cells were initialized with a random\nposition and velocity direction, with velocity magnitude in the range v\u2248\n14\u00b13\u00b5m/s (39). Cells were also initialized with a basal adhesin level of\nA=1. Adhesin level is regulated by an ordinary differential equation.\n\u02d9A=Pdark+I\u00d7Pillum\u2212kdegA [1]\nwhere I is a boolean variable representing whether a cell is being illumi-\nnated or not (calculated based on cell position). Pdarkand Pillum represent\nthe basal and light-activated production rates of adhesin protein, respec-\ntively. These proteins are in turn degraded at a rate kdeg. The parameter\nvalues Pdark=10\u22123s\u22121,Pillum=10\u22121s\u22121, and kdeg=10\u22123s\u22121were used\nso that in the dark cells revert to their original basal adhesin level A=1\nwith characteristic protein turnover time on the order of tens of minutes\n(53), and in the light, they increase their expression by two orders of mag-\nnitude (from Amin=1 to Amax=100)\u2014approximately the reported dynamic\nrange of pDawn (26). This ordinary differential equation was numerically\nsolved within the same forward Euler loop as the overall simulation.\nSimultaneously during each simulation time step, cell positions were\nupdated based on velocity, and cells tumbled with a probability of ptumble =\nftumble\u00d7dtbased on a tumbling frequency of ftumble\u22481 s\u22121(39). During\na tumbling event, a cell\u2019s velocity vector was reoriented randomly. Also\nat each time step, planktonic cells were adsorbed to the surface with a\n3702 |www.pnas.org/cgi/doi/10.1073/pnas.1720676115 Jin and Riedel-KruseDownloaded at STANFORD UNIV MED CENTER on April 10, 2020", "start_char_idx": 6467, "end_char_idx": 9485, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0f166413-6027-43c7-8302-a7229b23273d": {"__data__": {"id_": "0f166413-6027-43c7-8302-a7229b23273d", "embedding": null, "metadata": {"page_label": "3703", "file_name": "6_Bacterial_Lithography.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1c5a8482-67dd-4f6f-ad77-0347e49cbd87", "node_type": null, "metadata": {"page_label": "3703", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "7d66192afce8953e7c95c952fb032b0ff511ed82ad20ea154062cdc08334b819"}, "3": {"node_id": "d735a31b-8d83-44b9-af23-6904d1cc9313", "node_type": null, "metadata": {"page_label": "3703", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "28ec6591dc74faa198db2b7b3ef5e2f4fca904e6c403e552b88f3eab07c45dcc"}}, "hash": "da1cbae08a0b1dc0278e2fc0b20e070889ff9039bc3ef974e5fe09a90e98e2da", "text": "MICROBIOLOGYprobability padsorb =ka\u00d7dt, while adsorbed cells were desorbed with a\nprobability pdesorb =kd\u00d7dt. The rates of adsorption kaand desorption kd\nwere dictated by adhesin level A.\nIn the \ufb01rst model, where cell adsorption is increased upon illumination,\nthe relationships were set as ka=10\u22125s\u22121\u00d7Aand kd=10\u22123s\u22121. In the\nsecond model, where cell desorption was decreased upon illumination, the\nrelationships were set as ka=10\u22125s\u22121andkd=10\u22123s\u22121/A. The basal val-\nues for adsorption and desorption rate, ka=10\u22125s\u22121and kd=10\u22123s\u22121,\nwere derived from quantitative bacterial adsorption/desorption time mea-\nsurements (43) and approximately correspond to planktonic cells adsorbing\nevery few hours to the surface, after which they natively remain adsorbedfor a few minutes if not stimulated, or a few hours if stimulated. Simu-\nlations were run for 576,000 timesteps (16 h real time). The \ufb01nal state\nof the simulation was plotted with red dots marking the position of the\nattached cells.\nACKNOWLEDGMENTS. The authors thank D. Glass, H. Kim, A. Spormann,\nD. Endy, M. Covert, N. Cira, A. Choksi, S. Rajan, and A. Dvorak for helpful sug-\ngestions and the Spormann laboratory for access to its confocal microscope\nand furthermore acknowledge the support from Stanford Bio-X Bowes and\nNatural Sciences and Engineering Research Council of Canada-Postgraduate\nScholarship fellowships and the American Cancer Society (RSG-14-177-01).\n1. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM (1995)\nMicrobial bio\ufb01lms. Annu Rev Microbiol 49:711\u2013745.\n2. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial bio\ufb01lms: A common cause\nof persistent infections. Science 284:1318\u20131322.\n3. Flemming HC (2002) Biofouling in water systems\u2013Cases, causes and countermeasures.\nAppl Microbiol Biotechnol 59:629\u2013640.\n4. Grady CPL, Daigger GT, Love NG, Filipe CDM (2011) Biological Wastewater Treatment\n(CRC Press, Boca Raton, FL), 3rd Ed.\n5. Wood TL et al. (2016) Living biofouling-resistant membranes as a model for the ben-\ne\ufb01cial use of engineered bio\ufb01lms. Proc Natl Acad Sci USA 113:E2802\u2013E2811.\n6. Chen AY et al. (2014) Synthesis and patterning of tunable multiscale materials with\nengineered cells. Nat Mater 13:515\u2013523.\n7. Nguyen PQ, Botyanszki Z, Tay PKR, Joshi NS (2014) Programmable bio\ufb01lm-based\nmaterials from engineered curli nano\ufb01bres. Nat Commun 5:4945.\n8. Brenner K, You L, Arnold FH (2008) Engineering microbial consortia: A new frontier\nin synthetic biology. Trends Biotechnol 26:483\u2013489.\n9. Mee MT, Wang HH (2012) Engineering ecosystems and synthetic ecologies. Mol\nBioSyst 8:2470\u20132483.\n10. Christensen BB, Haagensen JA, Heydorn A, Molin S (2002) Metabolic commensal-\nism and competition in a two-species microbial consortium. Appl Environ Microbiol\n68:2495\u20132502.\n11. Terada A, Hibiya K, Nagai J, Tsuneda S, Hirata A (2003)", "start_char_idx": 0, "end_char_idx": 2832, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d735a31b-8d83-44b9-af23-6904d1cc9313": {"__data__": {"id_": "d735a31b-8d83-44b9-af23-6904d1cc9313", "embedding": null, "metadata": {"page_label": "3703", "file_name": "6_Bacterial_Lithography.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1c5a8482-67dd-4f6f-ad77-0347e49cbd87", "node_type": null, "metadata": {"page_label": "3703", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "7d66192afce8953e7c95c952fb032b0ff511ed82ad20ea154062cdc08334b819"}, "2": {"node_id": "0f166413-6027-43c7-8302-a7229b23273d", "node_type": null, "metadata": {"page_label": "3703", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "da1cbae08a0b1dc0278e2fc0b20e070889ff9039bc3ef974e5fe09a90e98e2da"}, "3": {"node_id": "3eb61476-9ed0-4c41-be89-c5008536f6c5", "node_type": null, "metadata": {"page_label": "3703", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "bb58ac179db7baaebea05cdb3d7cb18138281b323307b1302d392020e877d938"}}, "hash": "28ec6591dc74faa198db2b7b3ef5e2f4fca904e6c403e552b88f3eab07c45dcc", "text": "K, Nagai J, Tsuneda S, Hirata A (2003) Nitrogen removal charac-\nteristics and bio\ufb01lm analysis of a membrane-aerated bio\ufb01lm reactor applicable to\nhigh-strength nitrogenous wastewater treatment. J Biosci Bioeng 95:170\u2013178.\n12. Xu T et al. (2004) Construction of high-density bacterial colony arrays and patterns by\nthe ink-jet method. Biotechnol Bioeng 85:29\u201333.\n13. Merrin J, Leibler S, Chuang JS (2007) Printing multistrain bacterial patterns with a\npiezoelectric inkjet printer. PLoS One 2:e663.\n14. Cerf A, Cau JC, Vieu C (2008) Controlled assembly of bacteria on chemical patterns\nusing soft lithography. Colloids Surf B Biointerfaces 65:285\u2013291.\n15. Xu L et al. (2007) Microcontact printing of living bacteria arrays with cellular resolu-\ntion. Nano Lett 7:2068\u20132072.\n16. Eun YJ, Weibel DB (2009) Fabrication of microbial bio\ufb01lm arrays by geometric control\nof cell adhesion. Langmuir 25:4643\u20134654.\n17. Palacios-Cuesta M, Cortajarena AL, Garcia O, Rodriguez-Hernandez J (2015) Pattern-\ning of individual Staphylococcus aureus bacteria onto photogenerated polymeric sur-\nface structures. Polym Chem 6:2677\u20132684.\n18. Suo Z, Avci R, Yang X, Pascual DW (2008) Ef\ufb01cient immobilization and patterning of\nlive bacterial cells. Langmuir 24:4161\u20134167.\n19. Gu H, Hou S, Yongyat C, Detore S, Ren D (2013) Patterned bio\ufb01lm formation reveals\na mechanism for structural heterogeneity in bacterial bio\ufb01lms. Langmuir 29:11145\u2013\n11153.\n20. Kim HJ, Boedicker JQ, Choi JW, Ismagilov RF (2008) De\ufb01ned spatial structure stabi-\nlizes a synthetic multispecies bacterial community. Proc Natl Acad Sci USA 105:18188\u2013\n18193.\n21. Velema WA, van der Berg JP, Szymanski W, Driessen AJM, Feringa BL (2014) Bacterial\npatterning controlled by light exposure. Org Biomol Chem 13:1639\u20131642.\n22. Chen F, Wegner SV (2017) Blue light switchable bacterial adhesion as a key step\ntowards the design of bio\ufb01lms. ACS Synth Biol 6:2170\u20132174.\n23. Ryu MH, Fomicheva A, Moskvin OV, Gomelsky M (2017) Optogenetic module for\ndichromatic control of c-di-GMP signaling. J Bacteriol 199:e00014-17.\n24. Pu L, Yang S, Xia A, Jin F (2017) Optogenetics manipulation enables prevention of\nbio\ufb01lm formation of engineered Pseudomonas aeruginosa on surfaces. ACS Synth\nBiol7:200\u2013208.\n25. Levskaya A et al. (2005) Synthetic biology: Engineering Escherichia coli to see light.\nNature 438:441\u2013442.\n26. Ohlendorf R, Vidavski RR, Eldar A, Moffat K, M \u00a8oglich A (2012) From dusk till dawn:\nOne-plasmid systems for light-regulated gene expression. J Mol Biol 416:534\u2013542.27. Klemm P, Hjerrild L, Gjermansen M, Schembri MA (2004) Structure-function analysis\nof the self-recognizing Antigen 43 autotransporter protein from Escherichia coli. Mol\nMicrobiol", "start_char_idx": 2802, "end_char_idx": 5491, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3eb61476-9ed0-4c41-be89-c5008536f6c5": {"__data__": {"id_": "3eb61476-9ed0-4c41-be89-c5008536f6c5", "embedding": null, "metadata": {"page_label": "3703", "file_name": "6_Bacterial_Lithography.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1c5a8482-67dd-4f6f-ad77-0347e49cbd87", "node_type": null, "metadata": {"page_label": "3703", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "7d66192afce8953e7c95c952fb032b0ff511ed82ad20ea154062cdc08334b819"}, "2": {"node_id": "d735a31b-8d83-44b9-af23-6904d1cc9313", "node_type": null, "metadata": {"page_label": "3703", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "28ec6591dc74faa198db2b7b3ef5e2f4fca904e6c403e552b88f3eab07c45dcc"}, "3": {"node_id": "627cff98-0935-460c-9c2c-86091d8fc95c", "node_type": null, "metadata": {"page_label": "3703", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "989b1169bb429126d8c28f9dc44585c9066ee7e8bd82bc0b965ae4145a25bdb3"}}, "hash": "bb58ac179db7baaebea05cdb3d7cb18138281b323307b1302d392020e877d938", "text": "43 autotransporter protein from Escherichia coli. Mol\nMicrobiol 51:283\u2013296.\n28. Da Re S, Le Qu \u00b4er\u00b4e B, Ghigo JM, Beloin C (2007) Tight modulation of Escherichia coli\nbacterial bio\ufb01lm formation through controlled expression of adhesion factors. Appl\nEnviron Microbiol 73:3391\u20133403.\n29. Reisner A, Haagensen JAJ, Schembri MA, Zechner EL, Molin S (2003) Development\nand maturation of Escherichia coli K-12 bio\ufb01lms. Mol Microbiol 48:933\u2013946.\n30. O\u2019Toole GA (2011) Microtiter dish bio\ufb01lm formation assay. J Visualized Exp, e2437.\n31. Xia Y, Whitesides GM (1998) Soft lithography. Annu Rev Mater Sci 28:153\u2013184.\n32. Phillips R, Kondev J, Theriot J, Orme N (2013) Physical Biology of the Cell (Garland\nScience, New York).\n33. Flemming HC, Wingender J (2010) The bio\ufb01lm matrix. Nat Rev Microbiol 8:623\u201333.\n34. Murga R, Stewart PS, Daly D (1995) Quantitative analysis of bio\ufb01lm thickness variabil-\nity.Biotechnol Bioeng 45:503\u2013510.\n35. Thorsen T, Maerkl SJ, Quake SR (2002) Micro\ufb02uidic large-scale integration. Science\n298:580\u2013584.\n36. Donlan RM (2002) Bio\ufb01lms: Microbial life on surfaces. Emerging Infect Dis 8:\n881\u2013890.\n37. Dunne WM, Jr. (2002) Bacterial adhesion: Seen any good bio\ufb01lms lately? Clin Micro-\nbiol Rev 15:155\u2013166.\n38. Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG (2002) Pseudomonas aerug-\ninosa displays multiple phenotypes during development as a bio\ufb01lm. J Bacteriol\n184:1140\u20131154.\n39. Berg HC, Brown DA (1972) Chemotaxis in Escherichia coli analysed by three-\ndimensional tracking. Nature 239:500\u2013504.\n40. Henderson IR, Owen P (1999) The major phase-variable outer membrane protein\nof Escherichia coli structurally resembles the immunoglobulin A1 protease class of\nexported protein and is regulated by a novel mechanism involving dam and OxyR. J\nBacteriol 181:2132\u20132141.\n41. Vogel U, Jensen KF (1994) The RNA chain elongation rate in Escherichia coli depends\non the growth rate. J Bacteriol 176:2807\u20132813.\n42. Young R, Bremer H (1976) Polypeptide-chain-elongation rate in Escherichia coli B/r as\na function of growth rate. Biochem J 160:185\u2013194.\n43. Meinders JM, Van der Mei HC, Busscher HJ (1994) Physicochemical aspects of deposi-\ntion of Streptococcus thermophilus B to hydrophobic and hydrophilic substrata in a\nparallel plate \ufb02ow chamber. J Colloid Interf Sci 164:355\u2013363.\n44. Stirman JN, Crane MM, Husson SJ, Gottschalk A, Lu H (2012) A multispectral opti-\ncal illumination system with precise spatiotemporal control for the manipulation of\noptogenetic reagents. Nat Protoc 7:207\u2013220.\n45. Lee SA et al. (2015) Trap it! A playful human-biology interaction for a museum instal-\nlation. Proceedings of the 2015 CHI Conference on Human Factors in Computing Sys-\ntems (ACM, New York), pp 2593\u20132602.\n46. Beloin C, Roux A,", "start_char_idx": 5466, "end_char_idx": 8208, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "627cff98-0935-460c-9c2c-86091d8fc95c": {"__data__": {"id_": "627cff98-0935-460c-9c2c-86091d8fc95c", "embedding": null, "metadata": {"page_label": "3703", "file_name": "6_Bacterial_Lithography.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1c5a8482-67dd-4f6f-ad77-0347e49cbd87", "node_type": null, "metadata": {"page_label": "3703", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "7d66192afce8953e7c95c952fb032b0ff511ed82ad20ea154062cdc08334b819"}, "2": {"node_id": "3eb61476-9ed0-4c41-be89-c5008536f6c5", "node_type": null, "metadata": {"page_label": "3703", "file_name": "6_Bacterial_Lithography.pdf"}, "hash": "bb58ac179db7baaebea05cdb3d7cb18138281b323307b1302d392020e877d938"}}, "hash": "989b1169bb429126d8c28f9dc44585c9066ee7e8bd82bc0b965ae4145a25bdb3", "text": "York), pp 2593\u20132602.\n46. Beloin C, Roux A, Ghigo JM (2008) Escherichia coli bio\ufb01lms. Curr Top Microbiol\nImmunol 322:249\u2013289.\n47. Kreft JU (2004) Bio\ufb01lms promote altruism. Microbiology 150:2751\u20132760.\n48. Rudge TJ, Steiner PJ, Phillips A, Haseloff J (2012) Computational modeling of synthetic\nmicrobial bio\ufb01lms. ACS Synth Biol 1:345\u2013352.\n49. Chen AH, Silver PA (2012) Designing biological compartmentalization. Trends Cell Biol\n22:662\u2013670.\n50. Unger MA, Chou HP, Thorsen T, Scherer A, Quake SR (2000) Monolithic microfabri-\ncated valves and pumps by multilayer soft lithography. Science 288:113\u2013116.\n51. Burbank DP (1999) The near impossibility of making a microchip. Am Heritage Invent\nTechnol 15:44\u201353.\n52. Garner CM (2012) Lithography for enabling advances in integrated circuits and\ndevices. Phil Trans A Math Phys Eng Soc 370:4015\u20134041.\n53. Nath K, Koch AL (1970) Protein degradation in Escherichia coli. I. Measurement of\nrapidly and slowly decaying components. J Biol Chem 245:2889\u20132900.\nJin and Riedel-Kruse PNAS |April 3, 2018 |vol. 115 |no. 14 |3703Downloaded at STANFORD UNIV MED CENTER on April 10, 2020", "start_char_idx": 8223, "end_char_idx": 9336, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d443a53b-e2c1-4ea5-bf06-78e9e220ddbb": {"__data__": {"id_": "d443a53b-e2c1-4ea5-bf06-78e9e220ddbb", "embedding": null, "metadata": {"page_label": "78", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0c6386b0-e9fa-45fc-9979-461bcb548ca7", "node_type": null, "metadata": {"page_label": "78", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "bb863da3572ec8a37a1e21498eb4b20708e90a9420e6273899dd9864ecff685d"}, "3": {"node_id": "38022e6d-f4c4-40b7-b696-0c01bdcf7b82", "node_type": null, "metadata": {"page_label": "78", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "98a5c15ee4b9c91be44d9040993cefa0c8d1c4361bf2e6ad6b2ff6356be7c675"}}, "hash": "9579cb1f8eec2fbcc145060222d59c842f33d25c61ca5e31059a48931f88f9d4", "text": "78 VOLUME 34   NUMBER 1   JANUARY 2016   NATURE BIOTECHNOLOGY\nLETTERS1Department of Life Sciences, Imperial College London, London, UK. 2Dipartimento di Medicina Sperimentale Via Gambuli, Centro di Genomica Funzionale, \nUniversity of Perugia, Perugia, Italy. 3Department of Genetics, University of Cambridge, Cambridge, UK. 4INSERM U963, CNRS UPR9022, Universit\u00e9 de Strasbourg, \nInstitut de Biologie Mol\u00e9culaire et Cellulaire, Strasbourg, France. Correspondence should be addressed to N.W. ( nikolai.windbichler@imperial.ac.uk ) or  \nA.C. ( a.crisanti@imperial.ac.uk ) or T.N. ( t.nolan@imperial.ac.uk ).\nReceived 12 September 2015; accepted 23 November 2015; published online 7 December 2015; doi:10.1038/nbt.3439homozygote in a process known as \u2018homing\u2019 . Through this mechanism, \nthe frequency of an HEG can rapidly increase in a population. Naturally \noccurring HEGs can in principle be adapted to function as a gene drive \nsystem in mosquitoes because they can be re-engineered to recognize \nmosquito genes2. An HEG expressed in the male mosquito germline that \nrecognizes an artificially introduced recognition site shows high rates \nof super-Mendelian inheritance and rapidly invades a caged popula -\ntion2. The increased transmission rate provided by endonuclease-based \ngene drive systems could theoretically outweigh the fitness costs arising \nfrom the cleavage activity and disruption of the targeted sites. If this \nproviso is met, a drive construct can spread through a population until \nit reaches an equilibrium frequency, with a reduced mean fitness for \nthe population1.\nAny nuclease with a sufficiently long recognition sequence could \nhypothetically be redesigned to function as a gene drive system akin \nto an HEG, provided that it can be engineered to recognize and insert \nin a specific genomic locus. For example, we have previously shown \nthat modular nucleases such as zinc finger nucleases or transcription \nactivator\u2013like effector nucleases (TALENs), for which the DNA-binding \nspecificity of each module is well-characterized, can be combined to \nfunction as a synthetic selfish element in Drosophila , albeit with low \nreplication fidelity owing to their repetitive nature3. More recently, the \ndevelopment of the CRISPR-Cas9 (clustered, regularly interspaced, \nshort palindromic repeats (CRISPR) and CRISPR-associated protein \n(Cas)) system4\u20136 has radically simplified the process of engineering \nnucleases that can cleave specific genomic sequences. A guide RNA \n(gRNA) complementary to a DNA target site directs the activity of \nthe Cas9 endonuclease to that sequence, providing a means to edit \nalmost any chosen DNA sequence without the need to undertake \ncomplex protein engineering and selection procedures. In addition to \napplications in genome editing, the specificity and the flexibility of the \nCRISPR-Cas9 system offers unprecedented opportunities to expedite \nthe development of gene drive systems for the control of insect vec -\ntors of disease7. In a proof-of-principle experiment for such a use, a \nCRISPR-based construct was used to demonstrate gene drive activity Gene drive systems that enable super-Mendelian \ninheritance of a transgene have the potential to modify \ninsect populations over a timeframe of a few years. We \ndescribe CRISPR-Cas9 endonuclease constructs that \nfunction as gene drive systems in Anopheles gambiae , \nthe main vector for malaria. We identified three genes \n(AGAP005958 , AGAP011377  and AGAP007280 )", "start_char_idx": 0, "end_char_idx": 3477, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "38022e6d-f4c4-40b7-b696-0c01bdcf7b82": {"__data__": {"id_": "38022e6d-f4c4-40b7-b696-0c01bdcf7b82", "embedding": null, "metadata": {"page_label": "78", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0c6386b0-e9fa-45fc-9979-461bcb548ca7", "node_type": null, "metadata": {"page_label": "78", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "bb863da3572ec8a37a1e21498eb4b20708e90a9420e6273899dd9864ecff685d"}, "2": {"node_id": "d443a53b-e2c1-4ea5-bf06-78e9e220ddbb", "node_type": null, "metadata": {"page_label": "78", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "9579cb1f8eec2fbcc145060222d59c842f33d25c61ca5e31059a48931f88f9d4"}}, "hash": "98a5c15ee4b9c91be44d9040993cefa0c8d1c4361bf2e6ad6b2ff6356be7c675", "text": ", AGAP011377  and AGAP007280 ) \nthat confer a recessive female-sterility phenotype upon \ndisruption, and inserted into each locus CRISPR-Cas9 \ngene drive constructs designed to target and edit each \ngene. For each targeted locus we observed a strong gene \ndrive at the molecular level, with transmission rates to \nprogeny of 91.4 to 99.6%. Population modeling and \ncage experiments indicate that a CRISPR-Cas9 construct \ntargeting one of these loci, AGAP007280 , meets the \nminimum requirement for a gene drive targeting female \nreproduction in an insect population. These findings \ncould expedite the development of gene drives to \nsuppress mosquito populations to levels that do not \nsupport malaria transmission.\nSynthetic gene drive systems using site-specific endonucleases to spread \ntraits into a population were first proposed more than a decade ago1. \nThis proposal was initially inspired by the action of a class of natural \nselfish genetic elements, found in many single-cell organisms, named \nhoming endonuclease genes (HEGs). HEG-encoded proteins can recog -\nnize and cleave a 15- to 30-bp DNA sequence. HEGs are located within \nthe DNA recognition sequence, rendering it resistant to further cleavage. \nHowever, when the HEG comes into contact with a chromosome con -\ntaining the uninterrupted recognition sequence, the double-strand break \n(DSB) induced by the cleavage is often repaired using the homologous \nchromosome as a template, effectively converting a heterozygote into a A CRISPR-Cas9 gene drive system targeting female \nreproduction in the malaria mosquito vector Anopheles \ngambiae\nAndrew Hammond1, Roberto Galizi1, Kyros Kyrou1, Alekos Simoni1, Carla Siniscalchi2, Dimitris Katsanos1, \nMatthew Gribble1, Dean Baker3, Eric Marois4, Steven Russell3, Austin Burt1, Nikolai Windbichler1,  \nAndrea Crisanti1 & Tony Nolan1\nnpg \u00a9 2016 Nature America, Inc. All rights reserved.", "start_char_idx": 3447, "end_char_idx": 5344, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0bd6f479-1ed4-4c7d-bb87-2fcadf02f8f4": {"__data__": {"id_": "0bd6f479-1ed4-4c7d-bb87-2fcadf02f8f4", "embedding": null, "metadata": {"page_label": "79", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2a9fffc5-cb4d-4256-bf15-3ae118b45cc6", "node_type": null, "metadata": {"page_label": "79", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "61bfa9f13bbfa96046cedac70dab70c7cf9c05fcf43e178057d155196bd360f2"}, "3": {"node_id": "326f48af-3c8b-498d-8ba8-7eb9b0687d88", "node_type": null, "metadata": {"page_label": "79", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "90dd6c9d8af948bd9d7e97d3ee5fff11be931e8739316814c2746116a8d2f18f"}}, "hash": "d72817953bbb4eb1edf125c85cb4f43f6cf0d127e69b5914cf4147a7bca5fb91", "text": "NATURE BIOTECHNOLOGY    VOLUME 34   NUMBER 1   JANUARY 2016  79\nLETTERSin a single generation at an eye color locus in Drosophila  and using a \nsplit-drive system in yeast8,9.\nTranslation of this technology for the control of the insect vector of \nhuman malaria requires development of an endonuclease-based gene \ndrive system that interferes with the ability of A. gambiae  mosquitoes to \ntransmit the disease. This could be achieved either by blocking parasite \ndevelopment or by reducing the reproductive capability of the insect \nvector. Modeling of vector populations indicates that the latter might be \nachieved through the use of an endonuclease designed to \u2018home\u2019 to and \nyield a recessive mutation in a gene that is essential for viability or female \nfertility, with the latter being more effective, provided that homing is \ntemporally and spatially confined to the germline during, or before, \nthe process of gamete formation1,10. This is essential to avoid somatic \ndisruption of the wild-type (WT) allele and allow the normal develop -\nment of heterozygous mosquitoes, critical for transmitting the endo -\nnuclease to subsequent generations. Along these lines we have developed \na CRISPR-based gene drive system designed to home, in both sexes of \nthe human malaria vector A. gambiae , to haplosufficient, somatically \nexpressed female-fertility genes.\nTo identify putative female-fertility genes in A. gambiae , we used a \ncombination of orthology and a sterility index based on a logistic regres -\nsion model that correlated gene expression features with the likelihood of \nfemale sterile alleles in the model dipteran Drosophila  melanogaster11,12. \nThree candidate genes with high ovary expression and tissue specificity \nwere chosen from this analysis: AGAP005958  (ortholog of Drosophila \nyellow-g , a haplosufficient female-fertility gene expressed in somatic fol -\nlicle cells13); AGAP007280  (ortholog of Drosophila nudel , a haplosuffi -\ncient female-fertility gene expressed in somatic follicle cells involved in \ndorsoventral patterning of the embryo14); AGAP011377  (no apparent \nDrosophila  ortholog but contains a probable chitin binding domain).\nWe used either CRISPR-Cas9 nuclease or TALENs to selectively \ndisrupt the coding sequence of these candidate genes and analyzed \nreproductive phenotypes to validate the suitability of these genes as \nhoming targets. The gene knockout strategy generated \u2018docking lines\u2019 \nthrough homologous recombination inserting a GFP transcription unit flanked by two attP sites suitable for subsequent insertion of active drive \n constructs ( Fig. 1a ). Though not strictly necessary for the purpose of \ninserting a gene drive element, the generation of the docking lines allows \nan unambiguous assessment of the phenotype caused by gene disrup -\ntion, in the absence of ongoing Cas9 activity, and the tracking of mutant \nalleles by the presence of the fluorescent marker. In each case the inser -\ntion of the attP-GFP docking cassette was designed to produce a null \nphenotype. Both TALENs and Cas9 nuclease were effective in cutting \nthe corresponding target sequences and in promoting the insertion of \nthe docking construct at the cleavage site. At each of the three selected \ntarget loci, transformed GFP+ individuals were recovered at a relatively \nhigh frequency with rates at least comparable to those in our experi -\nence of transposon-mediated germline transformation ( Supplementary \nTable 1 ), and they were confirmed in PCR experiments to carry the \ndesired homologous recombination events ( Supplementary Fig. 1 ). G1 \nindividuals of the docking lines were fertile and were intercrossed to pro -\nduce", "start_char_idx": 0, "end_char_idx": 3674, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "326f48af-3c8b-498d-8ba8-7eb9b0687d88": {"__data__": {"id_": "326f48af-3c8b-498d-8ba8-7eb9b0687d88", "embedding": null, "metadata": {"page_label": "79", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2a9fffc5-cb4d-4256-bf15-3ae118b45cc6", "node_type": null, "metadata": {"page_label": "79", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "61bfa9f13bbfa96046cedac70dab70c7cf9c05fcf43e178057d155196bd360f2"}, "2": {"node_id": "0bd6f479-1ed4-4c7d-bb87-2fcadf02f8f4", "node_type": null, "metadata": {"page_label": "79", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "d72817953bbb4eb1edf125c85cb4f43f6cf0d127e69b5914cf4147a7bca5fb91"}}, "hash": "90dd6c9d8af948bd9d7e97d3ee5fff11be931e8739316814c2746116a8d2f18f", "text": "of the docking lines were fertile and were intercrossed to pro -\nduce G2 progeny, expected to include individuals both heterozygous and Table 1  RMCE to insert CRISPRh alleles at their target locus\nTarget gene Injected eggs G0 crossed Founders (%)Cassette exchange  \nprogeny (%)Crosses of fertile G1 containing CRISPRh allele\nG1 crossG2 progenyTransmission  \nrate (%) CRISPRh/+ CRISPRh\nAGAP007280 540 56 \u22657.1 (4/56)a0.38 (15/4,000)1 \u2640G1 \u00d7 WT 34 2 94.4\n8 \u2642G1 \u00d7 WT 666 3 99.6\nAGAP011377 500 21 \u22654.8 (1/21)a0.13 (4/2,990) 1 \u2640G1 \u00d7 WT 35 0 100.0\nAGAP005958 400 49 \u22652.0 (1/49)a0.05 (2/4,000) 1 \u2642G1 \u00d7 WT 236 0 100.0\nCRISPR homing constructs were injected into the respective docking lines with a plasmid source of vasa2 -driven integrase. Successful recombinase-mediated exchange events (RMCE) were \nscored visually for the replacement of GFP at the docking site with the RFP contained within the CRISPRh construct. The proportion of G1 progeny containing putative cassette exchange events \nis also shown. aIn these cases the progeny were screened from group crosses, hence the estimate for the number of founders is a minimum.\nFigure 1  Gene disruption by homology-directed repair (HDR) at three \nseparate loci causes recessive female sterility. ( a) A plasmid-based source \nof either a TALEN or Cas9 coupled with a gRNA induces a DSB at the target \nlocus. A plasmid (hdrGFP) containing regions of homology immediately \nupstream and downstream of the cut site acts as a template for homology-\ndirected repair. Internal to the homology regions a 3xP3::GFP cassette \nidentifies hdrGFP integration events and two attP sites facilitate secondary \nmodification of the locus through RMCE. ( b) PCR was used to confirm the \ntargeted loci in WT individuals as well as those homozygous and heterozygous \nfor the hdrGFP  allele. The primer pair used is indicated in a (blue arrows). \n(c) Counts of larval progeny from individual females homozygous or \nheterozygous for hdrGFP  alleles mated to WT males. Heterozygous docking \nlines for all three loci showed at least full fertility compared to WT females. A \nminimum of 20 individuals were tested for each line. Vertical bars represent \nthe mean and error bars the s.e.m.\nhdrGFP/++/+\nhdrGFP/hdrGFP\nhdrGFP/+\nhdrGFP/hdrGFP\nhdrGFP/+\nhdrGFP/hdrGFP\n0Parental genotype of docking line\nNo. larval progeny50 100 150 200 250\u201811377\u2019\n\u20185958\u2019\n\u20187280\u20193xP3\n5' Homology 3' Homology attP attP 3xP3\nTarget\nTarget gene 5' Target gene 3'GeneGFP\nattP attP 3xP3\n\u201811377\u2019 \u20185958\u2019 \u20187280\u2019GFPCRISPR-Cas9/TALEN\nhdrGFP\nhdrGFP/\nhdrGFPhdrGFP/+ +/+hdrGFP/\nhdrGFPhdrGFP/+ +/+hdrGFP/\nhdrGFPhdrGFP/+ +/+DSBRFPa\nb\nc\nnpg \u00a9 2016 Nature America, Inc. All rights reserved.", "start_char_idx": 3605, "end_char_idx": 6269, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7e51c9a9-a114-4f7a-b47d-05fcdfccd3be": {"__data__": {"id_": "7e51c9a9-a114-4f7a-b47d-05fcdfccd3be", "embedding": null, "metadata": {"page_label": "80", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bf4ed3e7-72df-4708-b175-cfe7b30c6df6", "node_type": null, "metadata": {"page_label": "80", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "c0551279fc7fed058a2808cd1b9f75627e3db47af6f0e4b20f2870cde0ff03db"}, "3": {"node_id": "778b8b0d-0771-4ce5-89aa-a1f6954f483d", "node_type": null, "metadata": {"page_label": "80", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "60d201668cd2c18257746e6e954c47a3fce102d1fad54237773fa371a78b6ec8"}}, "hash": "cf3cc6f593465dbcc4d741eff36b062442cb482f9202d8b9500dc63fad0ab2bc", "text": "80 VOLUME 34   NUMBER 1   JANUARY 2016   NATURE BIOTECHNOLOGY\nLETTERSFigure 2  CRISPRh alleles inserted at female-fertility loci show highly efficient gene drive activity and can spread in a caged population. ( a) RMCE was used \nto replace the GFP transcription unit in hdrGFP docking lines with a CRISPR homing construct (CRISPRh consisting of a 3xP3::RFP  marker, Cas9 under the \ntranscriptional control of the vasa2  promoter and a gRNA under the control of the ubiquitous U6 PolIII. The gRNA cleaves at the nondisrupted WT allele. \nRepair of the cleaved chromosome through HDR leads to copying of the CRISPRh allele and homing. ( b) Confinement of homing to the germline should lead \nto super-Mendelian inheritance of a homing construct (indicated in red) that, when targeting a haplosufficient, somatic female-fertility gene, will reduce the \nnumber of fertile females. ( c) High levels of homing at all three female-fertility loci were observed. Male or female CRISPRh/+ heterozygotes were mated to \nWT. Progeny from individual heterozygous females were scored for the presence of the RFP linked to the CRISPRh construct and the average transmission \nrate indicated by vertical bar (\u00b1 s.e.m.). A minimum of 34 females were analyzed for each cross. The average homing rate is also shown. ( d,e) Counts of \neggs and hatching larvae for the individual crosses revealed a strong fertility effect in heterozygous CRISPRh/+ females ( d) that was not seen in equivalent \nheterozygous males ( e). (f) Dynamics calculated using recurrence equations in Deredec et al.10, using the observed homing rates in males and females and \neffects on female fertility. We assume no fitness effects in males and that the initial release consists of heterozygous males equal to 10% of the prerelease \nadult male population (i.e., 5% of the overall population). The model assumes discrete generations (one per month) and random mating; results are plotted \nstarting from the first generation after release and do not account for evolution of either the CRISPR  allele or the target sequence. ( g) Increase in frequency \nof CRISPRh allele in cage population experiments. An equal number of CRISPRh/+ and WT individuals were used to start a population, and the frequency of \nindividuals containing a CRISPRh allele was recorded in each subsequent generation. Black line shows deterministic prediction based on observed parameter \nvalues (homing rates 98.4%, heterozygous female fitness of 9.3%, homozygous females completely sterile), assuming no fitness effects in males. Gray lines \nshow results from 20 stochastic simulations assuming 300 males and 300 females are used to start the next generation, females mate randomly with a \nsingle male and 15% of females fail to mate, using random numbers drawn from the appropriate multinomial distributions. Red lines show results from two \nreplicate cages.\nCount\nTime (months)\nNon-Mendelian segregation of CRISPRh\nCRISPRh -RFP progeny (%)Loci ID\nGenerationsAllele frequency Frequency of CRISPRh allele  (%)\nReproductive loadCRISPRh/+ females\nCRISPRh/+ malesLoci ID Loci ID\n90\n80\n70\n60\n50\n40\n01 23 41.0\n0.8\n0.6\n0.4\n0.2\n0\n03 0 10 40 20\n0 100 505005 0 100 150 200a\nb\nfed\ncgHoming analysis\u201811377\u2019 (eggs)\n\u201811377\u2019 (larvae)\n\u20185958\u2019 (eggs)\n\u20185958\u2019 (larvae)\n\u20187280\u2019 (eggs)\n\u20187280\u2019", "start_char_idx": 0, "end_char_idx": 3293, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "778b8b0d-0771-4ce5-89aa-a1f6954f483d": {"__data__": {"id_": "778b8b0d-0771-4ce5-89aa-a1f6954f483d", "embedding": null, "metadata": {"page_label": "80", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bf4ed3e7-72df-4708-b175-cfe7b30c6df6", "node_type": null, "metadata": {"page_label": "80", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "c0551279fc7fed058a2808cd1b9f75627e3db47af6f0e4b20f2870cde0ff03db"}, "2": {"node_id": "7e51c9a9-a114-4f7a-b47d-05fcdfccd3be", "node_type": null, "metadata": {"page_label": "80", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "cf3cc6f593465dbcc4d741eff36b062442cb482f9202d8b9500dc63fad0ab2bc"}}, "hash": "60d201668cd2c18257746e6e954c47a3fce102d1fad54237773fa371a78b6ec8", "text": "(eggs)\n\u20187280\u2019 (larvae)\n\u201811377\u2019 (eggs)\n\u201811377\u2019 (larvae)\n\u20185958\u2019 (eggs)\n\u20185958\u2019 (larvae)\n\u20187280\u2019 (eggs)\n\u20187280\u2019 (larvae)\n\u201811377\u2019Homing rate\n87.3%\n91.6%\n95.9%\n99.3%\n95.4%\u20185958\u2019\n\u20187280\u2019\u201811377\u2019\n\u20185958\u2019\n\u20187280\u2019attB RFP attBattP attP\n3xP3 Vas2 Cas9 gRNA U6\nattL RFP attL 3xP3 Vas2 Cas9 gRNA U6\nattL RFP attL 3xP3 Vas2 Cas9 gRNA U6\nattL RFP\nSoma Soma\nGermline\nhomingGermlineattL 3xP3 Vas2 Cas9 gRNA U63xP3\nRMCEGFPhdrGFP\nCRISPRh alleleTarget gene 5'\nTarget GeneTarget gene 3'\nnpg \u00a9 2016 Nature America, Inc. All rights reserved.", "start_char_idx": 3280, "end_char_idx": 3792, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7a504931-95d1-4c33-96f7-93655e7371a4": {"__data__": {"id_": "7a504931-95d1-4c33-96f7-93655e7371a4", "embedding": null, "metadata": {"page_label": "81", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7d793112-63e0-4df1-a230-2a88b2814a91", "node_type": null, "metadata": {"page_label": "81", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "84b14f8ee154124cb5d8df9364ad05f5398f3a10f24aaf0377ba7736afffa92a"}, "3": {"node_id": "d594a625-15f7-426d-a964-06a4c405e80e", "node_type": null, "metadata": {"page_label": "81", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "d5027124d95f04dffb176b0dcd2dc53d6b3049dae407a414e8d54c65dd68a65e"}}, "hash": "b838df5f65dbcdfb51787af92e78a10a5c89327b0727411277678f944444e68d", "text": "NATURE BIOTECHNOLOGY   VOLUME 34   NUMBER 1   JANUARY 2016  81\nLETTERSthe fertility genes, thereby initiating homologous recombination repair \nevents that lead to the homing of the CRISPRh construct into the WT \nallele ( Fig. 2a). Visual screening was used to analyze the frequency of \nthe RFP-linked CRISPRh allele in the progeny of heterozygous parents \ncrossed to WT mosquitoes to detect signs of non-Mendelian inheri-tance, above the expected frequency of 50%, that would reveal gene drive activity (Fig. 2b).\nIn several of the CRISPR\nh/+ G1 individuals that we recovered at each \nlocus we noticed super-Mendelian inheritance of the RFP-marked CRISPR\nh allele, with rates of 94.4\u2013100% (Table 1 ) among the progeny. \nTo further investigate the activity of these CRISPRh alleles, we looked \nat homing ability and sterility in the G2 generation and beyond, scor -\ning the progeny of large numbers of single crosses to WT mosquitoes. Invariably, we saw high rates of transmission in every fertile cross we examined ( Fig. 2c), representing average homing rates (defined as the \nproportion of non-CRISPR alleles converted to CRISPR\nh in the gametes) \nranging from 87.3% to 99.3% across the three target genes. Importantly, though we observed more variability (69\u201398%) across generations over time, we observed no obvious decrease in homing performance (Table 2 ), \nsuggesting that the majority of CRISPR homing events regenerate an intact allele. Furthermore, the transmission rate of the CRISPR\nh allele \nat AGAP007280 and AGAP011377 was high in both male and female \nCRISPRh/+ individuals, in agreement with the predicted activity of the \nvasa2  promoter in both sexes during early gametogenesis16. In those rare \nprogeny that did not contain a CRISPR homing allele, we looked for evi-dence of repair by nonhomologous end joining (NHEJ), microhomology-mediated end joining (MMEJ)\n19 or other noncanonical homing events at \nthe three target loci. In a total of 32 offspring derived from a minimum of 7 individuals, we found a total of 13 indel mutations (6 unique, including two examples of a 6-bp deletion that preserved reading frame and could represent a resistant allele), presumably arising from NHEJ or MMEJ repair, and two events from the same parent producing a 195-bp insertion at AGAP007280, most parsimoniously explained by an incomplete hom-\ning event that was resolved using homology between the gRNA sequence in the construct and its cognate target in the genome (Supplementary Fig. 4). Consistent with rare incomplete homing events generating a nonfunctional homing allele, we recovered an identical event in a single individual that produced progeny with a normal Mendelian segregation of the transgenic phenotype.\nThough homing rates were high in the germline of both males and \nfemales, the fertility of females heterozygous for a homing construct was markedly reduced, with the number of larvae produced only 4.6% of WT (bootstrap 95% confidence limits 2.3\u20137.7%) for AGAP011377 and 9.3% (5.7\u201314.2%) of WT for AGAP007280. We did not recover a single larva from females heterozygous for a CRISPR\nh allele at AGAP005958  \n(Fig. 2d). In contrast, males heterozygous for CRISPRh alleles showed \nnormal fertility (Fig. 2e). The fertility reduction observed for hetero-zygous CRISPR\nh females was at odds with the phenotype observed \nin heterozygous docking line females where the disruption of single homozygous", "start_char_idx": 0, "end_char_idx": 3424, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d594a625-15f7-426d-a964-06a4c405e80e": {"__data__": {"id_": "d594a625-15f7-426d-a964-06a4c405e80e", "embedding": null, "metadata": {"page_label": "81", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7d793112-63e0-4df1-a230-2a88b2814a91", "node_type": null, "metadata": {"page_label": "81", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "84b14f8ee154124cb5d8df9364ad05f5398f3a10f24aaf0377ba7736afffa92a"}, "2": {"node_id": "7a504931-95d1-4c33-96f7-93655e7371a4", "node_type": null, "metadata": {"page_label": "81", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "b838df5f65dbcdfb51787af92e78a10a5c89327b0727411277678f944444e68d"}, "3": {"node_id": "6ed7d1f8-06b4-4202-8442-8fb6a861e809", "node_type": null, "metadata": {"page_label": "81", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "f20ac1748482dfbece70fd626e927168a0cb695558e38a53614e7a4697e63c3b"}}, "hash": "d5027124d95f04dffb176b0dcd2dc53d6b3049dae407a414e8d54c65dd68a65e", "text": "heterozygous docking line females where the disruption of single homozygous for the insertion. Visual inspection of G2 progeny identified \ntwo classes of mosquitoes on the basis of GFP intensity, \u2018intermediate\u2019 and \u2018strong\u2019 , which we attributed to the presence of one or two copies of the GFP gene in the heterozygous or homozygous state, respectively, and later confirmed by molecular analysis (Fig. 1b). Fertility assays (egg laying and hatching) performed on individual mosquitoes showed that all homozygous female mosquitoes were sterile, whereas heterozygous females showed normal rates of egg laying and hatching (Fig. 1c). On the basis of these results we concluded that the selected genes should be regarded as haplosufficient female-sterility genes. Manifestation of the impaired fertility phenotype differed across the three genes targeted, consistent with their function at distinct stages of egg production and embryo development: homozygous females carrying two disrupted alleles of either AGAP005958 or AGAP011377 failed to lay eggs, whereas \nhomozygous mutant females at AGAP007280 laid eggs that did not hatch (Supplementary Fig. 2 ).\nAfter validating the female-fertility phenotype of the target genes, \nwe inserted a gene drive construct (CRISPR homing allele, CRISPR\nh) \n(Fig. 2a) into the docking site by recombinase-mediated cassette \nexchange (RMCE)15. Each drive construct was designed to home, in \nboth sexes, into the cognate WT locus and contained the following components: (i) the Cas9  nuclease gene under the control of the vasa2  \npromoter, shown in a previous report to be active in the germline of both sexes\n16; (ii) a gRNA sequence designed to direct the cleavage activity of \nthe nuclease to the same sequence targeted in the gene-knockout experi-ments and under the promoter of the ubiquitously expressed, PolIII-transcribed U6 gene\n17; and (iii) a visual marker (3xP3::RFP). AttB sites \nflanking the CRISPRh construct were used to direct \u0424C31 integrase-\nmediated recombination at the docking site. Aware of the potential for these mosquitoes to show gene drive activity, we housed our mosquitoes in a containment facility consistent with recent recommendations for safeguards in such experiments\n18. Successful cassette exchange events \nwere visually identified among G1 progeny as GFP+ to RFP+ pheno -\ntype conversions, and confirmed using PCR (Supplementary Fig. 3 ). \nAt all three female-fertility loci we recovered double-crossover events that resulted in cassette exchange and insertion of the CRISPR\nh allele, at \ntransformation frequencies of 2\u20137% (Table 1 ). In the cassette exchange \nreaction we observed the insertion of both complete and incomplete CRISPR\nh alleles, the latter probably the result of intramolecular recom-\nbination between regions of homology in the gRNA construct and its endogenous target at the insertion site.\nEach complete integration event generated a CRISPR\nh allele encoding \na Cas9-gRNA endonuclease designed to target the corresponding inte-gration site on a WT chromosome. Accordingly, the CRISPR\nh allele was \nresistant to nuclease cleavage as its target sequence had been interrupted by the insertion of the CRISPR\nh construct itself. In heterozygous mos-\nquitoes the activation of the vasa2  promoter during gamete formation \nshould induce the synthesis of the Cas9 nuclease that, in concert with the ubiquitously expressed gRNA, should cleave the target sequence in Table 2  CRISPRh homing rates remain high across several generations\nLineProgeny with CRISPRh allele in crosses to WT", "start_char_idx": 3359, "end_char_idx": 6923, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6ed7d1f8-06b4-4202-8442-8fb6a861e809": {"__data__": {"id_": "6ed7d1f8-06b4-4202-8442-8fb6a861e809", "embedding": null, "metadata": {"page_label": "81", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7d793112-63e0-4df1-a230-2a88b2814a91", "node_type": null, "metadata": {"page_label": "81", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "84b14f8ee154124cb5d8df9364ad05f5398f3a10f24aaf0377ba7736afffa92a"}, "2": {"node_id": "d594a625-15f7-426d-a964-06a4c405e80e", "node_type": null, "metadata": {"page_label": "81", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "d5027124d95f04dffb176b0dcd2dc53d6b3049dae407a414e8d54c65dd68a65e"}}, "hash": "f20ac1748482dfbece70fd626e927168a0cb695558e38a53614e7a4697e63c3b", "text": "generations\nLineProgeny with CRISPRh allele in crosses to WT (%)Average transmission \nrate per generation (%)Average homing rate \nper generation (%) G2 cross G3 cross G4 cross G5 cross\nAGAP011377 \u2642+/- 91.4 (581/636) 88.4 (1,442/1,631) 93.7 (1,550/1,654) 97.3 (491/505) 92.4 85\nAGAP011377 \u2640+/- 91.7 (55/60) 76.1 (70/92) 85.2 (121/142) 84.6 69\nAGAP005958 \u2642+/- 97.9 (1,654/1,689) 96.4 (268/278) 97.2 94\nAGAP005958 \u2640+/-\nAGAP007280 \u2642+/- 99.6 (1,377/1,383) 98.8 (499/505) 99.2 98\nAGAP007280 \u2640+/- 99.2 (255/257) 99.2 98\nEach generation, heterozygous individuals of each sex from each homing line were crossed to WT mosquitoes and the frequency of the CRISPRh allele among the progeny estimated by scoring \nvisually for the presence of the RFP gene contained within the CRISPRh construct. In all cases the progeny of the CRISPRh male cross were used to maintain the line each generation. Homing \nrate is calculated as the percentage of WT chromosomes converted to homed chromosomes (i.e., (transmission rate \u2013 0.5)*2).\nnpg \u00a9 2016 Nature America, Inc. All rights reserved.", "start_char_idx": 6929, "end_char_idx": 7992, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "15b86604-a610-46df-95e9-f4f391bac995": {"__data__": {"id_": "15b86604-a610-46df-95e9-f4f391bac995", "embedding": null, "metadata": {"page_label": "82", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "da1ae84b-def8-4b78-bc8c-3d7e923d352d", "node_type": null, "metadata": {"page_label": "82", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "8852f6de83b25170cfd9be9bef0ca6df0081b7688cb2f48ffbd581c2c7b206e2"}, "3": {"node_id": "b3faf751-82a0-4ed9-ac47-40c0d5d99d0d", "node_type": null, "metadata": {"page_label": "82", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "9909be5ab2651d7b85d75879f978b18e35af79173f94f9f21cc55d636252fc5d"}}, "hash": "b9d230c1d163ddb586405303b25ea9e1016ed62e0a93f39de6af7b9f31b7f688", "text": "82 V OLUME 34   NUMBER 1   JANUARY 2016   NATURE BIOTECHNOLOGY\nLETTERSalleles of AGAP011377 , AGAP007280 and AGAP005958 apparently did \nnot affect female fertility. This reduction in fertility is probably due to \nsomatic expression of the Cas9 nuclease, as we have observed for a simi -\nlar construct targeting GFP (Supplementary Fig. 5 ), and as others have \nobserved in Drosophila9,20. The nos  promoter has recently been found \nto be substantially more germline-specific in directing Cas9 activity in Drosophila\n20, and our system is flexible so it can accommodate alterna-\ntive promoters.\nOur measures of homing rates and fertility effects can be used with \nthe model of Deredec et al.10 to derive an initial prediction about \nwhether the constructs would be expected to spread if released into a population. This analysis revealed that the fitness cost in terms of reduced reproductive capability imposed by the CRISPR\nh constructs \nat AGAP011377 and AGAP005958 outweigh the homing rate, and the \nconstructs would be expected to disappear from a population over time\u2014in many aspects these constructs match the requirements of female-specific RIDL (release of insects with a dominant lethal) with enhanced transmission\n21, a potent form of the sterile insect technique, \nthough conditional rescue of the sterility may be required for efficient production. However, the higher homing rates observed for CRISPR\nh at \nAGAP007280, combined with the milder fertility reduction observed in heterozygous females indicate that this construct could spread through a population, at least initially, and impose a reproductive load on the population as it does so, fulfilling one of the major requirements for a functional gene drive measure for vector control (Fig. 2f). To investigate the ability of the CRISPR\nh allele to spread at the AGAP007280 locus, \ncaged populations were initiated with CRISPRh/+ and WT individuals \nat equal frequency and monitored over several generations. Consistent with the modeling predictions we observed a progressive increase in the frequency of individuals positive for the CRISPR\nh allele from 50% \nto 75.1% over four generations (Fig. 2g). Such a reproductive load will impose a strong selection pressure for resistant alleles, some of which will be generated by the gene drive system itself through NHEJ or MMEJ repair of endonuclease-induced chromosome breaks, as we previously showed molecularly ( Supplementary Fig. 4 ). The longer term dynamics \nwill depend on the efficiency of spreading on the one hand and the fit-ness cost of mutations arising at the cleavage site on the other hand\n10,22. \nUltimately the effect of these mutations could be mitigated by designing nucleases that target conserved, functionally constrained regions in the target gene and that are tolerant of mutations\n1. This could be achieved \nusing a CRISPR-Cas9 gene drive through the use of multiple gRNAs targeting sequence variants\n7.\nThe high frequency with which gene knockouts were achieved at three \nseparate loci and the ease with which these could be both tracked using a visual marker and secondarily modified to include genes of choice verify the CRISPR-Cas9 gene drive system as a robust gene editing tool that will be valuable for functional genetics in the malaria mosquito. The rates of super-Mendelian inheritance that we observed with CRISPR-based homing constructs at female-fertility loci establish a solid basis for the development of a gene drive system that has the potential to substantially reduce mosquito populations. Moreover, our gene drive element was able to carry substantial additional sequence in the form of the RFP marker unit, indicating that this technology is also resilient to bringing along additional cargo, making it suitable for population-modification strategies that are aimed at modifying vector", "start_char_idx": 0, "end_char_idx": 3849, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b3faf751-82a0-4ed9-ac47-40c0d5d99d0d": {"__data__": {"id_": "b3faf751-82a0-4ed9-ac47-40c0d5d99d0d", "embedding": null, "metadata": {"page_label": "82", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "da1ae84b-def8-4b78-bc8c-3d7e923d352d", "node_type": null, "metadata": {"page_label": "82", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "8852f6de83b25170cfd9be9bef0ca6df0081b7688cb2f48ffbd581c2c7b206e2"}, "2": {"node_id": "15b86604-a610-46df-95e9-f4f391bac995", "node_type": null, "metadata": {"page_label": "82", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "b9d230c1d163ddb586405303b25ea9e1016ed62e0a93f39de6af7b9f31b7f688"}, "3": {"node_id": "95081197-c928-47b0-872c-a1a76b4fa6df", "node_type": null, "metadata": {"page_label": "82", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "dd29de47a10d45744a66f6eb03b99c38ca9f8cd8b8c4e3d2e7da1f5fa4df4920"}}, "hash": "9909be5ab2651d7b85d75879f978b18e35af79173f94f9f21cc55d636252fc5d", "text": "making it suitable for population-modification strategies that are aimed at modifying vector populations with transgenes conferring useful phenotypes such as parasite resistance. Being able to use CRISPR-Cas9 in mosquitoes means that genome edit -\ning and nuclease engineering will no longer be technical bottlenecks in this major pest insect.\nThe success of gene drive technology for vector control will depend \non the choice of suitable promoters to effectively drive homing during the process of gametogenesis, the phenotype of the disrupted genes, the robustness of the nuclease during homing and the ability of the target population to generate compensatory mutations.\nMETHODS\nMethods and any associated references are available in the online \n \nversion \nof the paper .\nAccession codes.  GenBank: KU183683\u2013 KU183700 (sequences of the \ntarget loci, both wild type and those showing mutations);  KU189142  \n(full sequence of vector p165).\nNote: Any Supplementary Information and Source Data files are available in the \nonline version of the paper .\nACKNOWLEDGMENTS\nWe are grateful to C. Bamikole, A. Hall and D. Fabrigar for experimental assistance and to P . Papathanos and S. Fuchs for useful discussion. This work was supported by a grant from the Foundation for the National Institutes of Health through the Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative of the Bill & Melinda Gates Foundation and by the European Research Council under the European Union\u2019s Seventh Framework Programme ERC grant no. 335724 to N.W .\nAUTHOR CONTRIBUTIONS\nA.H., R.G., K.K., A.S., C.S., D.K. and M.G. performed the experiments. E.M. and N.W . developed mosquito reagents. D.B., S.R., T.N. and A.B. developed the logistic regression model. A.B. did the experimental modeling. A.H., R.G., N.W . and T.N. designed the experiments. A.H., A.C., A.B. and T.N. analyzed the data. A.H., A.C. and T.N. wrote the paper.\nCOMPETING FINANCIAL INTERESTS\nThe authors declare no competing financial interests.\nReprints and permissions information is available online at http://www.nature.com/\nreprints/index.html.\n1. Burt, A. Site-specific selfish genes as tools for the control and genetic engineering of  \nnatural populations. Proc. R. Soc. Lond. B 270, 921\u2013928 (2003).\n2. W\nindbichler, N. et al. A synthetic homing endonuclease-based gene drive system in \nthe human malaria mosquito. Nature 473, 212\u2013215 (2011).\n3. Simoni, A. \net al. Development of synthetic selfish elements based on modular nucleases \nin Drosophila melanogaster. Nucleic Acids Res. 42, 7461\u20137472 (2014).\n4. F\nu, Y., Sander, J.D., Reyon, D., Cascio, V.M. & Joung, J.K. Improving CRISPR-Cas \nnuclease specificity using truncated guide RNAs. Nat. Biotechnol. 32, 279\u2013284 \n(2014).\n5. Hsu, P\n.D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. \nBiotechnol. 31, 827\u2013832 (2013).\n6. J\ninek, M. et al.  A programmable dual-RNA-guided DNA endonuclease in adaptive \nbacterial immunity. Science 337, 816\u2013821 (2012).\n7. Esvelt, K.M., Smidler\n, A.L., Catteruccia, F. & Church, G.M. Concerning RNA-guided \ngene drives for the alteration", "start_char_idx": 3769, "end_char_idx": 6930, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "95081197-c928-47b0-872c-a1a76b4fa6df": {"__data__": {"id_": "95081197-c928-47b0-872c-a1a76b4fa6df", "embedding": null, "metadata": {"page_label": "82", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "da1ae84b-def8-4b78-bc8c-3d7e923d352d", "node_type": null, "metadata": {"page_label": "82", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "8852f6de83b25170cfd9be9bef0ca6df0081b7688cb2f48ffbd581c2c7b206e2"}, "2": {"node_id": "b3faf751-82a0-4ed9-ac47-40c0d5d99d0d", "node_type": null, "metadata": {"page_label": "82", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "9909be5ab2651d7b85d75879f978b18e35af79173f94f9f21cc55d636252fc5d"}}, "hash": "dd29de47a10d45744a66f6eb03b99c38ca9f8cd8b8c4e3d2e7da1f5fa4df4920", "text": "Church, G.M. Concerning RNA-guided \ngene drives for the alteration of wild populations. eLife e03401 (2014).\n8. DiCar\nlo, J.E., Chavez, A., Dietz, S.L., Esvelt, K.M. & Church, G.M. Safeguarding \nCRISPR-Cas9 gene drives in yeast. Nat. Biotechnol. doi:10.1038/nbt.3412 (16 \nNovember 2015).\n9. Gantz, V\n.M. & Bier, E. Genome editing. The mutagenic chain reaction: a method for \nconverting heterozygous to homozygous mutations. Science 348, 442\u2013444 (2015).\n10.\n Deredec, A., Burt, A. & Godfray\n, H.C. The population genetics of using homing endo-\nnuclease genes in vector and pest management. Genetics 179, 2013\u20132026 (2008).\n11.\n \nBaker, D.A. et al. A comprehensive gene expression atlas of sex- and tissue-specificity \nin the malaria vector, Anopheles gambiae. BMC Genomics 12, 296 (2011).\n12.\n \nGiraldo-Calder\u00f3n, G.I. et al. VectorBase: an updated bioinformatics resource for inver -\ntebrate vectors and other organisms related with human diseases. Nucleic Acids Res.  \n43, D707\u2013D713 (2015).\n13. Claycomb, J.M., Benasutti, M., Bosco, G., Fenger\n, D.D. & Orr-Weaver, T.L. Gene ampli-\nfication as a developmental strategy: isolation of two developmental amplicons in \nDrosophila. Dev. Cell 6, 145\u2013155 (2004).\n14.\n Hong, C.C. & Hashimoto, C. The maternal nudel protein of \nDrosophila has two distinct \nroles important for embryogenesis. Genetics 143, 1653\u20131661 (1996).\n15. Bateman, J.R., Lee, A.M. & W\nu, C.T. Site-specific transformation of Drosophila via \nphiC31 integrase-mediated cassette exchange. Genetics 173, 769\u2013777 (2006).\n16. Papathanos, P\n.A., Windbichler, N., Menichelli, M., Burt, A. & Crisanti, A. The vasa \nregulatory region mediates germline expression and maternal transmission of proteins in the malaria mosquito Anopheles gambiae: a versatile tool for genetic control strate-gies. BMC Mol. Biol. 10, 65 (2009).\n17.\n \nKonet, D.S. et al. Short-hairpin RNA expressed from polymerase III promoters mediates \nRNA interference in mosquito cells. Insect Mol. Biol. 16, 199\u2013206 (2007).\nnpg \u00a9 2016 Nature America, Inc. All rights reserved.", "start_char_idx": 6945, "end_char_idx": 8990, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "cff898c1-49b3-471c-8436-77ef467f0a0e": {"__data__": {"id_": "cff898c1-49b3-471c-8436-77ef467f0a0e", "embedding": null, "metadata": {"page_label": "83", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b2a8144f-e260-41ce-9862-13cb8a4f9d1b", "node_type": null, "metadata": {"page_label": "83", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "eac86e64011bf8838aaaa4991c467031919a4282ba2eed8b8ca89a7a97b0d660"}}, "hash": "eac86e64011bf8838aaaa4991c467031919a4282ba2eed8b8ca89a7a97b0d660", "text": "NATURE BIOTECHNOLOGY   VOLUME 34   NUMBER 1   JANUARY 2016  83\nLETTERS111, E2967\u2013E2976 (2014).\n21. Thomas, \nD.D., Donnelly, C.A., Wood, R.J. & Alphey, L.S. Insect population control \nusing a dominant, repressible, lethal genetic system. Science 287, 2474\u20132476 \n(2000).\n22.\n Deredec, \nA., Godfray, H.C. & Burt, A. Requirements for effective malaria control with \nhoming endonuclease genes. Proc. Natl. Acad. Sci. USA 108, E874\u2013E880 (2011).18.  Akbari, O.S. et al. BIOSAFETY. Safeguarding gene drive experiments in the laboratory. \nScience 349, 927\u2013929 (2015).\n19. Bae, S., Kweon, J., Kim, H.S. & Kim, J.S. Microhomology-based choice of Cas9 nucle\n-\nase target sites. Nat. Methods 11, 705\u2013706 (2014).\n20.\n Port, \nF., Chen, H.M., Lee, T. & Bullock, S.L. Optimized CRISPR/Cas tools for efficient \ngermline and somatic genome engineering in Drosophila. Proc. Natl. Acad. Sci. USA  \nnpg \u00a9 2016 Nature America, Inc. All rights reserved.", "start_char_idx": 0, "end_char_idx": 929, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5ee2f055-d432-49c6-a2b4-816efc6f18e4": {"__data__": {"id_": "5ee2f055-d432-49c6-a2b4-816efc6f18e4", "embedding": null, "metadata": {"page_label": "OM1", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6d517ac0-ad80-48de-9fb0-6d941c193baf", "node_type": null, "metadata": {"page_label": "OM1", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "d50f9b056f11a12d6b3134477aa3958fbab868e503cedf5e9ee1732cbe8c6b03"}, "3": {"node_id": "6383e10c-3f31-4a32-b4a7-ab1b65e1cd3a", "node_type": null, "metadata": {"page_label": "OM1", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "2c5bcbc94590ac39d717ded3a2feced30b9d4d0df538ee6833467268c1611921"}}, "hash": "90473791c5d276be7a39d74c9a871430e59a31d59e9fe13b15e346a8425ff62a", "text": "NATURE BIOTECHNOLOGY  doi:10.1038/nbt.3439ONLINE METHODS\nChoice of target genes. Sterility Index \u2013 p(sterile). To assess the likely effects on \nsterility as a result of gene inactivation, we created a sterility index with logistic regression models in Drosophila  on the basis of gene expression and the corre-\nlated effects of genetic knock before applying model parameters to the Anopheles  \ngenome. The models were analyzed with the R statistical programming language (http://www.r-project.org/).\nGene expression.  MozAtlas\n11 and FlyAtlas23 gene expression estimates were \nobtained for both Anopheles  and Drosophila  probe sets. In order to make \nAnopheles  gene expression comparable with Drosophila , we pooled together \nsex-specific samples and recorded the maximum intensity in either sex. If mul-tiple probes were present for a gene, expression in each tissue was calculated as maximum probe intensity, whereas probes present in multiple genes were omitted from further analysis. Only probes indicating expression as \u2018present\u2019 in at least three of four biological replicates were included in this analysis. Models were constructed on the basis of rank normalized gene expression in the Head, Carcass, Testis and Ovary of Drosophila  gene expression. For each tissue, gene expression \nwas ranked from lowest to highest expression intensity (ties were allocated the minimum rank for that group of genes) and divided by the number of genes in the data set. Rank-normalized values fall between 0 and 1, which reflect the propor -\ntion of genes with a lower expression value in that tissue, for example, a value of 0.8 indicates that 80% of other genes in that tissue have a lower expression level. Tissue specificity was represented by the tau-statistic\n24. Expression was normal-\nized in each tissue against maximum expression for that gene. These values are divided by the number of tissues (n  \u2013 1) and subsequently summed together. The \nvalue will lie between 0 and 1. A value of 1 equals specific expression. A value of 0 is equal to ubiquitous expression.\nPhenotype annotations.  Phenotype annotations were obtained from FlyBase \n(2011_7) (ref. 25) (Supplementary Table 2 ). For modeling, annotations were \naccepted if the associated gene had either more than ten alleles or evidence of a null sterile annotation. Specifically, genes with more than ten alleles, but not annotated as sterile, were included in the model as NONSTERILE (n = 1,509). Genes annotated with a sterile identifier, and either more than ten alleles or evi-dence of a null sterile mutation were included in models as STERILE (n  = 536). \nThe remaining genes were left as UNKNOWN and not included in modeling (n = 8,886).\nLogistic regression . The results of the logistic regression are shown in \nSupplementary Table 3 . The product (ovary:tau) of ranked ovary expression and \ntissue specificity had the highest correlation with a female sterile annotation. Once we extended the coefficients obtained for Drosophila  to the Anopheles  expression \ndata set for the same tissues, we found 271 Anopheles  genes with a P (sterile) score \n\u22650.5 (the three genes chosen for this study are shown in Supplementary Table 4 , \nthe full list is provided in Supplementary Table 5 ). We refer to the P (sterile) value \nof genes as the sterility index.\nGeneration of donor constructs for gene targeting by CRISPR or TALEN-\nmediated HDR. Gene-targeting vectors were assembled by Gateway cloning (Invitrogen) and designed to contain an attP-flanked 3xP3::GFP marker con-struct enclosed within homology arms extending 2 kb either direction of the expected CRISPR\nh cleavage site, as well as an external 3xP3::RFP marker. Regions \nflanking the target sites for each", "start_char_idx": 0, "end_char_idx": 3729, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6383e10c-3f31-4a32-b4a7-ab1b65e1cd3a": {"__data__": {"id_": "6383e10c-3f31-4a32-b4a7-ab1b65e1cd3a", "embedding": null, "metadata": {"page_label": "OM1", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6d517ac0-ad80-48de-9fb0-6d941c193baf", "node_type": null, "metadata": {"page_label": "OM1", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "d50f9b056f11a12d6b3134477aa3958fbab868e503cedf5e9ee1732cbe8c6b03"}, "2": {"node_id": "5ee2f055-d432-49c6-a2b4-816efc6f18e4", "node_type": null, "metadata": {"page_label": "OM1", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "90473791c5d276be7a39d74c9a871430e59a31d59e9fe13b15e346a8425ff62a"}, "3": {"node_id": "93783ed7-dea3-4ba8-b9dd-0b6403ddec51", "node_type": null, "metadata": {"page_label": "OM1", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "3af2fa049e02acb5b04810a8432818596572145c0e3d41940a3ad28949f489d8"}}, "hash": "2c5bcbc94590ac39d717ded3a2feced30b9d4d0df538ee6833467268c1611921", "text": "3xP3::RFP marker. Regions \nflanking the target sites for each gene were amplified with primers that included the necessary recombinase sites for the Gateway reaction (underlined ). For \nAGAP005958: 5958-T1[5\u02b9 F1]B1\n(GGGGACAAGTTTGTACAAAAAAGCAGGCTGTGCAAGCTAGCCGTTT\n \nC\nGAG) and 5958-T1[5 \u02b9R1]B4 \n(GGGGACAACTTTGTATAGAAAAGTTGGGTGCGCGGCTCCAGTATCT  \nC\nGTCA) as well as 5958-T1[3\u02b9 F1]B3 \n(GGGGACAACTTTGTATAATAAAGTTGAGCTGGATTTCACAATCTCC  \nGA) a\nnd 5958-T1[3\u02b9 R1]B2 \n(GGGGACCACTTTGTACAAGAAAGCTGGGTACTCGTGCATTTGACTG  \nCT\nTCC) to generate the left and right arms of homology, respectively. Regions \nflanking the AGAP007280 target site were amplified using 7280-T1[5\u02b9 F1]B1 \n(GGGGACAAGTTTGTACAAAAAAGCAGGCTCAGATACTGATGCCGCA  \nGGT\nTCA) and 7280-T1[5\u02b9 R1]B4 \n(GGGGACAACTTTGTATAGAAAAGTTGGGTGGAAAGTGAGGAGGAG  \nGGT\nGGTAGTG) as well as 7280-T1[3\u02b9 F1]B3 \n(GGGGACAACTTTGTATAATAAAGTTGTTTCTTCCTCACCTCGCTGCGA)  and 7280-T1[3\u02b9 R1]B2 (GGGGACCACTTTGTACAAGAAAGCTGGGT ACCC  \nCT\nCCAGCTATGAT  CAA\nCATGC) \nto generate the left and right arms of homology, respectively. Regions flanking the AGAP011377 target site were amplified using \n11377-T1[5\u02b9 F1]B1 (GGGGACAAGTTTGTACAAAAAAGCAGGCT CTAG\n \nT\nGGCTACAGGCAG\n GC\nC) and 11377-T1[5\u02b9 R1]B4 (GGGGACAACTTTG  \nT\nATAGAAAAGTTGGGTGGAAATTTTCCGGCGCC\n A\nGGC) as well as \n11377-T1[3\u02b9 F1]B3 (GGGGACAACTTTGTATAATAAAGTTGTTTCTACGT  \nCT\nGCTACAACG) and 11377-T1[3\u02b9 R1]B2 (GGGGACCACTTTGTACAAG  \nAAA\nGCTGGGTAGACGAGTCAACTCCAG\n GGCT) t\no \ngenerate the left and right arms of homology, respectively.\nThe amplified left and right homology arms were cloned by BP reaction \n(Invitrogen) into pDONR221-P1P4 and pDONR221-P3P2, respectively. The resultant pENTR vectors were assembled into donor vectors (pHDRgfp-11377; pHDRgfp-5958; pHDRgfp-7280) by LR reaction (Invitrogen) with an attP-GFP-attP pENTR vector and a destination vector containing a 3xP3::RFP marker exter -\nnal to the arms of the homology that should not be inserted into the target locus during a legitimate homology-directed repair event.\nGeneration of CRISPR and TALEN constructs. A human codon-optimized \nversion of the Streptococcus pyogenes Cas9  gene ( hCas9) was amplified from \npX330 (AddGene/Zhang laboratory) using primers containing SalI and PacI sites, SalI-hCas9-F (aacgtcgacGATCCCGGTGCCACCATGGA) and PacI-hCas9-R", "start_char_idx": 3677, "end_char_idx": 5957, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "93783ed7-dea3-4ba8-b9dd-0b6403ddec51": {"__data__": {"id_": "93783ed7-dea3-4ba8-b9dd-0b6403ddec51", "embedding": null, "metadata": {"page_label": "OM1", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6d517ac0-ad80-48de-9fb0-6d941c193baf", "node_type": null, "metadata": {"page_label": "OM1", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "d50f9b056f11a12d6b3134477aa3958fbab868e503cedf5e9ee1732cbe8c6b03"}, "2": {"node_id": "6383e10c-3f31-4a32-b4a7-ab1b65e1cd3a", "node_type": null, "metadata": {"page_label": "OM1", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "2c5bcbc94590ac39d717ded3a2feced30b9d4d0df538ee6833467268c1611921"}}, "hash": "3af2fa049e02acb5b04810a8432818596572145c0e3d41940a3ad28949f489d8", "text": "and PacI-hCas9-R (aacttaattaaTTTCGTGGCCGCCGGCCTTTT). hCas9 was then subcloned with SalI and PacI into a vasa2  promoter\u2013containing vector before \ncloning into a RMCE vector synthesized by DNA2.0 to contain the vasa   \n3\u02b9 UTR regulatory sequence and a U6::gRNA cassette containing a spacer \ncloning site based on Hwang et al.\n26, all flanked by attB recombination sites. \nThe U6 snRNA polymerase III promoter and terminator sequences were used as described previously\n17. The resultant vector, p165, was digested with BsaI \nand modified to contain individual gRNA spacers by Golden Gate cloning of appropriately designed and annealed oligos bearing complete homology to the intended target sequence with unidirectional overhangs compatible with BsaI-digested p165. The full sequence of vector p165 has been deposited to GenBank (accession ID: KU189142). The resultant vectors containing gRNAs targeting AGAP011377 (gRNA sequence: GCAGACGTAGAAATTTTC), \nAGAP005958 (GAGATACTGGAGCCGCGAGC) and AGAP007280  \n(GGAAGAAAGTGAGGAGGA) were named p16503, p16505 and p16501 respectively. Individual gRNA target sites were identified and assessed for off-targets using both the ZiFiT (http://zifit.partners.org/) and ChopChop (https://chopchop.rc.fas.harvard.edu) websites.\nTALEN binding sites targeting the AGAP011377  gene \nwere selected using the TALE-NT software\n27 and the site \nTCGAAAACACGGGCctggcgccggaaaatTTCTACGTCTGCTAC was cho-sen to cleave at AGAP011377 at a site that overlapped with the corresponding CRISPR site (underlined) in the same gene (Supplementary Fig. 6 ). TALEN-\nexpressing plasmids were assembled by Golden Gate cloning as described\n8 using \nthe GoldyTALEN scaffold as destination vector28. Subsequently, each TALEN \nmonomer was cloned into an Anopheles  expression vector under the expression \nof the vasa2  promoter and 3 \u02b9UTR and the FoKI cleavage domains were modified \nto be active as obligate heterodimer (DD/RR variants).\nThe location of the TALEN and CRISPR recognition sites in relation to the \ncoding sequence of the target genes is shown in Supplementary Figure 6 . Each \nrecognition sequence is followed by the obligatory PAM sequence of 5\u02b9-NGG distal to the region of complementarity in the gRNA sequence.\nMicroinjection of mosquito embryos and selection of transformants. Freshly \nlaid embryos of the Anopheles gambiae  G3 strain, herein referred to as wild type, \nreared under standard conditions of 70% relative humidity at 26 \u00b1 2 \u00b0C were used for microinjections as described elsewhere\n29.\nFor the generation of the hdrGFP docking lines the donor construct (300 ng/\u00b5 l) \ncontaining regions of homology to the relevant target locus was injected together with the relevant CRISPR plasmid (300 ng/\n\u00b5l) f\nor AGAP007280 (p16501) and \nAGAP005958 (p16505) or, for AGAP011377, plasmids expressing the left and right monomers of the TALEN (each at 300 ng/\n\u00b5l). S\nurviving G0 individuals were \ncrossed to WT and positive transformants were identified under fluorescence microscopy as GFP\n+ larvae among the G1 progeny.\nnpg \u00a9 2016 Nature America, Inc. All rights reserved.", "start_char_idx": 5994, "end_char_idx": 9083, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "16c72702-0871-4a87-ad4d-9f26c7329045": {"__data__": {"id_": "16c72702-0871-4a87-ad4d-9f26c7329045", "embedding": null, "metadata": {"page_label": "OM2", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d5999fc5-6e91-4b03-a590-22bbb863d842", "node_type": null, "metadata": {"page_label": "OM2", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "36c57517e7b78afff558407303639901476d2c5d7ffd2bce4a0899519043d192"}, "3": {"node_id": "47b8cce7-5baf-4743-a1e0-854e8523c399", "node_type": null, "metadata": {"page_label": "OM2", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "7aa4cc2da8f646e43ec41841323f28e1758c7aef422282115bb9d3684f3b2f0b"}}, "hash": "52aa62349b14d1e013465b0416cedf0b8b2b91357d2badc1b22df592e45c64f7", "text": "doi:10.1038/nbt.3439    NATURE BIOTECHNOLOGY(TCCGGTGGACCGTTTGTGTG). The sequences of the target loci (both WT \nand those showing mutations) have been deposited in GenBank (accession IDs: KU183683- KU183700).\nFertility assays.  Heterozygous \u2018docking line\u2019 individuals were intercrossed to gen-\nerate heterozygous and homozygous hdrGFP mutants. Offspring were screened for homozygous or heterozygous knock-in mutations by \u2018strong\u2019 or \u2018interme-diate\u2019 intensity of GFP fluorescence, respectively. Male and female individuals from each screened homozygous and heterozygous class were mated to an equal number of wild-type mosquitoes for 5 d. Females were blood fed on an anesthe-tized mouse on the sixth day and a minimum of 40 mosquitoes were isolated individually into 300-ml beakers and allowed to lay 3 d later into a 25-ml cup filled with water and lined with filter paper\n32. For each female, eggs and larvae \nwere counted and 16 larvae were screened for GFP expression using a Nikon inverted fluorescence microscope (Eclipse TE200) to confirm parental hetero/homozygosity at the HDR locus. Heterozygotes were confirmed by the presence of GFP\n\u2013 progeny. Females that did not give larvae were dissected and checked \nunder a microscope for the presence of sperm in their spermathecae. Those which were unmated were excluded from the phenotypic analysis.\nTo confirm HDR hetero/homozygosity in transgenic females that were mated \nbut failed to give progeny, a PCR was performed across the HDR locus using a primer pair designed to amplify both the WT allele (1 kb) and the HDR\n+ allele \n(2.5 kb). The following primer pairs were used for the three genes: AGAP011377  \nusing Seq-11377-F and Seq-11377-R), AGAP005958 using Seq-5958-F and Seq-5958-R, and AGAP007280 using Seq-7280-F and Seq-7280-R.\nFertility assays were performed using CRISPR\nh hemizygotes essentially the \nsame as the docking line phenotype assays with the exception that 50 progeny from each parent were screened for the presence of an RFP-linked CRISPR\nh allele \nto assess the frequency of CRISPRh transmission.\nEthics statement. All animal work was conducted according to UK Home Office Regulations and approved under Home Office License PPL 70/6453.\nCage experiments.  First instar mosquito larvae heterozygous for the CRISPRh  \nallele at AGAP007280 were mixed within 12 h of eclosion with an equal number \nof age-matched WT larvae in rearing trays at a density of 200 per tray (in ~1 liter rearing water). The mixed population was used to seed two starting cages with 600 adult mosquitoes each. For four generations, each cage was fed after allowing 5 d for mating, and an egg bowl placed in the cage 48 h after a blood meal to allow overnight oviposition. After allowing full eclosion, a random sample of offspring were scored under fluorescence microscopy for the presence or absence of the RFP-linked CRISPR\nh allele, then reared together in the same trays and 600 were \nused to populate the next generation.\n23. Chintapalli, V .R., Wang, J. & Dow, J.A. Using FlyAtlas to identify better Drosophila \nmelanogaster models of human disease. Nat. Genet. 39, 715\u2013720 (2007).\n24. \nYanai, I. et al. Genome-wide midrange transcription profiles reveal expression level \nrelationships in human tissue specification. Bioinformatics 21,", "start_char_idx": 0, "end_char_idx": 3295, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "47b8cce7-5baf-4743-a1e0-854e8523c399": {"__data__": {"id_": "47b8cce7-5baf-4743-a1e0-854e8523c399", "embedding": null, "metadata": {"page_label": "OM2", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d5999fc5-6e91-4b03-a590-22bbb863d842", "node_type": null, "metadata": {"page_label": "OM2", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "36c57517e7b78afff558407303639901476d2c5d7ffd2bce4a0899519043d192"}, "2": {"node_id": "16c72702-0871-4a87-ad4d-9f26c7329045", "node_type": null, "metadata": {"page_label": "OM2", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "52aa62349b14d1e013465b0416cedf0b8b2b91357d2badc1b22df592e45c64f7"}, "3": {"node_id": "4a63da66-e883-40d9-89d2-58b2431546cf", "node_type": null, "metadata": {"page_label": "OM2", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "68c9868415e6bfe84b824fae6573f900f7fdce75a1770358b4bbbc7afc435a87"}}, "hash": "7aa4cc2da8f646e43ec41841323f28e1758c7aef422282115bb9d3684f3b2f0b", "text": "reveal expression level \nrelationships in human tissue specification. Bioinformatics 21, 650\u2013659 (2005).\n25. Drysdale, R.A. & Crosby\n, M.A.; FlyBase Consortium. FlyBase: genes and gene \nmodels. Nucleic Acids Res. 33, D390\u2013D395 (2005).\n26. \nHwang, W.Y. et al. Efficient genome editing in zebrafish using a CRISPR-Cas \nsystem. Nat. Biotechnol. 31, 227\u2013229 (2013).\n27. \nCermak, T. et al. Efficient design and assembly of custom TALEN and other TAL \neffector-based constructs for DNA targeting. Nucleic Acids Res. 39, e82 (2011).\n28. \nCarlson, D.F. et al. Efficient TALEN-mediated gene knockout in livestock. Proc. \nNatl. Acad. Sci. USA 109, 17382\u201317387 (2012).\n29. Fuchs, S., Nolan, T\n. & Crisanti, A. Mosquito transgenic technologies to reduce \nPlasmodium transmission. Methods Mol. Biol. 923, 601\u2013622 (2013).\n30.\n \nVolohonsky, G. et al. Tools for Anopheles gambiae transgenesis. G3 (Bethesda) 5, \n1151\u20131163 (2015).\n31.\n Scott, \nT.W. Containment of arthropod disease vectors. ILAR J. 46, 53\u201361 (2005).\n32. Thailayil, J., Magnusson, K., Godfray\n, H.C., Crisanti, A. & Catteruccia, F. Spermless \nmales elicit large-scale female responses to mating in the malaria mosquito \nAnopheles gambiae. Proc. Natl. Acad. Sci. USA 108, 13677\u201313681 (2011).For the recombinase-mediated cassette exchange reactions a mix containing \nthe relevant CRISPR plasmid (200 ng/\n\u00b5l) a\nnd 400 ng/\n\u00b5l va\nsa2::integrase helper \nplasmid30 was injected into embryos of the hdrGFP docking lines. Progeny from \nthe outcross of surviving G0 individuals to WT were screened for the presence \nof RFP and the absence of GFP that should be indicative of a successful cassette-\nexchange event.\nContainment of mosquitoes transformed with a gene drive. All mosquitoes \nwere housed at Imperial College London in an insectary that is compliant with \nArthropod Containment Guidelines Level 2 (ref. 31). All work with transformed mosquitoes was performed under institutionally approved biosafety and proto-cols for genetically modified organisms. In particular GM mosquitoes containing constructs with the potential to show gene drive activity were housed in dedicated cubicles, separated by at least six doors from the external environment and requir -\ning two levels of security card access. Moreover, because of its location in a city with a Northern temperate climate, Anopheles gambiae  mosquitoes housed in \nthe insectary are also ecologically contained. The physical and ecological con-tainment of the insectary are compliant with guidelines set out in a recent com-mentary calling for safeguards in the study of synthetic gene drive technologies\n18.\nMolecular confirmation of gene targeting and recombinase-mediated cas -\nsette exchange. To confirm molecularly the successful integration of docking or CRISPR\nh constructs into their genomic target site, genomic DNA was extracted \nusing the Wizard Genomic DNA purification kit (Promega) from GFP+ or RFP+ \nG1 mosquitoes respectively. Docking sites were interrogated by PCR using prim -\ners binding the docking construct, 5 \u02b9GFP-R (TGAACAGCTCCTCGCCCTTG) \nand 3\u02b9GFP-F (GCCCTGAGCAAAGACCCCAA) with primers binding \nthe genome", "start_char_idx": 3217, "end_char_idx": 6349, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4a63da66-e883-40d9-89d2-58b2431546cf": {"__data__": {"id_": "4a63da66-e883-40d9-89d2-58b2431546cf", "embedding": null, "metadata": {"page_label": "OM2", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d5999fc5-6e91-4b03-a590-22bbb863d842", "node_type": null, "metadata": {"page_label": "OM2", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "36c57517e7b78afff558407303639901476d2c5d7ffd2bce4a0899519043d192"}, "2": {"node_id": "47b8cce7-5baf-4743-a1e0-854e8523c399", "node_type": null, "metadata": {"page_label": "OM2", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}, "hash": "7aa4cc2da8f646e43ec41841323f28e1758c7aef422282115bb9d3684f3b2f0b"}}, "hash": "68c9868415e6bfe84b824fae6573f900f7fdce75a1770358b4bbbc7afc435a87", "text": "with primers binding \nthe genome outside of the homology arms (as portrayed in Supplementary Fig. 1 ): AGAP11377  using DL-11377-F (GGGTGTTAACGTTCCGCCTA) \nand DL-11377-R (ACCCAAGACCACCCAAAGAC), AGAP005958  \nusing DL-5958-F1 (CGGACACGCGGAAGTCTGAA) and DL-5958-R1 (CGACTTTCCCGGAACATTTACCA), and AGAP007280  using \nDL-7280-F1 (AGCACGTGCCGGCTAAAGCT) and DL-7280-R1 (GCCACACCAGCAACAGCCTTATC). For the purposes of producing a shorter amplicon that could reliably amplify both the WT allele and the hdrGFP allele in the same PCR reaction (e.g., Fig. 1 ), the following primer \npairs were used: AGAP011377  (Seq-11377-F (AACCGACAGTCCATCCTTGT) \nand Seq-11377-R (GAGCGTCTTTCGACCTGTTC)); AGAP007280  (Seq-7280-F (GCACAAATCCGATCGTGACA) and \n \nSeq-7280-R (CAGTGGCAGTTCCGTAGAGA)); AGAP005958  \n (\nSeq-5958-F (GCACTCGTCCGCGTTCTGAA) and Seq-5958-R \n(TTTGTGCTGGTGTCCGCGCT)).\nSuccessful cassette exchange of CRISPRh alleles was inter -\nrogated by PCR using primers binding the CRISPRh construct, \nRFP2q-F (GTGCTGAAGGGCGAGATCCACA) and hCas9-F7 (CGGCGAACTGCAGAAGGGAA) with primers binding the genome: AGAP011377  using Seq-5958-F and Seq-5958-R, AGAP005958  using Seq-\n5958-F and Seq-5958-R, and AGAP007280  using Seq-7280-F and Seq-7280-R.\nMolecular confirmation of CRISPR activity at target loci. To assess molecu -\nlarly the activity of CRISPR at the target locus, the target site was sequenced in those progeny (RFP\n\u2013) that apparently failed to receive a CRISPR hom-\ning allele from a hemizygous RFP+ parent. Genomic DNA was extracted \nusing the Wizard Genomic DNA purification kit (Promega). Amplicons 2.5 kb either side of the CRISPR\nh target site in AGAP011377,  AGAP005958 \nand AGAP007280 were amplified with Phusion HF polymerase (Thermo \nScientific) using Seq-11377-F and Seq-11377-R, Seq-5958-F and Seq-5958-R, and Seq-7280-F and Seq-7280-R primers (described above), respectively. PCR products were purified (Qiagen PCR purification kit) and sequenced using internal primers, Seq-11377-F2 (TCGCCATGTACGCCACCAAC), Seq-5958-F2 (CTTGCCGCTGCGCAGATGTT) and Seq-7280-F2 \nnpg \u00a9 2016 Nature America, Inc. All rights reserved.", "start_char_idx": 6396, "end_char_idx": 8505, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0a9f933a-93c1-4b31-a179-f17d05d92bdf": {"__data__": {"id_": "0a9f933a-93c1-4b31-a179-f17d05d92bdf", "embedding": null, "metadata": {"page_label": "1", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1af20325-881e-40df-aa99-7173fcbc25c7", "node_type": null, "metadata": {"page_label": "1", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "9702499dcd271841c8f79b30b271eea8ec2762201f2d8e81980e40f447eeb2b8"}, "3": {"node_id": "feb8aa93-a1cf-4250-9a9a-b0d99c584026", "node_type": null, "metadata": {"page_label": "1", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "434664dea4b84142e2b95e57c93cfc7edde758065c93f7a21b6ed7602bdc22b0"}}, "hash": "2379ea8c2531825273b2b337e75cd3cdb15805d3125b8708d5a9a812ddabce33", "text": "Identification of an infectious progenitor\nfor the multiple-copy HERV-K humanendogenous retroelements\nMarie Dewannieux,1,3Francis Harper,2,4Aur\u00e9lien Richaud,1,4Claire Letzelter,1\nDavid Ribet,1G\u00e9rard Pierron,2and Thierry Heidmann1,5\n1Unit\u00e9 des R\u00e9trovirus Endog\u00e8nes et El\u00e9ments R\u00e9tro\u00efdes des Eucaryotes Sup\u00e9rieurs, UMR 8122 CNRS, Institut Gustave Roussy,\n94805 Villejuif Cedex, France;2Laboratoire de R\u00e9plication de l\u2019ADN et Ultrastructure du Noyau, UPR1983 Institut Andr\u00e9 Lwoff,\n94801 Villejuif Cedex, France\nHuman Endogenous Retroviruses are expected to be the remnants of ancestral infections of primates by active\nretroviruses that have thereafter been transmitted in a Mendelian fashion. Here, we derived in silico the sequence ofthe putative ancestral \u201cprogenitor\u201d element of one of the most recently amplified family\u2014the HERV-K family\u2014andconstructed it. This element, Phoenix, produces viral particles that disclose all of the structural and functional\nproperties of a bona-fide retrovirus, can infect mammalian, including human, cells, and integrate with the exactsignature of the presently found endogenous HERV-K progeny. We also show that this element amplifies via anextracellular pathway involving reinfection, at variance with the non-LTR-retrotransposons (LINEs, SINEs) orLTR-retrotransposons, thus recapitulating ex vivo the molecular events responsible for its dissemination in the hostgenomes. We also show that in vitro recombinations among present-day human HERV-K (also known as ERVK) loci\ncan similarly generate functional HERV-K elements, indicating that human cells still have the potential to produceinfectious retroviruses.\n[Supplemental material is available online at www.genome.org.]\nNearly 8% of the human genome is composed of sequences of\nretroviral origin. Most of them are degenerate, either due to re-combination between the two provirus LTRs or to mutations in-terrupting the retroviral ORFs. The envgene seems to be best\nconserved, with 18 intact genes retaining a full coding capacityin the human genome (Benit et al. 2001; de Parseval et al. 2003;Villesen et al. 2004), possibly because of its potential role in hu-man physiology. The HERV-K(HML2) family of endogenous ret-roviruses is an exception to this general rule, since some copiesstill contain complete ORFs for the other retroviral genes (L\u00f6weret al. 1996; for review, see Bannert and Kurth 2004). This familyincludes the most recently amplified endogenous retroviruses,most of which have integrated into the genome <5 million yearsago, with a few insertions showing polymorphism within thehuman population (Steinhuber et al. 1995; Medstrand and Mager1998; Barbulescu et al. 1999; Turner et al. 2001; Hughes andCoffin 2004; Belshaw et al. 2005). Some of these recently inte-grated proviruses are responsible for the synthesis of retroviralparticles that can be observed in teratocarcinoma and mela-noma-derived cell lines (Boller et al. 1993; L\u00f6wer et al. 1993;Bieda et al. 2001; Muster et al. 2003; Buscher et al. 2005), andpossibly in human placenta (Kalter et al. 1973; Dirksen and Levy1977; Wilkinson et al. 1994). Because of this \u201cactivity,\u201d theHERV-K(HML2) family has been the subject of numerous studiesin the past years, with the description of alleles with nearly intactproviruses and complete coding capacity (Mayer", "start_char_idx": 0, "end_char_idx": 3321, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "feb8aa93-a1cf-4250-9a9a-b0d99c584026": {"__data__": {"id_": "feb8aa93-a1cf-4250-9a9a-b0d99c584026", "embedding": null, "metadata": {"page_label": "1", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1af20325-881e-40df-aa99-7173fcbc25c7", "node_type": null, "metadata": {"page_label": "1", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "9702499dcd271841c8f79b30b271eea8ec2762201f2d8e81980e40f447eeb2b8"}, "2": {"node_id": "0a9f933a-93c1-4b31-a179-f17d05d92bdf", "node_type": null, "metadata": {"page_label": "1", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "2379ea8c2531825273b2b337e75cd3cdb15805d3125b8708d5a9a812ddabce33"}}, "hash": "434664dea4b84142e2b95e57c93cfc7edde758065c93f7a21b6ed7602bdc22b0", "text": "description of alleles with nearly intactproviruses and complete coding capacity (Mayer et al. 1999; Reuset al. 2001; Turner et al. 2001). Despite these efforts, no func-tional provirus able to produce infectious particles has yet beendescribed. Even if several loci containing complete ORFs havebeen identified, and in spite of the availability of the completesequence of the human genome, the search for a functional pro-virus is hampered by the significant polymorphism that can bedetected at each HERV-K(HML2) locus within the human popu-\nlation. To overcome this limitation, we used a reverse strategyand generated a consensus HERV-K(HML2) provirus, thus \u201cresus-citating\u201d Phoenix, the likely progenitor of the last, human-\nspecific HERV-K(HML2) amplification burst. This allowed a defi-nite characterization of the structure and life cycle of an \u201cances-tral\u201d retroviral element and recapitulation of the molecularevents responsible for its amplification.\nResults\nPhoenix, the ancestral HERV-K(HML2) retrovirus\nTo construct a consensus HERV-K(HML2) provirus, we assembledall of the complete copies of the 9.4-kb proviruses that are humanspecific (excluding those with the 292-nt deletion at the begin-ning of the envgene) and aligned their nucleotide sequence to\ngenerate the consensus in silico, taking for each position themost frequent nucleotide. The resulting provirus sequence con-tains, as expected, ORFs for all of the HERV-K(HML2)-encodedproteins (Gag, Pro, Pol, Env, and the accessory Rec protein), withgag,pro, and polseparated by /H115021 frameshifts. Noteworthily, this\nconsensus provirus is distinct from each of the sequences used togenerate it, with at least 20 amino acid changes on the overallsequences (Fig. 1).\nBased on this in silico reconstruction, we then generated a\n3Present address: Department of Immunology and Molecular Pa-\nthology, University College of London, Windeyer Institute, London\nW1T 4JF, UK.\n4These authors contributed equally to this work.\n5Corresponding author.\nE-mail heidmann@igr.fr; fax 33-1-42-11-53-42.Article published online before print. Article and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.5565706.Letter\n1548 Genome Research\nwww.genome.org16:1548\u20131556 \u00a92006 by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/06; www.genome.org Cold Spring Harbor Laboratory Press  on July 28, 2023 - Published by genome.cshlp.org Downloaded from", "start_char_idx": 3234, "end_char_idx": 5646, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "754b8b70-29ff-4a25-99eb-97e0a9383ff3": {"__data__": {"id_": "754b8b70-29ff-4a25-99eb-97e0a9383ff3", "embedding": null, "metadata": {"page_label": "2", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f09b998a-1082-4b58-afec-3686b619651f", "node_type": null, "metadata": {"page_label": "2", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "01e470d088330769126ea3a690306d4772e8c3a5f50fa7028e78e2b6a88c2792"}, "3": {"node_id": "f15684df-522b-42b9-8490-1f0219d2c30c", "node_type": null, "metadata": {"page_label": "2", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "07386a7ccec599d48812a152a064d9c03f6f3a8e4464e8a4d9a3a2c2e10a80f1"}}, "hash": "f31a6ba085bad0fde47216f5dbca0ea079241813181352e832b101637d313908", "text": "molecular clone corresponding to the consensus DNA proviral\nsequence that we named Phoenix, using the related K108 and\nK109 proviruses (which we had previously cloned from a com-mercial human BAC library) as a backbone, and a commercial kitto introduce single nucleotide mutations at each position re-quired to match the consensus. As the HERV-K(HML2) LTRs arenot functional in every cell line (Ruda et al. 2004; Lavie et al.2005), we also replaced the U3 part of the 5 /H11032LTR by the CMVpromoter, with its start site positionedso as to conserve the expected nucleo-tide sequence of the native retroviraltranscript. We also introduced a cloningsite downstream of the envgene into the\nnoncoding U3 region of the 3/H11032 LTR to\npossibly tag (with the neogene) the ret-\nroviral transcript without altering itscoding capacity.\nPhoenix codes for bona-fide\nretroviral particles\nIn a first assay, we introduced the Phoe-\nnixexpression vector into human 293T\ncells, and looked for retroviral particlesby transmission electron microscopy. Asillustrated in Figure 2, A and B, this re-sulted in the synthesis of particles bud-ding from the plasma membrane (notobserved with a control vector), as clas-sically observed with /H9253- (type-C) or /H9254-\n(HTLV) retroviruses, or even lentiviruses(HIV). No preassembled particles weredetected within the cytoplasm, althoughHERV-K(HML2) elements are moreclosely related to /H9252- (type-B/D) retrovi-\nruses based on their polgene (but this is\nconsistent with viral particle morphol-ogy and site of assembly being essen-tially dependent on the gagrather than\nthepolgene). In the extracellular space,\ntwo classes of particles could be ob-served, either with a hollow interior sur-rounded by a dense ring of stain corre-sponding to immature particles or with acondensed hexagonal core correspond-ing most probably to the mature form ofthe virus (Fig. 2C), in which the polypro-teins are cleaved into the final products.Consistently, a provirus with a mutationintroduced into the active site of theprotease (Pro) also produces particles,but all of them disclose the immaturemorphology (Fig. 2F). The particles aresurrounded by prominent spikes (Fig.2D) that can be marked in immuno-electron microscopy experiments withan antibody directed against the SU sub-unit of the HERV-K(HML2) envelopeprotein (Fig. 2E). As expected, thesespikes are absent when the provirus con-tains a premature Stop codon in the env\ngene (Fig. 2G). Altogether, these features\nsuggest that Phoenix can direct the synthesis of complete retro-\nviral particles.\nAs a confirmation, we performed immunoblot analyses of\nthe 293T cells transfected with the proviral vector. As illustratedin Figure 3A, Phoenix, as well as its promutant, promotes the\nsynthesis of a Gag precursor of \u223c80 kDa in cell lysates, as well as\nsome cleaved products (not observed with the promutant).\nCleavage products could also be observed in the supernatant of\nFigure 1. HERV-K(HML2) \u201cendogenization\u201d and present-day human proviruses. (A) Evolutionary\nscheme for HERV-K(HML2) entry into and invasion of the genome of primates. (B) Map of the full-\nlength 9.4-kb long human-specific HERV-K(HML2) proviruses and comparison with the in silico-engineered consensus sequence. Each provirus is represented by a solid dark line, with the amino acidsubstitutions in Gag, Pro,", "start_char_idx": 0, "end_char_idx": 3344, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f15684df-522b-42b9-8490-1f0219d2c30c": {"__data__": {"id_": "f15684df-522b-42b9-8490-1f0219d2c30c", "embedding": null, "metadata": {"page_label": "2", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f09b998a-1082-4b58-afec-3686b619651f", "node_type": null, "metadata": {"page_label": "2", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "01e470d088330769126ea3a690306d4772e8c3a5f50fa7028e78e2b6a88c2792"}, "2": {"node_id": "754b8b70-29ff-4a25-99eb-97e0a9383ff3", "node_type": null, "metadata": {"page_label": "2", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "f31a6ba085bad0fde47216f5dbca0ea079241813181352e832b101637d313908"}}, "hash": "07386a7ccec599d48812a152a064d9c03f6f3a8e4464e8a4d9a3a2c2e10a80f1", "text": "solid dark line, with the amino acidsubstitutions in Gag, Pro, Pol, and Env as compared with the consensus element indicated below the\nline, and the insertions/deletions (ins//H9004) and premature Stop codons (red stars) indicated above the\nline. The ORF map of the consensus provirus is shown, with gagin green, proin pink, polin blue, env\nin orange and yellow, the bipartite recin orange, and the two LTRs as gray boxes. (Note that the first\ncoding exon of recbelongs to the envORF). The transcripts responsible for the expression of the viral\nproteins, with the corresponding spliced out domains (dotted lines), are schematized below the ORF map.A functional HERV-K human endogenous retrovirus\nGenome Research 1549\nwww.genome.org Cold Spring Harbor Laboratory Press  on July 28, 2023 - Published by genome.cshlp.org Downloaded from", "start_char_idx": 3282, "end_char_idx": 4116, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "09b00673-3361-47a6-afa9-10be2001c91e": {"__data__": {"id_": "09b00673-3361-47a6-afa9-10be2001c91e", "embedding": null, "metadata": {"page_label": "3", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "10e3b110-c6bd-4324-aeaf-8389002f32ed", "node_type": null, "metadata": {"page_label": "3", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "bf411a519b838d1d1d54cb86dffa5cec1640cdca2d86d0dd3dd204e68af39390"}, "3": {"node_id": "3e092ae2-3e8a-4cec-be85-263c0c831924", "node_type": null, "metadata": {"page_label": "3", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "b3559d580d0d3ce3473f205a04e39b00d15ec92a5952e22c025db70e6824d0fe"}}, "hash": "104ca9fe67d392cced6ba79fb7f2ce377206abe74e7af3368babd6a5e1b73802", "text": "the transfected cells, except for the promutant that only ex-\npresses the Gag precursor. Similarly, using an antibody directed\nagainst the SU component of the HERV-K(HML2) envelope pro-tein, we detected, in the supernatants, a protein of a size (55 kDa)consistent with that of the processed SU subunit, but we wereunable to detect the Env protein in cell lysates, most probablybecause of a too-low expression level. Notwithstanding, expres-sion of the envelope protein could be observed by immunofluo-rescence analysis using HeLa and 293T cells transiently trans-fected with Phoenix (Fig. 3B). In these cells, it can further be\nobserved that Gag and Env colocalize to some common subcel-lular domains including, as expected, the plasma membrane.\nPhoenix is an infectious retrovirus\nTo get insight into the functionality of this ancestral virus, wethen looked for a reverse-transcriptase activity in the supernatantof the transfected cells. Using the previously described sensitiveproduct-enhanced reverse transcriptase (PERT) assay (Pyra et al.1994; see Methods), an RT activity could indeed be detected inthe supernatant of cells transfected with Phoenix, not observed\nwith a provirus in which we had introduced a mutation withinthe catalytic site of the RT domain (Fig. 3C). To further study theinfectivity potential of Phoenix-derived particles, we then in-\nfected a panel of mammalian cell lines with the supernatant of293T cells transfected with a neo-marked Phoenix provirus, and\nsubjected them to G418 selection. G418\nRclones were obtained\nfor several target cells including hamster BHK21 cells, felineG355.5 cells, and, noteworthily, the human SH-SY5Y and 293cells, indicating that Phoenix is fully functional and infectious\n(Fig. 4A). In the same assay, the human HeLa cells and the mu-rine WOP cells seemed to be resistant to infection, most probablydue to the absence of the appropriate receptor for the Env proteinat the cell surface. We then ensured that the G418\nRclones that\nwere obtained are the result of bona-fide infection. Their occur-rence actually depends on the presence of intact gag,pro,pol, and\nenvgenes, since the inactivation of any of the encoded proteins\nrenders Phoenix noninfectious without decreasing the amount of\nviral particles produced, except for the gagmutant, as assessed by\nWestern Blot (Fig. 4A; data not shown). In these experiments, theapparent titer of Phoenix is quite low even for the cell lines per-\nmissive for infection. A quantitative assay by real-time PCR onthe genomic DNA from BHK21 cells infected with particles gen-erated by Phoenix, marked, or not, by the neogene (see Methods),\nindicated that the presence of neowithin the provirus contributes\nonly to a limited extent to this low titer. A possible explanationis that infection with Phoenix occurs more efficiently via cell\u2013cell\ninteraction, as observed for HTLV and in some cases HIV (seeDiscussion), consistent with some images obtained by electronmicroscopy where budding particles appear to be directly cap-tured by a recipient cell (Fig. 4B).\nNext, we characterized further the G418\nRclones that we\nisolated and determined the provirus insertion sites using an in-verse PCR strategy. Identification of the target loci of these newinsertions was further asserted by direct PCR reactions betweenthe identified flanking sequences and the neogene of the marked\nproviruses (see Methods). In all cases, we found complete LTRswith short target-site duplications (TSDs) bordering the newlyinserted proviruses (Fig. 5), thus confirming that the infectionprocess is canonical. Rather surprisingly, the TSDs were of a vari-able length (one of 5 bp and two of 6 bp), which was", "start_char_idx": 0, "end_char_idx": 3678, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3e092ae2-3e8a-4cec-be85-263c0c831924": {"__data__": {"id_": "3e092ae2-3e8a-4cec-be85-263c0c831924", "embedding": null, "metadata": {"page_label": "3", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "10e3b110-c6bd-4324-aeaf-8389002f32ed", "node_type": null, "metadata": {"page_label": "3", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "bf411a519b838d1d1d54cb86dffa5cec1640cdca2d86d0dd3dd204e68af39390"}, "2": {"node_id": "09b00673-3361-47a6-afa9-10be2001c91e", "node_type": null, "metadata": {"page_label": "3", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "104ca9fe67d392cced6ba79fb7f2ce377206abe74e7af3368babd6a5e1b73802"}}, "hash": "b3559d580d0d3ce3473f205a04e39b00d15ec92a5952e22c025db70e6824d0fe", "text": "were of a vari-able length (one of 5 bp and two of 6 bp), which was unexpectedsince well-characterized retroviral integrases yield TSDs of a fixedlength (for review, see Brown 1997). However, our data are con-sistent with the structures observed for the HERV-K(HML2) en-dogenous copies of the human genome, since, even if the mostcommon length of the endogenous HERV-K proviruses TSD is 6bp, we could identify, both in the literature (Barbulescu et al.1999; Turner et al. 2001) and databases (our unpublished obser-vation), a few elements (three of 15 full-length proviruses) bor-dered by perfect TSD of only 5 bp (see the endogenous K115\nFigure 2. Electron microscopy of the viral-like particles generated by the Phoenix provirus. Human 293T cells were transfected with an expression\nvector for Phoenix (A\u2013E), or mutants (F,G), and observed 48 h post-transfection. (A) Low magnification of particles assembled at the cell membrane. (B)\nRepresentative image of particles budding from the plasma membrane. ( C) High magnification of two particles, one of which (bottom) discloses a mature\n(M) morphology with a condensed core, while the other appears to be still immature (IM) with two dark peripheral rings surrounding an electron-lucent\ncore. (D) High magnification of a particle with prominent spikes, corresponding to the Env protein. (E) Image of a particle after labeling with an antibody\nspecific for the HERV-K envelope protein and a secondary antibody linked to gold beads, obtained by immuno-electron microscopy. Quantification ofthe labeling on 11 independent fields demonstrates association of the gold beads with the viral particles: 307 /H11506121 gold beads/\u00b5m\n2for the viral\nparticles, versus 4.9 /H115063.2 and 1.1 /H115061.5 gold beads/\u00b5m2for the cytoplasm and particle-free extracellular space, respectively (P < 0.001 between viral\nparticles and any of the two other compartments, Student\u2019s t-test). (F) Image of representative particles obtained after transfection with an expression\nvector for the Phoenix pro mutant. All of them disclosed an immature morphology (41 of 41 identified \u201cfree\u201d particles, i.e., no more in the budding\nprocess, for the promutant, vs. 15 of 37 for Phoenix WT). (G) High magnification of a particle obtained after transfection with an expression vector for\nthePhoenix env mutant. The membrane surrounding the particle is clearly detectable, without any spike. Scale bars: (A): 200 nm, (B\u2013G):100 nm.Dewannieux et al.\n1550 Genome Research\nwww.genome.org Cold Spring Harbor Laboratory Press  on July 28, 2023 - Published by genome.cshlp.org Downloaded from", "start_char_idx": 3611, "end_char_idx": 6212, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "30286db6-3820-4c30-896b-24a15d0bad99": {"__data__": {"id_": "30286db6-3820-4c30-896b-24a15d0bad99", "embedding": null, "metadata": {"page_label": "4", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1dbe0886-2bdb-4948-893a-8e1289135704", "node_type": null, "metadata": {"page_label": "4", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "b82fbd8e790248d28470f910b75084116968e146b695cdf4ae0803307ea24143"}, "3": {"node_id": "ae2d3c06-526a-445c-a533-0183b92ec72e", "node_type": null, "metadata": {"page_label": "4", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "0bd1a599e46f9d24866ac3b6a9b265daa3da07854e60977fbe003fd15827e4d9"}}, "hash": "2cdc96c54d89634ed77e5c0cfd7054e754cf010b798d7b55a87b21cb801bd546", "text": "provirus in the lower part of Fig. 5 for an illustration). Finally, we\nmapped the three Phoenix insertion sites using the UCSC Ge-\nnome Browser and found that integration occurred within (fortwo of three) or close to (<20 kb, for one of three) genes. Al-though the number of target sites that we characterized is low,and thus cannot reveal subtle insertion site preferences, the iden-tified loci are consistent with the preferences observed for clas-sical retroviruses that favor insertion in transcribed regions (forreview, see Bushman 2003). Interestingly, the characterization ofthe insertion sites of 11 (nearly) full-length HERV-K(HML2) en-dogenous elements gave a rather different result, with five ofthem found far from known human genes (>100 kb on eachside), four being in the vicinity (<20 kb) of genes, and only twoinserted within genes (M. Dewannieux, unpubl.). This discrep-ancy is probably due to the strong counter-selection that shouldoperate in vivo against insertions within genes, which are mostprobably deleterious for the proper expression of the targetedgenes.HERV-K(HML2) provirus amplification via reinfection\nNext, to get an insight into the possible physiological mecha-nism responsible for the amplification of the HERV-K(HML2)family of endogenous retroviruses, we analyzed the relative effi-ciency of intracellular retrotransposition versus reinfection byPhoenix. To do so, we marked Phoenix with a specific neoindicator\ngene (neo\nTNF), in which neobecomes active only after the marked\nelement has been transcribed, reverse-transcribed, and integrated(Esnault et al. 2002). The marked element was introduced bytransfection into various cell lines, permissive or not, for infec-\nFigure 3. Characterization of Phoenix.( A) Immunoblot analysis of the\nPhoenix products present in the lysates of transiently transfected 293T\ncells, or in the concentrated supernatant. Cells were transfected with (1)\na control plasmid (pCMV-/H9252), (2) an expression vector for Phoenix,o r( 3 )\nan expression vector for a promutant. The membranes were hybridized\nwith an antibody directed against the Gag protein (left) or the Env protein(right). (B ) Immunofluorescence study of 293T cells transfected with\nPhoenix. Gag is marked in red, Env in green, and the nuclei are stained inblue. Note the colocalization of the two proteins, especially at the mem-brane that separates the two adjacent marked cells. (C) Detection of RTactivity in the concentrated supernatant of 293T cells transfected withPhoenix and a series of proviral and control vectors. Concentrated virions\nwere used as a source of RT activity to reverse transcribe synthetic MS2RNA. Presence of cDNA was revealed via a PCR amplification using ap-propriate primers. (1) pCMV-/H9252;( 2)Phoenix;( 3)Phoenix mutated in RT;\n(4) chimera K109-K115; (5) chimera K109-K113; (6) chimera K109-K108;\n(7) MLV core proteins).\nFigure 4. Infectious properties of Phoenix encoded particles. (A) Infec-\ntivity of the HERV-K retroviral particles. The apparent viral titer observedwith the neo-marked HERV-K(HML2) provirus is indicated for a panel of\ntarget cell lines (the quantitative results for the 293 cell line is not shownsince their restricted adherence impaired the proper quantification ofindividual G418\nRclones), together with that obtained with a mutant for\nthe RT domain tested in the same conditions (no clone observed); dataare the results from three to eight independent experiments, with thestandard deviation indicated. The other mutants (gag, pro, and env)", "start_char_idx": 0, "end_char_idx": 3530, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ae2d3c06-526a-445c-a533-0183b92ec72e": {"__data__": {"id_": "ae2d3c06-526a-445c-a533-0183b92ec72e", "embedding": null, "metadata": {"page_label": "4", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1dbe0886-2bdb-4948-893a-8e1289135704", "node_type": null, "metadata": {"page_label": "4", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "b82fbd8e790248d28470f910b75084116968e146b695cdf4ae0803307ea24143"}, "2": {"node_id": "30286db6-3820-4c30-896b-24a15d0bad99", "node_type": null, "metadata": {"page_label": "4", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "2cdc96c54d89634ed77e5c0cfd7054e754cf010b798d7b55a87b21cb801bd546"}}, "hash": "0bd1a599e46f9d24866ac3b6a9b265daa3da07854e60977fbe003fd15827e4d9", "text": "thestandard deviation indicated. The other mutants (gag, pro, and env) gave\nthe same, negative, results when assayed, with no clone observed in threeindependent experiments (difference measured between Phoenix WT and\nmutants significant with P<0.001 for G355.5 and BHK21 cells and P\n<0.01 for SH-SY5Y cells, Student\u2019s t-test). The rationale of the assay is\nschematized at top.( B) Infection of cells by Phoenix particles. On the left,\ntwo mature particles appear to interact with the cell membrane of theclosest cell, with a thickening of the membrane at the exact point ofinteraction with the particle. In the middle and on the right, two images\nsuggestive of a cell-to-cell infection are presented, with a particle stillbudding from its progenitor cell already in contact with the neighboringcell.A functional HERV-K human endogenous retrovirus\nGenome Research 1551\nwww.genome.org Cold Spring Harbor Laboratory Press  on July 28, 2023 - Published by genome.cshlp.org Downloaded from", "start_char_idx": 3460, "end_char_idx": 4444, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ceb39412-e202-44ec-b691-f59091b70308": {"__data__": {"id_": "ceb39412-e202-44ec-b691-f59091b70308", "embedding": null, "metadata": {"page_label": "5", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4b8a3c67-6899-4add-b562-df68a9d3ec82", "node_type": null, "metadata": {"page_label": "5", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "b10c2c74ccd159919bcac9d18ed4d9b72d7711d103ab4d443c34e9f378810e19"}, "3": {"node_id": "4dc9194d-24bf-4b02-aa7f-88362cd168da", "node_type": null, "metadata": {"page_label": "5", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "3e2bd0136e6e003e70461d9fe53e92826919e65e9f54ac794307692d90985c75"}}, "hash": "61fb9046b5851b935509ae1ef9babe0f0311958a9c77a5cc5d30d8831c302f38", "text": "tion. Under these conditions, we reproductively obtained G418R\nclones only with the cell lines permissive for infection (i.e., the\nfeline G355.5 cells, the hamster BHK21 cells, and the humanSH-SY5Y cells) (Fig. 6; data not shown). This suggests that theamplification process must, at some stage, get the envelope pro-tein receptor involved, and thus should occur via an extracellularreinfection process. To confirm this hypothesis, we performedthe same experiment as above, but with the provirus defective fortheenvgene (see Methods), using SH-SY5Y permissive cells. Un-\nder these conditions, no amplification of the marked mutantprovirus was observed. As a control, addition of a CMV-drivenexpression vector for the envelope protein restored, at least par-tially, the mobility of the env-defective provirus (Fig. 6) (partial\nrestoration might be due, indirectly, to an identified cytotoxiceffect of Env overexpression, as commonly observed with thisclass of retroviral transmembrane proteins). Altogether, the re-sults strongly support the hypothesis that HERV-K(HML2) am-plification in the human genome took place via a reinfectionprocess, possibly in the germ line of the developing embryo, aprocess consistent both with evolutionary data indicating thatthe HERV-K(HML2) envgene has been subjected to the same\npurifying selection as the other retroviral genes during amplifi-cation of this family (Belshaw et al. 2004) and with the presenceof retroviral particles in human placenta and in germ-line tumorsmorphologically similar to those produced by Phoenix (Kalter et\nal. 1973; Dirksen and Levy 1977; Boller et al. 1993; L\u00f6wer et al.1993; Wilkinson et al. 1994).\n\u201cRecombination\u201d of human endogenous HERV-K(HML2) loci\ncan generate an infectious retrovirus\nFinally, taking advantage of our present knowledge on the \u201can-\ncestor\u201d of the HERV-K(HML2) family, we asked whether an \u201cav-\nerage human genome\u201d would still be able to generate fully infec-\ntious retroviral particles. With the proviruses that were used toassemble the consensus sequence, we constructed a set of chi-meric elements that could spontaneously emerge via recombina-tion between definite human alleles and were able to express allof the retroviral genes. As described in the Methods, the 5/H11032 part\nwas\u201cborrowed\u201d from the HERV-K109 element, the 3/H11032 end from\nK108, K113, or K115 (Fig. 7), and the heterologous CMV pro-moter was introduced, as for Phoenix, in place of the U3 part of\nthe 5/H11032 LTR. We assayed these three proviruses for a virion-\nassociated RT activity in the supernatant of human 293T cellsfollowing their transient transfection and, remarkably, foundthat the K109/K115 chimera was positive (Figs. 3C, 7). However,this construct is not infectious on its own, most probably becauseof defects in the HERV-K115 envgene (which is noninfectious in\nFigure 6. Assay for Phoenix \u201cretrotransposition.\u201d (Top) Rationale of the\nassay. Phoenix was marked with the neoTNFindicator gene for retrotrans-\nposition (Esnault et al. 2002), in which neobecomes active only after a\ncomplete retrotransposition cycle (i.e., transcription, reverse transcrip-\ntion, and integration), and the marked element was introduced by trans-fection into SH-SY5Y human cells permissive for Phoenix infection. The\ncells were then amplified and subjected to G418 selection for 2 wk; thenumber of G418\nRclones (several of which were assayed by PCR to", "start_char_idx": 0, "end_char_idx": 3407, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4dc9194d-24bf-4b02-aa7f-88362cd168da": {"__data__": {"id_": "4dc9194d-24bf-4b02-aa7f-88362cd168da", "embedding": null, "metadata": {"page_label": "5", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4b8a3c67-6899-4add-b562-df68a9d3ec82", "node_type": null, "metadata": {"page_label": "5", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "b10c2c74ccd159919bcac9d18ed4d9b72d7711d103ab4d443c34e9f378810e19"}, "2": {"node_id": "ceb39412-e202-44ec-b691-f59091b70308", "node_type": null, "metadata": {"page_label": "5", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "61fb9046b5851b935509ae1ef9babe0f0311958a9c77a5cc5d30d8831c302f38"}}, "hash": "3e2bd0136e6e003e70461d9fe53e92826919e65e9f54ac794307692d90985c75", "text": "of G418\nRclones (several of which were assayed by PCR to dem-\nonstrate splicing out of the intron within the neoindicator gene) yielded\nthe frequency of retrotransposition of the marked elements. (Bottom)\u201cRetrotransposition\u201d is dependent on the presence of a functional env\ngene, either present within the native Phoenix provirus (Phoenix WT) or\nadded in trans to an env-mutated Phoenix provirus (Phoenix Stop Env) by\ncotransfection of the cells with an envexpression vector (CMV Env). The\nresults presented here correspond to three independent experiments,performed with 5\u201310 /H1150310\n6cells, and are given as relative transposition\nfrequencies as compared to neoTNF-marked Phoenix (whose transposition\nfrequency is 2 /H1150310/H115025clone/seeded cell under these conditions).\nFigure 5. Structure of three de novo integration sites of Phoenix pro-\nvirus, and comparison with the structure of natural HERV-K provirus in-sertions. The complete characterization of inserted Phoenix elements and\ninsertion sites was performed using individual clones from human SH-SY5Y cells after infection and G418 selection. A provirus insertion and thecorresponding empty site are schematized at the top. The sequences of\nthree characterized Phoenix de novo insertions are shown below, with the\nflanking DNA in uppercase and the proviral sequences in lowercase; tar-get-site duplications of 5/6 bp (TSD, yellow) are found in all cases, asso-ciated with full-length LTRs. For comparison, the corresponding struc-tures of two resident HERV-K proviruses with a polymorphic insertion inhumans (Turner et al. 2001) are presented in the lower part, one with a\n5-bp TSD and one with a 6-bp TSD.Dewannieux et al.\n1552 Genome Research\nwww.genome.org Cold Spring Harbor Laboratory Press  on July 28, 2023 - Published by genome.cshlp.org Downloaded from", "start_char_idx": 3351, "end_char_idx": 5179, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "07341d95-7cd2-4c7d-8535-ad8d7922a35d": {"__data__": {"id_": "07341d95-7cd2-4c7d-8535-ad8d7922a35d", "embedding": null, "metadata": {"page_label": "6", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8e5b980b-174d-4b0a-b125-fc1edbc3e3f1", "node_type": null, "metadata": {"page_label": "6", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "c9e58759d3f14b3aa6b28c79676a979f7e83a45dd085dcc6e1a7a82f827b4c50"}, "3": {"node_id": "b14a46f7-90a2-4a98-9a90-dae4a681d3e4", "node_type": null, "metadata": {"page_label": "6", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "37c9a477c5e4be5a0fea1d89af95605d70ba2af94a0df57b062a5c2f4016c07e"}}, "hash": "995874d82f09dc59d1aecacfce99af3a86bac9b1a0c96360097fb62a875dc04b", "text": "pseudotype experiments, at variance with the K108 envgene)\n(Dewannieux et al. 2005). Therefore we generated a \u201ctriple chi-\nmera\u201d by replacing the envregion in the above construct with\nthat from K108 and assayed it for infection. With this element,\nspecific integration of the provirus (i.e., not observed with Phoe-\nnixmutated in the RT domain used as a control) could be de-\ntected in the BHK21 cells by quantitative PCR (see Methods) at alevel only five- to 10-fold lower than that observed with Phoenix\n(Fig. 7). This indicates that, as observed in AKR mice where amultistep recombination process reproductively generates newinfectious retroviruses (Stoye et al. 1991; Boeke and Stoye 1997),some individuals could reconstitute functional HERV-K(HML2)proviruses either via a three-fragment recombination event, ormore likely via a single recombination event between 2 HERV-Kcopies (e.g., K109 and K115) with complementation in trans by\nan intact envelope protein (e.g., K108). Recombination eventshave indeed occurred frequently between HERV-K(HML2) provi-ruses (Hughes and Coffin 2005). In this way, or even using func-tional (but still uncharacterized) alleles that might be present insome individuals, the HERV-K(HML2) family could repeat its lifecycle and regenerate functional elements that could, in turn, bethe initiators of amplification events to come.\nDiscussion\nIn the present investigation, the reconstruction of an activeHERV-K(HML2) provirus gives access de facto to the first identi-fied human retrovirus of endogenous origin that can conse-quently be characterized at both the structural and functionallevel. Actually, following \u201cendogenization,\u201d which transformed\nits retroviral status into that of a host genomic locus and thusdramatically reduced its evolutionary rate, this element has beenfrozen in time in its ancestral state, which we have recoveredhere. The essential attributes of Phoenix are those of a type-C\nretrovirus, with assembly and budding at the cell membrane,release in the cell supernatant of particles disclosing protrudingspikes that can be unambiguously identified as envelope pro-teins, morphological maturation of the core structure upon viralprotease processing, and finally, infectivity of the particles for arange of target cells. Furthermore, analysis of the integrated pro-viruses associated with infection discloses the specific structuralfeatures of retroviral integration, with precise opening of the tar-get sites, insertion of complete proviral structures with reconsti-tuted LTR, and target-site duplications of a few base pairs. Ofnote, the target-site duplications are not of a fixed length, butvary from 5 to 6 bp. Although this is not common for present-dayinfectious retroviruses, where the target site duplications are offixed lengths (for review, see Brown 1997), this peculiarity is alsoobserved for the endogenous proviral HERV-K loci, as illustrated\nin Figure 5. Possibly, this unusual feature might reflect the \u201cage\u201d\nofPhoenix and be a specific characteristic of its ancestral inte-\ngrase.\nAnother particular trait of Phoenix is its low infectious titer.\nOne possible interpretation could be that this results from itssensitivity to one or more of the multiple cellular defense mecha-nisms that have evolved to counteract the amplification of ret-roelements, thus guarding their hosts against the potentiallyharmful consequences of retrotransposition. The replication ofPhoenix could be limited by RNA interference-mediated gene si-\nlencing, as well as by the action of a variety of host gene-encodedrestriction factors, such as members of the AID/APOBEC cytosinedeaminase family or of the TRIM protein family (for review, seeGoff", "start_char_idx": 0, "end_char_idx": 3696, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b14a46f7-90a2-4a98-9a90-dae4a681d3e4": {"__data__": {"id_": "b14a46f7-90a2-4a98-9a90-dae4a681d3e4", "embedding": null, "metadata": {"page_label": "6", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8e5b980b-174d-4b0a-b125-fc1edbc3e3f1", "node_type": null, "metadata": {"page_label": "6", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "c9e58759d3f14b3aa6b28c79676a979f7e83a45dd085dcc6e1a7a82f827b4c50"}, "2": {"node_id": "07341d95-7cd2-4c7d-8535-ad8d7922a35d", "node_type": null, "metadata": {"page_label": "6", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "995874d82f09dc59d1aecacfce99af3a86bac9b1a0c96360097fb62a875dc04b"}}, "hash": "37c9a477c5e4be5a0fea1d89af95605d70ba2af94a0df57b062a5c2f4016c07e", "text": "family or of the TRIM protein family (for review, seeGoff 2004; Harris and Liddament 2004). Another possible inter-pretation could be that the still not-identified receptor for thisancestral retrovirus has diverged since its entry into the primategenome and is no more adapted to Phoenix, and could even have\nbeen positively selected for this divergence for the sake of thehost. However, a more likely interpretation, consistent with thefrequently observed images shown in Figure 4B, is that its modeof transmission is more closely related to that of retroviruses suchas human HTLV, where virions are poorly infectious and spreadessentially via cell\u2013cell contacts, most probably at the level ofdedicated \u201cvirological synapses\u201d (for review, see Jolly and Satten-\ntau 2004). Similar structures might exist for Phoenix, also consis-\ntent with its relative phylogenetic proximity to delta- (HTLV) andlenti- (HIV) viruses (Tristem 2000; Benit et al. 2001), and shouldactually be particularly well suited to optimize cell reinfectionand proviral amplification. As a matter of fact, despite its lowinfectious titer, another important and related outcome of thepresent investigation is the demonstration that past amplifica-tion of HERV-K has most probably involved an extracellular\npathway and cell reinfection: Indeed, using an appropriate ret-rotransposition assay, we demonstrate that amplification re-quires the presence of a functional envgene, and is only observed\nwith cells that are permissive for infection. Accordingly, themode of amplification of Phoenix is clearly distinct from that\nprevailing for most retroelements naturally present in eukaryotegenomes, which amplify via a strictly intracellular pathway.These elements include the highly reiterated LINE and SINE se-quences, which are non-LTR retrotransposons that replicate alsoby a copy-and-paste mechanism but are not infectious, and theclassical LTR retrotransposons, such as the yeast Ty1 and theDrosophila copia elements, which are closely related to retrovi-\nruses, of which they are most probably the evolutionary precur-sors but do not possess an envgene and transpose intracellularly\n(for review, see Boeke and Stoye 1997; Kazazian Jr. 2004; Dewan-nieux and Heidmann 2005). In this respect, the HERV-K family ofelements has a distinct and specific mode of amplification, whichvery likely also applies to most of the so-called \u201cendogenous\nretroviruses,\u201d and Phoenix, being actually the first infectious\nFigure 7. An infectious HERV-K(HML2) retrovirus can be generated by\nin vitro recombination from cloned HERV-K loci. Structure of the cloned\nHERV-K(HML2) proviruses and of the in vitro constructed chimera (see\nMethods), with the RT activities in the supernatant of 293T cells trans-fected with the corresponding plasmids measured as in Figure 3C, andthe associated infection efficiencies measured by quantitative PCR on thetarget cell genomic DNA (BHK21 cells, see Methods).A functional HERV-K human endogenous retrovirus\nGenome Research 1553\nwww.genome.org Cold Spring Harbor Laboratory Press  on July 28, 2023 - Published by genome.cshlp.org Downloaded from", "start_char_idx": 3639, "end_char_idx": 6768, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3a3df280-effb-488a-9877-348fc9eb5675": {"__data__": {"id_": "3a3df280-effb-488a-9877-348fc9eb5675", "embedding": null, "metadata": {"page_label": "7", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1da45cb7-ec01-418b-9699-1d611a9eb1ea", "node_type": null, "metadata": {"page_label": "7", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "539df705a59035f89e491c47e506ba0eb2db21182110d249ba1da0d1f51bade3"}, "3": {"node_id": "e0f4f9c9-3fc4-4f00-93cd-f13e28621d60", "node_type": null, "metadata": {"page_label": "7", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "83b4fef3bb61a28b23b94ac0b2d174c4243dea6926fc335eb77ed3c1f12cd04d"}}, "hash": "523dd5b62f32fcc7941fc76738d90a6ea140dad23a83124921ef7b507f271ab7", "text": "HERV available to date, can therefore be considered as a model\nelement to characterize the life cycle of these invaders of allmammalian genomes.\nFinally, the present active cloned element provides a potent\ntool to appraise the role of elements of the HERV-K family in arange of diseases where related particles and viral proteins havebeen detected. These include essentially, but not exclusively, hu-man tumors such as germ-line tumors and melanomas, wheresuch elements have been suggested to play a role (Boller et al.1993; L\u00f6wer et al. 1993, 1996; Bieda et al. 2001; Muster et al.2003; Buscher et al. 2005) (for review, see Bannert and Kurth2004). Taking into account their retroviral origin, firmly estab-lished by the present investigation, it is indeed legitimate to hy-pothesize that HERV-K elements have conserved some of thepathological potency of infectious retroviruses, which could ariseupon their transcriptional activation. Clearly, most present-dayinfectious retroviruses are pathogenic and mediate such effectsvia both insertional mutagenesis and the activity of the viralproteins they encode. The present study clearly shows that Phoe-\nnixis a complex retrovirus that can insert into new genomic\nlocations, and that most probably, human cells can generate ac-tive retroviruses by recombination between genomic loci. Asshown in the Results section, in vitro recombination betweencloned HERV-K copies indeed generate a functional element (andactive when further placed under the control of the strong CMVpromoter) and it is likely, taking into account the polymorphismof such elements in the human population, that some allelesmight still be functional and even become fully active in somedefinite circumstances. Search for such alleles, possibly amongindividuals with specific tumors where HERV-K elements are ex-pressed and viral particles detected, should now be performedusing Phoenix as a functional \u201creference\u201d element together with\nthe presently devised infectivity assay.\nAltogether, the present results have allowed the structural\nand functional characterization of the oldest active retrovirusisolated to date and the unraveling of the molecular scenarioresponsible for its successful amplification in primate genomes.They also provide tools for elucidating the role of its \u201cgenomic\noffspring\u201d in human diseases, in particular in some tumors that\nhave primarily been qualified as of genetic origin, but could ul-timately turn out to have a bona-fide retroviral basis. In thisrespect, this study also suggests that more appropriate safety con-ditions should be considered for the manipulation of such tissuesand tumor cell lines.\nMethods\nIn silico engineering and in vitro reconstruction\nof the HERV-K(HML2) consensus provirus\nTo generate the consensus HERV-K(HML2) provirus sequence, we\ntook the nucleotide sequences of the nine full-length, human-specific, 9.4-kb class proviruses that can be found in sequencedatabases and publications and aligned them using ClustalW togenerate the consensus sequence (see Supplemental Fig. 1;Supplemental Table 1). To obtain a backbone for the Phoenix\nprovirus expression vector, we subcloned the K108 and K109proviruses by digesting commercial BAC clones RP11-33P21 andRP11-152J15 (BACPAC Resources), and generated chimeric con-structs to get closer to the consensus sequence. Fragments fromthese chimeric constructs were placed in pALTER-1 plasmid (Pro-mega) and subjected to successive rounds of site-directed muta-genesis using the Altered Sites II in vitro Mutagenesis System(Promega) and appropriate primers. When all expected muta-tions had been introduced, the Phoenix provirus was reassembled\nin the pBluescript plasmid and we checked the whole constructby sequencing. To generate the CMV expression vector, the", "start_char_idx": 0, "end_char_idx": 3781, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e0f4f9c9-3fc4-4f00-93cd-f13e28621d60": {"__data__": {"id_": "e0f4f9c9-3fc4-4f00-93cd-f13e28621d60", "embedding": null, "metadata": {"page_label": "7", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1da45cb7-ec01-418b-9699-1d611a9eb1ea", "node_type": null, "metadata": {"page_label": "7", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "539df705a59035f89e491c47e506ba0eb2db21182110d249ba1da0d1f51bade3"}, "2": {"node_id": "3a3df280-effb-488a-9877-348fc9eb5675", "node_type": null, "metadata": {"page_label": "7", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "523dd5b62f32fcc7941fc76738d90a6ea140dad23a83124921ef7b507f271ab7"}, "3": {"node_id": "ea160cf8-1bb7-4ea0-9668-65cc0062314d", "node_type": null, "metadata": {"page_label": "7", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "50589c62dc08916de1ad513215b5d804b7e48fa8414e4677f46373d244474e53"}}, "hash": "83b4fef3bb61a28b23b94ac0b2d174c4243dea6926fc335eb77ed3c1f12cd04d", "text": "we checked the whole constructby sequencing. To generate the CMV expression vector, the CMVpromoter region was isolated from pCMV\u00df (Clontech, EcoRI\u2013\nSacI fragment) and used it to replace the U3 part of the 5/H11032 LTR,\nusing PCR, so as to keep the transcription start site unchanged.\nPoint mutations within the protease and RT motifs (from\nLVDTGA to LVaaaA and from YIDD to aIaa, respectively) wereintroduced using the Altered Sites II in vitro Mutagenesis System(Promega) and appropriate primers. Inactivation of the gaggene\nwas achieved via an in-phase deletion between the SfoI andPshAI unique sites, and the envgene was disrupted by inserting a\nsmall synthetic linker containing Stop codons in all six frames atthe unique StuI site (located at the end of the SU subunit, posi-tion 7784 in the sequence provided in Supplemental Fig. 1).\nThis series of expression vectors was marked with the SV neo\nresistance gene or SV neo\nTNFretrotransposition indicator gene by\ninserting fragments taken from pSVneo* and pSVneoTNFplas-\nmids (Esnault et al. 2002), respectively, at position 8662 of theconsensus sequence (position according to the sequence pro-vided in Supplemental Fig. 1).\nConstruction of chimeric HERV-K proviruses\nTo generate the chimeric HERV-K proviruses, we first constructedan expression vector for the HERV-K109 copy by replacing theU3 part of its 5/H11032 LTR by the CMV promoter region. The 3/H11032 part of\nthis provirus was replaced by the corresponding sequences ofK113 and K115 proviruses (from the unique SexAI site to the end)or K108-1 (from the SacI site to the end). For the triple chimeraK109-K115-K108, the 3/H11032 domain of K109-K115 was replaced by\nthe corresponding part of the K108-1 provirus (from the XbaI siteto the end).\nProduction of antibodies: Western blot analysis\nand immunofluorescence studies\nWe developed a polyclonal anti-HERV-K Gag antiserum by im-\nmunizing rabbits with a mix of purified recombinant proteinsproduced in bacteria, covering the complete HERV-K113 Gagprotein. The resulting sera were checked by Immunoblot analysesand affinity-purified before use (Agrobio). The monoclonal anti-body directed against the SU subunit of the HERV-K envelopeprotein has already been described (Dewannieux et al. 2005). Wealso raised a rabbit antiserum specific for the HERV-K envelopeprotein using a recombinant protein produced in bacteria, cor-responding to aa 223\u2013437 of the K109 Env protein.\nFor analysis of retroviral protein expression and cleavage,\n293T cells transiently transfected with the provirus expressionvectors (using Lipofectamine and +Reagent; Invitrogen) werelysed in Laemmli buffer 48 h post-transfection and lysate pro-teins directly separated by SDS-PAGE, followed by transfer ontonitrocellulose membranes (Schleicher and Schuell) and incuba-tion with the appropriate antibody and with a secondary anti-body linked to Horseradish peroxidase. For analysis of cell super-natants, 293T cells were transfected by the Calcium Phosphatemethod using the MBS commercial kit (Stratagene). Particulatematerial in the medium was concentrated by ultracentrifugationon a 20% sucrose cushion 48 h post-transfection, and the virionswere lysed in Laemmli buffer before viral protein analysis bySDS-PAGE and immunoblotting.\nImmunofluorescence analysis of the intracellular localiza-\ntion of Gag and Env was carried", "start_char_idx": 3707, "end_char_idx": 7066, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ea160cf8-1bb7-4ea0-9668-65cc0062314d": {"__data__": {"id_": "ea160cf8-1bb7-4ea0-9668-65cc0062314d", "embedding": null, "metadata": {"page_label": "7", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1da45cb7-ec01-418b-9699-1d611a9eb1ea", "node_type": null, "metadata": {"page_label": "7", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "539df705a59035f89e491c47e506ba0eb2db21182110d249ba1da0d1f51bade3"}, "2": {"node_id": "e0f4f9c9-3fc4-4f00-93cd-f13e28621d60", "node_type": null, "metadata": {"page_label": "7", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "83b4fef3bb61a28b23b94ac0b2d174c4243dea6926fc335eb77ed3c1f12cd04d"}}, "hash": "50589c62dc08916de1ad513215b5d804b7e48fa8414e4677f46373d244474e53", "text": "analysis of the intracellular localiza-\ntion of Gag and Env was carried out on 293T cells transientlytransfected with the Phoenix expression vector. Cells were fixed\n30 h post-transfection, permeabilized, and stained with a rabbitDewannieux et al.\n1554 Genome Research\nwww.genome.org Cold Spring Harbor Laboratory Press  on July 28, 2023 - Published by genome.cshlp.org Downloaded from", "start_char_idx": 7070, "end_char_idx": 7455, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b2b1abc5-e4a4-4fc3-90e7-a092a00250fb": {"__data__": {"id_": "b2b1abc5-e4a4-4fc3-90e7-a092a00250fb", "embedding": null, "metadata": {"page_label": "8", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c4d62c21-fd18-44c7-8cae-887634363ed4", "node_type": null, "metadata": {"page_label": "8", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "fb0136697ebb32c463f11ffd13d02fbbe61b860ea76cb21198bc45136b5656b2"}, "3": {"node_id": "c3891d57-6330-4e6c-ad04-bbc8ee57b996", "node_type": null, "metadata": {"page_label": "8", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "64f5f68f2d5831b02fd95cd456ef05922c728217c887990c751fa9f42e3d3f05"}}, "hash": "79882198c2d5b6664144899554848bb008d3a5c9a625435c3970caec7d976872", "text": "polyclonal anti-Gag serum and a mouse monoclonal anti-Env\nantibody. Alexa 546-conjugated goat anti-rabbit IgG and Alexa488-conjugated goat anti-mouse IgG were used as secondary an-tibodies (Molecular Probes); nuclei were stained with Dapi andTopro3 (Molecular Probes).\nElectron microscopy\nFor morphological studies, cells were fixed in phosphate buffer(pH 7.2), 3% glutaraldehyde for 1 h, and post-fixed in 0.1 Mcacodylate buffer, 1% osmium tetroxyde for 2 h. After beingrinsed for 5 min in water and 15 min in 0.1 M cacodylate buffer,cells were transferred to 0.2 M cacodylate buffer for 30 min. Cellswere washed in 30% methanol for 10 min, stained in 2% uranylacetate in 0.1 M cacodylate buffer , 30% methanol for 1 h, andwashed in 30% methanol. Cells were then dehydrated through agraded ethanol-propylene oxide series and embedded in Epon812. Ultrathin sections were collected on formvar-carbon-coatedgold grids (200-mesh), stained with 4% uranyl acetate and leadcitrate, and examined with a Zeiss 902 microscope at 80 Kv.\nFor immuno-electron microscopy experiments, transfected\ncells were fixed for1ha t4 \u00b0C with either 4% formaldehyde or\n1.6% glutaraldehyde in 0.1 M phosphate buffer (pH 7.3). Duringfixation, the cells were scraped from the plates and centrifuged.Pellets were dehydrated in increasing concentrations of metha-nol and embedded in Lowicryl K4M at low temperature. Poly-merization was carried out for5da t\u2013 30\u00b0C under long-\nwavelength UV light. Ultrathin sections of Lowicryl-embeddedmaterial were collected on formvar-carbon-coated gold grids(200-mesh) and used for labeling with a rabbit antiserum specificfor the SU subunit of the HERV-K envelope protein, followed byincubation with a goat anti-rabbit IgG conjugated to gold par-ticles, 10 nm in diameter. Sections were contrasted as above. Thespecificity of the association between the gold beads and the viralparticles was performed by counting, in 11 independent fields,the number of gold particles/\u00b5m\n2within three \u201ccompartments\u201d\n(viral particles, cytoplasm, and particle-free extracellular space).\nRT assay\nAssays for the presence of RT activity in cell supernatants wereperformed using transiently transfected 293T cells. At day 2 post-transfection, the medium was harvested, filtered through 0.45-\u00b5m pore-sized membranes, and particulate material concentratedby ultracentrifugation on a 20% sucrose cushion. The virionswere lysed in Buffer A (25 mM Tris, 0.25 mM EDTA, 50 mM KCl,5 mM DTT, 0.025% Triton X-100, 50% glycerol) and used as areverse-transcriptase source for reverse transcription of commer-cial MS2 RNA (adapted from the PERT assay described in Pyra etal. 1994). Briefly, 300 ng of MS2 RNA were annealed to 16 pmolof RT-1 primer and incubated with viral lysate corresponding to1\u20132 mL of cell supernatant. cDNA synthesis was then assayedusing 1/25 of the RT reaction as a template for a 25 cycle PCRreaction conducted with RT-1 and RT-2 primers (Pyra et al. 1994).In these assays, expression vectors for the MLV and HIV coreproteins were used as positive controls and CMV-/H9252 (Clontech)\nas a negative control.\nInfection and retrotransposition", "start_char_idx": 0, "end_char_idx": 3137, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c3891d57-6330-4e6c-ad04-bbc8ee57b996": {"__data__": {"id_": "c3891d57-6330-4e6c-ad04-bbc8ee57b996", "embedding": null, "metadata": {"page_label": "8", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c4d62c21-fd18-44c7-8cae-887634363ed4", "node_type": null, "metadata": {"page_label": "8", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "fb0136697ebb32c463f11ffd13d02fbbe61b860ea76cb21198bc45136b5656b2"}, "2": {"node_id": "b2b1abc5-e4a4-4fc3-90e7-a092a00250fb", "node_type": null, "metadata": {"page_label": "8", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "79882198c2d5b6664144899554848bb008d3a5c9a625435c3970caec7d976872"}, "3": {"node_id": "692cab3c-7b0c-49b6-a137-0f8b7e11c60b", "node_type": null, "metadata": {"page_label": "8", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "07acf7f53cc98994efd04d0d15f0da2cf3bca346ee5479e84864777d59ba9c79"}}, "hash": "64f5f68f2d5831b02fd95cd456ef05922c728217c887990c751fa9f42e3d3f05", "text": "(Clontech)\nas a negative control.\nInfection and retrotransposition assays\nFor infection assays, 293T cells were used as producer cells, fol-lowing transient transfection with the consensus provirus by theCalcium Phosphate method (Stratagene MBS commercial kit).Target cell lines (SH-SY5Y, BHK21, G355.5, HeLa, and WOP) wereseeded the day before infection in 6-well plates. The day of in-fection, the supernatants of 293T cells were harvested, filteredthrough 0.45-\u00b5m pore-sized membranes, and added to targetcells (1 mL per well, with 4 \u00b5g/mL polybrene). To increase thesensitivity of the assay, the target cells were then subjected to\u201cspinoculation\u201d (centrifugation at 1200g for 2.5 h) and incubated\novernight at 37\u00b0C before medium change. For detection of infec-tion events, target cells were split into 10-cm plates (\u223c5 /H1150310\n5\ncells per plate) at day 3 post infection and subjected to G418selection 24 h later. For infection assays using quantitative PCR,10\n5BHK21 cells were seeded in 6-well plates and used as target\ncells. At day 2 post-infection, the cells were washed with DNaseIto remove residual DNA and split, and genomic DNA was recov-ered at days 5\u20136 post-infection. DNA purification was performedvia two successive phenol/chloroform extractions followed byethanol precipitation. Integration events were detected with theTaqman technology using a 5/H11032 -FAM MGB probe (6FAM-\nATAGTGTATGGGTACCTGGC-MGBNFQ, Applied Biosystems)and primers specific for the HERV-K(HML2) family (5/H11032-GCCTTTCCCGCCCTTAATT-3/H11032 and 5/H11032 -GCAGGGCAGCGATCATCTA-3/H11032 ),\nand 500 ng of genomic DNA as a template. The infectious titerswere estimated by comparison with a standard obtained by mix-ing genomic DNAs extracted from naive BHK21 cells and from aclone containing a single inserted provirus in varying propor-tions. In this assay, the titer of Phoenix WT was in the 10\n3in-\nfectious particles/milliliter range. BHK21 cells were chosen as thetarget cell line, since their genomic DNA generates only verylimited background with the HERV-K-specific primers and probe\nused in this assay; genomic DNA of BHK21 cells infected withPhoenix particles deficient for the RT was used as a negative con-\ntrol to rule out contamination by residual DNA that could origi-nate from the transfected plasmid or genomic DNA of the pro-ducer cells.\nFor retrotransposition assays, 7.5 /H1150310\n5SH-SY5Y cells were\nseeded in 60-mm dishes the day prior to transfection. Transfec-tion was performed using 8 \u00b5L of Plus Reagent (Invitrogen), 12 \u00b5Lof Lipofectamine (Invitrogen), and 3 \u00b5g of DNA (2.5 \u00b5g of Phoe-\nnix-derived expression vector and 0.5 \u00b5g of envexpression plas-\nmid or control plasmid). Cells were grown for 1 wk before platingon 10-cm plates and subsequent selection with G418. The resultspresented here correspond to three independent experimentsperformed with 5\u201310 /H1150310\n6cells and are given as relative trans-\nposition frequencies as compared with neoTNF-marked Phoenix\n(whose absolute transposition frequency is 2 /H1150310/H115025clone/\nseeded cell under these conditions).\nCharacterization of HERV-K(HML2) de novo insertion sites\nIntegration sites were analyzed by inverse PCR using individualG418\nRclones essentially as described", "start_char_idx": 3077, "end_char_idx": 6319, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "692cab3c-7b0c-49b6-a137-0f8b7e11c60b": {"__data__": {"id_": "692cab3c-7b0c-49b6-a137-0f8b7e11c60b", "embedding": null, "metadata": {"page_label": "8", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c4d62c21-fd18-44c7-8cae-887634363ed4", "node_type": null, "metadata": {"page_label": "8", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "fb0136697ebb32c463f11ffd13d02fbbe61b860ea76cb21198bc45136b5656b2"}, "2": {"node_id": "c3891d57-6330-4e6c-ad04-bbc8ee57b996", "node_type": null, "metadata": {"page_label": "8", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "64f5f68f2d5831b02fd95cd456ef05922c728217c887990c751fa9f42e3d3f05"}}, "hash": "07acf7f53cc98994efd04d0d15f0da2cf3bca346ee5479e84864777d59ba9c79", "text": "were analyzed by inverse PCR using individualG418\nRclones essentially as described (Dewannieux et al. 2003).\nBriefly, 5 \u00b5g of DNA from each clone was digested with PvuII andeither (1) DraI, (2) SspI, or (3) with a mix of XbaI, AvrII, and SpeI,or (4) with ApoI alone. After enzyme removal, DNA was dilutedand self-ligated overnight. It was ethanol-precipitated, dissolvedin 20 \u00b5L of Tris 10 mM, and subjected to one (or in some casestwo) round of PCR with sets of divergent primers located withintheneogene and designed for the amplification of the 5/H11032 or 3/H11032\nend and flanking sequences of the newly inserted proviruses. Theamplified DNAs were gel-purified, cloned, and sequenced, thusyielding the target-site sequences. The identification of these in-sertion sites was further confirmed by PCR reactions allowingdirect amplification of both left and right junctions between thenewly inserted proviruses and the identified loci, using for eachreaction a primer specific for the identified insertion locus and aninternal primer located in the neogene. In each case, we checked\nthat the same reactions performed on the naive, noninfectedtarget cells did not yield any specific amplification. Primer se-quences are available on request.A functional HERV-K human endogenous retrovirus\nGenome Research 1555\nwww.genome.org Cold Spring Harbor Laboratory Press  on July 28, 2023 - Published by genome.cshlp.org Downloaded from", "start_char_idx": 6298, "end_char_idx": 7725, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "41f86849-1423-4f47-843d-3a4189de53b4": {"__data__": {"id_": "41f86849-1423-4f47-843d-3a4189de53b4", "embedding": null, "metadata": {"page_label": "9", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9c07f040-46fc-410b-a8c6-3ffd10943c0f", "node_type": null, "metadata": {"page_label": "9", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "ddec4f4f7501245ec18fd44825fc3a230daaaccd212b041f1afb8b656f9a5c2c"}, "3": {"node_id": "9ed0940b-daf0-437b-b813-fea55fcbac5a", "node_type": null, "metadata": {"page_label": "9", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "7c12976ed6881519ddd3e8332fcbd56039bff5ff19dec828a554e7e04e1450af"}}, "hash": "2451aedd2c3772e3b5dd6d839ec8db91e58e8d197ff7603ea4a9d3833256db7f", "text": "Safety precautions\nAll manipulations involving the reconstructed HERV-K were car-\nried out in our lab according to the rules established by the\u201cCommission de G\u00e9nie G\u00e9n\u00e9tique\u201d from the \u201cMinist\u00e8re d\u00e9l\u00e9gu\u00e9\n\u00e0l\u2019Enseignement sup\u00e9rieur et \u00e0la Recherche\u201d French authority\nthat regulates handling of genetically modified organisms in allresearch institutions in France.\nAlbeit the HERV-K virus has a very low infectivity and does\nnot sustain multiple-cycle infection, at least in all the cells tested,Phoenix is a retrovirus, and as such, is a priori eligible to BL3\nconditions for manipulation. Accordingly, the material will onlybe sent to other labs in appropriate sealed containers in the formof small amounts of plasmid DNA that will require it to be am-plified before use as a transfection vector to produce viral par-ticles. At the present time and as a precautionary principle, it willonly be distributed under a material transfer agreement specify-ing the commitment of the recipient labs to carry out every ex-periment using the material under BL3 conditions and accompa-nied by a duly signed authorization form from the BiosafetyCommittee responsible for genetic manipulations in their coun-try of origin.\nAcknowledgments\nWe thank A. Jalil for assistance with confocal microscopy, E.Pichard for technical assistance, and C. Lavialle for critical read-ing of the manuscript. This work was supported by the CNRS andby grants from the Ligue Nationale contre Le Cancer (EquipeLabellis\u00e9e).\nReferences\nBannert, N. and Kurth, R. 2004. Retroelements and the human genome:\nNew perspectives on an old relation. Proc. Natl. Acad. Sci.\n101: 14572\u201314579.\nBarbulescu, M., Turner, G., Seaman, M.I., Deinard, A.S., Kidd, K.K., and\nLenz, J. 1999. Many human endogenous retrovirus K (HERV-K)\nproviruses are unique to humans. Curr. Biol. 9:861\u2013868.\nBelshaw, R., Pereira, V., Katzourakis, A., Talbot, G., Paces, J., Burt, A.,\nand Tristem, M. 2004. Long-term reinfection of the human genomeby endogenous retroviruses. Proc. Natl. Acad. Sci. 25:25.\nBelshaw, R., Dawson, A.L., Woolven-Allen, J., Redding, J., Burt, A., and\nTristem, M. 2005. Genomewide screening reveals high levels ofinsertional polymorphism in the human endogenous retrovirusfamily HERV-K(HML2): Implications for present-day activity. J. Virol.\n79:12507\u201312514.\nBenit, L., Dessen, P., and Heidmann, T. 2001. Identification, phylogeny,\nand evolution of retroviral elements based on their envelope genes.J. Virol. 75:11709\u201311719.\nBieda, K., Hoffmann, A., and Boller, K. 2001. Phenotypic heterogeneity\nof human endogenous retrovirus particles produced byteratocarcinoma cell lines. J. Gen. Virol. 82:591\u2013596.\nBoeke, J.D. and Stoye, J.P. 1997. Retrotransposons, endogenous\nretroviruses, and the evolution of retroelements. In Retroviruses (eds.\nJ.M. Coffin et al.), pp. 343\u2013435. Cold Spring Harbor LaboratoryPress, Cold Spring Harbor, NY.\nBoller, K., K\u00f6nig, H., Sauter, M., Mueller-Lantzsch, N., L\u00f6wer, R., L\u00f6wer,\nJ., and Kurth, R. 1993. Evidence that HERV-K is the endogenousretrovirus sequence that codes for the", "start_char_idx": 0, "end_char_idx": 3056, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9ed0940b-daf0-437b-b813-fea55fcbac5a": {"__data__": {"id_": "9ed0940b-daf0-437b-b813-fea55fcbac5a", "embedding": null, "metadata": {"page_label": "9", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9c07f040-46fc-410b-a8c6-3ffd10943c0f", "node_type": null, "metadata": {"page_label": "9", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "ddec4f4f7501245ec18fd44825fc3a230daaaccd212b041f1afb8b656f9a5c2c"}, "2": {"node_id": "41f86849-1423-4f47-843d-3a4189de53b4", "node_type": null, "metadata": {"page_label": "9", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "2451aedd2c3772e3b5dd6d839ec8db91e58e8d197ff7603ea4a9d3833256db7f"}, "3": {"node_id": "835b5bac-2732-4be4-95f4-d9b21d41d39e", "node_type": null, "metadata": {"page_label": "9", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "c47c53c8051e1a7b8f0445886b55acdf0f40e735d4a192bdb00070419dd0c59f"}}, "hash": "7c12976ed6881519ddd3e8332fcbd56039bff5ff19dec828a554e7e04e1450af", "text": "1993. Evidence that HERV-K is the endogenousretrovirus sequence that codes for the humanteratocarcinoma-derived retrovirus HTDV. Virology 196: 349\u2013353.\nBrown, P.O. 1997. Integration. In Retroviruses (eds. J.M. Coffin et al.),\npp. 161\u2013204. Cold Spring Harbor Laboratory Press, Cold SpringHarbor, NY.\nBuscher, K., Trefzer, U., Hofmann, M., Sterry, W., Kurth, R., and\nDenner, J. 2005. Expression of human endogenous retrovirus K inmelanomas and melanoma cell lines. Cancer Res. 65:4172\u20134180.\nBushman, F.D. 2003. Targeting survival. Integration site selection by\nretroviruses and LTR-retrotransposons. Cell115: 135\u2013138.\nde Parseval, N., Lazar, V., B\u00e9nit, L., Casella, J., and Heidmann, T. 2003.\nSurvey of human genes of retroviral origin: Identification andtranscriptome of the genes with coding capacity for completeenvelope proteins. J. Virol. 77:10414\u201310422.Dewannieux, M. and Heidmann, T. 2005. LINEs, SINEs and processed\npseudogenes: Parasitic strategies for genome modeling. Cytogenet.\nGenome Res. 110: 35\u201348.\nDewannieux, M., Esnault, C., and Heidmann, T. 2003. LINE-mediated\nretrotransposition of marked Alusequences. Nat. Genet. 35:41\u201348.\nDewannieux, M., Blaise, S., and Heidmann, T. 2005. Identification of a\nfunctional envelope protein from the HERV-K family of humanendogenous retroviruses. J. Virol. 79:15573\u201315577.\nDirksen, E. and Levy, J. 1977. Virus-like particles in placentas from\nnormal individuals and patients with systemic lupus erythematosus.J. Natl. Cancer Inst. 59:1187\u20131192.\nEsnault, C., Casella, J.F., and Heidmann, T. 2002. A Tetrahymena\nthermophila ribozyme-based indicator gene to detect transpositionof marked retroelements in mammalian cells. Nucleic Acids Res. 30:e49.\nGoff, S. 2004. Retrovirus restriction factors. Mol. Cell 16:849\u2013859.\nHarris, R.S. and Liddament, M.T. 2004. Retroviral restriction by APOBEC\nproteins. Nat. Rev. Immunol. 4:868\u2013877.\nHughes, J.F. and Coffin, J.M. 2004. Human endogenous retrovirus K\nsolo-LTR formation and insertional polymorphisms: Implications forhuman and viral evolution. Proc. Natl. Acad. Sci. 101: 1668\u20131672.\nHughes, J.F. and Coffin, J.M. 2005. Human endogenous retroviral\nelements as indicators of ectopic recombination events in theprimate genome. Genetics 12:12.\nJolly, C. and Sattentau, Q.J. 2004. Retroviral spread by induction of\nvirological synapses. Traffic 5:643\u2013650.\nKalter, S.S., Helmke, R.J., Heberling, R.L., Panigel, M., Fowler, A.K.,\nStrickland, J.E., and Hellman, A. 1973. C-Type particles in normalhuman placentas. J. Natl. Cancer Inst. 50:1081\u20131084.\nKazazian Jr., H.H. 2004. Mobile elements: Drivers of genome evolution.\nScience 303: 1626\u20131632.\nLavie, L., Kitova, M., Maldener, E., Meese, E., and Mayer, J. 2005. CpG\nmethylation directly", "start_char_idx": 2986, "end_char_idx": 5708, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "835b5bac-2732-4be4-95f4-d9b21d41d39e": {"__data__": {"id_": "835b5bac-2732-4be4-95f4-d9b21d41d39e", "embedding": null, "metadata": {"page_label": "9", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9c07f040-46fc-410b-a8c6-3ffd10943c0f", "node_type": null, "metadata": {"page_label": "9", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "ddec4f4f7501245ec18fd44825fc3a230daaaccd212b041f1afb8b656f9a5c2c"}, "2": {"node_id": "9ed0940b-daf0-437b-b813-fea55fcbac5a", "node_type": null, "metadata": {"page_label": "9", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "7c12976ed6881519ddd3e8332fcbd56039bff5ff19dec828a554e7e04e1450af"}, "3": {"node_id": "2ae4bccc-0ecd-490b-b71f-011c5e3e7beb", "node_type": null, "metadata": {"page_label": "9", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "a33a49c396fd99bda01729cf0d40b77192f81a37cccf02cd808ae1a8190b3f52"}}, "hash": "c47c53c8051e1a7b8f0445886b55acdf0f40e735d4a192bdb00070419dd0c59f", "text": "E., and Mayer, J. 2005. CpG\nmethylation directly regulates transcriptional activity of the humanendogenous retrovirus family HERV-K(HML-2). J. Virol. 79:876\u2013883.\nL\u00f6wer, R., Boller, K., Hasenmaier, B., Korbmacher, C., Mueller-Lantzsch,\nN., L\u00f6wer, J., and Kurth, R. 1993. Identification of humanendogenous retroviruses with complex mRNA expression andparticle formation. Proc. Natl. Acad. Sci. 90:4480\u20134484.\nL\u00f6wer, R., L\u00f6wer, J., and Kurth, R. 1996. The viruses in all of us:\nCharacteristics and biological significance of human endogenousretrovirus sequences. Proc. Natl. Acad. Sci. 93:5177\u20135184.\nMayer, J., Sauter, M., Racz, A., Scherer, D., Mueller-Lantzsch, N., and\nMeese, E. 1999. An almost-intact human endogenous retrovirus K onhuman chromosome 7. Nat. Genet. 21:257\u2013258.\nMedstrand, P. and Mager, D.L. 1998. Human-specific integrations of the\nHERV-K endogenous retrovirus family. J. Virol. 72:9782\u20139787.\nMuster, T., Waltenberger, A., Grassauer, A., Hirschl, S., Caucig, P.,\nRomirer, I., Fodinger, D., Seppele, H., Schanab, O.,Magin-Lachmann, C., et al. 2003. An endogenous retrovirus derivedfrom human melanoma cells. Cancer Res. 63:8735\u20138741.\nPyra, H., Boni, J., and Schupbach, J. 1994. Ultrasensitive retrovirus\ndetection by a reverse transcriptase assay based on productenhancement. Proc. Natl. Acad. Sci. 91:1544\u20131548.\nReus, K., Mayer, J., Sauter, M., Scherer, D., Muller-Lantzsch, N., and\nMeese, E. 2001. Genomic organization of the human endogenousretrovirus HERV-K(HML-2.HOM) (ERVK6) on chromosome 7.Genomics 72:314\u2013320.\nRuda, V.M., Akopov, S.B., Trubetskoy, D.O., Manuylov, N.L.,\nVetchinova, A.S., Zavalova, L.L., Nikolaev, L.G., and Sverdlov, E.D.2004. Tissue specificity of enhancer and promoter activities of aHERV-K(HML-2) LTR. Virus Res. 104: 11\u201316.\nSteinhuber, S., Brack, M., Hunsmann, G., Schwelberger, H., Dierich,\nM.P., and Vogetseder, W. 1995. Distribution of human endogenousretrovirus HERV-K genomes in humans and different primates. Hum.\nGenet. 96:188\u2013192.\nStoye, J.P., Moroni, C., and Coffin, J.M. 1991. Virological events leading\nto spontaneous AKR thymomas. J. Virol. 65:1273\u20131285.\nTristem, M. 2000. Identification and characterization of novel human\nendogenous retrovirus families by phylogenetic screening of thehuman genome mapping project database. J. Virol. 74:3715\u20133730.\nTurner, G., Barbulescu, M., Su, M., Jensen-Seaman, M.I., Kidd, K.K., and\nLenz, J. 2001. Insertional polymorphisms of full-length endogenousretroviruses in humans. Curr. Biol. 11:1531\u20131535.\nVillesen, P., Aagaard, L., Wiuf, C., and Pedersen, F.S. 2004. Identification\nof endogenous", "start_char_idx": 5738, "end_char_idx": 8323, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2ae4bccc-0ecd-490b-b71f-011c5e3e7beb": {"__data__": {"id_": "2ae4bccc-0ecd-490b-b71f-011c5e3e7beb", "embedding": null, "metadata": {"page_label": "9", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9c07f040-46fc-410b-a8c6-3ffd10943c0f", "node_type": null, "metadata": {"page_label": "9", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "ddec4f4f7501245ec18fd44825fc3a230daaaccd212b041f1afb8b656f9a5c2c"}, "2": {"node_id": "835b5bac-2732-4be4-95f4-d9b21d41d39e", "node_type": null, "metadata": {"page_label": "9", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "c47c53c8051e1a7b8f0445886b55acdf0f40e735d4a192bdb00070419dd0c59f"}}, "hash": "a33a49c396fd99bda01729cf0d40b77192f81a37cccf02cd808ae1a8190b3f52", "text": "C., and Pedersen, F.S. 2004. Identification\nof endogenous retroviral reading frames in the human genome.Retrovirology 1:32.\nWilkinson, D.A., Mager, D.L., and Leong, J.A.C. 1994. Endogenous\nhuman retroviruses. In The retroviridae (ed. J.A. Levy), pp. 465\u2013535.\nPlenum Press, New York.\nReceived May 28, 2006; accepted in revised form August 30, 2006.Dewannieux et al.\n1556 Genome Research\nwww.genome.org Cold Spring Harbor Laboratory Press  on July 28, 2023 - Published by genome.cshlp.org Downloaded from", "start_char_idx": 8308, "end_char_idx": 8810, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fcee602a-d1a8-4768-b530-579010d93ddb": {"__data__": {"id_": "fcee602a-d1a8-4768-b530-579010d93ddb", "embedding": null, "metadata": {"page_label": "10", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d3eda07a-cfaa-4dc5-8564-4909ff605fe4", "node_type": null, "metadata": {"page_label": "10", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}, "hash": "c2e28c071bd46cc50e0e61e4446d6120d0cf86bbde2bd95c94e89f6d819c1671"}}, "hash": "aac1186c21e967f754f6bc93a36f2a150b5d8ad28cc4f5f0a5750d2c5fb8c399", "text": "10.1101/gr.5565706 Access the most recent version at doi:2006 16: 1548-1556 originally published online October 31, 2006 Genome Res.\u00a0\u00a0 Marie Dewannieux, Francis Harper, Aur\u00e9lien Richaud, et al. \u00a0 HERV-K human endogenous retroelementsIdentification of an infectious progenitor for the multiple-copy\n\u00a0 MaterialSupplemental\n\u00a0  http://genome.cshlp.org/content/suppl/2006/11/06/gr.5565706.DC1\n\u00a0 References\n\u00a0  http://genome.cshlp.org/content/16/12/1548.full.html#ref-list-1This article cites 34 articles, 16 of which can be accessed free at:\n\u00a0 License\nServiceEmail Alerting\n\u00a0  click here. top right corner of the article or Receive free email alerts when new articles cite this article - sign up in the box at the\n https://genome.cshlp.org/subscriptionsgo to: Genome Research To subscribe to \nCopyright \u00a9 2006, Cold Spring Harbor Laboratory Press Cold Spring Harbor Laboratory Press  on July 28, 2023 - Published by genome.cshlp.org Downloaded from", "start_char_idx": 0, "end_char_idx": 942, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e951c7c0-aea0-4a8b-a86c-e4210701c0c8": {"__data__": {"id_": "e951c7c0-aea0-4a8b-a86c-e4210701c0c8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "923a94ef-af9f-42ac-b099-640e707f6931", "node_type": null, "metadata": {}, "hash": "afcc03779af36b0a388628af50f2a052f97638df9bc7b45e37b184af09bfbe8e"}, "3": {"node_id": "ea555bc5-96f4-499c-ae8f-dea28f846e18", "node_type": null, "metadata": {}, "hash": "404fe352757cb1c35e08ff62762d373f88aca4d372c3684fa605c0587eba4d36"}}, "hash": "39eaaa35ae3029353a48d14d865e0a1a74a2f9e5e8ac94b4c6d084d3f56b9d16", "text": "WEEK 1 MONDAY LECTURE 1\n\nYou'll see I have some particular views and wishes for what you will learn and accomplish as a result of this course, not just in the quarter, but between now and the year 2030, so stay tuned for that. What I'd like to do is share a screen and just give you a visual reprise of this. So, hopefully you can see that. Here's the TA teaching team. Underneath the names of each of our TAs, you can see their lead responsibility. So, as noted, this will be in the slides from today's class.\n\nAnd following up is Subhash, Michael, and myself. What we'd like to transition to is an imagination exercise. And the way this exercise is going to work is, please grab a piece of paper or just something you can jot some thoughts down on and get ready to think about a question. Here we go. Before going any further in this course, we wish for you to imagine a bioengineer. Just close your eyes and clear your mind and think about bioengineering, what attracted you to the course, anything you're thinking about.\n\nAnd if you have a piece of scratch pad, just sketch the bioengineer that you can imagine. Little stick figure or however you like to draw. Spend a minute or two on it once you imagine a bioengineer and what they're doing or who they are, whatever you see in the world, whatever you wish for a bioengineer to be. And after you sketched your bioengineer, take on the second challenge, come up with three words to describe the bioengineer.\n\nSo everybody, please go ahead and do that by yourself right now. Silence. Okay. If you're new to Zoom, again, you can bring up the chat window by clicking on the chat icon in the bottom, and there'll be some text there. Anybody's welcome to put any message. You'll see what I just said as a quick prompt now typed out. So, we're just going to spend one more minute on these two prompts. We wish for you to imagine your bioengineer, what you think that person looks like and what their, how would you describe them if you were to pick three words?\n\nOkay, so what we're going to do now is we're going to push everybody into breakout rooms and you'll be in a breakout room with four or five other students in the course. And we'd like you to talk about in your breakout rooms, what is the, to compare your bioengineers and to see if you can identify any aspects of your bioengineers that are the same or different. Okay, so we're looking for similarities or differences among your bioengineers. I'll put that right here. And we'll give you a couple minutes to discuss this. Okay, here we go. Silence.\n\nSo, Okay. Thank you. Silence. So, if you're joining us, please bring up the chat window, and if you could just type into the chat window for yourself and what you learned, what was a similarity shared with your peers in terms of your bioengineers and what was the difference that struck you? Just put, you know, similar equals this, difference equals this.\n\nThe thing that most struck you from your own thinking and your discussion in your small breakouts. Lab equipment, innovative, creative, curious. Curious, problem solver, interdisciplinary, smart, lab coat, ethical. Kali has a great difference, using nature versus improving nature. Marvin has an interesting difference, specialization versus, what would that be, general? Clarice, interesting, difference is medicine or sustainability, like human health or environmental health. Very interesting. Troy, Troy's, everybody was aligned, no differences.\n\nDeja, that's amazing. Wow, Deja, that's amazing. Differences are bioengineers for good or bioengineers for evil. Wow. You hit the jackpot. Oh, thanks. What a good start. Yeah, yeah. So this is a pretty interesting exercise.\n\nMaybe you've seen it, we've adapted it from colleagues in mechanical engineering. One of the reasons we like to open the quarter with it is to help you think about for yourself before you hear much from us, what bioengineering is about and", "start_char_idx": 0, "end_char_idx": 3936, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ea555bc5-96f4-499c-ae8f-dea28f846e18": {"__data__": {"id_": "ea555bc5-96f4-499c-ae8f-dea28f846e18", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "923a94ef-af9f-42ac-b099-640e707f6931", "node_type": null, "metadata": {}, "hash": "afcc03779af36b0a388628af50f2a052f97638df9bc7b45e37b184af09bfbe8e"}, "2": {"node_id": "e951c7c0-aea0-4a8b-a86c-e4210701c0c8", "node_type": null, "metadata": {}, "hash": "39eaaa35ae3029353a48d14d865e0a1a74a2f9e5e8ac94b4c6d084d3f56b9d16"}, "3": {"node_id": "4611531f-7be8-42ab-b0bd-724b85e40363", "node_type": null, "metadata": {}, "hash": "4cd5538681c72afc1bf03eecdaa322566809cdc7ae2490c72f4a5f0179bf8e16"}}, "hash": "404fe352757cb1c35e08ff62762d373f88aca4d372c3684fa605c0587eba4d36", "text": "think about for yourself before you hear much from us, what bioengineering is about and how you envision it. Most of bioengineering hasn't been imagined yet. There's a core, but what you can do with it, there's a core that's totally solid that we'll cover, but what you can do with it and how it relates to the world mostly hasn't been imagined yet, and who gets to do the imagining and how it's translated into reality is very much up for grabs.\n\nSo we'd really like to hit you with this out of the gate and to let you interact with each other to see how you think about it. We want to tackle one more thing up front. And John, I think I'm going to call on you to help with this. We're going to ask you to redirect to a Google forum to do a quick pre-class survey. Well, this might take you five minutes, so it's not like a total breeze through. And I just want to share some quick information about it so you can handle it more quickly.\n\nSo what we're going to ask you is a series of questions, 14 questions in the survey. John's put the survey link in the chat. So if you can see that also and go to it, but really quickly, we're just looking for a numerical score, zero to five on each of the prompts, where zero means you're using words, I don't know what the words mean. That's totally fine.\n\nIt's an introductory class. That's what we're here for. We just want to know what your baseline is. So zero means I have almost no knowledge or no knowledge of what you're asking me about. One is I kind of know what these words, I've heard of these words. Two is I've done it in class somewhere. Three, I can do this by myself. Four, I could help somebody else learn how to do this.\n\nAnd five, I'm such a guru on this topic, I could teach you and make it better for everybody. So if you go to the survey, we're going to spend five to eight minutes. We'll wait until people come back until we pick things up. So take your time. And just for the 14 questions, self-evaluate, zero to five, and we'll come back and ask you to do this at the end of the quarter so that you can see if we moved the needle at all. It doesn't matter what \u2013 we just wish for you to be honest now, right? So correct answers are honest answers here as you self-assess. So please go divert to the Google form and see how that goes. And if you're super good with Zoom, when you come back, if you're finished, if you go into the participant window, you can just click a green yes button and that Also, please feel free to use the chat if any of the questions in the survey are unclear or you want any clarifications, please make sure to ask.\n\nI'm sure other people will have the same questions you all have. Thanks, John Silence. Okay. Silence. Wow, we got 85 responses already. 89. Josh, where do you buy your emojis? Oh, they are at the, you know, like where the managed participants and chat is. It's a reaction option.\n\nSo there is a clapping and a, and then there's a thumbs up. Do you see them? No, I'll look later. I think you have to get. Yeah, I do see it. Right on. We're all discovering and experiencing Zoom and learning as we go. This is my fourth Zoom of the day. So if you're back and can see the participant tab at the bottom, if you open that up, if you haven't opened that up and click yes, a green yes, that's a great thing to do.\n\nWe'll use that throughout the quarter just to get quick feedback, yes or no. So, good to work that out now. Yeah, we've got 84 yeses, 86, 90 yeses. John, how many survey results have come in? John Riegel We have 100 survey results in. Great. And while we're finishing this up, let me just do a quick technical check. Is the audio and video working reasonably well coming from me? Yeah. Anna Claire, how are you doing? Can you hear me okay? Yes. Okay, great. Thank you. And Richard, how about you? Can you", "start_char_idx": 3864, "end_char_idx": 7687, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4611531f-7be8-42ab-b0bd-724b85e40363": {"__data__": {"id_": "4611531f-7be8-42ab-b0bd-724b85e40363", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "923a94ef-af9f-42ac-b099-640e707f6931", "node_type": null, "metadata": {}, "hash": "afcc03779af36b0a388628af50f2a052f97638df9bc7b45e37b184af09bfbe8e"}, "2": {"node_id": "ea555bc5-96f4-499c-ae8f-dea28f846e18", "node_type": null, "metadata": {}, "hash": "404fe352757cb1c35e08ff62762d373f88aca4d372c3684fa605c0587eba4d36"}, "3": {"node_id": "8d3e7748-e1ec-4c66-aea5-3df8ab4258e4", "node_type": null, "metadata": {}, "hash": "20423033bd60754ae2d36cfd0e0cec7975af1cd83e5b4808cb064a0718c0b31f"}}, "hash": "4cd5538681c72afc1bf03eecdaa322566809cdc7ae2490c72f4a5f0179bf8e16", "text": "Yes. Okay, great. Thank you. And Richard, how about you? Can you hear me okay?\n\nYep, fine, thank you. Okay. Yeah, if anything comes up, beg patience in advance and please just slam a note in the chat or wave your arms around and we'll be watching and so on. I had a fun time over the weekend cutting a hole through the wall and the floor to get a direct Cat6 line to the router, try and get better bandwidth for this. Okay, so thank you very much for that. And you'll see that again at the end of the quarter. That will help us calibrate the exact detail that we're providing as well. Again, the point isn't to expect you to have mastery of all of those topics, but those will be things that we'll be touching upon.\n\nLet me compliment that by going back to my screen and sharing a little bit about the class. So what's this class about? So I'm just gonna say out loud some of the things you may have read already. We wish for you to learn how to think about the engineering of living matter. So our view of bioengineering is very particular, very 21st century. We're a new bioengineering department at Stanford.\n\nWe're the newest engineering department at Stanford. And so we have the benefit of starting from scratch with our undergraduate major within the last decade. So we're really focused on the engineering of living matter as opposed to the engineering of electrical systems or mechanical systems for clinical or agricultural settings. Nothing against that important work, but we're really focused on the biology, if you will, that's number one. Number two, we wish for you to become better at learning about bioengineering and teaching others about bioengineering. So teaching yourself and teaching others. This is definitely a frontier with a lot of open-endedness. Three, to be capable of leading discussions about why this matters, including with people who may not know anything about biology. And then four, which is very, very particular for this quarter.\n\nIt would be obvious to say, but I'll say it, that anybody paying attention to reality right now is learning that biology matters even more than we already appreciated, and therefore biotechnology matters even more than we already appreciate. There's nobody to first approximation who's escaping the reality of COVID-19, as we all know. On the other side of this perturbation is whatever comes next. And in particular, one of the things we're going to leverage this quarter is to encourage you and to enable you to think about what you wish to be true regarding bioengineering within this decade.\n\nSo where do you wish to land in 2030, so far as bioengineering goes? Both figuring out what that should be by listening to others, by incorporating diverse perspectives, but also figuring out how to make it practically true. When we look at the demographics of you, you know, about a quarter of you are first year, second year, third year, fourth year undergraduates. That means some of you, a good fraction of you are seniors. And so, after this quarter, you'll have earned degrees.\n\nYou may be going to school, or you may be going on the job market. I think the idea of going on the conventional job market is daunting, but I have a hypothesis I want to share right away. There is a jobs problem in bioengineering. We're not going to have enough bioengineers by a lot. The amount of bioengineering that's going to need to get done between 2020 and 2030 is so great that we couldn't possibly enable enough people to study bioengineering.\n\nNow, the trick is likely to be the case that most people don't understand what is needed from a bioengineer. And so that means for many of you graduating, you're probably going to have to construct opportunities from scratch for yourself. Our job collectively will be to create air cover such that everybody knows how important bioengineering is. But there's a special thread running through this quarter, this fourth point. What do you want to make true via bioengineering over the next decade and how are you going to do it? Okay.\n\nSo, I want to talk briefly about grading up front. To get a satisfactory grade in the course, there are two conditions to meet.", "start_char_idx": 7708, "end_char_idx": 11878, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8d3e7748-e1ec-4c66-aea5-3df8ab4258e4": {"__data__": {"id_": "8d3e7748-e1ec-4c66-aea5-3df8ab4258e4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "923a94ef-af9f-42ac-b099-640e707f6931", "node_type": null, "metadata": {}, "hash": "afcc03779af36b0a388628af50f2a052f97638df9bc7b45e37b184af09bfbe8e"}, "2": {"node_id": "4611531f-7be8-42ab-b0bd-724b85e40363", "node_type": null, "metadata": {}, "hash": "4cd5538681c72afc1bf03eecdaa322566809cdc7ae2490c72f4a5f0179bf8e16"}, "3": {"node_id": "30ed782e-28bd-470e-afaa-3c722c82d995", "node_type": null, "metadata": {}, "hash": "f7b19b9510b0c25e55a50451762de3bb27bed75bde0c6e789506beb76ef5e0ee"}}, "hash": "20423033bd60754ae2d36cfd0e0cec7975af1cd83e5b4808cb064a0718c0b31f", "text": "To get a satisfactory grade in the course, there are two conditions to meet. Two conditions to meet. Number one, we're going to have P-sets, and you should earn an average grade of 70 or greater, percentage-wise. lowest P set shouldn't be an issue so long as you can stay on top of things roughly. Second, we'll have a final project. Ideally, it's team-based, but there may be some extraordinary circumstances we'll handle on an ad hoc basis. And for the final project, you should also earn a 70 percent or above. We will have, in addition to this, some self-study quizzes throughout the quarter that come with the readings and so on, that will allow you to accumulate quiz points, if you will, that could be used to reduce these thresholds from 70 to 60.\n\nSo that passing the bar, so to speak, on the PSETs in the project is less burdensome, as it were. Mostly, what we're trying to communicate to you is we wish for you to learn via the PSETs and the final project, not one or the other, but both. Other thing to say, at the bottom on the slide, we're very sensitive to the transition to S and C grading. If you need reference or recommendation coming out of this course, we, the teaching team, are looking forward to and expecting to write very specific and detailed and celebratory letters of reference as appropriate, if and as useful to each of you, right? So if that's something you're worried about, we're standing ready to help with that.\n\nOkay. I'm gonna do a quick tour. You can see this on the Canvas, it's a PDF. I'll just give you a quick tour of the topics. For those of you who are thinking about how to spend your time in the quarter, wanna give you an upfront overview of this. Why engineer biology? We'll get to that in a little bit today. What makes living matter special from an engineer's perspective?\n\nWednesday. And because we're a frontier discipline, how to read the primary literature by yourself, right? So how to read a research paper. Next week we're going to talk about people health, medicine, planet health, the environment, and political health, how technology relates to culture and power. We want to give you that up front so you can think about your final projects with a diversity of perspectives from the beginning. Then we'll talk about tools for seeing. For those of you who gave us your shipping address, we will be overnighting you an origami microscope as well as some other materials for two activities. We'll do that on the 20th.\n\nThen we'll do analysis and design of molecules, starting with proteins, followed by analysis and design of genetic systems in general. From that, on the 27th, we'll transition into abstraction as a concept for bioengineering, Boolean logic as developed in a diversity of cell types from microbes to mammals to plants, and then from that, a very general-purpose system architecture for engineering biology. Starting on the 1st of May, working in teams will support you in developing skills and tools for advancing your projects. Then the following week, we'll talk about DNA synthesis as a core technology, past, present, and future. That feeds into a qualitative insight and disruption.\n\nThat's an overused word, but it's real in this case, how biology is basically going on the Internet via DNA read-write, but we're on team projects. Thereafter, we introduce you to the physics of living matter in a particular way, starting with molecular-scale diffusion, how that leads to spontaneous behavior. We'll give you practice with that through an activity. We'll ship you materials for self-organizing, spontaneously moving droplets. From that, we return to tissue engineering and developmental biology morphed together to think about how would you program growth and form of shapes.\n\nWhat's shown on this slide is plants as found in nature, and as the words come up, you'll see what the plants are. Now the form of these plants is prior to human domestication. So this is the natural form of the plants, if you will. Corn without a cob, and so on. Let's see if this plays. No audio,", "start_char_idx": 11869, "end_char_idx": 15926, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "30ed782e-28bd-470e-afaa-3c722c82d995": {"__data__": {"id_": "30ed782e-28bd-470e-afaa-3c722c82d995", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "923a94ef-af9f-42ac-b099-640e707f6931", "node_type": null, "metadata": {}, "hash": "afcc03779af36b0a388628af50f2a052f97638df9bc7b45e37b184af09bfbe8e"}, "2": {"node_id": "8d3e7748-e1ec-4c66-aea5-3df8ab4258e4", "node_type": null, "metadata": {}, "hash": "20423033bd60754ae2d36cfd0e0cec7975af1cd83e5b4808cb064a0718c0b31f"}, "3": {"node_id": "4131791d-6d8a-4620-a6e7-eb9d5a21d5cf", "node_type": null, "metadata": {}, "hash": "de748e0915d09ed061a3fae6030021e4c953033a960864c614aa4aeee872f8ae"}}, "hash": "f7b19b9510b0c25e55a50451762de3bb27bed75bde0c6e789506beb76ef5e0ee", "text": "Corn without a cob, and so on. Let's see if this plays. No audio, at least on my end. Or on mine. There should be a way for you to share your computer audio. It's okay. So, I'm just going to tell you, this wonderful lady is so excited about the dog that she has bred.\n\nAnd so, just like domestication of plants has occurred, domestication and breeding of animals has occurred. Another type of interaction with biology has been the changing of the use of land. What's shown here is the replacement of a forest or jungle, if you will, with oil palm plantations. As you change the use of biology on the land, you change the habitat for the biology, as well as the diversity or lack thereof of the species operating on the land.\n\n40 years ago now, here's a patent owned by Stanford University, human beings invented genetic engineering. So starting in 1980, people began to bring to market the capacity to cut and paste DNA to make novel or chimeric molecules. That immediately went to market economically and has been doubling as an economic activity for the last 40 years with a doubling time of about seven to eight years. So this plot ends about eight years ago.\n\nIt's doubled since again. And what you're looking at is the major sectors by which the engineering of biology shows up as products. Food in terms of GMO crops, not without controversy, biologics, which is shorthand for medicine, and industrial means industrial chemicals, intermediates and supply chains. If you've not seen this before, this is what it looks like. So this is an image of yeast cells, which would normally ferment sugar and make wine or produce bread, and they've been engineered to make an industrial intermediate, farnesine, which is that oily yellow substance, the yeast cells being the blue little circles.\n\nYou can engineer yeast to make approximately any natural chemical found in nature. So here's my wife and her team working at Stanford years ago now, engineered yeast to brew chemicals found in the opiate poppy. So instead of farming poppies, you could take a fermenter, feed it sugar, and out comes medicinal compounds. Dennis, working in Hawaii in the early days of genetic engineering, did almost a DIY local genetic engineering project.\n\nHe took the papaya crop, which was suffering from a virus called the ring spot virus. You can see that in the top middle, the papaya with the green rings on it. And he used first-generation genetic engineering to make a strain of papaya that's resistant to the virus. And on the bottom right, you can see papaya plants on the right, which are not susceptible to the virus growing and healthy, and the ones, natural ones susceptible to the virus not growing very well. So that's just a quick example of industrial chemicals, medicines, and food. Open question is how far can we push it? How much better can we get at engineering living matter?\n\nAnd the first approximation response is as good as we wish to become good. It doesn't seem like there's a physical limit for why we can't become arbitrarily good at engineering living matter. There's a lot behind that that we'll get to throughout the quarter. I want to give you an analogy or comparison to where this seems like it is in time, just so you calibrate your expectations and have a sense of how immature some of the tooling is. So, there's a really neat quote in Gates Hall on campus in the computer science building where when that program was getting started in the early 1960s, they recognized that enough is known about all the different things you can do with a computer that we can figure out how to write computer code in a way that doesn't really care what you're using the computer to do, that the structure of computing is much the same.\n\nAnd by analogy, it appears to be the case that the same thing is playing out in bioengineering. Whether you're using biology to make things for industrial stuff, medicines, food, store data, create works of art, whatever, the structure by which you do the bioengineering in terms of working with the biology is much the same. Now, filling that out and making that as capable and as true and mature", "start_char_idx": 15938, "end_char_idx": 20074, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4131791d-6d8a-4620-a6e7-eb9d5a21d5cf": {"__data__": {"id_": "4131791d-6d8a-4620-a6e7-eb9d5a21d5cf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "923a94ef-af9f-42ac-b099-640e707f6931", "node_type": null, "metadata": {}, "hash": "afcc03779af36b0a388628af50f2a052f97638df9bc7b45e37b184af09bfbe8e"}, "2": {"node_id": "30ed782e-28bd-470e-afaa-3c722c82d995", "node_type": null, "metadata": {}, "hash": "f7b19b9510b0c25e55a50451762de3bb27bed75bde0c6e789506beb76ef5e0ee"}, "3": {"node_id": "d1d42f18-6022-409a-85b0-f996a77f8477", "node_type": null, "metadata": {}, "hash": "34aa60acfed9d31f908ef663a511ce666b7a790dbd1a1ea0e11e680dc198f67e"}}, "hash": "de748e0915d09ed061a3fae6030021e4c953033a960864c614aa4aeee872f8ae", "text": "same. Now, filling that out and making that as capable and as true and mature as computer science and what not is a formidable task for everybody. It's not just academics thinking about this.\n\nHere's a screen grab of a workshop from six years ago where the leadership of DuPont, home headquarters in Delaware, came out to imagine all the different things they could do with biology. They, at the time, had six or seven products on the market that were grown, biological made, and they imagined when they were a 300-year-old company, their entire product portfolio would be biomanufactured. How to get there from here is the big strategic question.\n\nWhat's interesting is the question is not just about hardcore science and engineering, it's also a question of culture and politics and how people are organized. They also brought to me the recognition that most of bioengineering hasn't been imagined yet, even though there's been this amazing history where we're still the snowflake on the tip of the iceberg in terms of what could be done. Here's just an example of that. So this is a supply chain, if you will, for all of industrial society, starting with fossil inputs on the left, petroleum, natural gas, and so on, and going from left to right, the large-scale chemical engineering processes that would let you take those inputs and produce all the things people need at civilization scale.\n\nThe proposal, approximately, is to replace all of that with real-time biological feedstocks grown in the moment and making the exact same things, but to do this, you have to completely remake civilization's supply chains for all industrial compounds. So that's in part, just through one dimension, what's in front of bioengineering. Remake the entirety of the supply chains for civilization such that we can make all the things that 10 billion people would wish to have without trashing the planet.\n\nOf course, when you go to do this, you can overshoot, right? So, this is an example of fertilizer runoff leading to an algal bloom in a swimming pavilion, sailing pavilion, back in 2000. But it just keeps going and going and going. When you look at all the things that biology grows and you start to imagine what could we do if we partnered with biology better, is it about nature or is it about engineering? Well, maybe it's just about connectedness and partnering. What could we do, right?\n\nSo, here's a photo I took at a farm down in Monterey, interspersed within the strawberry fields. They get this type of input, which is ground-up wood chips from the Central Valley of California, for example, when the almond farms turn over. And you know what they do with these wood chips? They grow mushrooms on them. They take the organisms that eat wood, the white rot fungus, and they turn that input of wood chips into gourmet mushrooms that you could buy at the boutique mushroom providers like the Farmer's Market up in San Francisco.\n\nIt also turns out that you can take these organisms to do other things. Here is a company called micro works up in Emeryville that takes the same organisms and instead of growing food, basically we will put the wood chips in a giant lasagna tray and the organisms will grow in the wood chips until they get to the surface, it will be like a spongy mass and the surface will differentiate into a type of mushroom skin. Over time that mushroom skin will strengthen and you can peel it off and put it through a tanning process. And so suddenly now you have a replacement for animal leather, but there's no vertebrate, there's no mammal involved in the manufacturing process. It's a wood fungus with wood chips making leather replacement.\n\nAnd if you were at New York Fashion Week before things shut down a couple months ago, you would have seen this company bring their products to market initially. They partnered with the design houses to create a type of sustainable leather that doesn't involve animals in its manufacture. I want to keep going by hitting you with a wild card. And a lot of times when I think about biology, I think about what's limiting what we can make with biology in terms of how much photosynthesis there is on Earth. It turns out that recently I've discovered this is a false limitation, a", "start_char_idx": 20064, "end_char_idx": 24309, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d1d42f18-6022-409a-85b0-f996a77f8477": {"__data__": {"id_": "d1d42f18-6022-409a-85b0-f996a77f8477", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "923a94ef-af9f-42ac-b099-640e707f6931", "node_type": null, "metadata": {}, "hash": "afcc03779af36b0a388628af50f2a052f97638df9bc7b45e37b184af09bfbe8e"}, "2": {"node_id": "4131791d-6d8a-4620-a6e7-eb9d5a21d5cf", "node_type": null, "metadata": {}, "hash": "de748e0915d09ed061a3fae6030021e4c953033a960864c614aa4aeee872f8ae"}, "3": {"node_id": "e8ec6d48-4535-4668-b392-e0d1bad9680a", "node_type": null, "metadata": {}, "hash": "c67d13e6d588b72298664cb3131c5b95dc37fa87495c350875f54450ba45ee83"}}, "hash": "34aa60acfed9d31f908ef663a511ce666b7a790dbd1a1ea0e11e680dc198f67e", "text": "It turns out that recently I've discovered this is a false limitation, a false ceiling on how much we can make with biology. So here's something you might not have expected to see in a bioengineering course, but beg patience.\n\nHere's a paper that's doing an analysis on photovoltaic solar panels, how much energy they take to make the panel, and how long you need to operate the panel to get your energy back. This is called the Energy Return on Energy Investment, or EROI. It's like Return on Investment, money in, money out, but in this case, it's energy in, energy out. And that highlighted thing towards the bottom, the mean energy return on investment is between 8.7 and 34.2. What that means is a photovoltaic solar panel, according to this analysis, let's just pick a number in between, 20, makes 20 times as much energy as it took to make the panel. And that hasn't been true a decade ago. That wasn't true.\n\nThis is recently true, a transition over the last decade. So stated differently, photovoltaic solar panels make 20 times more energy than you need to make them. That implies that we're transitioning to an electricity generation abundant civilization. We're going to have plenty of electricity, so long as we keep making solar panels. Huh, now transportation of electricity and storage of electricity, big deal. What does this have to do with bioengineering?\n\nCheck this out. So remember on Friday, we'll handle how to read research papers. I'm just giving you postcard snapshots, all right? On the left, you can see this paper, conversion of E. coli to generate biomass from carbon dioxide. And E. coli normally grows on glucose, sugar, right? Like a soft drink. But here it's growing on this thing called formate, which is this strange little compound in brown.\n\nAnd when you feed the E. coli formate, it's been engineered to eat formate. And by the way, you see this paper was published in November of 2019, so this is less than half a year old. That microbe eats formate and fixes carbon dioxide and grows. So you can feed organisms formate and carbon dioxide from the atmosphere and get more organisms, more biology. Now how about this paper on the right from 12 years ago? Electro-reduction of carbon dioxide to formate on lead electrode in water. Basically what this paper is reporting is you can take electricity, split water in the presence of carbon dioxide and the right catalyst, and you make formate. Okay, so put those two facts together. Electricity makes formate, formate makes biology. I can grow biology on electricity if you put those two things together. And the napkin math down at the bottom is a summary, one kilowatt hour is a gram of biology.\n\nFrom talking with Tom Harabio in chemical engineering at Stanford, my analysis is 30 fold too conservative. That should really be, he thinks one kilowatt hour should make 30 grams of biology, which is a crazy amount of biology. All right, so let me hit you with this as one last for instance. Imagine having a box in the year 2030, hopefully it gets here sooner. Into the box comes electricity and internet, which will give you DNA sequences and carbon dioxide.\n\nAnd what comes out of the box is whatever biology you can program it to do, whatever bioengineering you've mastered. I'm going to call this thing the personal biosynthesizer, right, or the pocket bioengineer. It's like the personal computer, but it's for bioengineering. And it'll be enabled by a network of genetic sequence information, the Bionet. So between now and 2030, why not build the Bionet and the PB? How would that change the world? Pretty quickly, you pivot and have to get to some other questions.\n\nLike what does it mean to do this? Who should be doing it? What should we be wishing for? What's the culture around this technology? When people talk about the personal computer as a revolution, it's a cultural revolution on top of the technology advancing. If you care about nature, what's the relationship between all these would-be bioengineers and people who care about preserving nature and biodiversity? Gonna have to figure that one out. Collectively, what are we up to?", "start_char_idx": 24313, "end_char_idx": 28451, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e8ec6d48-4535-4668-b392-e0d1bad9680a": {"__data__": {"id_": "e8ec6d48-4535-4668-b392-e0d1bad9680a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "923a94ef-af9f-42ac-b099-640e707f6931", "node_type": null, "metadata": {}, "hash": "afcc03779af36b0a388628af50f2a052f97638df9bc7b45e37b184af09bfbe8e"}, "2": {"node_id": "d1d42f18-6022-409a-85b0-f996a77f8477", "node_type": null, "metadata": {}, "hash": "34aa60acfed9d31f908ef663a511ce666b7a790dbd1a1ea0e11e680dc198f67e"}}, "hash": "c67d13e6d588b72298664cb3131c5b95dc37fa87495c350875f54450ba45ee83", "text": "Gonna have to figure that one out. Collectively, what are we up to? What do we wish of biology? What do we wish of our relationship with the natural living world and whatever we have to do with it.\n\nSo I'll end with this slide today. This is the double-decker suspension bridge grown in place from the roots of a rubber plant. It fixes carbon, it gets stronger over time, it can be passed down from one generation to the next. It represents in a direct way all the things that biology could do. I'll summarize that by saying, we've got a capacity with biology on this planet to do at least 90 terawatts of manufacturing.\n\n90 terawatts is an energy level, civilization's pulling 20 terawatts. So four and a half times as much power is running through natural photosynthesis as civilization's running on. But if you parse the electro biosynthesis, this 90 terawatts is not a cap. We can basically implement a near arbitrary amount of biosynthesis if we play our cards right. The question before us that we'll explore in addition to the science and technology is what should we do with this capacity at scale?\n\nRight, that's what you all will confront if you choose as a second generation of genetic engineering, whether you are the protagonist in genetic engineering or just a citizen going into the future along with it. So what if we provision for 10 billion people without trashing the planet? What if we took infectious diseases completely off the table? Why should we be surprised in terms of infectious disease when we don't like to be surprised in any other way. That's insane.\n\nIt'd be nice to have a culture of citizenship as opposed to consumption or subject or objecthood. And obviously if we learn how to build things, we'll understand life better. So there we go. Welcome to the quarter and welcome to the class. What we have in front of us is an on-ramp to help you think about these things and to get to the practical starting line. If you're already an expert, you know, as a fourth-year undergrad, we'll give you some things to go deeper with.", "start_char_idx": 28444, "end_char_idx": 30502, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c952cc82-ca2c-480f-8db2-1304a9099ccf": {"__data__": {"id_": "c952cc82-ca2c-480f-8db2-1304a9099ccf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6ca606fd-0454-4a3c-8f6e-a99d1368dab4", "node_type": null, "metadata": {}, "hash": "252f71dce2def4660af35a6d733a7263e3caa204c425bcccfaf7352569d02431"}, "3": {"node_id": "9046d928-4cc2-41c6-a747-da6856fbe30c", "node_type": null, "metadata": {}, "hash": "8a00a661649f33b2d125eb5abdd782014e2c88f81e210c48d013fff62e683a29"}}, "hash": "97b1fa590d269f6f1d5f2df24cf4d08e530f1a13cd1a189fd1dba3843fc2f60d", "text": "WEEK 1 WEDNESDAY LECTURE 2\n\nToday's theme is uniqueness of living matter, and we're going to cover three different aspects of uniqueness. This is a complement to what we set up on the first day, which is why does the engineering of biology matter in the first place. Now we're going to pivot and look at what makes biology matter as a type of material. So to get right into it, the first part of this will be about the physics of living matter, matter as stuff. And just as a pause, we're shipping now pre-class material. So on the course website on GitHub, you should have seen in advance of today a whole bunch of video and a little bit of readings and some self-study questions. And so we're transitioning into that mode of learning where before each class we will make available some materials and learning for you to do before the class in this first topic the physics of building matter, I'll give you a little bit of a revisiting of the pre-class material Just to help you transition into this mode of learning if you've not experienced that type of class before Taken taken differently what I'm trying to communicate is, please, please, please, we're counting on you to follow up with the posted material before and after class and that's where you can really add a lot of value to your learning. \n\nWhere we ended last time was basically, I didn't use these words, but this was the takeaway, we've got a planetary scale natural nanotechnology. We've got biological stuff all over the surface of the planet and it's operating on a scale that is about four to five times bigger than what human civilization operates on in terms of energy. And it's operating from atomic scale, molecular precision, all the way up to ecosystems. So it's totally unbelievable what living matter is capable of. But now we've got to lift the lid on this a little bit, both from a science perspective and a practical perspective. So in the video that was nicely recorded by a very close colleague, Professor Jan Lippard, hopefully you saw some examples of physical uniqueness of living matter. Take the brain of a human, for example. If you look inside brains, you can see architecture and patterning of cells. This isn't a human brain, but another nice brain. If you go deeper and deeper, you can see neurons and synapses and so on and so forth. If you go deeper and deeper, you can see membranes and bilayers and proteins spanning. \n\nOne of the points Jan was trying to land with you in the pre-class material is that biology operates with a spectrum of complexity that's continuous. You can go from an object that's a meter or tens of meters all the way down to an object of angstroms, and you've just got detail and sophistication and complexity continuously across all these length scales. Whereas most inert manufactured objects, a car was one of the examples, even a computer, you know, it has some complexity to certain length scale, but then when you transition length scales, it just gets boring, not much there. So something very unique about living matter, how sophisticated it is in terms of the encoding of form and function and information across many, many length scales. By contrast, right, you take something like the car and the things going into the car and it's got some ingredients. It's got a supply chain that's global. But it's not, you know, the supply chain's complicated, but the object really isn't, compared to biology, that complicated. Another thing Jan was trying to land with you is that if the car has a global supply chain, the biology has a local supply chain. Yeah, it's part of the globe, it's part of the ecosystem, but what's the supply chain for a tree? Well, it's the stuff arriving where the tree is, right? The photons for photosynthesis, the water, the air, the carbon, the nitrogen from the atmosphere or from the soil. So all the inputs, the physics inputs, the material, the energy, the jewels, it's right there where the biology is. You have stated differently, a distributed manufacturing capacity. We have grown up in modernity in the West, on the legacy and benefiting from centralized industrial scale of manufacturing, biology starts by being", "start_char_idx": 0, "end_char_idx": 4181, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9046d928-4cc2-41c6-a747-da6856fbe30c": {"__data__": {"id_": "9046d928-4cc2-41c6-a747-da6856fbe30c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6ca606fd-0454-4a3c-8f6e-a99d1368dab4", "node_type": null, "metadata": {}, "hash": "252f71dce2def4660af35a6d733a7263e3caa204c425bcccfaf7352569d02431"}, "2": {"node_id": "c952cc82-ca2c-480f-8db2-1304a9099ccf", "node_type": null, "metadata": {}, "hash": "97b1fa590d269f6f1d5f2df24cf4d08e530f1a13cd1a189fd1dba3843fc2f60d"}, "3": {"node_id": "280cf2df-4e33-4e8b-b2a7-e09fbf21dfe0", "node_type": null, "metadata": {}, "hash": "2ae4bfc711303cbb631337a0981cf59e8b2e03185539c4ea3a50ce7a97e83d7e"}}, "hash": "8a00a661649f33b2d125eb5abdd782014e2c88f81e210c48d013fff62e683a29", "text": "the legacy and benefiting from centralized industrial scale of manufacturing, biology starts by being distributed, right? It's everywhere the biology is and the biology makes itself wherever the biology is. Kind of incredible. The reason we're trying to offer this to you through the lens of uniqueness is because we've all, we are of biology, we've all experienced biology since we were born by definition, and we kind of take the uniqueness of it for granted oftentimes. And so it's strange to reorient and contrast it. So to summarize and begin to summarize what Jan was pointing out was, biology has got a lot of different parts at a lot of different length scales. It can be very energy efficient. It runs in parallel, it uses local inputs. It's capable of self-mixing of molecules moving around. The self-mixing leads to spontaneous organization. These systems are capable of replicating. I've never seen my cell phone manage to give birth to another cell phone, right? But it's normal for a yeast cell to make another yeast cell, or a person plus another person to make a third person. You cut your skin, hopefully your skin will heal, and so on. So, I'd like to turn it over to Nikolai in a moment to set up our first breakout. We'd ask that you work in your groups to reprise some of the pre-class study, and Nikolai will give you some specific instructions for how to best organize. The task we're asking each breakout group to come back with is, how many different unique physical aspects of living matter can you remember from the pre-class or think about anew with your group, number one. Number two, at the microscopic scale, say atoms to molecules to subcellular, what do you think the most interesting or important aspect of the physics of living matter is? And also at the macroscopic scale, at the ecosystem to planetary, what do you think the most interesting or important aspect of living matter? So we'll post these in the chat, but we're asking each breakout group to return and we'll give you five minutes or so with your answers to these three questions. And on the first one, we'll just look for a number. Like, how many different ones can you remember or come up with? Let me stop my share and... Cool.\n\nHey Drew. Yes sir. There is some confusion regarding the first bullet point there, how many unique physical aspects? Do you have any clarifications for people?\n\nThis is a great question, just go for how many, like go for the number, it's almost like a brainstorm. Okay, but what would you consider like a physical aspect? Self-mixing, reproduction, healing, many different types of components. Just anything about the physics of the biology.\n\nIt would be really great if one person from each breakout reports back and says, we found, you know, we came up with this many physical aspects. Here was the most exciting microscopic. Here was the most exciting macroscopic. So if we can get that all together, that would be awesome. And we'll be patient with you, if you'll be patient with us, this is the second day of class and we're learning how to crank this a lot. Yes.\n\nWe were discussing like aspects of unique physical aspects, reproduction, both at the microscopic aspect came up, that how do cells reproduce, how do a molecule replicates itself, and how does that give rise to like an whole organism, you know, replicating itself. And how would we as engineers would utilize that to build the things that we would like to build, as opposed to studying them. So how, like in the chat right now, how DNA can code so many different organisms with just four bases is another example, right? A very cool idea that came up in my group, and Liam can speak to this, was the idea of symbiosis. Liam, do you want to chime in?\n\nYeah, so we were sort of saying that, I think his name was Adonis, he said that biology has a special feature of symbiosis and how at a macroscopic level, lots of different and unique living things can come together in like a community in order to work together.\n\nSo there's like this network effect, right? That we don't necessarily know all of the rules of the network,", "start_char_idx": 4094, "end_char_idx": 8216, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "280cf2df-4e33-4e8b-b2a7-e09fbf21dfe0": {"__data__": {"id_": "280cf2df-4e33-4e8b-b2a7-e09fbf21dfe0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6ca606fd-0454-4a3c-8f6e-a99d1368dab4", "node_type": null, "metadata": {}, "hash": "252f71dce2def4660af35a6d733a7263e3caa204c425bcccfaf7352569d02431"}, "2": {"node_id": "9046d928-4cc2-41c6-a747-da6856fbe30c", "node_type": null, "metadata": {}, "hash": "8a00a661649f33b2d125eb5abdd782014e2c88f81e210c48d013fff62e683a29"}, "3": {"node_id": "efca8c91-0add-4ef7-bf3d-737c4f8319a7", "node_type": null, "metadata": {}, "hash": "9f6b97419b6d4d007066901eb1f138e274edad94b9d435be9459917f2ff5bbeb"}}, "hash": "2ae4bfc711303cbb631337a0981cf59e8b2e03185539c4ea3a50ce7a97e83d7e", "text": "network effect, right? That we don't necessarily know all of the rules of the network, unlike, you know, like internet as an engineered network that we have control over the roots. Naomi, any other thing we should highlight? Yeah, so one thing that seems to be coming a lot on the microscopic level, people, at least in my group, and then I'm also seeing in the chat, people thought that DNA or one DNA or like the genome, like using CRISPR or GMOs, just kind of modifying the genetic code is kind of the most microscopic level. And one key thing that is sort of an interesting idea that came up in my group, I think it was Oliver who brought this up, was that, Oliver, if you want to jump in, feel free, but the idea was that kind of maybe DNA is like the bottom level, or like the only important microscopic thing to engineer because, you know, even on the cellular level, like DNA is what's controlling the cell. So like DNA will always kind of be able to control other kind of things in the microscopic realm.\n\nI think another interesting thing that seems to be coming up that my, or the group I was in was also talking about was just how on the microscopic level, a lot of things might seem to act like kind of autonomously or not really know what's going on. But then when you like zoom out into the macroscopic level, there's like some higher order function going on.\n\nAnd a lot of people seem to find that extremely interesting.\n\nRight, I personally often struggle with this thinking of putting my scientist hat on versus putting my engineer hat on. That's like, how would I navigate these complexities as an engineer? And I think we speak about this later in the course, that we, like, what are the standards that we would need at the microscopic level or macroscopic level to be able to use this uniqueness of biology?\n\nOkay, thanks everybody. So we're gonna, let me take the screen back and we're gonna jump in and go to, you know, the next dimension of uniqueness, which is related to the physics of living matter, but now it's getting into opportunities and challenges arising or derived from the unique physical aspects. So stay tuned. And this is gonna stretch you a little bit beyond the pre-class material. Can everybody see my screen okay? Thank you, or at least the people I can see are giving me thumbs up. So, one of the amazing things about humans is that we're not just humans, we have microbes. And you've already been talking about in some of the unique things, exponential growth and so on and so forth. So I just wanted to share as an opportunity, what would it be like if we could partner with the microbes that live on our skin or live inside us? You know, if you think about COVID-19 diagnostics, why do I have to go get a test? Couldn't I have an engineered microbe that lives on me or in me that just like changes my breath or changes the color of something I excrete if I have a coronavirus infection? That would be way better than having to go to the doctor. So what if there's some opportunity to partner with the biology that comprises ourselves to do what we want? Here's a neat project that Cicel and Christina did years ago now, I'm still smitten with. So they took microbes from the skin of colleagues at Harvard and then got raw goat milk or sheep milk, I can't remember, and they inoculated the milk with the human-associated skin microbes and made cheese. Cheese from the microbes found on the toe of a Harvard philosopher, from Christina's foot or Cicel's nose and so on. And wouldn't you know it, you can use the biology and the awesome power of replication and biosynthesis and conversion to make cheese from human skin microbes. I still remember when they presented the 48 cheeses they made, and how beautiful the bouquet of Daisy's armpit microbe cheese was, and how wrong the bouquet of cheese made from the toe of a philosopher's toe, Harvard philosopher's toe microbiome. But what does this teach us about the opportunity or challenges of biology? If my mom said, eat the broccoli, eat your", "start_char_idx": 8233, "end_char_idx": 12274, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "efca8c91-0add-4ef7-bf3d-737c4f8319a7": {"__data__": {"id_": "efca8c91-0add-4ef7-bf3d-737c4f8319a7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6ca606fd-0454-4a3c-8f6e-a99d1368dab4", "node_type": null, "metadata": {}, "hash": "252f71dce2def4660af35a6d733a7263e3caa204c425bcccfaf7352569d02431"}, "2": {"node_id": "280cf2df-4e33-4e8b-b2a7-e09fbf21dfe0", "node_type": null, "metadata": {}, "hash": "2ae4bfc711303cbb631337a0981cf59e8b2e03185539c4ea3a50ce7a97e83d7e"}, "3": {"node_id": "46d74122-a40d-429b-a7dd-a289dc0bd2aa", "node_type": null, "metadata": {}, "hash": "16cc56993427eaae27f5988b7742447597040be3716c738735fad69fe1346984"}}, "hash": "9f6b97419b6d4d007066901eb1f138e274edad94b9d435be9459917f2ff5bbeb", "text": "or challenges of biology? If my mom said, eat the broccoli, eat your vegetables, you are what you eat, this suggests there's an opportunity to, well, we eat what we are, and maybe there's a way of engaging differently in how we interact with the biology. To keep pushing on this, here's a undergraduate project from 2008 where these students, by bioengineering bacteria, reprogrammed its bouquet so that instead of having a fecal odor, the bacteria would smell like wintergreen because they could get the bacteria to make methyl salicylate, a chemical that is the odor associated with wintergreen, or isolamyl acetate, bananas. So what if your skin is smelling like bananas because you've got a particular infection? What if you could download your perfume as DNA code and install it in your cells, whether they be microbial or not, and grow your perfume where you are in response to the signals that you're getting. What a neat set of opportunities. If we could partner with biology to make the things we want where the biology is, including where we are.\n\nAnd within this, and this was one of the, just link it back to the physical unique aspects, there's a little video of cells doubling. These cells are quite small. These are E. coli, about a micron per cell. That's about tens of billions of atoms. So you've got an object of micron scale that within 20 minutes is capable of organizing an ensemble of atoms and molecules into a near perfect physical copy of itself.\n\nWhoa, like just imagine the opportunity associated with engineering something that's capable of organizing matter into copies of itself. There's nothing else like that that we could think about. Now there's a puzzle, here's a challenge. And on Friday, by the way, we'll give you skills for quickly parsing papers, and that'll be part of the pre-class for Friday. I just wanna acknowledge something out of the gate, if you're thinking about being a bioengineer in the year 2020, there is no cell on earth that anybody fully understands.\n\nI don't care how many Nobel laureates you're working with, or how many degrees you have, there's not a cell on earth that human civilization fully understands. And roughly, the numbers here give you an example, like the simplest best studied cells have about 450, 500 genes. There's about 100 genes that are absolutely essential for the life of that cell. And nobody on Earth knows what they do. What does that mean to the bioengineer? Good luck engineering a system where 25 percent of the componentry in the object you're engineering is a total mystery, among other challenges. So I just want to give you an example of a challenge associated with some of the opportunities. It begs the question, what don't we understand about biology? There are things that are essential to life still that we don't understand. And it's not that we're not hardworking and smart, it's probably that we don't have the tools. And who's gonna make the tools? Maybe it's the engineers. So maybe this opportunity and challenge thing interrelates.\n\nSo hopefully that gives you a taste of opportunity and challenge, making new things in new ways in new places, exponential manufacturing capacity, and we don't understand it. We still don't perfectly understand it. We don't even have it operationally understood. So, breakout number two, same operational detail as before, but here are the new questions. What do you think the most important opportunity is for bioengineering right now? Obviously, we'll return to this question, but for today, what do you think the most important challenge is to bioengineering or bioengineers? What do you think is most frightening about one of these opportunities or challenges? And what do you think is most exciting? So most important opportunity, most important challenge, most frightening, most exciting.\n\nIf I may briefly add one thing we recognize collectively that many of the opportunities and challenges and exciting and frightening were not very easy to decouple, that they were always like they came together. So it was very interesting and exciting that we didn't fully understand the cell. But it was also frightening that given all these years that we've", "start_char_idx": 12291, "end_char_idx": 16484, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "46d74122-a40d-429b-a7dd-a289dc0bd2aa": {"__data__": {"id_": "46d74122-a40d-429b-a7dd-a289dc0bd2aa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6ca606fd-0454-4a3c-8f6e-a99d1368dab4", "node_type": null, "metadata": {}, "hash": "252f71dce2def4660af35a6d733a7263e3caa204c425bcccfaf7352569d02431"}, "2": {"node_id": "efca8c91-0add-4ef7-bf3d-737c4f8319a7", "node_type": null, "metadata": {}, "hash": "9f6b97419b6d4d007066901eb1f138e274edad94b9d435be9459917f2ff5bbeb"}, "3": {"node_id": "645b24d2-e0ce-43a9-9e08-b3bcfc0e5f75", "node_type": null, "metadata": {}, "hash": "a86a369621657b703698779cf74ac9782b2c47232d009d64009cc3921a7e637a"}}, "hash": "16cc56993427eaae27f5988b7742447597040be3716c738735fad69fe1346984", "text": "understand the cell. But it was also frightening that given all these years that we've studied these cells, we still don't fully understand. So what's the lesson there, Sivash, for the woodpecker engineer? Yes, the lesson is to acknowledge the ambiguity, at least as far as I can tell, and try to operate with not thinking that these two views are the extreme truths, that we are operating in this regime, that both of them are simultaneously true.\n\nSo Ella, your breakout was talking about the challenge of engineering polygenetic traits, like height and intelligence, presumably in humans. And Montana, you're reporting that you got the opportunity of improving human fitness and survival likelihood, but also the ethics around this stuff, so are either or both of you willing to pick up on that and talk it out a little bit, please?\n\nSure, we kind of discussed human survival as both a challenge and an opportunity and the ethics around it as sort of like how do you how do you create a line between survival and like improving past like unnecessary improvements and who's going to end up making that decision I guess and whether it's people in politics or people in bioengineering or like the people at large and then it sort of moves into a, well, who's in power? And yeah, so all these things are gonna need to be decided at some point and who's gonna be deciding them.\n\nWhat do you think the right answer is or the right way of approaching who gets to make the choice? Personally, I think it, like, I think that's a really tough question, but I do think that it should not come from people who are in politics and be led at least by scientists because we also discussed a little bit of this as well. I think that bioengineering and similar fields have a certain amount of accountability. accountability and we sort of mentioned the CRISPR gene editing in the Child and I believe it was in China and I'm not I don't know all the facts off the top of my head You know sort of accountability The accountability that followed the release of that paper or whatever they were doing\n\nWould you happen to know where that person who edited the twin girls in China a few years ago did their postdoctoral studies. At Stanford. In bioengineering.\n\nYeah. And sort of the fallout of that procedure, I think is something that you don't necessarily see in other fields, such as software engineering or I don't know. So I think that's really cool to see that accountability already existing in such a new field, especially considering that it is so tied to so many things beyond just the science itself, because we are affecting living things for the first time, and there's such a line between how we treat living things and how we treat inert things.\n\nSo just to give \u2013 great, thank you so much. And just to give everybody some context, in the course itself, we'll pick up early and at the end aspects of culture and politics as part of bioengineering, not a separate thing, but intrinsic to the discipline. And if you end up further and deeper into the program, typically junior or senior year, we have a required bioethics course for the undergrads. It's not required of graduate students or postdocs, which is interesting, maybe a loophole, but for your information.\n\nI think we have a hand raised. Natalia, did you want to comment? I just want to say that, yeah, it's hard to decide who wants to do that because, yeah, politician, I mean, sorry, scientists are the ones working with the system and doing the actual bioengineering of it, but also like a bias that scientists could have is that you know they want to see how much knowledge they can get from the you know what they're doing and like you know they're excited about the science of it so they're like trying to kind of want to know everything which I totally would be like that I would want to know like everything I possibly can so that's a downside of it you know. In In my group, I think Olivia made some really insightful comments on this topic as well.\n\nDo you want to chime in, Olivia? Olivia Miller Yeah, sorry, I can. Yeah, we just talked a little bit about the idea of something that was brought up in our group is the", "start_char_idx": 16469, "end_char_idx": 20653, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "645b24d2-e0ce-43a9-9e08-b3bcfc0e5f75": {"__data__": {"id_": "645b24d2-e0ce-43a9-9e08-b3bcfc0e5f75", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6ca606fd-0454-4a3c-8f6e-a99d1368dab4", "node_type": null, "metadata": {}, "hash": "252f71dce2def4660af35a6d733a7263e3caa204c425bcccfaf7352569d02431"}, "2": {"node_id": "46d74122-a40d-429b-a7dd-a289dc0bd2aa", "node_type": null, "metadata": {}, "hash": "16cc56993427eaae27f5988b7742447597040be3716c738735fad69fe1346984"}, "3": {"node_id": "2cefc23a-55c6-4ca7-9337-572cf128bf49", "node_type": null, "metadata": {}, "hash": "b347ba434820f7b37e52b666f7fec2a1c872c0cdf19abd0e5f4ec8ee8dfafa7a"}}, "hash": "a86a369621657b703698779cf74ac9782b2c47232d009d64009cc3921a7e637a", "text": "a little bit about the idea of something that was brought up in our group is the idea of science advancing faster than society. And I just sort of made the comment that I think it's dangerous to think of some of these potential like gene editing and those things existing in a vacuum of a world without inequities, because we would hope that if we're creating these things, we are thinking about the idea that if they're not really evenly distributed or used, like rich people could be genetically different than poor people, and the global south can be genetically different than the global north. So I think it's important to think about those things as existing in conjunction with science and not as something completely separate. You like have to think about the effect.\n\nGreat. I think what I'd like to do is transition to the third topic. We'll make a slight adjustment and we'll keep it all together for the sake of time so that we can close in the next five or six minutes, so There's a lot here in the chat, and we'll share the chat. I think if we curate it So people can can benefit from all the great thinking that came back from the last breakouts So I'll share screen again and just hit you with a couple slides this third topic is going to be about the here and now. So what is it about living matter that's unique as it relates to the here and now? And I'll set up one example real quick. One thing that's happening right now is, quote, unquote, surprise. I don't think a lot of people at the start of fall quarter last year, this academic year, were expecting to be Zooming in the spring. And so there's a surprise coming from Living Matter, COVID-19. What's interesting about the surprise is it's not really a surprise. If you are paying attention to the literature, if you're watching Bill Gates giving a TED Talk about pandemics, if you're reading Wired magazine five years ago, very specifically, people are saying we need to be prepared for a pandemic. And that's not to do with the immediate organization and politics of the response since COVID-19 arose, but it's just for the last 10 years, 20 years, 30 years, 40 years, people who are in positions of responsibility and leadership have been saying, we need to be ready for pandemics. And we're not. Historically, I wanna draw your attention to another quote unquote surprise. This is from 1957. This is when the Soviet Union launched and orbited the first man-made object around the Earth, Sputnik. And to many and to most politically, this was a big surprise and really turbocharged the space race and led to the Apollo program in the United States. Again, if you were paying attention to what was going on, if you were reading the newspaper, you could find reports in the preceding years that the Soviets were about to launch a satellite. Nevertheless, it was a surprising thing. So something that's unique about bioengineering today, and will ramify for the remainder of the decade, no doubt, is that the whole world, all of humanity, is going through this surprise perturbation. What becomes of that, how you engage with that surprise to do things you wish to do or not, or how those pressures oppose what you're trying to accomplish will matter, would be my bet. So that's an example of what is unique about living matter in terms of the here and now. Surprise, hi, living matters here. I don't expect you to read all this. I'll give you a different type of uniqueness in the here and now by drawing a comparison to electrical engineering. So this is part of an interview with one of the co-founders of Pixar, the movie animation studio. I'm sure most of you have seen a wonderful movie or film or short from Pixar. And what Albie Ray Smith is reporting here is in the 1980s when they were moving towards making a computer animated film, how many times it didn't work. They were so excited to do it, they set out to do it, and they didn't do it. And they were failing for the same reason. They weren't able to afford the computational power sufficient to render the animation. They didn't have enough money, the computers weren't powerful enough, and so on. And they failed once, and they", "start_char_idx": 20662, "end_char_idx": 24831, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2cefc23a-55c6-4ca7-9337-572cf128bf49": {"__data__": {"id_": "2cefc23a-55c6-4ca7-9337-572cf128bf49", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6ca606fd-0454-4a3c-8f6e-a99d1368dab4", "node_type": null, "metadata": {}, "hash": "252f71dce2def4660af35a6d733a7263e3caa204c425bcccfaf7352569d02431"}, "2": {"node_id": "645b24d2-e0ce-43a9-9e08-b3bcfc0e5f75", "node_type": null, "metadata": {}, "hash": "a86a369621657b703698779cf74ac9782b2c47232d009d64009cc3921a7e637a"}}, "hash": "b347ba434820f7b37e52b666f7fec2a1c872c0cdf19abd0e5f4ec8ee8dfafa7a", "text": "the computers weren't powerful enough, and so on. And they failed once, and they learned from that, and then they tried again a couple years later, and they figured out they didn't have enough money to do the computing, so they were failing twice. But now they had two data points, and they made a projection. They were learning how quickly computers were getting better over time, so they could get a sense of the uniqueness of computing from a pacing perspective, what is more commonly known as Moore's Law, and we'll pick this up in detail in week five, when we talk about sequencing and synthesis of DNA, reading and writing of DNA. But as soon as they had those two data points, everybody knows a line is defined by two points. So once they had two data points, they could make a projection into the future and accurately estimate when they should make their first feature-length animated movie, Toy Story, in 1995 or thereabouts. And they got that exactly right. So pace of change is something that's very unique to bioengineering today. I'm showing you the pace of change historically for computers, but equivalent trends are true for DNA. What surfaced in the first breakout is one of the unique things about living matter, this code for life. So how do we navigate the next 10 years? How do you navigate your lives and careers when you've got a pace of change around DNA read-write that looks like what people experienced over the last generation for a computer?\n\nWe're not gonna go to breakout, but I wanna leave this here for a little bit so you see the prompt and might consider it. So for you, given whatever you're seeing, I'd ask if you could please write down or think about between now and Friday, what about the here and now do you think matters most to bioengineering or bioengineers? And when we come back together on Friday, if you could collapse that into a single word, what we're gonna ask you to do is rename yourself around the here and now, what's unique about the here and now to you regarding bioengineering. So we'll make a note about that in the pre-class for today just so you see it. So hopefully today, you got a chance to practice with your peers and remember, or maybe if you didn't get a chance to see the pre-class because it's the first time we've shipped pre-class, what about the physics of living matter is unique? Then we talked about opportunity challenges and uniqueness there, and now we're talking about the here and now. Gave you two examples of surprise and pacing. Hopefully you can add your own perspective. I expect you can. To wrap up for today, and again, just to get you in the pattern of how the course is gonna operate, for most classes we will have pre-class reading, activity, or video. Shouldn't take you too long. Shouldn't take you more than an hour. For Friday, we have a little algorithm we want you to run. There are two papers posted from the research literature and bioengineering, and we have a little algorithm on the right, just five steps we want you to do very quickly to see if you can accelerate how you learn from the primary literature, not the news reports, but the actual front line reports from bioengineers of what bioengineers are doing.", "start_char_idx": 24815, "end_char_idx": 28033, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9c9c9e3e-72a1-4bc0-a733-ba77d7eae0d8": {"__data__": {"id_": "9c9c9e3e-72a1-4bc0-a733-ba77d7eae0d8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0cedf0fa-abc8-4f72-b929-bb6af80badc5", "node_type": null, "metadata": {}, "hash": "659bdb2bb3a044da65cb9c81f4d953a516c4f6ddc45b2f37aa01b8437e66dcf1"}, "3": {"node_id": "eee3b41f-2b36-431f-9239-cc7b5db9b33b", "node_type": null, "metadata": {}, "hash": "8bd83e4235c747cd2a886adf9bade559d822051480942873527cece51eba8987"}}, "hash": "d086d4d206383b5608a874b9f0c8fde8a46df09cdc048dfd687d4b5dd5a15eda", "text": "WEEK 1 FRIDAY LECTURE 3\n\nHey, everyone. Welcome to the first Friday class. So for the warm-up today, we're going to have everyone rename themselves to your favorite COVID quarantine pastime that you've discovered, like baking, crafting, reading, TV shows, like really whatever you guys have found you like the most, just hover over your own image. There's a dot, dot, dot button. You can click on that and then scroll down to rename. And you guys can just go ahead and start renaming yourselves. And we can take a look at what everyone else likes doing right now. Cool, so I see YouTube videos, baking bread watching Harry Potter Animal Crossing\n\nIf you can see this website here, this is the front page of the New Yorker magazine and Michael, our colleague on the teaching team, has a front page story on Tony Fauci. So if you're interested in Dr. Fauci, you can spend some time this weekend taking a look at that article. Now, back to today. So, the main goal for today is to, if you've never done this before, give you a turbocharged toolkit for parsing primary research papers in the bioengineering literature. If you are already really good at this, nevertheless, I'll submit for consideration, we can help you level up. And so, the activity today is to go through the process, the algorithm of reading a bioengineering research paper. And I need to be very particular about it. The goal is not to perfectly understand these papers or get distracted by the content of these papers. These papers are substrates to practice the algorithm. So we're really aiming to enable you to get skills for parsing papers. Some of the papers we've chosen on purpose to be distracting and some of them I've chosen to be boring, so it'll be harder, easier. Now, what's going to happen is I will just remind you from the pre-class, then we'll get into one of the papers that you looked at, hopefully, and then I'll do practice through four other papers or three other papers, and then we'll go into activities that other folks on the team will lead. So here's the algorithm, just as a very brief reprise. When you're going to read a paper, the first thing you should do is not read the paper. It is a tragic blunder of the first order to read a research paper by reading the paper, because if you do that, you will spend so much time reading the paper, you just run out of time. Instead, here's the suggestion. Read the title, see if it makes sense. Any word you don't understand, pay attention, but don't worry about it. Second, read the abstract. You're not reading the abstract to read the abstract. You're reading the abstract to hunt down and capture the most important or remarkable statement, declarative claim, that is being presented by the writers, the authors. If you cannot find a compelling claim in the abstract, you should throw the paper out or recycle it gently. Just don't spend more time on it. If the authors fail to write their abstract in a way that makes it obvious why the thing matters, set it aside.\n\nSo you're going to have to make this real critical go-no-go right away. If you come up with a claim, then don't read the paper still. Skim the figures and look for the most compelling evidence where you think you could see evidence of that claim. And if you can't find evidence of the claim, set the paper aside. Find a different paper to read. There are plenty of papers to read. So that's what we gave you in pre-class. And what I'd like to do is jump into one of the two papers from the pre-class and see if we can apply this algorithm together. Now, again, I'm just gonna give you the demonstration of this with four papers real quick, and then we'll transition into activities with papers you haven't seen. And obviously three of the four you haven't seen, but this one you should have seen. So can everybody see the top of this paper starts with identification of an infectious something or other? Naomi, can you see that?\n\nRead the title and see if you can make any sense of the title. Identification of an infectious progenitor for the multiple copy HERV-VK human endogenous retro elements. The only word I", "start_char_idx": 0, "end_char_idx": 4128, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "eee3b41f-2b36-431f-9239-cc7b5db9b33b": {"__data__": {"id_": "eee3b41f-2b36-431f-9239-cc7b5db9b33b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0cedf0fa-abc8-4f72-b929-bb6af80badc5", "node_type": null, "metadata": {}, "hash": "659bdb2bb3a044da65cb9c81f4d953a516c4f6ddc45b2f37aa01b8437e66dcf1"}, "2": {"node_id": "9c9c9e3e-72a1-4bc0-a733-ba77d7eae0d8", "node_type": null, "metadata": {}, "hash": "d086d4d206383b5608a874b9f0c8fde8a46df09cdc048dfd687d4b5dd5a15eda"}, "3": {"node_id": "332e7a22-5ed5-420d-a269-89a7221df196", "node_type": null, "metadata": {}, "hash": "533d1d208582e855d79800fe0216a5fd8a4525706a34fe78301bfd2419e01593"}}, "hash": "8bd83e4235c747cd2a886adf9bade559d822051480942873527cece51eba8987", "text": "for the multiple copy HERV-VK human endogenous retro elements. The only word I understand there is identification and infectious. And the rest of the words I can kind of understand like progenitor like the thing that comes before Multi multi copy okay, but like herve K. What? So identify so I'm just going to abstract this title identification of something All right, all right, so okay Now I also when I look at papers. I'm kind of thinking it like buying a bottle of wine I'm looking at the label for all sorts of information So like who are the authors and where do they work? And you can see that right here. So there's a lot more information you can sort of parse on the side without too much effort. And that'll help you set expectations. So now I'm gonna look at the abstract, that's the text here, okay? Human endogenous retroviruses, these things, are remnants of ancient infections in primates long ago. Here we're using something in silico. That means computer. Here we're deriving in a computer the sequence of a putative, we expect ancestor of one of these things. This element, which they're calling Phoenix, produces virus particles and looks like a bonafide retrovirus that can infect human cells. We show this element amplifies and so on and so forth. We show that recombination, I'm now at the last sentence, and note I'm not like actually reading it word for word, I'm jumping around a little bit. We show that in vitro recombination among humans could generate this thing. All right, so there's a lot in here. It's like 80% jargon. What am I taking away? Apparently, there were viruses that infected ancestors of humans a long, long time ago. Some of these things get into the genome of the ancestor and gets transmitted. That's what they mean by Mendelian fashion. Apparently, they found one of these things. They called it Phoenix, like the bird, if you saw Harry Potter, the phoenix that, you know, regrows after it burns. They found one of these things, they named it Phoenix, and they found out that it's a bonafide retrovirus. And then they say, and yeah, it's, okay. So basically at this point, I'm confused. But I see this claim, they're claiming there's this thing called Phoenix that's a bona fide retrovirus. So, that seems pretty interesting. And if I stitch that together, that's right in the middle, highlighted, if I stitch that together with remnants of ancient infections of primates, I can kind of make a guess at what this paper is about. There are genetic remnants of infections of our ancestors going way, way back in time, and if you stitch them back together in the right way, you can get a retrovirus reactivated. So, if I take a leap based on what I'm reading here, in the human genome, in your genomes, in my genome, in our genomes, there are these genetic fossils of old infections, and if you recombine them in the right way, you can resurrect the ancient virus from millions of years ago. And they claim to have done it with this thing called Phoenix. All right. So this is feeling like there's a claim. So I'm going to decide to continue with this paper. And so the next thing, if you go back to the algorithm, is find the evidence. And I'm not reading the paper. I'm just scrolling and I'm looking at the figure. And this is a cartoon, so there's no evidence here. Keep going. And, oh, this is a microscope image of what looks to be virus particles. And when I read the beginning of the, when I read the beginning of the figure title, microscope of virus particles generated by Phoenix. And it looks like, yes, indeed, there's virus particles here. Okay, so now I would make another decision. If I care about this topic, ancient infections leading to genetic fossils that could be recovered to remake viruses, then I'd say, well, let's spend more time on this paper. If I don't care about that, I'd say this is a good paper, but it's not that important for me. Hey, can I jump in for 30 seconds?\n\nGo for it. I wrote a long story", "start_char_idx": 4063, "end_char_idx": 8043, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "332e7a22-5ed5-420d-a269-89a7221df196": {"__data__": {"id_": "332e7a22-5ed5-420d-a269-89a7221df196", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0cedf0fa-abc8-4f72-b929-bb6af80badc5", "node_type": null, "metadata": {}, "hash": "659bdb2bb3a044da65cb9c81f4d953a516c4f6ddc45b2f37aa01b8437e66dcf1"}, "2": {"node_id": "eee3b41f-2b36-431f-9239-cc7b5db9b33b", "node_type": null, "metadata": {}, "hash": "8bd83e4235c747cd2a886adf9bade559d822051480942873527cece51eba8987"}, "3": {"node_id": "7cc8e856-a0fd-4655-ba46-303968bdd965", "node_type": null, "metadata": {}, "hash": "61958dfce3e09ff21140a90da64e827af7ca564f64d869ac951ee229d029f945"}}, "hash": "533d1d208582e855d79800fe0216a5fd8a4525706a34fe78301bfd2419e01593", "text": "can I jump in for 30 seconds?\n\nGo for it. I wrote a long story for the New Yorker on this paper based only on the word Phoenix. Because I didn't understand any of the other words at the time, and I went to my editors and said, this guy has a Phoenix virus. It's a virus that comes back to life. And based on that, my editors, possibly not intelligently, sent me all over the world to look for pieces of virus. So you can focus on, and it turned out, maybe through luck, that that worked. You can look at a small part of a piece and get a sense of whether you want to keep studying.\n\nI am going to take that question with the second paper. So this is a paper that I selected because it's boring, relatively speaking. So let's go through it Gemini a bifunctional reporter of gene expression something That is a reporter of gene expression and then and then the abstracts already organized So I'm just going to write to the findings here we described Making this thing Gemini. That's a fusion of other things We show that it has functional activity and functional activity. It has two activities. So maybe that's why they called it Gemini. Okay, so at this point, there's a type of claim. There's a secondary claim, I won't belabor, and so I'd keep going. Now, playing with siblings, your question. We see down here some additional information on the wine label. This is what you were asking about. What this says here is this paper was received for peer review at the Journal on the 4th of September in 2009. And about a month later, on the 5th of October, the same year, it was accepted for publication. And then it was published about a month later. So from when the authors submitted the manuscript for scientific peer review, to when it was published was two months. One month was spent reviewing the paper and making an editorial decision. And the next month was just production to get it typeset for publication. So this is about as fast as you would see something happen unless it's totally extraordinary. And what this implies is that the paper was not difficult for the reviewers to review. The reviewers did not ask for more experiments to support the claims, right? Because you can, you can get a sense of what's involved. The paper has to get there. The editor has to look at it. They have to decide to send it to somebody, they have to get people to agree to review it, and so on and so forth. So that just takes days and weeks. Great question, audiobooks. Hang on to your question. Audiobooks got a question in the chat about what about COVID-19 research? What about peer review in the time of pandemic? Be patient. We'll get to that. So I've published other papers that have been a year or two years between when we sent it in and when it got accepted. And that's because we did massive amounts of additional experiments. So this is about as fast as it would go. If it's shorter than this, something funny is happening, like the peer review process being short-circuited or accelerated due to extraordinary circumstances. So you might be a little bit more skeptical if you see something shorter than this, or at least I would. Okay, I don't want to get too distracted because I just want to come back to the algorithm. So we found a claim that \u2013 sorry, playing with siblings. Does that make sense?\n\nYeah, I guess. So if there was a longer review time, is there something that you can do to follow up or specific things you would want to look for in the paper to kind of understand where that longer time came in, or is that kind of like not transparent to you?\n\nSo what it, mostly what it signals is if it's shorter than two months, I would say there's some funny business going on. And so I might be a little bit more critical or skeptical, just I might have my feelers out a little bit more. If it takes say four months or longer, three months or four months or longer, I would expect there might've been a significant revision, maybe more experiments. And so I I might just have a mental model that the authors went through a revising process of some significance. And so I try and see how that played out if I really went deep into the paper. So that's that's all I", "start_char_idx": 8061, "end_char_idx": 12243, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7cc8e856-a0fd-4655-ba46-303968bdd965": {"__data__": {"id_": "7cc8e856-a0fd-4655-ba46-303968bdd965", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0cedf0fa-abc8-4f72-b929-bb6af80badc5", "node_type": null, "metadata": {}, "hash": "659bdb2bb3a044da65cb9c81f4d953a516c4f6ddc45b2f37aa01b8437e66dcf1"}, "2": {"node_id": "332e7a22-5ed5-420d-a269-89a7221df196", "node_type": null, "metadata": {}, "hash": "533d1d208582e855d79800fe0216a5fd8a4525706a34fe78301bfd2419e01593"}, "3": {"node_id": "c318d636-18e3-4f3d-ab84-26eb05c26352", "node_type": null, "metadata": {}, "hash": "b6d738a4b498fbcebbeb9383d811b486f9dc0b84ec3330b27acdd209aa1682ea"}}, "hash": "61958dfce3e09ff21140a90da64e827af7ca564f64d869ac951ee229d029f945", "text": "how that played out if I really went deep into the paper. So that's that's all I would take from the from the latency of the publication process. I wouldn't I wouldn't think less of a paper that took a long time to get published. Usually the opposite. Right. I think more of it's a survivor. It's really been well-baked, so to speak.\n\nSo, there's a claim that there's this two-component protein. So I'm just gonna go into the figures. Can I find it? Okay, design, okay, that's a cartoon. Gemini encodes both functional, enzymatic, and fluorescent activity. Probably here, I'd start. All right, so it looks like there's evidence. It's clearly presented. The figure title is a declarative statement making a claim, supporting the claim in the abstract, so okay. Let's go to another paper. And this is going to come right to the question that audio books has posted in chat. How has this changed for covid related research? So check out this paper. This paper has the title Rapid Reconstruction of SARS CoV-2 using a synthetic genomics platform. So rapid reconstruction, okay, SARS-CoV-2, okay, that's all over the news, using a synthetic genomics platform. Kind of jargony, but I guess that means they're gonna synthesize a genome. And if I put it together, they're gonna synthesize the genome of the coronavirus, COVID-19. Now, this is a paper that's related to COVID, like audiobooks question, but it's not a peer-reviewed paper yet. This is something called a pre-print. It's pre-peer review. It's published free online through a pre-print server, in this case called BioRxiv. So one way to accelerate publication is to skip peer review for the moment and just publish your pre-print and then let peer review happen later so everybody can read the pre-peer review version of the paper. Does that make sense? Enough sense. Okay, so I wanted to just hit you with a preprint Let's see if we can get to an abstract so it's not it's not nicely typeset right Reverse genetics blah blah blah large thing da da da. Yeah here we show yeast based synthetic genomics to reconstruct Viruses and viruses and blah, blah, blah. Based on our platform, we were able to engineer and resurrect the recent epidemic after a week of receiving the DNA. Okay, so basically it sounds to me like they made the claim of they're downloading the sequence of this virus off the internet, they're synthesizing the genome from scratch, they're assembling it and recovering the virus. So that's kind of amazing, which is an understatement. and recovering the virus. So that's kind of amazing, which is an understatement. It means if you have an internet terminal and a DNA synthesizer, you can build viruses. Okay, so look, there's no figures until you have to go all the way to the thing, to the end. Oh my gosh, oh geez. Okay, where are the figures? Do they even have figures? Ah, here we are. It's trickier to figure out because the figure legends are not next to the figures. I have to go back up to look at them. But it looks to me like they've got plates of human cells or mammalian cells, and they're doing an assay to see if the virus is destroying the cells. And everything that came before looks like it's DNA construction. Yeah, and here's the timeline. So this is really interesting actually. There's an infection in Wuhan in December. Somebody got a clinical sample of the virus and the genome got sequenced by DNA sequencing. That genome was published on the internet on the 10th of January. Four days later, a group in Germany, not in China, a group in Germany downloads that sequence and redesigns 14 variants of the COVID genome for synthesis. It took them about three weeks to get the DNA synthesized from 14th January to 4th Feb. And within a week, they had rescued, meaning gotten infectious virus in their laboratory in Germany. So all via the internet", "start_char_idx": 12229, "end_char_idx": 16070, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c318d636-18e3-4f3d-ab84-26eb05c26352": {"__data__": {"id_": "c318d636-18e3-4f3d-ab84-26eb05c26352", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0cedf0fa-abc8-4f72-b929-bb6af80badc5", "node_type": null, "metadata": {}, "hash": "659bdb2bb3a044da65cb9c81f4d953a516c4f6ddc45b2f37aa01b8437e66dcf1"}, "2": {"node_id": "7cc8e856-a0fd-4655-ba46-303968bdd965", "node_type": null, "metadata": {}, "hash": "61958dfce3e09ff21140a90da64e827af7ca564f64d869ac951ee229d029f945"}, "3": {"node_id": "c678010c-fe8e-47a0-b15c-834f84e9c30d", "node_type": null, "metadata": {}, "hash": "01a98a6bd9a75bc60c2e487320223ee4b27c5ddbfd53f3956600831da20a25e9"}}, "hash": "b6d738a4b498fbcebbeb9383d811b486f9dc0b84ec3330b27acdd209aa1682ea", "text": "meaning gotten infectious virus in their laboratory in Germany. So all via the internet and DNA synthesis. Okay, so now we're distracting you again with the content of a paper, but don't forget the algorithm Can you understand the title? Can you find a claim in the abstract? Can you find evidence in a figure supporting the claim if at any point you answer no? Then you should stop on the paper All right. I'll do one more and then we'll turn it over. So a A DNA of things storage architecture to create materials with embedded memory.\n\nWhat the heck is this?\n\nLike buzzword bingo. I don't know what this is about. I've never heard of DNA things before. Architecture, memory. Okay, so I don't know if I want to read this paper yet. Let me try the abstract. DNA storage, substantial information density. We devised a quote DNA of things thing to produce materials with immutable memory. In our framework, DNA molecules record the data and these molecules are encapsulated in nanometer glass beads, which are fused into materials that are used to print or cast objects in any shape. Oh my gosh, what's this? Okay, first we applied DNA of things to three-dimensionally print a Stanford bunny, whatever that is, that contained 45 kilobytes of digital DNA blueprint for synthesis of the Stanford bunny. We synthesized five generations of the bunny, each from the memory of the previous generation without additional DNA synthesis. To test scalability, we stored a video from YouTube in DNA of glasses and then retrieved the video by cutting out a piece of the lens of the glass. DNA of things could be applied to store electronic health records in artificial knees, to hide data in any object you want, to manufacture objects containing their own blueprints.\n\nWhat?\n\nOkay. So, I guess they're putting DNA-based data storage in objects, and the data they're putting in the objects is the information for making the objects in one case. Ah, that's the cartoon here. So, they're synthesizing DNA that is the file for programming the 3D printer to make this bunny rabbit. The DNA encodes the instructions for making the bunny rabbit. The polymer that makes the bunny rabbit has DNA in the polymer. So the bunny rabbit has DNA in it, which contains the instructions for 3D printing the next generation of the bunny rabbit.\n\nGot it?\n\nOkay. And they did it. Okay. And looks like they did it. Yeah, and they just did multiple generations where they recovered the DNA, they sequence out the instructions, they remake the bunny with the copied DNA and they keep going. And even though there's mutation and error in the process, it somehow works. Wow. So you could put arbitrary information in arbitrary objects. You could put the instructions for rebuilding civilization into abiotic DNA and put that in the door of your refrigerator. What's up with that? You'll have to figure out why that's gonna change the world, but I bet it does. Okay, so I'll pause, stop pushing. We'll post all the papers on the Canvas. So read the title, don't have to understand it, just see what it's about, then hunt through the abstract for the primary claim. If no claim, abort, don't spend time. If claim, hunt the figures to see where the evidence is. If you get better and better and better at those simple steps, you will be way more empowered to navigate bioengineering. Bioengineering as a 21st century field is operating on and beyond the frontier all the time. So you're good to go if you can navigate. Sivash, back to you and team, or what comes next?\n\nSo we have three papers that we've selected that we want to collectively apply the algorithm to. So Brianna has, or baking copious amount of junk food, has the first paper that she's going to introduce, and then we're going to go to breakout, and then we'll come back.\n\nSo take it away, Brianna.\n\nAll right, let me just post this link in the chat.\n\nOkay, so everyone can access this paper. We're going to... Oh, and Drew, do you think you can bring up the slides of that", "start_char_idx": 16061, "end_char_idx": 20060, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c678010c-fe8e-47a0-b15c-834f84e9c30d": {"__data__": {"id_": "c678010c-fe8e-47a0-b15c-834f84e9c30d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0cedf0fa-abc8-4f72-b929-bb6af80badc5", "node_type": null, "metadata": {}, "hash": "659bdb2bb3a044da65cb9c81f4d953a516c4f6ddc45b2f37aa01b8437e66dcf1"}, "2": {"node_id": "c318d636-18e3-4f3d-ab84-26eb05c26352", "node_type": null, "metadata": {}, "hash": "b6d738a4b498fbcebbeb9383d811b486f9dc0b84ec3330b27acdd209aa1682ea"}, "3": {"node_id": "3a144196-f49d-48fa-9472-a206a7b637db", "node_type": null, "metadata": {}, "hash": "8d4e13c8d63e83629b2dbcc62bc5cd37a68c38da02bea7da469f6cd748f3fa04"}}, "hash": "01a98a6bd9a75bc60c2e487320223ee4b27c5ddbfd53f3956600831da20a25e9", "text": "to... Oh, and Drew, do you think you can bring up the slides of that algorithm? And we can go into break-up room. Wait, we're going to spend five minutes, I think, reading the paper, and then we're going through the algorithm, explicitly not reading the paper, and then five minutes in our breakout groups kind of discussing each step of the algorithm and what claims we found. So yeah, go ahead and click on the link. I like this paper because, disclaimer, there's some really big, scary words in it but I think there's enough not scary words for everyone to be able to find the claims. \n\nGo for a main claim, I know they're talking about COVID-19 and how it's, I guess, maybe being talking about like the, not transition is not the right word, but, oh yeah, maybe like with increased transition mutation frequency, and like RNA or something like that. But yeah, that's what I got from the abstract. I don't know if anybody else wants to chime in here.\n\nYeah, if you swallow it and it goes into your digestive system, the active pharmaceutical ingredient will end up circulating throughout the body and be available to have a biological effect. So you can take it by mouth. You can take the medicine by mouth as opposed to an injection. One of the things when I was looking at the abstract, I'm wondering, crafting what you think. Whenever I see words like here or we show, so the second sentence of the abstract is, it has all those words, like herein we show, that's always been for me a great clue that they're about to claim something. What do you think that sentence is claiming, if you had to simplify it and delete all jargon with just words a seven-year-old could parse.\n\nThey're basically showing that this compound that they're using works against a number of different coronavirus family. So they're planning on showing that their antiviral works and not only that it works, but it also works against like a variety of different coronaviruses. I also saw like the broad spectrum of antiviral activity meaning that like it can affect or it can inhibit the spread of the virus in numerous ways and so like for example it says at least afterwards it says it improves pulmonary function, virus titer, and I'm not really sure why they include body weight loss and how that's supposed to help, but I don't know.\n\nSo if I had to, again, I'm not seeing this, I had to explain it to my seven-year-old,\n\nI'd say these folks found a medicine for helping people who are sick with COVID-19, with the coronavirus. They know what coronavirus is. It hasn't been typeset. Yeah. Oh, God. What is this? So the medicine is abbreviated NHC, if I go back to the abstract, so that's a helpful clue.\n\nSo figure one's got a bunch of NHC, maybe it inhibits replication. And so it's got a bunch of plots that have the medicine concentration on the X axis and then different effects on the Y axis, like percent of inhibition, virus titers going, like the plot C, that red line, titer reduction goes down as medicine concentration goes up.\n\nAll right.\n\nThen figure two, NHC is highly active against SARS-CoV and so on and so forth in primary human epithelial cell cultures. Figure three, resistance to the medicine, that's a secondary figure. Figure four, effective against. Often also when looking at these figures, it's nice to form a sentence of if blank goes up, or if X goes up, then Y goes up or down. Just like put it in really clear logic. So, does anyone want to try that with one of figure one's graphs? As the amount of NHC increases, we see a decrease in both the number of COVID-2 cells and then also the titer reduction ones and the genome. We just see a genome reduction in those cells as well as the concentration or the amount of AHC increases.\n\nYeah, so that's a good pattern. You notice some things are going down and some things are going", "start_char_idx": 20081, "end_char_idx": 23922, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3a144196-f49d-48fa-9472-a206a7b637db": {"__data__": {"id_": "3a144196-f49d-48fa-9472-a206a7b637db", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0cedf0fa-abc8-4f72-b929-bb6af80badc5", "node_type": null, "metadata": {}, "hash": "659bdb2bb3a044da65cb9c81f4d953a516c4f6ddc45b2f37aa01b8437e66dcf1"}, "2": {"node_id": "c678010c-fe8e-47a0-b15c-834f84e9c30d", "node_type": null, "metadata": {}, "hash": "01a98a6bd9a75bc60c2e487320223ee4b27c5ddbfd53f3956600831da20a25e9"}, "3": {"node_id": "4737476f-7377-408b-ad53-3d3c71b408b3", "node_type": null, "metadata": {}, "hash": "6206e8542d843ef274968ccbcf3b64c1eff886deae63b37d63f4b552884e3719"}}, "hash": "8d4e13c8d63e83629b2dbcc62bc5cd37a68c38da02bea7da469f6cd748f3fa04", "text": "so that's a good pattern. You notice some things are going down and some things are going up. Also the things that are going up all follow this weird S pattern, which maybe if you read the paper more thoroughly, you could analyze more. But yeah, does someone want to tell us what's going up? You can see in C and D, the left sides are going down as, I don't remember who responded, drama or crafting.\n\nSo what's...\n\nSo I see percent inhibition. Does someone wanna take a stab at what that means? So it's like looking. I don't know what method they're using to measure it, but it would be whatever like the activity of the virus is. So, it's measuring like a decrease in activity.\n\nYeah, if you go to figure this out sometimes, like sometimes you can figure it out just right from the figure label, the Y-axis label. Like 1C says SARS-CoV-2 tighter, it's like the amount of the virus. But if you look at 1A, the y-axis says percent inhibition. And so it begs the question, inhibition of what? And to answer that, they did a good job. The easiest way is to go down to the legend right below. Can somebody read out just the words in the figure legend, both the first sentence and then the words right after the bold letter A.\n\nOh, sorry, yeah. So I'm looking at figure one and it says, oh yeah, so right, you're right. So the bold part of the figure says inhibits MERS-CoV. That doesn't tell you what does it mean by inhibit go to the next sentence where it says percent inhibition of do you see that? Of Maris Kobe replication and managed to say to talk to city, right? So great perfect So so now when you go back up to the figure you see there's a y-axis on the left. That's percent inhibition That's inhibition of replication of the virus. So as medicine concentration goes up Inhibition of replication goes up. What about the right Y axis? It says percent toxicity. Can somebody turn that into a sentence? As medicine concentration goes up, what's the impact on toxicity? Presumably to the cells that are getting the medicine. The medicine's supposed to help the cells. So would you want the medicine to be toxic or not? You wouldn't, and so that's why you want to see it be flat which is good in A. Yeah. Perfect, absolutely. Okay, Animal Crossing, you're gonna have to bring us back home with our report out. Oh, shit.\n\nIt is Biofilm Littography Enables High-Resolution Cell Patterning via Optogenetic Adhesin Expression. And this is one of those titles that, as Brianna was saying, the title is really jargon filled and confusing, but the rest of the paper is pretty straightforward.\n\nFun fact, this work was done in the bioengineering department here, and it was done in the Clark center, which is right next to Shroom.\n\nOkay, so can I get a volunteer from anyone who thinks they have found the claim from the paper. And just please go ahead and speak. It's trying to say they can grow bacteria in specified, like, where they want them to grow using blue light. Right. And where did you find that in abstract? You're absolutely right. It's the third sentence. With this tool, you're able to use blue light to pattern E. coli biofilms.\n\nSo they have genetically modified E. coli, and now they can express this, they can induce this gene and therefore they can pattern it to form biofilms. Great. So someone else wants, and they also claim that they can do this down to 25 micrometers. Someone else wants to tell us where did they find evidence for this claim or not.\n\nThank you, running. And yes, so if I am looking at figure 1B, specifically the first one and comparing it with the other conditions, it looks like that E. coli MG1655, where it had light, where it didn't have, you can see those purple stains that the E. coli got stuck. And very briefly, just in the interest of time, if we go to figure two, actually used a projected light, like 2A, where they have put", "start_char_idx": 23904, "end_char_idx": 27779, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4737476f-7377-408b-ad53-3d3c71b408b3": {"__data__": {"id_": "4737476f-7377-408b-ad53-3d3c71b408b3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0cedf0fa-abc8-4f72-b929-bb6af80badc5", "node_type": null, "metadata": {}, "hash": "659bdb2bb3a044da65cb9c81f4d953a516c4f6ddc45b2f37aa01b8437e66dcf1"}, "2": {"node_id": "3a144196-f49d-48fa-9472-a206a7b637db", "node_type": null, "metadata": {}, "hash": "8d4e13c8d63e83629b2dbcc62bc5cd37a68c38da02bea7da469f6cd748f3fa04"}}, "hash": "6206e8542d843ef274968ccbcf3b64c1eff886deae63b37d63f4b552884e3719", "text": "go to figure two, actually used a projected light, like 2A, where they have put down bacteria that are formed by a film versus where they have put, like, you know, where there was dark or no light, and then bacteria did not get stuck or did not form by them. So where does the 25 micrometers. You can post in chat or you can speak up.\n\nThis is interesting because this is the most quantitative claim we've seen in any of the papers we've covered today. They are claiming a spatial resolution with a number, which means they have to defend not only that they have spatial resolution, but that they have that specific number. Right.\n\nAnd it seems like we're getting some signal on figure 3C, which is correct.\n\nPerfect. So, painting, thank you for pointing out figure 3C. So the 25 micrometer comes from like the lower panel of figure 3C. And painting, are you convinced looking at 25 micrometer that that's a reliable number. Do you wish for something else? Are you happy with that claim? What are your thoughts? Or anyone else, if you would wish to help fake it. I mean, there seems to be a highlighted gray range. But also, yeah, so it just drops off pretty significantly, like around 25 meters. Right. So what when I looked at this, I've been meaning to read this paper for a very long time. When I read this, I really loved everything to be very transparent, except that claim of 25, because I looked at it and it to me seems one experiment with like not very like I'm not sure exactly how how they measure that. that I I personally wish for more experiments to back that twenty five micrometer claim a little bit more. The reason I'm highlighting this is because like. When we read papers, it's also good to from my point of view, it's good to be skeptical of thinking about their claims and seeing how they arrive at those, as Jonathan said, those quantitative numbers, how do they back that up? What are the parts of the paper that are more, you know, like more easily, you know, provable. Like, I believe them that they've engineered the collide that is, you know, conformed by a film with blue light. 25 micrometer resolution. I'm a bit iffy. I wish for a bit more evidence. And that's that this paper. So since we're almost out of time, we'll pass this back to Drew to give us conclusions and and we'll go forward.\n\nThanks so much, and thanks, everybody, for sticking around a little bit beyond time. So again, we wanted to give you, first week into the class, a tool for your toolkit and to level up your tool if you've got it and how to parse papers. Motivation, again, is bioengineering is very diverse in application and tooling and research. It's on a frontier. So if you have this capacity in your toolkit, you'll be better enabled to explore and flourish as a bioengineer. Also as a citizen of a world that increasingly depends on biology and biotechnology and just knowledge in general, it's very good to have a upgrade in your abilities to understand what reality is as opposed to what the representations of reality is in the news. So with that, we'll hit pause for now. P-SET I is posted on the course website. It's due a week from today. And the pre-class for next week will go live shortly, later today. Next week, we're gonna talk about human health, planet health, and political health. And we're doing that early so that you can consider and diversify your interest and wishes for bioengineering between now and the year 2030, such that you begin to think about what you want to contribute to making true over the next decade, either right away or something bigger in ambition, and that'll feed into the final projects. So again, just as a reminder, PSET's live, pre-class for next week will go live.", "start_char_idx": 27773, "end_char_idx": 31498, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6f2c9210-3779-4b74-9279-2560073d8734": {"__data__": {"id_": "6f2c9210-3779-4b74-9279-2560073d8734", "embedding": null, "metadata": {"page_label": "1", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3e6bd924-2c5f-459f-9318-9420a9e33ba3", "node_type": null, "metadata": {"page_label": "1", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "711e4fcc269c20d345633a6c86f749f5ec84f4e4d07d4e99092a5b600f08acaf"}, "3": {"node_id": "835a6315-1e1c-40e0-9cb5-119335cf01d4", "node_type": null, "metadata": {"page_label": "1", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "624509af7d4c242b5e5be32c1e5895a6d99d15d8b8822564e26073d84db5aa1a"}}, "hash": "b47c05bb4b50b585586e32ee2e6419f8f3793d47502a7408cfd59506be584387", "text": "LETTER\ndoi:10.1038/nature12051\nHigh-level semi-synthetic production of the potent\nantimalarial artemisinin\nC. J. Paddon1, P. J. Westfall1{, D. J. Pitera1, K. Benjamin1, K. Fisher1, D. McPhee1, M. D. Leavell1,A .T a i1, A. Main1{, D. Eng1,\nD. R. Polichuk2, K. H. Teoh2{, D. W. Reed2, T. Treynor1, J. Lenihan1{, M. Fleck1, S. Bajad1{,G .D a n g1{, D. Dengrove1, D. Diola1,\nG. Dorin1, K. W. Ellens2{, S. Fickes1, J. Galazzo1, S. P. Gaucher1, T. Geistlinger1, R. Henry1, M. Hepp2{, T. Horning1, T. Iqbal1,\nH. Jiang1, L. Kizer1, B. Lieu1, D. Melis1, N. Moss1, R. Regentin1{, S. Secrest1, H. Tsuruta1, R. Vazquez1, L. F. Westblade1,L .X u1,M .Y u1,\nY. Zhang2{,L .Z h a o1, J. Lievense1{, P. S. Covello2, J. D. Keasling3,4,5,6, K. K. Reiling1, N. S. Renninger1& J. D. Newman1\nIn 2010 there were more than 200 million cases of malaria, and at\nleast 655,000 deaths1. The World Health Organization has recom-\nmended artemisinin-based combination therapies (ACTs) for the\ntreatment of uncomplicated malaria caused by the parasite\nPlasmodium falciparum . Artemisinin is a sesquiterpene endoper-\noxide with potent antimalarial properties, produced by the plant\nArtemisia annua . However, the supply of plant-derived artemisi-\nnin is unstable, resulting in shortages and price fluctuations, com-\nplicating production planning by ACT manufacturers2. A stable\nsource of affordable artemisinin is required. Here we use synthetic\nbiology to develop strains of Saccharomyces cerevisiae (baker\u2019s\nyeast) for high-yielding biological production of artemisinic acid,\na precursor of artemisinin. Previous attempts to produce commer-\ncially relevant concentrations of artemisinic acid were unsuccess-\nful, allowing production of only 1.6 grams per litre of artemisinic\nacid3. Here we demonstrate the complete biosynthetic pathway,\nincluding the discovery of a plant dehydrogenase and a second\ncytochrome that provide an efficient biosynthetic route to artemi-\nsinic acid, with fermentation titres of 25 grams per litre of artemi-\nsinic acid. Furthermore, we have developed a practical, efficient\nand scalable chemical process for the conversion of artemisinic\nacid to artemisinin using a chemical source of singlet oxygen, thus\navoiding the need for specialized photochemical equipment. The\nstrains and processes described here form the basis of a viable\nindustrial process for the production of semi-synthetic artemisinin\nto stabilize the supply of artemisinin for derivatization into active\npharmaceutical ingredients (for example, artesunate) for incor-\nporation into ACTs. Because all intellectual property rights have\nbeen provided free of charge, this technology has the potential to\nincrease provision of first-line antimalarial treatments to the deve-\nloping world at a reduced average annual price.\nBefore the discovery of the enzymes that complete the biosynthetic\npathway of artemisinin production (see Supplementary Fig. 1 for a\ncomplete overview),", "start_char_idx": 0, "end_char_idx": 2935, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "835a6315-1e1c-40e0-9cb5-119335cf01d4": {"__data__": {"id_": "835a6315-1e1c-40e0-9cb5-119335cf01d4", "embedding": null, "metadata": {"page_label": "1", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3e6bd924-2c5f-459f-9318-9420a9e33ba3", "node_type": null, "metadata": {"page_label": "1", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "711e4fcc269c20d345633a6c86f749f5ec84f4e4d07d4e99092a5b600f08acaf"}, "2": {"node_id": "6f2c9210-3779-4b74-9279-2560073d8734", "node_type": null, "metadata": {"page_label": "1", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "b47c05bb4b50b585586e32ee2e6419f8f3793d47502a7408cfd59506be584387"}, "3": {"node_id": "5311c2f1-b538-44e3-9a3e-b07d609207d7", "node_type": null, "metadata": {"page_label": "1", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "4bb126308058f3f213cd665c795c64d61c7e30657ee3a2e61df4d7b10fe46fa6"}}, "hash": "624509af7d4c242b5e5be32c1e5895a6d99d15d8b8822564e26073d84db5aa1a", "text": "of artemisinin production (see Supplementary Fig. 1 for a\ncomplete overview), several improvements were made to the original\namorphadiene-producing strain Y337 (ref. 3). We replaced the MET3\npromoter with the copper-regulated CTR3 promoter (Fig. 1a), enab-\nling restriction of ERG9 expression ( ERG9 encodes squalene syn-\nthase, which catalyses the competing reaction of joining two farnesyl\ndiphosphate moieties to form squalene) by addition of the inexpen-\nsive repressor CuSO 4to the medium rather than the more expensive\nmethionine4\u20136. Strains Y1516 ( PCTR3-ERG9 ) and Y337 ( PMET3-ERG9 )(Supplementary Table 1) both produced similar amounts of amorpha-\ndiene (Supplementary Fig. 2), demonstrating the equivalence of the\nMET3 andCTR3 promoters for repression of ERG9 expression. We\ncompared the production of amorphadiene from Y337 with the pro-\nduction of artemisinic acid from Y285, a variant of Y337 that also\nexpressed the amorphadiene oxidase CYP71AV1 (a cytochrome\nP450) and A. annua CPR1 (its cognate reductase) from a high-copy\nplasmid (pAM322)3. Both strains were grown in a fed-batch fermentor\nwith mixed glucose and ethanol feed. Whereas Y337 produced more\nthan 12 g l21of amorphadiene, Y285 produced significantly less sesqui-\nterpene: 3.3 g l21of artemisinic acid (Fig. 2a and Supplementary Table\n2) plus 0.3 g l21amorphadiene, 0.18 g l21artemisinic alcohol and no\ndetectable artemisinic aldehyde (Supplementary Table 3). The viability\nof the Y285 culture also decreased markedly after CYP71AV1 andCPR1\nexpression (Fig. 2a). We surmised that the decreased viability and\nreduced production of sesquiterpene products in Y285 might be caused\nby the cytochrome P450 responsible for oxidizing amorphadiene, or by\nthe rapid accumulation of artemisinic acid.\nPoor coupling between P450 cytochromes and their reductases can\nresult in the release of reactive oxygen species7. In liver microsomes,\nthe P450 enzyme is generally present in excess over its reductase8,\nwhereas in Y285 and Y301 both enzymes are expressed from strong\ngalactose-regulated promoters on a high-copy plasmid, and are pre-\nsumably present at similar levels. We reduced expression of CPR1 by\nexpressing it from a weaker promoter ( GAL3 promoter) and integrat-\ning a single copy into genomic DNA, generating strain Y657 (Sup-\nplementary Table 1). Y657 had an increase in cell growth (Fig. 2b) and\nviability (Supplementary Fig. 3) compared to either Y285 or Y301\n(isogenic to Y285, but with PCTR3-ERG9 replacing PMET3-ERG9 ), but\nshowed lower artemisinic acid production in shake-flask cultures\n(Fig. 2c) and mixed-feed fed-batch fermentors (Supplementary\nTables 2 and 3). Comparison of all amorphadiene-derived sesquiter-\npenes showed that although reducing CPR1 expression decreased arte-\nmisinic acid production, total sesquiterpene production remained\nrelatively high, indicating that low CPR1 levels increase cell health,\nbut decrease the total rate of amorphadiene oxidations (Fig. 3a; com-\npare Y301 and Y657). The reaction rate of some cytochromes P450 is\nenhanced by their interaction with cytochrome b5as explained by\nseveral possible mechanisms9,10. We identified a cytochrome b5com-\nplementary DNA from A. annua (CYB5 ; Supplementary Fig. 4) and\nexpressed a chromosomally integrated copy from a strong", "start_char_idx": 2868, "end_char_idx": 6159, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5311c2f1-b538-44e3-9a3e-b07d609207d7": {"__data__": {"id_": "5311c2f1-b538-44e3-9a3e-b07d609207d7", "embedding": null, "metadata": {"page_label": "1", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3e6bd924-2c5f-459f-9318-9420a9e33ba3", "node_type": null, "metadata": {"page_label": "1", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "711e4fcc269c20d345633a6c86f749f5ec84f4e4d07d4e99092a5b600f08acaf"}, "2": {"node_id": "835a6315-1e1c-40e0-9cb5-119335cf01d4", "node_type": null, "metadata": {"page_label": "1", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "624509af7d4c242b5e5be32c1e5895a6d99d15d8b8822564e26073d84db5aa1a"}}, "hash": "4bb126308058f3f213cd665c795c64d61c7e30657ee3a2e61df4d7b10fe46fa6", "text": "Fig. 4) and\nexpressed a chromosomally integrated copy from a strong promoter\n1Amyris, Inc., 5885 Hollis Street, Suite 100, Emeryville, California 94608, USA.2National Research Council of Canada, 110 Gymnasium Place, Saskatoon, Saskatchewan S7N 0W9, Canada.3Department of\nChemical and Biomolecular Engineering, University of California, Berkeley, California 94720, USA.4Department of Bioengineering, University of California, Berkeley, California 94720, USA.5Physical\nBiosciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA.6Joint BioEnergy Institute, 5885 Hollis Street, Emeryville, California 94608, USA. {Present addresses: Dow\nAgroSciences, 9330 Zionsville Road, Indianapolis, Indiana 46268, USA (P.J.W.); Radiant Genomics, Inc., 2430 Fifth Street, Suite D, Berkeley, Cali fornia 94710, USA (A.M.); Arkansas Biosciences Institute,\nArkansas State University, Jonesboro, Arkansas 72401, USA (K.H.T.); Solazyme, Inc., 225 Gateway Boulevard, South San Francisco, California 94080, USA (J. Lenihan); Sutro Biopharma Inc., 310 Utah\nAvenue, South San Francisco, California 94080, USA (S.B.); Abbvie, 1500 Seaport Boulevard, Redwood City, California 94063, USA (G. Dang); Horticul tural Sciences Department, University of Florida, PO\nBox 110690, Gainesville, Florida 32611-0690, USA (K.W.E.); Department of Plant Sciences, University of Saskatchewan, 51 Campus Drive, Saskatoon, Saskatchewan S7N 5A8, Canada (M.H.); Regentin\nConsulting, 25409 Modoc Court, Hayward, California 94542, USA (R.R.); AS Key Laboratory of Plant Germplasm Enhancement and Specialty Agriculture, Wuhan Botanical Garden, The Chinese Academy of\nScience, Wuhan 430074, China (Y.Z.); Genomatica, Inc., 10520 Wateridge Circle, San Diego, California 92121, USA (J. Lievense).\n5 2 8|N A T U R E|V O L4 9 6|2 5A P R I L2 0 1 3\nMacmillan Publishers Limited. All rights reserved \u00a9201 3", "start_char_idx": 6160, "end_char_idx": 8042, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f588c98b-61fb-4b05-b4a4-ecf270bcbc89": {"__data__": {"id_": "f588c98b-61fb-4b05-b4a4-ecf270bcbc89", "embedding": null, "metadata": {"page_label": "2", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "66fefaef-6ba7-4df7-81ff-c072fe119879", "node_type": null, "metadata": {"page_label": "2", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "e8a5ec6c4fa724a001a8d8374c6e1494154994f93bd82a61ad5b777dc1446091"}, "3": {"node_id": "93a5025b-9233-4750-b5a6-9011c81d15d6", "node_type": null, "metadata": {"page_label": "2", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "8e4de11d961403d9003780ce418ac6355b34bf2800952579ded7515065422952"}}, "hash": "635f312a08449ffd92ae30dfdc759e93039c0e0e835da1b82fd5b2a74326b342", "text": "(GAL7 promoter) in a strain with low CPR1 expression. The resulting\nstrain, Y692 (Supplementary Table 1), produced higher concentrations\nof artemisinic acid than strains without CYB5 (Fig. 2c and Sup-\nplementary Tables 2 and 3; compare Y657 and Y692). Expression of\nCYB5 also increased the production of artemisinic aldehyde, leading to\na 40% increase in total sesquiterpene production in shake-flask\ncultures (Fig. 3a; compare Y657 and Y692), and almost doubled the\nproduction of artemisinic aldehyde in fermentors (Supplementary\nTable 3). In view of the reactivity and presumed toxicity of artemisinic\naldehyde, we expressed a recently isolated cDNA encoding A. annua\nartemisinic aldehyde dehydrogenase ( ALDH1 )11in Y692 to produce\nY973 and Y1368 (also expressing increased levels of cytosolic catalase\nto reduce oxidative stress; Supplementary Table 1). Expression of\nALDH1 markedly increased the production of artemisinic acid in both\nflask (Fig. 2c; Y1368) and fermentor cultures (Supplementary Tables 2\nand 3; Y973). Artemisinic aldehyde was undetectable in flask cultures\n(Fig. 3a; Y1368), and barely detectable in fermentors (Supplemen-\ntary Table 3; Y973). Furthermore, the expression of ALDH1 in Y973\nallowed early induction of fermentor cultures immediately after inocu-\nlation (previous attempts at early induction with Y285 and Y301 had\nresulted in rapid loss of viability), further increasing production to\n7.7 g l21artemisinic acid (Supplementary Tables 2 and 4). The yield\n(Cmol% of substrate carbon incorporated into artemisinic acid) was\nmore than doubled compared to the initial Y285 cultures (Supplemen-\ntary Tables 3 and 4).In the course of investigating the biosynthesis of artemisinin in\nA. annua glandular trichomes, a gene encoding a putative alcohol\ndehydrogenase ( ADH1 ) was examined. The gene is represented by a\ncontiguous set of glandular trichome-derived expressed sequence tags\n(ESTs)12corresponding to 1.3% of the EST collection. The A. annua\nADH1 open reading frame (ORF) was expressed as a fusion protein\nand purified from Escherichia coli . Sequence analysis and in vitro\ncharacterization revealed that ADH1 is an NAD-dependent alcohol\ndehydrogenase of the medium chain dehydrogenase/reductase super-\nfamily, with specificity towards artemisinic alcohol (Michaelis constant\n(Km)51163mM,kcat54165s21(mean 6s.e.m.); Supplementary\nFig. 5). This specificity and the evidence for strong glandular trichome\nexpression indicate a role for ADH1 in the formation of artemisinic\naldehyde in the artemisinin pathway of A. annua . Therefore, we pro-\npose that all five enzymes (CYP71AV1, CPR1, CYB5, ADH1 and\nALDH1) are involved in the oxidation of amorphadiene to artemisinic\nacid in A. annua plants, and set out to reconstitute the entire hetero-\nlogous biosynthetic pathway in yeast (Fig. 1b).\nObserving the accumulation of artemisinic alcohol in strain Y1368\n(Fig. 3a), we completed the biosynthetic pathway by expressing ADH1\nin conjunction with ALDH1 ,CYP71AV1 ,CYB5 andCPR1 . The result-\ning strain, Y1283, produced no detectable artemisinic alcohol in flask\ncultures, and increased artemisinic acid production by 18% (Figs 2c\nand 3a; compare Y1368 and Y1283). In fermentors, ADH1 increased\nproduction to", "start_char_idx": 0, "end_char_idx": 3237, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "93a5025b-9233-4750-b5a6-9011c81d15d6": {"__data__": {"id_": "93a5025b-9233-4750-b5a6-9011c81d15d6", "embedding": null, "metadata": {"page_label": "2", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "66fefaef-6ba7-4df7-81ff-c072fe119879", "node_type": null, "metadata": {"page_label": "2", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "e8a5ec6c4fa724a001a8d8374c6e1494154994f93bd82a61ad5b777dc1446091"}, "2": {"node_id": "f588c98b-61fb-4b05-b4a4-ecf270bcbc89", "node_type": null, "metadata": {"page_label": "2", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "635f312a08449ffd92ae30dfdc759e93039c0e0e835da1b82fd5b2a74326b342"}}, "hash": "8e4de11d961403d9003780ce418ac6355b34bf2800952579ded7515065422952", "text": "and Y1283). In fermentors, ADH1 increased\nproduction to 8.1 g l21in an early induction, mixed-feed process, while\nOPPC H3SCoAO\nAcetyl-CoAERG10\nERG13\ntHMG1 (X3)\nOHHO2CC H3 OH\nMevalonateERG12\nERG8\nERG19\nCH3OPP C H2\nCH3C H3 OPP\nERG20\nP       -ERG9CTR3\nErgosterolADS\nO HHHADH1\nALDH1\nERG1 \nERG7 \nERG11 \nERG24 \nERG2 \nERG25 \nERG6 \nERG2 \nERG3 \nERG5 \nERG4IPP DMAPP\nFPPH\nH\nOH\nArtemisinic \nacidO\nP       -ERG9MET3IDI1\nH\nH\nO H\nH\nH\nH\nO\nH\nH\nOHOH\nH\nADH1\nALDH1\nArtemisinic \nacidArtemisinic \naldehydeArtemisinic \nalcoholCYP71AV1, CPR1, CYB5CYP71AV1, CPR1, CYB5ab Figure 1 |Artemisinic acid production pathway\ninS. cerevisiae and summary of strains described.\na, Overview of artemisinic acid production\npathway. Overexpressed genes controlled by the\nGAL induction system are shown in green.\nCopper- or methionine-repressed squalene\nsynthase ( ERG9 ) is shown in red. DMAPP,\ndimethylallyl diphosphate; FPP, farnesyl\ndiphosphate; IPP, isopentenyl diphosphate.\ntHMG1 encodes truncated HMG-CoA reductase.\nb, The full three-step oxidation of amorphadiene to\nartemisinic acid from A. annua expressed in S.\ncerevisiae . CYP71AV1, CPR1 and CYB5 oxidize\namorphadiene to artemisinic alcohol; ADH1\noxidizes artemisinic alcohol to artemisinic\naldehyde; ALDH1 oxidizes artemisinic aldehyde to\nartemisinic acid. Strains containing these genes are\ndescribed in Supplementary Table 1.\n0102030405060708090100\n02468101214\n0 20 40 60 80 100Artemisinic acid, amorphadiene (g l\u20131)\nTime (h)Y285 AA\nY337 AD\nY285 viability\nY337 viabilityCell viability (% viable)a\n0481216\n02 4 4 8 7 2Growth ( D600 nm)\nTime (h)Y285\nY301\nY657b\n00.20.40.60.8\n24 48 72Artemisinic acid (g l\u20131)\nTime (h)Y285\nY301\nY657\nY692\nY1368\nY1283c\nFigure 2 |Growth, viability and production by S. cerevisiae strains.\na, Production and cell viability of artemisinic acid production strain Y285 and\namorphadiene production strain Y337 in the glucose and ethanol mixed-feed,\nfed-batch fermentation process. AA, artemisinic acid; AD, amorphadiene.b, Growth of artemisinic-acid-producing strains in shake-flasks. c, Production\nof artemisinic acid in shake-flasks by different strains. Error bars denote\nstandard deviation of triplicate shake-flask cultures.LETTER RESEARCH\n25 APRIL 2013 | VOL 496 | NATURE | 529\nMacmillan Publishers Limited. All rights reserved \u00a9201 3", "start_char_idx": 3182, "end_char_idx": 5469, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1f98cb1d-b748-4579-91b0-ac0d4536ee17": {"__data__": {"id_": "1f98cb1d-b748-4579-91b0-ac0d4536ee17", "embedding": null, "metadata": {"page_label": "3", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bfde1ebb-63ba-4ac6-8622-c91fe12c3a89", "node_type": null, "metadata": {"page_label": "3", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "9fb3903134d6d7b5247faaed01837ec75169b1cdb9f41f2bfb1684256ef32163"}, "3": {"node_id": "95de104c-cd78-4f43-9edc-530a9abceebe", "node_type": null, "metadata": {"page_label": "3", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "fcc2b0446720bc99639c8c9536f17aef5fef511ea439d873d8d72a0263023be2"}}, "hash": "2819fae4614f453098d719549bd666671c69c5e4d89da176db9292c7f0647e37", "text": "reducing production of artemisinic alcohol (Supplementary Table 4).\nThe improved viability (Supplementary Fig. 6) of Y1283, which also\ncontained the added catalase activity, allowed us to express all hetero-\nlogous galactose-regulated enzymes constitutively by deletion of GAL80 ,\na strategy used previously to increase production in amorphadiene-\nproduction strains3. This strain, Y1284, does not require the inducer\ngalactose, yet produces higher concentrations of artemisinic acid com-\npared to its parent (Supplementary Tables 2\u20134).\nWe observed that strains expressing ALDH1 produced artemi-\nsinic acid as a crystalline extracellular precipitate (Supplementary\nFigs 7 and 8). Precipitation was also observed in early induction fed-\nbatch mixed-feed fermentors, complicating accurate measurement of\nproduct from the heterogeneous fermentor samples. To overcome the\nsampling difficulties associated with artemisinic acid precipitation,\nwe investigated the effect of solubilizing the precipitate by extractive\nfermentation13, growing the cultures in the presence of isopropyl myri-\nstate (IPM) oil. Addition of 10% (v/v) IPM to flask cultures resulted in\na marked increase in the viability of all strains, shown for Y301 and\nY1283 in Fig. 3b. Whereas the addition of IPM to earlier strains (Y285,\nY301, Y657 and Y692) lacking ALDH1 and ADH1 resulted in extrac-\ntion of intermediates (amorphadiene, artemisinic alcohol and alde-\nhyde; Fig. 3c), IPM addition to strains containing ALDH1 and\nADH1 produced artemisinic acid to .14 g l21in a mixed-feed, early\ninduction fermentation process (Supplementary Table 2), with a six-\nfold increase in yield compared to Y285 (Supplementary Table 5).\nThe IPM extractive fermentation of Y1284 allowed us to increase\nproduction further by developing a feedback-controlled ethanol\npulse-feed process; in this process Y1284 produced 25 g l21of artemi-\nsinic acid, with a sevenfold higher yield than Y285 (Fig. 3d and\nSupplementary Tables 2 and 5). Artemisinic acid production in the\nmixed-feed process was seen to reach a maximum concentration due\nto precipitation from the culture broth mixture and a cessation in\nproduction while the fed-batch fermentation continued. Additional\nIPM was added to the ethanol-feed fermentation to avoid precipita-\ntion. To take advantage of this high-titre process we developed a\nmethod for extracting artemisinic acid from IPM with high yield\nand purity (see Methods).Numerous total and partial chemical syntheses of artemisinin\nexist14\u201316. Here we report one starting from our purified artemisinic\nacid (Fig. 4a). For this route to be scalable and practical, several modi-\nfications of the previously published syntheses are required. The first\nstep is the reduction of the D11(13) double bond (numbering system of\nSy and Brown17) to give dihydroartemisinic acid, which has two epi-\nmers, of which only the ( R)-11 one has the correct stereochemistry\nfound in artemisinin. This had typically been carried out with \u2018nickel\nboride\u2019 (NaBH 4or LiBH 4plus NiCl 2), which gives a ,3:1 to 85:15 ratio\nof the 11-epimers, favouring the desired one, but the use of a stoichi-\nometric excess of the reducing agent and the poor isomer ratio are\nunacceptable for a cost-effective scalable synthesis. We found that cata-\nlytic hydrogenation using several different noble metal catalysts affords\nnearly quantitative yields of the reduced acid in ( R)-11:(S)-11epimer\nratios as high as 94:6, without any significant", "start_char_idx": 0, "end_char_idx": 3469, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "95de104c-cd78-4f43-9edc-530a9abceebe": {"__data__": {"id_": "95de104c-cd78-4f43-9edc-530a9abceebe", "embedding": null, "metadata": {"page_label": "3", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bfde1ebb-63ba-4ac6-8622-c91fe12c3a89", "node_type": null, "metadata": {"page_label": "3", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "9fb3903134d6d7b5247faaed01837ec75169b1cdb9f41f2bfb1684256ef32163"}, "2": {"node_id": "1f98cb1d-b748-4579-91b0-ac0d4536ee17", "node_type": null, "metadata": {"page_label": "3", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "2819fae4614f453098d719549bd666671c69c5e4d89da176db9292c7f0647e37"}}, "hash": "fcc2b0446720bc99639c8c9536f17aef5fef511ea439d873d8d72a0263023be2", "text": "as high as 94:6, without any significant overreduction to tetrahy-\ndroartemisinic acid (Supplementary Fig. 9 and Supplementary Table 6).\nThe next step is the esterification of the carboxylic acid. The sub-\nsequent reactions can be performed using the acid (R 5H), but this\nresults in considerable yield losses owing to the formation of the\nfive-membered lactone-containing compound dihydroepideoxyar-\nteannuin B, a side-reaction blocked by the presence of the ester.\nLarge-scale esterification was readily accomplished by carboxyl activa-\ntion by acid chloride formation, followed by an alcohol quench\n(Supplementary Fig. 10).\nThe third step is an \u2018ene-type\u2019 reaction of the C4\u2013C5 double bond\nwith singlet oxygen (1O2) to give an allylic 3-hydroperoxide. In previ-\nous syntheses, the1O2was invariably generated by photosensitized\nenergy transfer from dye molecules (such as rose bengal, methylene\nblue and porphyrins)18\u201320, but because photosynthetic steps are rarely\nfound in manufacturing facilities, we sought another source of1O2.A\npractical alternative was found in the group VI metal salt-induced\ndisproportionation of concentrated H 2O2(ref. 21). With this tech-\nnique the hydroperoxide could be formed cleanly with no evidence\nof isomers or rearrangement products.\nIn the final step the allylic hydroperoxide undergoes an acid-\ncatalysed Hock fragmentation and rearrangement to afford a ring-\nopened keto-aldehyde enol. Trapping of this enol with3O2produces0255075100\n0 2 44 87 2Viable cells (%)\nTime (h)Y301\nY301 + IPM\nY1283\nY1283 + IPM\nMixed feed\nMixed feed + IPM\nEthanol feed + IPM\n051015202530\n0 20 40 60 80 100 120 140 160Artemisinic acid (g l\u20131)\nTime (h)b\nda\n0.20.40.60.8\nY285 Y301 Y657 Y692 Y1368 Y1283 StrainA.CHO\nA.OH\nAD\nAASesquiterpene (g l\u20131)\nERG9 repression\nCPR1 expression\nCYB5\nALDH1\nADH1PMET3PCTR3\nHigh Low\nNo\nNo\nNoYes\nYes\nYes\nc\n00.20.40.60.81.01.2\nY285 Y301 Y657 Y692 Y1368 Y1283Sesquiterpene (g l\u20131)A.CHO\nA.OH\nAD\nAA\nStrain\nERG9 repression\nCPR1 expression\nCYB5\nALDH1\nADH1PMET3PCTR3\nHigh Low\nNo\nNo\nNoYes\nYes\nYesFigure 3 |Increasing production of artemisinic\nacid by strain engineering and addition of IPM to\ncultures. a , Artemisinic acid production in flasks\n(no IPM). A.CHO, artemisinic aldehyde; A.OH,\nartemisinic alcohol. b, Effect of IPM addition on\nthe viability of strains Y301 and Y1283 in shake-\nflask cultures. c, Production of artemisinic acid in\nflasks containing IPM. d, Artemisinic acid\nproduction of strain Y1284 in fed-batch\nfermentation processes. All fermentations were run\nwith early repression (150 mM CuSO 4was added\nbefore inoculation). Because Y1284 has the gal80D\ngenotype, no galactose was added to the\nfermentations. Error bars denote standard\ndeviation of triplicate shake-flask cultures.RESEARCH LETTER\n5 3 0|N A T U R E|V O L4 9 6|2 5A P R I L2 0 1 3\nMacmillan Publishers Limited. All rights reserved \u00a9201 3", "start_char_idx": 3429, "end_char_idx": 6287, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "53629363-3e58-4e13-a368-82f7ef1565d2": {"__data__": {"id_": "53629363-3e58-4e13-a368-82f7ef1565d2", "embedding": null, "metadata": {"page_label": "4", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "322a8bcf-c775-4b29-8426-bdfeaf0ad72b", "node_type": null, "metadata": {"page_label": "4", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "a421084883e90aba0ad1669458c48e5c8d1303d0b4c47a927fc4fd8585e19f80"}, "3": {"node_id": "84318884-e5d5-4892-bb4b-d704a3f4d452", "node_type": null, "metadata": {"page_label": "4", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "2eac0bec7a133c8f2238478e8e2943ff5fa1bca0875b15a14130040f5c660298"}}, "hash": "4fd265a0bd61f10c3a9af81eaf0ee4f5b5709dd203cee57498f752b1a222a565", "text": "a vicinal hydroperoxide aldehyde, which in a cascade of acid-catalysed\ncyclizations forms an endoperoxide bridge, a seven-membered cyclic\nether, and finally a six-membered lactone, thus producing good\nyields of artemisinin with the correct stereochemistry (Supplemen-\ntary Figs 11\u201313). Improvements of this step involved substitution of\nexpensive copper triflate16with benzenesulphonic acid/sulphonate\ncopper( II) DOWEX resin and replacement (for safety reasons) of pure\nO2by air, in addition to reaction cond ition optimization to maximize\nthe yield of artemisinin. These c hanges produced a scalable four-\nstep synthesis that gave artemisinin in 40\u201345% overall yield, a markedimprovement over the typical yields reported in the literature18\u201320(Sup-\nplementary Table 7). The product is pur er than the plant -sourced arte-\nmisinin used in ACT production, as sh own by high-performance liquid\nchromatography (HPLC) comparison of our material with a selection of\ncommercial plant samples (Fig. 4b and Supplementary Table 8).\nOur results describe for the first time, to our knowledge, the expres-\nsion of the complete pathway for artemisinic acid production, which\nresulted in a greater than tenfold increase in artemisinic acid titres. In\naddition, we demonstrated a significant increase in the efficiency of\nartemisinic acid conversion to artemisinin compared with earlier\nwork18\u201320. We show that expression of CYP71AV1 and its cognate\nreductase is not sufficient for high-level production of artemisinic acid,\ninstead requiring three additional plant enzymes (CYB5, ADH1 and\nALDH1 (ref. 11); Fig. 1b). Optimization of the CYP71AV1:CPR1\nexpression ratio, combined with CYB5 expression, overcame initial\nviability problems, but high titre and increased yield were only\nachieved when A. annua artemisinic alcohol and aldehyde dehydro-\ngenases were co-expressed. These observations in yeast lend strong\nsupport to the importance of the dehydrogenases in artemisinin bio-\nsynthesis in the native plant system22. Extractive fermentation with a\nbio-compatible solvent (IPM) increased the production of artemisinic\nacid through an uncharacterized effect, perhaps by effectively remov-\ning the acid from the aqueous phase. The development of a facile\nprocedure for purification of artemisinic acid from IPM in high yield\nand purity allows a ready supply for chemical conversion to artemi-\nsinin. The chemical conversion procedure is notable for its simpli-\ncity, scalability, economy of reagents, and the high yield obtained.\nNevertheless, given investment in suitable large-scale photoreactors,\nimprovements of the classical photochemistry syntheses have the\npotential to increase the overall process yields further (see Sup-\nplementary Information for details and comparison to photochemical\nsyntheses18\u201320).\nIn summary, we have determined the full artemisinic acid biosyn-\nthetic pathway and developed a process for the production of the\nantimalarial drug artemisinin by fermentation of simple inexpensive\ncarbon substrates using engineered S. cerevisiae to produce artemisinic\nacid, followed by extraction and chemical conversion to artemisinin.\nThese key developments in yeast strain engineering, fermentation, and\nartemisinin synthetic chemistry pave the way for an industrial process\ncapable of supplementing the world supply of artemisinin from a\nsecond source independent of the uncertainties associated with bota-\nnical production.\nMETHODS SUMMARY\nThe A. annua cytochrome b5cDNA sequence was identified from a trichome\nexpressed sequence tag library (NCBI accession 35608) by searching for sequence\nsimilarity to Crepis alpina", "start_char_idx": 0, "end_char_idx": 3628, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "84318884-e5d5-4892-bb4b-d704a3f4d452": {"__data__": {"id_": "84318884-e5d5-4892-bb4b-d704a3f4d452", "embedding": null, "metadata": {"page_label": "4", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "322a8bcf-c775-4b29-8426-bdfeaf0ad72b", "node_type": null, "metadata": {"page_label": "4", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "a421084883e90aba0ad1669458c48e5c8d1303d0b4c47a927fc4fd8585e19f80"}, "2": {"node_id": "53629363-3e58-4e13-a368-82f7ef1565d2", "node_type": null, "metadata": {"page_label": "4", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "4fd265a0bd61f10c3a9af81eaf0ee4f5b5709dd203cee57498f752b1a222a565"}, "3": {"node_id": "fd5e26a7-bbbd-4404-884b-6a51055b8954", "node_type": null, "metadata": {"page_label": "4", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "c09f78a07ee390d4a910b66db2fb4e2f92219840ba757885dd792624ee0ff6f9"}}, "hash": "2eac0bec7a133c8f2238478e8e2943ff5fa1bca0875b15a14130040f5c660298", "text": "accession 35608) by searching for sequence\nsimilarity to Crepis alpina cytochrome b5type 11 (ref. 23). A cDNA encoding\nA. annua ADH1 was identified and the encoded protein characterized essentially\nas described for ALDH1 (ref. 11). Growth of strains, general genetic methodology\nand construction of synthetic genes were as described3. Yeast strains were derived\nfrom Y337 (ref. 3). Salient features of DNA constructs are as follows: (1) for\nexpression of ERG9 from the CTR3 promoter the MET3 promoter was replaced\nwith nucleotides 21t o2734 of the CTR3 promoter, integration being selected by\nD-serine24(erg9D::dsdA_P CTR3-ERG9 ) or nourseothricin25(erg9D::natA_P CTR3-\nERG9 ) resistance; (2) for reduced expression of cytochrome P450 reductase\n(CPR1 ),CPR1 was removed from plasmid pAM322 (ref. 3) by digestion and\nrecircularization to generate pAM552, which expresses only ADS and\nCYP71AV1. A single copy of CPR1 was expressed from the GAL3 promoter\n(PGAL3) (nucleotides 21t o 2660) integrated between GAL1 andGAL7 (gal1/\n10/7D::natA_P GAL3-CPR1-T CYC1, in which TCYC1 denotes the CYC1 terminator);\n(3) a single integrated copy of A. annua cytochrome b5was expressed from the\nGAL7 promoter (nucleotides 21t o 2725; leu2::hisMX D::kanA_P GAL7-CYB5-\nTCYC1); (4) a single integrated copy of A. annua aldehyde dehydrogenase\n(ALDH1 ) was expressed from the GAL7 promoter, selecting for hygromycin B\n(ref. 25) ( ndt80::hphA_P GAL7-ALDH1-T TDH1 and his3::hphA_P GAL7-ALDH1-\nTTDH1); (5) a single integrated copy of A. annua alcohol dehydrogenase ( ADH1 )\nwas expressed from the GAL7 promoter, selecting for uracil prototrophy\n(natAD::URA3_P GAL7-ADH1-T TDH1 and gal80D::URA3_P GAL7-ADH1-T GAL80 ).H\nH\nHOOCH\nHOOCH\nH\nROOCHOOH\nROOCH\nH\nO\nO\nOH\nHO\nOMeOHOOH\nOMeOH\nOO\nOHCO HO\nMeOO2\nOH\nO\nOO\nOIsolated from fermentation brothH2/cat.\nChemically \ngenerated 1O2  \nCu( II) salt\nArtemisininH+Esterification\nR = H, \u2013H2O2R = H R = CH3\n\u2013MeOH\n0C\nC\nC\nC\nC\nC\nTime (min)(i)\n(ii)\n(iii)\n(iv)\n(v)\n(vi)\n(vii)\n(viii)A212 nm\nC\nCAB\nA\nA\nA\nA\nA7.7 min\n0 5 10 15 20a\nb\nFigure 4 |Chemical conversion of artemisinic acid to artemisinin. a , Semi-\nsynthesis of artemisinin from microbially produced artemisinic acid.\nCompounds in square brackets denote intermediates detected but not isolated.\nb, HPLC ultraviolet traces of crude, partially purified and purified semi-\nsynthetic artemisinin and commercial samples of plant-derived artemisinin.\nFor HPLC conditions see Supplementary Information. Major peak\nidentification (retention time in min): artemisitene (5.93\u20135.96, peak A), 9- epi-\nartemisinin (6.54, peak B); artemisinin", "start_char_idx": 3567, "end_char_idx": 6151, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fd5e26a7-bbbd-4404-884b-6a51055b8954": {"__data__": {"id_": "fd5e26a7-bbbd-4404-884b-6a51055b8954", "embedding": null, "metadata": {"page_label": "4", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "322a8bcf-c775-4b29-8426-bdfeaf0ad72b", "node_type": null, "metadata": {"page_label": "4", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "a421084883e90aba0ad1669458c48e5c8d1303d0b4c47a927fc4fd8585e19f80"}, "2": {"node_id": "84318884-e5d5-4892-bb4b-d704a3f4d452", "node_type": null, "metadata": {"page_label": "4", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "2eac0bec7a133c8f2238478e8e2943ff5fa1bca0875b15a14130040f5c660298"}}, "hash": "c09f78a07ee390d4a910b66db2fb4e2f92219840ba757885dd792624ee0ff6f9", "text": "epi-\nartemisinin (6.54, peak B); artemisinin (7.72\u20137.74, peak C). Traces: (i) crude\nreaction mixture: ,33% pure; (ii) crude mixture filtered through silica gel:\n90.5% pure; (iii) recrystallized: 99.6% pure; (iv\u2013viii) samples of plant\nartemisinin from different Chinese commercial suppliers, all quality control\napproved as raw materials suitable for ACT manufacture (97.2\u201397.8% pure).LETTER RESEARCH\n25 APRIL 2013 | VOL 496 | NATURE | 531\nMacmillan Publishers Limited. All rights reserved \u00a9201 3", "start_char_idx": 6169, "end_char_idx": 6664, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "00166eef-598f-4437-95e1-b9402d28c055": {"__data__": {"id_": "00166eef-598f-4437-95e1-b9402d28c055", "embedding": null, "metadata": {"page_label": "5", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "43f9ca28-4532-4a92-9c07-59013df56d1a", "node_type": null, "metadata": {"page_label": "5", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "56e2f48223eab72a03c586dc4f2594ef2bef879b72b13e685185cae5c6ca2661"}, "3": {"node_id": "67393e03-69fb-4a8f-a671-07d440da96c8", "node_type": null, "metadata": {"page_label": "5", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "ed087cbfd21e071eb4e401433ea233045bc19fe02ca59407e8c03174b1e8745d"}}, "hash": "7c92b7c997c169726ae3d433370aa83c0bd35485c51ddee395edf82cee87c16f", "text": "Flask and fermentor culture conditions were essentially as described3. Fermen-\ntations requiring IPM contained 400 ml IPM added to 800 ml fermentor volume\nbefore inoculation. Artemisinic acid was purified from IPM by aqueous extraction\nat pH 10.7, followed by precipitation at pH 5.0. Assays for amorph-4,11-diene and\nartemisinic acid are essentially as described3. Artemisinic alcohol and artemisinic\naldehyde were monitored by gas chromatography with flame-ionization detection.\nFull Methods and any associated references are available in the online version of\nthe paper.\nReceived 8 July 2012; accepted 4 March 2013.\nPublished online 10 April; corrected online 24 April 2013 (see full-text HTML\nversion for details).\n1. World Health Organization. World Malaria Report 2011 http://www.who.int/\nmalaria/publications/atoz/9789241564403/en/index.html (World Health\nOrganization, 2011).\n2. Hale, V., Keasling, J. D., Renninger, N. & Diagana, T. T. Microbially derived\nartemisinin: a biotechnology solution to the global problem of access to affordable\nantimalarial drugs. Am. J. Trop. Med. Hyg. 77,198\u2013202 (2007).\n3. Westfall, P. J. et al. Production of amorphadiene in yeast, and its conversion to\ndihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc. Natl\nAcad. Sci. USA 109, E111\u2013E118 (2012).\n4. Ro, D. K. et al. Production of the antimalarial drug precursor artemisinic acid in\nengineered yeast. Nature 440, 940\u2013943 (2006).\n5. Paradise, E. M., Kirby, J., Chan, R. & Keasling, J. D. Redirection of flux through the\nFPP branch-point in Saccharomyces cerevisiae by down-regulating squalene\nsynthase. Biotechnol. Bioeng. 100, 371\u2013378 (2008).\n6. Asadollahi, M. A. et al. Production of plant sesquiterpenes in Saccharomyces\ncerevisiae : effect of ERG9 repression on sesquiterpene biosynthesis. Biotechnol.\nBioeng. 99,666\u2013677 (2008).\n7. Zangar, R. C., Davydov, D. R. & Verma, S. Mechanisms that regulate production of\nreactive oxygen species by cytochrome P450. Toxicol. Appl. Pharmacol. 199,\n316\u2013331 (2004).\n8. Peterson, J. A., Ebel, R. E., O\u2019Keeffe, D. H., Matsubara, T. & Estabrook, R. W.\nTemperature dependence of cytochrome P-450 reduction. A model for NADPH-\ncytochrome P-450 reductase:cytochrome P-450 interaction. J. Biol. Chem. 251,\n4010\u20134016 (1976).\n9. Schenkman, J. B. & Jansson, I. The many roles of cytochrome b5.Pharmacol. Ther.\n97,139\u2013152 (2003).\n10. Zhang, H., Im, S. C. & Waskell, L. Cytochrome b5increases the rate of product\nformation by cytochrome P450 2B4 and competes with cytochrome P450\nreductase for a binding site on cytochrome P450 2B4. J. Biol. Chem. 282,\n29766\u201329776 (2007).\n11. Teoh, K. H., Polichuk, D. R., Reed, D. W. & Covello, P. S. Molecular cloning of an\naldehyde dehydrogenase implicated in artemisinin biosynthesis in Artemisia\nannua. Botany 87,635\u2013642 (2009).\n12. Teoh, K. H., Polichuk, D. R., Reed, D. W.,", "start_char_idx": 0, "end_char_idx": 2865, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "67393e03-69fb-4a8f-a671-07d440da96c8": {"__data__": {"id_": "67393e03-69fb-4a8f-a671-07d440da96c8", "embedding": null, "metadata": {"page_label": "5", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "43f9ca28-4532-4a92-9c07-59013df56d1a", "node_type": null, "metadata": {"page_label": "5", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "56e2f48223eab72a03c586dc4f2594ef2bef879b72b13e685185cae5c6ca2661"}, "2": {"node_id": "00166eef-598f-4437-95e1-b9402d28c055", "node_type": null, "metadata": {"page_label": "5", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "7c92b7c997c169726ae3d433370aa83c0bd35485c51ddee395edf82cee87c16f"}, "3": {"node_id": "e75788aa-d349-4147-912e-1ca0666c14b0", "node_type": null, "metadata": {"page_label": "5", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "9968609cb7f62f666a03e9beadad5762acbd2ea59db2d255f405d43f01f73ff6"}}, "hash": "ed087cbfd21e071eb4e401433ea233045bc19fe02ca59407e8c03174b1e8745d", "text": "K. H., Polichuk, D. R., Reed, D. W., Nowak, G. & Covello, P. S. Artemisia annua L.\n(Asteraceae) trichome-specific cDNAs reveal CYP71AV1, a cytochrome P450 with\na key role inthe biosynthesisof the antimalarial sesquiterpene lactone artemisinin.\nFEBS Lett. 580, 1411\u20131416 (2006).\n13. Daugulis, A. J. Partitioning bioreactors. Curr. Opin. Biotechnol. 8,169\u2013174 (1997).\n14. Li, Y., Huang, H. & Wu, Y.-L. in Medicinal Chemistry of Bioactive Natural Products (eds\nLiang, X.-T. & Fang, W.-S.) 183\u2013256 (John Wiley and Sons, 2006).15. Kim, B. & Sasaki, T. Recent progress in the synthesis of artemisinin and its\nderivatives. Org. Prep. Proced. Int. 38,1\u201380 (2006).\n16. Haynes, R. K. From artemisinin to new artemisinin antimalarials: biosynthesis,\nextraction, old and new derivatives, stereochemistry and medicinal chemistry\nrequirements. Curr. Top. Med. Chem. 6,509\u2013537 (2006).\n17. Sy, L.-K. & Brown, G. D. The role of the 12-carboxylic acid group in the spontaneous\nautoxidation of dihydroartemisinic acid. Tetrahedron 58,909\u2013923 (2002).\n18. Haynes, R. K. & Vonwiller, S. C. Catalysed oxygenatation of allylic hydroperoxides\nderived from qinghao (artemisinic) acid. Conversion of qinghao acid into\ndehydroqinghaosu (artemisitene) and qinghaosu (artemisinin). J. Chem. Soc.\nChem. Commun. 6,451\u2013453 (1990).\n19. Roth, R. J. & Roth, N. A. Simple conversion of artemisinic acid into artemisinin. US\npatent 4,992 561 (1991).\n20. Le \u00b4vesque, F. & Seeberger, P. H. Continuous-flow synthesis of the anti-malaria drug\nartemisinin. Angew. Chem. Int. Edn Engl. 51,1706\u20131709 (2012).\n21. Boehme, K. & Brauer, H.-D. Generation of singlet oxygen from hydrogen peroxide\ndisproportionation catalyzed by molybdate ions. Inorg. Chem. 31,3468\u20133471\n(1992).\n22. Bertea, C. M. et al.Identification of intermediates and enzymes involved in the early\nsteps of artemisinin biosynthesis in Artemisia annua .Planta Med. 71,40\u201347\n(2005).\n23. Nam, J. W. & Kappock, T. J. Cloning and transcriptional analysis of Crepis alpina\nfatty acid desaturases affecting the biosynthesis of crepenynic acid. J. Exp. Bot. 58,\n1421\u20131432 (2007).\n24. Vorachek-Warren, M. K. & McCusker, J. H. DsdA ( D-serine deaminase): a new\nheterologous MX cassette for gene disruption and selection in Saccharomyces\ncerevisiae. Yeast 21,163\u2013171 (2004).\n25. Goldstein, A. L. & McCusker, J. H.Three newdominant drug resistance cassettes for\ngene disruption in Saccharomyces cerevisiae. Yeast 15,1541\u20131553 (1999).\nSupplementary Information is available in the online version of the paper.\nAcknowledgements We thank D. Rathbone for advice on native A. annua ADH1\nexpression, and our friends and colleagues at Sanofi, especially D. Thibaut, C. Lehmann,\nC. Masson-Brocard, B.", "start_char_idx": 2837, "end_char_idx": 5537, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e75788aa-d349-4147-912e-1ca0666c14b0": {"__data__": {"id_": "e75788aa-d349-4147-912e-1ca0666c14b0", "embedding": null, "metadata": {"page_label": "5", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "43f9ca28-4532-4a92-9c07-59013df56d1a", "node_type": null, "metadata": {"page_label": "5", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "56e2f48223eab72a03c586dc4f2594ef2bef879b72b13e685185cae5c6ca2661"}, "2": {"node_id": "67393e03-69fb-4a8f-a671-07d440da96c8", "node_type": null, "metadata": {"page_label": "5", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "ed087cbfd21e071eb4e401433ea233045bc19fe02ca59407e8c03174b1e8745d"}}, "hash": "9968609cb7f62f666a03e9beadad5762acbd2ea59db2d255f405d43f01f73ff6", "text": "C. Lehmann,\nC. Masson-Brocard, B. Dumas, P. Baduel and H. Farret. We also thank J. Rine, P. Ortiz de\nMontellano and H. van Dijken for many conversations. This research was conducted\nunder the sponsorship of the Institute for OneWorld Health through generous support\nof the Bill & Melinda Gates Foundation for this non-profit project.\nAuthor Contributions P.J.W., D.J.P., K.B., K.F., A.T., A.M., D.E., D.R.P., K.H.T., D.W.R., T.T.,\nJ. Lenihan, M.F., S.B.,G. Dang, D. Dengrove, D. Diola, G. Dorin, K.W.E., S.F., J.G., S.P.G., T.G.,\nR.H., M.H., T.H., T.I., H.J., L.K., B.L., D.M., N.M., S.S., H.T., R.V., L.F.W., L.X., M.Y., Y.Z. and L.Z.\nperformed experiments; C.J.P., P.J.W., D.J.P., K.B., K.F., D.M., M.D.L., T.T., J.L., S.B., S.F.,\nJ.G., S.P.G., L.K., R.R., L.Z., J. Lievense, P.S.C., J.D.K., K.K.R., N.S.R. and J.D.N. designed\nexperiments and analysed data; C.J.P., D.M. and J.D.N. supervised and coordinated\nexperiments; C.J.P. wrote the paper. C.J.P., P.J.W., D.J.P. and K.B. contributed equally\nto this work.\nAuthor Information Novel DNA sequences have been deposited in GenBank with the\nfollowing accession numbers: native A. annua ADH1, JF910157; codon-optimized A.\nannua ADH1, JQ582842; codon-optimized A. annua CYB5, JQ582841;\ncodon-optimized A. annua ALDH1, JQ609276. Reprints and permissions information is\navailable at www.nature.com/reprints. Readers are welcome to comment on the online\nversion of the paper. The authors declare competing financial interests: details\naccompany the full-text HTML version of the paper at www.nature.com/nature.\nCorrespondence and requests for materials should be addressed to C.J.P.\n(paddon@amyris.com) or J.D.N. (newman@amyris.com).RESEARCH LETTER\n532 | NATURE | VOL 496 | 25 APRIL 2013\nMacmillan Publishers Limited. All rights reserved \u00a9201 3", "start_char_idx": 5533, "end_char_idx": 7324, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4a7a7e3f-997b-407f-9028-66c5aa865cd4": {"__data__": {"id_": "4a7a7e3f-997b-407f-9028-66c5aa865cd4", "embedding": null, "metadata": {"page_label": "6", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "877bbf1f-5106-4894-a5e1-3285b410d669", "node_type": null, "metadata": {"page_label": "6", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "38e19614a8e645e763f3e8d5c61db9dcdc5a5a37f1da1a0698031ff4a04770ff"}, "3": {"node_id": "bc209971-7e4e-45c3-ba1e-463ad943adf6", "node_type": null, "metadata": {"page_label": "6", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "e816aa447a459bfae169e0aea99423a3964457566bdeff787f1900f9e854f5df"}}, "hash": "4f9851f2e4aed61dfc60a9c16363fde10ca0424770f1a62ef8acb54f2d853c7e", "text": "METHODS\nThe A. annua cytochrome b5cDNA sequence was identified from a trichome\nexpressed sequence tag library (NCBI accession 35608) by searching for sequence\nsimilarity to Crepis alpina cytochrome b5type 11 (ref. 23). Dominant selection\nmarkers for yeast strain engineering were D-serine24, nourseothricin25and hygro-\nmycin B25.\nYeast strain engineering. S. cerevisiae codon-optimized synthetic genes of\nA. annua ADS ,CYP71AV1 andCPR1 have been previously described3. Codon-\noptimized synthetic genes for A. annua CYB5 (GenBank accession JQ582841),\nA. annua ALDH1 (JQ609276) and A. annua ADH1 (JQ582842) were synthesized\nby DNA 2.0 (https://www.dna20.com/) or Biosearch Technologies.\nConstruction of genome integration cassettes. The oligonucleotide primers\nused in this study are listed in Supplementary Table 9.\ndsdA-P CTR3-ERG9 .Replacement of the MET3 promoter with the CTR3 promoter\nin Y301 and Y592 was accomplished as follows. The dsdA gene (encoding D-serine\ndeaminase) was amplified from pAM577 (containing the promoter and termin-\nator of Kluyveromyces lactis TEF1 ) by PCR amplification with oligonucleo-\ntides PW91-031-CPK275-G and DE_PW91-027-CPK262-G. PCR amplification\nof the wild-type CTR3 promoter from positions 21t o2734 was performed with\noligonucleotides PW61-104-CPK116-G and DE_PW91-027-CPK263-G using\nCEN.PK2-1C (ref. 3) genomic DNA as the template. These two PCR products\nshared a 44-base-pair (bp) overlap at the 3 9end of the promoter and the 5 9end of\nthe gene. For the secondary PCR, 25 ng each of the purified CTR3 promoter ( 21t o\n2734) and dsdA PCR were used as the DNA templates and PCR amplified with\noligonucleotides PW91-031-CPK275-G and PW61-104-CPK116-G to give\nPCTR3( 21t o 2734)-dsdA .\ngal1/10/7::natA_P GAL3-CPR1-T CYC1.Targeted integration of the PGAL3-CPR1\nexpression cassette in Y657 at the GAL7 locus was accomplished as follows.\nPCR amplification of the wild-type GAL7 locus from positions 30 to 1021 was\nperformed with oligonucleotides PW91-014-CPK236-G and PW-91-079-\nCPK384-G using CEN.PK2-1C genomic DNA as the template. PCR amplification\nof the CPR1 ORF and CYC1 terminator was performed with oligonucleotides PW-\n91-079-CPK385-G and PW-91-079-CPK392-G using plasmid pAM322 (ref. 3) as\nthe template. PCR of the wild-type GAL3 promoter from positions 21t o2660\nwas performed with oligonucleotides PW-91-079-CPK393-G and PW-91-079-\nCPK394-G using CEN.PK2-1C genomic DNA as the template. PCR of the natA\nmarker (nourseothricin resistance) was performed with oligonucleotides PW-91-\n079-CPK383-G and PW-91-079-CPK395-G. Each of the DNA elements from the\nfirst round of PCR was designed to share a 20\u201330-bp overlap with the adjacent\nelement, by using non-templated", "start_char_idx": 0, "end_char_idx": 2711, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "bc209971-7e4e-45c3-ba1e-463ad943adf6": {"__data__": {"id_": "bc209971-7e4e-45c3-ba1e-463ad943adf6", "embedding": null, "metadata": {"page_label": "6", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "877bbf1f-5106-4894-a5e1-3285b410d669", "node_type": null, "metadata": {"page_label": "6", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "38e19614a8e645e763f3e8d5c61db9dcdc5a5a37f1da1a0698031ff4a04770ff"}, "2": {"node_id": "4a7a7e3f-997b-407f-9028-66c5aa865cd4", "node_type": null, "metadata": {"page_label": "6", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "4f9851f2e4aed61dfc60a9c16363fde10ca0424770f1a62ef8acb54f2d853c7e"}, "3": {"node_id": "7d13c077-5950-4f2b-ab27-94831f0c9f8b", "node_type": null, "metadata": {"page_label": "6", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "cac7a6ff26f2a5c24ee5e1474acad3651c3f2099150fcb4ac945b69af700c85c"}}, "hash": "e816aa447a459bfae169e0aea99423a3964457566bdeff787f1900f9e854f5df", "text": "overlap with the adjacent\nelement, by using non-templated tails on the oligonucleotides. For the secondary\nPCR amplification, 25 ng each of the purified GAL7 ,CPR1 -CYC1 ,GAL3 promoter\nandnatA PCR products were used as the DNA template and PCR amplified with\noligonucleotides PW91-014-CPK236-G and PW-91-079-CPK383-G to give\nGAL7(30 to 1021)_P GAL3 (21t o 2660)-CPR1 -TCYC1_natA .\nleu2::hisMX D::kanA_P GAL7-CYB5-T CYC1.Targeted replacement of the leu2::\nhisMX locus in Y657 was accomplished as follows. PCR amplification of the\nwild-type ERG19 locus from positions 489 to 1341 was performed with oligonu-\ncleotides AM/PW-91-093-CPK461-G and AM/PW-91-093-CPK462-G using\nCEN.PK2-1C genomic DNA as the template. PCR amplification of the kanA\nmarker (G418 resistance) was performed with oligonucleotides AM/PW-91-\n093-CPK460-G and AM-125-50-CPK514-G using pAM575 (containing the pro-\nmoter and terminator of K. lactis TEF1 ) as the template. PCR amplification of the\nGAL7 promoter from positions 21t o2725 was performed with oligonucleotides\nAM-125-50-CPK513-G and AT-126-103-CPK593-G using CEN.PK2-1C geno-\nmic DNA as the template. PCR amplification of the S. cerevisiae codon-optimized\nA. annua CYB5 ORF was performed with oligonucleotides AT-126-103-CPK592-\nG and PW-91-093-CPK426-G. PCR amplification of the CYC1 terminator ( TCYC1)\nfrom positions 331 to 830 was performed with oligonucleotides PW-91-093-\nCPK425-G and AT-126-103-CPK595-G using CEN.PK2-1C genomic DNA as\nthe template. PCR amplification of the LEU2 locus from positions 1 to 450 was\nperformed with oligonucleotides AT-126-103-CPK594-G and AM/PW-91-093-\nCPK457-G using CEN.PK2-1C genomic DNA as the template. For the secondary\nPCR, 25 ng each of the purified ERG19(489 to 1341) ,kanA ,PGAL7( 21t o 2725),\nA. annua CYB5 ,TCYC1(331 to 830) , and LEU2(1 to 450) PCR products were used\nas the DNA template and PCR amplified with oligonucleotides AM/PW-91-\n093-CPK462-G and AM/PW-91-093-CPK457-G to give ERG19(489 to 1341)_\nkanA_P GAL7( 21t o 2725)-CYB5-T CYC1(331 to 830) _LEU2(1 to 450).\nndt80D::PTDH1 -HEM1_hphA_P PGK1-CTT1 .Targeted replacement of the\nNDT80 locus in Y1368 with constitutively expressed CTT1 and HEM1 was\naccomplished as follows. PCR amplification of the wild-type NDT80 locus from\npositions 2187 to 2951 was performed with oligonucleotides PW-091-144-\nCPK640-G and PW-091-144-CPK654-G using CEN.PK2-1C genomic DNA asthe template. PCR of the wild-type HEM1 locus from positions 1 to 1947 was\nperformed with oligonucleotides", "start_char_idx": 2661, "end_char_idx": 5165, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7d13c077-5950-4f2b-ab27-94831f0c9f8b": {"__data__": {"id_": "7d13c077-5950-4f2b-ab27-94831f0c9f8b", "embedding": null, "metadata": {"page_label": "6", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "877bbf1f-5106-4894-a5e1-3285b410d669", "node_type": null, "metadata": {"page_label": "6", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "38e19614a8e645e763f3e8d5c61db9dcdc5a5a37f1da1a0698031ff4a04770ff"}, "2": {"node_id": "bc209971-7e4e-45c3-ba1e-463ad943adf6", "node_type": null, "metadata": {"page_label": "6", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "e816aa447a459bfae169e0aea99423a3964457566bdeff787f1900f9e854f5df"}, "3": {"node_id": "f7a1d006-8fa7-4b9c-8c94-d0a5eba3c810", "node_type": null, "metadata": {"page_label": "6", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "fd81a17bdc5f094f0863135519c6a5e1cf600129d038f85dca6f3129ca6f5af2"}}, "hash": "cac7a6ff26f2a5c24ee5e1474acad3651c3f2099150fcb4ac945b69af700c85c", "text": "locus from positions 1 to 1947 was\nperformed with oligonucleotides PW-091-144-CPK655-G and PW-091-\n144-CPK656-G using CEN.PK2-1C genomic DNA as the template. PCR of\ntheTDH1 promoter ( PTDH1) from positions 21t o 2577 was performed with\noligonucleotides PW-091-144-CPK657-G and PW-091-144-CPK658-G using\nCEN.PK2-1C genomic DNA as the template. PCR of the hphA marker was\nperformed with oligonucleotides PW-091-144-CPK659-G and PW-091-\n144-CPK643-G using BY4710 (ref. 4) genomic DNA as the template. PCR of\nthePGK1 promoter ( PPGK1) from positions 21t o 2623 was performed with\noligonucleotides PW-091-144-CPK644-G and PW-091-144-CPK645-G using\nCEN.PK2-1C genomic DNA as the template. PCR of the CTT1 locus from posi-\ntions 1 to 2000 was performed with oligonucleotides PW-091-144-CPK646-G and\nPW-091-144-CPK647-G using CEN.PK2-1C genomic DNA as the template. PCR\nof the wild-type NDT80 locus from positions 1684 to 2470 was performed with\noligonucleotides PW-091-144-CPK648-G and PW-091-144-CPK649-G using\nCEN.PK2-1C genomic DNA as the template. For the secondary PCR, 25 ng each\nof the purified NDT80( 2187 to 2951),HEM1(1 to 1947) ,PTDH1( 21t o2577),hphA ,\nPPGK1( 21t o 2623),CTT1(1 to 2000) and NDT80(1684 to 2470) PCR products\nwere used as the DNA template and PCR amplified with oligonucleotides PW-\n091-144-CPK640-G and PW-091-144-CPK649-G to give NDT80( 2187 to\n2951)_P TDH1( 21t o 2577)-HEM1(1 to 1947)_ hphA_ P PGK1( 21t o 2623)- CTT1(1 to\n2000)_ NDT80(1684 to 2470).\nndt80::hphA_P GAL7-ALDH1-T TDH1 .Targeted replacement of the NDT80 locus\nwith PGAL7-ALDH1 in Y973 was accomplished as follows. PCR amplification of\nthe wild-type NDT80 locus from positions 2187 to 2951 was performed with\noligonucleotides PW-091-144-CPK640-G and PW-091-144-CPK641-G using\nCEN.PK2-1C genomic DNA as the template. PCR amplification of the hphA\nmarker was performed with oligonucleotides PW-091-144-CPK642-G and AM-\n125-50-CPK514-G using pAM578 pAM575 (containing the promoter and ter-\nminator of K. lactis TEF1 ) as the template. PCR amplification of the GAL7 pro-\nmoter ( PGAL7) from positions 21t o2725 was performed with oligonucleotides\nAM-125-50-CPK513-G and AM-125-107-CPK756-G using CEN.PK2-1C geno-\nmic DNA as the template. PCR amplification of the S. cerevisiae codon-optimized\nALDH1 ORF was performed with oligonucleotides AM-125-107-CPK754-G and\nAM-125-107-CPK755-G. PCR amplification of the TDH1 terminator (", "start_char_idx": 5159, "end_char_idx": 7569, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f7a1d006-8fa7-4b9c-8c94-d0a5eba3c810": {"__data__": {"id_": "f7a1d006-8fa7-4b9c-8c94-d0a5eba3c810", "embedding": null, "metadata": {"page_label": "6", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "877bbf1f-5106-4894-a5e1-3285b410d669", "node_type": null, "metadata": {"page_label": "6", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "38e19614a8e645e763f3e8d5c61db9dcdc5a5a37f1da1a0698031ff4a04770ff"}, "2": {"node_id": "7d13c077-5950-4f2b-ab27-94831f0c9f8b", "node_type": null, "metadata": {"page_label": "6", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "cac7a6ff26f2a5c24ee5e1474acad3651c3f2099150fcb4ac945b69af700c85c"}, "3": {"node_id": "ec1ee651-4b0c-47b7-9f98-0fdcacda9311", "node_type": null, "metadata": {"page_label": "6", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "c2becfe4f6d79273190875a8df33aac946e23f824b8e29da0482a5f7cd9da7a6"}}, "hash": "fd81a17bdc5f094f0863135519c6a5e1cf600129d038f85dca6f3129ca6f5af2", "text": "PCR amplification of the TDH1 terminator ( TTDH1)\nfrom positions 1000 to 1997 was performed with oligonucleotides AM-125-107-\n752G and AM-125-107-CPK753-G using CEN.PK2-1C genomic DNA as the\ntemplate. PCR amplification of the wild-type NDT80 locus from positions 1684\nto 2470 was performed with oligonucleotides AM-125-107-CPK751-G and PW-\n091-144-CPK649-G using CEN.PK2-1C genomic DNA as the template. For the\nsecondary PCR amplification, 25 ng each of the purified NDT80( 2187 to 2951),\nhphA ,PGAL7( 21t o2725),A. annua ALDH1 ,TTDH1(1000 to 21997)andNDT80 (1684 to\n2470) PCR products were used as the DNA templates and PCR amplified with\noligonucleotides PW-091-144-CPK640-G and PW-091-144-CPK649-G to give\nNDT80( 2187 to 2951)_ hphA_P GAL7( 21t o 2725)-ALDH1-T TDH1(1000 to 21997)_\nNDT80(1684 to 2470).\nhis3::hphA_P GAL7-ALDH1-T TDH1 .Targeted replacement of the his3::hisMX\nlocus with PGAL7-ALDH1 to create Y1368 was accomplished as follows. PCR\namplification of the wild-type HIS3 locus from positions 232 to 2630 was per-\nformed with oligonucleotides PW-91-129-CPK543-G and PW-91-129-CPK544-\nG using BY4710 genomic DNA as the template. PCR of the hphA marker was\nperformed with oligonucleotides PW-91-129-CPK545-G and AM-125-50-\nCPK514-G using pAM578 as the template. PCR amplification of the GAL7 pro-\nmoter ( PGAL7) from positions 21t o2725 was performed with oligonucleotides\nAM-125-50-CPK513-G and AM-125-107-CPK756-G using CEN.PK2-1C geno-\nmic DNA as the template. PCR amplification of the A. annua ALDH1 ORF\nwas performed with oligonucleotides AM-125-107-CPK754-G and AM-\n125-107-CPK755-G using a synthetic, S. cerevisiae codon-optimized template\n(DNA2.0). PCR amplification of the TDH1 terminator ( TTDH1) from positions\n1000 to 1997 was performed with oligonucleotides PW-191-015-CPK859-G and\nAM-125-107-CPK753-G using CEN.PK2-1C genomic DNA as the template. PCR\namplification of the wild-type ERG12 locus from positions 883 to 1456 was per-\nformed with oligonucleotides PW-191-015-CPK860-G and PW-91-129-CPK550-\nG using CEN.PK2-1C genomic DNA as the template. For the secondary PCR\namplification, 25 ng each of the purified HIS3( 232 to 2630),hphA ,PGAL7( 21t o2725),\nA. annua ALDH1 ,TTDH1(1000 to 21997) andERG12(883 to 1456) PCR products\nwere used as the DNA templates and PCR amplified with oligonucleotides\nPW-91-129-CPK543-G and PW-91-129-CPK550-G to give NDT80( 2187 to\n2951)_ hphA_P GAL7 ( 21t o2725)-ALDH1-T TDH1(1000 to 21997)_ERG12(883 to 1456).\nnatAD::URA3_P", "start_char_idx": 7592, "end_char_idx": 10076, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ec1ee651-4b0c-47b7-9f98-0fdcacda9311": {"__data__": {"id_": "ec1ee651-4b0c-47b7-9f98-0fdcacda9311", "embedding": null, "metadata": {"page_label": "6", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "877bbf1f-5106-4894-a5e1-3285b410d669", "node_type": null, "metadata": {"page_label": "6", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "38e19614a8e645e763f3e8d5c61db9dcdc5a5a37f1da1a0698031ff4a04770ff"}, "2": {"node_id": "f7a1d006-8fa7-4b9c-8c94-d0a5eba3c810", "node_type": null, "metadata": {"page_label": "6", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "fd81a17bdc5f094f0863135519c6a5e1cf600129d038f85dca6f3129ca6f5af2"}}, "hash": "c2becfe4f6d79273190875a8df33aac946e23f824b8e29da0482a5f7cd9da7a6", "text": "21997)_ERG12(883 to 1456).\nnatAD::URA3_P GAL7-ADH1-T TDH1 .Targeted replacement of the natA locus\nwith PGAL7-ADH1 for creation of Y1283 was accomplished as follows. PCR\namplification of the wild-type GAL3 promoter ( PGAL3) from positions 277\nto2660 was performed with oligonucleotides PW-191-015-CPK866-G andLETTER RESEARCH\nMacmillan Publishers Limited. All rights reserved \u00a9201 3", "start_char_idx": 10072, "end_char_idx": 10452, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b272c3e0-9341-4072-9fea-6a1e71531d70": {"__data__": {"id_": "b272c3e0-9341-4072-9fea-6a1e71531d70", "embedding": null, "metadata": {"page_label": "7", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "52764204-8803-47f3-ad26-052cfabc7f84", "node_type": null, "metadata": {"page_label": "7", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "6151860c98543d9a1a3bde02e9862c1a17e4f59f593cab0b81bddb0af2edfaa9"}, "3": {"node_id": "1930f2b0-29d3-4b06-9846-619eaf1207f4", "node_type": null, "metadata": {"page_label": "7", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "bc592de0953929ac98fea1043d8bb7d81315000ab3aa49581030952a55f2b98a"}}, "hash": "f378e7bcc608334e6d6ca1c85316f2fe5a6f4cfd18a4d31c70955681618e210c", "text": "PW-191-015-CPK867-G using BY4710 genomic DNA as the template. PCR amp-\nlification of the URA3 locus from position 2226 to 884 was performed with\noligonucleotides PW-191-015-CPK868-G and PW-191-015-CPK869-G using\nCEN.PK2-1C genomic DNA as the template. PCR amplification of the GAL7\npromoter ( PGAL7) from positions 21t o2725 was performed with oligonucleo-\ntides PW-191-015-CPK870-G and PW-191-015-CPK871-G using CEN.PK2-1C\ngenomic DNA as the template. PCR amplification of the S. cerevisiae codon-\noptimized A. annua ADH1 ORF was performed with oligonucleotides PW-191-\n015-CPK872-G and PW-191-015-CPK873-G. PCR amplification of the TDH1\nterminator ( TTDH1) from positions 1000 to 1750 was performed with oligonucleo-\ntides PW-191-015-CPK874-G and PW-191-015-CPK875-G using CEN.PK2-1C\ngenomic DNA as the template. PCR amplification of the wild-type GAL1 locus\nfrom positions 1637 to 2436 was performed with oligonucleotides PW-191-015-\nCPK876-G and PW-191-015-CPK877-G using CEN.PK2-1C genomic DNA as\nthe template. For the secondary PCR amplification, 25 ng each of the purified\nPGAL3( 277 to 2660),URA3( 2226 to 884) ,PGAL7( 21t o 2725),A. annua ADH1 ,\nTTDH1(1000 to 21750) and GAL1(1637 to 2436) PCR products were used as the\nDNA templates and PCR amplified with oligonucleotides PW-191-015-\nCPK866-G and PW-191-015-CPK877-G to give PGAL3( 277 to 2660)_URA3( 2226\nto 884)_ P GAL7( 21t o 2725)-ADH1 -TTDH1(1000 to 21750)-GAL1(1637 to 2436).\ngal80D::URA3_P GAL7-ADH1-T GAL80 .Targeted replacement of the GAL80 locus\nwith PGAL7-ADH1 to create Y1284 was accomplished as follows. PCR amplifica-\ntion of the wild-type GAL80 locus from positions 228 to 2760 was performed\nwith oligonucleotides PW-191-015-CPK882-G and PW-191-015-CPK883-G\nusing CEN.PK2-1C genomic DNA as the template. PCR amplification of the\nURA3 locus from position 2226 to 884 was performed with oligonucleotides\nPW-191-015-CPK884-G and PW-191-015-CPK869-G using BY4710 genomic\nDNA as the template. PCR of the GAL7 promoter ( PGAL7) from positions 21t o\n2725 was performed with oligonucleotides PW-191-015-CPK870-G and PW-\n191-015-CPK871-G using CEN.PK2-1C genomic DNA as the template. PCR\namplification of the A. annua ADH1 ORF was performed with oligonucleotides\nPW-191-015-CPK872-G and PW-191-015-CPK873-G using a synthetic S. cere-\nvisiae codon-optimized template (DNA2.0). PCR amplification of the wild-type\nGAL80 locus from positions 1320 to 2117 was performed with oligonucleotides\nPW-191-015-CPK886-G and", "start_char_idx": 0, "end_char_idx": 2477, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1930f2b0-29d3-4b06-9846-619eaf1207f4": {"__data__": {"id_": "1930f2b0-29d3-4b06-9846-619eaf1207f4", "embedding": null, "metadata": {"page_label": "7", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "52764204-8803-47f3-ad26-052cfabc7f84", "node_type": null, "metadata": {"page_label": "7", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "6151860c98543d9a1a3bde02e9862c1a17e4f59f593cab0b81bddb0af2edfaa9"}, "2": {"node_id": "b272c3e0-9341-4072-9fea-6a1e71531d70", "node_type": null, "metadata": {"page_label": "7", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "f378e7bcc608334e6d6ca1c85316f2fe5a6f4cfd18a4d31c70955681618e210c"}, "3": {"node_id": "1776d018-bd97-44ce-9ec2-42e827e10b31", "node_type": null, "metadata": {"page_label": "7", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "822208bb58053ec2498c7652f77c5716255c092160d0364fba04e028a17a6928"}}, "hash": "bc592de0953929ac98fea1043d8bb7d81315000ab3aa49581030952a55f2b98a", "text": "with oligonucleotides\nPW-191-015-CPK886-G and PW-191-015-CPK887-G using CEN.PK2-1C geno-\nmic DNA as the template. For the secondary PCR amplification, 25 ng each of the\npurified GAL80( 228 to 2760),URA3( 2226 to 884) ,PGAL7( 21t o 2725),A. annua\nADH1 , and GAL80(1320 to 2117) PCR products were used as the DNA templates\nand PCR amplified with oligonucleotides PW-191-015-CPK882-G and PW-191-\n015-CPK887-G to give GAL80( 228 to 2760)_URA3( 2226 to 884)_P GAL7( 21t o2725)-\nADH1-GAL80(1320 to 2117).\nAll strains were confirmed with diagnostic PCR to contain the expected integ-\nration constructs and, where appropriate, all integrations were verified by\nsequence analysis.\nCloning and characterization of A. annua ADH1. Analysis of a previously\ndeveloped A. annua EST collection12,26,27identified a contig corresponding to an\napparently full-length ORF encoding a putative trichome-expressed alcohol dehy-\ndrogenase. The corresponding gene, designated A. annua ADH1 , was associated\nwith 2.2%, 1.3% and 0.06% of ESTs in the \u2018trichome-minus-flower-bud\u2019 (desig-\nnated GSTSUB in ref. 12), glandular trichome (designated AAGST12) and flower\nbud (designated AAFB12) collections, respectively. Similarly, based on the genera-\ntion of expressed sequence tags by 454 sequencing of A. annua28, the gene expres-\nsion pattern of ADH1 was found to be comparable to that of CYP71AV1 in a range\nof tissues, with negligible expression in cotyledons and mature leaf trichomes and\n0.21, 0.53 and 0.03% of sequences in each of the EST collections derived from\nyoung leaf trichomes, flower bud trichomes and meristem/young leaf, respectively.\nA full-length ADH1 ORF was cloned by reverse transcriptase PCR (RT\u2013PCR)\n(using oligonucleotide primers PSC1 and PSC2 and the vector pENTR/D\nTOPO (Invitrogen)). The A. annua ADH1 gene has an ORF encoding a polypep-\ntide of 378 amino acids with a relative molecular mass of 40,415 daltons. On the\nbasis of sequence similarities, A. annua ADH1 is a member of the medium chain\nalcohol dehydrogenase/reductase superfamily that is related to predicted proteins\nofPopulus trichocarpa (61% identity, GenBank accession XP_002324694) and\nCynara cardunculus (72% identity over 214 amino acids, GenBank accession\nGE588275).\nTheA. annua ADH1 ORF was subcloned into the pET15b vector modified to\ncontain a PreScission protease cleavage site. The vector containing the A. annua\nADH1 ORF was used to transform the E. coli BLR (DE3). Protein expression was\ninduced by adding 0.4 mM isopropyl- b-D-thiogalactoside (IPTG) and cultures\ntotalling 5 l were incubated at 16 uC for 16 h. ADH1 was subjected to two rounds\nof Ni-column purification, analysis by SDS\u2013PAGE and dialysis. The final frac-\ntions containing ADH1 were pooled and dialysed against protein storage buffer\n(20 mM Tris-HCl, pH 8.0, 200 mM NaCl, 200 mM KCl, 10% glycerol and 1 mMdithiothreitol (DTT)). Protein concentration was determined by Bradford assay\nand aliquots were", "start_char_idx": 2435, "end_char_idx": 5377, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1776d018-bd97-44ce-9ec2-42e827e10b31": {"__data__": {"id_": "1776d018-bd97-44ce-9ec2-42e827e10b31", "embedding": null, "metadata": {"page_label": "7", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "52764204-8803-47f3-ad26-052cfabc7f84", "node_type": null, "metadata": {"page_label": "7", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "6151860c98543d9a1a3bde02e9862c1a17e4f59f593cab0b81bddb0af2edfaa9"}, "2": {"node_id": "1930f2b0-29d3-4b06-9846-619eaf1207f4", "node_type": null, "metadata": {"page_label": "7", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "bc592de0953929ac98fea1043d8bb7d81315000ab3aa49581030952a55f2b98a"}, "3": {"node_id": "a91f861a-ba1e-48c6-ab49-ce861b1925b4", "node_type": null, "metadata": {"page_label": "7", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "1644c60dc04bd1b3b592a2b8dd3b32cdffebca6497db9ab67d17576205185757"}}, "hash": "822208bb58053ec2498c7652f77c5716255c092160d0364fba04e028a17a6928", "text": "Protein concentration was determined by Bradford assay\nand aliquots were stored at 280uC. ADH1 purity by SDS\u2013PAGE was judged to be\n95%.\nUnless otherwise stated, ADH1 enzyme assays included 50 mM Tris buffer,\npH 8.5, 250 mM NaCl, 0.4 mg ml21BSA, 50 mM substrate, 1 mM NAD, 3 mgo f\noctadecane (as internal standard; Sigma-Aldrich) and 80 ng of recombinant A.\nannua ADH1 in a total volume of 200 ml. Negative controls were carried out in the\nabsence of NAD. Reactions were allowed to proceed for 4 min at 30 uC with\nshaking (500 r.p.m.), and immediately stopped by extraction with 500 ml pentane.\nAll quantitative analyses were done with 3\u20136 technical replicates per treatment.\nPentane extracts were concentrated to ,30ml under a stream of nitrogen and\neither 10 ml ethyl acetate or 10 ml of a mixture of 1:1 N,O-bis-(trimethylsilyl)ace-\ntamide (Sigma-Aldrich)/pyridine (Fluka) was added. The remainder of the pent-\nane was carefully removed under a stream of nitrogen and the final 10- ml sample\nwas analysed by gas chromatography\u2013mass spectrometry (GC\u2013MS)26.\nSubstrate specificity was determined in 15-min, 600- ml assays using ( 1)-bor-\nneol (Fluka), ( 2)-borneol (Fluka) and artemisinic, dihydroartemisinic, artemi-\nsia26, coniferyl (Sigma-Aldrich), and cinnamyl (Sigma-Aldrich) alcohols. ADH1\nonly showed considerable dehydrogenase activity with artemisinic alcohol and to a\nlesser extent with dihydroartemisinic alcohol (4.2% relative to artemisinic alcohol;\nSupplementary Fig. 5). The identity of the aldehyde products was confirmed by\nGC\u2013MS in comparison to authentic standards. When assayed with artemisinic\nalcohol and NAD, recombinant A. annua ADH1 showed a pH optimum of 8.5.\nUsing 1 mM NADP as the cofactor, oxidation of artemisinic alcohol by ADH1 was\n30-fold lower (Supplementary Fig. 5). The linear range of the ADH1 assay with\nrespect to time was tested by reactions under standard assay conditions except\nvarying the time up to 30 min. The pH optimum of the purified ADH1 was\ndetermined to be 8.5 based on a series of 15-min assays with the pH range from\n5.5 to 10 in intervals of 0.5-pH units using 50 mM citrate, phosphate, Tris, CHES\nand CAPS buffers. Kinetic parameters were determined by varying the concentra-\ntions of artemisinic alcohol (3.0\u201325 mM) in 600- ml assays using 240 ng ADH1.\nSubstrate solubility prevented the use of higher concentrations. Octadecane was\nused as an internal standard to quantify the substrate and product from the\nreactions by gas chromatography using response factors determined by using\nknown concentrations of standards. Kinetic constants were determined by fitting\nthe data to the Michaelis\u2013Menten equation using nonlinear regression and\nEnzFitter software (Biosoft).\nMedia and growth conditions. Fermentation media: The media used for this\nwork were based on media described previously29. The trace metal solution con-\ntained 5.75 g l21ZnSO 4?7H2O, 0.32 g l21MnCl 2?4H2O, 0.47 g l21CoCl 2?6H2O,\n0.48 g l21Na2MoO 4?2H2O, 2.9 g l21CaCl 2?2H2O, 2.8 g l21FeSO 4?7H2O and\n80 ml l210.5 M EDTA,", "start_char_idx": 5357, "end_char_idx": 8400, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a91f861a-ba1e-48c6-ab49-ce861b1925b4": {"__data__": {"id_": "a91f861a-ba1e-48c6-ab49-ce861b1925b4", "embedding": null, "metadata": {"page_label": "7", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "52764204-8803-47f3-ad26-052cfabc7f84", "node_type": null, "metadata": {"page_label": "7", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "6151860c98543d9a1a3bde02e9862c1a17e4f59f593cab0b81bddb0af2edfaa9"}, "2": {"node_id": "1776d018-bd97-44ce-9ec2-42e827e10b31", "node_type": null, "metadata": {"page_label": "7", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "822208bb58053ec2498c7652f77c5716255c092160d0364fba04e028a17a6928"}}, "hash": "1644c60dc04bd1b3b592a2b8dd3b32cdffebca6497db9ab67d17576205185757", "text": "4?7H2O and\n80 ml l210.5 M EDTA, pH 8.0. The vitamin solution contained 0.05 g l21biotin,\n1gl21calcium pantothenate, 1 g l21nicotinic acid, 25 g l21myo-inositol, 1 g l21\nthiamine HCl, 1 g l21pyridoxal HCl and 0.2 g l21p-aminobenzoic acid. The batch\nmedium for all fermentations contained 19.5 g l21glucose, 15 g l21(NH 4)2SO4,\n8gl21KH 2PO4, 6.2 g l21MgSO 4?7H2O, 12 ml l21vitamin solution and 10 ml l21\ntrace metal solution.\nThe batch medium also contained additional components depending on the\nstrain and the process being run. For the glucose and ethanol mixed-feed process,\nfor all strains except Y285, CuSO 4was added to the batch medium to a concen-\ntration of 0.25 mM CuSO 4. For Y285, the batch medium contained 20 mM CuSO 4.\nThe bioreactor feed media also varied for the different processes and for differ-\nent strains. All mixed glucose/ethanol processes used bioreactor feed base that\ncontained 386g l21glucose, 9 g l21KH 2PO4, 5.12 g l21MgSO 4?7H2O, 3.5 g l21\nK2SO4,0 . 2 8gl21Na2SO4and 237 ml l21ethanol (95% v/v).\nFor the glucose and ethanol mixed feed process, two different feed media were\nprepared for the fermentation: pre-induction-feed media and induction-feed\nmedia (includes small molecule inducers and repressors). For both feed media,\nstock solutions of vitamins and trace metals were added to the bioreactor feed base\nas follows: 12 ml vitamin solution per litre feed base, and 10 ml trace metals\nsolution per litre feed base. The pre-induction-feed media contained 0.25 mM\nCuSO 4and no other additions. For fermentation of Y285, the pre-induction-feed\nmedia contained 20 mM CuSO 4.\nTo the induction-feed medium, two different inducers/repressors were added to\nthe medium dependent on the strain. For Y285, concentrated solutions of galac-\ntose and methionine were added to the induction-feed medium to bring the final\nconcentrations to 10 g l21galactose and 1 g l21methionine. For all other strains,\nconcentrated solutions of galactose and CuSO 4were added to the feed medium to\nbring the final concentrations to 10 g l21galactose and 150 mM CuSO 4. All addi-\ntions to the medium were made in a sterile hood.\nShake-flask media: Seed medium for pre-culture was the batch fermentation\nmedium modified with the addition of 100 ml l21succinate buffer (0.5 M, pH 5.0).\nFor strain Y285, the concentration of CuSO 4in the seed medium was 20 mM. ForRESEARCH LETTER\nMacmillan Publishers Limited. All rights reserved \u00a9201 3", "start_char_idx": 8433, "end_char_idx": 10871, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d6891c34-5c10-4b73-bad8-3764f7d150e9": {"__data__": {"id_": "d6891c34-5c10-4b73-bad8-3764f7d150e9", "embedding": null, "metadata": {"page_label": "8", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "36132048-5b84-4c1f-9209-2abff9297b0b", "node_type": null, "metadata": {"page_label": "8", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "1039a97b3059433362abb96dc8e48649d4d11e4d6eedb6e31105ef3707247d23"}, "3": {"node_id": "44f15c74-ff06-4684-bd29-179f36f1e075", "node_type": null, "metadata": {"page_label": "8", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "7e5c5a27ab6954cd8713ab736027526a2a32a3981d9c8de24850a8b761470941"}}, "hash": "f579d405737ec45651d5ef8cb04c1c0a19b9f959a42262c3632672449bdab4ee", "text": "all other strains tested (which contain a copper-repressible promoter controlling\nERG9 expression), low-copper seed medium, containing only 0.25 mM CuSO 4,\nwas used.\nFlask-production medium was modified seed media which contained 40 g l21\nglucose, 5 g l21galactose, 1.7 mM methionine and 150 mM CuSO 4.\nShake-flask methods. To prepare seed vials, single isolates of each strain from\nagar plates were grown for 18\u201324 h in 20-ml low-copper seed medium containing\n0.25mMC u S O 4. Cultures were then inoculated at an attenuance ( D600 nm )o f0 . 0 5\ninto fresh low-copper seed medium and grown for a further 18\u201324 h to an D600 nm\nof between 2 and 3 (measured using a Thermo Scientific Genesys 10 Vis spectro-\nphotometer). Six-hundred microlitres of this culture was added to 400 ml of 50%\nglycerol and stored in 1-ml aliquots (20% glycerol (v/v) final) at 280uC.\nTo acclimate cells before inoculation into production medium, frozen seed vials\nwere thawed to room temperature and inoculated into 20-ml low-copper seed\nmedium. Cultures were grown for 18\u201324 h at 30 uC with shaking at 200 r.p.m. The\nnext day, the cultures were diluted to a D600 nm of 0.05 in 20-ml low-copper seed\nmedium and grown for ,18 h at 30 uC with shaking at 200 r.p.m.\nCells from the second overnight acclimation were diluted to a D600 nm of 0.05 in\n250 ml unbaffled flasks containing 25 ml flask-production medium. Flasks con-\ntained an additional 5 ml IPM where indicated. All cultures were inoculated in\ntriplicate and incubated at 30 uC for 72 h with shaking at 200 r.p.m. in a humidified\nInnova incubator. Flasks were sampled periodically for growth ( D600 nm ), viability\nand product titres. Viability was measured using the LIVE/DEAD Funga Light\nyeast viability kit for flow cytometry (Invitrogen Corporation) and a Guava tech-\nnologies EasyCyte Plus flow cytometer.\nFor the production of insoluble artemisinic acid in shake-flask cultures,\n15.8 g l21of 95% ethanol was added to the production flask after 72, 96 and\n120 h growth. The flask was inspected for formation of insoluble material after\n144 h.\nGlucose and ethanol mixed-feed process. Preparation of seed cultures and pro-\ncedures for setting up and running glucose and ethanol mixed-feed fermentations\nhave been described3. The production process was induced with the addition of\n10 g l21galactose and 0.25 g l21methionine (for Y285), or 10 g l21galactose and\n150mM CuSO 4(all other strains) to the bioreactor after the culture reached an\nD600 nm value of approximately 50. At this time, the feed bottle containing pre-\ninduction-feed medium was exchanged for a feed bottle containing induction-feed\nmedium.\nMixed glucose/ethanol feed process with early induction/repression. The\nmixed glucose/ethanol feed process was modified by changing the time of induc-\ntion (the time of addition of galactose and methionine, or galactose and high\nCuSO 4) from the time the culture reached a D600 nm of 50 to the time of inocu-\nlation. The mixed glucose/ethanol feed process with early induction/repression\nwas identical to the mixed feed process except that batch and feed media were\nmodified. Immediately before inoculation, concentrated solutions of galactose,\nmethionine and/or CuSO 4were added to the batch medium to bring the final\nconcentrations to 10 g l21galactose and 0.25 g", "start_char_idx": 0, "end_char_idx": 3310, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "44f15c74-ff06-4684-bd29-179f36f1e075": {"__data__": {"id_": "44f15c74-ff06-4684-bd29-179f36f1e075", "embedding": null, "metadata": {"page_label": "8", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "36132048-5b84-4c1f-9209-2abff9297b0b", "node_type": null, "metadata": {"page_label": "8", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "1039a97b3059433362abb96dc8e48649d4d11e4d6eedb6e31105ef3707247d23"}, "2": {"node_id": "d6891c34-5c10-4b73-bad8-3764f7d150e9", "node_type": null, "metadata": {"page_label": "8", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "f579d405737ec45651d5ef8cb04c1c0a19b9f959a42262c3632672449bdab4ee"}, "3": {"node_id": "8d94b934-4534-41e3-b277-15b52285367c", "node_type": null, "metadata": {"page_label": "8", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "260448813c97b2fc2b0b4abf2fb0c57f208b41e7817b5e1e60260961a201fef3"}}, "hash": "7e5c5a27ab6954cd8713ab736027526a2a32a3981d9c8de24850a8b761470941", "text": "bring the final\nconcentrations to 10 g l21galactose and 0.25 g l21methionine (for Y285), or\n10 g l21galactose and 150 mMC u S O 4(for all other strains). Only the induction-\nfeed medium was used in the fed-batch phase of the process (no pre-induction\nmedium). All other parameters were the same as the mixed glucose/ethanol feed\nprocess.\nAt later time points (42\u201396 h), in some fermentation runs of strains Y1283 and\nY1284, artemisinic acid precipitated from the liquid fermentor broth. Solid pre-\ncipitate was visible in the fermentor and adhered onto the side of the bioreactor\nand the head plate. During the runs, artemisinic acid concentration was still\nassayed from fermentor broth samples over the course of the fermentation as\ndescribed below. However, for select fermentations of Y1284, artemisinic acid\nwas also assayed at the end of the fermentation after complete solubilization of\nthe precipitate by high pH treatment of the fermentor broth. At the end of the\nfermentation, the culture was adjusted to pH 8.1 with 10 M NH 4OH and allowed\nto stir at 1,500 r.p.m. (maximum rpm) at 30 uC for at least 1 h to dissolve the\nprecipitated artemisinic acid. After the pH adjustment, the cell broth was collected\nand water was added the tank to wash any residual precipitate from the tank. The\nwater was adjusted to pH 9.1 with 10 M NH 4OH and allowed to stir at 1,200 r.p.m.\novernight. Together, this provided a more accurate measurement of artemisinic\nacid at the final time point.\nMixed glucose/ethanol feed process with induction/repression and IPM. The\naddition of an IPM phase to yeast cultures was tested at the fermentor scale using\nstrains Y1283 and Y1284. The fermentation process used was the mixed glucose/\nethanol feed process with early induction/repression. The only process change was\nthe addition of 200 ml IPM to the fermentor before inoculation. The initial aque-\nous batch volume of the fermentations was 0.7 l.\nThe IPM phase and the aqueous cell broth formed a well-mixed emulsion in the\nreactor at later times in the fermentation ( .24 h). To assay artemisinic acid titre infermentations with IPM, samples of the combined IPM and cell broth mixture/\nemulsion were extracted with solvent. The mixture was first vortexed then added\nto the methanol/formic acid as described below. The concentrations measured by\nliquid chromatography with ultraviolet detection are reported in terms of grams\nper litre total volume (aqueous cell broth plus IPM). Using the ratio of aqueous cell\nbroth volume to IPM volume at the time of sampling, the titres are converted to\nterms of grams per litre aqueous volume to allow for direct comparison with runs\nthat do not use IPM.\nAt 30 uC, artemisinic acid has a solubility of approximately 100\u2013115 g l21in\nIPM (empirically determined). At later times in the fed-batch fermentation, after a\nlarge volume of aqueous feed has been added to the fermentor, the ratio of IPM/\naqueous volume is significantly lower and the solubility limit could restrict addi-\ntional production.\nEthanol pulse-feed process with IPM. Yeast strain Y1284 was tested in an ethanol\npulse-feed process with the addition of IPM to the culture medium. The temper-\nature, pH and dissolved oxygen were controlled at the set points described above.\nThe batch medium for this process was the same as for the glucose/ethanol mixed-\nfeed process with early induction, described above, except that no galactose was\nadded (Y1284 does not require galactose for induction). Four-hundred millilitres\nof IPM was", "start_char_idx": 3258, "end_char_idx": 6778, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8d94b934-4534-41e3-b277-15b52285367c": {"__data__": {"id_": "8d94b934-4534-41e3-b277-15b52285367c", "embedding": null, "metadata": {"page_label": "8", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "36132048-5b84-4c1f-9209-2abff9297b0b", "node_type": null, "metadata": {"page_label": "8", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "1039a97b3059433362abb96dc8e48649d4d11e4d6eedb6e31105ef3707247d23"}, "2": {"node_id": "44f15c74-ff06-4684-bd29-179f36f1e075", "node_type": null, "metadata": {"page_label": "8", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "7e5c5a27ab6954cd8713ab736027526a2a32a3981d9c8de24850a8b761470941"}, "3": {"node_id": "2ed823d7-d9d2-4399-8257-b987af381099", "node_type": null, "metadata": {"page_label": "8", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "d737a1bfb5ffb16e5360e7fb7e8e92c56878ffbb1671715a8a20ddc7fb84f927"}}, "hash": "260448813c97b2fc2b0b4abf2fb0c57f208b41e7817b5e1e60260961a201fef3", "text": "require galactose for induction). Four-hundred millilitres\nof IPM was added to a starting aqueous fermentor volume of 0.8 l, before inocu-\nlation.\nThe feed for the ethanol pulse-feed fed-batch phase of the process was 95% (v/v)\nethanol. Because none of the salts, trace metals or vitamins was soluble in 95% (v/\nv) ethanol, concentrated feed components were combined into a concentrated\npost-sterile addition (PSA) solution. The concentrated PSA solution consisted\nof 72.9 g l21KH 2PO4, 41.4 g l21MgSO 4?7H2O, 28.3 g l21K2SO4,2 . 3 g l21\nNa2SO4, 1.2 mM CuSO 4,1 0 m l l21trace metals solution and 12 ml l21vitamin\nsolution. The concentrated PSA solution was injected through a septum in the\nbioreactor head plate with a syringe once per day according to how much volume\nof 95% (v/v) ethanol volume had been delivered since the previous addition of feed\ncomponents. One-hundred-and-twenty-four millilitres of concentrated PSA solu-\ntion was added per litre of 95% (v/v) ethanol added.\nAfter the batch carbon was consumed (detected as described above) the ethanol\npulse-feed algorithm was initiated. As the culture grew and consumed O 2, dis-\nsolved O 2was maintained at 40% by an agitation cascade followed by oxygen\nenrichment (as described above). In the first phase of the fed-batch fermentation,\nbefore the stir rate of the reactor reached the maximum allowed for the unit, the\npulse feed algorithm used stir rate (Stir) measurements to control ethanol feed\ndelivery (Supplementary Fig. 14a). The computer algorithm assigned a variable\n(Stir Max) that tracked the maximum stir rate obtained so far in the process. While\ngrowing on ethanol, O 2demand increased and stir rate increased until the sub-\nstrate was depleted from the fermentor medium. At that point, the dissolved O 2\nincreased and the controller decreased stir rate to maintain dissolved O 2540%.\nWhen Stir decreased to less than 75% of the value of Stir Max, the ethanol feed\npump was activated for the length of time necessary to add 10 g ethanol per litre\nfermentor volume to the reactor. The computer algorithm calculated the time\nnecessary to add 10 g ethanol per litre fermentor volume to the reactor (Timer\nMax) after each cycle. The first phase of the algorithm iterated unit O 2enrichment\nas required.\nAfter the stir rate of the reactor reached the maximum allowed for the unit,\noxygen enrichment was used to maintain dissolved O 2540%. During this stage of\nthe fed-batch fermentation, the second phase of the control algorithm was\ninitiated. Dissolved O 2measurements were used to control ethanol feed delivery\n(Supplementary Fig. 14b). When ethanol was depleted from the fermentor med-\nium, the dissolved O 2began to increase rapidly\u2014faster than the dissolved O 2\ncontroller could compensate. When dissolved O 2.50%, the ethanol feed pump\nwas activated for the length of time necessary to add 10 g ethanol per litre fermen-\ntor volume to the reactor. After the addition of ethanol, the dissolved O 2would\nrapidly decrease to ,50%. The variable Timer Max was again calculated by the\ncomputer algorithm after each cycle. This algorithm iterated for the remainder of\nthe fermentation.\nPurification of artemisinic acid from IPM. IPM was isolated from artemisinic\nacid fermentations by centrifugation. IPM was mixed with 1% NaH 2PO4?12H 2O\nand the pH was adjusted to 10.7 by the addition of 5 M NaOH. The solution", "start_char_idx": 6770, "end_char_idx": 10154, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2ed823d7-d9d2-4399-8257-b987af381099": {"__data__": {"id_": "2ed823d7-d9d2-4399-8257-b987af381099", "embedding": null, "metadata": {"page_label": "8", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "36132048-5b84-4c1f-9209-2abff9297b0b", "node_type": null, "metadata": {"page_label": "8", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "1039a97b3059433362abb96dc8e48649d4d11e4d6eedb6e31105ef3707247d23"}, "2": {"node_id": "8d94b934-4534-41e3-b277-15b52285367c", "node_type": null, "metadata": {"page_label": "8", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "260448813c97b2fc2b0b4abf2fb0c57f208b41e7817b5e1e60260961a201fef3"}}, "hash": "d737a1bfb5ffb16e5360e7fb7e8e92c56878ffbb1671715a8a20ddc7fb84f927", "text": "was adjusted to 10.7 by the addition of 5 M NaOH. The solution was\nthen stirred at ambient temperature for 60 min. After mixing, the solution was\nallowed to separate by gravity in a separatory funnel at ambient temperature. The\nbottom aqueous phase was drawn off from the upper IPM phase. The bottom\naqueous phase was run through a liquid: liquid annular centrifugal contactor\n(CINC Industries) to ensure complete removal of any residual IPM. A 10% (w/\nv) SDS solution was added to the aqueous phase to bring the final SDS concen-\ntration to 0.03%. The solution was mixed and the pH adjusted to 5.0 with 2.5 M\nH2SO4. The acidification resulted in the formation of a fine white precipitate,\nwhich was captured on a 0.45- mm PTFE (polytetrafluoroethylene) filter, rinsedLETTER RESEARCH\nMacmillan Publishers Limited. All rights reserved \u00a9201 3", "start_char_idx": 10154, "end_char_idx": 10994, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "beebd843-d8bd-4fd8-9476-662122f8326e": {"__data__": {"id_": "beebd843-d8bd-4fd8-9476-662122f8326e", "embedding": null, "metadata": {"page_label": "9", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "11bbdfb9-b55b-420b-893e-42c5b2be6732", "node_type": null, "metadata": {"page_label": "9", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "2fef7c940702b8efa00d3ed2ee7aa1acf3bd21a1cdfc2b97f82053955c1e57ec"}, "3": {"node_id": "ffa77d7d-e5ed-4a05-9319-a59768aaf549", "node_type": null, "metadata": {"page_label": "9", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "c7e3879706fe2a1b72e9dff7355b233de0f07124bd9b3496e4de9b8c6e3aca4e"}}, "hash": "d3806b17b081a4f26c79d9874abd4fa39da7e26a7ff1cb1a82b45512cdec0356", "text": "with purified water and then dried. Analysis of the IPM before and after aqueous\nextraction showed that 5% of the artemisinic acid remained in the IPM after\nextraction ( ,95% step yield). Analysis of the filtrate after precipitation showed\nthat 2% of the artemisinic acid present in the aqueous phase remained in the\nfiltrate after acidification ( ,98% step yield). The overall purification yield\nobtained was ,93%. Additional aqueous extractions of the remaining IPM should\nincrease the overall yield. Analysis of the dried precipitate by gas chromatography\nwith flame-ionization detection (GC\u2013FID) gave artemisinic acid purities of ,96%\nby area and ,98% by weight.\nBroth extraction. Amorpha-4,11-diene, artemisinic alcohol and artemisinic alde-\nhyde were extracted from cells and broth as follows. Cell lysis cocktail was pre-\npared by combining two parts Novagen YeastBuster protein reagent (EMD\nBiosciences) and one part 2 M HCl. Samples were prepared by mixing 0.4 ml cell\nlysis cocktail with 0.1 ml whole broth and 1 ml ethyl acetate containing 10 mg l21\ntrans -caryophyllene (internal standard, $98.5% purity; Sigma-Aldric ) in a 2-ml\nglass vial. The sample was mixed for 30 min on a vortex mixer. After mixing, the\nvial was placed on the bench top to allow the phases to separate. If necessary, the\nvial was centrifuged at 1,000 gto break any emulsion that had formed. Six-hundred\nmicrolitres of the ethyl acetate layer was transferred to a gas chromatography vial\nfor analysis.\nGas chromatography. The production of amorpha-4,11-diene, artemisinic alco-\nhol and artemisinic aldehyde was monitored by GC\u2013FID. The ethyl acetate-\nextracted samples were analysed using on the GC\u2013FID. Amorpha-4,11-diene,\nartemisinic alcohol and A.CHO peak areas were converted to concentration mea-\nsurements from external standard calibrations using authentic compounds. To\nexpedite run times, the temperature program and column were modified to\nachieve optimal resolution and the shortest overall run-time with minimal inter-\nferences. A 10- ml sample was split 1:20 and was separated using a DB-WAX\ncolumn (50 m 3200mm30.2mm; Agilent), with hydrogen as the carrier gas at\na flow rate of 1.57 ml min21. The temperature program for the analysis was as\nfollows: the column was initially held at 150 uC for 3 min, followed by a temper-\nature gradient of 5 uC min21to a temperature of 250 uC, and then the column was\nheld at 250 uC for 5 min to elute all remaining components. Under these condi-\ntions, trans -caryophyllene, amorpha-4,11-diene, artemisinic aldehyde and arte-\nmisinic alcohol elute at 4.95, 5.77, 12.94 and 18.60 min, respectively.\nBroth preparation with and without IPM. A 1-ml aliquot of well-mixed fer-\nmentation broth was diluted in 9 ml of methanol plus 0.1% formic acid (IPM\nformed an emulsion with the cell broth when it was used). The mixture was thenmixed on a vortex mixer for 30 min and centrifuged at 16,000 gfor 5 min. One-\nhundred microlitres of the supernatant was diluted into 900 ml methanol plus 0.1%\nformic acid, and analysed by the HPLC method described below.\nIn-process assay for titre measurement. A screening method was developed to\nrank artemisinic-acid-producing strains. This method was used only to rank\nstrains, and not determine final titre. A 20- ml aliquot was injected on an Agilent\n1200", "start_char_idx": 0, "end_char_idx": 3322, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ffa77d7d-e5ed-4a05-9319-a59768aaf549": {"__data__": {"id_": "ffa77d7d-e5ed-4a05-9319-a59768aaf549", "embedding": null, "metadata": {"page_label": "9", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "11bbdfb9-b55b-420b-893e-42c5b2be6732", "node_type": null, "metadata": {"page_label": "9", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "2fef7c940702b8efa00d3ed2ee7aa1acf3bd21a1cdfc2b97f82053955c1e57ec"}, "2": {"node_id": "beebd843-d8bd-4fd8-9476-662122f8326e", "node_type": null, "metadata": {"page_label": "9", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}, "hash": "d3806b17b081a4f26c79d9874abd4fa39da7e26a7ff1cb1a82b45512cdec0356"}}, "hash": "c7e3879706fe2a1b72e9dff7355b233de0f07124bd9b3496e4de9b8c6e3aca4e", "text": "A 20- ml aliquot was injected on an Agilent\n1200 HPLC with ultraviolet detection at 212 nm. An Supelco Discovery C 8column\n(4.6 mm 3100 mm 35.0mm; Supelco) equipped with the appropriate guard col-\numn (4.0 mm 320.0 mm; Supelco) was used for separation, with the following\ngradient at a flow rate of 1 ml min21(channel A: water plus 0.1% formic acid;\nchannel B: methanol plus 0.1% formic acid): 0\u20130.5 min 70% B, gradually increased\nto 97% B from 0.5 to 6.7 min, held at 97% B until 7 min, decreased to 70% B from 7\nto 7.5 min, and re-equilibrated to 70% B from 7.5 to 9.5 min. The column was held\nat 25 uC during the separation. Under these conditions, artemisinic acid was found\nto elute at 6.3 min. AA peak areas were converted to concentrations from external\nstandard calibrations of authentic compounds.\nFinal titre measurement. A 20-ml aliquot was injected on an Agilent 1200 HPLC\nwith ultraviolet detection at 212 nm. An Agilent Eclipse XDB-C 18column (4.6 mm\n3100 mm 33.5mm, Agilent) equipped with the appropriate guard column\n(4.6 mm 312.5 mm 35mm, Agilent) was used for separation, with the following\ngradient at a flow rate of 1 ml min21(channel A: water plus 0.1% formic acid;\nchannel B: acetonitrile plus 0.1% formic acid): 0\u201310 min 50% B, gradually\nincreased to 100% B from 10 to 21 min, held at 100% B until 26 min, decreased\nto 50% B from 26 to 26.1 min, and re-equilibrated to 50% B from 26.1 to 31 min.\nThe column was held at 45 uC during the separation. Under these conditions,\nartemisinic acid was found to elute at 15.54 min. AA peak areas were converted\nto concentrations from external standard calibrations of authentic compounds.\n26. Polichuk, D. R., Zhang, Y., Reed, D. W., Schmidt, J. F. & Covello, P. S. A glandular\ntrichome-specific monoterpene alcohol dehydrogenase from Artemisia annua .\nPhytochemistry 71,1264\u20131269 (2010).\n27. Zhang, Y. et al.The molecular cloning of artemisinic aldehyde D11(13) reductase\nand its role in glandular trichome-dependent biosynthesis of artemisinin in\nArtemisia annua .J. Biol. Chem. 283, 21501\u201321508 (2008).\n28. Graham, I. A. et al. The genetic map of Artemisia annua L. identifies loci affecting\nyield of the antimalarial drug artemisinin. Science 327, 328\u2013331 (2010).\n29. van Hoek, P., de Hulster, E., van Dijken, J. P. & Pronk, J. T. Fermentative capacity in\nhigh-cell-density fed-batch cultures of baker\u2019s yeast. Biotechnol. Bioeng. 68,\n517\u2013523 (2000).RESEARCH LETTER\nMacmillan Publishers Limited. All rights reserved \u00a9201 3", "start_char_idx": 3274, "end_char_idx": 5763, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0a9fee56-a758-44ff-ade0-b89d8bd83863": {"__data__": {"id_": "0a9fee56-a758-44ff-ade0-b89d8bd83863", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "564be214-2fe9-4681-84be-93f26b887790", "node_type": null, "metadata": {}, "hash": "f0971494f866f05377a25d01cab5640df97af2df17f57af403a13739f1cabf04"}, "3": {"node_id": "6b106609-5372-4d2a-a375-d0dc224cf81e", "node_type": null, "metadata": {}, "hash": "dc4522a6dd639eab2c2da1bd9511f254b1050fe704454b16265bbc5be6882ba4"}}, "hash": "57c2390847b6cfe9c00d1a57aacedc0037a8ac1a1011b9ec7c177cb1c3768abc", "text": "The Perils and Promises of Gene-Drive Technology\n\nBy Michael Specter\n\nJune 10, 2016\n\nGene-drive technology may help eradicate malaria and other serious diseases. But is it worth the risk?\n\nWhat if, with a wave of the wand, we could eliminate some of the world\u2019s most devastating causes of illness and death? First, we might fight over which of our many maladies causes the most harm. Cardiovascular disease kills more people every year than any other, but it almost always develops over a lifetime: heart attacks may be sudden, but their causes are not. H.I.V./aids is another worthy candidate; it claims more than a million lives each year, and nearly forty million people are currently infected.\n\nBut my vote would go to malaria. Despite progress in reducing infections and deaths over the past decade, malaria still kills as many as half a million people a year, most of whom are under the age of five. They are invariably the poorest people in the world. Nearly two hundred million people become infected every year, and almost half of the planet\u2019s population lives in areas in which the anopheles mosquito, malaria\u2019s carrier, thrives. The global economic burden of the disease\u2014including the impact on impoverished families from time lost at work, at school, and on the farm\u2014is, as it has always been, nearly incalculable.\n\nThe magic wand is now within reach. It is called a gene drive, and it works by overriding the traditional rules of genetic inheritance. Normally, the progeny of any sexually reproductive organism receives half its genome from each parent. For decades, however, biologists have been aware that some genetic elements are \u201cselfish\u201d: evolution has bestowed on them a better-than-fifty-per-cent chance of being inherited. But, until scientists began to work with crispr, which permits DNA to be edited with uncanny ease and accuracy, they lacked the tools to make those changes.\n\nThen the evolutionary biologist Kevin Esvelt, who runs the Sculpting Evolution Group at M.I.T.\u2019s Media Lab, realized that, by attaching a gene drive to a desired DNA sequence with crispr, you could permanently alter the genetic destiny of a species. That\u2019s because, with crispr, a change made on one chromosome would copy itself in every successive generation, so that nearly all descendants would inherit the change. A mutation that blocked the parasite responsible for malaria, for instance, could be engineered into a mosquito and passed down every time it reproduced. Within a year or two, none of the original mosquito\u2019s offspring would be able to transmit the infection. And if gene drives work for malaria they ought to work for other mosquito-borne diseases, such as dengue, yellow fever, and Zika.\n\nThis is tremendously promising news, but nothing so powerful comes without risk\u2014and there has never been a more powerful biological tool. Esvelt hopes to use the very power of gene-drive technology as a lever to force scientists to make their work more accessible than it has ever been. It should be possible to eliminate a variety of illnesses: editing white-footed mice, for example, so that they are resistant to tick bites or the pathogen that causes Lyme disease would make them incapable of passing the infection along to us (or other species). And, by vanquishing invasive species and saving those that are endangered, gene drives could alter entire ecosystems.\n\nAs a worthy, if somewhat tepid, report released this week by the National Academies of Sciences, Engineering, and Medicine stresses, research needs to move forward, but deliberately and openly. Communities that could be affected\u2014and, eventually, that would include us all\u2014need to be engaged before experiments are designed, or even seriously contemplated.\n\nPretty soon, we are going to have to make some of the most pressing decisions we have ever made about how, whether, and when to deploy a new technology. The science and some of the researchers", "start_char_idx": 0, "end_char_idx": 3930, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6b106609-5372-4d2a-a375-d0dc224cf81e": {"__data__": {"id_": "6b106609-5372-4d2a-a375-d0dc224cf81e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "564be214-2fe9-4681-84be-93f26b887790", "node_type": null, "metadata": {}, "hash": "f0971494f866f05377a25d01cab5640df97af2df17f57af403a13739f1cabf04"}, "2": {"node_id": "0a9fee56-a758-44ff-ade0-b89d8bd83863", "node_type": null, "metadata": {}, "hash": "57c2390847b6cfe9c00d1a57aacedc0037a8ac1a1011b9ec7c177cb1c3768abc"}}, "hash": "dc4522a6dd639eab2c2da1bd9511f254b1050fe704454b16265bbc5be6882ba4", "text": "and when to deploy a new technology. The science and some of the researchers may be ready, but society clearly is not, and these decisions are far too consequential to be left to scientists alone. Once released from the laboratory, an engineered organism might be difficult to contain in the wild. Its new genes might have unintended consequences. People who express fears over G.M.O. crops often worry about what might happen if the modified genes spread throughout the environment, to other organisms. This has proved to be a baseless concern, but altering the environment would be the entire purpose of introducing a gene drive. Why else use one?\n\nThe pioneering geneticist George Church, who has joint appointments at Harvard Medical School and M.I.T., and was Esvelt\u2019s mentor, has told me that he considers it essential to design reversal mechanisms for any gene drive. If you can edit genes, you ought to be able to restore them to their original condition.\n\nThis is not a trivial matter, and I have not encountered a single scientist who fails to understand the stakes. Fear of new or altered technologies is common. People were reluctant to get into elevators when operators began to be superfluous. Driverless cars will present similar anxieties. Gene drives, too, have many people worried, and not without reason. Until we do it, we simply cannot know the full impact of releasing a mosquito that is unable to carry the parasite that causes malaria. By the time we realize the consequences, it could be too late to turn back. Organisms do not always behave in the wild the way they do in the perfectly controlled environment of a laboratory.\n\nIn the case of gene drives, the fear is warranted\u2014but we also need to contemplate the horrific cost of doing nothing. Malaria, dengue, yellow fever, and now Zika, among other vector-borne diseases, are responsible for untold suffering. Tens of millions of lives have been destroyed by a mosquito bite. What are we willing to risk to make that stop?", "start_char_idx": 3854, "end_char_idx": 5855, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ea066f63-8af9-43e5-968e-0e4212d94a71": {"__data__": {"id_": "ea066f63-8af9-43e5-968e-0e4212d94a71", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a07c1f81-e112-4d24-b379-3173bda1f275", "node_type": null, "metadata": {}, "hash": "354846497d492d9f6c60e545d68843f3dfe32d0996d394baedce2c7a913c0919"}, "3": {"node_id": "45a5b192-fb73-4765-81e0-46ee07af9845", "node_type": null, "metadata": {}, "hash": "75d89a97bbfced90901adeadde731ab4852642b4f86a9f148d0635a34fc4e2fb"}}, "hash": "e277dc4107b1c9dfba02a2b3379ce949acae9e0f86e7fcdbe14ff06d8a9be8ee", "text": "WEEK 2 MONDAY LECTURE 4\n\nIs everyone in here? Hi, everyone. Okay, welcome back to Introduction to Bioengineering. Happy Monday. I hope you all had a restful and relaxing weekend. \n\nWelcome everybody, hope you're well this Monday and or maybe Tuesday, depending on where you are. So we'll get right into it. I'm gonna start by sharing screen and push some slides for a little bit, then we'll have a chat-based discussion and two breakouts today. So let's get right into it.\n\nAnd, stretchy limbs, John, does that look okay to you? It does indeed. Thanks so much.\n\nOkay, day three. So just to give you sort of a template to keep track of things, looking back at last week, we answered questions relating to two concepts and one skill. Why engineer biology? Well, we've got a generation of biotech. It's a planetary scale, natural nanotech, and it's no longer looking to be constrained by photosynthesis. So just an amazing capacity to make stuff and do things. Other concept from last week, what makes living matter unique? We talked about the uniqueness of the physics of living matter. We talked about the uniqueness of the challenges and opportunities associated with bioengineering, biology. We talked about the uniqueness of our time, the surprise or not of a pandemic, the pace of change. The skill from last week, because bioengineering is a frontier discipline in engineering, was how to read a research paper, how to read the primary literature. And there's a little bit of a misnaming there. Actually didn't teach you how to read, we taught you how to triage at every step, hunt for the claim in the abstract, hunt for the evidence. So we will give you after action summaries like this for each week, it should match the syllabus. So we're going forward and backwards, but just want to give you a waypoint so you can remember where we're picking up from. And each week we'll have one or more concepts and a skill that we wish for you to put in your toolbox, so to speak.\n\nSo here's week two. And we're putting this early in the quarter because of the concepts. We wish for you to, by the end of this week, be thinking about bioengineering being used for different purposes. For people, directly people health. For the planet, for the environment, for ecosystems, call that planet health. And then how it all connects together, culture, politics, society. What do bioengineers have to do with that? So this week we're going to introduce three concepts around people health, planet health, political health, and we'll focus on people health today. But hopefully we're all very excited and curious about your ability to find the connections between these three dimensions of bioengineering application. The tools for this week are the framing of puzzles and the discovery of connections. So we're going to name those tools, borrowing from the d.school, Framestorming, and Future Wheel. That's a little bit of a teaser looking ahead for the week. So I want to get right into it. Here's the front page of the national paper from France today, and looks like the confinement is being prolonged for about another month over in France. So that means all the shelter in place orders and so on, if I'm reading the newspaper correctly, are being extended in France for another month or so, and we'll see what happens due to COVID-19. So obviously we can, within the class, reflect this back immediately and say, well, what do bioengineers do in terms of people health? And here's the frontline website for the bioengineering department at Stanford. If you ever wish to know what bioengineers are doing, you could just go to the website and see what they say they're doing. So what I'd like to do is pop out of this deck and go into.\n\nThis website live.\n\nJohn, is this still sharing?\n\nCan you unmute? Yes, it is. We have the bioengineering website in the middle of your screen on Maximized.\n\nGreat.\n\nSo, I'm just going to see what the bioengineers are doing. And what I'm getting here is it looks like there's a bunch of projects around preventing COVID-19, about", "start_char_idx": 0, "end_char_idx": 4058, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "45a5b192-fb73-4765-81e0-46ee07af9845": {"__data__": {"id_": "45a5b192-fb73-4765-81e0-46ee07af9845", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a07c1f81-e112-4d24-b379-3173bda1f275", "node_type": null, "metadata": {}, "hash": "354846497d492d9f6c60e545d68843f3dfe32d0996d394baedce2c7a913c0919"}, "2": {"node_id": "ea066f63-8af9-43e5-968e-0e4212d94a71", "node_type": null, "metadata": {}, "hash": "e277dc4107b1c9dfba02a2b3379ce949acae9e0f86e7fcdbe14ff06d8a9be8ee"}, "3": {"node_id": "2486d01e-60e9-4a64-b240-cb67eeed7690", "node_type": null, "metadata": {}, "hash": "07286133d3505232f84d16770ffaa3543db0f49219393cd9249ab31c7b60fce4"}}, "hash": "75d89a97bbfced90901adeadde731ab4852642b4f86a9f148d0635a34fc4e2fb", "text": "looks like there's a bunch of projects around preventing COVID-19, about diagnosing COVID-19, about treating COVID-19, and about talking about doing all of this. So what does it look like if we go into prevention?\n\nCotton candy machine for distributed manufacturing\n\nof N95 masks, remote control ventilator project. Reusable snorkel mask. Off-the-shelf ventilator. So if I click one of these, I see a whole bunch of text, and if I click one more, I'll go to a website that is from Manu Prakash's lab, Manu's a colleague in bioengineering, and you've got this thing called the new mask. And maybe you've seen something like this coming out of Italy as well. They're basically taking a snorkel mask and using 3D printing and off-the-shelf componentry to put filtration over a snorkel mask such that you have a type of face shield for a healthcare worker. Okay.\n\nVentilator remote control, genetic methods for eliminating the virus.\n\nSo these are all prevention. I'll pop into here.\n\nSerological testing for immunity.\n\nWhat is that about? at the bottom. And until basically what it says is until there's a widely available vaccine testing whether or not somebody is immune to COVID is going to be one of the best tools for public health. All right. So, there are a bunch of people working on that. That's diagnosis. So, we've done prevention, diagnosis. Let's see if there's anything under treatment. Lots of things here. So computational screens identify drug candidates to treat COVID. What's happening here is biocomputational experts are looking at the entire collection of drugs that are safe to give people. So they're already pre-approved to be safe for people. Now trying to use machine learning and other tools to figure out whether or not any of these drugs might target any of the steps in covid replication or so forth.\n\nUse CRISPR to eliminate covid.\n\nSo CRISPR is a tool for cutting DNA. If you could target the DNA cutting machinery to the covid genome, then maybe you could cut covered wherever it is. And so this is from Stanley Key and colleagues with a lot of work by heroic students to try and use this DNA cutting tool as a possible future treatment against both coronavirus infection, but in this case, flu infection. All right, let me back up. So, one of the things that's fairly amazing is pretty fast, it looks to me like half the department has deployed its skills in a lot of collaborations to figure out how to prevent COVID, how to diagnose COVID, how to treat COVID, and how to enable other people to do similar things. So that's amazing, actually. And I'd feel much still less comfortable than I do already if I didn't know about all these things. So I want to, though, ask you a question, because I think you can help me figure out something that's bothering me about all of this. So let me just go back to here. bothering me about all of this. So let me just go back to here.\n\nSo if you parse that tour and can remember, you know, test your recall, what do all of these examples of bioengineers\n\nworking on the topic of COVID-19 to help people and people's health have in common? What's, what's, what's, what's, what's like, what do we got? Diagnosis, prevention, treatment, all these detailed examples. So can anybody, just please think about it. And if you have any idea, please put it in the chat to everybody. What are, what are all these examples we just went through? What do they have in common? If anything, at a high level and as a hint, are there things in these examples that seem to be missing? So time manipulation, lacking implementation strategies, focusing on science, not implementation. Keep, yep, great. Anything else? Unlimited powers, only targeting one part of the problem. Unlimited powers, could you jump in and say a little bit more about what you're thinking, please?\n\nI was just thinking that it seems like they're all super specific and all super focused on one", "start_char_idx": 3997, "end_char_idx": 7916, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2486d01e-60e9-4a64-b240-cb67eeed7690": {"__data__": {"id_": "2486d01e-60e9-4a64-b240-cb67eeed7690", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a07c1f81-e112-4d24-b379-3173bda1f275", "node_type": null, "metadata": {}, "hash": "354846497d492d9f6c60e545d68843f3dfe32d0996d394baedce2c7a913c0919"}, "2": {"node_id": "45a5b192-fb73-4765-81e0-46ee07af9845", "node_type": null, "metadata": {}, "hash": "75d89a97bbfced90901adeadde731ab4852642b4f86a9f148d0635a34fc4e2fb"}, "3": {"node_id": "84cad516-4adb-45aa-9ce0-d241ed187470", "node_type": null, "metadata": {}, "hash": "8270d5f7c856d5da743dde0fecf5682619fed0dd8dc75610e0607354b5c9059f"}}, "hash": "07286133d3505232f84d16770ffaa3543db0f49219393cd9249ab31c7b60fce4", "text": "was just thinking that it seems like they're all super specific and all super focused on one aspect of COVID, whether that's trying to prevent the transmission from one person to another, trying to prevent infection within a cell, or after that, maybe trying to limit symptoms. And I don't think there's any answer to that, but it is interesting that you can't find something that just works at any stage. So you have to get that specific to really solve the problem.\n\nYeah, thank you. The plan for implementation and whatnot\n\nand the socioeconomic backing, I don't know which time manipulation it is, but time manipulation who added into the chat socio-economic backing, RN. Does that mean right now? Or could you say a little bit more about that?\n\nYeah, it does mean right now. And just kind of that because we're like all trying to mobilize really fast for this one thing, we're able to throw a lot of resources at it\n\nand a lot of energy. I\n\ndidn't do a perfect job giving you the tour, and in part that's because there's probably limited information on the website. But those projects, as described, are directly coupled in to what's scaling within UCSF hospitals, Stanford hospitals, the San Francisco Peninsula, the. The project, I'll just, I'll share one thing real quick. Sorry, just to give a sense of it. Like, you go. You see the standards working group. Coronavirus Standards Working Group, this is led by a colleague in bioengineering and at SLAC, the National Lab, and it's an ad hoc working group of about 100 organizations, companies and governments all over the world working to develop standard materials so that you could calibrate testing and everything needed to do any of the work in a way that supports reliability, scaling, repeatability. So I didn't do a great job in my initial tour, but there's a tremendous amount of applied translation baked into some of these activities, more than I would take for granted. Portal for students to help. That's pretty interesting. How many people, can you just raise your hand if you feel like you're disconnected and not in a position to help out with doing anything that needs doing right now?\n\nYeah, let me just see.\n\nI'm sorry if you're on the phone only. You can raise your hand in the participant thing. Yeah, I put, can I just make a comment about that?\n\nI don't know if that's something like that exists and I just haven't found it. But do you think that that would be even a feasible idea? Because obviously there's a lot of like reliability issues and maybe trying to train students while working on the issue ends up being not the best use of time. But do you think that that is something feasible that,\n\nwhether it's the bioengineering department or other departments, that there is a place for\n\nstudents to help? So let me, that's a great question. Thank you. If I take the standards working group as a benchmark, they're doing that work not to solve any problem today, because there's nothing they're going to get done today or tomorrow. The soonest they'll ship a product that would support global coordination of better and more reliable testing is about 10 weeks out. So call that June. So the reason they're doing the work in part is to get to a better June and beyond, because COVID is going to matter in June and it's going to matter in October and it's going to matter in June of 2021 somewhere. Maybe not at Stanford as much as it does now, but who knows? So this is not a totally goes away super fast situation. The other reason they're doing that work is to learn how to do such work such that the next time we have a pandemic, it doesn't take six months to figure out how to get the cooperation globally. It takes six hours or six days because the mechanic is pre-baked. And Flying just made a great comment there again, linking back to your question, manipulate time. Think about how it's going to play out in a refugee camp, right? Or think about how it's going to play out somewhere else. Right. And and it's not it's just daunting, be the simple thing to say. So what I'm what I'm seeing manipulate time in answer to your question is most", "start_char_idx": 7903, "end_char_idx": 12034, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "84cad516-4adb-45aa-9ce0-d241ed187470": {"__data__": {"id_": "84cad516-4adb-45aa-9ce0-d241ed187470", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a07c1f81-e112-4d24-b379-3173bda1f275", "node_type": null, "metadata": {}, "hash": "354846497d492d9f6c60e545d68843f3dfe32d0996d394baedce2c7a913c0919"}, "2": {"node_id": "2486d01e-60e9-4a64-b240-cb67eeed7690", "node_type": null, "metadata": {}, "hash": "07286133d3505232f84d16770ffaa3543db0f49219393cd9249ab31c7b60fce4"}, "3": {"node_id": "0c6ab53d-cabd-4b4d-b7e8-ba6ffe96aee7", "node_type": null, "metadata": {}, "hash": "f8f5de6f77f137509357865283e7f3b6a569bff7ea995abac7e56c15649acee5"}}, "hash": "8270d5f7c856d5da743dde0fecf5682619fed0dd8dc75610e0607354b5c9059f", "text": "So what I'm what I'm seeing manipulate time in answer to your question is most people who are in positions of organizing people to do stuff are bandwidth limited and don't have additional bandwidth to organize people to do stuff. So in my lab, for example, with the PhD students, I would say about a third of them have now retasked what they're doing to do covid related stuff of their own initiative. And there's significant work taking place, but it's it's self-organized in a way. So my reflected question back to you would be and to everybody in the class, to the extent that it would be important or useful to you to contribute to the doing of something in the here and now, what would be the best mechanic by which to do that? And Sivash, the quiz that's open for this week, can we add a third question to it? That's a bonus question that would just simply be picking up on this, we'll get the words exactly right, but effectively, if you would like to contribute to something, by what mechanic would it be best to be organized to do that from your perspective? Okay, there's a lot more to talk about here\n\nand I know it's a very powerful topic\n\nand it's tricky to use it in class because it's so overwhelming. But I want to keep going because I want to try and illustrate something that didn't come up in the chat. All right. So let's try that.\n\nAnd I want to give you an example that's outside of bioengineering. So this is an example of the Cuyahoga River\n\nin the United States that in the 20th century would catch on fire. Rivers usually don't burn. Rivers of water usually don't burn. But post-industrialization, this river, the Cuyahoga, caught on fire a dozen or more times. And you can see the pictures of how they react to the fire. They put out the fire, the waterfront burns down, the wharf burns down, and so on. So this is an example from pollution control and environmental engineering. And I'm going to use this to introduce one of the skills for this week, which is to come up with ideas via spontaneous group discussion, and we'll come back to that. But before you brainstorm, really want to focus your attention on this word called framestorm. And this comes from a colleague, Tina Selig. The takeaway is basically, the question you ask will frame the answers you get. I'll give you a simple example, and then we'll practice this. If I said, okay, let's plan a birthday party for Mary, go brainstorm. I'm sure you'd do a great job planning a wonderful birthday party for Mary. But if I ask you a different question or task, let's plan something that Mary would enjoy. Maybe it would be a birthday party, maybe it would be something else. So the question you ask frames the answers you get. Implicit in the COVID experience is a question, what do we do about COVID? And it's an overwhelming question, but it's not the only question we can ask. So I'm going to come back to this. So let me come back to it through this example of pollution. The first engineering strategy for pollution is to ignore the pollution. This is called dilution solves pollution. And not that long ago, for most people, because there weren't that many people on Earth, less than a billion people on Earth just a few generations ago, you could ignore most pollution because the Earth was so much bigger than the pollution. That's a viable strategy.\n\nIf that doesn't, so the question would be,\n\nhow can we ignore pollution? Now you just ignore it. But then the next question would be, well, how do we react to pollution? The oil on top of the river that's causing the fire or providing the fuel for the fire. Well, we put out the fire. Or we could react better, like we'll buy a fire boat or a fire truck. Or how can we get even better at reacting? Maybe we'll capture the oil before it gets in the waterway and we'll treat it. So there's a whole other category of questions you could ask. Instead of ignoring the problem, you could say, how do we react to the problem or how do we get better at reacting to the problem? And when you look at COVID, we're operating in these two", "start_char_idx": 12047, "end_char_idx": 16120, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0c6ab53d-cabd-4b4d-b7e8-ba6ffe96aee7": {"__data__": {"id_": "0c6ab53d-cabd-4b4d-b7e8-ba6ffe96aee7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a07c1f81-e112-4d24-b379-3173bda1f275", "node_type": null, "metadata": {}, "hash": "354846497d492d9f6c60e545d68843f3dfe32d0996d394baedce2c7a913c0919"}, "2": {"node_id": "84cad516-4adb-45aa-9ce0-d241ed187470", "node_type": null, "metadata": {}, "hash": "8270d5f7c856d5da743dde0fecf5682619fed0dd8dc75610e0607354b5c9059f"}, "3": {"node_id": "5edf3f53-8c1a-484d-9172-b7f4f482fa4a", "node_type": null, "metadata": {}, "hash": "45c9febad4210fae65c33ef819cf1f9dc14fd70973f49d9f47c0963a70b2245a"}}, "hash": "f8f5de6f77f137509357865283e7f3b6a569bff7ea995abac7e56c15649acee5", "text": "to the problem? And when you look at COVID, we're operating in these two regimes mostly, these two frames, if that makes sense. We're either acting in the, we're ignoring it frame or not so much anymore. Now we're in the reacting frame, we're trying to put out the fire.\n\nBut it also could prevent it.\n\nYou could prevent the fires. You could, could you prevent a pandemic? Maybe you could change the environment.\n\nAll right.\n\nLike the spare the air days for air pollution in San Francisco is an example of that. Maybe you could change the system inputs and that would prevent the problem in pollution, right? I go from leaded gas to unleaded gas. Maybe I could change the system. Refrigeration without chlorofluorocarbons, changing the system of refrigeration, solve the ozone problem. So it's very interesting to me about the solutions bioengineers are taking to address COVID, is they all seem to be in this orange category of reaction.\n\nIt's asking the question,\n\nhow do we get better at reacting to a pandemic. So, what I'd like you to do, if I can ask the class to set up into breakouts, is take this frame of reference set of options and see if you can fill in the blanks. All right? Bioengineering approaches to ignoring COVID or changing the system, changing the human. How could you change a human to prevent COVID? prevent covid. More specifically, when we go into breakout in a few seconds, see with your group if you can fill in all the blanks or ignore, react, prevent and then wildcard. Could you come up with a totally different strategy, a totally different category of strategy? So with that, if I could ask, we head into breakouts and try and tackle those questions.\n\nWell, so we're now gonna break up into groups of five or six people. We're gonna talk about brainstorming in the sense of COVID. So I'm gonna put everyone in breakout rooms and whoever has an alphabetical order of your first name, that person can go first. Okay.\n\nCelia. All right. Anyone else? You're getting the 1st 1 was like, right? And I think like. that case it's pretty straightforward. That would just be like not doing anything about the virus and just hoping that people will naturally develop an immunity or like already have that.\n\nThere was a lot of examples in reacting. So I feel like I feel, you know, like better ventilators, better diagnostics, better personal protective equipment. So I don't know if that came across to you or not, but that one I felt pretty comfortable with, the reactive part, like an outbreak happens and we'll react and we can try and get better at reacting, but I'm not sure if you would agree with that. Does that one seem filled out to you?\n\nSo, it's ignore, react, prevent, and getting better at reaction and prevention.\n\nIn terms of preventing, we could also say, for like changing the environment, that could be like cleaning surfaces and those kind of things as soon as it kind of dies down and going back through and cleaning surfaces and buildings and things like that to help prevent a further outbreak or continuing from how it's been.\n\nWhy would you put something like distancing? The fact that we have to have class via Zoom. What is that? I think that's a reaction to like slow the spread. Not necessarily, I wouldn't say it's a prevention.\n\nYeah, I think it's also a reaction because these are measures that were implemented after we realized that, you know, it came after there was the first couple of cases in Santa Clara County. And so in response to the first few cases already appearing, we're reacting by implementing these measures. It's interesting, it is a reaction, but it seems like it's a change in the environment, right?\n\nWe're changing the environment that the virus is encountering such that it's harder to transmit. Would the prevention be the prevention of like me myself getting sick or would it be like preventing a pandemic in the future? That's good.\n\nWhat do you think?\n\nI mean, I think I was considering it more as in like preventing", "start_char_idx": 16126, "end_char_idx": 20125, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5edf3f53-8c1a-484d-9172-b7f4f482fa4a": {"__data__": {"id_": "5edf3f53-8c1a-484d-9172-b7f4f482fa4a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a07c1f81-e112-4d24-b379-3173bda1f275", "node_type": null, "metadata": {}, "hash": "354846497d492d9f6c60e545d68843f3dfe32d0996d394baedce2c7a913c0919"}, "2": {"node_id": "0c6ab53d-cabd-4b4d-b7e8-ba6ffe96aee7", "node_type": null, "metadata": {}, "hash": "f8f5de6f77f137509357865283e7f3b6a569bff7ea995abac7e56c15649acee5"}, "3": {"node_id": "6f69f89c-9cd8-4aaf-a35d-5de457acae66", "node_type": null, "metadata": {}, "hash": "6434599eff20ce6d49eaf95500741e02e11a71df026fbd8fb81b9d6a42b9351c"}}, "hash": "45c9febad4210fae65c33ef819cf1f9dc14fd70973f49d9f47c0963a70b2245a", "text": "mean, I think I was considering it more as in like preventing future pandemics. But I guess you could consider it either.\n\nYes, so you could have a vaccine to cove it right. And that might help. Or you could have an ability to make vaccines instantaneously for anything. Yeah, I guess it's not necessarily doing anything to COVID specifically, it's like, more about symptoms or like, I guess kind of because like, if you get better, like, that means it's gone and my feet are out and my body's whatever, but like, I guess I'm wondering, like, where would treatment come?\n\nI would put it under reacting better with better medicines. So you can you can react in nature. You could react outside of nature in the hospital. So medicines, I think, would be better reaction. I also know Stanford has developed a bunch of different tests.\n\nI think most recently they have went at this new antibody test. I was wondering which category does that fall under? Diagnostics. Testing and diagnostics are synonymous. So I would put it under better reaction.\n\nWhat does ignoring look like in this case? Pandemic runs its course. Oh, OK. Just like doing nothing.\n\nSo, a lot of interesting comments here. One that I think is interesting is changing the environment to basically reduce the risk of pandemics. I know there's a lot of discussion about how climate change is influencing all of this. So something to think about from a bioengineering perspective. Teleportation says there's an interesting debate about whether social distancing A lot of people are talking about vaccines. One interesting frame of reference, so changing the animal genes that spread the pandemic. So fundamentally kind of altering the way that the disease is spread. Of course, you could think about how that might help or might harm if things go wrong.\n\nI wanna pick up on something that's coming in a couple different ways.\n\nIgnore it, let it spread till it dies out naturally, call the herd, embrace adaptive immunity approach. It's a valid strategy. One of the puzzles that we'll get to on Friday regarding this is the connectedness between biological reality and political expectation. So, for example, the Black Death, the plague in Europe centuries ago killed about one third of the population of Europe. There's more people in Europe today than there were back then. So, from a biological perspective, the species, the human, totally fine. But culturally, if I had to guess, I'm pretty sure everybody here has heard the words black death or plague, right? Because culturally and politically, that experience had a massive imprint on our history. So to abstract that, there's this big puzzle, which is how does one reconcile the reality of survival of the fittest in nature with the expectations of representative democracies that are meaning to protect individuals? And so I actually don't think you can reconcile that fundamentally, but hence the tension. So just note the connectedness there, and we'll get to that on Friday. Other things showing up in the chat you want to highlight? I'm seeing a lot of people talking about how we can change the environment.\n\nSo again, whether it be decreasing the risk of new pandemics from emerging, changing the genes of COVID itself.\n\nI also think there's a pretty strong strain of let's change the animals who give us the virus. What can we do about that? There must be something we can do about that. We can rewrite their genes. We can get rid of bats. We can make bats our friends. Bats our friends. Batman. Batman and Batwoman. Okay. Humanize the bats.\n\nDid anybody say anything about changing the people? Couldn't we, like, engineer the human genome to not be infected by this thing? Wouldn't that be useful?\n\nMy team said that. First they said, let's make bats our friends. Then they said, let's make us the friends of the bats.\n\nI see.\n\nOkay. This is great. I'm glad we have stretched a little bit and have a framework now to think about engineering approaches to anything. We use pollution as an example, we use COVID as an example. I wanna bring it back to people health and I'll transition by doing my", "start_char_idx": 20135, "end_char_idx": 24256, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6f69f89c-9cd8-4aaf-a35d-5de457acae66": {"__data__": {"id_": "6f69f89c-9cd8-4aaf-a35d-5de457acae66", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a07c1f81-e112-4d24-b379-3173bda1f275", "node_type": null, "metadata": {}, "hash": "354846497d492d9f6c60e545d68843f3dfe32d0996d394baedce2c7a913c0919"}, "2": {"node_id": "5edf3f53-8c1a-484d-9172-b7f4f482fa4a", "node_type": null, "metadata": {}, "hash": "45c9febad4210fae65c33ef819cf1f9dc14fd70973f49d9f47c0963a70b2245a"}, "3": {"node_id": "8a2fb072-28cd-4006-9676-89a8eb8434bb", "node_type": null, "metadata": {}, "hash": "73fe6179eb38d3f61389e19a1e3dbc8cfd6f13325321b953667e55320d601e1a"}}, "hash": "6434599eff20ce6d49eaf95500741e02e11a71df026fbd8fb81b9d6a42b9351c", "text": "an example. I wanna bring it back to people health and I'll transition by doing my best to share what I could come up with, what I see. So here's how, when I filled in the blanks, ignore is you let the pandemic run its course, you call the herd, react, better urgent care, ICU's ventilators, excuse me, whatever you got, better reaction, be better diagnosis, you could deploy them in situ, ex-situ means in the hospital or somewhere else, so more better PPE, better medicines. I scored social distancing as reacting to the event, but you're changing the environment. So changing the environment for the virus, change inputs to the virus, the patient, the possible host would be a vaccine. And then what Michael and I were just talking about, could you change the human itself or the bats, you change the system, you do germline engineering, not without controversy. Here's a bonus topic. And again, recall one of the fourth, the fourth goal we have for the quarter is you developing action plans in your projects for the quarter. So, here's a wild card. What would we need to do to make all infectious diseases obsolete? And how about we go do that? So that we're never surprised by an infectious disease ever again. Is that right, John? What do we want to call it? We want to call this avoiding Sputnik in biology. OK, so no more no more surprise in epidemiology. No more no more surprise pandemics, please. So I'm trying to get I'm just trying to nudge people a little bit out of the mindset. Well, let's just wait for the next one and we'll get better at reacting because that's like a bad strategy. It's like qualitatively bad strategy. So maybe there's some projects to think about on this wildcard. All right.\n\nTake a breath.\n\nIn the pre-class for today, you got a whole bunch of data and some examples, and I just want to acknowledge that and now zoom out and highlight an aspect of it. So not that long ago, people didn't really pay attention to what killed people. But within the last several hundred years, we've started to do more than ignore what's going on systematically. And so you can see the data for Boston, for example, just over 200 years ago for causes of death in the year 1812. You can see the trends between 1900 and 2010 for causes of death. So hopefully you took a look at this. It's numbers of death per year per 100,000 people, so that's gone down.\n\nI don't wanna belabor it, but the boxes are moving, and hopefully when you looked at this and you thought about some of the study questions, you lifted the lid on that. So I wanna pose some questions for a second breakout that we're gonna try and fit in, because we've got 10 minutes and this should fit in nicely. We'll do maybe four minutes and break out. If you go back to this trend line or trend plot, you can kind of get a sense of what's changing.\n\nAnd so if you wanted to be a bio engineer in the year 2030 or 2040, working on people's health, maybe you'll become a doctor, maybe you'll be a tool developer, maybe you'll be an entrepreneur, maybe you'll be a policy leader. How should you spend your life energy? What should you be working on? And do you follow these historical trends here? Does that give you some insight into what people and people's health will most demand in 10 years, 20 years? That's one question. So what should bioengineers focus on as related to people health? Drawing on your pre-class studying, but then drawing from today's experience. Is there something missing in this data?\n\nIs there some gap in the portfolio of opportunity that bioengineers need to see? It's a blind spot. And we don't we don't know to look for it because it's not giving a signal. So. So I want to pause there and ask for another breakout, please. And we'll pose the two questions in the chat. The questions, again, are based on the trends, what should bioengineers focus on? And is there something missing from the trends that if you wanted to prevent", "start_char_idx": 24240, "end_char_idx": 28181, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8a2fb072-28cd-4006-9676-89a8eb8434bb": {"__data__": {"id_": "8a2fb072-28cd-4006-9676-89a8eb8434bb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a07c1f81-e112-4d24-b379-3173bda1f275", "node_type": null, "metadata": {}, "hash": "354846497d492d9f6c60e545d68843f3dfe32d0996d394baedce2c7a913c0919"}, "2": {"node_id": "6f69f89c-9cd8-4aaf-a35d-5de457acae66", "node_type": null, "metadata": {}, "hash": "6434599eff20ce6d49eaf95500741e02e11a71df026fbd8fb81b9d6a42b9351c"}, "3": {"node_id": "a6f3cd15-fb77-4b97-9d4b-a5492ca8770c", "node_type": null, "metadata": {}, "hash": "b718c477f02660c16b231666918bf34105bd6cc7038e63b4408bc6c4a5502c5c"}}, "hash": "73fe6179eb38d3f61389e19a1e3dbc8cfd6f13325321b953667e55320d601e1a", "text": "on? And is there something missing from the trends that if you wanted to prevent surprise regarding people's health, we should start working on right now, so that we're not surprised when it shows up in five, 10, 15, 20 years.\n\nPhotographic memory, huh? Yeah, I think that'd be very, very helpful in terms of studying and also research reason. You don't have to worry about writing everything down your lab notebook anymore. Do you think photographic memory, does that come with infinite bandwidth? Meaning there's no latency in terms of recall? That's what I was hoping it would be. Okay, so it's photographic memory with infinite, no infinite no latency yeah yeah so that sort of becomes a form of teleportation or telekinesis because they're the information has to be stored somewhere so I wonder if that gets you telekinesis so it could be photographic memory is the ultimate superpower which I should telekinesis and then get you time travel\n\nThat would be amazing.\n\nIt was a good conversation. I think we were just getting going there. If you go back to the pre-class material for today and you look at those two plots, the 1900 plot and the 2010 plot, the biggest things in that 2010 plot are heart disease and cancer, right? And then a lot of other things that collectively are the remaining 40%.\n\nSo it's a little bit interesting how what's coming back in the chat is not matched to that, which is fine. Right, and it's the contrast at least to the last year, which was very focused on both cardiovascular health and cancer as well.\n\nDid anybody surface drug resistance, antibiotic resistance? If you go back and look 100 years ago or so, death to infectious disease is pretty high and gone away. Our group did talk about antibiotic resistance. How did it come up or why were you thinking about that?\n\nWe were just thinking about how, like the previous data circa 1900, how a lot of those diseases we've solved, quote unquote, with penicillin, et cetera, but now we're seeing that these diseases are mutating and adapting, and we're not necessarily adapting along with it in terms of our funding and our research. So those can become threats again.\n\nWould you consider resistance to be a gap then in the trend line that's not showing up in the bar chart?\n\nI don't think I would know enough to say that it's necessarily a gap, but I think that maybe some of the most vulnerable populations would be seeing this more so than the United States, and so who knows if that's being reported or not.\n\nAnybody come up with a I'm trying to call it out of the chat. Does anybody do any other group have a real strong theme around why we're just totally blind to this puzzle or need or challenge regarding people's health. I don't know if this is a correct interpretation, but in our group, we also talked a little bit about the food industry, and I think the common denominator with all of the health problems that were at the top of the list today, other than the lung issues, was related to things that people put in their body, like when you talk about heart disease and cancer, the food that you eat plays a huge role in that. And so it's interesting as to why we're not putting more energy into engineering our food, like how we grow it, how we can make healthier foods less expensive. And I think it's really interesting because we don't have to wait on any new technology to do that. I mean, like we have all the technology right now. So I think it's a matter of where the money is and also where, like who's doing the research.\n\nI totally agree with you. And I would add to that, the questions being asked that are used to tell stories that motivate people to be organized to do something is incredibly limiting. So let me pick that to wrap for today. And just gonna share a few slides back and one more slide. So, you've seen this plot, right? This is a clue for what the existing market is, so to speak, the conventional market for people's health in the West, which is not most people, but it's imperfect representation of reality. We've talked about how if you only look at an opportunity that's a crisis, like health, we have to react to", "start_char_idx": 28183, "end_char_idx": 32331, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a6f3cd15-fb77-4b97-9d4b-a5492ca8770c": {"__data__": {"id_": "a6f3cd15-fb77-4b97-9d4b-a5492ca8770c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a07c1f81-e112-4d24-b379-3173bda1f275", "node_type": null, "metadata": {}, "hash": "354846497d492d9f6c60e545d68843f3dfe32d0996d394baedce2c7a913c0919"}, "2": {"node_id": "8a2fb072-28cd-4006-9676-89a8eb8434bb", "node_type": null, "metadata": {}, "hash": "73fe6179eb38d3f61389e19a1e3dbc8cfd6f13325321b953667e55320d601e1a"}}, "hash": "b718c477f02660c16b231666918bf34105bd6cc7038e63b4408bc6c4a5502c5c", "text": "look at an opportunity that's a crisis, like health, we have to react to when things are bad, you're missing most of what you could do as an opportunity. And so we're introducing you and we'll come back to this idea of framestorming as a tool. So lots and lots of opportunity to contribute to people health, lots of opportunity to be amazing as a leader and a storyteller and as a doer by escaping conventional frames of reference that are just reactive at best. So here's the last slide just to share for today. It was part of today's reading. It has to do with malaria transmitted by a mosquito and how we have treatments for malaria, how we make those treatments can change through bioengineering practice, but the change in practice has connectedness to other things such as livelihoods, employment, supply chain reliability, emergence or not of drug resistance to the treatment, and so on and so on and so on and so on. And so hopefully you were able to build your knowledge base around malaria for today's class. And as we head into Wednesday, we'll be picking up on planetary health and the connectedness between people health and planet health, and that'll spill into Friday. Subhash, you want to give us an additional comment on this?\n\nYes. As we go next class, we will have the, an additional tool that talks about that, if we pick a solution, how would that solution have primary and secondary effects around that topic. And as you think about, like we focused on health today, but our wish is also added to having the content and the skills is to introduce you to these material early so that you begin to think about your project, your group project going forward.\n\nSo hopefully you've got people health in your mind and you've got the idea of frame of reference shift and framestorming. We'll do planet health and political health next and the next tool will be the future wheel that's Subhash is leading. John, do we have any announcements before we wrap up?", "start_char_idx": 32325, "end_char_idx": 34298, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b128157d-9f1a-4199-8dbd-4e4b35385ff8": {"__data__": {"id_": "b128157d-9f1a-4199-8dbd-4e4b35385ff8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "24d748fb-a338-4061-b032-0466ee6697e8", "node_type": null, "metadata": {}, "hash": "547a1c1d19073802813c98b4c62d330163dfcde31d47598e6e406693e4c3d4a8"}, "3": {"node_id": "8d0e1396-8165-431d-b0ac-2f58a0952892", "node_type": null, "metadata": {}, "hash": "9b515358b2f71f8762356bfad0edeb213696cd8bbb62ffec3c31a1add090284d"}}, "hash": "ae6dc3d26662aa913bc8e7b4588d659706def321ed56e5dd48d6134e21d25e87", "text": "WEEK 2 WEDNESDAY LECTURE 5\n\nWe're in the middle of Health Week, so we did People Health on Monday. We're going to do Planet Health today, and we'll do Political Health on Friday. And again, the reason we have this set up in the second week of class is to help you de-constrain yourself with respect to possibilities for your projects and what bioengineers might do. So we're going to do planet health today and the other thing we're going to do today is a skill very specific skill called the futures wheel. So that'll come after we do a tour of planet health reflecting on the readings. So what I'll do is I'll share and get right into it for today.\n\nCan you see this okay? Montana, can you see this slide?\n\nThank you so much, yeah, great. All right, so here's a nice plot. On Monday we're talking about people and people health, and this is a plot showing the number of people on the earth. Going back to 1700, you see there are a billion people in 1804, two billion people in 1920 and so on. And we're clipping towards eight billion people. 2024 is the estimate, and maybe nine billion around 2050. All right. And if you want to contextualize this, the engineering school at Stanford starts in 1925. So the engineering school is 95 years old. There's like one and a half, one and three quarters billion people. If you think about the California state flag with the bear, a wild grizzly bear was last seen in California in nature in 1924, 96 years ago. If you want to think about why Redwood City is called Redwood City, it was the place you would ship Redwood lumber for building structures. So that's not that long ago. If we think about the living things on Earth, on the planet besides the humans, so to speak, how are they doing? And a number of them are not doing so well. So this is a recent article, the last individual of a species of snail, which had been given the name George, died, so no more of that species. And if you zoom out and try and make sense of what's going on, there's a representation that there's very significant biodiversity loss that's playing out all over the Earth across every type of life form except for the human. So for example, drawing from this paper, since 1900, 69 mammal species extinct. 400 other types of vertebrate species extinct. Evidence for other types of animals going extinct is harder to come by, because they're not as big, they're not as charismatic, but no reason to think they're doing better. Why is this happening? but no reason to think they're doing better. Why is this happening? Change in habitat due to changes in how the land is being used by people. Species coming into new locations, so an invasive species disrupting a native ecosystem. Byproducts of industrialization, carbon dioxide. Changing ecosystems as well, changes in the pH, the acidity of the ocean and Then just pollution that we touched upon previously. Those are the four major reasons. They're citing Let me just give you examples of this as reminders and on ramps This is an oil palm plantation you change the jungle or forest to a monocrop culture Organisms that depend on living in the forest as their habitat aren't going to live as well with the same diversity in a monoculture. This is a snake that is invasive to the island of Guam. It lives up in the tree canopy of the jungles in Guam, in one example, and this snake will eat the native species, things like birds and reptiles. It's thought to have arrived in Guam through airplanes and cargo ships in the in the 20th century if I remember correctly. Ocean acidification, blights basically bleaching, hitting the corals. It's a change in environment and so species that are optimized for one environment or adapted for one environment may not fare well. Presumably, if you wait long enough, a new species will show up to reclaim the niche. But if the environment changes faster than biology can evolve, that'll be problematic. So this is an abstracted representation of what's going on with the non-human biodiversity on the planet. It's a Living Planet Index. You hopefully saw it in the pre-class reading for today as one of the follow-on additional readings. And", "start_char_idx": 0, "end_char_idx": 4157, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8d0e1396-8165-431d-b0ac-2f58a0952892": {"__data__": {"id_": "8d0e1396-8165-431d-b0ac-2f58a0952892", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "24d748fb-a338-4061-b032-0466ee6697e8", "node_type": null, "metadata": {}, "hash": "547a1c1d19073802813c98b4c62d330163dfcde31d47598e6e406693e4c3d4a8"}, "2": {"node_id": "b128157d-9f1a-4199-8dbd-4e4b35385ff8", "node_type": null, "metadata": {}, "hash": "ae6dc3d26662aa913bc8e7b4588d659706def321ed56e5dd48d6134e21d25e87"}, "3": {"node_id": "5d44643a-88e5-4095-975e-0f373e9b38fe", "node_type": null, "metadata": {}, "hash": "b71d3b3fc1ac71df19294f23a4c7a70d21535176b2edcb5ba10564aebd0ebba1"}}, "hash": "9b515358b2f71f8762356bfad0edeb213696cd8bbb62ffec3c31a1add090284d", "text": "the pre-class reading for today as one of the follow-on additional readings. And basically, if you normalize to 1970 and say, whatever the biodiversity was on Earth in 1970, and run it forward, what's been going on? And it looks like it's dropping. It looks like it's dropping by this index by a factor of two. And of course, you can make your own index. And so, however you want to calibrate things and normalize things, I presume you can get different scales here. But roughly, why I chose this one to share today is it nicely illustrates that as the human population, if you go back to that human population graph, human population has doubled over a period of 50 years. The non-human biology on earth, its diversity has dropped by a factor of two. And I don't wanna leap into causation, but at least there's a correlation here. And if you go back to the paper I was just surfacing, that suggests there are reasons to think it's not merely correlation, but it's causal as well.\n\nJust checking the chat. In the time of COVID and just other things besides COVID, it's not getting better. It would seem to be getting worse. And by it here, it's the biology on the planet besides the human stuff. So this is a recent article in The New York Times from a week ago where, because tourists are no longer going to visit wild species on preserves, including rhinoceroses, and there's a loss of income, poachers are filling back in and harvesting or killing or poaching the wild animals. So even COVID-19 is hurting the non-human biology indirectly. So let me try and stop here. And I want to pose a poll if I can do that. So the question is, should bio Should bioengineers care about any of this? Should bioengineers care about natural biodiversity? And your options are yes, no, and other, and this is an anonymous poll. So let's see what we got. 65, 66, 92%.\n\nSo it looks like 94%, yeah, should care about what's going on, natural biodiversity. The extra human biodiversity, 2% no, and 5% other. So great. Does anybody who said other want to chime into the chat and offer what you would have preferred as a response option? There's a great question in there from Yash regarding whether pollution decrease during shelter in place may have resulted in increase of biodiversity. In San Francisco, there's a lot of news stories about the coyotes coming back into the city and reoccupying the urban niche, so to speak. Okay, well, if you have a strong feeling about other,\n\nIt's the protein database. So we'll come back to this in class when we get into molecular engineering. But I'm drawing from this website today a cartoon depiction of a protein called antifreeze protein. So this is a protein that scientists have studied and bioengineers and others have repurposed. And one use of this protein is, turns out to be ice cream. So you can make ice cream with reduced fat, but normally when you do that, the ice crystals during a freeze-thaw cycle grow and make the ice cream crunchy. You know, so if you have like an old container of ice cream in your freezer, it'll get these ice crystals in it. But you can accommodate that in part by having a lot of fat content in your ice cream, but of course that causes problems with cardiac health and so on. So could you have a no fat ice cream that was really creamy as if it had lots of fat by dealing with ice crystal structure and size? And so it turns out that this protein that modulates the capacity for water to form certain types of ice structures, ice structuring protein has been used as a food ingredient to change the freezing properties or the free-thaw properties of ice cream. And where does this come from? It comes from natural living systems, in this case a pelt, who are adapted to survive, have high fitness in environments where the temperatures are slightly below freezing. So could you have an organism that exists in water where the water's below freezing? The answer is yes, but you have to figure out how to keep that organism from freezing. And in this case, you have an ice", "start_char_idx": 4090, "end_char_idx": 8128, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5d44643a-88e5-4095-975e-0f373e9b38fe": {"__data__": {"id_": "5d44643a-88e5-4095-975e-0f373e9b38fe", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "24d748fb-a338-4061-b032-0466ee6697e8", "node_type": null, "metadata": {}, "hash": "547a1c1d19073802813c98b4c62d330163dfcde31d47598e6e406693e4c3d4a8"}, "2": {"node_id": "8d0e1396-8165-431d-b0ac-2f58a0952892", "node_type": null, "metadata": {}, "hash": "9b515358b2f71f8762356bfad0edeb213696cd8bbb62ffec3c31a1add090284d"}, "3": {"node_id": "9e9cecca-6015-44bd-96cf-3deb12ac24cc", "node_type": null, "metadata": {}, "hash": "15e21cd165c6da634eb4f14e266fc212d979297cfd5bf7808d0b1d55c2bc3711"}}, "hash": "b71d3b3fc1ac71df19294f23a4c7a70d21535176b2edcb5ba10564aebd0ebba1", "text": "out how to keep that organism from freezing. And in this case, you have an ice structuring protein that helps with that. So one reason, a lot of people, it's not the only reason, but a lot of people might care about natural biodiversity as it's a source of gizmos, it's a source of function, it's a source of utility for bioengineers, right? Like better ice cream because we've got fish adapted for cold water climates. There are many other reasons to care if you were in the yes column. Some would argue there's an intrinsic innate value to nature and to species. I'm surfacing here a very general purpose question. How does one decide if something is good or bad, if a decision itself is right or wrong? And one way of thinking about that personally is to understand your moral compass, how you answer these questions and by what framework or set of tools do you develop answers to these questions for me personally? I'm not sure I had a great answer to the question. What is my moral compass? Until I was 30 years old, no reason to wait that long. It's just I hadn't really thought about it. So I'm surfacing this. And as you begin to think about what you wish to make true for your final projects between now and 2030 and by engineering along with that, I hope and will ask you to think about, is it a good or bad thing to be doing? And we'll come back to this. So regarding planet health, are there any bioengineering opportunities? And what I've got on this slide is what are we seeing as the causes of decrease in biodiversity is just one topic, land use, invasive species, climate change, pollution. And if we take the results of the very tiny framestorm from people health last time, what could we choose to do about it? We could ignore these changes and consequences, we could react to these changes and consequences, we could try and prevent these changes or consequences, or we could do something else. Now, remember framestorming from last time, the question you ask will frame the answers you get. Is there anything missing that's right at the heart of this that somebody could think of? Just chime in, come off mic and chime in. That left column of four problems or, you know, land use causes, invasive species, climate change solution, if you were to framestorm on the topic of climate health and you think about the readings for today, is there anything that is missing. Could we change the question about loss of biodiversity in a way that would allow us to do something new, so to speak? Jack, Jack Campbell, good to see you. What do you think about this?\n\nI mean, like, are you referring to, like, reacting and preventing, like, the three or four things that were listed in that slide? Or... So is there anything else besides that? So could we change the question somehow? Instead of trying to roll back changes in land use or remove invasive species or address climate change or remediate pollution, is there something else we could do besides reacting or preventing the things we already know about? Is there a completely new wildcard opportunity that might show up for addressing planet health or biodiversity collapse? Did you ever... sorry, go ahead. Oh, no, nothing. Did you ever see... you must have seen Jurassic Park, Jurassic World, something like that? Yeah. What's going on in those movies? Like what's the core of the plot?\n\nLike they brought back dinosaurs.\n\nYeah, yeah. So if something that people care about around planet health is things going extinct, everything that's being surfaced so far is just retard or hinder the extinction process. Right? Right. It's like, try and keep things from going extinct. But what if we change the question like, OK, things go extinct all the time. That was happening before people. That was happening before civilization, industrialization. What if we just change the question? Like, what if we got good at it? Things go extinct. We'll just bring them back.\n\nI mean, obviously that like relates to the reading about the woolly mammoth project thing.\n\nExactly, exactly. Okay, so I just wanted to tie it back to the Framestorming tool, right? The question you're asking will frame the answers you're getting, right? So if", "start_char_idx": 8134, "end_char_idx": 12326, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9e9cecca-6015-44bd-96cf-3deb12ac24cc": {"__data__": {"id_": "9e9cecca-6015-44bd-96cf-3deb12ac24cc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "24d748fb-a338-4061-b032-0466ee6697e8", "node_type": null, "metadata": {}, "hash": "547a1c1d19073802813c98b4c62d330163dfcde31d47598e6e406693e4c3d4a8"}, "2": {"node_id": "5d44643a-88e5-4095-975e-0f373e9b38fe", "node_type": null, "metadata": {}, "hash": "b71d3b3fc1ac71df19294f23a4c7a70d21535176b2edcb5ba10564aebd0ebba1"}, "3": {"node_id": "3c2c4feb-38aa-4df3-9050-10c1c7da9c64", "node_type": null, "metadata": {}, "hash": "6acd27885da7fd4b9d9fb421d2c78a16acee22c25b424eed7ab0a823ba4b1ed7"}}, "hash": "15e21cd165c6da634eb4f14e266fc212d979297cfd5bf7808d0b1d55c2bc3711", "text": "The question you're asking will frame the answers you're getting, right? So if the question is, how do we keep things from going extinct, we'll get a whole bunch of answers like what's shown on this slide. But if we allow ourself to frame some new questions, we might get a new suite of answers, right? So there's something to ponder and we'll work with you on this, on the projects. So let me just jump back into this deck. So thank you, that was perfect. And you actually see you've got that there. So this is all I was trying to get to, right? If extinction is something that we actually care about but it's not listed here, what if we just address that directly? Another thing I want to emphasize is there are so many opportunities for bioengineers to. Dig in and address what's going on in terms of planet health, if you choose to care about it, and one of the things we typically experience in this class is people, humans, we are really good at caring about people and it's much harder for us to care about other things and there are valid reasons for that. But usually when students pick up their projects, it's like two thirds of them are human health focused or people health focused. And so we're trying, at least I'm trying this year to not prescribe the balance, but give you enough of a bolus of substrate to think about what's going on beyond humans that you might find bioengineering opportunities. It's much less explored than health and medicine for people. So, picking up on Jack's comment and the reading, I want to just walk through an example of how this might play out. The point isn't to land every detail on how this works, but I just want to show you a workflow so you have a sense of plausibility and a sense of expectation for what people are attempting today. So this is a representation of the passenger pigeon, which was massive in number in population in North America, just a few human generations ago, circa 1900. And of course, the passenger pigeon is now extinct. There are no more living passenger pigeons on Earth. So let's bioengineer back an extinct species. Let's bring back the passenger pigeon. Could you imagine doing this? Well, there's a project to do this, operated by a charity based out of San Francisco called Revive and Restore. And I'm just gonna run you through the approach, again, not to parse every detail, but to give you a sense of plausibility. So step one, find a related bird that's still alive and read out its genome, so that you understand the genetic instructions for the near relative that's living. Number two, go to museums or other collections where they have dead birds or tissues, access the DNA, which hopefully is still intact, and read that out. So now you have the genome, the DNA sequence of the living relative and the extinct bird. Step three, use a computer and compare. Look for the differences between the two genomes. If you understand what those differences are, then you can make patches that will change. Step four, the genome of the living bird to have the differences of the extinct species. So you're patching genetically the living bird to have a genome that's more like the extinct species. Next, having done that, editing and so on, you'd have to inject that material, that genetic material, into a living animal that's a brood species that will basically incorporate it into the reproductive germline and off we go. So we're gonna now give birth to these creatures. After that, you raise them and help them grow up and develop flocks and so on. Of course, they're gonna have to have surrogate parents, which will be a different species of bird, right, and so on, and eventually it all gets figured out. And final step is you release them into the wild. All right, so I'm just taking this from the plan of attack on their website, and I'll close with a roadmap. So this is a project that's been underway for about eight years, maybe a little bit longer, and their goal is to release de-extincted or revived passenger pigeons by 2030, 2035. Just checking the chat real quick.\n\nSo I just want to acknowledge two questions that have come into the chat right here.\n\nSo", "start_char_idx": 12324, "end_char_idx": 16479, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3c2c4feb-38aa-4df3-9050-10c1c7da9c64": {"__data__": {"id_": "3c2c4feb-38aa-4df3-9050-10c1c7da9c64", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "24d748fb-a338-4061-b032-0466ee6697e8", "node_type": null, "metadata": {}, "hash": "547a1c1d19073802813c98b4c62d330163dfcde31d47598e6e406693e4c3d4a8"}, "2": {"node_id": "9e9cecca-6015-44bd-96cf-3deb12ac24cc", "node_type": null, "metadata": {}, "hash": "15e21cd165c6da634eb4f14e266fc212d979297cfd5bf7808d0b1d55c2bc3711"}, "3": {"node_id": "d00a2be3-59f8-40ab-a2ad-d0f056b35294", "node_type": null, "metadata": {}, "hash": "4c2a108c999f9e94999a19962fa28da5a39da3d3245e70384d317d1282a85f9c"}}, "hash": "6acd27885da7fd4b9d9fb421d2c78a16acee22c25b424eed7ab0a823ba4b1ed7", "text": "want to acknowledge two questions that have come into the chat right here.\n\nSo from Coco, we're referring to the final project a lot and talking about potential topics for it. Can you please expand on the project purpose, prompt, or structure so you have a better framework for what we're saying now? That's a great question. So let me just catch breath and reflect on that for a little bit. So your final projects are a chance for you to articulate a wish. What do you wish to see made true in the world within or by the next 10 years? So it could be something that comes true within a year or 10 years. And it's a wish that should be advanceable entirely or in part via bioengineering. And so the final projects will engage you and colleagues in working together to decide what your wish should be, and then to figure out how to make that into a plan that can be represented, i.e. communicated to others, so that off it could go. And we mean this very literally, meaning we wish for these plans to be real and actionable, and we wish for these wishes to be your wishes based on what you're experiencing and seeing and learning in class, but also what you're bringing from your own history and perspectives. So hopefully that gives you a taste of what's coming. We will start work on these in class time earnestly in about two weeks, on the first of May. And so what we're doing this week is trying to give you a set of options around how existing opportunities might show up in bioengineering, not as prescriptions, but just to diversify your thinking and introduce you to some possibilities.\n\nDiego asked a great question. If you bring back an extinct species and it works, but don't address root cause, that caused it to go extinct, won't it just go extinct again, maybe? Yash is asking, in the readings for species where we already have very low numbers, the white rhino, is there a way to introduce diversity to avoid bottlenecks in the genetics? That's a very detailed question, and the answer is probably yes, by synthesizing, by bioengineering the diversity, but I haven't seen that done, but at least I can give you a placeholder there. All right, I'm gonna jump back into sharing.\n\nGiving you a screen grab of their website and just to, as a postcard, give you a sense of how many different things they're thinking about and working on. It's not just woolly mammoth and passenger pigeon. There's many, many applications of biotechnology applied to conservation, in case that might be of interest in project formulation. Okay, let's do a simpler example, and then we're going to set up the futures wheel activity. So this is something that draws upon the pre-class readings for the week. What this is showing on the slide is how one would use brewing as a way of making a medicine, the medicine artemisinin for treating malaria. And it's comparing and contrasting the two different approaches. So, one approach is cultivation of the plant that has the medicinally active compound in it, and then extracting the medicine from the plant. That's what's shown on top through agriculture. And the bottom row shows what would happen if you engineer yeast to make the same molecule by fermentation or brewing. So it's hard to get a sense of the consequences of this, like which way should you go? And what we're gonna set up in the futures wheel is give you a tool for thinking about impacts, both direct and indirect impacts and consequences. So some of the things that are coming up in the chat questions right now, the futures wheel is a great tool for working through thinking and so on. So just sharing here an email exchange I had with a friend, Jim Thomas, where Jim is trying to think about, wait a minute, wait a minute, wait a minute. If I shifted over how we're making this medicine from farming a tree, basically a shrub, and instead I was taking sugar that comes from potatoes or something like that into a yeast fermenter, what's the impact on land? Are we using more or less land? So think about how much land you'd have to plant with the trees to get the", "start_char_idx": 16480, "end_char_idx": 20553, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d00a2be3-59f8-40ab-a2ad-d0f056b35294": {"__data__": {"id_": "d00a2be3-59f8-40ab-a2ad-d0f056b35294", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "24d748fb-a338-4061-b032-0466ee6697e8", "node_type": null, "metadata": {}, "hash": "547a1c1d19073802813c98b4c62d330163dfcde31d47598e6e406693e4c3d4a8"}, "2": {"node_id": "3c2c4feb-38aa-4df3-9050-10c1c7da9c64", "node_type": null, "metadata": {}, "hash": "6acd27885da7fd4b9d9fb421d2c78a16acee22c25b424eed7ab0a823ba4b1ed7"}, "3": {"node_id": "352c27a2-6598-434e-9c3b-4d75d2c9989c", "node_type": null, "metadata": {}, "hash": "4e28b0eec7537ff1f7915870c7bc05cf75907fd214d256b4f5c8ec730865a290"}}, "hash": "4c2a108c999f9e94999a19962fa28da5a39da3d3245e70384d317d1282a85f9c", "text": "land? So think about how much land you'd have to plant with the trees to get the medicine extracted from the tree, versus if I'm just making a sugar beet or a potato farm, and then taking the sugar made by that industrial crop, basically, and putting that in a fermenter. And so he works through the math and concludes that in terms of land use, brewing this medicine, as opposed to farming the plant that makes the medicine, if you were brewing the medicine, you would use 35 times less land in the brewing process, meaning the amount of land needed to make sugar, whether it's sugarcane, potato, sugar beet, 35 times more land efficient compared to growing the sweet wormwood crop. Another consequence, since the land use would be so greatly reduced is you basically displace employment for thousands or tens of thousands of people who would be the agricultural workers growing the plants versus seasonal workers making a sugar crop. So if you get focused only on the science and technology of biosynthesis and advanced bioengineering used to make medicines, you might not think about any of the external consequences, the direct and indirect impacts of doing this. So that's where the Futures Wheel tool comes in. And the Futures Wheel is a tool or method for visualizing direct and indirect consequences of a particular change or development. So let me show you an example of this, okay? And then we'll set up an activity where you can practice this. So something happens that's in blue, and then you've got to just make a map of, well, what would be the direct consequences of the thing that happened? The change that occurred, the invention that got deployed, the decision that got made, and then once you think about the direct consequences around that, well, what are the indirect consequences or the consequences of the consequences and so on and so forth? All right, here's an example. Let's say you're at work and suddenly the change is you have to work one hour later. And so there's some consequences. You're gonna have less time to cook dinner. You're gonna have the dog that needs to be let out, but it won't be let out, so it'll pee on the carpet. The kids will be left at the bus stop, right? These are the direct consequences of having to be at work. And note that in filling out these red circles, what I'm doing is I'm brainstorming. Okay, so I'm just like, well, what would be the direct consequences of this change? And once I get those red circles filled in, then what are the consequences of those consequences? So, well, if the dog pees on the carpet, then my carpet's gonna be stained, or the next time I'm going to work, maybe I'll leave the dog outside because I don't wanna leave him inside in case he has to go pee. And then what would be the consequences of the consequences, right? So the third layer of consequences. Well, the dog might be barking all day outside and then what's the consequence of that? I might get a citation from the animal officer. Right, so you see what's going on here. So the futures wheel is a tool for mapping out the consequences following a change or an invention or a product or a plan, a decision, and then the consequences of the consequences, the consequences of the consequences of the consequences, and so on. Here's one more example, and this will be a nice hint at part of Friday's class. What would happen if the United States used a biological weapon? Maybe the weapon would infect people in the United States. Maybe other countries would counterattack. What would be the consequence of that? People would die. What would be the consequences of that? Death and famine. What would be the consequences of that? The world unites itself into a federation, right? It's not meant to be 100% correct, but it's just meant to be a tool to allow you to organize brainstorming of consequences in a chain of impact.\n\nSo this is called the future wheel.\n\nAnd then, and then what happened, and then what happened, or and then what would happen, and so on and so", "start_char_idx": 20556, "end_char_idx": 24574, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "352c27a2-6598-434e-9c3b-4d75d2c9989c": {"__data__": {"id_": "352c27a2-6598-434e-9c3b-4d75d2c9989c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "24d748fb-a338-4061-b032-0466ee6697e8", "node_type": null, "metadata": {}, "hash": "547a1c1d19073802813c98b4c62d330163dfcde31d47598e6e406693e4c3d4a8"}, "2": {"node_id": "d00a2be3-59f8-40ab-a2ad-d0f056b35294", "node_type": null, "metadata": {}, "hash": "4c2a108c999f9e94999a19962fa28da5a39da3d3245e70384d317d1282a85f9c"}, "3": {"node_id": "7f10eeb0-701d-4d63-9b9c-f29d74424d7e", "node_type": null, "metadata": {}, "hash": "6c0b7bca569fe2a7994ec00f1f3b19c19744b8d8a902ce6a2a3cb0fb62af454a"}}, "hash": "4e28b0eec7537ff1f7915870c7bc05cf75907fd214d256b4f5c8ec730865a290", "text": "then what happened, or and then what would happen, and so on and so forth. So for the breakout, which John, I hope you can set up, we want you to work in groups and ideally if you're nearby something like a piece of paper or whatnot, just sketch out this mapping of consequences. The disruption or the invention or the change to the world is all medicines can now be brewed at home. Bioengineers have gotten so good at engineering yeast that you can use a bread machine or a home brew beer apparatus and you can brew any medicine you want to brew. Okay, so that's the change. And when you go into your breakout, we want you to make a future wheel and talk out loud as you're making it. Use the breakout to brainstorm with each other as you're making out your future wheel. But coming back from the breakouts, we wish for each breakout group to report on two topics. If you could homebrew all medicines, what would be the most important impact on planet health? Not people health, but planet health. And second, so that's question number one. Second, what is the most, according to your breakout group, what's the most surprising indirect impact, something you didn't expect would show up? Okay, let's go.\n\nWould buy engineers be responsible for predicting how something would, you know, see what I mean? So like who has responsibility for that? And it's just a great question.\n\nYeah, I don't know how to best reflect this or word this, but I think that idea more broadly is like engineers don't have to worry just about the technical details of implementation at like the Adams level, but also at the policy implementation at the global implementation and the effects there from.\n\nI don't know how to best word that, John, is to just do a quick on-ramp into professional ethics in engineering. Code of ethics would typically have a umbrella term, a clause that says an engineer shall uphold the public welfare as paramount, which supersedes what used to only be in place, which was approximately, don't bad mouth your fellow engineer when bidding on a public works project and do what the client hires you to do. Do what you're ordered to do. So that's what it used to be in the late 1800s and then following the environmental movement and some massive engineering failures in the mid 20th century, we got the uphold public welfare as paramount.\n\nSuperseding.\n\nI want to pick up on a question Zach Teflon posted right before we went to breakout. It reads, would bioengineers be responsible for predicting how reintroducing something could disrupt an ecosystem? Who's responsible for the impacts? Who's responsible for the impacts of a bioengineering perturbation, a bioengineering project, a bioengineering product? The direct impacts and the indirect impacts are the are the bioengineers responsible? How far out into the impact chain does responsibility go? That's a really good question. If you were a professional engineer, the ethics codes would say an engineer shall uphold the public welfare as paramount, as the most important thing. Now, what's the public welfare and who gets to decide is the next layer of question.\n\nI wanna highlight something that's coming up in the chat. Ella brings up an interesting point that you can get, you can in a futures wheel get two things that contradict each other. For example, hope-bringing medicines may contribute to increased pollution rates as well as mitigate or reduce pollution rates. So when brainstorming you have this frequent situation where you can have two competing forces that you identify the forces but you don't know their relative importances and that's where it's important to look into where, why you're getting these ideas of, there'll be more pollution versus there'll be less pollution and then start doing a more of a quantitative analysis of which factors are more important.\n\nSo who would be doing the brewing and the indirect impacts of that coming back from a breakout and how that relates to gender equity or inequity and workforce? Would the women be responsible for brewing because it's more like cooking or would it cause more women to pursue STEM careers? All right, because you have access to 21st century biotechnology. That's amazing. I had never thought about", "start_char_idx": 24585, "end_char_idx": 28828, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7f10eeb0-701d-4d63-9b9c-f29d74424d7e": {"__data__": {"id_": "7f10eeb0-701d-4d63-9b9c-f29d74424d7e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "24d748fb-a338-4061-b032-0466ee6697e8", "node_type": null, "metadata": {}, "hash": "547a1c1d19073802813c98b4c62d330163dfcde31d47598e6e406693e4c3d4a8"}, "2": {"node_id": "352c27a2-6598-434e-9c3b-4d75d2c9989c", "node_type": null, "metadata": {}, "hash": "4e28b0eec7537ff1f7915870c7bc05cf75907fd214d256b4f5c8ec730865a290"}}, "hash": "6c0b7bca569fe2a7994ec00f1f3b19c19744b8d8a902ce6a2a3cb0fb62af454a", "text": "you have access to 21st century biotechnology. That's amazing. I had never thought about that.\n\nHey, can I throw in one that my folks brought up, which I thought was interesting. If you were able to brew everything at home and there wasn't proper regulation, wouldn't you develop a lot of resistance to some of the heavily used drugs? I mean, how would we deal with that?\n\nSeemed like a legitimate question to me.\n\nYeah, superbugs, disposal, the sewage treatment plant workers, right? Okay. Great. Okay, great. So hopefully that was a good experience. The goal of course was to have all of you experience using a futures wheel. It'll be a nice tool to have in your toolkit when you think about what your project might be. So just remember it in that mode primarily. It's a way of working through impacts and impacts and impacts and impacts and impacts so that you can make better decisions about what to do or what not to do. Again, I'll acknowledge the question of who's responsible for the impacts. And the easy answer is, well, we are, bioengineers are. But sometimes the impacts aren't easy to anticipate or manage. So that's what we've done today. We've done Futures Wheel in your toolkit as an introduction and hopefully you can see and begin to relate to yourself and others that Planet Health has a cornucopia of opportunities for bioengineers that are being explored already but it's a snowflake on tip of iceberg situation there too. So that's what we've got and I'll turn it back to the team for closing comments and announcements.\n\nJonathan, do you want to say something about the packages?\n\nYes, I do. So yesterday, Sivash and I packaged up 115 FedEx envelopes filled with two care kits that you all should receive in approximately one week. These contain kits for two activities that we like to run in BioE80. You will get more information on these as we do the activities, but one of which is going to be an activity where we send you an origami microscope developed here at Stanford called Foldscope, and we're gonna unleash you on the world to see if you can find some really cool microscopic oddities in the comfort of your own homes. The other is another work coming out of the Manu Prakash lab here at Stanford called Dancing Droplets where we're going to challenge you to program kinetic matter and see if you can program the motion of small actors, in this case water droplets, using simple rules and see if you can get more complicated behavior out of them. When you receive your packets in the mail, just receive them, put them in a nice, small little corner of your desk, and forget about them until we tell you to open them. Please, you don't have to do anything. There's nothing that's cold sensitive or needs proper storage. Just put it on the side of your desk and wait for further instructions. Yes.", "start_char_idx": 28794, "end_char_idx": 31623, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f1d6febf-03aa-4ef0-9507-02a8c1bb6f0e": {"__data__": {"id_": "f1d6febf-03aa-4ef0-9507-02a8c1bb6f0e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "96613642-e63d-4b1e-8252-ecb4d4e26853", "node_type": null, "metadata": {}, "hash": "ba174d57ceb0febb8ae056f28396e73f06817980b2b2bed3da830f0f74651a2a"}, "3": {"node_id": "5ce8fa17-089a-4270-8ede-7b08fc823da5", "node_type": null, "metadata": {}, "hash": "bbf261cc9d8c411fb5c679cc72488d46b2aa955436029858dd0c738c4fbb6061"}}, "hash": "534b436c23f93d60526df19578a4b6bf02ab18792e9bf21f4fe3b1fe797d7ec2", "text": "WEEK 2 FRIDAY LECTURE 6\n\nBefore we jump into the political health, which is the main topic of today, just wanted to open for questions looking back at people health and planet health, the other two topics we handled Monday and Wednesday this week, respectively. Does anybody want to surface a question or a comment from what we covered earlier in the week or what you've been thinking or wondering about since those two classes? Just checking in and seeing how you're doing. The context, again, is we're pre-positioning frames of reference for utility, if you will, as it relates to bioengineering, so that you can think about that early in the quarter. Next week we'll be transitioning into tools and technology of bioengineering, molecular design, genetic system design, microscopes. Most of you, almost all of you should have received a FedEx with a microscope and some other materials in it. So just to talk out loud and give you some context. Okay, no problem. Great. So, let's do political health. So, this is a, oh wait, colorful liquids are. In the envelopes, the colorful liquids. Yeah, well. So, I think now might be a good time for an announcement.\n\nSo, you all received some colorful liquids in the mail. Please don't open them yet. And if you have, don't worry about them. Put them back in the envelope, leave them on your desk, wait until Monday. These are for activities later on in the year, and by opening them, you do no damage to yourself, but you do risk damaging the reagents inside, which slowly deteriorate in quality over time. So please leave them closed in their envelopes. There'll be a more in-depth announcement at the end of this lecture.\n\nWell, so I completely agree with what John just said. However, I will compliment it or yes end it by saying, we trust you all, and so please do whatever you need to do. And if your curiosity insists upon you opening the package and doing it, go for it. Just recognize that the debugging and learning later may be out of control. So do what you need to do and that'll be great. The goal is learning, so let's go with that. Okay, so political health.\n\nActivities associated with the governance of a country, an area, making decisions that apply to groups of members and achieving and exercising positions of governance. Organized control over humans. That's political and politics. Organized control over humans, the assertion of power over others. Health, a condition in which someone or something is thriving or doing well. So when we talk about political health in this class, what I'm making reference to and trying to invoke is the system by which humans are controlled. There's organized control of people by people over people. Is that system thriving and doing well? And at first blush, I would hope all of you are asking the question, what the heck does this have to do with bioengineering? All right. So so we're going to have to set that up. And you got a taste of it in the pre-class readings. But now we've got to pull it together and make it very explicit. So for example, we've already seen this week in people health and planet health that bioengineers will do things like cure diseases for people health. Bioengineers will save environments or fix environments for planet health. And in doing of these things, we're gonna do some underlying stuff like understand how biology works. And if it's not working right, if it's broken, we'll fix it. And maybe we'll get better at designing and building organisms, because that will be part of what we need to do to save the environments and cure the diseases and do the other things. And because the toolkit, the tooling infrastructure, the ways of seeing biology, modeling biology, making biology are being developed, we're going to have to get better at doing everything above, get better at curing diseases, get better at saving environments, get better at understanding and fixing biology, and so on. And when we represent and pursue biological engineering in this way, we're instantiating a historical tradition as it relates to what it means to be a human and political theory, believe it or not. So one point of reference from Europe centuries ago would be the work of Rousseau, who, when thinking about the human,", "start_char_idx": 0, "end_char_idx": 4249, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5ce8fa17-089a-4270-8ede-7b08fc823da5": {"__data__": {"id_": "5ce8fa17-089a-4270-8ede-7b08fc823da5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "96613642-e63d-4b1e-8252-ecb4d4e26853", "node_type": null, "metadata": {}, "hash": "ba174d57ceb0febb8ae056f28396e73f06817980b2b2bed3da830f0f74651a2a"}, "2": {"node_id": "f1d6febf-03aa-4ef0-9507-02a8c1bb6f0e", "node_type": null, "metadata": {}, "hash": "534b436c23f93d60526df19578a4b6bf02ab18792e9bf21f4fe3b1fe797d7ec2"}, "3": {"node_id": "9dd45a83-1df4-48ad-a252-ee84ecab1741", "node_type": null, "metadata": {}, "hash": "bfb70b7d40c501b4ec16048396bc8a7e97617c911e972a491437500baf1e9403"}}, "hash": "bbf261cc9d8c411fb5c679cc72488d46b2aa955436029858dd0c738c4fbb6061", "text": "centuries ago would be the work of Rousseau, who, when thinking about the human, was trying to understand what humans were like in nature, so to speak, before they might be corrupted by society and civilization. And two of Rousseau's are non-destructive and have a love of self. So a non-destructive love of oneself, number one, and number two, a pity or compassion for the suffering of others. And if one has pity and compassion for suffering of others, you might take action to mitigate or ameliorate that suffering, cure the disease, save the environment. So in this frame of reference, bioengineering is very naturally aligned with the political discourse of what it means to be a human. Now, there's other ways of thinking about people. And if you don't take Rousseau's view of what the natural human is, somebody else's view, you could come up with a different set of expectations for bioengineers. Bioengineers will inevitably or accidentally create diseases, destroy environments, misunderstand and abuse biology and ecology, design and build harmful organisms.\n\nThey'll get better at doing all these things.\n\nThat fifth thing is the only thing that's apparently the same in this way of thinking. Huh, now where does this come from? This comes from a different model, if you will, of the human, of what is a person by themselves left alone. So I'm quoting here, we're quoting here from Hobbes, when men live without a common power to keep them in awe, they're in a condition which is going to be war. If there's nobody to keep people from fighting with each other, then people are going to fight, and it will be everybody against everybody else, every human for themselves. And when you think about what this would be like, there's going to be no industry, no culture, no economy, no knowledge, no arts and letters, no society, and this incredibly famous closing statement in political theory, under such conditions, the life of man, solitary, poor, nasty, brutish, and short. So that's a valid way of thinking, you could argue, that informs how our society is constructed. When we talk about construction of society, one theory or model is called the social contract. And again, I'm just building a framework to set up a conversation and introduce you to the idea of bioengineering for political health. So the social contract is an idea that has to do with how the individual in a society relates to the state or the authority of the society. So a contract is an agreement between parties. In this case, the social contract is the idea of a contract between a citizen of a society and the government of that society. Social contracts typically posit that individuals have consented explicitly or tacitly to surrender some freedoms and submit to the authority, whether it be a king or queen or an elected government, in exchange for protection of remaining rights and maintenance of order. So as a citizen of the United States, I will give up certain rights. I am not allowed to shout out loud, fire in a crowded theater. Even though we have free speech, that's not allowed. And in exchange for giving up those and other freedoms, like I can't harm Sivash, I can't, you know, like punch him in the face, that's a crime, right? But by giving up certain freedoms that I would have naturally, society and the government protects me from others and the vagaries of nature to a degree. And the pictures shown down below are the covers of both Rousseau and Hobbes' reflections on this idea, exploration of the social contract. Depending on your view of what the human is as a natural beast, if you will, a noble savage or a state of war, you may have very different expectations for how this contract should be developed and what you would expect will be playing out. before the United States Senate last month by Dr. Megan Palmer, who's a bioengineer. And she's making recommendations to the United States Congress regarding what the United States Congress should be doing as it relates to leadership in biotechnology and the bioeconomy. So hopefully you're able to see Dr. Palmer present. If not, I would encourage you to go back to the video, it's only five", "start_char_idx": 4183, "end_char_idx": 8346, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9dd45a83-1df4-48ad-a252-ee84ecab1741": {"__data__": {"id_": "9dd45a83-1df4-48ad-a252-ee84ecab1741", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "96613642-e63d-4b1e-8252-ecb4d4e26853", "node_type": null, "metadata": {}, "hash": "ba174d57ceb0febb8ae056f28396e73f06817980b2b2bed3da830f0f74651a2a"}, "2": {"node_id": "5ce8fa17-089a-4270-8ede-7b08fc823da5", "node_type": null, "metadata": {}, "hash": "bbf261cc9d8c411fb5c679cc72488d46b2aa955436029858dd0c738c4fbb6061"}, "3": {"node_id": "5abc2c8e-e5b8-43c6-b732-985766fc22fb", "node_type": null, "metadata": {}, "hash": "34cd28b9c51cf065610f70e9ce0c090f1f85672b68e01d4f0653b751851a22a3"}}, "hash": "bfb70b7d40c501b4ec16048396bc8a7e97617c911e972a491437500baf1e9403", "text": "If not, I would encourage you to go back to the video, it's only five minutes, take a look at it. I just want to quote two sentences from her recommendations. And again, I'm just trying to build out examples of how bioengineering connects to political health. And so what you have here is a citizen talking to the government, the Leviathan, the all-powerful other party in the contract. And so Dr. Palmer says, states third, the United States must have community and citizenship. Everyone, the U.S. must enable everyone to engage with this biological technology and its many uses to foster the best ideas and to make sure they are genuinely in the public interest. Everyone in the country should be should be trained to be literate in biotechnology. And the United States should be building the diverse training programs needed to grow the interdisciplinary bioeconomy workforce of the future. Wow. Now, there's a bunch of reasoning behind this, presumably, but this is a pretty pretty clear request from a bioengineer to the government regarding what the government must do. Everybody should engage with biological technologies, and everyone should be literate in biotechnology. Those are two prescriptions being made here.\n\nPalmer's prescriptions can be linked to some of the founding ideas in the United States. So, this is an example of one way to think about it. It's a letter from Tom Jefferson to John Adams in the 1813s on the topic of the aristocracy and how you would construct a country to move beyond inheritance and heredity as it relates to aristocracy, what is thought of as a natural aristocracy at the time, what you could think of as a meritocracy, perhaps. And the question that's showing up here is literally the question that leads to Palmer's answer from the preceding slide. What capacity should all citizens have the option of accessing? And the details of Jefferson's reasoning are polluted and imperfect, really strongly so, from the details of the moment, but I want to read it as it is and then abstract from it the general purpose argument. So Jefferson writes, if you just follow the square brackets inside, here, everyone may have land to labor for himself if he chooses, or preferring the exercise of any other industry may exact for it such compensation as not only to afford a comfortable subsistence, but wherewith to provide for a cessation from labor in old age. Everyone by his property or satisfactory situation is interested in the support of law and order. Now, the flaw in this should be apparent to all. In the conditions of 1813, it was property owners and white men. So it's a very limited reality. If you abstract the reasoning, though, what Jefferson is saying is that the option of accessing land, which is the dominant means of manufacturing at the time, fertile land, is a type of defense against political oppression. Because if John is going to try and oppress me where I am, thanks, John, I'm just going to leave and go somewhere else because there's more fertile land over there. And if that's mutual, then we're less likely to oppress each other. And if we're doing okay where we are, then we'll be, in a simplistic sense, conservative, meaning we want to maintain the status quo, so we'll be interested in law and order. We'll reinforce the social contract and the stability of the society. Let me try and abstract this one degree further. Jefferson's argument, I would submit for your consideration is that optionality regarding access to the means of production is the ultimate defense against oppression by monopoly individuals or government because if so oppressed you just have the option of dealing with it by some other way of making and There from you can enable everybody to be a citizen so all citizens should have the option of accessing the means of production is the restatement of this reasoning I would say it begs the question What are the means of production that are most relevant as a citizen of the 21st century? And what would it mean to provide or what would it require to provide all citizens the option of accessing that? Now these are strange words, but let me make it simple when we talk about literacy with language reading and writing It's like everybody should have the option of a basic primary education and so on. What about reading and writing in Python? Well, computer science for all says, everybody", "start_char_idx": 8359, "end_char_idx": 12749, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5abc2c8e-e5b8-43c6-b732-985766fc22fb": {"__data__": {"id_": "5abc2c8e-e5b8-43c6-b732-985766fc22fb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "96613642-e63d-4b1e-8252-ecb4d4e26853", "node_type": null, "metadata": {}, "hash": "ba174d57ceb0febb8ae056f28396e73f06817980b2b2bed3da830f0f74651a2a"}, "2": {"node_id": "9dd45a83-1df4-48ad-a252-ee84ecab1741", "node_type": null, "metadata": {}, "hash": "bfb70b7d40c501b4ec16048396bc8a7e97617c911e972a491437500baf1e9403"}, "3": {"node_id": "ffecce29-2cc7-474a-b89c-ad8e750e8111", "node_type": null, "metadata": {}, "hash": "bfecb447f23ac9b2cefd9c4c69b0f3e62f63c4f7cd8f68a096d70364efd98eff"}}, "hash": "34cd28b9c51cf065610f70e9ce0c090f1f85672b68e01d4f0653b751851a22a3", "text": "What about reading and writing in Python? Well, computer science for all says, everybody should also have the option of learning to write computer code. What about the option of learning to read and write DNA? And Palmer comes to the conclusion, apparently, that everybody should have the option of this. Because in Jefferson's sense, living matter, biology, is one of the dominant modes of production for our time. Okay. So let's play this out. Remember, the topic we're introducing you to today is bioengineering for political health. I went online right before class and I got this snippet of DNA code. This is a natural sequence of DNA. It was identified from a frozen body in Alaska. The corpse was a person who succumbed to the influenza virus that was ravaging the world as a pandemic 102 years ago in 1918. And so this is one segment of that virus's genome. It's a free download online. You can get the sequence from a government website. And if you want to know what Stanford was like when this pandemic was happening. Here's the students on campus wearing masks. And that was an order. And I believe, I don't know the exact number of deaths, but it was at least seven students died during this on-campus outbreak, but it was a global pandemic. So, is it a good or bad thing that any of us could go online and download the DNA sequence for the genome that encodes the pandemic that killed 50 million people in 1918? Some would argue, Ray and Bill in this editorial, when the sequence was first discovered and put online for free, this is crazy. The blueprint for a weapon of mass destruction has just been made freely available. And unlike a nuclear weapon, it's just biology. So if you could figure out how to print that DNA and recover the infectious virus, off you go. This is a very Hobbesian view. Do you see what I mean? It's a view where human nature is such that humans left alone are intrinsically at war with one another. A competing editorial from the same time, Phil Sharp, a Nobel Laureate at MIT, is, well, you know, it's actually the right thing to do, to sequence this and make the sequence freely available so that everybody can learn from it, everybody can be literate with respect to this dangerous human pathogen and better prepare for the next possible influenza pandemic. This is very Rousseauian. It's a model for the human which is one interested in love of self and preservation of self and mitigation of suffering. These are two valid political traditions, if you will. What happens practically though, is these frames of reference tend to get polarized in the public sphere, in public conversation. So I put them on a half pipe to give you a sense of what it's like to be operating as a bioengineer where something is happening at this intersection of science and technology involving biology, and you instantly get these polarized extremes, one representing the Hobbesian tradition in the most simplistic way, the other representing the Rousseauian in the most simplistic way. I call this the half pipe of doom and salvation, where you go from one extreme of discourse, the Hobbesian destruction, to the we're going to save everybody. And the problem with this polarization is the reality of what bioengineers might do to create a healthy political framework or system is in between. It's not in the dramatic tricks you do off either lip of the half pipe, it's building out the reality in the middle. So if I use this specific example, which played out starting in 2005, you know, the things that bioengineers actually did are shown here. We worked with the FBI and the government and with industry to come up with screening frameworks so that people ordering DNA from companies couldn't accidentally or purposely order the DNA and coding a human pathogen. The scientists who showed how to print genomes from scratch for viruses learned how to use that to make automatic vaccine candidates. Just instant print of a vaccine candidate using a computer to design an alternate genome. Wow, if you could print a vaccine anywhere you wanted to, you could transmit the instructions over the internet and have much more accelerated response to an emerging pandemic. In the extreme fantasy, you would", "start_char_idx": 12730, "end_char_idx": 16958, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ffecce29-2cc7-474a-b89c-ad8e750e8111": {"__data__": {"id_": "ffecce29-2cc7-474a-b89c-ad8e750e8111", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "96613642-e63d-4b1e-8252-ecb4d4e26853", "node_type": null, "metadata": {}, "hash": "ba174d57ceb0febb8ae056f28396e73f06817980b2b2bed3da830f0f74651a2a"}, "2": {"node_id": "5abc2c8e-e5b8-43c6-b732-985766fc22fb", "node_type": null, "metadata": {}, "hash": "34cd28b9c51cf065610f70e9ce0c090f1f85672b68e01d4f0653b751851a22a3"}, "3": {"node_id": "929d9da9-c77e-4d30-9866-f5da79d36830", "node_type": null, "metadata": {}, "hash": "de5b8a24785768bfdc3a6bb58ec6bd1bca965a70b348d0cf0d8d9fe56db58a84"}}, "hash": "bfecb447f23ac9b2cefd9c4c69b0f3e62f63c4f7cd8f68a096d70364efd98eff", "text": "accelerated response to an emerging pandemic. In the extreme fantasy, you would sequence a pathogen and transmit the instructions for how to vaccinate against it faster than a plane could move if bioengineers really got their act together. So, you wouldn't worry about global spread. You'd be spreading the cure or the prevention faster than the pathogen could spread by direct physical transmission. We'll have to fill in some of the technical details for why this is possible to imagine now when we get to the coming weeks. But I just wanna give you a sense of the reality for the bioengineers is typically in between these polarizing extremes. How about today? So, not quite today, this is from the 8th of April. We're dealing with a different pandemic caused by COVID-19. And so a poll recently published by Pew Research asked people in the United States, do you think that COVID-19 arose from nature? Or was it developed on purpose as a bioweapon, if you will, or some other agent designed on purpose, or it arose in nature but something changed in the laboratory, so there was some accident in a lab, or do you not know? So that's what these bars are on the right. Did it come about naturally? For the adults in the U.S. surveyed, 43% say, yeah, COVID-19 arose from nature in a bat or something like that, and it jumped into the human. About a quarter, 23% on average across all categories say COVID-19 was developed intentionally in a laboratory. Somebody made it on purpose. 6% said it was made in a lab, but it was not made on purpose. It was made by accident. Not bioterror so much as bioerror, if you will. And 25% say, I don't know, on average. And you can see how that split across categories. One thing I found interesting was if you have a college education or above, apparently you're more likely to think it came about naturally. Not quite sure why that is. Other thing I found interesting was the older you are, the more likely you think it came about naturally. The younger you are, the more likely you are to think it was made in a laboratory. That's that's kind of interesting to think about. But what about this question? Is COVID-19 a biological weapon? Is that an important question to be able to answer? Definitely. Why? Because it fits immediately into the framework of political health. If we knew for certain that somebody had made this thing and intentionally released it and we could attribute that with high confidence, you know how that plays out at the level of geopolitics and nation states. itself could be exploited for political purposes, that creates not the same type of risk, but a risk of pretty significant scale, right, where you could lead a group of people to take action against another group of people incorrectly. I just added this slide to our deck five minutes before class, came across a archive on GitHub that is being authored by an anonymous group of researchers who are collectively trying to explore and answer the question, what can we say about the origin of COVID-19? And there's a lot of information here, and I haven't studied more than the first page of it, so I'm not endorsing this, but I'm just giving you a sense of suddenly political health and biology and bioengineering are all over the place and deeply important.\n\nOne of the things that came up in the people health topic on Monday in the discussion was, how would we feel about editing the human itself? Could you edit the human to improve health by, for example, removing genetic traits or changing genetic traits associated with disease? It's incredibly tricky topic because of the ethics of changing future generations of humans. Now what's very interesting is in 2017 in the United States there was a advisory group to the government in the National Academies which as Amy Harmon's reporting here, I'll just read it out, this group lent its support to the once unthinkable proposition, the modification of human embryos to create genetic traits that can be passed down to future generations, okay, only for alterations designed to prevent babies from acquiring genes known to cause serious diseases and disabilities, and when there is no other alternative but to change the gene.\n\nThe report provides a rationale", "start_char_idx": 16966, "end_char_idx": 21204, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "929d9da9-c77e-4d30-9866-f5da79d36830": {"__data__": {"id_": "929d9da9-c77e-4d30-9866-f5da79d36830", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "96613642-e63d-4b1e-8252-ecb4d4e26853", "node_type": null, "metadata": {}, "hash": "ba174d57ceb0febb8ae056f28396e73f06817980b2b2bed3da830f0f74651a2a"}, "2": {"node_id": "ffecce29-2cc7-474a-b89c-ad8e750e8111", "node_type": null, "metadata": {}, "hash": "bfecb447f23ac9b2cefd9c4c69b0f3e62f63c4f7cd8f68a096d70364efd98eff"}, "3": {"node_id": "4a84a8a3-0b30-498f-af20-1bfe7b1fd16d", "node_type": null, "metadata": {}, "hash": "3410fc5c40280a248f0878b3a0488f6a9e735189a29e27ee95afb7c15db70af8"}}, "hash": "de5b8a24785768bfdc3a6bb58ec6bd1bca965a70b348d0cf0d8d9fe56db58a84", "text": "no other alternative but to change the gene.\n\nThe report provides a rationale for this type of work, which the government in the United States has avoided, but the work is being done in Sweden and China already. So, hmm, okay. Now I wanna give you another article in the New York Times that's about 20 years earlier. It was also published in the Washington Post. If you think big government interferes in your life too much now, wait till the government starts regulating the genetic constitution of your children. Such regulation will inevitably follow the introduction of genetic engineering of humans because the consequences of unregulated genetic engineering of humans would be disastrous. Now remember, we're talking about things like the social contract and political health and what's happening here. This is a paragraph that's talking about the relationship between the government asserting power over the individual, the citizen, and also the future citizens, the children of the citizens as yet unborn. Continuing on, the usual response to such concerns is to talk about ethics, but a code of ethics wouldn't protect freedom, it would only make things worse. Somebody, jumping down to line four in paragraph 124, somebody, probably the upper middle class, would decide that such and such applications of genetic engineering were ethical and others aren't. Even if a code of ethics was chosen on a democratic basis, the majority would be imposing values on any minorities who might have a Going down to the third to last line, since to the majority of people, many of the applications of genetic engineering to the human will seem obviously unequivocally good, perens, eliminating diseases, inevitably it's going to happen. So the reasoning presented in this piece is, I would argue, exactly the same as what the government advisory group came to 20 years later. This picture here, the portrait of the gentleman, is taken on the campus of Cal, UC Berkeley, but if you wanted to see his more recent portrait, he's serving multiple life sentences in a federal penitentiary. He's known publicly as the Oona Bomber. He was a person who would send mail-order bombs to airline executives, to computer scientists, faculty at universities, and to a few geneticists as well. Again, right at the intersection of political health, government, citizen, bioengineering, and so on. So, with all of this as introduction, we're gonna set up the first breakout, and Naomi, are you operating the first breakout? Yes.\n\nWhat should bioengineers do such that all infectious diseases are totally obsolete by 2030? And by all infectious diseases, I mean whether it's a natural one, whether it's an engineered one, and by obsolete, I mean, practically speaking, they may exist, but they don't matter, or they don't exist, I don't know, right? So we're gonna head into the breakout and we'd like you to come up with answers to this. Think about the skills we've been positioning this week, the framestorming, can you change the question completely? And also the futures wheel. If you did this, what would be the consequence and then what would happen and then what would happen? So I'll pause there, Naomi, and over to you, please.\n\nSo, Drew, in this framing, the opposite of a citizen is a consumer, correct? Not necessarily. I think about it as, and I'll use a hierarchy just to organize it. You could have a society constructed of citizens. You could have a society constructed of consumers. You could have a society constructed of subjects. You could have a society constructed of objects. So subject to a king, for example, object would be property, the slave. A consumer would be somebody who can access the means of production only and directly via purchasing, but not via production directly, right? Can access the products of production, but not production itself. Whereas citizens would have the option of accessing the production capacity directly.\n\nIf you look at the trajectory of the United States, we've gone from a society of citizens and subjects and objects to a society of citizens and consumers, where I would say, although we're all\u2014well, although most are\u2014I think we're more now than", "start_char_idx": 21207, "end_char_idx": 25397, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4a84a8a3-0b30-498f-af20-1bfe7b1fd16d": {"__data__": {"id_": "4a84a8a3-0b30-498f-af20-1bfe7b1fd16d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "96613642-e63d-4b1e-8252-ecb4d4e26853", "node_type": null, "metadata": {}, "hash": "ba174d57ceb0febb8ae056f28396e73f06817980b2b2bed3da830f0f74651a2a"}, "2": {"node_id": "929d9da9-c77e-4d30-9866-f5da79d36830", "node_type": null, "metadata": {}, "hash": "de5b8a24785768bfdc3a6bb58ec6bd1bca965a70b348d0cf0d8d9fe56db58a84"}, "3": {"node_id": "64084fbc-0d40-4ce2-bf17-f5dcd7232297", "node_type": null, "metadata": {}, "hash": "71f86dbd010fbd8a96b3a97a1c95a4008d349c7e0566aca45f70d839be93a6bf"}}, "hash": "3410fc5c40280a248f0878b3a0488f6a9e735189a29e27ee95afb7c15db70af8", "text": "say, although we're all\u2014well, although most are\u2014I think we're more now than citizen. But anyway, the positioning of people within a society is not stable, right? It changes over time.\n\nThe current strategy is to frame the physical molecules of proteins in DNA and RNA as just specific instantiations of polymers and just really drill the idea that biology does additive synthesis because it makes it easier to describe what a genetic code is by saying you read this many monomers of DNA and you add this many monomers of amino acids and the mapping of those is a genetic code. Then it allows you to also just say the process of adding monomers can be regulated and that's transcription, translation.\n\nI think that's great. I would also offer for some it may be useful to think about the puzzle of going from abstracted information to three-dimensional organization of matter, right? And so the bases of DNA are an abstraction of an information register, and that's in one dimension. mRNA is in one dimension. A peptide is in one dimension, but then the peptide folds into three. And so suddenly you go from this abstracted information that's linear to three-dimensional structure. And that's, if you haven't thought about it that way, it's amazing, right? It's where that shows up.\n\nLike what would happen if, if like things that could happen if just infectious diseases became obsolete. And so then we started talking about like that means like, should we even, should we do it? Like what potentially could happen if you don't, if bioengineers chose not to, or if they did choose to? You guys have any specifics? Yeah, we were thinking that, let's say they did choose to, that would then, it would probably be expensive, that whatever happens. So then the problem of who gets the solution would come and then that would bring things like racism into it. It would bring discrimination into it. It would bring, you know, it would need, there would need to be like global cohesion for all the countries to like agree together and if they don't, then that means that again goes against, goes to discrimination, et cetera.\n\nYeah, those are good points. It looks like, so we had a family. You commented on what, like how resistance of these diseases would occur, like to our treatments. Did you want to comment or anyone else in your group want to comment more on like how resistance would be a problem or how that could be kind of tackle? Yeah, so we were talking about, so given that like viruses and bacteria can mutate, it might not ever be possible to eradicate infectious disease even if we had an infinite amount of time. So one of the solutions that we brainstormed was like could scientists possibly develop develop some sort of methodology for or simple algorithm, not simple, but an algorithm by which they get a virus, they expose this algorithm to a virus and then it produces a vaccine pretty pretty quickly or an antibiotic pretty quickly but I mean that's super super like futuristic but I think that was the only way we saw like infectious disease ever being eradicated.\n\nhelping a lot of people come up with a lot of like less technical and more like social solutions. And like, for example, this one about how we change funding and how we discuss funding to promote research for new vaccines and treatments and stuff. So not just trying to think of the technical or technology aspect of trying to make infectious diseases obsolete, but also funding and social interactions like here, not shaking hands and disinfecting, just more public health type solutions?\n\nThese are great questions. And one of them is, if this happened to develop countries, would it leave poorer countries more susceptible? I think those are really legitimate questions to ask. I think the answer is yes.\n\nI was like, so Jordan made a comment saying like a lot of people view maybe other countries or parts of the world as kind of over there, them, and that like the us is protected, but maybe this whole kind of discussion is bringing up the idea that maybe our concept of who's they versus us might change or could be made even worse if we try to make all diseases obsolete. I don't know,", "start_char_idx": 25400, "end_char_idx": 29577, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "64084fbc-0d40-4ce2-bf17-f5dcd7232297": {"__data__": {"id_": "64084fbc-0d40-4ce2-bf17-f5dcd7232297", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "96613642-e63d-4b1e-8252-ecb4d4e26853", "node_type": null, "metadata": {}, "hash": "ba174d57ceb0febb8ae056f28396e73f06817980b2b2bed3da830f0f74651a2a"}, "2": {"node_id": "4a84a8a3-0b30-498f-af20-1bfe7b1fd16d", "node_type": null, "metadata": {}, "hash": "3410fc5c40280a248f0878b3a0488f6a9e735189a29e27ee95afb7c15db70af8"}, "3": {"node_id": "6ee6fab6-6f36-4f8a-907e-97225c01d8f0", "node_type": null, "metadata": {}, "hash": "900c93666b958248dc84e8c04e94bded0a4c32f9a0fb03091da6a554509d137e"}}, "hash": "71f86dbd010fbd8a96b3a97a1c95a4008d349c7e0566aca45f70d839be93a6bf", "text": "even worse if we try to make all diseases obsolete. I don't know, Jordan, if you wanted to talk more about, like, if you guys thought that this would be kind of a, improve this type of problem or make it worse. Yeah, I think that it would, like, if we could shift to a mindset where we understand how interconnected the world and like, how, even if like in the US looks at it from a completely objective lens, it is in our self-interest to, like, take care of the rest of the world because our health is so intertwined with everyone. And I do think that eliminating infectious diseases would be, like, a net positive on that, like, us-them divide, just because they're kind of inherently, like, you have a disease and could infect me. So it's a disease that kind of pits people against each other naturally. And like, that's obviously really bad. I'm like, it's not anyone's fault. But you can see that, like, even with COVID.\n\nCan I just ask a quick question about that, which is what you said is really quite true. But it is also true that the current leadership of the United States has rejected that approach to the world. Do you think this international pandemic will change minds to a degree that we can start thinking a little bit more about protecting ourselves by protecting others?\n\nI think it really depends on if the narrative shifts and I guess that's like, all has a lot to do with the election. But I think if the people kind of continue with the current rhetoric, then we were probably just gonna like fall into the same mistake or maybe have like temporary change and then go back to the way we are. And like the over there language I use is like from, or at least where I remember that from, is like how our idea of over there got destroyed by the bombing of Pearl Harbor and that something so far away could intimately affect us. But that also would suggest that people are kind of gonna maybe momentarily change and then go back to the way things were.\n\nThis is great. That's a great response. And I wanna highlight one thing and then pass it back to Naomi to wrap this up. Sivaj, to ask you to help us parse this chat and get it out to everybody and John for the closing comment. But the thing to loop back to from today is you can experience a pandemic from the perspective of Rousseau and parse it as a public health crisis, a global public health crisis, and to act together to mitigate suffering globally. Or you can parse it through the perspective of Hobbes, that this is a security issue. This is an act of violence. And depending on which frame you invoke or which frame gets invoked by the culture of the body politic, you will either be more likely to work together across boundaries or faction in opposition. So it's pretty interesting to ponder some of this. As bioengineers, you might not have expected to be deeply connected to political theory, but here we are. And as you become leaders in particular ways, this type of thinking and decision-making will become as essential, if not more important to how much nerd awesomeness you can bring. Both are important, but this is really critical. So thanks again for really amazing feedback from the breakouts. Naomi, you want to have any final word on the breakout?\n\nI mean, I think you had a \u2013 you kind of had a good summary. I think \u2013 yeah. But I think you guys all \u2013 like, these are really great comments. We will try to synthesize them all and kind of make a brief post about kind of a summary. But thanks for all \u2013 for all of you guys for participating so well in these breakout sessions. John, did you have any specific announcements about assignments and...\n\nI have two announcements. Actually, I have three announcements. First of all, please start looking for P-SET 2. That is up or will be up shortly. Two, I wanted to speak specifically about what's in the packages that you've received from us, because I think it's important that you all, as informed receivers of these packages, know what you're holding. They're all very benign objects, one of which is an origami microscope made here at Stanford that's basically paper and", "start_char_idx": 29589, "end_char_idx": 33708, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6ee6fab6-6f36-4f8a-907e-97225c01d8f0": {"__data__": {"id_": "6ee6fab6-6f36-4f8a-907e-97225c01d8f0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "96613642-e63d-4b1e-8252-ecb4d4e26853", "node_type": null, "metadata": {}, "hash": "ba174d57ceb0febb8ae056f28396e73f06817980b2b2bed3da830f0f74651a2a"}, "2": {"node_id": "64084fbc-0d40-4ce2-bf17-f5dcd7232297", "node_type": null, "metadata": {}, "hash": "71f86dbd010fbd8a96b3a97a1c95a4008d349c7e0566aca45f70d839be93a6bf"}}, "hash": "900c93666b958248dc84e8c04e94bded0a4c32f9a0fb03091da6a554509d137e", "text": "one of which is an origami microscope made here at Stanford that's basically paper and plastic. The colorful liquids that you received are part of another lab that is called Dancing Droplets. These are solutions of water and propylene glycol, which is a common food additive. In fact, it's food grade. I don't recommend drinking it, but in theory you could, along with some food coloring, plastic pipettes, and some glass slides. The reason why we asked you not to open these packages is because those glass slides have been treated such that their surfaces are ultra clean. This is necessary for the experiment. We're gonna ask you also to do a cleaning step before we run that experiment later on, but that cleaning step is much easier for you if those glass slides are left unperturbed in their original packaging. So if you've received these packages, that's awesome. We're really excited. If not, we expect that the internationally shipped packages should arrive by Monday. If you ask for a domestic package and haven't received it yet, please ping the instructing staff. Last announcement, next week we're going to be getting into a lot of really cool nitty gritty around engineering the individual molecular machines that make up life. Like, so we're going to peer into the cell and look at subcellular machinery, how they interact and how we can engineer those objects such that we can do things as bioengineers. We also recognize that this is an introductory course and there are no prerequisites of any biological information needed to join this class. But there are prerequisites of biological information that you need to understand these lectures. So in order to bridge that knowledge gap, we are hosting on Sunday during my office hours a biological on-ramping session in which we're going to cover just nitty-gritty basics of molecular biology and biochemistry. We're going to describe what DNA really is, what proteins really are, how they're made, how information flows in biology, how biology regulates itself. So if you feel shaky on any of the specifics of the biology, I strongly recommend you pop in.", "start_char_idx": 33675, "end_char_idx": 35797, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "dd8aa3f5-cec3-4794-807d-10e726bf074c": {"__data__": {"id_": "dd8aa3f5-cec3-4794-807d-10e726bf074c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aafa609a-4cb3-42f7-8637-aa761dc4f733", "node_type": null, "metadata": {}, "hash": "1a7ee453f78e2d6dda67284488d956265465841e38f28c07c5a3131199ba7722"}, "3": {"node_id": "d7d40529-0952-4823-99b7-b571aecfd62b", "node_type": null, "metadata": {}, "hash": "cb3e03996ce9461b70b337c3416f06b61a1c1f79ad13f6913ae53decfeeb96c1"}}, "hash": "cc5fb3c0597eb185c2c222225d7b8adf4858a408e9d665ce775f78e0f1e7f95f", "text": "WEEK 3 MONDAY LECTURE 7\n\nWe had a tutorial over the weekend on Sunday on the basics of biomolecules and the physical composition of living matter. All of those materials are now available online. In addition, there will be a second tutorial next Monday, which will be not on the physical construction of living matter, but rather the abstraction of living matter, talking about the genetic systems that control living matter and how we might engineer them. So if you feel uncomfortable with the words transcriptional regulation, phosphorylation, post-translational modification, networks, AND gates, if any of these words are less than familiar, this will be the tutorial for you. This will be given by Victor on Monday.\n\nSo we looked last week at domains of opportunity as a concept, what do bioengineers wish for? And we focused your attention on three different aspects. People, disease, wellness, what do people care about from bioengineers? The planet, what do species have to do with bioengineering? What do ecosystems have to do with bioengineering? So planet health and political health, how the practice of bioengineering is connected to so many things, and it manifests in terms of how people relate to each other and to the government. So those are the big concepts from last week. The tools or skills we wanted to introduce you to are shown here, Framestorming, which to read it back, the question you ask frames the answer you get. So Framestorm before you brainstorm, as Tina Selig would say. Or if you're stuck trying to figure out an answer to a question, maybe you got the wrong question, so you should reframe the question. That was Framestorming. And we also did futures wheel. What happens as a consequence of doing something? This is a tool that can be used to understand what the impacts are, both direct impacts and indirect impacts. So when you're trying to make a decision as a leader about whether to advance or oppose a particular application of bioengineering or bioengineering development, maybe you'd want to use a futures wheel as a tool to understand consequences of success.\n\nIf you've got questions about Week 2, I'd really pick up on Sivash's comment. Let us know. Bring it to office hours. Ask us for a one-on-one at a better time. Not going to reprise last week any further right now. Looking ahead to this week, we've got four concepts and three skills. Who are you and how are you motivated is a concept we're gonna cover today. How should engineers think about tools is another concept we'll cover today. And then Wednesday and Friday are analysis and design of molecules and systems in biology respectively. The skills are gonna be build your own microscope, tools for representing biomolecules, tools for representing genetic systems.\n\nSo let's get right into it.\n\nI bet many of you, if not all of you, are familiar with physical activities like going up and down stairs or kicking a ball. And when you think about it, you might have a preferred stance. You're going to kick that soccer ball with your right foot or your left foot if you had a choice. When you go up a staircase, you'll put your right foot first or your left foot first, depending on your preference, depending on your natural stance if you were Skateboarding or surfing or snowboarding you'd have a right foot forward or a left foot forward as well And so finding your stance how you prefer to start something is is familiar with physical activities But perhaps less familiar with mental activities and so in the pre class for today. We had an activity That is designed to help you find your natural stance with respect to learning scientific and technical knowledge. And so I'll turn this over to Sivash to walk us through this.\n\nRight. So the activity was that you have a box that you've spent some time building, right? And then you flip the switch and you're expecting to light come up, but instead you get a poof and a smoke that starts pouring out of the device. And we ask you that what would you respond? Would you say darn or would you say cool? And how does that help us to think about our stance towards bioengineering? So some of us might care about discovering. We are really excited to figure out how", "start_char_idx": 0, "end_char_idx": 4224, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d7d40529-0952-4823-99b7-b571aecfd62b": {"__data__": {"id_": "d7d40529-0952-4823-99b7-b571aecfd62b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aafa609a-4cb3-42f7-8637-aa761dc4f733", "node_type": null, "metadata": {}, "hash": "1a7ee453f78e2d6dda67284488d956265465841e38f28c07c5a3131199ba7722"}, "2": {"node_id": "dd8aa3f5-cec3-4794-807d-10e726bf074c", "node_type": null, "metadata": {}, "hash": "cc5fb3c0597eb185c2c222225d7b8adf4858a408e9d665ce775f78e0f1e7f95f"}, "3": {"node_id": "16317337-af6a-47f3-9966-c28247926065", "node_type": null, "metadata": {}, "hash": "ca8a5a4b313f2a9f7c9e6d3b5db310b3a13a3482524c5736b7df66bbcd16987f"}}, "hash": "cb3e03996ce9461b70b337c3416f06b61a1c1f79ad13f6913ae53decfeeb96c1", "text": "So some of us might care about discovering. We are really excited to figure out how things might work. How does a cell work? Some of us really want the thing that we spent a long time building to work. That's what we care about. Like, you know, we wanted to work and and that might help us to be a maker or the other one might help us being an explorer. The idea here is that you have to be able to switch both to switch and be able to do both. But just like, you know, kicking a ball, you have a first foot that you would put forward as a bioengineer and you would be able to switch these perspective or switch these hats. So I see that 20% had said cool, about 40% have said darn, a fraction, like I think 30% have said both, and 5% are saying other. Other is fair too.\n\nI'm going to end the poll and just share the results so everybody can see what you're saying there. This is super helpful. This this tool came to me from Tom Knight, an electrical engineer and friend at MIT long ago. One way of interpreting the results is if you say, darn, I just want this thing to work, that might indicate that your preference is to learn by tinkering, by building. If you say, cool, like is there a mystery here? I don't know why it's not working like it's supposed to, but I'm gonna find out. That might give you a sense of you prefer to first learn something in a more scientific mindset. And as Sivash is pointing out, and a number of you are saying both, you prefer both. That's fine too, you can hop up the staircase. No problem. And that's valid. So this isn't meant to be a prescription. But when you start to see what we're doing in bioengineering, for example, you know, Anna Maria, if I wished for you to learn everything about how peptides interact with nucleic acids, I could give you a problem like here's a natural biological system that uses this type of molecule and figure out how it works. Or if you were a tinkerer, I'd say you could build Boolean logic with DNA binding proteins. The same knowledge is underneath those questions, but how you're motivated to learn could be complementary or distinct. And again, it's not a prescription, it's just a tool to consider when you're working to motivate yourself and finding classes that help you learn. Anything else on this, Subhash? No, that's about it. Okay, great.\n\nSo we've got one more concept to land today.\n\nSo the second concept we wish for you to pick up on is how bioengineers or how engineers in general think about tools. And we're going to give you two ways of thinking about it. So what's shown on this slide is a very simplistic cycle of how engineers work through projects. Once you know what your project is, you've got to prototype it or design it, build it and test it. So you could call this the core of the engineering cycle. And of course, when we navigate this core, we're dependent on the tools we have. And so not only do you care about the tools you have, but as an engineer, we also care about making the tools we have better, improving the tools. And so there's a tremendous domain of work and success in bioengineering in particular, and making better tools. And you can think about a, better is a subjective term, right? So better could be what? Better could be faster. You could do part of the cycle more quickly. Better could be smarter. It might take a while, but whatever you make works. It's like the perfect design. It's easy to build. It's easy to test. It's a smart way of going about it. Or maybe you could take something and do it a billion times in parallel, each a little bit different. Biology does this all the time with mutation and evolution. So maybe we could get better at engineering biology by enabling more shots on goal, so to speak. So one of the things we wish to give you consideration of is how tools are central to bioengineering and improvements to tools in particular are particularly central to bioengineering. Second, and this is going to sound a little bit strange, just the words line up in a strange way, so I want you to both be patient and have fun with what I'm introducing", "start_char_idx": 4157, "end_char_idx": 8256, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "16317337-af6a-47f3-9966-c28247926065": {"__data__": {"id_": "16317337-af6a-47f3-9966-c28247926065", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aafa609a-4cb3-42f7-8637-aa761dc4f733", "node_type": null, "metadata": {}, "hash": "1a7ee453f78e2d6dda67284488d956265465841e38f28c07c5a3131199ba7722"}, "2": {"node_id": "d7d40529-0952-4823-99b7-b571aecfd62b", "node_type": null, "metadata": {}, "hash": "cb3e03996ce9461b70b337c3416f06b61a1c1f79ad13f6913ae53decfeeb96c1"}, "3": {"node_id": "e247ef33-5c3f-4884-a641-b9849175f7f0", "node_type": null, "metadata": {}, "hash": "eb2248265f34fb5b3e5e01ebb8d65bfda96cff0671da5694984b8d05a9b2bb7a"}}, "hash": "ca8a5a4b313f2a9f7c9e6d3b5db310b3a13a3482524c5736b7df66bbcd16987f", "text": "way, so I want you to both be patient and have fun with what I'm introducing you to here. Tools are not tools. It depends on the form of a tool. And I'm going to give an example of painting as a way of thinking about it, but of course the fold scope, which we'll work on shortly, is a great example of this as well. So it used to be not that long ago that most artists, most painters would mix up their own paints from pigments, from scratch. And only just over a century ago maybe that quote, unquote, ready-made paints in foil tubes became widely available. This matters because it impacts who can use a tool, the paint, and where they can use the tool. For example, in this painting here from 1870, a scene at the beach, if you look at the painting carefully, you can actually see sand in the paint, on the painting, apparently. And so at least part of this painting was painted at the beach. So who is painting where? The answer to that question depends on whether or not the tool can be used in the scene shown here. Why does that matter? Well, that matters because depending on who's doing the painting and where they're doing the painting, that informs who's being painted. In this case, the painting is not of a matron in a salon in an urban setting who can afford to hire a painter to make a portrait. No, instead, this is workers in a field. So for this painting to have been painted, the tools of painting have to be accessible to the people who would paint in the field. This is interesting because it shapes the representation of what's being captured in the painting, the practice, and that then leads to things like meaning and culture. Depending on if you can paint quickly or not, you are going to capture effects of sunlight that might be transient and so on and so forth. I don't want to belabor the painting example, first, because it's not my expertise, but second, because I think it lands the point already. You can hopefully quickly think about comparisons to computers. An industrial computer that operates in the basement of a building is not the same as a personal computer. When people refer to the personal computer as a revolution, it's not really a revolution in science or technology. You know, like the logic of Bool doesn't change. It's who can compute where for what purpose. It's likely also the case that the personal bioengineering toolkit will have ramifications and opportunities all its own. So with that, we're now set up to introduce and operate on a tool for seeing biology, the Foldscope, which hopefully many of you now have a kit to assemble. And if you want to think about this in the era of hashtags, this is a tool that enables you to explore who you are and how you like to learn when you observe things through your microscope? Are you looking for useful gizmos in biology? Are you looking to discover? It's an example of an improved tool. It's an example of enabling you to engage with nature. And it's an example of a form of technology that enables many to access a technology. \n\nAnd our guest is here as well. Who is our guest, Sivash? Would our guest be willing to introduce himself or should we go ahead and introduce him?\n\nHey everybody, this is Manu here. \n\nYou are all dispersed across the country. And the world. And the world, actually. Yeah, no, that's... and you are about to join if you have not as yet already built your Foldscopes. You're about to join the world's largest amateur microscopy community globally. Foldscopes are distributed around 150 plus countries. Last year we crossed a million marks, so there's a million folks just like you who love to explore and are curious about the world. I think I can give you just a one-line backstory. Why we did this was to just make the experience of science accessible to every single person. And, you know, we all talk about the challenges. Science is fairly complex. It's also not everybody has the chance to be at Stanford, take these types of classes that really emphasize the, you know, in the context of a pandemic, you can think about this. Why is it that there are protests right now on the streets", "start_char_idx": 8264, "end_char_idx": 12387, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e247ef33-5c3f-4884-a641-b9849175f7f0": {"__data__": {"id_": "e247ef33-5c3f-4884-a641-b9849175f7f0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aafa609a-4cb3-42f7-8637-aa761dc4f733", "node_type": null, "metadata": {}, "hash": "1a7ee453f78e2d6dda67284488d956265465841e38f28c07c5a3131199ba7722"}, "2": {"node_id": "16317337-af6a-47f3-9966-c28247926065", "node_type": null, "metadata": {}, "hash": "ca8a5a4b313f2a9f7c9e6d3b5db310b3a13a3482524c5736b7df66bbcd16987f"}, "3": {"node_id": "c19dffdf-2bf6-4350-9f08-54a3a709f677", "node_type": null, "metadata": {}, "hash": "e696d3caaae7a78da0b8eff0dddccc250e01d1581a8860ea9238d57b42548282"}}, "hash": "eb2248265f34fb5b3e5e01ebb8d65bfda96cff0671da5694984b8d05a9b2bb7a", "text": "you can think about this. Why is it that there are protests right now on the streets of people wanting to just open up? So how do you really grapple these sets of issues? And the approach we have taken is that not everybody gets to genuinely have their own aha moments in science. And I think the sets of tools that we can make accessible would allow not just you, so I think I have a very specific ask for all of you. I know probably Drew and Subhash and have their own homeworks, but I have a very specific ask. You know, I'm not worried at all about you guys. You have made it in a way that you're gonna do brilliant work no matter what, whether you have this tool or not. My hope is what you can see yourself is a conduit to actually bringing the experience of microscopy and microbiology in general and show life in its real form at the microscopic scale to a much larger group of people in your community. And what a better way to do this assignment in your home, but physically in your communities yourself, because right now you're not in some dorm at Stanford, you are actually in your community. So a challenge to all of you would be is, first of all, make your own observations. See what's the craziest possible object that you can image. And I can guarantee you, when you dive in into the microscopic world, every preconceived notion, every one of your intuition will break down. You'll see kinds of things that just, your, I mean, human mind, frankly, is so limited in our imagination, unfortunately, from when you look at the natural world at the microscopic scale, it just truly stretches in balance in what you will observe. And, but you're going to do that in the context not of a lab, but in your living environment, outdoors or indoors, for example. The other big ask that I have is to just make sure that you engage with the community. When I literally said a million kids around the world, maybe what I'm gonna do is, Harish, how am I doing on time? I wanna show one picture to everybody. So that's- Let's show it. But I want to make sure that we have the time to show that picture.\n\nLet's do one picture and then we got to get to building the scope.\n\nSo, yes, and then I will disappear at that time. I'm just going to share my screen for a second and if you go to this community site it's called microcosmos.foldscope.com and this is literally the live wire of the Foldscope community. And, you know, I was just browsing through and it is all different languages. There will be some languages you won't understand. And I stumbled upon this post and I was just starting to read it. And I want you to engage with this community primarily because you will see the context of science, not just from your own eyes. So what's beautiful about this, this is about the COVID pandemic, and this person basically took all the mass that they could find in their community and they imaged it through a full scope. So what you're looking at is all this data that's coming out of full scope on all kinds of mass that this person could find. But importantly, this person is actually in Iraq right now. So this data is coming out of Iraq. And now you can click on his author ID and you start seeing what this person does and you can start seeing that this is not the first time he's engaged with the community. And this is what changes when you think about your context, but everybody is dealing with the same context. And the picture that I want you to see in terms of thinking about who you are joining as a community is, of course, I can never find my pictures. Okay, we could use this picture. is Fullscope as a community is not demarcated by age groups or by your academic degree or the capacity of your prior accomplishments. It's driven purely by curiosity. So what I'm gonna challenge all of you is make an observation as creative as these three girls actually already made in the community site. And I'm not joking, this is actually a real challenge. I've done this with many academic groups in classrooms at Caltech, the first intro to the classroom, and I put their posts and what they did right next to what a few groups of young kids in a slum in India did. And", "start_char_idx": 12381, "end_char_idx": 16560, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c19dffdf-2bf6-4350-9f08-54a3a709f677": {"__data__": {"id_": "c19dffdf-2bf6-4350-9f08-54a3a709f677", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aafa609a-4cb3-42f7-8637-aa761dc4f733", "node_type": null, "metadata": {}, "hash": "1a7ee453f78e2d6dda67284488d956265465841e38f28c07c5a3131199ba7722"}, "2": {"node_id": "e247ef33-5c3f-4884-a641-b9849175f7f0", "node_type": null, "metadata": {}, "hash": "eb2248265f34fb5b3e5e01ebb8d65bfda96cff0671da5694984b8d05a9b2bb7a"}}, "hash": "e696d3caaae7a78da0b8eff0dddccc250e01d1581a8860ea9238d57b42548282", "text": "did right next to what a few groups of young kids in a slum in India did. And it was an explosive thing where they were literally thinking about their surroundings in a way that I just could not even fathom. So here is a, you know, you want some competition. These three kids are your competition. And I'm actually, you might think this is a joke. I can, I, you know, that's a pretty high bar for you to think about. What are you gonna image? And on that note, the important bit is that you all share what you image because the moment you share, you will be mentors to these people around the world as well. So this is not about you per se, but how you use this tool as an act of activism to actually engage with this broader community. And especially in the context of a pandemic where people are scared, quite literally, with what it means, the microscopic world, is it all bad? So with that note, I'm going to shut up and I'll let you guys build your microscopes. You want to find videos and stuff, there are tons of tutorials online.\n\nManu, just want to read back before you go. Just want to read back. So challenge number one from Manu is wherever we all are, can we use Foldscopes and ourselves to engage as educators? And then second, your challenge is, what is the most amazing thing we can find? It's almost like, are you smarter than a fifth grader? Yeah. Yeah. So it's back with Microcosmos. Yeah. And we'll be back. So great. So thank you so much, Manu.\n\nBye, everybody. Thanks, Manu.", "start_char_idx": 16551, "end_char_idx": 18047, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "660755ea-048e-41a4-b58d-ea38c2776a26": {"__data__": {"id_": "660755ea-048e-41a4-b58d-ea38c2776a26", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2edfb660-1efa-4517-b3d7-2c7c42053af2", "node_type": null, "metadata": {}, "hash": "46ddd77afbb2a01ce15d8da0be74f66bffc6654b8f1d7f44268b62608cd3c42f"}, "3": {"node_id": "8b9bec50-67ce-4940-a5be-b99a7a838eaf", "node_type": null, "metadata": {}, "hash": "47c74735233168f39036c30612973913bf37bd2aab4762135f500cfed2ee77b7"}}, "hash": "35a8ebaff817b3486c6f8512c0af876d9847fd2c45c7db3ff0205ba88c19332c", "text": "WEEK 3 WEDNESDAY LECTURE 8\n\nHas anybody has anybody found something as exciting as what the young people all over the world are finding with these pocket microscopes? It's so interesting to me how it changes the perception of a microscope. Normally you think of a microscope as this precious, expensive piece of laboratory equipment that's almost sacred because of how much it costs. But these things you could use as a bookmark. These things you could put on the ground and stomp on it, accidentally or on purpose. It would probably still work. You can take it with you. So it's sort of like, you know, the cameras are now parts of the phone, oftentimes, right? And so the fact that you have a camera with you means that you use the camera. You all now hopefully have a microscope with you, which means that no matter where you are, you can see microscopic things. Yeah, yeah. Yeah, go ahead, Subash. That Yash said that they looked at the microbes in their in their pool. And yeah, you can see a lot of micro swimmers in standing like water with voltscope. They work very well for that. Yash, were they swimming or were they static, just subject to currents? Any idea? I think my mom had just put chlorine in the pool, so they were not swimming. They seemed to have been dead. Great.\n\nWhat's the magnification of the foldscope? Does anybody know? How small an object can you see on your origami microscope? About 150 times the size.\n\nSo something that would normally take up about a centimeter in your vision, you can now see, I guess, like 10 millimeters. I mean 10, I'm not doing math right, pardon. 10 microns, John? Okay, so two micron resolution, one to 10 micron resolution. So, an E. coli is gonna be about a micron, a yeast is gonna be about four microns, paramecium could be a little bit bigger. Cool.\n\nGreat, so there's more to explore with the foldscope that'll show up in the PSET coming out on Friday. Let's jump into, if you can think of a microscope as a measurement tool, and you've now been introduced and have a measurement tool. Today, we're going to pick up on analysis and design tools and introduction to analysis and design tools in bioengineering. Today, we'll focus on molecules, biomolecules, and then Friday we'll focus on systems, genetic systems. So the way today is going to go is I'm going to cover some DNA molecule stuff. Then we'll have an exercise. If you can think ahead to the exercise and find a piece of paper, if you can grab a piece of scrap paper wherever you are, even two, that'll be helpful for the exercise. After the exercise, we'll move on to peptides and proteins, analysis and design of them, and some tools for that. And we'll close if we have time with a breakout regarding what tool properties you would wish for. So, if you're patient with me, I'll jump into screen share and off we go. Brianna, can you see that okay? Thank you. Analysis and design of biomolecules. So this is an amazing microscopic image of a very thin, tiny strand of DNA, hair-like, this is decades old, going through the middle of this image. And then you can see just barely the process of transcription and translation. So where that arrow is on the right is where the DNA is being bound by an RNA polymerase and read out to make messenger RNA. So transcription starts on the right and heads off to the left. So it looks like maybe you can see an RNA polymerase molecule binding and getting ready to go. As the polymerase goes from right to left, it makes the transcript, and the transcript is recognized by ribosomes, the molecules that take the information on an mRNA transcript and turn it into a peptide, a polymer of amino acids that folds into a protein. So right above where it says 0.5 microns, you can see some dark splotches. Those are ribosomes assembled, many ribosomes assembled on transcripts, and they're, as soon as the transcript is being made, the ribosomes are loading and beginning to make protein. And you can't see the protein here,", "start_char_idx": 0, "end_char_idx": 3984, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8b9bec50-67ce-4940-a5be-b99a7a838eaf": {"__data__": {"id_": "8b9bec50-67ce-4940-a5be-b99a7a838eaf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2edfb660-1efa-4517-b3d7-2c7c42053af2", "node_type": null, "metadata": {}, "hash": "46ddd77afbb2a01ce15d8da0be74f66bffc6654b8f1d7f44268b62608cd3c42f"}, "2": {"node_id": "660755ea-048e-41a4-b58d-ea38c2776a26", "node_type": null, "metadata": {}, "hash": "35a8ebaff817b3486c6f8512c0af876d9847fd2c45c7db3ff0205ba88c19332c"}, "3": {"node_id": "1fa23db0-433f-47b4-91fd-2fc81a00a227", "node_type": null, "metadata": {}, "hash": "d10baa685ae677859d992f3ca1041268235c43ebc27c936309838101e7c39a9e"}}, "hash": "47c74735233168f39036c30612973913bf37bd2aab4762135f500cfed2ee77b7", "text": "are loading and beginning to make protein. And you can't see the protein here, if I remember correctly. So it's great to be able to see what it looks like if you can capture it on a microscope. But let's think about it more from an engineering perspective where we're gonna wanna eventually reprogram this stuff, change what's being read out, change what molecules are being made. So, yeah, promoter, transcription initiation, it's going to end off onto the left. So here is an information universe representation of a genome. a natural DNA sequence, meaning a sequence of DNA found in nature. This is for the biological system that it encodes, the entirety of the DNA sequence. So it's a relatively small DNA sequence. This is the genome of a virus, a virus of bacterium. And so when you take the physical object and you sequence it or read out the DNA, you get this abstracted information. That's not the real thing. It's a representation of the actual object, and it's these letters of A, T, C, and G.\n\nAnd so how do we make sense of this?\n\nAnd there's this wonderful quote from Eric Lander, who was one of the leaders of the public effort to sequence the human genome. He was asked to summarize the project in six or seven words. And he said, well, you know, bought the book, meaning we read out, we decoded all the letters that make up the human genome in this case, hard to read, hard to make sense of how this works. When you are confronted with this information, all you got, it's like, it'd be looking at a piece of software and you just get the zeros and ones in the compiled binary. You know, like it's hyper detailed. It's very hard to understand what's going on. So we need tools for analysis, whether you're a scientist, a discoverer, or a tinkerer, a maker, you need tools for analyzing these sequences. By the way, when we go to synthesize DNA, the equivalent statement from me is going to be, you know, can write DNA little to say. information into the printer is going to show up later. Practically, in words, analysis of biomolecules often starts as pattern recognition. We make models based on what we've already discovered about biology, and then we use those models to define patterns. And then we use computers to try and find matches to the patterns. Sometimes we're informed by biochemical mechanics. Sometimes we're just looking for patterns.\n\nSo here's an example.\n\nWhat's shown here is the table of genetic code. The DNA, when it goes to RNA and then protein, is gonna be decoded in what are called triplets or triplet codons, and you see here different triplets, combination of letters, this is representing the triplets as if they were on RNA, not DNA. So in DNA it would be a T instead of a U, which is shown here. So RNA uses U instead of T. So we've got A, C, U, and G. And depending on what triplet one encounters on the RNA, a different amino acid is going to be specified during protein synthesis as mediated by the ribosome. So for example, in red, you see the triplet AUG towards the bottom left, and that specifies the amino acid methionine. On the top right, you can see three different triplets, UAA, UGA, UAG, and those specify stop signals. When protein synthesis machinery, the ribosome encounters one of those triplets, it should stop making the protein. The red methionine, although it's called methionine, it's also a start signal. Protein synthesis should start there. So this is going to allow us to create a model for what a type of pattern is on a piece of DNA that gets read out into RNA. It's going to be called an open reading frame. It is a section of DNA that is read out by the ribosome and turned into a protein. And it starts with an AUG, and then it samples from this table of triplets, however is needed, and it ends with one of those three-stop codons.\n\nThis is an overwhelming image, but it gives you a lot of information, if you want to think about this from a physics perspective and a chemistry perspective, there's something amazing here", "start_char_idx": 3920, "end_char_idx": 7924, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1fa23db0-433f-47b4-91fd-2fc81a00a227": {"__data__": {"id_": "1fa23db0-433f-47b4-91fd-2fc81a00a227", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2edfb660-1efa-4517-b3d7-2c7c42053af2", "node_type": null, "metadata": {}, "hash": "46ddd77afbb2a01ce15d8da0be74f66bffc6654b8f1d7f44268b62608cd3c42f"}, "2": {"node_id": "8b9bec50-67ce-4940-a5be-b99a7a838eaf", "node_type": null, "metadata": {}, "hash": "47c74735233168f39036c30612973913bf37bd2aab4762135f500cfed2ee77b7"}, "3": {"node_id": "96f4fe87-4e21-4088-8381-6279675def54", "node_type": null, "metadata": {}, "hash": "f6ff3bedb63e2debd9084b14330c47a8ee5f1e64444c0d25c5e9d24722355759"}}, "hash": "d10baa685ae677859d992f3ca1041268235c43ebc27c936309838101e7c39a9e", "text": "a physics perspective and a chemistry perspective, there's something amazing here that John did a super nice job in the tutorial on Sunday. What's going on here is you're taking a linear polymer, a thread like DNA and RNA, and somehow that is being converted, which is basically a storage of information system, that linear polymer, and that's being converted into a framework that allows you to create three-dimensional objects, the folded-up protein, which is organizing atoms in three-dimensional space. So the significance of this lookup table is it's taking this linear triplet, the codon on the left, and it's coupling it to an amino acid, hisidine, lysine, and so on. And this table, this colorful plot on the right, rather, shows you how you go out the triplets from the first, second, third, as you go out the wheel to the amino acid, and then what the amino acid side chains are, that chemical structure, which is literally how the atoms are organized off the polypeptide backbone when you get a folded up protein. We'll come back and see more of this. I just want to hit you with this coupling of single-dimensional information polymers to what becomes a three-dimensional structuring of atoms. That's at the heart of biology and what makes it not just information science, but physical science and chemical science.\n\nWe now have a pattern for a type of function that we can identify when we do analysis of biomolecules, genetic molecules. The pattern here is an open reading frame, a section of the molecule that makes a codes for a protein, starts with an AUG and then goes until there's a stop, in this case, a UAA. So, anywhere we would find an AUG and then going into a UAA, we're going to say, oh, that could be an open reading. If we go back to the sequence I was showing you from before, highlighted in bold, starting at the bottom, you can see that that darker lettering and a green ATG about 10 lines up from the bottom. Hopefully, Brianna, can you see that? Thank you. That's the start code on for an open reading frame, and it just goes and goes and goes because there's no stop code on. It just keeps going, go, go, go. Goes all the way to the bottom, wraps around, goes across the top line, and then in this natural sequence, ends at a TGA, which would be a UGA on the DNA. So that's an open reading frame. How do we know that? Because we've got this model for open reading frames. Start with an ATG and end with a TGA, TAA, or TAG.\n\nHere's something strange.\n\nStarting three lines from the bottom is another ATG, and it goes around and ends at a TGA in the middle of the top row. This is a wraparound sequence, so in reality it's a circle. So there's no real breakpoint. What's strange about this open reading frame is it's inside the first one I was telling you about. How could an open reading frame be inside another open reading frame? And this is a nuance of the triplet nature of the code because it's decoded in triplets, you can start at any register, the register defined by the first A-ATG, or if you shift over one, you can have a totally different protein in the same real estate, in the same sequence of DNA. If you've never thought about that before and are excited about it, that's an expert-level topic, but just to give you a taste of that, because I presume some of you have heard about open reading frames and translation. So I just want to give those of you who are higher level that teaser. Now, here's a problem. When you just use this model for analysis of a sequence, hopefully you get what's shown on the left, because this is what the biologists tell us is true. These are actually the open reading frames on this natural sequence of DNA that are actually turned into proteins to make the virus. But if you just apply that pattern recognition tool, what you get is the map shown on the right, where each bar or arrow is a different, totally valid open reading frame that starts with a start codon, AUG, and ends with a stop codon. It is very hard to make sense of this. On the left, there's about 11 of these open reading frames that everybody agrees exist, but the computer, the analysis tool on", "start_char_idx": 7919, "end_char_idx": 12067, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "96f4fe87-4e21-4088-8381-6279675def54": {"__data__": {"id_": "96f4fe87-4e21-4088-8381-6279675def54", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2edfb660-1efa-4517-b3d7-2c7c42053af2", "node_type": null, "metadata": {}, "hash": "46ddd77afbb2a01ce15d8da0be74f66bffc6654b8f1d7f44268b62608cd3c42f"}, "2": {"node_id": "1fa23db0-433f-47b4-91fd-2fc81a00a227", "node_type": null, "metadata": {}, "hash": "d10baa685ae677859d992f3ca1041268235c43ebc27c936309838101e7c39a9e"}, "3": {"node_id": "5937a12d-c359-47dc-b0e8-7d42ef8f6d69", "node_type": null, "metadata": {}, "hash": "33a755a78d3ce05f4b814a5d20a85ccb936074c79cb6db9591b39a0041299941"}}, "hash": "f6ff3bedb63e2debd9084b14330c47a8ee5f1e64444c0d25c5e9d24722355759", "text": "of these open reading frames that everybody agrees exist, but the computer, the analysis tool on the right would tell you there's several hundred. That's hard to make sense of. And as an aside, since we're talking about tools and so on, I just wanna grab the... link off the bottom of that page. And, Brianna, can you see the page loading here, the web page? Is that a yes?\n\nThanks.\n\nSo, what I've done is I've grabbed the link off the bottom of the slide and loaded that up, and this is an example of a tool, it's a web browser based tool called BenchLink that was started by some students long ago out of MIT, and it's a sequence analysis tool that then feeds into a sequence design tool. So if you've never seen actual tools for analysis and design of sequences, I can point you to BenchLink as one example of a first, second order type of visual word processor for DNA sequence analysis and design. Let me pop back in to the slide deck. So another thing I'd hit you with is these tools we have for analysis by themselves are often insufficient because they don't capture the subtleties of how biology actually works. They just give you whatever the tool can do as an analysis tool.\n\nAnd the reason it's hard for the tools is. The tools are struggling to represent what's actually happening in terms of the physics of the biology, the physics of living matter, and. Just because you think you have a perfect genetic code model for a perfect open reading frame model.\n\nThe molecules that make up biology don't know that those are our models. In fact, they don't care what we know. They're just molecules doing their molecule business. This is a movie we made with colleagues up at Autodesk to show a ribosome binding on a nucleic acid sequence. And what this should give you a sense of is, you know, there's no hand of God that is purposely insisting on exactly the right thing happening. This is all being mediated by physical forces that are oftentimes very subtle and weak. So, for example, if you look at the patterns of stark codons and where the ribosome binds upstream of a stark codon across all known valid protein coding sequences or open reading frames in a genome, like the bacterial genome for E. coli, this analysis is showing you that, well, most of the time, the start codon is an ATG. The bigger the letter here, the more likely it is that that's going to be the base you see at that position. So, most start codons are ATG, but not all of them. Some start codons are actually GTG. Some start codons are T, TG. And then if you look at where the ribosome binds and the sequence it tends to like, it's much less deterministic. Many sequences can serve as valid start signals for protein synthesis. You'll have a lot of A's and G's. So the strongest one might be AGG, AGG, and you can kind of see that pattern in that hill, but it's not a deterministic situation. So what happens practically from an analytical perspective is you start to look for multiple clues coming together. It's as if you were a detective or a private investigator. It's like, well, I didn't see somebody commit the crime, but I got a little bit of indirect evidence over here and a little bit of other evidence over here that's circumstantial, and this looks pretty good. And I get enough different indications that something's happening, and I'll have increasing confidence that something might really be happening. So the analysis tools in biology and bioengineering sort of suffer from that oftentimes if we can't see the thing directly. Here's an advanced topic just to bounce back into that for a second. I was indicating that start codons here aren't always ATG? Well, a number, just a few years ago, we measured all 64 codons, could they make proteins? And it looks like they all can, but just to varying degrees. Meaning, every codon could be a start codon, just not as good a start codon as the conventional one, the AUG. Why am I telling you this if you're not already an expert. Well, a couple of things. First, bioengineering is operating on a frontier of analysis and design and our tools are meaning nobody", "start_char_idx": 12058, "end_char_idx": 16168, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5937a12d-c359-47dc-b0e8-7d42ef8f6d69": {"__data__": {"id_": "5937a12d-c359-47dc-b0e8-7d42ef8f6d69", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2edfb660-1efa-4517-b3d7-2c7c42053af2", "node_type": null, "metadata": {}, "hash": "46ddd77afbb2a01ce15d8da0be74f66bffc6654b8f1d7f44268b62608cd3c42f"}, "2": {"node_id": "96f4fe87-4e21-4088-8381-6279675def54", "node_type": null, "metadata": {}, "hash": "f6ff3bedb63e2debd9084b14330c47a8ee5f1e64444c0d25c5e9d24722355759"}, "3": {"node_id": "0063b3ea-0801-4263-9c56-75cca5255a7b", "node_type": null, "metadata": {}, "hash": "eab2e09ffac735f9d209470f24d99cba69d6cfc8b5f7bfaba2ae15708494cebd"}}, "hash": "33a755a78d3ce05f4b814a5d20a85ccb936074c79cb6db9591b39a0041299941", "text": "is operating on a frontier of analysis and design and our tools are meaning nobody understands perfectly how biology works. And so our tools can't possibly help us represent that perfectly. That means there's opportunity for better tools and hopefully we'll get to that at the end of the day. The other thing is when people talk about programming DNA, the word programming is dominated by the experience of software programming. And so here's a valid expression in C, the computer programming language. And if you typed out this thing and put return, you would expect it to work with 100 percent reliability. There's very few things you could put in the quotes there that would cause this print statement to not work. In bioengineering, we'd like to represent that there's something equivalent to that, that in a cell, if you put DNA encoding an expression cassette that would cause your favorite protein to be manufactured by the cell, getting this function to work from scratch is 50-50 likelihood. Maybe if you're really good, it's a 90% likelihood, meaning you put in the DNA code for your favorite protein, maybe 10% of the time it won't get made, or won't get made to the extent you wish it got made. And that's again, because our analysis tools and the reality of biology, the physics of biology are not artificially determined as in computer software to work all the time. And so there's that frontier of ignorance and opportunity in bioengineering. Let me pause, pop out of this. If you happen, we're gonna do a quick exercise. Wherever you are, I'd like you to, if you have a piece of scrap paper, find something you'd like to throw a paper airplane at and quickly make a paper airplane and throw it and hit the thing you're trying to hit, okay, across the room or something like that. So we're just gonna spend like 45 seconds on this, not very much time. So if you have the ability to make a paper airplane and find like the light switch across the room, please design and build a paper airplane and then test it by flying it. This is the engineering cycle, design, build, test, and let's go. Who can make a paper airplane and throw it across the room? We're just doing this exercise to give everybody directly or indirectly the experience of what it's like to analyze and design as a bioengineer.\n\nSo far, we've talked a little bit, just giving you a taste of nucleic acid as molecules and some of the tools. Let me turn to proteins.\n\nIn the pre-class for this week, there was a story about a project that was initiated as an undergraduate student project up at the University of Washington and this project was seeking to engineer a protein to treat gluten intolerance And Effectively what this project did was engineer an enzyme, a protein, to break down gluten in the diet so that you could ingest an enzyme, an engineered protein, and that would allow people who were intolerant to gluten to handle gluten in the diet, so to speak, incidental or accidental. What's interesting about this project is not only the protein engineering project, but the practical outcomes of the project. So, Ingrid, shown here, was one of the students involved. She since earned a PhD. Right from the student project, given its practical utility as a potential drug for the disease, they were able to get an investment agreement with a pharmaceutical company from raise money to start a professional team to bring this into clinical trials. And so the project that was done by students in 2011 becomes a company by 2017. And then if you follow this story, it's interesting, April 8th, 2020, so that's what, a couple weeks ago, the company was acquired for 330 million to bring it into the clinic. So I mentioned this because. You know, this might be typical in social or software based work, but it's neat to see an example where with a relatively small team, I think about 3030 staff, they were able to go from a student project to a pretty significant outcome that should help people as a medicine in about nine years. So maybe that's slow in some areas, but it's pretty nice that bioengineering, even with the tools we're about to explore, can pull that off. Okay, so back to Ingrid. So to make this therapy, this therapeutic molecule, they had", "start_char_idx": 16182, "end_char_idx": 20426, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0063b3ea-0801-4263-9c56-75cca5255a7b": {"__data__": {"id_": "0063b3ea-0801-4263-9c56-75cca5255a7b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2edfb660-1efa-4517-b3d7-2c7c42053af2", "node_type": null, "metadata": {}, "hash": "46ddd77afbb2a01ce15d8da0be74f66bffc6654b8f1d7f44268b62608cd3c42f"}, "2": {"node_id": "5937a12d-c359-47dc-b0e8-7d42ef8f6d69", "node_type": null, "metadata": {}, "hash": "33a755a78d3ce05f4b814a5d20a85ccb936074c79cb6db9591b39a0041299941"}, "3": {"node_id": "99423ed5-0c4e-40d0-ac63-d76dd2ecaadd", "node_type": null, "metadata": {}, "hash": "81ba5efadd52bbaa93cd0a169badde45113394316745a02fde9c5fc0203c6ec2"}}, "hash": "eab2e09ffac735f9d209470f24d99cba69d6cfc8b5f7bfaba2ae15708494cebd", "text": "Ingrid. So to make this therapy, this therapeutic molecule, they had to figure out how to achieve four design goals. And they're going to use tools to help them achieve these goals. They want the enzyme to degrade gluten, ideally in the pH of the stomach after a meal, so very low pH, pH of 2 to 4. The enzyme, they'd like it to not be digested easily, because if the enzyme that degrades gluten is digested, it won't be able to degrade gluten. So it needs to resist digestion by proteases. Three, you need to be able to make this protein that they've designed, this biomolecule. You have to be able to make it. You have to be able to manufacture it easily so that you can afford to make it and turn it into a pill or a supplement so that people can take it. for. They needed to have specificity for a certain motif. OK, now, if you want to see in great detail how they went about it, the link to the paper reporting their design work is at the bottom of the slide. So, again, if you want to level up and do advanced work, we are including that link for you. Here's a visual representation and a summary of what they did, and there's a lot of jargon here, so we're going to walk through it. And the next slide. To make this molecule, they start with an existing natural molecule. They're not building a biomolecule from scratch, they're starting with a scaffold, an enzyme that already works, and they're going to change it. And the way they're going to change it is they're going to make seven amino acid substitutions. They're going to change seven of the residues in that peptide that comprise the enzyme, the protein. The nomenclature across the bottom, V119D, S22262K and so on, that's biocode for what changes they're making. So they're changing the amino acid V at position 119 into the amino acid D, where the letters are the single letter abbreviations for the 20 amino acids. And so if you had the native enzyme and you had this set of seven changes at the bottom, you could tell what changes they made in order to produce the engineered enzyme.\n\nChanging amino acids, what does that mean?\n\nWell, you're changing the positioning of atoms in the molecule, but these amino acids have different properties. They could be hydrophobic, they could be tiny or big, they could be acidic, they could be charged or not. So by changing the amino acids, you can change both the chemical activity of the molecule, the protein, and also how things can fit into it, where that reaction might take place. So, this is just a cheat sheet, if you will, for how different amino acids have different chemical implications. So, now we come back to what they were doing. And the goal, summarized in somewhat plain English at the top, is to change a native enzyme that catalyzes digestion of collagen or, quote unquote, eats collagen to an engineered enzyme that catalyzes the digestion or cleavage of gluten. And to go from the collagen eater to the gluten eater, their solution, which they determined by computational design, is shown in this jargon again. So, for example, if we look at position in the middle, D293T, see that? If you go to the top left of the screen, you should be able to see a little yellow protuberance with two red ears. That's residue 293 on the native protein, and it's a D amino acid. That's what the side chain indicates. If you jump over to the same position on the right, they've changed that D to a T. It's very subtle, but the different amino acid has a different configuration of atoms. 291, just next to it, is changing from an N to a D, and so on. 262 changes from an S to a K. Now, what are we looking at here? What we're looking at here is a cartoon representation of the structure of the protein. So, this is a tool, because the protein, we can't see.\n\nIt's so tiny, right?\n\nNo foldscope will ever let us see the protein. This is a representation of how the atoms that comprise this protein,", "start_char_idx": 20437, "end_char_idx": 24353, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "99423ed5-0c4e-40d0-ac63-d76dd2ecaadd": {"__data__": {"id_": "99423ed5-0c4e-40d0-ac63-d76dd2ecaadd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2edfb660-1efa-4517-b3d7-2c7c42053af2", "node_type": null, "metadata": {}, "hash": "46ddd77afbb2a01ce15d8da0be74f66bffc6654b8f1d7f44268b62608cd3c42f"}, "2": {"node_id": "0063b3ea-0801-4263-9c56-75cca5255a7b", "node_type": null, "metadata": {}, "hash": "eab2e09ffac735f9d209470f24d99cba69d6cfc8b5f7bfaba2ae15708494cebd"}, "3": {"node_id": "16529f6c-0a09-4e13-8fbd-9a602de72665", "node_type": null, "metadata": {}, "hash": "dff339d9a88b37dd2c789b2beeb8a17910cd5a34ce01405321347eeb32cdfbd6"}}, "hash": "81ba5efadd52bbaa93cd0a169badde45113394316745a02fde9c5fc0203c6ec2", "text": "see the protein. This is a representation of how the atoms that comprise this protein, once you fold the polypeptide up into a three-dimensional structure, how they're configured in space, right? And so by using a protein analysis tool to give you a model of how the atoms are, you can begin to get a sense of what's going on. Just, excuse me, you can begin to get a sense of where things are. It's very, very hard to get a sense of what's going on. Is anybody able to tell me, for example, what the change from D at position 293 to T does by inspection, by looking at this cartoon representation? We know overall that these changes collectively turn the collagen-eating protein or collagen-digesting protein into a gluten-digesting protein. But can anybody elaborate or just explain to us how any of these changes pull this off?\n\nQuestion about the notation of the protein. Do the blue and the red caps indicate charge? I'd have to be careful and double check what they're using for their color code here. Could be charge, could be atom. Can you go back to the image in particular? So red should represent oxygen atoms and blue should represent nitrogen atoms.\n\nI don't want to belabor it, but I'm hitting you with the question just to again give you a sense of where these tools are on the frontier of bioengineering. So what's shown here in this bullet list are the designers' understanding of what these changes do. So, if I go down to the fourth sub-bullet, D293T likely introduces an interaction with other residues in the protein outside the catalytic site. So, it's somehow stabilizing the structure of the protein, maybe to make it less likely to be digested or operate at the low pH of the stomach after a meal. They're not claiming that. How are they coming up with these designs? Oh, that's interesting. So they're using a program, a piece of software that takes the sequence of amino acids and has a physics model for the most likely low energy state of the atoms in the polypeptide chain. And the computer program just tries to jiggle around and minimize the energetic state of the molecule, the most likely favorable thermodynamic state of the molecule as they're trying to get these different properties to show up. Practically, it's something that by itself the computer tool is not sufficient to guarantee a right answer. It's very much a tinker and then test in reality process. I'm gonna mention one tool that you'll see again as a very nice tool for looking at proteins, but we're not going to spend class time on it, called PyMOL. I'll summarize the workflow of the example we were just going through and then give you a simpler tool for looking at proteins that's nicely connected to structures of proteins. So, they're using modeling and simulation tools, Ingrid and her colleagues, to suggest mutations that would better bind the desired substrate motif found in gluten, which is itself a peptide, right, so the PQLP. They then are given a list of candidates coming out of the design tool. They make those by DNA synthesis, which we'll talk about later. They make the physical protein and then they experimentally test it out. So, you know, imagine writing computer software where, you know, you've got, you know, an integrated design environment that's kind of suggesting code that might work. And then you'll make a hundred versions of the program in parallel and see which ones work by testing them. That's probably not how most people design software because we have better tools for compile, check and navigating this process. But anyway, that's what's happening in this example and is typical, I would say, of biomolecular design for proteins. Let me give you just a visual exploration of a complementary tool for looking at proteins, both supporting analysis and design. So this is going to be the embedded viewer in what's known as the protein data bank. And what's amazing about this, if you look at it at the very top, you see they have over 100,000 biomolecular structures. This is a free database where anybody can go to and get access to the arrangement of atoms comprising proteins as they actually assemble into three dimensional objects.\n\nSo the the name of this", "start_char_idx": 24340, "end_char_idx": 28543, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "16529f6c-0a09-4e13-8fbd-9a602de72665": {"__data__": {"id_": "16529f6c-0a09-4e13-8fbd-9a602de72665", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2edfb660-1efa-4517-b3d7-2c7c42053af2", "node_type": null, "metadata": {}, "hash": "46ddd77afbb2a01ce15d8da0be74f66bffc6654b8f1d7f44268b62608cd3c42f"}, "2": {"node_id": "99423ed5-0c4e-40d0-ac63-d76dd2ecaadd", "node_type": null, "metadata": {}, "hash": "81ba5efadd52bbaa93cd0a169badde45113394316745a02fde9c5fc0203c6ec2"}, "3": {"node_id": "eeeb62d0-d13a-4581-84e2-e5fee3a5aaa5", "node_type": null, "metadata": {}, "hash": "dec7f39a490a54d54b11bdd5d0218e9ba8dcc7d96723b968055242dcc18bee6e"}}, "hash": "dff339d9a88b37dd2c789b2beeb8a17910cd5a34ce01405321347eeb32cdfbd6", "text": "as they actually assemble into three dimensional objects.\n\nSo the the name of this molecule is here, ZIF-268 Zinc Figure DNA Complex. And what's cool about this is I've got a cartoon representation of how the atoms are arranged to make this object. The atomic structure is determined by measurement techniques such as X-ray crystallography or so on. And what we're looking at here are actually several molecules linked together by just how they fit together and how they interact physically and chemically. So right here in this orientation, if you can see the orange and green, we're looking down the interior of a double helix of DNA. So the orange and green are the backbones of DNA, double-stranded, and those little staircase pads are representations of the bases that are pairing with each other. So, we're going to line that up again like this. So, now we're looking down the backbone. And then, wrapped around the DNA is a cartoon of a protein called a zinc finger. This is a type of protein that can interact with specific DNA sequences. And you can see how that interaction might happen. You see the folds of the protein sort of looping around the groove of the DNA and slotting in there, almost like a lock and key mechanism, but at a molecular scale. Let me see if I can bring up another one. So, this is another DNA binding protein, so we should be able to see the DNA again. There, we're looking down the DNA, or we can see it this way. Right here is DNA in orange and green. And then this protein, make it a little bit bigger, this protein is actually what's called a dimer. So that means there's two copies of the protein. One is magenta and the other is purple or pale purple. And they're interacting with each other through this long zipper-like arm. This is called a leucine zipper. That's a set of amino acids that tend to homodimerize or interact. You see all these little specks, those are water molecules. So I'm just gonna, if you can see them, I'm just going to get rid of the water to clean this up. And the two leucine arms interact to make a zipper, and then these zinc fingers, again, like we were just looking at, are interacting with the grooves of DNA. So just by looking, you can begin to analyze how this molecule might be I think it's, for example, the regions down here that are coupled through the helix and the grooves in the helix of the DNA are gonna cause this protein to bind a particular sequence of DNA, which could be useful later. We could turn on gene expression by binding a particular sequence of DNA. Or maybe we could turn off gene expression by finding a particular sequence of DNA defined by the amino acids in the protein and what sequence they interact with. Similarly, by changing the leucine zipper, I can determine whether or not this protein is gonna bind with itself or binds with a different protein. So I might be able to use that if I had two different zippers to implement a Boolean logic function like AND. I have to have the magenta protein and I need to have the blue protein together at the same time in order to turn on gene expression. And maybe I can control how proteins interact and whether they interact or not by the amino acid sequence in this zipper region, if that makes sense. So simple analysis tools that just give you cartoon representations based on where the atoms actually are. I don't want to belittle that. It's amazing, are very helpful because they set the engineer up to design. And as soon as you can see where things are and imagine changing them, well, we can go back to the biocode and try it out. Again, just to be faithful and emphasize the point, I don't know of any perfect design tool that allows for the engineer to make a exact change on the computer and then that sequence of DNA. So encoding the molecule is guaranteed to work. Instead, it's always this tinker and test reality for now, at least. But maybe some of you could go on and make the perfect bio design tool. That's a lot to cover in one session.\n\nWhy did it take nine years to get the company started, from a student project to an acquisition, it was not that long to do the protein", "start_char_idx": 28546, "end_char_idx": 32692, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "eeeb62d0-d13a-4581-84e2-e5fee3a5aaa5": {"__data__": {"id_": "eeeb62d0-d13a-4581-84e2-e5fee3a5aaa5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2edfb660-1efa-4517-b3d7-2c7c42053af2", "node_type": null, "metadata": {}, "hash": "46ddd77afbb2a01ce15d8da0be74f66bffc6654b8f1d7f44268b62608cd3c42f"}, "2": {"node_id": "16529f6c-0a09-4e13-8fbd-9a602de72665", "node_type": null, "metadata": {}, "hash": "dff339d9a88b37dd2c789b2beeb8a17910cd5a34ce01405321347eeb32cdfbd6"}}, "hash": "dec7f39a490a54d54b11bdd5d0218e9ba8dcc7d96723b968055242dcc18bee6e", "text": "started, from a student project to an acquisition, it was not that long to do the protein engineering and to show that you could have this engineered protein that would degrade gluten. But now you're talking about a human therapeutic. And so it has to be tested for two things. It has to be tested and shown to be safe, and it has to be shown to be efficacious. Right? And so that testing for safety and efficacy are not activities that even begin until after you have a molecule that looks like it's working, because that's gonna be expensive. So a lot of the latency in the process is testing for safety and efficacy. The other thing is you have to demonstrate that you can take it from a benchtop prototype that maybe you can make a little bit of and it kind of works. And now you need to be able to make it to treat everybody who needs it, right? So you might need to be able to make 100,000 or a million doses of the molecule. So testing for safety and efficacy and scale up are where a lot of the time goes. It's not, so it's stated differently. If you wanted to deploy a web service from your new app, there's Amazon Web Services, there's cloud computing, there's app stores, right? There's infrastructure that makes the scaling of a piece of software go to market very, very quickly. That infrastructure mostly doesn't exist in bioengineering. Since the questions come up, and I don't know we'll have a reason to do it later. I'll give you just one example for those who are sticking around via screen share. So this is a website of a company that was started by some graduates of Stanford's chemistry program and it's called Emerald Cloud Laboratory. And the way this works is you can access their laboratory remotely by running experiments through scripting, a scripting language, a web interface, and then they have a laboratory in the old South San Francisco mail sorting facility that will carry out the experimental results and then report back the data for your consideration. So, nothing like that's existed, you know, five years ago, and they're doing experiments around how would you just operate a laboratory that anybody could access through the web on the clouds, right? That's a great question, Sierra, and hopefully that gives you a taste of why it takes a little while. Yeah, thank you for answering that. And then do you know what percentage about of drugs that go into clinical trials, like what percentage won't get to go into market? About 80 percent of any drug that gets that far won't make it to market. Sometimes it's even more than that. It's a very difficult thing to go through the safety and the efficacy and come out the other end with a viable product.", "start_char_idx": 32673, "end_char_idx": 35363, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4f1ff419-1c3b-4a6b-925f-e5a1062f2be1": {"__data__": {"id_": "4f1ff419-1c3b-4a6b-925f-e5a1062f2be1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4029a4e4-3c05-41b1-aab2-3512cb045dbd", "node_type": null, "metadata": {}, "hash": "2dda1466baa1267f1a8b470ee695a4bfcea9fbb6ad8183e00dc76720d5b4729f"}, "3": {"node_id": "f9c3f23d-e0c4-4758-a2ac-37eaf8f61d91", "node_type": null, "metadata": {}, "hash": "f80edccbc6e5bf328a3e92ef6c594627e8209a0f019fa301cc605b0e1bf8b339"}}, "hash": "f110e5e82e780609b26e979d6d461a94322ef6d88c114fc682271e7254255f77", "text": "WEEK 3 FRIDAY LECTURE 9\n\nSo we're going from analysis and design of biomolecules to analysis and design of biosystems with a particular introductory focus on genetic systems. And so from molecules to systems, we can anticipate that we'll be dealing with more than one molecule, and hopefully you got a sense of that from the pre-class reading. We'll pick right up and use the pre-class reading to introduce what it's like to think about, i.e. analyze systems of molecules and set up to design them. I'm going to jump into a screen share and head off to today's slides. Nikolai, can you see those thumbs up? Thank you. So here's the first of two papers, an oldie but a goodie, 20 years old. This paper was published maybe just before, maybe right around the average birthday of the class, I wonder. Maybe you're just a year younger on average. So a synthetic oscillatory network of transcriptional regulators, Mike Elowitz, Stan Liebler. Let's use our paper parsing tool. So can we make sense of the title? A synthetic network of transcriptional regulators, an oscillatory network, something that's oscillating, something that's oscillating involving regulators of transcription. From Wednesday and the tutorials, hopefully we can think of that as the reading out of DNA, the transcription of DNA to make messenger RNA. Now when we skim this abstract, I won't belabor it, I'll go right to what I would consider to be the main claim. We used three transcriptional repressor systems to build an oscillating network. So in the double-bolded text is what I think the most succinct main claim of this paper is. We used three repressors to build an oscillating network. So there's a strong claim, curious title. The next step in the paper parsing tool, everyone should remember, is go find the evidence. And the main evidence, I would argue, shows up in figure two. So again, hopefully you saw this. I won't spend too much time on it, but to remind you or warm you up, at the top of this, we're looking at a time series. Each snapshot is an image taken of a colony of bacteria growing on a microscope. The bar in row B, that's this black bar, I guess that's about a micron or a couple of microns. And the numbers across the top, 60, 140, 250, and so on, those are minutes. So it's a time-lapse movie going up to 600 minutes or 10 hours. The A row, which is a black background, that's recording the glowingness of the cells, the fluorescence of the cells. And the gray background row, row B, that's a light image, what you would see just with normal light. So if you focus on row B for now, you can see that the cells are rod-shaped bacteria, E. coli in this case, and they're growing and dividing on a two-dimensional surface. They're building into a little colony, a little village of bacterial cells. The arrow in both row B and row A are pointing at exactly the same cell. The lower row is what it looks like under normal light, and then the top row is what it looks like in terms of the glowingness of the cell. And if you follow where that white arrow is pointing, you can sort of see at time 60 minutes on the left, the cell is dark, and then it gets a little bit brighter at time 140 minutes, and then it gets dark again at 250 minutes, and then it gets brighter again around 300 minutes, and dark again around 390 minutes, and bright again around 450 minutes, and dark again at 550 minutes, and bright again at 600 minutes. And this is quantified in the plot below, where the x-axis of the plot is the same time in minutes, but it's showing more data points, not just the snapshots or postcards up top. Then the y-axis is the glowingness or fluorescence of that cell pointed out. And a couple trends, or one trend and then one observation, the trend is overall the fluorescence is going up. So independent of anything else, these cells are just getting brighter with some glowing object inside them. But then if you look at the rise and fall of the glowingness, you follow this messy", "start_char_idx": 0, "end_char_idx": 3984, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f9c3f23d-e0c4-4758-a2ac-37eaf8f61d91": {"__data__": {"id_": "f9c3f23d-e0c4-4758-a2ac-37eaf8f61d91", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4029a4e4-3c05-41b1-aab2-3512cb045dbd", "node_type": null, "metadata": {}, "hash": "2dda1466baa1267f1a8b470ee695a4bfcea9fbb6ad8183e00dc76720d5b4729f"}, "2": {"node_id": "4f1ff419-1c3b-4a6b-925f-e5a1062f2be1", "node_type": null, "metadata": {}, "hash": "f110e5e82e780609b26e979d6d461a94322ef6d88c114fc682271e7254255f77"}, "3": {"node_id": "67a91526-3d60-4a7b-a97f-4740da4a7fd7", "node_type": null, "metadata": {}, "hash": "146dda9d63768edcfe52a4a433397b775f92d04f311ce710db748396c4915623"}}, "hash": "f80edccbc6e5bf328a3e92ef6c594627e8209a0f019fa301cc605b0e1bf8b339", "text": "then if you look at the rise and fall of the glowingness, you follow this messy trace over time. It's going up and it's going down, it's going up, it's going down, it's going up, it's going down, it comes back up again. Does anybody have any questions? Let me pop out of this. Does anybody have any questions about this main evidence? Yash has a question in chat that talks about the inspiration for the work.\n\nHe's talking about the PRE circadian rhythm as inspiration for the work.\n\nWas this study inspired by circadian rhythms? How is the mechanic different from that? It's a good question. Absolutely. Michael is inspired by oscillations found all throughout nature, timing with respect to day-night cycles. The timing of pattern formation is in development. But there's another thing that was motivating Michael, which was a type of curiosity regarding, do we understand enough about how proteins or biomolecules behave inside cells such that we could engineer a system that would have a chance of behaving like we expect? So this is a project done 20 years ago, which means the project was actually done several, started several years before it was published. So it started, say, in 1997. It was started when Michael was a student at Princeton in the physics program working in biology. And the question back then was, could we put together a system of four genes, as you're about to see, and have it behave as we intend. So part of the motivation is, of course, the curiosity of oscillations and how important and beautiful they are in nature. But at a very fundamental level, scientific and engineering, it's like, can we operate biology at all, according to our intentions, at this scale of complexity? So there's two motivations, I would say. So thank you, Yash, for the question. I'm just skimming the other questions. Why do the maximum fluorescent peaks increase gradually with time as the system continues to oscillate? So that's a question from Ahmed. Thank you. That's a great question. Why does the amount of fluorescence ever go down? Why doesn't it keep stepping up like a staircase? So the fact that it's actually going away at all, that indicates that whatever is causing the fluorescence is being actively degraded by some type of garbage disposal, protein chomper inside the cell that will recycle proteins. And that if the protein wasn't continuously remade or made under the control of this oscillator, the cells would be totally dark. Now it looks like the rate of production on average is greater than the average rate of degradation. And so you get this trend, this upward trend, like the upward trend in atmospheric carbon dioxide just keeps going up, up, up. The other thing that's causing the cell's fluorescence to go down is the amount of proteins in the cell get diluted out by the new growth, if you will, unless they're remade. So if you just stop and think about a cell doubling, a cell doubling is not some poof, magically the cell's twice as big. Every object in the cell got copied, approximately. So balancing production and dilution due to growth and active degradation to get a horizontal line is quite an engineering feat that's not perfectly accomplished here. If you're asking about degradation, Josh, it's not that. It's an SSRI system and we can take that offline.\n\nYeah, so the main evidence here is just this signal, this brightness of the cell that's going up and down, up and down, up and down over a period of 10 hours, maybe five peaks, and there you go. So, how'd they do it? How did Michael and Stanislas do this? And this is their schematic, if you will, their blueprint for their genetic system, their oscillator. And what's shown here is the layout. It's literally a blueprint of the DNA that encodes the oscillating system, which Michael named the repressilator, for reasons that'll become apparent in a moment. The circle on the left that's got the beautiful colors, the orange, red, and blue, that's the oscillating system. And the circle on the right, that's just the readout system that's gonna control the making of fluorescence or not. So let's talk about the making of fluorescence", "start_char_idx": 3921, "end_char_idx": 8069, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "67a91526-3d60-4a7b-a97f-4740da4a7fd7": {"__data__": {"id_": "67a91526-3d60-4a7b-a97f-4740da4a7fd7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4029a4e4-3c05-41b1-aab2-3512cb045dbd", "node_type": null, "metadata": {}, "hash": "2dda1466baa1267f1a8b470ee695a4bfcea9fbb6ad8183e00dc76720d5b4729f"}, "2": {"node_id": "f9c3f23d-e0c4-4758-a2ac-37eaf8f61d91", "node_type": null, "metadata": {}, "hash": "f80edccbc6e5bf328a3e92ef6c594627e8209a0f019fa301cc605b0e1bf8b339"}, "3": {"node_id": "bde6d71c-aed5-49d6-9b79-796edda986cc", "node_type": null, "metadata": {}, "hash": "e79a5af788d419302d5df33ae7cc7f2380d1fcef6e6f0d07d3bfaa0aebed9d96"}}, "hash": "146dda9d63768edcfe52a4a433397b775f92d04f311ce710db748396c4915623", "text": "control the making of fluorescence or not. So let's talk about the making of fluorescence because that's simpler. On this circle, you can see there's a block on the right which is green, and that's the open reading frame. Remember open reading frames from Wednesday start with an AUG or ATG, end with a UAA or equivalent. So there's a set of triplet codons on DNA. Oh, right, these circles represent abstractly DNA sequence. The circuit DNA sequence, which is the reporter system on the right, within that reporter system, on the right-hand side in the green block, I've got the DNA sequence, the open reading frame for the green fluorescent protein. And the production of that is controlled by the orange block just above it, which has this funny nomenclature PL1001. So basically, that orange block, if it's turned on, will cause the green protein to be made. And if it's turned off, you won't get the green protein made. And all the stuff grayed out on this right side circle is just maintenance functions to keep the DNA around. So we're going to not talk about that today. So the only thing that right circle is doing is when the signal is correct, make more green glowing protein or not. The oscillator is shown on the left, or at least it's schematic. And if you're just keep the same idea, if that green block on the right is an open reading frame for a protein, all the longer blocks on the left are going to be open reading frames for different proteins. The orange one is called TetR-Lite, the red one is called LacI-Lite, and the blue one is called LambdaC1-Lite. And there's no consistency in nomenclature here. LacI, that fourth letter in the name is LacI, whereas CI, it's not CI, it's C1, and that's just biology mumbo-jumbo, so we're not going to worry about it, but that's why I'm talking fun. So I've got a system on the left, and the blueprint says I've got three different open reading frames for three different proteins. And the way Michael has set this up is the proteins are going to control whether or not each other are made. the orange protein, Tet-R, is going to bind down at the bottom in front of the blue box for the C1 protein, the lambda protein. That blue box, that C1 protein, that'll bind in front of the red box for the lacI protein. The lacI protein will bind in front of the Tet-R open reading frame in its red box. So, the colors match each other. Where you see these arrows pointing clockwise, that's where the proteins encoded by the colored open reading frames bind and control the other open reading frame. Holy moly.\n\nI want to pause and backfill a little bit of knowledge for those who need it. So I want to talk for just a minute about regulation of gene expression via repressors. So how does gene expression in prokaryotes or bacteria work? Typically you're gonna have a gene. In bioengineering you can make it your favorite gene. So imagine you have an open reading frame as shown in the blue box here for your favorite gene. It could be any gene you like. To the left of that, often called upstream, there's going to be a region on the DNA, which is where the RNA polymerase molecule physically binds the DNA and initiates transcription, or promotes transcription, the reading out of the DNA to make RNA. And that region, because it promotes transcription or promotes gene expression, is conveniently referred to as a promoter. And within the promoter region, there are going to be specific sequences in a prokaryote often where the physical molecule of the RNA polymerase touches with the DNA to recognize that sequence as a promoter and initiate transcription. And those can often be referred to as minus 10 and minus 35. That's the number of base pairs before the RNA transcript starts. So this is just background information that you need to have in order to understand how one of these repressor proteins are going to work. So a repressor protein is going to be a separate, distinct biomolecule. It will also bind DNA. It'll bind DNA at what are known as operator sites, where the repressor operates, quote unquote, on the DNA. And the operator sites,", "start_char_idx": 8059, "end_char_idx": 12167, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "bde6d71c-aed5-49d6-9b79-796edda986cc": {"__data__": {"id_": "bde6d71c-aed5-49d6-9b79-796edda986cc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4029a4e4-3c05-41b1-aab2-3512cb045dbd", "node_type": null, "metadata": {}, "hash": "2dda1466baa1267f1a8b470ee695a4bfcea9fbb6ad8183e00dc76720d5b4729f"}, "2": {"node_id": "67a91526-3d60-4a7b-a97f-4740da4a7fd7", "node_type": null, "metadata": {}, "hash": "146dda9d63768edcfe52a4a433397b775f92d04f311ce710db748396c4915623"}, "3": {"node_id": "96e63029-1f71-42fe-818c-58017536a9b5", "node_type": null, "metadata": {}, "hash": "b190880c9ddc6394cabf310dd4078a47c57694202093004e73cf020166c7b798"}}, "hash": "e79a5af788d419302d5df33ae7cc7f2380d1fcef6e6f0d07d3bfaa0aebed9d96", "text": "where the repressor operates, quote unquote, on the DNA. And the operator sites, there can be one, two, or three of them in locations like what's now shown in these red boxes with the O's inside them, just imagine what's gonna happen. If another protein binds, say, in that middle O between the green minus 10 and 35 boxes, and that protein's just hunkered down on the DNA, it's gonna compete with the RNA polymerase for binding. So repressors regulate gene expression in this very simple principle that every three-year-old, four-year-old, or five-year-old can understand. You cannot have two objects in the same position in spacetime. So if you have one molecule on the DNA doing one thing, you cannot have another molecule in that same exact location in space at that time doing some other thing. So if a repressor protein is binding in one of its sites and that occludes or blocks the RNA polymerase from binding, the RNA polymerase will not bind, and you'll get little or no gene expression. Stated differently, when a repressor's concentration is high inside a cell, if it acts at a promoter to turn it off, whatever gene is next to that promoter will be not expressed at all or very weakly expressed. I want to pause there and do a check-in and ask for questions of clarification or anything else.\n\nIf you're following along, you should be able to get to a next type of protein. Imagine you have a site next to the promoter, not blocking the RNA polymerase, but a place where a protein could interact with the DNA and help the RNA polymerase bind and initiate transcription. Such a protein would be called not a repressor that turns off or represses transcription, but an activator that turns on gene expression. So as soon as you get the idea that you can dock proteins on DNA and they can block or help other proteins binding DNA, then you can begin to think about how to construct control systems and logic related to anything to do with gene expression.\n\nSince we were looking at visualization tools and analysis tools for proteins, I pulled from the protein data bank, the links and the actual structures for all the proteins that comprise this repressilator system. So on the left is a crystal structure cartoon representation of the lambda repressor binding its operator sites on DNA. Lactose repressor is in the middle. Tetracycline repressor is the blue object towards the right, second from the right. And the green fluorescent protein has this famous barrel shape standing alone and when hit with the right wavelength of light will emit a green wavelength of light typically. So if you want to follow up and look at what sequences they interact with, how to think about reprogramming what sequences a repressor binds to, you can take a look at the structures, get the exact sequences, see what happens if you start to change the residues and so on. So, Vash, can I rely on you to call out any questions that are showing up in the chat? Yeah, thanks. So I want to come back to this blueprint and try and talk it out. How does this thing actually produce an oscillation? So imagine a starting situation where the lambda repressor, the protein encoded by the blue box is high. When that protein is high, it's going to act on its operator site upstream of the lack red box. So it's gonna turn off the production of red. So blue is high, red is gonna be low, that red protein. If that red protein is low, then it won't turn off the expression of TET. So the yellow protein will go up. But if the yellow protein will go up, look how it regulates the production of the blue protein. So the blue protein will go down. If the blue protein goes down, then the red protein can go up. If the red protein goes up, then the yellow protein will go down. If the yellow protein goes down, then the blue protein can come up. So the way Michael's laid out the operator sites in relation to the open reading frames is causing one repressor to regulate the next repressor, the second repressor to regulate the third repressor, and the third repressor to loop back and regulate the first repression and it happens to be the case that one of the three the tet or orange one yellow one is regulating the green", "start_char_idx": 12175, "end_char_idx": 16378, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "96e63029-1f71-42fe-818c-58017536a9b5": {"__data__": {"id_": "96e63029-1f71-42fe-818c-58017536a9b5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4029a4e4-3c05-41b1-aab2-3512cb045dbd", "node_type": null, "metadata": {}, "hash": "2dda1466baa1267f1a8b470ee695a4bfcea9fbb6ad8183e00dc76720d5b4729f"}, "2": {"node_id": "bde6d71c-aed5-49d6-9b79-796edda986cc", "node_type": null, "metadata": {}, "hash": "e79a5af788d419302d5df33ae7cc7f2380d1fcef6e6f0d07d3bfaa0aebed9d96"}, "3": {"node_id": "0a34bd99-0674-4038-b979-d20aa5c00460", "node_type": null, "metadata": {}, "hash": "978a6ea15bb611b271d7d0369c693757fcf262466a6244960afc11a57815dc3e"}}, "hash": "b190880c9ddc6394cabf310dd4078a47c57694202093004e73cf020166c7b798", "text": "the case that one of the three the tet or orange one yellow one is regulating the green so that's what's coupling this to an oscillatory readout but the heart of the oscillator is three negative interactions a turns off B turns off C turns off a and when a is high B is low. And so C is high, so A goes low. So B can go high, so C can go low. Right, so there's a closed loop, closed cycle of the system speeding back on itself dynamically, that results in an oscillation.\n\nWhat would happen if, for example, instead of having three repressors in a cycle, you had four? So to make the word simple, A turns off B, B turns off C, C turns off D, D turns off A. What would that system do dynamically over time? Anybody want to take a guess? Just chime in on that.\n\nMore generally, what would be the difference in the behavior of this synthetic genetic system if you had an even number of negative regulations in a cycle versus an odd number? So Jack has a comment on chat who he says it won't oscillate. It won't oscillate, that's correct. So what will it do instead, would you guess?\n\nWhat's the opposite of a oscillation in time? If I have A and it's high and it's turning off B, so B is low, then B won't be present so it won't be able to turn off A, so A will stay high. So if I have two of these negative regulators cross-regulating each other, I'll have one of two possibilities. A will be high and B will be low and they'll stay like that, or B could be high and A could be low and they'll stay like that. And so it serves as a memory element to hold state in one of two counterbalance positions. So it's pretty interesting just by thinking about how the connections are related to one another, you can get qualitatively different dynamical behavior, store a memory or make a pattern over time.\n\nSo it's from the same paper, but it's just the full movie. And you can see it at your leisure at Vimeo through the link below. Michael was nice enough to post it there. a better sense of what's going on with the growth of the bacteria and the blinking, the oscillation of the fluorescence. I'll just run it back. Victor, does that work well enough coming across for you to see it clearly? Thank you. So let's just stop and I want to ask a question. Can you see my mouse pointer? Okay, see these cells right here that just divided and they're in this intermediate bright state?\n\nLet's just watch them go forward in time. Now they're dividing again.\n\nSo now there's four children in the family. And look how, you know, one, two, three, four cells. These two cells over here, which are more closely related, are significantly brighter than these over here. And if we play this out a little bit more, now these are totally off and these are still on. Why are they different? And look how fast they're different. You know, like they're becoming different in minutes. These are genetically identical cells all running the same DNA code, so far as we know. And if you just follow the bright one turning on right here, super bright, they're just not, and then some of them come back on but they don't. So this is what you would call in simple language a noisy system. It's performance over time. It quickly diverges one system to the next.\n\nThe second paper we asked you to parse sets up a question about why or why not that may be occurring. And so this is looking at a different genetic system, which is a natural system in this case, a system called bacteriophage lambda, from which Michael got one of his repressor proteins when he made his oscillator. So if we parse this paper quickly, the claim is highlighted at the bottom of the abstract in this case. The question posed in the title is, what's determining when a cell is infected with a virus whether the cell is destroyed and releases progeny or survives but carries a dormant virus? And the claim here is that variation in the size of the cell, the volume of the cell at the time of infection can be used to predict and perhaps determine cell fate. A twofold difference in", "start_char_idx": 16377, "end_char_idx": 20401, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0a34bd99-0674-4038-b979-d20aa5c00460": {"__data__": {"id_": "0a34bd99-0674-4038-b979-d20aa5c00460", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4029a4e4-3c05-41b1-aab2-3512cb045dbd", "node_type": null, "metadata": {}, "hash": "2dda1466baa1267f1a8b470ee695a4bfcea9fbb6ad8183e00dc76720d5b4729f"}, "2": {"node_id": "96e63029-1f71-42fe-818c-58017536a9b5", "node_type": null, "metadata": {}, "hash": "b190880c9ddc6394cabf310dd4078a47c57694202093004e73cf020166c7b798"}, "3": {"node_id": "36442997-87ec-4cb2-b348-77450a7d15bd", "node_type": null, "metadata": {}, "hash": "0c559297f1fc7944842d878423a50ccf15c13c9b341358c3867db6cb6159676e"}}, "hash": "978a6ea15bb611b271d7d0369c693757fcf262466a6244960afc11a57815dc3e", "text": "used to predict and perhaps determine cell fate. A twofold difference in volume leads to a fivefold biasing in what happens. And the evidence here is a plot buried in the paper that says how big is the cell on the X axis and then shows what's the outcome of the infection of the virus. The blue curve that goes up from left to right says the cell is more likely to be destroyed the bigger the cell was when it was infected. The magenta curve that goes down from left to right, the cell is more likely to survive the smaller it is when it was infected, and it's well studied in part because it's the benchmark system for understanding how genes are regulated by repressors and activators. So, I'm highlighting a book that's a wonderful book to learn from, and in this book you can You can see an operator region where an RNA polymerase is interacting with DNA to turn on gene expression. It can turn on gene expression in either direction on the DNA, to the left or to the right. The top cartoon is showing what happens if the RNA polymerase binds and initiates gene expression to the left. That results in a viral infection outcome where the cell survives, it's infected, but the infection is dormant. Alternatively, if the polymerase initiates transcription enough times heading in the opposite direction to the right, a different set of regulatory molecules repressors will get made. It will reinforce that outcome, and the developmental pathway controlled off to the right on the DNA will happen, and you'll get a viral infection that kills the cell. So the determination of when a virus called Lambda infects a bacteria results in death of the cell and release of progeny or dormant infection and survival of the cell all comes down to whether repressor proteins that are turning on and off gene expression, how they bind around an operator site. This has been very complicated for biologists to figure out, but they figured it out, but it's been way more complicated for bioengineers to think about. So here's a beautiful paper from Stanford, a real good friend, Adam Arkin, did back when he was a postdoc, and he's talking about the analysis of this bifurcation. By bifurcation, he means, does the RNA polymerase bind this part of DNA and go to the left, or bind this part of DNA and go to the right? And the text highlighted here, I'll just read it out. When two proteins act at low concentrations in a cell, competing with each other at a switch point, stochastic, which is a fancy word for random, random variations in the concentrations of the proteins lead to probabilistic pathway selection, in plain English, lead to a coin flip, such that an initially homogenous, identical population of cells spontaneously partitions into distinct subpopulations. What Adam's arguing is, because cells are so tiny, when you start thinking about biomolecules, proteins that make up systems acting, the actual number of proteins in the cell is maybe it's like 10 proteins in the cell, or maybe it's even smaller than that, maybe it's two. And suddenly you can't think about this like a bulk continuum system. It's a discrete, almost single molecule system that's going to be subject to all sorts of random thermal noise and random behaviors. And if you set up a switch-like element where something could go one way or another way, depending on where a repressor protein binds at that moment, you'll just get a coin flip. Holy cow. Imagine if that's true. Imagine if would-be engineers of biology somehow have to navigate randomness at the fundamental level of molecules interacting with other molecules because we simply can't control it, right? And it's part of the miracle of life, but now you want to engineer something and how's that gonna work?\n\nI'll just show you what it looks like from a systems engineer perspective. You know, Adam's got that switch region in that box called the Lambda switch where there's three operator sites and the polymerase can go left or right, but then he's linking that up to all the other feedbacks and outcomes and so on. So he can better think about it and analyze", "start_char_idx": 20411, "end_char_idx": 24511, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "36442997-87ec-4cb2-b348-77450a7d15bd": {"__data__": {"id_": "36442997-87ec-4cb2-b348-77450a7d15bd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4029a4e4-3c05-41b1-aab2-3512cb045dbd", "node_type": null, "metadata": {}, "hash": "2dda1466baa1267f1a8b470ee695a4bfcea9fbb6ad8183e00dc76720d5b4729f"}, "2": {"node_id": "0a34bd99-0674-4038-b979-d20aa5c00460", "node_type": null, "metadata": {}, "hash": "978a6ea15bb611b271d7d0369c693757fcf262466a6244960afc11a57815dc3e"}, "3": {"node_id": "283d0512-492c-4e90-9b45-e2f585ccdf1a", "node_type": null, "metadata": {}, "hash": "592b5fce32aeefea2485b0e6a3015982a1e9275bdddc9d5d9bcb8a1abb75ed6d"}}, "hash": "0c559297f1fc7944842d878423a50ccf15c13c9b341358c3867db6cb6159676e", "text": "other feedbacks and outcomes and so on. So he can better think about it and analyze the system. Just to give you a hint at what's coming when you try and make sense of these natural systems. Okay, so I wanna set up a breakout and we'll spend five minutes and breakout, but let me set it up by spending a moment here on this movie. This is a movie from the pre-class, but I want to bring us all together and narrate some of the significance of it.\n\nSo this is a time-lapse movie of bacteria growing and dividing. I'll pause and just go, whoa! Like, I've got bacteria growing and dividing? This is an object of like 20, 30 billion atoms that can make a copy of itself? That's incredible. That's one of the fundamental things that's incredibly exciting about bioengineering. We can operate with objects that organize disorganized matter into structures like themselves, and they do it in tens of minutes. We've got reproducing machines. So if you're an engineer who likes to build things and that doesn't blow you away, whoa, like you just, we gotta talk, because this is amazing. All right, now, editorial side. These cells, which are growing and dividing, they're also infected by a virus, at least some of them are. The cells that are infected turn green and you can see in this movie the cell in the top right that just got blown up, that was infected, so we'll let the movie reset and see. Okay, just okay got infected and poof it just lysed. You can't see the virus particles on this light microscope because they're too tiny. They're only like 60 nanometers, shorter than the wavelength being used on the microscope. So this cell is infected up here, gone. This cell down here, it's infected, it divides, and it survives. And its progeny survives. So right in this movie, genetically identical cells, each infected with exactly one copy of the same virus. One cell experiences death by viral infection, the other cell survives. You might be wondering, why don't the other cells get infected and there's just not enough time for the virus to get over there. But so here's the setup for the breakout. There's a binary outcome here, life or death, survival or not. You can think of that if you want as zero and one. If you take the claim from the second paper, you might notice that the cell that pops is bigger when it turned green. The larger cells tend to pop or get destroyed. The cell that survives is smaller at the beginning. But at the breakout, please just think about, well, what do you think? Do you think biological system behavior at this scale, at the scale of individual cells, is it random? Is it a coin flip or is it determined? Or could it be determined? So, I'd like to break up to discuss that question. The second question is, why does the answer to this question matter in general to bioengineers? Why would a bioengineer care about whether or not the control of behavior in biology can be determined or is always going to be random. So if we could pause there and go to breakouts for five minutes or so, and come back with answers to those two questions, that would be fabulous.\n\nI hadn't appreciated that Adam Arkin had done a kinetic model of the lambda switch? Yeah, it's very, very important. It was the first mapping of a developmental biological process onto a representation of intercellular physics that was better than continuum differential equations. So it's a really profound step to take. In this case, I believe it to be entirely incorrect in terms of what it predicts about the biology.\n\nSorry, I don't have my glasses, appreciate the extreme beautiful connection to very fundamental physics about the nature. So that's, that's, that's an answer. It's a good answer. It's similar to quantum physics, there are probabilities. And as engineers, it seems unlikely, because we are, because we are complex machines, and that level of abstraction seems unlikely. Jordan, can you add a little bit to that? What do you mean?\n\nNo, that's okay. I'm not explaining it very", "start_char_idx": 24505, "end_char_idx": 28505, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "283d0512-492c-4e90-9b45-e2f585ccdf1a": {"__data__": {"id_": "283d0512-492c-4e90-9b45-e2f585ccdf1a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4029a4e4-3c05-41b1-aab2-3512cb045dbd", "node_type": null, "metadata": {}, "hash": "2dda1466baa1267f1a8b470ee695a4bfcea9fbb6ad8183e00dc76720d5b4729f"}, "2": {"node_id": "36442997-87ec-4cb2-b348-77450a7d15bd", "node_type": null, "metadata": {}, "hash": "0c559297f1fc7944842d878423a50ccf15c13c9b341358c3867db6cb6159676e"}, "3": {"node_id": "ce33a154-1d5a-43a8-ab28-897485fb0942", "node_type": null, "metadata": {}, "hash": "ba37b97effb2db3e304aeffcefeb5750e8d6c46f107db97885a3787783e57afa"}}, "hash": "592b5fce32aeefea2485b0e6a3015982a1e9275bdddc9d5d9bcb8a1abb75ed6d", "text": "do you mean?\n\nNo, that's okay. I'm not explaining it very well. But I was saying, so like from like a biologist or physicist point of view, to see that unity with like, with the quantum level that at some point, there's like the bifurcation point, but we see that with like electrons and on like a much more fundamental and less abstracted scale. So to see that at this level, like to see that bifurcation point that is that random probability seems unlikely, but it would be really cool. But then also from an engineering point of view, it's obviously a pretty big problem if you do have that like fundamental randomness.\n\nSo to read back as engineers, if there's a random element in a system that I engineered, that might be an extra layer of challenge. And I also think that it's unlikely that that would have evolved unless it is some like inevitable, very fundamental like connection. But I don't think that that would have ever evolved in nature because that's not really an engineering advantage. At least I don't have the mathematical skills to know or know the game theory if that's actually an advantage.\n\nSo Ahmed said that preexisting differences in the features of the cells, likely the size of the cell, also influence the outcome of the infection. But I have a follow-up question to that. So what if every single thing about the cell between the two cells were the exact same, do you still think you would see that kind of randomness in the outcome to Ahmed?\n\nI think to an extent, you'd still see differences due to, again, stochastic elements, but it implies that there's a degree of non-randomness to it that can be of help to engineers obviously when they're trying to create models to kind of streamline the process and trying to extrapolate information from what they see.\n\nThese are fabulous responses coming in on the chat. And I just want to celebrate the, you know, the sort of, there's a cultural reality here at the intersection of science and engineering that manifests because the biology is operating at the scale of atoms and molecules. And it's immersed in this thermal noise bath, if you will. Schrodinger, the physicist, when writing the book, What is Life? 80 years ago or so, you know, just wondered at how life could ever work because in all the noisiness of random motion to get order that we see throughout living systems seems impossibly improbable. So Henry, for example, my group agreed that a degree of randomness is unavoidable in every aspect of life. With this in mind, bioengineers should never expect to be able to wield control, perfect control over organisms. We may get close, but there are always the uncertainties and anomalies. It's very interesting, it's very rare in my experience that you go from fundamental science, like fundamental physics, fundamental biology, to massive ramifications in terms of cultural expectation. And so it's so amazing to see that close linkage of the physics of living matter then playing out. I think there's a lot of cultural bias in exploring this question coming from the sciences and your perspective as tinker or observer. And I think the question is still open to be answered. It matters greatly for the reasons that are being hinted at here or stated plainly. Should bioengineers expect to be able to obtain reliable control over the operation of living systems or not? And so, yeah, you've got it. I'm going to set up in \u2013 we're going to go two minutes over, but I'm going to set up some teasers for what's coming that build on this puzzle with some more recent evidence. Should be new to most of you, that's okay. These are just gonna be fun things to look at. This is a movie showing a more recent genetic oscillator.\n\nAnd they're synchronized.\n\nThey're synchronized locally and over centimeter scales. The oscillations running in micron-scale bacteria, this work was done by Jeff Hastie and his team at San Diego. So they start up out of phase and they lock in phase and then train. And there's some funny things going on, like there's some bright spots. It kind of reminds me of having like a blown pixel on an LED television or computer", "start_char_idx": 28526, "end_char_idx": 32662, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ce33a154-1d5a-43a8-ab28-897485fb0942": {"__data__": {"id_": "ce33a154-1d5a-43a8-ab28-897485fb0942", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4029a4e4-3c05-41b1-aab2-3512cb045dbd", "node_type": null, "metadata": {}, "hash": "2dda1466baa1267f1a8b470ee695a4bfcea9fbb6ad8183e00dc76720d5b4729f"}, "2": {"node_id": "283d0512-492c-4e90-9b45-e2f585ccdf1a", "node_type": null, "metadata": {}, "hash": "592b5fce32aeefea2485b0e6a3015982a1e9275bdddc9d5d9bcb8a1abb75ed6d"}, "3": {"node_id": "df42b3a9-20b8-4ec0-876f-9fc355bc1e02", "node_type": null, "metadata": {}, "hash": "d247c4f44dbdda4143d9c96b1317bd943a1eddba29ab48a6620f98c8d829eb86"}}, "hash": "ba37b97effb2db3e304aeffcefeb5750e8d6c46f107db97885a3787783e57afa", "text": "It kind of reminds me of having like a blown pixel on an LED television or computer screen. So maybe it's random like that, maybe it's a manufacturing defect, I don't know. I'll give you a close-up look at this. Each one of those glowing blocks is a colony of a thousand, a couple thousand bacteria. They're growing and dividing and getting washed away, but as that's happening, they're also running a different type of oscillator that's better at synchronizing itself, both within each little block, but somehow all crosswalk, such that when you go all the way back up to the original movie, I can run this again, all the blocks start syncing up. So here's an existence proof that you can get much more reliable dynamic behavior, both at the single cell scale and across tens of millions or hundreds of millions of cells. If we look at the diagram of how the system works, this is what it looks like. It's also a four-gene system. Just four genes, different genes organized in a different way, it's a different type of oscillator, and you can see that there's all these arrows going around, and it's more complicated. So we're setting up a question for next week, which is, how do bioengineers manage complexity inside the overwhelming complexity of the cellular milieu, we're going to use an engineering tool called abstraction applied to bioengineering to teach you how to do that. So, we're not expecting you to figure this out on the fly. You're welcome to try, but this will be a good example that we can come back and test our knowledge of abstraction that we should develop next week. Want to give you one more teaser for week five with the last slide for today. So, in this week, we're beginning to introduce you to tools for analysis and design of biomolecules, analysis and design of genetic systems. We're just scratching the surface of that. And so, in week five, when we get into genomics and reading and writing of DNA sequencing and synthesis, we're going to park this year as a special, an opportunity to do an on-ramp into bioinformatics tools. And I grabbed from an amazing website an annotation of the open reading frames for the genome, 30,000 base pairs or so, of the COVID-19 coronavirus. And it's such a beautiful website and annotation. Let me just bring up the website so I encourage you to spend some time this weekend poking around at it. Not only do they have the open reading frames, they've got every tool and online service for analyzing open reading frames, proteins, predicting structure, online service. Look at this left menu bar. All right. And now, if you come down, well, this open reading frame, number one, translates to this peptide sequence, which has this structure. And if I scooch over to the right, it makes this a little bit bigger, which has this function. Protein number two, is it, you know, does this, what it does, this is what it looks like, right? So if you wanted to spend the weekend teaching yourself or your friends or anybody, everything humanity knows at a molecular and system scale about the components and genome of COVID-19, here you go. And we'll come back to on-ramping that more formally within the class on the week after next, week five.\n\nAnd I just jump in. And also, please think about the spacing. Some of you do a fantastic job of typing the answers already, but, you know, like leave us a bit like it takes us some time to read. And the faster and easier we can read it, the faster and more comprehensive feedback we can give you. Cool. So. Thank you, Sivash. We recognize that the material presented today has more technical detail with the biology than we've had previously. We're really starting to get into the nitty-gritty of the actual biomolecules that do the things we claim that bioengineers are unable to do. If this feels uncomfortable, if you want to freshen up on your biology, if you want to try and ask us any questions on this, there is another bio tutorial on Monday hosted by Victor. He's over here for", "start_char_idx": 32644, "end_char_idx": 36639, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "df42b3a9-20b8-4ec0-876f-9fc355bc1e02": {"__data__": {"id_": "df42b3a9-20b8-4ec0-876f-9fc355bc1e02", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4029a4e4-3c05-41b1-aab2-3512cb045dbd", "node_type": null, "metadata": {}, "hash": "2dda1466baa1267f1a8b470ee695a4bfcea9fbb6ad8183e00dc76720d5b4729f"}, "2": {"node_id": "ce33a154-1d5a-43a8-ab28-897485fb0942", "node_type": null, "metadata": {}, "hash": "ba37b97effb2db3e304aeffcefeb5750e8d6c46f107db97885a3787783e57afa"}}, "hash": "d247c4f44dbdda4143d9c96b1317bd943a1eddba29ab48a6620f98c8d829eb86", "text": "there is another bio tutorial on Monday hosted by Victor. He's over here for me, I don't know where he is for you. He's gonna be going over a lot of the language that we're talking about today, transcriptional control, translational control, talking about how you actually design a system where transcriptional units are interacting with each other. Similarly, if you are stuck on the actual biomolecules themselves, like what makes up the DNA and the RNA and the proteins, please go to the course materials and look up the tutorial that I posted. There's video and lecture slides for that that are available online.", "start_char_idx": 36630, "end_char_idx": 37246, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ea639285-da04-477f-baf9-537e9d2196f7": {"__data__": {"id_": "ea639285-da04-477f-baf9-537e9d2196f7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4d4d8996-38b7-4922-a5a3-8d460bdcccdd", "node_type": null, "metadata": {}, "hash": "6b028aa514ef1db23906b33ad859e2f4ed5feb56ba4b16a96ad8c3ec7aeba3ca"}}, "hash": "dafd0fe0f6df4b912370b25ef05b13a2a4de5efea8cfe5024a924e388f3a8878", "text": "Zoom link (same as class)\nhttps://stanford.zoom.us/j/861034342?pwd=NkVXNUcwNVBKb1RCWnk3aTVydWJFQT09", "start_char_idx": 0, "end_char_idx": 99, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0a46df26-0faa-4880-9cb0-a018de3ab880": {"__data__": {"id_": "0a46df26-0faa-4880-9cb0-a018de3ab880", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "22a72e50-3350-486e-897a-d10f1865f945", "node_type": null, "metadata": {}, "hash": "98ee9f00ddddf809bde137759a4e110d8629ab4f9fe7aa87383b66289f1efc8f"}}, "hash": "affbe47713376bc896a1a7e01c9772c24aee354a1057397812d1f1405371cee6", "text": "Calendar", "start_char_idx": 0, "end_char_idx": 8, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ba4865c4-44fb-41a3-b835-5dd528115af3": {"__data__": {"id_": "ba4865c4-44fb-41a3-b835-5dd528115af3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "47f3f53c-3ea9-42d0-80da-1817d6feef8e", "node_type": null, "metadata": {}, "hash": "476bd08e5b25d117ddd457c152855d9a7c7ad53dcb41f4387fdf063a2de70910"}}, "hash": "0445da38fac77ae4f9c85085b7885bb09d5775f4d3fb5ac50a6e756fbd268fe8", "text": "Teaching Assistants\n\n\n\n\nJon Calles; Office Hours Fri 15:00-16:00; jecalles@stanford.edu\n\nNicolai Ostberg; Office Hours  Fri 15:30-16:30; nostberg@stanford.edu\n\nNaomi Pacalin; Office Hours Tues 10:00-11:00; npacalin@stanford.edu\n\nJulisia Chau; Office Hours Mon 09:00-10:00; jhchau@stanford.edu\n\nBrianna Chrisman; Office Hours Wed 09:00-10:00; briannac@stanford.edu\n\nVictor Tieu; Office Hours Mon 16:00-17:00; vtieu@stanford.edu", "start_char_idx": 0, "end_char_idx": 426, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ede47257-aa3d-4826-b5b1-ed154d6ca766": {"__data__": {"id_": "ede47257-aa3d-4826-b5b1-ed154d6ca766", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f80344a4-f951-44f4-b562-cf9c2eafcd14", "node_type": null, "metadata": {}, "hash": "d2d4552246342ea1754858007d24c480642e7fded344219e8fdd933babd9b607"}}, "hash": "ada99048874310acfd6f38db3c2e8e1b151778b7478a9dbd690210d59d340e3a", "text": "Introduce the World to Bioengineering\n\nThe goal of the group project is for you, as BIOE.80 and ENGR.80 students, to communicate and introduce Bioengineering to a non-expert audience of your choice. (For example, you may choose your audience to be next year's incoming BIOE.80 class.) The goal of this project is to enable you to think about and reflect on Bioengineering as a 21st-century discipline grounded in engineering living matter.\n\nIn this project, you will answer the questions, \"What is bioengineering?\" and \"Why is it important to know about it?\"  \nThis may include a description of the application of Bioengineering to contemporary challenges, an explanation of new ways of thinking that emerge as various bioengineering technologies develop (e.g.: DNA sequencing, synthesis, and CRISPR gene editing tools), or the application and description of sciences (e.g.: evolution and diffusion) at the intersection of engineering living matter. \n\nIn groups of 3-4, you will create a world-readable webpage **\"BIOE 80 Wiki Post\"** addressing your topic of choice.  The final report should be between 3-4 pages (excluding references).  \n\nPlease form teams and share your group member list with the course staff by week 4. \n\nThe Final project is due on our last class session of week 10 (i.e., Wednesday, June 5th). \n\n**Support:** Your team will be assigned a primary mentor (one of the teaching assistants),  that will check in with you throughout the quarter. You will be asked to submit parts of your progress throughout the quarter as part of the problem sets. \n\nThe Hume Center for Writing is another on-campus resource link\n\nYour grade will be based on the following:\n\n**Identification and Description of the topic:** 20 points\n* Define Bioengineering and identify a particular context (i.e., need or topic that Bioengineering addresses)\n* Describe the relevance of that topic to your chosen audience\n* Provide relevant historical and scientific background for your topic\n\n**Description of the Science & Technology:** 20 points\n* Describe the role of Bioengineering in impacting your topic \n* Identify advantages, disadvantages, and limitations of engineering living matter\n* Identify resources for getting more information\n\n**Description of Social Ramifications:** 15 points\n* Identify the stakeholders associated with your topic\n* Describe the social, political, and/or economic implications of new technologies in this area\n\n**Quantitative Due Diligence:** 10 points\n* Include back-of-the-envelope calculations, e.g.: estimate of requirements, cost, or impact (how many people would be impacted)\n\n**References:** 5 points\n* Students should include citations, as appropriate (looking for a consistent style)\n\n**Structure:** 10 points\n* Clarity, Spelling, Grammar, etc.\n* Definition of key terms and limited use of jargon\n* Appropriate use of visuals\n\n**Group Participation:** 20 points\n* Since this is a group project, each student will evaluate how much other students contributed to the project. \nGrades may differ between students within a group.\n\nTotal: 100 points  \n\n**Scaffolding, Logistics, and Milestones:**\n* Each group will be assigned a TA as a mentor\n* Group formation and initial brainstorming by the end of **week 4**\n* Topic identification by the end of **week 5**\n* Required TA check-in during **weeks 7, 8, and 9**\n* Project due Wednesday, June 5th (Final class session) **week 10**", "start_char_idx": 0, "end_char_idx": 3409, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "933ae657-3341-4562-be4c-d3e5f9a17aab": {"__data__": {"id_": "933ae657-3341-4562-be4c-d3e5f9a17aab", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9985ffb1-0998-483b-8b2d-b3bf7665cc35", "node_type": null, "metadata": {}, "hash": "47e7c4497fe944783b5f3285c3840dfbfb8c199d190ecb8f90660eb3274bf0f8"}}, "hash": "7953d7bf2048c7f101be9985802523102ef3ccb23d9954654791d621e4b05450", "text": "FINAL PROJECT INTRODUCTION\n\n**Your Wish, Your Plan, Your Play**\n\nYour final project has three major parts: (1) your wish, (2) your plan, and (3) your play.  \n\nClass projects must be submitted electronically via a link that will be shared later! We will host your projects on the class website.", "start_char_idx": 0, "end_char_idx": 293, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b0e470e9-c52c-4b2e-bd79-b1d2bece0655": {"__data__": {"id_": "b0e470e9-c52c-4b2e-bd79-b1d2bece0655", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "65c43e63-3cad-4eea-8e2e-2eefdd741572", "node_type": null, "metadata": {}, "hash": "4dd0c80cd2b269b77ac91eeded7fbb76a8c72a1ea23ede03e3dc48815218b2a4"}}, "hash": "8cb5e2283c0425c7c21a26333fefc10d520daf8abaa6138b7ba60cc8ed35d658", "text": "LEARNING GOALS & MOTIVATION\n\nOur goal with the group project is to empower you to think about and plan for the future you wish to realize or contribute to via bioengineering.  We aim to enable you to devise and express your team's ***wish*** that can be made true by of before the year 2030.  We will help you develop a descriptive but practical ***plan*** for realizing your wish.  Finally, we will ask you to represent your wishes and plans as a story, specifically as a three-act ***play*** that you make and record via Zoom with your team.   \n\nIndependent of your academic level, whether a first-year or a graduating senior, we hope that the class project will enable you to take steps towards organizing your plans.  As a first-year, the project may help you decide what other courses to take in the future (i.e., serve as a cornerstone to your curriculum).  As a graduating senior, the project may help you reflect on what you have learned and use them in realizing your next steps, and may even serve as the first-draft of a specific plan for what you do next.", "start_char_idx": 0, "end_char_idx": 1067, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "71ff9a68-a58e-480d-9cb9-7ba7bf4a5608": {"__data__": {"id_": "71ff9a68-a58e-480d-9cb9-7ba7bf4a5608", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "46715ff1-001c-42a3-b1c7-c5f9aafdcdba", "node_type": null, "metadata": {}, "hash": "a6ed71733b393028a0acf407c12ac46ee8e6cf4d433faf0752c7b06c97531600"}}, "hash": "9eb1a1aa21358a5532529ccb142a5dcc2735399066ae24f5e2464f7c2e7809d3", "text": "PROJECT COMPONENTS & POINT ALLOCATIONS\n\nYou and your team will have to complete the following deliverables as part of the project.  Some of the deliverables are due along the way (i.e., not everything is turned in at the end of quarter).\n\n***Team rules (6 pts, Due: Fri 15 May)***  \n\n***Brainstorm and ideation (5 pts, Due: Fri 15 May)***  \n\n***Priority setting and project selection (10 pts, Due: Fri 22 May)***  \n\n***Written project description (24 pts, 3 points per, Due: Monday June 1st)***  \n\n(Notes: Please turn in a single document per group, via Gradescope.  Include your group number.  Bullet point answers are fine.  Make sure to include references.)\n\nAnswer the following eight questions (adapted from DARPA's Heilmeier Catechism):\n\n- What are you trying to do? Succinctly articulate your wish using absolutely no jargon.\n\n- What's happening today, what is the problem, or what are the limits of current practice?\n\n- What is new in your approach and why do you think you will be successful?\n\n- Who cares? If you are successful, what difference will your success make?\n\n- What are the mid-term and final \u201cexams\u201d to check for success?\n\n- What is the greatest obstacle to your success?\n\n- What could go horribly wrong? What are the risks?\n\n- How much will it cost?  How long will it take?\n\n***High-level storyboard (15 pts, Due: Fri 5 June)*** \n\n- Act 1 -- Your wish has come  true \n  (key dialog, scene detailsm and mood setting re: your wish being true (i.e., living in the future)) \n\n- Act 2 -- Despair, challenge, disaster \n  (ditto but re: the most dramatic challenge encountered in making wish true)\n\n- Act 3 -- Path to victory \n  (ditto but re: the most important success realized along the path to success)\n    \n***Final recording of play's performance (35 pts,  Due: Thu 11 June)***\n\t\n***Internal team member reviews (5 pts,   Due: Thu 11 June)***\n\nThere will be additional information and deadlines for each deliverable.\nBriefly, your team\u2019s final recording should be a 9-12 min zoom recording of your play, each Act being 3-4 min long. \n\nPlease turn in your final project **not later than 5p on Thursday 11 June.** \n\nYou will NOT need to do a formal presentation or report in class.   \n\nPlease ask us if you have any questions.   \n\n\n github source code for teaching staff", "start_char_idx": 0, "end_char_idx": 2290, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d7e4d261-5579-4cf2-b2c6-c0a67c07b2f4": {"__data__": {"id_": "d7e4d261-5579-4cf2-b2c6-c0a67c07b2f4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "065fd747-9054-4a38-aea8-0afc053c9abe", "node_type": null, "metadata": {}, "hash": "e57d184a3f7a563347c6f762bf2ed14dd62ee700bff3f750419e37ad72b97931"}}, "hash": "e5655db6ec821227851deed5d66347ab0fbe29b298a5c60528f707db7b17b130", "text": "BIOE 80 Final Project (15% of Grade)\n\nThe goal of this project is to help students integrate the different concepts in class and practice designing Bioengineering solutions to current problems. \n\nIn groups of 3-4, students will identify a current need and propose a bioengineering solution. They will create a BIOE 80 Wiki post (about 3 to 4 pages of text) that will be accessible to future students which will explain how bioengineering can be used to solve the world\u2019s problems.\n\nAssessment will be based on the following:\n\n**Identification and Description of Need:** 15 points\n* Instructors can offer suggested sources, ie: kiva.org\n* Describe the problem and who is affected by it\n\n**Description of Currently Available Solutions:** 15 points\n* Both bioengineering and non-bioengineering\n\n**Proposal of bioengineering-based solution:** 25 points\n* Describe advantages, disadvantages, and limitations of this solution\n* Back-of-the-envelope calculations can be required, ie: estimate of cost, estimate of how many people would be impacted\n* What other trends and technologies are required for the bioengineering solution \n\n**Description of Ethical Ramifications:** 15 points\n* Ethical implications of taking action\n* Ethical implications of inaction\n\n**References:** 10 points\n* Students should include citations, as appropriate\n\n**Structure:** 10 points\n* Clarity, Spelling, Grammar, etc.\n* Appropriate use of visuals\n\n**Group Participation:** 10 points\n* Since this is a group project, each student will evaluate how much other students contributed to the project. Grades may thus differ between students within a group.\n\nTotal: 100 points\n\n**Scaffolding, Logistics, and milestones:**\n* Group formation and initial brainstorming by the end of week 4\n* A TA can be assigned to each group as a mentor\n* Problem identification by the end of week 6\n* Required TA check-in during week 8 \n* Project due Wednesday, June 5th (Final class session) week 10 \n* Submit link to mateiral to the teaching team\n\n* To simplify other aspacts problem sets can be shortend", "start_char_idx": 0, "end_char_idx": 2056, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ae5931d9-818f-4a26-91f3-a133fe31128b": {"__data__": {"id_": "ae5931d9-818f-4a26-91f3-a133fe31128b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba303aa1-ca51-4ca1-ab01-b46b11269478", "node_type": null, "metadata": {}, "hash": "a20453949aafb835750d072e74e2d3b34f916c05986f68f1f0f8515775bacbc8"}}, "hash": "492f76bf994beb0d83d0076393f01e7736e052b1152cce3a576c49d77da2d61a", "text": "Introduction to Bioengineering (Engineering Living Matter)", "start_char_idx": 0, "end_char_idx": 58, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ab86afae-c3bc-4c8e-ac98-215c4efe1662": {"__data__": {"id_": "ab86afae-c3bc-4c8e-ac98-215c4efe1662", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "eb6c427c-364e-4849-8a79-0e46f568a1f9", "node_type": null, "metadata": {}, "hash": "8f3c2dadfc9fb40fe4baf5c0959e740c8ea78af09d541d69abd06d9790a1f6aa"}}, "hash": "ed98f19344eed83c42591cbdc4c32d451694e170abf422b4843fac35b4663055", "text": "Course Goals\n\nStudents successfully completing BIOE/ENGR.80 will have a working understanding for how to approach the systematic engineering of living systems to benefit all people and the planet. Our four main goals for the quarter are (1) to help you learn ways of thinking about engineering living matter, (2) to empower you to explore and do bioengineering starting from DNA, and (3) for you to become more capable of learning and explaining bioengineering to yourself and others, including discussing the broader ramifications of engineering the living world. (4) Specific to Spring 2020, in the time of COVID-19 and at the dawn of a decade, we also aim to enable you to devise and express your wishes for bioengineering as might be made true by or before 2030, and to develop practical plans for making you wishes real.", "start_char_idx": 0, "end_char_idx": 825, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fda80048-74b1-45b2-93f9-5a3a02f895f2": {"__data__": {"id_": "fda80048-74b1-45b2-93f9-5a3a02f895f2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a69db317-69d6-4df8-87d3-3b67e5ef98ee", "node_type": null, "metadata": {}, "hash": "851ea07f4312367611af49f1fdf1f10a93cf29b9b13ce4af0003285a041a857e"}}, "hash": "4f7a1dc2258c688272834d0f51a319d5c6d2f296f082b59a927ae5e048466a25", "text": "How does this class work?\n\nThere are usually three class sessions each week (MWF).  The in-class sessions are a mix of active learning and short lectures.  In a typical week, you will read the pre- or post-class material, attend the in-class sessions or activity, and do one problem set.  The course grade is based on your problem sets and your final group project, with quizes serving to make it easier to pass your PSETS and Final Project.  Bioengineering is a fast moving area, with big advances (and controversies) every few weeks, so keep your eyes open and let us all know when you learn about things that relate to bioengineering, genomics, or synthetic biology!", "start_char_idx": 0, "end_char_idx": 669, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5b92a4e0-4b8c-4138-b2f7-9bb16179456e": {"__data__": {"id_": "5b92a4e0-4b8c-4138-b2f7-9bb16179456e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "557ebe60-20be-48ca-9271-cf6bd9e97759", "node_type": null, "metadata": {}, "hash": "be6093d6037964924b35f2094cfffa7325c453af51b78134ca24dc4945fd0737"}}, "hash": "b3f076f53bbcbea5d92d17cb14463da2afcc6dc227416cc4a927b1533825c6c5", "text": "Additional Links\n\nPiazza\n\nCanvas", "start_char_idx": 0, "end_char_idx": 32, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f80d0539-2eaa-477f-a6a2-3d03911209c7": {"__data__": {"id_": "f80d0539-2eaa-477f-a6a2-3d03911209c7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0c365bc2-bcc0-40d8-8359-312d7db0ea2c", "node_type": null, "metadata": {}, "hash": "96055c423bd030c13bce822c120e0d4b65ae1b9665b5e4fadc81f54647cf5183"}}, "hash": "0d612378544004c20eeb77a91209b5224c47556d6c8a9a3c1974fd80251f3b02", "text": "Summary\nDue to the shift in remote learning due to the COVID19 emergency, BIOE/ENGR.80 will be using several online learning and communication platforms this quarter. In order to promote the best possible learning for all students in the class under these circumstances, it is important to adhere to a shared set of expectations and guidelines for the use of each online platform. This document outlines the various online learning platforms that will be used by BIOE/ENGR.80 this quarter and lays out the expectations and guidelines for their use. We are excited and look forward to engaging and communicating with you throughout the course.", "start_char_idx": 0, "end_char_idx": 642, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4ce29ceb-24c0-4b1d-a98d-be9dae95d663": {"__data__": {"id_": "4ce29ceb-24c0-4b1d-a98d-be9dae95d663", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "11760da2-6cb5-44a1-b8cb-24ec0da66b81", "node_type": null, "metadata": {}, "hash": "8f64f5e1318b1935c27175bf47ca437a966de3906580603ce8b22b03b2778641"}}, "hash": "2bddba887fe4eb10a92a0e47bc8e29ebee75bfe5f0001e6edd9e681cf4fb26fc", "text": "General Guidelines\nThe impacts of the COVID19 emergency are stressful to all students in a variety of different ways. \nPlease approach all communications with fellow students with empathy, compassion, and respect.", "start_char_idx": 0, "end_char_idx": 213, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "80625897-7eec-4d3c-9d2f-a61ac33a9975": {"__data__": {"id_": "80625897-7eec-4d3c-9d2f-a61ac33a9975", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2cd72a0a-e948-4ff7-9f40-dbc3b9d4ea8b", "node_type": null, "metadata": {}, "hash": "b11154f8dd86a005fc24d03f67ceaf0cc57af5587429db3ea19ce9d3bd8934b5"}}, "hash": "8989311930ff9756de262165adb2f522cd2a177555bf4f201f1a9aad56a83ba4", "text": "Class Website\nThe class website (this website, https://stanford-bioe80.github.io/docs/introduction/) will be the main resource for course content, including syllabus, pre-class readings, and assignments. Lecture videos will be posted to canvas.", "start_char_idx": 0, "end_char_idx": 244, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f8a1a392-b154-44f9-8bae-129585e85a3c": {"__data__": {"id_": "f8a1a392-b154-44f9-8bae-129585e85a3c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2231a9a6-e601-4296-ada5-8372b6438bca", "node_type": null, "metadata": {}, "hash": "7fefeec552eb710ec0c827be406d75e9bfa4ab3801c52d7cc5e748ddf6f437bd"}}, "hash": "cb5db584dca67abea6d5ec6772d9fc205a4ba4de95e4054664c5956b0cea5a5e", "text": "Canvas\nMajor announcements will be posted on Canvas. Grades will be posted on Canvas. Quizzes will be taken on Canvas.", "start_char_idx": 0, "end_char_idx": 118, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "68abbf8e-d10b-405f-86c5-c8b768f25f12": {"__data__": {"id_": "68abbf8e-d10b-405f-86c5-c8b768f25f12", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "454d8df7-3e4e-48db-afa0-93c1996ca420", "node_type": null, "metadata": {}, "hash": "741e3b8bb96ca649f5ed476092e0f0f955647a1da8c9ab15d8ba99d51c2b2e51"}}, "hash": "1411729c2f184c3ea2b57df3014510e4d75c0df42f971987cbdb702a391a14f6", "text": "Gradescope (Access Code: MY5JE8)\nGradescope will be used to turn in assignments. Please indicate the beginning and the end of each question (boundaries). Regrade requests are also handled via Gradescope.", "start_char_idx": 0, "end_char_idx": 203, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0e04afd8-0560-48ae-9243-bb105902157e": {"__data__": {"id_": "0e04afd8-0560-48ae-9243-bb105902157e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "08b94b43-9af2-497c-bb3f-ebe575c982a7", "node_type": null, "metadata": {}, "hash": "458ff3f5e86e92c2ac90998e7d8d4882461206114f873b5871e4428ce0503947"}}, "hash": "267a382395a0d060f9acac6860d48042587849ae2dbd105a1926d8c25f48043e", "text": "Zoom\nZoom will be used for lectures and office hours. Zoom chat will be available during lectures. Comments and questions regarding lecture material are highly encouraged. TAs will monitor the Zoom chat during lecture and highlight key questions and comments in real time. The chat should not be used for social comments, as this is distracting to other students.", "start_char_idx": 0, "end_char_idx": 363, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d8c8d4a2-75c9-4cc6-8972-2ea9ec05b57e": {"__data__": {"id_": "d8c8d4a2-75c9-4cc6-8972-2ea9ec05b57e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fc50f281-55d5-4bca-8c0e-b00942990a56", "node_type": null, "metadata": {}, "hash": "33c9eac5f0cfb8b8bc32eedb4c2209b3ecde60d150ce37fe7bb633a4bf684578"}}, "hash": "c9fc876d3651984a30a0ffec6bffe15f1170c81db26d9a8daaa2b915730bddce", "text": "Piazza\nPiazza (https://piazza.com/class/k8kvf0kfg5q3vl?cid=6) is a platform where students can ask questions relating to course content and academic class material, including material from the lectures, assignments, and final projects, as well as logistical or administrative questions about the class. TAs will monitor Piazza to answer questions in a timely manner.  Students can also answer questions (peer feedback are welcomed and valued). The teaching team will share a weekly FAQ (highlighting questions from office hours etc.) at the end of each week.  Private Piazza posts can be used to communicate privately to TAs about assignments and other matters.", "start_char_idx": 0, "end_char_idx": 661, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d819f5ef-910f-497c-8d79-f30abea08677": {"__data__": {"id_": "d819f5ef-910f-497c-8d79-f30abea08677", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7b190dc8-87f9-4544-ae07-5279ce3046df", "node_type": null, "metadata": {}, "hash": "54a055e30ca30e96bd0c3896ccc269a51128f72a2a2b5cdb66297b8405735c2c"}}, "hash": "eb20a1aa835755d72d5d8565c3cb2e1cabce83779ff120e923c0140f72b24a30", "text": "Email\nPlease use email as a last resort mode of communication. If possible, please communicate with the teaching team via one of the above modes of communication. Please include \u201cBIOE/ENGR.80\u201d as part of the email subject.", "start_char_idx": 0, "end_char_idx": 222, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7b29d162-82a2-4187-9091-d23cee72e09f": {"__data__": {"id_": "7b29d162-82a2-4187-9091-d23cee72e09f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d7dd4540-5a15-48fc-b18c-11de029555bf", "node_type": null, "metadata": {}, "hash": "b93e92e988c356fdb6583980be38bc2af64299882a41126824d1ee15e2b6b988"}}, "hash": "ac997c78199ea780c66f2e0ca84677fa331f0cf335b076789cca6fdba2a23f7b", "text": "Biomolecular Analysis and Design Tools\n- Benchling: Useful online tool offered by for-profit company started by iGEM students from MIT. Supports tracking of DNA parts and analysis and layout of DNA sequences, primarily at the scale of plasmids (vectors)\n\n- PDB Structure Viewer: In-browser structure viewers from the Protein Data Bank (every molecule at PDB can be viewed in browser).\n\n- Meta Link: Many molecular graphics analysis and design tools curated by the Protein Data Bank.\n\n- PyMol: Professional grade molecular structure viewer.\n\n- FoldIt: Protein folding computer game (based on software engine used to design proteins, like KumaMax example).\n\n- eterna: Tool, game, and community for analysis and design of RNA molecules", "start_char_idx": 0, "end_char_idx": 732, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "037e4d8c-80e8-4e17-b8a1-a51ebdd4467e": {"__data__": {"id_": "037e4d8c-80e8-4e17-b8a1-a51ebdd4467e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1fab887a-2cc2-448b-9138-3857e0701c2a", "node_type": null, "metadata": {}, "hash": "f6af5c76e0775b952a54183d7630270502b6aef80bd109d9bf39fb843288fe0d"}}, "hash": "4e119ca0dc587144fe74b25eea69b35bdf1a11b3645362c6c5cc5dbfee55471c", "text": "Extra Learning Resources\n\n- Molecular Biology of the Cell: 4th edition by Bruce Alberts, Alexander Johnson, Julian Lewis, Martin Raff, Keith Roberts, and Peter Walter. This is the go-to molecular biology textbook used by advanced undergrad classes and graduate students. Older editions are ok because foundational biology topics are generally unchanged. Topics include: molecular biology, DNA, RNA, protein, translation, transcription, and others. Available from amazon here.\n\n- The Molecules of Life: Physical and Chemical Properties by John Kuriyan, Boyana Konforti, and David Wemmer. This textbook is for advanced undergraduates interested in exploring more in-depth material on the biochemical structure of macromolecules, energetics of protein folding, and other biophysical concepts. Chapters 1-4 are especially relevant to topics discussed in class. Link to Stanford Libraries catalog. Unfortunately I can't find a full online version, but the Google books preview is here.\n\n- Allen Institute's Cell Explorer: Resource for looking at mammallian cells as they are being observed via microscopy, studied, and figured out.\n\n- Lehninger: Principles of Biochemistry by David L. Nelson; Michael M. Cox. Ebook\n\n- The Machinery of Life by David S. Goodsell. An electronic copy of the book is available for free from Stanford Library and you should be able to access from here.\n\n- Cell Biology by the Numbers by Ron Milo: order of magnitude estimations in biology free download and website from here.", "start_char_idx": 0, "end_char_idx": 1498, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "69afcf26-b0f3-487b-b5dc-f088976df4e0": {"__data__": {"id_": "69afcf26-b0f3-487b-b5dc-f088976df4e0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8636484c-e14b-44dd-a251-e385c4fc294b", "node_type": null, "metadata": {}, "hash": "c3800f2cc4296f8c231fecb2238af1d3776a295738c607ad086acfe9a97afb20"}}, "hash": "21fdd963a3dc91821b8d3acfbcd89a8bc5af47b3c3586bab8f97cef39033a9cc", "text": "Introduction to Markdown: How to edit files and add new materials\n\nYou can use the editor on GitHub to maintain and preview the content for your website in Markdown files.\n\nWhenever you commit to this repository, GitHub Pages will run Jekyll to rebuild the pages in your site, from the content in your Markdown files.", "start_char_idx": 0, "end_char_idx": 317, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "547b89ac-a120-46ee-9499-6189be3d72e7": {"__data__": {"id_": "547b89ac-a120-46ee-9499-6189be3d72e7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "62bbae2d-2a78-4e00-9e92-693cdbb875c3", "node_type": null, "metadata": {}, "hash": "d4f5c4fadf9ba42311834853adf477002b71606dc35f0b37de604d80b9f6dbc1"}}, "hash": "75ad9c3378c0795931c49b76875e9ac9c4dc331981867f671d1660fc5d69b5ad", "text": "Markdown - Basics\n\nMarkdown is a lightweight and easy-to-use syntax for styling your writing. It includes conventions for\n\n```markdown\nSyntax highlighted code block", "start_char_idx": 0, "end_char_idx": 164, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3b93d38c-c0db-466d-92f9-00c12ba4f80a": {"__data__": {"id_": "3b93d38c-c0db-466d-92f9-00c12ba4f80a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c73013c9-4787-41d0-9d00-34488ecc060d", "node_type": null, "metadata": {}, "hash": "104237cd24b689b00824c254be48098ea3ef6aecbb7fbce1e916fdf1389e5046"}}, "hash": "10899eed5b64dc801dc0d7620b65265956ccfbef13b2f980863dce151429318f", "text": "Header 1\n\n- Bulleted\n- List\n\n1. Numbered\n2. List\n\n**Bold** and _Italic_ and `Code` text\n\nLink and !Image\n```\n\nFor more details see GitHub Flavored Markdown.\n\nHere are some examples of what a post with images might look like. If you want to display two or three images next to each other responsively use `figure` with the appropriate `class`. Each instance of `figure` is auto-numbered and displayed in the caption.", "start_char_idx": 0, "end_char_idx": 415, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "35dbaa95-d457-477d-a828-db6329496d1e": {"__data__": {"id_": "35dbaa95-d457-477d-a828-db6329496d1e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fc3608e5-730c-4c90-b7d1-7929f0c13535", "node_type": null, "metadata": {}, "hash": "4ef02a8ec55df35be11d9aed1f999127ace13601e6e9bf4f0bcef0f34fb999c0"}}, "hash": "bf53781b773893399df66bba0cff48a2dd842b68415a03bc1d99bfbadc1d6714", "text": "Markdown - Jekyll Themes\n\nYour Pages site will use the layout and styles from the Jekyll theme you have selected in your repository settings. The name of this theme is saved in the Jekyll `_config.yml` configuration file.", "start_char_idx": 0, "end_char_idx": 221, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "afc91496-fabd-4eea-83ca-3cf28945f4e3": {"__data__": {"id_": "afc91496-fabd-4eea-83ca-3cf28945f4e3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4f11f617-4d24-45ad-b7d3-8d85bb8ce0ec", "node_type": null, "metadata": {}, "hash": "a3ab8293e3aaff061fd7e54c633fead1b1c6940c9dba0365ad1fcc02293959d5"}}, "hash": "bc8239c901e5e45913ebdfbc7a5da946889e70dd2aa78733fcc4038d27f0958d", "text": "Markdown - Figures (for images or video)", "start_char_idx": 0, "end_char_idx": 40, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1931b393-296f-49d7-96a6-470cca4f8435": {"__data__": {"id_": "1931b393-296f-49d7-96a6-470cca4f8435", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "164c284c-7d6e-406a-ab4a-01fe063f918a", "node_type": null, "metadata": {}, "hash": "4baba4e78f8ee187236adbfe1c7cfa8fcc4433caaa82698a9ea8e9388baa40d0"}}, "hash": "4b15c2fabc023b66292745d3bd6ab1d8aadd7a3e297e29a4dc5eee2b71426be1", "text": "One Up\n\nHere is an example of a figure with a caption and links to the sources. Where possible, please use permalinks, or link directly to the source, as opposed to linking to Google searches. \n\n```html\n\n\nFigure 1. \nLeft. Van Leeuwenhoek's simple yet powerful microscope 1670s (arrow points at the lens,  \nHistory of the microscope). \nRight. An artist etching of a person\u2019s reaction to a magnified drop of Thames water (monster soup), revealing the impurity of London drinking water 1828. Source\nsource.\n\n\n```\n\nAnd you'll get something that looks like this:\n\n\n\nFigure 1. \nLeft. Van Leeuwenhoek's simple yet powerful microscope 1670s (arrow points at the lens,  \nHistory of the microscope). \nRight. An artist etching of a person\u2019s reaction to a magnified drop of Thames water (monster soup), revealing the impurity of London drinking water 1828. Source", "start_char_idx": 0, "end_char_idx": 851, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8acd034d-14ef-4902-8b6c-6c612d3afe8e": {"__data__": {"id_": "8acd034d-14ef-4902-8b6c-6c612d3afe8e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7551b48e-58a2-4aa1-9488-450efbb970bc", "node_type": null, "metadata": {}, "hash": "2189e6e190e7d923bafd82de08c7fdfbd9a50c9c16bc7a3635e16370a1be1345"}}, "hash": "f53048eeb74ef0a7d8bb3f674a272c25996e831de2cb2c1faa3be984aaceb6a7", "text": "Two Up\n\nApply the `half` class like so to display two images side by side that share the same caption.\n\n```html\n\n    \n    \n    Caption describing these two images.\n\n```\n\nAnd you'll get something that looks like this:\n\n\n\t\n\t\n\tTwo images.", "start_char_idx": 0, "end_char_idx": 235, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "217514ac-0302-4024-be7c-5c9c129f10fb": {"__data__": {"id_": "217514ac-0302-4024-be7c-5c9c129f10fb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6eb7cbf9-595d-4db0-9b59-a948ae86bc15", "node_type": null, "metadata": {}, "hash": "84a5cfbb810fe63fd4f68423678f47e3a9192cb941f14d1446d26f8fe01e74e3"}}, "hash": "b1d8fd3f9b54f78cc578f4994d62c80d8dce2db7b5db20403ddf9fd560239f4c", "text": "Support or Contact\n\nHaving trouble with Pages? Check out our documentation or contact support and we\u2019ll help you sort it out.", "start_char_idx": 0, "end_char_idx": 125, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f9e5e153-602d-4b20-be33-63c5a27df942": {"__data__": {"id_": "f9e5e153-602d-4b20-be33-63c5a27df942", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4edb0ee4-816a-491d-b66e-d989f8566872", "node_type": null, "metadata": {}, "hash": "80e90df7d3866409f209f8ab848e1690c0dd50bd57f00be568e3abfe5650677d"}}, "hash": "92c5b527f35f2a1e5fb8ef0f91488eb6771cd430ebacebae8a8f5cae77bbba74", "text": "BIOE/ENGR.80 - Spring 2020\n\n**_Introduction to Bioengineering (Engineering Living Matter)_**\n\nStudents successfully completing BIOE/ENGR.80 will have a working understanding for how to approach the systematic engineering of living systems to benefit all people and the planet. Our four main goals for the quarter are (1) to help you learn ways of thinking about engineering living matter, (2) to empower you to explore and do bioengineering starting from DNA, and (3) for you to become more capable of learning and explaining bioengineering to yourself and others, including discussing the broader ramifications of engineering the living world. (4) Specific to Spring 2020, in the time of COVID-19 and at the dawn of a decade, we also aim to enable you to devise and express your wishes for bioengineering as might be made true by or before 2030, and to develop practical plans for making you wishes real.", "start_char_idx": 0, "end_char_idx": 905, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5aebc125-9b5b-4cdc-9bb7-652a1baf1189": {"__data__": {"id_": "5aebc125-9b5b-4cdc-9bb7-652a1baf1189", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0830e9d3-f18c-471f-8483-3041ab118bf3", "node_type": null, "metadata": {}, "hash": "fc6547474b8ae33bff96200918f5af0b67359e53bf9e400e545922c17225a774"}}, "hash": "90b384101c359036c7c3d1b35d024e61938805c2a2f2f74a15436e68fe7ef951", "text": "When\n\n6 April to 10 June 2020\n\nMWF, 1:30-2:20p, Lectures & Activities via Zoom", "start_char_idx": 0, "end_char_idx": 78, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "74136630-c072-42e6-a157-1f74252eaf71": {"__data__": {"id_": "74136630-c072-42e6-a157-1f74252eaf71", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6805abe0-1bef-47af-8148-626d40fda5a9", "node_type": null, "metadata": {}, "hash": "154639e2cefd3614f7b89331746d77ad5718214b096c98f4c411a98b9cab6396"}}, "hash": "c3641f47b90d3f10cdde7c5314c69318d79d819630ab63c83d19f7998ff52b7d", "text": "Where (Class & Office Hours, same link)\n\nZoom: https://stanford.zoom.us/j/861034342?pwd=NkVXNUcwNVBKb1RCWnk3aTVydWJFQT09", "start_char_idx": 0, "end_char_idx": 120, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "91b2c7cd-cdf3-4435-92ea-ca40473b5075": {"__data__": {"id_": "91b2c7cd-cdf3-4435-92ea-ca40473b5075", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b9740561-4cd0-4c2d-b92b-a2889e1c4ee9", "node_type": null, "metadata": {}, "hash": "b0bfa8b71fb8741ee667b666205fa6433d94f9d6fd33d83dd0a4357c7fd2757f"}}, "hash": "bdf44dc086f7a20735bea25104ecc5510bacbf7884177abea55c47241327740f", "text": "Instructors\n\nCourse Lead, Prof. Drew Endy; Office Hours (PST) Mon/Wed/Fri 14:20-15:00 (after class) (after class) and by appointment via endy@stanford.edu (can also schedule by emailing marc4@stanford.edu)\n\nCo-Instructor, Dr. Siavash Ahrar; Office Hours Tue 11:30-12:30, Sat 09:30 AM-10:30; sahrar@stanford.edu\n\nCo-Instructor, Prof. Michael Specter; Office Hours Wed 16:00-17:00; specterm@stanford.edu", "start_char_idx": 0, "end_char_idx": 401, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4a4ebe49-5c0d-47b9-8636-8704494eb3d6": {"__data__": {"id_": "4a4ebe49-5c0d-47b9-8636-8704494eb3d6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3023d401-35be-42ca-b3cb-cbf86baa1b62", "node_type": null, "metadata": {}, "hash": "fd2f4ac0b67a4b45adcfa179a5c1e3a7128f9240e4b945826afa3860dfea0603"}}, "hash": "3558c5f88cc67586331f3ee74cf20cdb7216e72e83e5cda9b7de4b4de733267f", "text": "Teaching Assistants\n\nJon Calles; Office Hours Fri 15:00-16:00; jecalles@stanford.edu\n\nNicolai Ostberg; Office Hours  Fri 15:30-16:30; nostberg@stanford.edu\n\nNaomi Pacalin; Office Hours Tues 10:00-11:00; npacalin@stanford.edu\n\nJulisia Chau; Office Hours Mon 09:00-10:00; jhchau@stanford.edu\n\nBrianna Chrisman; Office Hours Wed 09:00-10:00; briannac@stanford.edu\n\nVictor Tieu; Office Hours Mon 16:00-17:00; vtieu@stanford.edu\n\nIf the schedule does not work well for you, please contact us on Piazza with suggestions on how we can better accommodate your circumstances. All times in PST. Office hours are held on the same zoom link as class.", "start_char_idx": 0, "end_char_idx": 638, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "88f72e55-2042-4efd-8841-8e883a11aa05": {"__data__": {"id_": "88f72e55-2042-4efd-8841-8e883a11aa05", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "abd74dc6-fe7d-4741-9b1c-86cf92e9dabf", "node_type": null, "metadata": {}, "hash": "a184486d4b2c74d9124df5ebd194e2e33ef892b90819863af04ab7eb900f04d5"}}, "hash": "8572fbfd49a04aec7601292b3f4eca867bde956312b17cd429c6e958bbcbd8fc", "text": "Grading\n\nThe course is designed to operate on a S/NC basis.  To earn a S grade a student must satisfy the following two conditions:\n \n(1)\tEarn an average grade of 70% or above on the PSETS.\n\n(2)\tEarn a cumulative grade of 70% or above on the Final Project (team-based).\n\nPlease note your lowest PSET grade will be dropped from your PSET average.\n\nPlease also note that we will offer quizzes throughout the quarter that will accrue points.  You can apply your cumulative quiz points to reduce the threshold for (1) and (2) to as low as 60% given sufficient quiz points.", "start_char_idx": 0, "end_char_idx": 568, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e0ba8016-d0d1-4755-ab00-0dabef4c6e16": {"__data__": {"id_": "e0ba8016-d0d1-4755-ab00-0dabef4c6e16", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4f3b0d9b-3d9c-4ecf-94d8-82ff1cae6797", "node_type": null, "metadata": {}, "hash": "985ce7952551293f7cf2345a45649c322b9fe71f687f36588177ad733f769829"}}, "hash": "4fd94556fda74df20df03bb77e8dca0a04ac96c6b051b9769dd35674db361f28", "text": "Key Dates\n\n6 April 2020; first class\n\n25 May 2020; no class\n\n10 June 2020; last class", "start_char_idx": 0, "end_char_idx": 85, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f3a92e71-4b5c-4585-b284-c141bcf3d68f": {"__data__": {"id_": "f3a92e71-4b5c-4585-b284-c141bcf3d68f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "45404661-bab7-4afc-b84f-ad80c34e64ef", "node_type": null, "metadata": {}, "hash": "6c38caeb982dc318b2123be16a9f50ee5da9c5a86938405b668e38adca4feb1d"}}, "hash": "eb225c7c8cce3493a7b5bf5b889ded5826956625d02d327c699c2196d7c56493", "text": "Honor Code\n\nWe expect you will uphold Stanford\u2019s Honor Code. Discussion among peers and with the teaching staff is strongly encouraged. All submitted work must be completed individually unless explicitly noted otherwise.", "start_char_idx": 0, "end_char_idx": 220, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3e99523d-5c41-42e2-b34e-49ca61162bcc": {"__data__": {"id_": "3e99523d-5c41-42e2-b34e-49ca61162bcc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7141c8aa-45df-4258-857b-3f22bede7a91", "node_type": null, "metadata": {}, "hash": "2efd68ea84189343576fb305416f47ba4e284c2870dac6bcbb18f908abbf0ad9"}}, "hash": "18e22c14510ba578a7ecf4f0897d55ee228c0b2ca42ff7b405a9f713eea98fd0", "text": "Students with Documented Disabilities:\n\nStudents who may need an academic accommodation based on the impact of a disability must initiate the request with the Office of Accessible Education (OAE). Professional staff will evaluate the request with required documentation, recommend reasonable accommodations, and prepare an Accommodation Letter for faculty. Unless the student has a temporary disability, Accommodation letters are issued for the entire academic year. Students should contact the OAE as soon as possible since timely notice is needed to coordinate accommodations. The OAE is located at 563 Salvatierra Walk (phone: 723-1066).\n\nOffice of Accessible Education site", "start_char_idx": 0, "end_char_idx": 677, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2ba61e40-2efb-490e-b098-5e104b25402e": {"__data__": {"id_": "2ba61e40-2efb-490e-b098-5e104b25402e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d1ad9bc5-6a79-4608-b573-62003c3ac7ea", "node_type": null, "metadata": {}, "hash": "c02df4d1f63b176beb10555295471dcee5014621d43c24af240d11308026e16d"}}, "hash": "b3d3e76aa158c41ea77247083217ac6a63244a41bd1ce13fffbc9cf73d01c950", "text": "Week 1: Getting Started\n\n| Day         | Title  |\n| ----------- | -------|\n| Mon 6 April | Why engineering biology? |\n| Wed 8 April | What makes living matter unique? |\n| Fri 10 April| How to read a bioengineering research paper  |", "start_char_idx": 0, "end_char_idx": 231, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "00adc7df-e795-43b3-9281-3038e36fc896": {"__data__": {"id_": "00adc7df-e795-43b3-9281-3038e36fc896", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "af45694e-1feb-4877-bb4e-50acd4f43140", "node_type": null, "metadata": {}, "hash": "e623aa9c52411f4b0ee7e6d1ca4ae010600019a8f8f109840ba16302c4b69644"}}, "hash": "869e7b39ab1b67e8348eaada73802c3274477427b102fb6d9b539107b2fbf9ac", "text": "Week 2: People, Planet, & Political Health\n\n| Day         | Title  |\n| ----------- | -------|\n| Mon 13 April | People health (what do people need of bioengineers?) |\n| Wed 15 April | Planet health (what does everything else \u201cneed\u201d?) |\n| Fri 17 April | Political health (what does it mean to engineer biology at social scales)  |", "start_char_idx": 0, "end_char_idx": 328, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b8841d32-bfa2-498e-a6d2-2cc15e813f53": {"__data__": {"id_": "b8841d32-bfa2-498e-a6d2-2cc15e813f53", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "523b1e56-c39b-4a4a-8a56-ccd03adb8d44", "node_type": null, "metadata": {}, "hash": "f83160a0484abbbb97db38281d842adad51d92b3a56df8fc383a0206ac4c1785"}}, "hash": "23ec15e40bd5391b45ef4ce2807eee1dc1975eb42041c71c2792bc9359f59a00", "text": "Week 3:  Analysis & Design of Molecules & Genetic Systems\n\n| Day         | Title  |\n| ----------- | -------|\n| Mon 20 April | Activity \u2013 Tools for seeing biology (Foldscope) |\n| Wed 22 April | Analysis and design of molecules  |\n| Fri 24 April | Analysis and design a genetic systems |", "start_char_idx": 0, "end_char_idx": 285, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5bf5ec7a-fac5-4130-a024-2404ca9d4755": {"__data__": {"id_": "5bf5ec7a-fac5-4130-a024-2404ca9d4755", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "82e70b4e-1015-49a6-b739-e34dd8156fab", "node_type": null, "metadata": {}, "hash": "bb46a42290e852f6e1fe6c3dca6b436ccc2cc6c0a2b3da3a0c56d7a5610aac9f"}}, "hash": "6a55edcfa0b2e7c9774f2c324cee2a0a436de7f9ae4d8ecb73c51c3848e66721", "text": "Week 4: Engineering Abstraction in Biology\n\n| Day         | Title  |\n| ----------- | -------|\n| Mon 27 April | Engineering abstraction in living matter \u2013 synthetic genetic logic |\n| Wed 29 April | Engineering abstraction in living matter \u2013 generic system architecture |\n| Fri 1 May | Team Project:  Brainstorming + project introduction |", "start_char_idx": 0, "end_char_idx": 337, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8995be51-bc15-44fb-b62c-b7f3329ff100": {"__data__": {"id_": "8995be51-bc15-44fb-b62c-b7f3329ff100", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "86778868-7bb3-4f49-9a26-c78b2494eade", "node_type": null, "metadata": {}, "hash": "f35b8cf496fa3004ff0ba0221a9b9b28e2637501c4be0fb5ff211dbc11457ac3"}}, "hash": "c8f0c0ae2fff05ad04e0908a270bfbe90ba8991331ea2a3630210fddf86b169d", "text": "Week 5: DNA Reading & Writing\n\n| Day         | Title  |\n| ----------- | -------|\n| Mon 4 May | DNA sequencing (read) and synthesis (write), core concepts  |\n| Wed 6 May | DNA read/write strategy, from exponentials to interconvertibility of matter and information |\n| Fri 8 May | Team Project \u2013 Project priorities + story spine   |", "start_char_idx": 0, "end_char_idx": 330, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0b2ebfac-3563-44bc-8800-e0fd2deefe6c": {"__data__": {"id_": "0b2ebfac-3563-44bc-8800-e0fd2deefe6c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f4f60c32-d5f9-44d4-b601-312e24eff0b7", "node_type": null, "metadata": {}, "hash": "168d875b84b28ec35b08ddbd99d7ddd539de7b8d7a6c35966a186f1c63a5ba88"}}, "hash": "570bcff01af04728f0f8662dbc3485c17a76f1b37981849bff22de1164ab4f8b", "text": "Week 6: From Diffusion to Programmed Development\n\n| Day         | Title  |\n| ----------- | -------|\n| Mon 11 May | Molecular diffusion and spontaneous behaviors |\n| Wed 13 May | Activity \u2013 Dancing droplets |\n| Fri 15 May | Programming morphogenesis (could you grow an arm?) |", "start_char_idx": 0, "end_char_idx": 275, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "67556386-09dd-4bd5-9b39-10802a53e8e0": {"__data__": {"id_": "67556386-09dd-4bd5-9b39-10802a53e8e0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d60fb424-3065-4c56-97b2-f1cbd9afde27", "node_type": null, "metadata": {}, "hash": "afd70c0609780344acc32f2ef1cb8f2b7bd8db500948f2a5751281e50b861e24"}}, "hash": "6f31c37c3c0400710e540eb26c26465250d38aaa64dc0ea60e9700f2351db1df", "text": "Week 7: Project\n\n| Day         | Title  |\n| ----------- | -------|\n| Mon 18 May | Team Project \u2013 Planning |\n| Wed 20 May | Team Project \u2013 Story (Play.1) |\n| Fri 22 May | Team Project\u2013 Story (Play.2)|", "start_char_idx": 0, "end_char_idx": 199, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "926d310a-3165-4ce6-99c7-db589da8c99f": {"__data__": {"id_": "926d310a-3165-4ce6-99c7-db589da8c99f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "be98ff6f-3e0b-4d15-b1e0-45cf596f670e", "node_type": null, "metadata": {}, "hash": "0c9ce6b226951e8f47702077b6f7a2b12572f26b3efff7e90acd2af202084fc7"}}, "hash": "606a0116be78d1efef91bd899dab9e1c83e930a9e754ee1810aa967de724ccc5", "text": "Week 8: Evolution as Tool for Engineering\n\n| Day         | Title  |\n| ----------- | -------|\n| Mon 25 May | No class  |\n| Wed 27 May | Evolution as an algorithm |\n| Fri 29 May | Evolution as a service|", "start_char_idx": 0, "end_char_idx": 201, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f120ad7b-51ac-4619-8cbb-7391534f5c18": {"__data__": {"id_": "f120ad7b-51ac-4619-8cbb-7391534f5c18", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d618ac31-f76b-4fb9-9f01-aeb7219e1f8c", "node_type": null, "metadata": {}, "hash": "3dc5e89a95b1186620a94a8ed848faa2292ec568a0b4f767e574337c254da276"}}, "hash": "f34500563b3ee4a9e398a6ebef98c244db20ea0a917bc5093fda6688b2d31a8a", "text": "Week 9: Bioengineering Futures\n\n| Day         | Title  |\n| ----------- | -------|\n| Mon 1 June | Bioengineering futures related to planet health |\n| Wed 3 June | Bioengineering futures related to human health|\n| Fri 5 June | Bioengineering futures related to Political health |", "start_char_idx": 0, "end_char_idx": 277, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "af72457b-c4c8-4ad6-9b38-cb9d41939956": {"__data__": {"id_": "af72457b-c4c8-4ad6-9b38-cb9d41939956", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a9c80840-7405-4c0d-8877-02e68e887912", "node_type": null, "metadata": {}, "hash": "58b2d763d091a914f8fa5e518853ab922aefe3ac851b40490a85faf18397a057"}}, "hash": "672367d6ae783a1b509c1ea94025e2f6791c593ac5e616b9d593e9462c42d2af", "text": "Week 10: Bioengineering Futures & Charge to Class\n\n| Day         | Title  |\n| ----------- | -------|\n| Mon 8 June | Closing discussion and charge -1  |\n| Wed 10 June | Closing discussion and charge -2 |\n\n\n\n<!--", "start_char_idx": 0, "end_char_idx": 210, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a651bbec-9897-478d-a598-7aa2d99b79ef": {"__data__": {"id_": "a651bbec-9897-478d-a598-7aa2d99b79ef", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d17a71fa-869f-4b81-98d3-ff8349298260", "node_type": null, "metadata": {}, "hash": "b5976e13fd10c7b437c239a37f57aa5dbb36b5af3b676e9e6a768c86ff7c717b"}}, "hash": "5863a2523085e633a0c17e291e38aa9d7a9cba77e3cf1b5d5544e09498158e7e", "text": "BIOE/ENGR.80 Roadmap - 2019", "start_char_idx": 0, "end_char_idx": 27, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "13275b11-c875-48c3-8737-a36bb3a43668": {"__data__": {"id_": "13275b11-c875-48c3-8737-a36bb3a43668", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "73e33618-683d-4bc7-9faf-051ffc48cc4b", "node_type": null, "metadata": {}, "hash": "4d40c0c7a908b741229c324c48fe45336ae2a3d55e41efa0fe59c56a22b3fc15"}}, "hash": "f4cb98582f61d08ce3ced9713f8dc3fb94686c957c477739e9bf5504e9eed5c8", "text": "Extra Resources\nDavid Goodsell (2009): The Machinery of Life \n-->\n\n\n github source code for teaching staff", "start_char_idx": 0, "end_char_idx": 106, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a6baf061-15fc-4a0c-aa59-1a9e919e880a": {"__data__": {"id_": "a6baf061-15fc-4a0c-aa59-1a9e919e880a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "320656b7-73a3-4842-b9c3-168530bde414", "node_type": null, "metadata": {}, "hash": "e00ae308ff019abaf7d7ba3c3a3a9fa4e867ad5d755b17f61512d70f86f1c546"}, "3": {"node_id": "14463634-2918-4934-aa20-bbc7e8fec7b1", "node_type": null, "metadata": {}, "hash": "21836642f0e1592812c551fd2e83d5217057ce2d14792b5c78b0fc6e59b6ac74"}}, "hash": "2e1ffb3fb69f886a6071ea7c3d2b12b02bad6d4be1c832fbe69f587f46d6991f", "text": "Synthesizing DNA\n\nA Beginner\u2019s Guide to Artificial DNA Synthesis\n\nBasics of Synthetic DNA and Gene Synthesis\n\nArtificial DNA synthesis, a fundamental tool of synthetic biology, enables scientists to create DNA molecules of virtually any sequence without a template. Construction begins with the base-by-base synthesis of oligonucleotides (oligos), followed by assembly into double-stranded DNA (dsDNA) fragments. These custom DNA fragments can be used directly, cloned into vectors, or assembled into larger constructs to serve a variety of research uses.\n\nCompared to classical molecular biology techniques like site-directed mutagenesis, gene synthesis technology generates novel sequences with an unmatched combination of speed, precision, and flexibility. Below, we\u2019ll explore how linear and cloned DNA fragments are made and discuss what factors to consider favoring project success.\n\nDNA Synthesis Process\n\nA gene synthesis project has both wet and dry lab components. It can be broken down into the following steps:\n\nDefine project goals\nDesign the sequence\nSynthesize oligos\nAssemble oligos into linear fragments and larger constructs (if applicable)\nVerify the sequence of the gene fragment or cloned product\n\n1. Define Project Goals\n\nKey Considerations\n\nCommunication with collaborators\nProject timeline planning\nNo matter your molecular target, properly scoping your project will promote success by minimizing revisions. Be sure to consider factors like timelines for downstream assay work or collaborator availability in addition to the overarching project deadlines. It may be more efficient to prioritize the gene products in a specific synthetic order or use a combination of synthetic and molecular techniques to construct them. Speed is normally critical for a gene synthesis project, but a high-quality final product is just as important to reduce repeat syntheses or failed experiments.\n\n2. Sequence Design\n\nKey Considerations\n\nLiterature knowledge and precedence\n\nSequence and codon optimization\n\nOnce you understand the full scope of your project, it\u2019s time to map a route to synthetic success. A survey of the literature will reveal known issues in the synthesis of your target sequence and how to choose the best codons for optimized expression in your target organism. After a literature survey, further analyze the coding DNA sequence (CDS) for critical elements such as repeats, guanine-cytosine (GC) nucleotide content, unstable motifs or secondary structures, and unintended restriction enzyme sites that will complicate cloning. Access to a free codon optimization tool allows you to skip the literature review. It automatically improves the sequence for optimal synthesis and downstream performance in your experiments. Once optimized, the full nucleotide sequence is then deconstructed into a series of overlapping oligo sequences.\n\n3. Oligo Synthesis\n\nKey Considerations\n\nAccess to instrumentation\n\nPlanning a synthetic route\n\nWith a route planned, it\u2019s time to roll your sleeves up and get to synthesizing. Oligo synthesis is a highly automated process. The oligo chain is built on a solid support through cycles of chemical reactions involving precursors called phosphoramidites (Figure 1). With current technologies, it\u2019s not possible to achieve 100% efficiency in each cycle of reactions, leading to a subpopulation of oligos with truncations and point mutations. This issue worsens with oligo length since more cycles are needed to build the molecule. As a result, there is a tradeoff between using longer oligos, which generally simplifies assembly, and the sequence fidelity of the final product.\n\n4. Gene Assembly\n\nKey Considerations\n\nLinear DNA fragments vs. cloned DNA\nExperience with and access to plasmid vectors\nDue to technical limitations of phosphoramidite-based oligo synthesis, it\u2019s best to build dsDNA fragments (>150 nt) via polymerase cycling assembly. Purified oligos are mixed and allowed to", "start_char_idx": 0, "end_char_idx": 3946, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "14463634-2918-4934-aa20-bbc7e8fec7b1": {"__data__": {"id_": "14463634-2918-4934-aa20-bbc7e8fec7b1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "320656b7-73a3-4842-b9c3-168530bde414", "node_type": null, "metadata": {}, "hash": "e00ae308ff019abaf7d7ba3c3a3a9fa4e867ad5d755b17f61512d70f86f1c546"}, "2": {"node_id": "a6baf061-15fc-4a0c-aa59-1a9e919e880a", "node_type": null, "metadata": {}, "hash": "2e1ffb3fb69f886a6071ea7c3d2b12b02bad6d4be1c832fbe69f587f46d6991f"}}, "hash": "21836642f0e1592812c551fd2e83d5217057ce2d14792b5c78b0fc6e59b6ac74", "text": "via polymerase cycling assembly. Purified oligos are mixed and allowed to anneal to one another. Primer extension with DNA polymerase generates dsDNA, which is then amplified by PCR. Depending on the application, the linear products can be used \u201cas-is,\u201d, used as building blocks for larger fragments via methods like Gibson assembly, or cloned into a vector. Since gene fragments are a heterogeneous mixture of DNA molecules, it\u2019s generally preferable to clone them prior to downstream use.\n\n5. Sequence Verification\n\nKey Considerations\n\nAccess to instrumentation\nRigor of quality control based on product\nLastly, the final synthetic DNA product should be analyzed for sequence accuracy via Sanger sequencing or next-generation sequencing. The latter can also quantitate the diversity of a library of DNA products. Restriction enzyme digests are a good complement to sequencing, especially when the vector backbone is not fully sequenced.\n\nSynthetic DNA Services\n\nThe steps above can be laborious to perform in-house. Instead, to save time and focus on the downstream applications of synthetic products, consider a service provider for gene synthesis. This provider should be considered a partner in your research, and as such, they should help you achieve the project goals of today and beyond. To enable your success, think about access to local support, reputation for quality and reliability, expertise in synthesis and cloning, as well as the ability to support long-term and multi-institution projects that have goals in pre-clinical and clinical trials with CLIA or GLP requirements.\n\nKey Takeaways\n\nArtificial DNA synthesis has the power to generate virtually any DNA sequence\nPlanning, optimized design, and rigorous sequence verification are critical to efficient gene synthesis and project success\nA service provider can dramatically reduce error, labor, and time required for synthesizing genes as compared to do-it-yourself approaches", "start_char_idx": 3873, "end_char_idx": 5820, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "945ff3e4-4a48-4595-9ca0-00f596c38f37": {"__data__": {"id_": "945ff3e4-4a48-4595-9ca0-00f596c38f37", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e9428e8d-3031-4b47-ab08-aca218f40ef6", "node_type": null, "metadata": {}, "hash": "1e2bdf6407b630bee2a0d0079a446a8a97622d0f59a20004fc471c774cf5714c"}}, "hash": "8df18ce925a9405e3eb091c0aca1e37f8bf4458aa48b1a1854e28a5e148469ee", "text": "Day 27: June 8, 2020\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 39, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "de4a92f0-e385-4258-8f07-8cf05dc11a33": {"__data__": {"id_": "de4a92f0-e385-4258-8f07-8cf05dc11a33", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "20ad4412-10a8-4773-ac3d-ac540932b472", "node_type": null, "metadata": {}, "hash": "8bcecbabc05cf18c5cfec9388a082de9ede4776cd1d42e2b84e464cb5414a9e8"}}, "hash": "facc0b369e2e0a5eb4e17ea6bb07d49315407e226096ee2bb95db9be7e575b12", "text": "Day 28: June 12, 2020\n\nClass Slides\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 54, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "910029f0-9e4a-487a-9bb3-9be05d353706": {"__data__": {"id_": "910029f0-9e4a-487a-9bb3-9be05d353706", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "121b4028-703c-44b1-9338-f482f68f9e35", "node_type": null, "metadata": {}, "hash": "bfd8118dedee8edea33de16347a23d6374bb12ad72bd1b956ca68e5663921d58"}}, "hash": "728d4a5ad385bb4ed48558dc1a5110f050c0b620519857a4d9d958af8de5d2ab", "text": "Post-class for Monday\n\nPlease consider the following as post-class material. \n\nFirst read, I Run a G.M.O. Company \u2014 and I Support G.M.O. Labeling by Jason Kelly. \n\nAnd next, listen to the following NPR segment, titled: Bioengineers Hope to Build Life.", "start_char_idx": 0, "end_char_idx": 251, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "52763446-f37b-4c10-8f3c-7e3f1aff0e0b": {"__data__": {"id_": "52763446-f37b-4c10-8f3c-7e3f1aff0e0b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3bc50e88-cce7-4421-805d-9e3007b2187e", "node_type": null, "metadata": {}, "hash": "fbee78a218baf61aed2d60a9a1a6c5197153f8fb2f26ac37f4474a31beff0762"}}, "hash": "209f0e1534aa928a75af5955ee55205101b9570940f1e5dc22a3a2007c108571", "text": "Day 1: April 6, 2020\n\nClass Slides\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 53, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e350a3a4-7d4f-4971-b7da-2921f83ab1f2": {"__data__": {"id_": "e350a3a4-7d4f-4971-b7da-2921f83ab1f2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d0646bfb-0b1d-4b34-b0df-5d5a7945cea2", "node_type": null, "metadata": {}, "hash": "4fe51a9b82532624dcdb911a7d9b202bbcf56baa7d4bdd038f0b4fbe18fe928e"}}, "hash": "1062873da12ed6e431458e86d90f1a713eb2d2d01e4a91d9b0f37347bc99484a", "text": "Day 2: April 8, 2020\n\nClass Slides\n\nClass Audio/Video\n\n<!--", "start_char_idx": 0, "end_char_idx": 59, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e03cc3c3-c480-45f8-8d4a-a349fe103c89": {"__data__": {"id_": "e03cc3c3-c480-45f8-8d4a-a349fe103c89", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "00706bb0-b713-4b31-be38-a28d086dd506", "node_type": null, "metadata": {}, "hash": "8cacecd7dbe86be41dac145197326ca46e2ba3b31c391aba9d448a519e7a263d"}}, "hash": "f5df91903549c55f83f3c861689a8d8734f599190aa5b10ad37cedd5d4f0e4e4", "text": "Day 3: April 10, 2020\n\nClass Slides\n\nClass Audio/Video\n-->", "start_char_idx": 0, "end_char_idx": 58, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "299cdbad-23bb-4048-b8ff-4bac8d6bb318": {"__data__": {"id_": "299cdbad-23bb-4048-b8ff-4bac8d6bb318", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5582fb45-e245-45e8-a48a-ef2e232df2ed", "node_type": null, "metadata": {}, "hash": "89f989f2cd7fb08036d81b6ef31591f259e57c6425d3e34b3f616edfccc83e34"}}, "hash": "12d979bfcfe0f4536bc8be3ee2b4feeb2cd71e492c8ebe06acaea519f574bfcf", "text": "**(Q1) Who is your bioengineer? (10 pts)**\n\nReturn to your &quot;Imagine a Bioengineer&quot; exercise from the first day of class. Sketch your imagined bioengineer as best as you can, on a piece of paper or digitally. Describe your bioengineer with three words. Include your sketch and three words in your submission. At the end of the course, you&#39;ll have a chance to pick three new words.", "start_char_idx": 0, "end_char_idx": 393, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b75cfa21-4137-4e47-8fa6-e5ab52c15b86": {"__data__": {"id_": "b75cfa21-4137-4e47-8fa6-e5ab52c15b86", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1350de92-7f10-40f9-9c9e-febcc0126be8", "node_type": null, "metadata": {}, "hash": "5fc01bb1c7045f4f780d87019b1e02c6a8b0efc747e5735d3716e68016cf3b23"}}, "hash": "8496a0d95424ca4b9b725aa043367ca36471af6656791263771c2dc669a31edb", "text": "**(Q2) What do or could bioengineers do? (20 pts)**\n\nAfter the first week of the class, a friend asks you about bioengineering. Your friend is specifically interested in the impact of bioengineering on humanity and civilization to date. Think back and review the three examples provided in the Monday&#39;s post-class reading (e.g., polio vaccine).\n\n**2.a.** Identify on your own another example (similar to the three examples from the reading) of an impact of bioengineering today.\n\nNotes: Keep your answer to one paragraph. Include two to three key references in support of your new example (i.e., newspaper articles, reports, websites). Images are optional.\n\n**2.b.** Now think about the future. What future do you wish to realize? What roles should bioengineering play in realizing your future? How would you define &quot;success?&quot; Do you have any questions on how to realize this future? What trends, tools, policies, and technologies could help you realize this future? Craft an answer in response to some or all of the preceding questions, as before not more than one paragraph.\n\nComment: Our aim is to enable you to begin to identify, organize, and communicate the topics that you are excited about. Last year, initial efforts from this question helped guide students in considering possible final project topics.", "start_char_idx": 0, "end_char_idx": 1326, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d25f949c-b3f8-40a7-80d7-64aa92f76caa": {"__data__": {"id_": "d25f949c-b3f8-40a7-80d7-64aa92f76caa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6590eeee-6173-4372-8040-49481b4dcd11", "node_type": null, "metadata": {}, "hash": "308eb7a98b8c1a4254a685601985622deea831bff3cbbf2165e25acfb719ff0f"}, "3": {"node_id": "384e8ffc-ab56-4f74-b8ae-2ed822ee3b98", "node_type": null, "metadata": {}, "hash": "426746a72da3042ee1d163e1c9a3e8dea069aef17af3d2b7ba443c730e297cf4"}}, "hash": "ca924b76d777d0774ade9672644f5ca6cc3538e9d63faa3466b76db10dc8befb", "text": "**(Q3) Approximate and rapid numerical estimates (30 pts)**\n\nOften, bioengineers encounter a new biological system for which they have no intuition. How can we build intuition such that we have a better understanding of what is physically possible in a new system? As an example, let&#39;s say you wanted to ferment potatoes with wild yeast to make rubbing alcohol. How much alcohol could you make per potato? Or, let&#39;s say you wanted to know how many _E. coli_ cells fit on the head of a pin. These problems don&#39;t seem important on their own, but the process of thinking about and answering them makes it easier to tackle the harder problems in bioengineering.\n\n&quot;Fermi problems&quot; are order-of-magnitude estimation puzzles that aim to quickly and approximately answer complicated questions. Engineers do so by using a series of simpler estimations, often using physical principles that are either widely known or easy to guess. For example, before knowing how many bacterial cells might live on the head of a pin, we first need to guess the size of a single cell and the size of the pin head.\n\nSuch an approach the thinking helps build quantitative intuition for new or unintuitive systems. Bioengineers use Fermi problems to determine the feasibility of an idea or better understand a new system. Again, most such estimates are rough: they are designed to give you a quick, order-of-magnitude intuition for what might be possible or what the likely answer could be. Thus, keep in mind that the exactly correct numerical could be different.\n\nFor each calculation below please develop your answers to two significant figures and provide units where appropriate. Show your work. You should only need simple math and arithmetic; a couple of lines of work at most.\n\n_Escherichia coli_ is a well-studied bacteria considered to be representative of how single-cell microbial systems work generally (i.e., a &#39;model&#39; organism). _E. coli_ is also easy to grow in the lab and divides rapidly (as fast as 20 mins for one cell to make two cells) . As a result, _E. coli_ is frequently used in bioengineering research.\n\n**3.a.** First, estimate the volume of an _E. coli_ cell by approximating the cell as a rectangular box 2 um x 1 um x 1 um. Next, estimate the cell volume by approximating the cell as a spherocylinder, as shown in Figure 1. How different are these two approximations? Go to the following page. How does your estimation compare with the measured values? (Optional practice: convert the volume to liters instead of m3)\n\n\n\n\nFigure 1.E. coli is shaped like a rod, which we can approximate as a spherocylinder: a cylinder with hemispherical caps. (Of note, MG1655 is a strain derived from a lineage of E. coli variants that was originally isolated from a diphtheria patient at the Palo Alto hospital in 1922.)\n\n\n\n_E. coli_ cells are shaped like rods with rounded ends, which we can approximate as spherocylinders (i.e., cylinder with hemispherical caps). Of historical note, MG1655 is the name for a commonly used lab strain of _E. coli_ that was originally derived from a diphtheria patient at the Palo Alto hospital in 1922.\n\nFor the rest of question 3 problem, please use your volume estimate arrived at via your rectangular-box approximation.\n\n**3.b.** The mean diameter of a typical protein is roughly 4 nanometers (1 billionth of a meter, abbreviated as nm). Presuming all proteins are spheres of this average size, what is the upper bound for how many proteins could fit inside a typical _E. coli_ cell?\n\n**3.c.** The mean volume of a DNA base pair is 10-27 m3 (1 over 10 followed by 27 zeros). What is the upper bound on how many DNA base pairs could fit inside a typical _E.", "start_char_idx": 0, "end_char_idx": 3710, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "384e8ffc-ab56-4f74-b8ae-2ed822ee3b98": {"__data__": {"id_": "384e8ffc-ab56-4f74-b8ae-2ed822ee3b98", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6590eeee-6173-4372-8040-49481b4dcd11", "node_type": null, "metadata": {}, "hash": "308eb7a98b8c1a4254a685601985622deea831bff3cbbf2165e25acfb719ff0f"}, "2": {"node_id": "d25f949c-b3f8-40a7-80d7-64aa92f76caa", "node_type": null, "metadata": {}, "hash": "ca924b76d777d0774ade9672644f5ca6cc3538e9d63faa3466b76db10dc8befb"}}, "hash": "426746a72da3042ee1d163e1c9a3e8dea069aef17af3d2b7ba443c730e297cf4", "text": "is the upper bound on how many DNA base pairs could fit inside a typical _E. coli_ cell?\n\n**3.d.** Take a look at the actual estimated numbers of proteins and DNA in an E. coli cell from Figure 6a of the following link. What is the ratio of your upper bound numbers to the actual estimated numbers? (present your results in a table) Are you surprised by your result (the upper bound vs actual)? Why or why not?\n\n&quot;Cell Biology by the Numbers&quot; is a useful resource for learning estimation problems in biology. You can get a free copy of the draft version here. The authors have recently published an informative SARS-CoV-2 (COVID-19) by the numbers as well.", "start_char_idx": 3634, "end_char_idx": 4299, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "afe77b60-4255-4a25-8ed1-f526ff848693": {"__data__": {"id_": "afe77b60-4255-4a25-8ed1-f526ff848693", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "267fddab-aaeb-4434-b1ca-f4883a1d767d", "node_type": null, "metadata": {}, "hash": "7e43916df34f090353a977dab89e384176f95bc6d6c43fdf53ec9b2113a90a60"}}, "hash": "9cb59b915163ec84e44f4bb83db5f3b0b05f1f25cff54fb487abfbc4da58e6e8", "text": "(Q4) What&39;s Unique About Living Matter? (10 pts)\n\nRevisit the video describing the unique properties of living matter.\n\n**4.a.** According to the video, what makes living matter unique? (please give two reasons and explain each in 2-3 sentences)\n\n**4.b.** After watching the video, what did you find most surprising? (2-3 sentences)", "start_char_idx": 0, "end_char_idx": 335, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "91cfe710-79e6-4a28-9f6c-3f7cd5b6d353": {"__data__": {"id_": "91cfe710-79e6-4a28-9f6c-3f7cd5b6d353", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "61a98377-5bf1-4862-a502-94a14a74c755", "node_type": null, "metadata": {}, "hash": "e377e887931a999d9aff064ae3dfac8e39fbb4dff6840372006d56785de01592"}}, "hash": "65ec08c1ba2eabd44dae4debad8ec4186933f1ef985717ff8674226bcb758c49", "text": "(Q5) Reading research papers (30 pts)\n\nResearch papers serve as a primary source of information for many fields. One of the goals for BIOE/ENGR.80 is to give you tools (or improve your tools) that enable you to quickly read and learn from the primary research literature.\n\nBriefly read the following paper or preprint: &quot;Enabling community-based metrology for wood-degrading fungi&quot; available from: link\n\n5.a. In your own words, what is the primary claim of the paper? Take a look at the abstract (1-2 sentences)\n\n5.b. In your own words, what is the primary evidence in support of the claim? Take a look at the figures)? (1-2 sentences)\n\n5.c. What did you find as the most interesting idea, fact, conclusion from the abstract of the paper? (From the abstract, figure, or conclusion)", "start_char_idx": 0, "end_char_idx": 790, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "335b5e7c-00e5-42f9-a3a3-cd2d9cfb78cd": {"__data__": {"id_": "335b5e7c-00e5-42f9-a3a3-cd2d9cfb78cd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aeb2cb41-13b7-44f1-b621-cf924cc08d97", "node_type": null, "metadata": {}, "hash": "66cae1640fa6f48b2f6b9defd916d0dc997ce0d602428fc8d17eb7401f9b3391"}}, "hash": "75b3cea947d413010861697b69349ef83eaecda5db985f7458060caf3092132b", "text": "YOUR QUESTIONS\n\nDo you have any unanswered questions or comments from the first week of class that you would like to share with us?", "start_char_idx": 0, "end_char_idx": 131, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "526e119b-9ca6-4d6f-92a1-3bb8e3c85683": {"__data__": {"id_": "526e119b-9ca6-4d6f-92a1-3bb8e3c85683", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3769e52b-d842-45ac-8b7a-3c33f489dfef", "node_type": null, "metadata": {}, "hash": "d23f754dc10bdd008692924d67713e8d2411b9f8fb98f8e7bf6dbc6c901f1ec5"}}, "hash": "bf935bca5716e0bb27ad1676229f45d50e44e52da78a43de26cc5afe8bd463e9", "text": "Additional Learning Resources:\n\nYou can make and keep track of your own private library of bioengineering research papers.  Tools can help.  For example here is a link to a free and useful resource: Zotero The takeaway here is to make sure you have a system in place for managing your resources that support your thinking and problem solving.\n\nBiology refresher-1: If you need additional learning materials or refresher for biology you can start by going through the first three chapters (very brief don&#39;t worry) of The Machinery of Life by David S. Goodsell. An electronic copy of the book is available from Stanford Library and you should be able to access from here\n\n\n github source code for teaching staff", "start_char_idx": 0, "end_char_idx": 713, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "265564f4-fb91-410f-9567-6b3eb05d4a09": {"__data__": {"id_": "265564f4-fb91-410f-9567-6b3eb05d4a09", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "16fe3a9d-d8bb-4065-9958-448ae109fc6b", "node_type": null, "metadata": {}, "hash": "0f4577da5c7be1a4f750f688fa2bfcbca14164e3f4563354d65abbe5defa933d"}}, "hash": "a561b7c8769060288c69d0df570d295f0bd57758642d3f0947555e4b6c0ef8aa", "text": "Why are you here? Why engineer biology? What's unique about living matter?\n\nPlease read and consider the below. Monday's materials can be skimmed following Monday's class.  Wednesday's and Friday's materials should be studied before class.  The questions given are only study questions not homework to be graded. Talk about anything you find interesting with your classmates, friends, or TAs, as you like, using Piazza or email the instructors!", "start_char_idx": 0, "end_char_idx": 444, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0eceda12-9049-4396-a1b1-8d495580b8dd": {"__data__": {"id_": "0eceda12-9049-4396-a1b1-8d495580b8dd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "30f5fc87-1a02-46f0-80e8-51751b8f5215", "node_type": null, "metadata": {}, "hash": "8851b6f886dbef32ed01fd96ed0630fc4528ed3590f5a6c57abca0410ec49cc6"}}, "hash": "b8e33041dd5fd95f6bd0e8b5b8096a985a1ff49e3e44b5e650d3329eac1ceb85", "text": "Post-class readings from Monday", "start_char_idx": 0, "end_char_idx": 31, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2dcab1ec-8af2-44f5-a1ad-a8bca77eca2e": {"__data__": {"id_": "2dcab1ec-8af2-44f5-a1ad-a8bca77eca2e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d0c6b54c-3a08-49ee-bb80-d5364fb49707", "node_type": null, "metadata": {}, "hash": "57aba1cb8d0edb456107cd21d4e0922a4af01b71dcdf9b6a3f3b5455aa52a14d"}}, "hash": "bb2bb4b38bc47a05dca659518725e673c8bf78be7b41752b1db01e8da28d1c80", "text": "What has been the impact of engineering interacting with biology?\n\nHere you will review the role that bioengineering, with a core emphasis on living matter, has already had in the world. Stated differently, we ask: Why has bioengineering mattered?\n\n**Goal 1:** After considering the following examples you should be able to describe example impacts of bioengineering on humanity and civilization to this day.\n\n**Goal 2:** Prepare yourself for a constructive class discussion about the future impact and ramifications of engineering living matter for realizing a future to benefit, and not to harm, all people and the planet.\n\nFirst let's examine in more detail an interesting topic, some of the ancient origins of bioengineering:\n\nIs bioengineering a new field? What events mark the \"start point\" of bioengineering? For example, as far as we know fermentation of beer or use of lactic acid bacteria to make cheese or yogurt dates back to 7000 - 6000 BC. Is that the start of bioengineering? Or is the starting point the work of Leonardo da Vinci in 1450 in analyzing muscles and joint functions? Perhaps it is the work of Anton van Leeuwenhock and his amazing microscopes in the 1600s that enabled him to see bacteria everywhere. Or is the origin more recent, beginning with the discovery of penicillin? Is it the discovery of the double helical structure of DNA? And what of the various strategies and types of application that humanity has developed in partnering with living matter and nature in order to solve problems? Perhaps partnership between humanity and biology is as old as humanity, by definition.\n\nHere, we organize these partnerships into three general categories:\n\nFirst, is the application of the new tools and technologies to engineer **for** living matter. I.e., using other modes of engineering to do something for biology as a science or biology as a type of stuff.  Examples of this category include prosthetic limbs, surgical tools, microscopes, technologies for controlled drug delivery, and machines to read and write DNA.\n\nSecond, is the use or adaptation of living matter as a type of material (cells, enzymes, plants, animals) towards various goals. We call this engineering **with** living matter. This approach has brought us, for example, vaccines such as for polio, leather made with mushrooms in place of vertebrates, and initial progress in growing human some types of human tissues.\n\nThe third and final category is the engineering **of** living matter. This involves the manipulation of biological organisms directly, typically starting from their DNA. This approach has brought us innovations like large scale manufacturing of human therapeutics via microbes (e.g., insulin), genetically modified plants (e.g., virus-resistant papaya), therapeutic immune cells for fighting some types of cancer, (e.g,. CAR-T cells), animal-free meat, and so on.\n\nLet's examine one example from each category.  Please note, there are a few questions after each example (10 total).  Please think of these as study questions, not questions on an assignment.  I.e., you do not have to turn in anything from the reading and study questions in the pre-class material.  We estimate you will spend about 10 minutes on each example, or more but only if you wish to follow-up re: details via the curated links provided.", "start_char_idx": 0, "end_char_idx": 3330, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a42feef0-0d08-4fc2-9af6-3a7b5a6c826e": {"__data__": {"id_": "a42feef0-0d08-4fc2-9af6-3a7b5a6c826e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fe9b8670-2917-4f81-b168-34eb07a0a8b5", "node_type": null, "metadata": {}, "hash": "3194aa2ce993dd2e8b175779f587f14b8eb7864b216d79d9b1873c7ba5abe612"}}, "hash": "53c2f5c4959ba76cd93eeeb021228b80c5f799d96e8d0f28d842ce068acec62c", "text": "Example 1 - Microscopes\n\nThe history of the microscope is an amazing example of how partnership between engineering (i.e., building a new technology) and biology can enable an entirely new paradigm (i.e., world) of discoveries.\n\nIn mid 17th century Anton van Leeuwenhoek was an amature lens maker (he ran a haberdashery business). Van Leeuwenhoek was not a trained scholar; he didn't speak Latin, the scientific language of his time. But he was an excellent lens maker, incredibly curious, and a meticulous experimentalist. His unique lenses (small spheres of glass) enabled him to magnify objects up to 270 times. Leeuwenhoek\u2019s simple microscope was the best microscope of his time. Prior to his work the typical compound microscopes were only able to magnify objects only up to 20-50 times. He was perhaps the first person to see many forms of living matter. [1,2]\n\nObservations enabled by microscopes were one of the most visceral discoveries that astounded the public, including all of the many microorganisms that can be found in a drop of water, a historical depiction of which is shown below.\n\n\n\nFigure 1.\nLeft. Van Leeuwenhoek's simple yet powerful microscope 1670s (arrow points at the lens,  \nHistory of the microscope).\nRight. An artist etching of a person\u2019s reaction to a magnified drop of Thames water (monster soup), revealing the impurity of London drinking water 1828. Source\n\n\n\n**Q.1. What do you think was the impact of the invention of the microscope? How do you think it changed the attitudes of both the practitioners (scientists) and the citizens of 17th century?**\n\n**Q.2. Do you think the developer of the early microscopes could predict all the many applications of their technology to this day?**\n\n**Q.3. Identify one example of a modern day necessity that would have been impossible without the invention of the microscope (yes, there are many examples but just identify your favorite!).**\n\n**Q.4. Now, let's think about a contemporary technology that enables us to read DNA.** DNA sequencing technology allows you to take a physical sample of DNA (e.g., the genome of an organism, which is the physical object comprising all the DNA of an organism) and identify the specific sequence of DNA bases (typically represented by the letters A, T, C, and G) that comprise the DNA.  (Don\u2019t worry if you do not know much about the details DNA sequencing, we will cover this later in the course. optional link) What do you think has been the impact of DNA sequencing technology? Stated differently, what do you think has been the impact of being able to read out the \"letters\" in DNA encoding organisms.  Do you know of any current applications of DNA sequencing? Can you imagine what would be the impact of DNA sequencing  in 10, 50, or 100 years given developments occurring right now?\n\nIf you are excited about learning more about microscopy please follow this fantastic optional link. If you want to know more about the discovery of bacteria by Van Leeuwenhoek  please follow this optional link 2.", "start_char_idx": 0, "end_char_idx": 3019, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5c2f61bd-f4ab-4bfa-873b-e247a07a1fdc": {"__data__": {"id_": "5c2f61bd-f4ab-4bfa-873b-e247a07a1fdc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cb162009-3a11-4c0a-aae3-23b0ec30497c", "node_type": null, "metadata": {}, "hash": "4b26089756402675d739b2e7aa49791039de664f3ffe3a9cea59ed1d8241e943"}}, "hash": "c03d60db52459a2d4e5d7b45d9c788742ad26123295f93b26cf24ba8494edc14", "text": "Example 2 - Polio Vaccine\n\nPolio is a crippling and potentially deadly disease and is caused by the very contagious poliovirus that spreads rapidly from person to person. Polio can lead to paralysis if the virus invades the person's brain and spinal cord. About 1 out of 200 people infected with poliovirus will suffer from this outcome.\n\nIn the early 20th century, fewer diseases frightened parents more than polio. Children could come down with polio suddenly, and rapidly suffer from permanent paralysis in one or both legs. A tank respirator, better known as \"Iron Lung,\" was developed to help patients breathe. These giant tanks engulfing a whole person from their neck down were often required as a long-term solution and patients' survival depended (and depends) on them. Here is an additional interview with people that depend on iron lungs for their survival to this day. [3,4]\n\nIn 1955, Jonas Salk and his team successfully developed a vaccine for polio. Salk's team manipulated the virulent poliovirus to inactivate it. This inactivation engineered the native virus into a form that was safe to the host (i.e., person) but still had the immune stimulating components that would lead to successful immunization via the vaccine.\n\nWatch this video which will bring you back to 1955 when the clinical trials for the vaccine were released.\n\n**Q.5. What do you think was the social impact of the successful development of the polio vaccine?**\n\n**Q.6. What cultures and attitudes had to be coupled with Salk's discovery to ensure the transfer and success of the vaccination campaign?**\n\n**Q.7. The video of the released clinical trial results shows the public's excitement and faith in research at that time. What discoveries today would lead to that type of response? Could bioengineers take for granted a similar response today?  Why or why not?**", "start_char_idx": 0, "end_char_idx": 1853, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c0966a18-53c6-46c8-b5a4-ed0965af8f06": {"__data__": {"id_": "c0966a18-53c6-46c8-b5a4-ed0965af8f06", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "75d77322-5d9e-40d0-adcd-324b2274e3f0", "node_type": null, "metadata": {}, "hash": "fd85d4e40434fc7207111dc5bf54be67838420303bd241cee0b8219b9afe2965"}}, "hash": "31e30b01b351e47ab66c58c93c7f043c3147056ed1789b710096c80f3c99f22b", "text": "Example 3 - Ringspot Resistant Papaya\n\nIn the early 90s, hundreds of Hawaiian papaya farmers were in the state of panic. Papaya Ring Spot Virus (PRSV), named since it leaves discolored spots resembling tiny rings, were spreading across their fields. For the next several years, the farmers would lose most of their fields after and crop to PRSV.\n\nIn 1992, a plant pathologist at Cornell University, Dennis Gonsalves, who grew up in the region most affected by the virus, suggested a vaccination approach to stop the spread of this devastating virus. After a decade of work Gonsalves and his team carefully genetically modified the papaya plant by inserting a gene from the PRSV. They were able to create (i.e., cultivate) a papaya plant -- which they named the Rainbow papaya - that was genetically resistant to the ringspot virus, effectively saving the papaya industry in Hawaii. Their work is an example of engineering of living matter. Here is a fascinating interview with Dennis Gonslaves about the Rainbow Papaya and the social impact titled Why public sector biotechnology research matters?. However, this story did not end there\u2026 (read on)\n\n\n\nFigure 2. Symptoms of Papaya Ring Spot Virus (PRSV) on the tree and the fruit (a,b). Abandoned fields of papaya (early 90s) juxtaposed against the cultivation of Rainbow papya (late 90s) developed by Dennis Gonslaves. Source.\n\n\nIn 2013 anti-Genetically Modified Organism (GMO) groups strongly and successfully advocated, and passed a ban in Hawaii restricting cultivation of GMOs. Naturally this was faced with strong opposition from the local papaya farmers. The bill was amended to make exception of genetically modified papaya (and corn). The ban was turned into law in 2014, which was stuck in a legal limbo. Eventually, a U.S. Court of Appeals overturned the bill ruling that counties in Hawaii could not enact their own GMO bans. However, this was not the end of the story either. The debate over the Hawaii bill sparked numerous bills around the country seeking to limit or to ban GMO food, crops, or ingredients. Finally in 2016 President Obama signed the first national GMO labeling law, which required food makers to list any GMO ingredients. Currently there are numerous active anti-GMO organizations all around the country, as well an many for-profit companies working to make and deliver products (and realize profits) via genetically modified organisms.   \n\n**Q.8. What do you think was the social impact of the successful development of the Rainbow Papaya?**\n\n**Q.9. What cultures and attitudes were coupled with the development and cultivation of the Rainbow Papaya?**\n\n**Q.10. Who are the  stakeholders in the debate between the pro Rainbow Papaya and the anti-GMO campaign? Who (or what process) should decide the outcome of this debate?**\n\nIf you are excited about the ringspot resistant papaya and want to learn more, follow these optional links:\nlink 1,\nlink 2, and\nlink 3.", "start_char_idx": 0, "end_char_idx": 2945, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "66abc75b-1312-45de-ab81-19fd54d49ab3": {"__data__": {"id_": "66abc75b-1312-45de-ab81-19fd54d49ab3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3f498d54-3613-4c3c-aae9-1d2d8887754f", "node_type": null, "metadata": {}, "hash": "b51d42af85f4e7014c34c29de933bbdb8698d7991166146359d6eca8b36b91c0"}}, "hash": "c7c14c5374b7593c4650c88a88ea861f1b1f547e80be0bab0ff994f05ac0d72c", "text": "Summary\n\nIn Day 1's post-class material you reviewed representative cases highlighting the impact and role of bioengineering, broadly defined, in society. First, you examined the role and development of a transformative technology, the microscope, that opened opportunities and vistas previously inconceivable. From this you examined, what **tools and technologies** do we want coupled with biology? Next, you examined development of a life saving vaccine for polio (an example for engineering with biology). Here you examined what **cultures** do we want coupled with bioengineering? Finally, you learned more about the Rainbow Papaya as a case for engineering of biology. Here you began to examine what **futures** we wish to realize via bioengineering? And who gets to decide?", "start_char_idx": 0, "end_char_idx": 779, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "600ce937-46d3-4b4a-9a87-aba1f4e14d70": {"__data__": {"id_": "600ce937-46d3-4b4a-9a87-aba1f4e14d70", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "55793051-95e5-4bc3-8f97-b1a7430c48cd", "node_type": null, "metadata": {}, "hash": "2f44a1cbdc9b7adee1a344dfa96668cae4b0a30da3b5f662414fef555603c235"}}, "hash": "d5329ae5fd638c83f9e4e971f03238af9a47feea1bb77b83f33c193af8918017", "text": "Additional References:\n\n1] [History of the microscope\n2] Ed Young, [I Contain Multitude\n3] [CDC Poliovirus\n4] [History of Polio vaccines\n5] [Erin Brodwin \"This Cornell scientist saved an $11-million industry\n6] [Ban in Hawaii on GMO Crops Is Ruled Invalid\n7] [U.S. GMO food labeling bill passes Senate\n________________________________________________", "start_char_idx": 0, "end_char_idx": 350, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f973e596-e39e-4f06-a675-9553a560d491": {"__data__": {"id_": "f973e596-e39e-4f06-a675-9553a560d491", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "76aa9e20-2532-45e3-8834-c6bf10f1c929", "node_type": null, "metadata": {}, "hash": "d1a458bc5985898515d9475717d188fe017b68eedb7b8cfa8eb253d5ce4a4e9c"}}, "hash": "11018fae173f26cfc34ea66d21b58fbecca79b40696bba76b1b7d6885fd49bce", "text": "Preclass for Wednesday\n\n**What's Unique About Living Matter?**\n\nHere you will learn and think about what makes living matter such a unique material when compared to inert matter by considering the specific and distinctive properties and capabilities of biological stuff from an engineers perspective.\n\n**Goal:** After watching the following video you should be able to explain the properties of living matter that make it more effective at solving many engineering challenges compared to inert matter.\n\nYou can watch this video from Stanford Bioengineering Prof. Jan Liphardt detailing the unique properties of living matter. Write down any questions you have so you can ask your peers, TA's, and professors in class or office hours.\n\n\n\n\n**Q.1. Think of at least two more applications which could benefit from the use of living matter that weren't mentioned in the video.**\n\n**Q.2. According to the video, what is the universal code that makes engineering and tinkering with living matter feasible?**\n\n**Q.3. Describe what it means that living matter functions and is organized on many orders of magnitude (multiple scales). Think about an additional example (video discusses the brain) to explain organization from nanometers to meters to scale.**\n\n**Q.4. What did you find most surprising?**\n\n________________________________________________", "start_char_idx": 0, "end_char_idx": 1343, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "928aa4d8-f827-46e5-a260-5824d5da7538": {"__data__": {"id_": "928aa4d8-f827-46e5-a260-5824d5da7538", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c920ead1-8e97-4ee1-a373-bd138608e3f4", "node_type": null, "metadata": {}, "hash": "e039b05b72d55c36cf831297e29b2a9b1ff9c760df84c7ff0959c5268cdf17d3"}}, "hash": "2a5840800bff45adbb34c1de50ffa2fea8b576be56e3f1e9abf23e2db509d440", "text": "Preclass for Friday\n\nA specific skill we wish you to learn or improve is how to quickly and effectively benefit from research reports that appear routinely on the \u201cfront lines\u201d of bioengineering.  To gain or improve your research manuscript analysis skills please study the two papers listed below.  NOTE \u2014 we are not asking you to read these papers.  Rather, simply apply the first five points as noted below.  Your two objectives are to see if you can identify the main claim in the paper (only by skimming and thinking about the title and the abstract) and then to see if you can determine *where* in the paper the evidence is presented that supports the main claim (only by skimming and thinking about what is presented in the figures or illustrations).  Please practice the method outlined below before class on Friday on the two papers given here.\n\nHow to read a research paper:\n\n(0) DO NOT SIT DOWN AND READ THE ENTIRE PAPER.  STOP.  DO WHAT FOLLOWS INSTEAD.\n\n(1) Read the title.  Does it make any sense?  Note words you don\u2019t understand.\n\n(2) Read the abstract.  Find the single most apparent or remarkable claim.  \n\n(3) If you fail to find any main claim from the abstract don\u2019t bother reading the paper.\n\n(4) Skim the figures, looking for evidence in support of the main claim.\n\n(5) If you can\u2019t find clear and apparent evidence in support of the main claim stop spending time on the paper.\n\nSTOP HERE REGARDLESS AND DECIDE IF YOU HAVE MORE TIME TO SPEND ON THE PAPER\n\n(6-10) If you are spending more time on the paper the next thing to do is to find the main weakness or limitation of the work. Finding the main weakness requires much more effort, beyond scope of Intro to BIOE.\n\n**Papers** \n\n1. [A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector *Anopheles\ngambiae*](https://www.nature.com/articles/nbt.3439)\n\n2. Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements\n\n\n\n github source code for teaching staff", "start_char_idx": 0, "end_char_idx": 2012, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ba2f78bb-ffdf-4aee-8673-57fcc0246a3e": {"__data__": {"id_": "ba2f78bb-ffdf-4aee-8673-57fcc0246a3e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "706afe10-1d21-41e7-a56a-a9714dfa220d", "node_type": null, "metadata": {}, "hash": "3dad99bc0de83e3afb3e040136f62c95a0ff2de68d67f159e5aec2047554d7a2"}}, "hash": "0ba677078971e9f02febeca021aca159aabd581e828322408786ba7a1bcc40a1", "text": "Day 4: April 13, 2020\n\nClass Slides\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 54, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "28f391d7-b209-44e1-b3eb-e9a373688552": {"__data__": {"id_": "28f391d7-b209-44e1-b3eb-e9a373688552", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a7fc0c2c-cfaf-4a3a-bb82-593ec92ba62b", "node_type": null, "metadata": {}, "hash": "52effeccc5945193bda8ca032bf1b4d1b6da26981d920b17ca835d3e7fdabff3"}}, "hash": "40dd39173c1835718eaeb56541520a327d0bfb51b2ecdd1537dacd53722403ef", "text": "Day 5: April 15, 2020\n\nClass Slides\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 54, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d9db22eb-bf05-4b6a-b9ac-19ab505a6a3f": {"__data__": {"id_": "d9db22eb-bf05-4b6a-b9ac-19ab505a6a3f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1ff26edc-6068-4418-87a6-5f6954af649e", "node_type": null, "metadata": {}, "hash": "2d5dfec8b80a4c144df77186f779398642d7e0356890ece066f0c0023c5f097a"}}, "hash": "ebfd7e88573e6f58250f97c82350b5629a597f518c30319c4317b38e6dc924c3", "text": "Day 6: April 17, 2020\n\nClass Slides\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 54, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0d291464-a5cb-45d3-aea0-a3d4fcf715e8": {"__data__": {"id_": "0d291464-a5cb-45d3-aea0-a3d4fcf715e8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "50af3b9a-9078-4af7-9d3a-fcafc326ca7e", "node_type": null, "metadata": {}, "hash": "72987cc03c857ff110c4d9bfd10b1c05cbb3b2e579b0fde92c4639669bf3ac4b"}}, "hash": "7a8eecb04b44f563bb2c29fd62215b52879df0bff7d48100a2026153ac3d0ca3", "text": "People, Planet, & Political Health\nPlease read and consider the below before the start of each class.\nThe questions are study-questions and not homework to be graded.\n Talk about anything you find interesting with your classmates, friends, or TAs, as you like, using Piazza or email the instructors!", "start_char_idx": 0, "end_char_idx": 299, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6a1bb986-4981-41a5-8013-1c0ea2d830be": {"__data__": {"id_": "6a1bb986-4981-41a5-8013-1c0ea2d830be", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dcf0a36f-cf81-405c-8222-597a4ab35fff", "node_type": null, "metadata": {}, "hash": "b8efb19c139a443683c1678c6c6d53c37bdbfb00b8e1ba51ccc3c4116f2cc9b3"}}, "hash": "1462ab86f8463badc244917aa127f9a68c2509c2efb56bccd2371e0749ba1210", "text": "Preclass for Monday\nThe intersection of Bioengineering and human health is an active and exciting area of research. \nTo better discuss the role that bioengineering can play -in addressing challenges in human health- briefly skim the following, The Burden of Disease and the Changing Task of Medicine, available from link-1 and also a summary of the same material from link-2.  \n\n**Q.1. What is the definition of burden of disease?**\n\n**Q.2. How has the burden of disease for various diseases changed over time?**\n\nNext, familiarize yourself with some background information on malaria from the two links:\n\n1. WHO - 10 facts on Malaria\n\n2. CDC- Malaria\n\n**Q.3. What causes malaria? How is malaria spread?**\n\n**Q.4. How is malaria diagnosed and treated?**  \n\n**Q.5. What are the challenges associated with 'drug resistance'?**\n\n*Optional reading:  \nThe Nobel Prize in Physiology or Medicine 2015 to Youyou Tu for her discoveries concerning a novel therapy against Malaria\nOptional Link-1,\nOptional Link-2*\n\nOne approach to address malaria via bioengineering is to produce active pharmaceutical ingredients (APIs), or key ingredients of a medication, via engineered organisms (e.g. an engineered yeast).  See optional link for a primary research paper High-level semi-synthetic production of the potent antimalarial artemisinin.  \n\nWith this in mind, please consider the following articles describing the reaction of the market to such endeavors:\n\nSynthetic biology's first malaria drug meets market resistance\n\n**Q.6. What was the only source of artemisinin before engineered yeast-based biosynthetic production?**\n\n**Q.7. What were the challenges that the yeast-made drug faced ?**\n\n**Q.8. What steps might have prevented some of those challenges?**\n\n*Optional reading:  \nInterview with Dr. Jay Keasling ' whose work led to the industrial production of this important drug in yeast using synthetic biology.'\nOptional Link-3*\n\nLater we will also talk about **Gene-Drives** as a potential solution to address diseases such as malaria. If you have time and wish to get a start on learning about gene drives, check out this article The Perils and Promises of Gene-Drive Technology by our very own Michael Specter.\n\n______________________________________________________", "start_char_idx": 0, "end_char_idx": 2264, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "23ac4044-81e5-4ae2-9e15-ad50dc9f9a62": {"__data__": {"id_": "23ac4044-81e5-4ae2-9e15-ad50dc9f9a62", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2c4eee77-7889-4fd0-9b3c-5cf27e31e117", "node_type": null, "metadata": {}, "hash": "48a24b4cde34546705bd2dcd2b80196209b609ac0794f596ac65a38f61f097f4"}}, "hash": "dc55dbbfe84937d9f652ff2bc70146ee31215fb9f98b94c46bc1628fb57290c9", "text": "Preclass for Wednesday", "start_char_idx": 0, "end_char_idx": 22, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9621eae2-edde-49ab-9404-5473ab25f901": {"__data__": {"id_": "9621eae2-edde-49ab-9404-5473ab25f901", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b8040aff-46eb-4b9d-b564-38e42aa53bfc", "node_type": null, "metadata": {}, "hash": "56e3d02dc9583f359812fd1a60e4bbfc61735f2c1d3d28d10e3dc2bb754674bc"}}, "hash": "b0077c5027a35942ffac80103f390889f1aa4bc3ac05c6c7051278a205b4676c", "text": "Planet health (what does everything else \u201cneed\u201d?)\n**Extinction of Species and Bioengineering**\n\nIn the 1960s, 2300 northern white rhinos lived in the wild. By the 1990s, their population was estimated to be a few dozen. In 2008, the white rhino was believed to be extinct in the wild. On March 20, 2018, the last captive white rhinoceros (named Sudan) died at the Ol Pejeta Conservancy in Kenya. A team of vets put the 45-year-old Sudan to rest when his age-related health complications took a turn for the worse. Two female rhinos -- Sudan\u2019s daughter (Najin), and granddaughter (Fatu) -- are the only remaining individuals of their species. Northern white rhinoceros were functionally extinct even before the death of Sudan, since neither daughters are capable of reproduction. Currently, the only way to continue their species would be to artificially inseminate their eggs with stored sperm from Sudan or other males, and implant the resulting eggs into females of the closely related southern white rhino.source-1, source-2, source-3. \n\n*Optional reading: An Endling is the last known individual of a species or subspecies. Once the endling dies, the species becomes extinct Optional Link-1:Endling, Optional Link-2: what do you call the last of a species*\n\nExcessive hunting has been the primary cause of the extinction of rhinos. However, across all of life, hunting and poaching is not the only or even the primary cause of extinction and rapid loss of biodiversity.\n**Climate change** and **moving species** around the world (due to human movement) are other significant factors causing the extinction of species. Let's focus on moving species for now.\n\nWhile this seems ordinary, we routinely (intentionally or otherwise) move species around the globe at a rapid rate. This movement often brings together two species that have never encountered one another; the two wild species may have long-evolved along distinct evolutionary paths. Their human-assisted introduction can have both distributive and devastating effects. For example, the intentional introduction of Pacific rats to New Zealand had a devastating impact on the population of many flightless birds that had no previous predators. \n\nAnother example is the introduction of pathogens. For example, white nose syndrome or WNS a disease affecting hibernating bats that has devastated the population of bats in North America. A fungus discovered in 2008, Pseudogymnoascus destructans (formerly Geomyces destructans) has been demonstrated to cause WNS. Scientists are investigating the dynamics of fungal infection and transmission, and searching for a way to control it. \n\n**Q.1. Could or might bioengineering help us revive and restore extinct species? If yes, how?**\n\n**Q.2.Could bioengineering help us eliminate (or reduce) invasive species?** \n\n**Q.3. Could bioengineering help us eliminate factors accelerating ecosystem damage or change?**\n\nBriefly familiarize yourself with the following project Revive & Restore.  As you see, the project seeks to 'De-Extinct' and revive woolly mammoths using genetic engineering and cloning.\n\n**Q.4. What challenges might the bioengineers face in reviving woolly mammoths?**\n\n**Q.5. If successful, what challenges might the woolly mammoths face?**\n\n**Q.6. Could bioengineering help us establish life somewhere else (e.g., Mars)? If yes, who should decide?**\n\n*Optional reading: \nDe-Extinction Debate: Should We Bring Back the Woolly Mammoth?. and The Living Planet Index\n\nLooking ahead to Friday's class and if you would like a thought-provoking essay by Ursula K. Le Guin, please find She Unnames Them\n______________________________________________________", "start_char_idx": 0, "end_char_idx": 3667, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ab3b63f2-7083-4428-b7b8-219dbecba0ec": {"__data__": {"id_": "ab3b63f2-7083-4428-b7b8-219dbecba0ec", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "03a32e3a-9ec1-4327-99bf-588d27b47a52", "node_type": null, "metadata": {}, "hash": "e9be3bb70f1358daeb24df906958e8c825d4a484111c41228d915bf552870403"}}, "hash": "f45aa709296b89493f08e0322fc81d1a53822e662ec8368a64ab562bfdce7c23", "text": "Preclass for Friday", "start_char_idx": 0, "end_char_idx": 19, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3b00b9e9-3fa9-4767-abda-3f5bedc2fca1": {"__data__": {"id_": "3b00b9e9-3fa9-4767-abda-3f5bedc2fca1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "40048bb9-df3b-4ec7-bb92-de8f0695610c", "node_type": null, "metadata": {}, "hash": "682bd6c65159c7296656f3d718552144710944ec06340278c77d51e383f12fb2"}}, "hash": "7b44fca610d23b298e6dd8492e2b18071a39f4db1b9bd559857c7544afb0be11", "text": "Political health (what does it mean to engineer biology at social scales?)\n\nIn getting started please familiarize yourself with the thinking of Hobbes and Rousseau.  \n\nBoth explored tradeoffs between individual rights and the formation of collective government (i.e., the social contract):  \n\nBriefly introduce yourself to Hobbes\u2019 thinking regarding the formation of government via the four \nparagraphs that start with, \"In Leviathan, Hobbes set out his \ndoctrine of the foundation ofstatesand legitimate governments...\"\nlink Hobbes\n\nSimilarly introduce yourself to Rousseau's thinking by studying the eight paragraphs that begin with, \n\"Rousseau's text is divided into four main parts...\"\nlink Rousseau\n\n**Q.1. How do Rousseau\u2019s assumptions about human nature differ from Hobbes\u2019?** \n\n**Q.2. How might such assumptions lead to differences in terms of how people are organized, or organize themselves?**\n\nNext, please skim the 2018 NY Times article, \u201cAs D.I.Y. Gene Editing Gains Popularity, \u2018Someone Is Going to Get Hurt\u2019\u201d\n\n**Q.3. Do you think bioengineers should be licensed?  What most informed your choice?**\n\nFinally, please watch the ~5' video of testimony by bioengineer Dr. Megan Palmer before the US Senate on the topic of \"Securing U.S. Leadership in the Bioeconomy\".  Please skip directly to the 52:35' timestamp to go directly to Dr. Palmer's testimony.  \n\n**Q.4. Dr. Palmer offers five recommendations for the Senators.  What are her five recommendations?**\n\n**Q.5. What do you think of her recommendations?  Which one sounds best or worst to you?**\n\n**Q.6. Would you have offered a different recommendation?  What and why?**\n\n\n\n______________________________________________________\n github source code for teaching staff", "start_char_idx": 0, "end_char_idx": 1735, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "74e668d9-6710-47ed-bd9e-ef1aeabca33c": {"__data__": {"id_": "74e668d9-6710-47ed-bd9e-ef1aeabca33c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b5077bf6-30b9-41af-9bf3-761cee8b9bad", "node_type": null, "metadata": {}, "hash": "f387bbea5424df57f8f0ee14009460386c15a5b7c3d52fff34a2da3f04723ea5"}}, "hash": "9abfeb28e694b041e8fb79d3b5d389f74644987c6bd1aaf600f49c5c48bcd045", "text": "(Q1) Malaria and Artemisinin (20 points)\n\nThink back to the case study: Production of artemisinin via yeast\n\n**Q.1.a.** List three major lessons from the pre-class reading? (bullet points)\n\n**Q.1.b.** List two to three questions that can help you frame a solution for addressing malaria? (bullet points)\n\nNote:  For the following estimation questions please show your step-by-step calculations, keep track of units, and clearly state your assumptions. \n\n**Q.1.c.** The World Health Organization (WHO) estimated that in 2017 there were 219 million cases of malaria. If 3 grams (3 g) of artemisinin are required per treatment of 1 individual, how many total grams of artemisinin are needed per year?\n\n**Q.1.d.**  Sweet wormwood plants can produce 70 kg of artemisinin/ha land, where ha is a hectare of land.  Using your answer from Q.1.b., estimate how many total hectares of land would be needed to produce enough artemisinin to treat all individuals suffering from malaria each year? \n\n**Q.1.e.**  Producing artemisinin via yeast-based fermentation can yield 25 g of artemisinin/liter. What volume of a reactor do you need to produce enough supply of artemisinin to treat all individuals suffering from malaria each year? Use your answer from Q.1.c.\n\n**Q.1.f.**  Imagine that in the near future you are the head of the WHO's Malaria Project.  In this future, land usage has become a challenge for the production of artemisinin given the need to grow food. You are presented with the following data: in order to \"feed\" the yeast-based brewing process you need to supply 1.6 kg sugar/liter (which yields 25 g artemisinin/liter). If you can produce 7500 kg sugar from 1 hectare, how many hectares of land would you need to produce enough artemisinin?\n\n**Q.1.g.**  As the head of the WHO's Malaria Project, would you switch artemisinin production from wormwood to production via yeast?  If yes, please explain why. If not, what would you want to see before considering a switch?", "start_char_idx": 0, "end_char_idx": 1974, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "431de908-7ca4-46fe-93d7-5287dc3677ae": {"__data__": {"id_": "431de908-7ca4-46fe-93d7-5287dc3677ae", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8174bae9-4522-4adc-bc8b-192a8f06cb11", "node_type": null, "metadata": {}, "hash": "5f57b7109c0202b80664c15710fa58249e8330d3e341af2c735787d274cc67ac"}}, "hash": "4e389117ef8771c953aae39b88fe3faaf2f618c70835bf0b2eaaa946b9f3be4c", "text": "(Q2) Fantastic Voyage (20 Points)\n\nIn the near future, you and your team are planning to remove an inoperable tumor from the brain of an important scientist. You conclude that the only way that the tumor can be destroyed is to remove it from the inside of the patient's own body. You imagine a submarine that can be shrunk and will carry the team of experts and doctors.            \nSadly, however, a shrink ray does not exist in this future Fantastic Voyage\n\nInstead, you can begin to engineer living matter, microbes or patient's cells that are already small.\nBriefly read the abstract of the paper titled Acoustic reporter genes for noninvasive imaging of microorganisms in mammalian hosts, which enables imaging and control of living matter in mammalian hosts.\n\n**Q.2.a.** In your own words, summarize the abstract in 2-3 sentences. What is the main claim of this paper?\n\n**Q.2.b.** According to the paper, what is the origin and purpose of the gas-filled protein nanostructures in nature?  \nWhat is the typical size of the gas-filled proteins?  How are the gas-filled proteins visualized in the paper (what technique)?  Can the gas-filled proteins be visualized directly via a light microscope (yes/no)? Why? \n\n**Q.2.c.** Can you think about and describe another application (medical or other) for these engineered microbes (bullet points). \n\n**Q.2.d.** In your opinion, what are the paper\u2019s strengths and significance?  What are the paper's shortcomings and deficiencies? How can the paper improve?", "start_char_idx": 0, "end_char_idx": 1504, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "49a6317d-f8b8-45de-b0e5-0f7faaa41b45": {"__data__": {"id_": "49a6317d-f8b8-45de-b0e5-0f7faaa41b45", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "80e1dba3-3e11-4412-b88f-283d539a6a80", "node_type": null, "metadata": {}, "hash": "3e06568b69388e866f6713e67b3f3cef8452d70e2be32ee76312bc16054680d8"}}, "hash": "afc4b04bcecb818da529d027fb8f3b82f4505c9a4548506c791c4db2e4fe3a13", "text": "(Q3) Rousseau and Hobbes (30 Points)\n\n**Q.3.a.** How do Rousseau\u2019s assumptions about human nature differ from Hobbes\u2019? (2 bullet points)\n\n**Q.3.b.** Do you think those practicing bioengineering should be licensed? If yes or no, who gets to decide? \n\n(As you think about the above question, also consider:  What are the advantages or disadvantages of a license?  Who gets to be licensed? Who decides the rules for the license?  Is there an exam? Where do practitioners go to receive a permit? How the assumptions from Hobbes and Rousseau could lead to differences regarding how people are organized, or organize themselves.)\n\nCraft an answer in response to some or all of the above questions.  \nDo your best to summarize your thoughts in one paragraph.\n\nNote: In Q.3.b., we are looking for a clearly stated and logical argument that uses the stated assumptions from Q.3.a. Use these assumptions, combine them with examples, and describe your position.", "start_char_idx": 0, "end_char_idx": 950, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "faf54093-7e8a-4628-97f7-f034f0dcc6f0": {"__data__": {"id_": "faf54093-7e8a-4628-97f7-f034f0dcc6f0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b2ac548d-5e76-40a5-b2b3-987488dcba02", "node_type": null, "metadata": {}, "hash": "8bb98eb3a0038b560dbc06d2ac9612a9e036305eb2ab262972bbba62fc211009"}}, "hash": "4ca76d33f82acf06b5cc79354eeee019282f8419fdb7ade431dcf0206259a599", "text": "(Q4) Leadership and Bioengineering (30 Points)\n\nConsider the following scenario; many people around the world do not have access to safe, essential pain medication.  On the other hand, opioid abuse and addiction to painkillers is a crisis in the United States.  Today it is technically feasible to produce opioids in yeast via a fermentation process link\nBut a more difficult question remains.  What should bioengineers do so that by 2030 all people (8 billion) have responsible access to pain medications?  \n\n**Q.4.a.** Practice a Framestorm, what questions you should ask to best frame your desired future? (5 questions)\n\n**Q.4.b.** Practice a Futures wheel, What would be the direct and indirect future consequences of your wish (draw a map similar to here)\n\nNext, revisit Dr. Palmer\u2019s testimony from the reading (Transcript from here.  Dr. Palmer offers five recommendations for the Senators to secure future U.S. leadership in the bioeconomy. \n\n**Q.4.C.** Which recommendation(s) might help you in realizing a responsible access to pain medications? Which recommendation(s) might prevent you from realizing it? Why? Would you have offered a different recommendation? What and why? (Do your best to summarize your thoughts in one paragraph.)\n\nNote: In Q.4 we don't have a \"correct answer\" in mind.  Instead, we wish for you to think deeply.  We want to enable you to practice your written communication skills.  Finally, we wish for you to take steps towards becoming a leader (similar to Dr. Palmer) to be able to direct discussions around bioengineering.", "start_char_idx": 0, "end_char_idx": 1560, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "81304499-aa85-4a57-b325-6d9a6478211c": {"__data__": {"id_": "81304499-aa85-4a57-b325-6d9a6478211c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "183de8bd-164f-43d1-ab3b-15a1589f21f5", "node_type": null, "metadata": {}, "hash": "3caf0c91c2f5e42bceaf35bf6a256f65565604ac00840d9ecb1a0ccb087e016f"}}, "hash": "4c944f9656e7731e146fa2e326e06e25db4e1ae615d910d742b5f42b17b52ea0", "text": "Additional Learning Resource\n\n**Biology refresher-2:** If you would like to review or learn more about the structure of  DNA, use the following resource link-1.  If you would like to watch brief videos describing transcription (going from DNA to RNA) use:  video-1 and video-2 Next, if you need a refresher on amino acids and proteins, use the following resources: Video: What is a Protein? And Slides from PDB101. A review of the above topics will be helpful in understanding the material in the subsequent weeks.  \nIn general, explore biology is a useful resource.\n\n**Extra learning-1:** Entirely optional videos for all learners that explore useful topics related to this week\u2019s learning.  You are not expected to watch all of these videos.  We simply want to enable you and give you the option of learning more as you wish. \n\n1.  Coronaviruses 101: Focus on Molecular Virology by Britt Glaunsinger\n\n2. Engineering Microbes to Solve Global Challenges by Jay Keasling\n\n3. Realizing Synthetic Carbon Dioxide Fixation by Tobias Erb\n\n4. Synthetic Biology in a Societal Context by Emma Frow \n\n github source code for teaching staff", "start_char_idx": 0, "end_char_idx": 1129, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4ce45d0e-5e6d-4f56-93b2-166e4a4cca9d": {"__data__": {"id_": "4ce45d0e-5e6d-4f56-93b2-166e4a4cca9d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "36d87278-720a-4186-8abc-502e01c4c92c", "node_type": null, "metadata": {}, "hash": "e7bb8c918060d9ef2630482d871271f3b32327e3d1016adaa9630c58d01d8558"}}, "hash": "5b8b399bc825af82d9780c523d9bc04dedaa58938d55bd056e8f673cce8b7384", "text": "Day 7: April 20, 2020\n\nClass Slides\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 54, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "bf8b70de-44fc-4838-974c-0c4822b65e14": {"__data__": {"id_": "bf8b70de-44fc-4838-974c-0c4822b65e14", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c6a3cd14-4f5d-4453-97d5-2c412c6b872f", "node_type": null, "metadata": {}, "hash": "193e21005418f36053f72100ebf6ae0a1902c2a0649fad4d734fab42ce070813"}}, "hash": "781c98f7e59ee967f4fe66a6fd67824540fbc4943de77a12c342eb1e8b7960b6", "text": "Day 8: April 22, 2020\n\nClass Slides\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 54, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6ff5a90b-45e3-4777-805c-d8377ea4c098": {"__data__": {"id_": "6ff5a90b-45e3-4777-805c-d8377ea4c098", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "50bf6623-bca6-47b7-bafd-bcba7cd025dd", "node_type": null, "metadata": {}, "hash": "7fe1bd971eaf5457ba53f79ed38d53126917826745c15bd5e9b6709c3839b446"}}, "hash": "f8d498e85ee37b79ce916b558f548bb9d2ca296ea1d2bc49b67513d632fe9dc9", "text": "Day 9: April 24, 2020\n\nClass Slides\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 54, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "39d97ab4-a99d-463b-a950-eacfe53dd664": {"__data__": {"id_": "39d97ab4-a99d-463b-a950-eacfe53dd664", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "51184f76-ff7d-4635-a3fe-782c187e98ca", "node_type": null, "metadata": {}, "hash": "d1dd3031c8a9488c58a93c1b7b801558d6ea0c1e6a65c38567ff424947037b29"}}, "hash": "751e4f5a7b1cc0488df39200dd32be68c93c489b749999976deebdafc2c85b5f", "text": "Analysis & Design of Molecules & Genetic Systems\nPlease read and consider the below before the start of each class.\nThe questions are study-questions and not homework to be graded.\nTalk about anything you find interesting with your classmates, friends, or TAs, as you like, using Piazza or email the instructors!", "start_char_idx": 0, "end_char_idx": 312, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "42f114aa-529c-47e7-adc9-07910d150a62": {"__data__": {"id_": "42f114aa-529c-47e7-adc9-07910d150a62", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ed366a82-5a01-474e-9658-ea4995f6816f", "node_type": null, "metadata": {}, "hash": "cfba2ab63f8829fe1a01af5327eafb514ed5bbacccb09b0d9f34ae90e9016ede"}}, "hash": "225831275dcada8b28f88b7a541244c967e90dc7e0625960ccbb9c1ed683d6a9", "text": "Optional On-Ramping\nWe recognize this is an introductory class and many may be unfamiliar with some molecular and cellular biology terms (DNA, protein, transcription, translation, etc.). Those who would like a bit of \"on-ramping\" to the molecular biology jargon we will be using in class from Week 3 onwards should feel free to look over.\n- Slides\n from on-ramping office hours\n- Recording of on-ramping office hours", "start_char_idx": 0, "end_char_idx": 416, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d3515af2-41fd-4f90-9415-8a3e37d92e24": {"__data__": {"id_": "d3515af2-41fd-4f90-9415-8a3e37d92e24", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e03429d5-b5b0-41f1-8298-da426c6d8cb1", "node_type": null, "metadata": {}, "hash": "4382dc3acf419e8750c1470f19e73a26883d932ffd0bc2262718ae685f03cc9b"}}, "hash": "f6444c6b19a491726650d6a7dcc62c48c07e77ffefab10484cd911f4c68ae2aa", "text": "Preclass for Monday", "start_char_idx": 0, "end_char_idx": 19, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7fe85003-e71f-496c-8ac2-7adf9a52086b": {"__data__": {"id_": "7fe85003-e71f-496c-8ac2-7adf9a52086b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "592ef5db-5488-4678-bdcf-a395d808d1e7", "node_type": null, "metadata": {}, "hash": "3403d086ccb8fb9bec698a5b4fa72bd09476c0d393b8a23a4c727f492559f360"}}, "hash": "7808d643cd2d25feee252233faddfb3c988888ca0d3218c7a4e9b42c6397d561", "text": "Activity \u2013 Tools for seeing biology (Foldscope)\n\n\"If you want to know how nature works, (you) looked at it, carefully. Looking at it, that's the way it looks.  You don't like it? Go somewhere else, to another universe where the rules are simpler...\" - Richard Feynman source", "start_char_idx": 0, "end_char_idx": 274, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3b8fa743-65f5-49dd-99cf-fd8cef6445b2": {"__data__": {"id_": "3b8fa743-65f5-49dd-99cf-fd8cef6445b2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "08e01526-25ca-40a7-b3dc-dcff6052c0bc", "node_type": null, "metadata": {}, "hash": "363243074370c5de3ef442a439c4fcc2b702bbb8530818d3d6e601d69458358e"}}, "hash": "2853c432a75f24f2b2dcacabeea106fae1e3645734fa16639146f0922bf5e40d", "text": "Self-Assessment:\n\nImagine that you spend hours assembling a device (a box) that, once finished, is supposed to power a light bulb when a button is pushed. You place your finished construction on your workshop table and press the button... POOF! \nSmoke pours from the device but the bulb remains dark. \n\nDo you exclaim (choose one):\n\n          DARN!!! \tCOOL!!!\n\nWhy did you pick your choice? Remember your answer for the class.", "start_char_idx": 0, "end_char_idx": 426, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8edfccdb-292f-43e0-bf79-83180b6b59b0": {"__data__": {"id_": "8edfccdb-292f-43e0-bf79-83180b6b59b0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d40a7492-e2e2-4de8-9478-08d112579e1e", "node_type": null, "metadata": {}, "hash": "217622cb9589a4ad75e984da7ed1f43ba7195db341eca23f88b3a03e08b11e3b"}}, "hash": "d6205e21d9806e7f360143c53f702c3e54b166b4677259d2083e0b0428a5fbfc", "text": "Microscopes\n\nMicroscopes are a fantastic tool for exploring the beauty of living systems.  \nIn week-1's reading, you encountered Van Leeuwenhoek's simple yet powerful microscope.  Since Van Leeuwenhoek's time, building microscopes - that enable us to observe living matter across various scales - have been ongoing and exciting area research. \nMicroscopes are routinely used by bioengineers to test, quantify, and visualize natural and engineered organisms. For example, you, as part of BIOE.44 (Fundamentals for Engineering Biology Lab), could build a genetic circuit in *E. coli* that produces green fluorescent proteins in response to environmental toxins such as lead or arsenic. Or you can build a genetic clock (oscillator) that expresses fluorescent proteins at predefined time frequencies. For both examples, you can use a fluorescent microscope to see, quantify, and test the operation of your engineered organisms.  \n\n*Optional reading: Nobel prize in chemistry 2014, for the development of super-resolved fluorescence microscopy How the optical microscope became a nanoscope, and Scientifc Background .*\n\n*Optional reading: Nobel prize in chemistry 2017, for developing cryo-electron microscopy for the high-resolution structure determination of biomolecules in solution They captured life in atomic detail, and Scientifc Background *\n\nDespite the tremendous progress in microscopy, modern microscopes (for the most part) are expensive lab instruments that cannot easily be used or shared outside of labs. \n\n**Q.1. But what if you do not have access to a lab with a microscope?  \n(Wouldn't it be nice to take your microscope with you wherever you go and explore the living matter?**  \n\n**Q.2. How can we -as Bioengineers- enable all learners, explorers, and makers to have access to tools such as microscopes?**", "start_char_idx": 0, "end_char_idx": 1822, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3739e152-4112-49cf-bff2-25ace0bbad70": {"__data__": {"id_": "3739e152-4112-49cf-bff2-25ace0bbad70", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "76092514-2027-4582-b797-e282c30074c5", "node_type": null, "metadata": {}, "hash": "a77f7bf40e7f68325299544be8f81cb7cbdc4b7c968f1ec493a1791ed91dc435"}}, "hash": "a67a5562f4f4fc7e55b3411784571aee12c4137352e1b704bb7b538ebc103e19", "text": "Foldscope\n\nFoldscope is a field-deployable paper origami microscope designed and built here at Stanford by Manu Prakash and his team. \n\nFirst, spend 10' and watch the Manu's TED talk on Foldscopes, here\n\n**Q.3. According to Manu, what are the problems with modern microscopes?**\n\n**Q.4. According to Manu, what is the relationship between hands on science education tools and global health?**\n\nNext, familiarize yourself with the global community of Foldscope users from Microcosmos\n\n**Putting your Foldscope together**\n\n*We will do this together in class on Monday.*\n\nIf you requested the BIOE.80 Education Kit and have received your Foldscopes follow the video instructions on Foldscope Tutorials or the written instruction inside the Foldscope kit to assemble your microscope. You can also find additional videos on how to use your Foldscope from the website.  \n\nIf you didn't ask for a Foldscope, don't worry.  You can still complete the problem set question without one.  \n\nMake sure to remember your answer to the Self-Assessment.  \n___________________________________________________________________________________________________", "start_char_idx": 0, "end_char_idx": 1138, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9eb98e97-1386-4a6a-a52d-29169a2849d1": {"__data__": {"id_": "9eb98e97-1386-4a6a-a52d-29169a2849d1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e84abbec-d22f-41ea-9b98-807ba9ecc40a", "node_type": null, "metadata": {}, "hash": "48a24b4cde34546705bd2dcd2b80196209b609ac0794f596ac65a38f61f097f4"}}, "hash": "dc55dbbfe84937d9f652ff2bc70146ee31215fb9f98b94c46bc1628fb57290c9", "text": "Preclass for Wednesday", "start_char_idx": 0, "end_char_idx": 22, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "753f5604-f539-4b4b-b959-a54cf7ac9cbf": {"__data__": {"id_": "753f5604-f539-4b4b-b959-a54cf7ac9cbf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "18b64455-6332-49ab-9827-1f0737061d77", "node_type": null, "metadata": {}, "hash": "725fc494bac74b71071a44ea6ab982cc7e0856eed0d582d97cf604100f9df006"}}, "hash": "071c3c2a95163851f9033e5a003d33d94a436d13a1138005741574f56aeb41c9", "text": "Analysis and design of molecules\n\nOn Monday, we discussed microscopes to visualize cells and organisms. You may have also encountered (cryo-electron) microscopes that enable visualization of biomolecules. Here we discuss tools that will allow computer visualization, analysis, and design of molecules. First, read this case study:", "start_char_idx": 0, "end_char_idx": 330, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "39a99b8b-7b07-465d-9ddf-bb1409012fa2": {"__data__": {"id_": "39a99b8b-7b07-465d-9ddf-bb1409012fa2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba275713-5ed4-4998-ae30-e6c7c907d010", "node_type": null, "metadata": {}, "hash": "7262faa76d78868a4fa1798228cf5f9ad9768e395d901656abdf11eacd5ce46a"}}, "hash": "4ed363ea5a17f94ef199ba19c0b2a67953ea90562d72f6e7019c3c7d4b319100", "text": "Celiac Disease and KumaMax\n\nCeliac disease is an autoimmune disease of the small intestine that is triggered by eating gluten - a protein found in wheat, barley, and rye - and causes damage to the fingerlike projections lining your small intestine (villi) necessary for nutrient absorption (Celiac Disease). \n\nIt is estimated that 1% of the US population has celiac disease. Still, despite increasing attention in the media, almost 83% of those 3 million people remain undiagnosed (NOTE:  Beyond Celiac: What is Celiac Disease?). While misdiagnosis is common, some postulate that this lack of diagnosis (and awareness) can be linked to the limited clinical treatment offerings. Currently, the only approved therapy is adherence to a strict gluten-free diet. Avoiding gluten can be difficult when hidden sources are lurking around us (NOTE:  Medivizor: 300 facts you didn't know about gluten). Further, many who do adhere to a strict gluten-free diet do not see a recovery of the small intestinal mucosa. source-1,source-2,source-3\n,and source-4.\n\n\nRecognizing the need for a true therapy, a 2011 undergraduate iGEM team from the University of Washington began to design a drug that could potentially provide relief. Six years later, that drug (KumaMax) was funded to undergo phase I clinical trials to the tune of $35 million.  \n\nTo learn more skim the following two websites:\n\niGEM Startup PvP Biologics Closes a $35 Million Agreement with Pharmaceutical Company Takeda \n\nUW iGEM Wiki: Gluten Destruction\n\n**Q.1. According to the team's website, why had other approaches failed?**\n\n**Q.2. What was unique about their approach?**\n\n**Q.3. How did they choose their starting enzyme? What key design specification made this a great choice?**\n\n**Q.4. How did they design their enzyme? What tools did they use?**\n\n**Q.5. How did they test their enzyme?**\n\n**Q.6. What would you have done differently?**\n\n(You can also read the paper that they published in 2012)", "start_char_idx": 0, "end_char_idx": 1956, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "51750201-7ff4-451f-bf12-45ea13fedc6b": {"__data__": {"id_": "51750201-7ff4-451f-bf12-45ea13fedc6b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c29cde0f-500a-436d-b4cf-ba2cea602e2b", "node_type": null, "metadata": {}, "hash": "27c4dc604a5a85300f2aa21c15d2bf3e86e72680d5c2661d06ab31028391fc54"}}, "hash": "311e7df4acbdbd29b89c714d16d7b3159591416bf2b063d8296e641a72efa08e", "text": "Design Tools\n\nKumaMax example highlights the power of tools that enables us to visualize and design molecules. These tools can be used much like any traditional computer-aided design (CAD) application. For example, you may have used Onshape (as part of BIOE.123) to create, modify, and 3D print objects. Multiple design tools are available to Bioengineers.  For example, you can design and modify biomolecules via PyMOL. FoldIt is another example that enables all learners to interact with protein folding and advance discovery via playing a game.  There are also tools such as Cadnano simplify the process of designing three-dimensional DNA origami.  As design tools have improved, so has our ability to (rationally) modify and create molecules.   \n\n**Q.7. What are the roles of design and analysis tools in the engineering of biology?**\n\n(Note: The KumaMax example highlights the utility of the Design-Build-Test Cycle (DBT), a core process used across all disciplines of engineering, for living matter.)\n\n___________________________________________________________________________________________________", "start_char_idx": 0, "end_char_idx": 1107, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ca94cb58-b2bb-4582-a65b-0d2c632f5904": {"__data__": {"id_": "ca94cb58-b2bb-4582-a65b-0d2c632f5904", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aefbd97e-0df7-492f-8b63-46cce30bbc67", "node_type": null, "metadata": {}, "hash": "e9be3bb70f1358daeb24df906958e8c825d4a484111c41228d915bf552870403"}}, "hash": "f45aa709296b89493f08e0322fc81d1a53822e662ec8368a64ab562bfdce7c23", "text": "Preclass for Friday", "start_char_idx": 0, "end_char_idx": 19, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b9ca5db3-cc71-43ce-9f25-378f5a4e7efc": {"__data__": {"id_": "b9ca5db3-cc71-43ce-9f25-378f5a4e7efc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "68bbc07e-2bff-444b-9669-da38603e38c3", "node_type": null, "metadata": {}, "hash": "70487b421d075886699be386f87a854ead9683888d9ca7a5c135ac8d54c37ada"}}, "hash": "9625c0ad163b16fb9b04eda477561cda64373fbd94cd9d569fa906a038688466", "text": "Analysis and design a genetic systems\n\nApply parse paper tool to this paper\u2026\n\nA synthetic oscillatory network of transcriptional regulators\n\n**Q.1.  The living cells have been engineered with a synthetic genetic system that results in an oscillating dynamical system (biomolecule levels go up and down, repeatedly, over time).  At the level of biomolecules, what is causing the oscillation to occur?**\n\n**Q.2. what is the most important claim and main evidence in support of this claim?**\n\n**Q.3. Looking at Figure 2, are all cells oscillation together (i.e., turning bright in synch. with one another)?  Why not?**\n\nNext, apply parse paper tool to this paper\u2026\n\nDetermination of cell fate selection during phage lambda infection\n\n**Q.4. what is the most important claim and main evidence in support of this claim?**\n\nWatch this video\n\nIn the movie cells infected with virus turn green\u2026 \n\n**Q.5. According to the authors, why do some cells infected with virus break open, releasing new progeny virus into the environment, whereas other infected cells survive?**\n\n**Q.6. How does your answer to the preceding question change or inform your thinking about why the \u201crepressilator\u201d goes out of phase with itself, at the single cell level?**\n\nAdditional reading,\n- Repressilator, \n- Lambda phage\n\n_________________________________________________________________________________________________\n\n**Additional Resources:**\n\n- We strongly encourage you to check out this additional resource about creativity and design in the context of modernity titled: \"Art, Critique, Design and Our World\" by Alexandra Daisy Ginsberg link\n\n- Video lecture: Synthetic Biology: Principles and Applications by Jan van der Meer.\n\n- Video lecture: Synthetic Biology and Biological Circuits by Timothy Lu.\n\n- Video lecture: Programming Living Bacteria by Chris Voigt.\n\n- A comprehensive video series on microscopy (includes: fundmentals, tools, and techniques) from iBiology resources \n\n github source code for teaching staff", "start_char_idx": 0, "end_char_idx": 1998, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1cb2a82a-f5ab-45bd-9c0b-24bb350f57cc": {"__data__": {"id_": "1cb2a82a-f5ab-45bd-9c0b-24bb350f57cc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1d329a1e-0703-4833-99fb-677b52c7c2df", "node_type": null, "metadata": {}, "hash": "95b5d390a7d398f2c1ee705b65bc1a90daa6672973daddaf5d288d97318bed77"}}, "hash": "b9f70b56858306cfd9f540b8bbbf54182e87641fb0395819e26ecdb33b63aa4d", "text": "(Q1) Revisiting Design Tools (PyMol) (30 pts)\n\nIn this problem, you will use PyMol to visualize green fluorescent protein (GFP).\nGFP is a 238 amino acid protein. For more information about GFP, check out the Wikipedia page, or see the resources below.\n\nCheck out the website where the GFP structure is housed: https://www.rcsb.org/structure/1gfl. Notice that we are looking at a homo-dimer, meaning that 2 identical 238 amino acid chains are in the structure. \n\nNote:  Please include figure labels when sharing figures. \n\n**1.a.** What is the experimental method used to get the structure of the protein? What is the listed resolution of the structure? (bullet points)\n\n**1.b.** Add a screenshot of your GFP structure in PyMol showing the \"beta barrel\" structure of fluorescent proteins. \n\nTo do so:\n\n1. Download PyMol from this Pymol Link and open PyMol on your laptop or computer. \n\n2. Type in the command \u201cfetch 1gfl\u201d in PyMol. This command downloads the structure of Green Fluorescent Protein (GFP) from the Protein Data Bank (PDB)\n\n3. In PyMol and take a look at the GFP structure.  Under the menus \u201cH\u201d and \u201cS\u201d  listed near the structure name on the toolbar on the right, click `Hide everything` and `Show cartoon`. \n\n4. **Take a screenshot of the protein structure to share as part of the problem set**\n\n*Extra activity-1*\n\n5. Click on  to enable scrolling.\n\n6. Click on  to see the amino acid sequence for GFP.\n\n7. Select residues 64-66 SYG and color these residues red. This is the **chromophore** of GFP, the portion of the molecule responsible for the fluorescence.\n\n8. Render the SYG portion of the protein as \u2018sticks\u2019. You should now be able to see the (cyclized) ring of the GFP chromophore. Take a second screenshot of the protein with chromophore highlighted. \n\n**1.c.**  Go back to the Protein Data Bank website and find a `.pdb` file for another fluorescent protein. Use PyMol to visualize this second protein. Provide a screenshot and tell us what color and wavelength the protein fluoresces.\nBriefly compare the similarity/ differences in the structure of the two fluorescent proteins (yours vs. GFP).\n\n*Extra activity-2*\nWould you like to build your own 3D GFP paper model?  Go to the following link and use the instruction and the template to build your own model. If you did make the model please share a photo with us. \n\nAdditional Resources (Fluorescent Proteins):\nFluorescent Proteins and the Story Behind GFP (by Roger Tsien ibiology) link-1\nIntroduction to Fluorescent Proteins link-2\nInteractive graph describing Fluorescent protein properties link-3", "start_char_idx": 0, "end_char_idx": 2578, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ca72572a-d14e-49c0-9281-14cc6bc32135": {"__data__": {"id_": "ca72572a-d14e-49c0-9281-14cc6bc32135", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f5f941f3-33c1-4129-b048-86958c4ce59f", "node_type": null, "metadata": {}, "hash": "d7d3d84f29030d7419c9f7a97859a054d20a881d066b9a7489fc232d668806cc"}}, "hash": "44dc55784b3d531d17dc8e6d6d083bf07cdeaa5b700494a78f58a89f60807cba", "text": "(Q2) Foldscope (40 pts)\n\n**2020 Note:** Given the unique circumstance of this quarter and if you don't have access to your own foldscope you can use the photos available from Microcosmos. \nFor example, see an entry from last year\u2019s BIOE80 class: link.\n\nThe following is an exercise carefully designed by Tom Knight to help you understand if you are more interested in science or engineering. There is no right answer and all types are welcome in the course! Rather, what you experience via the following can help you (and us) understand how you most like to work and learn. I.e., what follows is analogous to learning which foot you prefer to put forward on a skateboard, surfboard, or snowboard (right of left), or whether you prefer to throw with your right or left hand, etc.", "start_char_idx": 0, "end_char_idx": 778, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a00bb63b-0ca0-4562-8a6a-02adbc8994b2": {"__data__": {"id_": "a00bb63b-0ca0-4562-8a6a-02adbc8994b2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bd32f1cc-9490-4fdf-a7f9-af9c8727de96", "node_type": null, "metadata": {}, "hash": "55585bb1bd67bed8df5c53341a5db409f4922dad07bac42f803be83781bfb5de"}}, "hash": "c1d64b02458b1ad920435e0d183f36675fbbbf2e9c9b4be87524dc66f1d1731e", "text": "Self-Assessment:\n\nImagine that you spend hours assembling a device (a box) that, once finished, is supposed to power a light bulb when a button is pushed. You place your finished construction on your workshop table and press the button... POOF! \nSmoke pours from the device but the bulb remains dark. \n\nDo you exclaim (choose one):\n\n          DARN!!! \tCOOL!!!\n\n**2.a.** Why did you pick your choice? (1-2 sentences)\n\nRelax again. Close your eyes and look inside yourself. Relax some more. \nMight you want to be an Explorer of the Unknown? Or, a Maker of New Things? \nChoose one path to follow for now. Focus on one path for now so that you can really push yourself in the context of this activity. Use your answer to Step 1 to think about your choice. \n\nIf you picked DARN!!! please go to the **Maker** step. \n\nIf you picked COOL!!! please go to the **Explorer** step.\n\n\n**2.b. Welcome Explorers!**\n\nYou have been granted the status, **biologically curious explorer of the microcosmic universe!** Your job is to explore objects, mysteries, and open questions that relate to the microscopic world. Equiped with your own microscope. \n\nFirstly, you have to ask a question in the realm of micro-cosmos, an original question. \nIt does not matter if somebody has answered it 100 years ago or if science does not know \nhow to begin to think about it. Choose a question that can be explored with microscale observations. Such as - how many cells thick is a leaf, how do hairs split, do insects also have blood cells, what does insect skin look like, what mold is growing in my fridge, what grows in a drop of pond water...You get the idea.  Now based on your emerging  question, collect samples and visulize them with your microscope. \n\nTo complete this activity, prepare and submit the following entry (1 paragraph). \n\nConsider including responses to the following items below. (If you use a photo from microcosmos instead of your own photo make sure to reference the source).\n\n- What question or what range of questions did you ask? \n- What did you see / find as a result? \n- A great image or data to support your findings and conclusions (Note for 2020, photo does not have to be your own).\n- Your concluding thoughts or open questions.\n\n**2.b. Welcome Makers!**\n\nYou have been granted the status, **biologically empowered tinkerer of the microcosmic universe!** Your job is to explore nature, searching for tiny objects that might be useful either as inspiration, or as bits and pieces that might be directly reused to make something. \n\nFirstly, you have to learn to explore various realms of microcosmos. It does not matter if\nsomebody has searched the same space 100 years ago or if engineers do not know how to begin to think about the tiny things you find. Hunt the patterns, solutions, and objects that can be explored with microscale observations. Such as how do plants transport water, how do grasshoppers hop without barrel rolling, how does a spider make a web, where do leaves go\u2026 You get the idea.\n\nYour goal is to go on a journey to find the answer yourself, without any other aids. Lots and lots of samples that could give you the diversity of answers you might be looking for.\n\nTo complete this activity, prepare and submit the following entry (1 paragraph). \n\nConsider including responses to the following items below. (If you use a photo from microcosmos instead of your own photo make sure to reference the source).\n\n- What useful biological object or potential inspiration from nature did you find?\n- How and where did these samples were found?\n- A great image or data to support your findings and conclusions (Note for 2020, photo does not have to be your own).\n- Your concluding thoughts or open questions.\n\n*Extra activity-3: Submit a photo you have taken with Foldscope to Microcosmos and share the link with us as part of PSET*", "start_char_idx": 0, "end_char_idx": 3846, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "88adc248-6f71-434e-8ef6-7e3f3e62b82a": {"__data__": {"id_": "88adc248-6f71-434e-8ef6-7e3f3e62b82a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "889cd50e-629c-4ca0-a8d5-0fd3e5725da8", "node_type": null, "metadata": {}, "hash": "f7e23e0d07091595b9babae415e74380c145189db11675a30c699c7dd382598c"}}, "hash": "f9bb1d92f6800283283e528d78e4bd25069c7c254c00abb7a0fa839bddb2dd72", "text": "(Q3) Papers: KumaMax & Repressilator (15 pts)\n\nIn the pre-class material you were introduced to KumaMax designed via the student iGEM project. \nThe following link will take you to the paper that the group published summarizing their efforts, Computational Design of an \u03b1-Gliadin Peptidase\n\n**3.a.** In your own words, what is the primary claim of the paper? What are the primary evidence in support of the claim? (2-3 sentences)\n\nNext, visit the famous Repressilator paper, A synthetic oscillatory network of transcriptional regulators.\n\n**3.b.** In your own words, what is the primary claim of the paper? What are the primary evidence in support of the claim? In your own words, describe how does the Repressilator work?  (2-3 sentences) \n\n**3.c.** Are all cells oscillation together (i.e., turning bright in synch. with one another)? Why not? (2-3 sentences) \n\n*Extra reading: A review titled, Synchronous long-term oscillations in a synthetic gene circuit*", "start_char_idx": 0, "end_char_idx": 959, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "67288be1-b886-4cd8-ba98-f6bd551db859": {"__data__": {"id_": "67288be1-b886-4cd8-ba98-f6bd551db859", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e4211359-7d89-4f16-a277-172fc2824132", "node_type": null, "metadata": {}, "hash": "894f287891bf3843e272fd3eda6ffd762bc49019177dd2e7d340e406cf857137"}}, "hash": "c914d2f27ec51ce3fa5ed1d894ef8a51da73176dd00887f7e7731d9899f45418", "text": "(Q4) Prepare for the Group Project (15 pts)\n\n\nKiva is a charity that has a unique approach to the alleviation of wants and needs. \n\nInstead of soliciting donations, Kiva provides a platform for individuals and groups around the world to request loans for their cause, empowering them to build a better future for themselves, their families, and their community.\n\n**Take a few minutes to browse the Kiva website, noting the geographic location of the groups you see and their goals.**\n\nNote that you can select various sectors (health, food, agriculture, arts, education, \u2026 ) or locations across the world.\n\n**4.a.** What is your initial response to the Kiva platform? (1-2 sentences)\n\nKiva breaks down into different topics, allowing the potential lender to filter by the topic they find the most compelling. Looking at a few of the most common loan requests and we can extract a general structure:\n\n\n  \n    Campaign...\n    Goal / Use of Loan...\n  \n  \n    Cruz Celina, H\u00f9ng, Loan\n    Buying materials to build a latrine\n  \n  \n    Channy's Group, Sreymai\u2019s Group\n    Buying water filters\n  \n  \n    Jane\u2019s Group, Sin Kyoe(2)D Village Group, Zulaykha\n\n    Buying fertilizer, seed\n  \n  \n    Kantiembou Group, Dumitru, Glenda, Zhanybek\n    Buying livestock\n  \n\n\nThis focuses on solving problems immediately by providing (consuming) products as they currently exist. In this class, we have the opportunity to step outside the bounds of current offerings and thinking about **designing** and **building better** solutions that fix unmet **needs**.\n\n**4.b.** Name 3 sectors that are of interest to you? \n\n**4.c.** What role, imagined or as yet unimagined, can bioengineering play in addressing the needs in these sectors? (2 to 3 sentences)\n\n**4.d.** Pick a location (ideally a region that you are not familiar with). What are 3 to 4 specific requests that people from this location have?\n\n**4.e.** What role, imagined or as yet unimagined, can bioengineering play in addressing these requests? (2 to 3 sentences)\n\n(Added to turning in the answers as part of the PSET, have them ready as \"introduction cards\" to exchange ideas with your future team)", "start_char_idx": 0, "end_char_idx": 2141, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9d6881f0-6667-4c21-94a7-9c63003f9cc7": {"__data__": {"id_": "9d6881f0-6667-4c21-94a7-9c63003f9cc7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e18d9d14-5d55-4e48-9694-9c345ca4c553", "node_type": null, "metadata": {}, "hash": "1d4402fa1a1f2d2e2b11e91717de1ad439b81db895f5729f4edfd30781cada58"}}, "hash": "35090f52ec0b4975eacfefefc8f3dad1664cc21072d98b9de2e4b9d4059d0b0a", "text": "Extra resources, learning, and Practice Questions\n\nThe following suggested reading and questions are 100% optional additional. They are meant to help you engage with various aspects of the topics that we have covered in each segment based on your interest and level. They are not required as part of your problem sets. But we hope that they enable you to enhance your learning based on your interest.\n\nOptional video lectures from Protein design by David Baker", "start_char_idx": 0, "end_char_idx": 460, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "eb1868ee-381d-4a49-b76e-8f7e8da02e01": {"__data__": {"id_": "eb1868ee-381d-4a49-b76e-8f7e8da02e01", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "091ec803-2613-4a04-bd73-56767fd6700d", "node_type": null, "metadata": {}, "hash": "533af6d345025a34986245cc054469520e6faf0e0ff174515aca46a908554766"}}, "hash": "f2647cd019ff70b27768ca3012f05d07dc4dbd587dbec570ce5945e511a126d9", "text": "Q.EX1. Practice Questions: Physics of Fluorescence (0 pts)\n\nThis question is a guide to enable you to learn (or review) some key physics of how fluorescence works. \nUse the following resources to familiarize youself with physics of fluorescence:\nHyperphysics-link\nThermo fisher-link\n\nThe following equation relates a photon\u2019s energy to its wavelength: \n\n$\nE=\n\\frac{hc}{\\lambda}\n$\n\n- E is the energy of the photon (in electron volts, eV, or in joules, J), \n- c is the speed of light (in meters per second, m/s), \n- h is the Planck constant (equal to 6.626\u00d710^\u221234 J*s, with units of energy times second), \n- and \n$\n\\lambda\n$\nis the wavelength of the photon (with units of length, in nanometers, nm). \n\n**EX.1.a** What happens to the energy of a photon as the wavelength of light increases? (Extra activity demonstrates to yourself that eV and J are equivalent to each other?)\n\n**EX.1.b**  If a traveling photon hits a GFP molecule, the probability that the photon gets absorbed by GFP depends on the wavelength of the photon. In a sense, GFP \u201cprefers\u201d photons around a certain energy level. If GFP absorbs a photon, it enters a higher energy excited state for a brief period, then relaxes back to a lower energy state. The absorbed photon\u2019s energy is converted into the jiggling of the GFP molecule, heat that the GFP vents to its environment, and a photon that gets emitted from the GFP. The wavelength of the emitted photon depends on how much energy is converted to jiggling and heat versus how much energy is converted to an emitted photon, which is determined somewhat randomly.\n\nThe most probable wavelengths of absorbed and emitted light respectively, are the \u201cexcitation\u201d and \u201cemission\u201d peaks. Typical excitation and emission peaks for GFP are reported below. What are the energies of photons typically absorbed and emitted from GFP? \n\n\n  \n    GFP\n    Wavelength (nm)\n    Photon Energy [unit]\n  \n  \n    Excitation Peak\n    395 nm \n    ? [unit]\n  \n  \n    Emission peak\n    509 nm\n    ? [unit]\n  \n\n\n**EX.1.c**  What is the difference in the wavelength between the emission and excitation peaks of GFP? What is the difference in energy between photons at these two peaks?\n\n**EX.1.d**  Does it make sense that the wavelength of an emitted photon is longer than the wavelength of an absorbed photon? (Yes/No) Why? (Use the calculated numbers from part B in your answer).\n\n**EX.1.e** You are studying how GFP absorbs and emits light when you notice something odd. Under certain conditions, GFP seems to have a smaller excitation peak around 800 nm. Why might this be the case?", "start_char_idx": 0, "end_char_idx": 2576, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8ac18525-2496-4838-87c2-154537173ca3": {"__data__": {"id_": "8ac18525-2496-4838-87c2-154537173ca3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "30a60ecd-2d11-43ae-b311-b812c138845d", "node_type": null, "metadata": {}, "hash": "d597de737a2dbd89f8a1b13146f0681f3ed2a20313174b75cf1bcb902492174b"}}, "hash": "0714bfbed952303fff59b465a928c0b7b9da413e017fd256670db36e8bda0351", "text": "Q.EX.2. Foldscope Engineer (0 pts)\n\nAfter finishing BIOE.80 you have joined the team that develops Foldscope.\n\nFirst and briefly familiarize yourself with this open source scientific paper summarizing various aspects of the Foldscope. Briefly read the abstract and go through the Figures 1-5 and Table-1. \n\n**EX.2.a** What is the main claim of the paper based on the abstract? What key evidence is provided in support of this claim? (Bullet points.) \n\nNext, your new manager shares the following equations describing the optical properties of a ball lens from the paper\u2019s supplementary material.\n\n$\nM=\\frac{250mm}{EFL}\n$\n\n- M is the magnification, \n- EFL is Effective focal length, \n- 250mm is the distance between the lens and where the image forms. \n\nAdditionally: \n\n$\nEFL=\\frac{nr}{2(n-1)}\n$\n\n- r is the lens\u2019s radius,\n- n is the index of refraction \n\nYou want to create a figure to communicate to your team the relationship between M as you change the radius of the lens.\n\nAssume the index of refraction for the borosilicate glass lens is n =1.517. \nAlso, assume that you can purchase glass lenses ranging from 150, 250, 400, 750, and 1000 \u00b5m in radii. \n\n**EX.2.b** Using your favorite software/application (e.g., Spreadsheets, Matlab, Python, R, etc.) create two graphs demonstrating the relationship between EFL vs. r, and M vs. r. Make sure to label each figure and each axis with appropriate units. \n\n**EX.2.c** Next, state your conclusions from these graphs summarizing your findings in 1-2 sentences to the rest of your team.\n\n**EX.2.d** Next, you come across sapphire lenses, with n=1.77. Using the equations above, compare the Magnification of a Sapphire lens against a borosilicate lens. (Hint: Assume that both lenses have the same size)\n\n**EX.2.e** As you are going through this design activity, a team member asks you about the difference between resolution and magnification. First, Describe the difference between resolution and magnification and include your reference(s). \n(Hint take a look at figure-4.b from the paper, describe the relationship resolution and magnification)\n\n github source code for teaching staff", "start_char_idx": 0, "end_char_idx": 2136, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "19faec39-55ed-4d84-95bf-027d54d4f2dd": {"__data__": {"id_": "19faec39-55ed-4d84-95bf-027d54d4f2dd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "665f4910-425a-4a19-80e3-3ee30f9af373", "node_type": null, "metadata": {}, "hash": "088494e682c28be9dbc411a3cf4e6e76b8af884d79e8bfaaff3b40485f40859a"}}, "hash": "5cb2662c59a11728897d4d9154ab66a49931d375563841965a9f32bf239ecfd2", "text": "Day 10: April 27, 2020\n\nClass Slides\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 55, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f0d53255-0bbd-404d-aba1-614f7a016feb": {"__data__": {"id_": "f0d53255-0bbd-404d-aba1-614f7a016feb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8a98ee00-4caf-4f06-ae25-e4dbc0edd485", "node_type": null, "metadata": {}, "hash": "94e233ed698752727fe1952b837c12febba354305294f4ec8e2d8d8e01bdd5f8"}}, "hash": "a3e3465afbe894f30dccc4c0df4c159aa66589326cc639c263458fb19b4af73c", "text": "Day 11: April 29, 2020\n\nClass Slides\n\nClass Audio/Video\n\n\n<!--", "start_char_idx": 0, "end_char_idx": 62, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "36dc1a2c-82e0-4305-8493-805b3ec5dc4f": {"__data__": {"id_": "36dc1a2c-82e0-4305-8493-805b3ec5dc4f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "751589dd-2e81-4c07-9036-3f2bd12521c8", "node_type": null, "metadata": {}, "hash": "834b05797f2fc801b19be8093dfa5ed1d7fd4e598cf6774045730abc0ed1f4ee"}}, "hash": "203d3d7b156e5246fafd142a9a781137715b364e3ca6f91332ef99392ec5ff82", "text": "Day 12: May 1, 2020\n\nClass Slides\n\nClass Audio/Video\n-->", "start_char_idx": 0, "end_char_idx": 56, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "235f43b5-181a-4c46-946f-6157d339d318": {"__data__": {"id_": "235f43b5-181a-4c46-946f-6157d339d318", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "abd0c72c-4a87-47ca-bd66-66ba21d56103", "node_type": null, "metadata": {}, "hash": "aaf17115ce40d2fd8a355fd2cc9befd9c7a14664db2c5cd1918579c31f5e20ea"}}, "hash": "462137f30d260ec2d81c900dc4a63756fa272024c919a432c211fe42b362635a", "text": "Engineering Abstraction in Biology\n\nPlease read and consider the below before the start of each class. The questions are study-questions and not homework to be graded. Talk about anything you find interesting with your classmates, friends, or TAs, as you like, using Piazza or email the instructors!\n\n**Goal-1:** You will able to describe the role of abstraction as a tool for helping \nto manage complexity in biological systems.\n\n**Goal-2:** You will also be able to apply abstraction (in the form of black box diagrams) to decompose \nor synthesize the designs systems that could then be implemented in living matter for example viaengineered \n(i.e., designer) DNA.\n\n(Study note: previous BIOE/ENGR.80 students described Engineering Abstraction in Biology as challenging and time-consuming material.)", "start_char_idx": 0, "end_char_idx": 801, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f08699df-cfb2-400a-981b-391444220f25": {"__data__": {"id_": "f08699df-cfb2-400a-981b-391444220f25", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "39d1ae6e-aa3d-499c-9e51-56bb223f7d48", "node_type": null, "metadata": {}, "hash": "4382dc3acf419e8750c1470f19e73a26883d932ffd0bc2262718ae685f03cc9b"}}, "hash": "f6444c6b19a491726650d6a7dcc62c48c07e77ffefab10484cd911f4c68ae2aa", "text": "Preclass for Monday", "start_char_idx": 0, "end_char_idx": 19, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "56e114b6-a3d8-4eca-8e8d-6979e368370e": {"__data__": {"id_": "56e114b6-a3d8-4eca-8e8d-6979e368370e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1f4943a8-9181-4030-aed5-6d8c2537c119", "node_type": null, "metadata": {}, "hash": "2291a645c21a4dda4dc7a55ba412307f2d54f9cce378851d0578be299701ee76"}}, "hash": "042ce2a44e6c844d6a1eae1e5a447814d284ed31b5578c7e155b25f140f771f1", "text": "Engineering abstraction in living matter \u2013 synthetic genetic logic\n\nRead the first two parts from the following comic Adventures in Synthetic Biology (**Programming DNA** and **Engineered Genetic Devices**)  where key ideas in designing and realizing biological circuits and systems are discussed\n(Same comic book in other languages)\n\nBiology background, particularly  Information Transfer in Cells and Regulation of Transcription and Translation may help you have a richer understanding of the topic discussed in the comic. \n\nAccording to the comic,\n\n**Q.1  what is a genetic device? for example, what is an inverter device?** \n\n**Q.2  What is the utility of using the Device abstraction to describe the DNA inverter?**\n\nNext, briefly study the abstract and figures 1-3 from Amplifying Genetic Logic Gates (Alternative link).\n\n**Q.3  What is a the main claim of the paper?** \n\n**Q.4  What logic-gate devices were demonstrated in this paper?  How were the performances (and digital output) measured?**\n\nOptional video-1 Transcriptors & Boolean Integrase Logic (BIL) gates, explained\n\nNext, read the following NYtimes article, Taking Faster and Smarter to New Physical Frontiers\n\n**Q.5 How can we better define and measure the intrinsic worth of computation?**\n\nExtra resources:\n\n- Khan Academy, Central Dogma\n- Bruce Alberts Molecular Biology of the Cell (2015)- Central Dogma  Chapter 6 \n- Claude Shannon, A symbolic analysis of relay and switching circuits\n- Principles of genetic circuit design\n- Foundations for engineering biology\n\n_______________________________________________", "start_char_idx": 0, "end_char_idx": 1584, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a9e9655c-f5a8-44a7-a033-2d8e4e25b1f5": {"__data__": {"id_": "a9e9655c-f5a8-44a7-a033-2d8e4e25b1f5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d7f47c7f-3166-4fd7-be4a-0536779e410f", "node_type": null, "metadata": {}, "hash": "48a24b4cde34546705bd2dcd2b80196209b609ac0794f596ac65a38f61f097f4"}}, "hash": "dc55dbbfe84937d9f652ff2bc70146ee31215fb9f98b94c46bc1628fb57290c9", "text": "Preclass for Wednesday", "start_char_idx": 0, "end_char_idx": 22, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e5077f7c-6d27-4fd7-82c5-0a2fc5bbbb6e": {"__data__": {"id_": "e5077f7c-6d27-4fd7-82c5-0a2fc5bbbb6e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5c855c94-1d62-4907-84c6-71f7a45fa42a", "node_type": null, "metadata": {}, "hash": "708ffeb254a4c5a6eb621c6b12e49392306e5b7a0af24287a72f18a0950b5a52"}}, "hash": "ab50a17eb345b946b59eb2b12b003f484ccfd6fbfd3ac99c67fe48f7100b42fe", "text": "Engineering abstraction in living matter \u2013 generic system architecture\n\nRead the (**Common Signal Carriers**) part from this free comic book Adventures in Synthetic Biology before the class. \n\n**Q.1  What is the advantage of using a  common signal carrier to construct a system out of devices?  Specifically what common signal carrier is used in the comic?**", "start_char_idx": 0, "end_char_idx": 358, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a861ccb5-a594-4f13-b903-bfc332ab5505": {"__data__": {"id_": "a861ccb5-a594-4f13-b903-bfc332ab5505", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c75d8b1d-2bd0-4d16-97c2-86ddee171fcb", "node_type": null, "metadata": {}, "hash": "a0387f7758bd0b8297fe6c8d56c59ec92d560f7c16dca2d08d7a29d4e8c8f9af"}, "3": {"node_id": "d5eb1fe6-7042-43e3-b692-52210be9acb2", "node_type": null, "metadata": {}, "hash": "e6dd3686d406ae6344934a0b20c93fa5e3b7931d46ce126d9749e596c760c9af"}}, "hash": "0d95dc3452ee16da2e4487ed43f4783252cde11b36646670c5959e3d309c5e81", "text": "Bacterial Flash Mob\n\n**Write down the DNA sequence** encoding a dynamic bacterial flash mob (see animation below in Figure.1 )\n\n\n\n \n\n**Figure-1** Bacterial flash mob. Credit to MIT students 2004: Polkadorks. \n\n**Q.2. What is the first base of your DNA program?  A, T, C, or G?  \n(Hint: Do not spend more than 100 seconds pondering and answering this question.  Time\u2019s up!).**  \n\n*Figure 1.  Dynamic bacterial flash mob.* \nA collection of engineered bacteria (black dots)move randomly in two dimensions.One cell activates randomly, turns red, and secretes a diffusing attractant molecule (green circle). All other cells sense and move towards the source of the attractant.After a period of time all cells return to their original stateuntil the process repeats over and again.\n\n**Q.3. Why is Q1 a difficult question to answer?**   \n(Hint: Consider the difference between what you do and what must physically occur to use a smartphone to take a photograph and send an image to your best friend via text message.  Are you ever typing 0s and 1s into your phone?  What\u2019s happening instead?)\n\nOne simple-but-powerful and general-purpose approach for organizing engineered systems is shown in figure-1.  For example, a computer has a keyboard that receives input via keys (sensors), performs logical operations (computation), and can output via a display, printer or other device (actuation).  As a second example, a pilot can control a Boeing 787 airplane by moving the yoke, whose inputs are combined with other inputs collected by additional sensors (e.g., air pressure), and then a flight computer determines what the actuated flight surfaces on the wings and tail physically do, as controlled by a \u201cfly-by-wire\u201d system.\n\nNote that our thinking about such systems can quickly become complicated by the details of any one example, but that each example follows a similar pattern; inputs are received by one or more sensors; so-received information is computed upon as needed via an intermediate process; and finally some action is taken.  Please also note that in more complicated systems the output of a system can itself be an input, creating a \u201cloop\u201d or feedback to realize more sophisticated dynamics(e.g., repeating or other dynamically controlled behaviors, such as in the case of the looping bacterial flash mob).\n\n\n\nFigure 2. Generic system architecture.\n\n\nA sensor measures environmental properties or inputs  (for example: a keyboard) and transfers this information to a computer (logic unit) to be processed. The results are then transferred to an actuator (e.g., a printer or a display) that can output these results.\n\nThis same framework can be applied to help manage the engineering of biological systems. Stated differently, the desired behavior of a complicated biological process can be represented at an intermediate level of abstraction via a simpler-to-understand  \u201cBlack box\u201d diagram.\n\n**Q.4. Revisit to the bacterial flash mob and develop a device-level block diagram that would result in the so-shownbehavior.  Label simple sensors, logic blocks, and actuators, as needed.  Connect outputs to inputs (i.e., connectboxes together via ines) where and as required.**  \n(Hint: Only give simple device names (e.g., \u201ccoin flip,\u201d \u201cturn red,\u201d etc.);do not describe any biology in any molecular detail).\n\n**Key Concept:** What we are practicing via this generic system architecture is called **abstraction**. \nAbstraction is a tool that allows engineers (and others) to modularize and manage the complexity of a system. Abstraction establishes a level of simplicity at which a person interacts with the system, temporarily hiding more complex details for later consideration, only if and as such details must be considered.  \n\nBut, returning to the Bacterial Flash Mob example.\n\nNow that you have thought about the above", "start_char_idx": 0, "end_char_idx": 3830, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d5eb1fe6-7042-43e3-b692-52210be9acb2": {"__data__": {"id_": "d5eb1fe6-7042-43e3-b692-52210be9acb2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c75d8b1d-2bd0-4d16-97c2-86ddee171fcb", "node_type": null, "metadata": {}, "hash": "a0387f7758bd0b8297fe6c8d56c59ec92d560f7c16dca2d08d7a29d4e8c8f9af"}, "2": {"node_id": "a861ccb5-a594-4f13-b903-bfc332ab5505", "node_type": null, "metadata": {}, "hash": "0d95dc3452ee16da2e4487ed43f4783252cde11b36646670c5959e3d309c5e81"}}, "hash": "e6dd3686d406ae6344934a0b20c93fa5e3b7931d46ce126d9749e596c760c9af", "text": "returning to the Bacterial Flash Mob example.\n\nNow that you have thought about the above questions check out from Here  MIT students solution. \n\n\n\n\n\nFrom a different perspective, note how George Boole observed ways in which human language results in a type of abstraction that can be used to organize and link our experiences to actions.  For example: if it is raining **AND** snowing then bundle up **OR** if it is warm **AND** sunny then go the beach.\n\n**Q.5. When we go to actually implement any sensor, computer, or actuator, what exactly is inside the boxes?  Are there actually black boxes inside a cell?  What \u201cwires\u201d connect one box to another?**\n\nThese are challenging questions that we will resolve!\n\n______________________________________________________", "start_char_idx": 3742, "end_char_idx": 4507, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b533ce53-6263-43bf-a3a8-1000d24f8971": {"__data__": {"id_": "b533ce53-6263-43bf-a3a8-1000d24f8971", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "403c7a90-f672-476a-805a-30ffcffc9ac4", "node_type": null, "metadata": {}, "hash": "89445202579b00aed3d1f44dee83f7e55db56acea8ff2c74c9335ade3ff7c2ed"}}, "hash": "954650e91ad88aad3ba0ac03df755791dd94af41991029cdfa8dd34a95ffafcf", "text": "Preclass for Friday\n\nVisit the following two resources to prepare for a productive in-class team activity:\n\nFirst, examine Brainstorming-Method\n\nSecond, briefly examine I like, I wish, What if.  \n\n\n github source code for teaching staff", "start_char_idx": 0, "end_char_idx": 236, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e177f1a3-1c67-4f53-9a45-6ffddfa14ba6": {"__data__": {"id_": "e177f1a3-1c67-4f53-9a45-6ffddfa14ba6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4c7d94f0-0b39-4907-adf6-198ca9f103ef", "node_type": null, "metadata": {}, "hash": "e91894908efdb802491284a128126d122173120ca535c78384a0b2452bb2bc59"}}, "hash": "812fda96dd2c8b6e71182118bd6dcd51f3407e2648b1aafa587eabb54b3d1d99", "text": "(Q1) Generic System Architecture (25 pts)\n\nIn class you encountered the **Generic System Architecture** composed of: \n\n  - Sensors (to measure properties or inputs), \n  - Logic Unit (to process information measured via sensors), and \n  - Actuator (that can act or output the desired result). \n\nWe can apply this same architecture to abstract a diversity of systems.\nFor example, imagine yourself riding your bicycle on University Avenue and encountering a stop sign. \n\nIn one scenario you can describe yourself as the system.  In this case, your eyes are the sensor, your brain is the computation unit, and your hands are the actuator (i.e., pressing the levers to stop your bike).  \n\nIn another scenario, you can describe your bike as the system.  In this case, the levers are the sensors. There is no computation unit, and the signal is directly transferred via a cable to the brakes (i.e., actuators on the wheels).  \n\n**Q.1.a.** Look around the world from the perspective of an integrated systems engineer. Find an example of an integrated system, either natural or engineered. Submit a photo of the system you found and provide a one line description of the system itself. \n\n**Q.1.b.** Draw the generic system architecture with appropriate units for your system. Label the input(s) and output(s) to the system. What signals are used as inputs and outputs (Add units if appropriate)?  \nHint: Do your best to draw a clear and easy to follow diagram. \n\n**Q.1.c.** Revisit Acoustic reporter genes for noninvasive imaging of microorganisms in mammalian hosts paper.  \n\nThis paper introduces a new class of reporter genes, akin to fluorescent proteins but different.  Intead of taking in one waverlength of light and emitting a different wavelength (e.g., green fluorescent protein) these genes are activated by sound of a particular frequency and scatter the sound waves, creating a signal that can be detected by an ultrasound scanner.  Thus, these genes allow the creation of a new family of actuator devices, wherein a transcription signal and sound are the inputs and scattered sound waves are the output.  Draw a transparent black-box diagram that correctly notes the input and outputs for such an acoustic reporter device.  Please show the exact device boundary between PoPS-source and ribosome binding site for the first open-reading frame (ORF) in the acoustic reporter device.  Please also show the sound and scatter input and output.\n\nNote: If you want to learn more  about abstraction, sensors, and actuators in living matter check out **BIOE 44: Fundamentals for Engineering Biology Lab**", "start_char_idx": 0, "end_char_idx": 2600, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "95c1194f-f587-4497-b357-2489eb58e3be": {"__data__": {"id_": "95c1194f-f587-4497-b357-2489eb58e3be", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fd7c1274-1898-4c64-be35-3330e31dbd2d", "node_type": null, "metadata": {}, "hash": "9f25b5dfa38bbd9fb286ab92a54fdecfe53a41509ad662fa5a78a060cadc0d5d"}}, "hash": "cf2bbde190df4e0e0565dd600314e13a09b49242505856066b30c7ab5ebc3f1f", "text": "(Q2) CHOMP Circuits (25 pts)\n\nReferring back to class, recall the hierarchy based on the Part (bioparts), Devices, and Systems approach to abstraction. \nIf you need a refresher, please use the following link.\n\n**Q.2.a.**  In your own words, provide a 1 sentence definitions for Parts, Devices, and Systems. \n\nBriefly read the abstract from the paper titled: Programmable protein circuits in living cells. \n\n**Q.2.b.** In your own words, summarize the abstract in 2-3 sentences. What is the main claim of this paper? (1-2 sentences)\n\n**Q.2.c.** What are the primary evidence in support of the claim?(1-2 sentences)\n\n**Q.2.d.** Take a look at Figure-1 below  (reproduced from the paper). Briefly describe what are the inputs and the output to this logic device? (Bullet points)\n\n**Q.2.e.** Does the presented logic device (Figure-1) use a *Common Signal Carrier*?  Why or Why not?  If the logic device does use a *Common Signal Carrier*, what is the common signal carrier? (Bullet points)  (Hint: We define Common Signal Carriers from a very formal engineering perspective in this class; specifically, any output from a device must manifest via exactly the same type of physical variable or process as any input to the device)\n\n\n\nFigure 1. Logic Device diagram of CHOMP circuits.", "start_char_idx": 0, "end_char_idx": 1277, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a88973d1-4a1d-4e13-9c84-a9012b798772": {"__data__": {"id_": "a88973d1-4a1d-4e13-9c84-a9012b798772", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "53ec4ed4-b3c8-4993-a3bb-b1d829bcbbc5", "node_type": null, "metadata": {}, "hash": "2fe2a1b7b5ca910f5588c34ebc40173ec7c20b725e344b88ebb23b6f02823ca1"}}, "hash": "4d07879f12692c0d9acb412f651af9ab702755c21f0caf3d2c90df0058c846a2", "text": "(Q3) Plants with Genetically Encoded Autoluminescence (50 pts)\n\nFirst read the abstract of the paper titled Plants with Genetically Encoded Autoluminescence.   \n\n**Q.3.a.** In your own words, what is the main claim of this paper? (2-3 sentences)\n\n**Q.3.b.** In your opinion, what are the paper\u2019s strengths and significance? What are the paper\u2019s shortcomings and deficiencies? How can the paper improve? (2-3 sentences)\n\n**Q.3.c** Estimation problem - Let\u2019s try and estimate the total amount of light that an engineered plant could make via an engineered luminescence system. How many watt-hours of illumination should we expect from a glowing plant, per day? What is the potential upper limit?\n\n(Use the following hints)\n\n- First use the U.S. Solar Radiation Resource Map to look up the average light-energy hitting the surface of the earth (say in California).  Your number should have the unit of watt hours per m^2 per day.\n\n- Next, assume that a plant has a surface area of 1 m^2 and it has 1% photosynthetic efficiency. (This is the fraction of the total energy that gets converted by plants into useful biochemical energy) \n\n- Finally, assume 5% efficiency for the luminescence system (this is the fraction of the available energy that gets converted into light)\n\n**Q.3.d** Your have received a special commission to bioengineer the control program for glowing plants.  \nSpecifically, you need to design an integrated genetic system, built from reuseable genetic devices, that implements the following program:  \n  \n  - When daylight is NOT present AND only in cells comprising the flower\u2019s stamen filament then plant autoluminscence should be ON. Please note that cells comprising the flower\u2019s stamen filament can be uniquely identified because they contain two active transcription factors, thorny AND slender.  \n\nDraw a system's level diagram that implements this glowing plant.  \n\n*Extra Estimation problem (0 points)*  Let's consider the specific plants reporterd in the paper. The paper states that the plant emits lights reaching up to 10^10 photons per minute. Looking at Figure-1.a, you may assume that the emitted light has a wavelength of 525 nm.  How many watt-hours of illumination per day do you expect from a glowing plant presented in the paper?\n(Hints: You will need to use Planck constant and speed of light to calculate a photon's energy for a given wavelength)", "start_char_idx": 0, "end_char_idx": 2386, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "69163d6d-5721-4ced-bc83-d7e6a1e5ff0e": {"__data__": {"id_": "69163d6d-5721-4ced-bc83-d7e6a1e5ff0e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6ed45376-0993-4862-80ff-81bbc9430f32", "node_type": null, "metadata": {}, "hash": "86d467d735f8d23a7ba9b3f08a9ab58e2c51b6e44b545052c4a02dd75b802f16"}}, "hash": "24f14cd89b946d2d36619f7caad0a299c15b9dc46bda32268cfc7c5a7e95c359", "text": "Extra resources, learning, and Practice Questions\n\nThe following suggested reading and questions are 100% optional additional. They are meant to help you engage with various aspects of the topics that we have covered in each segment based on your interest and level. They are not required as part of your problem sets. But we hope that they enable you to enhance your learning based on your interest.", "start_char_idx": 0, "end_char_idx": 400, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1ea99c6e-a7a9-47e4-b0a9-98ed10e4c8e5": {"__data__": {"id_": "1ea99c6e-a7a9-47e4-b0a9-98ed10e4c8e5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "662e1f61-bdc1-4564-b941-fd74ebfd115d", "node_type": null, "metadata": {}, "hash": "8bed0f0cafb0a2492277993c4a1ed8efeb8db4ce0e812012cc9d7d7148759ba9"}}, "hash": "16de609834ead6533f307729d5a83cb5eb97f32cefd84e3f91b69e2301c849f1", "text": "Q.EX1.Navigating the Abstraction Hierarchy (0 pts)\n\nRecall from the class that we can use abstraction to help and manage complexity in engineering biological systems. \n\n**Q.EX1.a.**  Imagine an engineered living system with a function of your choice.  What does this system do?\n Example engineered bacteria (*E.coli* for example) to detect lead or arsenic and produce a color pigment (red for lead, purple for arsenic) (1-2 sentences)\n\n**Q.EX1.b.**  Sketch a black box \u201cdevice-level\u201d systems diagram that would implement your system.  \n\n**Hint:** Your boxes should have simple names, such as \u201cchange color,\u201d \u201cdetect lead,\u201d \u201cOR,\u201d or whatever human-defined functions are needed and appropriate.  Make sure also to connect each black box device to the others as needed.    \n\nNext, going down the abstraction hierarchy, you need parts.  Where to get parts?  How about a student-produced collection of thousands of DNA parts.  Sure! Go to the iGEM Parts Registry.  \n\n**Q.EX1.c.** Find parts that could be used to implement your device.  Share the name of those parts as part of PSET-3.  \nIf you can\u2019t find what you need, make a note and move on.\n\n**Q.EX1.d.**   Sketch how your parts should be organized as DNA elements in relation to one another so that they would implement the function as you desire.  Draw a black box around your parts.  Add inputs and output arrows to the box as appropriate. Are your input and output signals generic or specific to your device?", "start_char_idx": 0, "end_char_idx": 1462, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "979c9a0c-7fb8-47eb-8c63-5f929e43f5a2": {"__data__": {"id_": "979c9a0c-7fb8-47eb-8c63-5f929e43f5a2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "27799c77-1c88-4b19-913a-be1a43e96d5e", "node_type": null, "metadata": {}, "hash": "5f3a6a1fb9baed030d83787799ab3701902c4952bea9fee347890e31941ae134"}}, "hash": "65002a312335f80fd7beefa49c27dba042e219089fa1f597174073960b93035a", "text": "Q.EX2.  Buggy Bacterial Flash Mob? (0 pts)\n \n Students at MIT are claiming that they have designed a genetic program to realize \n arepeating bacterial flash mob.  See their work yet again via:\n \nPolkadorks, iGEM-2006\n \nIn an epic East Coast versus West Coast technology \u201cbattle,\u201d some of your colleagues\nare now claiming that the genetic program designed at MIT won\u2019t actually produce the\nso-desired behavior.  Looking only at their proposed \u201cdevice-level system diagram\u201d...\n\n**Q.EX2.a.** What do you think?  Will their program work or not?   \n\nYES or NO (circle one)\n\n**Q.EX2.b.**  Why or why not? (bullet points)", "start_char_idx": 0, "end_char_idx": 614, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1b34bdc3-53d9-468b-9087-8156159ee081": {"__data__": {"id_": "1b34bdc3-53d9-468b-9087-8156159ee081", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "31932e3a-b7b8-41ec-8d9d-5733fd7da724", "node_type": null, "metadata": {}, "hash": "38d46397158d866d56f0c94a0aaf4cff9e5020c1cbfc2bbee3592f3ba706143b"}}, "hash": "02b70b5b1f4525815e829274c07383b35ba59a0043a83a42731df27fb1a8b5df", "text": "(EX3) Unknown genetic circuit (0 pts)\n\nTake a look at the following, genetic circuit.  \n\n**Q.EX3.a.** What are the circuit input(s) and output(s)?\n\n**Q.EX3.b.** Complete the following time trace diagram. What happens to the GFP signal after  $\\sigma70$ is added to the circuit? Explain your answer. \n\n\n\nFigure 2. Unknown genetic circuit.\n\n\n**Q.EX3.c.** Describe the behavior of this circuit via a name (e.g., AND gate, NAND gate, Toggle switch)?", "start_char_idx": 0, "end_char_idx": 445, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "dbffbdc5-d447-4b7b-92f9-352fd7cfacc6": {"__data__": {"id_": "dbffbdc5-d447-4b7b-92f9-352fd7cfacc6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "84e7383c-40d5-443a-94a7-5a7bcf59e66c", "node_type": null, "metadata": {}, "hash": "d55f0451279b2492e271a30e29c23f67dd3ecc84af30fd144a11b298e28735de"}}, "hash": "9e749fae9893a3f0f5dba0ad339a4cf12a0942ac1bdd795baaf6f3d7bf3beceb", "text": "(EX4) Toggle switch (0 pts)\n\nThe toggle switch is a common network motif that can be implemented as a genetic circuit. Two inputs are used to switch the system between two stable states. A diagram of the gene-regulatory network is shown below.\n\nA transcriptionally represses B, while B transcriptionally represses A. B also represses the reporter molecule C. SM1 is a small molecule that allosterically inhibits repression of B by A, while SM2 is a small molecule that allosterically inhibits repression of A by B.\n\n\n\nFigure 3. Toggle switch circuit.\n\n\n**Q.EX4.a.**  Describe the overall behavior of the system. What are the inputs? What are the two states? How does the system state respond to the given inputs?\n\n**Q.EX4.b.**  A toolkit of biological parts is shown below:\n\n\n  \n     Part name \n     Description \n  \n  \n    tetR\n    Repressor from the tet operon\n  \n  \n    tetO\n    Operator from the tet operon\n  \n  \n    doxycycline (dox)\n    Small molecule that binds to tetR\n  \n  \n    lacI\n    Repressor from the lac operon\n  \n  \n    lacO\n    Operator from the lac operon\n  \n  \n    IPTG\n    Small molecule that binds to lacI\n  \n  \n    GFP\n    Green fluorescent protein\n  \n\n\nUsing this toolkit, label the gene-regulatory network diagram with the corresponding part names by answering the following questions. (*Note: You should choose parts that can work together to achieve the overall system behavior you described in Q.4.a.*)\n- What part did you assign to A?\n- What part did you assign to B?\n- What part did you assign to C?\n- What part did you assign to SM1?\n- What part did you assign to SM2?\n\n**Q.EX4.c.**   Use the toolkit and the DNA templates below to implement the toggle switch according to your labeled gene-regulatory network from *Q.4.b*.\n\n\n\nFigure 4. Implement the toggle switch according to your labeled gene-regulatory network.\n\n\n\n github source code for teaching staff", "start_char_idx": 0, "end_char_idx": 1886, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f0ae845c-eb81-43da-a725-0f7492261826": {"__data__": {"id_": "f0ae845c-eb81-43da-a725-0f7492261826", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2fe1d8c2-5a5c-4ead-91b0-051b3b1c6c9e", "node_type": null, "metadata": {}, "hash": "73090eaa955135134b8081958ff8d2ca146c595896dff7d3ee852fe83b1812e8"}}, "hash": "d50f9125c385a8c269576a23cf0a98c43d72cb92c6da02a105e8e0e80fb8c4dd", "text": "Day 13: May 4, 2020\n\nClass Slides (main)\n\nClass Slides (sequencing)\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 86, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "dfcbeaf4-e847-43c5-84ad-44cd8fe34ca2": {"__data__": {"id_": "dfcbeaf4-e847-43c5-84ad-44cd8fe34ca2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8bfcac68-b6a3-4f3f-aa57-c4871b18cd8e", "node_type": null, "metadata": {}, "hash": "ddaade98320c299df693bc98c78d2d75b6755854d89d5b44ead83e726de4fdc6"}}, "hash": "9725e849d9dbd07ac80a983e645e6cc4ec813252159faf43522f9b616d0c9173", "text": "Day 14: May 6, 2020\n\nClass Slides\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 52, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "cf102e4f-0665-40d4-9659-fda6aa99fbd3": {"__data__": {"id_": "cf102e4f-0665-40d4-9659-fda6aa99fbd3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1de97efb-4656-4e94-95e6-478e452fe11b", "node_type": null, "metadata": {}, "hash": "5655ba4b981294a0698539ac568514a598fc0536644dd56e5289f6303a999ee0"}}, "hash": "01c389cfd2513b8196dce216db97c8d1a3b6ea944e9251c4a897ed4681362b01", "text": "Day 15: May 8, 2020\n\nClass Slides\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 52, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "25a5b9be-ca88-4ffb-b1db-229a6f0ca12e": {"__data__": {"id_": "25a5b9be-ca88-4ffb-b1db-229a6f0ca12e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a49a2160-6510-49d7-a44e-318221aa98eb", "node_type": null, "metadata": {}, "hash": "ebf37add24cd0e49d6c5265c12c05d50520766f877fc4273b7f11b23ff182b2d"}}, "hash": "4d0ecec46fdb47af696b923b6daa64e96b55e2eff350024c2846576bfabfb439", "text": "DNA Reading & Writing", "start_char_idx": 0, "end_char_idx": 21, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3cd1e1b2-13fa-4f7d-8575-9fc605ff3268": {"__data__": {"id_": "3cd1e1b2-13fa-4f7d-8575-9fc605ff3268", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2fe85357-3333-462e-8bfb-86fd13130c4c", "node_type": null, "metadata": {}, "hash": "5c4a1eacdc50b757d33270a4c939735979d28ad878b439aed1113542f0e6e9ce"}}, "hash": "c1bfb69ef47ae4c500ea040b737a90337b72ae85327d079ad34a785d4ade6fbd", "text": "Preclass for Monday\nPlease read and consider the below before start of class on Monday.\nThe questions given are only study questions not homework to be graded.\nTalk about it all with your classmates, friends, or TAs, as you like.", "start_char_idx": 0, "end_char_idx": 229, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ff19db76-d9e9-49db-aef8-0945b94ea412": {"__data__": {"id_": "ff19db76-d9e9-49db-aef8-0945b94ea412", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2761301d-6f02-4aa5-be7a-e8f7ef1c9123", "node_type": null, "metadata": {}, "hash": "3b4508201f4500778f85219e3b6ad479818e0f445b9237e6e541f0b6acd7060c"}}, "hash": "69c3c7f9887847c277d188eeb364fa06b3059dd6224d2f96388edd8731dd0c0f", "text": "Introduction - DNA read and write past, present, and future\n\nThis week we will explore **What changes may arise via trends in DNA read and write tools may matter for the rest of our lives?**  We hope you will learn more about the core capacities for accessing and encoding DNA and also consider the quantitative pacing of how these tools are improving. Monday's pre-class material focuses mostly on DNA sequencing, whereas Wednesday's pre-class material focuses on DNA synthesis...\n\n**Goal 1:** You should be able to describe how DNA sequencing works.\n\n**Goal 2:** You should be able to describe the pace of developments in DNA read and write and be ready to discuss the ramifications of this development.\n\n**Goal 3:** You should also be able to describe how DNA synthesis works.\n\n**Goal 4:** You should gain a capacity to strategically evaluate quantitative trends and qualitative transitions.\n\nLet\u2019s begin!", "start_char_idx": 0, "end_char_idx": 908, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "760cf1b0-416f-4022-bba0-7fa4f8c83eb1": {"__data__": {"id_": "760cf1b0-416f-4022-bba0-7fa4f8c83eb1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5b01e8da-cdf8-498c-97be-d7fec3306a22", "node_type": null, "metadata": {}, "hash": "98e6aef587d5024d984cac0ad20ec6bdb1f7ac913e815e8f0192656b54762d8f"}}, "hash": "cf5dc080e9d4f8f7c85a292ce617c1cdc1158da3e9674436ad6bf1c3fc7f4b8e", "text": "DNA literacy -- DNA read\n\nDNA is made up of nucleotides. These nucleotides have four possible bases;\nadenine (A), thymine (T),guanine (G), and cytosine (C). All DNA is made up of sequences of these four bases. Imagine a four key typewriter that is able to type the DNA codes for all of the biodiversity seen on earth. Being able to both **read DNA** (sequencing) and **write DNA** (synthesizing) has and will continue to give bioengineers the ability to design and build with living matter in ways that were hard to imagine very recently.\n\nLet\u2019s delve into how current sequencing technologies work.\n\nStart with this video that provides background about sequencing and its use to decode the human genome, with a focus on \u201cmassively parallel sequencing\u201d (often marketed as \u201cnext-generation\u201d sequencing technology). Figure-2, also breaks down the same process described in the video.\n\n\n\n\n\n**Figure.2.** \"Breakdown of DNA sequencing steps (specifically next generationsequencing). In this approach instead of reading a long sequence of DNA one baseper at a time, the sequence is divided into many pieces (fragments) which are all read simultaneously\". Source\n\nDuring sequencing first, the genomic DNA (the DNA that we want to read) is broken into smaller pieces (fragmented). Then a synthetic linker sequence is added to the end ofthe fragments (adaptor) which helps the DNA fragments get attached to a surface on which the sequencing happens (flow cell). Next, the DNA fragments are separated inspace and read individually. Each fragment is amplified (thousands of copies of eachpiece is made) to make sure the correct sequence is detected. To actually read the fragments, pre-labeled nucleotides (nucleotides with color) and enzymes (that incorporate nucleotides into the fragments) are added to the flow cell. As each colored base pair is added to the fragments a new colorful spot is introduced. By taking images from the spots we are able to decode the sequence. Finally, the fragments are stitched together to reveal the original sequence of the genomic DNA. Here is an additional video that describes this process in even more detail optional link.\n\n\n*Optional reading-1: DNA sequencing at 40: past, present and future.*\n\n**Q.1. According to the \u201cHow to sequence the human genome\u201d video when was the first human genome sequenced? How long did it take? How much did it cost?**\n\n**Q.2. How much would it cost if you were to sequence the human genome in 2018?**\n\n**Q.3. Thinking back to the design, build, and test (DBT) class. What are theconsequences of lowering sequencing cost (both money and time)?**", "start_char_idx": 0, "end_char_idx": 2605, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3f3bd525-02b4-493f-a792-502ef3bdc737": {"__data__": {"id_": "3f3bd525-02b4-493f-a792-502ef3bdc737", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "84db34e3-f7a7-40ea-aa21-a25df08d2118", "node_type": null, "metadata": {}, "hash": "f1fd20989243f40b5fc25a9089e9e2f8f75020d80f0652fef4dc741a190552bb"}}, "hash": "ba62a35955d4f024699c69e39aa0d07e03e35fbd2eb1656746aec9481a8838f3", "text": "DNA literacy -- DNA write\n\n1. A less than 4 minute video introducing how Agilent builds 60mer oligos using inkjet dispensing.\nlink\n\n**Q.4. How is inkjet printing used to write DNA?**\n\n2. A summary of existing and recent DNA synthesis companies:\nlink\n\n*Optional reading-2:  Synthetic DNA Synthesis and Assembly\n\nExtra learning: \n\nAdvanced learning-1: Next Generation Sequencing video lectures By Eric Chow\n\nAdvanced learning-2: Genome Sequencing for Pathogen Discovery\nvideo lectures Joe DeRisi\n\nAn article on difference approaches to DNA synthesis:\nlink\n\nImage Sources:\n\n1. Next-Generation Sequencing: Shendure et al, Nature 2017  link\n\n____________________________________________________________", "start_char_idx": 0, "end_char_idx": 697, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "efa85554-8b85-44cd-b46c-5cead059591a": {"__data__": {"id_": "efa85554-8b85-44cd-b46c-5cead059591a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8c64ef8d-0cef-4420-b875-ed74ca20af63", "node_type": null, "metadata": {}, "hash": "f6035251aafd43f9fc0129615f4a9338d7bede259d4087b0d6d509b678ebeb0c"}}, "hash": "6f78e6bd05a294e97ce05f8c878e931eccc0fa538f73c5308a11db9fe842097f", "text": "Preclass for Wednesday\nPlease read and consider the below before start of class on Wednesday\n\nOn Monday, we discussed the technology and science behind DNA sequencing and synthesis.  Today's reading addresses the quantitative and qualitative pace of change and the consequences arising from these changes.", "start_char_idx": 0, "end_char_idx": 305, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f4241ec7-b9fb-4ff3-8c1f-7eff3436ac02": {"__data__": {"id_": "f4241ec7-b9fb-4ff3-8c1f-7eff3436ac02", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e1bc2c2b-2118-407b-bdbe-c5cebae82411", "node_type": null, "metadata": {}, "hash": "48cd68957fd3839a47f1b3ae5fee2e43cd2822b7908ae036d442d3e1b51dedc6"}}, "hash": "f54c420312d17f9dc59459f4017da084bb3dbcb86f44dcbbfe1f012d3ca80ccf", "text": "Example 1: DNA trends:  Non-invasive prenatal testing\n\nPut yourself in the shoes of a couple who recently discovered they were pregnant, and are worried about genetic disorders in their unborn child (e.g., Down syndrome).\n\n**Scenario-1:** It is 2010 and the standard of care is amniocentesis, an invasive procedurein which a large needle is used to directly sample fluid from the amniotic sac optional link\n\n**Q.1. What do you think about the test, would you take it? Why?**\n\n**Scenario-2:** It is 2020 and in leading-edge children\u2019s hospitals amniocentesis has been replaced by non-invasive prenatal testing (NIPT), previously known as cell free DNA testing. NIPT is based on a simple blood draw that enables determination of geneticdisorders and even the sex of an unborn fetus. The test works because it turns out that there is DNA from the fetus circulating in the pregnant woman\u2019s blood (e.g., if a pregnant woman has Y chromosome DNA in her blood then she is carrying a malefetus). Please watch video about cell free fetal DNA analysis if you want moredetail.\n\n\n\n\n\n**Figure.1.** \"Reduction of the Price of DNA sequencing and synthesis per base per over past 30 years.  Source\n\n**Q.2. Do you think NIPT could have been economically feasible in the year 2010? What about 2000, or 1990? Why?**\n\n**Q.3. What factors do you think led to exponential cost reduction in DNA sequencing?**\n\nHumans as individual biological organisms have historically been defined, literally, by a natural reproductive process in which the genetic material of our parents leads to us as individuals, and so on. Increasingly it is becoming apparent that we can assert our intention into the human reproductive process. E.g., about 4% of humans born in the US today arise and arrive via in-vitro fertilization. At the on-campus children's hospital it is now standard practice for the DNA of the fetus to be partially sequenced at 10 weeks post-fertilization in order to screen for various genetic conditions, and this information is used to inform health decisions. Others are now beginning to apply advanced genetic engineering tools to edit genes within viable human embryos - see here for example link\n\nNext, let's consider what happens when information and material become **interconvertible**.  \n\n(Interconversion - a process in which two things are each converted into the other)\n\nNot long ago, to listen to music, you had to have the musicians manipulating the air to make sounds. With the invention of recording, sound could be turned into information and stored in various physical objects (vinyl records, wires, cassette tapes, CDs,...).  Given access to the object and a player,  you could listen to music.  Also, note that each medium quantitatively could store more information.  However, with the introduction of the internet, there was an additional qualitative change. Now music could be shared as information via the network and played (or reconstructed into a physical object CD).\n\nSimilar interconversion is now possible for living matter.  With the progress of DNA sequencing and synthesis, now it is possible to read the genome of a given cell in one location-A (Palo Alto), store, and transfer the DNA information to location-B (Boston).  Then DNA information can be resynthesized into a physical object (DNA polymer) from scratch. \n\nInterconversion of DNA information into physical DNA can also be used to read the genome of animals, cells, or viruses that have been extinct and reconstruct them from scratch. \n \nNext consider the following example:\n\nThis link provides the full genome of the 1918 flu that infected up to one third of the world population a century ago: Flu genome sequenced.\n\n**Q.4.Should the sequence of the virus be available online?**\n\n**Q.5.Who should have access to tools (DNA read and write) for engineering living matter? How (or should) it be controlled?**\n\nImage Sources:\n1. Carlson Curves link\n\n____________________________________________________________", "start_char_idx": 0, "end_char_idx": 3983, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fc925d48-7a94-413c-b7c0-284bd3b65ec2": {"__data__": {"id_": "fc925d48-7a94-413c-b7c0-284bd3b65ec2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6faff7ed-f9fe-416d-b93b-66ff57602eea", "node_type": null, "metadata": {}, "hash": "f11885197299eb0df978892fc4b10ea3731b2bdb51884bb39ff1649562aa9e2c"}}, "hash": "0d19c9391e63dc998de8c6a0b84f5a6f84c95cffb9e03fbce31f27207e8f3321", "text": "Preclass Reading for Friday\n\nTask: As a team attempt a brainstorm and bring at least one idea per person to class on Friday.\n\n github source code for teaching staff", "start_char_idx": 0, "end_char_idx": 164, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8550ecc3-10be-47af-b379-a581cb908df9": {"__data__": {"id_": "8550ecc3-10be-47af-b379-a581cb908df9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5d51fdf4-b97f-4932-9aeb-12a44a11ad9e", "node_type": null, "metadata": {}, "hash": "cbe3d7a2977929b5f34368620ad4757ae54cdc824dbfd9b924516bf6e287f3fb"}}, "hash": "97d160f5550df5ce29336504c67956343dedfe29e891d839d61d935efdef730a", "text": "(Q1) Sequencing the Total DNA in the Biosphere (20 pts)\n\n**Q.1.a** The following paper estimates that there are about 5.3 * 10^37 bases of DNA in the biosphere.  \n\nGiven the increasing trends in productivity of sequencing. In what century can a team of 10 sequence 5.3 * 10^37 bases in a month?  We will use the information from Carlson Curves to provide a projection. \n\n![Carlson Curves](/assets/images/PSET6_Crlson_Productivity.png\n \"Productivity in DNA Sequencing and Synthesis\")\n \n There are many ways to solve this problem.  You can use your method or use the suggested assumptions and steps.\n (Your final answer depends on your assumptions).\n   \n   \n Assumption.1 assumes the trend in sequencing productivity since 2005 will continue.\n   \n   - estimate 2005 productivity at 10^7 (bases per person per day)\n    \n   - estimate 2010 productivity at 10^10  (bases per person per day)\n    \n   - from above numbers produtivity rate (R) for every 5 years, 1000x better\n\nAssumption.2 from the graph, we can estimate our current productivity P0 = 10^11 (bases per person per day) for the year 2015.  (Note: The trend we are assuming (that every five years, the rate increases by 10^3) does not fit the actual data perfectly. That is ok for our estimate. Although 2015 should have a rate of 10^13 according to our assumption, we will use a P0 of 10^11 as shown on the graph.)\n\nStep.1 (you have to do):\n\nNormalize total DNA (5.3 * 10^37)  bases to our team size (10) and time (30 days) to calculate expected productivity (P) with units (bases per person per day)\n\n$P= \\frac{total DNA}{team Size * 30 days}$\n\nStep.2 (you have to do):\n\nConstruct a function that relates expected productivity to the productivity rate, current productivity, and time. \n \n  - Expected productivity: P (bases per person per day)\n  - Current productivity: P0 (bases per person per day)\n  - Time: t (number of five year periods)\n  - Current productivity rate: R (=1000, no units)\n \n$ \nP = function (P0, R, t)\n$\n \n$ \nP = P0 * R^t \n$\n\nThen solve for t (number of five year periods)\n \nStep.3 (you have to do):\n\nChange t form number of five year periods to years. Add to initial time starting at (2015).\n \n*Q.1. Extra activity* Construct a table comparing expected time for R: (1000, 2500, 5000, and 10,000).  Construct a second table where t is number of two year periods instead of five.", "start_char_idx": 0, "end_char_idx": 2356, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "451854f1-a9f9-4328-a8a7-d226f6b388e0": {"__data__": {"id_": "451854f1-a9f9-4328-a8a7-d226f6b388e0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7b1bcf56-e8a1-4d60-858d-873a215c8797", "node_type": null, "metadata": {}, "hash": "80931861d5bdcd8922c332e2b136e699fe91e11e534529ae282a642af3726052"}}, "hash": "f344323f50774b18053152c06781c5fbbf2f3c18cdbb8a010ae5f886c272ffdc", "text": "(Q2) DNA as a Storage Medium (30 pts)\n\nThe US government has been using an underground salt mine in Pennsylvania as a long term storage facility for physical documents, primarily retirement-related papers. According to the Washington Post, in this facility, approximately 1000 employees pass thousands of case files from cavern to cavern and then type in retirees\u2019 data, one line at a time. Basic document retrieval involves a forklift and takes days. \n\nGiven the trends in DNA read and write, consider using DNA as an alternative storage medium for these documents.\n\nHelpful numbers:\n\n- Volume of storage facility = 10 million m^3\n- Letters per cubic meter of typical government document = 10^9 letters/m^3\n- Volume of a DNA base pair ~ 10^-27 m^3\n\n**Q.2.a.** Since DNA has only 4 bases, but English has 26 letters, you will somehow have to map letters to bases. \nBriefly specify an encoding scheme for mapping bases into the 26 English letters. (You *do not* have to give a letter to DNA mapping for all letters. The first few will do the trick.)\n \n- Hint-1: In your encoding scheme, the length of the bases should be consistent for the entire mapping. \n\n- Hint-2: What is the minimum number of bases you need to map the entire 26 English letters. Consider what would be the problem if you pick 2 bases (AA, TA, CA, GA,...) to map 26 letters. \n\n**Q.2.b.** Using your letter to DNA mapping, how many total base pairs of DNA would be needed to store the archival contents of the salt mine. Assume that the salt mine is completely packed with documents.\n\n**Q.2.c.** What would be the physical volume of DNA encoding the salt mine documents?  \nWill the DNA fit into a thimble?  Yes / No\n\n**Q.2.d.**  How expensive would it be to print the DNA (assume cost ~1 cents/base)?  Compare your number against the United States GDP (20.54 trillion USD - 2018)\n\n**Q.2.e.** Give two advantages and two disadvantages of using DNA as a storage medium (4 bullet points)\n\n**Q.2.f.** Can information be stored in the DNA in a living organism as opposed to DNA stored in a frozen tube (-80 freezer)? If yes, what are one advantage and one disadvantage of using live-cell storage? (2 bullet points)\n\nHelpful resources:\n\n- How DNA Could Store All the World's Data\n\n- Taking Cells to the Movies\n\n- Hardy microbe\u2019s DNA could be a time capsule for the ages", "start_char_idx": 0, "end_char_idx": 2332, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2dc3e64d-7418-4a7f-bcec-022df3923f8e": {"__data__": {"id_": "2dc3e64d-7418-4a7f-bcec-022df3923f8e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6f5f8819-8c97-4618-8c22-231e7a63b9e9", "node_type": null, "metadata": {}, "hash": "f2d261af0a8728bee0498dd33c88a0727fc8579a5c84e13333cea25a4d76cb92"}}, "hash": "4068eb4da4b04c52f053cda99b3d994a11bc5b63092dd456c5e6859b560fb30b", "text": "(Q3) Cost of Education vs Cost of Germline Editing (20 pts)\n\nOver the past 12 years, the price of synthesizing genes has dropped from  4 USD to 0.04 USD\nper base pair. Presume the future price of DNA synthesis will continue to drop two-fold every two years.\n\nStanford\u2019s undergraduate tuition is approximately 50,000 USD per year, up from 25,000 USD in 2000.  \nPresume Stanford\u2019s tuition will continue to double every 15 years.\n\n**Q.3.a** If a human genome is 4 billion base pairs long, then when will the cost of synthesizing the DNA encoding an entire human genome be roughly the same as the tuition cost associated with attending Stanford for one year?\n\nHint: Use the facts given. Keep your math simple. Show your work. An approximate answer is fine.\n\n**Q.3.b**  What would be your estimate if the price of synthesizing genes continue to drop two-fold every 2.5 years instead of 2 years (i.e., only a 6-month longer doubling time)? An approximate answer is fine.\n\n**Q.3.c** Given your answer from part (a) presume that you could then design, build, and bring to life a human encoded by a genome that you design (e.g., with any and all mutations that you and your partner choose).  As potential parents, would you prefer to spend your savings on college tuition for a natural child or on realizing a genetically engineered offspring who then has to make their own way? Why? (2-3 sentences)", "start_char_idx": 0, "end_char_idx": 1390, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5752e04a-09ea-4a59-a33c-55ad523ac00b": {"__data__": {"id_": "5752e04a-09ea-4a59-a33c-55ad523ac00b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6a9f4369-38b1-4b58-96c9-53477b30e0d0", "node_type": null, "metadata": {}, "hash": "0b2153ec23130454484b42af7033a1be99a3f2783fbc713bd619ac01b72b697d"}}, "hash": "13c72450b57928e4729edefc2f0435a054402dc9c78d6949ca6189b94ba8ab1e", "text": "(Q4) Paper reading activity (30 pts)\n \nFirst examine, Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform or here\n \n**Q.4.a** In your own words, what is the primary claim of the paper? What are the primary evidence in support of the claim?  (2-3 sentences)\n \n**Q.4.b.** What is your reaction and thoughts to this work? What are the benefits and risks of this work? Do the benefits of the paper outweigh its risks?  Should this work be published?  Think back to Rousseau and Hobbes's discussion from Week-2, and consider the interconvertability of DNA as matter and information. (3-4 sentences)\n \n(We wish to hear your thoughts, and we don't have a \"correct answer\" in mind. Instead, we want you to think deeply and  practice your written communication skills.)\n \nNext examine,Design and synthesis of a minimal bacterial genome.\n\n**Q.4.c** In your own words, what is the primary claim of the paper? What are the primary evidence in support of the claim? (2-3 sentences)\n\n**Q.4.d** What were the genome size and number of genes in JCV-syn3.0?  How many were essential genes of previously unknown function discovered in this work? How is the whole genome synthesized in this work?", "start_char_idx": 0, "end_char_idx": 1196, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5916a9c6-7cd1-4921-9698-237d1ee568e9": {"__data__": {"id_": "5916a9c6-7cd1-4921-9698-237d1ee568e9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0976cd84-8c3b-44fe-b76c-79d43a093462", "node_type": null, "metadata": {}, "hash": "e3d36e6219363ffc0643fc1acdde68f884979c48bf65a3d1293b8d451aa4651e"}}, "hash": "66805b3e42eb7543157cb74ebfd8fe5f387ac3f3f9c317c5c40dcca498328444", "text": "Final Project - Group Activity.1", "start_char_idx": 0, "end_char_idx": 32, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "37397fbc-e0f3-4db6-9442-2c976661e7a7": {"__data__": {"id_": "37397fbc-e0f3-4db6-9442-2c976661e7a7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1632a9d5-d901-414b-9f23-4d288dcbe667", "node_type": null, "metadata": {}, "hash": "3353947ff1ed2ce58892b12996cdb8d88cc5406d6c2c0f695c94c57bfdb05639"}}, "hash": "3fee4a881a6d7f31e6a6564e5aee13c308a5ac6b3e7b2411c7915e2dba55af85", "text": "Brainstorm report + Team Rules\n\nASSIGNED: Friday 08 May 2020\n\nDUE: 5:00p Pacific 15 May 2020\n\n**NOTES:**\n\n- Include your group number and names of your group members.\n- Team Rules is 6 points of your Final Project.\n- Brainstorm is 5 points of your Final Project.\n- Please turn in a **single** (one person per team) electronic copy of your Group Activity.1 via Gradescope.\n\n**Q.1.** What is your group number? (If you have a group name - let us know)\n\n\n**Q.2.** Turn in a copy of your team rules. We expect to see between 8 and 20 rules (8 rules < # rules < 20 rules) that you have all agreed upon. (6 points)\n\n**Q.3.** Brainstorm report: \nAs a group for your project brainstorm ideas.  Brainstorm should include following three themes:\n\n- People health \n\n- Planet health \n\n- Political health \n\nwe expect 30 ideas for each theme **total  90 ideas**.  If you have more ideas, please share them.\n\n__________________________________________________", "start_char_idx": 0, "end_char_idx": 944, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "12e0c405-2466-4d23-b7f7-0ea28c98e1d7": {"__data__": {"id_": "12e0c405-2466-4d23-b7f7-0ea28c98e1d7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cbc9625c-b832-4841-9f4a-79d7ef4eb00a", "node_type": null, "metadata": {}, "hash": "5001356a739b8e79cd7e2a75bb68a481d3d6eecae26d825e234791eb1b607141"}}, "hash": "cbfcd707d60da9026c1aad9cede9b949a5658831006f872db0a1d585f4bc65f5", "text": "Extra learning (100% optional):", "start_char_idx": 0, "end_char_idx": 31, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2f10864b-b493-4ab9-863f-d5ef10c5cc0f": {"__data__": {"id_": "2f10864b-b493-4ab9-863f-d5ef10c5cc0f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "53c38a42-adeb-4cba-9f02-fce031194822", "node_type": null, "metadata": {}, "hash": "eb1f9c0cf5a9823eda7754669f22bc8ac6827047fe6ad1d8a4fb5eebb7fd75c8"}}, "hash": "1aeb78ac3c777cd025f66d36db5997a065178d578731ba8d94bd7c8ec6942e61", "text": "(Q5)Sequencing and Synthesis technologies (0 pts)\n\nIn the pre-class material, you were introduced to a DNA read method commonly referred to as next-generation sequencing (NGS) or massively parallel sequencing. Let\u2019s examine an alternative approach, namely nanopore sequencing.\n\nWatch this video\n\n**5.a.** Describe how Nanopore sequencing works (use bullet points)\n\nMinION is a product that uses Nanopores for sequencing.\nWhile the error rate with Nanopore technology is between 5-10%. additional Link. This tool can be used to sequence and assemble a human genome\nadditional link.  Now briefly examine the various product sequencing technology from Illumina link.\n\n**5.b.** How are NGS and Nanopore sequencing different?\n\n**5.c.** Imagine that the storage of information in DNA from the previous question has become a routine platform.\nYou have been hired as a consultant for a library that seeks to store its archive inside the DNA medium.\nYour task is to determine suitable reading platforms. What type of\u201cread technology\u201d would you recommend:\na sequencer that gives massive simultaneous short reads with low error,\nor fast readers that read long sequences with error rates as high as 15 %.\nPlease include quantitative reasoning in your answer.  \n\n**5.d.** Where would you use an Illumina sequencing machine instead of a minION sequencing machine?\nAnd vice versa?\n\n github source code for teaching staff", "start_char_idx": 0, "end_char_idx": 1405, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f8de43e2-0837-4fee-9cf0-e0119786e8e1": {"__data__": {"id_": "f8de43e2-0837-4fee-9cf0-e0119786e8e1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab3afd9f-61b9-4672-a80f-7929b53381a5", "node_type": null, "metadata": {}, "hash": "b53e579e773d5edd49a0a49b5e893dea6060adeea4b40ef212fa1dacefc32e0d"}}, "hash": "73a19225a6d3aa674616799053e3d8fb7fc7ad3d7e87cfd337fb1a11881a2a29", "text": "Day 16: May 11, 2020\n\nClass Slides\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 53, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "703cbfaf-bca3-4485-9868-0d5127984e32": {"__data__": {"id_": "703cbfaf-bca3-4485-9868-0d5127984e32", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8562775b-0cc5-4cfe-b91b-c570ebd28d69", "node_type": null, "metadata": {}, "hash": "2e4a6efb5892d00dfc0d8adccaf44b8521bd628a2c326505f4dde24c408f07dd"}}, "hash": "94761c5dd62dc32cb5d8ca2fd9055bca2e82f80928dd1b3817fe8238caad6d76", "text": "Day 17: May 13, 2020\n\nClass Slides\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 53, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "cb404a40-6e9e-4dcd-b998-a2aa9c4f98e0": {"__data__": {"id_": "cb404a40-6e9e-4dcd-b998-a2aa9c4f98e0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0f7cc04c-c62f-4a04-8b8e-5fcafe22108f", "node_type": null, "metadata": {}, "hash": "2e4f3d3231043a0a4f42d852993a51dc6391fbce362e5cd0647b7a41649c5198"}}, "hash": "ca2565c3e4f6a59948de24665a722e0f9acc0fa35a8074710120977bc33c8796", "text": "Day 18: May 15, 2020\n\nClass Slides\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 53, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6d910027-5cdc-42d6-913a-f12a30e4b91b": {"__data__": {"id_": "6d910027-5cdc-42d6-913a-f12a30e4b91b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6181ad41-099c-4f46-bc34-22c438fb9110", "node_type": null, "metadata": {}, "hash": "5366adf4cf998e084420d14e52c7884194a799512cf05c2b52b4e77d20595330"}}, "hash": "31cbe0fea22cd81434c8f24fc38ae9c09c4a9409feed420b1750d13f64102a44", "text": "Something from \"Nothing.\" Why do molecules move? How do patterns grow?\n\nPlease read and consider the below before start of class on Monday.\nThe questions given are only study questions not homework to be graded.\nTalk about it all with your classmates, friends, or TAs, as you like.", "start_char_idx": 0, "end_char_idx": 281, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f99014cf-b613-40e1-82fd-a0c8e9728068": {"__data__": {"id_": "f99014cf-b613-40e1-82fd-a0c8e9728068", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6bc4fb2e-ff80-4ba2-9cdb-c4b48fb96cc8", "node_type": null, "metadata": {}, "hash": "4382dc3acf419e8750c1470f19e73a26883d932ffd0bc2262718ae685f03cc9b"}}, "hash": "f6444c6b19a491726650d6a7dcc62c48c07e77ffefab10484cd911f4c68ae2aa", "text": "Preclass for Monday", "start_char_idx": 0, "end_char_idx": 19, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d4fffb0a-1351-4761-b023-1c6b0b19082d": {"__data__": {"id_": "d4fffb0a-1351-4761-b023-1c6b0b19082d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "219dd4f0-169b-4eb3-aed1-a1c071bd2e81", "node_type": null, "metadata": {}, "hash": "baa4dd3ddf33b3713c87260206410b02a27c0b02e8f754574c1540461456f94c"}}, "hash": "156014b3c63be784c583b0f3a2c82fb5a5df97f6e7735a4e9e0b92798f326183", "text": "Introduction - Diffusion Happens\n\nWelcome to the first pre-class material for Diffusion and Patterning.\nThe examples here will prepare you (and provide you with a mindset and a feeling) before the the class towards\nthe following goals:\n\n**Goal-1:** You will be able to recognize that diffusion is everywhere in biology and beyond.\n\n**Goal-2:** You will be able to describe the mechanism behind diffusion (microscopically and macroscopically).\nStated differently, you will be able to describe what does it mean that diffusion happens.\n\n**Goal-3:** You will be able to describe the role and application of diffusion in engineering living matter.\n\nLet's briefly learn about application of diffusion in engineering living matter with an interesting example of\n**Blinking Squares** ...", "start_char_idx": 0, "end_char_idx": 780, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3fb366e6-ee1f-4b2e-9780-8ee059c8d139": {"__data__": {"id_": "3fb366e6-ee1f-4b2e-9780-8ee059c8d139", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8bdd227f-6d71-496d-beea-90ccbaf24cd1", "node_type": null, "metadata": {}, "hash": "1f54685ead873938fc0fbc903877b92a83e18ebc01833435826a8849ed46b2ca"}}, "hash": "156f1bce4ddd230ca5a6a1c7d6429fab076e9f09b561bb9e3c1b519678cf9aca", "text": "Case-1: Blinking Squares\n\nWe've uploaded two videos to Canvas of some blinking squares. Please see *w6_preclass_video_1.mov*, which shows 500 blinking squares. Each square is about 100\u03bcm x 100\u03bcm and there are 25 \u03bcm gaps between each square. Each square contains about 5,000 bacterial cells.  You may remember this video from class (Day 9: April 24) during the analysis and design of the genetic systems lecture earlier in the quarter.\n\nNOTE: if you have a hard time finding or playing the video upload to Canvas, you can find it in the original paper in the Supplementary Material (Sup Movie 1). You can also use the paper as a reference in answering the questions below.\n\n**Q.1. What do you observe?**\n\n**Q.2. How long does it take for all the squares to synchronize (i.e., blink ON/OFF all together)?**\n\n**Q.3. What is the simplest mechanism you can imagine that would cause all the squares to synchronize their blinking?**\n\n**Q.4. Can the squares synchronize their blinking together without an external signal? If yes how would that signal synchronize the squares together?**\n\n**Q.5. Can autonomous agents synchronize their behavior, and if so how?**", "start_char_idx": 0, "end_char_idx": 1153, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c188c748-f7bd-4642-82cc-6fc14a674992": {"__data__": {"id_": "c188c748-f7bd-4642-82cc-6fc14a674992", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6bcc1e8c-952b-4fe2-a07c-60f677d54836", "node_type": null, "metadata": {}, "hash": "bc08542b1af04b0bf25b1c36361ee86ac5ac71783f095db4d1d99917c8226a3d"}}, "hash": "96ba42b2e9a52606f372f22006befbafdcaed950145e9a39191983335189b0cc", "text": "Case-2: Blinking Square\n\nWe've also uploaded a second video to Canvas, titled *w6_preclass_video_2.mov*, which depicts single blinking square (100\u03bcm x1 00\u03bcm) containing about approximately 5,000 cells. Please watch it.\n\nNOTE: if you have a hard time finding or playing the video upload to Canvas, you can find it in the original paper. You can also use the paper as a reference in answering the questions below.\n\n**Q.6. What do you observe?**\n\n**Q.7. What is the simplest mechanism you canimagine that would cause the square to synchronize its blinking?**\n\n**Q.8. Watching  cells inside the square do you see a different brightness levels within each cell- how uniformed is the distribution of fluorescentproteins inside each individual cell in the square?**  \n\n*Optional reading-1: A synchronized quorum of genetic clocks*\n\n*Optional reading-2:  A sensing array of radically coupled genetic biopixels*", "start_char_idx": 0, "end_char_idx": 902, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a2059d8b-ed25-4a40-ac5f-683610fbc349": {"__data__": {"id_": "a2059d8b-ed25-4a40-ac5f-683610fbc349", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "814542d0-a943-45c8-8b7f-17312ea9f32c", "node_type": null, "metadata": {}, "hash": "6ca0886ce7050ef02209b302422001240e397af797a9b2ea756ca555d764dba8"}}, "hash": "f2e3b4c8c7f5c735f15d6e859b27186570051924a869e8ab08c27e04f0d9b6b2", "text": "What Is Diffusion\n\nDiffusion is everywhere in living matter and beyond. We encounter diffusion routinely in our daily lives.\n\n**Diffusion** is a spontaneous net movement of matter (e.g., molecules, atoms) from regions of high concentration to a region of low concentration. Stated differently, diffusion is a transfer of mass that causes the distribution of molecules, or atoms to be more uniform in space as time evolves.\n\n**Q.9. Can you think about everyday examples of diffusion in your life?**", "start_char_idx": 0, "end_char_idx": 497, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3087930b-1e6e-4fef-a911-6bd6639b8166": {"__data__": {"id_": "3087930b-1e6e-4fef-a911-6bd6639b8166", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d94d010b-1367-42f0-86a1-a31e8489c1d1", "node_type": null, "metadata": {}, "hash": "cc9ff7157a8ca43e3c066a62c15eee1ed1b2c8379c2a0319f9957bf555755206"}}, "hash": "5133a0aa0bbc50205105c0e3a0dd0a8d9657d9632304f39d5f1fd2d0d836a460", "text": "Is this Diffusion?\n\nTake a look at the following video\n\n\n\n**Q.10. Is this diffusion? why or why not? How can you tell?**\n\n*Optional reading-3: Life at Low Reynolds_Number*\n\n*Additional Resource*\n\n- Entropy Explained link-1\n\nKhan Academy videos:  \n\n- Diffusion - Membranes and transport link-2\n- Diffusion and osmosis membranes and transport link-3\n- Fick's law of diffusion and respiratory system physiology link-4", "start_char_idx": 0, "end_char_idx": 414, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4a2bb702-e7a6-4051-ad15-f5de720411e8": {"__data__": {"id_": "4a2bb702-e7a6-4051-ad15-f5de720411e8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "56b566c1-7e01-4dad-8f70-08e80810707c", "node_type": null, "metadata": {}, "hash": "15df3149f8bc8b2b761d6379e6001c18e5febd8b6bee7d85ae455d0ca6d25f03"}}, "hash": "c917d8c74afb82cdfbef87a735f07bc056209c57a283f749087520fa7084d535", "text": "Preclass for Wednesday: Dancing Droplets\n\nNote:  To prepare for Wednesday's class, you can attend Physics of Dancing Droplets tutorial (video recording is available at this link and slides are on Canvas), or read the following pre-class material.\n\nTo get started please spend ~5 minutes watching these two videos:\n\nDancing Droplets\n\nBriefly examine:\n\n- Vapour-mediated sensing and motility in two-component droplets\n\n- NYtimes video: the physics of droplets\n\n**Here is what we will do in class together on Wednesday**\n\n**Goal** our practical goal is to gain experience programing the behavior of simple systems in space and time.\n\nWe ask,\n\n- What rule did you observe (or read) about - which droplets chase which?\n\n- Why does the sharpie marker create a physical barrier and how do the droplets respond to it?\n\n- To what extent were you able to realize increasingly autonomous behavior?\n\n- How would you use autonomous behaviors (with droplets or cells) to generate pattersn?\n\nTo explore these concepts we are challenging you to realize three types of behaviors that illustrate the three modes\nof patterning.\n\nFirst, a pattern that you control directly by your own hand marking a path.\n\nSecond, a pattern that you control somewhat indirectly, by using spontaneous physical processes to create an external coordinate system.\n\nThird, a pattern that you initiate but that otherwise entirely controls itself via its own autogeneration of a coordinate\nsystem.\n\n**MATERIALS & METHODS**\n\nMaterials (you have recieved):\n- 3 cleaned glass slides (side with a black dot is cleaned),\n- 4 colored solutions,\n- 4 transfer pipettes\n\nYou will also need a sharpie marker.\n\n\nWe have prepared the following solutions of propylene glycol and water (% v/v)\n\n30% (Purple),\n15% (Teal),\n5% (Orange),\n2.5% (Pink).\n\nA few notes on the glass slides and cleanliness:\n\nTo preserve the cleanliness of the slides and help the activity work properly, please do not touch the slide\nsurface with your hands. Hold the slide from the side.  Glass slides have been cleaned with a Plasma cleaning machine; this makes the glass slides both incredibly clean and hydrophilic.\n\nNow, practice by playing with making droplets dance:\n\n- Place the slide on the paper work surface, with the marked treated side facing UP.\n\n- Place small volumes (< 10 \u03bcL) of varying solutions of propylene glycol and colored water onto the slides\nusing pipettes (use one pipette per color).\n\n- Observe. The droplets should start moving.\n\n- To gain additional controls over the system, you can draw on the slides with sharpie markers.\nAsk questions or ask for help as needed!\n\nWhen you feel ready...\n\n**Three Challenge**", "start_char_idx": 0, "end_char_idx": 2656, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fde02f39-122b-4659-b015-cdd88952b979": {"__data__": {"id_": "fde02f39-122b-4659-b015-cdd88952b979", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "93f90cd7-76ce-468e-9609-829ed002d25a", "node_type": null, "metadata": {}, "hash": "e20c9ef180b3f171ad513c5ddcae20b346f59019f62fcfd9adcdb71697265e9b"}}, "hash": "d755f1deb9e09a065c85d7263e72ba7b7c35e95554c043e2306f8dadaae6bbdd", "text": "Challenge 1.( ~ 5-7 minutes)\nCan you get one droplet to chase another along a curved path between two points? (Hint: Sharpie)", "start_char_idx": 0, "end_char_idx": 125, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6cd1d26e-7baf-4750-b787-a94b0d1f44c0": {"__data__": {"id_": "6cd1d26e-7baf-4750-b787-a94b0d1f44c0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c87ef109-5034-45a5-817b-5b7089cf2be8", "node_type": null, "metadata": {}, "hash": "c9501d2793d2a7bfa90a03b3a6b8fa3d5918856305e021f63448d7b99049387d"}}, "hash": "111250942a91c04860b19a759e47745583a30f44e753e06a1f7af3ec4d2c752b", "text": "Challenge 2. (~ 10-12 minutes)\nCan you get one droplet to follow a defined path withoutusing the black sharpie, only by placing other droplets in the field? How few \u201ccontrol\u201d droplets can you use?", "start_char_idx": 0, "end_char_idx": 196, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "998824e0-c58c-4486-bfd9-d59833b68c54": {"__data__": {"id_": "998824e0-c58c-4486-bfd9-d59833b68c54", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "98a71733-3765-4d3f-941f-0d0c73e1436a", "node_type": null, "metadata": {}, "hash": "87ebaf3e51855ffc3d8b37ad569b586bbffd756b6022824b8938a67517eea9c0"}}, "hash": "950b11c0c436b7aa622dc04bef44bcbfcd3e863768c32efb7dc1fd17f9504ff7", "text": "Challenge 3. (All remaining time)\nBy only placing droplets in a confined initial region, can you get a droplet to eject and follow a defined path (again, all without placing any droplets elsewhere in the field)?\n\nNote: Take pictures to help you answer the problem set questions.\n\n***QUESTIONS***\n\nPart of these questions will also appear on PSET:\n\n\u2014 If you have two different droplets why do they chase each other? What other behaviors have you observed?\n\n\u2014 Why does the sharpie marker create a physical barrier and how do the droplets respond to it?\n\n\u2014 To what extent were you able to realize increasingly autonomous behavior?\n\n\u2014 How good do we have to become at implementing these different frames of reference in order to engineer living matter?\n\n\u2014 Extra:  Make your own dancing droplet video (30 to 60 seconds) with your own choice of background music.", "start_char_idx": 0, "end_char_idx": 856, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "12f6a891-3671-4ab3-885f-87ac1b63fe11": {"__data__": {"id_": "12f6a891-3671-4ab3-885f-87ac1b63fe11", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "026288bc-f373-4e0f-a2fc-fff67d7d0d65", "node_type": null, "metadata": {}, "hash": "e7fcd24bbb086ee5feb33490c78bf571d11ee68763ceaa05429be1bf6a40a4e9"}}, "hash": "5222237734305475a553505e202f29703d8c11a3797171b731a3dc2f87454ba1", "text": "Preclass for Friday:\n\nWe ended class on Monday with an initial consideration of diffusion, introducing the idea that spontaneous diffusion of systems comprised of more than one molecule can *temporarily* result in non-trivial spatial patterns (e.g., a bullseye).\n\nNext we used simple rules to create a complex pattern with droplets.\n\nOn Friday, we will build on both ideas.E.g,. how can state (i.e., memory) be used to capture and make permanent fleeting patterns? How can patterns build upon patterns?\n\nWe'll start by drawing again upon the preclass from Monday(i.e., the bacterial blinking oscillators) and end by working through a challenge of how to program the growth an arm-like structure.\n\nPlease ponder how cells can act... I.e., the various primary functions that cells can \"execute\" or carry out.\nBy combining spontaneous physical processes starting from diffusion with programmed cellular functions, both natural and engineered biological systems can realize non-trivial behaviors over both space and time. More specifically:", "start_char_idx": 0, "end_char_idx": 1036, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a66036bc-2b0d-4e66-97a8-bb08e113c087": {"__data__": {"id_": "a66036bc-2b0d-4e66-97a8-bb08e113c087", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0fa70009-c74f-452a-827d-e23cef0a4264", "node_type": null, "metadata": {}, "hash": "d25a1ac1486728e96692806ccce1ef968764f9e8851fb4eb8ad14d6ee310e761"}}, "hash": "75d3a803cfefe43fb947d8b9a5d66a4cd280952b1c770ec66d98eecb33ebdd32", "text": "(1) Cells can grow and divide.\nI.e., one cell can become two and so on.\nCell Division - Exponential", "start_char_idx": 0, "end_char_idx": 99, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "724c90cf-2ad0-4781-b684-cb29c7892327": {"__data__": {"id_": "724c90cf-2ad0-4781-b684-cb29c7892327", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a22d8d37-6647-4f99-905a-802fb2dada39", "node_type": null, "metadata": {}, "hash": "1068e3e4e50aeb3d85d30b2c63243f5da72c44dfc6cd4be5a41828fb2e1643c7"}}, "hash": "22afa6fbf7722f2567d7ca8bcbac9abbf07fae53cf17a0ef740daaf6dd6b1b39", "text": "(2) Cells can move.\nI.e., cell migration can result in significant changes in shape and form. Don't believe See a brand new movie of an immune cell moving inside the ear of a fish...\nImmune Cell Migration in the Zebrafish Inner Ear\n\nOr, a slime mold swarming on a plate and growing a stalk...\nSwarming", "start_char_idx": 0, "end_char_idx": 301, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f93180f4-09c3-41b3-b553-ed3a29ac7027": {"__data__": {"id_": "f93180f4-09c3-41b3-b553-ed3a29ac7027", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3f4f69cc-dbda-4249-8138-4b543a63dbe9", "node_type": null, "metadata": {}, "hash": "6c80e9b2c13f550aabcaa771956d11b66b6e6b91cd3fde3399a95a1a675a574f"}}, "hash": "3652032d4c718ca290bbcfcffdeba9a4063508a89c60b662ddede1cedf52d250", "text": "(3) Cells can communicate with each other.\nI.e., cells can send chemical messages between and among each other.\nE.g., here's a type of \"pulse\" in gene expression generated across many cells during development of a tail-like structure...\nWave of gene expression in an embryo", "start_char_idx": 0, "end_char_idx": 273, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6cf8a60b-6975-495c-8949-5971fc6582e0": {"__data__": {"id_": "6cf8a60b-6975-495c-8949-5971fc6582e0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b037187b-168e-47a0-a234-40424e837049", "node_type": null, "metadata": {}, "hash": "63df13819e2e16425eea636aa615490fad9e8dec6bc70423faa8d8b3e6a871e6"}}, "hash": "08b300a9793aaa3f88210760f2aa9900249589e39a6beb60f9f7786e435c648a", "text": "(4) Cells canchange state.\nI.e., one type of cell can become another type of cell, in response to signals or even spontaneously.E.g., here are bacterial cells infected with virus realizing different cell-fate outcomes.\nBacteriophage lambda lysis and lysogeny", "start_char_idx": 0, "end_char_idx": 258, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2a58c021-9886-4791-ba83-d7924108955b": {"__data__": {"id_": "2a58c021-9886-4791-ba83-d7924108955b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e190678b-93a7-4aba-bc84-dc2e3d026831", "node_type": null, "metadata": {}, "hash": "e096e08c15351cc37c6cf3e623ad19ed3910b8426fa74cf96aa1204f59249fbd"}}, "hash": "eec4457455c293e930c82d3540e924d448b94a6ae4c2891bbc5cee8556a1fa69", "text": "(5) Cells can undergo programmed cell death\nI.e., cells can die.\nApoptosis\n\nTaken together these functions can be used to realize incredible outcomes.E.g., watch this old-time movie of a frog egg becoming a frog.\n\nThe Development of a Frog\n\n**Question: How many of the five mechanisms introduced above can you observe or infer in the formation of a frog?**\n\nAdditional video, if you have time watch Marvels of Bacterial Behavior\n\n github source code for teaching staff", "start_char_idx": 0, "end_char_idx": 468, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "da53c304-2bbf-4f7f-8142-ea573a71a157": {"__data__": {"id_": "da53c304-2bbf-4f7f-8142-ea573a71a157", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "67dde4f9-e0a7-4bb0-b2d9-cacb212fad75", "node_type": null, "metadata": {}, "hash": "e624bba8faa851f6e1ad8baaae168376c5c74b468b7fb9f74660e477a63b4e17"}}, "hash": "d6ae738512f0060286369dc75738031c3f026b5ebc62e219e8662c043f70778b", "text": "(Q1) Diffusion, Diffusion constant, and Diffusion time (30 pts)\n\nIn this question you will explore diffusion both qualitatively and quantitatively.\n\nFirst let's warm up:\n\nThe diffusion coefficient is described by the following equation: $D=\\frac{k_BT}{6\\pi \\eta a}$\n\n - $k_B$ is Boltzmann's constant 1.3807 x 10 ^-23 $ \\frac{J}{K} $\n - $T$ is the temperature (K) of the surrounding medium ,\n - $\\eta$ is viscosity of surrounding medium $ \\frac{N \\cdot s}{m^2} $,\n - $a$ is a measure of length (radius of a sphere approximating the molecule).  \n\n**1.a.** Using the facts above determine the units for diffusion coefficient (show your work):\n\nYou learn that the diffusion coefficient for a protein (green fluorescent protein, GFP) in water is about 100 \u00b5m^2/s.\nBut, the diffusion coefficient for the same protein in the cytoplasm of a living cell is only 30 \u00b5m^2/s.\n\n**1.b.** Intuitively do these numbers make sense? (Yes or No) Why? (Bullet points)\n\nNext, let\u2019s estimate the time it takes for a protein to diffuse spontaneously across different types of cells\n(diffusion time \u03c4). \n\n- We will use the formula $\\tau =\\frac{R^2}{6D} $, where $R$ is the traverse distance.\n\n**1.c.** Calculate the times it takes for the GFP protein with a diffusion constant D=30 \u00b5m^2/s to diffuse across four different cell types:\n\n- (i) *E.coli* with R\u22481 \u03bcm,\n\n- (ii)  Yeast cell with R\u224810 \u03bcm,\n\n- (iii) HeLa cell with R\u224820 \u03bcm, \n\n- (iv) A neuronal cell axon with R\u22481 cm.\n\n**1.d.** Create a $\\tau$ vs $R$ plot (use the above four cases). \n\n**1.e.** What does the the diffusion time for the axon suggests to you in terms of how axons work?\n\nThis question is from the Cell Biology by the Numbers", "start_char_idx": 0, "end_char_idx": 1670, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "693daaea-aa59-4eab-ba1e-a62ffd6d773e": {"__data__": {"id_": "693daaea-aa59-4eab-ba1e-a62ffd6d773e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e672f2b1-52e9-466d-b00e-8971b3239a2e", "node_type": null, "metadata": {}, "hash": "d6c8430bfba1c37365fb83ead9d739370ff3c0ee71c32da6dd5f37c803ef9b7c"}}, "hash": "4f8cb40b2e656bcd36fd8db8a5699eb04e3e3a5c8f0a38ad50051db862c215ba", "text": "(Q2) Diffusion and Spatial DNA devices (20 pts)\n\nTwo DNA devices have been engineered for use in a *cell-free extract* (i.e., a \"goopy\" solution derived from living cells, aka \"GOOP\") (Figure, below).  Bioengineered DNA-based devices placed into the extract will have their encoded DNA transcribed into mRNA and the mRNA translated into protein. \n\n- Device A expresses protein A in the absence of protein B.  \n\n- Device B expresses protein B in the presence of protein A.  \n\n- Device A can also make GFP.  \n\nEach device is placed in a distinct reservoir within a micro-scale fluidic channel. \n\nFresh extract is supplied from one end of the channel.   Using various channel lengths experimenters are testing a genetic system made from the two devices.\n\n**2.a.**  By studying the diagram in Figure 1.B, describe the expected relationships and behavior of the system.  \n(1-2 sentences max)\n\n**2.b.** Figure 1.C shows two spatial arrangements of the genetic system. In the top arrangement device A is 50 \u00b5m away from device B. In the lower arrangement device A is 150 \u00b5m away from device B. The time responses for each arrangement is measured by GFP production from device A as presented below.  Does \u201ctrace-1\u201d come from the 50 \u00b5m or 150 \u00b5m arrangement?\n\n**2.c.** Explain your choice. (Hint: think about diffusion) (1-2 sentences max or math)\n\n\n\nFigure 1. Spatial GOOP .", "start_char_idx": 0, "end_char_idx": 1366, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ab4a228e-3073-4453-bd4d-4101169cd9ee": {"__data__": {"id_": "ab4a228e-3073-4453-bd4d-4101169cd9ee", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cb1885e7-5557-4608-9163-5cf17eb20ac2", "node_type": null, "metadata": {}, "hash": "910cb33b3e13f2641fa9db1d6cfa2d7d877886c486ad9562c2cc2604cf048f4e"}}, "hash": "7a6cc420cfd076bfe05812336211ca63e8c6dce5ebf12ac2b59ab689ff936060", "text": "(Q3) Bacterial Edge Detection (20)\n\nWe have talked about engineered *E.coli* which detects light earlier in the quarter. \n\nBuilding on earlier work first published in 2005, Jeff Tabor and colleagues eventually demonstrated a bacterial edge detection system. \n\nIn their system a bacterial lawn (i.e., a uniform layer of identically engineered bacteria growing on a plate) detect a light-encoded image. The bacteria are initially all the same but, depending on whether they are exposed to light or not, send or receive small molecule-encoded signals that diffuse across the light/dark boundary.\n\nOnly bacteria positioned at the boundary between light and dark express an enzyme that results in formation of a dark pigment (HINT: see Figure and also the primary source article).\n\n\n\nFigure 2. Bacterial edge detection.\n\n\nCarefully study the photo of the system in action. Note various details about the edge detection beahvoir in the case of a square or Alfred Hitchcock\u2019s portrait.\n\n**3.a.** What do you observe? Are all the edges uniform?  (1-2 sentences)\n\n**3.b.** Using concepts from this week, why is there more pigment inside the corners of the square, or inside the bottom left angle of Alfred\u2019s portrait?", "start_char_idx": 0, "end_char_idx": 1208, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b6239cb8-38b7-4cbb-9561-9ebd848418aa": {"__data__": {"id_": "b6239cb8-38b7-4cbb-9561-9ebd848418aa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "48e2f4cc-40df-435b-b25d-966a29140255", "node_type": null, "metadata": {}, "hash": "bb1567804f8e70435347fb51c1d39b784604a652248fe9ab298c31cd1e367bdc"}}, "hash": "9365eae824752cbe35ae58a013b0fb963bc165d9f9a9cf020d6bcccd7896b856", "text": "(Q4) Regrowing a newt arm (30 pts)\n\nPlease watch this video of a newt regrowing its arm.  \n\nHow does this work? Let's apply the concepts we've learned from dancing droplets challenges to figure this out from a programming patterns perspective. \n\n**Q.4.a. \"The hand of god\"**\n\nPictured below is a newt's body with five regenerative cells (green circles) that are ready to regenerate a limb. \nYou are a sculptor of limbs and create a physical scaffold that outlines and limits the aggregate shape that the cells should grow into. The cells just need to grow into the shape that you\u2019ve defined (the simple \u201cbent-arm\u201d solid line trace). \n\n***What do the cells need to do in order fill the physical form you have preshaped for them?***\n\n\n\n\n**Q.4.b. \"Celestial navigation\"** \n\nNext, consider a different set of starting conditions: You no longer exist. \n\nIn the picture below, the newt still has to regrow its arm into the shape indicated by the faint dotted line, but this time, without your barrier into which the cells could simply grow. However, two external beacon cells (purple and blue) have been added to the system. Each beacon cell emits a distinct and freely diffusing small molecule (see \"time > 0 inset) that the regenerative cells (green) can detect and respond to using the following programmed functions:\n```\nmove, divide, sense, attract, repel, change color, count cell divisions\n```\n\n***Describe how the five green cells can use their programmed functions to grow into the desired pattern in response to the signals initially emanating from the external beacons.***\n\n\n\n\n**Q.4.c. \"Full autonomy\"** \n\nFinally, pictured below is a newt that needs to regrow its arm using only its own regenerative cells (there are no external inputs to the system). The two outside regenerative cells have differentiated into distinct left and right cells (below). \n\n***Describe how the five originating cells (purple, green, green, green, blue) can use their programmed functions to grow into the desired pattern by themselves, using no outside information or control.***\n\n\n\n\n**Q.4.d.  Applications**\n\nThe concept of using gradients to drive the behavior of autonomous devices can be observed in many other applications besides newt arm regeneration.\n\n***Briefly describe (in 1-2 sentences) another application of this concept: where else is this behavior seen and how does it relate?***\n\n_____________________________________________________________", "start_char_idx": 0, "end_char_idx": 2443, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e3b3ae4f-afee-450d-a113-7ef3370ec372": {"__data__": {"id_": "e3b3ae4f-afee-450d-a113-7ef3370ec372", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8c924ce5-dbc9-47cc-85fa-b5415399c7bb", "node_type": null, "metadata": {}, "hash": "93ca99d0839314bdf83058a7fd4efb7429d6c01cae0e357407ce4f3b056df2dd"}}, "hash": "596391e8b0754efd534df253205e4a120edee373353ef6769f0758190a99937f", "text": "Final Project - Group Activity.2 (10 points)\n\nNOTES:\n\n- Due: Next Tuesday (with PSET)\n\n- Include your group number, names of your group members, and name of your digital (TA) mentor.\n\n- Please turn in a single electronic copy of your\u00a0Group Activity\u00a0via Gradescope.\n\n**Group Activity.2.a.**\u00a0Please share your team's top selection for the final project. \n\n**Group Activity.2.b.**\u00a0Please share two back-up selections for the final project.\n\n**Group Activity.2.c.**\u00a0Why did your team select your top choice? (about 150 words)\n\n**Group Activity.2.d.**\u00a0How did you reach your decision? *Please also include each individual team member's \"bang for your buck\" (effort v. impact) plot.* (about 150 words)\n\n_____________________________________________________________\n\n*Additional Questions and Resources*", "start_char_idx": 0, "end_char_idx": 796, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "162404ad-a136-4c43-bc17-6c3e0779acb3": {"__data__": {"id_": "162404ad-a136-4c43-bc17-6c3e0779acb3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fa9d4ee3-efef-4660-969f-0e664b9e7965", "node_type": null, "metadata": {}, "hash": "b91c13e7e5a3b2e21a1ff5c75cae1a5a024583addd3747d4350a78f40d094452"}}, "hash": "ace416f4b1a7436ad85ce5f6a5322330d7b8b1326bf7847b5e38d88e97682b08", "text": "(Q5) Paper reading activity (0 pts)\n\nFirst examine, A synchronized quorum of genetic clocks.\n\n**Q.5.a** In your own words, what is the primary claim of the paper? What are the primary evidence in support of the claim? (2-3 sentences)\n\n**Q.5.b** In your opinion, what are the paper\u2019s strengths and significance? What are the paper's shortcomings and deficiencies? How can the paper improve?", "start_char_idx": 0, "end_char_idx": 389, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0ad1bee6-bda9-4d64-9f1a-2c0f6d91b1b9": {"__data__": {"id_": "0ad1bee6-bda9-4d64-9f1a-2c0f6d91b1b9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8b664315-0da8-477f-b771-ded25b832a1f", "node_type": null, "metadata": {}, "hash": "ddd503704d56ee2abf95e380aa94a76edd8497a495ff577893188215e45d9269"}}, "hash": "4fe7599d989f383212e3068c8da3ab90db75f8e997ac68d81ed8f81ee1a32e8b", "text": "(Q6)  Dancing Droplets (0 pts)\n\nOn Wednesday you experienced (or read about) the the Dancing Droplets.  Use pictures, diagrams, or drawings as appropriate.\n\n**6.a.** What rule did you observe (or read) about - which droplets chase which?  \n\n**6.b.** Why does the sharpie marker create a physical barrier and how do the droplets respond to it?\n\n**6.c.** To what extent were you able to realize increasingly autonomous behavior? \n\n**6.d.** How would you use autonomous behaviors (with droplets or cells) to generate pattersn?  What patterns will you build - what will they do? How good do we have to become at implementing autonomous behaviors to achieve your patterns? \n(2-3 sentences)\n\n*Extra-activity*  Make your own dancing droplet video (30 to 60 seconds) with your own choice of background music and share a link with us.\n\n\nThe following link takes you to a paper titled Life at Low Reynolds Number that examines physics at the scale of a bacteria.  \n\n*The following links* are **explorables** that can help you explore and build an intuition about patterns and pattern formation.  We hope that you take some time and examine them on your own:\n\n\n(1) Fireflies and Patterns\n\n(2) Explorables Collection \n\n\n github source code for teaching staff", "start_char_idx": 0, "end_char_idx": 1246, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7936686d-e216-40c2-8060-6c4395245639": {"__data__": {"id_": "7936686d-e216-40c2-8060-6c4395245639", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "43d0a6c4-1751-43c4-9a86-0081f573b732", "node_type": null, "metadata": {}, "hash": "1762f72cea1e5902ec4c782ee607de9c190ca9eb141daeeb9ec388301f80f915"}}, "hash": "1a26e496eb2faffe92f3d93c0d774a3a8ef36dae24f272ccbbd3e5da8c1a7d0d", "text": "Day 19: May 18, 2020\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 39, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3d1b75b6-db29-4951-aa6f-a9062c38e1d1": {"__data__": {"id_": "3d1b75b6-db29-4951-aa6f-a9062c38e1d1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "08ca0299-2d3b-4d06-a6e4-e38785018b19", "node_type": null, "metadata": {}, "hash": "6b50fc9df86eea08b32bc1c9a576482dc11a2f1c07c22c670fcb12995ae5bcf3"}}, "hash": "d2ce432a3f08e330c0d95a52afbcb48839d7f9dcbfccbbece88c123897ce9632", "text": "Day 20: May 20, 2020\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 39, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "43574f83-da1d-4bed-b832-840be1f0c44f": {"__data__": {"id_": "43574f83-da1d-4bed-b832-840be1f0c44f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "41760108-e91e-4910-a3b0-abd0a5074054", "node_type": null, "metadata": {}, "hash": "5e95bb23be42080cccab02ccc6416e9a7726b7cc47cfef2edc943037be670702"}}, "hash": "53c0903613da775d9f48afcfc766b8aa759682ce3504a49858612c5796547849", "text": "Day 21: May 22, 2020\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 39, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d94fa6c4-5ab2-42a4-9261-6444b8b7cbb6": {"__data__": {"id_": "d94fa6c4-5ab2-42a4-9261-6444b8b7cbb6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b4fd54f1-65b3-4753-b6bb-ba929903a383", "node_type": null, "metadata": {}, "hash": "bf7f1f4a497dfdde9621101d9b701c104e7e05d645d86b107d1838cae534a7f0"}}, "hash": "523af235b3f57670feee9019f587e2f1a21b41fab5ecf02d9f50e196189a58f1", "text": "Week 7: Project\n\nWeek-7 is about the group project.  There are two goals for this week: \n\n**Goal-1** Help you select your project\u2019s topic. If you make a good decision, then the rest of your project work will also be pretty good!\n\n\n**Goal-2** Enable you with three skills that are needed for an excellent project.  These skills are tools for \u201ccommunicating,\u201d \u201cstorytelling,\u201d and \u201cperforming.\u201d\n\n_______________________________________________________________________", "start_char_idx": 0, "end_char_idx": 464, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6116d24f-d37e-450b-adc5-b0da78848a78": {"__data__": {"id_": "6116d24f-d37e-450b-adc5-b0da78848a78", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5091eaca-5116-4288-a894-e579c77ce2f2", "node_type": null, "metadata": {}, "hash": "534c23fc54366ecd4d837d26704eec8efb07f307d5ebdd9742e814389cc6160c"}}, "hash": "7ea1cdcbca980d715d156ef2f4c0b0bf0000ad7135331759c09b48e7676ab68a", "text": "Postclass for Monday", "start_char_idx": 0, "end_char_idx": 20, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8dd463ec-c44b-4494-990e-13a29e55132a": {"__data__": {"id_": "8dd463ec-c44b-4494-990e-13a29e55132a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b495504f-99f2-4f00-8289-e132287648eb", "node_type": null, "metadata": {}, "hash": "45b42e9be17685302c8e5b9f6ba3e76f269fc45be604637d9e085d9b5fdfddb3"}, "3": {"node_id": "52018ce0-2f4e-453b-a81f-2a2a24accea9", "node_type": null, "metadata": {}, "hash": "b36507a8831a20e780712cb3235f61731e8b31b55854e1d33f5b32dd0743b9d8"}}, "hash": "9fa45b6061b98ede8438d151611d7d7b6867f9173102e582513407d47007bed2", "text": "Some advice about writing.\n\n(Written by: Michael Specter.)\n\nThe first rules of writing about science are the first rules of any writing: **Be clear; be brief; be simple.**\n\nSay what you have to say in as few words as possible.  Then say something else.  Simplicity does not imply stupidity any more than repetitive prose draped in fancy adjectives implies intelligence.\n\nThe most important information in the world is worth nothing if nobody reads it.  If you are a scientist who cannot explain technical work to people who are not steeped in the technology they will stop reading. And you will have lost them.\n\nStudents often seem to think that prose is better when it is crammed with superlatives, laden with terms that only a few hundred people will understand, and then packed into verbal cul-de sacs.  (This is just as true of students in the humanities as it is of those who major in scientific subjects.)\n\nThat is REALLY not the case.  It is never EVER the case. By the way, the words in all caps are useless and their presence makes each of those sentences weaker.  Nothing on earth is \u201cvery\u201d unique.  \n\nUnless you are writing about religious dogma, the phrases \u201cI think\u201d and \u201cI believe\u201d are meaningless crutches.  If you doubt me, give it a try.  \n\nDrop one of those phrases into a sentence, as in: *I believe* this professor is a pedant. Or: *I think*  the writer is full of himself. The terms are not only useless, they weaken they point you are trying to make.  Retire them.\n\nIf you write that data is unbelievably valuable, that means it\u2019s worthless.  Nor is data ever \u201cincredibly\u201d interesting or \u201cabsolutely\u201d essential.  Be a reader\u2019s friend, not an obstacle. If you don\u2019t need a word don\u2019t use it.\n  \nMany successful academics, including people who teach at places like Stanford and Harvard, write in language that seems chosen to obfuscate rather than to illuminate. I have never understood why.  \n\nSomewhere along the line, though, a lot of academic writing became obscure, confusing and prolix. I know that because I have spent a good deal of my life trying to translate it into English for readers of The New Yorker. (There are obviously MANY exceptions at universities everywhere. And some of the best  science writers are, or were, scientists: Richard Dawkins; Lewis Thomas; Oliver Sacks, Carl Sagan. This is a somewhat random list. There are many others.)\n\nYour goal is to make what you write understandable. Nothing else matters nearly as much. One suggestion: read what you have done out loud. Even if only to yourself. I always do. Does each sentence matter? Does it sound confusing? Are there words that add nothing? Is it repetitious? If so, delete with abandon.  The best writing is rewriting. But you have to get the ore out of the ground before you can extract the gem. If you saw my rough drafts you would laugh but my editors never do. Because they know a first draft is a beginning. Only a beginning.\n\n**Goals of your final project:**\n\nA few words about narrative structure and this project: for the purposes of your project think of a play as a box or a filing cabinet with, in this case, three sections. You can put whatever you want into that box as long as it is driven by a narrative that takes the reader on a journey with you. We want you to do it in three acts and we have given you the outlines of that journey: \n \n- Act 1)  You are in the future. Wow. How great is it now that we have your chosen tool working in 2030? \n\n- Act 2) Nobody achieves greatness without crises (and failures) along the way. What were yours?  Did they change your approach, your outcome, your goals?  \n\n- Act 3) Finally, how did you get where you were going? What were the big achievements and how did you navigate? How did your perspective change once", "start_char_idx": 0, "end_char_idx": 3771, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "52018ce0-2f4e-453b-a81f-2a2a24accea9": {"__data__": {"id_": "52018ce0-2f4e-453b-a81f-2a2a24accea9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b495504f-99f2-4f00-8289-e132287648eb", "node_type": null, "metadata": {}, "hash": "45b42e9be17685302c8e5b9f6ba3e76f269fc45be604637d9e085d9b5fdfddb3"}, "2": {"node_id": "8dd463ec-c44b-4494-990e-13a29e55132a", "node_type": null, "metadata": {}, "hash": "9fa45b6061b98ede8438d151611d7d7b6867f9173102e582513407d47007bed2"}}, "hash": "b36507a8831a20e780712cb3235f61731e8b31b55854e1d33f5b32dd0743b9d8", "text": "the big achievements and how did you navigate? How did your perspective change once you got your hands dirty and started to build this tool?\n\nFocus on the scientific evidence you need to show how you accomplished your goal by the end of this decade.  That is critical. A play (or a book, or movie) is simply a device that lets you put that information into a digestible package. An essential part of your job, as scientists and bioengineers in the future, will be to communicate the value and purpose of your work to people who do not understand it. This project should help you do that.\n\nWhy not just ask for a powerpoint presentation or something more conventional?  Powerpoint presentations are dull, and even when they are thoughtful they are conventional. We are not looking for convention. Try something new, different,  even (intellectually) dangerous. This is not only a challenge. It ought to be fun. Weird is good. Nobody changes the world by moving two inches to one side or the other. You will not be penalized for taking a risk.\n\n\n**Making it easy to understand complicated ideas.**\n\nThis is the hardest part of my job as a writer. By far. But it is also the most rewarding. Below I have included a few examples of the more complicated terms I have had to explain in stories for The New Yorker. They are not perfect, and you can probably find others that are as good or better.  But this is just to give you an idea how one writer tries to make smart, non-technical people, pay attention to complicated ideas. Read a few or all or none. If you have questions about anything in this memo I will be happy to answer them.", "start_char_idx": 3688, "end_char_idx": 5319, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "07674c8f-96eb-48fc-af03-4652c649af05": {"__data__": {"id_": "07674c8f-96eb-48fc-af03-4652c649af05", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ce38c990-8ff4-48cc-ad74-b1716523ee85", "node_type": null, "metadata": {}, "hash": "d7fca937390da4cc808d40233f9c6c70ce358cd0f6954543e5ab81deb2872d5a"}}, "hash": "4388a02a8dc861d9dac3de87d4474681af5db96dbfa47dd4b2c7fc28723be169", "text": "Example-1: Viruses\n\nViruses reproduce rapidly and often with violent results, yet they are so rudimentary that many scientists don\u2019t even consider them to be alive. A virus is nothing more than a few strands of genetic material wrapped in a package of protein\u2014a parasite, unable to function on its own. In order to survive, it must \ufb01nd a cell to infect. Only then can any virus make use of its single talent, which is to take control of a host\u2019s cellular machinery and use it to churn out thousands of copies of itself. These viruses then move from one cell to the next, transforming each new host into a factory that makes even more virus. In this way, one infected cell soon becomes billions.", "start_char_idx": 0, "end_char_idx": 694, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7a467993-8164-4434-834f-a26527bed0ed": {"__data__": {"id_": "7a467993-8164-4434-834f-a26527bed0ed", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "54ab014f-1bc1-4451-967a-3a09aa3d6682", "node_type": null, "metadata": {}, "hash": "217959e43fb1e28b191125ff1d9e5921436d365a34d023ec1eb120bc5ef34f80"}}, "hash": "9cbb45597a7b33a140db964346380d08c0c73cd9a64e1e8f47df0998d8b949cb", "text": "Example-2: What on earth is an endogenous retrovirus?  And why do we care?\n\nIt takes less than two per cent of our genome to create all the proteins necessary for us to live. Eight per cent, however, is composed of broken and disabled retroviruses, which, millions of years ago, managed to embed themselves in the DNA of our ancestors. They are called endogenous retroviruses, because once they infect the DNA of a species they become part of that species. One by one, though, after molecular battles that raged for thousands of generations, they have been defeated by evolution. Like dinosaur bones, these viral fragments are fossils. Instead of having been buried in sand, they reside within each of us, carrying a record that goes back millions of years.", "start_char_idx": 0, "end_char_idx": 757, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c3984da4-6798-49f9-b181-049000963206": {"__data__": {"id_": "c3984da4-6798-49f9-b181-049000963206", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1e93cd10-201f-4094-bbce-8f55d589895c", "node_type": null, "metadata": {}, "hash": "1bbe6874dc4bf58efdb946ffd41a92a32da75a7d6ba71996419a319ab849dc14"}}, "hash": "73959556b7a7b04836150abee59e56b28a404b150f2aa3abee14e563762cc49a", "text": "Example-3: What is so great about DNA?\n\nThe rungs of the ladder of human DNA consist of three billion pairs of nucleotides spread across forty-six chromosomes. \nThe sequences of those nucleotides determine how each person di\ufb00ers from another, and from all other living things.", "start_char_idx": 0, "end_char_idx": 276, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5f1293be-9034-492d-a954-c9c165d6ab2f": {"__data__": {"id_": "5f1293be-9034-492d-a954-c9c165d6ab2f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d8a38b2a-6d9d-4ab1-9448-8bc2d106f785", "node_type": null, "metadata": {}, "hash": "8ebd8617e0311cbed4c12540cdb3d447b9ca31099e35ece7995df068ada8de63"}}, "hash": "31887501b110adc0ce76f0476d7b825a812f6fadc0cd52afae065d56dc7e7a19", "text": "Example-4: This CRISPR thing. Why the fuss?\n\nCRISPR is a strange cluster of DNA sequences that can recognize invading viruses, dispatch a special enzyme to chop them into pieces, and use the viral shards that remain to form a rudimentary immune system. The sequences, identical strings of nucleotides that could be read the same way backward and forward, look like Morse code, a series of dashes punctuated by an occasional dot.\n\nCRISPR has two components. The \ufb01rst is essentially a cellular scalpel that cuts DNA. The other consists of RNA, the molecule most often used to transmit biological information throughout the genome. It serves as a guide, leading the scalpel on a search past thousands of genes until it \ufb01nds and \ufb01xes itself to the precise string of nucleotides it needs to cut.\n\nScientists took the \ufb01rst serious step toward controlling our genes in the early nineteen-seventies, when they learned to cut chains of DNA by using proteins called restriction enzymes. Suddenly, genes from organisms that would never have been able to mate in nature could be combined in the laboratory. But those initial tools were more hatchet than scalpel, and, because they could recognize only short stretches within the vast universe of the human genome, the editing was rarely precise. (Imagine searching through all of Shakespeare for Hamlet\u2019s soliloquy on suicide, relying solely on the phrase \u201cto be.\u201d You\u2019d \ufb01nd the passage, but only after landing on several hundred others.)", "start_char_idx": 0, "end_char_idx": 1476, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5e7a5dd8-19b3-4f19-88ab-1b86fa7bfca3": {"__data__": {"id_": "5e7a5dd8-19b3-4f19-88ab-1b86fa7bfca3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c54999e7-a083-46f1-8977-cba0591d7b82", "node_type": null, "metadata": {}, "hash": "a6425d0d9418e9768bf8befb14a1b82d83827d6d030fc8d1af5591ea8ac72876"}}, "hash": "320ed74bad3555ffefbc989986118192f876df344e75cf6b2e1efe94eaaf1c44", "text": "Example-5: What is a microbiome?\n\nWe inherit every one of our genes, but we leave the womb without a single microbe. As we pass through our mother\u2019s birth canal, we begin to attract entire colonies of bacteria. By the time a child can crawl, he has been blanketed by an enormous, unseen cloud of microorganisms\u2014a hundred trillion or more. They are bacteria, mostly, but also viruses and fungi (including a variety of yeasts), and they come at us from all directions: other people, food, furniture, clothing, cars, buildings, trees, pets, even the air we breathe. They congregate in our digestive systems and our mouths, \ufb01ll the space between our teeth, cover our skin, and line our throats. We are inhabited by as many as ten thousand bacterial species; these cells outnumber those which we consider our own by ten to one, and weigh, all told, about three pounds\u2014the same as our brain. Together, they are referred to as our microbiome\u2014and they play such a crucial role in our lives that  some scientists have begun to reconsider what it means to be human.", "start_char_idx": 0, "end_char_idx": 1055, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "517dbeb2-2672-4324-991a-918a22b7b3cb": {"__data__": {"id_": "517dbeb2-2672-4324-991a-918a22b7b3cb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "08ba7508-b6cc-4a57-9273-e78e7bc33d38", "node_type": null, "metadata": {}, "hash": "b3bf8a2cdb676b2f824c4473dd0bf10971338b4ed51bddc6311e8128118d817c"}}, "hash": "f572d8de6d421c8cf95fa317763e7774d128a0f0ff2881ce5742b62c31ece931", "text": "Example-6: Why are we so susceptible to viruses from far away?\n\nDeadly viruses have always threatened humanity, but a virus can travel only as far as the cells it infects. For most of human history, that wasn\u2019t very far. A few hundred years ago, if H.I.V. had passed from an ape to a hunter, that person would have become sick and died. He might even have infected his entire village, killing everyone around him. But that would have been the end of it. There were no motorcycles to carry the infected carcasses of slaughtered apes to markets in Yaound\u00e9, and, for that matter, no airplanes to ship them to Paris or New York. Forests had been impenetrable for thousands of years. In the past few decades, however, new roads, built largely by logging companies, have brought economic opportunity to millions of Africans, along with better medicine, clean water, and improved access to education. Yet, seen from the perspective of a virus, those roads, combined with air travel, have created another kind of opportunity, transforming humanity into one long chain of easily infected hosts\u2014no less vulnerable in California than in Cameroon.\n\n_______________________________________________________________________", "start_char_idx": 0, "end_char_idx": 1208, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e120fec8-1074-430f-bf4f-a10ddd946a88": {"__data__": {"id_": "e120fec8-1074-430f-bf4f-a10ddd946a88", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3ca03a1f-4216-4d0d-a111-7f9ac455d319", "node_type": null, "metadata": {}, "hash": "edb0941ddca0583aa56cbfebd4fbe050082170215d44b401a9526dbe3aa85c0e"}}, "hash": "8bc6d1f7ff45662117fb6f1eaf038863fde1e1bc5d23aea3814af8bf0de317c8", "text": "Preclass for Wednesday\n\nWatch the free two-minute introductory video for Wednesday\u2019s in-class guest, Malcolm Gladwell, here.\n\nNext, ponder Kurt Vonnegut\u2019s eight rules for writing fiction here.\n\n**Q.1. What do you think about Vonnegut's rules?**\n\nRule.8 states, *'Give your readers as much information as possible as soon as possible.'*\n\n**Q.2. How would you apply this rule in your written work (papers, essays)? How would you apply this rule in your presentations?**  \n\nExtra reading-1: Kurt Vonnegut graphed the world\u2019s most popular stories\n\n\nExtra reading-2: How to write with style by Kurt Vonnegut\n\n_______________________________________________________________________", "start_char_idx": 0, "end_char_idx": 675, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "eec26144-b4e2-49fd-87e6-6b11519585ca": {"__data__": {"id_": "eec26144-b4e2-49fd-87e6-6b11519585ca", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9c0dc66a-4a2f-4e60-bc3b-55ffa499c387", "node_type": null, "metadata": {}, "hash": "4eeae9083e46a95eacd7f30889e0f81fa07216940beec55ee8a3811cb1500680"}}, "hash": "7771e9c6bdaf5e4deeaace7952d4f6717302c11bb9e01128ccf15c9a7ea0296f", "text": "Preclass for Friday\n\nWatch the video Mouse Trap - Cheese Advertisement start to finish.  \n\n**Q.1. How many acts or chapters in this performance?**  \n\n**Q.2. What emotions do you experience specific to each chapter?** \n\n**Q.3. What is the role of music (i.e., soundtrack) is setting your emotional state?**  \n\n**Q.4. How much dialog or text was used?**\n\nNext, watch Embrace Life - always wear your seat belt.\n\nComplete the following *\u201cStory Spine\u201d* prompts to reveal the narrative structure for this performance.  \n\n-Once upon a time _________.  \n\n-Every day _______. \n\n-But, one day _______. \n\n-Because of that ________. \n\n-Until, finally, ________.\n\n-And, ever since then ________.\n\nExtra-reading The Story Spine: Pixar's 4th Rule of Storytelling and a Video to accompany the reading.\n\nPlease select and watch (minimum) one of the following videos: #24 Viral Monologues.\n\n**Q.5. What works in their video?  What can be improved?** \n\n**Inspirational Examples:**\n\nNote: Though these examples were not recorded on Zoom, feel free to use Zoom to record, or use your own software to mix audio/video!\n\n- Hamilton Original Broadway Cast Zoom Performance \"Alexander Hamilton\"\n\n- Stanford's Talisman perform \"Amazing Grace\"\n\n- Cub Scouts Video Challenge: Camouflage\n\n\n github source code for teaching staff", "start_char_idx": 0, "end_char_idx": 1298, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a1f90c99-e4bf-4cd0-870c-6c8192953a5e": {"__data__": {"id_": "a1f90c99-e4bf-4cd0-870c-6c8192953a5e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e49a5757-2aaa-42ca-9ecc-92280809f8f9", "node_type": null, "metadata": {}, "hash": "a508c987f8828d178302b235bb60b4ef51fb14490da5e4e2268dbd007c3c0fa8"}}, "hash": "afbb167fa943ec584ae4a6bdc77167318481be0f201ce29eefd65b461db7dad2", "text": "---\ntitle: \"Week 7 Problem sets\"\npermalink: /docs/w7ps/\n2018: Week 8\n---\n***Written project description (24 pts, 3 points per, Due: Monday June 1st)***  \n\nAnswer the following eight questions (adapted from DARPA's Heilmeier Catechism):\n\n- What are you trying to do? Succinctly articulate your wish using absolutely no jargon.\n\n- What's happening today, what is the problem, or what are the limits of current practice?\n\n- What is new in your approach and why do you think you will be successful?\n\n- Who cares? If you are successful, what difference will your success make?\n\n- What are the mid-term and final \u201cexams\u201d to check for success?\n\n- What is the greatest obstacle to your success?\n\n- What could go horribly wrong? What are the risks?\n\n- How much will it cost?  How long will it take?\n\n github source code for teaching staff", "start_char_idx": 0, "end_char_idx": 829, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ec6406b3-0f36-4f7b-8ca7-8137a363cc61": {"__data__": {"id_": "ec6406b3-0f36-4f7b-8ca7-8137a363cc61", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4b99f63e-c492-4cb2-b40e-72d8d78aa5e3", "node_type": null, "metadata": {}, "hash": "c751161d2c4a2d06543746470aece70d3850755b2c05027508ddef27ee9a22f4"}}, "hash": "3000a826692e2fbf0af063426de9aab20eaf39a5a960280973d4222cb8aa7d2e", "text": "Day 22: May 27, 2020\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 39, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "34e7d15a-d9e6-4d73-a5bf-5c99ada6e793": {"__data__": {"id_": "34e7d15a-d9e6-4d73-a5bf-5c99ada6e793", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a68ed2a5-faa4-4695-ad41-30c66ac6865e", "node_type": null, "metadata": {}, "hash": "fb1a82275a9f8cc35bcc1693c85cbcce4c9f07171b6a58f2a81bca9aa537d403"}}, "hash": "3187babbc676a4b0c3049d80c77d43deaeea47cd89f31d53cf32b11b08acfff3", "text": "Day 23: May 29, 2020\n\nClass Slides\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 53, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e17aae44-dad8-4f49-bd63-bc92f421185c": {"__data__": {"id_": "e17aae44-dad8-4f49-bd63-bc92f421185c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "871c5359-e2cf-45f5-b029-325a1695579c", "node_type": null, "metadata": {}, "hash": "d37dbe90d6d67b558dfcfde6939ec63df98bb0d96b2c6ad9efc2e32fc939d9a7"}}, "hash": "9ff7760e46fe5a7eaa112f196b9849e92ff43c2c2d6d050562b9d2f0cb7a1205", "text": "Evolution as Tool for Engineering\n\nPlease read and consider the below before start of class.\nThe questions given are only study questions not homework to be graded.\nTalk about it all with your classmates, friends, or TAs, as you like.", "start_char_idx": 0, "end_char_idx": 234, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e1dee07a-8a97-420a-95da-36762653bd04": {"__data__": {"id_": "e1dee07a-8a97-420a-95da-36762653bd04", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0c17d98a-ad42-406e-ba96-b074716ece41", "node_type": null, "metadata": {}, "hash": "16492301115fed4e4139c31b9a2aad9d37bb2d2ee832bb25e7a290af78580625"}}, "hash": "80e7e148ee3b87af5c2e68f5240432697eb167168ec4dc92b23f8479f951a700", "text": "No class on Monday", "start_char_idx": 0, "end_char_idx": 18, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "29c0a0c3-c270-4e19-9038-2884cb8c1bbe": {"__data__": {"id_": "29c0a0c3-c270-4e19-9038-2884cb8c1bbe", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "396f56a4-7757-4959-adaf-5ce628011ea2", "node_type": null, "metadata": {}, "hash": "48a24b4cde34546705bd2dcd2b80196209b609ac0794f596ac65a38f61f097f4"}}, "hash": "dc55dbbfe84937d9f652ff2bc70146ee31215fb9f98b94c46bc1628fb57290c9", "text": "Preclass for Wednesday", "start_char_idx": 0, "end_char_idx": 22, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5e2536c0-e3a1-46be-aeb9-9333ef5234af": {"__data__": {"id_": "5e2536c0-e3a1-46be-aeb9-9333ef5234af", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "28cb1650-ce1b-4752-bf3b-5374d5a0c862", "node_type": null, "metadata": {}, "hash": "2a0d3ba9b7a22a0e1624d4830284a66c1ed87537acaaf9313a00433d1c0368a5"}}, "hash": "22a416f1d72ffcad68b851594c5d292e30c6285c858a767f96683e91d75f8961", "text": "From Natural Algorithm to Engineering Service\n\nThis week you will examine the role of evolution from a Bioengineering perspective. \nAfter considering the following example and the material throughout this week you will be able to: \n\n**Goal-1:** Describe evolution as an algorithm that follows a set of rules.  \n\n**Goal-2:** Utilize evolution as an algorithm. *\u201cEvolution, at your service!\u201d*:  \nThis robust algorithm is a service that can be deployed in diverse contexts. \n\n**Goal-3:** Describe the limitations when used as a service, and begin to describe what evolution \ncould look like in the future *(\u201cEvolution 2.0\u201d)*.\n\n**The Core concept for this week includes:** Evolution: Population, Diversity, Fitness, \nSelection (Pressure), Mechanics (Random Mutations), and Algorithm vs Service.\n\nBefore we begin briefly explore these: link \nand link-2\nto better appreciate these examples.", "start_char_idx": 0, "end_char_idx": 884, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "dcb83664-0098-48d4-91f0-2434118747c0": {"__data__": {"id_": "dcb83664-0098-48d4-91f0-2434118747c0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b16f0d93-7d87-4f19-9ab2-efdc2f07508a", "node_type": null, "metadata": {}, "hash": "a1f10dac50db6490a5a6271003442dc68cf0c440c3a35d9ccb3334b04de86276"}}, "hash": "88b7d9e17b114c8b91887225648b7b128c62a0438067f486a445e2666d59b3ab", "text": "Example-1: Why do you need to get a flu shot every year?\n\nTo begin, let us consider 2018 flu season, which was considered as the worst flu season since 2009-2010.\n\nFollowing is from an article \npublished in January 2018: \n\n\u201cEvery winter brings cautionary tales that the flu\u2014just the regular old flu\u2014can kill. And the cautionary tales this year are hard to beat. Twenty-one-year-old Kyler Baughman, for example, a fitness buff who liked to show off his six-pack, recently died a few days after getting a runny nose.\" source\n\nAccording to the numbers, this (2018) year\u2019s flu season is in fact worse than usual. It got started early, and it\u2019s been more severe. Twenty kids have died of the flu since October. And in the week ending January 6, 22.7 out of every 100,000 hospitalizations in the U.S. were for flu\u2014twice the number of the previous week.\u201d \n\nEvery year, we are reminded to go get a flu shot. \n\n**Q.1. If you got a flu vaccine last year, why do you still have to get a flu shot again this year?**\n\n**Q.2. What are the two populations that are interacting in the above story and graph?**\n\n**Q.3. How do new flu strains arise every year? Where do they come from?**\n\n**Q.4. What causes the flu virus to change?**\n\nBriefly examine the two following links:\n\n1. Why You Need the Flu Shot Every Year \n\nLet\u2019s highlight to the following from above link: **\u201cTiny mutations help the virus evade detection, and as it evades detection, it\u2019s more successful at multiplying.\u201d**\n\n2. How the Flu Virus Can Change\n\nAn **algorithm** can be defined as:  \n\u201cA process or set of rules to be followed in calculations or other problem-solving operations, especially by a computer.\u201d (via Google) \n\nGiven this definition, think about evolution in this new context.  \n\n**Q.5. If evolution is an algorithm, what problem is being solved, and by whom (or what)? What are the rules?**\n\nExtracting out the idea of Evolution from this example evolution is the results of two intertwined processes: \n\n- Random Mutations beget genetic variation; non-random selection to improve \u201cfitness\u201d. \n\n- The end result may look non-random, but the mechanism that enables evolution and natural selection to occur is entirely random. \n\nThe example of flu virus highlights the algorithm of evolution acting on a *timescale* that is easy for us to understand.", "start_char_idx": 0, "end_char_idx": 2315, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6cb78328-cbcd-4dc8-aa7a-8b080b17c331": {"__data__": {"id_": "6cb78328-cbcd-4dc8-aa7a-8b080b17c331", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "36606f32-0c53-471f-9449-c6c88bd25c55", "node_type": null, "metadata": {}, "hash": "84016eb4c7a9b5bcbf2184464d839af461a6921a9a4458f7015e80ce91544739"}}, "hash": "de9c6e502e97b5fc412698ffb4d74dc98d7f63fe97ed0f50a94833f86644e1f8", "text": "Example-2: Ancient virus genomes reveal complex evolution of Hepatitis B\n\nIn a fascinating research article see also (article), \u201cScientists reported on Wednesday that they have recovered DNA from the oldest viruses known to have infected humans \u2014 and have succeeded in resurrecting some of them in the laboratory. The viruses were all strains of hepatitis B. Two teams of researchers independently discovered its DNA in 15 ancient skeletons, the oldest a farmer who lived 7,000 years ago in what is now Germany. Until now, the oldest viral DNA ever recovered from human remains was just 450 years old.\u201d \n\nHere is the abstract from the article: \n\n\u201cThe hepatitis B virus (HBV) is one of the most widespread human pathogens known today,  yet its origin and evolutionary history are still unclear and controversial. Here, we report the analysis of three ancient HBV genomes recovered from human skeletons found at three  different archaeological sites in Germany. \n\nWe reconstructed two Neolithic and one medieval  HBV genomes by de novo assembly from shotgun DNA sequencing data. Additionally, we observed HBV-specific peptides using paleo-proteomics. Our results show that HBV circulates in the European population for at least 7000 years. **The Neolithic HBV genomes show a high genomic similarity to each other. In a phylogenetic network, they do not group with any human-associated HBV genome and are most closely related to those infecting African non-human primates. These ancient virus forms appear to represent distinct lineages that have no close relatives today and went possibly extinct.** \n\nOur results reveal the great  potential of ancient DNA from human skeletons in order to study the long-time evolution of blood borne viruses.\u201d\n\nNote the highlighted lines from the abstract.\n\n\n\n\n\n**Figure-1** Network of 495 modern, two published ancient genomes (light yellow box), and three ancient hepatitis B virus (HBV) obtained in this study (grey box). Colors indicating the 8 human HBV Genotypes (A-H), two monkey genotypes (Monkeys I, African apes and Monkeys II, Asian monkeys) and ancient genomes (red).research article\n\n\n**Q.6. What is the role of evolution (as an algorithm) in this example?**", "start_char_idx": 0, "end_char_idx": 2204, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d527b497-fe27-4005-ae0c-e464617ea9b5": {"__data__": {"id_": "d527b497-fe27-4005-ae0c-e464617ea9b5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "de452f0f-b7ca-4fef-9cb2-d1100b0820e1", "node_type": null, "metadata": {}, "hash": "58368a4406a0dc4a69f8b31f54e35fc19dfd9bdd9231c6dbcb5e478f4cedae4f"}}, "hash": "4ffe256d26d52e52f9197ccf9c7e1245d34b11c236515e785c2dd5af5c6e030c", "text": "Summary\n\nThrough the two examples, you have started to synthesize the workings of evolution and natural selection as an algorithm. This week you will engage with this algorithm as a tool (and service) that can be used to solve challenges in science and engineering. In doing so, you will start to identify the current limitations of evolution, and consider what it would mean to \u201cimprove\u201d evolution. \n\n*Additional Resources:*\n Please make sure to briefly take a look at these great resources: \n \n 1. Collection of links - excellent place to learn about fundamental concepts in evolution \n \n 2. Misconceptions about evolution\n \n 3. Host and Viral Evolution: Molecular Evolutionary Arms Race Between Primate and Viral Genomes link\n\n4. Spanish Influenza Pandemic and Vaccines\n\n____________________________________________________________", "start_char_idx": 0, "end_char_idx": 834, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a181c69c-f0ab-4594-ad98-b845148eb48a": {"__data__": {"id_": "a181c69c-f0ab-4594-ad98-b845148eb48a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f96687e2-8b36-42ed-89aa-043031f280fb", "node_type": null, "metadata": {}, "hash": "1eb9d095b64511c254e46b3535eaeb4d31ac8efcb268129ff6a7f72079924dc6"}}, "hash": "83e57ee74c3a3e3c712175640442a707c94d9ea7ea7d6885aff54cdbe78cdcd5", "text": "Preclass for Friday\n\nIn the previous class you were introduced to evolution as an algorithm. Next, you will examine the role of evolution as an engineering solution and approach. After considering the following example and the material throughout this week you will be able to:\n\n**Goal-1:** Abstract evolution from a population-wide biological force to a service that can be deployed by a group or an individual. (\u201cEvolution, at your service!\u201d) \n\n**Goal-2:** Be able to identify when evolution is a good engineering choice and why? (also begin to address who gets to decide?) \n\n**Goal-3:** Understand the limitations and benefits of this approach.", "start_char_idx": 0, "end_char_idx": 647, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b2838f06-7ebc-4ddf-83a3-171011bb15bf": {"__data__": {"id_": "b2838f06-7ebc-4ddf-83a3-171011bb15bf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "114209dd-c3f0-4c23-952a-2eb3841c4e0f", "node_type": null, "metadata": {}, "hash": "36734fe536498107e974e7796cedb3466d0534ab259f4cab400aa31e8364960e"}}, "hash": "911b416467b72eda0d046681dc1d2a3cd8beddba70022f8694e199ca8ef33da1", "text": "Example-1: \u201cEvolution, at your service!\u201d\n \nSince the days of Gregor Mendel, geneticists (and avid gardeners/monks) have understood that we can breed populations for certain traits.  By taking advantage of our understanding of heritability and genetics, we can - for example - make chickens with extravagant traits see here: (link, link)\n\n\nAnother example of human intervention in evolution is dog breeding. Take a look at the link to see the evolution of Petface here From the article: Cranial length, snout length and skull length all contribute to the difficulties brachy dogs have in breathing. (PLOS One)\n\n**Q.1. Think back to the pre-class material for Wednesday. What are the selection pressures (and their sources) in the case of flu and dog/chicken breeding? How is the fitness determined in each case?**\n\n**Q.2. Thinking of evolution as an algorithm, where else can we intervene?**", "start_char_idx": 0, "end_char_idx": 890, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "bf56bd92-3eb8-468c-a837-b738466906b4": {"__data__": {"id_": "bf56bd92-3eb8-468c-a837-b738466906b4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c92d7b7d-d307-40c5-9463-4201f68950c7", "node_type": null, "metadata": {}, "hash": "ea9c9ac9dca546c22a707695f05ba2ecd5bf978a38fd32fc01f3c89a57740a04"}}, "hash": "eabb09cca391e9c4f88642429dd28686ed683b0444dd9a55a8a6f577fe14eece", "text": "Example-2: Directed evolution of proteins\n \nDirected evolution is an effective strategy for improving or altering the activity of biomolecules for industrial, research and therapeutic applications. \n\nLaboratory evolution of proteins requires methods for generating genetic diversity coupled with identifying protein variants with desired properties. (You can read on the scientific background on the Nobel Prize in Chemistry 2018 awarded to the Directed Evolution of enzymes and  binding proteins from Link)\n\nHere is an introduction from Methods for the directed evolution of proteins\n\n\u201c Over many generations, iterated mutation and natural selection during biological evolution provide solutions for challenges that organisms face in the natural world. However, the traits that result from natural selection only occasionally overlap with features of organisms and biomolecules that are sought by humans. To guide evolution to access useful phenotypes more frequently, humans for centuries have used artificial selection, beginning with the selective breeding of crops and domestication of animals. \n\nMore recently, directed evolution in the laboratory has proved to be a highly effective and broadly applicable framework for optimizing or altering the activities of individual genes and gene products, which are the fundamental units of biology Genetic diversity fuels both natural and laboratory evolution. **The occurrence rate of spontaneous mutations is generally insufficient to access desired gene variants on a time scale that is practical for laboratory evolution. A number of genetic diversification techniques are therefore used to generate libraries of gene variants that accelerate the exploration of a gene's sequence space.**\n\n**Methods to identify and isolate library members with desired properties are a second crucial component of laboratory evolution.** During organismal evolution, phenotype and genotype are intrinsically coupled within each organism. However, during laboratory evolution, it is often inconvenient or impossible to manipulate genes and gene products in a coupled manner. Therefore, single-gene evolution in the laboratory requires carefully designed strategies for screening or selecting functional variants in ways that maintain the genotype\u2013phenotype association.\"\n\n\n\n\n\n**Figure-1** The work flow for the directed evolution of enzymes. Source\n\n**Natural selection:** A process by which individuals with the highest reproductive fitness pass on their genetic material to their offspring, thus maintaining and enriching heritable traits that are adaptive to the natural environment. \n\n**Artificial selection:** A process by which human intervention in the reproductive cycle imposes a selection pressure for phenotypic traits desired by the breeder. (Also known as selective breeding).  \n\n**Libraries:** Diverse populations of DNA fragments that are subject to downstream screening and selection. \n\n**Q.3. How can directed evolution be used an approach to evolve desired proteins?**\n\n**Q.4. What are the challenges associated with this approach?** \n\n**Q.5. When is directed evolution a good choice?**", "start_char_idx": 0, "end_char_idx": 3140, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "54eb5e22-7122-4475-87cf-8a02fbbd084a": {"__data__": {"id_": "54eb5e22-7122-4475-87cf-8a02fbbd084a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb6c8e65-ce9c-4bcb-89f3-3fcbc085e6d9", "node_type": null, "metadata": {}, "hash": "bf97d7e7f50509e417f29c21496035c0d46d4f5a14830a0c578d604f696a500d"}}, "hash": "ac4e3b815797cd9e17a59b5f5b16fdbd611efe68cdf0e027e41bcceb34b38e7e", "text": "Example-3: Antibiotic resistance\n \n Antibiotic resistance and the threat of drug resistance bacteria is an emerging challenge that grows every year.\n (link-1, \n link-2).\n \nAccording to CDC:\n \n\u201cOveruse and misuse of antibiotics can promote the development of antibiotic resistance. Every time a person takes antibiotics, sensitive bacteria (bacteria that antibiotics can still attack) are killed, but resistant bacteria are left to grow and multiply. \n\nThis is how repeated use of antibiotics can increase the number of drug-resistant bacteria.  Antibiotics are not effective against viral infections like the common cold, flu, most sore throats, bronchitis, and many sinus and ear infections. Widespread use of antibiotics for these illnesses is an example of how overuse of antibiotics can promote the spread of antibiotic resistance. Smart use of antibiotics is key to controlling the spread of resistance.\u201d\n \n**Q.6. What is the role of evolution in antibiotic resistance?**\n\nTo answer the question above recall that in an earlier module you came across the MEGA-plate. \nThe (120 \u00d7 60 centimeters) plate on which bacteria spread and evolved on a large antibiotic landscape\n(Mega-plate video)\n\nHere is the abstract from the paper:\n\n\"A key aspect of bacterial survival is the ability to evolve while migrating across spatially varying environmental challenges. Laboratory experiments, however, often study evolution in well-mixed systems. Here, we introduce an experimental device, the microbial evolution and growth arena (MEGA)\u2013plate, in which bacteria spread and evolved on a large antibiotic landscape (120 \u00d7 60 centimeters) that allowed visual observation of mutation and selection in a migrating bacterial front. While resistance increased consistently, multiple coexisting lineages diversified both phenotypically and genotypically. Analyzing mutants at and behind the propagating front, we found that evolution is not always led by the most resistant mutants; highly resistant mutants may be trapped behind more sensitive lineages. The MEGA-plate provides a versatile platform for studying microbial adaption and directly visualizing evolutionary dynamics.\" \n\n**Q.7. Could we use evolution to combat antibiotic resistance?**\n\n*Useful Additional Resource:* \nReview the key Takeaways from: \nMethods for the directed evolution of proteins\n\n\n\n\n github source code for teaching staff", "start_char_idx": 0, "end_char_idx": 2386, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e957f483-d986-4571-a571-18169bbae733": {"__data__": {"id_": "e957f483-d986-4571-a571-18169bbae733", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "199dc43a-fa99-416f-9f9a-dca34492d54b", "node_type": null, "metadata": {}, "hash": "328531c49ed55b3d7822092f63fcbfe0ec0ca308ea5c78cd765dcde84e8c9a0c"}}, "hash": "eaa4d0efe552138b714aabdee03ee151f2a486aedab635963dd53d78e0d4e2bf", "text": "(Q1) Evolution Fundamentals & Misconceptions (20 points)\n\nTrue / False questions, please select the best answer.  If **False** please explain why (1-2 sentences).\nPlease see preclass materials for background material.\n\n**Q.1.a.** Individual mutations occur at random (True /  False)\n\n**Q.1.b.** Evolution of living matter is independent of the environment (True /  False)\n\n**Q.1.c.** Selection is random and unbiased (True /  False)\n\n**Q.1.d.** Evolution works on the scale of individuals, not on populations (True /  False)\n\n**Q.1.e.** Engineers, including bioengineers, can use evolution to optimize human-designed systems  (True /  False)", "start_char_idx": 0, "end_char_idx": 641, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "92ab99f4-0247-4551-9193-600249d217a9": {"__data__": {"id_": "92ab99f4-0247-4551-9193-600249d217a9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a194c74a-dee7-4eb3-b608-20799ce20975", "node_type": null, "metadata": {}, "hash": "9bc2774581253b2e3fb860be9cf33034bfd999b2bfd718650cdf754f9ef828b3"}}, "hash": "0362ea51bd9267c1c6524b42c5fc684b3a0c7d7253984f459be8904231a1ab70", "text": "(Q2) Understanding the \"Search Space\" of Evolution (30 points)\n\nIn class, we talked about thinking of evolution as an algorithm. In this problem we will try and make some elements of this metaphor more concrete. We can think of evolution as a type of optimization algorithm. In lecture we talked about so called \"evolutionary algorithms,\" which are a type of optimization algorithm in the field of computer science that borrows heavily from biological evolution.\n\nThese optimization algorithms seek to find the best solution, or at least a really good one, from a set of possible choices. What is defined as \"really good\" depends on the particular problem being optimized, but generally engineers deal with systems where an input choice maps to an output number. The goal then becomes to maximize or minimize the output number over all possible choices. This output number could be something like a \"cost of production,\" or an \"energy consumption,\" or the \"mass of product\". For example, a manufacturing engineer may wish to maximize the number of Foldscopes that can be made with $1M. The set of all possible input choices defines a \"search space\" over which the evolutionary algorithm seeks to find the best set of outputs.\n\nIn biological evolution, the search space is the space of all possible genomes (the **\"genotype space\"**) and the output is biological fitness.\n\n**Q.2.a.** Recall that there are 4 nucleotides / letters in the DNA alphabet (A, C, T, G). If asked to make a genome that is one base long, how many possible genomes could you make? As in, how many unique genomes of length 1 could exist? How many unique genomes of length 2 could exist? Of length 3?\n\nNote: it may be very helpful to write out all the possible genomes by hand.\n\n**Q.2.b.** How does the number of unique genomes grow as you increased the length of the genome? Given a genome length of _n_, how many unique genome of length _n_ could exist?\n\n**Q.2.c.** A microbial genome is approximately _n_ ~ 107. How many unique microbial genomes could be made of this length? We will use this number for the rest of the problem set as an approximation for the number of possible microbial genomes.\n\n**Q.2.d.** Physicists estimate that there are 1080 atoms in the known Universe (link to popular science article describing how this number was estimated). How does the number of atoms in the known Universe compare to the number of possible microbial genomes?  \n\nNote: Use a calculator that can handle large numbers. Or use Log to compare the exponents of large numbers.", "start_char_idx": 0, "end_char_idx": 2542, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "72efe6de-19af-4447-aae2-495fd629c2ac": {"__data__": {"id_": "72efe6de-19af-4447-aae2-495fd629c2ac", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5c480dc4-f289-4b8d-a582-b69db29fcbc6", "node_type": null, "metadata": {}, "hash": "619951cda33a982784dd43c8588e3569a4e79584692cb5c45629a530691bcd34"}, "3": {"node_id": "28dc8eba-27fc-4085-b0fb-70338b9fb5db", "node_type": null, "metadata": {}, "hash": "de67426c94c17d8d5e9accb866dcdc00ff72bab52b34a0903006da142641aa0a"}}, "hash": "7b644237793e3c23b6e9711336deda6ff4eb61a9e6b08b2be36d43088c04608a", "text": "Question 3: Evolution vs Random Searching (35 points)\nTo illustrate just how powerful evolution is as an \"algorithm\" for optimization, let's consider the following toy system. Imagine a species with a **genome of 100 genes**. Suppose that each of these 100 genes has **one of two forms: 0 or 1**. We can describe the genome of one of these imaginary organisms as a list of a hundred 0s and 1s (e.g., \"0110001...010\").\n\nIn general, it is difficult or impossible to quantitatively predict the fitness of an organism from the organism's *genotype*. This is because the fitness of an organism depends only indirectly on genotype. Fitness depends directly on how the organism looks and acts (its *phenotype*) in the context of a given *environment*, which is difficult to predict. In order to avoid some of these complications, let's make our toy system have the following properties:\n- the total population of our system remains constant throughout (e.g., if 4 organisms die, 4 new ones will be born)\n- the 1 form of each gene is more fit than the 0 form of the same gene\n- genes can only change form by \"mutation\"; a gene in the 0 form mutates to 1 form and vice versa\n- each time an organism reproduces, it's offspring will have a random mutation in exactly one of its genes (e.g., an organism with genome \"010\" may give rise to an offspring with genome \"110\", \"000\", or \"011\" with equal probability)\n- the fitness of a given organism is equal to the number of genes in its genome in the 1 form (e.g., an organism with genome \"011\" has a fitness of 2)\n\nSuppose that we wish find the most fit genome \"111...111\" in the space of all genomes, but we don't know ahead of time which genome is the most fit. That is to say, we don't know that the 1 form is more fit than the 0 form.\n\n**3.a.** Let's first try and guess how long it will take to find the most fit genome by randomly searching the space of all genomes. How big is the space of possible genomes of 100 genes if each gene has 2 forms?\n\nHINT: this problem uses the same math you used for Question 2a and 2b. Instead of considering n nucleotides (of which there are 4 types), we are considering 100 genes (of which there are 2 types)\n\n**3.b.** Let's now try and get a better sense of how long it takes evolution to find the fittest genome in our toy system. Check out this cloud notebook, which simulates the evolution of a population of ten thousand (1e4) organisms in our toy system. To run this notebook, go to the toolbar at the top of the page and click Runtime > Run all.\n\nHow many generations does it take for our simulated population to evolve a genome of fitness 100? How many genome-generations does it take? How does the size of the genome space (from 3.a) compare to the number of genome generations it took for our simulation to find the most fit genome?\n\nHINT: genome-generations is a unit that combines the number of individuals in a population and the number of generations over which that population evolves. You can derive the number of genome-generations by multiplying the number of genomes and the number of generations (e.g., a population of 10 individuals over 4 generations represent 40 genome-generations)\n\n**3.c.** Let's try and see how sensitive our evolving system is to the parameters we chose for our simulation. We may have just gotten lucky! First, let's try changing the size of our population, which is represented by the parameter named \"NUM_GENOMES\".\n\nRepeat the simulation using a population size of one thousand (1e3) individuals. Run the simulation by clicking Runtime > Run all, otherwise the code will run using the default parameters instead of the updated ones. Does this simulation to converge to a genome of fitness 100? If so, how many genome-generations does it take?\n\nRepeat the simulation again using a", "start_char_idx": 0, "end_char_idx": 3803, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "28dc8eba-27fc-4085-b0fb-70338b9fb5db": {"__data__": {"id_": "28dc8eba-27fc-4085-b0fb-70338b9fb5db", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5c480dc4-f289-4b8d-a582-b69db29fcbc6", "node_type": null, "metadata": {}, "hash": "619951cda33a982784dd43c8588e3569a4e79584692cb5c45629a530691bcd34"}, "2": {"node_id": "72efe6de-19af-4447-aae2-495fd629c2ac", "node_type": null, "metadata": {}, "hash": "7b644237793e3c23b6e9711336deda6ff4eb61a9e6b08b2be36d43088c04608a"}}, "hash": "de67426c94c17d8d5e9accb866dcdc00ff72bab52b34a0903006da142641aa0a", "text": "how many genome-generations does it take?\n\nRepeat the simulation again using a population size of one hundred thousand (1e5) individuals. Does this simulation to converge to a genome of fitness 100? If so, how many genome-generations does it take? Given the answers you got in this problem, how sensitive is our model to the population size?\n\n**3.d.** Now, let's try and change the strength of selection that we impose on our system, which is represented by the parameter named \"SELECTION\". SELECTION represents the percentage of the population that dies within each generation and is replaced by newborn individuals. With SELECTION = 0.5, which is the default setting we've used thusfar, half of the population is replaced every generation!\n\nRepeat the simulation using a population size of ten thousand (1e4) individuals, like we did in 3.b, but set the selective pressure to 0.2. Does this simulation to converge to a genome of fitness 100? If so, how many genome-generations does it take?\n\nRepeat the simulation using a population size of ten thousand (1e4) individuals and a selective pressure of 0.9. Does this simulation to converge to a genome of fitness 100? If so, how many genome-generations does it take? Given the answers you got in this problem, how sensitive is our model to the selective pressure?\n\nEXTRA INFORMATION: In making our toy system, we made some implicit assumptions in order for the properties listed above to hold. Below, we highlight some of these assumptions.\n- the fitness that any given gene contributes to the organism is only determined by the form of that gene (there is no epistasis in this system)\n- the fitness of one organism does not affect the fitness of any other organism (there is no density dependence or frequency dependence)\n- the organisms reproduce asexually and cannot perform recombination\n- the Environment does not change over time\nIn general, these assumptions do not apply. However, scientists have made great headway in describing evolution using simple models that make some or all of these assumptions.", "start_char_idx": 3725, "end_char_idx": 5786, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f767fc25-451a-4b9c-86d2-dccbfa9426ef": {"__data__": {"id_": "f767fc25-451a-4b9c-86d2-dccbfa9426ef", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "be16816a-89f7-4570-adb0-cb6bc4aa1929", "node_type": null, "metadata": {}, "hash": "4bb2d35be0bc5d6848b9b261e6d4813477483946b59cb565168b6b25ee07f626"}}, "hash": "e2799603facc6322a9cc42ca67e220aba5ae7b34c7ada871cc17da063dddb544", "text": "(Q4) Paper reading activity (15 points)\n\nRead the following paper, Fail-safe genetic codes designed to intrinsically contain engineered organisms\n\n**Q.4.a** In your own words, what is the primary claim of the paper? What are the primary evidence in support of the claim? (2-3 Bullet points)\n\n**Q.4.b** What are the paper\u2019s strengths and significance? What are the paper\u2019s shortcomings and deficiencies?  (Bullet points)? How can the paper improve? (3-4 Bullet points)\n\n\nRead the following pre-print, Content-based similarity search in large-scale DNA data storage systems\n\n**Q.4.c** In your own words, what is the primary claim of the paper? What are the primary evidence in support of the claim? (2-3 Bullet points)\n\n**Q.4.d** What are the paper\u2019s strengths and significance? What are the paper\u2019s shortcomings and deficiencies?  (Bullet points)? How can the paper improve? (3-4 Bullet points)", "start_char_idx": 0, "end_char_idx": 893, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3020b8bb-de31-4d16-8094-a2416d352d5f": {"__data__": {"id_": "3020b8bb-de31-4d16-8094-a2416d352d5f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "eed48874-0ca6-4536-b38d-3ac2b5459f23", "node_type": null, "metadata": {}, "hash": "ca4e747f3f0eda6a62bfe36ec469e93c59b4ce3249f35812ca875735f8f8e9b1"}}, "hash": "1595c6e2a32d4e845e95220f0b050e4d58c66d85d9338519c6cc03524f63eaa1", "text": "Extra Credit - Design and solve a question (20 points)\n\nDesign your own BIOE\\ENGR 80 question based on any of the material that we have covered so far in the class.  A student successfully finishing BIOE\\ENGR 80 should be able to answer your question.  \n\n- Start by thinking about your learning goals.  What do you expect the learners to gain after engaging your question?\n\n- Next, provide your question. Your questions can have multiple parts.  Make sure to include references if you draw inspiration from a source.\n- Finally, provide an answer to the question. (Optional: you can also include potential mistakes and misunderstandings.)\n\n github source code for teaching staff", "start_char_idx": 0, "end_char_idx": 677, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0d4e5db9-ae9b-437a-8795-f9bcc90e0b84": {"__data__": {"id_": "0d4e5db9-ae9b-437a-8795-f9bcc90e0b84", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bcaee994-c85e-4a0b-b683-c8650ef622bd", "node_type": null, "metadata": {}, "hash": "1906ece24181b71e849615dada8a1770f27ff309da26f0e24b0076d9de6708d9"}}, "hash": "b9d7d32b91590fe3573ae3dedc8d848f36dba9d7c15639071823511a44a25397", "text": "Day 24: June 1, 2020\n\nClass Slides\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 53, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1ee037e6-5c10-44f7-be67-2f47d502b3a2": {"__data__": {"id_": "1ee037e6-5c10-44f7-be67-2f47d502b3a2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fd74c8ba-c371-4b34-a41b-11dcd76beec1", "node_type": null, "metadata": {}, "hash": "e0a5707076d524662cf587c6c08a3f6fcd67ef2b13cf308c02953954dcc28021"}}, "hash": "7d2b2f2fcb44e921f2750867d7170566d7ccece88a3a02882da40e2d4689c1b9", "text": "Day 25: June 3, 2020\n\nClass Slides\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 53, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8b41760e-e087-4f6c-accb-4799186f769b": {"__data__": {"id_": "8b41760e-e087-4f6c-accb-4799186f769b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa1dc9d5-9637-4cad-8683-0d3b78b6a5f3", "node_type": null, "metadata": {}, "hash": "e2d09ec5a99cda8e5fb4758d85f29560822ec8cbbdac8beeca45970b5a37a9fe"}}, "hash": "eb40e6ff14409acb990f226c3b399eb478a7d87233b1a0b5b14da467f1647fdb", "text": "Day 26: June 5, 2020\n\nClass Slides\n\nClass Audio/Video", "start_char_idx": 0, "end_char_idx": 53, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7315d2d8-ee17-4929-9fe5-0cee967aa820": {"__data__": {"id_": "7315d2d8-ee17-4929-9fe5-0cee967aa820", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "29fed515-9919-45b0-b19f-c438861dd2c1", "node_type": null, "metadata": {}, "hash": "f5d07f35db049c74114580a2667556284d3c19800df5cf4ac0ea72099e880f70"}}, "hash": "5fc2357c9eaac6194680d2dfe807fb78c05819707624d1302387caf91fbb8677", "text": "Post-class for Monday\n   \n(1) Please read the brief article, *\"George the Snail, Believed to Be the Last of His Species, Dies at 14 in Hawaii.\u201d*\n\nAvailable online via: George the Snail, Believed to Be the Last of His Species, Dies at 14 in Hawaii  \n\n**Q.1. What fraction of Hawaiian snail species have gone extinct in the last several hundred years?**  \n\n**Q.2. What three factors are thought or known to have contributed to snail extinctions on Hawaii?**  \n\n**Q.3. What hope motivated deep-freezing a two millimeter slice of George\u2019s foot in 2017?** \n\n\n(2) Please skim the article by our own Michael Specter, *\u201cCould Genetically Modified Mosquitoes Save Hawaii\u2019s Endangered Birds?\u201d*  \n\nAvailable online via: Could Genetically Modified Mosquitoes Save Hawaii\u2019s Endangered Birds?   \n\n**Q.4. How do mosquitoes contribute to the extinction of native Hawaiian birds?**  \n\n**Q.5. Why are there mosquitos on Hawaii?**   \n\n(3) Please consider the video introduction to *\u201cgene drives\u201d* available here: What's a gene drive?   \nPlease pay special attention to the 2.5 minutes of material starting around 30 seconds into the video.   \n\n*Self-study Questions:* \n\n**Q.6. What is a gene drive?**\n\nSee   \n\n**Q.7. What is CRISPR?**   \n\nSee   \n\n**Q.8. What is the key insight enabling CRISPR-enabled gene drives?**    \n\nSee (Hint \u2014 listen for when the narrator exclaims, \u201c\u2026also contained a little bit of code\u2026\u201d)", "start_char_idx": 0, "end_char_idx": 1394, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b1145a33-5999-40ca-b7aa-4a355b78c23e": {"__data__": {"id_": "b1145a33-5999-40ca-b7aa-4a355b78c23e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "06ba733b-9eb8-48f4-a13d-2712d158fbbc", "node_type": null, "metadata": {}, "hash": "4d320728e141e032d0bc2a35e7ce55db0762b4b587cabeb41ab0f33fb507374e"}}, "hash": "c958ca8d6155ba84b1e19912dcaed12ce8f88348a3a68ab129eac138088e22c7", "text": "Post-class for Wednesday\n\nPost-class will be shared after the class.", "start_char_idx": 0, "end_char_idx": 68, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2a3cd050-c677-4408-9eb3-5fb0ae196566": {"__data__": {"id_": "2a3cd050-c677-4408-9eb3-5fb0ae196566", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "508f3977-f5b5-4d30-b48a-cd0b28b9648c", "node_type": null, "metadata": {}, "hash": "a25e64a72d5953e8d1728bf58af51ba48a09804f9703b0d63af05602ddbe4a7b"}}, "hash": "681b6996dc9fa78786ad43fb77281450c2fc3a84ec84f226a67a353c2a05efd3", "text": "Preclass for Friday\n\nPlease skim the essay by John Maynard Keynes, Economic Possibilities for Our Grandchildren\n\n*full link also: http://www.econ.yale.edu/smith/econ116a/keynes1.pdf*\n\n**Q.1.\u00a0What was the state of the global economy when Keynes published his essay?**\n\n**Q.2.\u00a0Who are Keynes \"grandchildren\" and what does Keynes conclude regarding their future economic prospects?**\n\n**Q.3. Did Keynes' prediction come true? If not, why?**\n\nNext, watch the following 5' of Martin Luther King, Jr. I Have A Dream speech\n\n**Q.4. What is the difference between a dream and a plan?**\n\n**Q.5. How would the speech be different if it was addressing a plan instead of a dream?**\n\nPlease briefly examine the United Nations' 17 Sustainable Development Goals (SDGs)\n\n**Q.6. Which one do you think is most important?**\n\n**Q.7. Are these goals articulated as a dream or a plan?**\n\nNow watch Michael Render's (AKA Killer Mike) Plot, Plan, Strategize, Organize and Mobilize speech from last week.\n\n**Q.8. What is Mike's message?**\n\nFamiliarize yourself with Brandenburg v. Ohio, 395 U.S. 444 (1969) by skimming the material online here:\n\nBrandenburg v. Ohio\n\n**Q.9. According to this case, what conditions must all be met in order to make certain speech or acts illegal?**\n\nFinally, familiarize yourself with Jacobellis v. Ohio, 378 U.S. 184 (1964) by skimming the material online here:\n\nJacobellis v. Ohio\n\n**Q.10. What is Justice Potter Stewart most known for regarding his opinion in this case?** \n\nOptional video: Please watch late Elijah Cummings' remarks at Cohen hearing\nfrom Feb of 2019.  Particularly pay attention to his wish (start around 2\u2019) for a better and intact democracy, the greatest gift,\u00a0that we can can give to our children.\n\n\n github source code for teaching staff", "start_char_idx": 0, "end_char_idx": 1770, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "525ddb01-fabb-4e5b-90fa-4b356e8b6cb9": {"__data__": {"id_": "525ddb01-fabb-4e5b-90fa-4b356e8b6cb9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a6c54a9a-220e-4a7e-b4ba-db36984ed438", "node_type": null, "metadata": {}, "hash": "2cf6217addd9a41f038ee1a689f0ae16e35679911b04c2deb3755588696d83fc"}}, "hash": "b3ba5c644e1e28a7f86123d0219c7f573e706e237869e2eb7f74885098b885ce", "text": "(Q1) Design and Synthesis of a Minimal Bacterial Genome (40 pts)\n\nA key skill that you will need as bioengineers is to read, understand, and extract informationfrom research papers that are shaping and defining the frontiers of bioengineering. This is inpart due to the fast changing pace of bioengineering. We would like you to practice this skill as early as possible, to help you become better at it.\n\n\nIn class we started to discuss the paper *\u201cDesign and synthesis of a minimal bacterial genome\"*. In this problem you will review the the paper to level up your ability to read and extractinformation from a research paper.\n\n1.a. Re-read the abstract from the paper, in your own words describe what was the paper\u2019s goal(s), \nwhat did the authors discover by working on these goal(s). (bullet points)\n\n1.b. Take a look at Figure-1 from the paper titled: \u201cThe JCVI DBT cycle for bacterial genomes\u201d. \nThink back to what you have learned during the DBT Week. Based on the figure and your prior knowledge, \nwhat tools and technologies were used to design, build, and test Syn3.0.?  (bullet points)\n\n1.c. Take a look at Figure-2 titled: \u201cStrategy for whole-genome synthesis\u201d. What do the red, blue, and green arrows represent? What does the orange arrow represent? \nUsing the figure briefly explain how they went from Oligos to a whole genome? (bullet points)\n\n1.d. Assuming $0.04 per base pair what is the minimum cost ofsynthesizing the Syn3.0 genome?\n\n1.e. Take a look at Figure-7. Let\u2019s compare the phenotype of Syn1.0 and Syn3.0.\nDescribe what you see when comparing panel A and B and panel C?(bullet points) \nWhich cellsgrow faster? ( Syn1.0 or Syn3.0.)", "start_char_idx": 0, "end_char_idx": 1657, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "132e1696-ae47-49cd-b1bd-63dd983a194a": {"__data__": {"id_": "132e1696-ae47-49cd-b1bd-63dd983a194a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "75145522-13df-486d-9407-fcb25dbc61c9", "node_type": null, "metadata": {}, "hash": "ab239d692ae0b82c7f74fbd66bb036ef4e9e4bdf0a16d9fa502efe4b8266d92f"}}, "hash": "f4b2fe25c9da7958f1376e4cc9622f8ad33230d2fc027e8f237438e8a6746ba7", "text": "(Q2) Approximation and estimation - Genome Size (40 pts)\n\nNow thatyou have examined a minimal genome have you wondered how big is a typical genome?\n\nThe *E. coli* MG1655 genome is 4.6 Mbp (megabasepairs) long, or approximately 4,600,000base pairs. \nA good rule of thumb for the length of a single DNA base pair is that it is \u2153 nm long.\nAs another rule of thumb, let\u2019s treat the volume of an *E. coli* cell as being approximately 1 \u03bcm^3 see. This is a rough, order-of-magnitude estimate. \n\nIn real life, cell size and volume willv ary based upon species, growth rate, and stage of division \nin addition to many other factors.\n\n2.a. How long would the *E. coli* genome be as a linear strand of DNA?  Provide your answerin \u03bcm. How long would the Syn3.0 genome be as as a linear strand of DNA?\n\n2.b. The *E. coli* genome is actually circular. What is the radius of the genome, assuming thegenome is arranged as a perfect circle and given the linear length that you calculated above?\n\n2.c. Consider your answers in relation to the size specifications for *E. coli* given above. Whatdoes this imply about the layout of DNA inside a living cell? (Two sentences).\n\nNote: A good rule of thumb for the volume of a DNA base pair is that one base pair has avolume of approximately 1 nm^3.\n\n2.d. How much DNA could be packed into an *E. coli* cell, assuming that the whole cellvolume only contains DNA? Why is this number ridiculous? (i.e., the *E. coli* genome issignificantly smaller: why?)\n\nAdditional resources: If you like to learn more about various genome sizes please visit this link\n\n\n\n github source code for teaching staff", "start_char_idx": 0, "end_char_idx": 1620, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2ad2424d-e85f-4020-a7a9-1f895b06b6f9": {"__data__": {"id_": "2ad2424d-e85f-4020-a7a9-1f895b06b6f9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "249e5398-ad37-4e63-b758-6ad6581a4ec1", "node_type": null, "metadata": {}, "hash": "04341b7d4b7a460bf370244ceda2eab4cfadfb94f499293993c7b5245563a266"}}, "hash": "74822d580451068d4ef395807613490c294f9d8464cc622bbf84868cce82f91e", "text": "BIOE 80 Who is a bioengineer? Activity\n\n**Goal:** As part of the introduction to the course, assess student viewpoints on what makes up a bioengineer. As a relatively young discipline, bioengineering can be hard to define. This activity will help students think about their own conceptions of bioengineers and how this course might affect those ideas. This activity can be repeated at the end of the course to see how, if at all, ideas of bioengineers may have changed.\n\n**Prompt:** Imagine a bioengineer. In the following diagram, sketch your idea of a bioengineer. In the 3 circles, write down 3 words to describe bioengineers.\n\n!alt text\n\n**Activity:** Give students 5-10 minutes to fill out the sheet. Then, have them discuss in pairs how their sketches/words were similar, and how they differed. Bring this back into the large group and ask for a few volunteers to share back on their ideas of who is a bioengineer. Offer the instructors\u2019 vision of a bioengineer--or questions of what makes up a bioengineer--and how this class will examine those viewpoints. \n\n**Follow-up:** Collect the handouts from students. Quickly glance through them, and share impressions from the sketches in the next class. Ie: you notice everyone drew someone holding a pipette, or there were very few similarities among the drawings. \n\n**Alternate activity:** Using PollEverywhere (Stanford has a license to this clicker-type survey system), submit 3 words that describe Bioengineers (or hyphenated phrases). Allow students to respond via phone or laptop, then display the results as a word cloud. Ask students to take a minute to share with their neighbor anything that strikes them about bioengineers. Again, you can bring this back into a large group, and comment on how this class will require (or not) those adjectives.", "start_char_idx": 0, "end_char_idx": 1807, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9111114d-7007-4495-a3c4-ce006224eddd": {"__data__": {"id_": "9111114d-7007-4495-a3c4-ce006224eddd", "embedding": null, "metadata": {"page_label": "1", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1393e96d-5672-4c1f-964c-1bf711a54242", "node_type": null, "metadata": {"page_label": "1", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "4bc3654fa32635860fcbcc1b67957d6bc562b2919be7a2ce84f7ab56b3effbf9"}}, "hash": "4bc3654fa32635860fcbcc1b67957d6bc562b2919be7a2ce84f7ab56b3effbf9", "text": "Extra Material: BiomoleculesThe stuff that makes up living stuff", "start_char_idx": 0, "end_char_idx": 64, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a56b2916-5c93-4b6b-973d-ddfefb3193bc": {"__data__": {"id_": "a56b2916-5c93-4b6b-973d-ddfefb3193bc", "embedding": null, "metadata": {"page_label": "2", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b5efe434-5d4a-4b07-863a-78270ede227a", "node_type": null, "metadata": {"page_label": "2", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "a318baef34f7d83e6143ee096ce780e8d1e3bdc878f7878e8c9e725f62cc7a27"}}, "hash": "a318baef34f7d83e6143ee096ce780e8d1e3bdc878f7878e8c9e725f62cc7a27", "text": "Biomolecules make up  living matter", "start_char_idx": 0, "end_char_idx": 35, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b7e4e73b-7d6e-48bc-8a1d-5281b21c1871": {"__data__": {"id_": "b7e4e73b-7d6e-48bc-8a1d-5281b21c1871", "embedding": null, "metadata": {"page_label": "3", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b68f706a-4896-4b7e-ab61-53d9c369c487", "node_type": null, "metadata": {"page_label": "3", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "caeb006993d953bb2e62e5d3c89afc8d99f5ae409f7bb6a7d1df3f1f02baa5eb"}}, "hash": "caeb006993d953bb2e62e5d3c89afc8d99f5ae409f7bb6a7d1df3f1f02baa5eb", "text": "From: https://e360.yale.edu/features/as-oceans-warm-the-worlds-giant-kelp-forests-begin-to-disappear#\nFrom: https://cheezburger.com/6771324928https://svs.gsfc.nasa.gov/10394\n(living matter)", "start_char_idx": 0, "end_char_idx": 189, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a67b9481-40d3-491d-8dc3-08d81038bda5": {"__data__": {"id_": "a67b9481-40d3-491d-8dc3-08d81038bda5", "embedding": null, "metadata": {"page_label": "4", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d5fcdfed-41f5-4f2d-a2e2-1089c0fac632", "node_type": null, "metadata": {"page_label": "4", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "1255b8d174ae07b92185dbea29e2e2ca83aa5f6bcc3481ce9c76437b7d22760f"}}, "hash": "1255b8d174ae07b92185dbea29e2e2ca83aa5f6bcc3481ce9c76437b7d22760f", "text": "Mycoplasma mycoides (David Goodsell, 2011)\nFrom: https://pdb101.rcsb.org/sci-art/goodsell-gallery/mycoplasma-mycoides", "start_char_idx": 0, "end_char_idx": 117, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ad2a2470-bfda-48db-829c-91683ef020c1": {"__data__": {"id_": "ad2a2470-bfda-48db-829c-91683ef020c1", "embedding": null, "metadata": {"page_label": "5", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cb1d5f08-8e88-4fa9-aba4-8f8914f57612", "node_type": null, "metadata": {"page_label": "5", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "e3061a28d89674ba6a4a32fbed1605d9dffbf62c4b0f1b156c10b947fa3b6f04"}}, "hash": "e414256a51f1330f37976c565fd4471ca91e743dcaa6b1b6aaa533b9fa3e6d87", "text": "Most biomolecules fall into four classesnucleic acids \nFrom: David Goodsell (https://pdb101.rcsb.org/motm/42) and Googleproteins\nFrom: SF Chronicle (https://www.sfchronicle.com/environment/article/Biggest-private-sequoia-grove-to-be-preserved-in-14444748.php) and Googlesaccharides \nFrom: Nature (doi.org/10.1038/s41580-018-0037-7) and Googlelipids \nFrom: NIH (https://ghr.nlm.nih.gov/primer/basics/dna)", "start_char_idx": 0, "end_char_idx": 403, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4bdb01bf-ea29-454e-939f-8e29a7f01a8a": {"__data__": {"id_": "4bdb01bf-ea29-454e-939f-8e29a7f01a8a", "embedding": null, "metadata": {"page_label": "6", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2f875451-b71b-41f1-abab-d58e1f8b87f7", "node_type": null, "metadata": {"page_label": "6", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "8e332837518cab987e63c5ac8e69b7c564a9c728a2d5b335b0591fcae1c83fa3"}}, "hash": "8e332837518cab987e63c5ac8e69b7c564a9c728a2d5b335b0591fcae1c83fa3", "text": "Biomolecules perform the  basic tasks of biology", "start_char_idx": 0, "end_char_idx": 48, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e643902d-e70e-40f8-a8cc-d2f18d100f8c": {"__data__": {"id_": "e643902d-e70e-40f8-a8cc-d2f18d100f8c", "embedding": null, "metadata": {"page_label": "7", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "56154760-10c7-47a4-8a8c-1d1b2e68a24c", "node_type": null, "metadata": {"page_label": "7", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "3c7b326de4573dcc0fb5245d24377110211396b9999d0fe74b4843e07cc6fa44"}}, "hash": "3c7b326de4573dcc0fb5245d24377110211396b9999d0fe74b4843e07cc6fa44", "text": "Red blood cells catch oxygen with a protein called hemoglobin\nFrom: PDB (https://pdb101.rcsb.org/motm/41) and Flickr", "start_char_idx": 0, "end_char_idx": 116, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8dcd3a28-54f3-490d-8633-42d5710f2567": {"__data__": {"id_": "8dcd3a28-54f3-490d-8633-42d5710f2567", "embedding": null, "metadata": {"page_label": "8", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "372234ac-74c6-4632-ac11-6d73f036cd2c", "node_type": null, "metadata": {"page_label": "8", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "6e7916a46c9e5c6e2cba2d368cf198679b21a0ddc0f535eb1d95747806d229fd"}}, "hash": "6e7916a46c9e5c6e2cba2d368cf198679b21a0ddc0f535eb1d95747806d229fd", "text": "ATP Synthase (complex of proteins) powers cells\nFrom: Stuart Lab (https://www.youtube.com/watch?v=b_cp8MsnZFA&feature=youtu.be&t=53)", "start_char_idx": 0, "end_char_idx": 132, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a82075c7-fff8-4e83-bfbf-0c87bd40d5b2": {"__data__": {"id_": "a82075c7-fff8-4e83-bfbf-0c87bd40d5b2", "embedding": null, "metadata": {"page_label": "9", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e6d60321-b32b-46a7-9192-011c10f3b05a", "node_type": null, "metadata": {"page_label": "9", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "3016793145b61253c1c49412dc781b38023d56f442e5ca608f8cd4a6ec83f991"}}, "hash": "3016793145b61253c1c49412dc781b38023d56f442e5ca608f8cd4a6ec83f991", "text": "DNA replicase (complex of proteins) copies DNA\nFrom: Walter and Eliza Hall Institute (https://www.youtube.com/watch?v=mDZLiZB0iPY&feature=youtu.be&t=174)", "start_char_idx": 0, "end_char_idx": 153, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b55cc126-485e-4c16-931b-5bf403ca028f": {"__data__": {"id_": "b55cc126-485e-4c16-931b-5bf403ca028f", "embedding": null, "metadata": {"page_label": "10", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7eac9f2b-9698-48b3-b65f-869b28114dd3", "node_type": null, "metadata": {"page_label": "10", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "2b07558cb0d3c9bc3bf7ebed2440076fb8b891169e6a8f6b23871b17877761f3"}}, "hash": "2b07558cb0d3c9bc3bf7ebed2440076fb8b891169e6a8f6b23871b17877761f3", "text": "What are biomolecules made of?", "start_char_idx": 0, "end_char_idx": 30, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fbeb3bd7-a905-4c0f-84f1-ad921ad4d0e6": {"__data__": {"id_": "fbeb3bd7-a905-4c0f-84f1-ad921ad4d0e6", "embedding": null, "metadata": {"page_label": "11", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "030c4b85-035d-4b57-a196-dec5b10f3dc2", "node_type": null, "metadata": {"page_label": "11", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "ea943388e97fabc84917b70d56e1aaafe3100233a7fc4b34c1646f43d31b51dd"}}, "hash": "297d385ab5befca41a672f0f1e7afdb8dea450d96e21e3a6d2cc8d0e59401088", "text": "Most biomolecules are polymers\nFrom: David Goodsell (https://pdb101.rcsb.org/motm/42) and Googleproteins\nFrom: SF Chronicle (https://www.sfchronicle.com/environment/article/Biggest-private-sequoia-grove-to-be-preserved-in-14444748.php) and Googlesaccharides \nFrom: Nature (doi.org/10.1038/s41580-018-0037-7) and Googlelipids \nnucleic acids \nFrom: NIH (https://ghr.nlm.nih.gov/primer/basics/dna)", "start_char_idx": 0, "end_char_idx": 394, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b1a3237d-02ad-48d4-b09d-f99136b973a0": {"__data__": {"id_": "b1a3237d-02ad-48d4-b09d-f99136b973a0", "embedding": null, "metadata": {"page_label": "12", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "02c64c2b-2d3a-4ff4-b647-6582aa1bd20d", "node_type": null, "metadata": {"page_label": "12", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "18fec1e268eae7b2adf847c03f8ec50a4c15b7452af4fca48cdf3ea8ec35c861"}}, "hash": "18fec1e268eae7b2adf847c03f8ec50a4c15b7452af4fca48cdf3ea8ec35c861", "text": "monomersABCpolymersABAAABAA\nCBCBAABACBCBAABACBCBAABA", "start_char_idx": 0, "end_char_idx": 52, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b0daa1ac-5efc-4614-b793-42178c895d39": {"__data__": {"id_": "b0daa1ac-5efc-4614-b793-42178c895d39", "embedding": null, "metadata": {"page_label": "13", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bbf1da6a-2921-4a4e-955c-33ce1ef6f3ec", "node_type": null, "metadata": {"page_label": "13", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "409bc8f24cc7b2cdbb23f7a186fdfa95de004ac4817952f5bb5baadf9a7bf31f"}}, "hash": "409bc8f24cc7b2cdbb23f7a186fdfa95de004ac4817952f5bb5baadf9a7bf31f", "text": "Polysaccharides are made of monosaccharides\nRiboseDeoxyribose", "start_char_idx": 0, "end_char_idx": 61, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f2a9382d-a200-4481-a4c6-ac2ee0c47eca": {"__data__": {"id_": "f2a9382d-a200-4481-a4c6-ac2ee0c47eca", "embedding": null, "metadata": {"page_label": "14", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2ddd6854-53df-486c-b20c-9061691d57e6", "node_type": null, "metadata": {"page_label": "14", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "b33cfe24dc548a10162e8ad4e178996c9ff0cd335de18e77ef1894015d8fb794"}}, "hash": "d534c029c89eef4f62129086e3f6292ef49a44481e8df7f83b0eed9b84d5291f", "text": "Polysaccharides form straight or branched chains\nFrom: Lumen Learning (https://courses.lumenlearning.com/wm-biology1/chapter/reading-types-of-carbohydrates/)", "start_char_idx": 0, "end_char_idx": 157, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f34bb0c3-1819-425e-8c67-2201da1338cb": {"__data__": {"id_": "f34bb0c3-1819-425e-8c67-2201da1338cb", "embedding": null, "metadata": {"page_label": "15", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b35bf376-96d7-457a-8501-d8ab87a56741", "node_type": null, "metadata": {"page_label": "15", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "9056337a78bd6cd413584f6046cd0bf3cc77b6f1d85a612ca73939fc05c25fec"}}, "hash": "9056337a78bd6cd413584f6046cd0bf3cc77b6f1d85a612ca73939fc05c25fec", "text": "Proteins are made of amino acids\nL-alanineNH2 \u2014> \u201camino group\u201d (N)<\u2014 COOH \u201cacid group\u201d (C)", "start_char_idx": 0, "end_char_idx": 90, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "232ef1e8-2993-4040-9432-ea652369d380": {"__data__": {"id_": "232ef1e8-2993-4040-9432-ea652369d380", "embedding": null, "metadata": {"page_label": "16", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7cea3a13-0def-4e49-bbed-d0df8dc4e13e", "node_type": null, "metadata": {"page_label": "16", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "151cae36a9f33750ef913cd88ad20bc25106be7e66255fa79875b56e514630aa"}}, "hash": "151cae36a9f33750ef913cd88ad20bc25106be7e66255fa79875b56e514630aa", "text": "From: Biological Science, 2nd Ed (grabbed from https://sites.google.com/a/providenceday.org/apbiology/codon-charts-periodic-table)There are  20 amino acids* *(kinda, biology makes more kinds of amino acids by modifying these twenty)", "start_char_idx": 0, "end_char_idx": 232, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a289e731-9deb-490f-a9b9-f8d1f46c842d": {"__data__": {"id_": "a289e731-9deb-490f-a9b9-f8d1f46c842d", "embedding": null, "metadata": {"page_label": "17", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4b32e8ce-2449-497e-8b28-3b08c60d4005", "node_type": null, "metadata": {"page_label": "17", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "bf8dca0827de504cc56de3095bca374fa30f0590977a7ccf1d972615616284c0"}}, "hash": "bf8dca0827de504cc56de3095bca374fa30f0590977a7ccf1d972615616284c0", "text": "Nucleic acids are made of nucleotides\nDeoxyadenosine triphosphate (dATP)triphosphate ^<- sugar (deoxyribose)<\u2014 nucleobase (adenosine)", "start_char_idx": 0, "end_char_idx": 133, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a9118504-f382-41da-aea4-7ced17e70074": {"__data__": {"id_": "a9118504-f382-41da-aea4-7ced17e70074", "embedding": null, "metadata": {"page_label": "18", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2b3e6e4e-593b-4b70-9fc4-ff01a1cf338f", "node_type": null, "metadata": {"page_label": "18", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "c6799a38a967a9ade9ef8129811dc4a876d7ce873b5bb6b567c3d27b18c1b032"}}, "hash": "c6799a38a967a9ade9ef8129811dc4a876d7ce873b5bb6b567c3d27b18c1b032", "text": "DNA (deoxyribonucleic acid)RNA (ribonucleic acid)\nRiboseDeoxyribose", "start_char_idx": 0, "end_char_idx": 67, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c2bd5547-c7af-425d-be59-b8c5449cae32": {"__data__": {"id_": "c2bd5547-c7af-425d-be59-b8c5449cae32", "embedding": null, "metadata": {"page_label": "19", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2b2be256-a302-4ad1-97cd-3bf2f4e7157a", "node_type": null, "metadata": {"page_label": "19", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "df10432efe635ef617699c6bbdf02e67f25bb8fb85d566286ed477174ff21204"}}, "hash": "785f58c017dea82ad2d927522ff9139776a2b3a848b2536befe9cd8a2d386409", "text": "DNA (deoxyribonucleic acid)RNA (ribonucleic acid)\nrGTPdATP", "start_char_idx": 0, "end_char_idx": 58, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3183e05d-a528-49b2-82c0-3bf1abf030ce": {"__data__": {"id_": "3183e05d-a528-49b2-82c0-3bf1abf030ce", "embedding": null, "metadata": {"page_label": "20", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9906c64e-7aa8-42cd-8ea6-4df35ba83ca9", "node_type": null, "metadata": {"page_label": "20", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "f353d0fe24e63569171dce7392406f236fe7ee91a94c17325f20fa80f77b93e2"}}, "hash": "f353d0fe24e63569171dce7392406f236fe7ee91a94c17325f20fa80f77b93e2", "text": "From: Wikimedia Commons (https://commons.wikimedia.org/wiki/File:Difference_DNA_RNA-EN.svg)", "start_char_idx": 0, "end_char_idx": 91, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "306648fa-2bd9-4d0e-9cf1-74d4759c769b": {"__data__": {"id_": "306648fa-2bd9-4d0e-9cf1-74d4759c769b", "embedding": null, "metadata": {"page_label": "21", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b34325f6-4d87-4ee5-918a-ab92adba3181", "node_type": null, "metadata": {"page_label": "21", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "a0fcf4af5d2cd6c0fe1fec93e251596326fb3708c09cbd42820fc69d13d13342"}}, "hash": "4bc7520f3e25776cd2ac2bfaa877d5cbe168684aacc7bd1c74c554e54409fdd5", "text": "Lipids take on a variety of forms\ntrans-Retinal", "start_char_idx": 0, "end_char_idx": 47, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ce6f1050-e242-4dec-9595-5c8ce24aed2c": {"__data__": {"id_": "ce6f1050-e242-4dec-9595-5c8ce24aed2c", "embedding": null, "metadata": {"page_label": "22", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e6494872-b79c-43bd-ad90-496a4276dc0f", "node_type": null, "metadata": {"page_label": "22", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "85e59f071c191154fe25246b5c0e07fb4603ae4df0c4cb01a45c1c98a8ff11e4"}}, "hash": "85e59f071c191154fe25246b5c0e07fb4603ae4df0c4cb01a45c1c98a8ff11e4", "text": "Lipids take on a variety of forms\nFrom: Wikimedia Commons (https://commons.wikimedia.org/wiki/File:222_Other_Important_Lipids-01.jpg)\ntrans-Retinal \ntetrahydrocannabinol", "start_char_idx": 0, "end_char_idx": 169, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2fcd8041-02e6-4e96-a35d-801c2169a81b": {"__data__": {"id_": "2fcd8041-02e6-4e96-a35d-801c2169a81b", "embedding": null, "metadata": {"page_label": "23", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1699a1e2-f7eb-4715-91b2-76171e32e8d9", "node_type": null, "metadata": {"page_label": "23", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "b738f30b38cf34a7337c66f8fbcc6f2b5ef2ea0e8313c9758188d44107779e5d"}}, "hash": "e88fbecd15f2ec95d28bd4eb6c7a6adfe182a0a493fa50aea090f53e24a84d11", "text": "Biopolymers are  programmable materials", "start_char_idx": 0, "end_char_idx": 39, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "45e0528a-2bb9-40aa-9fa3-b6e6b04fdad8": {"__data__": {"id_": "45e0528a-2bb9-40aa-9fa3-b6e6b04fdad8", "embedding": null, "metadata": {"page_label": "24", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2e89285d-cd67-438a-a1c6-cd37dad1ddaa", "node_type": null, "metadata": {"page_label": "24", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "bf2d6d10006b0c17b36769df02d92d1bf440785b09a648ac440f767140a4dcd2"}}, "hash": "bf2d6d10006b0c17b36769df02d92d1bf440785b09a648ac440f767140a4dcd2", "text": "monomersABCpolymersABAAABAA\nCBCBAABACBCBAABACBCBAABA", "start_char_idx": 0, "end_char_idx": 52, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f83ea746-90c3-44b0-ab22-c56b782a20b6": {"__data__": {"id_": "f83ea746-90c3-44b0-ab22-c56b782a20b6", "embedding": null, "metadata": {"page_label": "25", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2177da75-a3c9-4dd7-91c7-396eff74e80e", "node_type": null, "metadata": {"page_label": "25", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "fad6ceae468b788a31f19cd13bd3b6c35783a4149d665562cf274e430d83df7c"}}, "hash": "fad6ceae468b788a31f19cd13bd3b6c35783a4149d665562cf274e430d83df7c", "text": "programmable materials: e.g., DNA origami \nFrom: Rothemund, P.W.K, 2006 (doi.org/10.1038/nature04586)", "start_char_idx": 0, "end_char_idx": 101, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "189947f0-7d6b-4918-9666-58c239ebb017": {"__data__": {"id_": "189947f0-7d6b-4918-9666-58c239ebb017", "embedding": null, "metadata": {"page_label": "26", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8acc95f1-80e7-4628-8f6e-f3a072acf140", "node_type": null, "metadata": {"page_label": "26", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "7a9ca3ea8079d5f39ccdb1d463d2155ec51a4f1fb9a67520b70b4159eae9aaab"}}, "hash": "7a9ca3ea8079d5f39ccdb1d463d2155ec51a4f1fb9a67520b70b4159eae9aaab", "text": "From: Crick, F., 1956", "start_char_idx": 0, "end_char_idx": 21, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "366ff943-1a55-4abf-a2ca-0da61dc257bd": {"__data__": {"id_": "366ff943-1a55-4abf-a2ca-0da61dc257bd", "embedding": null, "metadata": {"page_label": "27", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "faed7418-4f49-477d-9c3e-6735993d8d1c", "node_type": null, "metadata": {"page_label": "27", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "dabab3d99e1b9306f216ec04c85d417ffe00b37f43eec1f2067c6742fa834caf"}}, "hash": "dabab3d99e1b9306f216ec04c85d417ffe00b37f43eec1f2067c6742fa834caf", "text": "From: Khan Academy (https://www.khanacademy.org/science/high-school-biology/hs-molecular-genetics/hs-rna-and-protein-synthesis/a/intro-to-gene-expression-central-dogma)", "start_char_idx": 0, "end_char_idx": 168, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fabaa199-2b29-4304-9293-ca23965ee003": {"__data__": {"id_": "fabaa199-2b29-4304-9293-ca23965ee003", "embedding": null, "metadata": {"page_label": "28", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aba80f52-0638-4bcd-ae24-ef59f7531a5a", "node_type": null, "metadata": {"page_label": "28", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "23559e37a8f853ab38a0c09f9ca98e629dcd075494083e952f854b92a0d9df5b"}}, "hash": "23559e37a8f853ab38a0c09f9ca98e629dcd075494083e952f854b92a0d9df5b", "text": "How does information get converted from DNA to proteins?How do atoms  get converted from DNA to proteins?", "start_char_idx": 0, "end_char_idx": 105, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b46ce821-b02b-477d-b474-3f1e16ae68e9": {"__data__": {"id_": "b46ce821-b02b-477d-b474-3f1e16ae68e9", "embedding": null, "metadata": {"page_label": "29", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0364ed87-108a-43a2-8955-ff5f81d645c9", "node_type": null, "metadata": {"page_label": "29", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "a825d5fb921eb8a4a45980ffd1fbcaaef5996338b300e4275a246f76c334cf86"}}, "hash": "a825d5fb921eb8a4a45980ffd1fbcaaef5996338b300e4275a246f76c334cf86", "text": "Atoms: RNA polymerase reads DNA, writes RNA\nFrom: Walter and Eliza Hall Institute (https://www.youtube.com/watch?v=mDZLiZB0iPY&feature=youtu.be&t=174)", "start_char_idx": 0, "end_char_idx": 150, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "977039c1-b9e7-4a92-b6d1-9549604bcaad": {"__data__": {"id_": "977039c1-b9e7-4a92-b6d1-9549604bcaad", "embedding": null, "metadata": {"page_label": "30", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ebf888b7-020e-4ebc-8c44-4fa407b3ad71", "node_type": null, "metadata": {"page_label": "30", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "1f7d187491bd7c6b6d1e19561218f5a96b530cb84f51352da0fd84804b852e79"}}, "hash": "1f7d187491bd7c6b6d1e19561218f5a96b530cb84f51352da0fd84804b852e79", "text": "Atoms: the Ribosome reads RNA, writes protein\nFrom: Walter and Eliza Hall Institute (https://www.youtube.com/watch?v=mDZLiZB0iPY&feature=youtu.be&t=174)", "start_char_idx": 0, "end_char_idx": 152, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6308d5d2-4f2b-4a87-806e-171df07e67df": {"__data__": {"id_": "6308d5d2-4f2b-4a87-806e-171df07e67df", "embedding": null, "metadata": {"page_label": "31", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c035b128-3007-4740-bdbd-52378a31b460", "node_type": null, "metadata": {"page_label": "31", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "c38f6422e54e2abf5f061b37ef7e2de938c397b61e25cc5831a607b8e8afa962"}}, "hash": "50a23c1e81df57370429af0dbd09a293607999cdfd42b75ab5bf61510b6390ce", "text": "Information: the Genetic Code maps RNA to Protein", "start_char_idx": 0, "end_char_idx": 49, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1e0c8a40-7b35-4c2f-894e-9d35dc21e1a9": {"__data__": {"id_": "1e0c8a40-7b35-4c2f-894e-9d35dc21e1a9", "embedding": null, "metadata": {"page_label": "32", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d257ddfa-46b0-4265-ba8d-1e0ca181ff05", "node_type": null, "metadata": {"page_label": "32", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "142a5aa9968f7cde418002f11f65819f3b2f13b1d69f034a3d00ec5d27dca209"}}, "hash": "8c7f77d377ba754b813b16f9210bfec7dd7800056dd4be99fb1b1735c06dc505", "text": "Information: the Genetic Code maps RNA to Protein  \nmRNAUUA\nProteinLeucine", "start_char_idx": 0, "end_char_idx": 74, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6b0f32a0-8e23-4d08-a6dc-48f0e5aa6ba1": {"__data__": {"id_": "6b0f32a0-8e23-4d08-a6dc-48f0e5aa6ba1", "embedding": null, "metadata": {"page_label": "33", "file_name": "200419_biomolecules_deck.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4aa28399-d79d-4307-9ac0-887ee43f9917", "node_type": null, "metadata": {"page_label": "33", "file_name": "200419_biomolecules_deck.pdf"}, "hash": "47ce4ccb2e2ab03cf96f12624c248621caa8b9000b67785883a8a8277b01f51a"}}, "hash": "47ce4ccb2e2ab03cf96f12624c248621caa8b9000b67785883a8a8277b01f51a", "text": "Some awesome links for extra infoProtein Data Bank (web page)Khan Academy - Central Dogma (videos)XBio (e-book)Cell Biology by the Numbers (e-book)Khan Academy - Biomolecules (videos)", "start_char_idx": 0, "end_char_idx": 183, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ee97dd64-c214-4a0a-b67d-0748c3fde2d1": {"__data__": {"id_": "ee97dd64-c214-4a0a-b67d-0748c3fde2d1", "embedding": null, "metadata": {"page_label": "1", "file_name": "Engr_BioE_80_PSET1.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f4b1972e-8a52-466f-8256-3cc01a6214d3", "node_type": null, "metadata": {"page_label": "1", "file_name": "Engr_BioE_80_PSET1.pdf"}, "hash": "5d52cea7a0ae3639b5eecc4d5a2bdfcc2f025c7fe25f33db11f673a6d7f6d51e"}}, "hash": "b85aa1ecf09840500cd3f841462dc90dd78ffc9ae900ed930c3b67f8e7c3b9f8", "text": "Stanford ENGR/BIOE.80 Spring 2020  PSET #1  ASSIGNED: Friday 10 April 2020 DUE: 5:00p Pacific Friday 17 April 2020 NOTES: \u25cf Given the unique circumstance of Spring 2020, we ask you to do your best to maximize your learning. Each problem set is an opportunity to assess your learning, identify gaps, reflect on what you have learned, and determine what you wish to learn next. \u25cf Problem sets must be completed individually unless stated otherwise. \u25cf Please turn in your completed problem sets as an electronic copy via Gradescope. Please make sure to clearly indicate the starting and ending boundaries of your answers to each question on Gradescope.  \u25cf Please do not go over any word limits and where appropriate show your work (e.g., calculations with appropriate units). PSET #1 GOALS:  To help you reflect on the implications and possibilities of engineering living matter. To help you prepare for the quarter by thinking about your individual goals for the class. To introduce or remind you to back-of-the enveloped calculations that enable engineers to quickly frame what might be possible versus what\u2019s likely impossible. (Q1) Who is your bioengineer? (10 pts) Return to your \u201cImagine a Bioengineer\u201d exercise from the first day of class. Sketch your imagined bioengineer as best as you can, on a piece of paper or digitally. Describe your bioengineer with three words. Include your sketch and three words in your submission. At the end of the course, you\u2019ll have a chance to pick three new words. (Q2) What do or could bioengineers do? (20 pts) After the first week of the class, a friend asks you about bioengineering. Your friend is specifically interested in the impact of bioengineering on humanity and civilization to date. Think back and review the three examples provided in the Monday\u2019s post-class reading (e.g., polio vaccine).", "start_char_idx": 0, "end_char_idx": 1842, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a4ea7b18-8d35-4489-b26c-244e1dea05ab": {"__data__": {"id_": "a4ea7b18-8d35-4489-b26c-244e1dea05ab", "embedding": null, "metadata": {"page_label": "2", "file_name": "Engr_BioE_80_PSET1.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "61654af1-2de7-4da1-b49f-1e66dc467aaa", "node_type": null, "metadata": {"page_label": "2", "file_name": "Engr_BioE_80_PSET1.pdf"}, "hash": "e7aa633363377b2c36ac6a097ea49642badbd04a4586e6afe50cc4d94caf112d"}}, "hash": "dab0dabf715eca67c490ed3f4cc8fdcd971e16ff251b210331af42a6b376f924", "text": "2.a. Identify on your own another example (similar to the three examples from the reading) of an impact of bioengineering today. Notes: Keep your answer to one paragraph. Include two to three key references in support of your new example (i.e., newspaper articles, reports, websites). Images are optional. 2.b. Now think about the future. What future do you wish to realize? What roles should bioengineering play in realizing your future? How would you define \u201csuccess?\u201d Do you have any questions on how to realize this future? What trends, tools, policies, and technologies could help you realize this future? Craft an answer in response to some or all of the preceding questions, as before not more than one paragraph.   Comment: Our aim is to enable you to begin to identify, organize, and communicate the topics that you are excited about. Last year, initial efforts from this question helped guide students in considering possible final project topics. (Q3) Approximate and rapid numerical estimates (30 pts) Often, bioengineers encounter a new biological system for which they have no intuition. How can we build intuition such that we have a better understanding of what is physically possible in a new system? As an example, let\u2019s say you wanted to ferment potatoes with wild yeast to make rubbing alcohol. How much alcohol could you make per potato? Or, let\u2019s say you wanted to know how many E. coli cells fit on the head of a pin. These problems don\u2019t seem important on their own, but the process of thinking about and answering them makes it easier to tackle the harder problems in bioengineering.  \u201cFermi problems\u201d are order-of-magnitude estimation puzzles that aim to quickly and approximately answer complicated questions. Engineers do so by using a series of simpler estimations, often using physical principles that are either widely known or easy to guess. For example, before knowing how many bacterial cells might live on the head of a pin, we first need to guess the size of a single cell and the size of the pin head. Such an approach the thinking helps build quantitative intuition for new or unintuitive systems. Bioengineers use Fermi problems to determine the feasibility of an idea or better understand a new system. Again, most such estimates are rough: they are designed to give you a quick, order-of-magnitude intuition for what might be possible or what the likely answer could be. Thus, keep in mind that the exactly correct numerical could be different.", "start_char_idx": 0, "end_char_idx": 2485, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "cb946c0a-3453-46ac-b1c0-64a9413d77ad": {"__data__": {"id_": "cb946c0a-3453-46ac-b1c0-64a9413d77ad", "embedding": null, "metadata": {"page_label": "3", "file_name": "Engr_BioE_80_PSET1.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8c3ae60d-c0bc-4932-ac62-f612bfe01745", "node_type": null, "metadata": {"page_label": "3", "file_name": "Engr_BioE_80_PSET1.pdf"}, "hash": "d4477925af0e29a451d98ba82b24312ad8327c6062ae2098a2875cc74cfd7d04"}}, "hash": "ed53c2ee001963916a184943775f11d69531b1f47395a1d6ece6a832a37be4b0", "text": "For each calculation below please develop your answers to two significant figures and provide units where appropriate. Show your work. You should only need simple math and arithmetic; a couple of lines of work at most. Escherichia coli is a well-studied bacteria considered to be representative of how single-cell microbial systems work generally (i.e., a \u2018model\u2019 organism). E. coli is also easy to grow in the lab and divides rapidly (as fast as 20 mins for one cell to make two cells) . As a result, E. coli is frequently used in bioengineering research. 3.a. First, estimate the volume of an E. coli cell by approximating the cell as a rectangular box 2 um x 1 um x 1 um. Next, estimate the cell volume by approximating the cell as a spherocylinder, as shown in Figure 1. How different are these two approximations? Go to the following page. How does your estimation compare with the measured values? (Optional practice: convert the volume to liters instead of m3) \n  E. coli cells are shaped like rods with rounded ends, which we can approximate as spherocylinders (i.e., cylinder with hemispherical caps). Of historical note, MG1655 is the name for a commonly used lab strain of E. coli that was originally derived from a diphtheria patient at the Palo Alto hospital in 1922.  For the rest of question 3 problem, please use your volume estimate arrived at via your rectangular-box approximation. 3.b. The mean diameter of a typical protein is roughly 4 nanometers (1 billionth of a meter, abbreviated as nm). Presuming all proteins are spheres of this average size, what is the upper bound for how many proteins could fit inside a typical E. coli cell? 3.c. The mean volume of a DNA base pair is 10-27 m3 (1 over 10 followed by 27 zeros). What is the upper bound on how many DNA base pairs could fit inside a typical E. coli cell?", "start_char_idx": 0, "end_char_idx": 1835, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5d23be60-5a7a-4422-b4b3-590f23ce0b23": {"__data__": {"id_": "5d23be60-5a7a-4422-b4b3-590f23ce0b23", "embedding": null, "metadata": {"page_label": "4", "file_name": "Engr_BioE_80_PSET1.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "502271a1-a919-4ec7-affa-60086b96a7ab", "node_type": null, "metadata": {"page_label": "4", "file_name": "Engr_BioE_80_PSET1.pdf"}, "hash": "8e920086d99005fb3d35aa0eb9ffcef1d2585d165ce621aa873ddb07370226cf"}}, "hash": "e95fcee2ba5337f500ad47f6eeb2d2b40a226cbb226155d9b5b47fd52c3acd91", "text": "3.d. Take a look at the actual estimated numbers of proteins and DNA in an E. coli cell from Figure 6a of the following link. What is the ratio of your upper bound numbers to the actual estimated numbers? (present your results in a table) Are you surprised by your result (the upper bound vs actual)? Why or why not? \u201cCell Biology by the Numbers\u201d is a useful resource for learning estimation problems in biology. You can get a free copy of the draft version here. The authors have recently published an informative SARS-CoV-2 (COVID-19) by the numbers as well. (Q4) What's Unique About Living Matter? (10 pts) Revisit the video describing the unique properties of living matter. 4.a. According to the video, what makes living matter unique? (please give two reasons and explain each in 2-3 sentences) 4.b. After watching the video, what did you find most surprising? (2-3 sentences) (Q5) Reading research papers (30 pts) Research papers serve as a primary source of information for many fields. One of the goals for BIOE/ENGR.80 is to give you tools (or improve your tools) that enable you to quickly read and learn from the primary research literature. Briefly read the following paper or preprint: \u201cEnabling community-based metrology for wood-degrading fungi\u201d available from: link 5.a. In your own words, what is the primary claim of the paper? Take a look at the abstract (1-2 sentences) 5.b. In your own words, what is the primary evidence in support of the claim? Take a look at the figures)? (1-2 sentences) 5.c. What did you find as the most interesting idea, fact, conclusion from the abstract of the paper? (From the abstract, figure, or conclusion) (***) YOUR QUESTIONS Do you have any unanswered questions or comments from the first week of class that you would like to share with us?", "start_char_idx": 0, "end_char_idx": 1795, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5ed3e715-fff0-4ff2-bb7e-550a051678f1": {"__data__": {"id_": "5ed3e715-fff0-4ff2-bb7e-550a051678f1", "embedding": null, "metadata": {"page_label": "5", "file_name": "Engr_BioE_80_PSET1.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a66bc89b-3d68-4032-9d33-844381ab7fc9", "node_type": null, "metadata": {"page_label": "5", "file_name": "Engr_BioE_80_PSET1.pdf"}, "hash": "a08dc7a6d0433a8805235c4c538491e8cbfa04e4236db537ea70c5864b24e27b"}}, "hash": "5857509460d2a0f05b6899da19ae43f2cf40432b9867fe57b92be203eb832b09", "text": "Additional Learning Resources: You can make and keep track of your own private library of bioengineering research papers.  Tools can help.  For example here is a link to a free and useful resource: Zotero The takeaway here is to make sure you have a system in place for managing your resources that support your thinking and problem solving. Biology refresher-1: If you need additional learning materials or refresher for biology you can start by going through the first three chapters (very brief don't worry) of The Machinery of Life by David S. Goodsell. An electronic copy of the book is available from Stanford Library and you should be able to access from here", "start_char_idx": 0, "end_char_idx": 666, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c0468e9c-d9f3-4bd4-b8bb-8c05b63370f0": {"__data__": {"id_": "c0468e9c-d9f3-4bd4-b8bb-8c05b63370f0", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "af3149a5-22ae-4a37-ba9f-0daa7bbc7c9a", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "dbe88df6e8810c1d033591b34ee265157f8f20277ff7d1299c8bed28cfd46cd8"}}, "hash": "6585f21dad5a8060035814e65e5dc52e3aaa83aff68813f1f33fbf0753c78e2a", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 1027 April 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 354, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "83f76be8-5781-45a3-bcca-9e75f840e5d5": {"__data__": {"id_": "83f76be8-5781-45a3-bcca-9e75f840e5d5", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a927777f-51d0-4918-8821-d113c1d616d7", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "17613e1131213e1e459978aee8e6bc93b197891d3e1d52fcafcbf8469f5b0194"}}, "hash": "17613e1131213e1e459978aee8e6bc93b197891d3e1d52fcafcbf8469f5b0194", "text": "Week 3 repriseWho are you and how are you motivated?Analysis and design of biomoleculesBuild & use your own microscope-Foldscope-Bioengineers make and improve tools-The value of a technology is in large part de\ufb01ned by who can use the technology where CONCEPTSKILLAnalysis and design of genetic systems-Learn by understanding or learn by doing or other\u2026-DNA encodes useful molecules that can be redesigned -Biosystems can be designed bottom-up; profound noise?", "start_char_idx": 0, "end_char_idx": 459, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f808eb8a-9d9f-4b9a-b123-90fb64f37d1a": {"__data__": {"id_": "f808eb8a-9d9f-4b9a-b123-90fb64f37d1a", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "db0c8ecf-f252-41fd-bf90-2a2f2f45d1b4", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "f1f74d06f5acd5d3eddd633d0e02a173ab4a48c7d62108cbe6061f0716092ab9"}}, "hash": "f1f74d06f5acd5d3eddd633d0e02a173ab4a48c7d62108cbe6061f0716092ab9", "text": "STATED DIFFERENTLY RE: FOLDSCOPE \u2014    GO FOR IT; B.E. AWESOME; DISCOVER; INVENT; TEACH", "start_char_idx": 0, "end_char_idx": 86, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7c14baa3-cf9f-4b7b-bd9a-de0e8c933b80": {"__data__": {"id_": "7c14baa3-cf9f-4b7b-bd9a-de0e8c933b80", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9d2c51f3-1f65-43c3-848d-7b8c9aaaae30", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "cc392b363fd1199bae5da9ffbd447b4e283741492fafa676c528f759d5871edb"}}, "hash": "cc392b363fd1199bae5da9ffbd447b4e283741492fafa676c528f759d5871edb", "text": "Week 4 look aheadAbstraction as a tool for managing biocomplexity General system architecture for genetic engineeringI like, I wish, what if?CONCEPTSKILL\nT eam(s) rule(s)", "start_char_idx": 0, "end_char_idx": 170, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "bfb98fbd-69f8-4a74-9bfc-1d5f3779a1b5": {"__data__": {"id_": "bfb98fbd-69f8-4a74-9bfc-1d5f3779a1b5", "embedding": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "de77d731-5d31-480e-9b02-e0a148e6f2fa", "node_type": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "369d961713730e3111f4d5c7ce1081086a341694abb1c3665f2fa64d4604f2e3"}}, "hash": "369d961713730e3111f4d5c7ce1081086a341694abb1c3665f2fa64d4604f2e3", "text": "Claude Shannon, c.1937\nGeorge Boole, c.1854\nFrom George (logic) to Claude (electrical relays) to \u2026", "start_char_idx": 0, "end_char_idx": 98, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ac60a717-41fd-4e23-9a9c-8b3861548e85": {"__data__": {"id_": "ac60a717-41fd-4e23-9a9c-8b3861548e85", "embedding": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c0a248b4-1429-412f-85a2-7cfb4f97a35b", "node_type": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "ce0671e4f20d45cd360641f99cc98770027e15b7da4a50f8f0a290cf03621df1"}}, "hash": "ce0671e4f20d45cd360641f99cc98770027e15b7da4a50f8f0a290cf03621df1", "text": "Let\u2019s bioengineer living computers!!!", "start_char_idx": 0, "end_char_idx": 37, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fa6a722a-90a2-4baf-9482-68e72cdba3b9": {"__data__": {"id_": "fa6a722a-90a2-4baf-9482-68e72cdba3b9", "embedding": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8a8e756c-7d2f-4aef-acde-8abe31a85285", "node_type": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "fb718a36f1488fc3a16c8e8de0318db6ec0e0ad1ba9f658c7cdd2d67b2b09976"}}, "hash": "fb718a36f1488fc3a16c8e8de0318db6ec0e0ad1ba9f658c7cdd2d67b2b09976", "text": "https://www.cshlpress.com/link/genswitp.htmHmm.  As an engineer I was expecting a switch I could use, but instead I got a super complicated never-ending story.", "start_char_idx": 0, "end_char_idx": 159, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fb5d495d-c999-4156-9d54-92b088813f42": {"__data__": {"id_": "fb5d495d-c999-4156-9d54-92b088813f42", "embedding": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7aae59f0-f6c5-4c31-b9d6-1818fe4caae7", "node_type": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "6866b9e1e4e70ac8d4d05779267af8eed3ae92ab66797deeaedf320a6141c5f5"}}, "hash": "6866b9e1e4e70ac8d4d05779267af8eed3ae92ab66797deeaedf320a6141c5f5", "text": "St-Pierre & Endy PNAS USA 2008\nhttp://youtu.be/sLkZ9FPHJGM\nc/o Dinsdale Lab, SDSU", "start_char_idx": 0, "end_char_idx": 81, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fa973945-4a4d-45b5-a690-4ccab4f2ee91": {"__data__": {"id_": "fa973945-4a4d-45b5-a690-4ccab4f2ee91", "embedding": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c3f6d652-1d3a-4011-8345-7b43154d447b", "node_type": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "7e1aafbf0789e0fd3c9ad0a07211615a317cd92d0c38948279a3cfb324abae1a"}}, "hash": "7e1aafbf0789e0fd3c9ad0a07211615a317cd92d0c38948279a3cfb324abae1a", "text": "https://en.wikipedia.org/wiki/Bacteriophage", "start_char_idx": 0, "end_char_idx": 43, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "342ae22d-56c2-4f88-b8fa-645ef98e84cf": {"__data__": {"id_": "342ae22d-56c2-4f88-b8fa-645ef98e84cf", "embedding": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "214c2c80-da52-4e5e-9eca-340ef182e59b", "node_type": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "8ed86d3825a5882a36b364d7ef2b2e3b004ff803a71a812507fa34ecfa967ab2"}}, "hash": "756f62ad4ea2f0ed456e78dd196eb80c155f965ce1e3ae04a0bcfc7eba7f0b9a", "text": "http://bio.classes.ucsc.edu/bio105l/EXERCISES/PHAGE/dH.pdfhttps://en.wikipedia.org/wiki/F%C3%A9lix_d%27Herelle", "start_char_idx": 0, "end_char_idx": 110, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f4097ff7-e5e2-4a95-ad80-a7b71922fbb0": {"__data__": {"id_": "f4097ff7-e5e2-4a95-ad80-a7b71922fbb0", "embedding": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0a5a8146-d989-43db-bd13-071849a61dc8", "node_type": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "8ce904af98697ded4913e4297d5ddf693319657de4cdb403d4e83947d68f68be"}}, "hash": "7f5dffc26465f2de6244faa8b9b5eb00435fbf1cd88180ea14c1713d0419c0d3", "text": "http://bio.classes.ucsc.edu/bio105l/EXERCISES/PHAGE/dH.pdf", "start_char_idx": 0, "end_char_idx": 58, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2ae0d4e8-0e4b-4a0c-9174-030aea9bad7c": {"__data__": {"id_": "2ae0d4e8-0e4b-4a0c-9174-030aea9bad7c", "embedding": null, "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "12a1ccb9-4cd9-401e-b78a-284992d075b3", "node_type": null, "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "04f6ff1d897e99c35c4a0f26c6472f394015c7f040de5e5077d6f4533082ef07"}}, "hash": "04f6ff1d897e99c35c4a0f26c6472f394015c7f040de5e5077d6f4533082ef07", "text": "23\nKaren Rutherford & Gregory D Van Duyne (2014) The ins and outs of serine integrase site-speci\ufb01c recombination http://dx.doi.org/10.1016/j.sbi.2014.01.003\u201cRecombinases\u201d mediate \u201ccut, exchange, & paste\u201d among two DNA molecules", "start_char_idx": 0, "end_char_idx": 227, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7eb22c98-9365-42a0-94a4-5a5490a82774": {"__data__": {"id_": "7eb22c98-9365-42a0-94a4-5a5490a82774", "embedding": null, "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "14633116-3be4-49c1-ac2a-af6833fb77e8", "node_type": null, "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "409f0e6a5bbcdd5783ec9d25f3a2d588e22dec003bda6029f467ee21abcac5b7"}}, "hash": "409f0e6a5bbcdd5783ec9d25f3a2d588e22dec003bda6029f467ee21abcac5b7", "text": "24Karen Rutherford & Gregory D Van Duyne (2014) The ins and outs of serine integrase site-speci\ufb01c recombination http://dx.doi.org/10.1016/j.sbi.2014.01.003Recombinase Directionality Factors (RDFs) can reverse the recombination reaction \nA plausible model for recombination directionality factor (RDF)-stimulated excision. The RDFs (yellow) could bind to the Int CC motifs and disrupt the intra-molecular interactions responsible for inhibiting attL \u00d7 attR recombination. The RDFs may also interact with additional integrase domains and in some systems may interact with one another. Integrase domains are colored as in Figure 1.", "start_char_idx": 0, "end_char_idx": 628, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b97cf4d7-39b5-4b33-aa25-2a3787dd278a": {"__data__": {"id_": "b97cf4d7-39b5-4b33-aa25-2a3787dd278a", "embedding": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "384ee793-8cfc-4eef-bb78-2279591ec169", "node_type": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "e3f8fed11e2f91283fdf7dfd30e6c36514b043669c62792fbf02fdd7920cc341"}}, "hash": "6f024f3c43bb94eef2a0f2f567a671f4205b88e072baca53e74867114b6d912a", "text": "Wait\u2026     Unending biological details\u2026       Overwhelming complexity\u2026            Having to do science\u2026                No end in sight\u2026", "start_char_idx": 0, "end_char_idx": 134, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1384580d-2dca-437c-8a6e-ae3f49fa47d4": {"__data__": {"id_": "1384580d-2dca-437c-8a6e-ae3f49fa47d4", "embedding": null, "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8eacd4ca-96bd-4d7a-ae66-84fcfa82fecf", "node_type": null, "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "2a90ac01dd99b6f1eb113a0ea20833e761d62b7f315f57b4569704c82dd12cff"}}, "hash": "2a90ac01dd99b6f1eb113a0ea20833e761d62b7f315f57b4569704c82dd12cff", "text": "http://images2.layoutsparks.com/1/210989/beach-paradise-deault-trees.jpg", "start_char_idx": 0, "end_char_idx": 72, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a3e6426d-3c71-4323-9449-ced0a6857fe7": {"__data__": {"id_": "a3e6426d-3c71-4323-9449-ced0a6857fe7", "embedding": null, "metadata": {"page_label": "27", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4cfc7e19-b986-47ac-8230-1fe5c89a1d7c", "node_type": null, "metadata": {"page_label": "27", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "b6cebb8a809a4ddd69d5c460b36e79d1ce815cbe737836300a4058433ab4d7f9"}}, "hash": "b6cebb8a809a4ddd69d5c460b36e79d1ce815cbe737836300a4058433ab4d7f9", "text": "https://www.123rf.com/photo_7546464_a-tangle-of-cables-and-wires-in-shanghai-china.htmlQ.  What is the magnetic \ufb01eld?\nA.  Who cares!", "start_char_idx": 0, "end_char_idx": 132, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e5542335-5114-4da7-bea6-e1acba868855": {"__data__": {"id_": "e5542335-5114-4da7-bea6-e1acba868855", "embedding": null, "metadata": {"page_label": "29", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f5decd1b-4ffa-446c-8671-1cb14dd17f5d", "node_type": null, "metadata": {"page_label": "29", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "ee09beae01873eb1ec101225af01877eee975bcf221b7f775560821d37d08721"}}, "hash": "ee09beae01873eb1ec101225af01877eee975bcf221b7f775560821d37d08721", "text": "Systems = One or more devices encoding a human de\ufb01ned function(s).  Note that my system your device, and so on.Devices = One or more parts encoding a human de\ufb01ned function(s).Parts = Basic biological functions encoded via molecules.DNA = Material encoding moleculesTAATACGACTCACTATAGGGAGA\n8-bit counter\nAbstraction barrier!  Do not cross!\nAbstraction barrier!  Do not cross!\nAbstraction barrier!  Do not cross!", "start_char_idx": 0, "end_char_idx": 410, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ec884725-99c2-43fa-ba57-cc1125ab4593": {"__data__": {"id_": "ec884725-99c2-43fa-ba57-cc1125ab4593", "embedding": null, "metadata": {"page_label": "30", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "45ee9676-4042-413c-a5c2-9739ae78450c", "node_type": null, "metadata": {"page_label": "30", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "1b746c846b5d71d375882fd4107de96141a3c8a79e11838a5e156e905ae64639"}}, "hash": "1b01b4dae2f351118f14672d1f859bea506b5c062f9c6dd463fa56a34af148d9", "text": "30\nKaren Rutherford & Gregory D Van Duyne (2014) The ins and outs of serine integrase site-speci\ufb01c recombination http://dx.doi.org/10.1016/j.sbi.2014.01.003If we connect the two pieces of DNA then the connecting fragment would be \ufb02ipped!", "start_char_idx": 0, "end_char_idx": 237, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "058a97e4-77f5-44fc-babc-e3ba976fc8fb": {"__data__": {"id_": "058a97e4-77f5-44fc-babc-e3ba976fc8fb", "embedding": null, "metadata": {"page_label": "31", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aa63fe36-66ab-4604-a512-1a24bf9efddf", "node_type": null, "metadata": {"page_label": "31", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "4c2feb87359baf86b0b3c30b48467866014b5581e6d09527cc3dbf83d579fd11"}}, "hash": "4c2feb87359baf86b0b3c30b48467866014b5581e6d09527cc3dbf83d579fd11", "text": "Control Signal #1Control Signal #2\n31TTPolymerasePolymeraseMr. Boole\u2019s AND in DNA\nControl Signal #1Control Signal #2\nBonnet et al., Science, 2013", "start_char_idx": 0, "end_char_idx": 145, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5d6692b1-5bc8-4ef6-83fe-b6386f60c7d1": {"__data__": {"id_": "5d6692b1-5bc8-4ef6-83fe-b6386f60c7d1", "embedding": null, "metadata": {"page_label": "32", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7e66a00c-9e2b-43ba-9963-7d9dc0c0e8f0", "node_type": null, "metadata": {"page_label": "32", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "cebab36555f95b01c8b91a02253cf8babe8936ee57945ac92a58a27fceb4fc3e"}}, "hash": "db1d6c8a2a47ba01faf8663b4d6490be866abf10de75acbe13aff6e625d4751b", "text": "32Transcriptor ElementsInputOutputRecombinationControllerControls\nBonnet et al., Science, 28 March 2013Generic device-level architecture for recombinase-based genetic logic gates", "start_char_idx": 0, "end_char_idx": 178, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c300f158-5d99-4fc2-b681-d41e3d26b222": {"__data__": {"id_": "c300f158-5d99-4fc2-b681-d41e3d26b222", "embedding": null, "metadata": {"page_label": "33", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "091195b6-77f7-4c41-9a95-d2e7458e1454", "node_type": null, "metadata": {"page_label": "33", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "e1c081e30d3bfdb651e4bcc2e5560cf1c38bdf658a1df1ad4ae82d4da6c17979"}}, "hash": "e1c081e30d3bfdb651e4bcc2e5560cf1c38bdf658a1df1ad4ae82d4da6c17979", "text": "33\nSetting up goal of engineering genetic \u201cblack box\u201d that allows us readily reuse higher-level, human-de\ufb01ned functions\u2026Inputs: generic (i.e., device agnostic) signals that control levels of gene expressionOutput:  generic signals that control levels of gene expression", "start_char_idx": 0, "end_char_idx": 269, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "54447828-fb03-4280-8f44-cff96ea6b8c8": {"__data__": {"id_": "54447828-fb03-4280-8f44-cff96ea6b8c8", "embedding": null, "metadata": {"page_label": "34", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b5c8f1fa-1d35-4434-aef9-5a73150765fc", "node_type": null, "metadata": {"page_label": "34", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "993764522384772f51f0fec10e97a40cfefb54ae261433ed669fda59162fdc3f"}}, "hash": "a931400503b04c845c6761e0040def30113730aaba3db3c815d260cc65110ce8", "text": "Dr. Jennifer Brophy", "start_char_idx": 0, "end_char_idx": 19, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fc064960-13bd-4e43-a7de-84295a9e1336": {"__data__": {"id_": "fc064960-13bd-4e43-a7de-84295a9e1336", "embedding": null, "metadata": {"page_label": "35", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8d8847a0-8a60-4d44-a48c-cfe9a329fced", "node_type": null, "metadata": {"page_label": "35", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}, "hash": "2f7bf8ebe5a497a7bf61b94a25278748fbd1ce770f198aa87d7ee04b98fb280c"}}, "hash": "67b64c134643b8c9c25d4e5c375d1bdd9b4bf1cdaf4661f6254ff79d6afb1310", "text": "BREAKOUTImagine Y our Biocomputer\n35Where in biology (i.e., living matter) would you    wish to bioengineer a computation?  How many bits need to be handled?  How fast does your biocomputer need to be?", "start_char_idx": 0, "end_char_idx": 201, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9ecc34e4-d4c2-42ea-9044-2ed4b4532ebe": {"__data__": {"id_": "9ecc34e4-d4c2-42ea-9044-2ed4b4532ebe", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "847cc523-ad0a-430e-9a4d-10c322d69765", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "04c2c9bb0866d670c9bcaf9691a64d41dc6868d681ff305235916a49558f63ce"}}, "hash": "064c778907961ff4498c7c7ff3542c2d3151fd295f53e7f4619c9b17e3248664", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 1129 April 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 354, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c0d8ce06-93ba-44a1-a160-b53a3ee45f2c": {"__data__": {"id_": "c0d8ce06-93ba-44a1-a160-b53a3ee45f2c", "embedding": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c43957d4-d1c4-483d-9617-f253fd4ce501", "node_type": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "0398d8c091110607b3b81c784431afe823ce4860ebb1efb211e641e84f09490e"}}, "hash": "0398d8c091110607b3b81c784431afe823ce4860ebb1efb211e641e84f09490e", "text": "https://www.nature.com/articles/s41587-020-0500-9Plants that make their own light?!", "start_char_idx": 0, "end_char_idx": 83, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "08cddb51-3849-4cea-aaf4-c0da244d1053": {"__data__": {"id_": "08cddb51-3849-4cea-aaf4-c0da244d1053", "embedding": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8cc7038e-4a92-4545-9eae-b44d918c4034", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "e9e0619c6eb53577a18ca05be7358faa3ca3df4dbbd2b264d30ff15f9650576c"}}, "hash": "e9e0619c6eb53577a18ca05be7358faa3ca3df4dbbd2b264d30ff15f9650576c", "text": "https://www.nature.com/articles/s41587-020-0500-9Plants that make their own light?!", "start_char_idx": 0, "end_char_idx": 83, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1183b9b3-19f3-4429-93a4-c7f3c1e31590": {"__data__": {"id_": "1183b9b3-19f3-4429-93a4-c7f3c1e31590", "embedding": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2ba33c6f-138c-497a-8c34-2e26dcee99d8", "node_type": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "3176b63e65ef55bc6f4c92bc34e40c15ecbf41d0c58858df16583e30450734e2"}}, "hash": "3176b63e65ef55bc6f4c92bc34e40c15ecbf41d0c58858df16583e30450734e2", "text": "https://www.nature.com/articles/s41587-020-0500-9Plants that make their own light?!", "start_char_idx": 0, "end_char_idx": 83, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1c7b442b-2145-4df4-844c-80476f5a3c3e": {"__data__": {"id_": "1c7b442b-2145-4df4-844c-80476f5a3c3e", "embedding": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b6e75d96-528d-4876-98cb-3bb412d062e3", "node_type": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "1404045710350326c5010e4330e1d6942045127293056577b6ce83e2bd2e78aa"}}, "hash": "1404045710350326c5010e4330e1d6942045127293056577b6ce83e2bd2e78aa", "text": "https://www.nature.com/articles/s41587-020-0500-9Trillion-fold less bright than 100w bulb?\nI like glowing plantsI wish for brighter, more colors, controlWhat if we used bioengineering abstraction?", "start_char_idx": 0, "end_char_idx": 196, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b32e5894-f76a-4de6-9a31-182d73c787e1": {"__data__": {"id_": "b32e5894-f76a-4de6-9a31-182d73c787e1", "embedding": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2add9834-e099-46b5-92e6-1bf112a8c8e2", "node_type": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "53ef477bcd7889d4a093a9faad7234664768f158c9217245e5d8d39734aaf099"}}, "hash": "044c49c252a99d40ba9471f308617dcabf649bdc07ea48a7f510108a15fa43ea", "text": "Dr. Jennifer Brophy       (previous class)\nT urn light on/off?At speci\ufb01c locations?Different logic \u201cgates\u201d set their output values depending on their input values", "start_char_idx": 0, "end_char_idx": 162, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "15f7d3da-a0d5-41bd-9199-de4c90444ef9": {"__data__": {"id_": "15f7d3da-a0d5-41bd-9199-de4c90444ef9", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "558b39a2-a42c-49c9-8965-e91aeefb5e8c", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "8395ee5b066a2603e60b5dfcdeaab757e96bbb71cbd32f3b38277d25db2fe675"}}, "hash": "8395ee5b066a2603e60b5dfcdeaab757e96bbb71cbd32f3b38277d25db2fe675", "text": "How do we bioengineer genetic logic gates so that they are easy for others to use*?*if we can do so for logic gates then we can likely do so for any sort of genetically-encoded device\nThe challenge of abstraction\u2026", "start_char_idx": 0, "end_char_idx": 213, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "08bca4d2-56a8-4342-97ac-2b24f0d780e6": {"__data__": {"id_": "08bca4d2-56a8-4342-97ac-2b24f0d780e6", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5b3cd6cc-74ab-4144-bd11-836d4294b1a1", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "fd14fc52152fe20f789cf83905157ba20f10871d11a5534b60a1533a5572e53b"}}, "hash": "fd14fc52152fe20f789cf83905157ba20f10871d11a5534b60a1533a5572e53b", "text": "https://en.wikipedia.org/wiki/Synthetic_biological_circuitAND gate (transcription-initiation based)", "start_char_idx": 0, "end_char_idx": 99, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "50949945-c3b3-4eab-888d-2678fd288602": {"__data__": {"id_": "50949945-c3b3-4eab-888d-2678fd288602", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "76dd1dd1-a980-469c-929d-45be7af573fb", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "1ce5ea466866013afc65ca9c319215a2f42d1691dfd2f9b76294e7d8eb68238c"}}, "hash": "1ce5ea466866013afc65ca9c319215a2f42d1691dfd2f9b76294e7d8eb68238c", "text": "https://en.wikipedia.org/wiki/Synthetic_biological_circuit\nOR gate (transcription-initiation based)", "start_char_idx": 0, "end_char_idx": 99, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8561daae-3c82-4130-9618-5e68d14d35ec": {"__data__": {"id_": "8561daae-3c82-4130-9618-5e68d14d35ec", "embedding": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "536ed06a-1bf1-4332-ab44-6a24ca0a70ab", "node_type": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "1349ccead5788ea05c0e396aab487b7ba8a6b047e9038e0fcbe67dd12e5438ae"}}, "hash": "1349ccead5788ea05c0e396aab487b7ba8a6b047e9038e0fcbe67dd12e5438ae", "text": "https://en.wikipedia.org/wiki/Synthetic_biological_circuit\nNAND gate (transcription-initiation based)", "start_char_idx": 0, "end_char_idx": 101, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8852690d-563a-4a1c-a387-543081112713": {"__data__": {"id_": "8852690d-563a-4a1c-a387-543081112713", "embedding": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7056acff-81fd-4c47-ac1d-aa3d44039b2d", "node_type": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "e316d8eacbb768c10407308710d715c8e46fc0c6d398a2078be91fec03d30f62"}}, "hash": "e316d8eacbb768c10407308710d715c8e46fc0c6d398a2078be91fec03d30f62", "text": "https://en.wikipedia.org/wiki/Synthetic_biological_circuitAND gate Where we draw the \u201cbox\u201d determines how easy/hard device will be to reuse", "start_char_idx": 0, "end_char_idx": 139, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e2622b0e-c5f4-43b8-9d08-3fbde9ef4c2f": {"__data__": {"id_": "e2622b0e-c5f4-43b8-9d08-3fbde9ef4c2f", "embedding": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a5f75fd9-5e62-454d-a1e0-c530dda55998", "node_type": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "6e59e82c392b310c3df2bf144898b59ab3f30e387fe7002f0ae70e8ab483b5ce"}}, "hash": "84286ed09d23f9da3cfaf727f5dacb733c32e56be4946f7a802a29e1909c4a06", "text": "https://en.wikipedia.org/wiki/Synthetic_biological_circuitAND gate (PoPS-based)A common-signal carrier enables proper abstraction", "start_char_idx": 0, "end_char_idx": 129, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "466b73ef-2ef1-4d7e-a903-5949c4f03dfb": {"__data__": {"id_": "466b73ef-2ef1-4d7e-a903-5949c4f03dfb", "embedding": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f89f877f-a5d2-4a17-9e73-55b60b4c07e5", "node_type": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "16cc34b68795096c1dc166c34bd9eff7da6e890a004887b38c45ba656bc58125"}}, "hash": "16cc34b68795096c1dc166c34bd9eff7da6e890a004887b38c45ba656bc58125", "text": "PolymerasePolymerasePolymerasePolymerasePolymerasePolymerasePolymerase(from any source)(to any destination)Polymerase Per Second(transcription elongation \u2018current\u2019)", "start_char_idx": 0, "end_char_idx": 164, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5bb8219a-03ce-4699-b13d-ddaf870c96a3": {"__data__": {"id_": "5bb8219a-03ce-4699-b13d-ddaf870c96a3", "embedding": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f4773fad-1731-4484-9bfe-6c969b86c51f", "node_type": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "ba378f8756c3cbfa6220dcae114cfcaba97b9bbcbf18beb9be63fd7e6c2de0c3"}}, "hash": "ba378f8756c3cbfa6220dcae114cfcaba97b9bbcbf18beb9be63fd7e6c2de0c3", "text": "Control Signal #1Control Signal #2TTPolymerasePolymeraseAND gate (transcription-elongation based)\nBonnet et al., Science, 2013", "start_char_idx": 0, "end_char_idx": 126, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "93fc4c02-6c4e-4bb2-8383-6c74a5511f65": {"__data__": {"id_": "93fc4c02-6c4e-4bb2-8383-6c74a5511f65", "embedding": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dad44534-f2f8-4299-8541-aac67e0adebb", "node_type": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "e474534efcc4d4322a7bbfef25fc9f0cfaa2f96be0b87e0a5d902ad4f5e32509"}}, "hash": "e474534efcc4d4322a7bbfef25fc9f0cfaa2f96be0b87e0a5d902ad4f5e32509", "text": "Control SignalsTPolymerasePolymerase\nBonnet et al., Science, 2013XOR gate (transcription-elongation based)", "start_char_idx": 0, "end_char_idx": 106, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0a829309-4572-4c18-9f2b-879a527394f1": {"__data__": {"id_": "0a829309-4572-4c18-9f2b-879a527394f1", "embedding": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dee24cd6-e25a-4e11-95cc-d1dd600fb258", "node_type": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "8bc47f9dc831efed788c88fe702f23233a1d24331ec15536ab22ef15e2772caa"}}, "hash": "8bc47f9dc831efed788c88fe702f23233a1d24331ec15536ab22ef15e2772caa", "text": "Computer(Logic & Memory)Can abstract and connect not only logic but sensing and actuation via PoPS\n17SensorsEnvironmental InputsActuatorsOutputs, Activities, & Phenotypes", "start_char_idx": 0, "end_char_idx": 170, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e417585b-1cca-459f-9fca-4669ede2b095": {"__data__": {"id_": "e417585b-1cca-459f-9fca-4669ede2b095", "embedding": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7910c92b-e77a-4593-8e8e-c052461c22ff", "node_type": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "beaa19c20205a4fe90fadfc8f6efe0f8eba333bee15168ace5274a5db3c6977f"}}, "hash": "beaa19c20205a4fe90fadfc8f6efe0f8eba333bee15168ace5274a5db3c6977f", "text": "* Li & Cannon, J Bacteriol, May 1998, p. 2450-2458, Vol. 180, No. 9 (U. Mass. Amherst)", "start_char_idx": 0, "end_char_idx": 86, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "af597769-f624-48bf-9104-560849b54ccc": {"__data__": {"id_": "af597769-f624-48bf-9104-560849b54ccc", "embedding": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4fb31344-41d5-491a-b3af-3c8cfb080810", "node_type": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "69125fe4e25ca21c1a50e77961c821528b875953f9fe58edb72ba0427578c2dd"}}, "hash": "5e56b887adb4432549930bc8ab3bb7b636234885ee40a22236fa02a296cd2372", "text": "Protein Balloon DNA", "start_char_idx": 0, "end_char_idx": 19, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "42720fb3-d2f7-4d1f-aa80-1ac0b3608158": {"__data__": {"id_": "42720fb3-d2f7-4d1f-aa80-1ac0b3608158", "embedding": null, "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "28eb9a33-5d63-4346-8782-6cc4c110c7ef", "node_type": null, "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "079fa2b90a4cedb06095a380a5a467b6c2ac8d4beb4e16d77db6803878be7f9b"}}, "hash": "079fa2b90a4cedb06095a380a5a467b6c2ac8d4beb4e16d77db6803878be7f9b", "text": "Many thousand so-called BioBrick DNA parts.Freely available.To d ay.", "start_char_idx": 0, "end_char_idx": 68, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7e5a0b44-f57d-4ec8-914c-be80a6141d00": {"__data__": {"id_": "7e5a0b44-f57d-4ec8-914c-be80a6141d00", "embedding": null, "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a381e99d-428e-4584-b1d8-1f38875bb39d", "node_type": null, "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "4dd22d0ba77d0e9b60031667422e8f857d0aab896ffea8e8dbef1b6c90bf1abb"}}, "hash": "4dd22d0ba77d0e9b60031667422e8f857d0aab896ffea8e8dbef1b6c90bf1abb", "text": "iGEM 2010\n23", "start_char_idx": 0, "end_char_idx": 12, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "cb9e95d1-1e47-4320-b97a-60eb34180a79": {"__data__": {"id_": "cb9e95d1-1e47-4320-b97a-60eb34180a79", "embedding": null, "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cfebc3f6-a515-426c-9fbe-8664a8d0a0f7", "node_type": null, "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "870cd8ac67c3099424fe21c2c9c77ca826162f111232f5d01828afa00ea9108a"}}, "hash": "870cd8ac67c3099424fe21c2c9c77ca826162f111232f5d01828afa00ea9108a", "text": "Polymerase Per Second (PoPS) as common signal carrier for transcription-based devices24Sensor AOutputInputActuator AInputOutputFunctional composition... what should the \u201coutput\u201d of any Sensor be so that it can connect with the \u201cinput\u201d of any Actuator?Actuator BInputOutputActuator CInputOutputActuator DInputOutputSensor BOutputInputSensor COutputInput", "start_char_idx": 0, "end_char_idx": 352, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d5e11156-e53e-4dd6-bfe5-ecf30222e4da": {"__data__": {"id_": "d5e11156-e53e-4dd6-bfe5-ecf30222e4da", "embedding": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "73c156b3-4447-40cf-a167-5f3a9c734ba9", "node_type": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "b10eb66a40fe26d9ca2e3c7453c7eb86aa4d589df417d940f354330ed30bdba9"}}, "hash": "b10eb66a40fe26d9ca2e3c7453c7eb86aa4d589df417d940f354330ed30bdba9", "text": "https://www.allaboutcircuits.com/textbook/digital/chpt-3/logic-signal-voltage-levels/Signal levels (standards) & digitization", "start_char_idx": 0, "end_char_idx": 125, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2821b06f-8e6b-475d-9da1-310ef9af7cd9": {"__data__": {"id_": "2821b06f-8e6b-475d-9da1-310ef9af7cd9", "embedding": null, "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0521c137-7569-46fb-a7f5-ec9863101883", "node_type": null, "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}, "hash": "e8ab806a1f80029be0a1e48c068918ccaaea3124f51f9fde49e9b5b309321273"}}, "hash": "e8ab806a1f80029be0a1e48c068918ccaaea3124f51f9fde49e9b5b309321273", "text": "Y ou can make genetically-encoded molecular machines.Doing so smartly requires going up and down our abstraction hierarchy (otherwise too complicated).Most of these engineering approaches are entirely new to biology (i.e., this type of bioengineering is v. new).Details include: Identifying and implementing device boundaries & common signal carriers. Considering signal level matching & digitization/                         ampli\ufb01cationComputer(Logic)SensorsEnvironmental InputsActuatorsOutputs, Activities, & Phenotypes", "start_char_idx": 0, "end_char_idx": 522, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c2ee4bd6-dbbf-4991-99ba-0f8c5efe2485": {"__data__": {"id_": "c2ee4bd6-dbbf-4991-99ba-0f8c5efe2485", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "59d266c8-e7ee-40b0-9bab-23daf7d679cc", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "9931bc7fe6479da3de7f1a3aa2bfac3d5aaec146147f020ecb380654d17a4f6c"}}, "hash": "131e3bbdad5ad5f2d6c195a3dc8e52c2239a8637e5dbe51bde1e7c156e7a47d6", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 134 May 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 351, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9c2b8f81-ff0b-4942-a01f-ecea43702233": {"__data__": {"id_": "9c2b8f81-ff0b-4942-a01f-ecea43702233", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "93e4e1d4-2431-490e-9736-b0ee0c6a03d3", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "ed57fa5749dbb44dc2427b430e6a46fcf9afdd99f8db9558543385ddf510ab62"}}, "hash": "ed57fa5749dbb44dc2427b430e6a46fcf9afdd99f8db9558543385ddf510ab62", "text": "Week 4 repriseAbstraction as a tool for managing biocomplexity Brain Storm; I Like, I Wish; What IfGeneral system architecture for genetic engineering-Go for quantity (how many ideas can you imagine?)-Don\u2019t be constrained by what exists (> vanilla ice cream)-Engage others on a constructive basis-Bioengineers can compose higher-level human-de\ufb01ned functions (i.e., devices) from functional biomolecules.-Common-signal carriers facilitate device reuse.-Synthetic logic can operate inside living systems. -Sense, Compute,  Act enables general purpose cell-system programming.CONCEPTSKILL", "start_char_idx": 0, "end_char_idx": 585, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d4f58d19-7c2c-4dcb-9f46-bf4556991918": {"__data__": {"id_": "d4f58d19-7c2c-4dcb-9f46-bf4556991918", "embedding": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "64b1958f-904f-4b8a-a68a-d910a22ec84f", "node_type": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "88bbcda22e1e34d1c8d4b8f5a29b4933082db28250c5fe25757232441683c991"}}, "hash": "88bbcda22e1e34d1c8d4b8f5a29b4933082db28250c5fe25757232441683c991", "text": "Week 5 look aheadDNA sequencing (reading) DNA synthesis (writing)T eam rules & priority setting tools CONCEPTSKILLSur\ufb01ng exponentialsInterconvertibility of matter and information", "start_char_idx": 0, "end_char_idx": 178, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2fae1aab-9948-49b7-a9b6-ef8ddbfb7c21": {"__data__": {"id_": "2fae1aab-9948-49b7-a9b6-ef8ddbfb7c21", "embedding": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "98736360-5799-4d99-a700-7eeef2383c98", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "8f680531f74b08e4ad86039eefeb6404a06e99785cb2973cfa6bf5acf1198978"}}, "hash": "8f680531f74b08e4ad86039eefeb6404a06e99785cb2973cfa6bf5acf1198978", "text": "sequencing(reading DNA)((see separate slide deck from Brianna))", "start_char_idx": 0, "end_char_idx": 63, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "27a7d603-f229-475d-87fc-07388bf0438b": {"__data__": {"id_": "27a7d603-f229-475d-87fc-07388bf0438b", "embedding": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7e08d210-08ca-4beb-a8c3-3164760a1faf", "node_type": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "a5d13b87405a95ca08cff2ea75f203c927f08cfb2dacd22b4c2f85b20de60540"}}, "hash": "a5d13b87405a95ca08cff2ea75f203c927f08cfb2dacd22b4c2f85b20de60540", "text": "synthesis(writing DNA)((slides follow in this deck))", "start_char_idx": 0, "end_char_idx": 52, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "962660d0-984d-48fe-942e-6cdd7ae29d0a": {"__data__": {"id_": "962660d0-984d-48fe-942e-6cdd7ae29d0a", "embedding": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ff8420b1-db58-417b-a095-401a8ae6ceda", "node_type": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "7024c091a5695b43ed74e6503235473cedca3ac87daba36ef170cda5b2d4a9ae"}}, "hash": "7024c091a5695b43ed74e6503235473cedca3ac87daba36ef170cda5b2d4a9ae", "text": "TAATACGACTCACTATAGGGAGA\nDNA synthesis = 4 key keyboard for genetic stuffRaw chemicals, not derived from existing DNA\nPlay however you like to get the DNA you want, from scratch.", "start_char_idx": 0, "end_char_idx": 177, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "19b0f0fb-067f-4a17-bf45-3cebd85574a7": {"__data__": {"id_": "19b0f0fb-067f-4a17-bf45-3cebd85574a7", "embedding": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "22f664b1-429f-464a-9ab5-8efd85bbe601", "node_type": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "9ab209e92a93bbbd7a1349cb831f679e39777c7ca54405eebf642996b3ae89f1"}}, "hash": "9ab209e92a93bbbd7a1349cb831f679e39777c7ca54405eebf642996b3ae89f1", "text": "from \u201cA Roadmap to the Assembly of Synthetic DNA from Raw Materials\u201d by Sanghvi, Y ogesh (http://dspace.mit.edu/handle/1721.1/39657)How atoms can be organized to make molecules. How DNA has been evolved to evolve (i.e., store data).", "start_char_idx": 0, "end_char_idx": 232, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7fa03572-a33a-461c-8089-b191bdb97781": {"__data__": {"id_": "7fa03572-a33a-461c-8089-b191bdb97781", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e35c7e90-66e4-4f57-928e-807d4e44f915", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "0ab6cb376966596a3795cbd72abebde34dfa30e0d0f83c4aae181f861071e3b7"}}, "hash": "0ab6cb376966596a3795cbd72abebde34dfa30e0d0f83c4aae181f861071e3b7", "text": "Step 1. Couple 1st base to a surfaceAAAAAAAA", "start_char_idx": 0, "end_char_idx": 44, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "47c39ab0-6e60-4512-8e2f-57f85979a3b8": {"__data__": {"id_": "47c39ab0-6e60-4512-8e2f-57f85979a3b8", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "54866c51-7519-4431-9896-e77009cc1bd6", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "1dec3ad7570f349f1a6da5c51b3553c19c84d48dabe8bac0011f3200b9088b41"}}, "hash": "1dec3ad7570f349f1a6da5c51b3553c19c84d48dabe8bac0011f3200b9088b41", "text": "Step 2. Add & attach desired 2nd baseAAAAAAAATTTTTTTTTT", "start_char_idx": 0, "end_char_idx": 55, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "49cf98e2-1feb-4ef5-b6b2-4b28af9cab5f": {"__data__": {"id_": "49cf98e2-1feb-4ef5-b6b2-4b28af9cab5f", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6e0cbbfa-923c-44db-83df-1be863618107", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "e0a9d0a85aafb1e4198f402ea2d0ecaa9f71d695c7f874c4fbb5eedc6d57a862"}}, "hash": "e0a9d0a85aafb1e4198f402ea2d0ecaa9f71d695c7f874c4fbb5eedc6d57a862", "text": "Step 3 (Ideal). Couple 2nd base to 1stAAAAAAAATTTTTTTT", "start_char_idx": 0, "end_char_idx": 54, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "594bbe8e-8a41-4439-a579-faa90d873f41": {"__data__": {"id_": "594bbe8e-8a41-4439-a579-faa90d873f41", "embedding": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dc39979f-ab7f-4685-a505-4cb71d028e8d", "node_type": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "a43409693bb619bc1763d8fae2839fe6d265ddf6d458894ef441699d426c941a"}}, "hash": "a43409693bb619bc1763d8fae2839fe6d265ddf6d458894ef441699d426c941a", "text": "Repeat steps 2 & 3 as you wish! (Ideally)AAAAAAAATTTTTTTTCCCCCCCCCCCCCCCCGGGGGGGGTTTTTTTT", "start_char_idx": 0, "end_char_idx": 89, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c21d5739-2da0-4606-b6af-6b563d1a22c2": {"__data__": {"id_": "c21d5739-2da0-4606-b6af-6b563d1a22c2", "embedding": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "95bb94e0-96b5-48fc-b902-5519599b1622", "node_type": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "c8a5cbd0a12634417be35a80b6d6cd374b2ed5a2d7e8aa431d0924103be3021c"}}, "hash": "c8a5cbd0a12634417be35a80b6d6cd374b2ed5a2d7e8aa431d0924103be3021c", "text": "Unfortunately, things are not so simple...", "start_char_idx": 0, "end_char_idx": 42, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c0cd86a2-d5b2-444c-ba15-74535398736e": {"__data__": {"id_": "c0cd86a2-d5b2-444c-ba15-74535398736e", "embedding": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "262c71ad-8937-4d67-ae60-2a027cdcbc8b", "node_type": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "a997126deaedbb49a9e0c3da11e01e00cd5245fecd04c5868493b1a381047000"}}, "hash": "a997126deaedbb49a9e0c3da11e01e00cd5245fecd04c5868493b1a381047000", "text": "Fail 1. Extra bases added (insertion mutations)AAAAAAAATTTTTTT\nTTT", "start_char_idx": 0, "end_char_idx": 66, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7580d9ef-63e6-4060-aa4f-f37202224077": {"__data__": {"id_": "7580d9ef-63e6-4060-aa4f-f37202224077", "embedding": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "18cb0e6d-7b31-4119-9d26-eba95623c599", "node_type": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "1d85030e0450d8044913e0a7f398cd82dc78fbac39bb8cccbaa716569c2c30a9"}}, "hash": "1d85030e0450d8044913e0a7f398cd82dc78fbac39bb8cccbaa716569c2c30a9", "text": "AAAAAAAATTTTTTTTTTFail 1. Extra bases added (insertion mutations)CCCCCCCCCCCCCCCCGGGGGGGGTTTTTT", "start_char_idx": 0, "end_char_idx": 95, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "704129c3-ac87-4153-ba50-8cfe4ecce372": {"__data__": {"id_": "704129c3-ac87-4153-ba50-8cfe4ecce372", "embedding": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b3203d08-981c-4ff2-b907-6a89028ef19b", "node_type": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "729080d746a13ef5599a124a272e83ebe1976ee1b6495e2a1a123a03348619f8"}}, "hash": "729080d746a13ef5599a124a272e83ebe1976ee1b6495e2a1a123a03348619f8", "text": "AAAAAAAATTTTTT\nFail 2. Bases missing (deletion mutations)", "start_char_idx": 0, "end_char_idx": 57, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "adf64a4d-8604-4f78-b045-8df47fd981a8": {"__data__": {"id_": "adf64a4d-8604-4f78-b045-8df47fd981a8", "embedding": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "601b2877-bd45-4a3a-9ea4-72e2c8a63667", "node_type": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "0efb72008003213cc302dc581c888272b5834ad473148c62c14b57e23afc345b"}}, "hash": "0efb72008003213cc302dc581c888272b5834ad473148c62c14b57e23afc345b", "text": "AAAAAAAATTTTTTFail 2. Bases missing (deletion mutations)CCCCCCCCCCCCCCCCGGGGGGGGTTTTTTTT", "start_char_idx": 0, "end_char_idx": 88, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "96772174-818c-4356-90e7-76bd0c7acc09": {"__data__": {"id_": "96772174-818c-4356-90e7-76bd0c7acc09", "embedding": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb4c07d3-82e0-4e31-b4fa-c472c09ddd56", "node_type": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "e8211131a41ec9799a99bde6891b764bd1f0fb8b27566561d3278dbc9482d16a"}}, "hash": "e8211131a41ec9799a99bde6891b764bd1f0fb8b27566561d3278dbc9482d16a", "text": "from \u201cA Roadmap to the Assembly of Synthetic DNA from Raw Materials\u201d by Sanghvi, Y ogesh (http://dspace.mit.edu/handle/1721.1/39657)\nHow to print DNA from scratch. How to optimize synthetic chemistry for accuracy.", "start_char_idx": 0, "end_char_idx": 213, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f6bc4646-1d26-49f9-870b-c3672966511c": {"__data__": {"id_": "f6bc4646-1d26-49f9-870b-c3672966511c", "embedding": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "89c917ad-9b8b-4b12-b468-535274738573", "node_type": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "78e86dd77951ddd552b97081f87255492ef0c6b508a86b3eac6284866b826426"}}, "hash": "78e86dd77951ddd552b97081f87255492ef0c6b508a86b3eac6284866b826426", "text": "Chemistry of DNA de\ufb01nes what must be added (e.g., bases).Sources of error in synthesis process de\ufb01ne added necessary steps:- failure to couple leads to capping step that prevents deletions.- propensity to react leads to blocking group that prevents insertions.", "start_char_idx": 0, "end_char_idx": 260, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "dd52a6fc-a68d-4e9c-8fc8-4c57c46027d4": {"__data__": {"id_": "dd52a6fc-a68d-4e9c-8fc8-4c57c46027d4", "embedding": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c2e3a3c4-f216-45f6-a45c-292a3e326572", "node_type": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "bd02057ae0fd610dbebdbcf1143ea331551635662f0b439fbeff59f37b0d9e58"}}, "hash": "bd02057ae0fd610dbebdbcf1143ea331551635662f0b439fbeff59f37b0d9e58", "text": "Cycle ef\ufb01ciency limits length of what can be made from scratch (on conventional DNA synthesizers).yield = (coupling %)#bp36% = (0.99)100mer", "start_char_idx": 0, "end_char_idx": 139, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b826317b-ad42-4f91-b10f-ae277e698e9d": {"__data__": {"id_": "b826317b-ad42-4f91-b10f-ae277e698e9d", "embedding": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d0cf6711-65cc-4616-828b-6fb8297d7735", "node_type": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "b2210bad4a90da51816a765e0ec3ca61aff062259537d785052de1d46e373817"}, "3": {"node_id": "95dfbc90-cff5-4825-8126-7fe9734ea14e", "node_type": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "3f73844c30024d959ec343f42e5245d9197307741005a4a535cb9111cfd5b35b"}}, "hash": "fa7dcc06bf325dbe88c48e2d552e5914cdaf33d92e574e54d0759988d73df4d5", "text": ">KumaMax (amino acid sequence) MSDMEKPWKEGEEARA VLQGHARAQAPQA VDKGPV AGDERMA VTVVLRRQRAGELAAHVERQAAIAP HAREHLKREAFAASHGASLDDFAELRRFADAHGLALDRANV AAGTA VLSGPDDAINRAFGVELRHFDHPD GSYRSYLGEVTVPASIAPMIEA VLGLDTRPV ARPHFRMQRRAEGGFEARSQAAAPTAYTPLDV AQAYQFPE GLDGQGQCIAIIELGGGYDEASLAQYFASLGVPAPQVVSVSVDGASNQPTGDPKGPDGEVELDIEV AGALA PGAKFA VYFAPDTTAGFLDAITTAIHDPTLKPSVVSISWSGPEDSWTSAAIAAMNRAFLDAAALGVTVLAA AGDSGSTGGEQDGLYHVHFPAASPYVLACGGTRLV ASGGRIAQETVWNDGPDGGATGGGVSRIFPLPAW QEHANVPPSANPGASSGRGVPDLAGNADPATGYEVVIDGEATVIGGTSA V APLFAALV ARINQKLGKA VG YLNPTL YQLP ADVFHDITEGNNDIANRAQIYQAGPGWDPCTGLGSPIGVRLLQALLPSASQPQPGSTENL YF QSGALEHHHHHH >KumaMax (DNA sequence)", "start_char_idx": 0, "end_char_idx": 655, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "95dfbc90-cff5-4825-8126-7fe9734ea14e": {"__data__": {"id_": "95dfbc90-cff5-4825-8126-7fe9734ea14e", "embedding": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d0cf6711-65cc-4616-828b-6fb8297d7735", "node_type": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "b2210bad4a90da51816a765e0ec3ca61aff062259537d785052de1d46e373817"}, "2": {"node_id": "b826317b-ad42-4f91-b10f-ae277e698e9d", "node_type": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "fa7dcc06bf325dbe88c48e2d552e5914cdaf33d92e574e54d0759988d73df4d5"}}, "hash": "3f73844c30024d959ec343f42e5245d9197307741005a4a535cb9111cfd5b35b", "text": "YF QSGALEHHHHHH >KumaMax (DNA sequence) atgagcgatatggaaaaaccgtggaaagaaggcgaagaagcgcgcgcggtgctgcagggccatgcgcgcgcgcaggcgccgcaggcggtggataaaggcccggtggcgggcgatgaacgcatggcggtgaccgtggtgctgcgccgccagcgcgcgggcgaactggcggcgcatgtggaacgccaggcggcgattgcgccgcatgcgcgcgaacatctgaaacgcgaagcgtttgcggcgagccatggcgcgagcctggatgattttgcggaactgcgccgctttgcggatgcgcatggcctggcgctggatcgcgcgaacgtggcggcgggcaccgcggtgctgagcggcccggatgatgcgattaaccgcgcgtttggcgtggaactgcgccattttgatcatccggatggcagctatcgcagctatctgggcgaagtgaccgtgccggcgagcattgcgccgatgattgaagcggtgctgggcctggatacccgcccggtggcgcgcccgcattttcgcatgcagcgccgcgcggaaggcggctttgaagcgcgcagccaggcggcggcgccgaccgcgtataccccgctggatgtggcgcaggcgtatcagtttccggaaggcctggatggccagggccagtgcattgcgattattgaactgggcggcggctatgatgaagcgagcctggcgcagtattttgcgagcctgggcgtgccggcgccgcaggtggtgagcgtgagcgtggatggcgcgagcaaccagccgaccggcgatccgaaaggcccggatggcgaagtggaactggatattgaagtggcgggcgcgctggcgccgggcgcgaaatttgcggtgtattttgcgccggataccaccgcgggctttctggatgcgattaccaccgcgattcatgatccgaccctgaaaccgagcgtggtgagcattagctggagcggcccggaagatagctggaccagcgcggcgattgcggcgatgaaccgcgcgtttctggatgcggcggcgctgggcgtgaccgtgctggcggcggcgggcgatagcggcagcaccggcggcgaacaggatggcctgtatcatgtgcattttccggcggcgagcccgtatgtgctggcgtgcggcggcacccgcctggtggcgagcggcggccgcattgcgcaggaaaccgtgtggaacgatggcccggatggcggcgcgaccggcggcggcgtgagccgcatttttccgctgccggcgtggcaggaacatgcgaacgtgccgccgagcgcgaacccgggcgcgagcagcggccgcggcgtgccggatctggcgggcaacgcggatccggcgaccggctatgaagtggtgattgatggcgaagcgaccgtgattggcggcaccagcgcggtggcgccgctgtttgcggcgctggtggcgcgcattaaccagaaactgggcaaagcggtgggctatctgaacccgaccctgtatcagctgccggcggatgtgtttcatgatattaccgaaggcaacaacgatattgcgaaccgcgcgcagatttatcaggcgggcccgggctgggatccgtgcaccggcctgggcagcccgattggcgtgcgcctgctgcaggcgctgctgccgagcgcgagccagccgcagccgggcagcaccgaaaacctgtattttcagagcggcgcgctggaacatcatcatcatcatcatE.g., how do I make KumaMax?", "start_char_idx": 616, "end_char_idx": 2403, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "dfb0dfc3-fe73-4206-b304-0b11ae68fe97": {"__data__": {"id_": "dfb0dfc3-fe73-4206-b304-0b11ae68fe97", "embedding": null, "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e40940b5-496b-4c8a-b343-991dc5e15c1d", "node_type": null, "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "0381fec04a9025ab7efdf5a12d102ac9ac7c3603b0d1bbc2f5b416f0403626d0"}}, "hash": "0381fec04a9025ab7efdf5a12d102ac9ac7c3603b0d1bbc2f5b416f0403626d0", "text": "Short synthetic DNA fragments can be assembled into longer and longer fragments\nfrom \u201cA Roadmap to the Assembly of Synthetic DNA from Raw Materials\u201d by Sanghvi, Y ogesh (http://dspace.mit.edu/handle/1721.1/39657)", "start_char_idx": 0, "end_char_idx": 212, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d4a3cdf8-4635-4977-8f22-f5316353a1b6": {"__data__": {"id_": "d4a3cdf8-4635-4977-8f22-f5316353a1b6", "embedding": null, "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0b707e58-b244-48a8-acae-3951a8a07440", "node_type": null, "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "53fae4df44ed699189786836683c6fac8823c5dbe58c16504bb74be0801bde52"}}, "hash": "e2d86d0ebe24f6d53805f078283e470329ffb0c5cfa6fdbf67382fb42ea94fa3", "text": "How I make KumaMax!\nT oday: web-based ordering, 3 week latency, T omorrow: Desktop?", "start_char_idx": 0, "end_char_idx": 83, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "524633a4-370f-4299-8797-0d49b51adef6": {"__data__": {"id_": "524633a4-370f-4299-8797-0d49b51adef6", "embedding": null, "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c0d6491f-4e66-4870-916f-39ccd91893de", "node_type": null, "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}, "hash": "a019f78c8fbd8847b6098f85900baeebd8c7c973cfeca311cada1b232f3c6306"}}, "hash": "a019f78c8fbd8847b6098f85900baeebd8c7c973cfeca311cada1b232f3c6306", "text": "DNA = industrial polymer of 21st century.DNA read/write tools progressing\u2026  Signi\ufb01cant opportunities remain for improving DNA sequencing and synthesis.For example\u2026Single-molecule synthesisClosed loop error detection & correctionWater-based chemistriesEnzymatic (i.e., genetically encoded)Genes on demand\u2026Genomes as a Service\u2026", "start_char_idx": 0, "end_char_idx": 325, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f2d9d198-36a0-42f2-9626-c05220a56a23": {"__data__": {"id_": "f2d9d198-36a0-42f2-9626-c05220a56a23", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8e244258-ce82-48e4-ab09-b4985835d6ff", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "hash": "3b7f1157126e7e80c88b415e269bce819aa7f97f4a0554a8e67ea5c44edaa45b"}}, "hash": "5eddb1f5736474090cfdb16989bf7c1b1d44df8976c197e0b2ee710f38a98281", "text": "Reading Genetic Material \nStanford BIOE 80 \nMay 4, 2020", "start_char_idx": 0, "end_char_idx": 55, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "10a13c11-5674-4ec9-9d79-4571487c4345": {"__data__": {"id_": "10a13c11-5674-4ec9-9d79-4571487c4345", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "05a21a83-38b5-4631-8527-b1e1be17a6a7", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "hash": "452748bbb326c654c72423a444146ab7c6611ba2a4643c873e4e31d0cc70bed0"}}, "hash": "6427549dcbd65676626f1d2687b80e9866519b608d77f6c5d527a7a9e4aca1d0", "text": "From an bioscience perspective,  why is \nknowing the exact sequence of DNA or RNA \nin an organism interesting?", "start_char_idx": 0, "end_char_idx": 110, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a2be7ffc-1b58-4756-bc92-e4a6b51ac21a": {"__data__": {"id_": "a2be7ffc-1b58-4756-bc92-e4a6b51ac21a", "embedding": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8b07e036-a70a-4f5d-a8e1-bfe9c64c33dd", "node_type": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "hash": "67e04fe42cbed3319716be95ed49f04f1a9dd46ff521304aa06655b61d35de3b"}}, "hash": "ee0d0e66c6e41e106f5a2d981d14b95bfb69144dc67da941aa71eb0d1cb96b7f", "text": "From an bioengineering perspective,  why \ncan knowing the exact sequence of DNA or \nRNA in an organism help us?", "start_char_idx": 0, "end_char_idx": 111, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "10764762-bd24-42ea-bad6-3c66ed5d9a48": {"__data__": {"id_": "10764762-bd24-42ea-bad6-3c66ed5d9a48", "embedding": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f123db96-bde5-4cf4-bf62-59c8ebabcfa2", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "hash": "6607b97581764b28132e12c1b56854057108ab6d298f0b13a57ab216ca6aa8b0"}}, "hash": "315a93ed652a8c5d62e9502b8263e4b4ec92adc75178d51e4b6256ea2dc20b3d", "text": "Sequencing by Synthesis \n(1st gen) Nanopore-Based Sequencing \n(3rd gen) \nParallelization/Multiplexing \n(2nd gen)", "start_char_idx": 0, "end_char_idx": 112, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b4a5fe1a-6153-4e11-91a6-aca748d54048": {"__data__": {"id_": "b4a5fe1a-6153-4e11-91a6-aca748d54048", "embedding": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b9b4f284-6b1f-44be-8e63-1789dd16d0b0", "node_type": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "hash": "72b64df06409257e2431fdc1d074ef820f8996860813ec125198c6d2ae9213dd"}}, "hash": "295b869436ed24cdadaa08098d0b228dc77b02322f13ab8947ccf048d40dc8ce", "text": "Sequencing By Synthesis \nIllumina", "start_char_idx": 0, "end_char_idx": 33, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9e4c2221-66c4-467b-bb9e-02f3af6173a0": {"__data__": {"id_": "9e4c2221-66c4-467b-bb9e-02f3af6173a0", "embedding": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7ec26ca4-978d-428d-8853-3c19af52e1dc", "node_type": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "hash": "f3c5ddde07d862e51bce157c732b6c446939cf0f6c7fd4182af8116f6aa4bd68"}}, "hash": "942e43398b2842301d135d6e3997b1273816df054274dfe8017d60c84c4155cb", "text": "Seq By Synth. - Limited to short reads", "start_char_idx": 0, "end_char_idx": 38, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ed64d3fc-08cf-4768-9129-8cad3602c35b": {"__data__": {"id_": "ed64d3fc-08cf-4768-9129-8cad3602c35b", "embedding": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3fb390ab-5fe8-4517-ba8b-1aaf75651131", "node_type": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "hash": "bf5f760204cfe4fd27e4ef1c4de936c994523026fdd9382f53a8a8d6b3f3645e"}}, "hash": "b3ed0114f3a5bff4cddea261024ba65a249325e0eec97518f1e6b47c8d216f19", "text": "Seq By Synth. - Limited to short reads", "start_char_idx": 0, "end_char_idx": 38, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d41a65c8-8fcf-4c7c-abfb-498c8e4cd5aa": {"__data__": {"id_": "d41a65c8-8fcf-4c7c-abfb-498c8e4cd5aa", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "12d59e46-b053-4d4d-a2ef-9b55e9637041", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "hash": "4a91b5bb1a79bd3c2b5aaf39838c0325dc8053c956e01e0942e4be1f1db537ab"}}, "hash": "310086565ea866a570b956986a9b4cd8809026d6150797ef46415ff850bfbdb4", "text": "Nanopore-Based Sequencing", "start_char_idx": 0, "end_char_idx": 25, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d8361ba6-42d7-406a-a3dd-283334f73b4e": {"__data__": {"id_": "d8361ba6-42d7-406a-a3dd-283334f73b4e", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "25996ae0-abbc-4a3e-94ed-2be6180ab372", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "hash": "192afe7816e6ea593bca8a785dcef0a9e5f8f350af8a7b4a48e378de7b15d1d6"}}, "hash": "7895a2db355e339a0da36868765705398f11535cedd1e9fb31b35433499ba50b", "text": "Pros and Cons of Sequencing Technologies", "start_char_idx": 0, "end_char_idx": 40, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b6da2fc8-3880-4cc2-9671-2ffd416e06a7": {"__data__": {"id_": "b6da2fc8-3880-4cc2-9671-2ffd416e06a7", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e958eaac-faff-4d6d-b39a-de6b38bec378", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "hash": "9f5d9f0c45936da06c3ef9a2b0f1a586dd1d552ef20f52488cbe05faa3fe105c"}}, "hash": "be4fbc16680ea98e3acd3442b75979a4d298027147936ad2032bb865f1b37d36", "text": "Genotyping vs. Sequencing \n\u201cWhat about 23andMe?\u201d", "start_char_idx": 0, "end_char_idx": 48, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a232b068-7f5c-4f65-bd46-2c77b1d9f059": {"__data__": {"id_": "a232b068-7f5c-4f65-bd46-2c77b1d9f059", "embedding": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e191e3d9-7ea5-4785-9d54-de14eaa891b1", "node_type": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "hash": "2a6a4a55c717cd4cc8c2ab3f292a5362ae66777a208c5da004558d58bc1e29fb"}}, "hash": "6583f77dadd04f03f4e642e4b3e724c06a90b83c0b0283f23fd63fca6b6f82ac", "text": "Sequencing by Synthesis \n(1st gen) Nanopore-Based Sequencing \n(3rd gen) \nParallelization/Multiplexing \n(2nd gen)", "start_char_idx": 0, "end_char_idx": 112, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f35a511a-f5c3-4ff0-92a7-5ff211288cf5": {"__data__": {"id_": "f35a511a-f5c3-4ff0-92a7-5ff211288cf5", "embedding": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "20ba0f61-f859-4ee7-bb7c-43c8f133e7ea", "node_type": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "hash": "86013f1ceba1b15660830ccbcab16e5300b02047ec16b7215cbb6ae644c32613"}}, "hash": "61ac4fe4028b549ee7df79b4d53c94c6eaee18a548b2e2035625bb4715c030a9", "text": "Parallelization/Multiplexing \nTo the invisible kindergartner next to you:  \nExplain what it means to parallelize  something.", "start_char_idx": 0, "end_char_idx": 124, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fccedcba-ada4-49b5-9023-357f9c1446b9": {"__data__": {"id_": "fccedcba-ada4-49b5-9023-357f9c1446b9", "embedding": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a328156d-2d2d-463f-83f7-89897fdd01b6", "node_type": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "hash": "6281cfcd5d9187c0f62a24a6e5b5845978a4ff4ba0c0da7ce027f2000e8ed916"}}, "hash": "8f711a188523a1af852928f711fce1172db6e47726e6b08b0d865625e1df1593", "text": "Parallelization/Multiplexing \nParallelize : To modify a system so that computations  \nor processes  can be carried out simultaneously.  \nMultiplex : Method by which multiple signals are  \ncombined into one signal over a shared medium, in  \norder to share a scarce resource. \nMultiplexing and parallelization often go  \nhand-in-hand in bioengineering.", "start_char_idx": 0, "end_char_idx": 350, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ce7b68fe-8fd8-49a7-8163-96f379212c70": {"__data__": {"id_": "ce7b68fe-8fd8-49a7-8163-96f379212c70", "embedding": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8b82c6ff-cfe1-43dd-bf17-47e22b82d1e7", "node_type": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "hash": "6f3c0b91675a0e43ad8714befc3d7affbe6832252ba83d1b31b23820d0fbbf08"}}, "hash": "b878baca8caea776eb94a17b6ae4760086886e5511e6dc95ebddef31ac61e1cc", "text": "Parallelization  vs Multiplexing \nE.g., i n a department-wide brownie-baking effort,  each  \nstudent in the BIOE department spoons batter into a  \npan simultaneously. We then put all the pans in a  \ngiant oven so that they can bake at the same time.  \nThese brownie batches have been poured and cooked  \nin parallel.", "start_char_idx": 0, "end_char_idx": 316, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2617fae3-a51e-406a-9e31-1b7de76824cd": {"__data__": {"id_": "2617fae3-a51e-406a-9e31-1b7de76824cd", "embedding": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5ab9ab3a-ea89-4cf4-98be-79809b993d4d", "node_type": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "hash": "27287c0c5d04f5264fb4c6fd8ba3c903f7a4abd8c3729fdc9b19a92afcb18cb2"}}, "hash": "5d9e795e1eb2c4d7c873bf817c9a139406bb250f37afc4294498e630469851c5", "text": "We want to be able to identify which brownies belong  \nto whom when they come out of the oven. So, each  \nperson puts a dye into their brownies, and when the  \nbrownies come out we separate them by color. The  \nprocess of putting dye into the brownies is  \nmultiplexing , and the process of separating them by  \ncolor demultiplexing .Parallelization vs Multiplexing", "start_char_idx": 0, "end_char_idx": 365, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a5ca573b-4663-4278-a22d-4ea3c17c9b57": {"__data__": {"id_": "a5ca573b-4663-4278-a22d-4ea3c17c9b57", "embedding": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "74343b6a-befb-4945-83cd-8624afc21a78", "node_type": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "hash": "b8b3be8baf14a85d9e75b481723f881e16fbcf268bc4ebd7899ff09bb43c470b"}}, "hash": "76d73d89a8b7039b5dd9b4aaf04225cb9c77c3bfd68b04dba75438e84969c5cb", "text": "Parallelization/Multiplexing \nCome up with an example: \n1.From day-to-day life? \n2.From engineering? \n3.From bioengineering?", "start_char_idx": 0, "end_char_idx": 124, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a151a985-1f96-4900-b4d7-9dcf034bdab7": {"__data__": {"id_": "a151a985-1f96-4900-b4d7-9dcf034bdab7", "embedding": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "49773c2e-553c-438a-83e3-9ee8bff9dd02", "node_type": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}, "hash": "59151e41a64c1fc42388847c5d7d383660d1f13ff169b4bd116ec0cfe7ea3b16"}}, "hash": "76a0678f6b4839952566febda81167638f1d625c980bec497a5f1eb42257fd42", "text": "Parallelization/Multiplexing for Sequencing \nDNA barcoding \u201cMassively Parallel\u201d", "start_char_idx": 0, "end_char_idx": 79, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "364712e9-39c8-45eb-80a1-1ab7a2d1d4d1": {"__data__": {"id_": "364712e9-39c8-45eb-80a1-1ab7a2d1d4d1", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c8895567-d7d3-41f0-af4d-323e66ca12a5", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "9da98cdd2546ec32f76fbb008b1b8eaaed4d6ef84cc5a289590a9bc8bd044313"}}, "hash": "f6180775ad0c2d1a71978f7a5471fc28b7949a1239eab62472ab528f869d4415", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 146 May 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 351, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8e590a6f-ba5d-4613-91e7-64c095596c33": {"__data__": {"id_": "8e590a6f-ba5d-4613-91e7-64c095596c33", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b7cd3b05-b387-4e47-bd73-6332868d2f71", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "675a2bff7d15e87dc5a35adb01bc89da003a1e567a6aa31307a39355567359c1"}}, "hash": "675a2bff7d15e87dc5a35adb01bc89da003a1e567a6aa31307a39355567359c1", "text": "Week 5 look aheadDNA sequencing (reading) DNA synthesis (writing)T eam rules & priority setting tools CONCEPTSKILLSur\ufb01ng exponentialsInterconvertibility of matter and informationWE ARE HERE", "start_char_idx": 0, "end_char_idx": 189, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "930cb0cd-dd9c-4cd5-9f7f-e242d6839570": {"__data__": {"id_": "930cb0cd-dd9c-4cd5-9f7f-e242d6839570", "embedding": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "80c09984-4352-4c08-9c7d-3849fe2af964", "node_type": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "2e9c8a6f51283ac70b1438d5f1eb601790e7450f5909031bd1303bf04e7b68f7"}}, "hash": "2e9c8a6f51283ac70b1438d5f1eb601790e7450f5909031bd1303bf04e7b68f7", "text": "DNA read/write increasingly affordable \nQ. what becomes possible as DNA read/write becomes more affordable?", "start_char_idx": 0, "end_char_idx": 107, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "52b4edfe-cccc-454b-830e-a12ba4a99ea1": {"__data__": {"id_": "52b4edfe-cccc-454b-830e-a12ba4a99ea1", "embedding": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2644ea91-18a5-492e-a493-618e2b18453c", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "970b2165a5c22690f6bd861218deba81f4e624742bcc40f8b248c8f006ec6a03"}}, "hash": "bee95c2f09547b854e0c73575b83bc4716ec0d3256fd5a66ce690e58bd7edb08", "text": "1990, DNAr @ $2/base, $6 billion!\nhttps://en.wikipedia.org/wiki/Human_Genome_ProjectA. can set out to sequence human genome for \ufb01rst time\u2026", "start_char_idx": 0, "end_char_idx": 138, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "bc9f0df5-2eab-4138-9c5e-8e4100e6adc0": {"__data__": {"id_": "bc9f0df5-2eab-4138-9c5e-8e4100e6adc0", "embedding": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c9251f5f-1c6d-4e16-9134-2c2ac3c139b0", "node_type": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "c7fc545b63dbb99c5c1284216009ebfd66772fa23c10e0ac81cf32aef81f9c11"}}, "hash": "c7fc545b63dbb99c5c1284216009ebfd66772fa23c10e0ac81cf32aef81f9c11", "text": "2011-15, DNAr @ $1E-6/base, $1000!\nhttps://geneton.sk/en/trisomytest-non-invasive-prenatal-screening/A. can determine properties of fetus from fetal DNA circulating in woman\u2019s blood.", "start_char_idx": 0, "end_char_idx": 182, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "109f0e51-71bc-4ebc-ba5a-e2319f3bb773": {"__data__": {"id_": "109f0e51-71bc-4ebc-ba5a-e2319f3bb773", "embedding": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b7906c76-a271-4abd-8076-4718b552463c", "node_type": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "a63f0163916a9bc9602bf4ba11d182e89773c977c15db348135be1dd418b4e3d"}}, "hash": "a63f0163916a9bc9602bf4ba11d182e89773c977c15db348135be1dd418b4e3d", "text": "2020, DNAr @ $1E-7/base\u2026\nhttps://www.pooprints.com/\nA. can register your dog\u2019s DNA and assign blame to neighbors who don\u2019t clean up after their pets.", "start_char_idx": 0, "end_char_idx": 149, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9c2cce78-4759-4872-b117-933e7b398dbf": {"__data__": {"id_": "9c2cce78-4759-4872-b117-933e7b398dbf", "embedding": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "83d64e1e-4dc1-44c6-ae1f-e10e751821c8", "node_type": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "5ea4fb8f06a008368ba12143a0647a5e7ec797f6f5ea83953bf73710ee4a981b"}}, "hash": "783e1d400b2a7ac93b081c68a75501bf898bdecab2fe95d2f6751eaf6e8f856f", "text": "20??, DNAr @ $???/base\u2026\nhttps://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002168\nA. when should we expect to have sequenced all DNA on earth?", "start_char_idx": 0, "end_char_idx": 162, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e39e42ea-a156-4776-a7a1-c059a2accfe7": {"__data__": {"id_": "e39e42ea-a156-4776-a7a1-c059a2accfe7", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8ccecdc0-a929-4abe-8711-764bcce21d46", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "43f5fa812a6aac30d88b043ea16e3b86d28a0905ccd7f40f24fd416fc83e3085"}}, "hash": "53c62855fb756a23eee5c6d80f59dccabbd024e2323898551492649720dc8f0f", "text": "2003, DNAw @ $4/base, $4000/gene!\nhttps://en.wikipedia.org/wiki/Human_Genome_ProjectA. can afford to synthesize genes for undergraduates for the \ufb01rst time\u2026", "start_char_idx": 0, "end_char_idx": 155, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d8b5f0f2-b7bb-4a6b-9a9f-52d914f23d5b": {"__data__": {"id_": "d8b5f0f2-b7bb-4a6b-9a9f-52d914f23d5b", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1c5ae921-d2d4-4638-bcea-3268b4f399a7", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "a25a6cc7b9c23c1b7494235c41885d9ffeee91d349b49553e2fab0b90adc9ecb"}}, "hash": "3c7123b49fd480790198cee4faa017fffad984ff7934312fbed2469d8bbce8de", "text": "2010, DNAw @ $0.50/base($500,000/small bacterial genome!)\nhttps://science.sciencemag.org/content/329/5987/52A. can afford to synthesize a small bacterial genome from scratch\u2026", "start_char_idx": 0, "end_char_idx": 174, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b7547afa-2f98-470f-a76f-23374157fa3f": {"__data__": {"id_": "b7547afa-2f98-470f-a76f-23374157fa3f", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5b8f5770-46f0-4457-84ff-e4fead8b5ea8", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "5798a6baa493d0e8275c064ec8ab6a851228c8951286fb49275e42353f79e979"}}, "hash": "fa032ef68301e613054a3b15728f514fb3850c897f94d2329d0c9d19e903846c", "text": "2017/18, DNAw @ $0.10/base($1,000,000/eukaryotic genome)\nhttps://science.sciencemag.org/content/329/5987/52A. can afford to enable undergrads to attempt building cells, can rebuild single-cell eukaryotes\u2026", "start_char_idx": 0, "end_char_idx": 204, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "859f5d15-8c4a-4150-9cd1-47834beae28a": {"__data__": {"id_": "859f5d15-8c4a-4150-9cd1-47834beae28a", "embedding": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "65609a37-f6f0-4cbf-af03-0560605f4151", "node_type": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "fe36ff0685d4b4ef2c8c3d8bb6742d6a74f00a669b48f9adcb9d210bdfb55728"}}, "hash": "889653b65261eb96d08aa8a208903f45cd58e6f0234d08d35f76c8d1482c9dde", "text": "20??, DNAw @ $???/base\nA. when should we expect to be capable of synthesizing a human genome from scratch\u2026", "start_char_idx": 0, "end_char_idx": 106, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f2a63b53-3014-45a8-8d69-3f80a932522f": {"__data__": {"id_": "f2a63b53-3014-45a8-8d69-3f80a932522f", "embedding": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "06485463-bed3-463d-9461-a3115a18a41c", "node_type": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "de7ed1cf4b69bf8f62617c0ee335618f5baa93da24b9e098ac3c73857de2b39b"}}, "hash": "de7ed1cf4b69bf8f62617c0ee335618f5baa93da24b9e098ac3c73857de2b39b", "text": "Luxo Jr., Pixar Animation Studios\nHow to surf accelerating waves?", "start_char_idx": 0, "end_char_idx": 65, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "74e041a6-8e4f-4441-9fe7-e24717d60a8e": {"__data__": {"id_": "74e041a6-8e4f-4441-9fe7-e24717d60a8e", "embedding": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "da5f1789-484f-4b37-a625-7224e9af9bc1", "node_type": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "ea7bdcf3fc0c26e04948a08f387b5025b4de5a1148d1de965c7107ac6bb1f962"}}, "hash": "ea7bdcf3fc0c26e04948a08f387b5025b4de5a1148d1de965c7107ac6bb1f962", "text": "http://www.wired.com/2013/04/how-pixar-used-moores-law-to-predict-the-future/\u201cWhen the group moved to California to become part of Lucas\ufb01lm, we got close to making a computer-animated movie again in the mid-1980s \u2014 this time about a monkey with godlike powers but a missing prefrontal cortex. We had a sponsor, a story treatment, and a marketing survey. We were prepared to make a screen test: Our hot young animator John Lasseter had sketched numerous studies of the hero monkey and had the sponsor salivating over a glass-dragon protagonist. But when it came time to harden the deal and run the numbers for the contracts, I discovered to my dismay that computers were still too slow: The projected production cost was too high and the computation time way too long. We had to back out of the deal. This time, we [knew enough] to correctly apply Moore\u2019s Law \u2014 [] we had to wait another \ufb01ve years to start making the \ufb01rst movie.  And sure enough, \ufb01ve years later Disney approached us to make Toy Story.\u201d\u2014 Alvy Ray Smith", "start_char_idx": 0, "end_char_idx": 1019, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "580d0859-9c51-419a-ad3d-e2ab68417e36": {"__data__": {"id_": "580d0859-9c51-419a-ad3d-e2ab68417e36", "embedding": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0c190c38-2aca-4303-9904-a9d9e2aff4ad", "node_type": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "7fb20c8f49746bb690f42ef4b76453e207b7c5ef2298e18df5b0406a602076af"}}, "hash": "7fb20c8f49746bb690f42ef4b76453e207b7c5ef2298e18df5b0406a602076af", "text": "How much cheaper did computer rendering of animated movies get between ~1985 and ~1990?What information do you need to answer this question?", "start_char_idx": 0, "end_char_idx": 140, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e9ee20f1-391b-40e6-b1b4-73377ae0a521": {"__data__": {"id_": "e9ee20f1-391b-40e6-b1b4-73377ae0a521", "embedding": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3fa27da2-95c6-4e2f-9908-8ad616c2ac93", "node_type": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "d9ff3d04e1a9b3d4aac9f343ec15fa69b954ee182df62c2edb60d66b040eefeb"}}, "hash": "d9ff3d04e1a9b3d4aac9f343ec15fa69b954ee182df62c2edb60d66b040eefeb", "text": "http://en.wikipedia.org/wiki/Moore%27s_law", "start_char_idx": 0, "end_char_idx": 42, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "29a35073-a96d-4407-995d-398957872cd1": {"__data__": {"id_": "29a35073-a96d-4407-995d-398957872cd1", "embedding": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2b9c6b40-8ef1-4f1e-b712-a6618e6b2700", "node_type": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "37b2d446a381974c17c8662ab3a8569de4798e23fb3ef8aa2554c6f5bb57dd93"}}, "hash": "37b2d446a381974c17c8662ab3a8569de4798e23fb3ef8aa2554c6f5bb57dd93", "text": "Take away lesson\u2026 for T oy Story to arrive in theaters in 1995, people had to be making smart decisions in 1985\u2026 how?  By understanding underlying trends in key tools.  What smart decisions should bioengineers be making today?How to surf accelerating waves?", "start_char_idx": 0, "end_char_idx": 257, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4f066b06-1897-48f0-bb02-10a5941b8a00": {"__data__": {"id_": "4f066b06-1897-48f0-bb02-10a5941b8a00", "embedding": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "25806191-6fae-4531-bc02-c0cc86cdf675", "node_type": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "b1aec5ba9bcc1bb59b9797049dc6fc044b3ffb921ae8fa6d13b1f6d6e452d75e"}}, "hash": "b1aec5ba9bcc1bb59b9797049dc6fc044b3ffb921ae8fa6d13b1f6d6e452d75e", "text": "But wait\u2026Not just quantitative change\u2026Qualitatively new opportunities emerge\u2026", "start_char_idx": 0, "end_char_idx": 77, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8e4b1be8-d201-42ad-8b26-4fdba9bafd01": {"__data__": {"id_": "8e4b1be8-d201-42ad-8b26-4fdba9bafd01", "embedding": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4de1f6e0-fea2-4c63-8530-7f994b1dab01", "node_type": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "195011ffae36edc6290e96e86e7cc308cf58472d7cb1895f44b7d4e184447dfa"}}, "hash": "195011ffae36edc6290e96e86e7cc308cf58472d7cb1895f44b7d4e184447dfa", "text": "2. Screen & breed\n3. Edit w/ intentionT o begin to ponder\u2026 Life goes via four regimes  1. Natural lineages\n4. Networked & lineage agnostic", "start_char_idx": 0, "end_char_idx": 138, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a0500740-20c2-4149-97a5-b5ae11417d78": {"__data__": {"id_": "a0500740-20c2-4149-97a5-b5ae11417d78", "embedding": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e3c1da99-58cc-44f6-973f-ec416ff41ecb", "node_type": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "54ed69a39953aabe1bed7309c9eb34a770f000e6b6cced2c534436ef312fd8d8"}}, "hash": "f81e74c5c97a86fe64c902bb3135f8e5739ebf3067bbe416e61ac7f83ce51085", "text": "Download & print COVID from the web", "start_char_idx": 0, "end_char_idx": 35, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "dea23ae2-1f8d-40a8-b9f7-23804a8fef7b": {"__data__": {"id_": "dea23ae2-1f8d-40a8-b9f7-23804a8fef7b", "embedding": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "843db1e8-313f-4dcd-8a38-11fe49895ed2", "node_type": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "e93f7b45f2c04d352634c4da4ea7a464ec83ff3128120f3d862fedbbdea38ce3"}}, "hash": "410af0eed9f569abb8f3aaf0914e03a8cb69e481e85294d0bea497e7d92226d4", "text": "DNA as an abiotic tape for storing arbitrary digital data.  Storage market > biotech.", "start_char_idx": 0, "end_char_idx": 85, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a0368a94-525b-4c1b-9ed0-504971c7be55": {"__data__": {"id_": "a0368a94-525b-4c1b-9ed0-504971c7be55", "embedding": null, "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9b56996e-92f8-47a9-a2bb-aa13b6224d50", "node_type": null, "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "140352464caf8a100573b192b1bb2b8a487043e77c2a31daace22a7530b65d51"}}, "hash": "944a7aece22727011dae258837b0e5d26e9fda8b41e352a898fbb2def827681f", "text": "Encode a library in a test tube", "start_char_idx": 0, "end_char_idx": 31, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5efe383b-5b46-41ba-a015-0b926de97775": {"__data__": {"id_": "5efe383b-5b46-41ba-a015-0b926de97775", "embedding": null, "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f36e38dd-553c-4e0d-ac75-a5d7b713e845", "node_type": null, "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "97351790e42a9007fb62941edddceedabbfb9387751b452a36819fae42f45d0a"}}, "hash": "2960c5c9e7770cf597fa9dab9f87c48a8ec69c1edc5dfed0817de7b2175b6f17", "text": "Embed arbitrary info. in arbitrary objects", "start_char_idx": 0, "end_char_idx": 42, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "943aa60e-b93d-40db-9249-83c64b26cac6": {"__data__": {"id_": "943aa60e-b93d-40db-9249-83c64b26cac6", "embedding": null, "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "55162cc9-88dd-4f82-8993-ecde20fc8218", "node_type": null, "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "943764d7f50ae00681c434065b2904f8e0e858391741089324f42f74c9a69a91"}}, "hash": "2f0a9fcd5026f30064fc14758ebf2efa20806a9793ed864ebdeb3451cd05ed17", "text": "~1 kWh electricity = ~ 1 (to 30) grams biomass~$0.11 = ~ 1 (to 30) courses of antibiotics    From electricity to formate,                          from formate to bio-stuff", "start_char_idx": 0, "end_char_idx": 172, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "46776e83-1fee-4526-81ac-4944be38ba54": {"__data__": {"id_": "46776e83-1fee-4526-81ac-4944be38ba54", "embedding": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c612144b-a346-49a7-9f89-812486da452d", "node_type": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "633aeb402e7c0317a0a9f20e1b420cd3af1e0f9164c1fa7d7d9751d84e96c542"}}, "hash": "633aeb402e7c0317a0a9f20e1b420cd3af1e0f9164c1fa7d7d9751d84e96c542", "text": "Who will make the world\u2019s \ufb01rst personal biology synthesizer (aka, the PB)?", "start_char_idx": 0, "end_char_idx": 74, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "05254788-00b6-4611-87da-eb96cc536352": {"__data__": {"id_": "05254788-00b6-4611-87da-eb96cc536352", "embedding": null, "metadata": {"page_label": "28", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "55bf603a-fd80-4849-89d7-9cde89fc6608", "node_type": null, "metadata": {"page_label": "28", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "185117bdaeffbafa9e8f080aa66e7a924cb48ba8f88787aeb19177f4cddc30d6"}}, "hash": "185117bdaeffbafa9e8f080aa66e7a924cb48ba8f88787aeb19177f4cddc30d6", "text": "https://www.smithsonianmag.com/smart-news/what-happens-when-you-culture-bacteria-eight-year-olds-hand-180955528/What if skin microbes could be      programmed to make living perfumes?                     (that monitor blood sugar level, infection, other)", "start_char_idx": 0, "end_char_idx": 254, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "31832931-b874-44f8-8210-ecfcba1db792": {"__data__": {"id_": "31832931-b874-44f8-8210-ecfcba1db792", "embedding": null, "metadata": {"page_label": "29", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8a50997a-ce41-40a4-af4b-51b7c36cd5d4", "node_type": null, "metadata": {"page_label": "29", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "0ca6381cb760f2cb0fde7ddc2d59802baaa0578360400c94e4f46a173ef6cbe2"}}, "hash": "0ca6381cb760f2cb0fde7ddc2d59802baaa0578360400c94e4f46a173ef6cbe2", "text": "Q. How will this box change the world?\nQ. What will the \u201cPB\u201d + the \u201cbionet\u201d lead to?PersonalBiosynthesizer (PB)electricityinternet(biocode)air(N2, CO2, H2O)whatever biology can be programmed to make or do\u2026A. \u201cdesign anywhere, grow everywhere\u201d", "start_char_idx": 0, "end_char_idx": 242, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7932b02b-7e76-43c2-b3c5-7e740aaeba49": {"__data__": {"id_": "7932b02b-7e76-43c2-b3c5-7e740aaeba49", "embedding": null, "metadata": {"page_label": "30", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fd0096f8-c08c-4a89-9c46-4be58dd57aaf", "node_type": null, "metadata": {"page_label": "30", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}, "hash": "fe39fb2766614a732399d6fc92548f953dadbccb481b163d05ae7a51deda4dcc"}}, "hash": "6a1981d0debf09c39f2aed7b6d2e9e6e72935c2a6fdc44fb282052a54e562613", "text": "Friday \u2014 T eam Project \u2014 Priority SettingFirst 15\u2019 of class will be discussion with pioneering leader of organization whose mission is to help individuals understand their DNA.  Be here to learn what this person has learned about making decisions and setting priorities!", "start_char_idx": 0, "end_char_idx": 270, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "aceef56b-786c-442a-b654-f7aa36576798": {"__data__": {"id_": "aceef56b-786c-442a-b654-f7aa36576798", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "95c8c2e0-91c4-48e2-be73-551fe0c0faf4", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}, "hash": "4016bce3be94787e3ac2c315cc59571a2872858f9d9f90d78f7662e9d680bea9"}}, "hash": "ae0874e31eaa85a8907ed59f4bd6f8205a7547b0e5ba291dfabfa822bc6ba68a", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 158 May 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 351, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c77571bc-ab79-4d50-9d7a-c896600f31b3": {"__data__": {"id_": "c77571bc-ab79-4d50-9d7a-c896600f31b3", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e1458d9e-6811-4473-ba70-8d3f74ffedda", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}, "hash": "8e19840aff8f571622859ba7e1d3d64b3307ea9517f6e7bb1e2ac7891ee217d8"}}, "hash": "8e19840aff8f571622859ba7e1d3d64b3307ea9517f6e7bb1e2ac7891ee217d8", "text": "Week 5 look aheadDNA sequencing (reading) DNA synthesis (writing)Priority setting tools & team(s) rule(s) CONCEPTSKILLSur\ufb01ng exponentialsInterconvertibility of matter and informationWE ARE HERE", "start_char_idx": 0, "end_char_idx": 193, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "72a289b7-6157-47ab-af06-04e4aad155e8": {"__data__": {"id_": "72a289b7-6157-47ab-af06-04e4aad155e8", "embedding": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "563b72de-8eb3-4255-a09c-e178e130a693", "node_type": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}, "hash": "94f347ed0999fb9e5ecb4c0ceed1ac4a52503add961d78af037a4b74e6e7b3b7"}}, "hash": "94f347ed0999fb9e5ecb4c0ceed1ac4a52503add961d78af037a4b74e6e7b3b7", "text": "Getting to good goals & priorities\u2026How to make good decisions about de\ufb01ning goals and setting priorities?Is setting priorities easier or harder or somehow different as a function of context (e.g., crisis response versus \u201cblank slate\u201d)?Should priority setting for a team or organization be approached differently compared to working solo?", "start_char_idx": 0, "end_char_idx": 337, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f4daf9a6-e3fb-48dd-8b8b-2d39b579d758": {"__data__": {"id_": "f4daf9a6-e3fb-48dd-8b8b-2d39b579d758", "embedding": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7eeb2edb-fe43-4036-836d-7eef45d0310f", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}, "hash": "0b5857ce0d7d19824fdecce1aa09517cc978ec1230ce1389cd32b2798ff07d4a"}}, "hash": "0b5857ce0d7d19824fdecce1aa09517cc978ec1230ce1389cd32b2798ff07d4a", "text": "What did we learn?(class discussion)", "start_char_idx": 0, "end_char_idx": 36, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e9e05026-871f-49d8-8f89-dd6339e5fc06": {"__data__": {"id_": "e9e05026-871f-49d8-8f89-dd6339e5fc06", "embedding": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f5cc37e0-8d0c-4e05-9497-9c8b22631e6e", "node_type": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}, "hash": "14f2e2186b336047d59f2db8932306d2fcce2e67e8f863f0f9475b494f897f62"}}, "hash": "d5588b58236c0e7941916b94a412c53722dfd59c1dc934b26d8fdfb09b07a6bb", "text": "\u201cBang for buck\u201d(simple tool for mapping impact vs. effort)\nAdapted from Alon, How T o Choose a Good Scienti\ufb01c Problem, Molecular Cell (2009), doi:10.1016/j.molcel.2009.09.013", "start_char_idx": 0, "end_char_idx": 174, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5e780672-7164-4ed3-9d9a-bedf6561a105": {"__data__": {"id_": "5e780672-7164-4ed3-9d9a-bedf6561a105", "embedding": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca777b81-be46-4861-a040-2822409932fb", "node_type": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}, "hash": "186c79d694d44cd7fdbe5a25fa79127dc29cd69b3a8fd0b96eff80fae14cd351"}}, "hash": "54b88cfa4a22ba732f85b6028fe81039bc4aad919047997fb403a76295c9337b", "text": "\u201cBang for buck\u201d(simple tool for mapping impact vs. effort)\nAdapted from Alon, How T o Choose a Good Scienti\ufb01c Problem, Molecular Cell (2009), doi:10.1016/j.molcel.2009.09.013 good \ufb01rst project for beginning team or individual(e.g., N95 masks)ideal project for experienced individual or startup team(e.g., KumaMax)long-term project requiring sustained teamwork(e.g. Apollo; LIGO)", "start_char_idx": 0, "end_char_idx": 378, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0497ea76-86cf-411a-9b0c-34c997f34e6d": {"__data__": {"id_": "0497ea76-86cf-411a-9b0c-34c997f34e6d", "embedding": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1ca83fb1-02b6-4557-8ebc-2a2b07acceb0", "node_type": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}, "hash": "3b36abcabea4a89225f41b3dd29dd2d0afa3eebc500f3b86e13bb277aa8d2ba4"}}, "hash": "f8acf677123b4c2db1871807b8f5babd15b09e3d95cb84f61219016b49a7be37", "text": "BREAKOUTMAP YOUR IDEAS\n7Working in a group, map each person\u2019s idea    onto the dimensions of effort and impact.What underlies and de\ufb01nes impact?What underlies and de\ufb01nes effort?What would our guest prioritize (of your ideas)?", "start_char_idx": 0, "end_char_idx": 225, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1e4dca50-ec02-41ad-b048-e1c71c53508d": {"__data__": {"id_": "1e4dca50-ec02-41ad-b048-e1c71c53508d", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9c40b014-3149-41c4-99c4-fb5908945fcd", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}, "hash": "b6b7ecde58eb2497722d0e3aa14dbb120bbc1b9392422583a35817820ed0891d"}}, "hash": "b25da34484e48ab523e0d075cf4f8aa87e7a626fefc2cefeaf270660668ff157", "text": "T eam(s) Rule(s)(class discussion)For a team to function well what should team members expect of each other?(what makes a good team \u201csocial contract\u201d)", "start_char_idx": 0, "end_char_idx": 150, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1b4f3ba4-edcb-4c8d-b488-8a6f99eb78f4": {"__data__": {"id_": "1b4f3ba4-edcb-4c8d-b488-8a6f99eb78f4", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7cbc7b66-a5f4-40bb-8507-e2c6ef1a1798", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "hash": "b54f4a6a0de09bf6f4b4744b8374274c533e09a4ed24378372011f0beb785d59"}}, "hash": "c7c963a0e26033666dbda39b4ac1d6158dffe17ebee533564277a8a53ba4d93f", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 1611 May 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 352, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7e9aa9ab-fc1f-4611-9c4c-bfcce0afd3e8": {"__data__": {"id_": "7e9aa9ab-fc1f-4611-9c4c-bfcce0afd3e8", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d13f967e-a94f-4f32-9efb-297fed8be716", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "hash": "babd33ef59a2c40424454f1d9a1acf8c08b25f69b3aa65266b8f03985b20ed51"}}, "hash": "babd33ef59a2c40424454f1d9a1acf8c08b25f69b3aa65266b8f03985b20ed51", "text": "Week 5 repriseDNA sequencing (reading) DNA synthesis (writing)T eam rules & priority-setting tools CONCEPTSKILLSur\ufb01ng exponentialsInterconvertibility of matter and information-Sequencing-by-synthesis; pore-based-Phosphoramidite chemistry for low-error rates-Quantitative change poses, \u201cwhen\u2019s the right time?\u201d-DNA R/W together enabling networked bio/technology-Impact versus effort; get projects on leading-edge curve", "start_char_idx": 0, "end_char_idx": 417, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "07456e60-5c6e-4dfb-aacc-c4f7976ccdec": {"__data__": {"id_": "07456e60-5c6e-4dfb-aacc-c4f7976ccdec", "embedding": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3e450db7-6cce-456c-a366-296cc11772f7", "node_type": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "hash": "70396902d02a48aaf8cbdee719f979fe5d3a2c06964997b648417d639794e66f"}}, "hash": "70396902d02a48aaf8cbdee719f979fe5d3a2c06964997b648417d639794e66f", "text": "Week 6 look aheadDiffusion of molecules (space, time, abundances)Programming patterns in autonomous systems[T eam Project] -Brainstorms (three themes)-T eam Rules CONCEPTSKILLProgramming patterns in living systems", "start_char_idx": 0, "end_char_idx": 213, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9da110c3-f9d5-4dac-81e1-15ffebc73678": {"__data__": {"id_": "9da110c3-f9d5-4dac-81e1-15ffebc73678", "embedding": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "72f72bd8-581e-4857-bfcf-0d91ea609926", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "hash": "42d111e118fd53c0710259225529a35744bb1b54038a6cfafaf20153165c2817"}}, "hash": "7b0a610bd026d5ab49c89be241b5082039899f216349146c8bbc197bad00f867", "text": "https://en.wikipedia.org/wiki/Brownian_motionhttp://sciweb.nybg.org/science2/pdfs/dws/Brownian.pdf", "start_char_idx": 0, "end_char_idx": 98, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1bc25ce4-f0aa-4c0a-b604-bb314a15fa73": {"__data__": {"id_": "1bc25ce4-f0aa-4c0a-b604-bb314a15fa73", "embedding": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a4ddecbc-db0a-4788-b640-2b0c48ab3dd1", "node_type": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "hash": "c4ad4bf4d7a41f7ea53bf2d721e1ca5299ebbe0a0d3979e4f140ec42f01f5ab4"}}, "hash": "30aa21d3523baac9118d79e652c861c69ff76237b1ad32c6d1fc61a5300dc1ef", "text": "https://www.jstor.org/stable/j.ctv7r40w6T o go twice as far takes four times as long.\n1D2D3DA particle that is twice as big, R, goes ~0.7 as far.", "start_char_idx": 0, "end_char_idx": 145, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a5137f03-03f9-4c9e-bf99-1534cbd42abf": {"__data__": {"id_": "a5137f03-03f9-4c9e-bf99-1534cbd42abf", "embedding": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "31be2bfa-63db-47ee-98bd-d895e19d1f79", "node_type": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "hash": "98e2dddaea9b329c8e407accb6b974eef49be2c399fcb27e13745ffdc9bbf906"}}, "hash": "98e2dddaea9b329c8e407accb6b974eef49be2c399fcb27e13745ffdc9bbf906", "text": "Diffusing particles spread out over time\u2026\nhttps://www.jstor.org/stable/j.ctv7r40w6\nhttp://rpdata.caltech.edu/courses/aph162/2006/Protocols/diffusion.pdf", "start_char_idx": 0, "end_char_idx": 152, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5a3afb0c-dcd3-4e0b-add1-879e1ee86cb2": {"__data__": {"id_": "5a3afb0c-dcd3-4e0b-add1-879e1ee86cb2", "embedding": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3eeb9251-1278-4cba-bca6-1228f5ef77a4", "node_type": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "hash": "b0e13520af52631b29fc914c6fc8dfa613139675f02a284536a84dbe5ac9c220"}}, "hash": "b0e13520af52631b29fc914c6fc8dfa613139675f02a284536a84dbe5ac9c220", "text": "http://biodynamics.ucsd.edu/What can we infer about the diffusion of biomolecules in this system?", "start_char_idx": 0, "end_char_idx": 97, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "75031268-fe31-40a5-9cf0-ab51fb50ce36": {"__data__": {"id_": "75031268-fe31-40a5-9cf0-ab51fb50ce36", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "85d9eaac-aece-4fb1-b21f-3fed29f5b1f9", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "hash": "6637e1fd86fdc991984d8fb802429144678aa496010771b85ad6d7e3c3a36a97"}}, "hash": "6637e1fd86fdc991984d8fb802429144678aa496010771b85ad6d7e3c3a36a97", "text": "https://www.ncbi.nlm.nih.gov/pubmed/22178928\nWhat can we infer about the diffusion of biomolecules in this system?", "start_char_idx": 0, "end_char_idx": 114, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2093ff83-57a0-4cfb-a33f-b7d292576828": {"__data__": {"id_": "2093ff83-57a0-4cfb-a33f-b7d292576828", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e1ac18f8-8c2b-4df6-a9e9-df3add5dff8d", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "hash": "2762727fcb0c97c42e681737017cf5fe970bd79b070266a20f6c4613e408ca9a"}}, "hash": "2762727fcb0c97c42e681737017cf5fe970bd79b070266a20f6c4613e408ca9a", "text": "https://www.ncbi.nlm.nih.gov/pubmed/22178928What can we infer about the diffusion of biomolecules in this system?", "start_char_idx": 0, "end_char_idx": 113, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a04f252e-044c-4bfd-9b18-3b813645f5b5": {"__data__": {"id_": "a04f252e-044c-4bfd-9b18-3b813645f5b5", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b43afcef-a70c-4de2-91bf-045894da8b85", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "hash": "fecfa2db2b437e5754fcf6a55559fcbe3a48377315ace614c48825aad256ffe4"}}, "hash": "fecfa2db2b437e5754fcf6a55559fcbe3a48377315ace614c48825aad256ffe4", "text": "http://biodynamics.ucsd.edu/What can we infer about the diffusion of biomolecules in this system?", "start_char_idx": 0, "end_char_idx": 97, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2e772f81-9bc3-45bd-a270-ca251b0c7b77": {"__data__": {"id_": "2e772f81-9bc3-45bd-a270-ca251b0c7b77", "embedding": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "68a515dc-0738-48af-b90e-865a07583aa1", "node_type": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "hash": "a43abf9711487dcc0eae462b552127645c67dbf8bf9a34cd55ce2c47df6ddddb"}}, "hash": "a43abf9711487dcc0eae462b552127645c67dbf8bf9a34cd55ce2c47df6ddddb", "text": "http://biodynamics.ucsd.edu/What can we infer about the diffusion of biomolecules in this system?", "start_char_idx": 0, "end_char_idx": 97, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a899541c-31f4-4f35-ba52-15a92d1728ca": {"__data__": {"id_": "a899541c-31f4-4f35-ba52-15a92d1728ca", "embedding": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "adda00cd-fd82-47bb-ab6f-65f8106c5cd6", "node_type": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "hash": "d6ae108a00ae8f15552d557b7879233148e1c230a579fa812d65c311c948ba28"}}, "hash": "d6ae108a00ae8f15552d557b7879233148e1c230a579fa812d65c311c948ba28", "text": "T extT ext\nhttp://www.rowland.harvard.edu/labs/bacteria/movies/ecoli.php", "start_char_idx": 0, "end_char_idx": 72, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "af4d4531-602f-400d-a7a4-c4a6dba858ed": {"__data__": {"id_": "af4d4531-602f-400d-a7a4-c4a6dba858ed", "embedding": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "537c8940-b879-437c-af8c-e60eab39e36c", "node_type": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}, "hash": "fd79dc2537468953c590489b0ab96238a11be353d65fb9a7cbcc2e57dbc41066"}}, "hash": "fd79dc2537468953c590489b0ab96238a11be353d65fb9a7cbcc2e57dbc41066", "text": "http://www.rowland.harvard.edu/labs/bacteria/movies/ecoli.php", "start_char_idx": 0, "end_char_idx": 61, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "059f2bb3-657e-4996-9c20-8a3ead9c7e9d": {"__data__": {"id_": "059f2bb3-657e-4996-9c20-8a3ead9c7e9d", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dd866226-6628-438f-9b32-fa5540433fcf", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "hash": "7b1a8c10050098b4d31d00e111174d4fa364aa829d0ad53076e23b931a5f85b3"}}, "hash": "e4b2537a20ac6e318c2952946c8187ae4efd458388a110f3875494b0d11295d0", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 1713 May 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 352, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "bf0e753e-2220-4fc4-814f-6e26dc7d00e3": {"__data__": {"id_": "bf0e753e-2220-4fc4-814f-6e26dc7d00e3", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3e535bc6-a0b6-4cc1-b23b-941a8f71cbca", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "hash": "e5c06cb2e012e12f51495ba31e8c0c9c2a7baf2e93b182e037dd4a41bdb4c270"}}, "hash": "e5c06cb2e012e12f51495ba31e8c0c9c2a7baf2e93b182e037dd4a41bdb4c270", "text": "http://www.rowland.harvard.edu/labs/bacteria/movies/ecoli.phpIn self-mixing molecular systems dominated by atomic-scale thermal noise (i.e., diffusion) how are we ever going to bioengineer precision patterning by autonomous systems?As a next step we need to \u201cdeprogram\u201d how we think about making patterns at the macroscopic scale\u2026", "start_char_idx": 0, "end_char_idx": 330, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ccc0ad08-e978-4763-b521-0eeb119a5433": {"__data__": {"id_": "ccc0ad08-e978-4763-b521-0eeb119a5433", "embedding": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6326781e-f2ad-4de6-8ddc-f8896584e187", "node_type": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "hash": "d3d9d63f289cb369d8d6988be0f99d9bf80cdca5e5d9051c0b1724890c0c3d9b"}}, "hash": "d3d9d63f289cb369d8d6988be0f99d9bf80cdca5e5d9051c0b1724890c0c3d9b", "text": "http://www.rowland.harvard.edu/labs/bacteria/movies/ecoli.phpWe\u2019ve grown up learning to make patterns.  But, our approach to pattern making is typically \u2018hand of god\u2019 mode (i.e., draw the pattern from outside the pattern itself).", "start_char_idx": 0, "end_char_idx": 229, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d7ea3afc-6947-465c-bc7f-8d5a670fb4cb": {"__data__": {"id_": "d7ea3afc-6947-465c-bc7f-8d5a670fb4cb", "embedding": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5a52e576-ecca-46e5-abe8-afc9f8eaf98d", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "hash": "7c34280b71fcf778c4af828f087d3aec4ebde79079db83f1066fce478bce169a"}}, "hash": "c5fe7b1f5c33b1b9c1e4de9d34f37861305e6e5789c17019ce9ccbc155d8e95b", "text": "http://www.4004.com/assets/4004-mask-composite-hd-r2.gifInstead of top-down control from outside the system itself, how do we get to thinking correctly about programming patterns that grow themselves?", "start_char_idx": 0, "end_char_idx": 200, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "36e5b6fa-a7b9-481d-96bc-3557b9f29bc5": {"__data__": {"id_": "36e5b6fa-a7b9-481d-96bc-3557b9f29bc5", "embedding": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8b0ee7db-f668-4ab9-b6f8-5eacef6ce66f", "node_type": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "hash": "4386d6344566f5af304ac97dc301a4ea48aa843781ee4af403fd138ddd4ce441"}}, "hash": "4386d6344566f5af304ac97dc301a4ea48aa843781ee4af403fd138ddd4ce441", "text": "https://youtu.be/dXpAbezdOhoHow do we get to this level of bioengineering?!", "start_char_idx": 0, "end_char_idx": 75, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e940c6e3-653b-46f1-86d5-5d43179e2fb7": {"__data__": {"id_": "e940c6e3-653b-46f1-86d5-5d43179e2fb7", "embedding": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e95ead9b-daef-43d5-a7c4-f65903599fdd", "node_type": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "hash": "276c42d227d60f9135afccc9424527f70b17c2d7dbe8c3acd526c0c69b11436d"}}, "hash": "43af2c314b880afd06e7c093b5fdc02b02d96ffdef84f4d560e2a7dfe6368774", "text": "We\u2019re going to use a simpler abiotic system to change how we think about making patterns\u2026", "start_char_idx": 0, "end_char_idx": 89, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "570bdca0-3dc5-43f1-affc-f1187bbbb0d9": {"__data__": {"id_": "570bdca0-3dc5-43f1-affc-f1187bbbb0d9", "embedding": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c0f99a7c-927e-4f3b-bf34-a7955338e211", "node_type": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "hash": "7f480569fe3e2ffe3b7a078cb63d0c905bf7eff0ae924f85ce25b16650dd2c6a"}}, "hash": "7f480569fe3e2ffe3b7a078cb63d0c905bf7eff0ae924f85ce25b16650dd2c6a", "text": "https://www.nature.com/articles/nature14272", "start_char_idx": 0, "end_char_idx": 43, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fa56dd15-b2e8-4aa2-a91c-c3bfc8effc73": {"__data__": {"id_": "fa56dd15-b2e8-4aa2-a91c-c3bfc8effc73", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "11c68c32-5e28-409c-a38c-d23ed01226b0", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "hash": "ae9df7d8a360d41d72dc8b1d7bfc5d930934cd8d37976224743a6ee508d2eb56"}}, "hash": "ae9df7d8a360d41d72dc8b1d7bfc5d930934cd8d37976224743a6ee508d2eb56", "text": "https://www.nature.com/articles/nature14272What are the rules of droplet behavior?1. T wo droplets at a distance will _____.2. T wo droplets that are in contact with each other will either:(a) _____, if they have the same PG%(b)_____, when they have different PG%.3. Droplets will do ____ when they borders (edge of slide, sharpie ink).", "start_char_idx": 0, "end_char_idx": 336, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "05c11f84-da7b-495d-ac9c-3174f892815a": {"__data__": {"id_": "05c11f84-da7b-495d-ac9c-3174f892815a", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5137f702-1993-4c47-865c-54be5a4e01aa", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "hash": "18c0303f851036e472e6e04fdc18042ca23832805059230048b06273f04e0212"}}, "hash": "013df9e69e9d56498fcb088198bd2aeead4ca0b9e5f34d9469ad4ff61930ed9d", "text": "Challenge 1 \u2014 \u2018hand of god\u2019\nAB\nDraw a physical pattern on the slide that gets droplets to move from point A to point B (i.e., you are explicitly directing the behavior from outside the system)", "start_char_idx": 0, "end_char_idx": 192, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "92157c07-439c-4062-be9b-b8d3b250f703": {"__data__": {"id_": "92157c07-439c-4062-be9b-b8d3b250f703", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f1197c4f-56cf-42b3-ae02-2edbaa4c12f3", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "hash": "82c6b0a9281824a5d8708d80f48ac0b0e16d6b9ddedac7ee2b0a958b751c32fe"}}, "hash": "e9d0843e305bcd43179ef3ca6b82ea5d6fbe306189942f81412bb6348b031c56", "text": "Challenge 2 \u2014 \u2018external coordinates\u2019\nAB\nPlace droplets on the slide that establish a coordinate system, causing another droplet to move from point A to point B (i.e., you make a coordinate system but droplets otherwise on their own).", "start_char_idx": 0, "end_char_idx": 233, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9b8cffa0-7d61-442d-add0-7ed6fd167c78": {"__data__": {"id_": "9b8cffa0-7d61-442d-add0-7ed6fd167c78", "embedding": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8d1ca404-b26c-4e93-901a-5fd42e281f1b", "node_type": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "hash": "dc5774214dd8998b401b423c1c30056d75d6cb08d8b09c34f905fd51e7496a44"}}, "hash": "dc5774214dd8998b401b423c1c30056d75d6cb08d8b09c34f905fd51e7496a44", "text": "Challenge 3 \u2014 \u2018autonomous coordination\u2019\nABPlace droplets only in the seed box that causes a droplet to move from point A to point B (i.e., seed a system that autonomously controls its own behavior).", "start_char_idx": 0, "end_char_idx": 198, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a629a532-730f-467a-b7a7-72b3e699abcf": {"__data__": {"id_": "a629a532-730f-467a-b7a7-72b3e699abcf", "embedding": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8fc7f01f-eac6-4d4a-bc14-efd63530f1e6", "node_type": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "hash": "a6c6592782b356c84348548865e0cbb9a4840e6e3a4cf733858ca7d8508f83b1"}}, "hash": "a6c6592782b356c84348548865e0cbb9a4840e6e3a4cf733858ca7d8508f83b1", "text": "Examples of success\u2026", "start_char_idx": 0, "end_char_idx": 20, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8d877530-15d5-4c4c-8102-676e80e9041d": {"__data__": {"id_": "8d877530-15d5-4c4c-8102-676e80e9041d", "embedding": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "be20f6dd-0544-4400-81e9-90c49b9e1c87", "node_type": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}, "hash": "408bdad1b0524f846969cfb880402d42edf20183893ea3abb6c5cf0166965423"}}, "hash": "1055ff56941c2c8ca5c6d5a94b8944936e375565a56230ef6b69956455a7a5f8", "text": "Examples of success\u2026\nhttps://www.youtube.com/watch?v=CtdwOA5mU8s", "start_char_idx": 0, "end_char_idx": 64, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "35e5b796-1e58-4c78-9788-f0fffe02488f": {"__data__": {"id_": "35e5b796-1e58-4c78-9788-f0fffe02488f", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8c38fd15-c3b7-4aa2-a5c3-43f232285574", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "hash": "ffa9e42b6e83b533b33c234fa39758cee8d46bbdde1b433d7b633d1aa11c9edd"}}, "hash": "8da3e78eae2e86956e6dc445562d2ca9f1a20a2cf895c1c628c4f1e7d9bb1dea", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 1815 May 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 352, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d866e2d8-1346-4793-a4aa-8e5f2afcd480": {"__data__": {"id_": "d866e2d8-1346-4793-a4aa-8e5f2afcd480", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9fbcc2bd-481f-4a49-94d1-a8fc053fde3c", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "hash": "04230eb5e5cf457d6b97c54c7d1245106cf7a47ebfb699eb9c89e6d105ae2e0a"}}, "hash": "04230eb5e5cf457d6b97c54c7d1245106cf7a47ebfb699eb9c89e6d105ae2e0a", "text": "Week 6 look aheadDiffusion of molecules (space, time, abundances)Programming patterns in autonomous systems[T eam Project] -Brainstorms (three themes)-T eam Rules CONCEPTSKILLProgramming patterns in living systemsWE ARE HERE", "start_char_idx": 0, "end_char_idx": 224, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c4a2fcc3-d771-4b07-8078-55ff279f835d": {"__data__": {"id_": "c4a2fcc3-d771-4b07-8078-55ff279f835d", "embedding": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fbca77c3-84fe-4cc6-9bd5-cde8b169a07d", "node_type": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "hash": "bc14b607d72cf14fe783e81008827296bdf1953d5377a5a1683ecba071fe1d10"}}, "hash": "bc14b607d72cf14fe783e81008827296bdf1953d5377a5a1683ecba071fe1d10", "text": "https://www.amputee-coalition.org/resources/a-brief-history-of-prosthetics/", "start_char_idx": 0, "end_char_idx": 75, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "57dc438a-5746-4463-a2af-e3530221da08": {"__data__": {"id_": "57dc438a-5746-4463-a2af-e3530221da08", "embedding": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "93f70f2d-ccfe-4e5a-87bd-4c8e04a2cc60", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "hash": "3a1b2bd7987ed313775c4e7e8ac2878343d6c4b0fef9bc538920054b9e61aa3d"}}, "hash": "ec180527ae91a9e15422703901f0487c4772df35c7eb5fd274b95fc19fd2ab54", "text": "Doing the\u201cimpossible\u201dHow to decide what impossible things are actually possible?How to organize people and resources to make the impossible true?  I.e., how to plan and deliver?Lessons learned?  How do you get started?Ups and downs?What happens after success?Other?", "start_char_idx": 0, "end_char_idx": 265, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "01161378-09c7-4e3f-aa3d-dcf61e0599a9": {"__data__": {"id_": "01161378-09c7-4e3f-aa3d-dcf61e0599a9", "embedding": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4c95681c-666d-4d0b-a70e-58ad7f7d0c2e", "node_type": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "hash": "2b8deae704f23bc60de39055f387baca5d53d918457d93a40aa4f07789a053b1"}}, "hash": "2b8deae704f23bc60de39055f387baca5d53d918457d93a40aa4f07789a053b1", "text": "https://www.amputee-coalition.org/resources/a-brief-history-of-prosthetics/", "start_char_idx": 0, "end_char_idx": 75, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c95fcfa7-06d0-41e2-8385-0efbb1887855": {"__data__": {"id_": "c95fcfa7-06d0-41e2-8385-0efbb1887855", "embedding": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab2759f0-3cdf-4eed-9b89-034c5a4df81b", "node_type": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "hash": "cb4ce12b85c4d477a30910a1bed2932ebcf604a58ae1f30b4053adfac469e24b"}}, "hash": "cb4ce12b85c4d477a30910a1bed2932ebcf604a58ae1f30b4053adfac469e24b", "text": "http://www.hhmi.org/biointeractive/newt-limb-regeneration", "start_char_idx": 0, "end_char_idx": 57, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7ef83312-a150-44e5-b712-dd12be58d0e6": {"__data__": {"id_": "7ef83312-a150-44e5-b712-dd12be58d0e6", "embedding": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b55ee70e-c31d-488b-ac5c-a58989c8a7d3", "node_type": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "hash": "060353a988c85c6fe437ee2443fc891e48c377fbfa469f98102f642b2509c7d8"}}, "hash": "060353a988c85c6fe437ee2443fc891e48c377fbfa469f98102f642b2509c7d8", "text": "Do something!\nConcentrated source (stuff, energy, other)\nDiffuse homogeneity(heat death, etc)For cells, doing something can mean\u20261. Grow & divide2. Move3. Communicate4. Change state5. Self destruct 6. Other", "start_char_idx": 0, "end_char_idx": 206, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "72446381-df80-4ae6-a3c5-70742f5f9251": {"__data__": {"id_": "72446381-df80-4ae6-a3c5-70742f5f9251", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3a8bcb25-4f13-4666-818c-ef35089ac60c", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "hash": "ff9647289508abd9901d6b02d1f4d1bbdaf2ef01bddcda77910e49a5b99c7681"}}, "hash": "0f53a67882b5f484bb190358cc4dffc1c4dca024e1a4a69e6d82aa25b941b939", "text": "What\u2019s the simplest way you could grow a limb-like shape?", "start_char_idx": 0, "end_char_idx": 57, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fe3dd61e-0e93-4dfb-8859-c49bdb2750ad": {"__data__": {"id_": "fe3dd61e-0e93-4dfb-8859-c49bdb2750ad", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cbc32d79-dc69-4a2e-8c63-c9024836d8e1", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "hash": "c791cbc9e914bd71507c91d17ace12024cc8b953f14558d8a264defc17d0a823"}}, "hash": "0caf86ea2370c2a8d7f7860f38778fde38cd26a7bb43ce9f237fe9f79dedb7e5", "text": "What if there was no guiding hand, but there were external points of reference?", "start_char_idx": 0, "end_char_idx": 79, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "cefbde89-fc99-49a6-85ca-c221ed00235e": {"__data__": {"id_": "cefbde89-fc99-49a6-85ca-c221ed00235e", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b0b8a719-144f-4c58-91a4-3cdd04719217", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "hash": "c8857da3bf699620ae2376be9885f72712666994e1dcf47f1d04e3199d77eb52"}}, "hash": "0eb294995e4a4318c121025a8d13f6a342a141040341a4ddb19c1915a15c2a03", "text": "What if there were no external points of reference?", "start_char_idx": 0, "end_char_idx": 51, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "34cfbc64-e909-4b85-8f38-df8974e96468": {"__data__": {"id_": "34cfbc64-e909-4b85-8f38-df8974e96468", "embedding": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b5e73bf4-899d-4b93-86e4-d06a64514f30", "node_type": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "hash": "f1e687d005cfaa374d81eff6737f7b1ad92816cf588f15142157372510333a46"}}, "hash": "f1e687d005cfaa374d81eff6737f7b1ad92816cf588f15142157372510333a46", "text": "OK.  So, how would you grow a yin yang from a single seed cell?\nhttps://www.biorxiv.org/content/10.1101/549352v1", "start_char_idx": 0, "end_char_idx": 112, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b2b5db5d-6194-4952-955a-dd4bab48c19e": {"__data__": {"id_": "b2b5db5d-6194-4952-955a-dd4bab48c19e", "embedding": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1d58fd78-3f25-41f1-b741-fbe5daf17545", "node_type": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "hash": "d1de02016aad3a3103faa414a1ac1bef9a318d677ad9599363e4f641fb889ddc"}}, "hash": "d1de02016aad3a3103faa414a1ac1bef9a318d677ad9599363e4f641fb889ddc", "text": "Take a complicated problem and break it down into a set of simpler problems\u2026\nhttps://www.biorxiv.org/content/10.1101/549352v1", "start_char_idx": 0, "end_char_idx": 125, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "cc23551e-21c4-4128-8312-f5d3c86c7e98": {"__data__": {"id_": "cc23551e-21c4-4128-8312-f5d3c86c7e98", "embedding": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "be4c64c7-2ac6-4ff6-8315-424cadd800d0", "node_type": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "hash": "a71d768eb87e92c8e1371f0f74bf1c16927bf171ba0541102fb10358d0181c58"}}, "hash": "e4a759f8504bb8dc8636c3fa631a8835a2ce546b13737a033507462459858ea7", "text": "One interesting aspect is how the mechanical, chemical, and biological realms are coupled\u2026   how can we leverage such couplings as bioengineers?\nhttps://www.biorxiv.org/content/10.1101/549352v1", "start_char_idx": 0, "end_char_idx": 193, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "edcceba6-ada1-44ff-b3c0-954b6ebe5eff": {"__data__": {"id_": "edcceba6-ada1-44ff-b3c0-954b6ebe5eff", "embedding": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2b1c3246-6cd1-460d-9f84-97eae6be59a8", "node_type": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "hash": "317a8efbada5c48233093f797eda9d5e483d6fb05f8b6f52e187c6bf1395be7f"}}, "hash": "be12b5cc148d34b23d72217e394bbae7c19563365d5c13e263f63394a470a3de", "text": "Just changing two simple variables (relative growth rates and cell lengths) can produce all of the below\u2026\nhttps://www.biorxiv.org/content/10.1101/549352v1", "start_char_idx": 0, "end_char_idx": 154, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f5c19990-3452-4ef3-960d-eddd193e0f81": {"__data__": {"id_": "f5c19990-3452-4ef3-960d-eddd193e0f81", "embedding": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cc35bbe2-2f71-4bf7-805a-7aa04ccf3cec", "node_type": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "hash": "3c02fea2881c2382ab96152a2ce1f5a3eecfc7a8572b66d4f52953069aeb5500"}}, "hash": "33936363b502ceccfaf3090fe46129446d00b87c32d0de58e40f86652c7a2255", "text": "Abstraction again appears as a tool for managing biocompleixty\u2026\nhttps://www.biorxiv.org/content/10.1101/549352v1", "start_char_idx": 0, "end_char_idx": 112, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3b64ecad-15ff-4f20-87b5-798fec51a8ba": {"__data__": {"id_": "3b64ecad-15ff-4f20-87b5-798fec51a8ba", "embedding": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8f244968-058a-4b28-96c8-54231b836c86", "node_type": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "hash": "fe1d4ce8f87d4be2661b94e2d2218e0b1af41dff38646656f593aad68d21a24b"}}, "hash": "fe1d4ce8f87d4be2661b94e2d2218e0b1af41dff38646656f593aad68d21a24b", "text": "So, can bioengineers grow arbitrary patterns from living cells, from scratch?\nhttps://www.biorxiv.org/content/10.1101/549352v1", "start_char_idx": 0, "end_char_idx": 126, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5ecb1289-3517-4bda-a9d9-324d49d1e090": {"__data__": {"id_": "5ecb1289-3517-4bda-a9d9-324d49d1e090", "embedding": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a3cda906-642e-4693-b653-91e0e0930d44", "node_type": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "hash": "d0e7f8c7fac985267fbe1af0bad84e9c064bd26447c342d282a2c416548b4e64"}}, "hash": "d0e7f8c7fac985267fbe1af0bad84e9c064bd26447c342d282a2c416548b4e64", "text": "What about a hybrid approach?\nhttps://advances.sciencemag.org/content/5/9/eaaw2459Use the biology for what the biology is good at, combined with what we can control from outside!Vascular system on demand?", "start_char_idx": 0, "end_char_idx": 204, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "28ef66a9-f638-47d6-a8f1-791cf8f5eda1": {"__data__": {"id_": "28ef66a9-f638-47d6-a8f1-791cf8f5eda1", "embedding": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5d1aac2c-5dd0-400c-af4a-691963a335eb", "node_type": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "hash": "ca800ca46aa635fe5cdb79dc63bfe26f93daf47309e5b3b8831b564d4b8ab9a2"}}, "hash": "fcc82c7a8be0c37df8da7333142b804b9fbd825dec7b0e6d5a64a3ceb9245f31", "text": "What about a hybrid approach?\nhttps://advances.sciencemag.org/content/5/9/eaaw2459Use the biology for what the biology is good at, combined with what we can control from outside!Cardiac vascular system on demand?", "start_char_idx": 0, "end_char_idx": 212, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0f9562c4-e24c-42c4-9acd-7aa7d4fb878b": {"__data__": {"id_": "0f9562c4-e24c-42c4-9acd-7aa7d4fb878b", "embedding": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b246a1ef-6c8d-412b-b7a6-8ebbbc2fa4fa", "node_type": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}, "hash": "76ca9d68a972ef90ba8589c98585ea47a29cc9732e64b883a39fd8c01af45a71"}}, "hash": "b416b7cca6f1614bf77213a667aece06bb45e546aed93576f47db1befd80b5eb", "text": "Same hybrid approach\u2026Living 3D printed bionic coral\nhttps://www.nature.com/articles/s41467-020-15486-4", "start_char_idx": 0, "end_char_idx": 102, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7275e3a8-866a-417a-84e7-299188adf5bb": {"__data__": {"id_": "7275e3a8-866a-417a-84e7-299188adf5bb", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "48bb9627-0e93-4f1e-a663-882cbc8b48f1", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "56d0d07a4b526663aa1ad3c819f1b411591aae3b8bcdc9e04faf41b0a33c27c3"}}, "hash": "c4de34337cb7ac2c7225a45e65fbe993995fc8e1d96557ed641d2ee659a2e629", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 16 April 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 352, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fa9efaa9-4b09-4721-98ad-5ce2784a0dad": {"__data__": {"id_": "fa9efaa9-4b09-4721-98ad-5ce2784a0dad", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "96ca9ee5-accc-4efb-a58b-cbea598e1853", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "df5553415c75a993c5d5387d06df3a5c0a77b007ba652e38208cc18f698967c5"}}, "hash": "982bc04b55df7af07792e5562b594efaee85e32662eb3cc27751fde2f3d28b33", "text": "Jonathan Calles(Lead TA)Brianna Chrisman(Digital Infrastructure Lead)\nNaomi Pacalin(Student Liaison Lead)Victor Tieu(Digital Front-End Lead)Nicolai Ostberg(Lead Grader)Julisia Chau(Lead Editor)", "start_char_idx": 0, "end_char_idx": 193, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ec43a3d0-9dc4-4be1-b2b1-cbaf90932cec": {"__data__": {"id_": "ec43a3d0-9dc4-4be1-b2b1-cbaf90932cec", "embedding": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bfb93aa3-909f-43da-8b36-35068775b2d5", "node_type": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "cf4bdcd1a32d981b5163ecebc061dfaa15fd39d363b1b1478bf969839447ba1e"}}, "hash": "d76444793b913327911b8b99ec0f4ce0b4bd6d9c82c168e13c3f1b7971fc778b", "text": "Siavash Ahrar(Co-Instructor)Micheal Specter(Co-Instructor)Drew Endy(Head Instructor)", "start_char_idx": 0, "end_char_idx": 84, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "aadd0e4b-ab37-4ec9-85a1-1f00514439d4": {"__data__": {"id_": "aadd0e4b-ab37-4ec9-85a1-1f00514439d4", "embedding": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7ae3b18b-3148-48a1-93ff-f59a957801bf", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "0caee3a958f715246265e8fc67a4486f260663e3a6c9dcb90fbe0abf4e6b366b"}}, "hash": "0caee3a958f715246265e8fc67a4486f260663e3a6c9dcb90fbe0abf4e6b366b", "text": "Imagine a bioengineer\u20261. Draw a sketch of your bioengineer2. Write down three words to describe       your bioengineer", "start_char_idx": 0, "end_char_idx": 118, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "afc239eb-e9a2-4b74-a2f8-7521e64db9e3": {"__data__": {"id_": "afc239eb-e9a2-4b74-a2f8-7521e64db9e3", "embedding": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bd069c61-8ffa-44a6-833a-376b260d943f", "node_type": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "d5dd5144730d449012e2560848e38c2cf279db3f9314d16aa8ecb432ec5fd489"}}, "hash": "d5dd5144730d449012e2560848e38c2cf279db3f9314d16aa8ecb432ec5fd489", "text": "Imagine a bioengineer\u20263. Find a neighbor, pair up.4. Compare your bioengineers.5. Note what is the same or different.6. On a scale of 0 to 100         how different or alike are your bioengineers?", "start_char_idx": 0, "end_char_idx": 196, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a0fd4cd5-b198-4182-9b53-37323ecded8c": {"__data__": {"id_": "a0fd4cd5-b198-4182-9b53-37323ecded8c", "embedding": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "19d4a083-81f2-41cb-849b-0dfcdb2ba363", "node_type": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "d20c9a5a14d374f196efb084b4c305f28fd71f55b5c7d6473fb3ca3dfea58e6d"}}, "hash": "d20c9a5a14d374f196efb084b4c305f28fd71f55b5c7d6473fb3ca3dfea58e6d", "text": "Imagine a bioengineer\u2026", "start_char_idx": 0, "end_char_idx": 22, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c8182f1e-7184-484a-97f5-b8136a46f03c": {"__data__": {"id_": "c8182f1e-7184-484a-97f5-b8136a46f03c", "embedding": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "326f35aa-b7fb-4b59-9e5f-686bf8da67cb", "node_type": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "5ce4e6ada3ade295b6b0b1a34aa0d85427caef3f39c7d3936fd6a003a5215206"}}, "hash": "56f52f5dcd10b866c6d3535d038f1976ee56fe38ba160f55bb7780f5c63b8a5b", "text": "Start of Quarter Self-Assessment", "start_char_idx": 0, "end_char_idx": 32, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a91d4993-3b9a-46ae-af45-b226ff9e4189": {"__data__": {"id_": "a91d4993-3b9a-46ae-af45-b226ff9e4189", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b3a984a1-cc76-4ebd-a2dd-b859dec5e178", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "517616f50cde6814b7f921b6ce0adbb8189c376812f3c603ee50cacd25be7acc"}}, "hash": "517616f50cde6814b7f921b6ce0adbb8189c376812f3c603ee50cacd25be7acc", "text": "What is our class about?Students successfully completing BIOE/ENGR.80 will have a working understanding for how to approach the systematic engineering of living systems to bene\ufb01t all people and the planet. Our main goals for the quarter are:  (1) to help you learn ways of thinking about engineering        living matter,   (2) for you to become more capable of learning and        explaining bioengineering to yourself and others,  (3) for you to be capable of leading discussions of the        broader rami\ufb01cations of engineering the living world.  (4) what do you wish to make true re: bioengr. by 2030?", "start_char_idx": 0, "end_char_idx": 606, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "593e6482-2548-4455-9052-2c7243c6c2d1": {"__data__": {"id_": "593e6482-2548-4455-9052-2c7243c6c2d1", "embedding": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "340602bd-fd52-4c47-a88a-f60b2a334379", "node_type": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "296c3b1ac4a090f4f9414d8f44b9463d7b3cad06042ae63a8628329f47cf99ed"}}, "hash": "296c3b1ac4a090f4f9414d8f44b9463d7b3cad06042ae63a8628329f47cf99ed", "text": "watermeloneggplantcarrotbananacornbroccoli#include <domestication.h>", "start_char_idx": 0, "end_char_idx": 68, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "cb7fe02f-2084-463a-b900-ab5fb7282e55": {"__data__": {"id_": "cb7fe02f-2084-463a-b900-ab5fb7282e55", "embedding": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6cf3666e-c874-4a61-a829-fd4870acf4ad", "node_type": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "cd445bb922e7b1f6a8cca703090ee39fc07852527a8270db99023b83a4ffdcdb"}}, "hash": "cd445bb922e7b1f6a8cca703090ee39fc07852527a8270db99023b83a4ffdcdb", "text": "#include <breeding.h>", "start_char_idx": 0, "end_char_idx": 21, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b715ce9b-d232-4d4d-99bc-95c3a2fdacc7": {"__data__": {"id_": "b715ce9b-d232-4d4d-99bc-95c3a2fdacc7", "embedding": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ffed7e98-724f-4ecd-abd5-82c1c936fca1", "node_type": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "278b11b294dfc0d5aa21a512ed021235406f711a00164dc1b1e6359da5ffc851"}}, "hash": "278b11b294dfc0d5aa21a512ed021235406f711a00164dc1b1e6359da5ffc851", "text": "#include <landuse.h>", "start_char_idx": 0, "end_char_idx": 20, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fb80ed35-825a-492f-a748-a8458d94a5e5": {"__data__": {"id_": "fb80ed35-825a-492f-a748-a8458d94a5e5", "embedding": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "25350984-feb6-4e1c-8866-ee5a7d062813", "node_type": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "21a249206eb771fb2b65aa95125d77230bce7e224df20bd91ac105de425effba"}}, "hash": "21a249206eb771fb2b65aa95125d77230bce7e224df20bd91ac105de425effba", "text": "#include <geneticengr.h>", "start_char_idx": 0, "end_char_idx": 24, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b472e735-ce31-43fe-9efe-6b086b8e8593": {"__data__": {"id_": "b472e735-ce31-43fe-9efe-6b086b8e8593", "embedding": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0dbc89fb-1ed2-47b4-acd0-2fa69a22ab72", "node_type": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "91c82d32f0761f01348770ec04f4636672c7f3d33d7cabc251343ccb4d78fe27"}}, "hash": "b31a8c9406baabab8fe21c1d431dbc692efe88a13b819b171c8cab6b2c3949fc", "text": "Genetically Engineered U.S. Domestic Product (2012)\nhttp://www.nature.com/nbt/journal/v34/n3/abs/nbt.3491.html", "start_char_idx": 0, "end_char_idx": 110, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "39f7f34b-3cc7-4a0f-9014-0961df352474": {"__data__": {"id_": "39f7f34b-3cc7-4a0f-9014-0961df352474", "embedding": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cbfe7b95-bc81-40fc-9ac3-367c16bf4b08", "node_type": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "1f0da39d3de0d5b49edb3a687fc68959ff8999667f543e55438abcbeae3fee6d"}}, "hash": "1f0da39d3de0d5b49edb3a687fc68959ff8999667f543e55438abcbeae3fee6d", "text": "Graphic c/o \"Synthetic Aesthetics,\u201d MIT Press (2014)", "start_char_idx": 0, "end_char_idx": 52, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1c7b4eee-ede3-49da-a1b5-53b6fb19dbc5": {"__data__": {"id_": "1c7b4eee-ede3-49da-a1b5-53b6fb19dbc5", "embedding": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "40edf429-a462-41d0-b55f-5889cc3fdda1", "node_type": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "96cfe28f36699c3f37c38da97d844b9de3c6f34e9ea3a56505b25f4c29b2edf1"}}, "hash": "96cfe28f36699c3f37c38da97d844b9de3c6f34e9ea3a56505b25f4c29b2edf1", "text": "http://www.apsnet.org/edcenter/intropp/lessons/viruses/Pages/PapayaRingspotvirus.aspxDennis  Gonsalves", "start_char_idx": 0, "end_char_idx": 102, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3bd3cacf-6ee3-43bb-8ae3-35ab8760c9a7": {"__data__": {"id_": "3bd3cacf-6ee3-43bb-8ae3-35ab8760c9a7", "embedding": null, "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e4ef913b-8fb2-43e1-8799-9372b7c41da2", "node_type": null, "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "d0597db09645f2d4a7362709f9c533be1acf59c6619ebba6e69d4a0f3ac22011"}}, "hash": "d0597db09645f2d4a7362709f9c533be1acf59c6619ebba6e69d4a0f3ac22011", "text": "http://soefuture.stanford.edu/impact", "start_char_idx": 0, "end_char_idx": 36, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "29bd2599-ad0a-49d1-8d47-031341511b0a": {"__data__": {"id_": "29bd2599-ad0a-49d1-8d47-031341511b0a", "embedding": null, "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0db4f992-e1b5-4b2d-bb66-e2d857638072", "node_type": null, "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "9ba723a2d247544e65b99a00559f9e14cddbdb4b792ad1f470d4b5b8cf790b00"}}, "hash": "9ba723a2d247544e65b99a00559f9e14cddbdb4b792ad1f470d4b5b8cf790b00", "text": "\u201cEnough is known already of the diverse applications of computing for us to recognize the birth of a coherent body of technique, which I call computer science...Whether computers are used for engineering design, medical data processing, composing music, or other purposes, the structure of computing is much the same.                                                \u2014 George Forsythe, 1961\u201cEnough is known already of the diverse applications of biology for us to recognize the birth of a coherent body of technique, which we call bioengineering\u2026 Whether living matter is used for manufacturing, medicine, abiotic data storage, art, or other purposes, the structure of engineering life is much the same.                                                \u2014 Endy & Liphardt, 2017", "start_char_idx": 0, "end_char_idx": 772, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1e9fec63-e3fc-41bc-ade7-8abd03e9b406": {"__data__": {"id_": "1e9fec63-e3fc-41bc-ade7-8abd03e9b406", "embedding": null, "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5028cfdc-74f2-46d6-967b-f91496342667", "node_type": null, "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "858030c28dd46f4de8190d0260dbf2617979481b3f28cd06216e7d11ba5878e9"}}, "hash": "9e79e85fe8fa499e78a44cb8bdf4f41bae8eb4652600cd51b764d7728da7d1a0", "text": "23", "start_char_idx": 0, "end_char_idx": 2, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "61595e0b-bf98-47fa-b271-490ef7b1a2fa": {"__data__": {"id_": "61595e0b-bf98-47fa-b271-490ef7b1a2fa", "embedding": null, "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4e2426af-23d9-4557-94ba-7c70b1075ea9", "node_type": null, "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "93553ab5f1c302d57e84bed0a3b020fa0f8c0280f1c7f55e387a230695eb48be"}}, "hash": "93553ab5f1c302d57e84bed0a3b020fa0f8c0280f1c7f55e387a230695eb48be", "text": "FoodEnergyEnvironmentAgricultureHealthChemicals & MaterialsSecurity", "start_char_idx": 0, "end_char_idx": 67, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0a79cc6d-7432-4ffe-b2f3-418479d9c9a4": {"__data__": {"id_": "0a79cc6d-7432-4ffe-b2f3-418479d9c9a4", "embedding": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6baca1f2-5328-406d-8e50-faac2a4f3b23", "node_type": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "894be9431ceca2a723b501799ae59896bc591459fdb1aa79b1f766be0e287f37"}, "3": {"node_id": "997e2e07-8cb2-47ef-9bc3-46ff8c0b13d3", "node_type": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "a4ee45de6b58458365f91a561a2f3aedcd58bcb9faacffbed36e67f82eb4be65"}}, "hash": "7c5d9d586751e37542aa7b4aab48a68cd55f03a3a46b15a876587d7187ecd6e6", "text": "Glycerol\nAr5-Hydroxymethyl-furfuralSG\nFerulic acidGallic acidC6C5Higher alcoholsC2Oxo synthesis products\n3-Hydroxy-propionateLacticPropionic acidMalonic acidSerineSuccinic acidFumaric acidMalic acid3-Hydroxy-butyrolactoneAcetoinItaconic acidFurfuralLevulinic acidGlutamic acidXylonic acidXylitol/ArabitolH2MethanolMixed alcoholsBiobasedSyn Gas\nDirectPolymers & gumsTextilesCarpets, Fibers, fabrics, fabric coatings, foam cushions, upholstery, drapes, lycra, spandexSafe Food SupplyFood packaging, preservatives, fertilizers, pesticides, beverage bottles, appliances, beverage can coatings, vitaminsTransportationFuels, oxygenates, anti-freeze, wiper fluids molded plastics, car seats, belts hoses, bumpers, corrosion inhibitors\nHousingPaints, resins, siding, insulation, cements, coatings, varnishes, flame retardents, adhesives, carpetingRecreationFootgear, protective equipment, camera and film, bicycle parts & tires, wet suits, tapes-CD\u2019s-DVD\u2019s, golf equipment, camping gear, boatsHealth and HygienePlastic eyeglasses, cosmetics, detergents, pharmaceuticals, suntan lotion, medical-dental products, disinfectants, aspirinIso-synthesis productsFischer-TropschLiquidsC3C4Aspartic acid\nCitric/AconiticacidLysineGluconic acidSorbitolGlucaric acidAmmonia synthesis, hydrogenation productsLinear and branched 1\u00ba alcohols, and mixed higher alcoholsMethyl esters, Formaldehyde, Acetic acid, Dimethylether, Dimethylcarbonate,  Methyl amines, MTBE, olefins, gasolineOlefin hydroformylation products: aldehydes, alcohols, acidsIso-C4 molecules, isobutene and its derivatives!-olefins, gasoline, waxes, dieselFermentation products, Propylene glycol, malonic, 1,3-PDO, diacids, propyl alcohol, dialdehyde, epoxides Acrylates, L-Propylene glycol, Dioxanes, Polyesters, LactideAcrylates, Acrylamides, Esters, 1,3-Propanediol, Malonic acid and others \nTHF, 1,4-Butanediol, \"-butyrolactone, pyrrolidones, esters, diamines, 4,4-Bionelle, hydroxybutyric acidUnsaturated succinate derivatives (see above)\nHydroxybutyrates, epoxy-\"-butyrolactone, butenoic acid\nMethyl succinate derivatives (see above), unsaturated estersMany furan derivatives#-aminolevulinate, 2-Methyl THF, 1,4-diols, esters, succinate\nEG, PG, glycerol, lactate, hydroxy furans, sugar acidsAmino diols, glutaric acid,substituted pyrrolidones \n1,5-pentanediol, itaconic derivatives, pyrrolidones, estersNumerous furan derivatives, succinate, esters, levulinic acidCaprolactam, diamino alcohols, 1,5-diaminopentaneDilactones, monolactones, other productsGluconolactones, estersGlycols (EG, PG), glycerol, lactate, isosorbidePhenolics, food additivespolyhydroxyalkonoatespoyaminoacidspolysaccharidesHydroxy succinate derivatives (above), hydroxybutyrolactoneAmino succinate derivatives (see above)Butanediols, butenolsDiols, ketone derivatives, indeterminant\nLactones, estersAntifreeze and deicersFuel oxygenates\nGreen", "start_char_idx": 0, "end_char_idx": 2867, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "997e2e07-8cb2-47ef-9bc3-46ff8c0b13d3": {"__data__": {"id_": "997e2e07-8cb2-47ef-9bc3-46ff8c0b13d3", "embedding": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6baca1f2-5328-406d-8e50-faac2a4f3b23", "node_type": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "894be9431ceca2a723b501799ae59896bc591459fdb1aa79b1f766be0e287f37"}, "2": {"node_id": "0a79cc6d-7432-4ffe-b2f3-418479d9c9a4", "node_type": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "7c5d9d586751e37542aa7b4aab48a68cd55f03a3a46b15a876587d7187ecd6e6"}}, "hash": "a4ee45de6b58458365f91a561a2f3aedcd58bcb9faacffbed36e67f82eb4be65", "text": "estersAntifreeze and deicersFuel oxygenates\nGreen solvents\nPhthalate polyestersPlasticizers\nPolyacrylatesPolyacrylamides\nPhenol-formaldehyde resinsPEIT polymerPolyhydroxypolyestersPolyhydroxypolyamides Chelating agentsAminesSolvents\nNylons (polyamides)\nPolyurethanesBisphenol A replacement Polycarbonates Reagents-building unit\nEnvironmentWater chemicals, flocculants, chelators, cleaners and detergentsReagent, propionol, acrylatePharma. IntermediatesPolyvinyl acetate\nPolyvinyl alcoholSpecialty chemical intermediate\nPolyethersPolypyrrolidonesResins, crosslinkerspH control agentsEmulsifiers\nCommunicationMolded plastics, computer casings, optical fiber coatings, liquid crystal displays, pens, pencils, inks, dyes, paper products2-amino-1,3-PDO, 2-aminomalonic, (amino-3HP)\nThreonineIndustrialCorrosion inhibitors, dust control, boiler water treatment, gas purification, emission abatement, specialty lubricants, hoses, sealsIntermediate PlatformsBuilding BlocksSecondaryChemicalsProducts/UsesIntermediatesBiomassFeedstocks\nSugarsGlucoseFructoseXyloseArabinoseLactoseSucroseStarchStarchCelluloseLigninOilProteinHemicellulose\nFigure 3 \u2013 Analogous Model of a Biobased Product Flow-chart for Biomass FeedstocksFoodEnergyEnvironmentAgricultureHealthChemicals & MaterialsSecurity2004 DOE report lists 120 highvalue chemicals for biomanufacturing\n25", "start_char_idx": 2818, "end_char_idx": 4164, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5d55b35b-4c36-499a-ac78-0e2dae56dbde": {"__data__": {"id_": "5d55b35b-4c36-499a-ac78-0e2dae56dbde", "embedding": null, "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "df728331-6a32-4c9b-b5e1-ff7abe42926a", "node_type": null, "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "e7a3f08c8efaf3bdde717363e612d8c30193ff2f005b9c8bb067e3ae39e1e49d"}}, "hash": "e7a3f08c8efaf3bdde717363e612d8c30193ff2f005b9c8bb067e3ae39e1e49d", "text": "Graphic c/o \"Synthetic Aesthetics,\u201d MIT Press (2014)", "start_char_idx": 0, "end_char_idx": 52, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fad7ec60-2d03-4a9e-9c06-434889973b52": {"__data__": {"id_": "fad7ec60-2d03-4a9e-9c06-434889973b52", "embedding": null, "metadata": {"page_label": "27", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5400fae0-5fc5-4e30-ae1f-83d44dd5dd06", "node_type": null, "metadata": {"page_label": "27", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "a34e4f84f1291bd6b0cf7bb2d60bd7916f71b5e930fc9e31be6fddac7ee83acc"}}, "hash": "a34e4f84f1291bd6b0cf7bb2d60bd7916f71b5e930fc9e31be6fddac7ee83acc", "text": "Photo by Roger Lancaster (http://www.\ufb02ickr.com/photos/rogeral/5813079061/); educational fair use", "start_char_idx": 0, "end_char_idx": 96, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9995d704-a341-4b54-9e54-c93f1de21d74": {"__data__": {"id_": "9995d704-a341-4b54-9e54-c93f1de21d74", "embedding": null, "metadata": {"page_label": "28", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3a902a5e-83a1-4fbd-b444-4d2816941a25", "node_type": null, "metadata": {"page_label": "28", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "df0b5ca513febe0c940728ad06132bdca3a98266e82a854c6af2770002276bc6"}}, "hash": "4162ad372fe98f0f3914501e9968c0c249ee5101748b9fba3aaf331e114b9d36", "text": "28", "start_char_idx": 0, "end_char_idx": 2, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "df532cd8-936a-47ec-9464-c8c48ac2f010": {"__data__": {"id_": "df532cd8-936a-47ec-9464-c8c48ac2f010", "embedding": null, "metadata": {"page_label": "29", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dfe82da8-b5ee-470d-a706-d81394c80778", "node_type": null, "metadata": {"page_label": "29", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "b1ff80afbe0f28fa50a5ca8382dbf4b91d28870bd1a5dddc43fe634702b09993"}}, "hash": "4aba410ad663ad8ea5da53abe163d9b3b5318c10bae9bd3ae1f5e1e3736ea481", "text": "29", "start_char_idx": 0, "end_char_idx": 2, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "32310663-18b5-4101-956a-4ef25fc9bc5a": {"__data__": {"id_": "32310663-18b5-4101-956a-4ef25fc9bc5a", "embedding": null, "metadata": {"page_label": "31", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d984e73d-8443-4308-b6eb-ddc9c4475b3d", "node_type": null, "metadata": {"page_label": "31", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "79a5ae0e3549ec7cef3d1aee45810604e6d0b837be6594374a3153a7ee4964d0"}}, "hash": "5595d020785167d0f107c991ea08de34c4a444bbcbcb22d22e5fdb69ba82b993", "text": "Transitioning to electricity abundant civilization\nPhotovoltaic ROE >> 1", "start_char_idx": 0, "end_char_idx": 72, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f00e6f06-28d8-4eb6-ad66-df98a5959f35": {"__data__": {"id_": "f00e6f06-28d8-4eb6-ad66-df98a5959f35", "embedding": null, "metadata": {"page_label": "32", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "414e7d21-4569-4522-94cf-c6a7a4f97765", "node_type": null, "metadata": {"page_label": "32", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "0a3f68418e83fd06920f2447b5490a59c65ee0288a81640bfa0c83aaad754684"}}, "hash": "0a3f68418e83fd06920f2447b5490a59c65ee0288a81640bfa0c83aaad754684", "text": "~1 kWh electricity = ~ 1 gram new biomassElectro-fermentation\u2026\n~$0.11 = ~ 1 course of antibiotics", "start_char_idx": 0, "end_char_idx": 97, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "15e1bc63-62e7-4a70-b2f7-3c07e36901d0": {"__data__": {"id_": "15e1bc63-62e7-4a70-b2f7-3c07e36901d0", "embedding": null, "metadata": {"page_label": "33", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "74ed164e-b9dd-470c-a775-382f3165dec8", "node_type": null, "metadata": {"page_label": "33", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "899042dff0fb2340265d3bfeff908ca53f63c4c5f5aefc267cfe9e505601860f"}}, "hash": "899042dff0fb2340265d3bfeff908ca53f63c4c5f5aefc267cfe9e505601860f", "text": "Q. How will this box change the world?\nQ. What will the \u201cPB\u201d + the \u201cbionet\u201d lead to?electricityinternetCO2whatever biology can be programmed to make or do\u2026\n33A. \u201cdesign anywhere, grow everywhere\u201d", "start_char_idx": 0, "end_char_idx": 195, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ec6f7101-2cfa-4663-9de4-f52a76f1cf65": {"__data__": {"id_": "ec6f7101-2cfa-4663-9de4-f52a76f1cf65", "embedding": null, "metadata": {"page_label": "34", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e593b6e7-c1db-482c-9523-d3b18c67dea0", "node_type": null, "metadata": {"page_label": "34", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "1ee778c0ac4bb2076f673d7f0476f70fa24fadc178a6dd6c696bb6890da30a0b"}}, "hash": "1cac3234c516cf34ac8f131e9cdf8362383d9e4f58c91e6f8f1503c9872c229f", "text": "What might & should we wish for?                \n   What does it mean to engineer biology?        \n   Can we realize a culture of bioengineering?https://en.wikipedia.org/wiki/El_Jaleo", "start_char_idx": 0, "end_char_idx": 183, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "cfc1b58a-2a3e-43fd-99cf-a25f5e799f75": {"__data__": {"id_": "cfc1b58a-2a3e-43fd-99cf-a25f5e799f75", "embedding": null, "metadata": {"page_label": "35", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "56c936d7-0c72-4d5f-99c9-90851dfd3c4b", "node_type": null, "metadata": {"page_label": "35", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "5e374d3c977f913c7e34c63567b21e6f9671b3562b5fc79e8ecce3b5688c8662"}}, "hash": "5e374d3c977f913c7e34c63567b21e6f9671b3562b5fc79e8ecce3b5688c8662", "text": "https://secure3.convio.net/wcs/pdf/Synthetic_Biology_and_Conservation_Framing_Paper.pdf\n\u201cThe modern \ufb01eld of conservation was born as a crisis discipline and it really was focused on trying to stop extinction.So what does conversation want?  What it wants is to conserve nature.  Particular biodiversity and species and ecosystems with less emphasis on the genetic component.It is based on a set of foundational values that focus on the natural and the wilderness.It wants a world that doesn\u2019t change except by its own agency.  It embraces change but natural change.\u201d   \u2014 Kent Redfordhttps://vimeo.com/225308429", "start_char_idx": 0, "end_char_idx": 610, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "048a7971-7832-40cb-af48-846f1baa681e": {"__data__": {"id_": "048a7971-7832-40cb-af48-846f1baa681e", "embedding": null, "metadata": {"page_label": "36", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "82aeaad1-c8bf-43d2-82dc-446c5beba1b8", "node_type": null, "metadata": {"page_label": "36", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}, "hash": "949f4da21d49c2bc1ca035697a0319c8b7b1ea08e488efb0b2d854a669065fb3"}}, "hash": "949f4da21d49c2bc1ca035697a0319c8b7b1ea08e488efb0b2d854a669065fb3", "text": "The living bridges of Cherrapunji, India are made from the roots of the Ficus elastica tree. (http://rootbridges.blogspot.com/)What is our telos?\nReproducing, growing, & healing materials~90 terawatts via photosynthesis*Massively functional Living rami\ufb01cationsBiology is already  many places\n*electrobiosynthesis will remove this cap\nTake infectious & other diseases off the tableEnable humanity to provide for itselfStabilize & recover natural biodiversityEnable a culture  of citizenshipUnderstand life via building", "start_char_idx": 0, "end_char_idx": 517, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "689f7407-4fbe-476f-99db-f4a564b130f9": {"__data__": {"id_": "689f7407-4fbe-476f-99db-f4a564b130f9", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dfccef0c-5266-48d4-9ac0-cba82680f8e2", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "hash": "f6b95c5d775cca9407d97ca25480803357c212080d5fdfdfb4d909f5baf0f3dd"}}, "hash": "523420ff831d84d53c2112ed67766e643b68319d0398a8b77e2d026721e2a2f2", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 2227 May 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 352, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2f878312-5dd0-49f6-b331-9022466b864e": {"__data__": {"id_": "2f878312-5dd0-49f6-b331-9022466b864e", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d8f011d6-bdd1-4296-91d3-2212fd530a42", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "hash": "bcc718180c136fe65fa9236bfe359b0aa2d2214774f77c25878087238bd2a36c"}}, "hash": "b2428c1d0a0ffe5f5f2a39643d519106b32f814f32f2b44f96a47deb092b1ae4", "text": "Week 7 repriseImpact versus effort mappingProject topic selectionCommunicating clearlyPROJECTSKILLStorytelling for engagementPerforming for impact-Michael Specter\n-Alexandra Schwartz\n-Malcolm Gladwell", "start_char_idx": 0, "end_char_idx": 200, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "238ec9e9-5dbd-408c-81f8-491d6e9ad33d": {"__data__": {"id_": "238ec9e9-5dbd-408c-81f8-491d6e9ad33d", "embedding": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "61347e8b-48c7-4264-9306-9c7c54ba86d3", "node_type": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "hash": "4068ed12055239b6ce570cbd9570e4bb86eca737885ff98c0df4564b97866934"}}, "hash": "4068ed12055239b6ce570cbd9570e4bb86eca737885ff98c0df4564b97866934", "text": "Week 8 look aheadEvolution as algorithmEvolution as service<Evolutionary algorithm sandbox>CONCEPTSKILLEvolution 2.0?", "start_char_idx": 0, "end_char_idx": 117, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a4f39c2e-f564-4b33-9a09-0e0900fac1d0": {"__data__": {"id_": "a4f39c2e-f564-4b33-9a09-0e0900fac1d0", "embedding": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "80342e07-82a4-430f-b4d4-659d7582b928", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "hash": "807c1a0c45a11fd6486faf5cb23ffe402f2967be17ca1e02e9b9f24270c7c4c1"}}, "hash": "4987d4116da4a1a53e18bd87d822d79b17db24ce8c39519457d26d29a769784b", "text": "*By algorithm, we simply mean to represent that a few things must be happening for evolution to happen.  We do not mean to imply any higher purpose to the process. Evolution as algorithm*", "start_char_idx": 0, "end_char_idx": 187, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "99d359e9-69c1-43dd-b96d-480f958166da": {"__data__": {"id_": "99d359e9-69c1-43dd-b96d-480f958166da", "embedding": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "69b2d8eb-c43f-41cd-9936-c7591d645dde", "node_type": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "hash": "c858ec8f4fef0642c4b9db438a79441e4dc4ce4846da9e3ce54d1ced5c3e2adf"}}, "hash": "8f497366a843864b0a800e5c058d864c0db6495366138d7769d7f0c63dde16dc", "text": "survival of the fittest \ngenotypes influence phenotypes  Evolution as algorithm\nCompetition among \nindividuals whose behaviors \nvary (i.e., phenotypes).\nRandom changes in the \nheritable material passed from \nsurvivors to their offspring \n(i.e., genotypes)", "start_char_idx": 0, "end_char_idx": 255, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3ba100a0-44b6-43c2-aeeb-00ceabcd5ef9": {"__data__": {"id_": "3ba100a0-44b6-43c2-aeeb-00ceabcd5ef9", "embedding": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f3f8b529-843d-4e57-be0b-999636c81b66", "node_type": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "hash": "ebb1ae4225f26ceb7d35fae453c450d3cc959f41e110e4a76193a828c5ad1a71"}}, "hash": "2098e6dcb4df088ce5ad29b760737e978489408bbb4b941418fb7f8edbf68b87", "text": "survival of the fittest \ngenotypes influence phenotypes  Evolution as algorithm\nRandom changes in the \nheritable material passed from \nsurvivors to their offspring \n(i.e., genotypes) \nhttps://www.nature.com/articles/nature14181https://en.wikipedia.org/wiki/Darwin%27s_finches", "start_char_idx": 0, "end_char_idx": 275, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ab7fd245-e601-4a24-a0b8-def54ebd9210": {"__data__": {"id_": "ab7fd245-e601-4a24-a0b8-def54ebd9210", "embedding": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aeb8ba79-baba-4ff6-af11-0b792ece2cd8", "node_type": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "hash": "fa70d4ab88f73fbad6659e6a69fc84e46eedee00e9dad8a3bfa1cc51b13eb306"}}, "hash": "9e1a73391330cca89ac198bb27c5c1023be3cb3e9dc8ece7f043df34485d375a", "text": "Evolution as algorithm\nCompetition\n among \nindividuals whose behaviors \nvary (i.e., phenotypes).\nRandom\n changes in the \nheritable\n material passed from \nsurvivors to their offspring \n(i.e., genotypes) \n survival of the fittest \ngenotypes influence phenotypes", "start_char_idx": 0, "end_char_idx": 259, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "175642c0-4626-4118-a744-305d372f9fe3": {"__data__": {"id_": "175642c0-4626-4118-a744-305d372f9fe3", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0d9e8793-6891-4aa7-9231-8f0425b74ada", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "hash": "34546e2715aa4624a494ae8cad1be1f7e8327edfda9ca6f89c2a6b0f5cf6b6ab"}}, "hash": "ca438c6d32819b531df92f0f403d2001a67d29171d2feee294d3192ceaaebc91", "text": "Evolution as substrate agnostic algorithm\nhttps://www.scirp.org/journal/paperinformation.aspx?paperid=3201Q. what else can be evolved?Q. how to evolve electrical circuits?", "start_char_idx": 0, "end_char_idx": 171, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e0a0efa0-5b9e-4882-b549-ad60f1eca4cf": {"__data__": {"id_": "e0a0efa0-5b9e-4882-b549-ad60f1eca4cf", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c516e149-81fe-4c9d-b33b-1cd9405d2a7f", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "hash": "26b0fc26c1ddc20b6a1f0186cf38c359dc1b7fdc78af9cbd40851d3aef12db0a"}}, "hash": "26b0fc26c1ddc20b6a1f0186cf38c359dc1b7fdc78af9cbd40851d3aef12db0a", "text": "Factors in\ufb02uencing evolution\nCompetition among \nindividuals whose behaviors \nvary (i.e., phenotypes).\nRandom changes in the \nheritable material passed from \nsurvivors to their offspring \n(i.e., genotypes) \n survival of the fittest \ngenotypes influence phenotypes  \ndetails of the \ncompetition?\nto what extent?\nwhat sorts of changes?  \nhow many changes per \nindividual per generation? \nhow many survivors?", "start_char_idx": 0, "end_char_idx": 404, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1dcb0171-24f2-4b02-a7de-6fb004bb7f9f": {"__data__": {"id_": "1dcb0171-24f2-4b02-a7de-6fb004bb7f9f", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4bd96e82-36b4-4fa4-aeb3-73b90edde45e", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "hash": "bac1a18527411b9b638c928e5425f9316bc11bba0fe3525021a6680fa61967d9"}}, "hash": "bac1a18527411b9b638c928e5425f9316bc11bba0fe3525021a6680fa61967d9", "text": "https://academic.oup.com/nar/article/47/19/10439/5568210\nE.g., to what extent \n(do changes in genotypes \nresult in changes in \nphenotypes)?", "start_char_idx": 0, "end_char_idx": 139, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "789d0713-1183-4351-ba77-c953fe2a1db2": {"__data__": {"id_": "789d0713-1183-4351-ba77-c953fe2a1db2", "embedding": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b7872f07-08fb-41f6-bb4b-01043cdc3776", "node_type": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "hash": "cf31587c3babc88fc8535b789cacabfc50371d9222059e3917f82a00ab3a07d2"}}, "hash": "af629a22517e59e1c988164ee3a27ac9a2a980848af5016520c4edc1d1220fe4", "text": "https://academic.oup.com/nar/article/47/19/10439/5568210", "start_char_idx": 0, "end_char_idx": 56, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d5d3a7f4-5aa2-4104-af7e-65512d0a9611": {"__data__": {"id_": "d5d3a7f4-5aa2-4104-af7e-65512d0a9611", "embedding": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "70118c48-8006-4642-bdbc-650a44838811", "node_type": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "hash": "b495275e0ac2a48033aac40388dc9e8bab19b6af25192239c6050609e1d7e21f"}}, "hash": "3a31d3935341dd9061bcba6227f979d3bb1d373a4a263a84c3ab8f212be8326f", "text": "https://academic.oup.com/nar/article/47/19/10439/5568210", "start_char_idx": 0, "end_char_idx": 56, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4e6f42da-3bf1-4aca-92d3-e4829cdd2ef5": {"__data__": {"id_": "4e6f42da-3bf1-4aca-92d3-e4829cdd2ef5", "embedding": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f5ab21c7-4a41-4218-83e8-8d9d0a0a9720", "node_type": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "hash": "229fd83012144e86a4c01cc280aea9901af492020f41946bb2f34a06870b8b79"}}, "hash": "13959277cfe755bcadf16d226c0f637e06a3dfff8f2add53187c9645b8364322", "text": "https://academic.oup.com/nar/article/47/19/10439/5568210\nQ. why is the standard genetic code six-fold less likely to change an amino acid given any point mutation in an open reading frame?", "start_char_idx": 0, "end_char_idx": 188, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "183f8f70-4808-4829-83a0-384890479e57": {"__data__": {"id_": "183f8f70-4808-4829-83a0-384890479e57", "embedding": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b9435c82-af16-419a-b1a4-d8dde3b52a61", "node_type": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "hash": "89f1f0cd436ef1e8cf74a33235706ed113fc0d69865c37537a93598ec192cfb7"}}, "hash": "4e806c395ee4d23a6822549586d2d734351e632bc2f579181b4ee7ba20159f9c", "text": "https://academic.oup.com/nar/article/47/19/10439/5568210Q. what would be the expected impact on evolution for organisms in which most point mutations land on codons that cannot be decoded?", "start_char_idx": 0, "end_char_idx": 188, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9df3a1be-5cb8-41ae-857a-4ca3874a1fcc": {"__data__": {"id_": "9df3a1be-5cb8-41ae-857a-4ca3874a1fcc", "embedding": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "695e7042-7851-47be-9245-39cbb6e62990", "node_type": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "hash": "d743f398f6a08af07fbb33c9bf89c49130c68d1ca1895c20168a9126d51eb14f"}}, "hash": "d743f398f6a08af07fbb33c9bf89c49130c68d1ca1895c20168a9126d51eb14f", "text": "Claim \u2014 mutations are not random in occurrence, rather genes whose mutating would be most bene\ufb01cial for \ufb01tness in a given environment are somehow preferentially mutated\u2026Q.  How would this work?", "start_char_idx": 0, "end_char_idx": 193, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2ca5fd7e-f431-442c-a080-e7b0e7aacb4a": {"__data__": {"id_": "2ca5fd7e-f431-442c-a080-e7b0e7aacb4a", "embedding": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2f40d532-aa3b-4cec-9c92-b9b86ab2761a", "node_type": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "hash": "20d3393ef3599321002bc6b99e56e9ebb5c2a8d9f80abc283c392ae801edb7de"}}, "hash": "20d3393ef3599321002bc6b99e56e9ebb5c2a8d9f80abc283c392ae801edb7de", "text": "A.  Evolution is cleverer than we are*  \nhttps://en.wikipedia.org/wiki/Orgel%27s_rules*see Orgel\u2019s rules\u2026", "start_char_idx": 0, "end_char_idx": 105, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ab409f11-bc92-4a6b-bf15-dfc6c034299e": {"__data__": {"id_": "ab409f11-bc92-4a6b-bf15-dfc6c034299e", "embedding": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ad2a7a4c-d6c0-4249-9727-20cedbfec3ad", "node_type": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}, "hash": "3d87254c425f8d0f1b05311a514afba82b07b6957951ffbc27827512c16f3591"}}, "hash": "3d87254c425f8d0f1b05311a514afba82b07b6957951ffbc27827512c16f3591", "text": "Group-1GreenGroup-2Yellow - RedGroup-3RedGroup-4Yellow - RedGroup-5Yellow - RedGroup-6Yellow-GreenGroup-7RedGroup-8Green Group-9Yellow - RedGroup-10Yellow-GreenGroup-11Yellow-GreenGroup-12Yellow-GreenGroup-13Yellow - RedGroup-14Yellow - RedGroup-15Yellow-GreenGroup-16Yellow-GreenGroup-17YellowBioe BaddiesYellowIn-progress project assessments", "start_char_idx": 0, "end_char_idx": 343, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3dfe89c7-ce20-49e6-8cac-d3775bb68220": {"__data__": {"id_": "3dfe89c7-ce20-49e6-8cac-d3775bb68220", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f4a588de-9a68-4282-9e49-24f8e0684dc9", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "hash": "19e0914a45024b1332f2c2c03fdd0b1f2e98a225ab3d60d4cc328504083687d5"}}, "hash": "a337c28e1fe1ea660ed4149214cd075f439013c361fba2cfb6f77cb28064baf4", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 2329 May 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 352, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8ce5a58f-0e32-4be8-8b82-438f794750f8": {"__data__": {"id_": "8ce5a58f-0e32-4be8-8b82-438f794750f8", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7622fc68-037a-429a-8112-e6c7981b4385", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "hash": "938ff9b86be13b03783063d8d8e6dad5000b918839c3b9a3b4b26003363399e6"}}, "hash": "938ff9b86be13b03783063d8d8e6dad5000b918839c3b9a3b4b26003363399e6", "text": "Week 8 look aheadEvolution as algorithmEvolution as service<Evolutionary algorithm sandbox>CONCEPTSKILLEvolution 2.0?", "start_char_idx": 0, "end_char_idx": 117, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b0904091-99d2-4d1b-a59e-36d83819c48c": {"__data__": {"id_": "b0904091-99d2-4d1b-a59e-36d83819c48c", "embedding": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cfc0b404-7185-4d74-9a7f-c3779acdf1d0", "node_type": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "hash": "d4c43b7fb58967b9a243da989fd8b1d103662b3c28f3d85e33252476592b412b"}}, "hash": "0529f2f2ea1948a05422897bcb607119ce4d7441146b2d749b9e80ebbc5b9ad8", "text": "survival of the fittest \ngenotypes influence phenotypes  Evolution as algorithm\nCompetition among \nindividuals whose behaviors \nvary (i.e., phenotypes).\nRandom changes in the \nheritable material passed from \nsurvivors to their offspring \n(i.e., genotypes)", "start_char_idx": 0, "end_char_idx": 255, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c5824f60-7629-4259-bf52-a475329a1eb3": {"__data__": {"id_": "c5824f60-7629-4259-bf52-a475329a1eb3", "embedding": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6d4adbf4-53ae-48f8-afa7-cb29e2b56221", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "hash": "12d299197f43141618e80b1a900f2d27f62caf1abde241590c056c66415863a5"}}, "hash": "12d299197f43141618e80b1a900f2d27f62caf1abde241590c056c66415863a5", "text": "E.g., I wish for a string of 100 bits \nthat sum to the highest value\nHere you go!\nEvolution as a service", "start_char_idx": 0, "end_char_idx": 104, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3e824c69-1d60-4623-8f9c-98e57f83839a": {"__data__": {"id_": "3e824c69-1d60-4623-8f9c-98e57f83839a", "embedding": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f5171a67-45ed-4f46-87fa-e735da6bf8f5", "node_type": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "hash": "7896752cb4fc13cfe00f615e86dd6c2e8cfed71bc5559a28786357074b388530"}}, "hash": "7896752cb4fc13cfe00f615e86dd6c2e8cfed71bc5559a28786357074b388530", "text": "Practical Power of Evolution0010101010 01101010111010101100 10101010111010100101 10101110110110101100 10110101010011001101 0000110111sum of bits = 54max. sum = 1002^100 ~ 1.3E30 combinations \nJon Calle\u2019s evolutionary \nsandbox demo.  How many \ncombinations needed to get to \nbest answer?\nEvolutionary algorithm only required ~500 generations w/ a \npopulation of 10,000 individuals, so only 5E6 attempts total \n(much less than the entire 1.3E30 search space)!", "start_char_idx": 0, "end_char_idx": 457, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "96a05e0b-24ae-40a9-8246-d029a7fb792a": {"__data__": {"id_": "96a05e0b-24ae-40a9-8246-d029a7fb792a", "embedding": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab886341-ca4a-488f-b6c4-b8566cccb408", "node_type": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "hash": "10ea80e0f3ae4b6fb097510279224f8964f7fd1f770f5934b89f3f6ad100f31b"}}, "hash": "10ea80e0f3ae4b6fb097510279224f8964f7fd1f770f5934b89f3f6ad100f31b", "text": "Evolution as a service\nI wish BIOLOGY did the \nfollowing for me!\nHere you go!\nMassive Caveat!\nRequires mapping your wish \ninto an evolutionary process", "start_char_idx": 0, "end_char_idx": 150, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8a46a8b3-7569-42ac-8ffa-268ab0c68b91": {"__data__": {"id_": "8a46a8b3-7569-42ac-8ffa-268ab0c68b91", "embedding": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e5142296-fb57-4d5d-8471-8a2429789238", "node_type": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "hash": "a8dbb4e5510d4005916f660f1f9056cfa9b3634dfd57eb6a4b803e27d718c28a"}}, "hash": "04799dc87b50fe03ce9116b7f1c6453ba70d3644836d13c97d23c08f16e1db26", "text": "Massive Caveat!\nRequires mapping your wish \ninto an evolutionary processChallenge 1 \u2014 linking desired behavior   to heritable material that can mutateChallenge 2 \u2014 ensuring that selective   pressure (i.e., survival of the \ufb01ttest) is   actually selecting for the speci\ufb01c   property you care about", "start_char_idx": 0, "end_char_idx": 295, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0e9aee42-605b-41e8-aea3-1a2907092db6": {"__data__": {"id_": "0e9aee42-605b-41e8-aea3-1a2907092db6", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "88a79746-b3b1-4930-8de0-ef14e7bac47b", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "hash": "69769bfb1b1b89e15de02138eadaa28d724264639c4f17ce35f3244ab26f5bed"}}, "hash": "69769bfb1b1b89e15de02138eadaa28d724264639c4f17ce35f3244ab26f5bed", "text": "Historically practiced, limited to biological wishes in which both challenges implicitly addressed\u2026", "start_char_idx": 0, "end_char_idx": 99, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "46e9c00b-1fd0-4cc7-b086-d271bfcdb8ad": {"__data__": {"id_": "46e9c00b-1fd0-4cc7-b086-d271bfcdb8ad", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fefeb2e4-fa50-409b-b273-9a55d090854c", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "hash": "bef538ed14b30698d7a7a3fc4a1377a24a7d426de4df9ad9d27ec8a5bade55b9"}}, "hash": "0e17644e6e27f6985f3978f782aad362c87972d62f7b26ef57819ea6c1a4ff53", "text": "21st-century bioengineering continues in this tradition, but with an signi\ufb01cant expansion in scope via \u201cdirecting\u201d & \u201csculpting\u201d evolution\nhttps://www.sciencedirect.com/science/article/pii/S1389034407000664", "start_char_idx": 0, "end_char_idx": 206, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e7958613-e73b-426e-9cc8-a0daea64c468": {"__data__": {"id_": "e7958613-e73b-426e-9cc8-a0daea64c468", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dabfb1ec-1fec-423e-9e17-6a4a84193b0b", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "hash": "499c48f60d465b4c092446139858e14ebcbfdcec1bf7953e2055b8f0f62c6517"}}, "hash": "6dd2bd8ed2ce733b3967df7bd54d75eedf9499d7e07d9ad22364ee5fe6877f05", "text": "https://www.sciencedirect.com/science/article/pii/S1389034407000664SELEX implements a general-purpose system by which DNA or RNA sequences can be selected for interactions with other stuff\u2026", "start_char_idx": 0, "end_char_idx": 189, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "49a5b01c-eb79-4cf7-a53f-6f174629191c": {"__data__": {"id_": "49a5b01c-eb79-4cf7-a53f-6f174629191c", "embedding": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "47d534d4-569f-4124-9961-a543051103ae", "node_type": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "hash": "d1056c3a8d41c5b28bc80e0736c1c73a2f00a6bc9f1d0645093625c463e92439"}}, "hash": "d1056c3a8d41c5b28bc80e0736c1c73a2f00a6bc9f1d0645093625c463e92439", "text": "Second case study \u2014 Yeast Surface Display\u2026\nhttps://link.springer.com/protocol/10.1007/978-1-4939-2748-7_8", "start_char_idx": 0, "end_char_idx": 105, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a8315963-f5c3-4921-b1fb-e1c3c85d06a9": {"__data__": {"id_": "a8315963-f5c3-4921-b1fb-e1c3c85d06a9", "embedding": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9213abc8-699d-4d6a-b9b5-3c0d30d9c5e9", "node_type": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "hash": "64ed353de080d996b0a1d84d6340676cb82f5dfad6593dcb0d3868732d931e69"}}, "hash": "64ed353de080d996b0a1d84d6340676cb82f5dfad6593dcb0d3868732d931e69", "text": "https://link.springer.com/protocol/10.1007/978-1-4939-2748-7_8\nCreate a general-purpose system by which any protein of interest can be made by a yeast cell and presented on outside of the cell\u2026", "start_char_idx": 0, "end_char_idx": 193, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a2399b5d-5707-4db9-8dfe-4fdae3981326": {"__data__": {"id_": "a2399b5d-5707-4db9-8dfe-4fdae3981326", "embedding": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bd124f09-adbe-436d-9c99-1a05470cc56d", "node_type": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "hash": "3b4830a1a1bbc697996e6df18abda76f61ae4fca461326563d6300be0ff4e385"}}, "hash": "35cdc07c69f173610c29ae043d6ebedc7316a87da5a28843c0ba1b50b94b24b8", "text": "https://link.springer.com/protocol/10.1007/978-1-4939-2748-7_8Use to select for any behavior of the protein that you can implement a selection for\u2026 (e.g., binding, stability, enzyme activity)", "start_char_idx": 0, "end_char_idx": 191, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ee7f5154-c2e6-4a4e-87c5-8c2b1e39b3c3": {"__data__": {"id_": "ee7f5154-c2e6-4a4e-87c5-8c2b1e39b3c3", "embedding": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "334260e0-0bc2-4ef8-8466-e6c09bf5c427", "node_type": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "hash": "a1383a62b183705341a7c8e854c351bb246d5826b4e3c945c7168435c8e44b0e"}}, "hash": "dd7f0c95ec5b08a030130cd9dd445b7640fef36e1b2d067cfa8915efcc28e5b9", "text": "Third case study \u2014 Phage-Assisted Continuous Evolution (PACE)\u2026\nhttps://www.nature.com/articles/nature09929", "start_char_idx": 0, "end_char_idx": 106, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0f6dd000-5b1b-464b-a845-dd3eccfb6be6": {"__data__": {"id_": "0f6dd000-5b1b-464b-a845-dd3eccfb6be6", "embedding": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a02d10cf-7961-4714-bca0-c2f0057e0be7", "node_type": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "hash": "44dbf244b1d7a0c547901d282258b7e96f34b745d67798aededdfa2b808f719b"}}, "hash": "7958856b53fab9239d86324804498c51c7e66a0a399e7149372fead20dc0333c", "text": "https://www.nature.com/articles/nature09929PACE can be used to automatically select for anything that can be turned into something to activate gene expression\u2026.", "start_char_idx": 0, "end_char_idx": 160, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7a1c1630-b72a-48d5-baf3-338ec7dcf53b": {"__data__": {"id_": "7a1c1630-b72a-48d5-baf3-338ec7dcf53b", "embedding": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9ddabf22-f972-4a1a-87ea-f255e5d173f6", "node_type": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "hash": "421a254d0653a9293bd5d2f48c42bb919fb8d75a96789f801efe44b68a420777"}}, "hash": "031ae8cad97edb947758054b2537b8cf2f0a9b1a65ca951d27633fa0b94779af", "text": "https://www.nature.com/articles/nature09929PACE can be used to automatically select for anything that can be turned into something to activate gene expression\u2026.", "start_char_idx": 0, "end_char_idx": 160, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3bf1aa97-37d3-4994-9dd8-d13e884ce487": {"__data__": {"id_": "3bf1aa97-37d3-4994-9dd8-d13e884ce487", "embedding": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "14dfcf1c-bfe0-435c-b92f-4d541b041a13", "node_type": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "hash": "27c5a55b3a17669b2fa9c68457bb32ab9d4358989d3b9d72fdf7d1835fc4bb8d"}}, "hash": "0d50a5b835dd89e920de12e6d39021ba7c9835730dab3be9a07aeb47c88a426a", "text": "survival of the fittest \ngenotypes influence phenotypes  Gene Drive Example\u2026\nRandom changes in the \nheritable material passed from \nsurvivors to their offspring \n(i.e., genotypes) \nhttps://www.nature.com/articles/nature14181https://en.wikipedia.org/wiki/Darwin%27s_finches", "start_char_idx": 0, "end_char_idx": 272, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3271bb74-d320-4319-b1bf-aa97724fb697": {"__data__": {"id_": "3271bb74-d320-4319-b1bf-aa97724fb697", "embedding": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aea476da-fc3b-4f90-973c-6ca78b1f3f4e", "node_type": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "hash": "af1e517a60a4179981ec557969cee4ced7069f0e324800a5a82e32c00303202b"}}, "hash": "af1e517a60a4179981ec557969cee4ced7069f0e324800a5a82e32c00303202b", "text": "Note \u2014 all preceding examples maintain randomness of mutations and normal inheritance\u2026\nhttps://en.wikipedia.org/wiki/Gene_drive", "start_char_idx": 0, "end_char_idx": 127, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "231b76ca-87f9-4c38-bdf4-f2e4a390f8cf": {"__data__": {"id_": "231b76ca-87f9-4c38-bdf4-f2e4a390f8cf", "embedding": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d80db5c4-9be7-49c9-b200-ef5ee39ae91f", "node_type": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "hash": "2b1be58f21c37f30a07e807dc360a100d33244c629829bf480a1aa78efd7827d"}}, "hash": "2b1be58f21c37f30a07e807dc360a100d33244c629829bf480a1aa78efd7827d", "text": "What if bioengineers changed these fundamental aspects of the evolutionary process?  GENE DRIVES!!!\nhttps://en.wikipedia.org/wiki/Gene_drive", "start_char_idx": 0, "end_char_idx": 140, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "70873e6c-2c82-4328-8249-277958021442": {"__data__": {"id_": "70873e6c-2c82-4328-8249-277958021442", "embedding": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f6ec7068-4cb1-4aeb-a6f6-3e063d9ecf22", "node_type": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}, "hash": "04340455c749be9736a2bb36c495f8852940e78b6f55b35b486a9e16aa87eecb"}}, "hash": "04340455c749be9736a2bb36c495f8852940e78b6f55b35b486a9e16aa87eecb", "text": "Group #First assessment Second assessmentGroup-1Group-2Group-3Group-4Group-5Group-6Group-7Group-8Group-9Group-10Group-11Group-12Group-13Group-14Group-15Group-16Group-17Bioe BaddiesTBD15In-progress project assessments", "start_char_idx": 0, "end_char_idx": 216, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e7911243-ec7c-44ab-a314-2ed64ded7910": {"__data__": {"id_": "e7911243-ec7c-44ab-a314-2ed64ded7910", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "eb69c7c3-889f-40d7-90a1-803c125e3873", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "hash": "7f52b9ce96d323dd475889aedb17128931e582953a866068882de06f663fed72"}}, "hash": "d28e6ed58cad25c92c1515d1e586fea0f57d7717d7a9bdd4672523bdf0fbaa71", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 241 June 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 352, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "786219fa-d603-49bd-9527-0c901cbf5fd5": {"__data__": {"id_": "786219fa-d603-49bd-9527-0c901cbf5fd5", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "296186c2-9202-48c5-b70c-3294eaa81af6", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "hash": "f39d4a36f5eea9f0db34d3c2d4fc8ae536b9dc2d95da7d6b9a2396e53ae343ea"}}, "hash": "f39d4a36f5eea9f0db34d3c2d4fc8ae536b9dc2d95da7d6b9a2396e53ae343ea", "text": "Week 8 reprisePROJECTSKILLEvolution as algorithmEvolution as service<Evolutionary algorithm sandbox>Evolution 2.0? - four step process (population, select, reproduce, perform) - direct & sculpt w/ evolution in lab (SELEX, YSD, PACE)  - synthetic genetic codes that hinder evolution, gene drives  - how do population size, selection %, etc, impact outcomes?", "start_char_idx": 0, "end_char_idx": 356, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "270db915-93a4-4aab-9a3a-091112acaf8b": {"__data__": {"id_": "270db915-93a4-4aab-9a3a-091112acaf8b", "embedding": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cfda448e-23be-4c3d-a72d-943b7ea328f7", "node_type": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "hash": "737fb5fa41efff1d516f8b184e87a1a305a1bc56cfb87b19930a883b3b55d2f9"}}, "hash": "a462afe5bfa9f8b8cff9b253fa0d80e11dcf566f45f2e21f7cc24ff8d19dc640", "text": "Week 9 look aheadPlanet healthPeople health<Parsing & \u201cPlaying\u201d Politics>CONCEPTSKILLPolitical health", "start_char_idx": 0, "end_char_idx": 101, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "53f57b99-b6ff-4d9a-89b3-ee6cb358ac82": {"__data__": {"id_": "53f57b99-b6ff-4d9a-89b3-ee6cb358ac82", "embedding": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2a86203e-4954-4c9a-bf58-886c2274a6f2", "node_type": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "hash": "5574f7e6c6e02c66b374defcdd20507c91c51c280a45edafe0a690c40e978fab"}}, "hash": "5574f7e6c6e02c66b374defcdd20507c91c51c280a45edafe0a690c40e978fab", "text": "http://www.livingplanetindex.org/projects?main_page_project=AboutTheIndex&home_\ufb02ag=1Past ~50 years, humans x 2, animals / 2The Living Planet Index (LPI) is a measure of the state of global biological diversity based on population trends of vertebrate species from around the world\u2026  The global LPI as presented in the Living Planet Report 2018 (Figure 1) shows that a subset of 16,704 populations of 4,005 species has declined by 60% in abundance between 1970 and 2014. The Living Planet Report 2018 results indicate that species are faring much worse in freshwater systems and in tropical realms. Freshwater populations declined by an average of 83%, while realms - large regions separated by major barriers to plant and animal migration and therefore characterized by distinct assemblages of species - declined by between 23% and 89%, with the Neotropical and Indo-Paci\ufb01c realms showing the steepest declines (89% and 64%, respectively).", "start_char_idx": 0, "end_char_idx": 939, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e4ed45f1-3a53-4927-a26c-79070a591d8f": {"__data__": {"id_": "e4ed45f1-3a53-4927-a26c-79070a591d8f", "embedding": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "65382a9d-f1b6-4134-9420-99e6e3515f21", "node_type": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "hash": "293e417faa956187c236f41d7e485fc75a74085fe1acce1ad0fcd5b222bd6531"}}, "hash": "293e417faa956187c236f41d7e485fc75a74085fe1acce1ad0fcd5b222bd6531", "text": "https://youtu.be/ZZfBqdaafjA", "start_char_idx": 0, "end_char_idx": 28, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "decafcd9-a7ad-42af-b737-646cbcb31992": {"__data__": {"id_": "decafcd9-a7ad-42af-b737-646cbcb31992", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7c81ecd3-1852-4c8e-9e59-52c4cc960c88", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "hash": "cf1bde2ef6faded70db9b9dafd670e6c93b7c0924173d2feb87f651fbafef5f6"}}, "hash": "cf1bde2ef6faded70db9b9dafd670e6c93b7c0924173d2feb87f651fbafef5f6", "text": "http://www.guampdn.com/article/20131203/NEWS01/312030006/Mice-drops-help-kill-snakes", "start_char_idx": 0, "end_char_idx": 84, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8c34cecd-595f-4fc8-9270-26719b594f91": {"__data__": {"id_": "8c34cecd-595f-4fc8-9270-26719b594f91", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d13da3cb-9445-4e9f-bc4f-4086d3094aef", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "hash": "be6906b657ca8b1c9a43bde3cccb29d7dff19bfdcbf7b76f36e55f1b93968cae"}}, "hash": "be6906b657ca8b1c9a43bde3cccb29d7dff19bfdcbf7b76f36e55f1b93968cae", "text": "https://youtu.be/ATXFCryzvgU\nWhen what we add becomes a problem\u2026 ?", "start_char_idx": 0, "end_char_idx": 66, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5d0d9326-2550-4a4d-89e9-c70e2fc39a8f": {"__data__": {"id_": "5d0d9326-2550-4a4d-89e9-c70e2fc39a8f", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f3e2be62-9905-4c69-bb8e-e82dacfb0172", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "hash": "54062369d290cc5069f0ab46a9916af2cbbbcbc1bccb7ee4f28bc8543b8f523e"}}, "hash": "54062369d290cc5069f0ab46a9916af2cbbbcbc1bccb7ee4f28bc8543b8f523e", "text": "http://www.islandconservation.org/", "start_char_idx": 0, "end_char_idx": 34, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "cee5bec1-7ae2-4523-8370-b0e3acb635d4": {"__data__": {"id_": "cee5bec1-7ae2-4523-8370-b0e3acb635d4", "embedding": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fd117434-8cee-451c-ae80-6cdafb89ab36", "node_type": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "hash": "5ed0689d627e051a1ecf90022b32c6b4fdaebcb2326fe6872449a03d8c44f4bd"}}, "hash": "869e8e694b11ac6c1c87f1ba0a542c85f20695fab2006995eb3c3e7e72c70400", "text": "http://research.ncsu.edu/islandmice/What are our options?Which option would you choose?", "start_char_idx": 0, "end_char_idx": 87, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4c926c00-6f3d-4aaa-a306-98c7a214b943": {"__data__": {"id_": "4c926c00-6f3d-4aaa-a306-98c7a214b943", "embedding": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "46fab903-bd65-4bed-89fa-4215915b5a98", "node_type": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "hash": "458a2e4b59f4312f6688f7ae74f99505e69413ea75eade1520d2d709eb8d71ee"}}, "hash": "458a2e4b59f4312f6688f7ae74f99505e69413ea75eade1520d2d709eb8d71ee", "text": "http://www.latimes.com/science/sciencenow/la-sci-sn-hawaii-native-birds-20160907-snap-story.html", "start_char_idx": 0, "end_char_idx": 96, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "de2c544f-368b-4d19-879b-930644291fe0": {"__data__": {"id_": "de2c544f-368b-4d19-879b-930644291fe0", "embedding": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "53388152-0495-4488-b81f-a4f44c519302", "node_type": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "hash": "0e89c6b1ff6bde946374f93f8e100ebc5f18d5b070b1fbb277aec2085a78bf10"}}, "hash": "0e89c6b1ff6bde946374f93f8e100ebc5f18d5b070b1fbb277aec2085a78bf10", "text": "https://www.newyorker.com/news/daily-comment/could-genetically-modi\ufb01ed-mosquitoes-save-hawaiis-endangered-birds", "start_char_idx": 0, "end_char_idx": 111, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b34d8286-f02b-4765-aec4-e91982f1f0f1": {"__data__": {"id_": "b34d8286-f02b-4765-aec4-e91982f1f0f1", "embedding": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "969aa1b9-3650-4098-80cc-d4ff65a472c0", "node_type": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "hash": "6c3fe51029f6e970a9f2a5e1786e569669e7419d7f195a80243edbd27fed097d"}}, "hash": "6c3fe51029f6e970a9f2a5e1786e569669e7419d7f195a80243edbd27fed097d", "text": "\u201cDrive\u201d genes into wild populations \nhttp://blogs.scienti\ufb01camerican.com/guest-blog/gene-drives-and-crispr-could-revolutionize-ecosystem-management/\nDengue Fever\nZika\nHuman Malaria\nAvian Malaria\nLyme Disease\nRats, Snakes, Pigs, Other\nHerbicide Resistance\nOther?", "start_char_idx": 0, "end_char_idx": 260, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a98b9bf7-8fe5-41bc-a325-1073f7d138bb": {"__data__": {"id_": "a98b9bf7-8fe5-41bc-a325-1073f7d138bb", "embedding": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "602a1312-e439-4400-9e75-7ebd57787044", "node_type": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "hash": "42ce25fd44cc2d70e238bcaa307783a0ca8d8f61a4745fcfde112fd2cc0fabe2"}}, "hash": "42ce25fd44cc2d70e238bcaa307783a0ca8d8f61a4745fcfde112fd2cc0fabe2", "text": "https://secure3.convio.net/wcs/pdf/Synthetic_Biology_and_Conservation_Framing_Paper.pdf\n\u201cThe modern \ufb01eld of conservation was born as a crisis discipline and it really was focused on trying to stop extinction.So what does conversation want?  What it wants is to conserve nature.  Particular biodiversity and species and ecosystems with less emphasis on the genetic component.It is based on a set of foundational values that focus on the natural and the wilderness.It wants a world that doesn\u2019t change except by its own agency.  It embraces change but natural change.\u201d   \u2014 Kent Redfordhttps://vimeo.com/225308429", "start_char_idx": 0, "end_char_idx": 610, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "af1e9418-850b-4839-b21a-ad775d4b9ac8": {"__data__": {"id_": "af1e9418-850b-4839-b21a-ad775d4b9ac8", "embedding": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6081da8e-5f59-4c95-8879-f2d8e6fdf693", "node_type": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "hash": "672b25ebda24b119fb1af51526b1b9625edf9a3a75906c0cb0b0b845e081cc4b"}}, "hash": "ae33c2efafb7511098adde3fbeb8da686e4cf39971db0faf0e8ffe67b13dc9e4", "text": "BREAKOUTBIOLOGICAL         SPECULATION\n16Should conservations biologists and bioengineers work together?  If yes then what\u2019s the limit?  What\u2019s off limits?", "start_char_idx": 0, "end_char_idx": 155, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5614989e-d57a-41a0-bbdf-95ba30b37926": {"__data__": {"id_": "5614989e-d57a-41a0-bbdf-95ba30b37926", "embedding": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "09902bf0-884b-42b0-855b-0814e8e38eb3", "node_type": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "hash": "a8bc864f5aa6f4b4d52ce11d8ab2d7a85d388e82a7ebe7e88b14b70b963890dc"}}, "hash": "afc67abe85b1cb00e6150f4fbc7546a63229fead605763507db78de4c964b2dd", "text": "https://www.iucn.org/theme/science-and-economics/our-work/other-work/synthetic-biology-and-biodiversity-conservation/development-iucn-policy-synthetic-biology\nIUCN has a membership of over 1400 governmental and non-governmental organizations. Some 16,000 scientists and experts participate in the work of IUCN commissions on a voluntary basis. It employs approximately 1000 full-time staff in more than 50 countries.IUCN's mission is to \"in\ufb02uence, encourage and assist societies throughout the world to conserve nature and to ensure that any use of natural resources is equitable and ecologically sustainable\".", "start_char_idx": 0, "end_char_idx": 610, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f2e206dd-63d8-4640-92a5-407f2680c750": {"__data__": {"id_": "f2e206dd-63d8-4640-92a5-407f2680c750", "embedding": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4e5a221c-86af-4c7f-8ab6-fcc8923bbec8", "node_type": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "hash": "e9a7fec52d5b0e589b767a6bc0ee6efc32c33fbbb8b76786d5c6cf01b6f06eba"}}, "hash": "a7d81d325e8c6ac31036ca47950d6fc1131ad39bd1a18ca5be88ac31fe05374e", "text": "https://www.iucn.org/theme/science-and-economics/our-work/other-work/synthetic-biology-and-biodiversity-conservation/development-iucn-policy-synthetic-biology", "start_char_idx": 0, "end_char_idx": 158, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "34b6c13b-019f-4b87-836c-23d06bdbef7d": {"__data__": {"id_": "34b6c13b-019f-4b87-836c-23d06bdbef7d", "embedding": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b3de2038-fb5d-4cf4-92fb-c52b2d5053b5", "node_type": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "hash": "ef2589ccd551d25af9a2c2ffbfd8eec9445e3e9eb61b1e87595f87755afe72ea"}}, "hash": "db9e64b12b4f35488de3e7bc37e5f9e0784d9ecf6a25cf2beea4dcaef0d69605", "text": "https://www.iucn.org/theme/science-and-economics/our-work/other-work/synthetic-biology-and-biodiversity-conservation/development-iucn-policy-synthetic-biology", "start_char_idx": 0, "end_char_idx": 158, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f4cf3d1b-566c-4952-a176-f3166da36fd6": {"__data__": {"id_": "f4cf3d1b-566c-4952-a176-f3166da36fd6", "embedding": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5d6094d6-5229-4fda-8bdf-5b54ba3281ad", "node_type": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "hash": "5210203bb3fcf47002d97ed2c4028c9f81d48171e94381a735de05f224fa7c78"}}, "hash": "5210203bb3fcf47002d97ed2c4028c9f81d48171e94381a735de05f224fa7c78", "text": "https://www.iucn.org/theme/science-and-economics/our-work/other-work/synthetic-biology-and-biodiversity-conservation/task-force-and-technical-subgroup/statement-work-iucn-taskforce-synthetic-biology-and-biodiversityDefense of process integrity\nhttps://www.etcgroup.org/content/driving-under-in\ufb02uenceCritique of process integrity", "start_char_idx": 0, "end_char_idx": 328, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8d0cee87-b5a2-4417-b4fc-7558ffb81dc8": {"__data__": {"id_": "8d0cee87-b5a2-4417-b4fc-7558ffb81dc8", "embedding": null, "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a375168c-7ef6-43d7-baec-d629602c2e61", "node_type": null, "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "hash": "71e8aec7c0ff82f04aac7530f8d1bb96c43f6c4c18d3803a4b9407f930e811d2"}}, "hash": "3a6f96e2ebd1eb70ab2ef9c45201f62622811aea0a6d656104981f6f244c3f0c", "text": "https://www.iucncongress2020.org/Current status?   Motion for consideration at 2020 congress. What is the motion?   Principles (not policy) re: synthetic biology & gene drives. Formal policy as motion perhaps in 2024. What is happening until Marseille?   Translate documents into many languages, present at IUCN Regional Conservation Fora, extended online engagement, receive and process proposed edits, engage CBD AHTEG, etc.", "start_char_idx": 0, "end_char_idx": 426, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "cba00c07-eaa7-41a0-bf39-df29f8eddab8": {"__data__": {"id_": "cba00c07-eaa7-41a0-bf39-df29f8eddab8", "embedding": null, "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a873d01a-f583-45a5-9b1c-0acb4b421302", "node_type": null, "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}, "hash": "438c1b4c5a5bb51806016cbc4f95a88ba82c6c7a6fd139ab806057ed441d41d2"}}, "hash": "da33e42ecaf3aeb9e644065c7384b6444cee6f5b43e2e4678008e9ff40ce1099", "text": "We're just a biological speculationSittin' here, vibratin'And we don't know what we're vibratin' aboutAnd the animal instinct in meMakes me wanna defend meIt makes me want to live when it's time to dieY'all, see my pointI don't mean to come on strong but I am concernedI believe in GodThough I know that law and order must prevailOh, if and when the laws of manIs not just equal and fairThen the laws of nature will come and do her thingOh, she does not thinkShe just recti\ufb01esShe comes and balances the bookY'all see my point?https://en.wikipedia.org/wiki/America_Eats_Its_Young", "start_char_idx": 0, "end_char_idx": 578, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "96c30dcc-d977-4855-ab19-9c693d625c97": {"__data__": {"id_": "96c30dcc-d977-4855-ab19-9c693d625c97", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d4968a66-01e4-411f-ba47-88438d7131bd", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "hash": "eb0883ad3773782f09071aea4a073018c3e50f2d3e73448b1eaab69f94af2419"}}, "hash": "d46bb76fb897e8f146269b26f3952ced20e37c1692c2508d59c8e0f0732436d4", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 253 June 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 352, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2b21fc6f-9259-48c3-b76d-71ecdc31ad80": {"__data__": {"id_": "2b21fc6f-9259-48c3-b76d-71ecdc31ad80", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f198b2e5-6c47-4fec-8bd5-0f38a5b74b0b", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "hash": "270f1c846543c3b8d43c22d90f6bccd79153eec2c55cf75a4bd74b88a26119c7"}}, "hash": "d2f39af8d5dd5c1a805089e8ba319e610a00e94e649a3a72d23c4864cb5c51f0", "text": "Week 9 look aheadPlanet healthPeople health<Parsing & \u201cPlaying\u201d Politics>CONCEPTSKILLPolitical health", "start_char_idx": 0, "end_char_idx": 101, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "aa1b965b-7594-447d-8739-1fa0921944b4": {"__data__": {"id_": "aa1b965b-7594-447d-8739-1fa0921944b4", "embedding": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5b853828-4e4e-460a-9d9c-adb26ecd020d", "node_type": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "hash": "600872c562cf499189711aa669f5072bf12510490b2a7dc20b7c69de6817ab12"}}, "hash": "600872c562cf499189711aa669f5072bf12510490b2a7dc20b7c69de6817ab12", "text": "https://bioengineering.stanford.edu/research-areas", "start_char_idx": 0, "end_char_idx": 50, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "209b87ca-d3f4-4855-8c70-c3d0459a60d3": {"__data__": {"id_": "209b87ca-d3f4-4855-8c70-c3d0459a60d3", "embedding": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9e7d6bd3-f4d7-4f43-9080-fcd97e581879", "node_type": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "hash": "9ff8a6f407adaacf2a8c53d4fef645b9460b421e5f788fc49998c78c8f253f47"}}, "hash": "5b9d826af98a92c5c9714872ee3c5ca394636014912213d73257a9a2c1ce407e", "text": "https://bioengineering.stanford.edu/research-areas", "start_char_idx": 0, "end_char_idx": 50, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8702b66e-8c54-4c62-94d2-fc03909384a6": {"__data__": {"id_": "8702b66e-8c54-4c62-94d2-fc03909384a6", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "de7af606-e05a-429e-82f6-46659b800759", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "hash": "acb4077dee3b6f5ad3ac43b4647eb6967cceb5a51b10308e4b293e99a5882494"}}, "hash": "d5074bf447503509ae387abf7eba723749f2f120a61fa41fd3521444a2387707", "text": "https://bioengineering.stanford.edu/research-areas", "start_char_idx": 0, "end_char_idx": 50, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d2c7809d-15d0-4810-bf2b-658e29f54d77": {"__data__": {"id_": "d2c7809d-15d0-4810-bf2b-658e29f54d77", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "48e56db1-a34f-47b0-85f7-f8e0d4a498c7", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "hash": "7a23f444bf9b267e1153d0c3995b1466e2e3d3961444e37028b19aa2147c3a32"}}, "hash": "88685dbb399fa692b6918c950ca6be05d60c96b42f0b5ecbd443b9cde08a8c03", "text": "https://bioengineering.stanford.edu/research-areas", "start_char_idx": 0, "end_char_idx": 50, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f8b5e776-a7c7-44c6-b6b9-0b88ca2414ea": {"__data__": {"id_": "f8b5e776-a7c7-44c6-b6b9-0b88ca2414ea", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8ec066e6-b23f-4efe-a5c0-1c29405acbd8", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "hash": "bf5dd9842e3e16b602a60c9dd2d4331123494f32236fa9b7ae84e516e442d896"}}, "hash": "72e0ba14f41e620696ea648e7fa072df76b5bbd12cbc938c4b68891cb39333e3", "text": "https://bioengineering.stanford.edu/research-areas", "start_char_idx": 0, "end_char_idx": 50, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "af706123-e945-4102-aac6-8d5c5acc0fb2": {"__data__": {"id_": "af706123-e945-4102-aac6-8d5c5acc0fb2", "embedding": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "eac67285-dde7-410e-a8bf-9ed7417ab0fd", "node_type": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "hash": "e118307de0330f9927bc4d83ec3148865e505c05766e527bf93fd5528f08ee6c"}}, "hash": "a09924d7d562e0f46e2fd270afddcb2996de4eb89cb066de41c581589c75c525", "text": "https://bioengineering.stanford.edu/research-areas", "start_char_idx": 0, "end_char_idx": 50, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8e28b912-eb4f-44ee-98b6-c730092acf71": {"__data__": {"id_": "8e28b912-eb4f-44ee-98b6-c730092acf71", "embedding": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "240c6a92-ffb9-4379-8cc3-62c3b9bb6797", "node_type": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "hash": "784f63757d689a06f0232684fb01a6b097997b3e7ce6ded63bdb217a25cb0173"}}, "hash": "78a66a58ccc0f94381562542171e22c40a6e807188dd01aaf979719a9c0fa0ed", "text": "https://bioengineering.stanford.edu/research-areas", "start_char_idx": 0, "end_char_idx": 50, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f338f187-d88b-4867-b03f-cec8eb12f316": {"__data__": {"id_": "f338f187-d88b-4867-b03f-cec8eb12f316", "embedding": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7184ef01-821b-4940-8b97-77f57740fe36", "node_type": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "hash": "4349f7b5dec32a8f4c0ece0a7c4f1621a8c17dad2cb7cefced7c4de66bd329d2"}}, "hash": "ec115deee15c2d32e9a92af4075c6df005926eb06bfd2a591a742956a32092d3", "text": "Chethan Pandarinath, Paul Nuyujukian, Christine H Blabe, Brittany L Sorice, Jad Saab, Francis R Willett, Leigh R Hochberg, Krishna V Shenoy,Jaimie M Henderson", "start_char_idx": 0, "end_char_idx": 158, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5bea6282-f6b4-401e-9664-710e05e3116d": {"__data__": {"id_": "5bea6282-f6b4-401e-9664-710e05e3116d", "embedding": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e9575dc0-b5d3-47ed-a1b1-53bd518d6b4d", "node_type": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "hash": "f8db856d8ea10d7c58b396c2b7b808ec9ef1a81036f24efd1fcf9db2641a7ca7"}}, "hash": "f8db856d8ea10d7c58b396c2b7b808ec9ef1a81036f24efd1fcf9db2641a7ca7", "text": "http://heart\ufb02ow.com/", "start_char_idx": 0, "end_char_idx": 20, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "787dc2a2-10f3-4b51-9d45-68138174030a": {"__data__": {"id_": "787dc2a2-10f3-4b51-9d45-68138174030a", "embedding": null, "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "168da124-b2a2-46a4-a21c-6756a475ad72", "node_type": null, "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "hash": "56fd8bb094894776301b20762cee3bbb34169fc5a3d2eba2d022c2fade202561"}}, "hash": "56fd8bb094894776301b20762cee3bbb34169fc5a3d2eba2d022c2fade202561", "text": "21\niGEM ~ genetic engineering \u2018olympics\u2019\nigem.org", "start_char_idx": 0, "end_char_idx": 49, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5ec06432-240a-4da9-8143-a0cd8d1a0c85": {"__data__": {"id_": "5ec06432-240a-4da9-8143-a0cd8d1a0c85", "embedding": null, "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6372dea5-5c91-4cbc-b6c2-99db1f1ad824", "node_type": null, "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "hash": "b559bec330e252807a0d58d3c7ef49dc7590cbf4014ea1a8180a11185e4e969b"}}, "hash": "b559bec330e252807a0d58d3c7ef49dc7590cbf4014ea1a8180a11185e4e969b", "text": "http://diyhpl.us/wiki/dna/projects/", "start_char_idx": 0, "end_char_idx": 35, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "29ce71a9-59b5-4343-b873-662254de2f78": {"__data__": {"id_": "29ce71a9-59b5-4343-b873-662254de2f78", "embedding": null, "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "eed29472-a58a-4c50-bc20-6c10b3cf4b06", "node_type": null, "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "hash": "4581cc53363d8075fafe1a912ec36cc97e2624c1101ea3960498091b254146b0"}}, "hash": "4581cc53363d8075fafe1a912ec36cc97e2624c1101ea3960498091b254146b0", "text": "http://2015.igem.org/Team:Paris_Bettencourt/", "start_char_idx": 0, "end_char_idx": 44, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1ba84ce9-5faf-450e-979b-b658ad6114d8": {"__data__": {"id_": "1ba84ce9-5faf-450e-979b-b658ad6114d8", "embedding": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e9618c84-17fb-4d63-afde-315af3ee7994", "node_type": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "hash": "a3136f8c388067b5035c08eb2eeeebe0e2bb6ed6f1daecb94d59fe82d47761f0"}}, "hash": "a3136f8c388067b5035c08eb2eeeebe0e2bb6ed6f1daecb94d59fe82d47761f0", "text": "http://2015.igem.org/Team:Paris_Bettencourt/", "start_char_idx": 0, "end_char_idx": 44, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "643c4898-3826-4ded-8a19-b9834a6d6b34": {"__data__": {"id_": "643c4898-3826-4ded-8a19-b9834a6d6b34", "embedding": null, "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "766d11d7-0ee7-44ce-b991-66b9b044c35c", "node_type": null, "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "hash": "23eab5ed8560c8f8e20b3123d1856370972bac0d89e07ffe3eda033e2a8aa4c2"}}, "hash": "23eab5ed8560c8f8e20b3123d1856370972bac0d89e07ffe3eda033e2a8aa4c2", "text": "http://2015.igem.org/Team:Paris_Bettencourt/", "start_char_idx": 0, "end_char_idx": 44, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a828ceab-c5c5-425e-ad47-179c14f6d5b4": {"__data__": {"id_": "a828ceab-c5c5-425e-ad47-179c14f6d5b4", "embedding": null, "metadata": {"page_label": "27", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "96e540cb-c8be-4391-b8db-a6e7362b8bed", "node_type": null, "metadata": {"page_label": "27", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "hash": "89edb186ab9d00c96315a0158495329a8444edcbdab080a9a6972b81d279de2a"}}, "hash": "94ed7448865038694480c32139f2a922d7db0f56995a1e9066c89b1938340ca5", "text": "http://2015.igem.org/Team:Paris_Bettencourt/", "start_char_idx": 0, "end_char_idx": 44, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2e7055be-c0fd-46b1-accb-70dea0636a63": {"__data__": {"id_": "2e7055be-c0fd-46b1-accb-70dea0636a63", "embedding": null, "metadata": {"page_label": "28", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "093142eb-5b44-41bd-a7e0-0fb9c67094fb", "node_type": null, "metadata": {"page_label": "28", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}, "hash": "be337bff05d249b813fcad7f69f007c54118da5d4e78ef24e51a9c9e8e95898c"}}, "hash": "be337bff05d249b813fcad7f69f007c54118da5d4e78ef24e51a9c9e8e95898c", "text": "https://sustainabledevelopment.un.org/sdgsUnited Nation\u2019s SDGs(adopted by all UN Member States in 2015, provides a shared blueprint for peace and prosperity for people and the planet, now and into the future)", "start_char_idx": 0, "end_char_idx": 208, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c5bfdf2f-0b87-4b46-9af3-33b88b64f94f": {"__data__": {"id_": "c5bfdf2f-0b87-4b46-9af3-33b88b64f94f", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3c18afb4-9eea-4a32-ac32-fbe38fbe01cf", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "hash": "eccfc79727a2ecc15e84cb25b9be60875927282ffc4c1fe0b7d79a7cbf19bf43"}}, "hash": "692d6bfacd8b9d74a0d5abca84a7d4ecd32aed514320d4ba2819d7b8657e3d55", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 265 June 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 352, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8d762f62-ac38-4d08-8471-fe070575324f": {"__data__": {"id_": "8d762f62-ac38-4d08-8471-fe070575324f", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "47bf9623-b0cc-4780-b5f7-98913aa5676d", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "hash": "a907efb93b7ed2642b31a1bbdf30ff170c1322cb4806f1a7edc20d45018e0979"}}, "hash": "b35f34e910de10691453d0acf12fad63e04d902b59b36ca0611db8f68a9cbad2", "text": "Week 9 look aheadPlanet healthPeople health<Parsing & \u201cPlaying\u201d Politics>CONCEPTSKILLPolitical health", "start_char_idx": 0, "end_char_idx": 101, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "eb6cfab6-bd4c-406f-8bcd-f324d90a7350": {"__data__": {"id_": "eb6cfab6-bd4c-406f-8bcd-f324d90a7350", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "47275007-5bd9-4bd2-a364-a46daf657f56", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "hash": "736767d24054a7275449c102911b6731f967b48e1820183f35f78db480674d84"}}, "hash": "736767d24054a7275449c102911b6731f967b48e1820183f35f78db480674d84", "text": "https://xinampa.bio/", "start_char_idx": 0, "end_char_idx": 20, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a8659176-32d2-49b1-bc2d-ec694be160fd": {"__data__": {"id_": "a8659176-32d2-49b1-bc2d-ec694be160fd", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f16e9867-3d7f-4ab4-b0a4-730aa8ff021b", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "hash": "89d921f0c99ba5593d2c8f968f742a101612fd2139830e86e16355685d5d50da"}}, "hash": "89d921f0c99ba5593d2c8f968f742a101612fd2139830e86e16355685d5d50da", "text": "Ana IbarraRolando Perez", "start_char_idx": 0, "end_char_idx": 23, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c4e78711-331a-4361-8601-23fb9360a85f": {"__data__": {"id_": "c4e78711-331a-4361-8601-23fb9360a85f", "embedding": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8efc1757-450a-4101-85a8-6a8ac8a7cdc8", "node_type": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "hash": "058e5cb8bb667847f38cf217cd1ea2c7929c6fdd7f770ba65652bdab3e7165a7"}}, "hash": "f0322ee8f0fba019fe7fbd6d0c3657cbd9603871873980c444b9f1429118955c", "text": "Increasing compute Increasing DNA read Increasing DNA writeEquity? Meaning? Citizenship?", "start_char_idx": 0, "end_char_idx": 88, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e347eb9d-6f30-445d-a891-1bc827ec9a39": {"__data__": {"id_": "e347eb9d-6f30-445d-a891-1bc827ec9a39", "embedding": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b6eb5b1a-cf86-4208-af68-778b22528b3c", "node_type": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "hash": "c5c993a978146608a5040b101b8e8e6ab57f2de99931ba1ffc7e2eb3cd936e14"}}, "hash": "c5c993a978146608a5040b101b8e8e6ab57f2de99931ba1ffc7e2eb3cd936e14", "text": "\u201cI have a plan dream!\u201d\nhttps://news.stanford.edu/news/2011/august/i-have-a-dream-082511.html", "start_char_idx": 0, "end_char_idx": 92, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0709621f-d709-460b-91cf-cced4007ec7a": {"__data__": {"id_": "0709621f-d709-460b-91cf-cced4007ec7a", "embedding": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "17ce5a05-7749-4cad-94d0-e2a035a07589", "node_type": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "hash": "d6bd7783725d0683da4d105bf2e67fce865ab1df5e82643ec43ef7f32d97cff7"}}, "hash": "328d95d050514c9b6a768be187b79d2e5769c848ec0defaf64edf87b7347661f", "text": "What dream might we share?\nTake infectious & other diseases off the tableEnable humanity to provide for itselfStabilize & recover natural biodiversityEnable a culture  of citizenshipUnderstand life via building13All aspects enabled by (i.e., require) bioengineering", "start_char_idx": 0, "end_char_idx": 265, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c287223f-b131-4946-930f-f79a72e07312": {"__data__": {"id_": "c287223f-b131-4946-930f-f79a72e07312", "embedding": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "865dfd3d-082a-4c13-ba8c-d3f94173a2e5", "node_type": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "hash": "e195fd22e1e7aaa1a513535c16d1d84f74471f52d69876b4a1af5a092ee48717"}}, "hash": "5b56705a3766702c20ff00b8bb33de35784790b4e87ebd076b2656be42be45de", "text": "Paris ~500ADParis ~2025ADEnergy,  Information,  & Matter mostly local  & all limiting\u2026Energy,  Information,  & Matter all networked  & none limiting\u2026Design anywhere; grow/build anywhere>1% global literacy rate & empowermentROE >1 for a\ufb00ordable & sustainable energy", "start_char_idx": 0, "end_char_idx": 264, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4c0c6d47-e60d-4e66-aa81-475d109c75ad": {"__data__": {"id_": "4c0c6d47-e60d-4e66-aa81-475d109c75ad", "embedding": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "41b42745-8e37-4c18-b9bb-f5546abc7ca8", "node_type": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "hash": "b7fe40cd32791db2bb4160b472b31f8527b83383c11eea818286de8ab7307418"}}, "hash": "b7fe40cd32791db2bb4160b472b31f8527b83383c11eea818286de8ab7307418", "text": "Consider ROE, not just ROI\nI.e., how long to get my Joules back?", "start_char_idx": 0, "end_char_idx": 64, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "17776516-d1c3-4f70-8502-47dbef9b7724": {"__data__": {"id_": "17776516-d1c3-4f70-8502-47dbef9b7724", "embedding": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2c4b01fb-9624-4039-a5c3-b9601afc5505", "node_type": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "hash": "e04a235f1fa03ad32e8cd2d0b65a15fb03b7b80e0f93b67ccf0421f8246fbe05"}}, "hash": "e04a235f1fa03ad32e8cd2d0b65a15fb03b7b80e0f93b67ccf0421f8246fbe05", "text": "Transitioning to electricity generation abundant civilization\nPhotovoltaic ROE >> 1\n1616", "start_char_idx": 0, "end_char_idx": 88, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7d04c8bb-9181-4a53-bbb5-29fdc992a8eb": {"__data__": {"id_": "7d04c8bb-9181-4a53-bbb5-29fdc992a8eb", "embedding": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fcd73603-c506-4c9f-b171-88e41786b6fc", "node_type": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "hash": "97d66fc39ab9f5bdd756956c7df5688dfa9ceb5dda3c147d932371241a4188cd"}}, "hash": "bee00d569fb8240d30b248dbb81d8bacdfbc566f6f01434b0f7d2db4eeb0546f", "text": "How much energy to run a synthetic fresh water system for all of Earth\u2019s landmass?\nI.e., reverse osmosis + pumping to 1000m average elevation?", "start_char_idx": 0, "end_char_idx": 142, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "56e906c8-6ace-486c-bf8a-17fbcf8d44b0": {"__data__": {"id_": "56e906c8-6ace-486c-bf8a-17fbcf8d44b0", "embedding": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ace1e287-3f72-420a-925d-cb07dcffeb41", "node_type": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "hash": "3afd858b89772cd261ca5c428d729e4a0eafdc59d1fd436b711a06dec26523c9"}}, "hash": "3afd858b89772cd261ca5c428d729e4a0eafdc59d1fd436b711a06dec26523c9", "text": "~1 kWh electricity = ~ 1 (to 30) grams biomass~$0.11 = ~ 1 (to 30) courses of antibiotics    From electricity to formate,                          from formate to bio-stuff\n*electrobiosynthesis removes 90TW cap on building with biology", "start_char_idx": 0, "end_char_idx": 235, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0e2df1af-42da-49b6-aab1-ae19252779ed": {"__data__": {"id_": "0e2df1af-42da-49b6-aab1-ae19252779ed", "embedding": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "886dbe1a-cc89-4f6e-b87c-3cccc957e758", "node_type": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "hash": "7898c5d8eddc7b4a49f4fc64d5628b32792bd39854f74e757f915a95671948dc"}}, "hash": "7898c5d8eddc7b4a49f4fc64d5628b32792bd39854f74e757f915a95671948dc", "text": "Q. How will this box change the world?\nQ. What will the \u201cPB\u201d + the \u201cbionet\u201d lead to?PersonalBiosynthesizer (PB)electricityinternet(biocode)air(N2, CO2, H2O)whatever biology can be programmed to make or do\u2026A. \u201cdesign anywhere, grow everywhere\u201d", "start_char_idx": 0, "end_char_idx": 242, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d874027f-1aa8-4661-bef6-5bde8274ac6e": {"__data__": {"id_": "d874027f-1aa8-4661-bef6-5bde8274ac6e", "embedding": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a15f0fdc-e685-4859-a340-c571e43268f6", "node_type": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "hash": "b86451d2b807435e243e1ba4e80fe9dec6f8afe9fdf7ad16df3f6b31968c2028"}}, "hash": "b86451d2b807435e243e1ba4e80fe9dec6f8afe9fdf7ad16df3f6b31968c2028", "text": "igem.orgHow many people should have the option of learning to read & write DNA?  Of bioengineering cells?", "start_char_idx": 0, "end_char_idx": 105, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2b81d68a-82dd-475a-8456-0d21ce25cae7": {"__data__": {"id_": "2b81d68a-82dd-475a-8456-0d21ce25cae7", "embedding": null, "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8c6065d3-4518-4f9a-aac9-65c10b8e7326", "node_type": null, "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "hash": "e6c2b7e1e85394356bbcc189d2c738abd1d765ae15e83c420443ea7bbea97af6"}}, "hash": "e6c2b7e1e85394356bbcc189d2c738abd1d765ae15e83c420443ea7bbea97af6", "text": "http://githut.info/\nhttps://www.infoq.com/news/2014/01/IDC-software-developers\nHow many people should have the option of learning to read and write computer programs?", "start_char_idx": 0, "end_char_idx": 166, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c64671a2-d2de-4c6f-acef-7e4086cde925": {"__data__": {"id_": "c64671a2-d2de-4c6f-acef-7e4086cde925", "embedding": null, "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "eaff0afd-454f-45ee-b410-8a34b92ac9d1", "node_type": null, "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "hash": "3baed1d67ee805d8d29ad7ecf48c5cfea2f3380064fa577ffc61cee8341de090"}}, "hash": "3baed1d67ee805d8d29ad7ecf48c5cfea2f3380064fa577ffc61cee8341de090", "text": "How many people should have the option of learning to read and write?\nhttp://themindunleashed.com/2015/06/see-the-worlds-most-spoken-languages-in-one-eye-opening-infographic.html", "start_char_idx": 0, "end_char_idx": 178, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f141558e-a89e-4cd6-96f8-f4b718da8a9a": {"__data__": {"id_": "f141558e-a89e-4cd6-96f8-f4b718da8a9a", "embedding": null, "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c2c818c3-94f1-4d70-b757-e0308d0e6047", "node_type": null, "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "hash": "020b80aebf94c6971dccede15e1dd6796764aefe2abcdf47d0eeb4472f08879f"}}, "hash": "020b80aebf94c6971dccede15e1dd6796764aefe2abcdf47d0eeb4472f08879f", "text": "\u201cThe Court held that government cannot punish in\ufb02ammatory speech unless that speech is directed to inciting, AND is likely to incite, imminent lawless action.\u201dhttps://en.wikipedia.org/wiki/Brandenburg_v._OhioHow do we govern the press?  Speech?", "start_char_idx": 0, "end_char_idx": 244, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b1900855-520d-4e59-a351-5586feea8160": {"__data__": {"id_": "b1900855-520d-4e59-a351-5586feea8160", "embedding": null, "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f39ad70b-4517-4cea-9847-c4c7b96bb20c", "node_type": null, "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}, "hash": "b63aa5da7a7adaf4b345cc97d35b21237e5438f7a01b1c4aad75133428fa0ca1"}}, "hash": "b63aa5da7a7adaf4b345cc97d35b21237e5438f7a01b1c4aad75133428fa0ca1", "text": "\u201cI shall not today attempt further to de\ufb01ne the kinds of material I understand to be embraced within that shorthand description [\"hard-core pornography\"], and perhaps I could never succeed in intelligibly doing so. But I know it when I see it, and the motion picture involved in this case is not that.\u201d \u2014 USSC Justice Potter StewartHow do we govern the press?  Speech?", "start_char_idx": 0, "end_char_idx": 368, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "35fdc611-628f-4d1c-a1de-d891d598b4ca": {"__data__": {"id_": "35fdc611-628f-4d1c-a1de-d891d598b4ca", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0b3d603b-6f5c-452d-9e94-5d690fc02fcb", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}, "hash": "327ed7deddd92a0f225919323430f138414d59c9d95827708ab0be772b9453d3"}}, "hash": "327ed7deddd92a0f225919323430f138414d59c9d95827708ab0be772b9453d3", "text": "http://youtu.be/W7DUaxCPMt8\nthe march of the bioengineers\nhttps://youtu.be/6cBf-EGahvshttps://www.npr.org/templates/story/story.php?storyId=90014997", "start_char_idx": 0, "end_char_idx": 148, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "231b0a85-6f66-4535-ab14-f0e174d595b5": {"__data__": {"id_": "231b0a85-6f66-4535-ab14-f0e174d595b5", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e16dd13f-d22a-4924-a5cd-e5fc41c962ae", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}, "hash": "5084f38953cccc18015ad41b9d28094c35d2cef6f318d12db14adb53e8703c87"}}, "hash": "06cc3c23a649236bd32fd1d751507ed5399b57526fe9a68aa40c948d10d9bf23", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 28 \u2014 recorded, last day12 June 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 374, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "be6199aa-d4a8-47d9-a876-01b02a8383b9": {"__data__": {"id_": "be6199aa-d4a8-47d9-a876-01b02a8383b9", "embedding": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c531c61b-6774-4e5f-af49-dcc479bf860e", "node_type": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}, "hash": "8543e8a218497a4dc7bf7bd99e3b0a636361a5c396c0075b3367c27bde7bf516"}}, "hash": "8543e8a218497a4dc7bf7bd99e3b0a636361a5c396c0075b3367c27bde7bf516", "text": "Week 10 last day, recordedWhat have we learnedResources going forwardBenedictions", "start_char_idx": 0, "end_char_idx": 81, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c5a7f2bf-a06b-4225-a62c-20fccbea926c": {"__data__": {"id_": "c5a7f2bf-a06b-4225-a62c-20fccbea926c", "embedding": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5c89ec9e-8fe5-4fe6-8191-d55b40abb5d1", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}, "hash": "4719235972a73cfb2a6f3cc0818e6cb5c03acadde0676fac938f06f74c65d0a6"}}, "hash": "4719235972a73cfb2a6f3cc0818e6cb5c03acadde0676fac938f06f74c65d0a6", "text": "What is our class about?Students successfully completing BIOE/ENGR.80 will have a working understanding for how to approach the systematic engineering of living systems to bene\ufb01t all people and the planet. Our main goals for the quarter are:  (1) to help you learn ways of thinking about engineering        living matter,   (2) for you to become more capable of learning and        explaining bioengineering to yourself and others,  (3) for you to be capable of leading discussions of the        broader rami\ufb01cations of engineering the living world.", "start_char_idx": 0, "end_char_idx": 549, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0376581d-45ca-455d-9379-5ecec6925d35": {"__data__": {"id_": "0376581d-45ca-455d-9379-5ecec6925d35", "embedding": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e97a6fee-0257-45a0-996b-e4003e08f436", "node_type": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}, "hash": "7fde0363363acebd7453c644a88af977f0b7dc742bfdc5a1c64e2545043077ee"}}, "hash": "7fde0363363acebd7453c644a88af977f0b7dc742bfdc5a1c64e2545043077ee", "text": "Imagine your bioengineer\u2026", "start_char_idx": 0, "end_char_idx": 25, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "80bcdd99-2e69-4e1a-bc6b-2f573bc2df9d": {"__data__": {"id_": "80bcdd99-2e69-4e1a-bc6b-2f573bc2df9d", "embedding": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7b91c120-fd51-473a-8679-845e77d25a69", "node_type": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}, "hash": "924438f81821e5ca81a27053e31c1301cde04d6c837ef0fc56aa4f0037abe0e8"}}, "hash": "924438f81821e5ca81a27053e31c1301cde04d6c837ef0fc56aa4f0037abe0e8", "text": "Course Companions!", "start_char_idx": 0, "end_char_idx": 18, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e2d3a483-0e37-4d4b-939d-493ac2c03a17": {"__data__": {"id_": "e2d3a483-0e37-4d4b-939d-493ac2c03a17", "embedding": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "af3394b1-e0ad-4c6f-8797-05f32e48917c", "node_type": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}, "hash": "c86367c5ebe22ced6dd4f4d105ff51e659dcd83d3f9e01f7a9b3c11d14092933"}}, "hash": "c86367c5ebe22ced6dd4f4d105ff51e659dcd83d3f9e01f7a9b3c11d14092933", "text": "Goals & T opics", "start_char_idx": 0, "end_char_idx": 15, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d3fdda39-c5de-4db1-8b1e-d2145af877b1": {"__data__": {"id_": "d3fdda39-c5de-4db1-8b1e-d2145af877b1", "embedding": null, "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7211b10d-5d49-428b-a6ac-c8e52e775ede", "node_type": null, "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}, "hash": "f8c24fee861a34e66891d512787ee1c8a208772d2d14170775ec4900147d4f54"}}, "hash": "f8c24fee861a34e66891d512787ee1c8a208772d2d14170775ec4900147d4f54", "text": "Benediction & Gratitude", "start_char_idx": 0, "end_char_idx": 23, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "833692a4-8100-4efb-9a4c-7056060e3a7f": {"__data__": {"id_": "833692a4-8100-4efb-9a4c-7056060e3a7f", "embedding": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6bbf4b1e-91d7-4e0e-8415-43a3e9facda7", "node_type": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}, "hash": "ef81d0a630128158cb29d9b727e6e69d20bbd7a426d67ba61fa42752b33fe3d9"}}, "hash": "fd08b5be255dead539d4ac4e5f15f248bbe169ad8563021db5895d01dda78f3f", "text": "Jonathan Calles(Lead TA)Brianna Chrisman(Digital Infrastructure Lead)\nNaomi Pacalin(Student Liaison Lead)Victor Tieu(Digital Front-End Lead)Nicolai Ostberg(Lead Grader)Julisia Chau(Lead Editor)", "start_char_idx": 0, "end_char_idx": 193, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d9fda1a9-9628-4d4b-9de6-b658243a0736": {"__data__": {"id_": "d9fda1a9-9628-4d4b-9de6-b658243a0736", "embedding": null, "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ed92c2c6-1d2b-4944-a66c-a3f178c78963", "node_type": null, "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}, "hash": "a807669647fe15e92bcbc3a431cab25c4ec98940b5a9b6ce9a0720544e20464f"}}, "hash": "d982ce7c99cf53c2211077b06ee603cf6ad78ccab1e37f5a6f1b72252f24e4b6", "text": "Siavash Ahrar(Co-Instructor)Michael Specter(Co-Instructor)Drew Endy(Head Instructor)", "start_char_idx": 0, "end_char_idx": 84, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "11fcf3af-6add-4d95-a300-416a2c445acd": {"__data__": {"id_": "11fcf3af-6add-4d95-a300-416a2c445acd", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6395f535-202c-40ae-af13-5cd0750064de", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "047c6fe8d67318ed98488c9b766acfe48bdff5dda6052bea2891277c8cae0880"}}, "hash": "e9dd730c2aef9d3e39cd242ac223384a658c5f1f44b12c2fbc29f75da6a86ba1", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 28 April 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 352, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0698bd11-935e-4ba2-acfb-ac38311abe5a": {"__data__": {"id_": "0698bd11-935e-4ba2-acfb-ac38311abe5a", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "25251940-a9aa-4a44-be2a-d6d182a6643c", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "16391ce1c4eaad9a127648bfd62ae626ba5a0f37ba4bad6bc7302e4f37ae3e04"}}, "hash": "16391ce1c4eaad9a127648bfd62ae626ba5a0f37ba4bad6bc7302e4f37ae3e04", "text": "What makes living matter unique?1.Physics of living matter2.Opportunities & challenges3.The here & now", "start_char_idx": 0, "end_char_idx": 102, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "650d2d2f-d372-45ab-b589-fb68418f9bd8": {"__data__": {"id_": "650d2d2f-d372-45ab-b589-fb68418f9bd8", "embedding": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c488adb3-85df-415f-b162-2059539bd9e1", "node_type": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "cac95608b6373192a38acca1ae1f54b7c4b764ae49ec84689080ad7354239587"}}, "hash": "cac95608b6373192a38acca1ae1f54b7c4b764ae49ec84689080ad7354239587", "text": "The living bridges of Cherrapunji, India are made from the roots of the Ficus elastica tree. (http://rootbridges.blogspot.com/)Planetary-Scale Natural Nanotechnology\nReproducing, growing, & healing materials~90 terawatts via photosynthesis*Massively functional Living rami\ufb01cationsBiology is already  many places\n*electrobiosynthesis will remove this cap\nTake infectious & other diseases off the tableEnable humanity to provide for itselfStabilize & recover natural biodiversityEnable a culture  of citizenshipUnderstand life via building", "start_char_idx": 0, "end_char_idx": 537, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "af222551-8ce6-461f-bab7-7c67511a34b6": {"__data__": {"id_": "af222551-8ce6-461f-bab7-7c67511a34b6", "embedding": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "41620ec0-17d6-491d-b92e-f2feb3f5dafc", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "bfbd4931dd3f82f7f4790d550f010a14f4b8ca45873dde69f877ef2b10359f66"}}, "hash": "bfbd4931dd3f82f7f4790d550f010a14f4b8ca45873dde69f877ef2b10359f66", "text": "Organized over 10 orders of magnitude - 0.1 nanometers to meters Take a microscope and keep zooming in", "start_char_idx": 0, "end_char_idx": 102, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9454e10f-7ead-4d88-ac36-144d9a8d7e52": {"__data__": {"id_": "9454e10f-7ead-4d88-ac36-144d9a8d7e52", "embedding": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "77362737-2019-4275-b843-391f0f66c833", "node_type": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "c9732bbb1960bfecea26778838cc706460fb3a4316e9d6d9f44114216c3c1d9e"}}, "hash": "c9732bbb1960bfecea26778838cc706460fb3a4316e9d6d9f44114216c3c1d9e", "text": "Cars are global products", "start_char_idx": 0, "end_char_idx": 24, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "201a64ab-b912-41bf-99e7-4509de01a59d": {"__data__": {"id_": "201a64ab-b912-41bf-99e7-4509de01a59d", "embedding": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d4f9f3d6-5264-403b-8ed9-b3f55debc262", "node_type": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "7f8ea45b280af8bb703701f2ee1b2479d7fa13536cceba875be1aae8422b7f9a"}}, "hash": "7f8ea45b280af8bb703701f2ee1b2479d7fa13536cceba875be1aae8422b7f9a", "text": "MATERIALS USED TO MAKE A TREE (light/air/carbon/nitrogen/water) \nMATERIALS & INPUTS ARE LOCAL", "start_char_idx": 0, "end_char_idx": 93, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e1dff4df-3a33-4aba-b06a-ec7af357dde9": {"__data__": {"id_": "e1dff4df-3a33-4aba-b06a-ec7af357dde9", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d0124cc1-a30a-4d11-b057-b5cb518082ce", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "109e951c8dd7253b98951237178993a4e453f4116bb82ba32c18b87b1ac30e21"}}, "hash": "109e951c8dd7253b98951237178993a4e453f4116bb82ba32c18b87b1ac30e21", "text": "Lots and lots of parts; Computation is ultra energy ef\ufb01cient and massively parallelSelf-replicatingLight/air/carbon/nitrogen/water precursorsEach component can  reproduce the wholeSelf-healingSelf-organizing\nIntricately organized on multiple time  and spatial scalesWhat\u2019s physically special re: \u201cliving matter\u201d?\nSelf-mixing", "start_char_idx": 0, "end_char_idx": 324, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f7a084b9-063b-409f-b607-e755f72e31fe": {"__data__": {"id_": "f7a084b9-063b-409f-b607-e755f72e31fe", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "08ec5caf-db44-40e2-aa24-02749acf641f", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "cb23bf514210b4d54fb2cf3a475a542f306725f11acb873793f3e54e16d9dd89"}}, "hash": "cb23bf514210b4d54fb2cf3a475a542f306725f11acb873793f3e54e16d9dd89", "text": "Breakout #1- how many unique physical aspects? - most interesting / important microscopic?- most interesting / important macroscopic?", "start_char_idx": 0, "end_char_idx": 133, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e4f297b2-fef4-4f0e-abc5-628924830d1d": {"__data__": {"id_": "e4f297b2-fef4-4f0e-abc5-628924830d1d", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9464a974-34ee-4592-9db7-80cee722a664", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "52cd59a0ec47624e4ce905898eb222e5939e350b7aa7cf4e6aec1976732da73c"}}, "hash": "52cd59a0ec47624e4ce905898eb222e5939e350b7aa7cf4e6aec1976732da73c", "text": "What makes living matter unique?1.Physics of living matter2.Opportunities & challenges3.The here & now", "start_char_idx": 0, "end_char_idx": 102, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e5ba6a66-5a69-4aa3-8ff0-a7532a9fffa3": {"__data__": {"id_": "e5ba6a66-5a69-4aa3-8ff0-a7532a9fffa3", "embedding": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "81957cd5-b59d-4b41-bea7-cdce65fa0f74", "node_type": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "c2ae886fbb973bc02fccbd2d21853ef222fc94a3538ec21715b34a5f3845b41c"}}, "hash": "890b24218848132cfc5a478a50aa0c8b43fb36c795f9984220d7c3eb68d602ef", "text": "SISSEL TOLAASCHRISTINA AGAPAKISSISSEL TOLAASCHRISTINA AGAPAKISwww.syntheticaesthetics.org", "start_char_idx": 0, "end_char_idx": 89, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "98cbd58e-da25-4501-8260-d01964be8381": {"__data__": {"id_": "98cbd58e-da25-4501-8260-d01964be8381", "embedding": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "978509c9-644c-4cce-8779-41b73b77d6df", "node_type": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "b2236c5068f8e0a7fa089a459def8e6bfc1c5f5b17dfd9e53094469abdbddf22"}}, "hash": "ad115e25d1237024c872cd1e65fe9dfc2b3fc3f6b0b52688942099ab022bd7d4", "text": "SISSEL TOLAASCHRISTINA AGAPAKISwww.syntheticaesthetics.org", "start_char_idx": 0, "end_char_idx": 58, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "305980e2-5d57-426c-9434-5eaf483ed047": {"__data__": {"id_": "305980e2-5d57-426c-9434-5eaf483ed047", "embedding": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8a4cee62-34ff-489a-b469-9008fdac7c6f", "node_type": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "b2267212a82605eb000200e7de1ad7511a78a71eb4432e7c9c7d1bfb315580a4"}}, "hash": "c9743d42d3bd486f187bdd00df37db15dd691b876c2132a2741ea14189079be0", "text": "SISSEL TOLAASCHRISTINA AGAPAKISwww.syntheticaesthetics.org", "start_char_idx": 0, "end_char_idx": 58, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "cfa2bb4a-16d7-499b-845b-b6bc3cabe96a": {"__data__": {"id_": "cfa2bb4a-16d7-499b-845b-b6bc3cabe96a", "embedding": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "10bb66b5-b2ae-4876-a56b-73b97d570b8e", "node_type": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "b37b9cb798e649825f189908b860272af1460b9feb631531f55b30448199a224"}}, "hash": "054bfb1627b71d914fe045637efc2df8d1763e54a41afb07a6816a0b52d15b72", "text": "SISSEL TOLAASCHRISTINA AGAPAKISwww.syntheticaesthetics.org", "start_char_idx": 0, "end_char_idx": 58, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "23ddf73b-7d49-4ed3-9770-b062a7fbafea": {"__data__": {"id_": "23ddf73b-7d49-4ed3-9770-b062a7fbafea", "embedding": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2581dd4a-8231-4db4-a147-21247e3535e5", "node_type": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "d482b09844bc0304581fdaa944409c910abd8aa7d695a9fe055445b382701ab4"}}, "hash": "f774a3a0051f9bedf2b8837cb3f35d4e7cf9b0dff1760f2c1b5a34abcf336281", "text": "You are what you eat!We eat what we are...SISSEL TOLAASCHRISTINA AGAPAKISSISSEL TOLAASCHRISTINA AGAPAKISwww.syntheticaesthetics.org", "start_char_idx": 0, "end_char_idx": 131, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4cc89f8b-43b1-4519-9045-5016aa95c4ec": {"__data__": {"id_": "4cc89f8b-43b1-4519-9045-5016aa95c4ec", "embedding": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3053c4a2-649f-4da0-8b26-58906bb1e2aa", "node_type": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "06654ef3e7216e57c72870f6274a8a4efe6922d6cb9177fae85a1edd70757042"}}, "hash": "06654ef3e7216e57c72870f6274a8a4efe6922d6cb9177fae85a1edd70757042", "text": "Living cells make cells (& other things)", "start_char_idx": 0, "end_char_idx": 40, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "cc6bef92-7b63-4e78-ad4e-6c65a82717cb": {"__data__": {"id_": "cc6bef92-7b63-4e78-ad4e-6c65a82717cb", "embedding": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "768e62b1-4fd0-47cf-868f-29f51dddc810", "node_type": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "5f6f4e651f511ad59bbd2fcfa974c91d31825292bed6f0fce4eb517629b2efa0"}}, "hash": "5f6f4e651f511ad59bbd2fcfa974c91d31825292bed6f0fce4eb517629b2efa0", "text": "19We don\u2019t fully understand any cell.", "start_char_idx": 0, "end_char_idx": 37, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "263d9f44-1efa-4a9e-9d7c-61a7f9990f43": {"__data__": {"id_": "263d9f44-1efa-4a9e-9d7c-61a7f9990f43", "embedding": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f2fce29c-72c4-471c-9f2c-7aa2905e4800", "node_type": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "d7097195c3ae2f9d149d904e5d6c9a842e2a49956df25ab048be14ef19ddd423"}}, "hash": "d7097195c3ae2f9d149d904e5d6c9a842e2a49956df25ab048be14ef19ddd423", "text": "What don\u2019t biologists understand about biology?\n20", "start_char_idx": 0, "end_char_idx": 50, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0f446209-c32c-4fda-8f2b-deea19440081": {"__data__": {"id_": "0f446209-c32c-4fda-8f2b-deea19440081", "embedding": null, "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1a331528-9e76-438a-9b25-fecde62bfd6b", "node_type": null, "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "c14a1b03862906144ba9e946e66588d0fa986d056cf68589e8e79f13e989c460"}}, "hash": "c14a1b03862906144ba9e946e66588d0fa986d056cf68589e8e79f13e989c460", "text": "Breakout #2- most important opportunity? - most important challenge?- most frightening opportunity/challenge?- most exciting opportunity/challenge?", "start_char_idx": 0, "end_char_idx": 147, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "87975171-4a91-4bc4-bc90-16bf6f4a2222": {"__data__": {"id_": "87975171-4a91-4bc4-bc90-16bf6f4a2222", "embedding": null, "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "64fdaecc-2262-45c5-837f-b1c02a2b04ec", "node_type": null, "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "c44b216dbcb506d8f04dd19edbe847975ac4562334f6ac7c01964adccbe5c690"}}, "hash": "c44b216dbcb506d8f04dd19edbe847975ac4562334f6ac7c01964adccbe5c690", "text": "What makes living matter unique?1.Physics of living matter2.Opportunities & challenges3.The here & now", "start_char_idx": 0, "end_char_idx": 102, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7520ba72-4be4-420a-b59e-316e61182481": {"__data__": {"id_": "7520ba72-4be4-420a-b59e-316e61182481", "embedding": null, "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bfa27bcb-2237-40a5-b9b8-66e737ad0bf3", "node_type": null, "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "abf4c14041a25c927f82e0b219fd2b7d9a6c0b99bf15f5e1b45cf3843b0afe6a"}}, "hash": "abf4c14041a25c927f82e0b219fd2b7d9a6c0b99bf15f5e1b45cf3843b0afe6a", "text": "SputnikCOVID-19\u201cSurprise!\u201d19572019", "start_char_idx": 0, "end_char_idx": 34, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "074883ab-2928-42f9-9b33-3c25018f1741": {"__data__": {"id_": "074883ab-2928-42f9-9b33-3c25018f1741", "embedding": null, "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0438edf7-54b4-45fc-92ca-3e10b8691fd5", "node_type": null, "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "6bbab592f856a48b8532295ebaf7934936dedb1fded79b23213b55514ca2e31e"}}, "hash": "6bbab592f856a48b8532295ebaf7934936dedb1fded79b23213b55514ca2e31e", "text": "http://www.wired.com/2013/04/how-pixar-used-moores-law-to-predict-the-future/\u201cWhen the group moved to California to become part of Lucas\ufb01lm, we got close to making a computer-animated movie again in the mid-1980s \u2014 this time about a monkey with godlike powers but a missing prefrontal cortex. We had a sponsor, a story treatment, and a marketing survey. We were prepared to make a screen test: Our hot young animator John Lasseter had sketched numerous studies of the hero monkey and had the sponsor salivating over a glass-dragon protagonist. But when it came time to harden the deal and run the numbers for the contracts, I discovered to my dismay that computers were still too slow: The projected production cost was too high and the computation time way too long. We had to back out of the deal. This time, we [knew enough] to correctly apply Moore\u2019s Law \u2014 [] we had to wait another \ufb01ve years to start making the \ufb01rst movie.  And sure enough, \ufb01ve years later Disney approached us to make Toy Story.\u201d\u2014 Alvy Ray Smith", "start_char_idx": 0, "end_char_idx": 1019, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f4738d78-56f8-4815-90f5-4b367c4353e1": {"__data__": {"id_": "f4738d78-56f8-4815-90f5-4b367c4353e1", "embedding": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c1545690-c03d-429a-9824-919d39e1bb8b", "node_type": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "475597bc4acae83f79ddf76cf3244febf27d63dba235bb642316e625f8977906"}}, "hash": "475597bc4acae83f79ddf76cf3244febf27d63dba235bb642316e625f8977906", "text": "http://en.wikipedia.org/wiki/Moore%27s_lawPace of change\u2026", "start_char_idx": 0, "end_char_idx": 57, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d955fbfe-9da1-4085-9435-a5982590fec3": {"__data__": {"id_": "d955fbfe-9da1-4085-9435-a5982590fec3", "embedding": null, "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "500dd663-ab10-49a3-ba66-1e29de46d7b8", "node_type": null, "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "fb8bc4c0bc7f7a3d255544eef07c89e3113df845f5485e7ff80162c45fff3fd0"}}, "hash": "fb8bc4c0bc7f7a3d255544eef07c89e3113df845f5485e7ff80162c45fff3fd0", "text": "Breakout #3-what about the \u201chere & now\u201d do you think will matter most for bioengineering or bioengineers for the next ten years?", "start_char_idx": 0, "end_char_idx": 128, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "aa9173f8-801f-4b06-9bd4-8362c00e996a": {"__data__": {"id_": "aa9173f8-801f-4b06-9bd4-8362c00e996a", "embedding": null, "metadata": {"page_label": "27", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "19155338-de8b-47be-9b4f-923dbbd478f9", "node_type": null, "metadata": {"page_label": "27", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}, "hash": "411a1ca55cb79721e440dbd03e2ac1c3853a298282e8cf15e6be186fa95c6651"}}, "hash": "411a1ca55cb79721e440dbd03e2ac1c3853a298282e8cf15e6be186fa95c6651", "text": "Before Friday\u2019s class", "start_char_idx": 0, "end_char_idx": 21, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e8567626-3484-4ac1-95ae-ee8f0abc4b62": {"__data__": {"id_": "e8567626-3484-4ac1-95ae-ee8f0abc4b62", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8bfae649-ca7a-447e-b5ea-b4626bbc3cd8", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "hash": "a97695487bc24717efce03b7aa9f5960f5a9b38df261cce1fae0c3438751805e"}}, "hash": "3ccb5dd3b62f41efdf5fd3283ae2d7804217809ba76afe17e2ac7fe9bc9f839d", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 16 April 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 352, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5c466c4c-97a9-4ee2-8816-3b6f4e758a82": {"__data__": {"id_": "5c466c4c-97a9-4ee2-8816-3b6f4e758a82", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9aa7c006-17e3-45fd-8f1a-3baa73580c3b", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "hash": "8c2d2b49abcab45e16abe8808832fc4067ef002a6a1591a685ee303ff5b2bca8"}}, "hash": "8c2d2b49abcab45e16abe8808832fc4067ef002a6a1591a685ee303ff5b2bca8", "text": "Week 1Why engineer biology?What makes living matter unique?How to read a research paper-unique physics (e.g., continuous detail scaling)-unique challenges & opportunities (e.g., grow anywhere)-unique time (e.g., COVID, pace-of-change) -40 years of biotechnology-biology as nature\u2019s planetary-scale technology -biology++ (e.g., electrofermentation) \n-triage at every step-hunt for #1 declarative claim in Abstract  -hunt for primary evidence in Figures  CONCEPTSKILL", "start_char_idx": 0, "end_char_idx": 465, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "aba408d5-ac12-40a2-b823-7c3ccb8fd5ec": {"__data__": {"id_": "aba408d5-ac12-40a2-b823-7c3ccb8fd5ec", "embedding": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "78881e17-c525-4eba-970f-7a041e68e21a", "node_type": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "hash": "69bf917d3bab1a4cdaa0e45d50e162718b45019eb4627cacfbeb5b9df9b6ee26"}}, "hash": "69bf917d3bab1a4cdaa0e45d50e162718b45019eb4627cacfbeb5b9df9b6ee26", "text": "Week 2Bioengineering for people healthBioengineering for planet healthHow to frame puzzles & discover connections-Frame Storm-Future Wheel  CONCEPTSKILLBioengineering for political health", "start_char_idx": 0, "end_char_idx": 187, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f9171d4d-e27d-4ae9-9134-67609a4224a1": {"__data__": {"id_": "f9171d4d-e27d-4ae9-9134-67609a4224a1", "embedding": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3376a34d-1a3f-45fb-9da2-184d1178df59", "node_type": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "hash": "1b90e8ced0dd57081abafe2b391d5759d794ce2a6afcc876546a42ad0b3c73b8"}}, "hash": "1b90e8ced0dd57081abafe2b391d5759d794ce2a6afcc876546a42ad0b3c73b8", "text": "What do all these examples of bioengineers working to help people\u2019s health have in common?HINT \u2014 what sorts of things are or seem missing?", "start_char_idx": 0, "end_char_idx": 138, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "53786129-583f-4c93-b873-012fcd616dba": {"__data__": {"id_": "53786129-583f-4c93-b873-012fcd616dba", "embedding": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a9568b26-ee9b-4411-87f9-2ec374d23452", "node_type": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "hash": "2470c6577152855abb9527c3f29da95dad25e6aa8f26e0f2a0c3fee712db3a36"}}, "hash": "2470c6577152855abb9527c3f29da95dad25e6aa8f26e0f2a0c3fee712db3a36", "text": "https://www.smithsonianmag.com/history/cuyahoga-river-caught-\ufb01re-least-dozen-times-no-one-cared-until-1969-180972444/\n\u201cThe Cuyahoga River Caught Fire at Least a Dozen Times, but No One Cared Until 1969\u201d", "start_char_idx": 0, "end_char_idx": 202, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "18137675-f1dd-40f4-8b35-f6706b353ee8": {"__data__": {"id_": "18137675-f1dd-40f4-8b35-f6706b353ee8", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d6232089-f1fa-4846-99ab-d09259c97e72", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "hash": "0690504b6a26e62da7e5b7070f54b6c4ca4f413e08157dbd9f7b6947042ea3fb"}}, "hash": "8c1f771c612184a3f1fc82015ace07efc4fd9ae3282b2e26ceedf2efd8961995", "text": "BRAINSTORMFRAMESTORM\n8produce an idea or way of solving a problem by holding a spontaneous group discussion\n\u201cthe question you ask frames the answers you get\u201d \u2014 Tina Seelig Brainstorm your question (or at least question your question) before you go for solutions & answersFOR EXAMPLE\u201cLet\u2019s plan a birthday party for Mary\u201d versus \u201cLet\u2019s plan something that Mary would enjoy\u201d", "start_char_idx": 0, "end_char_idx": 372, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6e1aebe7-e0f7-4695-9b44-8414928ecc18": {"__data__": {"id_": "6e1aebe7-e0f7-4695-9b44-8414928ecc18", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6462ee0d-7760-434c-a7ad-bb2ab830e4cd", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "hash": "1697f044940454f86ddd8d1071801985a7590fb6635afa0d68e45dc751cf4b2f"}}, "hash": "1697f044940454f86ddd8d1071801985a7590fb6635afa0d68e45dc751cf4b2f", "text": "Engineering approaches to pollution\u20261. Ignore (e.g., dilution solves pollution) 2a. React (e.g., put out the \ufb01re) 2b. React better, in situ (e.g., buy a \ufb01re truck) 2c. React better, ex situ (e.g., capture fuel & treat) 3a. Prevent, change environment (e.g., spare-the-air)3b. Prevent, change system inputs (e.g., unleaded gas)3c. Prevent, change system (e.g., fridges w/o CFCs)", "start_char_idx": 0, "end_char_idx": 377, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "497efb4d-a759-4ba6-b2c2-7b192205b2a8": {"__data__": {"id_": "497efb4d-a759-4ba6-b2c2-7b192205b2a8", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "26ccd585-ed8c-4540-b663-ca78d36b32b5", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "hash": "9f726d355f44536c852d57712f635617eb3e4de8c9d2e5b5c3f71b38606d0c7f"}}, "hash": "9f726d355f44536c852d57712f635617eb3e4de8c9d2e5b5c3f71b38606d0c7f", "text": "Engineering approaches to COVID19\u20261. Ignore (e.g., ________ ) 2a. React (e.g., ________ ) 2b. React better, in situ (e.g., ________ ) 2c. React better, ex situ (e.g., ________ ) 3a. Prevent, change environment (e.g., ________ )3b. Prevent, change system inputs (e.g., ________ )3c. Prevent, change system (e.g., ________ )", "start_char_idx": 0, "end_char_idx": 322, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6b9f7abe-174d-480c-acca-85c9c4d0ace4": {"__data__": {"id_": "6b9f7abe-174d-480c-acca-85c9c4d0ace4", "embedding": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0872a95f-a12d-454b-8fb5-8fa8a8745c32", "node_type": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "hash": "bb59575fee8901feca2c923a621e0a577ebfa2059c165b6ebab300c98ef2a7dd"}}, "hash": "bb59575fee8901feca2c923a621e0a577ebfa2059c165b6ebab300c98ef2a7dd", "text": "BREAKOUT #1FRAMESTORM\n11Can you change the question re: COVID?Can you \ufb01ll in all the blanks?", "start_char_idx": 0, "end_char_idx": 92, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c0c227d1-cec8-45be-b95f-0ea75b94a5df": {"__data__": {"id_": "c0c227d1-cec8-45be-b95f-0ea75b94a5df", "embedding": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6954f9ca-a7ec-493a-be4d-db893e3fb581", "node_type": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "hash": "3020267a4f92141ab4dc3ae527f87e6fb225cb0a105a5f8aac6a1da7b6923ea7"}}, "hash": "3020267a4f92141ab4dc3ae527f87e6fb225cb0a105a5f8aac6a1da7b6923ea7", "text": "Engineering approaches to COVID19\u20261. Ignore (e.g., pandemic runs its course) 2a. React (e.g., urgent care, ICUs, ventilators) 2b. React better, in situ (e.g., diagnostics) 2c. React better, ex situ (e.g., better PPE, meds) 3a. Prevent, change environment (e.g., distancing)3b. Prevent, change system inputs (e.g., vaccine)3c. Prevent, change system (e.g., germ-line engr.?)*What would we need to do to make all infectious diseases obsolete by 2030?", "start_char_idx": 0, "end_char_idx": 448, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6c494515-3af4-4f76-8349-36d62b63c072": {"__data__": {"id_": "6c494515-3af4-4f76-8349-36d62b63c072", "embedding": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "01f8ccf6-c17b-444b-b86b-16ca2bd4519a", "node_type": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "hash": "7513840168fd77fd6f5687ff9c6c92ff4741345b8231098f4985cb1e5eff9c54"}}, "hash": "7513840168fd77fd6f5687ff9c6c92ff4741345b8231098f4985cb1e5eff9c54", "text": "https://www.nejm.org/doi/full/10.1056/NEJMp1113569Causes of Death, Boston 1812", "start_char_idx": 0, "end_char_idx": 78, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f8414fc6-d65d-4c4a-992d-67510fa066e7": {"__data__": {"id_": "f8414fc6-d65d-4c4a-992d-67510fa066e7", "embedding": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b0573aee-04b4-4eb9-8aff-1b831ea7adee", "node_type": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "hash": "450f79c9d0e07ef3a3a5bbe6ca0fc54090c8f8a15cbfeee3f5f4f470ea3caaed"}}, "hash": "23351d120e1cd35f484abd39b818f6066ccb5508e512a337c0a5ba442e7e1f3e", "text": "Jones DS et al. N Engl J Med 2012;366:2333-2338 (source)Changes in Causes, 1900 to 2010", "start_char_idx": 0, "end_char_idx": 87, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "05327225-a34f-42d9-a578-aba7c65d5074": {"__data__": {"id_": "05327225-a34f-42d9-a578-aba7c65d5074", "embedding": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "04273a0d-2536-4665-9838-ba4be1315332", "node_type": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "hash": "4e7816f0c88f34ba4024ba042ee9eae4215d1394574fa1c6e633256b8b27961e"}}, "hash": "4e7816f0c88f34ba4024ba042ee9eae4215d1394574fa1c6e633256b8b27961e", "text": "BREAKOUT #2FRAMESTORM\n15Drawing from today\u2019s reading and what you know, what\u2019s missing from the data?Re: people health, what should bioengineers focus on?", "start_char_idx": 0, "end_char_idx": 154, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3e239478-c7aa-49d8-8698-417595883121": {"__data__": {"id_": "3e239478-c7aa-49d8-8698-417595883121", "embedding": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cb9b74d6-c457-41ab-a698-be9e5117e15e", "node_type": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}, "hash": "6c44f1a3f0ac475a9d1c69b71d0005979c5189c2b03138863eccb10ed926188b"}}, "hash": "47c67e07c0b4f78a81c967a3658d418f09ce45af2b41234ecac5de4146b53f58", "text": "16", "start_char_idx": 0, "end_char_idx": 2, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "104d9cb6-83f6-4c8c-8c08-6db97fb6a85b": {"__data__": {"id_": "104d9cb6-83f6-4c8c-8c08-6db97fb6a85b", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "abe218d5-7fbd-46bd-a5ea-4ae4541ccf0a", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "ee4308a7bce245537979afeb14e5654c7ff0442365aa9a6f4b66da18aa5e2996"}}, "hash": "a8b588eccf96521319401c18b31ef8e99af019f53cc6a78f3c153ef7d51f23c1", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 515 April 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 353, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9d43e97a-feca-4c17-b52d-3b2b6ca5b7a0": {"__data__": {"id_": "9d43e97a-feca-4c17-b52d-3b2b6ca5b7a0", "embedding": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "395498b6-3b64-48e8-a76f-7570241b9d7c", "node_type": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "dae2143d6f20974d2e00c5551bad57e950896f7641b752a1d803bcd219c81ded"}}, "hash": "dae2143d6f20974d2e00c5551bad57e950896f7641b752a1d803bcd219c81ded", "text": "http://thebreakthrough.org/index.php/programs/conservation-and-development/can-palm-oil-deforestation-be-stoppedLoss of habitat due to changing land use", "start_char_idx": 0, "end_char_idx": 152, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "413a90a1-f253-4827-b283-9247329ad9e6": {"__data__": {"id_": "413a90a1-f253-4827-b283-9247329ad9e6", "embedding": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e22252c5-29e4-4c97-ab69-4d724bf10dda", "node_type": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "7f8c1e20c28d28b09c0bea474cb60ba31ee57bd3a5e8afa5f810e38fad3880fd"}}, "hash": "7f8c1e20c28d28b09c0bea474cb60ba31ee57bd3a5e8afa5f810e38fad3880fd", "text": "http://www.guampdn.com/article/20131203/NEWS01/312030006/Mice-drops-help-kill-snakes\nhttp://www.nbcnews.com/news/other/two-thousand-mice-dropped-guam-parachute-kill-snakes-f2D11685572Natural species in new places", "start_char_idx": 0, "end_char_idx": 212, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7edf93b9-48fe-4f62-b7a7-28b6bdb2aab3": {"__data__": {"id_": "7edf93b9-48fe-4f62-b7a7-28b6bdb2aab3", "embedding": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d68ce0ac-4b94-4063-bb5e-1b26b9549a34", "node_type": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "97601edee6ef19aa22ee030c3b7c5c77c2c18c9d701c35b2d87fb7386e6bdb53"}}, "hash": "97601edee6ef19aa22ee030c3b7c5c77c2c18c9d701c35b2d87fb7386e6bdb53", "text": "http://www.guampdn.com/article/20131203/NEWS01/312030006/Mice-drops-help-kill-snakeshttp://www.cnn.com/2016/04/20/asia/great-barrier-reef-coral-bleaching/\nGlobal impacts of industrialization", "start_char_idx": 0, "end_char_idx": 190, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "79794603-0892-49d5-9c3e-10e4e2cebd15": {"__data__": {"id_": "79794603-0892-49d5-9c3e-10e4e2cebd15", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f0bf4a6b-0bc9-4657-a02b-5f9928d52d02", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "38171eb5a279d17a82e7c3e34f0be9189914812165cc75e9c13f6aa9b82343db"}}, "hash": "38171eb5a279d17a82e7c3e34f0be9189914812165cc75e9c13f6aa9b82343db", "text": "http://www.livingplanetindex.org/projects?main_page_project=AboutTheIndex&home_\ufb02ag=1Past ~50 years, humans x 2, animals / 2The Living Planet Index (LPI) is a measure of the state of global biological diversity based on population trends of vertebrate species from around the world\u2026  The global LPI as presented in the Living Planet Report 2018 (Figure 1) shows that a subset of 16,704 populations of 4,005 species has declined by 60% in abundance between 1970 and 2014. The Living Planet Report 2018 results indicate that species are faring much worse in freshwater systems and in tropical realms. Freshwater populations declined by an average of 83%, while realms - large regions separated by major barriers to plant and animal migration and therefore characterized by distinct assemblages of species - declined by between 23% and 89%, with the Neotropical and Indo-Paci\ufb01c realms showing the steepest declines (89% and 64%, respectively).", "start_char_idx": 0, "end_char_idx": 939, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7451e935-9d04-41a2-a84b-c6449ed72809": {"__data__": {"id_": "7451e935-9d04-41a2-a84b-c6449ed72809", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f4d8fdda-7afb-42a4-b263-315c6759a080", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "e24c9cf63171069b30e2dada39ce134096beada50bde4ae71a33fa3180d27add"}}, "hash": "e24c9cf63171069b30e2dada39ce134096beada50bde4ae71a33fa3180d27add", "text": "https://www.nytimes.com/2020/04/08/science/coronavirus-poaching-rhinos.htmlIt\u2019s getting worse\u2026", "start_char_idx": 0, "end_char_idx": 94, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "bdf99cfc-f558-4d79-a3f8-0b73ce4a93ec": {"__data__": {"id_": "bdf99cfc-f558-4d79-a3f8-0b73ce4a93ec", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d3c06c8f-28b9-4ad2-9a41-3ea8061b8bb8", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "50f9c84e3b028b9e238eb5c0832a75cc5b685b505bf9b615da9c2d597abdbd0c"}}, "hash": "38ae1031d95f59b5831c703b9100fd1258b4703a62e74c00201ad82687147edc", "text": "What do you think?Should bioengineers care about natural biodiversity?", "start_char_idx": 0, "end_char_idx": 70, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5279ccad-e861-4718-8206-12395116270a": {"__data__": {"id_": "5279ccad-e861-4718-8206-12395116270a", "embedding": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5a9186a3-c5b2-421e-bad9-52037ff8f147", "node_type": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "44d8e6308c1bb860cc7c20bcc933ec8de1d14edb50e7479bd9202896c673365f"}}, "hash": "44d8e6308c1bb860cc7c20bcc933ec8de1d14edb50e7479bd9202896c673365f", "text": "http://www.nytimes.com/2006/07/26/dining/26cream.html", "start_char_idx": 0, "end_char_idx": 53, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "06b89863-1436-4597-a041-b380801f74f1": {"__data__": {"id_": "06b89863-1436-4597-a041-b380801f74f1", "embedding": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "414c19d2-8dc2-430c-96da-8392067048f1", "node_type": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "031faa4e16b4b12a9fc883ea9113bc7bf4fe01326957e9cf008b63a80a1c2aac"}}, "hash": "031faa4e16b4b12a9fc883ea9113bc7bf4fe01326957e9cf008b63a80a1c2aac", "text": "https://en.wikipedia.org/wiki/Ocean_poutBetter ice cream?  Y ou\u2019re welcome!", "start_char_idx": 0, "end_char_idx": 75, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0b64ccb6-91b9-4e8d-b385-55c9dd01cdf6": {"__data__": {"id_": "0b64ccb6-91b9-4e8d-b385-55c9dd01cdf6", "embedding": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e634a94d-f01a-40c1-97a9-b40e98f81cc9", "node_type": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "d86ae800efcbe190918cdb187ce51b5779bc016554ff2b92666f229adcb5fbe3"}}, "hash": "d86ae800efcbe190918cdb187ce51b5779bc016554ff2b92666f229adcb5fbe3", "text": "Generally, how to decide right or wrong?", "start_char_idx": 0, "end_char_idx": 40, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ea76787f-43af-4055-86da-e1b6754468ca": {"__data__": {"id_": "ea76787f-43af-4055-86da-e1b6754468ca", "embedding": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "da6b46e2-a30f-42c9-b5df-409135888d47", "node_type": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "55f2e7947d627901f7f4cba50e86f76dc74a624b4dec491c21f47a92d5111e03"}}, "hash": "55f2e7947d627901f7f4cba50e86f76dc74a624b4dec491c21f47a92d5111e03", "text": "Any bioengineering opportunities?1. Ignore2. React3. Prevent4. OtherLand useInvasive speciesClimate changePollutionRegarding \u201cPlanet Health\u201d\nExtinction\u201cthe question you ask frames the answers you get\u201d \u2014 Tina Seelig\nWhat do you wish for?  What do you want to make true by or before 2030?", "start_char_idx": 0, "end_char_idx": 286, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "804fb2e2-48c2-43b7-8b45-a6234b18926e": {"__data__": {"id_": "804fb2e2-48c2-43b7-8b45-a6234b18926e", "embedding": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "16fd00d8-ae5e-4807-877a-2779a8b43f3a", "node_type": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "0f42854f6e39c7edbb8ca9ca0d9e299e69bede018d246d80a741c6c438d16879"}}, "hash": "0f42854f6e39c7edbb8ca9ca0d9e299e69bede018d246d80a741c6c438d16879", "text": "http://reviverestore.org/about-the-passenger-pigeon/http://reviverestore.org/passenger-pigeon-de-extinction-roadmap/Let\u2019s bioengineer back an extinct species?!", "start_char_idx": 0, "end_char_idx": 159, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "95f44770-de1d-48fc-8f2f-1664a00417b4": {"__data__": {"id_": "95f44770-de1d-48fc-8f2f-1664a00417b4", "embedding": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "37ad5fb6-fd88-4971-8d40-64f08ff770b3", "node_type": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "5252b98370390722509117bfb54315ead3698c43f455375eed43bea727dc0da8"}}, "hash": "5252b98370390722509117bfb54315ead3698c43f455375eed43bea727dc0da8", "text": "http://reviverestore.org/about-the-passenger-pigeon/Read the genome of a living, near relative", "start_char_idx": 0, "end_char_idx": 94, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "27015a00-d915-494e-8ef2-f0ca78eb2c79": {"__data__": {"id_": "27015a00-d915-494e-8ef2-f0ca78eb2c79", "embedding": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c5da2eea-0177-43bd-ab5f-96b6c181450d", "node_type": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "af5ce9b0c9b2910466fadbd972e6480cfaee838fa82756b711dbdf4bdc178a85"}}, "hash": "af5ce9b0c9b2910466fadbd972e6480cfaee838fa82756b711dbdf4bdc178a85", "text": "http://reviverestore.org/about-the-passenger-pigeon/Read the genome of a dead birds", "start_char_idx": 0, "end_char_idx": 83, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5b60a166-cf63-4fdf-a385-33d12691b997": {"__data__": {"id_": "5b60a166-cf63-4fdf-a385-33d12691b997", "embedding": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9843dc54-2c66-4950-ae83-07365b0620c7", "node_type": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "b81dadb19997571b6b6f5a40f87be434d600e3e3eb7c3fcc8aa3c837cc1c73b4"}}, "hash": "b81dadb19997571b6b6f5a40f87be434d600e3e3eb7c3fcc8aa3c837cc1c73b4", "text": "http://reviverestore.org/about-the-passenger-pigeon/Find differences between two genomes", "start_char_idx": 0, "end_char_idx": 88, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a6848844-92e1-4451-8d10-2b808b05504e": {"__data__": {"id_": "a6848844-92e1-4451-8d10-2b808b05504e", "embedding": null, "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8539a61a-f8fd-4077-8507-154b939fd6b5", "node_type": null, "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "4134fd0f4be42a7f10ee49607e0961f6e2a0536545446e74c2a540f3b522ccfe"}}, "hash": "4134fd0f4be42a7f10ee49607e0961f6e2a0536545446e74c2a540f3b522ccfe", "text": "http://reviverestore.org/about-the-passenger-pigeon/Edit genome to match extinct species\u2019", "start_char_idx": 0, "end_char_idx": 89, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "25693c24-7cb9-424a-8ce8-264c489b5887": {"__data__": {"id_": "25693c24-7cb9-424a-8ce8-264c489b5887", "embedding": null, "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "445010af-be61-47fa-96e3-7e3311ae92e5", "node_type": null, "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "cde86f69711736bcf4ee85e6cb5ef1c9dc0cef0eb9fc3367454ecf421c2aacac"}}, "hash": "cde86f69711736bcf4ee85e6cb5ef1c9dc0cef0eb9fc3367454ecf421c2aacac", "text": "http://reviverestore.org/about-the-passenger-pigeon/Inject edited DNA into brooding species", "start_char_idx": 0, "end_char_idx": 91, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "39101dfe-3ca4-482a-8c22-d0162dd3f1e5": {"__data__": {"id_": "39101dfe-3ca4-482a-8c22-d0162dd3f1e5", "embedding": null, "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "78f83326-329d-4bba-9954-2e47fe4cdbde", "node_type": null, "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "d17a8ec303a8cff603d04f0bb611e82480da5326e7e9da68bbb40e996bfde601"}}, "hash": "d17a8ec303a8cff603d04f0bb611e82480da5326e7e9da68bbb40e996bfde601", "text": "http://reviverestore.org/about-the-passenger-pigeon/Raise revived species, no longer extinct", "start_char_idx": 0, "end_char_idx": 92, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f00ad10b-c03b-48ab-9c95-0b97f1cd28b7": {"__data__": {"id_": "f00ad10b-c03b-48ab-9c95-0b97f1cd28b7", "embedding": null, "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ced2e015-d42d-44a6-9896-5d7d5b6b035e", "node_type": null, "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "8d54cee5e3e27f479a7c4625d4d145b2756daf0344a06077bc92ae5cdc3904f3"}}, "hash": "8d54cee5e3e27f479a7c4625d4d145b2756daf0344a06077bc92ae5cdc3904f3", "text": "http://reviverestore.org/about-the-passenger-pigeon/Release revived species into nature", "start_char_idx": 0, "end_char_idx": 87, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4fa5e6b7-dfff-4977-8269-e9b61908841b": {"__data__": {"id_": "4fa5e6b7-dfff-4977-8269-e9b61908841b", "embedding": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "28f49267-5c6f-40a5-96c2-761c97e54565", "node_type": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "20e7d3ede98fd68b9770b05add18f261b0a164c05d1a68459fac89d667104995"}}, "hash": "20e7d3ede98fd68b9770b05add18f261b0a164c05d1a68459fac89d667104995", "text": "http://reviverestore.org/about-the-passenger-pigeon/Plan and deliver by c. 2035", "start_char_idx": 0, "end_char_idx": 79, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7a97ece0-372e-4199-b059-a7440ea2cc34": {"__data__": {"id_": "7a97ece0-372e-4199-b059-a7440ea2cc34", "embedding": null, "metadata": {"page_label": "27", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "27d7d2e1-8b17-40b0-bc1a-6bf7d1d99f29", "node_type": null, "metadata": {"page_label": "27", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "1b0196f4a881fef61150afd1d940a9285086f590ec4853db4934803e4af47f19"}}, "hash": "1b0196f4a881fef61150afd1d940a9285086f590ec4853db4934803e4af47f19", "text": "http://patentsforhumanity.devpost.com/submissions/10871-semi-synthetic-artemisinin-for-treating-malaria\n\u201cSimpler\u201d example \u2014 change land use by brewing \nmedicines in place of farming traditional plants\u2026", "start_char_idx": 0, "end_char_idx": 201, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4f219c82-8d76-4444-b55c-364efed94728": {"__data__": {"id_": "4f219c82-8d76-4444-b55c-364efed94728", "embedding": null, "metadata": {"page_label": "28", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "16196aef-a89a-4129-a589-8a59cacbe57b", "node_type": null, "metadata": {"page_label": "28", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "d6b1a5df1fd70484f5bd8595649713c6e19b966351198c225aa158328ee568bf"}}, "hash": "14b5d1c4ff3466f69cbc0e130277b8344bbe38ea7a8aac6d6f2c8ec20de7e227", "text": "\"Glucose can be produced in various ways: maize, sugar cane, potatoes.. Taking potatoes as a basis we estimate that 3 to 6 MT of glucose per hectare (4,5 average), 10 tons of glucose for one ton of artemisinic acid (2,2 ha per ton of artemisinic acid), 1,6 MT of artemisinic acid for 1 ton of artemisinin (3,5 ha per ton of artemisinin), so for the whole 200 MT artemisinin market around 700 ha for SSA For natural artemisinin: 2 MT per ha dry leaf with lets say 1% content and 75% industrial ef\ufb01ciency yields a number of 15 kg of artemisinin. For one MT this means close to 67 hectares per MT of artemisinin. so for the whole 200 MT artemisinin market around 13 000 ha for Natural artemisinin closer to 25 000 in actual Chinese conditions. There is 35 times more land use with natural compared to SSAIt would be too simple and naive to consider that the issue is a debate of land use for food crop versus a cash crop such as artemisia annua. Most often this is not the case.\"personal communication, Jim Thomas, ETC Group\u201cIt seems that two average size potato farms in Idaho (supporting say  100 seasonal workers between them with only very part-time employment)\u00a0could theoretically replace \u00a0approximately 100,000 growers in the global artemisinin trade.\u201d", "start_char_idx": 0, "end_char_idx": 1255, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "014365ab-f9ee-4603-b821-0cda078428f4": {"__data__": {"id_": "014365ab-f9ee-4603-b821-0cda078428f4", "embedding": null, "metadata": {"page_label": "29", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2828cf88-22b2-4f21-b1ec-e3b687d57b4b", "node_type": null, "metadata": {"page_label": "29", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "f7018f20959accb06a49a9a2364b78ea0c3076356ab54e653f35fcec1f7b2abe"}}, "hash": "f7018f20959accb06a49a9a2364b78ea0c3076356ab54e653f35fcec1f7b2abe", "text": "FUTURES     WHEEL\n29The futures wheel is a method for graphical visualization of direct and indirect future consequences of a particular change or development.", "start_char_idx": 0, "end_char_idx": 159, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9d44dd46-a4bc-4271-97db-13d254ce694b": {"__data__": {"id_": "9d44dd46-a4bc-4271-97db-13d254ce694b", "embedding": null, "metadata": {"page_label": "30", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dda42b98-4673-4f4c-b0a4-eb142ee475ae", "node_type": null, "metadata": {"page_label": "30", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "7c8eddf86281f8925551cb0c3fa273e835f232e656bc4b00973eafd723af76f9"}}, "hash": "843a4d06f11771c9a0358001f27bf01be62122fb1ed75f25bd6645354a5c7a97", "text": "30\nhttps://study.com/academy/lesson/decision-making-wheels-de\ufb01nition-use-in-managerial-decision-making.htmlT o start a futures wheel the central term describing the change to evaluate is positioned in the center of the page (or drawing area). \nThen, events or consequences following directly from that development are positioned around it.  Next, the (indirect) consequences of the direct consequences are positioned around the \ufb01rst level consequences. The terms may be connected as nodes in a tree (or even a web).", "start_char_idx": 0, "end_char_idx": 515, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "65502f8d-7c5a-4f3f-be8e-010147f09366": {"__data__": {"id_": "65502f8d-7c5a-4f3f-be8e-010147f09366", "embedding": null, "metadata": {"page_label": "31", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7b5f1e27-ce57-404b-b178-75462eac1191", "node_type": null, "metadata": {"page_label": "31", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "f3374d477560f5c07f03925ed82ab8c04d51627241b37c661efe318ced3038bd"}}, "hash": "c9a46da281562cfd7901c9fcf6f48b4072185464297ca9af5ef6b93ac50682da", "text": "31https://novelnarrative.blog/cause-and-effect/T o start a futures wheel the central term describing the change to evaluate is positioned in the center of the page (or drawing area). \nThen, events or consequences following directly from that development are positioned around it.  Next, the (indirect) consequences of the direct consequences are positioned around the \ufb01rst level consequences. The terms may be connected as nodes in a tree (or even a web).", "start_char_idx": 0, "end_char_idx": 455, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6a12453e-eb58-445a-8b79-805d81253dfd": {"__data__": {"id_": "6a12453e-eb58-445a-8b79-805d81253dfd", "embedding": null, "metadata": {"page_label": "32", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b30cca01-bca3-4cd6-8b28-ef040cdef698", "node_type": null, "metadata": {"page_label": "32", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "fbac300e08cb472664fee5162e79ed7a47f0c9512feda06fc2566b7ca1c42fbf"}}, "hash": "6e6d6bfcdf235eb094daa2b3bd3813005335ba1fa0290e6286aef85ce56888af", "text": "32https://www.google.com/imgres?imgurl=http%3A%2F%2Fwww.framtidsbygget.se%2FE%2Ftrendanalys%2Fimg%2Ffutures_wheel.gif&imgrefurl=http%3A%2F%2Fwww.framtidsbygget.se%2FE%2Ftrendanalys%2F&tbnid=6Fuxpa-xtiNBbM&vet=12ahUKEwic_bO5mevoAhUyAzQIHSCmBo4QMygOegUIARD4AQ..i&docid=wCsCICsNFRv9HM&w=500&h=375&q=futures%20wheel%20examples&hl=en&ved=2ahUKEwic_bO5mevoAhUyAzQIHSCmBo4QMygOegUIARD4AQ#h=375&imgdii=Mwn3cFED0qxG1M:&vet=12ahUKEwic_bO5mevoAhUyAzQIHSCmBo4QMygOegUIARD4AQ..i&w=500", "start_char_idx": 0, "end_char_idx": 471, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a326da56-f86b-43a5-9fd7-00e7f557f46f": {"__data__": {"id_": "a326da56-f86b-43a5-9fd7-00e7f557f46f", "embedding": null, "metadata": {"page_label": "33", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3d41d941-e12f-4b03-8278-95934e666eef", "node_type": null, "metadata": {"page_label": "33", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}, "hash": "0a36a36aaaa5b0471cee5f3aee0e94f8c70819bd1a4bfc4fe45dd5fd6b4f3a39"}}, "hash": "6289a6d4d99e43a12278144954bbd37d1a735e4da2acffa455c2914e7fda5bff", "text": "BREAKOUTFUTURES WHEEL\n332. Most surprising indirect impact?1. Most important planet-health impact?\nHome Brewing\nAll Medicines", "start_char_idx": 0, "end_char_idx": 125, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7ca740ad-e2f8-4b0d-875d-e4138b0cb3a0": {"__data__": {"id_": "7ca740ad-e2f8-4b0d-875d-e4138b0cb3a0", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0222e3b8-2e99-409d-9dc9-325350e1368c", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "hash": "3058cd9021d4aa5af8b2cdd0cb78abdda1382460fc4752ffff5dd6584b377b74"}}, "hash": "6e6d4188c8292e3282ec799e4af9941b2b00b4c2a819b662a6bd4789e2b31b2c", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 617 April 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 353, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0b3eff4e-e048-4b88-9395-6f48afeaa67e": {"__data__": {"id_": "0b3eff4e-e048-4b88-9395-6f48afeaa67e", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "da724003-f946-4e97-aab5-6723bf41167b", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "hash": "99b6ba63c28b5922361f4f694a5820508bc7a2bab14aadb648c2e1eaed366e78"}}, "hash": "99b6ba63c28b5922361f4f694a5820508bc7a2bab14aadb648c2e1eaed366e78", "text": "Political \u201c\u2026 the set of activities that are associated with the governance of a country, state or area. It involves making decisions that apply to groups of members and achieving and exercising positions of governance\u2014organized control over a human community.\u201d\nhttps://en.wikipedia.org/wiki/PoliticsHealth 1.\u201ca condition in which someone or something is thriving or doing well.\u201d\nhttps://www.merriam-webster.com/dictionary/health", "start_char_idx": 0, "end_char_idx": 428, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7b476d46-d041-427c-bb29-9f47f9f5d29c": {"__data__": {"id_": "7b476d46-d041-427c-bb29-9f47f9f5d29c", "embedding": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6a23ed58-8ff0-44eb-84a5-86be2329939e", "node_type": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "hash": "11d39ee6195ddc223953045864f7e651b3a441a96c7454a941f050f385a5810e"}}, "hash": "11d39ee6195ddc223953045864f7e651b3a441a96c7454a941f050f385a5810e", "text": "Cure diseases.Understand & \ufb01x broken     biological systems.Bioengineers will\u2026Save environments.Design & build useful organisms.Make doing the above easier.3", "start_char_idx": 0, "end_char_idx": 157, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6db9ff3c-3614-4652-9752-1f3b3bb29049": {"__data__": {"id_": "6db9ff3c-3614-4652-9752-1f3b3bb29049", "embedding": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb70d6a9-956a-42c7-a90e-340138353d6b", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "hash": "8ad4bd4e9e826240b2f57bb020ca0cdbd770196d6aa575f827a7e38f5da3fd04"}}, "hash": "8ad4bd4e9e826240b2f57bb020ca0cdbd770196d6aa575f827a7e38f5da3fd04", "text": "4\nhttp://en.wikipedia.org/wiki/Discourse_on_Inequality\u201cThe two fundamental principles of Rousseau's natural man are his natural, non-destructive love of self (amour de soi meme), and pity/compassion for the suffering of others.\u201d", "start_char_idx": 0, "end_char_idx": 228, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "cf3113a9-ae5a-476c-804c-9aacab526913": {"__data__": {"id_": "cf3113a9-ae5a-476c-804c-9aacab526913", "embedding": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c338b85b-5910-460f-8985-baf44b386a50", "node_type": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "hash": "8b482fe40d41efef097894fc37b7e389e8ae33412ad2b29f1b1ae3ebbc972663"}}, "hash": "8b482fe40d41efef097894fc37b7e389e8ae33412ad2b29f1b1ae3ebbc972663", "text": "Create diseases.Misunderstand & abuse natural    biology & ecology.Bioengineers will inevitably or accidentally\u2026Destroy environments.Design & build harmful organisms.Make doing the above easier.5", "start_char_idx": 0, "end_char_idx": 195, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "73cff873-8026-4bc1-a874-a82d3b155412": {"__data__": {"id_": "73cff873-8026-4bc1-a874-a82d3b155412", "embedding": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0cc39450-ffee-4e2a-a6fb-0cf4205ed138", "node_type": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "hash": "f56c8a77e48623d8111cae4cda7ac6a26f4935eb75c7d0b468c8b26a1cc2d2c4"}}, "hash": "f56c8a77e48623d8111cae4cda7ac6a26f4935eb75c7d0b468c8b26a1cc2d2c4", "text": "6\nhttp://ontologicalstatus.blogspot.com/2011/03/what-does-hobbes-have-to-do-with-french.htmlhttp://en.wikipedia.org/wiki/Leviathan_%28book%29\u201cHereby it is manifest that during the time men live without a common Power to keep them all in awe, they are in that condition which is called War; and such a war as is of every man against every man.[...] In such condition there is no place for Industry, because the fruit thereof is uncertain: and consequently no Culture of the Earth; no Navigation, nor use of the commodities that may be imported by Sea; no commodious Building; no Instruments of moving and removing such things as require much force; no Knowledge of the face of the Earth; no account of Time; no Arts; no Letters; no Society; and which is worst of all, continual Fear, and danger of violent death; And the life of man solitary, poor, nasty, brutish, and short.\u201d  \u2014 Hobbes, Leviathan", "start_char_idx": 0, "end_char_idx": 896, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e612b570-77b6-4976-ba42-dbeb750dba06": {"__data__": {"id_": "e612b570-77b6-4976-ba42-dbeb750dba06", "embedding": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fa97cbc6-dca5-4588-b3e2-5ac343963e64", "node_type": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "hash": "aadff34f0c7889ca43776d1e6eafdf81960a0e08d3af985245ce90ddd3f79622"}}, "hash": "aadff34f0c7889ca43776d1e6eafdf81960a0e08d3af985245ce90ddd3f79622", "text": "https://en.wikipedia.org/wiki/Social_contract\u201ca theory or model that originated during the Age of Enlightenment and usually concerns the legitimacy of the authority of the state over the individual. Social contract arguments typically posit that individuals have consented, either explicitly or tacitly, to surrender some of their freedoms and submit to the authority (of the ruler, or to the decision of a majority) in exchange for protection of their remaining rights or maintenance of the social order.\u201dSocial Contract", "start_char_idx": 0, "end_char_idx": 521, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f139d746-8a5d-4e11-9f17-1061bb5f1147": {"__data__": {"id_": "f139d746-8a5d-4e11-9f17-1061bb5f1147", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e429dcd4-fc5f-47d4-afc5-091d24ecf087", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "hash": "5e62ed6f1adf2cd32b1357aba8ec06e8696d005611cd4082ea123d22bbac6420"}}, "hash": "5e62ed6f1adf2cd32b1357aba8ec06e8696d005611cd4082ea123d22bbac6420", "text": "\u201cThird, the U.S needs Community & Citizenship. The U.S. must enable everyone to engage with this (biological) technology and its many uses to foster the best ideas and to make sure they are genuinely in the public interest. Everyone in the country should be trained to be literate in biotechnology and the U.S. should be building the diverse training programs needed to grow the interdisciplinary bioeconomy workforce of the future.\u201d \u2014 Bioengineer Dr. Megan Palmer testifying before US Senate March 2020\nhttps://www.commerce.senate.gov/2020/3/securing-u-s-leadership-in-the-bioeconomy", "start_char_idx": 0, "end_char_idx": 584, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "80247227-393d-469d-b2b5-ca4c6973aa10": {"__data__": {"id_": "80247227-393d-469d-b2b5-ca4c6973aa10", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9c5d9557-dc8f-4f83-a3e5-6482850caa45", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "hash": "a60bfb7c527c4c99f0b3b4a05fe23b3b8e2822bb8b159cd47b0276c3df6f63a5"}}, "hash": "a60bfb7c527c4c99f0b3b4a05fe23b3b8e2822bb8b159cd47b0276c3df6f63a5", "text": "What capacities should be available to all citizens?\nJefferson to Adams re: \u201cnatural aristocracy\u201d October 1813", "start_char_idx": 0, "end_char_idx": 110, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c186fbcf-baed-4224-9fd6-2b0ad9f57efd": {"__data__": {"id_": "c186fbcf-baed-4224-9fd6-2b0ad9f57efd", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "096f6d0f-a1b9-4d89-a030-b614f13b0928", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "hash": "ef007957c63f76c07b122e758da19f7f31b47190681fe935e717446fcbd3132f"}, "3": {"node_id": "02e19e6a-bb63-4d71-a33d-8f5e21a65654", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "hash": "53932b3adecaf8ca94fa650771e7a7b73f5b22c74a4deb072cf4266757e0541a"}}, "hash": "232b5fb091279b298683faab4c856b0cee77d9402a8b521b8e8470c98855aa5d", "text": ">DQ208311.1 In\ufb02uenza A virus (A/Brevig Mission/1/1918(H1N1)) polymerase PA (PA) mRNA, complete", "start_char_idx": 0, "end_char_idx": 94, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "02e19e6a-bb63-4d71-a33d-8f5e21a65654": {"__data__": {"id_": "02e19e6a-bb63-4d71-a33d-8f5e21a65654", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "096f6d0f-a1b9-4d89-a030-b614f13b0928", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "hash": "ef007957c63f76c07b122e758da19f7f31b47190681fe935e717446fcbd3132f"}, "2": {"node_id": "c186fbcf-baed-4224-9fd6-2b0ad9f57efd", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "hash": "232b5fb091279b298683faab4c856b0cee77d9402a8b521b8e8470c98855aa5d"}, "3": {"node_id": "3e8e1c22-e135-4c56-9af2-1faadcd33940", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "hash": "c72ac131390ecad57c34aa59aaa689da64ea0c2b044319931325d43da0387a3e"}}, "hash": "53932b3adecaf8ca94fa650771e7a7b73f5b22c74a4deb072cf4266757e0541a", "text": "polymerase PA (PA) mRNA, complete cdsATGGAAGACTTTGTGCGACAATGCTTCAATCCGATGATTGTCGAGCTTGCGGAAAAAGCAATGAAAGAGTATGGAGAGGACCTGAAAATCGAAACAAACAAATTTGCAGCAATATGCACTCACTTGGAAGTATGCTTCATGTATTCAGATTTTCACTTCATCAATGAGCGAGGCGAATCAATAATCGTAGAATCTGGCGATCCAAATGCACTCTTGAAGCACAGATTTGAAATAATCGAGGGAAGAGATCGCACAATGGCCTGGACGGTGGTAAACAGTATTTGCAACACTACAGGGGCTGAGAAACCAAAGTTTCTCCCAGATCTGTATGATTACAAGGAGAATAGATTCATTGAGATTGGAGTAACAAGGAGAGAAGTCCACATATACTATCTGGAAAAGGCCAATAAAATAAAATCTGAGAAGACACACATCCACATTTTCTCGTTCACTGGGGAAGAAATGGCCACAAAGGCCGACTACACTCTCGATGAGGAGAGCAGGGCTAGGATCAAAACCAGACTATTCACCATAAGACAAGAGATGGCCAGCAGAGGCCTCTGGGATTCCTTTCGTCAGTCCGAGAGAGGCGAAGAGACAATTGAAGAAAGATTTGAAATCACAGGAACAATGCGCAGGCTTGCCGACCAAAGTCTCCCACCGAACTTCTCCAGCCTTGAAAACTTTAGAGCCTATGTGGATGGATTCGAACCGAACGGCTACATTGAGGGCAAGCTTTCTCAAATGTCCAAAGAAGTAAATGCTAGAATTGAACCTTTTTTGAAGACAACACCACGCCCACTTAGGCTGCCAGATGGGCCTCCCTGTTCTCAGCGGTCCAAATTCCTGCTGATGGATGCCTTGAAATTAAGCATTGAGGACCCAAGCCATGAAGGAGAGGGGATACCGCTATATGATGCGATCAAGTGCATGAGAACATTCTTTGGGTGGAAGGAACCCAATGTTGTTAAGCCACACGAAAAGGGAATAAATCCAAATTATCTCTTGGCATGGAAGCAAGTACTGGCAGAACTGCAGGATATTGAGAATGAGGAGAAAATTCCAAAGACTAAAAATATGAAGAAAACGAGCCAGTTAAAGTGGGCACTTGGTGAGAATATGGCACCAGAAAAAGTGGATTTTGACGACTGTAAAGATGTAAGCGATCTGAAGCAATATGATAGTGATGAACCGGAATTGAGGTCGCTTGCAAGTTGGATTCAGAGTGAGTTCAACAAGGCATGCGAACTGACCGATTCAAGCTGGATAGAGCTCGATGAGATTGGAGAAGATGTGGCTCCAATTGAACACATTGCAAGCATGAGAAGGAATTATTTCACAGCAGAGGTGTCTCATTGCAGAGCCACAGAATACATAATGAAGGGGGTATACATCAATACTGCCTTGCTTAATGCATCCTGTGCAGCAATGGATGATTTCCAATTAATTCCAATGATAAGCAAGTGTAGAACTAAGGAGGGAAGACGAAAGACCAATTTGTACGGGTTCATCATAAAAGGAAGATCCCACTTAAGGAATGACACCGACGTGGTAAATTTTGTGAGCATGGAGTTTTCCCTCACTGATCCAAGACTTGAACCGCACAAATGGGAGAAGTACTGTGTCCTTGAGATAGGGGATATGCTTCTAAGAAGTGCCATAGGCCAAGTGTCAAGGCCCATGTTCTTGTATGTGAGGACAAATGGGACATCAAAAATTAAAATGAAATGGGGAATGGAAATGAGACGTTGCCTCCTTCAGTCACTTCAACAAATCGAGAGTATGATTGAAGCTGAGTCCTCTGTCAAGGAGAAAGACATGACCAAAGAATTCTTTGAGAACAAATCAGAAACATGGCCCATTGGAGAGTCCCCCAAAGGAGTGGAGGAAGG", "start_char_idx": 66, "end_char_idx": 1995, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3e8e1c22-e135-4c56-9af2-1faadcd33940": {"__data__": {"id_": "3e8e1c22-e135-4c56-9af2-1faadcd33940", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "096f6d0f-a1b9-4d89-a030-b614f13b0928", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "hash": "ef007957c63f76c07b122e758da19f7f31b47190681fe935e717446fcbd3132f"}, "2": {"node_id": "02e19e6a-bb63-4d71-a33d-8f5e21a65654", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "hash": "53932b3adecaf8ca94fa650771e7a7b73f5b22c74a4deb072cf4266757e0541a"}}, "hash": "c72ac131390ecad57c34aa59aaa689da64ea0c2b044319931325d43da0387a3e", "text": "TTCCATTGGGAAGGTCTGCAGGACTTTGTTGGCAAAATCGGTATTCAACAGCTTGTATGCATCTCCACAACTAGAAGGATTCTCAGCTGAATCAAGAAAACTGCTTCTTATCGTTCAGGCTCTTAGGGACAACCTGGAACCTGGAACCTTTGATCTTGGGGGGCTATATGAAGCAATTGAGGAGTGCCTGATTAATGATCCCTGGGTTTTGCTTAATGCGTCTTGGTTCAACTCCTTCCTCACACATGCACTGAGATAG", "start_char_idx": 2025, "end_char_idx": 2284, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3fad2f19-46d1-4dbc-9c9e-3b2c1f480e4d": {"__data__": {"id_": "3fad2f19-46d1-4dbc-9c9e-3b2c1f480e4d", "embedding": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0221f21f-533e-499e-8a6c-9ab3371aba6c", "node_type": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "hash": "512c92bcf0b4e541ab7b6129388b2692e2e06298901e831a86548a62d887952c"}}, "hash": "f91ca9a2fa13bd13bd02d727b175a28f601afaf2ecca9c2f5b82b75bd828acee", "text": "13http://orig06.deviantart.net/bb7a/f/2008/143/d/a/the_halfpipe_by_martybell.jpg", "start_char_idx": 0, "end_char_idx": 80, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9e1c85f5-9f5b-4f54-a43e-414b57b289d3": {"__data__": {"id_": "9e1c85f5-9f5b-4f54-a43e-414b57b289d3", "embedding": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "408c9afc-ae19-442e-b34e-6f4a968be1e9", "node_type": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "hash": "658f4526bbf9c55f7f7030100b04959efd0a66ceef6e4427e12f2a0cb6f97f9e"}}, "hash": "ea410ce6bfd9eb0305ea364078e0b759f54dd66e2655a52885a0347f2f78d0da", "text": "14http://orig06.deviantart.net/bb7a/f/2008/143/d/a/the_halfpipe_by_martybell.jpg", "start_char_idx": 0, "end_char_idx": 80, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5e95e6de-faed-446f-8903-adc75c4a2e65": {"__data__": {"id_": "5e95e6de-faed-446f-8903-adc75c4a2e65", "embedding": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7b198585-0651-4d18-9ad1-2c18c5384b89", "node_type": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "hash": "3802a8decd6b3132a1d91ef3d4a414f1d73f71baa16dc64d0d87f676df6c5fc4"}}, "hash": "3802a8decd6b3132a1d91ef3d4a414f1d73f71baa16dc64d0d87f676df6c5fc4", "text": "https://www.pewresearch.org/fact-tank/2020/04/08/nearly-three-in-ten-americans-believe-covid-19-was-made-in-a-lab/ft_20-04-01_covidlab_01b/\nIs COVID-19 a biological weapon?", "start_char_idx": 0, "end_char_idx": 172, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "179f412f-6314-45f7-8c50-6295f11efb67": {"__data__": {"id_": "179f412f-6314-45f7-8c50-6295f11efb67", "embedding": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9030a411-2fe7-490e-bf54-98da9e614fea", "node_type": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}, "hash": "4ffd2d42aed353d791fab27239387a1c03a7b922b55b42e71184c380b0c2998a"}}, "hash": "5761fd4ebb165525d942b68f74d69ca1a284c4c71ee84361a6cbce1fceb64475", "text": "BREAKOUTDOWN W/ DISEASE\n18What should bioengineers do so that all infectious diseases are obsolete by 2030?Hint \u2014 Tr y Framestorm & Futures Wheel Skills", "start_char_idx": 0, "end_char_idx": 152, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "73d90f82-4eac-4ba2-a3d3-ace3c78d2437": {"__data__": {"id_": "73d90f82-4eac-4ba2-a3d3-ace3c78d2437", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "15ed4db5-c25c-4510-b40a-b888c83dde49", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "hash": "1e30474004b91558e91f285de5dd70c26d83bc9b45e83fb877e9b3ddc8e2ca29"}}, "hash": "c6bb2d34406ab5ff844e66eb7af66390497df28f293a6fe375380dddc10329eb", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 720 April 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 353, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9b360ade-5e78-4247-90fa-fb06d11c8afa": {"__data__": {"id_": "9b360ade-5e78-4247-90fa-fb06d11c8afa", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7e9ce147-1d7d-46b0-926c-8d6c5b3236fc", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "hash": "0714ef50a2874e64b91f83176605a50f862b9cb89f240d674a1cfe2549e3af9a"}}, "hash": "0714ef50a2874e64b91f83176605a50f862b9cb89f240d674a1cfe2549e3af9a", "text": "Week 2 repriseDomains of opportunityFutures wheelFramestorming-What will happen as a consequence of doing something? -Direct impacts?-Indirect impacts?-People health (from disease to wellness)-Planet health (from species to ecosystems)-Political health (from citizenship to governance) -The question you ask frames the answers you get-Framestorm before you brainstorm (or if you get stuck)CONCEPTSKILL", "start_char_idx": 0, "end_char_idx": 401, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9ae0081c-a23e-4ff8-9396-333ac53752bc": {"__data__": {"id_": "9ae0081c-a23e-4ff8-9396-333ac53752bc", "embedding": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5076c786-4113-46e6-af09-3c1065253e6b", "node_type": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "hash": "971fca375b8033a3687d436d5ab61e3d4872ff22d48005c08aa633750ec12409"}}, "hash": "971fca375b8033a3687d436d5ab61e3d4872ff22d48005c08aa633750ec12409", "text": "Week 3 look aheadWho are you and how are you motivated?How should engineers think about tools?Build your own microscopeCONCEPTSKILLAnalysis and design of genetic systemsT ools for representing biomoleculesT ools for representing genetic systemsAnalysis and design of biomolecules", "start_char_idx": 0, "end_char_idx": 279, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d44a3be0-62ca-4398-8d96-5663689ab7bb": {"__data__": {"id_": "d44a3be0-62ca-4398-8d96-5663689ab7bb", "embedding": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7b116cc3-b924-4681-80a0-6f2942899ae0", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "hash": "4b869e56a38969245bacb4d472786dd01d2bec68dbe80eeb07ebc76173ff6f96"}}, "hash": "4b869e56a38969245bacb4d472786dd01d2bec68dbe80eeb07ebc76173ff6f96", "text": "https://www.wikihow.com/Determine-if-You%27re-Regular-or-Goofy-FootFinding your natural \u201cstance\u201d \nDoing so familiar for physical activities but less clear for mental activities?", "start_char_idx": 0, "end_char_idx": 177, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4f4db405-36df-478e-bb34-2b9dbbb4db19": {"__data__": {"id_": "4f4db405-36df-478e-bb34-2b9dbbb4db19", "embedding": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c3da7ba5-9756-4bbc-88a9-04f2b9c1d47c", "node_type": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "hash": "718a10526e7bb21d02cb415e9e468c6aef4aff9c80465c67a78f5f9add26b12c"}}, "hash": "718a10526e7bb21d02cb415e9e468c6aef4aff9c80465c67a78f5f9add26b12c", "text": "https://www.whiteonwhite.com/products/box-light-wood-table-lamp?variant=2576825122854COOL!!!  versus  DARN!?!\nDo you prefer to learn by discovering \ufb01rst or tinkering \ufb01rst? Both approaches are valid and essential!", "start_char_idx": 0, "end_char_idx": 212, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1819545b-84b5-4352-a907-4033433ddb4d": {"__data__": {"id_": "1819545b-84b5-4352-a907-4033433ddb4d", "embedding": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6e3ef52f-d2a2-435c-a94e-e183aff702dc", "node_type": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "hash": "5854743fe376dd6ba6b13ee12b9451b77d8aa0bee93670f83a18e9d49601339f"}}, "hash": "5854743fe376dd6ba6b13ee12b9451b77d8aa0bee93670f83a18e9d49601339f", "text": "Smarter!Faster!More!Design, build, & test(model)  (make)  (measure)\nGraphic adapted from \"Synthetic Aesthetics\" MIT Press (2014)Improving the tools that enable the core engineering cycle (above) is a big part of bioengineering.", "start_char_idx": 0, "end_char_idx": 227, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "326e2c56-4094-4678-a914-ad50f4a6ddcc": {"__data__": {"id_": "326e2c56-4094-4678-a914-ad50f4a6ddcc", "embedding": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ad883cdb-5bc4-4b28-9b53-d45eae2c3dac", "node_type": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "hash": "d20dfa5fefbefa2a17485a96ee159429d6c7d5c0f5be461fbb40db3da1197c1f"}}, "hash": "d20dfa5fefbefa2a17485a96ee159429d6c7d5c0f5be461fbb40db3da1197c1f", "text": "\u201cT ools\u201d are not \u201ctools\u201d\nWho can use a tool where is often the most impactful aspect of a tool(the speci\ufb01c form a tool takes matters greatly)", "start_char_idx": 0, "end_char_idx": 141, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b397fecb-f4e5-4db7-8ede-52cc116d9bae": {"__data__": {"id_": "b397fecb-f4e5-4db7-8ede-52cc116d9bae", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6544ec01-8856-411c-87c3-c9fdff15b75a", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "hash": "ffa8b12f0147ae18c1ef1b48b80c5d7779bdf860d27d742093554eea4b8f4b71"}}, "hash": "ffa8b12f0147ae18c1ef1b48b80c5d7779bdf860d27d742093554eea4b8f4b71", "text": "8http://www.nationalgallery.org.uk/paintings/learn-about-art/guide-to-impressionism/guide-to-impressionism/*/viewPage/4\nWho is painting where?(i.e., access shapes practice)", "start_char_idx": 0, "end_char_idx": 172, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3c8f6f71-f61d-428e-98e2-ff40229d5197": {"__data__": {"id_": "3c8f6f71-f61d-428e-98e2-ff40229d5197", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "97adca19-548a-4ca8-8bdb-139e790d4474", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "hash": "c5044e252266641025a147ea1c816784606e9c36ddea0b4b6141bfb4ae0bdcfd"}}, "hash": "c5044e252266641025a147ea1c816784606e9c36ddea0b4b6141bfb4ae0bdcfd", "text": "http://www.gallery.ca/en/see/collections/artwork.php?mkey=2108Who is being painted?(i.e., practice is representation)", "start_char_idx": 0, "end_char_idx": 117, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a21cbc0e-599d-46c3-8e1e-1d708ebc2284": {"__data__": {"id_": "a21cbc0e-599d-46c3-8e1e-1d708ebc2284", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8d03a7f9-e960-4642-9e43-7e040e6cf608", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "hash": "5c2a6e138819c376ea9277d9548abf3d7232542eb184073bfcb03b9aec12bc72"}}, "hash": "5c2a6e138819c376ea9277d9548abf3d7232542eb184073bfcb03b9aec12bc72", "text": "http://en.wikipedia.org/wiki/ImpressionismRepresentation underlies \u201cmeaning making\u201d and culture\u2026\n(not only \u201cready-made\u201d paints but also the \u201cpersonal\u201d computer and likely the \u201cpersonal\u201d bioengineering toolkit, etc\u2026)", "start_char_idx": 0, "end_char_idx": 215, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fb552bba-cf38-4dc5-9ed5-3cc1758e6e7f": {"__data__": {"id_": "fb552bba-cf38-4dc5-9ed5-3cc1758e6e7f", "embedding": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "80fdd1b4-fd4a-482c-b6bc-21072484a0aa", "node_type": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}, "hash": "88bd9b8ecf5107d4617fce00b1cc32d8ea5ae9c90076448d7f8335a0380d90c5"}}, "hash": "88bd9b8ecf5107d4617fce00b1cc32d8ea5ae9c90076448d7f8335a0380d90c5", "text": "https://www.foldscope.com/Engineering for biology to see better\u2026\n#knowyourself#tools#backtonature#BioEquality", "start_char_idx": 0, "end_char_idx": 109, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6bd82d4f-c603-469c-99ad-65b207169256": {"__data__": {"id_": "6bd82d4f-c603-469c-99ad-65b207169256", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba0f64b0-60c7-4bb6-9eae-f330517d1527", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "dea485a852c8aaa6958b8145ffb67342fbce888aefea31b410f9862501f07f30"}}, "hash": "de16ff39f2fba364f56e91a9c195bd3b4b577ae0a856218ddb6358db2f51afdd", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 8 22 April 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 354, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1653a7f3-0422-44ae-8c65-a5e0845a9c7f": {"__data__": {"id_": "1653a7f3-0422-44ae-8c65-a5e0845a9c7f", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "66236342-c64b-42a4-bd6a-21375720f8d2", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "509b244dbcde7f3145f6479de92eb928ab7df5c69a3fec89804e57e132494dd6"}}, "hash": "509b244dbcde7f3145f6479de92eb928ab7df5c69a3fec89804e57e132494dd6", "text": "Analysis & design of biomolecules", "start_char_idx": 0, "end_char_idx": 33, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f2f2c470-9e4c-4163-a3ac-52b07d62c2c7": {"__data__": {"id_": "f2f2c470-9e4c-4163-a3ac-52b07d62c2c7", "embedding": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d1183035-04d1-4881-bbce-bdcc1f90d454", "node_type": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "d0e3197d432f3257ca583ae4e7287cd1a6b4a0d4e40eaa29470e7e06aacf3cb6"}}, "hash": "d0e3197d432f3257ca583ae4e7287cd1a6b4a0d4e40eaa29470e7e06aacf3cb6", "text": "PromoterDNARNA polymerase initiating transcriptionmRNA loaded with ribosomes translating ORFs to make proteinTranscription terminator?(somewhere around here)", "start_char_idx": 0, "end_char_idx": 157, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fa3ad50d-aa0b-4ada-8eec-d8ca6882f263": {"__data__": {"id_": "fa3ad50d-aa0b-4ada-8eec-d8ca6882f263", "embedding": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d1d821a4-265f-424d-a1e9-ba9cd96749ef", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "c53f4e9c8b81ef5d87dceeddf71e02a8b7eec80444bd44182f025c5d3d2bd843"}, "3": {"node_id": "0915bb2c-0a10-4aa9-9c1d-0651ef0ec0f0", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "ada6a9ed5d779a46052f95f32d32f74120dd17d54324f7551f9c1213e913e75b"}}, "hash": "18adf62079546aff1720bf49f4974f2d663351aa02fdbb1a61c87d9c2260dc26", "text": "GAGTTTTATCGCTTCCATGACGCAGAAGTTAACACTTTCGGATATTTCTGATGAGTCGAAAAATTATCTTGATAAAGCAGGAATTACTACTGCTTGTTTACGAATTAAATCGAAGTGGACTGCTGGCGGAAAATGAGAAAATTCGACCTATCCTTGCGCAGCTCGAGAAGCTCTTACTTTGCGACCTTTCGCCATCAACTAACGATTCTGTCAAAAACTGACGCGTTGGATGAGGAGAAGTGGCTTAATATGCTTGGCACGTTCGTCAAGGACTGGTTTAGATATGAGTCACATTTTGTTCATGGTAGAGATTCTCTTGTTGACATTTTAAAAGAGCGTGGATTACTATCTGAGTCCGATGCTGTTCAACCACTAATAGGTAAGAAATCATGAGTCAAGTTACTGAACAATCCGTACGTTTCCAGACCGCTTTGGCCTCTATTAAGCTCATTCAGGCTTCTGCCGTTTTGGATTTAACCGAAGATGATTTCGATTTTCTGACGAGTAACAAAGTTTGGATTGCTACTGACCGCTCTCGTGCTCGTCGCTGCGTTGAGGCTTGCGTTTATGGTACGCTGGACTTTGTGGGATACCCTCGCTTTCCTGCTCCTGTTGAGTTTATTGCTGCCGTCATTGCTTATTATGTTCATCCCGTCAACATTCAAACGGCCTGTCTCATCATGGAAGGCGCTGAATTTACGGAAAACATTATTAATGGCGTCGAGCGTCCGGTTAAAGCCGCTGAATTGTTCGCGTTTACCTTGCGTGTACGCGCAGGAAACACTGACGTTCTTACTGACGCAGAAGAAAACGTGCGTCAAAAATTACGTGCGGAAGGAGTGATGTAATGTCTAAAGGTAAAAAACGTTCTGGCGCTCGCCCTGGTCGTCCGCAGCCGTTGCGAGGTACTAAAGGCAAGCGTAAAGGCGCTCGTCTTTGGTATGTAGGTGGTCAACAATTTTAATTGCAGGGGCTTCGGCCCCTTACTTGAGGATAAATTATGTCTAATATTCAAACTGGCGCCGAGCGTATGCCGCATGACCTTTCCCATCTTGGCTTCCTTGCTGGTCAGATTGGTCGTCTTATTACCATTTCAACTACTCCGGTTATCGCTGGCGACTCCTTCGAGATGGACGCCGTTGGCGCTCTCCGTCTTTCTCCATTGCGTCGTGGCCTTGCTATTGACTCTACTGTAGACATTTTTACTTTTTATGTCCCTCATCGTCACGTTTATGGTGAACAGTGGATTAAGTTCATGAAGGATGGTGTTAATGCCACTCCTCTCCCGACTGTTAACACTACTGGTTATATTGACCATGCCGCTTTTCTTGGCACGATTAACCCTGATACCAATAAAATCCCTAAGCATTTGTTTCAGGGTTATTTGAATATCTATAACAACTATTTTAAAGCGCCGTGGATGCCTGACCGTACCGAGGCTAACCCTAATGAGCTTAATCAAGATGATGCTCGTTATGGTTTCCGTTGCTGCCATCTCAAAAACATTTGGACTGCTCCGCTTCCTCCTGAGACTGAGCTTTCTCGCCAAATGACGACTTCTACCACATCTATTGACATTATGGGTCTGCAAGCTGCTTATGCTAATTTGCATACTGACCAAGAACGTGATTACTTCATGCAGCGTTACCATGATGTTATTTCTTCATTTGGAGGTAAAACCTCTTATGACGCTGACAACCGTCCTTTACTTGTCATGCGCTCTAATCTCTGGGCATCTGGCTATGATGTTGATGGAACTGACCAAACGTCGTTAGGCCAGTTTTCTGGTCGTGTTCAACAGACCTATAAACATTCTGTGCCGCGTTTCTTTGTTCCTGAGCATGGCACTATGTTTACTCTTGCGCTTGTTCGTTTTCCGCCTACTGCGACT", "start_char_idx": 0, "end_char_idx": 1891, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0915bb2c-0a10-4aa9-9c1d-0651ef0ec0f0": {"__data__": {"id_": "0915bb2c-0a10-4aa9-9c1d-0651ef0ec0f0", "embedding": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d1d821a4-265f-424d-a1e9-ba9cd96749ef", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "c53f4e9c8b81ef5d87dceeddf71e02a8b7eec80444bd44182f025c5d3d2bd843"}, "2": {"node_id": "fa3ad50d-aa0b-4ada-8eec-d8ca6882f263", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "18adf62079546aff1720bf49f4974f2d663351aa02fdbb1a61c87d9c2260dc26"}, "3": {"node_id": "59c90a06-351e-4525-9283-c0eda045c29b", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "0d6279c260216118bbf25d0fda37719a891468f4f6934c9ac970f98e208174db"}}, "hash": "ada6a9ed5d779a46052f95f32d32f74120dd17d54324f7551f9c1213e913e75b", "text": "AAAGAGATTCAGTACCTTAACGCTAAAGGTGCTTTGACTTATACCGATATTGCTGGCGACCCTGTTTTGTATGGCAACTTGCCGCCGCGTGAAATTTCTATGAAGGATGTTTTCCGTTCTGGTGATTCGTCTAAGAAGTTTAAGATTGCTGAGGGTCAGTGGTATCGTTATGCGCCTTCGTATGTTTCTCCTGCTTATCACCTTCTTGAAGGCTTCCCATTCATTCAGGAACCGCCTTCTGGTGATTTGCAAGAACGCGTACTTATTCGCCACCATGATTATGACCAGTGTTTCCAGTCCGTTCAGTTGTTGCAGTGGAATAGTCAGGTTAAATTTAATGTGACCGTTTATCGCAATCTGCCGACCACTCGCGATTCAATCATGACTTCGTGATAAAAGATTGAGTGTGAGGTTATAACGCCGAAGCGGTAAAAATTTTAATTTTTGCCGCTGAGGGGTTGACCAAGCGAAGCGCGGTAGGTTTTCTGCTTAGGAGTTTAATCATGTTTCAGACTTTTATTTCTCGCCATAATTCAAACTTTTTTTCTGATAAGCTGGTTCTCACTTCTGTTACTCCAGCTTCTTCGGCACCTGTTTTACAGACACCTAAAGCTACATCGTCAACGTTATATTTTGATAGTTTGACGGTTAATGCTGGTAATGGTGGTTTTCTTCATTGCATTCAGATGGATACATCTGTCAACGCCGCTAATCAGGTTGTTTCTGTTGGTGCTGATATTGCTTTTGATGCCGACCCTAAATTTTTTGCCTGTTTGGTTCGCTTTGAGTCTTCTTCGGTTCCGACTACCCTCCCGACTGCCTATGATGTTTATCCTTTGAATGGTCGCCATGATGGTGGTTATTATACCGTCAAGGACTGTGTGACTATTGACGTCCTTCCCCGTACGCCGGGCAATAACGTTTATGTTGGTTTCATGGTTTGGTCTAACTTTACCGCTACTAAATGCCGCGGATTGGTTTCGCTGAATCAGGTTATTAAAGAGATTATTTGTCTCCAGCCACTTAAGTGAGGTGATTTATGTTTGGTGCTATTGCTGGCGGTATTGCTTCTGCTCTTGCTGGTGGCGCCATGTCTAAATTGTTTGGAGGCGGTCAAAAAGCCGCCTCCGGTGGCATTCAAGGTGATGTGCTTGCTACCGATAACAATACTGTAGGCATGGGTGATGCTGGTATTAAATCTGCCATTCAAGGCTCTAATGTTCCTAACCCTGATGAGGCCGCCCCTAGTTTTGTTTCTGGTGCTATGGCTAAAGCTGGTAAAGGACTTCTTGAAGGTACGTTGCAGGCTGGCACTTCTGCCGTTTCTGATAAGTTGCTTGATTTGGTTGGACTTGGTGGCAAGTCTGCCGCTGATAAAGGAAAGGATACTCGTGATTATCTTGCTGCTGCATTTCCTGAGCTTAATGCTTGGGAGCGTGCTGGTGCTGATGCTTCCTCTGCTGGTATGGTTGACGCCGGATTTGAGAATCAAAAAGAGCTTACTAAAATGCAACTGGACAATCAGAAAGAGATTGCCGAGATGCAAAATGAGACTCAAAAAGAGATTGCTGGCATTCAGTCGGCGACTTCACGCCAGAATACGAAAGACCAGGTATATGCACAAAATGAGATGCTTGCTTATCAACAGAAGGAGTCTACTGCTCGCGTTGCGTCTATTATGGAAAACACCAATCTTTCCAAGCAACAGCAGGTTTCCGAGATTATGCGCCAAATGCTTACTCAAGCTCAAACGGCTGGTCAGTATTTTACCAATGACCAAATCAAAGAAATGACTCGCAAGGTTAGTGCTGAGGTTGACTTAGTTCATCAGCAAACGCAG", "start_char_idx": 1892, "end_char_idx": 3732, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "59c90a06-351e-4525-9283-c0eda045c29b": {"__data__": {"id_": "59c90a06-351e-4525-9283-c0eda045c29b", "embedding": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d1d821a4-265f-424d-a1e9-ba9cd96749ef", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "c53f4e9c8b81ef5d87dceeddf71e02a8b7eec80444bd44182f025c5d3d2bd843"}, "2": {"node_id": "0915bb2c-0a10-4aa9-9c1d-0651ef0ec0f0", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "ada6a9ed5d779a46052f95f32d32f74120dd17d54324f7551f9c1213e913e75b"}}, "hash": "0d6279c260216118bbf25d0fda37719a891468f4f6934c9ac970f98e208174db", "text": "AATCAGCGGTATGGCTCTTCTCATATTGGCGCTACTGCAAAGGATATTTCTAATGTCGTCACTGATGCTGCTTCTGGTGTGGTTGATATTTTTCATGGTATTGATAAAGCTGTTGCCGATACTTGGAACAATTTCTGGAAAGACGGTAAAGCTGATGGTATTGGCTCTAATTTGTCTAGGAAATAACCGTCAGGATTGACACCCTCCCAATTGTATGTTTTCATGCCTCCAAATCTTGGAGGCTTTTTTATGGTTCGTTCTTATTACCCTTCTGAATGTCACGCTGATTATTTTGACTTTGAGCGTATCGAGGCTCTTAAACCTGCTATTGAGGCTTGTGGCATTTCTACTCTTTCTCAATCCCCAATGCTTGGCTTCCATAAGCAGATGGATAACCGCATCAAGCTCTTGGAAGAGATTCTGTCTTTTCGTATGCAGGGCGTTGAGTTCGATAATGGTGATATGTATGTTGACGGCCATAAGGCTGCTTCTGACGTTCGTGATGAGTTTGTATCTGTTACTGAGAAGTTAATGGATGAATTGGCACAATGCTACAATGTGCTCCCCCAACTTGATATTAATAACACTATAGACCACCGCCCCGAAGGGGACGAAAAATGGTTTTTAGAGAACGAGAAGACGGTTACGCAGTTTTGCCGCAAGCTGGCTGCTGAACGCCCTCTTAAGGATATTCGCGATGAGTATAATTACCCCAAAAAGAAAGGTATTAAGGATGAGTGTTCAAGATTGCTGGAGGCCTCCACTATGAAATCGCGTAGAGGCTTTGCTATTCAGCGTTTGATGAATGCAATGCGACAGGCTCATGCTGATGGTTGGTTTATCGTTTTTGACACTCTCACGTTGGCTGACGACCGATTAGAGGCGTTTTATGATAATCCCAATGCTTTGCGTGACTATTTTCGTGATATTGGTCGTATGGTTCTTGCTGCCGAGGGTCGCAAGGCTAATGATTCACACGCCGACTGCTATCAGTATTTTTGTGTGCCTGAGTATGGTACAGCTAATGGCCGTCTTCATTTCCATGCGGTGCACTTTATGCGGACACTTCCTACAGGTAGCGTTGACCCTAATTTTGGTCGTCGGGTACGCAATCGCCGCCAGTTAAATAGCTTGCAAAATACGTGGCCTTATGGTTACAGTATGCCCATCGCAGTTCGCTACACGCAGGACGCTTTTTCACGTTCTGGTTGGTTGTGGCCTGTTGATGCTAAAGGTGAGCCGCTTAAAGCTACCAGTTATATGGCTGTTGGTTTCTATGTGGCTAAATACGTTAACAAAAAGTCAGATATGGACCTTGCTGCTAAAGGTCTAGGAGCTAAAGAATGGAACAACTCACTAAAAACCAAGCTGTCGCTACTTCCCAAGAAGCTGTTCAGAATCAGAATGAGCCGCAACTTCGGGATGAAAATGCTCACAATGACAAATCTGTCCACGGAGTGCTTAATCCAACTTACCAAGCTGGGTTACGACGCGACGCCGTTCAACCAGATATTGAAGCAGAACGCAAAAAGAGAGATGAGATTGAGGCTGGGAAAAGTTACTGTAGCCGACGTTTTGGCGGCGCAACCTGTGACGACAAATCTGCTCAAATTTATGCGCGCTTCGATAAAAATGATTGGCGTATCCAACCTGCA (wrapsaround)https://www.ncbi.nlm.nih.gov/nuccore/9626372\u201cGenome: bought the book; hard to read.\u201d          \u2014 Eric Lander", "start_char_idx": 3733, "end_char_idx": 5509, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fa7c69b7-e356-4ea7-94d6-c1a643f2dd2a": {"__data__": {"id_": "fa7c69b7-e356-4ea7-94d6-c1a643f2dd2a", "embedding": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "809252d7-09c1-45b4-8e0c-cd17abed0bc3", "node_type": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "657b14b641a5d657c9c9a18ef16648f3685f0512af76316c09c2e22bbc9e0089"}}, "hash": "657b14b641a5d657c9c9a18ef16648f3685f0512af76316c09c2e22bbc9e0089", "text": "Analysis of biomolecules often starts as pattern recognition, where patterns are set by what we already know for how biology works\u2026", "start_char_idx": 0, "end_char_idx": 131, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "73912734-e13e-4bbe-a30d-9dcf1db91563": {"__data__": {"id_": "73912734-e13e-4bbe-a30d-9dcf1db91563", "embedding": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3efc3db5-f691-49b1-915a-d33eb89b5584", "node_type": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "d13f7ff9bf210c10214ba78a6f4f6d2fce2428114f9a2252113cfef97933a1ad"}}, "hash": "054c1ff95dd2ccea27cac99cdd785afd804c1ef1e466cb4f8bdf81331a3880c5", "text": "Open Reading Frame (ORF)    Decoding scheme defined by genetic code\nhttps://en.wikipedia.org/wiki/Genetic_code\nhttps://www.khanacademy.org/science/biology/gene-expression-central-dogma/central-dogma-transcription/a/the-genetic-code-discovery-and-propertiesNOTE: mRNA is translated, not DNA. U (mRNA) = T (DNA). Hence coding tables use U.\nNOTE: AUG is the (best) start codon.", "start_char_idx": 0, "end_char_idx": 374, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ca45094f-cb2e-41cc-9270-3a487fc0637b": {"__data__": {"id_": "ca45094f-cb2e-41cc-9270-3a487fc0637b", "embedding": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3d7fb24b-545c-4805-b50e-cb64f3eefdb6", "node_type": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "d19d5b166d89f17b74428f316be9fce2184710132f321d778d259ebf3b81d0e5"}}, "hash": "9e3ca583b914aa6f0b005a8cf4153475227a280f19c69424fe10e36f18512623", "text": "Open Reading Frame (ORF)    DNA-encoded sequence that, as mRNA,     is decoded by the ribosome to make     the so-specified protein\nhttps://masters.agron.iastate.edu/classes/527/lesson08/detail/codons.htmlStart", "start_char_idx": 0, "end_char_idx": 210, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8e2ce759-1fd1-475b-84bd-4e16e2674df0": {"__data__": {"id_": "8e2ce759-1fd1-475b-84bd-4e16e2674df0", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d5d8e73b-cdbb-4bb4-bd44-5d5061357f0b", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "ac7e5d2c4f326450ef464c2cc581f7b331e741e94237893583cd51a37f489f1f"}, "3": {"node_id": "21ac7a76-22b8-41bd-a1d9-59fc31ff944d", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "e643b62354f88e85d42ee4e98a65ab2b4995e8a615cfbee86943ca9381ea6089"}}, "hash": "3b964d0b6642dbb6142d5105ca4bf67d12928473788b418831cf1f9decac5a8a", "text": "GAGTTTTATCGCTTCCATGACGCAGAAGTTAACACTTTCGGATATTTCTGATGAGTCGAAAAATTATCTTGATAAAGCAGGAATTACTACTGCTTGTTTACGAATTAAATCGAAGTGGACTGCTGGCGGAAAATGAGAAAATTCGACCTATCCTTGCGCAGCTCGAGAAGCTCTTACTTTGCGACCTTTCGCCATCAACTAACGATTCTGTCAAAAACTGACGCGTTGGATGAGGAGAAGTGGCTTAATATGCTTGGCACGTTCGTCAAGGACTGGTTTAGATATGAGTCACATTTTGTTCATGGTAGAGATTCTCTTGTTGACATTTTAAAAGAGCGTGGATTACTATCTGAGTCCGATGCTGTTCAACCACTAATAGGTAAGAAATCATGAGTCAAGTTACTGAACAATCCGTACGTTTCCAGACCGCTTTGGCCTCTATTAAGCTCATTCAGGCTTCTGCCGTTTTGGATTTAACCGAAGATGATTTCGATTTTCTGACGAGTAACAAAGTTTGGATTGCTACTGACCGCTCTCGTGCTCGTCGCTGCGTTGAGGCTTGCGTTTATGGTACGCTGGACTTTGTGGGATACCCTCGCTTTCCTGCTCCTGTTGAGTTTATTGCTGCCGTCATTGCTTATTATGTTCATCCCGTCAACATTCAAACGGCCTGTCTCATCATGGAAGGCGCTGAATTTACGGAAAACATTATTAATGGCGTCGAGCGTCCGGTTAAAGCCGCTGAATTGTTCGCGTTTACCTTGCGTGTACGCGCAGGAAACACTGACGTTCTTACTGACGCAGAAGAAAACGTGCGTCAAAAATTACGTGCGGAAGGAGTGATGTAATGTCTAAAGGTAAAAAACGTTCTGGCGCTCGCCCTGGTCGTCCGCAGCCGTTGCGAGGTACTAAAGGCAAGCGTAAAGGCGCTCGTCTTTGGTATGTAGGTGGTCAACAATTTTAATTGCAGGGGCTTCGGCCCCTTACTTGAGGATAAATTATGTCTAATATTCAAACTGGCGCCGAGCGTATGCCGCATGACCTTTCCCATCTTGGCTTCCTTGCTGGTCAGATTGGTCGTCTTATTACCATTTCAACTACTCCGGTTATCGCTGGCGACTCCTTCGAGATGGACGCCGTTGGCGCTCTCCGTCTTTCTCCATTGCGTCGTGGCCTTGCTATTGACTCTACTGTAGACATTTTTACTTTTTATGTCCCTCATCGTCACGTTTATGGTGAACAGTGGATTAAGTTCATGAAGGATGGTGTTAATGCCACTCCTCTCCCGACTGTTAACACTACTGGTTATATTGACCATGCCGCTTTTCTTGGCACGATTAACCCTGATACCAATAAAATCCCTAAGCATTTGTTTCAGGGTTATTTGAATATCTATAACAACTATTTTAAAGCGCCGTGGATGCCTGACCGTACCGAGGCTAACCCTAATGAGCTTAATCAAGATGATGCTCGTTATGGTTTCCGTTGCTGCCATCTCAAAAACATTTGGACTGCTCCGCTTCCTCCTGAGACTGAGCTTTCTCGCCAAATGACGACTTCTACCACATCTATTGACATTATGGGTCTGCAAGCTGCTTATGCTAATTTGCATACTGACCAAGAACGTGATTACTTCATGCAGCGTTACCATGATGTTATTTCTTCATTTGGAGGTAAAACCTCTTATGACGCTGACAACCGTCCTTTACTTGTCATGCGCTCTAATCTCTGGGCATCTGGCTATGATGTTGATGGAACTGACCAAACGTCGTTAGGCCAGTTTTCTGGTCGTGTTCAACAGACCTATAAACATTCTGTGCCGCGTTTCTTTGTTCCTGAGCATGGCACTATGTTTACTCTTGCGCTTGTTCGTTTTCCGCCTACTGCGACT", "start_char_idx": 0, "end_char_idx": 1891, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "21ac7a76-22b8-41bd-a1d9-59fc31ff944d": {"__data__": {"id_": "21ac7a76-22b8-41bd-a1d9-59fc31ff944d", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d5d8e73b-cdbb-4bb4-bd44-5d5061357f0b", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "ac7e5d2c4f326450ef464c2cc581f7b331e741e94237893583cd51a37f489f1f"}, "2": {"node_id": "8e2ce759-1fd1-475b-84bd-4e16e2674df0", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "3b964d0b6642dbb6142d5105ca4bf67d12928473788b418831cf1f9decac5a8a"}, "3": {"node_id": "d6f5c387-1516-40bc-90cd-8548ce468b16", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "fce3c78a5f6366ea471361c099acdc2a779964f8b86fde4151a95507012cd0c0"}}, "hash": "e643b62354f88e85d42ee4e98a65ab2b4995e8a615cfbee86943ca9381ea6089", "text": "AAAGAGATTCAGTACCTTAACGCTAAAGGTGCTTTGACTTATACCGATATTGCTGGCGACCCTGTTTTGTATGGCAACTTGCCGCCGCGTGAAATTTCTATGAAGGATGTTTTCCGTTCTGGTGATTCGTCTAAGAAGTTTAAGATTGCTGAGGGTCAGTGGTATCGTTATGCGCCTTCGTATGTTTCTCCTGCTTATCACCTTCTTGAAGGCTTCCCATTCATTCAGGAACCGCCTTCTGGTGATTTGCAAGAACGCGTACTTATTCGCCACCATGATTATGACCAGTGTTTCCAGTCCGTTCAGTTGTTGCAGTGGAATAGTCAGGTTAAATTTAATGTGACCGTTTATCGCAATCTGCCGACCACTCGCGATTCAATCATGACTTCGTGATAAAAGATTGAGTGTGAGGTTATAACGCCGAAGCGGTAAAAATTTTAATTTTTGCCGCTGAGGGGTTGACCAAGCGAAGCGCGGTAGGTTTTCTGCTTAGGAGTTTAATCATGTTTCAGACTTTTATTTCTCGCCATAATTCAAACTTTTTTTCTGATAAGCTGGTTCTCACTTCTGTTACTCCAGCTTCTTCGGCACCTGTTTTACAGACACCTAAAGCTACATCGTCAACGTTATATTTTGATAGTTTGACGGTTAATGCTGGTAATGGTGGTTTTCTTCATTGCATTCAGATGGATACATCTGTCAACGCCGCTAATCAGGTTGTTTCTGTTGGTGCTGATATTGCTTTTGATGCCGACCCTAAATTTTTTGCCTGTTTGGTTCGCTTTGAGTCTTCTTCGGTTCCGACTACCCTCCCGACTGCCTATGATGTTTATCCTTTGAATGGTCGCCATGATGGTGGTTATTATACCGTCAAGGACTGTGTGACTATTGACGTCCTTCCCCGTACGCCGGGCAATAACGTTTATGTTGGTTTCATGGTTTGGTCTAACTTTACCGCTACTAAATGCCGCGGATTGGTTTCGCTGAATCAGGTTATTAAAGAGATTATTTGTCTCCAGCCACTTAAGTGAGGTGATTTATGTTTGGTGCTATTGCTGGCGGTATTGCTTCTGCTCTTGCTGGTGGCGCCATGTCTAAATTGTTTGGAGGCGGTCAAAAAGCCGCCTCCGGTGGCATTCAAGGTGATGTGCTTGCTACCGATAACAATACTGTAGGCATGGGTGATGCTGGTATTAAATCTGCCATTCAAGGCTCTAATGTTCCTAACCCTGATGAGGCCGCCCCTAGTTTTGTTTCTGGTGCTATGGCTAAAGCTGGTAAAGGACTTCTTGAAGGTACGTTGCAGGCTGGCACTTCTGCCGTTTCTGATAAGTTGCTTGATTTGGTTGGACTTGGTGGCAAGTCTGCCGCTGATAAAGGAAAGGATACTCGTGATTATCTTGCTGCTGCATTTCCTGAGCTTAATGCTTGGGAGCGTGCTGGTGCTGATGCTTCCTCTGCTGGTATGGTTGACGCCGGATTTGAGAATCAAAAAGAGCTTACTAAAATGCAACTGGACAATCAGAAAGAGATTGCCGAGATGCAAAATGAGACTCAAAAAGAGATTGCTGGCATTCAGTCGGCGACTTCACGCCAGAATACGAAAGACCAGGTATATGCACAAAATGAGATGCTTGCTTATCAACAGAAGGAGTCTACTGCTCGCGTTGCGTCTATTATGGAAAACACCAATCTTTCCAAGCAACAGCAGGTTTCCGAGATTATGCGCCAAATGCTTACTCAAGCTCAAACGGCTGGTCAGTATTTTACCAATGACCAAATCAAAGAAATGACTCGCAAGGTTAGTGCTGAGGTTGACTTAGTTCATCAGCAAACGCAG", "start_char_idx": 1892, "end_char_idx": 3732, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d6f5c387-1516-40bc-90cd-8548ce468b16": {"__data__": {"id_": "d6f5c387-1516-40bc-90cd-8548ce468b16", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d5d8e73b-cdbb-4bb4-bd44-5d5061357f0b", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "ac7e5d2c4f326450ef464c2cc581f7b331e741e94237893583cd51a37f489f1f"}, "2": {"node_id": "21ac7a76-22b8-41bd-a1d9-59fc31ff944d", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "e643b62354f88e85d42ee4e98a65ab2b4995e8a615cfbee86943ca9381ea6089"}}, "hash": "fce3c78a5f6366ea471361c099acdc2a779964f8b86fde4151a95507012cd0c0", "text": "AATCAGCGGTATGGCTCTTCTCATATTGGCGCTACTGCAAAGGATATTTCTAATGTCGTCACTGATGCTGCTTCTGGTGTGGTTGATATTTTTCATGGTATTGATAAAGCTGTTGCCGATACTTGGAACAATTTCTGGAAAGACGGTAAAGCTGATGGTATTGGCTCTAATTTGTCTAGGAAATAACCGTCAGGATTGACACCCTCCCAATTGTATGTTTTCATGCCTCCAAATCTTGGAGGCTTTTTTATGGTTCGTTCTTATTACCCTTCTGAATGTCACGCTGATTATTTTGACTTTGAGCGTATCGAGGCTCTTAAACCTGCTATTGAGGCTTGTGGCATTTCTACTCTTTCTCAATCCCCAATGCTTGGCTTCCATAAGCAGATGGATAACCGCATCAAGCTCTTGGAAGAGATTCTGTCTTTTCGTATGCAGGGCGTTGAGTTCGATAATGGTGATATGTATGTTGACGGCCATAAGGCTGCTTCTGACGTTCGTGATGAGTTTGTATCTGTTACTGAGAAGTTAATGGATGAATTGGCACAATGCTACAATGTGCTCCCCCAACTTGATATTAATAACACTATAGACCACCGCCCCGAAGGGGACGAAAAATGGTTTTTAGAGAACGAGAAGACGGTTACGCAGTTTTGCCGCAAGCTGGCTGCTGAACGCCCTCTTAAGGATATTCGCGATGAGTATAATTACCCCAAAAAGAAAGGTATTAAGGATGAGTGTTCAAGATTGCTGGAGGCCTCCACTATGAAATCGCGTAGAGGCTTTGCTATTCAGCGTTTGATGAATGCAATGCGACAGGCTCATGCTGATGGTTGGTTTATCGTTTTTGACACTCTCACGTTGGCTGACGACCGATTAGAGGCGTTTTATGATAATCCCAATGCTTTGCGTGACTATTTTCGTGATATTGGTCGTATGGTTCTTGCTGCCGAGGGTCGCAAGGCTAATGATTCACACGCCGACTGCTATCAGTATTTTTGTGTGCCTGAGTATGGTACAGCTAATGGCCGTCTTCATTTCCATGCGGTGCACTTTATGCGGACACTTCCTACAGGTAGCGTTGACCCTAATTTTGGTCGTCGGGTACGCAATCGCCGCCAGTTAAATAGCTTGCAAAATACGTGGCCTTATGGTTACAGTATGCCCATCGCAGTTCGCTACACGCAGGACGCTTTTTCACGTTCTGGTTGGTTGTGGCCTGTTGATGCTAAAGGTGAGCCGCTTAAAGCTACCAGTTATATGGCTGTTGGTTTCTATGTGGCTAAATACGTTAACAAAAAGTCAGATATGGACCTTGCTGCTAAAGGTCTAGGAGCTAAAGAATGGAACAACTCACTAAAAACCAAGCTGTCGCTACTTCCCAAGAAGCTGTTCAGAATCAGAATGAGCCGCAACTTCGGGATGAAAATGCTCACAATGACAAATCTGTCCACGGAGTGCTTAATCCAACTTACCAAGCTGGGTTACGACGCGACGCCGTTCAACCAGATATTGAAGCAGAACGCAAAAAGAGAGATGAGATTGAGGCTGGGAAAAGTTACTGTAGCCGACGTTTTGGCGGCGCAACCTGTGACGACAAATCTGCTCAAATTTATGCGCGCTTCGATAAAAATGATTGGCGTATCCAACCTGCA (wrapsaround)https://www.ncbi.nlm.nih.gov/nuccore/9626372", "start_char_idx": 3733, "end_char_idx": 5446, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ad38e77d-e63b-4cce-962d-560a43e7da1a": {"__data__": {"id_": "ad38e77d-e63b-4cce-962d-560a43e7da1a", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ea015b4e-e9df-469c-8e4a-2540fd0ce2e2", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "b28dd3d4bfa278ba857aebc08a5fc7ec61a623ea1e3aed88340227b06ec44783"}, "3": {"node_id": "e2704c23-a290-4d79-8de3-c2757ba9f213", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "03e574ff9d56e234ba2dcf96712f7170d4106f76c1ca79b3cf8a6f8957b1961a"}}, "hash": "fa89c53317b5ade65931042391e601022a90bd79b5cae74ac6b6f68c58b6007f", "text": "GAGTTTTATCGCTTCCATGACGCAGAAGTTAACACTTTCGGATATTTCTGATGAGTCGAAAAATTATCTTGATAAAGCAGGAATTACTACTGCTTGTTTACGAATTAAATCGAAGTGGACTGCTGGCGGAAAATGAGAAAATTCGACCTATCCTTGCGCAGCTCGAGAAGCTCTTACTTTGCGACCTTTCGCCATCAACTAACGATTCTGTCAAAAACTGACGCGTTGGATGAGGAGAAGTGGCTTAATATGCTTGGCACGTTCGTCAAGGACTGGTTTAGATATGAGTCACATTTTGTTCATGGTAGAGATTCTCTTGTTGACATTTTAAAAGAGCGTGGATTACTATCTGAGTCCGATGCTGTTCAACCACTAATAGGTAAGAAATCATGAGTCAAGTTACTGAACAATCCGTACGTTTCCAGACCGCTTTGGCCTCTATTAAGCTCATTCAGGCTTCTGCCGTTTTGGATTTAACCGAAGATGATTTCGATTTTCTGACGAGTAACAAAGTTTGGATTGCTACTGACCGCTCTCGTGCTCGTCGCTGCGTTGAGGCTTGCGTTTATGGTACGCTGGACTTTGTGGGATACCCTCGCTTTCCTGCTCCTGTTGAGTTTATTGCTGCCGTCATTGCTTATTATGTTCATCCCGTCAACATTCAAACGGCCTGTCTCATCATGGAAGGCGCTGAATTTACGGAAAACATTATTAATGGCGTCGAGCGTCCGGTTAAAGCCGCTGAATTGTTCGCGTTTACCTTGCGTGTACGCGCAGGAAACACTGACGTTCTTACTGACGCAGAAGAAAACGTGCGTCAAAAATTACGTGCGGAAGGAGTGATGTAATGTCTAAAGGTAAAAAACGTTCTGGCGCTCGCCCTGGTCGTCCGCAGCCGTTGCGAGGTACTAAAGGCAAGCGTAAAGGCGCTCGTCTTTGGTATGTAGGTGGTCAACAATTTTAATTGCAGGGGCTTCGGCCCCTTACTTGAGGATAAATTATGTCTAATATTCAAACTGGCGCCGAGCGTATGCCGCATGACCTTTCCCATCTTGGCTTCCTTGCTGGTCAGATTGGTCGTCTTATTACCATTTCAACTACTCCGGTTATCGCTGGCGACTCCTTCGAGATGGACGCCGTTGGCGCTCTCCGTCTTTCTCCATTGCGTCGTGGCCTTGCTATTGACTCTACTGTAGACATTTTTACTTTTTATGTCCCTCATCGTCACGTTTATGGTGAACAGTGGATTAAGTTCATGAAGGATGGTGTTAATGCCACTCCTCTCCCGACTGTTAACACTACTGGTTATATTGACCATGCCGCTTTTCTTGGCACGATTAACCCTGATACCAATAAAATCCCTAAGCATTTGTTTCAGGGTTATTTGAATATCTATAACAACTATTTTAAAGCGCCGTGGATGCCTGACCGTACCGAGGCTAACCCTAATGAGCTTAATCAAGATGATGCTCGTTATGGTTTCCGTTGCTGCCATCTCAAAAACATTTGGACTGCTCCGCTTCCTCCTGAGACTGAGCTTTCTCGCCAAATGACGACTTCTACCACATCTATTGACATTATGGGTCTGCAAGCTGCTTATGCTAATTTGCATACTGACCAAGAACGTGATTACTTCATGCAGCGTTACCATGATGTTATTTCTTCATTTGGAGGTAAAACCTCTTATGACGCTGACAACCGTCCTTTACTTGTCATGCGCTCTAATCTCTGGGCATCTGGCTATGATGTTGATGGAACTGACCAAACGTCGTTAGGCCAGTTTTCTGGTCGTGTTCAACAGACCTATAAACATTCTGTGCCGCGTTTCTTTGTTCCTGAGCATGGCACTATGTTTACTCTTGCGCTTGTTCGTTTTCCGCCTACTGCGACT", "start_char_idx": 0, "end_char_idx": 1891, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e2704c23-a290-4d79-8de3-c2757ba9f213": {"__data__": {"id_": "e2704c23-a290-4d79-8de3-c2757ba9f213", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ea015b4e-e9df-469c-8e4a-2540fd0ce2e2", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "b28dd3d4bfa278ba857aebc08a5fc7ec61a623ea1e3aed88340227b06ec44783"}, "2": {"node_id": "ad38e77d-e63b-4cce-962d-560a43e7da1a", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "fa89c53317b5ade65931042391e601022a90bd79b5cae74ac6b6f68c58b6007f"}, "3": {"node_id": "c31913ef-e258-4037-bbe0-e848bc864b90", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "0c558888f5172c0b8c1023436bc88e7d6880be5d7453687847b4775bad408529"}}, "hash": "03e574ff9d56e234ba2dcf96712f7170d4106f76c1ca79b3cf8a6f8957b1961a", "text": "AAAGAGATTCAGTACCTTAACGCTAAAGGTGCTTTGACTTATACCGATATTGCTGGCGACCCTGTTTTGTATGGCAACTTGCCGCCGCGTGAAATTTCTATGAAGGATGTTTTCCGTTCTGGTGATTCGTCTAAGAAGTTTAAGATTGCTGAGGGTCAGTGGTATCGTTATGCGCCTTCGTATGTTTCTCCTGCTTATCACCTTCTTGAAGGCTTCCCATTCATTCAGGAACCGCCTTCTGGTGATTTGCAAGAACGCGTACTTATTCGCCACCATGATTATGACCAGTGTTTCCAGTCCGTTCAGTTGTTGCAGTGGAATAGTCAGGTTAAATTTAATGTGACCGTTTATCGCAATCTGCCGACCACTCGCGATTCAATCATGACTTCGTGATAAAAGATTGAGTGTGAGGTTATAACGCCGAAGCGGTAAAAATTTTAATTTTTGCCGCTGAGGGGTTGACCAAGCGAAGCGCGGTAGGTTTTCTGCTTAGGAGTTTAATCATGTTTCAGACTTTTATTTCTCGCCATAATTCAAACTTTTTTTCTGATAAGCTGGTTCTCACTTCTGTTACTCCAGCTTCTTCGGCACCTGTTTTACAGACACCTAAAGCTACATCGTCAACGTTATATTTTGATAGTTTGACGGTTAATGCTGGTAATGGTGGTTTTCTTCATTGCATTCAGATGGATACATCTGTCAACGCCGCTAATCAGGTTGTTTCTGTTGGTGCTGATATTGCTTTTGATGCCGACCCTAAATTTTTTGCCTGTTTGGTTCGCTTTGAGTCTTCTTCGGTTCCGACTACCCTCCCGACTGCCTATGATGTTTATCCTTTGAATGGTCGCCATGATGGTGGTTATTATACCGTCAAGGACTGTGTGACTATTGACGTCCTTCCCCGTACGCCGGGCAATAACGTTTATGTTGGTTTCATGGTTTGGTCTAACTTTACCGCTACTAAATGCCGCGGATTGGTTTCGCTGAATCAGGTTATTAAAGAGATTATTTGTCTCCAGCCACTTAAGTGAGGTGATTTATGTTTGGTGCTATTGCTGGCGGTATTGCTTCTGCTCTTGCTGGTGGCGCCATGTCTAAATTGTTTGGAGGCGGTCAAAAAGCCGCCTCCGGTGGCATTCAAGGTGATGTGCTTGCTACCGATAACAATACTGTAGGCATGGGTGATGCTGGTATTAAATCTGCCATTCAAGGCTCTAATGTTCCTAACCCTGATGAGGCCGCCCCTAGTTTTGTTTCTGGTGCTATGGCTAAAGCTGGTAAAGGACTTCTTGAAGGTACGTTGCAGGCTGGCACTTCTGCCGTTTCTGATAAGTTGCTTGATTTGGTTGGACTTGGTGGCAAGTCTGCCGCTGATAAAGGAAAGGATACTCGTGATTATCTTGCTGCTGCATTTCCTGAGCTTAATGCTTGGGAGCGTGCTGGTGCTGATGCTTCCTCTGCTGGTATGGTTGACGCCGGATTTGAGAATCAAAAAGAGCTTACTAAAATGCAACTGGACAATCAGAAAGAGATTGCCGAGATGCAAAATGAGACTCAAAAAGAGATTGCTGGCATTCAGTCGGCGACTTCACGCCAGAATACGAAAGACCAGGTATATGCACAAAATGAGATGCTTGCTTATCAACAGAAGGAGTCTACTGCTCGCGTTGCGTCTATTATGGAAAACACCAATCTTTCCAAGCAACAGCAGGTTTCCGAGATTATGCGCCAAATGCTTACTCAAGCTCAAACGGCTGGTCAGTATTTTACCAATGACCAAATCAAAGAAATGACTCGCAAGGTTAGTGCTGAGGTTGACTTAGTTCATCAGCAAACGCAG", "start_char_idx": 1892, "end_char_idx": 3732, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c31913ef-e258-4037-bbe0-e848bc864b90": {"__data__": {"id_": "c31913ef-e258-4037-bbe0-e848bc864b90", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ea015b4e-e9df-469c-8e4a-2540fd0ce2e2", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "b28dd3d4bfa278ba857aebc08a5fc7ec61a623ea1e3aed88340227b06ec44783"}, "2": {"node_id": "e2704c23-a290-4d79-8de3-c2757ba9f213", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "03e574ff9d56e234ba2dcf96712f7170d4106f76c1ca79b3cf8a6f8957b1961a"}}, "hash": "0c558888f5172c0b8c1023436bc88e7d6880be5d7453687847b4775bad408529", "text": "AATCAGCGGTATGGCTCTTCTCATATTGGCGCTACTGCAAAGGATATTTCTAATGTCGTCACTGATGCTGCTTCTGGTGTGGTTGATATTTTTCATGGTATTGATAAAGCTGTTGCCGATACTTGGAACAATTTCTGGAAAGACGGTAAAGCTGATGGTATTGGCTCTAATTTGTCTAGGAAATAACCGTCAGGATTGACACCCTCCCAATTGTATGTTTTCATGCCTCCAAATCTTGGAGGCTTTTTTATGGTTCGTTCTTATTACCCTTCTGAATGTCACGCTGATTATTTTGACTTTGAGCGTATCGAGGCTCTTAAACCTGCTATTGAGGCTTGTGGCATTTCTACTCTTTCTCAATCCCCAATGCTTGGCTTCCATAAGCAGATGGATAACCGCATCAAGCTCTTGGAAGAGATTCTGTCTTTTCGTATGCAGGGCGTTGAGTTCGATAATGGTGATATGTATGTTGACGGCCATAAGGCTGCTTCTGACGTTCGTGATGAGTTTGTATCTGTTACTGAGAAGTTAATGGATGAATTGGCACAATGCTACAATGTGCTCCCCCAACTTGATATTAATAACACTATAGACCACCGCCCCGAAGGGGACGAAAAATGGTTTTTAGAGAACGAGAAGACGGTTACGCAGTTTTGCCGCAAGCTGGCTGCTGAACGCCCTCTTAAGGATATTCGCGATGAGTATAATTACCCCAAAAAGAAAGGTATTAAGGATGAGTGTTCAAGATTGCTGGAGGCCTCCACTATGAAATCGCGTAGAGGCTTTGCTATTCAGCGTTTGATGAATGCAATGCGACAGGCTCATGCTGATGGTTGGTTTATCGTTTTTGACACTCTCACGTTGGCTGACGACCGATTAGAGGCGTTTTATGATAATCCCAATGCTTTGCGTGACTATTTTCGTGATATTGGTCGTATGGTTCTTGCTGCCGAGGGTCGCAAGGCTAATGATTCACACGCCGACTGCTATCAGTATTTTTGTGTGCCTGAGTATGGTACAGCTAATGGCCGTCTTCATTTCCATGCGGTGCACTTTATGCGGACACTTCCTACAGGTAGCGTTGACCCTAATTTTGGTCGTCGGGTACGCAATCGCCGCCAGTTAAATAGCTTGCAAAATACGTGGCCTTATGGTTACAGTATGCCCATCGCAGTTCGCTACACGCAGGACGCTTTTTCACGTTCTGGTTGGTTGTGGCCTGTTGATGCTAAAGGTGAGCCGCTTAAAGCTACCAGTTATATGGCTGTTGGTTTCTATGTGGCTAAATACGTTAACAAAAAGTCAGATATGGACCTTGCTGCTAAAGGTCTAGGAGCTAAAGAATGGAACAACTCACTAAAAACCAAGCTGTCGCTACTTCCCAAGAAGCTGTTCAGAATCAGAATGAGCCGCAACTTCGGGATGAAAATGCTCACAATGACAAATCTGTCCACGGAGTGCTTAATCCAACTTACCAAGCTGGGTTACGACGCGACGCCGTTCAACCAGATATTGAAGCAGAACGCAAAAAGAGAGATGAGATTGAGGCTGGGAAAAGTTACTGTAGCCGACGTTTTGGCGGCGCAACCTGTGACGACAAATCTGCTCAAATTTATGCGCGCTTCGATAAAAATGATTGGCGTATCCAACCTGCA (wrapsaround)https://www.ncbi.nlm.nih.gov/nuccore/9626372", "start_char_idx": 3733, "end_char_idx": 5446, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "56742981-38be-4dcf-90fa-98533897779e": {"__data__": {"id_": "56742981-38be-4dcf-90fa-98533897779e", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c0b9c18a-d7e8-41b4-9208-cd94722c46d0", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "46a69ab64b94fdbb3dfd65e1446b1fe178f6057e897e92f12dafdf7de0ea99a4"}}, "hash": "46a69ab64b94fdbb3dfd65e1446b1fe178f6057e897e92f12dafdf7de0ea99a4", "text": "https://www.google.com/search?q=phix174+benchlinghttps://en.wikipedia.org/wiki/Phi_X_174\nhttps://www.pnas.org/content/116/48/24206\u201cAccepted\u201d ORF annotation\u201cUnfiltered\u201d ORF annotation", "start_char_idx": 0, "end_char_idx": 182, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0d0156fe-6c03-40e8-9489-c6edbbb72c19": {"__data__": {"id_": "0d0156fe-6c03-40e8-9489-c6edbbb72c19", "embedding": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "56536342-369d-4ac0-9b53-6a7d41ef9093", "node_type": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "ca833ed2566829eeb6006d30b10fc83e2131471a4cd3fe20f064a364ffde73c7"}}, "hash": "ca833ed2566829eeb6006d30b10fc83e2131471a4cd3fe20f064a364ffde73c7", "text": "Ribosome loading on mRNA involves RNA:RNA interaction (base pairing)     \n \nhttp://www.nature.com/nmeth/journal/v10/n4/full/nmeth.2404.html", "start_char_idx": 0, "end_char_idx": 139, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d3cccacb-d0aa-4f54-9d35-d51a6f0e5b74": {"__data__": {"id_": "d3cccacb-d0aa-4f54-9d35-d51a6f0e5b74", "embedding": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "94c39ae4-911b-486c-afb6-ce3b469ab99e", "node_type": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "31fcdd0b030fc4d82fda34c8592604dfa3a1e82bf554dadb3d472f385ab4c386"}}, "hash": "0bb5232e526817073df91bf67bfa3152b44ab284f92c22ee10fa6bc18754926d", "text": "Ribosome Binding Site (RBS)     mRNA sequence recognized by ribosomes    to initiate translation\nhttps://schneider.ncifcrf.gov/paper/logopaper/", "start_char_idx": 0, "end_char_idx": 143, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "805cb416-9e03-408f-a2a7-708e174b719e": {"__data__": {"id_": "805cb416-9e03-408f-a2a7-708e174b719e", "embedding": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6fa2d6e4-5d6d-4b07-a521-2eb3ec602aca", "node_type": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "de0fd26fb5f350e4b38fff6e98e67bae90005457698da574b14e58fee1c8d917"}}, "hash": "0163fb1396e6f664c301682ea0dc3d723982fc2535279a6a8fc0e744d778fb43", "text": "Advanced Topic    What is a start codon, exactly?\nhttps://academic.oup.com/nar/article/45/7/3615/2990259", "start_char_idx": 0, "end_char_idx": 104, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7287c845-6be4-4d0e-b36d-68b2b3875699": {"__data__": {"id_": "7287c845-6be4-4d0e-b36d-68b2b3875699", "embedding": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6c6f8500-d42c-4ffd-9880-6bf8efb96eb5", "node_type": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "f6e976021ab43387f28b40afa4cf74d0b20310e8c40424585e86e700a3f784fe"}}, "hash": "f6e976021ab43387f28b40afa4cf74d0b20310e8c40424585e86e700a3f784fe", "text": "main( ){    printf(\"hello, world\\n\");}\nBrian KernighanProgramming in C: A Tutorial Bell Labs ~1970s", "start_char_idx": 0, "end_char_idx": 99, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8dffb8bf-71f5-412d-9531-a16981cc0e86": {"__data__": {"id_": "8dffb8bf-71f5-412d-9531-a16981cc0e86", "embedding": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2b2afbcf-c5d2-4f9c-a31c-b0623cfa21a7", "node_type": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "239a3c19df37d476a79064f08c4b433da7245bf3a04947ca46f2e1df5e1df9ee"}}, "hash": "239a3c19df37d476a79064f08c4b433da7245bf3a04947ca46f2e1df5e1df9ee", "text": "cell( ){    express(\"your favorite protein\");}\nIntro. to BioengineeringStanford, California2020", "start_char_idx": 0, "end_char_idx": 95, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "43848eed-d46d-44be-ace9-4af55a03b0f2": {"__data__": {"id_": "43848eed-d46d-44be-ace9-4af55a03b0f2", "embedding": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9a87e606-489f-4eca-8b52-5930f9294ecd", "node_type": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "f4682c189326615eada01342780b79283a4f805f0cf4962c983b2009f218b5e1"}}, "hash": "f4682c189326615eada01342780b79283a4f805f0cf4962c983b2009f218b5e1", "text": "What happens when you can\u2019t see and feel, etc?", "start_char_idx": 0, "end_char_idx": 46, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6b3cc094-9dbc-4987-b06d-4482d4fa4187": {"__data__": {"id_": "6b3cc094-9dbc-4987-b06d-4482d4fa4187", "embedding": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f3819c57-c2ad-4fdf-9ee5-1a9cebc0094a", "node_type": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "7b4137b3a22436616bbb5f582b87f1c48a9a493f68464a662a124f26a38fd35e"}}, "hash": "7b4137b3a22436616bbb5f582b87f1c48a9a493f68464a662a124f26a38fd35e", "text": "http://2011.igem.org/Team:Washington/Celiacs/Background", "start_char_idx": 0, "end_char_idx": 55, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3e610083-4be7-4ec2-b526-c86c0f2866dc": {"__data__": {"id_": "3e610083-4be7-4ec2-b526-c86c0f2866dc", "embedding": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "126e3063-fd17-40b2-9763-eb9ca89dd3ce", "node_type": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "56da5725afb4989d52cb19c0791fd8902022fca46c50d4e18676ffe7a81442c3"}}, "hash": "6ebe3bf4c16a59d26ee39f3f38dcc6d896e067a528415b3b621a05a1d61d2a58", "text": "http://partsregistry.org/wiki/index.php?title=Part:BBa_K590087", "start_char_idx": 0, "end_char_idx": 62, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9af7bbcc-5cf0-420d-8925-0a0974b5c077": {"__data__": {"id_": "9af7bbcc-5cf0-420d-8925-0a0974b5c077", "embedding": null, "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4fd7aef3-8287-4b77-86e3-e302dd2e0e1d", "node_type": null, "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "d7826e3bf197bf1b7501f0316bf14bec2474b1851fb63c9671667a45584f2500"}}, "hash": "d7826e3bf197bf1b7501f0316bf14bec2474b1851fb63c9671667a45584f2500", "text": "http://synbiobeta.com/news/igem-startup-pvp-biologics-closes-35-million-agreement-pharmaceutical-company-takeda/", "start_char_idx": 0, "end_char_idx": 112, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7e808ec4-48c7-418c-9d1a-c6d7347df526": {"__data__": {"id_": "7e808ec4-48c7-418c-9d1a-c6d7347df526", "embedding": null, "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "179f7de7-3417-4759-aea1-5af23e617098", "node_type": null, "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "00a73f31f13de72f4a712f52a8298d86238d03c968e09cddfef48720ca0aafa9"}}, "hash": "00a73f31f13de72f4a712f52a8298d86238d03c968e09cddfef48720ca0aafa9", "text": "https://www.geekwire.com/2020/buying-seattle-startup-pvp-biologics-330m-takeda-advance-celiac-disease-treatment/", "start_char_idx": 0, "end_char_idx": 112, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3cf6053b-7f68-4d51-b512-baab4d24abdd": {"__data__": {"id_": "3cf6053b-7f68-4d51-b512-baab4d24abdd", "embedding": null, "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b4c15fdd-cade-41fa-898f-8ce1b3698eda", "node_type": null, "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "bfe77c34aacb7d453b459a0a9405b96dd34fe0c8f034f9ed75cdc612ad9c202e"}}, "hash": "bfe77c34aacb7d453b459a0a9405b96dd34fe0c8f034f9ed75cdc612ad9c202e", "text": "\u201cAn ideal oral enzyme therapeutic (OET) for celiac disease would have the following traits:  (1) optimal activity at the pH of the stomach after a meal (in the range of 2\u20134);(7) (2) resistance to common digestive proteases; (3) facile recombinant production in a soluble form; and (4) specificity for the common proline\u2013glutamine (PQ) motif found in immunogenic \u03b1-gliadin  oligopeptides.(6, 8)\u201d\nGordon, Sydney R., et al. \"Computational design of an \u03b1-gliadin peptidase.\"  Journal of the American Chemical Society 134.50 (2012): 20513-20520.", "start_char_idx": 0, "end_char_idx": 540, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "172c7029-52b2-4eca-a63e-160e141a45d0": {"__data__": {"id_": "172c7029-52b2-4eca-a63e-160e141a45d0", "embedding": null, "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c348d70a-c948-4bbb-adfa-cd8d0584c6bc", "node_type": null, "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "10d995800527d9dcaa56f38bd2b98a0a5dea18c5950cad36eeea1953bc9cfc1a"}}, "hash": "10d995800527d9dcaa56f38bd2b98a0a5dea18c5950cad36eeea1953bc9cfc1a", "text": "Gordon, Sydney R., et al. \"Computational design of an \u03b1-gliadin peptidase.\"  Journal of the American Chemical Society 134.50 (2012): 20513-20520.V119D, S262K, N291D, D293T, G319S, D358G, D368H7 mutations provide solution\u2026", "start_char_idx": 0, "end_char_idx": 221, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ea62c283-6ca9-4350-84b6-139597832f11": {"__data__": {"id_": "ea62c283-6ca9-4350-84b6-139597832f11", "embedding": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "90f05822-ff9e-4dd6-a16f-74811208cea9", "node_type": null, "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "ef574da628a06dbba4867f21a3eb60a8adc4814a4a7bd968c707e75288b22b93"}}, "hash": "ef574da628a06dbba4867f21a3eb60a8adc4814a4a7bd968c707e75288b22b93", "text": "https://biology.stackexchange.com/questions/71272/reading-an-amino-acid-physicochemical-properties-diagram", "start_char_idx": 0, "end_char_idx": 106, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2b478724-1f73-4db3-a6c9-1e2fc3177fa8": {"__data__": {"id_": "2b478724-1f73-4db3-a6c9-1e2fc3177fa8", "embedding": null, "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c2cb36ea-501c-4d7a-94d8-57e04e2abccb", "node_type": null, "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "4242a1aa04902a78f2c5f8b951db404d78de7174ca0ebc82cd04530d699e9598"}}, "hash": "4242a1aa04902a78f2c5f8b951db404d78de7174ca0ebc82cd04530d699e9598", "text": "\u25e6 V119D (not shown) | in propeptide domain, does not affect catalytic activity\u25e6 S262K (S73K) | Likely introduces interaction other residues outside catalytic site\u25e6 N291D (N102D)| Likely introduces interaction other residues outside catalytic site\u25e6 D293T (D104T) | Likely introduces interaction other residues outside catalytic site\u25e6 G319S (G130S) | New H bond w/ Q at P1 position\u25e6 D358G (D169G) | New H bond w/ Q at P1 position\u25e6 D368H (D179H) | New H bond w/ Q at P1 positionGordon, Sydney R., et al. \"Computational design of an \u03b1-gliadin peptidase.\"  Journal of the American Chemical Society 134.50 (2012): 20513-20520.\u201cEats\u201d collagen (PR) v. \u201cEats\u201d gluten (PQ)V119D, S262K, N291D, D293T, G319S, D358G, D368H", "start_char_idx": 0, "end_char_idx": 709, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7c5b19ec-2c2f-4b2a-aa11-83af1ebb7380": {"__data__": {"id_": "7c5b19ec-2c2f-4b2a-aa11-83af1ebb7380", "embedding": null, "metadata": {"page_label": "27", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bad1e53b-3f75-49da-9933-9dfa87803513", "node_type": null, "metadata": {"page_label": "27", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "ef73726f229d97f8e2009f53117821ae5dca7e1a623605cb41ab32b18cf80e85"}}, "hash": "dc20d936e9e6e917a54fd7b006ad1438b7562b530330e27cd3ac43155b18c425", "text": "https://pymol.org/", "start_char_idx": 0, "end_char_idx": 18, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "35b90f3d-cdc3-4b29-829d-761368747c7e": {"__data__": {"id_": "35b90f3d-cdc3-4b29-829d-761368747c7e", "embedding": null, "metadata": {"page_label": "28", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "641565d9-5d94-42d9-8bf5-71065e432027", "node_type": null, "metadata": {"page_label": "28", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "cbe09d3efebbc9b1b15dfabfe45e79af27d39e17f0744eef196a652aa6fa4e41"}}, "hash": "cbe09d3efebbc9b1b15dfabfe45e79af27d39e17f0744eef196a652aa6fa4e41", "text": "Graphic from \"Synthetic Aesthetics\" MIT Press (2014)T o summarize Ingrid\u2019s work\ufb02ow\u2026\nMake variants via DNA synthesis & mutagenesis, express and purify candidate enzymesExperimentally check variants for cleavage activityUsing modeling & simulation tools (PyMol & Rosetta) to suggest mutants that better bind desired substrate motif (PQLP)", "start_char_idx": 0, "end_char_idx": 336, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b907b3c6-c073-42a6-ac1d-d060bf159ab2": {"__data__": {"id_": "b907b3c6-c073-42a6-ac1d-d060bf159ab2", "embedding": null, "metadata": {"page_label": "29", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9e355033-4d36-4402-9ae1-91586cae39c5", "node_type": null, "metadata": {"page_label": "29", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "24208b63a804b77146ff96f14d15c43ca471b42087883d9cb360e8d1f7bffe47"}}, "hash": "24208b63a804b77146ff96f14d15c43ca471b42087883d9cb360e8d1f7bffe47", "text": "https://www.rcsb.org/", "start_char_idx": 0, "end_char_idx": 21, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "99cf3815-df30-4adf-ab85-b18527495274": {"__data__": {"id_": "99cf3815-df30-4adf-ab85-b18527495274", "embedding": null, "metadata": {"page_label": "30", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d844d938-d107-4133-8b6d-943c8f6882e1", "node_type": null, "metadata": {"page_label": "30", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "59c83146c38fc32c5b57ca13bc29d758a44c6d9b518eacc94caa964b2e3f5e93"}}, "hash": "1e02f69944127439051ff6b869c15c0a7c798189155e4de677b23b7edf405aa0", "text": "https://www.rcsb.org/3d-view/1AAY/1", "start_char_idx": 0, "end_char_idx": 35, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ae12aafc-485a-4270-8cb6-7a6f99cc358f": {"__data__": {"id_": "ae12aafc-485a-4270-8cb6-7a6f99cc358f", "embedding": null, "metadata": {"page_label": "31", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "466948df-3193-49dd-aef9-5660f2d1b2f4", "node_type": null, "metadata": {"page_label": "31", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "d491aca4021c6eac3260db859e8c9d7ad1a1243805a613a15a91534a581c155b"}}, "hash": "5336617ad4ec8fb768dc9b992a084aa582a784356786139db8705108d7cb8a18", "text": "https://www.rcsb.org/3d-view/1LLM/1", "start_char_idx": 0, "end_char_idx": 35, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "36535690-c3f3-4b18-be8d-6ef47c81284a": {"__data__": {"id_": "36535690-c3f3-4b18-be8d-6ef47c81284a", "embedding": null, "metadata": {"page_label": "32", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d4ebb80b-57c2-4212-ae89-b7d03fed5808", "node_type": null, "metadata": {"page_label": "32", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "10bc2774c52f67a060f199b77781535317d55766babf72b191fcb70e1898e1a8"}}, "hash": "10bc2774c52f67a060f199b77781535317d55766babf72b191fcb70e1898e1a8", "text": "Smarter!Faster!More!Analysis & design tools(model)  (make)  (measure)\nGraphic adapted from \"Synthetic Aesthetics\" MIT Press (2014)Improving the tools that enable the core engineering cycle (above) is a big part of bioengineering.", "start_char_idx": 0, "end_char_idx": 229, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c6ae5842-961a-4e9e-a470-2430b4aa338d": {"__data__": {"id_": "c6ae5842-961a-4e9e-a470-2430b4aa338d", "embedding": null, "metadata": {"page_label": "33", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e986b28b-65f2-440c-9164-d1771d720e5b", "node_type": null, "metadata": {"page_label": "33", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}, "hash": "f5eed40d07e32360b1da73c617275c22a63eac661eda4ac82d65f89c367706c0"}}, "hash": "392cf150b1d6f04b81b7588c763937804edcc65f86b5537c8374f9a5fe7babc0", "text": "BREAKOUTBetter tools\u2026\n33Based on what you know and have learned so far, what features or wishes do you have for biomolecular analysis and design tools? Hint \u2014 Tr y Framestorm & Brainstorm Skills", "start_char_idx": 0, "end_char_idx": 194, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "bc1441a6-9e2a-48a1-8112-65ef2f2b0daf": {"__data__": {"id_": "bc1441a6-9e2a-48a1-8112-65ef2f2b0daf", "embedding": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b45fa1d8-31d2-4ace-9dbf-2985acbcc01e", "node_type": null, "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "hash": "7f1eca43e99e5ab43a4a9d8170313fcc5475db2a3b24d0af7dd5972f45960244"}}, "hash": "82b57ff865710df3fbebdb75004bb65dce7cd90aa1083e417d4887eb4924badd", "text": "Introduction to BioengineeringBIOE/ENGR.80Stanford UniversitySpring 2020 Class SlidesDay 924 April 2020These slides are made freely available to the fullest extent possible.  Any copyrighted images used herein are used in good faith subject to the fair use exception for education.   Please contact endy@stanford.edu directly re: any copyright concerns.", "start_char_idx": 0, "end_char_idx": 353, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fa4ff336-1a89-4e53-9026-c99c559ad65c": {"__data__": {"id_": "fa4ff336-1a89-4e53-9026-c99c559ad65c", "embedding": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b0a102fd-edb9-4528-8813-817a66edb6ce", "node_type": null, "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "hash": "65fddfdcaf2bb7b87865d6302bb63306cd7c7a703ae8108049fb32dae45b2ffe"}}, "hash": "65fddfdcaf2bb7b87865d6302bb63306cd7c7a703ae8108049fb32dae45b2ffe", "text": "Main claim", "start_char_idx": 0, "end_char_idx": 10, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ad927f5d-f066-4176-9c71-b426db155b63": {"__data__": {"id_": "ad927f5d-f066-4176-9c71-b426db155b63", "embedding": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0d9ab629-dc3a-46f4-a4f1-b274c1d61ecc", "node_type": null, "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "hash": "690d258f4106c1ac20da680d56c044895f8d988e74a318c8d0f1d029ade5b888"}}, "hash": "690d258f4106c1ac20da680d56c044895f8d988e74a318c8d0f1d029ade5b888", "text": "Main Evidence", "start_char_idx": 0, "end_char_idx": 13, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ddadac37-e15e-4cc4-bbb8-e5edc94962c3": {"__data__": {"id_": "ddadac37-e15e-4cc4-bbb8-e5edc94962c3", "embedding": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bbb4e867-9c55-45b4-89a8-110d3cd81088", "node_type": null, "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "hash": "7ae591be7f8583bf795b61f377e191ddd02a0e546dad234026b677eb690fb02f"}}, "hash": "7ae591be7f8583bf795b61f377e191ddd02a0e546dad234026b677eb690fb02f", "text": "How does this genetic system work?\n(oscillator is made of four proteins encoded by four open reading frames; three of the proteins regulate transcription w/in the system)", "start_char_idx": 0, "end_char_idx": 170, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "28e52fc1-9b5b-4e3d-898d-b2dd09d58bbd": {"__data__": {"id_": "28e52fc1-9b5b-4e3d-898d-b2dd09d58bbd", "embedding": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f76b4f24-17e7-49e3-af96-50f841fa4053", "node_type": null, "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "hash": "8e6312565726fef6aaeefb4b744a77cb0eafce9a3ce9140ea6810d15dc59d8bb"}}, "hash": "8e6312565726fef6aaeefb4b744a77cb0eafce9a3ce9140ea6810d15dc59d8bb", "text": "Regulation of gene expression via repressors(for a gene to be expressed an RNA polymerase molecule must bind DNA at a speci\ufb01c promoter to start transcription; repressors block binding at speci\ufb01c operator sites and inhibit transcription)\n(Repressors most-simply work by the principle of two objects cannot occupy the same space at the same time; if a repressor protein is bound to operator sequences interspersed within a promoter, then the RNA polymerase cannot bind the promoter. Note, activator proteins can turn on gene expression by binding to operator sites next to promoters, helping the RNA polymerase to start transcription)\nYOUR FAVORITE GENE\n-10\n-35PROMOTER\nO\nO\nOOPERATOR", "start_char_idx": 0, "end_char_idx": 681, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ce0cdc89-a26e-4b32-8bc7-c2f5e118814e": {"__data__": {"id_": "ce0cdc89-a26e-4b32-8bc7-c2f5e118814e", "embedding": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8b6161e9-28be-420c-9df5-e2cb8f3ddb00", "node_type": null, "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "hash": "69e98fd3d3e7e606b1c8d6b14604a2207eac6f0d7c25570499813012f4928024"}}, "hash": "69e98fd3d3e7e606b1c8d6b14604a2207eac6f0d7c25570499813012f4928024", "text": "Repressor are proteins that bind DNA(we can use biomolecule analysis and design tools to analyze and design DNA binding proteins, as per last class)\nhttps://www.rcsb.org/3d-view/1GFL/1https://www.rcsb.org/3d-view/1QPI/1https://www.rcsb.org/3d-view/1LBG/1https://www.rcsb.org/3d-view/1LMB/1\u201clambda\u201d repressor\u201clactose\u201d repressor\u201ctetracycline\u201d repressorgreen\ufb02uorescent protein", "start_char_idx": 0, "end_char_idx": 373, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "296495c7-b609-4d02-abb6-a7ae55a0e686": {"__data__": {"id_": "296495c7-b609-4d02-abb6-a7ae55a0e686", "embedding": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6aaba0e6-6fc2-4137-9d93-f9e28f1a8f96", "node_type": null, "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "hash": "52e914fdcb1d2355be183d2f21bea82e6f571df5a46883a75fa2d302df60a944"}}, "hash": "52e914fdcb1d2355be183d2f21bea82e6f571df5a46883a75fa2d302df60a944", "text": "How does this genetic system work?\n(when one repressor is highly abundant w/in a cell, the expression of the next repressor will be lowered, and so on.  Because an odd number of repressors have been engineered to form a closed cycle, the system feeds back on itself resulting in an oscillation)\n(what would happen if the system had two or four repressors in a cycle?)", "start_char_idx": 0, "end_char_idx": 367, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2cd52b86-6fc6-4267-b032-284ac54f2bc5": {"__data__": {"id_": "2cd52b86-6fc6-4267-b032-284ac54f2bc5", "embedding": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8144624d-fe3b-430f-9b0b-cb7f09d22a3f", "node_type": null, "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "hash": "c86aef899c5fc0e2d0fe6121ee220536abc7d58e105b19e32947e22d56add9d2"}}, "hash": "c86aef899c5fc0e2d0fe6121ee220536abc7d58e105b19e32947e22d56add9d2", "text": "Oscillations via a movie\u2026\nhttps://vimeo.com/291608242(how soon the cells start behaving differently!  why?)", "start_char_idx": 0, "end_char_idx": 107, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "33bca0c6-2906-448f-9b36-dcb088d7324d": {"__data__": {"id_": "33bca0c6-2906-448f-9b36-dcb088d7324d", "embedding": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dbbd87a3-3925-4eda-b0b4-f6b5997aa555", "node_type": null, "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "hash": "3dcbec1d043d4cb5a04690203ee681f0aa3d623a5a1b6170c500e14c04482eb9"}}, "hash": "3dcbec1d043d4cb5a04690203ee681f0aa3d623a5a1b6170c500e14c04482eb9", "text": "Main claim", "start_char_idx": 0, "end_char_idx": 10, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d122aad4-558e-41f4-9dda-0cc293924b38": {"__data__": {"id_": "d122aad4-558e-41f4-9dda-0cc293924b38", "embedding": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "be11db4e-3d43-4fe4-b75b-d6fd466fd959", "node_type": null, "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "hash": "79f1296e1577f4f8dd814b8f77bded9cf4efbd2443ac9b3cceb4f48b0af2975b"}}, "hash": "79f1296e1577f4f8dd814b8f77bded9cf4efbd2443ac9b3cceb4f48b0af2975b", "text": "Main Evidence", "start_char_idx": 0, "end_char_idx": 13, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "55718dab-2871-4de2-9ac3-ef0eb30823c5": {"__data__": {"id_": "55718dab-2871-4de2-9ac3-ef0eb30823c5", "embedding": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dce594c8-8c6f-46dd-ab57-c708e6af7f54", "node_type": null, "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "hash": "3000dacf3967666eea50ab9d2a4f8c9ec0e13c5125861d3d851f004b001b2caf"}}, "hash": "3000dacf3967666eea50ab9d2a4f8c9ec0e13c5125861d3d851f004b001b2caf", "text": "Cold Spring Harbor Laboratory Press; 3rd edition (April 8, 2004)\nIs this switch digital?  Life = 1; death = 0?", "start_char_idx": 0, "end_char_idx": 110, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "bcd1e528-6eb0-484e-b615-6e544246eac5": {"__data__": {"id_": "bcd1e528-6eb0-484e-b615-6e544246eac5", "embedding": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6fd743f9-6b2a-4993-a587-d1ebc3371876", "node_type": null, "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "hash": "1a9e6a11b1dc545060c33bfc1693e385d125aeed4bc3d75868fd197b0a6aabb7"}}, "hash": "552ff8ddab54d11165168a4f56ec0740f0346993d5bf39af4a2be171160e1c64", "text": "Arkin et al., Genetics. 1998 Aug;149(4):1633-48.", "start_char_idx": 0, "end_char_idx": 48, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f5d9bf1e-e570-460c-9c14-93f169ec21fe": {"__data__": {"id_": "f5d9bf1e-e570-460c-9c14-93f169ec21fe", "embedding": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "73585aa2-0aa6-4c2b-a2cb-d3a7054912ea", "node_type": null, "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "hash": "dd5e56d32dadcbb57c816eeb352a549518e6cdc59041f4e7d8a1b9b409cb1d8c"}}, "hash": "6fe45a25166a3dd5c6111c93ecd40916f4a697cd358d47aaa379d309e34c3bd0", "text": "Arkin et al., Genetics. 1998 Aug;149(4):1633-48.", "start_char_idx": 0, "end_char_idx": 48, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "33485320-eaea-44cf-93ee-2bcb91262453": {"__data__": {"id_": "33485320-eaea-44cf-93ee-2bcb91262453", "embedding": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1092826d-70a7-47fc-b815-a0fec2eca5a2", "node_type": null, "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "hash": "f05981aa4c7ce0295daa459bffe3ee2bbf0a4da54f48e4af001d77909f95268d"}}, "hash": "f05981aa4c7ce0295daa459bffe3ee2bbf0a4da54f48e4af001d77909f95268d", "text": "http://youtu.be/sLkZ9FPHJGMIs life (1) or death (0) random?(answering this question, in general, matters greatly for bioengineers.  why?)", "start_char_idx": 0, "end_char_idx": 137, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d9a0c41b-f874-4282-be09-8c0a144cb90d": {"__data__": {"id_": "d9a0c41b-f874-4282-be09-8c0a144cb90d", "embedding": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a5dcb2cd-9355-4083-8ce6-cdc64275d3b2", "node_type": null, "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "hash": "441894e35f1d2954cd04063d8d1b74736ec3d5425c227a716a969f0022b15989"}}, "hash": "441894e35f1d2954cd04063d8d1b74736ec3d5425c227a716a969f0022b15989", "text": "http://biodynamics.ucsd.edu/", "start_char_idx": 0, "end_char_idx": 28, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fc2c4993-3de8-4c3b-91a5-6399b0d501b7": {"__data__": {"id_": "fc2c4993-3de8-4c3b-91a5-6399b0d501b7", "embedding": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "38d2a0d1-c1e5-4181-a4c6-2483b114b7c4", "node_type": null, "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "hash": "4793a5777e6516a6849bb4137a4f9eacbb4192588193be2fa4606ba1d0ed5c7f"}}, "hash": "4793a5777e6516a6849bb4137a4f9eacbb4192588193be2fa4606ba1d0ed5c7f", "text": "https://www.ncbi.nlm.nih.gov/pubmed/22178928", "start_char_idx": 0, "end_char_idx": 44, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d9cdb572-14db-411d-b9f4-73d5d60af6fb": {"__data__": {"id_": "d9cdb572-14db-411d-b9f4-73d5d60af6fb", "embedding": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4d8006dc-bf0b-4e97-81fe-43f3818136f4", "node_type": null, "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "hash": "a1170dfa17a28c88e21f44609a7a7ccac388c7d2c08bf1a48181d8b3cd026fa2"}}, "hash": "a1170dfa17a28c88e21f44609a7a7ccac388c7d2c08bf1a48181d8b3cd026fa2", "text": "https://www.ncbi.nlm.nih.gov/pubmed/22178928", "start_char_idx": 0, "end_char_idx": 44, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "34078a83-8527-4793-9161-e88fb1b446cd": {"__data__": {"id_": "34078a83-8527-4793-9161-e88fb1b446cd", "embedding": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ec1a898c-61f2-4f2d-aa85-9924745205c9", "node_type": null, "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "hash": "7e48d1accf15f23908509547e32bd801e97e0d795c898fc3118248816cf8bbcc"}}, "hash": "7e48d1accf15f23908509547e32bd801e97e0d795c898fc3118248816cf8bbcc", "text": "http://biodynamics.ucsd.edu/", "start_char_idx": 0, "end_char_idx": 28, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8e173b85-7fcf-448f-8945-38ea7f373dab": {"__data__": {"id_": "8e173b85-7fcf-448f-8945-38ea7f373dab", "embedding": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "998a3f32-8c34-4aac-82ce-5e09116d7dc3", "node_type": null, "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "hash": "58cdf18324dea9fb34e2ed0321d7016530e7d257feee0b91ea69b693effd36f4"}}, "hash": "d00e4da6108ef5cc6274cc6e2a935eafa04d9da301bc3263520daf1cdba55d01", "text": "How can we manage how we think about systems like this?  Abstraction! (Week 4)\nhttps://www.ncbi.nlm.nih.gov/pubmed/22178928", "start_char_idx": 0, "end_char_idx": 123, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e5b05fb9-dc6e-4f95-a156-97b3de323d01": {"__data__": {"id_": "e5b05fb9-dc6e-4f95-a156-97b3de323d01", "embedding": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b0eb98a7-8078-4088-9626-0f0a1a73d54a", "node_type": null, "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}, "hash": "458d0a0d135966e6221ca10a2e7cf84304da040430e7a27eb552ccaa12dbccd2"}}, "hash": "8b8ceb20c1ae5d8a5a449c07bdf8f5eb0409009f7f76ec3708b5700767ff12fc", "text": "How to use tools to analyze natural systems?  Bioinformatics! (Week 5)\nhttps://zhanglab.ccmb.med.umich.edu/COVID-19/", "start_char_idx": 0, "end_char_idx": 116, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4dc97208-bea2-4a78-9841-29ef78f7260f": {"__data__": {"id_": "4dc97208-bea2-4a78-9841-29ef78f7260f", "embedding": null, "metadata": {"page_label": "1", "file_name": "w3ps.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8ac6b4ec-6c2c-4ce7-a6f3-09940035431a", "node_type": null, "metadata": {"page_label": "1", "file_name": "w3ps.pdf"}, "hash": "346169a0b08f6110261df93f58307808fd2c16e6066619f5d27aec04d3928d36"}}, "hash": "346169a0b08f6110261df93f58307808fd2c16e6066619f5d27aec04d3928d36", "text": "title: \"Week 3 Problem setslass\"\npermalink: /docs/w3ps/\nlast_modified_at: Feb.20.2019\n2018: Week 6\ntoc: true\nDUE:\n Next Friday, beginning of class.\nNOTES:\nAll BIOE.80 problem sets must be completed individually unless plainly noted otherwise.\nPlease turn in your completed problem sets as an electronic copy via Canvas.\nPlease make sure to not go over the word limits and when appropriate show your work\n(e.g., calculations).\n(Q1) Patterns with Logic\nYour goal is to engineer patterns in tissues using proteins delivered by the hardware\nplatform shown in Figure-1 (below). The platform itself consists of two channels (purple and\ngreen) through which proteins (ligands) are supplied continuously. A chamber in which\nengineered tissues develop (pink) sits between the two channels. Proteins from each channel\ncan slowly move (diffuse) throughout the developing tissue. When the protein ligands are\nsensed by cells\nwithin the tissue the cells respond according to whatever genetic logic is operating in each\ncell.\nThe concentration gradient of each protein ligand A and B is given in Figure-1. Note that\nvalues of A or B above the dotted line can be considered \u20181\u2019 or \u2018ON\u2019, and values below can be\nconsidered \u20180\u2019 or \u2018OFF\u2019.\nFigure-1\n \nConsider two different genetic logic devices (AND, XOR) that are responsive to proteins A and", "start_char_idx": 0, "end_char_idx": 1325, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9d8d3384-d30b-4823-8f86-7f615b3c725a": {"__data__": {"id_": "9d8d3384-d30b-4823-8f86-7f615b3c725a", "embedding": null, "metadata": {"page_label": "2", "file_name": "w3ps.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "11193413-5dfa-49ed-b554-659fb978048f", "node_type": null, "metadata": {"page_label": "2", "file_name": "w3ps.pdf"}, "hash": "f7288ef4614a29a2a25508db872a605b69d76b73ed1a7aa31b275656fc829b75"}}, "hash": "f7288ef4614a29a2a25508db872a605b69d76b73ed1a7aa31b275656fc829b75", "text": "B as inputs (\u201ctruth tables\u201d or input/output relationship are given for each gate). Sketch the\nexpected output (C) for each device as a function of the A and B inputs (draw on the figure\nbelow if useful).\nHint-1\n For each logic gate use the corresponding truth table.\nHint-2\n Each logic gate takes in two inputs, ligands A and B, then computes some output C to\nrealize a spatially defined pattern across the population of cells (pink).\nFigure-2\n Cells with genetic logic devices-1: AND Gate.\nFigure-3\n Cells with genetic logic devices-1: XOR Gate.\n(Q2) GOOP Tube (30 pts)\nOn Friday you were given two GOOP tubes, one tube of DNA (instruction to express GFP), and\none tube of water.\nQ.2.a.\n When and where did you add the water and DNA-expression to your GOOP tube.\nQ.2.b.\n Did the GOOP with expression instructions turn green (produce GFP)? How long did it\ntake? (Your grade does not depend on the expression of GFP). Include photos of both tubes\nat the start, about 6 hours and after 12 hours. (Time points don't have to be exact. Simply\nreport when you took the photos) Make sure to provide a figure legend.\nQ.2.c.\n Why might certain designs work in GOOP, but not in a cell? Why might certain designs\nwork in a cell, but not in GOOP? (2-3 sentences)\nPlease\ngive\nus\nfeedback.\nDid\nyou\nrun\ninto\nany\nproblems?\n(Q3) Bacterial edge detection (20 pts)\nBuilding on work first published in 2005, Jeff Tabor and colleagues eventually demonstrated a \nbacterial edge detection system. \nIn their system a bacterial lawn (i.e., a uniform layer of", "start_char_idx": 0, "end_char_idx": 1533, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b44c52cc-9444-4da4-a9bb-fc25b0a86e45": {"__data__": {"id_": "b44c52cc-9444-4da4-a9bb-fc25b0a86e45", "embedding": null, "metadata": {"page_label": "3", "file_name": "w3ps.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba6ae197-583e-41a3-acaa-e34f13ecd4a8", "node_type": null, "metadata": {"page_label": "3", "file_name": "w3ps.pdf"}, "hash": "e08f116ee7666e296c590cfe38865f26c9a2350c104d31a1a42921664c201404"}}, "hash": "e08f116ee7666e296c590cfe38865f26c9a2350c104d31a1a42921664c201404", "text": "identically engineered \nbacteria growing on a plate) detect a light-encoded image. \nThe bacteria are initially all the\nsame but, \ndepending on whether they are exposed to light or not, send or receive small molecule-\nencoded signals that diffuse \nacross the light/dark boundary. \nOnly cells positioned at the boundary between light and dark\nexpress an enzyme that \nresults in formation of a dark pigment (HINT: see Figure and also the primary \nsource\n)\n3.a. \nDevelop a device-level block diagram\n that would result in the so-shown behavior. Label\nsimple sensors, logic blocks, and actuators, as needed. \nConnect outputs to inputsif and as\nrequired. (Hint: \nOnly give simple device names (e.g., \u201cDark sensor,\u201d \u201cpigmentactuator\u201d etc.);\ndo not describe any biology in any molecular detail). \n(30 points)\n3.b. Take a look at the photo of the system in action. Note the edge detection in the case of\nasquare or Alfred Hitchcock\u2019s portrait. \nWhat do you observe?\n For example, why is there more\npigment inside the corners of the square, or inside the bottom left angle of Alfred\u2019s portrait?\n(bullet points, 10 points)\n(Q4) Approximate and rapid numerical estimates (40\npts)\nApproximations based on simple physical principles are known as Fermi problems. These\nproblems will help you build quantitative intuition for working with biology. Most of these\nestimates are rough: they are designed to give you a broad, order of magnitude intuition for\nthe biology, so keep in mind that that the exactly correct number could be different. Give your\nanswers to two significant figures and provide units where appropriate. You should only need\nsimple math and arithmetic; a couple of lines of work at most.\nAdditional resources: bionumbers is an excellent source for biological numbers \nlink\n . \"\nCell\nBiology\nby\nthe\nNumbers\n\" is a great book on estimation problems in biology. You can get a free\ncopy of the draft version \nhere\n.\nEscherichia\ncoli\n (\nFigure 1\n) is well-studied bacteria considered to be representative of how\nbacterial systems work generally (i.e., a 'model' organism). \nE.\ncoli\n is also easy to grow in the\nlab and divides rapidly (about 20 mins). As a result, \nE.\ncoli\n is frequently used in bioengineering\neither as a model organism (to be studied or engineered directly) or as a host to generate large\ncopies of user defined DNA. You will see (and setup your own in BIOE44) cultures tubes of \nE.\ncoli\n (with medium - food for bacteria) often growing overnight on shaking incubators (set to\n37C) (\nFigure 2\n).", "start_char_idx": 0, "end_char_idx": 2513, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "12ea6f5d-c178-44b8-8c1e-aba71d4e718b": {"__data__": {"id_": "12ea6f5d-c178-44b8-8c1e-aba71d4e718b", "embedding": null, "metadata": {"page_label": "4", "file_name": "w3ps.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a86d8f41-431b-418a-876e-738034e77aa2", "node_type": null, "metadata": {"page_label": "4", "file_name": "w3ps.pdf"}, "hash": "bfc030c43521d51b2fd41e4a5ad9fb15edd3f20c4a796545348c682fb8ed0763"}}, "hash": "822453318b496f8bdd4f76183e5294f1aaf5cc335a054cac373300b3422cb5f7", "text": "Figure 1\n. \nE.\ncoli\n is shaped like a rod, which we can approximate as a\nspherocylinder: a cylinder with hemispherical caps. Of note, MG1655 is a\nstrain derived from a lineage of \nE.\ncoli\n variants that was originally isolated from\na diphtheria patient at the Palo Alto hospital in 1922. \nSource TBD\nFigure 2\n. \nE.\ncoli\n grown to saturation (after 8-12 hours). \nE.\ncoli\n divides about\nevery 20 mins. \nSource: Cell Biology by the Numbers\nQ.4.a.\n Based on a spherocylinder model, calculate the volume of an \nE.\ncoli\n cell.\nQ.4.b.\n If an \nE.\ncoli\n cell were the size of a building, how big would a water molecule be?\nQ.4.c.\n The mean diameter of a protein is roughly 4 nm. What is the upper bound on how many\nproteins could fit inside an \nE.\ncoli\n cell?\nQ.4.d.\n How would you go about estimating the total number of carbon atoms in an \nE.coli\n cell?\nYou don't have to calculate this just define variables and describe your approach step by step.\nExtra learning\n (100% optional):\nIf you want to explore more re: a different type of DNA logic mentioned briefly in class,\npleasecheck out this video from Prof. Endy on how to to engineer Boolean integrase Logic\n(BIL) gatesbased on DNA flipping\u2026 \nTranscriptors & Boolean Integrase Logic (BIL) gates, explained\n(Q5) Ring Oscillator (0 pts)\nHere is a system level diagram of a 3-inverter Ring oscillator. Think back to the class on\nWednesday, imagine that you are a system's level \nBioengineer\n designing an oscillator\u2026\n5.a. What is an ideal inverter from a systems level perspective? (bullet points and a simple\ndiagram to describe inputs and outputs for the inverters) (5 points)\n5.b. Provide an example of a bad design choice, from system's level view, for these inverters?\n(Ring oscillator should still work) (5 points)\n## (Q6) \nBuggy Bacterial Flash Mob? (0 pts)\nStudents at MIT are claiming that they have designed a genetic program to realize", "start_char_idx": 0, "end_char_idx": 1890, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8118a288-8659-4620-ba33-666b97a3cb56": {"__data__": {"id_": "8118a288-8659-4620-ba33-666b97a3cb56", "embedding": null, "metadata": {"page_label": "5", "file_name": "w3ps.pdf"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "087c9eb8-b802-478b-a328-100010ddae24", "node_type": null, "metadata": {"page_label": "5", "file_name": "w3ps.pdf"}, "hash": "4462f4a7bc32f688e9260e046f37e6ec3404d7d3890055ba59a0c260506280f4"}}, "hash": "4462f4a7bc32f688e9260e046f37e6ec3404d7d3890055ba59a0c260506280f4", "text": "arepeating bacterial flash mob. \nSee their work yet again via:\nPolkadorks, iGEM-2006\nIn an epic East Coast versus West Coast technology \u201cbattle,\u201d some of your colleagues\nare now claiming that the genetic program designed at MIT won\u2019t actually produce the\nso-desired behavior. \nLooking only at their proposed \u201cdevice-level system diagram\u201d\u2026\n1.a. What do you think? \nWill their program work or not? \n(10 points)\nYES or NO (circle one)\n1.b. Why or why not? (bullet points) (10 points)", "start_char_idx": 0, "end_char_idx": 480, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6d6a2116-40c6-43d3-a908-837714912ed9": {"__data__": {"id_": "6d6a2116-40c6-43d3-a908-837714912ed9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "64c87987-c398-47fd-bdea-9ecb541e4b90", "node_type": null, "metadata": {}, "hash": "5fa02928458f8455c7dd8faa9cd60a227a539a7e9e1ebfd7f3dea10401e7ad9b"}, "3": {"node_id": "9bc9b730-2649-45ac-b008-0b74f44c5c9e", "node_type": null, "metadata": {}, "hash": "ae24c33de3798b843b1e46598663f06f45843acfe88af4ec98855ac816569233"}}, "hash": "0384698f1ff97ec414ec08d0ef9d5d793ccb25d56157df6d7e664c11f17de64a", "text": "Hey there! Welcome to Introduction to Bioengineering at Stanford University. Did you know that bioengineering is the newest engineering major here at Stanford? Yeah, it's the first major to get introduced since 1960, and that other major was computer science, which has been a pretty big deal. Yeah, I guess. I mean, computers are important, but they only deal with bits, you know, and biology deals with bits and atoms, the stuff of life. And, you know, that's what bioengineering is about. Now, of course, as the newest major, what does that mean? How old are we? 19? We're not that old. We're 18 years old, like a lot of you, perhaps. That means you're part of the first bioengineering generation. And we want to help you shape this bioengineering discipline. We want for you to become bionauts. Bionauts? Yeah, you know, like astronauts, but for biology. By learning about bioengineering, we hope that you get the option of becoming a leader or an adventurer who can shape a future and do good in a future that's increasingly biotic. Hmm, I like how that sounds, a biotic future. Well, that's the framing of the course, but how's the course gonna work? How are you gonna experience it? How are we gonna motivate all this hard work of learning? The first thing we're gonna do is we're gonna introduce you to bioengineering from accessible and pressing and important problems, things like cancer. What can bioengineers do about cancer? Cancel it. Sounds good. How about infectious disease? Make a mousseline. Mm-hmm. Bioengineers, could we help with the food supply? Yeah, they should make nutritious and cheap food for everybody. Let's see, bioengineers, could we work with the doctors and medicines? Yeah, let's make new medicines. Cure all the diseases. Every disease? Yeah, all of them. All right, so what about nature? I hear things are going extinct more than ever before. Well, let's fix that. How are we gonna fix that? I know medicines for our endangered friends. Oh, medicines for animals? Bringing things back from extinction? Oh, also that. Okay. Bioengineering beyond humans. Anyway, you get the idea. All these topics you're gonna experience through this course and we'll use these topics to motivate your learning around fundamental tools and skills in bioengineering. Yeah, but here's where it gets really neat. You're gonna learn some fundamental tools, things like how to manipulate and design DNA so that you can have an impact on all these different areas. There's a nice through line through bioengineering that allows you to make an impact in a lot of different spaces. Because when you learn how to engineer biology systematically, it's sort of like learning how to program a computer systematically. You know, you could write a program for music or financial analysis or planning a bus route. You know, that skill set needed to program a computer is agnostic with respect to the applications. The same thing's going on today in bioengineering. By learning the fundamental skills and tools needed to work from inside cells out, you get a general-purpose capacity to partner with biology to solve problems. Now, by the end of this class, we hope that you'll have an understanding of the enormous impact that bioengineering is already having on people and the planet. We want you to learn how to read, understand, and debate what's happening in bioengineering so that you can be a leader and a citizen about all things related to biotechnology. One of the parts of the class that's super important is because bioengineering is young, most of what you could do with it hasn't been imagined. Yes, we have plenty of compelling examples to help you learn, but most of what could be done in the future with bioengineering over your lifetime, nobody's imagined. And so an essential part of this course is you will have a project where you get to imagine what bioengineers could do. Something that's relevant to you wherever you are and how you see the world and what you wish the world to be. So this course project towards the end of the quarter will be a really essential and exciting component for the course. We're really excited to be your guides on", "start_char_idx": 0, "end_char_idx": 4171, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9bc9b730-2649-45ac-b008-0b74f44c5c9e": {"__data__": {"id_": "9bc9b730-2649-45ac-b008-0b74f44c5c9e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "64c87987-c398-47fd-bdea-9ecb541e4b90", "node_type": null, "metadata": {}, "hash": "5fa02928458f8455c7dd8faa9cd60a227a539a7e9e1ebfd7f3dea10401e7ad9b"}, "2": {"node_id": "6d6a2116-40c6-43d3-a908-837714912ed9", "node_type": null, "metadata": {}, "hash": "0384698f1ff97ec414ec08d0ef9d5d793ccb25d56157df6d7e664c11f17de64a"}}, "hash": "ae24c33de3798b843b1e46598663f06f45843acfe88af4ec98855ac816569233", "text": "essential and exciting component for the course. We're really excited to be your guides on this journey from where you are now to the bio frontier. How about us? Who are we, you might be wondering. Jen, what about you? Well, I'm Jen Brophy. I'm an assistant professor at Stanford and I teach classes, as you can tell, but I also run a research lab. In my lab, we engineer bacteria and plants in order to try to make them more resilient to climate change. I got interested in this when I was in college where I read an article in the school newspaper about people trying to engineer biofuels and bacteria and I thought that was really cool. It got me interested in bioengineering and that desire to make a difference in sustainability has been motivating me ever since. So cool. I am Jen's colleague, Professor Brophy's colleague. My name is Drew Endy, also a professor here in bioengineering at Stanford. I love teaching this class, mostly because I can't wait to see what you're gonna imagine to do with bioengineering to make the world more awesome. I don't grow up in California. I grew up in Pennsylvania. I love nature, but when I was a high school student, I really struggled with biology. I hate memorizing things. Like, oh my gosh, it just wasn't for me. But I do like to build things and I do like to understand how things work. You know, I thought I was gonna become a civil engineer and work on roads and bridges, but over time what I learned is that the best way to build something is to grow it. Biology is nature's builder. Anywhere on the planet you can work with life to grow something with atomic precision into some big structure or whatever you want. And so that's why I've become a bioengineer and, you know, gives you some sense of why this class is so exciting to me. In any case, the class is about you and Professor Brophy and I are really excited to be able to work with you over the next few months to introduce you to bioengineering. Yeah. Bionauts assemble!", "start_char_idx": 4081, "end_char_idx": 6066, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ae4edda3-09d7-465d-9a98-18995fd68954": {"__data__": {"id_": "ae4edda3-09d7-465d-9a98-18995fd68954", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0507fe5c-5eb7-4339-88b6-c0851636e608", "node_type": null, "metadata": {}, "hash": "7bffc83e6fa57e7885feaf78ab96f60521f854ddadaf67776149cfe6f8e72285"}, "3": {"node_id": "d6aed060-8f63-4d62-a893-6fe3e0e50feb", "node_type": null, "metadata": {}, "hash": "fe1834cd9e686a32cfe85ea6ebebcae8893f81d357f787c299ff188e80b262eb"}}, "hash": "54b1871bbf3d41792bb56acd337d855b0d4c6bc25a4b4d52de4b762195b246e4", "text": "My name is Ahmed Best. I don't necessarily have a title, I mean a professor maybe is probably the closest academic title that I have. I'm an artist, and I come at bioengineering from the storytelling world. And it really is, and I always tell this to Drew like I didn't go to school for science but I love it so much that I call myself like a science hobbyist, and most people look at hobbies like, you know, building model ships or, you know, saying that I learned how to play the guitar. I'm really more about like diving into some, some serious scientific ideas and and professionally. I try to be as communicative as possible when it comes to science when it comes to talking to people about it. I tend to live in these two worlds of, you know, as an artist, as a performing artist and somebody who does like film and TV for a living and theater for a living and games you know I also write and direct video games. I have an ability to communicate scientific ideas, emotionally, and be able to get across those ideas by scientists. So people can understand what they're passionate about, you know, a lot of times when we talk about science we talk about scientists we're talking about the opinions of the data, right, what through the science and not the passion of why scientists actually started doing this in the first place, right. So scientists are really kind of reduced to these people who spit data and there's just so much more to it than that. When it comes to bioengineering, especially when it comes to like the reason why I know you and the reason why Drew Endy is such a dear friend is because the way Drew comes out bioengineering is so incredibly creative and accessible and it doesn't frighten you, it excites you and every time people talk about biology or bioengineering or synthetic biology everyone gets afraid, right. And so talking to Drew you're more amazed, you're more fascinated, and you're more afraid and I just want to amplify that message, you know, especially when it comes to talking about things as important as bioengineering. You know I've always loved, I've always loved science since I was a kid, you know, I grew up in New York City, I was a very nerdy kid, I read a lot of comic books, but I really, all my science classes from elementary school were my favorite classes. And I remember, you know, I'm a slight bit older than you, but I remember when my science teacher in fifth grade wheeled a computer into the room and I was hooked, I was hooked. Ever since I first saw it, right, and it was a Commodore PET, I don't know if anybody even knows what the hell, this was like before the Commodore 64, which was like the computer of the 80s, right, but this was like a Commodore PET and the first language that I learned was called BASIC, I don't even know if BASIC even exists anymore, but I remember like doing this really super simple string scripts in BASIC and it was just my name, you know, I would just put my name in there and then the entire screen like filled with my name and it scrolled infinitely and I was just amazed, I loved it, I loved every minute of it. And so I just wanted to be a part of whatever was going on and, you know, computer science was the science class, right, and then when I got to high school it was like physics and I was just blown away by physics and I wanted to go into physics, if it wasn't for like music and acting really called me because I was going the science way, right, and when I was in high school they made you choose and I didn't want to choose, you know, I really wanted to do it all because I saw the relationship between science and the arts and, you know, historically back in the ancient times it was the same thing, you know, artists and scientists were one in the same and it wasn't until, you know, a lot later in the like, you know, late 18th, 19th century that it got separated into these two different schools of thought, right, but I always kept a little toe in the science world, you know, I always had friends who were scientists, I always talked to them, I'm intensely like curious, I always want to know something, I'm always fascinated by", "start_char_idx": 0, "end_char_idx": 4151, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d6aed060-8f63-4d62-a893-6fe3e0e50feb": {"__data__": {"id_": "d6aed060-8f63-4d62-a893-6fe3e0e50feb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0507fe5c-5eb7-4339-88b6-c0851636e608", "node_type": null, "metadata": {}, "hash": "7bffc83e6fa57e7885feaf78ab96f60521f854ddadaf67776149cfe6f8e72285"}, "2": {"node_id": "ae4edda3-09d7-465d-9a98-18995fd68954", "node_type": null, "metadata": {}, "hash": "54b1871bbf3d41792bb56acd337d855b0d4c6bc25a4b4d52de4b762195b246e4"}, "3": {"node_id": "3985d5b7-45ad-4fb1-a5e3-905b8d881841", "node_type": null, "metadata": {}, "hash": "f83f03b60974b9836692af19dfef86d59c8f124e167944dd03a8c486ad842ea2"}}, "hash": "fe1834cd9e686a32cfe85ea6ebebcae8893f81d357f787c299ff188e80b262eb", "text": "like curious, I always want to know something, I'm always fascinated by things and I love learning, like I'm a huge learner, so I get science newsletters every five minutes and I always have. It wasn't until, it wasn't really until COVID-19 dropped when I was just like somebody has to say something about this and I had been doing a lot of work with the National Academy of Science. I was doing, I do, I host events for the National Academy of Sciences Science and Entertainment Exchange, right, which is, it's a small department in the National Academy of Science that provides scientists with storytellers, right, so all the hard science that's in every movie that comes from the Science and Entertainment Exchange, right, so they connect scientists and movie producers, movie writers, artists, and so on and so forth, and so I started hosting events with the Science and Entertainment Exchange and I realized that a lot of scientists were not really good at talking about what they're doing and talking about it in a way that makes you feel why it's important, right, they can, they can talk about the data and they can tell you statistically why it's important, but you know what they don't tell you is how they feel about what they're doing and how they feel about your opinion of what they're doing, and so when COVID-19 came around and everybody had this enormous like mistrust of scientists, specifically like biologists, biologists, epidemiologists, I recognized that there was a little bit of a gap in the translation between the data, the scientists, and the rest of the people, and so that's when I kind of really jumped in and I was like, I speak these languages, I can speak both languages, I can understand enough to translate the science into something that's accessible and entertaining and fun, and that's when I kind of really jumped in. Yeah, I mean personally I believe that as an artist and as an artist who is inherently an optimist, it really is important for me to see that optimistic future, right, it's really important for me to help create that optimistic future, right, and I was a ridiculous Star Trek fan, right, so for me it's always been like I want to live in that world, like how do we make that happen, you know, how do we make replicators happen, how do we make tricorders happen, how do we make starships happen, right, and I think everyone who's seen a Star Trek and picked up something and invented something that reminds them of Star Trek, I think they have that same feeling, which is like we can do this, you know, one of the things that I loved about Star Trek is there's no money, nobody ever talks about like taxes, nobody ever talks about finance, and you know they go well we don't do money anymore, like we don't need it, you know, the wealth is in human experience, exploration, and learning, like that's currency, you know, and it sounds good, and when you think about it like oh in the future, in 100 years, in 200 years, we're going to have that, right, but who's thinking about how to get there, you know, who's thinking about what are the steps it takes to get to that place, scientists are, you know what I'm saying, like that's who's thinking about it, it's like artists and scientists, we're the ones thinking about that kind of stuff, how do we get to Star Trek, which is why when it comes together you have wonderful things like smartphones and VR headsets and tablets and, you know, the internet, you know, because we are trying to get to, you know, deep space, you know, we're trying to be able to explore that. Now when it comes to bioengineering, like the thing that Star Trek really doesn't talk about too much is sickbay, right, like I have, I wrote this whole thing that one of these days somebody's gonna buy from me and it'll be on some kind of a network, but I wrote a whole Star Trek show called Starfleet Medical, right, and it really is about the bio side of the federation, because nobody talks about how there's no cancer anymore, you know what I'm saying, like they look at these diseases in Star Trek and they just go let's do", "start_char_idx": 4092, "end_char_idx": 8197, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3985d5b7-45ad-4fb1-a5e3-905b8d881841": {"__data__": {"id_": "3985d5b7-45ad-4fb1-a5e3-905b8d881841", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0507fe5c-5eb7-4339-88b6-c0851636e608", "node_type": null, "metadata": {}, "hash": "7bffc83e6fa57e7885feaf78ab96f60521f854ddadaf67776149cfe6f8e72285"}, "2": {"node_id": "d6aed060-8f63-4d62-a893-6fe3e0e50feb", "node_type": null, "metadata": {}, "hash": "fe1834cd9e686a32cfe85ea6ebebcae8893f81d357f787c299ff188e80b262eb"}, "3": {"node_id": "2273510c-3b45-485e-aa6d-1fb84a4dfa8e", "node_type": null, "metadata": {}, "hash": "e0ae80fd4ff625d9148380e7c37d046ccb077c296ee0e9dbefa28761b4befa68"}}, "hash": "f83f03b60974b9836692af19dfef86d59c8f124e167944dd03a8c486ad842ea2", "text": "like they look at these diseases in Star Trek and they just go let's do that, synthesize that, make, and then all of a sudden there's a hypospray and it's like done, like no sickness anymore, you know, the whole bio side is like, oh we figured that out, like we figured how that, you know, synthesize these elements, put them together, hypospray, they don't even put it in arms, you know, it's like over clothes, you could be wearing like a down jacket and it's like, no, I'm cured, you're cured, you know what I'm saying, how do we get there, right, and if somewhere along the line, creating the federation, we all started trusting biology, you know, somewhere along the line, we all started trusting the fact that people have our best interests at heart when we're creating these things, right, but I think a lot of it is because there's a lot of mythology, especially in the west, around who we are, you know, how we got here, what are we made of, you know, and the mythology takes over from the research, the mythology takes over from the facts and I don't think people really understand that there are disciplines in science and science is not a religion, you know what I'm saying, like science is a method, it's a way of doing things, right, the same science that built the smartphone is the science that did the corona vaccine, right, and it's not because it's bioengineering and, you know, computer software and hardware engineering, it's like the steps that it takes to find the answers are the same and I don't think the community writ large really understands that it's the steps, right, and not necessarily the disciplines, so we have to make sure that everybody knows that we are all taking the same steps towards best interests. I think we also have to let everyone know that biology is not scary and that is only going to come if we give agency of our biology back to us. There's so much about our biology that we don't know for a reason, right, and our biology has become industry and, you know, Drew and I talk about this all the time, we always talk about how everyone should have the right to their own DNA, you know, we talk about how everyone should be able to print DNA in their living room or in their kitchen, right, we should all have, we should all have access and right to DNA, but there are some things about DNA that we don't talk about or we don't understand because it's not given to us, we have to go to Stanford or take a course like this and get that information where in actuality it should be every day, like we should all know what our DNA does, we should all be able to have access to our personal DNA information, we should all be able to know that, you know, where it comes from, how we create it, what makes us us, how to read it, we should be able to read the, you know, A's, C's, G's and T's just like we can read websites, you know, it should be bad accessible, but because of industry it's kept from us so that I can understand how there could be distrust and mistrust because when we start thinking about DNA, especially our DNA, we're all of a sudden we start talking about the pharmaceutical industry, we start talking about the medical industry, we're not talking about DNA anymore, now we're talking about systems, right, the systems have nothing to do with the biology, you're trusting or distrusting the systems, right, the biology ain't do nothing to you, you know what I'm saying, the information doesn't do anything to you, but the systems do, so regardless of, you know, how you feel and where you stand on it, what we don't trust and what needs to be articulated, it has nothing to do with the DNA, it has everything to do with the systems in place that keep our DNA information from us. For me, it first starts with this idea that science is awesome, like I love the awesomeness of it and I'm blown away by it, right, I'm blown away by it, I'm blown away that this series of steps can get you to innovations that can change everything, all of us, you know, it's really amazing, it's really awesome, it's really", "start_char_idx": 8201, "end_char_idx": 12269, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2273510c-3b45-485e-aa6d-1fb84a4dfa8e": {"__data__": {"id_": "2273510c-3b45-485e-aa6d-1fb84a4dfa8e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0507fe5c-5eb7-4339-88b6-c0851636e608", "node_type": null, "metadata": {}, "hash": "7bffc83e6fa57e7885feaf78ab96f60521f854ddadaf67776149cfe6f8e72285"}, "2": {"node_id": "3985d5b7-45ad-4fb1-a5e3-905b8d881841", "node_type": null, "metadata": {}, "hash": "f83f03b60974b9836692af19dfef86d59c8f124e167944dd03a8c486ad842ea2"}}, "hash": "e0ae80fd4ff625d9148380e7c37d046ccb077c296ee0e9dbefa28761b4befa68", "text": "us, you know, it's really amazing, it's really awesome, it's really awesome that we figured this out as human beings, you know, one chromosome away from the lesser primates, right, the lesser quote-unquote primates, but we got it, like we figured it out and it's fantastic and there's everything that, the reason why I can make the films that I make or the the things that I make, the creativity that I make and you can feel it, it doesn't exist without somebody coming up with a medium that can distribute it, right, even we're talking about theater, like somebody had to come up with lights, you know what I'm saying, and you know, a room that you can have sounded and, you know, a way to the, you know, the mathematical angles of a rake of a stage, so everybody can see what's going on, like it's all integrated, it's all a part of it, which is why I'm not big on like separating the arts and the sciences, I think, you know, as a collaborative system, we can, it needs to work together, but the first thing I have is like this idea of like exponential creativity and imagination, I want to see the future now, you know what I'm saying, and the best way for me to do that is to speculate on what the future could be, right, and so you'll come up with this ridiculous idea and you'll talk to a scientist and they'll be just like, oh, okay, we can do, you know what I'm saying, like we might not be able to do it today, but I definitely see a future in which that can be done, right, Drew has this really good talk on purple mucus, you ever hear him talk about this, pretty dope, it's pretty dope, right, you know what I'm saying, like he said, imagine if you have an ailment, right, yeah, and the color of your mucus can tell you what kind of ailment you have, right, so say you have COVID and your mucus is purple, you automatically know that you have COVID, you can go get treated, right, yeah, unreal, that is unbelievable, right, but from a bioengineer standpoint, bioengineers are just like, oh yeah, we can make that, let's make that, right, and so me as an artist, as a writer, as a director, as a creator, right, I can go, hey, let me write something that has purple mucus in it, right, and take away the fear, take away the stigma, because you see a story with that in it, you'll be like, oh, wow, this is something, right, can, is that really possible, and then you find somebody who can go, hey, yeah, we can do that, okay, let's do it, and then all of a sudden, like, we're all on the same page, moving towards the future together, right, but really the only way out of all of the scare is to make stories, it's the only way, we can't data our way out of it, we can't infotech our way out of it, we have to create narratives around it, so people can emotionally and tangibly embrace the ideas, and not be afraid of the ideas, the lack of information and the lack of creativity creates the fear, right, making things a lot less accessible creates the fear, the not knowing makes you fearful, as soon as you know, you're just like, oh, I know what that is, I don't have to, you know, I can just go forward, you know, I once saw, I was looking at a website, and I was talking to a bioengineer, and he was talking about, he put up on the screen, the DNA makeup of anthrax, and he was like, oh, you can make anthrax.", "start_char_idx": 12259, "end_char_idx": 15584, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "202b0011-9f12-4828-b7e7-351693fcd282": {"__data__": {"id_": "202b0011-9f12-4828-b7e7-351693fcd282", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f869ac5d-b608-49e6-b0ed-9106387e6c41", "node_type": null, "metadata": {}, "hash": "8d50df0d6555a78a0f72a99a2c11e0884a446b46eae01ba9999b07f39734c9fc"}, "3": {"node_id": "c0297a94-d151-40fb-891d-6df53182ecab", "node_type": null, "metadata": {}, "hash": "1ee6d32b4d6872347809ea578006064a0a8440cc0382f12e6e3de2b62ad26625"}}, "hash": "8fc05c0b17be59ef5df8508ab6dd88445c81ccf1c96c40101a41bc32713c4c20", "text": "in your fucking bedroom. You know what I'm saying? Like, here's the, here it is. Here's the DNA, right? And the way he talked about it, I was just like, oh, okay, that's cool. And it moved on, right? But the way this narrative gets weaved, anthrax available in your bedroom, news at 11, right? You know what I'm saying? Like, it's not the thing that we're scared of, it's the story, you know? The story that we're being fed is what puts us in fear, right? This whole Halloween, everybody was talking about fentanyl in your Halloween candy, more at 10. There was not nearly a fentanyl anywhere trick or treat-wise, nowhere, right? But the story, because it hits that reptilian part of our brain, right? The story makes you go, Halloween candy, fentanyl, them damn scientists are up to it again. You know what I'm saying? Like, that's not what it, that's just not the reality of it, you know? That's not the reality of it. But the hard part is like, scientists don't really know how to say, what the fuck is wrong with y'all? Like, we don't want, we don't spend 20 years after high school sitting around trying to kill everybody. Like, that's not what scientists do. Like, it's just, you know, you're talking about very introverted people who like to sit at a desk looking through microscopes. Like, that guy is not dangerous. You're not the Joker. You know what I'm saying? Like, it just doesn't, no scientist that I've ever met has been like, now I know, you know, I can eradicate the entire world. It's more like, oh, I found a new bacteria. Ain't that cool? You know? But it really is about being just completely in wonder of the things that we can do and make, and building stories around that, you know? And building stories around that and getting that word out there. That's why Star Trek is so influential, you know? Star Trek is Star Trek because they were just like, we got, we figured it out and now we're in, you know, the Alpha Quadrant. You know what I'm saying? Like, we out there. Yeah, a couple of things. One, I think we should have cool hunters out there who find, like, cool things about science and bring them to us, right? Because I think, especially as for bioengineers, the arts is a perfect way to get that message out, right? Because materials are expensive. And if you have access to cheaper materials that are sustainable, that last longer, that's going to completely change the game, right? I think a great way to come about bioengineering is food. And we don't really look at food as bioengineers as a way into bioengineering. I think developing specifically, like, kitchen appliances that turn bioengineering into, like, everyday practices would help the narrative and it would help get people interested and it would employ a lot of bioengineers, right? Because you can start thinking about ways to, like, you know, engineer a steak and save a cow. You know what I'm saying? Star Trek, the replicator was like, that changed everything, right? The fact that you can create these objects from nothing, right? From just create, you know, mass out of no mass, right? Create matter out of antimatter, right? That's the dream. Let's start making things that we can put in our world that kind of moves us towards replicators, right? Let's have 3D printers that can build us our mushroom shoes, you know what I'm saying? In the crib. Now, right now, it might take three days to build one shoe, right? The way we distribute the pattern of the shoe is you're buying the creativity, right? You're buying the pattern and you're downloading the pattern and the material is mushrooms. You just throw mushrooms in the hopper and in three days, in a week, you have a brand new pair of Jordans, you know what I'm saying? Like, those kind of ways to turn that bioengineering into, like, these everyday kind of things is the way in, I think. The first thing that's blowing me away,", "start_char_idx": 0, "end_char_idx": 3893, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c0297a94-d151-40fb-891d-6df53182ecab": {"__data__": {"id_": "c0297a94-d151-40fb-891d-6df53182ecab", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f869ac5d-b608-49e6-b0ed-9106387e6c41", "node_type": null, "metadata": {}, "hash": "8d50df0d6555a78a0f72a99a2c11e0884a446b46eae01ba9999b07f39734c9fc"}, "2": {"node_id": "202b0011-9f12-4828-b7e7-351693fcd282", "node_type": null, "metadata": {}, "hash": "8fc05c0b17be59ef5df8508ab6dd88445c81ccf1c96c40101a41bc32713c4c20"}, "3": {"node_id": "e8a86fe0-30a4-49c8-9412-446acf5b604d", "node_type": null, "metadata": {}, "hash": "050ba6da3cedd08679a9a4bbff6583738b6860dfc336c79caabac80fc2e30f93"}}, "hash": "1ee6d32b4d6872347809ea578006064a0a8440cc0382f12e6e3de2b62ad26625", "text": "of things is the way in, I think. The first thing that's blowing me away, I have to say, like, the COVID vaccine was pretty huge. It was pretty huge. I mean, I can't talk about it enough. That is just a feat of science that is kind of a once-in-a-lifetime thing and it happened in such a unique and collaborative way. Like, you know, a lot of people aren't in rooms with a lot of professional scientists, but it's kind of crazy, you know? Like, every scientist thinks the other scientist isn't doing enough in their science. Every scientist thinks that their research is better than the other scientist's research and so there's this yelling back and forth of, like, you think you can do my job, you know what I'm saying? And it's this volatile, like, very kinetic, very adversarial space, right? But when it's time to make something, everybody shuts up, puts all their data in the pool, and they make the thing, right? So for the COVID vaccine to get out there as the way it did and how it did is pretty Herculean, you know? It's pretty Herculean, especially this idea of mRNA and they were just like, let's try that, you know what I'm saying? Like, messenger RNA was just a really creative idea, you know? It was a really, really creative idea and everybody else is thinking that we're trying to make designer babies. Like, that doesn't... A, we're already doing that. We don't need DNA synthesis to do that, you know? We do it in the club. You do it at the bar. Like, when you find somebody, like, I want to have children with you, that's what you're doing. You're designing your children, you know what I'm saying? Like, we're already doing. So we don't need magical potions to do that, you know? But the fact that the world came together and did this thing is incredible. And so what's... And bioengineering is actually coming into coming of age right now, right? It's becoming kind of the science of now. It used to be like space exploration and then it was like astrophysics and then it was quantum physics, right? We're kind of moving into the age of biology. We're moving into the age of bioengineering and we're going to start seeing more and more things talking about bioengineering and biology, right? We're going to see more and more people doing it. We're going to see more and more stories about it. And stories about it as a good thing, right? And not as a bad thing, not as like genetically enhanced human beings, you know what I'm saying? Or genetically engineered. We're all genetically engineered. Like the way we think about it, it's going to change, right? And it's going to change. We're going to see many more purple mucus stories, right? It's really coming of age right now. So I'm trying to get my hands on as much information as possible, which is why I'm talking to Drew all the time, right? Because he's, you know, he kind of is the godfather of synthetic biology and he has such a creative imagination and, you know, I think our relationship works because everything he says, I'm just like, that is the most amazing thing I've ever heard in my life. You know what I'm saying? Like it's just, everything is just so mind-blowing. So there's so much that's exciting about synthetic biology. When I walked through Drew's lab at Stanford, right? Because we were co-teaching a class together at Stanford and which is how we really became friends. And then I walked through his lab at Stanford and he showed me the DNA printer and I was just like, can I have one of these? You know, I want one of these, you know? And he was like, I don't see why not, you know? And I was just like, I would love a DNA printer. I didn't even know that was a possibility until I walked around his lab, right? Then he showed me the gene delivery, like internet, where you can like order a gene and it'll come to your house and you can do experiments. And I was just like, there's a world out there of like people who are interested in this and who are", "start_char_idx": 3835, "end_char_idx": 7790, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e8a86fe0-30a4-49c8-9412-446acf5b604d": {"__data__": {"id_": "e8a86fe0-30a4-49c8-9412-446acf5b604d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f869ac5d-b608-49e6-b0ed-9106387e6c41", "node_type": null, "metadata": {}, "hash": "8d50df0d6555a78a0f72a99a2c11e0884a446b46eae01ba9999b07f39734c9fc"}, "2": {"node_id": "c0297a94-d151-40fb-891d-6df53182ecab", "node_type": null, "metadata": {}, "hash": "1ee6d32b4d6872347809ea578006064a0a8440cc0382f12e6e3de2b62ad26625"}, "3": {"node_id": "7ebe1b2f-427e-456d-9d40-3cff421955a8", "node_type": null, "metadata": {}, "hash": "efeb74b23ffc1f9a601fc61cb690ae26f2d64cc765ea74436e73f57fb46b4afe"}}, "hash": "050ba6da3cedd08679a9a4bbff6583738b6860dfc336c79caabac80fc2e30f93", "text": "just like, there's a world out there of like people who are interested in this and who are doing this work. And then one of Drew's students named David Kong, he teaches at MIT, he's also become a very dear friend. And he does this thing called the Bio Summit. And it's a lot of bioengineers, synthetic biologists and bioengineer hobbyists, like people without PhDs who really love bioengineering. And it's just a summit of everybody kind of getting together and talking about this thing and talking about what's possible, talking about what's next. And I did my first Bio Summit last year and I just loved it. And it was incredible. And just the fact that there's this coalition of people out there who are spinning ideas in biology is just incredibly exciting to me. And it's a whole new world that I didn't know existed. And now I'm glad it exists, because they're taking away the stigma of it, one person at a time and they're making it accessible. I think the accessibility to bioengineering is a big deal. I think it needs to be way more accessible, way more accessible, because more people who have their hands on it, the more good you can do. And I inherently believe that there is more good out there to be done and more people who are willing to do good. Well, yeah, I started writing this play about two people who live on the moon. And they're inherently running an archive. They're running an archive of the earth on the moon. So they're taking all of these things and all of this information and storing it on the moon just in case the earth goes up, right? And so the play is about them thinking that their job is like as librarians, they're just boring and they're mundane. And then all of a sudden the earth goes up. And they're like, holy, the day that we never thought would happen, would happen. Now what? And the whole play is about that question. Now what? Now what do we do? And throughout the play, they're making sure that the things that they have up on the moon are sustainable, right? Because now there's no pipeline between the earth and the moon. And so as they are doing these things, they're talking about how much sunlight they can get to their plants, because the plants are the lights. And it came from the same kind of idea of bioluminescent African violets, right? And so I have a scene where they're carrying these small buds of trees, but they're all lit up. They're bright. And when you're on stage, you can build up something that looks like a tree and just throw a light in. And in the scene, they're just carrying these things like it's no big deal, because they see them every day, right? But on stage, what happens is the stage is lit by these trees, by these lights. And the question is, what if all our lights were trees, right? What if photosynthesis provided the energy to trees, and when the sun went down, the trees just lit up, and those were our streetlights, right? Rather than taking energy from the grid, rather than burning coal, rather than having these metallic streetlights in the middle of the city, all you have to do is plant a tree, right? That's how I'm using that to inform the storyteller, right? And this idea is just like, oh, we just figured these things. We figured it out. We just grow these trees, right? And so when you see these little baby trees that are lit up, just being put on shelves, and them talking about something mundane, you're just like, what the f**k is that? Like, how does that, what is that, you know? And that's what sparks the imagination. I think a lot of times people try to shed a spotlight on things. It's not the spotlight we're paying attention to. It's what's behind the spotlight, right? It's the things that we don't say, right? It's the things that we don't point to, and sometimes it feels a little bit, you know, unfair, because, you know, take for example, GPS. Nobody ever questions GPS, ever, you know? They're just like, well, I gotta go make a left here, make a left here, right? Well, you are talking about instantaneous information that's being beamed to you from a", "start_char_idx": 7777, "end_char_idx": 11854, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7ebe1b2f-427e-456d-9d40-3cff421955a8": {"__data__": {"id_": "7ebe1b2f-427e-456d-9d40-3cff421955a8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f869ac5d-b608-49e6-b0ed-9106387e6c41", "node_type": null, "metadata": {}, "hash": "8d50df0d6555a78a0f72a99a2c11e0884a446b46eae01ba9999b07f39734c9fc"}, "2": {"node_id": "e8a86fe0-30a4-49c8-9412-446acf5b604d", "node_type": null, "metadata": {}, "hash": "050ba6da3cedd08679a9a4bbff6583738b6860dfc336c79caabac80fc2e30f93"}, "3": {"node_id": "0f2db9c3-2f91-443f-88f1-2b0d16896797", "node_type": null, "metadata": {}, "hash": "0e9dc01671626ef63e6ec10c62e1a6b90b4af56489bb9dc9152717fe261383dd"}}, "hash": "efeb74b23ffc1f9a601fc61cb690ae26f2d64cc765ea74436e73f57fb46b4afe", "text": "Well, you are talking about instantaneous information that's being beamed to you from a satellite onto your phone, integrating that into your car, and you making decisions based on that. What? That's crazy. If somebody 50 years ago saw an iPhone that's giving you directions, being from, they think you were from another planet. It's ridiculous. But nobody questions GPS. Everybody's fine with that, right? But the COVID vaccine, there's a microchip in it. Like, you know what I'm saying? Like, it doesn't, it's not, it's not fair that sometimes the things get the spotlight. You know what I'm saying? Like, it always blows my mind that people go to, like, fascist rallies on planes, or drive, and they're using, like, smartphones. And they're talking about how science is evil. You know what I'm saying? Like, you got here through science. Like, what? Right. You know, you're not putting these two things together. Together. Together. You know what I'm saying? Like, you got to put these two things together. So I think it's, like, also making bioengineering the everyday. You know, making it so mundane that you don't even think about it. You know, making a flu vaccine in your house. You know, like, you know, the new flu vaccine just got downloaded to my hypospray. Let me just do that. Let me just take that and move on. Right? Making it exclusive and putting a spotlight on it sometimes breeds the mistrust. Seeing bioengineering as, like, a kitchen. Right? You look at a kitchen, and it's a bioengineering lab. But you're just making food. Right? Looking at your kitchen that way. Right? Putting on, you know, your winter boots, and they're made from mushrooms. Like, it's just another material. It's not super special. It's not, you know, something that we need to be afraid of. It's just like, it's just a pair of boots. You know? No longer burning things. You know what I'm saying? Finding, you know, this idea of waste completely being eradicated from everything that we do. There's nothing wasteful. You know? And we have microbes and algae and all of these things breaking down what we call waste. It's being used by something. You know what I'm saying? And it's being put back in to create this cyclical biology on this planet. That's how this planet came to be. You know? For some reason, we got knocked into a Goldilocks zone where things started growing. You know? By chance. Just by chance. You know? All of a sudden, something biological started taking place. You know what I'm saying? Like, we're not Cybertron. We didn't, you know what I'm saying? Like, we didn't get knocked into a zone where mechanical things started growing. You know? Biology has probably been the beer of the longest out of everything. You know? And it's the thing that we're destroying the fastest. So, I think, you know, my hope is recognizing the beauty and the wonder and the awesomeness of it. And moving towards more of it. And having it be as ubiquitous and as mundane as this market. Yeah. I mean, for me, what I would say is a couple of things. One, this is probably the best time in all of human history to be alive. And as much as it doesn't feel like that, it really is. There are some things that exist right now that no other time in human history could even fathom. So, this time right now is wonderful. And there are so many things to be in awe about and so many wonders you can have. Find the wonder in everything. Just keep that awe. Just be awed by things. Let yourself be awed by things. And the other thing is, there are people out there who are listening to you and who are teaching you that want you to win. Your teachers aren't out here to make you look bad or make you look stupid. You know, your teachers out here, even if it doesn't seem like it, they want you to win the game. They want you to win. So, when you challenge your teachers, know that your challenge, at the end of the challenge, you're all fighting for the same thing, which is your knowledge", "start_char_idx": 11854, "end_char_idx": 15830, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0f2db9c3-2f91-443f-88f1-2b0d16896797": {"__data__": {"id_": "0f2db9c3-2f91-443f-88f1-2b0d16896797", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f869ac5d-b608-49e6-b0ed-9106387e6c41", "node_type": null, "metadata": {}, "hash": "8d50df0d6555a78a0f72a99a2c11e0884a446b46eae01ba9999b07f39734c9fc"}, "2": {"node_id": "7ebe1b2f-427e-456d-9d40-3cff421955a8", "node_type": null, "metadata": {}, "hash": "efeb74b23ffc1f9a601fc61cb690ae26f2d64cc765ea74436e73f57fb46b4afe"}}, "hash": "0e9dc01671626ef63e6ec10c62e1a6b90b4af56489bb9dc9152717fe261383dd", "text": "the end of the challenge, you're all fighting for the same thing, which is your knowledge and you to win the game and you to be the best you that there is. I know a lot of times when you're young, you think you know everything. I thought I knew everything when I was young. Nobody could tell me shit. And I'm from the Bronx. So, I was just like, man, get out of here. What are you going to teach me? But there were teachers out there that I just had to shut up and listen because they wanted me to win the game. And a lot of teachers won't articulate this. A lot of teachers won't tell you that they're wrong. A lot of teachers won't tell you that they have a vested interest in your success. But they do. They have a vested interest in your success. And there are people out there in the world who have a vested interest in your success. Hold on to those people. Hold on. Hold on. Because if you listen and you talk and you dive, you don't have to agree. But if you talk and you listen, you will win the game, whatever game you're playing, right? They want you to win, right? Hold on to the teachers that want you to win. Yeah, a couple of things. One, I'm working with the Science and Entertainment Exchange to try to make optimistic futures stories and involving science something even more accessible. And I'm trying to get as many scientists that I know into that storytelling world and that storytelling space. I'm also working with scientists to help them be better storytellers and connect with people that they're trying to reach emotionally. You know, one of the big things about the COVID vaccine that people don't hear, that I hear, is how much time scientists spend away from their families, how many sleepless nights, you know, how many birthday parties, how many anniversaries, how many weddings. They all miss those things because they were trying to keep us all alive. And we don't hear about that, right? We don't hear about their sacrifice. We don't hear about their struggles. We don't hear about them every day seeing millions of people dying and it keeping them up at night because they go, I need to get to the lab and try this. You know, that was, they are driven, as driven as everyone else is about everything else, right? As driven as Elon Musk is about being an a**hole, right? As driven as finance guys are about the economy. These people were driven to come up with this vaccine. They spent sleepless nights every day and night feeling guilt and stress and pain, taking time away from their families to make this thing. So I'm trying to get that story out there as much as I possibly can. And I think when people really engage with scientists emotionally, they really understand that they're people who have a passion and aptitude for something. And it's not otherworldly, it's not untouchable, you know, it's not intangible. It's like your neighbor, you know, your neighbor is a research scientist and they're spending time away from their families just to make the world better. Yeah. So I'm really working on getting those stories out. And then I'm working on, I'm actually going to do a panel at the Sundance Film Festival this year with Drew, talking about optimistic futures and storytelling. So it's like really getting the word out there that the future doesn't have to be this desolate, barren, dystopian, Mad Max, like we f***ed up the earth. You know, everybody's survived. We're like trying to find water and a shotgun, you know what I'm saying? Like it could really be something quite special. Our streetlights could be trees. Yeah, it could be. And so getting more people to tell those kinds of stories is what I'm working on right now, and I'm really passionate about.", "start_char_idx": 15815, "end_char_idx": 19528, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "054e0d4f-70d4-40d3-ad36-7470bd64a9cf": {"__data__": {"id_": "054e0d4f-70d4-40d3-ad36-7470bd64a9cf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4030aae3-0365-443e-a794-e358776dd6f3", "node_type": null, "metadata": {}, "hash": "7a18ac42d492a58d783375b3f237f338d5cb8ef3ecb782b0730be7c660a9777d"}, "3": {"node_id": "645efdf3-f569-468e-a48b-2927439533a7", "node_type": null, "metadata": {}, "hash": "6adb801efa14544de600361bb6151cce50e9a83ea91b95cc0ea728add1ab1d4b"}}, "hash": "d29a4fc111baede4fe8cbfe26f03cae55c80b66d6a46660d884c7bd7bf347c53", "text": "Yeah, sure. Hi, I'm Barbara Junkosa. I'm a Ph.D. community college faculty. I'm also a department chair for biomanufacturing and biotechnology at Maricosta College. That's in northern San Diego. And I am not a bioengineer. By training, I'm a microbiologist. That's what my Ph.D. was in. I studied the bacteria that cause stroke throat infection in humans. And kind of through a roundabout way, ended up teaching biotechnology out here in California. Yeah, so biotechnology chose me, kind of. After grad school, I really wanted to teach. So I came, I was in New York City for grad school. And then I moved to LA, where I was teaching at a community college there. And I was mostly teaching microbiology for students wanting to become nurses. But while I was there, the college decided they would like to pursue a biotechnology training program. And they asked me if I'd launch it. So that was a big lift. But it was really exciting. So I went around basically LA County meeting companies finding like where would our students work. And what I discovered is that a lot of the companies are in that biomanufacturing space. So using cells to produce proteins that are then used in different kinds of medicines. And then when I came, so I was there for five years, started that program. And then I came to San Diego, where I've been for almost six years. And now I only teach biotechnology. So it was a real big switch for me. So I teach students how to operate in a lab, how to do different kinds of lab testing, how to grow cells, how to purify proteins. So really looking at that biomanufacturing side of things. Yeah, so I was super interested in sharks. That was my obsession. Like Shark Week, I was watching every summer, loved it. So for undergrad, I actually studied marine biology, and discovered in the first summer that I'm super seasick. I went on this research cruise, and all I could eat was crackers for like two weeks. It was terrible. So after that, I basically went into a laboratory as a volunteer kind of student worker, where I was studying viruses that infect fish that cause cancers, tumors in fish. So then that kind of got me interested in microbiology. And then that's where I went for grad school. And so it's always kind of science, but it's been migrating to different areas, at least in the kind of biology end of things. Yeah, I mean, what's super fascinating about biotechnology is that it touches our daily lives, whether we think about it or not. So even in like the laundry detergent that you use, generally will have enzymes from bacteria in it that help to break down the dirt and the grime that's in our clothes. So something as simple as washing clothes is touched by biotechnology. And then if you think about greener plastics that are coming out, there's really interesting work around food right now, making lab-based meats. So there's a company down here in San Diego where they're growing cells from fish in petri dishes, and then making them into fish fillets. So it's really fascinating kind of the food revolution that's happening right now. And then of course, just all the amazing kinds of therapeutics for cancer and other kinds of diseases that require us to genetically engineer cells to make a protein that then we can put into people. So it's just really interesting to me, all the different ways that biotechnology touches us, even if we're not aware of it all the time. Yeah, I mean, even like something as simple as jeans that we wear, like denim jeans, they are often a lot of the kind of acid wash will have biological products in it. So it's everywhere, even if we don't know it. Yeah, I mean, there are lots of ethical questions around biotechnology and what we should be using it for, particularly around human medicine. I was recently teaching a class in CRISPR gene editing, and there's lots of controversy in that area. There was a Chinese scientist who CRISPR engineered apparently two or three babies in China. And so that was super controversial. There's just a lot of", "start_char_idx": 0, "end_char_idx": 4031, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "645efdf3-f569-468e-a48b-2927439533a7": {"__data__": {"id_": "645efdf3-f569-468e-a48b-2927439533a7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4030aae3-0365-443e-a794-e358776dd6f3", "node_type": null, "metadata": {}, "hash": "7a18ac42d492a58d783375b3f237f338d5cb8ef3ecb782b0730be7c660a9777d"}, "2": {"node_id": "054e0d4f-70d4-40d3-ad36-7470bd64a9cf", "node_type": null, "metadata": {}, "hash": "d29a4fc111baede4fe8cbfe26f03cae55c80b66d6a46660d884c7bd7bf347c53"}, "3": {"node_id": "f0d3ec22-99c1-473a-be4a-23d3a4c69192", "node_type": null, "metadata": {}, "hash": "9298d0ecbc7d73ef5d4ac6333ace7cbcd437bb7b794c6b4e030489635fe24c7f"}}, "hash": "6adb801efa14544de600361bb6151cce50e9a83ea91b95cc0ea728add1ab1d4b", "text": "three babies in China. And so that was super controversial. There's just a lot of questions around risk benefit, like how much benefit would outweigh risks of, especially with something like CRISPR, where you could get other edits that are unintended that may lead to things like cancer. There's just a lot of questions around also what we should be curing or not curing. And then, of course, there's always a discussion of designer babies and how far should we let people go in making edits to the next generation. So it's just an area with a lot of promise, but there is also a lot to consider in terms of where we should draw the line of what's ethically acceptable or not. Yeah, I mean, to me, it comes down to a really simple question, like just because you can, should you? And that, to me, is kind of the core of ethics. There's a lot of things we can do right now with biology and the tools that we have, like CRISPR gene editing. It's very precise. So you're right that we have been selecting mates for a long time based on a lot of different factors, and that has an impact. But now we're talking about very quickly and very precisely editing DNA. Because you could say, I want blue eyed babies, and I can find myself a blue eyed husband, but that does not guarantee blue eyed babies. Because the genetics are just more complicated than that. But with CRISPR, I could literally do some precise genome editing, assuming we know all the genes involved. So really, the question comes down to, should we do something? Just because we can do it doesn't necessarily mean that we should do it. And I think a big consideration is around equitable access. So yes, maybe these technologies are available and they're great, but are they accessible to all people? Or is it only a select group of individuals in society that get to benefit from something? And is that the right thing for us as a society? I'm a first generation American, my parents are Cuban immigrants. I did not come from a wealthy background, so I would not have had access to certain things. So I also think about it from that perspective, not just like, should we in general as humanity do something? But then also, if we think that it's beneficial, should we think about equitable access for those technologies? Yeah, that's a good question. I've always been very much in the healthcare space. In graduate school, I was studying human disease. In my biotechnology programs, most of the companies we work with in the area are healthcare-based companies. So I'm always thinking kind of along the lines of healthcare. So I think in 20 years, so one of the most interesting technologies right now is CAR-T cell therapy. And that's where we take immune cells from people who have cancer that's difficult to treat. In the laboratory, we program those immune cells to recognize the cancer cells, and then we transfer them back into the patient. And it's super successful. Those programmed immune cells, they are like heat-seeking missiles. They find the tumor, they destroy it. It's really impressive, the results that they're getting. But here we come with the access, right? It's super expensive, hundreds of thousands of dollars for a patient. And that's because you take the cells from the person, reprogram them, and put them back. So it's really super personalized medicine. But one thing they're moving towards is creating kind of banks of cells that you can just kind of, essentially like in a store, you have these cells available to treat different cancers. And depending on the person's cancer, you take the right cells off the shelf and you can give them to the person, which would make it a lot less expensive and a lot more accessible, and hopefully be able to treat a lot more different types of cancer. So I think that, I mean, I don't know, about 20 years, maybe something like that would be possible to have these kind of off-the-shelf, genetically-programmed cells that people could be given to destroy those specific tumors. And that's what brings these ethical questions to the forefront. It's literally the same kind of gene-editing technology, just applied to different things. So you can't say like, we're going to ban this technology, period. You know, we have to think more, we have to really dissect the different", "start_char_idx": 3965, "end_char_idx": 8268, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f0d3ec22-99c1-473a-be4a-23d3a4c69192": {"__data__": {"id_": "f0d3ec22-99c1-473a-be4a-23d3a4c69192", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4030aae3-0365-443e-a794-e358776dd6f3", "node_type": null, "metadata": {}, "hash": "7a18ac42d492a58d783375b3f237f338d5cb8ef3ecb782b0730be7c660a9777d"}, "2": {"node_id": "645efdf3-f569-468e-a48b-2927439533a7", "node_type": null, "metadata": {}, "hash": "6adb801efa14544de600361bb6151cce50e9a83ea91b95cc0ea728add1ab1d4b"}, "3": {"node_id": "40809ff8-cdf4-4867-aa6d-7b1b2678b9a7", "node_type": null, "metadata": {}, "hash": "81e5810b6a5ec1b99eb4352634f4732d2f6c2c2047e5d67b34720198faa9af50"}}, "hash": "9298d0ecbc7d73ef5d4ac6333ace7cbcd437bb7b794c6b4e030489635fe24c7f", "text": "period. You know, we have to think more, we have to really dissect the different purposes and the different roles that the technology can play. Yeah, I would say, you know, if this is an interesting field for you, I would highly encourage you to just keep going. There's so many different ways that this field can, so many different applications, right, for this field, so many different ways you can impact humanity. So if it's something of interest to you, just don't be dismayed by the math, because that's always the part that, you know, people feel like, I'm not good at math, good at math, which is not really a thing. Math just takes practice, and you get better over time. I mean, even me, I'm a community college faculty, I teach this all the time, but if I'm away from the classroom for like six months and I come back, I'm so rusty. Like, I need to sometimes remind myself of things. So, you know, I just always encourage students, like, follow your interests and don't be discouraged by what you might perceive as these huge barriers. There's lots of resources available. I mean, YouTube, nowadays, you can find videos to help you understand all sorts of stuff, but then whatever college you go to or university, there's going to be lots of support services that you just have to seek out, and it's okay to ask for help. Yeah, I mean, what I would say is, it's still hard to find role models sometimes, especially amongst faculty, and so, you know, if I think back to my college days, I really have to think hard here, maybe like one or two faculty of color when I was going through the process. I'm not sure it's changed that much, which is a sad thing to say in some ways. I think, you know, it depends on where you go to college or university, but what I would say is, you have to find community. Like, there'll be other students around that are students of color, and I've always found that that community can be super supportive as you're going through this journey, and, you know, nowadays, they're, like I said, with YouTube, you can find role models of color, which is great, but sometimes in the classroom, it's not as evident. So, the other thing I would say is that there's lots of programs to help students of color advance in STEM, of which I was a beneficiary when I was in college. There are, you know, summer research opportunities. There are sometimes scholarships you can find. So, again, it's kind of that don't be afraid to ask for help. Like, you know, go to financial aid offices and ask for information. Talk to faculty. Even if they're not faculty of color, they may have, you know, information about resources available. So, I just, I think the key thing is to not be intimidated, which is easier said than done, and just to go out there and, you know, interact with other students, ask for help, share resources, because that's where I think you're going to get the support you need to kind of push forward, because it's not easy, especially if you're first gen to college, and you don't have, you know, people at home that can help you navigate this crazy process sometimes. There's, higher ed is kind of a little bubble in its own sometimes, and you have to learn how to navigate that. So, you know, anyone that, I had friends who were not people of color, but came from families where they had, like, college educated parents who helped them navigate, so then I kind of piggybacked and learned from them how to navigate, and that's, you know, that's a really helpful resource. Yeah, absolutely. I think it depends. Depends on what you want to do. You know, I think the reality is, if you want to work on the technical side, you need some sort of formal training. Yes, there are now websites where you can buy stuff to do at home, and maybe some students can afford that, and kind of learn those skills. For a lot of people, it's probably still cost prohibitive, like you just can't afford those kinds of things. So, I think on the technical side, having access to equipment and learning techniques, it's not something you can do necessarily on YouTube. With that said, I don't think you", "start_char_idx": 8270, "end_char_idx": 12397, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "40809ff8-cdf4-4867-aa6d-7b1b2678b9a7": {"__data__": {"id_": "40809ff8-cdf4-4867-aa6d-7b1b2678b9a7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4030aae3-0365-443e-a794-e358776dd6f3", "node_type": null, "metadata": {}, "hash": "7a18ac42d492a58d783375b3f237f338d5cb8ef3ecb782b0730be7c660a9777d"}, "2": {"node_id": "f0d3ec22-99c1-473a-be4a-23d3a4c69192", "node_type": null, "metadata": {}, "hash": "9298d0ecbc7d73ef5d4ac6333ace7cbcd437bb7b794c6b4e030489635fe24c7f"}, "3": {"node_id": "00240aa9-6b8e-46dc-8d0e-a06189100603", "node_type": null, "metadata": {}, "hash": "82015f1e29bd1c101bafcc16e38d305109b27378970f520a4bda7c1a038df8f7"}}, "hash": "81e5810b6a5ec1b99eb4352634f4732d2f6c2c2047e5d67b34720198faa9af50", "text": "not something you can do necessarily on YouTube. With that said, I don't think you need a four-year degree. There's lots of community colleges, I've taught at two of them, that have biotechnology programs. You know, we're in California. In California, it's $46 a unit, and you can go and learn all the skills that you need to get entry-level employment. So, you know, from my perspective, like, you need some education on the technical side. I don't think you need a four-year degree. I think you could do a certificate, you could do an associate degree, you can get started, you can always come back. And then there are places, you know, there are paths where some people might choose to do the four-year degree. Some people might choose to go even beyond that. And that opens different kinds of opportunities, of course. But I think there's places for people along that whole pathway, from kind of community college all the way to graduate school. If you're not on the technical side, again, I think it depends on what your skills and interests are. You know, what I'm always telling students is, biotech is an amazing industry, and you don't have to be a scientist to be part of it. You could be in marketing, you could be in finance, you can be an accountant, you could be a lawyer, you could be, you know, someone who works in human resources, you could be someone who purchases supplies for the company. Like, there's so many different support roles. So I think depending on what the role is, you may or may not need a college degree. I know a lot of companies like to see a college degree. But again, that's why I say, like, community college is a really great place to start. Oh, at this point in my life, I would probably study humanities, because I've just, I've enjoyed sciences, but I feel like I've learned so much in that area. And now I would like to, like, round out my education with something more on the humanities side. Maybe, I don't know, psychology or philosophy or something. But I really enjoyed college, and I enjoyed everything I learned. So I'm just one of those people that if I could go to college forever, I totally would. And I just study different things. I mean, it's had a huge impact in medicine, and I don't think that's going to go away. But if I was thinking kind of like a new emerging area would probably be around plastic substitutes. So many of our plastics are made from petroleum products, fossil fuels, which of course have all contributed to climate change. And we just have a lot of plastics that just will never biodegrade, and they're just in these huge heaps on land, and also like these plastic islands and the oceans. So I feel like there's been a lot of work recently, and it continues around looking at bio-based plastics, or even using things like fungus to grow. You know, you grow fungus into these like blocks that you can use for cushion for shipping. So I think that that's a space where biotech can really disrupt in a positive way that we haven't yet seen very much of. You know, overall, I would just reiterate that there's like a space in biotech for everybody, regardless of what your interests are. You know, even if you're an artist, you could create the renderings of like cells and what they look like. And I just think there's so many opportunities for people to get involved in biotech and bioengineering, even if it's not on the science side. And it's just, it has such incredible potential to impact our lives in so many different ways. And I just hope that, you know, the students who listen to this are encouraged to keep going and keep pushing forward and just exploring and not get too intimidated by kind of the ivory tower of academia. And just remember that we all start in the same place, you know, which is what I always tell my students when I'm teaching them lab techniques. I say, you know, I'm going to do something. I'm going to show you something and it's going to look really easy. And when you do it, it's not going to feel so easy and that's okay. I've just done this literally thousands of times.", "start_char_idx": 12396, "end_char_idx": 16485, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "00240aa9-6b8e-46dc-8d0e-a06189100603": {"__data__": {"id_": "00240aa9-6b8e-46dc-8d0e-a06189100603", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4030aae3-0365-443e-a794-e358776dd6f3", "node_type": null, "metadata": {}, "hash": "7a18ac42d492a58d783375b3f237f338d5cb8ef3ecb782b0730be7c660a9777d"}, "2": {"node_id": "40809ff8-cdf4-4867-aa6d-7b1b2678b9a7", "node_type": null, "metadata": {}, "hash": "81e5810b6a5ec1b99eb4352634f4732d2f6c2c2047e5d67b34720198faa9af50"}}, "hash": "82015f1e29bd1c101bafcc16e38d305109b27378970f520a4bda7c1a038df8f7", "text": "feel so easy and that's okay. I've just done this literally thousands of times. And if you do it thousands of times, it's going to be super easy. So, you know, I think sometimes we look at our professors and we just think they were magically born that way. Like they just knew all of this or they could do all these things, but we all really start from the beginning always. So, you know, don't get discouraged and just keep trying.", "start_char_idx": 16474, "end_char_idx": 16906, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3fe71f0b-3204-4378-a7f3-d2dc305bf1ba": {"__data__": {"id_": "3fe71f0b-3204-4378-a7f3-d2dc305bf1ba", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "941ae92a-ee2d-40a9-9000-7b2e00b061f6", "node_type": null, "metadata": {}, "hash": "8926f648fa2599e09628fc8531012c509d2fcb1cd0baa622551fc41d3921eb80"}, "3": {"node_id": "fc59229f-ac16-43e0-a0e1-7a1a41db7881", "node_type": null, "metadata": {}, "hash": "effb0ae91f1c0dedc016bb74f1ce9924b0a620df872e4d1eec806e2875612450"}}, "hash": "b0a54cb8773224902aa6c7b6b8482fb0d336833cd1a5332149e82913bac3a34e", "text": "My name is Ben Novak. I am the lead scientist of Revive and Restore, the world's only nonprofit promoting the innovation and adoption of biotechnologies and conservation. For Revive and Restore, I work on a number of projects. I lead the project to recreate the extinct passenger pigeon and recreate the extinct heath hen through modern bioengineering and paleogenomics. I work on recovering genetic diversity for the endangered black-footed ferret and Schiffalski's horse through our conservation cloning programs, and I help oversee a wide array of conservation genomics projects. And just this year in 2022, I launched an entire program dedicated to innovating biotechnology for bird conservation in which I am managing science teams all over the world in Japan, Korea, Germany, and the U.S. that hopefully, as intended, will revolutionize bird science, not just for conservation, but as an entire science. So I will be working to genetically engineer pigeons over the next two years. This is as an individual private endeavor. This is separate from my day work. The reason I do not consider myself a bioengineer per se is that I personally do not have the computational biology skills. I actually lack computational skills entirely, and I do not have the genetic skills to really understand how to put together a gene construct for a transgene or how to design a gene edit. Those are things that I rely on having a collaborator to help do, where I have specialized myself in the work that I want to do is in the organismal side of things, of the animals that we want to engineer. So I want to engineer pigeons. So my expertise is in breeding and handling pigeons and how to manipulate their eggs and ensure that a transgenic animal gets from birth to adulthood and that type of thing. So it would be very different if we were talking about engineering yeast or engineering bacteria. I am in the field of wanting to engineer things that are multicellular organisms, and that is pretty different. That is in my hobby and in my day job. What I have been doing for the last 10 years is trying to find the real bioengineers out there that could do things that could make a difference in wildlife conservation and oversee and program manage where that goes. So I have been in a seat of what is the big vision for bioengineering in the world, while not always having to personally be the person in the lab figuring out how to do it. The world of biohacking is certainly opening up the possibility that many more people can get into bioengineering. In truth, if you are working at a laboratory that is engineering organisms, it is going to be pretty rare that you are a person who does every step of the work from point A to point B. We rely on collaborative teams. I am happy to call myself a bioengineer in the fact that I have specialized myself. I know the field conceptually. I have figured out where I can put my skills and expertise. The end goal of both my private laboratory work and my work for Revive and Restore is ultimately engineered organisms. So yeah, I will take the tag then. I have been working for 10 years for a non-profit organization called Revive and Restore. We are the only non-profit organization in the world with the sole mission to promote and foster the innovation and adoption of biotechnologies for conservation. We consider all forms of biotechnology, from simple genomic sequencing and bioinformatics data to augment conservation decisions already happening now, to the realm that more people would consider bioengineering, where we are actually manipulating an organism or an aspect of its ecosystem. I actually fell in love with the idea of biotechnology when I was about 13 years old. I wanted to get into conservation and do things to save biodiversity since I was probably 11, 12 years old when I really became aware of the problems facing biodiversity loss and ecosystem collapse. I became aware of recently extinct species, which fascinated me. The idea of restoring ecosystems was very fascinating to me. I grew up near a national park, Theodore Roosevelt National Park, where species had been restored. The bison, bighorn sheep, and elk", "start_char_idx": 0, "end_char_idx": 4177, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fc59229f-ac16-43e0-a0e1-7a1a41db7881": {"__data__": {"id_": "fc59229f-ac16-43e0-a0e1-7a1a41db7881", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "941ae92a-ee2d-40a9-9000-7b2e00b061f6", "node_type": null, "metadata": {}, "hash": "8926f648fa2599e09628fc8531012c509d2fcb1cd0baa622551fc41d3921eb80"}, "2": {"node_id": "3fe71f0b-3204-4378-a7f3-d2dc305bf1ba", "node_type": null, "metadata": {}, "hash": "b0a54cb8773224902aa6c7b6b8482fb0d336833cd1a5332149e82913bac3a34e"}, "3": {"node_id": "fe20bc37-aad7-4c0e-910f-e8f60e181fe5", "node_type": null, "metadata": {}, "hash": "cca6e401c3fb28947a23099cd30a631241999ed1f488e0d55f54c4eb11538c54"}}, "hash": "effb0ae91f1c0dedc016bb74f1ce9924b0a620df872e4d1eec806e2875612450", "text": "where species had been restored. The bison, bighorn sheep, and elk populations that are in Theodore Roosevelt National Park were all transplanted there. They had gone extinct due to extirpation in the 1800s and early 1900s. Decades later, conservationists grabbed some from the Rocky Mountains and northern Canada and other areas and brought them in. And I thought, well, why can't we do that for something like a dodo bird, or a woolly mammoth, or a passenger pigeon, which is my personal favorite, the one I'm working on. It happened to be about the same time in life that the human genome was being published. People were talking about genetic engineering a lot. With the sequencing of the human genome, the whole concept of where we go from there was really a hot topic in science and media. My brain made the click. It was like, well, maybe if we can sequence DNA from an extinct species, and we can engineer that DNA back into a living form, we can do a level of restoration that's just not open right now and not possible to us. In my education, I actually went down the road of ecology and evolution. I did a lot of paleontology study and some work, because I thought, okay, if I'm going to restore extinct species, then I need to understand extinction and extinct species. I think there's a lot of different ways someone could get into the work that I do through zoology and from a conservation genetics angle, from more land management angles, or from computational biology, genetics, genomics, and even programs now that are really focused on bacterial genetics and do genetic engineering early on. You can get into it from a lot of different levels, because the concept of applying biotech in conservation requires all those players, people who understand the environment, who understand the organismal biology and the population biology, people who understand animal husbandry and how to breed these species, animals who understand embryology and how you manipulate these things in development, to people who understand the genes and the genomics. Where I've gone with my job is basically understanding the big picture of what all that is, so that hopefully, I can continue to orchestrate programs that do all these things to help endangered species and the extinct ones. Personally, I am of the philosophy that we do not need entire generations to go to university and put the time and commitment into four years of school, sometimes five or six, due to complications that are out of our hands as students, to earn a degree for something that we could have gotten into straight out of high school through hands-on work. There may be some options to get into things like zoology and animal husbandry without degrees, but in truth, in the conservation realm, in the biotechnology conservation realm right now, it's probably extremely difficult to get into it without doing at least a bachelor's degree study. Actually, even for state agency and federal agency wildlife groups, sorry, wildlife agencies like Fish and Wildlife Service, it's recommended to at least get a master's or go higher in education, simply because, for one, the job turnover is much slower than it used to be. So prolonging your start date is just helpful. But second, there are also not a lot of entry positions where you can start getting that experience on the job like people used to. And third, if you're going to think about using biotechnology, even if you're not someone who's actively doing the biotech side of things, you really should understand it. And it's difficult to come in and understand if you don't at least have a very good background in genetics and genomics and things like, if you're going to work with wild species, things like conservation genetics and population ecology. These are things that require a lot of education to understand. It's very difficult to just go in without at least a couple years of enhanced biology and math. So yeah, so I think for anyone to get into the work that I'm doing with biotech and conservation, I highly recommend university degrees in at least one of the subfields that would lead into this. And no matter what subfield you go into, if it's strictly zoology or if it's just broader biology, you definitely need to be getting in some coursework that is intro to genetics, intro to bioengineering, things like that. With", "start_char_idx": 4122, "end_char_idx": 8487, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fe20bc37-aad7-4c0e-910f-e8f60e181fe5": {"__data__": {"id_": "fe20bc37-aad7-4c0e-910f-e8f60e181fe5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "941ae92a-ee2d-40a9-9000-7b2e00b061f6", "node_type": null, "metadata": {}, "hash": "8926f648fa2599e09628fc8531012c509d2fcb1cd0baa622551fc41d3921eb80"}, "2": {"node_id": "fc59229f-ac16-43e0-a0e1-7a1a41db7881", "node_type": null, "metadata": {}, "hash": "effb0ae91f1c0dedc016bb74f1ce9924b0a620df872e4d1eec806e2875612450"}, "3": {"node_id": "a4e3b13c-82b6-46f4-8b6b-c344fe41d9b0", "node_type": null, "metadata": {}, "hash": "b7886e91024e3228856e7244abc8a821bedf785296508565291eb191334e4d1b"}}, "hash": "cca6e401c3fb28947a23099cd30a631241999ed1f488e0d55f54c4eb11538c54", "text": "that is intro to genetics, intro to bioengineering, things like that. With bioengineering and where biotech is at, it just gives me this sense that you can imagine almost anything now. There's a lot we don't know about how genetics work, which genes are responsible for what traits, but the concept really is at a point where you can say, okay, well, maybe we'll engineer a population to be disease resistant. Maybe we'll engineer it to overcome climate change. Just the fact that I think one of the most powerful things we can even think about right now is the fact that not even creating an extinct species, which is what I'm most excited about, but the fact that the concept that I can take a specimen out of a museum drawer and take a tiny bit of tissue and sequence its genome and then compare that to its living relatives. Let's take, for instance, a species I work with, the black-footed ferret. In 1985 to 87, this species went down to a total of 18 surviving animals, of which there were families and related animals to the point that of the ones that saved the species and bred in conservation breeding centers, only seven were considered actually genetically distinct in some way. All living black-footed ferrets trace their ancestry to just seven individuals. We could now consider opening up museum drawers of animals from populations that are completely gone and wiped out, sequence their genomes, compare it to all the living black-footed ferrets and go, okay, what's some genetic diversity that this species is missing? Edit that back into a living population and make it as if a little bit of genetics survived more. The fact that we can reverse these once completely irreversible traumas to nature is what's really cool to me because we could do that for lots of species. Then when you think about, well, can we create a gene construct now that makes them self-vaccinating to overcome the diseases that we've introduced, which is work that Bridget Baumgartner at Reviving Restore is overseeing. I help support her in that. There's just a lot of things we can think about doing. The fact that island conservation and the G-Bird program are coming up with ways to potentially humanely eliminate invasive species using things like gene drives or other gene suppressing elements to remove the idea of using toxic pesticides. These just open up so many doors to change the way we live with nature. We could engineer livestock to not transmit disease to other species. We can engineer plants to grow larger on less water, less food. We could be enabling for the first time in history, a future in which rather than alienating other species and creating quality of life for humans off of the degradation of this planet, we can create a modern, even more futuristic idea of human quality of life that is in coexistence and harmony with the other billion species on this planet. Not only can we do that, but if we can push forward and recreate the legacy of extinct species, like recreate something that is a new passenger pigeon and put it in the wild, then we're looking at a future in which for the first time there might be a generation born in which there's finally more in the world than less in it. Because that's what hits me when I was born and I learned about things like the dodo bird and the thylacine and the passenger pigeon and the great auk, was that I was born into a world that had less life and diversity in it than the generation before me. And that's been every generation of human beings for basically the last 125,000 years that we've been spreading across the planet and altering the planet in ways that have caused the extinction of incredible species that, you know, we once lived with. We once lived with woolly mammoths and painted them in cave art. We don't have that anymore. People once lived with passenger pigeons just two human lifetimes ago and that's something that through carelessness and avarice has been robbed from the present-day generations. And my sons who were born just 30 years, oh my goodness, my sons were born just 32 years after me, were already born into a world that had hundreds if not thousands of species less than when I was born. And the sad reality is when I become a grandfather, my son's children will be in a world that has less in it.", "start_char_idx": 8481, "end_char_idx": 12787, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a4e3b13c-82b6-46f4-8b6b-c344fe41d9b0": {"__data__": {"id_": "a4e3b13c-82b6-46f4-8b6b-c344fe41d9b0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "941ae92a-ee2d-40a9-9000-7b2e00b061f6", "node_type": null, "metadata": {}, "hash": "8926f648fa2599e09628fc8531012c509d2fcb1cd0baa622551fc41d3921eb80"}, "2": {"node_id": "fe20bc37-aad7-4c0e-910f-e8f60e181fe5", "node_type": null, "metadata": {}, "hash": "cca6e401c3fb28947a23099cd30a631241999ed1f488e0d55f54c4eb11538c54"}}, "hash": "b7886e91024e3228856e7244abc8a821bedf785296508565291eb191334e4d1b", "text": "a grandfather, my son's children will be in a world that has less in it. And someday because of bioengineering we can change that and start putting more back into the world. That's what keeps me having faith in that there's a better future for humanity. The most important thing that's beyond bioengineering for me in the work that I do to try and restore nature with bioengineering is that we seldom appreciate the human connection to it. We live in a world where you know something like 70 to 90 percent of people depending on where you live are urban now and our urban environments are very disconnected from natural settings. And they don't have to be. We can build cities better to where they're not. We can invite species in but it is the state we're in that we have people that have grown up their entire lives with literally no exposure to other species around them. And that's actually very alien for human beings. For 300,000 years the condition of being human is tied within an environment that is co-inhabited with thousands of other species that we built our culture off of. You think of every indigenous tribe in the world they are connected to the species they live with. That's where their stories come from. That's where their culture comes from. And all of us have that indigenous origin as a white person from European descent. You go back several thousand years and our people are shamanistic druids, Celts wandering across the nation who tattoo designs of animals on their skin where animal hide and work it into their art and their stories. And it's something we've slowly drifted away from but it is still in us. If there's any case for there being kind of genetic memories the human condition is one that needs nature and green space. And there's now a whole lot of empirical research to show us that hearing the sounds of the ocean for an hour helps relieve stress. Walking in a park or a nature setting for an hour or two hours decompresses the physiological stress of the human body. We have empirical biological evidence now that we need biodiversity just to be happy human beings. And bioengineering literally is the key towards the future that has everything we've come to love about our modern life and still allows other species to live in it. And what's really awesome to me is just the fact that this grand vision of entire species coexisting with human beings better than ever before can start with cells in a petri dish, tissue in a micro centrifuge tube, gene sequences as digital information on a computer, and it can be an email chain between me and someone in the United Kingdom or Kenya or New Zealand exchanging ideas. I mean it's it's there's there's just so so much cool stuff to this field that I could talk about it forever.", "start_char_idx": 12778, "end_char_idx": 15548, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d09bea1b-2b0e-4317-8539-871ebeeef697": {"__data__": {"id_": "d09bea1b-2b0e-4317-8539-871ebeeef697", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5bd77dd5-0f77-412c-a16e-8fe9bcbd4f25", "node_type": null, "metadata": {}, "hash": "502b82893a3dba4237f2391574c9d808ce603e4be43f65714443a1a1dd8658e8"}, "3": {"node_id": "63bf84cc-6bb7-4880-9da2-a97913db3808", "node_type": null, "metadata": {}, "hash": "46cb0bbf880ec5b7805f52d56bf31b52f862de359a1228a828e629d9b9b0553b"}}, "hash": "27a4074daa185dbbd08aee60f215d1f351aa252cddebe6818469e948a7b3ea04", "text": "Well, so I'm quite lucky through my work with Revive and Restore that one of our roles as an organization is to connect people and convene meetings that bring biotechnologists with conservationists together. And, you know, there are people in almost every country of the world that are thinking of what bioengineering could do for them, either in biomedicine, agriculture, and more and more thinking about what it can do for nature, because one of the cool intersections right now for bioengineering and conservation and biomedicine is the fact that human health involves the environment. One of the hottest things in a lot of people's minds is malaria, and how many people it kills every year from mosquitoes. And could we engineer mosquitoes to stop transmitting malaria to people? Or engineer mosquitoes, simply to eliminate the three species that transmit the disease and leave all the other mosquito species and insects that pollinate flowers and do things in nature. And by thinking of how do we help human health, knowing that the problem comes from another species has forced people in biotech and medicine to think of the environment and the ecosystem. And so there's this direct intersection that then people start thinking, well, if we're talking about engineering mosquitoes to help humans, well, mosquitoes are transmitting malaria in Hawaii to native birds. You know, we could do this to save birds. We could do this to, you know, we could do this to save our poultry and then move on to other wild birds and quail in Africa, right? So people are seeing that this is, it's no longer distinct anymore between nature and human. It's really, really interconnecting. And it flares up a lot of opinions about anti-GMO sentiments, what right do we have to alter people or other species? But at the heart of it is this concept that there is technology now that forces us to have these questions that can be used for incredible, incredible changes in the world that are good. But how do we ensure that we actually do those things, not just for good intentions, but with responsible process so that the outcomes are as intended? And yes, it's really cool. You can get into this just through the network of people thinking about it from ethics and policy. And, you know, I guess, you know, we're looking at a future in which people could consider themselves bioengineers who work in politics and never once step into a laboratory. You know, there are things that bioengineering could do that could be imaginably bad. What I worry most about actually is not so much the bad things that could happen, but a system that enables bad players. And so right now, almost everyone working in this field that I know, well, everyone that I know, and I would assume almost everyone, you know, wants to bioengineer the world for good reasons. But not everyone has the same understanding of ecosystems and human societies that can make sure that the idea that they're driving forward actually does deliver a good consequence. So I worry a little bit on the regulation side, but I also worry very much most often that policies and regulations will put a barrier between the concepts and ideas of bioengineering and their real world applications. This is a field where some people get so worried about what could happen that they want to even stop research. And research contained in a laboratory is safe, it's well regulated, there's not only federal laws, but also institutional regulations that are quite oftentimes almost overburdensome. And, excuse me. Yeah, it can be quite overburdensome to a researcher. Sometimes they don't make a whole lot of sense. You know, you can imagine like when you get on an airplane and you think, well, why can't I have a nail clipper. You know, this is a little overboard, but the world of bioengineering is similar at a research level, where people are concerned is I've created something amazing in the laboratory, now I want to use it in the environment. That jump is bigger and we have a lot in place there as well to move forward, but a lot of people they're wanting to stop research before it starts. And we're not going to learn, we're not going to discover, we're not going to make a better world without research. So I'm actually most concerned about the process being cut off than", "start_char_idx": 0, "end_char_idx": 4316, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "63bf84cc-6bb7-4880-9da2-a97913db3808": {"__data__": {"id_": "63bf84cc-6bb7-4880-9da2-a97913db3808", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5bd77dd5-0f77-412c-a16e-8fe9bcbd4f25", "node_type": null, "metadata": {}, "hash": "502b82893a3dba4237f2391574c9d808ce603e4be43f65714443a1a1dd8658e8"}, "2": {"node_id": "d09bea1b-2b0e-4317-8539-871ebeeef697", "node_type": null, "metadata": {}, "hash": "27a4074daa185dbbd08aee60f215d1f351aa252cddebe6818469e948a7b3ea04"}, "3": {"node_id": "c8a846f2-eb26-4021-8703-a413ba958dbd", "node_type": null, "metadata": {}, "hash": "989236586333a55d34c455f34553b552c0fd7b5ab31de68c28b82812a7a085e5"}}, "hash": "46cb0bbf880ec5b7805f52d56bf31b52f862de359a1228a828e629d9b9b0553b", "text": "a better world without research. So I'm actually most concerned about the process being cut off than I am about people actually doing potentially bad things with bioengineering. One thing that I can say kind of potentially validates the concerns over bioengineering is the reality that we live in a world with huge, huge economic inequality. And the reason I bring this up is that there are people concerned about biohackers, whether or not people doing private lab work for fun or to create their own patented products will unleash a super virus or do something horrible. And the problem with thinking through that is it actually takes a lot of money to be a bioengineer. It doesn't take a lot of money to set up a laboratory that can do DNA extractions and PCRs, to where you could maybe order a transgene and put it into That doesn't cost a lot of money. But to be able to create an organism that functions and lives requires education. Education is expensive. Understanding what you're doing is expensive. Even if it only costs a few thousand dollars to set up your own private lab to do bacterial research, that is still a pretty large investment for most people living in the United States and most people in the world. And if you want to, say, create a genetically engineered mouse, the microscope you will need just to manipulate an embryo costs $150,000. There's a huge barrier economically to being a bioengineer that is capable of doing something that actually has potentially large impact to the rest of the globe. That's why most of, almost all of this research that's having real significant change for medicine, agriculture, or nature is occurring at universities where there has already been millions of dollars in grant money to set up laboratories, to establish the infrastructure to do this, where people have 10 to 20 to 30 years of career experience building this field. Those are the people that will make a difference, not the biohackers. But maybe in 40 to 50 years, biohacking will be something where someone comes up with a cure for a disease in their little lab space. But I guarantee for the next 50 to 100 years, those people are still going to be what we would consider rather gentrified, rather privileged. And so, you know, no matter how much we try to make it cheaper to engineer complex organisms, it still takes a lot of money to get into it. And what concerns me about that is if we don't change society and our economic structure, what we're doing is we are enabling the extremely rich to potentially build their own bio labs and do whatever they want above the radar of the regulations where that public institutions and even many commercial institutions have to adhere to that no other normal person or regular income person can do. And then it becomes something that it doesn't matter if the public speaks out or whatnot, is that no one can really have a strong voice against the world's billionaires. As an advocate for my job and my organization, Revive and Restore, I really should say I really hope that bioengineering solves, you know, some major nature problems, and I do. But actually, personally, I'm really hoping that bioengineering gives us as human beings medical breakthroughs that finally allow us to maybe live in a little less fear of things like cancer, that allows what I would really love to see is a world where no one has to suffer the symptoms of genetic disorders anymore, or die from genetic disorders. So I want to see a world where people born with tysax disease don't die from that disease and live a normal healthy life, that people born with muscular dystrophy can be Olympic medal winning athletes, that people born with certain types of genetic blindness open up their eyes for the first time and see because they've been cured before it happens. And, you know, that's a world where CRISPR and gene editing technologies actually can get us there and there are already human trials doing that. And so what I want is for those cures, literal cures, to problems that could have never been cured without bioengineering before to be available and free to everyone. I want a world in which we come up with ways where we can have a higher quality of life, the longer we live. I want people in their 90s to feel like they are 30 years old and have people that don't degrade as they", "start_char_idx": 4233, "end_char_idx": 8577, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c8a846f2-eb26-4021-8703-a413ba958dbd": {"__data__": {"id_": "c8a846f2-eb26-4021-8703-a413ba958dbd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5bd77dd5-0f77-412c-a16e-8fe9bcbd4f25", "node_type": null, "metadata": {}, "hash": "502b82893a3dba4237f2391574c9d808ce603e4be43f65714443a1a1dd8658e8"}, "2": {"node_id": "63bf84cc-6bb7-4880-9da2-a97913db3808", "node_type": null, "metadata": {}, "hash": "46cb0bbf880ec5b7805f52d56bf31b52f862de359a1228a828e629d9b9b0553b"}, "3": {"node_id": "9de35603-4cf4-4939-9bec-7d9360547d30", "node_type": null, "metadata": {}, "hash": "a48d3eb71a0db342ccb61b9bed29edb238c3386493c8c62bce261065889f855a"}}, "hash": "989236586333a55d34c455f34553b552c0fd7b5ab31de68c28b82812a7a085e5", "text": "90s to feel like they are 30 years old and have people that don't degrade as they age, just because it's the biological condition. I don't necessarily think we need to be people that live a lot longer, but I think we don't really know the limits of the human brain or the human body, simply because we haven't really optimized aging. We eat better now, we have more food security now in many places, so we're living longer, but we haven't figured out the right medical attention to live longer in a good quality way. So, you know, I want to overcome that. And then when it comes to nature, as I've kind of already said it, I really want... If I were to say there's one thing I want to see in the next 10 to 20 years, it's a genetically engineered organism in the environment. A whole population of them restoring an ecosystem, doing what they were naturally evolved to do, but what they got compromised from doing due to human activities. I want to see resilience in nature. And of course, personally, I want one of those species to be a recreated passenger pigeon. So, I guess we didn't really cover this, but I should just say to everyone that one of parts of my job for Reviver Store is a project to recreate the extinct passenger pigeon, among many other projects to use biotech with nature. The reason the passenger pigeon is really my favorite species, and I'm so passionate about it, is I learned about them when I was about 13 to 14 years old. And if you read the accounts of the passenger pigeon, they were once the most abundant bird on the planet. A single flock of passenger pigeons could have been 2 to 3 billion birds in size. And they flocked so densely that when they flew overhead, people said it was as if there was a solar eclipse. I mean, they blotted out the sun and it was dark. They created their own wind. They were a force of nature that's really difficult to imagine today because there's nothing of similar abundance and size today. And really, nature used to be like that everywhere. Maybe not billions, but here in North America, before the arrival of Europeans, there were nearly 100 million human beings living alongside 5 billion passenger pigeons, 50 million bison, 500 million prairie dogs, I think maybe 500 million geese, over a billion total numbers of different species of ducks. This is a continent with life everywhere. It's what you read in the accounts that these settlers come in and they're like, oh my gosh, today we saw this, this, this, this. And that's not what we have anymore. And I believe just that bio-abundance is captivating and fascinating. And it begs the question of why can't we have that today? What is it about that that would scare people today? How are we so distant from this power of nature that we're scared of these things, things that we really should be in awe about? I've always been in awe. I was born and raised in a rural natural setting and I want to see huge herds of buffalo. I want to see huge flocks of birds. And so, you know, it's just its history captivates me. And the more I research the bird and the more I've learned about it, the more we've come to understand in the field that this species is actually vital to the forest ecology of the eastern United States. This was a species that was flocking in billions of birds anywhere from maybe 50,000 years to a million years ago, shaping the evolution of species that we think, wait a second, you know, a pigeon or a bird couldn't do that, right? That the evolution of oak trees themselves, giant oak trees, is shaped by pigeons, you know, is kind of phenomenal and mind-blowing. But it's true that we have trees and plants and other species whose evolution for hundreds of thousands of years was shaped by these pigeons and that are in a state today of trouble because they need the types of things those pigeons did in the environment, the disturbances and the nutrient transport and the things that they were doing, we need that back. And so, yeah, so it's just anyone that wants to look up the story of these birds. There's a lot of kind of folklore", "start_char_idx": 8597, "end_char_idx": 12682, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9de35603-4cf4-4939-9bec-7d9360547d30": {"__data__": {"id_": "9de35603-4cf4-4939-9bec-7d9360547d30", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5bd77dd5-0f77-412c-a16e-8fe9bcbd4f25", "node_type": null, "metadata": {}, "hash": "502b82893a3dba4237f2391574c9d808ce603e4be43f65714443a1a1dd8658e8"}, "2": {"node_id": "c8a846f2-eb26-4021-8703-a413ba958dbd", "node_type": null, "metadata": {}, "hash": "989236586333a55d34c455f34553b552c0fd7b5ab31de68c28b82812a7a085e5"}}, "hash": "a48d3eb71a0db342ccb61b9bed29edb238c3386493c8c62bce261065889f855a", "text": "wants to look up the story of these birds. There's a lot of kind of folklore out there, but I've got some talks online about our research and other stuff like that, that you can get kind of the lowdown on what passenger pigeons were. They're an elegant and beautiful bird. They're not the street bird that you often think of when it comes to a pigeon. And for me, passenger pigeons, I hope for other people too, would be kind of a gateway animal into realizing there's actually a lot of diversity to pigeons in the world. From Victoria crown pigeons that are the size of a small turkey that are blue with blood red eyes and fruit doves that have pink heads and lime green bodies to desert living pigeons with black faces and long tails. There's 350 species of pigeons and doves in the world on every island and continent outside of the Arctic realm. They don't like the cold. And, you know, there's a whole lot there. And then if you look at regular pigeons that inspired Charles Darwin's work, you know, go to a pigeon show and see fancy pigeons and you can see what human beings have been able to do through selective breeding. So there's 350 different species of pigeon in the world, but there are nearly 700 different breeds of just one species, the rock pigeon. Some of them are so different. It's that back in Charles Darwin's day, people actually thought they didn't know, they'd forgotten the history of how the domestic pigeon was domesticated. So there were different breeds of domestic pigeon that people actually thought were different genuses of bird because they were so different, but they're the same animal. You know, there's a lot. This is cool stuff.", "start_char_idx": 12671, "end_char_idx": 14340, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "af5587a6-2593-4bae-a1ee-5782ba363497": {"__data__": {"id_": "af5587a6-2593-4bae-a1ee-5782ba363497", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "21c5150f-ba65-4463-b9a4-7b6cc46774d1", "node_type": null, "metadata": {}, "hash": "accb814e33441a0c4ca2aaa884d01c23054b73f5ed777c3d4b56fcea473b18a8"}, "3": {"node_id": "18398298-b91a-4ea2-b7b0-f494e0e7babe", "node_type": null, "metadata": {}, "hash": "91e05ab5cc2304bf3c5971b2b87b6199b4c3f89c21338471316f37f54f58e122"}}, "hash": "983afd503f61fd52f751a39f44cc9d28487e793b6322c5de056d5b2762c49716", "text": "So, my name is Carrie McInturff, I'm a special agent with the Federal Bureau of Investigation in the San Francisco Field Office, and currently I'm actually carrying two hats, I'm acting as a fellow as a National Security Affairs fellow for Stanford University's Hoover Institution, so I'm a special agent in my day job, and then just doing this as a side project for about nine months. So, I like to say that I'm a bioengineer to your leader. I am passionate about science, and I've spent 15 years of my career working with citizen scientists, DIY biologists, and then all the way up to, you know, subject matter experts in academia. So, I've been working with bioengineers to just try to make this world as advanced as possible scientifically and technologically, while also ensuring that we're leading the globe in innovation safely. So, my goal primarily as an FBI agent is to ensure we have kind of this biosecurity framework about where bioengineering is going, because it's such an advanced science and it's exponentially growing daily. Well, besides the fact that I have, you know, dogs that are licking my face every morning, my family is obviously the first thing to get me out of bed, but ultimately, I have a 15-year-old daughter, and so in my mind, the way that science is advancing and the curiosity behind that and knowing that my daughter's going to see things that I've never seen in my career is really what excites me, and just seeing the potential. I'm a huge Mad Max, I'm a huge Blade Runner fan, anything, you know, Altered Carbon, all of these kind of advanced movies and scientific or sci-fi shows. So, the fact that, you know, that bioengineering has the ability to advance and involve our species, and that's something that I might witness in my lifetime, but something my child will definitely witness is very exciting to me. So, I think the biggest concern I have is mostly just that we lose the optics on ethics. So, the whole, you know, I'm a nurse, my background is in nursing, and so the mindset of first do no harm, you know, that's something that I hope that we can maintain as a, you know, it's just a baseline, that ethical baseline in science. The advancement is so insane that we have to really make sure that, you know, that our ethics are what are driving us. So, yeah, just really that we lose the optics on ethics and doing good versus harm. The possibilities with engineering humans and medicine, our environment, food, manufacturing, all of these things are endless. So, if we don't have that ethical baseline and that ethical foundation, that mindset is what's concerning to me. I want science to advance, I want to protect it at the same time. I think from a national security standpoint, especially when you look at, you know, what the FBI is doing and what the government agencies are doing as a whole, our concern is that we have, you know, foreign adversaries that are trying to use this advancement in science against us. So, when we look at, you know, historically nuclear weapons, biology, I would argue, would be, you know, the next phase in our nuclear weapon concerns. So, if we don't have that ethical framework, then I think that's something that's going to be concerning, but I'm all for the advancement. Yeah, I mean, you know, it's, again, it's first do no harm. The sky's the limit, though. I think if you limit yourself to the obvious, then we're not going to ever grow as a species. I think we have to think big, but we also have to ensure that when we're thinking big, we're understanding what that means for us evolutionarily. Like, if we're going to advance as a species, we also don't want to completely wipe out our species. So, I think my biggest advice to the generation that's coming up, because they definitely have it more figured out than us Gen Xers, but really, it's looking at anything as possible at this point, but we also saw, you know, we've seen what happens in an evolution when things go wrong. So, we just want to make sure that we're figuring out what our", "start_char_idx": 0, "end_char_idx": 4041, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "18398298-b91a-4ea2-b7b0-f494e0e7babe": {"__data__": {"id_": "18398298-b91a-4ea2-b7b0-f494e0e7babe", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "21c5150f-ba65-4463-b9a4-7b6cc46774d1", "node_type": null, "metadata": {}, "hash": "accb814e33441a0c4ca2aaa884d01c23054b73f5ed777c3d4b56fcea473b18a8"}, "2": {"node_id": "af5587a6-2593-4bae-a1ee-5782ba363497", "node_type": null, "metadata": {}, "hash": "983afd503f61fd52f751a39f44cc9d28487e793b6322c5de056d5b2762c49716"}, "3": {"node_id": "fd241010-c07a-4b07-9399-d6a9d3fdcb11", "node_type": null, "metadata": {}, "hash": "b7e82a23b41328a926dc2afa3041d8604abe7d1c6722c75238082e8bef84a2de"}}, "hash": "91e05ab5cc2304bf3c5971b2b87b6199b4c3f89c21338471316f37f54f58e122", "text": "things go wrong. So, we just want to make sure that we're figuring out what our baseline is, but don't limit yourself to what we've done today. I think there's just so many more questions out there, and if we stop asking questions, we're never going to advance. Medicine, pharmaceuticals, I think that, like I said, I was a nurse first, so watching science advanced healthcare or advanced healthcare is something that's super important to me. Making access to healthcare affordable, not just for those that can actually afford intervention, but we're looking at cures for disease process that, you know, only if you were the elite would you be able to actually afford this intervention. So, I think with the advancement that bioengineering and synthetic biology is providing is an opportunity for understanding and curing disease process that, you know, things that we never would have thought possible, like cancer and Alzheimer's, Parkinson's, a lot of neurological disorders that, you know, historically, at least, you know, as I was growing up, it's something that we just knew was going to be the death of us, right, eventually, we're all going to die of cancer. So, I think that really in 20 years, we're going to see advancements in medicine that we never dreamed of, and I think that that's going to be amazing. The one thing that I think is so important is to acknowledge the fact that there are billions of discoveries out there just waiting for your imagination, and I think that as a young student, we go into this mindset that we're so placed in a box of education, we're forced to take certain classes, we're forced to learn certain things, because that creates that foundation of advanced learning, right? But if we don't keep asking questions and if we don't keep understanding that there's still a lot of discoveries out there that nobody has even thought about, then we limit ourselves. So, imagination is something that I think is so important, and I think we lose sight of it so early because we're teaching kids to read and write from a very, very early age and we're not focusing on the arts and music and the things that actually make our brains work in an imaginative way. So, I would say, you know, again, remember, there's a ton of discoveries waiting out there for you. It's just going to take some ingenuity and some imagination. Find somebody in a career that excites you, get their advice. The one thing that I think was super important to me was to find an advisor and someone that actually, you know, cared about the career that they were in and were passionate about it so that that trickled down to me and made me excited. And then just, again, keep asking questions, because the more questions we ask, you know, the less we're limiting ourselves to, you know, this boxed framework of education. Yeah, let me answer the second one first. I honestly, there is nothing that I would change about the way that I did my career. I am one of those individuals that gets bored very easily. So I actually went in as a pre-med and I only wanted to be a doctor. And then I took my first forensic anthropology class and I was like, screw medicine, I'm done. It's time for a change. So I actually, I spent a lot of years trying to figure out what I wanted to do. And I just kept working and I took some time off from school. And I, you know, I just, again, I found my passion. I wouldn't change anything. To say that college is mandatory for this, I think we're in a day and a time where I disagree with that. In fact, I encourage my daughter now, you know, take a break. College is not everything, you know, you can learn so much with just life experience. And I really think travel is important. I think just getting out of our own bubbles is important to learn, you know, different cultures, different aspects of, you know, different people's opinions. So I think for my career specifically as an FBI agent, unfortunately or fortunately, yes, you have to have a college degree. You have to have a lot of work experience. It usually does require an advanced degree. But we have a lot of individuals that work for", "start_char_idx": 3978, "end_char_idx": 8113, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fd241010-c07a-4b07-9399-d6a9d3fdcb11": {"__data__": {"id_": "fd241010-c07a-4b07-9399-d6a9d3fdcb11", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "21c5150f-ba65-4463-b9a4-7b6cc46774d1", "node_type": null, "metadata": {}, "hash": "accb814e33441a0c4ca2aaa884d01c23054b73f5ed777c3d4b56fcea473b18a8"}, "2": {"node_id": "18398298-b91a-4ea2-b7b0-f494e0e7babe", "node_type": null, "metadata": {}, "hash": "91e05ab5cc2304bf3c5971b2b87b6199b4c3f89c21338471316f37f54f58e122"}, "3": {"node_id": "0b8a87e9-0ef2-416b-981a-a36595da67be", "node_type": null, "metadata": {}, "hash": "280aadc0f5f2eb941a4a43c93131529de289bf65fc11176e2935092246aa3540"}}, "hash": "b7e82a23b41328a926dc2afa3041d8604abe7d1c6722c75238082e8bef84a2de", "text": "It usually does require an advanced degree. But we have a lot of individuals that work for the FBI, that work for the government as a whole that actually don't have college degrees. There are professional support staff that do amazing things. We have support staff that are trained in different aspects of, you know, surveillance and different techniques that don't actually require a degree. So I think it's really just about finding your passion. And if college works, and if it works for you as an individual, then absolutely do it. But I don't think it's required, especially in this day and age where citizen scientists are working out of their garage. We've got, you know, labs in the community that you can go to and become a member of and you can find advisors there. You can learn how to CRISPR a gene right now without a college education. You can buy genetic engineering kits online that will teach you the things that, you know, you spend hundreds of thousands of dollars in in college to learn. So I think there's just very different aspects in science that, you know, 20 years ago we didn't have access to. I have seen high school students teaching adults how to CRISPR. I've seen young, you know, like 18, 19 year olds looking at genetically modifying bacteria to do anything. I mean, we can genetically engineer yeast now to make certain pharmaceuticals. The citizen science labs are fantastic. They're an opportunity for people that either are into science or brand new into science. It gives them that kind of taste and feeling about what you can do to certain bacterias. Biomanufacturing is huge now. You have the, you know, the aspect to genetically engineer a bacteria to extract lithium from ore to help the environment. We're using genetically modified, you know, agriculture day to day. We're using, I just lost my brain of thought, insulin. So pharmaceuticals, if you look at pharmaceuticals, they're making insulin in the citizen sciences labs with just bacteria. So I think the aspect of, you know, our food supply, one of the, I can't remember which plant-based food product it was, but one of those started actually in a lab, so in a citizen science lab. So it's just the ability to go in at the ground level and the things that you can do just in your garage, let alone, you know, an actual community lab is so crazy. So I love it. So I think it's kind of twofold from the aspect of, you know, the science world. I think with STEM studies, there is a lot of recruiting, you know, for women more in the science realm. I've seen younger girls get, you know, into science, whether it's through engineering or computer science, artificial intelligence, that kind of thing, coding. I've seen a lot more uptick in women doing that. As a woman in law enforcement, it's been very different, you know, over my almost, it's been 15 years now, my career, you know, I, it's definitely a boys club. As a single mom, I had a really difficult time in the very beginning of my career, kind of, you know, raising a kid at home and then also trying to compete in this, you know, huge world of law enforcement that's very dominated by men. It's been a huge challenge, but I've seen a huge shift as well. In my experience, especially with the government, we have more women in leadership positions, which has been amazing. In the science labs, like I said, the actual girl that I was talking about, it's a female that's teaching, you know, these adults how to CRISPR in a lab, and she's 18. And, you know, I think there's just way more opportunity than there was, you know, 20 years ago for women, for sure. I think that's why it's so important to find an advisor too. If you, you know, I think some of my favorite leaders just over my career have been women and a lot of, and not because I'm more prone to listening to women over men, I just think that it was the aspect of, I identify with them more and I've seen, you know, their struggles and I've witnessed my own struggles. So I hope that I can be that advisor then to a young woman coming into either this field or into science or whatever", "start_char_idx": 8104, "end_char_idx": 12210, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0b8a87e9-0ef2-416b-981a-a36595da67be": {"__data__": {"id_": "0b8a87e9-0ef2-416b-981a-a36595da67be", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "21c5150f-ba65-4463-b9a4-7b6cc46774d1", "node_type": null, "metadata": {}, "hash": "accb814e33441a0c4ca2aaa884d01c23054b73f5ed777c3d4b56fcea473b18a8"}, "2": {"node_id": "fd241010-c07a-4b07-9399-d6a9d3fdcb11", "node_type": null, "metadata": {}, "hash": "b7e82a23b41328a926dc2afa3041d8604abe7d1c6722c75238082e8bef84a2de"}, "3": {"node_id": "42ab1fd4-ae05-48a2-bb36-7deef6db7bbc", "node_type": null, "metadata": {}, "hash": "37b0c7f68d241d3dd2c673f11c7bad931ea585ac357f3c43a54fc8b7ad3f7b9d"}}, "hash": "280aadc0f5f2eb941a4a43c93131529de289bf65fc11176e2935092246aa3540", "text": "can be that advisor then to a young woman coming into either this field or into science or whatever it is that she chooses. I think a lot of times too, we focus on this whole gender role, right? And I know as a kid, you know, I had people tell me, oh, you know, you'll never be a doctor, you'll never be a lawyer because that wasn't what, you know, Gen Xers did. You know, it's like, even though we were kind of on the cusp of trying to get out and build those careers, there was still a standard of what we could or couldn't dream of, right? And I think that depending on where you grew up, I grew up in Midwest Missouri. So the aspect of having women in these high power roles, I didn't have those role models. So I had to really get out of Missouri and get out of my comfort zone before I started realizing that the world was my oyster. There was so much more that I could actually get involved in and learn. And I just really think that that took, you know, finding somebody that I connected with, having an advisor that could really encourage me and finding people that I really looked up to and respected. So I, yeah, you're right. When I was in college, it was easy for me to, you know, have those professors that I kind of lobbed onto and was able to get that guidance from. But again, I think that goes back to thinking outside your bubble and actually, you know, in this day and age where social media is so prevalent. I mean, the aspect that you can follow somebody on social media that you respect and you look up to and the ability to even just DM them or, you know, there are a lot of scientists out there that are famous that love that, right? Like you have the option to just ask questions of them. If that's not even an opportunity, I think, again, it just gets, it's about getting outside of your bubble and getting into your community. There are plenty of people in the community that are doing things that are phenomenal and we just have to look for it. And I think sometimes we get so used to just being spoon fed information that we don't take initiative to actually seek out those experience. And so I think it's important to take that initiative and find somebody that you really do look up to and it's worth just pinging them and giving them your story. I know, you know, my dad said the other day, he's like, I have a high school student that's really interested in talking to you about the FBI. Would you talk to her? And I was like, of course I would. Like, I don't think that we're doing a good service by shutting people down. If we are supposed to be advancing as a species and as a community, we're not doing any favors by not encouraging and by not leading. So the best thing we can do is to get out and mentor people and talk to them about our careers or the aspect that there's so much out there that we don't even realize what kind of jobs there are. So I would like to say that this is all me, kind of, but I don't. I wish I could say this is all me. The one thing that I've been working on for 15 years and the one thing that I really saw that was a gap, you know, in biosecurity. So first, let me just talk about the aspect of biosecurity is so foreign to a lot of people, especially in my organization. When you go in to talk to agents that have been in for maybe 15 or 20 years before they retire and they have a military background or they have a law enforcement background. When you talk about the things that scare people the most, the first thing they're going to think of is like a nuclear weapon, right? Like that's terrifying for our country. And that's historically terrifying. When you talk about biology, half the time people are like, well, I can't even spell biology let alone, you know, understand the implications of why I should be concerned about it, right? So I spent a lot of time working with citizen scientists and academia to understand what are the implications of biology? What does that mean from a national security perspective? Why should the government be worried about that? And I think up until COVID, we were all kind of on this, this cheerleading, you know, session of we need to be watching out for biology. Everybody", "start_char_idx": 12204, "end_char_idx": 16394, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "42ab1fd4-ae05-48a2-bb36-7deef6db7bbc": {"__data__": {"id_": "42ab1fd4-ae05-48a2-bb36-7deef6db7bbc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "21c5150f-ba65-4463-b9a4-7b6cc46774d1", "node_type": null, "metadata": {}, "hash": "accb814e33441a0c4ca2aaa884d01c23054b73f5ed777c3d4b56fcea473b18a8"}, "2": {"node_id": "0b8a87e9-0ef2-416b-981a-a36595da67be", "node_type": null, "metadata": {}, "hash": "280aadc0f5f2eb941a4a43c93131529de289bf65fc11176e2935092246aa3540"}, "3": {"node_id": "8c9d0eab-2868-415f-b693-62327b8eb53f", "node_type": null, "metadata": {}, "hash": "0677ca331493623ee23c0f09caa6cdc5bf3fb6825fd71b108e993bccac325edf"}}, "hash": "37b0c7f68d241d3dd2c673f11c7bad931ea585ac357f3c43a54fc8b7ad3f7b9d", "text": "this cheerleading, you know, session of we need to be watching out for biology. Everybody needs to understand that this has the potential to be probably worse than a nuclear weapon. And then COVID hit and everybody was like, oh, why didn't we know about this? And it's like, we've been talking about this forever, right? So in my casework, cause I, you know, like I said, in my, in my normal day-to-day job, I'm a field agent. So I investigate national security cases. I look at foreign adversaries that are trying to, you know, attack our national security. So what does that mean? When we look at biological weapons, historically, the United States has looked at, you know, anthrax or ricin as a biological weapon, but because of synthetic biology and because of bioengineering, we're seeing advances in science that we, we never dreamed possible. Then when you add computer science to that and you add artificial intelligence and machine learning, now we have a whole different ball game when it comes to this biosecurity, right? So what I was looking at is, you know, in the last probably 10 years is companies like 23andMe, Ancestry, all of these genetic companies that, although are very good and help us identify genetically what we're predisposed to for a disease process, there can be a flip side of that, right? So in the United States, we don't have any laws that protect our genetic information. So in science, we want to share that information when it comes to discoveries. We want to work globally with our other counterparts to make sure that, again, we're advancing science around the world, but we also have to be very careful in the United States about maintaining this economic, economic power. We want to be the best, right? We want our country to come out with all the new discoveries because, you know, America is the greatest country in the world, right? So how do we protect that? So one of the things we've been looking at from, you know, from a national security perspective from the FBI, but also looking within academia is how do you protect genetic information? And what does that look like? The United States doesn't have a legislation right now to protect human genetic information. So when you go do these tests like 23andMe or Ancestry, they get sequenced in another country and that country then has access to that genetic information. So that doesn't necessarily mean that they're going to identify you individually, Eric, as you're the person that this genetic information comes in. But when you look at the aggregate of the data, you start to see a trend in the United States of, you know, who has this disease process? What's causing this aspect of, you know, of advancement or not? So when I came to Hoover at Stanford, the one thing that I really wanted to focus on for my research while I was here is, is there a way that we can either develop a technology to protect genetic information or should we be looking at legislation reform? The FBI is not a regulatory agency. We're not like the FDA. We're not going to come into a scientist and say, you know, we want to put regulation on your science. You can't share this information because it's a threat to national security, right? So I've spent years trying to encourage scientists. That's not what I'm here to do. I'm here to learn because I need to know how we can protect our country, right? And protect that science that's coming out. So really looking at, is there a technology? Can we use blockchain? Is there some way to protect and code our own genetic information, whether it's human sequencing or whether it's, you know, a disease process, a new disease process that we've identified? How do we protect that while still advancing science? And that comes back to sharing, you know, across the country. It creates this communal aspect of science where you can still work in a collaboration with somebody in a, you know, in a country thousands of miles away, but at the same time, you're still maintaining that advancement in the United States and protecting that intellectual property. So if we can do that, if we can discover a way to protect that without maybe necessarily creating a law to infringe on that science, that would be my goal. And I think looking, you", "start_char_idx": 16401, "end_char_idx": 20667, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8c9d0eab-2868-415f-b693-62327b8eb53f": {"__data__": {"id_": "8c9d0eab-2868-415f-b693-62327b8eb53f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "21c5150f-ba65-4463-b9a4-7b6cc46774d1", "node_type": null, "metadata": {}, "hash": "accb814e33441a0c4ca2aaa884d01c23054b73f5ed777c3d4b56fcea473b18a8"}, "2": {"node_id": "42ab1fd4-ae05-48a2-bb36-7deef6db7bbc", "node_type": null, "metadata": {}, "hash": "37b0c7f68d241d3dd2c673f11c7bad931ea585ac357f3c43a54fc8b7ad3f7b9d"}}, "hash": "0677ca331493623ee23c0f09caa6cdc5bf3fb6825fd71b108e993bccac325edf", "text": "law to infringe on that science, that would be my goal. And I think looking, you know, 15 years in the future, I'm hoping that we, that we are, you know, advanced enough that we can figure that out. Because I think there's this new term coming out now called Bionet. You know, like, how do we protect the Bionet? We've looked at the internet for so long now. Now we need to take that next step with biology and say, if we're not careful, we're going to lose that competitive edge. So how do we, how do we keep it here without actually regulating it and without creating, you know, more work for our scientists to create this advancement?", "start_char_idx": 20662, "end_char_idx": 21299, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "eabb7bdd-f29d-47d0-98ff-e74dc16139a9": {"__data__": {"id_": "eabb7bdd-f29d-47d0-98ff-e74dc16139a9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "acabbdc1-3dac-4cb0-a745-98ee92a31da5", "node_type": null, "metadata": {}, "hash": "fe143ad143ab8c6499187404c0940bcbb26757a4453b9b90dd5180b9e64740e3"}, "3": {"node_id": "1753cbf6-6289-4dd5-8cc1-ec396c4e7998", "node_type": null, "metadata": {}, "hash": "78c9dbdb4bcfbf2521e9348a113a0433967e95bad737c033c281208456f13e30"}}, "hash": "0414d6ceecd7b055d0d97c574d8c4810f0470ea7def6344d1ab23ae0be94e969", "text": "My name is Luis de Luna, I'm currently a bioengineering student here at Maricosa, and I don't have a professional title, but I do know that eventually I do want to be a scientist or a researcher in pharmaceuticals. Well, I didn't really choose it, I happened to stumble upon it. I was taking a lab course here at this college, and one of the professors just reached out to me and said, hey, look, listen, you're doing a good job in my classes, have you considered biotech? And at the time, I was really not wanting to go into pharmaceuticals or into the big biotech industry, I just wanted to, you know, do research and do like things that are more esoteric compared to biopharma. But I got into the program because I thought, okay, well, it's cheaper, I get to have a bachelor's degree at the end of it. And it turns out that that's what got me into it, the more I learned about it, the more fascinated and interesting it became. And it just got to the point where I was like, well, this is actually something that I wanted to do now. And I believe it's this humor and there were about like two years ago, I didn't want anything to do with pharma, but now I'm really want to and that's all I want to do now. I think that's just the way life goes. During high school, I knew that I liked learning about the sciences more, but I just didn't think that it would go this far. At high school, I didn't really think that I would even graduate until I did. And then when you put in that position, you're kind of forced to think about your future. And I was like, well, I don't really know much what I want to do yet. So I came to Maricosta. But I guess when it comes down to that, yeah, it just kind of flew by. And to be honest, I didn't really think that it was something that was possible for someone like me, especially who grew up in very different environments than what a child should live in that I was like, well, it is scary. But I think it was worth doing. And so when it comes to answering that question, yeah, I was always interested in science, but I didn't think it was something worth pursuing until I was right at the doorstep. And then I was like, well, why not just take the chance now? The one thing that I do love about it is that even if you work in just like manufacturing or even research in any, I guess, little section of biotech or bioengineering is that when you go to work, you always learn something new. And when you wake up and you think to yourself, OK, well, today I'm going to learn why this way is done this way. And when you realize that bioengineering has so many different fields attached to it and you learn something new every day, it becomes less of a job and more of a of a fun thing to do because you go into work, you expect to learn something new. And those expectations are always met. And so even if that doesn't fulfill your, what would you call it, like even if that doesn't fulfill what you want to do yet, you always know that as long as you keep staying on that track, you're eventually going to find out what you actually want to do. And I think that's part of the beauty of what this profession is. I think that, I mean, of course, making medicine for new diseases is something that is always going to be a thing. But when it comes to what we can do as people besides the biotech aspect of it, I think that we can definitely improve the accessibility for others. I think that a lot of talent is wasted because people kind of just like give you your title and you're kind of stuck in that role when biotech was introduced and it grew because of people going outside of their typical roles. And I think that the more we embrace that, the faster progress we can make towards these new innovative ideas and we can create and pump out medicines even faster. And I think that when you collaborate with someone who doesn't know anything or like know something, but doesn't know as much as you're doing compared to someone that knows everything about it, the mixture of different perspectives is what really like shoots the progress. It", "start_char_idx": 0, "end_char_idx": 4077, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1753cbf6-6289-4dd5-8cc1-ec396c4e7998": {"__data__": {"id_": "1753cbf6-6289-4dd5-8cc1-ec396c4e7998", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "acabbdc1-3dac-4cb0-a745-98ee92a31da5", "node_type": null, "metadata": {}, "hash": "fe143ad143ab8c6499187404c0940bcbb26757a4453b9b90dd5180b9e64740e3"}, "2": {"node_id": "eabb7bdd-f29d-47d0-98ff-e74dc16139a9", "node_type": null, "metadata": {}, "hash": "0414d6ceecd7b055d0d97c574d8c4810f0470ea7def6344d1ab23ae0be94e969"}, "3": {"node_id": "57c742fc-029c-4a52-ac80-9bf123e909f5", "node_type": null, "metadata": {}, "hash": "0d7bada09406590f9aa150e26105d5c81d2261134a70d0466dd6120264aa7adf"}}, "hash": "78c9dbdb4bcfbf2521e9348a113a0433967e95bad737c033c281208456f13e30", "text": "it, the mixture of different perspectives is what really like shoots the progress. It catalyzes it into something that is both collaborative and useful for the biotech industry. And I think that as time progresses, when you start removing labels and you see people for what they actually are and what they bring to the table, then I believe that we were actually going to start progressing farther than we do now. So that's something that I do hope changes over time. So I knew that since in high school, one of the things that drove me kind of like scared of this pathway was that like, oh, well, I don't see people like me doing any of this. Why should I do it? Right. And I think that as our generation right now has the most impact to be able to change that because it's because like education becoming more accessible because education has been able to include people like us into the circles that were unaccessible before. I think it gives us the opportunity to give us that mindset where it's like, well, it's not us, then who else if you and I can't break those barriers and we have to give it to somebody else to do it. But what if they can't do it, you know? And so I believe that as people of color like you and I, we have to make that strength not only for ourselves, but for others, because when you when it's like if we were to go back and look at who we were able to look upon, we want to be able to give that to other people who are still studying to give them that opportunity to look to somebody and say, well, if they can do it, then why can't I? And I think that as we continue to make that push together as a community, we're going to build more strength. And I mean, it's already being presented by women. So many women already introducing and being flooded into the biotech industry, and that's already made a significant change. Like we have been progressing further and better into the future, whereas before it seemed like it was hindering because there was such a limited like amount of thinking like it was groupthink. But I think that as people of brown and black and other colors, we should definitely make that effort ourselves. If we can't go as far as to go like a PhD, we can make little steps and more and more we step on that path, the more I guess cemented it becomes and it becomes easier for people behind us to walk into. I think the advice I would give is that it's always going to be a marathon. It's never a sprint. The faster you realize that, I think the more grounded you become and you realize that your efforts that you have in your habits now, when you teach yourself that, it becomes easier because you realize, okay, well, it gives you a second to stop and really think about what you're learning. And so I think for people who are in high school, so on that cusp, I would tell them, ultimately, I would recommend the biotech, but you can choose any other major, it's them related and you can still say to yourself, it's going to take a while. And when you give yourself that time, it gives you some of the opportunity to open up to other things and really develop yourself as a person. And I think that's one of the most important things you can do, especially professionally, it's just develop yourself. The more you develop yourself, the more discipline you earn, the more respect you get out of people and eventually opportunities just come to your door, you don't have to go look for them anymore. Yeah, I think that right now the leadership within the biotech industry is very small and very, I don't want to say the word monopolized, but it's very tightly knitted. And I think that as people leave those leadership positions and are flooded with people of our generation or black and brown individuals, the worry is that people who were still there because of tenure are going to oppose a lot of the new ideas and impede on the progress that we make. Another thing that I worry is that ethically as education and as all these equipment becomes so much more accessible and cheaper, that the lacking of education in terms of like high school and teaching of ethics is going to enable children to like, or not children, but like people who have that access to be able to", "start_char_idx": 4006, "end_char_idx": 8231, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "57c742fc-029c-4a52-ac80-9bf123e909f5": {"__data__": {"id_": "57c742fc-029c-4a52-ac80-9bf123e909f5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "acabbdc1-3dac-4cb0-a745-98ee92a31da5", "node_type": null, "metadata": {}, "hash": "fe143ad143ab8c6499187404c0940bcbb26757a4453b9b90dd5180b9e64740e3"}, "2": {"node_id": "1753cbf6-6289-4dd5-8cc1-ec396c4e7998", "node_type": null, "metadata": {}, "hash": "78c9dbdb4bcfbf2521e9348a113a0433967e95bad737c033c281208456f13e30"}, "3": {"node_id": "6ca95c29-59d9-4177-aba8-976cba88b82d", "node_type": null, "metadata": {}, "hash": "856c5b737877ab8a649efe993c79771d5656e640dc85b45793ca55d24064ac7b"}}, "hash": "0d7bada09406590f9aa150e26105d5c81d2261134a70d0466dd6120264aa7adf", "text": "enable children to like, or not children, but like people who have that access to be able to work on a lot of things at home and give them the opportunity to do things that aren't supervised and may create problems. And I think ethically, it enables people to make hypotheses and a lot of experiments that are not as ethical as they should. And that is why I believe that we should continue to teach children about ethical considerations and pharma, we should continue to teach children about the accessibility and the power that they have, and also teach them about the power of leadership and how you as an individual can influence others around you without even doing anything and why that power of being a leader is able to, you know, transform the lives of people around you. And that's why I believe that moving forward, we should always consider what can we do better? We should always consider how can we make this better for the people behind us? And how can we make this better so that people don't have to go through the unnecessary wastes and symptoms of unethical practices? I think that people who are below me in age are very confused because of how society has been changing so much lately. And so I think that people just resort to the path of these resistance, where like, if something's bad, it's completely bad. If something's good, it's completely good. But I think we should take a step back and understand that as a society, we have always been have social issues and that the implementation of change is always going to have resistance. And so I think that something that I would tell newer individuals is that nothing is really ever black and white. Everything is gray. You can do something good and it can have bad consequences and vice versa. You can do something bad and have it have good consequences. And I think that the most important thing that people below me should understand is that nothing you do, everything that you do actually has consequences. And I think that the more you understand about how your consequences affect others, the better decisions ethically we can make in the future. It definitely does have different pathways. I've known a lot of supervisors that in the biotech industry that don't have degrees that manage to learn as much as they do without it, because when it comes to accessibility, science has become so easy to understand now that pretty much anybody can learn it without a degree. So I would say that, yeah, you don't need a degree, but at the same time, it's almost like a tug of war. You don't really need one, but at the same time, getting one really opens your mind into different possibilities and it gives you that education to understand that there's more to it than just this biotech. Biotech affects this, biotech affects that. As long as you get that education, I think that you understand more about the considerations of some applications than others. And so I would agree that, yeah, getting a degree is not mandatory, but I would recommend it not only because of the things I said, but because also professionally, it does catalyze your progress and it makes things a lot easier because the diploma does make it easier for other employers to give you more credit and have more weight when you say things. I am very interested right now in gene editing, CRISPR molecules. I think that's something that I do want to work on my doctoral about, because right now, CRISPR is so limited because of its ability, I mean, yes, super specific, but it's also very hard to get it to where you need it to be. And I think that if we can manage to really make that molecule as specific as we want it to be, we can cure so many genetic diseases with just one application, as opposed to other diseases that have antibodies or different proteins like insulin or other things like HIV, but the ability to just edit a gene and call it a day, do just one simple application will actually transform the way we view medicine. And I think that that's something that I want to focus on because I know that if you make a breakthrough, it will significantly catalyze everything else in the biotech industry and it'll just like spew out different medicines that fast. And so I think that's something that in the future, we really got to keep our eye on now, especially too, if you're getting into this industry and you want to like work on something that's innovative and it's", "start_char_idx": 8229, "end_char_idx": 12660, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6ca95c29-59d9-4177-aba8-976cba88b82d": {"__data__": {"id_": "6ca95c29-59d9-4177-aba8-976cba88b82d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "acabbdc1-3dac-4cb0-a745-98ee92a31da5", "node_type": null, "metadata": {}, "hash": "fe143ad143ab8c6499187404c0940bcbb26757a4453b9b90dd5180b9e64740e3"}, "2": {"node_id": "57c742fc-029c-4a52-ac80-9bf123e909f5", "node_type": null, "metadata": {}, "hash": "0d7bada09406590f9aa150e26105d5c81d2261134a70d0466dd6120264aa7adf"}}, "hash": "856c5b737877ab8a649efe993c79771d5656e640dc85b45793ca55d24064ac7b", "text": "into this industry and you want to like work on something that's innovative and it's just not being many people understand it yet. People are still learning about it. I think that CRISPR technology is the way to go. It's definitely interesting. When people read about CRISPR, they think to themselves, wow, this seems very complicated to work on and to like get it perfectly. But when you actually work on them, you realize it's really that simple. It's just putting things in a tube and then letting it heat up and then just making sure that what you got was correct. It's actually literally just as simple as four steps. And I think that it's super interesting because of how easy that science is. I mean, as long as you understand basic biology that you're taught like in middle school and high school about cells and all that stuff, you realize very quickly, oh, this is where this applies to. And it definitely is something that you could spend years on just discussing about because of how interesting and the many different things that you can do with it. Because like with CRISPR, you can even edit like the plants that we eat to make them more nutritious or just the different applications that you can think of. Just one simple thing is just absolutely wild. And I think that anybody that wants to work in biotech should understand CRISPR. We had bacteria that had blue ledges for simple reasons, had blue dye as its products, right? And we were trying to change the genome to where instead of blue, it'll make it white. And so it was as simple as just grabbing those cells, transforming them to allow the CRISPR molecule to enter them. And after a day or two of letting them grow in a petri dish, you saw them grow white and you just think to yourself, wow, that's amazing. And so I think the application was as simple as if you can get it to work like this in a two-hour lab, imagine what you could do in an eight-hour lab. I think that once I get my doctorate, I want to go work in industry and for like the research of medicine pretty much and big biotech companies, because after what happened with COVID, the production of the COVID vaccine in just what, in about a year or two years is fascinating because stuff like that doesn't happen very often. And I think the process of like creating a drug from the very beginning, taking it all the way through all this different trials, and then finally at the end, it gets approved. I think that's the beauty in that magic to know that you created something that can definitely help other people's lives. And I think especially too, a lot of people do this because of the personal life, they have someone in their life that does suffer from something. And so that motivates them to want to find a cure for it. And I think that that enables the motivation and the fuel for a lot of researchers, especially black and brown students to just keep on going and learn more. I think just one piece of advice that really changed me and how I'm viewed is to definitely work on yourself and teach yourself how to get out there. I think that most people live inside their own box. When you stretch outside of your box is when real progress, real change starts to happen within yourself. And I think that the earlier you begin to understand that the world is always going to be uncomfortable, and so you must learn to put yourself in an uncomfortable situation, the faster you're going to progress because other people are already doing it. And I think that if someone were to teach me that in high school, I believe that I wouldn't have failed as much as I did to get to where I am today.", "start_char_idx": 12651, "end_char_idx": 16288, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "50ad5d94-7afb-433b-9d21-528ed8b432a6": {"__data__": {"id_": "50ad5d94-7afb-433b-9d21-528ed8b432a6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "880f2ccc-ce11-4f02-b940-ad9e5fbed360", "node_type": null, "metadata": {}, "hash": "53cada3a28dc3efda5124d657208133ab0f1da11f986de2e81b24717495dc212"}}, "hash": "53cada3a28dc3efda5124d657208133ab0f1da11f986de2e81b24717495dc212", "text": "Algo que me gusta mucho de la biengenier\u00eda y de poder manipular c\u00e9lulas y material biol\u00f3gico es que la complejidad del tipo de actividades que puedes tener es mucho m\u00e1s alta que la que tendr\u00edas con solo una mol\u00e9cula o una prote\u00edna. Nuestras c\u00e9lulas son capaces de moverse dentro de nuestro cuerpo, de recibir se\u00f1ales, interpretarlas y responder y me gusta mucho la idea de poder utilizar estas c\u00e9lulas como robots o algo que puedes programar para poder hacer diferentes funciones. Entonces, creo que estar en biengenier\u00eda te da la oportunidad de tener esta emoci\u00f3n de poder manipular c\u00e9lulas y al mismo tiempo pensar como si fueran un juego. Es algo que me gusta mucho. Creo que algo clave dentro de la ciencia y la biengenier\u00eda en general de tratar de entrar a este campo de hacer investigaci\u00f3n, es muy importante encontrar una comunidad y acercarse a la gente que ya est\u00e1n dentro de estas comunidades. No tener miedo a preguntar. Al menos as\u00ed fue mi entrenamiento. Quien preguntaba era quiz\u00e1 quien no entend\u00eda y eso es algo que inhibe mucho a las personas o me inhib\u00eda a m\u00ed en el pasado a preguntar, a acercarme a alguien a pesar de que ten\u00eda el inter\u00e9s o esta motivaci\u00f3n. Entonces, mi consejo o algo que creo que ser\u00eda muy importante es quitarse ese miedo poco a poco, acercarse a la gente, preguntar. Creo que siempre no sentirse desilusionado si alguien no te responde. Creo que algo parte de ser cient\u00edfico, estar en ciencia, es tambi\u00e9n esta parte de intentar hacer experimentos. Algunos van a fallar, otros van a ser exitosos. Entonces, eso empieza desde acercarse a la gente y pedir ayuda, pedir consejos. Creo que eso es algo importante dentro de nuestro campo.", "start_char_idx": 0, "end_char_idx": 1670, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8477a745-994c-4891-8706-e8cc46d58265": {"__data__": {"id_": "8477a745-994c-4891-8706-e8cc46d58265", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c2286310-5d5e-456f-bc5f-07dd356f904f", "node_type": null, "metadata": {}, "hash": "5001f2fce29ed2f69d4cfee11c6053f28465d68eb16127201274d6f73cb76cea"}, "3": {"node_id": "a301b8b7-9fdd-44ba-affc-b1de97c7c404", "node_type": null, "metadata": {}, "hash": "761ae2373fceed894529cb284b90c6564985748f86420f41dbe08fd8e89465e2"}}, "hash": "da3c00944cd2a6c424c9481c685445ebec91821b68ac4e198880e4f66b6d4ddd", "text": "Great. I am Rogelio Hernandez-Lopez, and I am also an assistant professor in the bioengineering department and in the genetics department at Stanford University. The type of bioengineer that I am is a cell engineer, meaning I work on trying to modify cells, not only to understand their biology, how they function at the single cell level, but also at the collective behavior level. And the idea is understand biology, but also perhaps make the cells to achieve new functions. And one system that I'm really interested and particularly excited about is the one of T-cells, with the idea of creating novel therapeutics for cancer treatment. Here what we're doing is putting synthetic receptors at the surface of these T-cells. And with these synthetic receptors, the T-cells are able now to recognize specific features of cancer cells so that you can redirect the cytotoxic activity of these T-cells against cancer. Yeah, that's a very good question. I started in science as a chemist, and I think I always liked the idea of creating molecules, creating novel things, not trying to build things out of fragments. And I think for that, chemistry is great. But as I progressed, like during college, and then later during my PhD, I got fascinated by biological matter, by proteins, and later by cells. And I just thought that there is so many things unknown in biology, but also at the same time, many things to discover or to create with biological materials that I just found fascinating to stay in this field of bioengineering or cellular engineering. I became interested in chemistry because of my experience with the Science Olympiads. So when I was in high school, there were these set of contests that are actually worldwide in math, in biology, in chemistry, and physics. I think later on, they came up with also computer science for them. So I started in math, but also because there were professors at my school that say, oh, it seems that you might be good for other subjects. Why don't you try chemistry? I turned out to be also better at chemistry than math, for example. So I had the opportunity to participate first in kind of like the regional contest and the national contest, and I went to the international competition when I was in high school representing Mexico. And through that process, I met so many people and had the opportunity to go and meet also college professors for the trainings and just to get prepared for this competition that I didn't know before that experience that you could actually dedicate yourself to do research and try to understand how things work. I always thought, oh, maybe I'm going to be an architect or perhaps an engineer, but more thinking about like chemical engineering. But through this experience of going to this competition and meeting other people, that's when I realized, oh, there is this other field of research, and you can actually make discoveries or like try to understand how things work or write new textbooks, things that we don't know. And yeah, that's when I decided that I wanted to actually do chemistry at that point, I guess, because I was also getting good results in this competition. But yeah, I've been always curious about how things work and function. I think what is exciting is that more and more there is, I think my engineering brings together people from different fields. And that's really exciting for me, like being able to interact with physicians or peer engineers or physicists or chemists. But now we are all together, working towards how do we control or work with biological matter. I think that's something that is really exciting about bioengineering that is multidisciplinary, interdisciplinary, not only like within the science, but also across fields. You can think about bioengineering in the context of art or in the context of like something that is very relevant to us now, policy. So I think that it is a great field to be in. What worries me is that at the same time that there is like a rapid development of technologies and tools to control biological matter, there is the discussions around how do we train and teach everybody to what the correct things are and what others are not. I think that's something that I'm slightly worried. For example, just to give you a concrete example, the idea of biohacking or like being able to make use of", "start_char_idx": 0, "end_char_idx": 4350, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a301b8b7-9fdd-44ba-affc-b1de97c7c404": {"__data__": {"id_": "a301b8b7-9fdd-44ba-affc-b1de97c7c404", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c2286310-5d5e-456f-bc5f-07dd356f904f", "node_type": null, "metadata": {}, "hash": "5001f2fce29ed2f69d4cfee11c6053f28465d68eb16127201274d6f73cb76cea"}, "2": {"node_id": "8477a745-994c-4891-8706-e8cc46d58265", "node_type": null, "metadata": {}, "hash": "da3c00944cd2a6c424c9481c685445ebec91821b68ac4e198880e4f66b6d4ddd"}, "3": {"node_id": "2ad05135-f727-4fe8-aa0e-067d950d0fce", "node_type": null, "metadata": {}, "hash": "0119a2e7c45d0c856ee4d4aa9008a8f5bf53665ed615056b7e70b27bf2d85b4b"}}, "hash": "761ae2373fceed894529cb284b90c6564985748f86420f41dbe08fd8e89465e2", "text": "concrete example, the idea of biohacking or like being able to make use of bioengineering or biotechnology tools in your garage. I think that's really cool. I think that has prompted a lot of discoveries and a lot of people to get involved and interested in science, technology, computers, now in biology or bioengineering. But at the same time, the same idea of how do you prevent incorrect use of technologies or inappropriate use of technologies, I think that's something that we should always be keeping in mind. We don't want to see things like undesired running around or being uncontained. I think it's more about not being afraid of this. It's just like building, I guess, a set of discussion or having enough interactions among the different stakeholders to actually agree on how we move forward. But I think I am more prone like, yes, we should democratize the access not to all these technologies, knowledge approaches, but not forgetting the aspect of what we should be thinking in terms of like the ethics and the regulations. I think hopefully finding bio-inspired solutions to the environment and all the challenges that we have as the population grows and there is more demand on food or how do we clean water, how do we avoid contamination in general pollution. I think there is a huge opportunity for bioengineering and bio-inspired solutions to make a contribution there. So hopefully now we're going to also have buildings or things that are integrated with biological material and that we can interface with in a different way. I think 20 years might be too soon for that, but I think right now there is a good time to start thinking about how do we get there. One practical advice, I think reach out to people. I think science and scientists or engineers, bioengineers, at the end of the day, there's a community, we are social entities and I think the best way to learn what the field is and what the opportunities are is to talk to people who are already there at all levels. I think for a high school student, maybe reaching out to college students that are already working there, but also maybe someone doing a PhD or a professor in that field because then that way you get different perspectives, different ideas of what the possibilities are. Then you start building a community as well through those interactions. That's something that I think is very important in a career in science, for example. Yeah, that's a very good question and point. I think thinking about what, I mean, there is many, many types of questions or things that you as a student might be wondering about. Then picking a few at a time, not trying to really, maybe also do a little bit of research on your own and have a set of questions. Oh, I find this interesting, but also I don't understand these other things. I think when we frame interactions in terms of common questions or common interests, that's an easier way just to get things going in a conversation. It's much harder when it's just like, oh, I want to talk to you or do you have some time to talk to me? Also, as the person who receives that message, it's very ambiguous to receive that kind of email. You get an email saying, oh, I read these and I found fascinating these, but I don't understand that. I think then that's already a way to start the conversation. I think people are going to be also excited about discussing those things, regardless of whether you are getting an email from another colleague or a professor or a college student or a high school student. I think it's always fun to hear what other people are thinking and how they are interpreting what excites them. Many times you will realize that the excitement of a high school student is the same as someone who has been in the field for 30 years or so. That's something that just creates this nice environment to start conversations. I think you are absolutely right that there is still a few of us and fewer in respect to how many people are in the field or in science in general. I like to think positively in the sense of we're making progress and connecting with people in the community that you identified with. I think for the most part, maybe I've been very lucky that the people who I have reached out to and identified with, they have always been willing to support and help. Because of that, I always also try to do the same or try to find this common interest, these common perhaps", "start_char_idx": 4290, "end_char_idx": 8721, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2ad05135-f727-4fe8-aa0e-067d950d0fce": {"__data__": {"id_": "2ad05135-f727-4fe8-aa0e-067d950d0fce", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c2286310-5d5e-456f-bc5f-07dd356f904f", "node_type": null, "metadata": {}, "hash": "5001f2fce29ed2f69d4cfee11c6053f28465d68eb16127201274d6f73cb76cea"}, "2": {"node_id": "a301b8b7-9fdd-44ba-affc-b1de97c7c404", "node_type": null, "metadata": {}, "hash": "761ae2373fceed894529cb284b90c6564985748f86420f41dbe08fd8e89465e2"}}, "hash": "0119a2e7c45d0c856ee4d4aa9008a8f5bf53665ed615056b7e70b27bf2d85b4b", "text": "I always also try to do the same or try to find this common interest, these common perhaps struggles, and discuss both. I think those are important. The aspect that for sure excites me the most about being in science is being part of a community. Finding that community and deciding who you want to talk to and what people you want to interact with. I think that's very, very important and valuable and something worth investing time and effort. Is college mandatory? I think not because of the knowledge, but again, because of the community and because of the interactions, because of establishing relationships across different stages of the career. The knowledge now is out there. Anyone probably at any point can go online and learn and hopefully not through different programs and the use of the internet. Now we are going to be spreading knowledge more and more and very high-quality content. There is still this aspect of discussing with other people and just sharing experiences. I think that's where the college experience is still unique and therefore will also propel you for the next steps and allow you to succeed in this area. I think that's where the importance of college is at the moment. What would I study different or as if I were back to college? I think maybe more biology. Even though now I'm very interested, I think a little bit more biology and more physics perhaps are the two things that I would like to have a little bit more knowledge on. Other than that, I feel that this aspect of having a different perspective and coming from a different field and then suddenly moving in towards now, as I said, not this bioengineering field that attracts people from different places. I've been feeling that I have a unique perspective to the type of problems that we are approaching or trying to solve. I think that's also good to have something to contribute. It feels good as well. Currently, I'm working on developing novel cellular therapies for the treatment of cancer. Why do we do that? If you, for example, think about the current therapies, they are either of chemical nature or biological nature but at the molecular scale. You have a protein or you have a small molecule, but that's very different from now using a cell that has autonomous behavior. The cells know how to navigate our body, where to go. They can send signals and process those signals and respond. I think then this higher order, higher level sophistication of the functions that you can encode, for example, into a therapeutics, that's something that will allow not only the treatment of cancer but probably the treatment of many other diseases. Having a way to really interface with cells and tell them where to go, tell them where to start the therapeutic functions, when and where to turn off. I think that level of sophistication, that's something that I think we can only achieve with cells. Just because also our bodies are biological material or nature is biological material. This interface between engineering cells or programming cells and having these higher order, more complex applications, that's something that hopefully we're going to get there one day. That really excites me about being in bioengineering. I think I'm going to say that many times, and that's because of a parallel work. As a grad student with a group of friends, we started an outreach program for high school and college students, first in Mexico, and now the program has expanded to Latin America. With this work over the years, what we have found is that the most interesting question or the most exciting questions are coming from high school students. I really think that all this curiosity and maybe at the same time not being familiar with the material and with the content of a particular area also sparks innovation and sparks these very interesting questions. I will just encourage all the high school students to continue asking those questions. I think those questions are really cool, really important. For me as a scientist, now a few years in this field, it's really interesting and cool to hear what is interesting for high school students. I will encourage you or encourage students to ask those questions.", "start_char_idx": 8692, "end_char_idx": 12899, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ae62338e-bd16-4de9-9f42-3fcabfe435b1": {"__data__": {"id_": "ae62338e-bd16-4de9-9f42-3fcabfe435b1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b79e56cc-1fc9-4282-a83e-d131ee3df67a", "node_type": null, "metadata": {}, "hash": "527dd879152175a46400cd759ae9e20b6ae930618d61a3acda97f39dea4a7ff6"}, "3": {"node_id": "49e36f9c-baad-4000-870f-8636af293ce5", "node_type": null, "metadata": {}, "hash": "876423f1168769593d1de42d83ab61c44373a6bdad754c77931591824712e247"}}, "hash": "0fec968d9be2a72329052ed1ba5bea99b6d348a7c6177efe0f38079e109e758d", "text": "So, hello, thank you so much for inviting me for the interview. My name is Siavash Arar. I'm an assistant professor, which means a new professor in CSU Long Beach, and I work in biomedical engineering, but I really think of myself as a bioengineer. So, my lab is made out of entirely undergrad students, and we work on a couple of cool projects. I'm going to pick one that I'm really excited about, not that the others are not good, but we're building tools to study aquatic organisms. We build very cheap microscopes, and these fluidic homes, essentially, if you will, these fluidic chips, to study sand dollar larvae. These are like, you know, when they grow up, they look like a giant circle, but when they're young, they look like the stealth bomber, essentially. And we're trying to, and also Hydra, which is like this crazy organism that if you cut it, you end up with two, and, you know, I can tell you all about that. But why we're working on these is because we want to use their hydrodynamics, like how they move inside the liquid environment, and how they respond to various, you know, environmental factors as a model to understand the impact of climate change on various organisms. And we're not biologists, so, and we love biology, we work with amazing biologists, but we're engineers. So, our approach is, like, we are smart enough to know that we know very little biology, given our background, so we partner up with awesome biologists. So, our approach is broadly to build tools that help biologists do their research and slowly begin to ask our own questions from an engineering perspective. So, you know, that's a great question. And I think folks can contribute based on what they know, and as long as they're happy to learn, you know, like, as long as you're willing to engage with the problem, think about it deeply. And if you have gaps in your knowledge, willing to, like, you know, fill it, I think you can begin to learn and contribute. Like, I don't, you know, like, when I started my undergrad studies, I was not a bioengineer, I was, and I went to a high school outside of the US, where we had to pick a major. So, I was a, kind of like a physics and math track student. So, the first biology course that I took was in college, and that was, like, in all honesty, the first ever biology course I had ever taken. It's, like, probably my lowest grade ever. But I really liked it, because it was really new. I had no idea what was happening, like, genuinely, like, I think I barely passed the course, and I had ruined my GPA, but it kind of didn't matter, because I was just, like, it's really cool. So, I started my research as a biomedical engineer, working on similar types of stuff, while I did not know any biology. But I actually grew to like it. At the beginning, I was not at all excited about learning biology. It seemed like a chore, but it kind of changed over time. To go back to one point that I guess maybe I didn't do a good job of emphasizing, is that, you know, like, we love to learn biology, but when I say we bring an engineering perspective to it, I really like building stuff. Essentially, you know, like, I've always been into kind of, like, making new types of tools, making devices, working on projects. So, when I was in high school, I was part of a theater group that we worked on, putting on the, you know, I guess the light pieces for the production. So, that was the thing that excited me, like, building stuff. So, we are at a place in bioengineering that we can build stuff for, you know, studying biology, or build with biology itself. And as long as that's a perspective that you bring in, I think you can contribute to the field, and you can grow and learn. So, you know, I thought about this question, and I wish I had, like, a very, like, a neat or, like, profound answer. I think that, you know, like, throughout, there were, so", "start_char_idx": 0, "end_char_idx": 3892, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "49e36f9c-baad-4000-870f-8636af293ce5": {"__data__": {"id_": "49e36f9c-baad-4000-870f-8636af293ce5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b79e56cc-1fc9-4282-a83e-d131ee3df67a", "node_type": null, "metadata": {}, "hash": "527dd879152175a46400cd759ae9e20b6ae930618d61a3acda97f39dea4a7ff6"}, "2": {"node_id": "ae62338e-bd16-4de9-9f42-3fcabfe435b1", "node_type": null, "metadata": {}, "hash": "0fec968d9be2a72329052ed1ba5bea99b6d348a7c6177efe0f38079e109e758d"}, "3": {"node_id": "ac8f5290-543f-4c15-b42e-523d5168341d", "node_type": null, "metadata": {}, "hash": "94ca47d2ab89850ecc2d93ce282aaedcab531f1378dc1080c73530b570faeec5"}}, "hash": "876423f1168769593d1de42d83ab61c44373a6bdad754c77931591824712e247", "text": "profound answer. I think that, you know, like, throughout, there were, so I've always been a little nerdy and academic. So, there were a lot of, and I read a lot, I read very broadly. And there were a lot of papers, research papers, that really genuinely captivated my imagination. I had no idea, when I first read some of those papers, what they were really talking about. Like, I did not at all understand the biology. But I just really liked the idea, right? I was, like, a second year undergrad in electrical engineering, reading a paper about kind of building, I guess, clock-like circuits inside bacteria. I did not really know what was a genome, like, how bacteria, like, worked. But I just really, you know, liked the idea. I was, like, oh, this sounds, genuinely, it just sounds cool. So, and there were a couple of other papers similar. So, that's how, like, I think my kind of attention shifted towards bioengineering as a young learner. And I guess there were a couple of steps along the way that this path became more obvious. One of the reasons I think it's a good time, one of the reasons I'm excited to be part of bioengineering today, is because I think the discipline, the community, is one of a big camp, right? Big tent approach. So, you can do many different things, and you can work on very exciting types of projects in the discipline. So, that's a very, you know, very good thing about the field. Not every community or the field approaches their studies or their profession this way. So, that, I guess, may, I don't know if I'm answering your question very well or not, but that's how I think about it. So, I think the safe bet type answer is that, you know, there is, there are now a lot of very cool opportunities that stuff that we've learned from biology itself can be kind of, like, useful, and that's a bad, bad way of maybe describing this, but they can be utilized in a fashion that we mean to use them that way. This is slightly off tangent. I'm, like many folks, I'm really worried about climate change. However, I think because of climate change, it's, you know, like doing exploration in the North or South Pole has become slightly easier. I think we've learned a lot of cool stuff from how aquatic organisms do very unusual things, things that we don't necessarily, like, on our everyday think about, and we've been able to use, you know, those resources and, for example, build impactful things in the context of our everyday lives. So, I think we're going to learn in the next, you know, like decade or so, we're going to learn a lot of cool things from how life behaves in those extreme environments. And we may be able to use some of those things that you're learning in building things that are exciting and cool. I love to, you know, like, my students in my courses have learned, have heard this story, like, maybe hundreds of times. They're probably really sick of it. But I tell them about the horseshoe crab and how we kind of just learned about its biology and its cool immune system and how we utilize that to kind of do drug, you know, drug discovery or working on, you know, biomedical applications. I'm pretty sure there are tons of other examples that are in these extreme environments, maybe at, you know, like, not as charismatic as a horseshoe crab, but maybe a bacteria that lives in very extreme environments that we can just learn cool stuff about how that organism lives and be able to use it. So, I think, you know, in the near future, those things might be more accessible for bad reasons, I guess, because of climate change, but maybe, you know, a positive outlook on that. On things that worry me, you know, like, obviously and naturally, there are some concerns about, you know, some of the ramifications of the field, like, for example, how we think about using or misusing some tools that have emerged over the past 10 years. Or maybe the society is not ready because we have not necessarily done a good job of communicating what is, you", "start_char_idx": 3831, "end_char_idx": 7835, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ac8f5290-543f-4c15-b42e-523d5168341d": {"__data__": {"id_": "ac8f5290-543f-4c15-b42e-523d5168341d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b79e56cc-1fc9-4282-a83e-d131ee3df67a", "node_type": null, "metadata": {}, "hash": "527dd879152175a46400cd759ae9e20b6ae930618d61a3acda97f39dea4a7ff6"}, "2": {"node_id": "49e36f9c-baad-4000-870f-8636af293ce5", "node_type": null, "metadata": {}, "hash": "876423f1168769593d1de42d83ab61c44373a6bdad754c77931591824712e247"}, "3": {"node_id": "4793a604-c914-470b-94a3-26f2175d1902", "node_type": null, "metadata": {}, "hash": "dc4eaf4f366cfd75ecd4c1cfee8a7ecdde19c18dc3afa1488dfa1dfc9c59b36c"}}, "hash": "94ca47d2ab89850ecc2d93ce282aaedcab531f1378dc1080c73530b570faeec5", "text": "is not ready because we have not necessarily done a good job of communicating what is, you know, what is emerging from the field. So, that's one thing that I worry about. The additional part that I'm concerned with is that if we don't do a good job of, you know, communicating and educating and kind of like really engaging, when I say communicating, I don't mean just talking at people, like actually listening to what they have to say as well. We might not be able to fully utilize or we might not reach our field's true potential either, right? So, there's a concern saying, well, someone will misuse, like, for example, a gene drive, right? That's a real concern, right? Or who gets to decide if we are going to use a gene drive or not? The flip side is that, you know, like maybe we, if we don't communicate well, we miss certain opportunities that are really important, right? So, thinking about climate change in an impactful way, addressing some of our needs to produce energy or food in a, you know, like a healthier way, healthy relative to the planet. So, if we don't communicate well to the broader, you know, everyone else in the society who does not have like a PhD in bioengineering, well, we're missing the opportunity. So, that worries me a lot. I did not know anything. So, here's an example of, you know, I guess I was ignorant. I did not know anything about sand dollars or sand dollar larvae until I started my position as a professor, as an assistant professor. I had just seen sand dollars, like essentially at the beach when they were dead, right? This is white, you know, like, I guess they're, you know, their remains. And when we started this project, it was scary, right? Because I was asking a couple of young folks at, you know, at the start of their academic career, like undergraduate scholars, that's like, okay, we're going to build tools to study this. So, I had to sit down and study, right? And it was, it was exciting. It was scary, but it was also really exciting because I learned, I am continuously learning new stuff. And, and I think that's, that's a good mindset to bring to any, any discipline or any learning environment, but particularly bioengineering as a discipline, because we know very little. And that's a good thing. That's an awesome thing. So, to be very honest, I don't know, right? That's, and that's exciting and scary in its own ways. One of the things that I hope that would happen is that some of these tools that have been developed and knowledge that's been gained over the maybe past 20 years will begin to present themselves as particularly impactful solutions. Let me give like specific examples. So, you know, if you read, so, so I have, I do not mean to at all be insensitive about this. I have family members who have suffered and are struggling with cancer. Cancer is a horrible disease. Too many people still perish because of it. And at the same time, if you read the original literature that came in from declaring war on cancer, we have met many of those milestones. We've accomplished so much. There's still a lot remains to be done, but we've done a good deal of, we've achieved a great deal of progress. And not just by engineers, all, you know, all disciplines together to address this horrible disease. We haven't accomplished similar, you know, milestones for neurodegenerative diseases. Hopefully the tools that are emerging through bioengineering, for example, optogenetics is one of them, will enable kind of like fundamental understanding of not necessarily even therapies, right? Fundamental understandings that begin to help us to address some of these neurodegenerative diseases that are really important. The global population is, you know, is aging. So maybe that's one aspect that I'm hoping in the near, selfishly, in the next 20 years that things will get better. In the context of climate change, I think there's a lot of very good ongoing efforts that are folks who are working on projects similar to metabolic engineering of different pathways that can fix carbon more effectively using", "start_char_idx": 7824, "end_char_idx": 11906, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4793a604-c914-470b-94a3-26f2175d1902": {"__data__": {"id_": "4793a604-c914-470b-94a3-26f2175d1902", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b79e56cc-1fc9-4282-a83e-d131ee3df67a", "node_type": null, "metadata": {}, "hash": "527dd879152175a46400cd759ae9e20b6ae930618d61a3acda97f39dea4a7ff6"}, "2": {"node_id": "ac8f5290-543f-4c15-b42e-523d5168341d", "node_type": null, "metadata": {}, "hash": "94ca47d2ab89850ecc2d93ce282aaedcab531f1378dc1080c73530b570faeec5"}, "3": {"node_id": "fabd75d6-8aac-434c-80d5-3a1616424456", "node_type": null, "metadata": {}, "hash": "1709cf21311410f414c209924ec36e314c802853da99c0bbf4bba19a4b09e710"}}, "hash": "dc4eaf4f366cfd75ecd4c1cfee8a7ecdde19c18dc3afa1488dfa1dfc9c59b36c", "text": "working on projects similar to metabolic engineering of different pathways that can fix carbon more effectively using various types of tools. So maybe that would be a front. I, you know, like, so that's like a conservative answer. The, you know, the, I guess the more excited answer is that why can't we have bioengineered trees genuinely that are better at fixing carbon, right? That could happen, right? It's, you know, like sometimes it's very, I think we were just briefly talking about the life before internet. That was 20 years ago. It wasn't, it wasn't that long ago, right? So it's, it's possible to imagine, you know, these things that these useful tools and technologies that might be on the horizon. And when they happen, folks just take them for granted, which is okay. It's good. So those are two areas that I'm hoping to see good, meaningful progress. Additionally, I think the way we built stuff that's, I think is less than 20 years, the way that we built stuff, the economics of it is trickier than I think the, the science part. And that's, that's, I guess, goes back to this big tent of bioengineering that we need awesome people. We need excited people who would think about aspects of policy, aspects of business development, aspects of deployment, and how to turn these, you know, cool ideas to, to viable solutions. I was very recent. I don't know if this is true. So, so take this with a grain of salt. I was recently told that lasers for, for the first, like almost five to six years that they were invented, folks were just treating them like toys. And I haven't had the time to double check this. It was like, apparently lasers at the beginning were considered this cool technology that was useless. I don't know if this is true, but you know, if, if, if there's a remote possibility that that's true, that's just mind boggling. You know, like we use lasers every day and everything today. Right. But, you know, apparently the inventors of lasers were like, okay, there is this thing. Right. And it's kind of cool. But, but, you know, like with that idea, like, I think sometimes we can't imagine the impact of a tool or technology, both positive and negative. But it's, it's an, it's, it's definitely a very exciting time to be in bioengineering. With that, actually, I think there's, there's an interesting problem in bioengineering and that's capacity building, right? The infrastructure for, for the discipline, you know, that's, there's tons of areas of opportunities for folks who may choose not to want to have like a PhD in bioengineering. Right. So, for example, I think the infrastructure for internet, because we don't see it, we don't think about it, but, but that took like probably, I don't know how long it took to put cables at the bottom of an ocean, right. To, to, to enable, you know, like, I think that was probably harder than, than building iPhones. I'm speculating. I don't know, but, but I think there's, there are many opportunities for the infrastructure of bioengineering. That are really important and, and they're going to be fun to, to think about. And I don't think necessarily to contribute one needs, you know, like a PhD. No, that's fair. And, and, and as you said, it's very hard for me to, to, so the first, the first part I think is easy. You, I think today it's possible to be in high school or even younger and begin to work in bioengineering. So you, you should not wait to, to kind of like start college before you kind of like get excited and do something. You can work in, I think there are now actually maker spaces around biology. There are opportunities with, with academic labs, with other types of resources. I think there are now kits and tools that, that folks can buy. We, we, you know, like I think folks in this class will experience using a foldscope. That's, you know, that can happen anywhere, anytime. And, and you can explore things.", "start_char_idx": 11880, "end_char_idx": 15799, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fabd75d6-8aac-434c-80d5-3a1616424456": {"__data__": {"id_": "fabd75d6-8aac-434c-80d5-3a1616424456", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b79e56cc-1fc9-4282-a83e-d131ee3df67a", "node_type": null, "metadata": {}, "hash": "527dd879152175a46400cd759ae9e20b6ae930618d61a3acda97f39dea4a7ff6"}, "2": {"node_id": "4793a604-c914-470b-94a3-26f2175d1902", "node_type": null, "metadata": {}, "hash": "dc4eaf4f366cfd75ecd4c1cfee8a7ecdde19c18dc3afa1488dfa1dfc9c59b36c"}}, "hash": "1709cf21311410f414c209924ec36e314c802853da99c0bbf4bba19a4b09e710", "text": "that can happen anywhere, anytime. And, and you can explore things. So, so to begin to explore and do stuff. I don't think you, you, you, you do not need to wait to go to college. That, that's for sure. I am biased. I'm obviously highly biased because I'm a professor, right? So if you ask me, should we go to college? My, my knee jerk reaction is yes. I don't know if that's, that's true or not. Just like, you know, telling you my, my ignorance, but that's my, that's my knee jerk reaction. And I think partially it's, it's not just because of getting a degree or like learning a profession. Those are really important. I, you know, I, I was, my, my background was such that I really needed to have a secure financial support for myself after, after graduating college. So I fully understand that. But I think, you know, other things that happen inside a college setting is like, you know, I grew up as a person, right? I made very good friends that I'm still close with to this day. I kind of like, you know, went to a lot of art exhibits as a college student, which I now don't have time. It's very funny because you would think there's like, oh my God, I'm so busy as a college student. The sad part is that you're going to get busier and busier. So, so I really had a very good, and I went to a public school. I went to UC Irvine, which was not as popular as it is now. It was still very, very popular, but it was not, I hear UCI is now really popular among UCs, which I take pride in obviously for no good reasons. But, but I think, you know, I had a very good part of my life. I experienced a very good part of my, my, my young adult life, I guess, in, in, in, in college. I think you asked me, what would I do differently? I'm just going to rephrase that a little bit, like, because I don't know, I'm going to kind of try to answer something that makes me like more comfortable. You know, I, I think I worry too much about short-term successes, like, you know, like I, I was, I had scholarships that depended on my, my grade. So I worried for good reasons for my grade, my grades. And, and because of that, at least at the end of the year.", "start_char_idx": 15833, "end_char_idx": 17981, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "19f8625c-c143-4001-8bba-4b54b49b596d": {"__data__": {"id_": "19f8625c-c143-4001-8bba-4b54b49b596d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8fa06bdf-3135-4003-9bfd-fbe0dd9501e5", "node_type": null, "metadata": {}, "hash": "72b5eceb43e437c0c913c02e501d4fe317b8829623df1b6e37fc9796f1d50d27"}, "3": {"node_id": "0cecde41-e8bc-432b-aed0-2b0091456b56", "node_type": null, "metadata": {}, "hash": "8eb87d08dcf7da9c6caa06f1d22c058869e8c439f67d4ad9defd15b820fa2ea9"}}, "hash": "b495c4b71c9d6eb14bf4d870e88e3e015cb41de5e67643dd5ad51020e651c565", "text": "the first half of my, I guess, college career, if you can call it that, I didn't take a lot of joy in some of the things that I was learning or doing. Like I was more focused on the transactional part of like, I need to get an A here. And I think that actually backfired in many ways. I mean, like in a very practical, pragmatic way. In subsequent courses, right, I had to go back and relearn a lot of things that I had an A on, but I just didn't know, right? That was hard. The other part is that I, you know, like I love my discipline. I really enjoy being a bioengineer. And at the same time now, today, I think that it's more important that what you do in, I think in college is more important than the courses you just take. And also taking courses outside of your immediate discipline are really important. I am genuinely the example of that, right? So I was on an electrical engineering track. I took a kind of like this, I forget what it was called. It was this elective course that I think someone was teaching because they wanted to teach an easy class talking about secrets of professors. And it was a pretty chill class that they were talking about various technologies that were made for studying biology. And that really captivated, you know, my attention, right? I did not know, like, I think from day one to, this was a 10-week class. Let's say they were meeting like twice a week. So each meeting, other than the exams, I legit learned something that I did not know anything about. It was like going to this class and I think the name of the professor was Professor Bachman. He would tell us about this new crazy thing. I was like, what is that, right? So it was like, and it was electrical engineering adjacent, but it was, you know, not like let's solve another circuit or let's take another Fourier transform. And that was very good because it really, you know, after that class, I signed up to get a minor in biomedical engineering. I ended up taking more BME classes than EE classes at the end. And that's, you know, really changed my, the trajectory of my, I guess, my STEM career. The other part that I should have done, and I was good about this. I took a lot of GE courses. This is my biggest fight with everyone in my lab because they're all awesome STEM students. And you know, like most of them have very, very good GPAs. So we don't fight about anything other than the importance of the GE courses. I wish I was making this up. And I'm in the, you know, I'm in the minority in this where I tell like folks in the lab that your history class is as important as my fluid mechanics class. If not, it's more important because, you know, you're not going to use Navier-Stokes with, you know, like remembering all of the equations. You'll just remember what it's about and you can look it up and you know its consequences. But, you know, like reading and writing well and effectively and thinking about context is something you're going to do for the rest of your life. And they're like, see, well, let's just go away. So this is the fight we have all the time in the lab. But I really think that, you know, even if you're a STEM student, I think this is perhaps my key takeaway. If you're a STEM student, please remember that your GE courses are critical for your career success as a STEM major and your success as a human being. But I think that's another story. And I'm sad to say I've not made good progress on that front. And it's hard. It's really, I acknowledge that it's really hard when, you know, I still, you know, my lab does a hodgepodge of stuff, which is a reflection of, we haven't like, you know, made up our mind fully about who we are. And that's okay. Like not knowing in this sense is completely okay. Or at least I am comfortable with it. And I think it's just good to have a sense of excitement for learning and also acknowledging that learning new things is hard. Like that biology course that I took, I almost like, you know, I'd never struggled with a course as much as that", "start_char_idx": 0, "end_char_idx": 4024, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0cecde41-e8bc-432b-aed0-2b0091456b56": {"__data__": {"id_": "0cecde41-e8bc-432b-aed0-2b0091456b56", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8fa06bdf-3135-4003-9bfd-fbe0dd9501e5", "node_type": null, "metadata": {}, "hash": "72b5eceb43e437c0c913c02e501d4fe317b8829623df1b6e37fc9796f1d50d27"}, "2": {"node_id": "19f8625c-c143-4001-8bba-4b54b49b596d", "node_type": null, "metadata": {}, "hash": "b495c4b71c9d6eb14bf4d870e88e3e015cb41de5e67643dd5ad51020e651c565"}, "3": {"node_id": "4feae115-4bd7-48b3-bfd2-2298e7460ee4", "node_type": null, "metadata": {}, "hash": "351744855caf197f2a609e217c06f046edf9aa54f857e10a5a82ba88e664406c"}}, "hash": "8eb87d08dcf7da9c6caa06f1d22c058869e8c439f67d4ad9defd15b820fa2ea9", "text": "I almost like, you know, I'd never struggled with a course as much as that class. And it was so easy to everyone else. But I was like, dude, I don't even know what you're talking about. It's like, the words do not make any sense to me. And it was funny because I had taken OCHEM in high school, actually. So I would understand the OCHEM, but then they would talk about, I forget. But there were so many things that, and we had this giant Bruce Albert's textbook that was like, you know, this brick of a book. So I would sit down and read all of that. But then, you know, like I would, I immediately learned that in similar to engineering, like I think some folks don't like biology because like me, naively, I taught that biology is a lot about memorizing stuff. And that's not it at all. Like, you know, there's a lot of organization in this field. There's a lot of like, you know, when I say organization, I don't mean like cells. I mean like the way that the knowledge is organized. And there's a lot of like, you know, like many, many layers, like length scales of how things are organized so that you would get a behavior. But if, you know, the first time you're learning this, you're just like, what is this pathway? I just got to know this so that I can like pass, right? But, you know, I regret that that's how our education system everywhere is organized. But if you can take a step back, you should get your good grades. But if you take a step back and try to understand as well, like why your friends in biology are really excited about this, that is gonna like give you a lot of very cool opportunities to kind of like bring your thinking, whatever it is, maybe it's engineering, maybe it's arts to that discipline. I think it's really good to learn from a lot of different people that care about very different things. I think the way we think about a major maybe is not fully healthy, even though I am responsible for helping organizing majors in my profession. But I think, you know, major is just a suggestion, right? It's a series of bets that folks who are in that field have placed to say, if you know these things, you know sufficiently so that you can learn for the rest of your life. But, you know, if you may choose not to want to be the carbon copy of Siavash because I exist, right? You might want to be your own, you know, your own kind of like person, your own, like bring your own perspective to it. Maybe that's a better way of thinking about it. So taking classes that are, or learning, not even classes, doing things that are a bit not part of that, like I guess the plan or the path is helpful. I think it helps you think about, or it's been helpful to me. It's helped me think about and learn things that I just couldn't imagine, right? Like sand dollars, I did not know that they look like, you know, the moon lander when they're baby, right? How would you guess that if you've only seen an adult sand dollar, it looks like a circle, right? So yeah, so it's quite amazing to kind of try to think about things that, or be open to learning and accept, I think this part is important, accept that learning is hard. Like the first time you learn something new, you're gonna feel discomfort, right? Because no one likes to feel stupid. But if you accept that, I think you're gonna have a happier time. You know, it's discomforting sometimes when things don't work out the way you'd imagine them. Like, you know, because it means that you missed something or you were wrong, but also it's really, really exciting. That's like, well, you know, there's a new puzzle. There's a, and it's, you're absolutely right. That because of the way I think our education system is configured, folks are just rewarded for knowing the answer to things that are known. And that's, you know, like, I felt bad the first time I got a C in a biology course as well. I absolutely felt bad. But, and maybe I shouldn't have, right? Maybe I should have worked hard, but, you know, at the same time, like the healthier approach is that, well, you", "start_char_idx": 3965, "end_char_idx": 8013, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4feae115-4bd7-48b3-bfd2-2298e7460ee4": {"__data__": {"id_": "4feae115-4bd7-48b3-bfd2-2298e7460ee4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8fa06bdf-3135-4003-9bfd-fbe0dd9501e5", "node_type": null, "metadata": {}, "hash": "72b5eceb43e437c0c913c02e501d4fe317b8829623df1b6e37fc9796f1d50d27"}, "2": {"node_id": "0cecde41-e8bc-432b-aed0-2b0091456b56", "node_type": null, "metadata": {}, "hash": "8eb87d08dcf7da9c6caa06f1d22c058869e8c439f67d4ad9defd15b820fa2ea9"}, "3": {"node_id": "e00a6891-4adf-48bb-8728-2ed6e8978622", "node_type": null, "metadata": {}, "hash": "311db32c3cd4cd9cd43c6d264f12f1af3b24df81bc3e784a1279a81d89d3f46f"}}, "hash": "351744855caf197f2a609e217c06f046edf9aa54f857e10a5a82ba88e664406c", "text": "you know, at the same time, like the healthier approach is that, well, you know, I learned something new. Yeah, it was hard. And it actually honestly didn't have, in limit of long time, it didn't have a negative impact on my career or my life. Genuinely, like I am not, well, one person happens to know because the person who taught that course ended up being my PhD mentor, actually, in a very funny way. So I think Elliot knows that I got a very low grade in his course, but heck, he hired me after, right? So, you know, like there's things to think about in that case. So like one bad grade did not have, or even multiple bad grades in limit of long time didn't have a profoundly negative impact on my career. I think it's just important to acknowledge that learning is also really hard, right? Learning new things is just a hard business. So I'm only speaking for me. So, you know, we moved to the US when I was at the end of my high school. And I, like most folks, I think at the end of high school, at the beginning of the college, I had a lot of worries. I had a lot of anxieties. You know, being in a new country did not help that either. I feel like that's a inflection point for all, everyone, but, you know, there was another added dimension of, I guess, challenges attached to it. And I actually had to start my academic career at a community college because I had not taken SATs. So I took a year or maybe a year and a half of courses at a local community college before I transferred. And I had this chem professor. His name is Kurt McClendon. And, you know, just by chance, I ended up going a lot to his office hours. And I didn't know what an office hours was. This is a time you, you know, your instructors have open time so you can go and essentially, I guess, ask questions about stuff. So where I come from, there are no office hours, right? Where I grew up, I guess. And so I just figured out that there's this thing that I used to go to office hours and we would not talk about chemistry because I actually happened to knew like most of the material from that class pretty well because we had chemistry in high school. So we would, you know, maybe I had an advantage that way. I was privileged. But we ended, we used to talk about essentially like life, genuinely. And that was really helpful to me because, you know, I was in a period of uncertainty and I am trying to get to this point that Dr. McClendon was not a bioengineer, right? He, I don't, I actually don't know what sorts of chemistry he had studied before being a professor at the community college. But I, but he was very instrumental in helping me kind of ground myself at a uncertain part of my life. And it just happened that he was an academic. Now, I think it's important to find, I guess this is where I'm going with this. It's important to find folks that are willing to, and I know the word mentor has been used a lot, but people who are willing to help you, whether they're mentors, whether they're friends, colleagues. And I think bioengineering as a whole has a good, I have benefited a lot from many folks who have just been kind and generous with their time in this field. To name a handful, like, you know, Will Grover, who's now a professor at Riverside. He was a postdoc when I was a first year grad student. And I just sent him an email, asked him a bunch of questions and he answered all of them and sent in everything that he knew. And my project was based on the work he had done as a, I guess, as a grad student. He could have taught of me as a threat, but instead he was like, okay, there's this, you know, new kid, I'm just gonna help him. Polly Fordyce, who's also at UC, sorry, at Stanford. She, you know, like I remember talking with Polly before like I actually knew her and she was very generous with her time and answering my questions seriously. And I think bioengineering as a whole", "start_char_idx": 8013, "end_char_idx": 11911, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e00a6891-4adf-48bb-8728-2ed6e8978622": {"__data__": {"id_": "e00a6891-4adf-48bb-8728-2ed6e8978622", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8fa06bdf-3135-4003-9bfd-fbe0dd9501e5", "node_type": null, "metadata": {}, "hash": "72b5eceb43e437c0c913c02e501d4fe317b8829623df1b6e37fc9796f1d50d27"}, "2": {"node_id": "4feae115-4bd7-48b3-bfd2-2298e7460ee4", "node_type": null, "metadata": {}, "hash": "351744855caf197f2a609e217c06f046edf9aa54f857e10a5a82ba88e664406c"}, "3": {"node_id": "e341310d-56b1-4fcd-ad0f-39d4d77bcbc2", "node_type": null, "metadata": {}, "hash": "a6690a25abc5c6da3e18c4964eb91d5d06024c47e946bd6fdf92d379355f2650"}}, "hash": "311db32c3cd4cd9cd43c6d264f12f1af3b24df81bc3e784a1279a81d89d3f46f", "text": "and answering my questions seriously. And I think bioengineering as a whole has a, broadly has a culture for that. And this is not a reflection of other disciplines. I think it's just, so I don't know how other disciplines are. I'm not saying they're not that way. I'm just speaking for bioengineering. I think folks are pretty, broadly pretty open. And I think finding people who can, who are willing to answer your questions seriously and talk with you and willing to spend their precious time with you is really important. And thankfully this community has many of those folks. I think maybe my small success within the community has been genuinely because of everyone who's been generous with their time. So I think of this as a paid forward model. And I, you know, tell this openly to folks in my lab that this is how we, what we strive for, right? That that's what we want, you know, that's an active choice, right? We want to be that way. We could be a different way, but why, right? So I'm not sure if I'm answering your question well, but that's what's on my mind. And I think, you know, like for some reason, we don't do a good job, like speaking of academic stuff, we don't do a good job of telling folks, like for example, what's in office hours, right? I had zero perception of what to expect. And actually I was very productive because I was not going in to ask for the solution to problem four, right? I was just going in to like, be like, hey, what are your thoughts about this thing that's happening to me? And the person on the other end was generous and thoughtful to kind of like give me at least an answer, you know, like not perhaps even the best answer, but just like, this is what I think about it. Now go make up your own mind, right? So I think that was luckily useful, not knowing, you know, what is the expected format, but I think, yeah, hopefully newer folks who are arriving in bioengineering, you know, the field has been generally maybe because of its age, I'm sure, because of its culture has been very open. And also I think younger folks who are now in, have more agency are very thoughtful about it. And that's awesome. That's something that I take a lot of joy in to see like, folks that I was maybe their TA, that they're like, you know, now part of this culture and they're very thoughtful about like, you know, the decisions that they make with respect to the community. Oh, okay, okay. That's a great question. I'm gonna dodge that question to talk about our science and I have a good reason for it. So, you know, so it's not, I'm not trying to like have a favorite project. I honestly mean this with every, like this, like I'm not very like, you know, I don't have a lot of strong beliefs, but this one is a very strong belief. So, you know, my lab is, so universities are divided in various categories. This is not particularly useful to you. The key thing that you need to know is that my lab is focused on, or my school is primarily undergraduate students, right? So we don't train PhD students, but we do research and we do science. Now, the key thing, the key outcome from our lab is actually not the science or the projects or the tools. We take pride in the small successes that we have and we take our work seriously, not ourselves. We take our work seriously, but the key outcome of the lab is the folks who learn how to be scientists and researchers and engineers. And I'm really proud of that. And I, you know, I don't brag, but I'm super happy to brag about that for hours. And we have data and evidence to back that part. I did not expect, so when I signed up for my role, I did not expect that we get as much done as we have with, you know, our lab is 10 undergraduate students. These are folks who are taking a lot of courses. And I think the primary thing, this is how I think in 10, 15 years, I am super excited to see where they go and what they do next, not because they're going to work on, you know, building", "start_char_idx": 11909, "end_char_idx": 15881, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e341310d-56b1-4fcd-ad0f-39d4d77bcbc2": {"__data__": {"id_": "e341310d-56b1-4fcd-ad0f-39d4d77bcbc2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8fa06bdf-3135-4003-9bfd-fbe0dd9501e5", "node_type": null, "metadata": {}, "hash": "72b5eceb43e437c0c913c02e501d4fe317b8829623df1b6e37fc9796f1d50d27"}, "2": {"node_id": "e00a6891-4adf-48bb-8728-2ed6e8978622", "node_type": null, "metadata": {}, "hash": "311db32c3cd4cd9cd43c6d264f12f1af3b24df81bc3e784a1279a81d89d3f46f"}, "3": {"node_id": "33563af5-af3d-4204-a53b-24c90e45019b", "node_type": null, "metadata": {}, "hash": "b9adea1c3f5de411b9d150b9577c5b693fc58655caaa0609178dceb4704c8e36"}}, "hash": "a6690a25abc5c6da3e18c4964eb91d5d06024c47e946bd6fdf92d379355f2650", "text": "go and what they do next, not because they're going to work on, you know, building fluidics that help us study sand dollars. That's really cool. I'm so excited about that. That brings me so much joy. I can talk about that for hours too, but I'm really excited to see what else these folks will do as they go on to do cooler and more exciting things that are really particularly exciting to them. And I take a lot of joy and kind of pride in that. And I'm pretty sure that most, you know, most academic researchers, I'm not at all trying to pretend that I am so unique about this. I'm pretty sure that most academic researchers are like me, that, you know, they love their science. They're a bit nerdy and geeky. You know, they love to think about like hydrodynamics of sand dollars, which the sand dollars don't care about either. But I think they really are in their role because they want to help folks learn and grow. And they're in it, even if they're not fully aware of it, they're in it for the people who are in their lab or in their class. And I think finding people that are the right fit for you at early stages of your career, it's not like, you know, I'm a very good mentor to some students. I'm probably a horrible mentor to some students because of the way I am, right? So finding good fits with people is very helpful and being receptive to kind of like, you know, exploring these things. That's my, I guess, long-winded answer that I'm mostly excited about the folks that are in my team and they're working together. And I just can't wait to see what they're going to do essentially. You know, I'm not sure, but perhaps maybe the most, this is particularly something that I think about. So some folks are worried about missing out of opportunities because of that, they kind of like, either don't start on stuff or they jump around a lot. It's like, oh, I'm going to do a little bit of this, a little bit of that. You know, I just feel like that. Let me put that in perspective of like an experience instead of like, kind of like giving a long-winded answer. So when I started as an undergraduate researcher, my first project was on brain computer interfaces. And that sounded so cool to me. And it's such an important and such a cool research. But in practice, it was mostly programming. I was good at that, but I really didn't enjoy it. And I had a choice, right? The choice was like, I'm going to stick to this and I'm just going to do this, or I'm going to be like, okay, this is an important opportunity, but I'm not liking it. So maybe I should explore something else. And I kind of think that I was really like, you know, thinking back, if I was in that person's lab and we're still friends, he's an awesome professor. I got nothing done, for real. Like I was a horrible undergraduate researcher, probably because I was, you know, everything I did was like really bad, probably because I was not enjoying it, right? My heart was not in it. So I think in that instance, I made a good decision that's like, okay, this is not a right fit for me and I should explore something else. And then I worked on other types of projects. I think being open with yourself in these ways is really important and not worrying about, I'm going to miss out. If I leave this, right, there might be nothing else for me. So I think that was really helpful, like being kind of like, I've made many horrible, bad decisions in that one I'm happy about that. And I'm still actually friends with the professor whose lab was working on and still works on brain computer interfaces. They do brilliant, good work, but you know, that was just not for me. So I think that it's, I guess it goes back to this idea of most of the things we're going to do, particularly in academic research is going to fail. It's going to fail, that's for sure. That's the one certainty. And if you don't take yourself too seriously and it's like, okay, it failed, now we got to do something else. And being okay with, I'm", "start_char_idx": 15879, "end_char_idx": 19872, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "33563af5-af3d-4204-a53b-24c90e45019b": {"__data__": {"id_": "33563af5-af3d-4204-a53b-24c90e45019b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8fa06bdf-3135-4003-9bfd-fbe0dd9501e5", "node_type": null, "metadata": {}, "hash": "72b5eceb43e437c0c913c02e501d4fe317b8829623df1b6e37fc9796f1d50d27"}, "2": {"node_id": "e341310d-56b1-4fcd-ad0f-39d4d77bcbc2", "node_type": null, "metadata": {}, "hash": "a6690a25abc5c6da3e18c4964eb91d5d06024c47e946bd6fdf92d379355f2650"}}, "hash": "b9adea1c3f5de411b9d150b9577c5b693fc58655caaa0609178dceb4704c8e36", "text": "it failed, now we got to do something else. And being okay with, I'm not saying BFA there, I'm saying be okay with the discomfort of things not working out. You'll just have a much more happier time and I would guarantee more productive time in meaningful limits of time. So, and I think I learned that slowly. Like I kind of was not, maybe I made one right decision, but my first few years of my more serious career, I was making bad decisions. It was like, okay, I just got to get this done and I just got to get this done. And that came to me with, you know, like with a lot of like, you know, struggle. And later on, like, well, you know, I learned a ton from this. Maybe it didn't work out the way, the science didn't work out the way I wanted, or maybe I didn't get the product that I wanted out of it. But now I can have more meaningful and better research experiences or life experiences because of it. And I think, yeah, that was an important lesson that I learned very slowly. So I wish I had learned that faster.", "start_char_idx": 19871, "end_char_idx": 20894, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4833f9f3-6a2a-45e0-bc29-77cd084ce264": {"__data__": {"id_": "4833f9f3-6a2a-45e0-bc29-77cd084ce264", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8cbd348c-8e10-494e-b9a9-a36551bb66ca", "node_type": null, "metadata": {}, "hash": "57c18b125c75ebfec22d7f7edfe95f30bec8533bc1dadd3ecda2c5b6f850a9f5"}, "3": {"node_id": "f6e45b3c-5d26-4c74-b74c-4380b8fd2fb3", "node_type": null, "metadata": {}, "hash": "c0caf03a563b2103aff7b831b7a0dee084e39b0631089c528ab11a569769e727"}}, "hash": "db81b70dc141afdb0b982ac4c91fdc3cda8a81eafd38af4b93a220f2c2d36f72", "text": "Hi, I am Sophia Wang. I am the co-founder and chief of culture at MycoWorks. And as far as what kind of bioengineer I am, I would say I am a cultural engineer of people within a biotechnology company. Sure. Yeah. So as chief of culture of MycoWorks, I set the values of the company and the culture that we're building here. And I make sure that we operationalize those values in the way that we work together as people and coworkers, and also in our partnerships with brands and consumers out in the world. So as far as an ethos of bioengineering and how that applies in a metaphoric way, I guess, to what you typically think of as bioengineering, I think of it as everything is a living system and everything can be considered a living organism. So if you think of a startup as a baby company that has very basic capabilities that you're trying to steer and grow into a grown-up company that has really robust systems for supporting everything that you need to do as a company, whether it's problem-solving technical issues with the product, or it's making sure that everyone gets paid on time regularly, all of that are skills that an organism that is a young company needs to learn. And so I think of the company very much as a living organism that is growing. And why not? Because it's made up of people. We've got 160 people working for MicroWorks today. We started out as a couple people in a basement in an art studio in San Francisco. So for me, it's very much a human system that has been growing continuously and will continue to do so. If you think about how that translates to bioengineering in the more traditional sense, you absolutely have to think about your systems in the same way. You have a biological system that is responsive to environmental, physical inputs and produces its own outputs, has its own growth dynamics, has its own chemical reactions, can be looked at at the atomic level, can be looked at at the macro level. And so how do you make sure that you have a handle on all of that in order to steer in a beneficial and non-destructive way? I think growing culture is very similar in that respect. There's ethics and responsibility, and also mechanics and analysis and close observation and responsiveness to relational dynamics that's involved in all of that. Sure. Well, it maybe helps to talk about the origin story of the company. This is an example of where our technology started. And if I had a mushroom in my other hand, I don't actually have one right now, that would be the other origin. So essentially, MycoWorks is making a mycelial option for leather. And the products that we make today, and we actually, our product is more like this, which is a sheet of material. So this is one of our finished sheets of mycelium leather alternative. And we sell that to brands, and they make stuff like this. So this is one of the direct consumer products that we released this year with a hat designer in LA named Nick Fouquet. And this is 100% our material. So this is mycelium. And backing up, mycelium, for those who don't know, refers to the root fibers of mushrooms. So if you think of mushrooms as the fruit of an organism, mycelium is the, it's kind of like the roots and the branches and the stem. It's the vegetative part of the organism, and mushrooms are the fruiting body. So where this all started was back in the 90s and the 2000s, my co-founder, Phil Ross, was starting to use mycelium as a material for art and design, and was making, essentially, structural materials, architectural materials, that he would cast into form. So he'd build a mold, put your wood sawdust or wood chips, plus mycelium spawn, plus nutrition and a little water, and you can grow mycelium into any shape that you want. And it's lightweight, and it's strong, and it seems like an amazing material for design and architecture and art objects. So Phil was working in the space of art and art objects and art exhibits for 10, 15 years or so, and started to get interest from companies around the world that actually wanted to use these materials in their products. So Phil and I had connected in the Bay Area in the, you know, 2007 or so as artist", "start_char_idx": 0, "end_char_idx": 4170, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f6e45b3c-5d26-4c74-b74c-4380b8fd2fb3": {"__data__": {"id_": "f6e45b3c-5d26-4c74-b74c-4380b8fd2fb3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8cbd348c-8e10-494e-b9a9-a36551bb66ca", "node_type": null, "metadata": {}, "hash": "57c18b125c75ebfec22d7f7edfe95f30bec8533bc1dadd3ecda2c5b6f850a9f5"}, "2": {"node_id": "4833f9f3-6a2a-45e0-bc29-77cd084ce264", "node_type": null, "metadata": {}, "hash": "db81b70dc141afdb0b982ac4c91fdc3cda8a81eafd38af4b93a220f2c2d36f72"}, "3": {"node_id": "630e35a9-f078-476c-a3b1-81f91bd4df25", "node_type": null, "metadata": {}, "hash": "d0ac4dad3412b610ef223ee7d25261087d0dadc99b5352f49aa0369f043e6833"}}, "hash": "c0caf03a563b2103aff7b831b7a0dee084e39b0631089c528ab11a569769e727", "text": "Phil and I had connected in the Bay Area in the, you know, 2007 or so as artist collaborators. We worked together on an exhibit on the history of biotechnology as something that humans have been practicing for a long time. If you think about plant cultivation or like baking bread or making beer, like that's all biotech, right? So we put an exhibit together based on the history of biotechnology. Had a good working relationship around 2012. Phil's like, hey, there's companies around the world that want to use, you know, I want to use my art material in their products, so let's start a company so that we can make this technology available to these companies, these global corporations. So that's how the company was started, and it's, we founded it in 2013. So in 2023, that will be 10 years of basically trying to scale this technology from an artist's handcraft, something that Phil was doing in his art studio by hand with his artist assistants, into something that we can replicate at a large scale in a factory with semi-mechanization and semi-automation. Yeah, it's been a while, right? We make beautiful things with artists and brands now. This is a limited edition pin that we made to commemorate some award I won this year, and you know, we have, you know, it's a material that can be fabricated and worked with like leather, so we like to show objects like this to show that you can sew and fabricate and glue it the way that you can with leather, and it's non-animal, non-plastic, so a lot of brands are interested in it. So that's what we do, and there's a lot more to say, but I'll pause. Yeah, yeah, well I would say that we do have a lab at Microworks, but that's not where their product is getting made. The lab is where we are doing technology development, so either understanding, you know, from a mycological perspective, you know, how the species of fungus that we're using can be steered in the way that we want. We do have a manufacturing facility here in Emeryville, California where the product gets made, and so it's not so much a day in the lab as it is a day in the factory, and that basically starts with preparing your substrate that the fungus wants to eat, and that's really just wood chips, wood sawdust. You amend with things that are going to make it optimal for the fungus to grow. That's typically a little bit of water, some nutrients. You put it into an autoclave, so something that can go up to to basically sterilize the substrate to make sure that there's no competing organisms in it. They're going to compete with our fungus for the food. Once it cools down the substrate, we inoculate it with fungal spawn, and it gets put into a tray, about two by three feet tray. That's the size of our current unit. It has a lid, and it allows for gas exchange and also allows for us to control the gas exchange as well as temperature, humidity, and light, of course, in the room in which it's growing. Then the tray moves through our storage and racking system for a number of weeks, and there's some magic things that happen to what we do while it's growing to make sure that it is grown to the strengths and the specifications that we want. This is a really interesting step because this is a stage at which we want customization. For instance, some customers that we work with want a certain kind of strength or flexibility in the material. As the mycelium is growing by basically colonizing the wood substrate, and then it effectively grows a skin, or we call it a hide, on top of the wood substrate mass. This is a point at which we can customize. Some brands want a certain strength or flexibility. We can add a textile layer onto the substrate and the mycelium that's growing. The mycelium will grow up through the textile to interweave itself into the textile to create a true composite. Then you have a mycelium sheet that has embedded and woven into it another textile. We've done a lot of cool things, experiments, just to show that we can do it. We've grown mycelium sheet with a copper fiber so that you can have a wired smart fabric, or we've grown", "start_char_idx": 4109, "end_char_idx": 8208, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "630e35a9-f078-476c-a3b1-81f91bd4df25": {"__data__": {"id_": "630e35a9-f078-476c-a3b1-81f91bd4df25", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8cbd348c-8e10-494e-b9a9-a36551bb66ca", "node_type": null, "metadata": {}, "hash": "57c18b125c75ebfec22d7f7edfe95f30bec8533bc1dadd3ecda2c5b6f850a9f5"}, "2": {"node_id": "f6e45b3c-5d26-4c74-b74c-4380b8fd2fb3", "node_type": null, "metadata": {}, "hash": "c0caf03a563b2103aff7b831b7a0dee084e39b0631089c528ab11a569769e727"}, "3": {"node_id": "b176a171-2e73-470c-b496-c03252252a63", "node_type": null, "metadata": {}, "hash": "6c8a292b4c1cab5f3c49f38ad9187f81e723b37bbc09ca6ad8bff5c06106c5dc"}}, "hash": "d0ac4dad3412b610ef223ee7d25261087d0dadc99b5352f49aa0369f043e6833", "text": "a copper fiber so that you can have a wired smart fabric, or we've grown a mycelium sheet with a piece of Kevlar fabric so you can approach a bulletproof mycelium sheet. We've done a lot of cool things like that. Anyway, you grow it for a period of weeks in this two-by-three tray. When you are ready to harvest, you basically peel the sheet off the top. I've had it described to me sometimes as like, imagine a sheet cake with a thick layer of icing on the top. Imagine you could pull that whole icing layer off. Then we stabilize it. We essentially add a fat to it, a fat liquor. Then we send it to our tannery partners who currently are all based in Europe. They are really skilled and knowledgeable in terms of finishing leather for the fishery industries. They are transferring their knowledge about how to finish and tan and dye leather to how to finish and tan and dye mycelium. It's a very interesting bio. It's a natural material. It is not literally animal collagen. Molecularly, it's different. There's a lot to learn, but we've managed to create beautiful material and products that look and feel like leather. Then also, some people who are looking really closely or who know leather really well are like, this is totally new and very exciting. That's the process. I like that 10 years ago or 15 years ago, even when Phil was first really starting to work with mycelium, no one really knew what mycelium was. There weren't as many other artists, designers, scientists, entrepreneurs working with mycelium as a material. People have known about mycelium essentially as a supplement, a health supplement, or mushrooms have culinary use, mushrooms have pharmaceutical use. People hadn't explored mycelium as a design material or something structural. In the 10, 15 years since, we now have a whole field of companies, startups, artists, and designers who are working with mycelium as an art material or as a material for industry. For me, that's the most exciting thing, which is out of this one person's art practice and our efforts as a company that was early in the space, we've now inspired an entire new materials science field. There's a lot to discover. It's going to keep people busy for a very long time. There's so much to learn about mushrooms and fungi in general. You think about the fact that fungi were not classified as their own kingdom until 1969 or something like that. We've studied plants and animals for much longer time than we've studied fungi as its own specific kingdom, an organism that is neither plant nor animal for very clear and important reasons. That's what's exciting to me, which is this is just the beginning of a new field of study and discovery and applications. It just feels limitless as far as where mycelium can go in the world and beyond. There's the more obvious answer where it has very, very broad adoption. It has that impact where you're essentially removing or mitigating some of the environmental impacts that you have from the manufacturing or disposal of traditional materials and products made with traditional materials. For me, because I'm a philosopher and I think about culture in a very broad sense, like ideological sense, I think that the large-scale impact to me is a shift in mindset in terms of how you make things with natural resources. There's the current model that is, if you think about anything that's fossil fuel-based, anything that's made from plastic, anything that depends on a monocrop farming system, it's a system that is essentially extractive and exerts a heavy toll on the environment and the ecosystem that supports the production of whatever the resources that you're harvesting. Mycelium as a material basically is mimicking one of the most important recycling and transformative processes on earth. Mycelium and fungi in general break down, digest, and make bioavailable all carbon-based matter. That's why you can use fungi to clean up oil spills and to mitigate radioactive waste sites. They basically just can process carbon-based matter, break it down, and make the biochemical components bioavailable to the environment again. I think that it starts with close observation of your environment and", "start_char_idx": 8213, "end_char_idx": 12410, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b176a171-2e73-470c-b496-c03252252a63": {"__data__": {"id_": "b176a171-2e73-470c-b496-c03252252a63", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8cbd348c-8e10-494e-b9a9-a36551bb66ca", "node_type": null, "metadata": {}, "hash": "57c18b125c75ebfec22d7f7edfe95f30bec8533bc1dadd3ecda2c5b6f850a9f5"}, "2": {"node_id": "630e35a9-f078-476c-a3b1-81f91bd4df25", "node_type": null, "metadata": {}, "hash": "d0ac4dad3412b610ef223ee7d25261087d0dadc99b5352f49aa0369f043e6833"}}, "hash": "6c8a292b4c1cab5f3c49f38ad9187f81e723b37bbc09ca6ad8bff5c06106c5dc", "text": "to the environment again. I think that it starts with close observation of your environment and think about your environment not just as like the natural world, but what is your human social environment. Any situation environment you're in, whether it's a team that you're on at school or a club or service organization that you contribute to or a part-time job that you have or a project that you're really excited about with a bunch of other people working on it, there are dynamics in play in terms of resources. How are you making it possible? What materials are you using? Who's paying for it? Whose time is going into organizing it? How do people collaborate and deal with conflict in that space? How do people share power? Who's in the room? Who's not? Why are they in the room? Why are they not in the room? Who is this for? Who is it not for? This is how you get to the most important questions of the power dynamics and the cost of what you're doing and also who you're in service to and to what end. For me, that's transferable to whatever you feel like doing, whether it's very literally in the bioengineering, biosciences space or if it's in a more humanities, social sciences-focused space. You want to make sure that you understand how your system works and whether you're okay with how the system works. If you're not, then what can you introduce or change or be an agent of in order to steer it more towards the system that you want to see? For me, I mean, I am the easiest way to talk about my personal ethics is that they're grounded. They're materialist. It's materialism. What do I mean by that? There's materials, actual physical goods, and then there's also the sense of the material wealth, money, resources, the things of value that make other things possible that serve as a channel for just making actions happen or making transactions happen. I'm a materialist in the sense that I think in terms of real, hard, physical realities, and that extends to the body. If you think about what does a person need for material survival, that's very basic, like food, water, shelter.", "start_char_idx": 12373, "end_char_idx": 14473, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e881883f-2b12-450a-a6e2-e089dd7bcb2c": {"__data__": {"id_": "e881883f-2b12-450a-a6e2-e089dd7bcb2c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6b692a4f-0b81-48ac-842b-07859deb3301", "node_type": null, "metadata": {}, "hash": "ff17bbe69af57876db14e4d43938a19273cf60ce613b778e2d3e8c798cde8dc1"}, "3": {"node_id": "a965164f-649c-489e-b828-24f27b52242f", "node_type": null, "metadata": {}, "hash": "21846f5bbde508181c667d62833443b5dd389da070cd642c375b2bd28f659988"}}, "hash": "8485d340503f27ba6336d38fa50c4730b8eb7de100836f013cd3fee3bffaeb0f", "text": "You know, and then it goes on from there, but there's some basics, right? Food, water, shelter. What we're doing at Microworks right now, selling, you know, this like very, very nice exclusive material to luxury brands is not stuff that you need for survival, right? Like that's like luxury by definition is excess. It's more than what is baseline needed. But if you have the wealth and you have the leisure and the access, then you can afford luxuries, right? So where ethics comes in for me, for what we're doing with Microworks starts within our walls. So I, as chief of culture, I'm like, all right, you know, we're trying to create a company where we are taking care of the people within our company in a way that aligns with our values. And, you know, that in a company has very literal meaning. Like, are you paying people enough? Are you giving them, you know, proper health benefits and support? Are you making sure that you're creating culture where everyone feels respected and can show up as their authentic selves, right? Everyone's included. There's no like us and them. Do we welcome in people who are traditionally marginalized in like corporate environments or, you know, the pockets of the world that are funded by venture money? So it starts with actually the material needs of the people here. And then to expand that out, the ethics of the company are, can we bring this technology and material to a large scale so that a lot of brands and companies can use it in a way that minimizes harm and negative impact either on our environment or like on the industry in terms of what we're modeling as a company. And so that's where it gets a little bit abstract and you can get into arguments about what is good and what is bad and what is a compromise. And, you know, we all are existing within global capitalism. So what is, you know, how do you evaluate the goodness of what we're doing? And so that's why I'm very grounded in materialism where I'm like literally who benefits, who is harmed and you start from there and you kind of, you keep your eye on that along the way. Well, I'm in a really fortunate position at Mikeworks because I am a founder. So I was grandfathered, grandmothered in, you know, so I'm now in like a very rare position of being like an executive leader at a biotechnology company by way of having co-founded it. I don't know that I would have been hired into this role given my background. I mean, I have a PhD in English, you know, like it's a very wild story how I got here. So for people looking to enter into a space like this other than co-founding your own enterprise, which I also recommend if you're up for it and you find a good crew of people to work with, it's a fun ride and it's intense and it's hard, but it's rewarding. What you absolutely want to do is look for the values that are visible and tangible in any project or organization that you're trying to join or sussing out because it'll become really clear in like the interactions, the inclusion, how power is shared, you know, who has a voice, who doesn't, whether that's a place that, you know, you want to bring your rare skills and value and resources to. There's something to be said for being a change agent, like being that like ambassador who's able to code switch and move through a lot of different spaces. And I say code switch very seriously because I'm an artist and academic who had to learn the language of corporate organization and management and also like learn the language of pitching to venture capitalists. And so like as an English, you know, English major, English PhD, this was very interesting to me. For me, it's just about like, oh, it's just learning a bunch of languages and each one has a different value system. And, you know, now I understand this culture and let me go look at that culture. So you can be very fluid if you think about it like anthropologically that way, where you're like, all right, what's this environment I'm about to enter? So this goes back to that first thing I said about like the system, like ecosystem. Like if you understand as an ecosystem, you understand the dynamics, the historic dynamics that are there. And you also understand that", "start_char_idx": 0, "end_char_idx": 4212, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a965164f-649c-489e-b828-24f27b52242f": {"__data__": {"id_": "a965164f-649c-489e-b828-24f27b52242f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6b692a4f-0b81-48ac-842b-07859deb3301", "node_type": null, "metadata": {}, "hash": "ff17bbe69af57876db14e4d43938a19273cf60ce613b778e2d3e8c798cde8dc1"}, "2": {"node_id": "e881883f-2b12-450a-a6e2-e089dd7bcb2c", "node_type": null, "metadata": {}, "hash": "8485d340503f27ba6336d38fa50c4730b8eb7de100836f013cd3fee3bffaeb0f"}, "3": {"node_id": "be874afb-a9a4-4e8a-925c-4fb98912acef", "node_type": null, "metadata": {}, "hash": "2e564e393e1754c40169f3405e1c4c6296f1c4efcfa27bced34088c203404d38"}}, "hash": "21846f5bbde508181c667d62833443b5dd389da070cd642c375b2bd28f659988", "text": "the dynamics, the historic dynamics that are there. And you also understand that it's a living system that can be shaped and steered. Just are you, you know, is that your fight that you wanna fight? And so, you know, I have had a long history of helping white people understand racism or understand the experience of being a not white person in cultures of white supremacy or, you know, just even microaggressions, the world of microaggressions have had a long, long practice of helping people see and understand that. And so a really important thing for any young person setting out with those kinds of ethics and investment in changing the world that way is to have really clear boundaries about when you do that work and when you don't. And that applies to your personal relationships, but it absolutely applies in your professional environments as well. It's an important way to avoid being tokenized or exploited for, you know, being a representative of a person of color within a space that's not fully committed to actually doing the work, everyone doing the work, whether you're a person of color or not to raise the level of awareness and the level of dialogue that everyone's participating in. So it's really like you have to check the values of the environment and the ecosystem that you're entering to make sure that it is a supportive place for you. And if not, there's many places that are available to you in the world. And some, you know, some places are a little slower to get on this ride, this journey. And, you know, you could make the choice to be like, I'm gonna help shepherd this group of people to a newer, better place. Or you could be like, you know what? Someone else is gonna do that work and I'm gonna go over there where it feels more like this is my level. Everyone in every culture is a product of a long period of influence, right? And so it's not any, I mean, this is a very optimistic, positive view, but it's not any one person's 100% fault. I mean, a really, really bad person who's not getting with it has made a lot of bad choices, but it came from somewhere. They learned it somewhere. It was validated somehow by some other force and some other reward system, right? So you just think of it as a system that way, where there's power dynamics and there's forces and there's people, you know, again, the materialism thing is like, what are the actual forces in play? Physical, like it sometimes feels physical forces, material rewards and inputs that are creating the system and how can you be a bug in that system, change it? Yeah, I think it depends a lot on what you want to do. So, you know, there are mycologists, biochemists, material scientists, engineers on our team, process engineers on our team, who I think to learn what they know how to do, school helps, but industry helps as well. So I feel like as long as you have some baseline principles for, you know, the technical knowledge, for the area that you're interested in and that can be happen a lot of different ways. It can absolutely happen on a hands-on, you know, apprenticeship style experiential way. And it can also happen within a school learning environment. That's really helpful. And then, you know, there are people who are on our team who did not graduate from high school, right? Like they followed a different path. They have developed like a whole other set of skills that are like absolutely applicable to what we're doing to create our material. So, you know, there's a lot of ways into this to say nothing of the fact that this is a biomaterials company that was started by artists. So Phil and I happen to have gone to college, but you don't have to go to school to be an artist. You know, yeah, we're biased as academics. Like I think school is a great environment to meet a lot of bunch of other people that are interested in what you're doing, but you can also do that, just getting involved in interesting projects and finding, you know, organizations that are focused on your study. I mean, one thing to say about the mycelium technology space is that because the study of fungi is so new relatively, a lot of the knowledge about mushrooms foraging, identifying them, what they can do came from peer-to-peer DIY", "start_char_idx": 4145, "end_char_idx": 8386, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "be874afb-a9a4-4e8a-925c-4fb98912acef": {"__data__": {"id_": "be874afb-a9a4-4e8a-925c-4fb98912acef", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6b692a4f-0b81-48ac-842b-07859deb3301", "node_type": null, "metadata": {}, "hash": "ff17bbe69af57876db14e4d43938a19273cf60ce613b778e2d3e8c798cde8dc1"}, "2": {"node_id": "a965164f-649c-489e-b828-24f27b52242f", "node_type": null, "metadata": {}, "hash": "21846f5bbde508181c667d62833443b5dd389da070cd642c375b2bd28f659988"}, "3": {"node_id": "feb6da34-b679-4bf1-97e8-12e8068995e1", "node_type": null, "metadata": {}, "hash": "e09c79c1f6f609f97df3b7d03a26991e122057af8974541aa81893955df8fc41"}}, "hash": "2e564e393e1754c40169f3405e1c4c6296f1c4efcfa27bced34088c203404d38", "text": "identifying them, what they can do came from peer-to-peer DIY networks. So it was people just learning about mushrooms on their own, going on mushroom foraging walks, creating like mycological societies to share information. A lot of the information about, or the knowledge about like cultivating mushrooms actually came out of people understanding the medicinal and like, you know, the medicinal and sacred, like ritual-based use for mushrooms. So people basically growing psychedelic mushrooms and understanding like, oh, here's how you create a clean environment to make sure that you grow the mushrooms that you want. So a lot of the knowledge of mycelium technology came out of non-institutional sources. So absolutely just community, peer-to-peer learning, absolutely just community, peer-to-peer learning. So a lot of wisdom to be found outside of institutions. Well, it's more like if I could leave, live like a bunch of different lives, because I wouldn't want to lose what I did because it's so, and like I've always loved stories and reading and writing. So I think the path of English and literature makes sense and I'm also an artist. So the path of like deepening into art practice and actually having some like college-based, you know, studio practice like as a foundation helped me, but I'm also really interested in philosophy and law. And of course, like, it's sort of like I get my biological sciences information sort of by osmosis, by like everything's around, like by the company that's around me, the people around me. So in a way I feel sort of satisfied there, but I feel like I would definitely find the study of philosophy and law really, really interesting because I think similar to my interest in steering culture, there's a lot of assumptions that people have made, like values assumptions about what is good, what is bad, what's the right way to organize a group of people, what, like why you need to have nations, why you need to have states, like why you even need to have certain kinds of, like legal structures or like governance structures, that stuff we just made up along the way. And at some point, certain things got like, like just rigid, like this is how it has to be. And I don't think things do not have to be that way. Like I said, everything is steerable. And so it'd be interesting to like know all the arguments and to know the key turning points for when certain structures solidified so that you could like twist it. You could go back and be like, well, that is assuming this, this, and this. And now we know that those assumptions are wrong. Or we know that that led to some bad stuff in terms of oppression and hierarchies. And maybe we go back to that turning point and we shift the assumption there and see what happens. So that's interesting to me is to like have, like, cause if you know history, then you know how to not repeat it. You know what to do differently. Well, I'll give a really literal material list answer. So what we're working on right now with MycoWorks is we are building our first commercial scale facility. So our factory here in Emeryville, California does 10,000 sheets a year, which sounds like a lot, but you know, for a company like, you know, Nike or Adidas, like you named before, like they need a whole lot more material to even release one product, right? So what we're doing right now is we're building another factory in South Carolina and it's gonna be a hundred thousand square feet in size. And we're gonna be able to produce several millions of square feet of our material per year. So that is getting to numbers that are actually relevant for a large brand. Or for instance, as a company, we just announced a partnership with GM, which as you know, makes vehicles, cars. And so the idea is they will be a strategic partner for us in scaling our processes and our technology and our product volumes so that we can be relevant to the auto industry. And so the volumes that you're looking at there, think about like all the places in the interior of a car where you have leather or a leather alternative, like a pleather, that's where we're headed. So the world will be different once we build and prove out this factory and show we", "start_char_idx": 8403, "end_char_idx": 12625, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "feb6da34-b679-4bf1-97e8-12e8068995e1": {"__data__": {"id_": "feb6da34-b679-4bf1-97e8-12e8068995e1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6b692a4f-0b81-48ac-842b-07859deb3301", "node_type": null, "metadata": {}, "hash": "ff17bbe69af57876db14e4d43938a19273cf60ce613b778e2d3e8c798cde8dc1"}, "2": {"node_id": "be874afb-a9a4-4e8a-925c-4fb98912acef", "node_type": null, "metadata": {}, "hash": "2e564e393e1754c40169f3405e1c4c6296f1c4efcfa27bced34088c203404d38"}}, "hash": "e09c79c1f6f609f97df3b7d03a26991e122057af8974541aa81893955df8fc41", "text": "So the world will be different once we build and prove out this factory and show we can do it, because at that point it's like, oh, this is now possible. And so the next question is just where's the next factory and then the next 10, right? 20 or whatever. So it's gonna be a really, really big pivot point for this materials science space at large. And then for us as a company, when that factory turns on and is working and is at full capacity, and that'll be sometime between 2023 and 2024. Oh, the non-material answer. I mean, I think that it goes back to the answer that I gave before, which was a shift. Yeah, like the early tagline that I wrote for the company was let's change the way things are made. And it's a little broad, but I still live by it. Cause it's like, if you can show the world that you can make things using a process that is very like holistically beneficial because you're using waste materials and you're processing waste materials into something of value, and then it can break down and be beneficial, non-harmful to the environment, and you can show that it works and it can be profitable. And it's not like you don't have to compromise in terms of the performance and the aesthetics of the product that you get. Then that gives people the incentive to keep working in that direction. And so that is the immaterial answer, which is also very material. Cause if we can change the way things are made, then literally we're gonna change the way things are made.", "start_char_idx": 12594, "end_char_idx": 14082, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "94b73e2c-db77-4fe7-88ed-fe3675652aab": {"__data__": {"id_": "94b73e2c-db77-4fe7-88ed-fe3675652aab", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "da06ef5a-6c94-43a2-9347-b7d0f6280998", "node_type": null, "metadata": {}, "hash": "8dcd567fe33c9e15808c8d7e232657b1b550caf7162c1ab8f78d720638c63472"}, "3": {"node_id": "3e60d765-da5b-472a-a5b8-7d6892f092b9", "node_type": null, "metadata": {}, "hash": "f9f79fbe86baed587691056cc8f02cdfa887238ed0cf31a34e98166796237d8a"}}, "hash": "5fcddf65d14c14987910c813ebbfb4d9b5e4254dd440d3535bb828e68e12bb37", "text": "Bioengineering for the biopharmaceutical industry. I don't do it myself because I'm in this role of CEO, but I used to actually manufacture biologic drugs on the manufacturing floor. And I used to also work with the bioengineering team to create or recreate or improve those manufacturing processes. So that's the bioengineer I am. I'm not a, what's the other one? A biomedical engineer is different, you know, that's more for dealing with doctors and whatever innovative ways you may come up with a different surgery or a different procedure. Maybe playing with something in the lab last minute. So that, you know, to give you an example of that, that's kind of how these immunosuppressant drugs and cell therapies came about. It was life scientists and R&D and stuff dealing with that stuff. But the people that kind of did it first was the biomedical engineers on site at the hospital. As far as a patient coming in and having an autoimmune disease and you having to figure that out. And so autoimmune diseases for a number of years, I'll probably say my cousin, I won't say his name, but I have two cousins with autoimmune disease called bubble boy disease with a, you know, the immune system attacks itself and they're very sensitive. When the oldest one was younger and he first got diagnosed, you had to do straight bone marrow transplants and we had to stock up the bone marrow and all that stuff at the hospital and they would do those treatments on site. Fast forward to this younger one that's about, I think it's about 10 years difference between maybe more than that, between his little brother, who's a twin. He's a fraternal twin with his sister and he has it. And so fast forward today where you have these treatments that you don't have to do the bone marrow transplants. Now you got the drugs such as the viral and gene vectors and cell therapies that you can just do with a syringe on the spot at home on a regimen. So I say that to say that, you know, it's different types of bioengineering, biomedical has definitely been just as instrumental as a traditional bioengineering for biopharmaceutical drugs, as well as bioengineering for agriculture, as well as bioengineering for the biofuels industry. But I'm in the biopharmaceuticals and so generating, creating those processes, improving those processes and actually manufacturing the drug themself is where I fit in. Oh, you know what? Y'all going to be mad because I didn't necessarily choose it. I fell into it. And I liked it later. I actually was at the time where I kind of fell into it. I was working at Walter Reed Army Institute of Research doing bench top research at the Naval Base in Silver Spring, now at the hospital. And at that time I was in the molecular, I think I was in the molecular pathology department and we were investigating, you know, I'm about to say COVID, not COVID, what's the one with the dengue virus, West Nile virus, thank you, that's what I couldn't think of. And then around that time, that's when the study of omega-3s and omega-6s and how they affected breast cancer. Those are the things that I was looking at at the time. And so our PI, who I won't name, who still works for the federal government, got caught with our hand in the cookie jar, misappropriated funds, federal government sent down, I mean, they sent down Army lieutenants and sergeants and higher ups down to the base, Navy, I'm saying for the Navy and Marines, I think we have one of each, come and sit with us and investigate us. And ironically at the time, you know, the team was mostly black and brown. Most of us was from a local university between Howard University in Maryland, University of Baltimore, all that stuff. And we didn't know. We think we just being interviewed, what we do every day. And so we're telling them, hey, we do this and that every day. This is the time we do this. We just talking. We don't know because we're not in the service, we're all civilians. And so I kind of found out I was doing an investigation of her misappropriated", "start_char_idx": 0, "end_char_idx": 4037, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3e60d765-da5b-472a-a5b8-7d6892f092b9": {"__data__": {"id_": "3e60d765-da5b-472a-a5b8-7d6892f092b9", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "da06ef5a-6c94-43a2-9347-b7d0f6280998", "node_type": null, "metadata": {}, "hash": "8dcd567fe33c9e15808c8d7e232657b1b550caf7162c1ab8f78d720638c63472"}, "2": {"node_id": "94b73e2c-db77-4fe7-88ed-fe3675652aab", "node_type": null, "metadata": {}, "hash": "5fcddf65d14c14987910c813ebbfb4d9b5e4254dd440d3535bb828e68e12bb37"}, "3": {"node_id": "b0df5462-4e19-41d0-9582-29730f587456", "node_type": null, "metadata": {}, "hash": "f30b1682bef0252bb81a035488fde51c152db01e244d99655103cdaed10e5105"}}, "hash": "f9f79fbe86baed587691056cc8f02cdfa887238ed0cf31a34e98166796237d8a", "text": "And so I kind of found out I was doing an investigation of her misappropriated funds. And so she started firing everybody. So me being the smart person I am, I was like, well, shit, I'm just going to wait till she fire me, but I'm going to get another job. And then I could just work two jobs, you know, I was partying six days in a week, got a reputation, you know, party schedule to keep up with in DC. And so I end up getting a job through a temp agency at Human Genome Sciences in Rockville, which is now GSK. And I had two jobs for about three months. And she was like, you know, finally, she's like, oh, well, it looks like you've already secured another place of employment, you know, go focus on that, whatever. But I had already, you know, caked up within that three months. And so that's how I kind of fell into it. And so when I first got to Human Genome and doing it, I didn't like it because, you know, working at Walter Reed, benchtop, I got my white coat, I got my name on my coat. I make my own schedule alongside, you know, meet the, meet my deadlines for my reports and my experiments and be on time with things. It didn't matter what time I came to work, it didn't matter what time I left, right? It's all based on my, you know, progress and my productivity. So it was an adjustment to work in a team like environment and to start at the bottom, right? Because even though big pharma and biopharma is life sciences, it's very corporate, right? So, you know, life sciences, your version of starting in the mail room, the version of corporate starting in the mail room and corporate, but life science is starting at the bottom. And at that time, it's being a gopher. You know, you had stainless steel equipment, you had unilateral facilities where you can only go in one way, come out one way, one side is this, one side is that. So once you get out of one area, you had to walk all the way around and re-gout in. So I was highly irritated, I was pretty vocal about it. And then I ended up getting a mentor, Sandra Brown, who still works at GSK Rockville today. And she kind of pulled me aside and helped me better understand things as far as the manufacturing facility, but more importantly, gave me some training to give me more autonomy, to get me more engaged. At the time, I was like, I'm not doing this, it was four o'clock for 30, I believe it on the dot. People know, you know, that work in biopharma or life science, especially in manufacturing, know that you're at the beg of the process, right? So if that step ain't done, we got to wait to do that step later today, you had to stay late and do it. Oftentimes, they'll put us up in hotels doing running stores to stay at a hotel. We had a hotel, like it was kind of across the street from Human Genome at that time or down the street, I can't remember. And so often they would put us up in hotels, so people didn't, you know, outside, your families and stuff didn't understand that. So people thought I was lying, they were like, oh, you spend the night at somebody's house, you're doing all this shit. I'm like, nah, like here's the receipt, like that's a hotel receipt, don't no job put you at no hotel for like no week or whatever, because sometimes there'll be a snowstorm, we had to stay there the whole week. But anyway, I definitely fell into it. And once I got more responsibility, definitely, definitely, I can't thank Sandra Brown enough for what she did for me, to get me engaged. And that just sparked curiosity. From there, I started learning things outside and really leaning into it, especially when I got diagnosed with a chronic condition before I had to finally go, you know, take time off. I kind of finally just like leaned into it, got more and more responsibility and just kind of fell in love with it. And it wasn't just about the bioengineering or the manufacturing piece of it. I think for me, I fell in love with it because", "start_char_idx": 3974, "end_char_idx": 7901, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b0df5462-4e19-41d0-9582-29730f587456": {"__data__": {"id_": "b0df5462-4e19-41d0-9582-29730f587456", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "da06ef5a-6c94-43a2-9347-b7d0f6280998", "node_type": null, "metadata": {}, "hash": "8dcd567fe33c9e15808c8d7e232657b1b550caf7162c1ab8f78d720638c63472"}, "2": {"node_id": "3e60d765-da5b-472a-a5b8-7d6892f092b9", "node_type": null, "metadata": {}, "hash": "f9f79fbe86baed587691056cc8f02cdfa887238ed0cf31a34e98166796237d8a"}, "3": {"node_id": "40d2dbad-fde0-490d-889e-ffa50bb1ee1e", "node_type": null, "metadata": {}, "hash": "7edf89c9299c60824c6df224b58eb90149f1512e9930d70cffb7c539b09898a5"}}, "hash": "f30b1682bef0252bb81a035488fde51c152db01e244d99655103cdaed10e5105", "text": "or the manufacturing piece of it. I think for me, I fell in love with it because of the extended benefits of it. And then the extended challenges of it, right. So I'm at a point where I'm just making these drugs. One of the drugs I was making at the time was still in clinical trials, but it was for anthrax and we had the anthrax deal at that time. And so we were stockpiling federal federal government. And so we was doing that. And then I was also part of a team who was manufacturing a drug for lupus. So that's how I kind of got my CDMO field, because at that time, and I think they still do that. I worked at the small scale pilot plant and human genome. And so that's where we tested out different manufacturing processes for, excuse me, different drugs and pretty much everything in that plant was either at the preclinical stage or the clinical stage. So we were doing different drugs, different, different points of the year. And so the lupus drug is what really got me because I went to a some type of seminar, whatever, sit down thing at the company at the time. And they were talking about the human clinical trials. And they mentioned that they'd recorded, I mean, they did not recruit any African-American women. They only recruited women from India. And so I raised my hand, I said, well, you know, I ain't no expert, but lupus has a high rate of occurrence in African-American women. So, you know, why don't y'all include, you know, African-American women in the study? And they said, well, it's simple. It's just easier to get women from India. And so when I, you know, started to take a deeper dive again on my own, because I'm a nerd and I was like, oh no, this is a, this is a financial thing and a regulatory thing. You know, you can go to India, get away with certain things, make the data look good, and you'll get the FDA approved because you want to be in an American market. You also know the history of working with African-Americans, knowing that you're probably not going to do them the right way, right? And or knowing that most likely this drug is not going to treat them because it wasn't discovered for them or by them. Right. And so when I learned that, I said, oh, I got to, I got to fix this. And the other thing I noticed was the impact, not just at Human Genome, but later in my career, especially when I got to Amgen in Thousand Oaks, California, working at the headquarters and I worked at a pilot plant there at the time. But I start paying attention to the neighborhoods and the people that work there and how all the white people had a house, three kids and a dog and two cars and college is paid for. And I said, well, if they can do this for their communities and, you know, what is the suburb before it becomes a suburb? It's a cornfield or it's the hood, right? It's never a suburb starting off, it's either rural or super urban and they clinked it up. And so at that time, the Thousand Oaks was more rural. A lot of cows out there and they had, you know, all these companies start moving in. So the biggest employers of Thousand Oaks at that time when I worked there was 3M, the people that make the tape, Amgen and Baxter. And what's that sauce? Let me get it, hold on. You're going to laugh at this. Damn, I ain't even got no room. It's a red chili sauce, a red chili sauce with the green top. Not the sriracha, right? Yes, the sriracha plant was in Thousand Oaks and then you had the farms. So coming down the highway, one side, you smell the sriracha, the other side, you might be smelling cows. Strawberries and oranges is what you, I mean, not oranges. What else is out there? Maybe it's not oranges. You had strawberries or something else. I forget. But mainly strawberries, which you can smell going down. I think it was a highway, I think it's five, highway five. That must have been an insane smell, just for the record. That mixture, but it was beautiful", "start_char_idx": 7902, "end_char_idx": 11816, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "40d2dbad-fde0-490d-889e-ffa50bb1ee1e": {"__data__": {"id_": "40d2dbad-fde0-490d-889e-ffa50bb1ee1e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "da06ef5a-6c94-43a2-9347-b7d0f6280998", "node_type": null, "metadata": {}, "hash": "8dcd567fe33c9e15808c8d7e232657b1b550caf7162c1ab8f78d720638c63472"}, "2": {"node_id": "b0df5462-4e19-41d0-9582-29730f587456", "node_type": null, "metadata": {}, "hash": "f30b1682bef0252bb81a035488fde51c152db01e244d99655103cdaed10e5105"}, "3": {"node_id": "ebdc86de-e786-46c2-92af-2ee95a78ed5c", "node_type": null, "metadata": {}, "hash": "4088307c1880f6bb3b0570d21d59e412cdff930d7e3239389a0e6706564cd9f8"}}, "hash": "7edf89c9299c60824c6df224b58eb90149f1512e9930d70cffb7c539b09898a5", "text": "an insane smell, just for the record. That mixture, but it was beautiful to see everybody working and being productive and poverty being really, you rarely saw a homeless person out there. You rarely saw, even at the sleazy motels in Thousand Oaks, you rarely saw somebody standing outside and conducting that type of business, if you understand what I'm saying. So for me, I was like, you know, I want to I want to do something similar. So I started making my plan for the company on paper back in 2014 or 2013, really. And figuring out where do I need to go to be ready to execute my company at the time? What education do I need and what other experience do I need? And so that's when I start making sure I put myself in position to get on the manager or management track. It was mentorship a little bit, but not so much. And the reason why I say not so much, because obviously I'm doing something that nobody's done. I'm the first African-American woman to do a second African-American person to do it, you know, six to eight years after Dr. Percy LaVon Julian in Chicago and Oak Park. But for me, I think, you know, once once I went to that lupus event, figured it out and then my mind was rolling like, what, like, how can I do this? And so at that time, probably about a year later from that point of that lupus event that I went to, I was still working there. That's when they just came out with single use equipment. It was Xcelerx. Xcelerx was the first person. Xcelerx got acquired by GE. Now today it's Citiva. But at that time, Xcelerx just came on the market and I'm not the finest, but the slogan was, you can literally set up your factory at a strip mall. That's what they said. So when I'm looking at some equipment and at that time they were still, you know, had the plastic shields around the plastic or the single use equipment, you stuck your gloves and they still have, they still sell that way if you want it that way. But at that time, that's what they were selling to say that you can literally do this in the parking lot if you didn't have, you know, I mean, a strip mall, if you didn't have the greatest HVAC system, that box over the bioreactor with the gloves was the solution to protect the product and protect you. So I ramped that shit up. I went to my manager, not really understanding the hierarchy of corporate at that time. And we had the same last name, so I used to tell him like, yo, aunt, like aunt, right? His last name was Williams, Anthony Williams. I was like, he'd be like looking at me crazy because I'd knock on his door and be like, yo, check this out. Like, did you see this? I was like, yo, you need to rip everything out, get rid of this. Not understanding regulatory all the way at that time, you know, as far as the facility built out and things of that nature. And so he looked at me, it was like, you need to go back to work. And I didn't. I went back to my desk. I had all this sprawled out of binders and articles and things on my desk and my cubicle. So I probably took over somebody else cubicle with all my shit, really trying to figure this out. And then I called Accelerate myself. I mean, I had them revved up like I had some big investment coming in and like I was really good, like set this thing up. And then that's when I got diagnosed and got sick. So I was there to stop. But from that point on and then fast forward to looking at the neighborhoods at Thousand Oaks where I worked in and what that looked like. And I was like, you know what, I can do this. I just got to put these pieces together. And the crazy thing is, you know, what most people don't know, especially this generation, no disrespect to this generation, but because everything's so accessible to this generation. And I had it, too. I guess one of my, what am I? I'm a millennial. Oh, yeah, yeah. Thirty, I'll be thirty nine next week. Twenty four. But by what is it? I think it's Gen Z now. Yeah. Gen Z had everything at a", "start_char_idx": 11821, "end_char_idx": 15781, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ebdc86de-e786-46c2-92af-2ee95a78ed5c": {"__data__": {"id_": "ebdc86de-e786-46c2-92af-2ee95a78ed5c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "da06ef5a-6c94-43a2-9347-b7d0f6280998", "node_type": null, "metadata": {}, "hash": "8dcd567fe33c9e15808c8d7e232657b1b550caf7162c1ab8f78d720638c63472"}, "2": {"node_id": "40d2dbad-fde0-490d-889e-ffa50bb1ee1e", "node_type": null, "metadata": {}, "hash": "7edf89c9299c60824c6df224b58eb90149f1512e9930d70cffb7c539b09898a5"}, "3": {"node_id": "8eda9e10-5a28-4399-83b6-bc34e233e286", "node_type": null, "metadata": {}, "hash": "f9d17ea95becbe53d83526fb8e1483a7667ce1e52284027181674f76d1dd3964"}}, "hash": "4088307c1880f6bb3b0570d21d59e412cdff930d7e3239389a0e6706564cd9f8", "text": "what is it? I think it's Gen Z now. Yeah. Gen Z had everything at a fingertip. So because they were so used to looking up things for what they want. Right. If it's the new shoes, sneakers, the latest song, the gospel, TMZ, they look it up. But when it comes to looking up things that can help them make money, I don't think they necessarily made that connection yet outside of being an influencer because the influencer can do things themselves. Right. You can make your own content. You have all these tools when it comes to entrepreneurship and doing something on the scale that I'm doing. It takes a team. It takes a mind that tends to think strategically and collaboratively, meaning not just who I'm going to do this with, but what's going to be the benefit for us to do this together? What is the exchange? And so those things they're not going to teach you in school. Hell, they don't even teach you that in the MBA program. I don't have an MBA, but I got a master's in business from for Full Sailor MS. And even in that program, they don't necessarily teach you precisely. They talk about it, but they don't lean into them to say this is probably the most critical things that you can learn and understand in order to be successful to start a venture capital backed company. That is the difference. Small business. You can raise me a booster as you can take your 401k, go run out of buildings, set up, make burgers or whatever widget that you make from that standpoint, go get a Copacker or whatever it is. You know, some of these terms that you probably see on Shark Tank, which I do recommend. I watch a lot. I've been watching Shark Tank since day one, so I learned a lot about pitching from that in different terms. But those are the things that I think people, the generation today that's graduated from college or entering college in order to do something different, in order to be successful on a magnitude where you're a million dollar to a billion or trillion dollar business, you have to go get that information yourself. You have to be willing to humble yourself and sit during your free time and Google and read because everything is not on Google. Some of the best books I'll show you right now. So I know this guy is not a popular guy right now, but some of the can you see that Peter Thiel? Let me tell you, I see. Yep. Peter Thiel there down at the bottom. Yeah. Yes. You can see that, right? Yeah. And this is my second, second time reading this book. These are the things that you got to do. And you also got to read books like this, you know what I'm saying? Tarray with balance to understand and get your personal mental health correct. Right. So this is this third book. I read every book this man puts out. He's still my pastor today when I was in when L.A. And then you also got to know, you know, background to give you that fight. Right. You got to read that, right? This is a new one. I think they published it right when he passed. But this John Lewis joint carry on me. You also got to stick to your roots, you know what I mean? I got that one. I haven't read this one yet. It's still sitting here. I got to get to it. But unconventional reads like this really give you drive. I don't care if you're black, white or whatever. When you read people to have unconventional says like Gucci Mane and Migo. Shout out to take our rest in peace. Quality control. And I don't get on top. But look at that story. Look how with Motown, a guy similar to me came from manufacturing cars and applied that business model to music to full circle the next generation of Motown, which is quality control. And now these guys are a partnership. Look at that. You're not going to get that from school, one of them, whether it was coach K or the other one, I apologize. I don't remember his name. One of them had to have that thought process to get an idea that making that deal with Motown was essential. And shout out to Ethiopia. I used to work with Tina Davis when I was working at Moonlight in the music industry. So that's how I made Ethiopia. But look how that came full circle, how you can use unconventional and", "start_char_idx": 15790, "end_char_idx": 19924, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8eda9e10-5a28-4399-83b6-bc34e233e286": {"__data__": {"id_": "8eda9e10-5a28-4399-83b6-bc34e233e286", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "da06ef5a-6c94-43a2-9347-b7d0f6280998", "node_type": null, "metadata": {}, "hash": "8dcd567fe33c9e15808c8d7e232657b1b550caf7162c1ab8f78d720638c63472"}, "2": {"node_id": "ebdc86de-e786-46c2-92af-2ee95a78ed5c", "node_type": null, "metadata": {}, "hash": "4088307c1880f6bb3b0570d21d59e412cdff930d7e3239389a0e6706564cd9f8"}}, "hash": "f9d17ea95becbe53d83526fb8e1483a7667ce1e52284027181674f76d1dd3964", "text": "But look how that came full circle, how you can use unconventional and conventional wisdom to do something great and to fill in the gap and fulfill a need, right? Nobody's done that right. Even the way Master P did it, the way what was that? I forgot something, House Records down in Houston. I was raised in Houston. And then you had Def Jam with Russell Simmons. All those cats did something unconventional and quality control took all those situations and they created it wrong and then ran it back full circle to the originator with Motown. Right. Same with, you know, with what Tyler Perry's doing. Like, I don't know if y'all seen the latest movie he got on Netflix, which is very different from his other works. But I knew he had that in him. I've been waiting on that. I've been telling everybody, like people hate on Tyler Perry. But he did the same thing I did. He went through the play route. He figured out how to draw a crowd. He figured out what his niche market wanted to see all the time. And then when he took his business from the next moment, from the Chitlin Circle of Pays to the film industry and did his deal with, what is it, Lionsgate? He also looked at what Spike Lee did, right?", "start_char_idx": 19906, "end_char_idx": 21111, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "225f51d1-82ac-472c-9009-31722b15eecb": {"__data__": {"id_": "225f51d1-82ac-472c-9009-31722b15eecb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "12171429-7444-4e97-b551-1ea5eed30f87", "node_type": null, "metadata": {}, "hash": "323eefb78991c6cd3d12f95d944e8669ce15be50cf211b5572d8d868ecea4f7f"}, "3": {"node_id": "0d1eba7e-2175-4f27-befd-39e4b87d9e94", "node_type": null, "metadata": {}, "hash": "9be521450375c22206c07258157a2aa9c3f5f3ca2f2d9548071b760a29c5c610"}}, "hash": "56bbf7232e7db6b21bd0ae568ea43002cdc54ee2569f29a2a135a2d1f0680194", "text": "He looked at all these other Black directors, Robert Townsend, all them guys, he looked at all what they did and said, okay, well, I started differently for them. No, I did not go to film school or art school, but I know how to hire experts. No, I don't know anything about marketing and distribution, but I can research and get lawyers, right? And then when it was time to make it to the next level, he did Lionsgate, and that's why he still has to deal with Lionsgate today. That's why he's been the only one to maintain that distribution deal, because he did his homework, guys. You guys got to be hungry. You got to do the work outside. You got to learn, you know, from the past of what they did, and full circle, right? I just talked about General Motors and Motown, right? So I'll tell you this, to put it in the plainest words, and so you can get to your next question, because I know I'm long-winded, but in order to be successful, you have to choose what success you want and what that looks like and what are the different pathways to get it. And last but not least, to sum all that up, what is your appetite for risk? Success all goes down to what's your appetite or risk, and that determines the level of success you want and what kind and what you want it to look like. If I want to leave my work at work and have my vacations with my family, pay for college, have a nice house, and just retire and be able to take care of my immediate situation, maybe do some volunteer work, go be an employee. Hell, go punch a clock is what you need to do, and there is nothing wrong with that. I commend that. Trust me. I think about like, maybe I should just go punch a clock. It'd be a lot easier than dealing with this, right? The next one to that that's a little bit higher than that is, okay, well, go be a salary employee, right? But what comes with that is what? Responsibility. So versus a hourly employee, a salary employee may not be able to take the vacations all the time when they want to take it. They may have to, more than likely, always bring some type of work home to finish it and not get paid for it. You will have to deal with people reporting to you, whether it's directly or indirectly, and be collaborative to get your work done. But nevertheless, you still have this built-in thing where you know your paycheck's coming from, right? You know exactly what it's going to be. You know exactly what your tax is going to be. You know exactly what your bills are, and you kind of know some way when you're getting to equity. But for most people, you know what steps to take to escalate to get up to director and C-suite role, right, once you get to that point. That's one way. Then you have one where you say, well, I just want to make my own hours and leave work at work, maybe take something home and, you know, do something a little bit different but have my own control. That's small business. You take your own money, you invest it, you come up with something, whether you do some of your own in retail or food service or whatever the case, cosmetics with barbershops, whatever, nails, whatever. Or you do a franchise and you invest your money into a Chick-fil-A, McDonald's, whatever, and you expand from there. And that is a great infrastructure if you want to do it that way because you can start literally what you have and do it, right? But if you want to be over here where I'm at with venture capital and a billion dollar industry with the potential for billions and millions of dollars, trillions of dollars of revenue and make an impact, a real dent, not just in your immediate family neighborhood situation, but in more of a global domestic situation, then you're going to have to put in that time. That is not teachable. What college and what's your employment experience, because that's important too, you can't, you know, I know we got, you know, you see, excuse my language, so many white folks jump from college to VC back, right? You want to give me some examples?", "start_char_idx": 0, "end_char_idx": 4004, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0d1eba7e-2175-4f27-befd-39e4b87d9e94": {"__data__": {"id_": "0d1eba7e-2175-4f27-befd-39e4b87d9e94", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "12171429-7444-4e97-b551-1ea5eed30f87", "node_type": null, "metadata": {}, "hash": "323eefb78991c6cd3d12f95d944e8669ce15be50cf211b5572d8d868ecea4f7f"}, "2": {"node_id": "225f51d1-82ac-472c-9009-31722b15eecb", "node_type": null, "metadata": {}, "hash": "56bbf7232e7db6b21bd0ae568ea43002cdc54ee2569f29a2a135a2d1f0680194"}, "3": {"node_id": "691fc26a-704f-437d-89b4-ef01fc7c93ae", "node_type": null, "metadata": {}, "hash": "28364c4af1cd52b9aabe3067ad9017297b38088f1912a7e413eaa5595516a569"}}, "hash": "9be521450375c22206c07258157a2aa9c3f5f3ca2f2d9548071b760a29c5c610", "text": "folks jump from college to VC back, right? You want to give me some examples? Theranos. You got Theranos. I think, who we just had recently? Somebody else just came out with something bogus. I can't think of the company. But anyway, you got that part, right? You got non-profitable companies like Uber, non-profitable. Tesla, non-profitable. Twitter, non-profitable. SpaceX, getting millions of dollars, billions of investment, non-profitable. What's the coworker space guy? I forgot his name. Oh yeah, the WeWork guy. WeWork, non-profitable, right? That's what they do. But folks that look like you and me, they're going to ask you when you become a profitable, how much, they're going to quiz you like you a neuroscientist in your business. And so, therefore, you got to do the extra work to be able to track those dollars, hit those milestones, and have a real impact on our community. And guess what? It ain't new to us. We did it already. You know when we did it? We did it during slavery. If it wasn't for us being smart enough to come up with things like the cotton gin and all these other different areas to help ourselves to make our lives somewhat easier that was within our control, we wouldn't have America what it is today. If we didn't build Black Wall Street, if we didn't do all these extra things like I'm just now learning about. I just partnered for a workforce development program with this organization called Philadelphia OIC, and it was founded by a civil rights leader back in, I say he's back in the 1940s, 1950s as well. So, he was right along there, 50s and 60s with Martin Luther King and Malcolm X. His name was Dr. Leon Sullivan, and he started a workforce development organization that not just spread domestically where he put his first one at in Philadelphia, it spread global. In fact, his set of principles were what was used to formulate the agreement and documentation to get Nelson Mandela and apartheid to end. No, I've never heard of Dr. Sullivan until recently. My mentor now, Sheila Ireland took over as president and CEO a few months ago. So, these are things that guys, we've already done research and it's obviously had an impact. Oh, full circle again, Dr. Sullivan was the first African American to be on the board of General Motors. You see how I keep making these connections, right? And each one of those cats did something very unique, but they had to take their own reins. They took their foundation of knowledge, whether it was traditional college and a lot of them had a lot of influence from the pulpit, right? Malcolm X, Martin Luther King and Sullivan all had a large foundation of support from the pulpit that did what? And they did it differently and it impacted business. Dr. Sullivan personally took it personal when they would not hire his people in North Philadelphia to work at factories like Tasty Cake. Y'all eat Tasty Cake, right? Y'all eat them damn donuts. He told them for about 90 days straight, every Sunday, do not buy Tasty Cake. Within 90 days, they sales plummeted. Guess what happened? Dr. Sullivan, we're going to go ahead and hire your folks. We got this. Oh, now you need us, right? That's what's going to happen. I'm not saying everybody has to be a venture-backed company, but if that's what you want to do, then you have signed up to be a leader. You have signed up to do the extra work for the long nights, long days of traveling. You have signed up to be humble enough to be broke and have a change of lifestyle than what you used to have if you was like me that was making seven, I mean, six figures and living in LA and doing what I did best at that time. But I knew if I stayed, if I did not make the strategic move to get back to the Ecos and get back to work from my perspective, then I wouldn't have what I'm doing today. And more importantly, outside of myself, I wouldn't be able to impact my community and where I'm trying to take our Black and Brown community to the next level. What drives me every morning", "start_char_idx": 3942, "end_char_idx": 7944, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "691fc26a-704f-437d-89b4-ef01fc7c93ae": {"__data__": {"id_": "691fc26a-704f-437d-89b4-ef01fc7c93ae", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "12171429-7444-4e97-b551-1ea5eed30f87", "node_type": null, "metadata": {}, "hash": "323eefb78991c6cd3d12f95d944e8669ce15be50cf211b5572d8d868ecea4f7f"}, "2": {"node_id": "0d1eba7e-2175-4f27-befd-39e4b87d9e94", "node_type": null, "metadata": {}, "hash": "9be521450375c22206c07258157a2aa9c3f5f3ca2f2d9548071b760a29c5c610"}, "3": {"node_id": "3d21d032-9889-4ff8-8c7f-0b9226a888fe", "node_type": null, "metadata": {}, "hash": "ffd7d4f5540d80ac6b3b0a500537283dd97e6290de8baa295bb9a5471a69e60b"}}, "hash": "28364c4af1cd52b9aabe3067ad9017297b38088f1912a7e413eaa5595516a569", "text": "trying to take our Black and Brown community to the next level. What drives me every morning is knowing that I have an opportunity to change the way that my people are accustomed to living, right? And it's a force of custom, right? We didn't ask to be brought over here. We didn't ask to be slaves. We didn't ask to live in these different areas that we call ghettos or hoods or whatever. And it's funny, right? Because if you're Jewish and you say you're from a ghetto, it's understandable, right? Understandable, even though they came over here by choice. We say we're from the ghetto, it's looked at like we're lazy. We ain't got no drive to do shit. In reality, the only times you're put in the ghetto because it's something that's forced. You're segregated, you're outcasted, you're told that you're different, you're told that you don't fit, right? So that's what drives me every day is being a part of a culture which entertainment is starting to do, not that they haven't, but you're really starting to do well. You're starting to see a lot more African-American shows that accurately depicts the African community at all levels of income, from All Rise to Reasonable Doubt to Hell, Take Your Pick. There's a ton of them out there, right? And so that's what drives me every day. Another thing that drives me every day is just knowing that I want to retire my parents, right? I got the support of my family right now, a lot of support of my family right now. And so I want to retire them and reward them for sticking with me to ride this thing out. And then the second question you said, what about bioengineering? Yeah, what specifically about bioengineering? I would say being able to, because so the name of the company is Lucas Pop Bio, contract drug manufacturer. We work in partnership with Jefferson University right now. We're able to perform or execute preclinical services. So we can develop a manufacturing process, including the cell line development, actual formulation recipe, and we can produce or manufacture material for animal studies. The future facility that we're building in Southwest Philadelphia, which will be a CG&P 80,000 square feet facility. And that's where we'll be able to start manufacturing for human clinical trials in the commercial market. Once those respective products are approved by a regulatory agency. So what drives me with that as a CDMO is that I get the opportunity to work with our target market, which are startups. I get the opportunity to work with a large amount of minority owned startups. So these are startups that are black and brown, whether they're Spanish descent, African descent or Indian descent or West Indian descent. But a lot of these companies don't have an opportunity to get the products off the ground. A lot of these companies just simply license their product and they lose out on money. So they can't necessarily always sustain their pipeline or other discoverable, drugable assets they may have in a pipeline. Or it may be something to the effect where because they can't get the product licensed because it doesn't have a favorable population to big pharma, meaning it's not enough money to them. It doesn't affect a lot of people, even though it disproportionately affect some of these disease indication, viral indication, disproportionately affect us as a people. So I get an opportunity to work with those companies to make an impact in my community. So it's just knowing that I think for me it's innovation of all. It's an opportunity to make an impact on a global scale. It's an opportunity to allow longevity of life for our people in more ways than one, not just that patience, but being able to help close that wealth gap, provide high quality jobs, high wage jobs, giving them the opportunity to pass on something to the next generation of their family, whether it's closing the wealth gap and or providing an opportunity for them to do the fullest of their educational priorities for what they want to do in any industry. It doesn't have to be life science. It's all these things that are definitely taken for granted and are considered rights and staples of the Caucasian community that I can help transform to not be something as a privilege in the Black and Brown community,", "start_char_idx": 7932, "end_char_idx": 12202, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3d21d032-9889-4ff8-8c7f-0b9226a888fe": {"__data__": {"id_": "3d21d032-9889-4ff8-8c7f-0b9226a888fe", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "12171429-7444-4e97-b551-1ea5eed30f87", "node_type": null, "metadata": {}, "hash": "323eefb78991c6cd3d12f95d944e8669ce15be50cf211b5572d8d868ecea4f7f"}, "2": {"node_id": "691fc26a-704f-437d-89b4-ef01fc7c93ae", "node_type": null, "metadata": {}, "hash": "28364c4af1cd52b9aabe3067ad9017297b38088f1912a7e413eaa5595516a569"}, "3": {"node_id": "485d5279-275c-4438-8e7e-c592032baeab", "node_type": null, "metadata": {}, "hash": "8e212cda78ebf3f4773e1e69916251573451a2cd7883d0dc89d4466007536e15"}}, "hash": "ffd7d4f5540d80ac6b3b0a500537283dd97e6290de8baa295bb9a5471a69e60b", "text": "that I can help transform to not be something as a privilege in the Black and Brown community, but it also become a staple and a requirement as far as expectations in our community as well. First question, no. So we actually have a workforce development program that we're piloting here in Philadelphia where we're training members of underserved communities with at least a GED or high school diploma to be a bioprocess operator or a quality control technician in the lab. So no, we're only requiring a sixth grade level of education as far as being able to read, write, and do math. And the reason for that is because everything is done according to what we call a standard operating procedure. So it's like a recipe. So similar to if you're working at In-N-Out and you have to follow instructions, how to construct a burger, how to cook the burger to a certain temperature, all that stuff, you do the same thing with manufacturing drugs and before you're following instructions, you do everything in twos, never by yourself, and you always use a calculator. Even down to, even if they're still using paper documentation, we oftentimes have the boxes to indicate how many decimal places to go over. We have instructions to say round this number, the number that you round up or down, that box is underlined. It's so many things that as long as you can read and write at a sixth grade level and have a high school diploma or GED that you can do. So those programs are starting to come more out there, but we're definitely exclusively doing that one out there. And then we have it two-fold. So we got the entry level and then we have one for people that already work in industry that may want to level up. So if you're a manufacturing worker, you want to switch over to quality assurance or quality control, we got certificates through that, through ISP, ASQ, and RAPS. So that's International Society for Pharmaceutical Engineering. ASQ is American Society of Quality and Regulatory is Regulatory Affairs for Professional, Regulatory Affairs Professional Society, I think. I might have that wrong. Sorry, RAPS. So now the second part of it is, what was the second question you asked me? The second question is if you were to go back to college now, what would you have pursued? What would you study? I wouldn't change anything. The only thing I would change in USC, University of Southern California, don't be pissed with me, but if I had known about RAPS then, I would have got the certification and not went to school. And the reason why I say that is because when I came to USC, I already had industry experience. I already had experience working with FDA, Europe, and Japan, doing regulatory responses and drafting things. And I've done all that, responded to 43s. I had done all that at that time. So had I known about RAPS, I just would have got the certification that I could have got done in a couple of weeks versus the two-year program that took $60,000 out of my pocket to get a master's degree. And that was my second master's degree. So that's the only thing I would have did different is take advantage. And I encourage you guys now, not every industry requires for you to be a PhD or a master's. Definitely with pay, master's does help. PhD, not necessarily. You'll spend that money and still not get a pay raise, especially in life sciences. But the certifications is what helped you get along further. And it's the best kept secret. So what you may not know is that in industry, oftentimes these certifications are paid for by big pharma, but they only pay for director level up to get them. Now think about that. By the time you get to director level, you should know this. Why am I paying? Even without a certification, you should have that much experience. You should know it, but there's a gap. So they're paying for them to fill that gap versus us that may be at lower levels on what I like to call the shop floor for 20 to 30 years that already have that knowledge. Without a certification, you just don't have the piece of paper to prove it or the title to prove it. So that point, it makes sense for you to go the certification route, pay the one-time fee of maybe five, 10, or figure", "start_char_idx": 12202, "end_char_idx": 16412, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "485d5279-275c-4438-8e7e-c592032baeab": {"__data__": {"id_": "485d5279-275c-4438-8e7e-c592032baeab", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "12171429-7444-4e97-b551-1ea5eed30f87", "node_type": null, "metadata": {}, "hash": "323eefb78991c6cd3d12f95d944e8669ce15be50cf211b5572d8d868ecea4f7f"}, "2": {"node_id": "3d21d032-9889-4ff8-8c7f-0b9226a888fe", "node_type": null, "metadata": {}, "hash": "ffd7d4f5540d80ac6b3b0a500537283dd97e6290de8baa295bb9a5471a69e60b"}, "3": {"node_id": "abd93524-e851-4886-be1f-933c2b83bc7f", "node_type": null, "metadata": {}, "hash": "3a998acb7296aaa8c91c746abf822ae76ce0eae86511c4b0b4aa401b82c37c22"}}, "hash": "8e212cda78ebf3f4773e1e69916251573451a2cd7883d0dc89d4466007536e15", "text": "go the certification route, pay the one-time fee of maybe five, 10, or figure out a way to get your company to pay for it too, or save your tax money and pay for that so that you can level up and go to the job. If you can't level up where you at, then you do like I did where you'll notice my LinkedIn profile moved every two and a half, three years on purpose because for some reason, that's the only way they take us seriously is having qualifications at a certain levels if we come from the outside. If we stay there too long, then they, for some reason, same like slavery, you only look at us where we started, not where we're going. Yeah. So heavily working on trying to finish acquiring this land and then start construction. We just received a $2.5 million grant from the state of Pennsylvania to help with construction, engineering, and build out of our life science park in partnership with Urbane here in Philadelphia. So that's big for us. We're in the middle of trying to complete a tech transfer for one of our customers. That deal right now, for the first part of the deal, which includes tech transfer and the development, investigation and development of the actual larger scale manufacturing process is worth about 125K. And that's for a proprietary cell therapy media, but they also have a drug that will hopefully get that contract as well. We're still working on that. And so the overall contract product for the media product will probably be, look, I say it won't be that much from my perspective. But our price, it'll probably get up to maybe a half a mil, maybe a little bit over half a mil for the proprietary media product. That's just for getting the process developed and manufacturing product for CGLP, which is still research and development. When they move into CGMP, then we may inch up, but that'll be on the regular cadence. And there'll be, excuse me, larger volumes at that point. So maybe we'll ink out a little over a million from just that product when it's all said and done. And then the drug product easily could be in the area of, for preclinical studies, there'll probably be around 15 to 20 million. And if we continue on from there and from clinical to the commercial market, there'll probably be maybe an additional 42 to 50 million, probably a little bit higher than that because of the clinical trial piece and how much product you have to have to service phase one, phase two phase, especially phase two, phase three, a lot more products. So that will probably be, I don't think it's going to be exactly at a hundred million, but it'll be probably close to it for the drug product. And that's coming from the same customer. And so then we're in the process of recruiting other customers. We finally getting re-signed a huge marketing deal, some paperwork. I've been negotiating that deal for two years. Did y'all hear what I said? Two years I've been negotiating with a lawyer back and forth to get this marketing deal, which is going to help us with our customer pipeline, rebuild our website, and get our name and our technical capabilities out there a lot more with white papers and things of that nature, which is really huge in our industry. And then outside of that, I just came back from the White House back in September and speaking on a bioeconomy, biotechnology panel. So we're waiting to hear back. And so we got to start getting with the lobbyists to keep our ears to the ground so that when that contract comes out, which is also financing to help support, build out of our facility, we could be ready to take advantage of that contract. And then there's some other things we look into. I'll share a little bit of it, but as we, we're in inflation, I'm pretty sure they're going to say we're in a recession first and second quarter. And so when you think of recession from these are the different mindsets, and I'll go through it again. And for my hourly working, I think a recession, I'm like, oh, I might get laid off. Maybe let me put in some extra time or go get a second job. If I'm in the salary level, it's like, ooh, let me make sure my actual role is relevant so that I don't be included in these huge layouts that you're starting to see with Twitter and Amazon and all those folks at the salary level be like,", "start_char_idx": 16426, "end_char_idx": 20709, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "abd93524-e851-4886-be1f-933c2b83bc7f": {"__data__": {"id_": "abd93524-e851-4886-be1f-933c2b83bc7f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "12171429-7444-4e97-b551-1ea5eed30f87", "node_type": null, "metadata": {}, "hash": "323eefb78991c6cd3d12f95d944e8669ce15be50cf211b5572d8d868ecea4f7f"}, "2": {"node_id": "485d5279-275c-4438-8e7e-c592032baeab", "node_type": null, "metadata": {}, "hash": "8e212cda78ebf3f4773e1e69916251573451a2cd7883d0dc89d4466007536e15"}, "3": {"node_id": "87d84eb6-9091-4b08-9905-90d1f2f1b539", "node_type": null, "metadata": {}, "hash": "2d255a3c0daa41db17f4bf14e43885b92bc82c36ea35dc01abec845872003883"}}, "hash": "3a998acb7296aaa8c91c746abf822ae76ce0eae86511c4b0b4aa401b82c37c22", "text": "starting to see with Twitter and Amazon and all those folks at the salary level be like, oh, let me make sure it's relevant. If it's not, let me volunteer, stay a little late, right? Because you don't get no extra pay, but it's just making yourself stand out, right? If I'm a small business owner, ooh, if we're in a recession, what kind of product, what kind of service can I offer to help my community to purchase at a cheap price so I can maintain business if these other things don't sell? If I'm venture capital bank like I am, hmm, how can I pivot to meet the market needs and what does that look like, right? And so for venture capital bank, it's a lot bigger. Like what am I going to do that's innovative, that meets the needs, that can give me the biggest bang for my buck if I was to attract a large account holder of whatever it is that I sell? And so let's just say healthcare is one of those things that has longevity, right? Whether it's a recession, depression, we're good, whatever. People always think pandemic, non-pandemic, epidemic, Pandora, I don't call this thing non-pandemic. But whether you have that, healthcare is always in. And so as a biotech company, that's one of the things that you can look at. You can look at what you're good at. You can look at the expertise of your team. What is financially appetizing to investors because we're a venture-backed company. So how can I attract additional investors? How can I attract additional money from the current investors I have or that I've been building relationships with that, what is this thing that's going to trigger? And so one of the things that trigger healthcare is how are we going to maintain healthcare costs? How are people going to hold on to their prescriptions for prescriptions they may have to take every day for the rest of their life, right? So let's just say LucasPotBio is just highly interested in the biosimilar biobetter market. And we just started those conversations yesterday. So we'll see what shakes out. For me, I think what's most important next 20 years is really bringing down the cost of goods and services for manufacturing to help encourage companies such as big farmers and other ones to bring down these drug prices. I just had a conversation right before I got on the phone with you for, you know, talking about the cell therapy industry and great technology, you know, novel technology, obviously doing what it's due. You still got former president Jimmy Carter standing there. I think, hell, he looked like he going in reverse last time. I saw him wrinkles fading and all that kind of stuff. But the reason why he is doing as good as he's doing or similar to Magic Johnson with what he has for his treatment for his HIV is because they have the money. They have the access to this technology to enable them to have longevity and be comfortable. And then they also have things to make them de-stressed in their life, right? They have money. They can go to spas. They can take trips. They can, this is getting too much and go sit somewhere during a pandemic for two years in the sun, not doing eating shrimp. And so what I'm hoping is that for bioengineers, that we find a way to really bring in higher titers of these products and lower the cost of goods and the manufacturing costs so that the people that actually need this can have it. You know, in black and brown community, when we get sick, it's just such a huge detrimental, you know, impact on the immediate family and extended family from that, right? Because nine times out of 10, it's the key people that are working the hardest that are the bread runners of the family that gets sick. And it's because they don't have the luxury. Like I told you about hourly worker, you know, you may not have the luxury of taking time off when you want. You're going to get it, but you may not be able to use it when you want to use it because you're the beck and call of that particular employer. So we're able to bring down the cost of drugs to help people get back on their feet a lot quicker and do what they need to do or not impact how we so often see black and brown families have kids in college or in graduate school", "start_char_idx": 20702, "end_char_idx": 24893, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "87d84eb6-9091-4b08-9905-90d1f2f1b539": {"__data__": {"id_": "87d84eb6-9091-4b08-9905-90d1f2f1b539", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "12171429-7444-4e97-b551-1ea5eed30f87", "node_type": null, "metadata": {}, "hash": "323eefb78991c6cd3d12f95d944e8669ce15be50cf211b5572d8d868ecea4f7f"}, "2": {"node_id": "abd93524-e851-4886-be1f-933c2b83bc7f", "node_type": null, "metadata": {}, "hash": "3a998acb7296aaa8c91c746abf822ae76ce0eae86511c4b0b4aa401b82c37c22"}}, "hash": "2d255a3c0daa41db17f4bf14e43885b92bc82c36ea35dc01abec845872003883", "text": "not impact how we so often see black and brown families have kids in college or in graduate school that often have to drop out to come help in and support the parent. Imagine if we had these drugs at a cheaper price with a parent or the person that's sick and get back on their feet fairly quickly and do what they need to do for their families. That changes our wealth gap and our income generation situation, or even just being business owners. That takes out them too, right? And that small business track is only you sometimes that's working, maybe one other employee. So as soon as you out, that's the downfall of your business. So making these drugs more affordable, working more closely with the federal government and being, even at the engineer level, being transparent on the actual cost to make these drugs, to formulate these drugs, is what I hope to see in the next 20 years.", "start_char_idx": 24867, "end_char_idx": 25755, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "76b4e163-8ba7-4e42-8876-f388dfb49388": {"__data__": {"id_": "76b4e163-8ba7-4e42-8876-f388dfb49388", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "73af4080-5016-4759-8e6d-3be2198c8d79", "node_type": null, "metadata": {}, "hash": "24db5f9057abc1d62e076bee199d82a41c605c179c0392c3010e3707ba0c81bc"}, "3": {"node_id": "760438f2-9c61-435c-8579-363639e9d235", "node_type": null, "metadata": {}, "hash": "3cb7d61277fe8839b900e89364222f892740e53f9a312db1c5ea512636b83dcf"}}, "hash": "34e2803334d20816e6a5982d8ad77e9dd1473583c333965c46891e216bd6120e", "text": "Abstract\n\nEngineered biological systems have been used to manipulate information, construct materials, process chemicals, produce energy, provide food, and help maintain or enhance human health and our environment. Unfortunately, our ability to quickly and reliably engineer biological systems that behave as expected remains quite limited. Foundational technologies that make routine the engineering of biology are needed. Vibrant, open research communities and strategic leadership are necessary to ensure that the development and application of biological technologies remains overwhelmingly constructive.\n\nMain\n\nPlease complete one of the following projects in the next hour: write down the DNA sequence that programmes a biofilm to take a photograph and perform distributed edge-detection on the light-encoded image; or, the DNA sequence that encodes a ring oscillator that works inside yeast; or, the DNA sequence that programmes any mammalian cell to count up to 256 in response to a generic input signal; or, the DNA sequence that programmes any prokaryote to produce 25 gl-1 artemisinic acid. Alternatively, describe in convincing detail the starting materials, experimental screens and genetic selections that could be used to evolve biological systems to perform these tasks... Time's up!\n\nThe abovementioned applications of synthetic biology could find uses in the construction of templated surfaces for nanoscale materials fabrication, the characterization of physical performance limits for eukaryotic gene expression, the study and control of cell division, animal development, ageing and cancer by modest amounts of genetically encoded memory and logic, or the cost-effective production of an anti-malaria drug precursor, respectively. Furthermore, each application is physically plausible, or is the direct extension of an already demonstrated result1,2,3. Yet, each project would be a unique, expert-driven research problem, with uncertain times to completion, costs and probabilities of success. For example, construction of the first genetically encoded \u2018ring oscillator\u2019 in bacteria took two of the world's best biophysicists at least one year of research2,4. Constructing a second genetically encoded ring oscillator would probably cost another group as much effort. In contrast, any competent electrical engineering student could build many working electronic ring oscillators in under one hour.\n\nIn 1978, Szybalksi and Skalka wrote5, \u2018The work on restriction nucleases not only permits us easily to construct recombinant DNA molecules and to analyse individual genes, but also has led us into the new era of \u2018synthetic biology\u2019 where not only existing genes are described and analyzed but also new gene arrangements can be constructed and evaluated. Twenty-seven years later, despite tremendous individual successes in genetic engineering and biotechnology6,7,8, why is the engineering of useful synthetic biological systems still an expensive, unreliable and ad hoc research process?\n\nThe first possibility is that we don't yet know enough about biological systems, or that biological systems are too complex to reliably engineer, or both. For example, some descriptions of natural biological systems are notoriously complex9,10. The large number of unique functional components combined with unexpected interactions among components (for example, pleiotropy) makes it hard to imagine that we might reliably engineer the behaviour of complex biological systems. Furthermore, it is possible that the designs of natural biological systems are not optimized by evolution for the purposes of human understanding and engineering11. Thankfully, these concerns are best evaluated by attempting to surmount them12.\n\nThe second possibility is that the engineering of biology remains a research problem because we have never invented and implemented foundational technologies that would make it an engineering problem. Stated plainly, the engineering of biology remains complex because we have never made it simple (T. F. Knight, personal communication). As above, the practicality of making biological engineering simple can best be evaluated by attempting to make it simple. Success would help to \u2018create the discipline of synthetic biology: an engineering technology based on living systems\u201013. Failures would directly illuminate and help prioritize the most relevant gaps in our current understanding of natural living systems, and", "start_char_idx": 0, "end_char_idx": 4450, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "760438f2-9c61-435c-8579-363639e9d235": {"__data__": {"id_": "760438f2-9c61-435c-8579-363639e9d235", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "73af4080-5016-4759-8e6d-3be2198c8d79", "node_type": null, "metadata": {}, "hash": "24db5f9057abc1d62e076bee199d82a41c605c179c0392c3010e3707ba0c81bc"}, "2": {"node_id": "76b4e163-8ba7-4e42-8876-f388dfb49388", "node_type": null, "metadata": {}, "hash": "34e2803334d20816e6a5982d8ad77e9dd1473583c333965c46891e216bd6120e"}, "3": {"node_id": "59a87990-7c5b-48c7-b4ab-86cf6c106250", "node_type": null, "metadata": {}, "hash": "fabcc8b4d627396717f9f27590c624a63e3db86846bd15b7f0b5b1b1af78e660"}}, "hash": "3cb7d61277fe8839b900e89364222f892740e53f9a312db1c5ea512636b83dcf", "text": "the most relevant gaps in our current understanding of natural living systems, and suggest how we might best eventually come to understand and apply nature's original technology14.\n\nWhat and why is synthetic biology?\n\nThe recent and ongoing interest in \u2018synthetic biology\u2019 is being driven by at least four different groups: biologists, chemists, \u2018re-writers\u2019 and engineers. Briefly, for biologists, the ability to design and construct synthetic biological systems provides a direct and compelling method for testing our current understanding of natural biological systems4,15; disagreements between expected and observed system behaviour can serve to highlight the science that is worth doing. For chemists, biology is chemistry, and thus synthetic biology is an extension of synthetic chemistry; the ability to create novel molecules and molecular systems allows the development of useful diagnostic assays and drugs, expansion of genetically encoded functions, study of the origins of life, and so on16. For \u2018re-writers\u2019, the designs of natural biological systems may not be optimized for human intentions (for example, scientific understanding, health and medicine); synthetic biology provides an opportunity to test the hypothesis that the genomes encoding natural biological systems can be \u2018re-written\u2019, producing engineered surrogates that might usefully supplant some natural biological systems11. Finally, for engineers, biology is a technology; building upon past work in genetic engineering, synthetic biology seeks to combine a broad expansion of biotechnology applications with\u2014as the focus of this article\u2014an emphasis on the development of foundational technologies that make the design and construction of engineered biological systems easier.\n\nFoundations for engineering biology\n\nMany times over, individuals and groups have adapted and applied different resources from nature to the service of human needs such as shelter, food, health and happiness; notably, natural resources are limited while our needs, in aggregate, may be unbounded. In this context, we should attempt to develop foundational technologies that make it easier and more efficient to satisfy human needs. For example, in the developed world, the design and construction of buildings is now a routine and reliable process. The success of the building process depends on (1) the existence of a limited set of predefined, refined materials that can be delivered on demand and that behave as expected, (2) generally useful rules (that is, simple models) that describe how materials can be used in combination (or not), and (3) skilled individuals with a working knowledge and means to apply these rules. Biology itself is a natural resource that can be further adapted to help satisfy human needs. What foundational engineering technologies would best enable the routine design and construction of useful synthetic biological systems?\n\nToday, four challenges that greatly limit the engineering of biology are (1) an inability to avoid or manage biological complexity, (2) the tedious and unreliable construction and characterization of synthetic biological systems, (3) the apparent spontaneous physical variation of biological system behaviour, and (4) evolution. In considering how best to address these engineering challenges, one practical starting point is to consider past lessons from when other engineering disciplines emerged from the natural sciences. Are any past lessons relevant to the engineering of biology today? For example, could we usefully consider adapting or extending ideas from structural engineering to synthetic biology?\n\nThe three past ideas that now seem most relevant to the engineering of biology are standardization, decoupling and abstraction (see the Acknowledgements for a list of people who have helped to contribute to these ideas). To be clear, these ideas and my prioritization of them could be wrong; I would explicitly encourage the widespread invention and discussion of alternative ideas. However, as introduced below, the successful development of foundational technologies based on these ideas would greatly ameliorate the first three engineering challenges posed above. The fourth challenge, evolution, is largely unaddressed within past engineering experience (discussed below).\n\nStandardization\n\nStandards underlie most aspects of the modern world17. Railroad gauges, screw threads, internet addresses,", "start_char_idx": 4381, "end_char_idx": 8812, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "59a87990-7c5b-48c7-b4ab-86cf6c106250": {"__data__": {"id_": "59a87990-7c5b-48c7-b4ab-86cf6c106250", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "73af4080-5016-4759-8e6d-3be2198c8d79", "node_type": null, "metadata": {}, "hash": "24db5f9057abc1d62e076bee199d82a41c605c179c0392c3010e3707ba0c81bc"}, "2": {"node_id": "760438f2-9c61-435c-8579-363639e9d235", "node_type": null, "metadata": {}, "hash": "3cb7d61277fe8839b900e89364222f892740e53f9a312db1c5ea512636b83dcf"}, "3": {"node_id": "b96afea9-d62b-4fb8-9d11-c5c3a7424d8f", "node_type": null, "metadata": {}, "hash": "a505166599ded9d7f8d540df7c3e9f052dde20ce71a77fabff4d89a1b924b98b"}}, "hash": "fabcc8b4d627396717f9f27590c624a63e3db86846bd15b7f0b5b1b1af78e660", "text": "the modern world17. Railroad gauges, screw threads, internet addresses, \u2018rebar\u2019 for reinforcing concrete, gasoline formulations, units of measure, and so on. In the science of biology, a number of useful standards have already arisen around the \u2018central dogma\u2019 that defines the core operations of most natural biological systems, and in response to the development of widely practiced methods that generate significant amounts of data. As representative examples, standards of varying utility now exist for DNA sequence data and genetic features18, microarray data19, protein crystallographic data20, enzyme nomenclature21, systems biology models22 and restriction endonuclease activities23. However, the biological engineering community has yet to develop formal, widely used standards for most classes of basic biological functions (for example, promoter activity), experimental measurements (for example, protein concentrations) and system operation (for example, genetic background, media, growth rate, environmental conditions, and so on).\n\nTremendous costs accrue owing to the lack of standards in biological engineering. For example, one would-be biological engineer's \u2018strong\u2019 ribosome binding site may be merely middling to another. As a second example, one group's genetic toggle switch may work in Jacques Monod's Escherichia coli strain JM2.300 (which may be the same as Sydney Brenner's E. coli strain XAO) when the cells are grown in Luria broth24, while another group's synthetic genetic oscillatory network will work in Malcolm Casadaban's E. coli strain MC4100 when the cells are grown in supplemented minimal media2. Could another group directly combine these two systems to produce a working \u2018toggle-lator\u201925? The obvious engineering cost is that we don't know it's a research project; but also note that it costs approximately 30 minutes just to track down all of this background information.\n\nLooking forward, the biological engineering community would benefit from the development of technologies and the promulgation of standards that support the definition, description and characterization of the basic biological parts26, as well as standard conditions that support the use of parts in combination and overall system operation. One very preliminary example of such work is emerging as the Registry of Standard Biological Parts (Fig. 1). However, beyond the technology itself, standards are also needed to support a vibrant, constructive and responsible community of biological engineers. For example, legal standards are needed to define means by which large collections of parts encoding basic biological functions, from a myriad of sources, can be easily shared and used in combination to realize many applications. Current legal standards such as uniform Materials Transfer Agreements (MTAs), which define the terms that allow researchers at different organizations to share biological materials, can take several weeks to execute, and typically do not resolve application rights. Meanwhile, direct chemical synthesis of up to \u223210,000-base-pair DNA fragments is a widely available commercial service (as entering \u2018gene synthesis\u2019 into an internet search engine will confirm); for cases in which the DNA sequence information encoding the desired part is freely available, it is often cheaper and faster to directly synthesize the part from scratch instead of executing an MTA. Thus, new low- or zero-cost legal strategies that facilitate and protect the exchange of the genetic information defining parts, and the use of parts in combination, are needed. As a second example, it seems prudent to develop community-wide standards for barcoding, signing and watermarking DNA in order to support the detection, identification and authentication of engineered biological systems, respectively27.\n\nFigure 1: The Registry of Standard Biological Parts.\nThis registry (http://parts.mit.edu/; modified image from the homepage shown), hosted by the MIT, provides free access to an open commons of basic biological functions that can be used to programme synthetic biological systems26. Anybody may contribute, draw upon, or improve the parts maintained within the Registry.\n\nDecoupling\n\nDecoupling is the idea that it is useful to separate a", "start_char_idx": 8820, "end_char_idx": 13079, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b96afea9-d62b-4fb8-9d11-c5c3a7424d8f": {"__data__": {"id_": "b96afea9-d62b-4fb8-9d11-c5c3a7424d8f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "73af4080-5016-4759-8e6d-3be2198c8d79", "node_type": null, "metadata": {}, "hash": "24db5f9057abc1d62e076bee199d82a41c605c179c0392c3010e3707ba0c81bc"}, "2": {"node_id": "59a87990-7c5b-48c7-b4ab-86cf6c106250", "node_type": null, "metadata": {}, "hash": "fabcc8b4d627396717f9f27590c624a63e3db86846bd15b7f0b5b1b1af78e660"}, "3": {"node_id": "28232525-2e59-4d84-b615-2d94881df3f5", "node_type": null, "metadata": {}, "hash": "832554511dea5633b1b0917ed55cd6fb2e42df638fd8ff837d634426e795af24"}}, "hash": "a505166599ded9d7f8d540df7c3e9f052dde20ce71a77fabff4d89a1b924b98b", "text": "is the idea that it is useful to separate a complicated problem into many simpler problems that can be worked on independently, such that the resulting work can eventually be combined to produce a functioning whole. Two representative examples of decoupling include (1) building projects, which are often separated into architecture, engineering, construction, project management and inspection tasks, and (2) very-large scale integrated (VLSI) electronics, which is an engineering technology that only became practical once rules were worked out to enable the separation of chip design from chip fabrication28.\n\nToday, in biological engineering, many useful types of decoupling could be developed within the context of standardization (discussed above) and abstraction (discussed below). For example, one engineer might develop standard \u2018power supply and chassis\u2019 cells that provide known rates of nucleotides, amino acids and other resources to any engineered biological system placed within the cell, independent of the details of the system29. Another engineer might develop technologies that enable the decomposition of complicated \u2018systems\u2019 into sets of independent \u2018devices\u2019 (discussed below). However, the simplest and most immediate type of decoupling is likely to be design from fabrication. The decoupling of design and fabrication in biological engineering is being driven by recent and ongoing improvements in the process of DNA synthesis. Bulk DNA synthesis capacity appears to have doubled every 18 months or so for the last ten years; the commercial price of synthesis of long fragments of DNA (> 500 base pairs) has continued to decrease by a factor of approximately two in each of the past three years30\u2014a trend that seems likely to continue over the next three years. More recently, downstream technology has been developed that allows for the automatic assembly of oligonucleotides and short DNA fragments into much longer molecules31,32,33. Given gene and genome synthesis technology, some individuals can and should focus on designing useful pieces of DNA, while other individuals focus on building DNA; each group need only be expert in their respective tasks.\n\nAbstraction\n\nNatural biological systems seem wonderfully complex. New molecular mechanisms that regulate cellular behaviour are still being discovered34 and \u2018exceptions to rules\u2019 abound35. Given this context, how might we make routine the engineering of many-component biological systems that behave as expected?\n\nOne powerful technology for managing complexity is abstraction. Two forms of abstraction now seem worth exploring in biological engineering. First, the information describing biological functions might be organized across levels of complexity using abstraction hierarchies (Fig. 2). To be useful, biological engineering abstraction hierarchies must (1) allow individuals to work at any one level of complexity without regard for the details that define other levels, yet (2) allow for the principled exchange of limited information across levels (see Fig. 2 legend for more information). Second, the parts and devices that comprise engineered biological systems should probably be redesigned and built anew so that they are simpler to model and easier to use in combination. For example, it is often hard to predict the expressed protein level that will be produced by the novel combination of a natural transcription promoter, ribosome binding site (RBS) and open reading frame (ORF); combination-specific messenger RNA secondary structures created across RBS-ORF junctions might occlude ribosome loading and prevent an otherwise \u2018strong\u2019 RBS from initiating protein synthesis. Thus, in this example, it is worth exploring whether libraries of parts might be refined to produce common part\u2014part junctions at the genetic level to help simplify the prediction of function when parts are used in combination. As a related example, ORF sets might be codon shuffled36 to \u2018erase\u2019 any cryptic regulatory elements and provide a common putative mRNA secondary structure, and so on. The refining of natural parts to produce engineered biological parts may be similar to nature's use of negative selection against promiscuous, deleterious molecular interactions within specific cell types37, and is analogous to the processing of physical materials in other engineering disciplines.", "start_char_idx": 13109, "end_char_idx": 17480, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "28232525-2e59-4d84-b615-2d94881df3f5": {"__data__": {"id_": "28232525-2e59-4d84-b615-2d94881df3f5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "73af4080-5016-4759-8e6d-3be2198c8d79", "node_type": null, "metadata": {}, "hash": "24db5f9057abc1d62e076bee199d82a41c605c179c0392c3010e3707ba0c81bc"}, "2": {"node_id": "b96afea9-d62b-4fb8-9d11-c5c3a7424d8f", "node_type": null, "metadata": {}, "hash": "a505166599ded9d7f8d540df7c3e9f052dde20ce71a77fabff4d89a1b924b98b"}, "3": {"node_id": "3984616d-c373-425b-9ebb-ce6f79bce0cb", "node_type": null, "metadata": {}, "hash": "6e591bec6bce6ea124419ff9f59b6c4f87c71e9d05b402e0690df83410f0caf6"}}, "hash": "832554511dea5633b1b0917ed55cd6fb2e42df638fd8ff837d634426e795af24", "text": "and is analogous to the processing of physical materials in other engineering disciplines. For comparison, microprocessors and other electronic systems are not built directly from chunks of metal and silicon found lying about the countryside.\n\nFigure 2: An abstraction hierarchy that supports the engineering of integrated genetic systems.\n\nThe purpose of an abstraction hierarchy is to hide information and manage complexity. Abstraction levels are listed (\u2018DNA\u2019, \u2018Parts\u2019, \u2018Devices\u2019, \u2018Systems\u2019). Here, \u2018DNA\u2019 is genetic material, \u2018Parts\u2019 are basic biological functions (for example, a DNA-binding protein), \u2018Devices\u2019 are any combination of \u2018Parts\u2019 that perform a human-defined function, and \u2018Systems\u2019 are any combination of \u2018Devices\u2019. Abstraction barriers (red) block all exchange of information between levels. Interfaces (green) enable the limited and principled exchange of information between levels. Naive exchanges are given in quotes. To be useful, individuals must be able to work independently at each level of the hierarchy. In synthetic biology, for example, parts-level researchers might need to know what sorts of parts that device-level researchers would like to use, how different types of parts actually work (for example, atomic interactions between amino acids and the major groove of DNA), and how to order a piece of DNA. But, parts-level researchers should not need to know anything about phosphoramidite chemistry, how short oligonucleotides are assembled into longer, contiguous DNA fragments, or how a genetic oscillator works, and so on. As a second example, device-level researchers must define devices that use common signal carriers, and thus can be reused in combination (A. Che et al., manuscript in preparation). Implicit in this hierarchy are formidable molecular engineering challenges; for example, engineering a set of 1,000 synthetic transcription factors based on zinc-finger-leucine-zipper chimaeras45, each recognizing a unique cognate DNA binding site with >99% specificity (C. O. Pabo, personal communication).\n\nEvolution or design of reproducing machines\n\nToday, almost all of engineering is limited to the design and production of disposable systems. For example, our computers, mobile phones and cars are not themselves designed to directly produce the next generation of computers, phones and cars; beyond some level of failure, engineered artefacts are recycled or abandoned. To an engineer, biological systems are replicating machines that make mistakes during the replication process (that is, biological systems are reproducing machines). At present, we do not have a practical theory that supports the design of reproducing biological machines, despite great progress in understanding how natural biological systems couple and tune error detection and correction during machine replication to organism fitness (for example, see refs 38, 39). To develop such a theory, areas worth exploring may initially include reliable computing with unreliable components, error detection and correcting codes, and theory of self-replicating automata40. If we fail to learn how to programme reproducing biological machines that we can understand, but can afford enough DNA synthesis, one fall-back option may be to engineer disposable biological systems, in which the system designs are decoupled from the constraints of direct descent and replication with error.\n\nConsequences of success\n\nThe successful development of foundational technologies based on the ideas of standardization, decoupling and abstraction would help make routine the engineering of synthetic biological systems that behave as expected. Once developed, many of these foundational technologies will take the form of ideas or information, and thus are likely to be freely distributed worldwide to the service of diverse human needs. By definition, foundational technologies would help to broadly enable many applications (that is, more than can be enumerated). The general utility of such technologies is what justifies the planning, investment and community organization needed for their development. In support of such work, what follows are a few", "start_char_idx": 17437, "end_char_idx": 21592, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3984616d-c373-425b-9ebb-ce6f79bce0cb": {"__data__": {"id_": "3984616d-c373-425b-9ebb-ce6f79bce0cb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "73af4080-5016-4759-8e6d-3be2198c8d79", "node_type": null, "metadata": {}, "hash": "24db5f9057abc1d62e076bee199d82a41c605c179c0392c3010e3707ba0c81bc"}, "2": {"node_id": "28232525-2e59-4d84-b615-2d94881df3f5", "node_type": null, "metadata": {}, "hash": "832554511dea5633b1b0917ed55cd6fb2e42df638fd8ff837d634426e795af24"}, "3": {"node_id": "5e69d876-a216-4a69-8181-efc445aed1e5", "node_type": null, "metadata": {}, "hash": "a7e80963e82e7582fc648361afeae0c92e7131a6718356944166691b9962a5bc"}}, "hash": "6e591bec6bce6ea124419ff9f59b6c4f87c71e9d05b402e0690df83410f0caf6", "text": "community organization needed for their development. In support of such work, what follows are a few representative examples that illustrate what should become possible within the next five years, given investment and advances in each technology class.\n\nStandardization\n\nUndergraduates and high school students, without prior training in biology or biological engineering, should, over a period of weeks, be able to design synthetic biological systems of their own invention comprised of several dozen pre-existing standard biological parts, order and receive the DNA encoding the system, and show it to work.\n\nDecoupling\n\nSystematic engineering of bacterial genomes and eukaryotic and plant chromosomes should be made possible by continued advances in DNA synthesis. Applications of genome and chromosome engineering will range from automated scientific discovery (for example, the annotation of a newly sequenced organism might be used to define a second genome that encodes only the annotated functions; synthesis of the second genome, in parts and in whole, could be used to test the accuracy of the original sequence and the sufficiency of its annotation) to biological safety (for example, orthogonal and \u2018fail-fast\u2019 codon tables that reduce the ecological impact of horizontal gene transfer) to biological defence (for example, rapid synthesis of DNA vaccines).\n\nAbstraction\n\nPerformance characteristics and signal carriers that delimit how engineered biological parts can be combined into many-part devices and systems will be defined and may, in turn, spur the development of new measurement technologies for the characterization of cellular state41.\n\nBiological risks, strategy and leadership\n\nThe development and distribution of foundational technologies that make the engineering of biology easier will have a direct impact on our exposure to natural and engineered biological risks. However, analysing the risk impact of such technologies is not straightforward (Fig. 3). For example, DNA synthesis has recently helped to enable the \u2018resurrection\u2019 of the 1918 influenza strain42, and is now widely believed capable of producing the smallpox genome from publicly available sequence information43; variants of these viruses and other pathogens could be readily constructed. But, when a natural or engineered biological threat next emerges, DNA synthesis would find immediate use in accelerating our analysis of the risk (for example, rapid synthesis of pathogen ORFs codon optimized for recombinant protein expression) and our response to the risk (for example, rapid synthesis of vaccines or vaccine precursors). Meanwhile, and most importantly, the most overwhelming and certain use of DNA synthesis will be its direct acceleration of ongoing, constructive experimental research. Today, for example, a practicing experimental biologist or biological engineer can easily spend around 50% of their effort manipulating DNA just to produce the genetic material needed for an experiment; \u2018instant\u2019 DNA synthesis would provide a general twofold increase in research productivity. Thus, an attempt to ban or limit access to DNA synthesis technology, and the sequence information that defines what to synthesize, would only be guaranteed to cripple biological engineering research and hinder biomedical research. In this context, our future biological security will depend not on limits to technology and research, but rather on the successful development of general, agile capabilities for detecting, understanding and responding to biological risks; work that is already needed given existing and emerging infectious diseases. Because technologies for engineering biology will be openly developed and widely distributed, political leadership is needed to encourage all members of society to help actively foster a worldwide community that celebrates the science of biology, and lead the overwhelmingly constructive development and application of future biological technologies44.\n\nFigure 3: Technology classes relevant to current and future biological risk.\nBoth nature's, and our own, ability to manipulate biological systems outpaces our ability to detect biological agents, analyse the resulting data, and respond appropriately. As a result, we are exposed to existing, emerging and engineered biological threats. Foundational technologies that affect the science and engineering of biology (for example, DNA synthesis) must be evaluated in the context of their net contribution to risk", "start_char_idx": 21586, "end_char_idx": 26082, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5e69d876-a216-4a69-8181-efc445aed1e5": {"__data__": {"id_": "5e69d876-a216-4a69-8181-efc445aed1e5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "73af4080-5016-4759-8e6d-3be2198c8d79", "node_type": null, "metadata": {}, "hash": "24db5f9057abc1d62e076bee199d82a41c605c179c0392c3010e3707ba0c81bc"}, "2": {"node_id": "3984616d-c373-425b-9ebb-ce6f79bce0cb", "node_type": null, "metadata": {}, "hash": "6e591bec6bce6ea124419ff9f59b6c4f87c71e9d05b402e0690df83410f0caf6"}, "3": {"node_id": "e0920a3f-17d9-4b88-8965-d662ec4802bb", "node_type": null, "metadata": {}, "hash": "178d83235c264fcd07c2f39d718d06fb1a276d77247a874339e91b4f810c2073"}}, "hash": "a7e80963e82e7582fc648361afeae0c92e7131a6718356944166691b9962a5bc", "text": "DNA synthesis) must be evaluated in the context of their net contribution to risk exposure and not only risk creation (see the text for a discussion).\n\nReferences\n\nLevskaya, A. et al. Bacterial photography: Engineering Escherichia coli to see light. Nature doi:10.1038/nature04405 (this issue)\n\nElowitz, M. B. & Leibler, S. A synthetic oscillatory network of transcriptional regulators. Nature 403, 335-338 (2000)\n\nMartin, V. J. et al. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nature Biotechnol. 21, 796-802 (2003)\n\nSprinzak, D. & Elowitz, M. B. Reconstruction of genetic circuits. Nature doi:10.1038/nature04335 (this issue)\n\nSzybalski, W. & Skalka, A. Nobel prizes and restriction enzymes. Gene 4, 181-182 (1978)\n\nGoeddel, D. V. et al. Expression in Escherichia coli of chemically synthesized genes for human insulin. Proc. Natl Acad. Sci. USA 76, 106-110 (1979)\n\nMurray, A. W. & Szostak, J. W. Construction of artificial chromosomes in yeast. Nature 305, 189-193 (1983)\n\nPerlak, F. J. et al. Insect resistant cotton plants. Biotechnology 8, 939-943 (1990)\n\nOltvai, Z. N. & Barabasi, A. L. Systems biology. Life's complexity pyramid. Science 298, 763-764 (2002)\n\nCsete, M. E. & Doyle, J. C. Reverse engineering of biological complexity. Science 295, 1664-1669 (2002)\n\nChan, L. Y., Kosuri, S. & Endy, D. Refactoring bacteriophage T7. Mol. Syst. Biol. published online, 13 September 2005 (doi:10.1038/msb4100025)\n\nWeber, M. in The Vocation Lectures (eds Owen, D. & Strong, T. B.; translator Livingstone, R.) 1-31 (Hackett Publishing, Indianapolis, Indiana, 2004).\n\nKnight, T. F. Engineering novel life. Mol. Syst. Biol. published online, 13 September 2005 (doi:10.1038/msb4100028)\n\nWhitesides, G. M. The once and future nanomachine. Sci. Am. 285, 78-83 (2001)\n\nKirschner, M. W. The meaning of systems biology. Cell 20, 503-504 (2005)\n\nBenner, S. A. & Sismour, A. M. Synthetic biology. Nature Rev. Genet. 6, 533-543 (2005)\n\nSurowiecki, J. Turn of the century.WIRED 10.01 (2002).\n\nInternational Nucleotide Sequence Database Collaboration. http://insdc.org/ (2005).\n\nBrazma, A. et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nature Genet. 29, 365-371 (2001)\n\nProtein Data Bank. http://www.rcsb.org/pdb/index.html (2005).\n\nNomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC-IUBMB), Enzyme supplement 5. Eur. J. Biochem. 264, 610-650 (1999)\n\nHucka, M. et al. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 19, 524-531 (2003)\n\nRoberts, R. J., Vincze, T., Posfai, J. & Macelis, D. REBASE-restriction enzymes and DNA methyltransferases. Nucleic Acids Res. 1, D230-D232 (2005)\n\nGardner, T. S., Cantor, C. R. & Collins, J. J. Construction of a genetic toggle switch in Escherichia coli. Nature 403, 339-342", "start_char_idx": 26100, "end_char_idx": 29019, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e0920a3f-17d9-4b88-8965-d662ec4802bb": {"__data__": {"id_": "e0920a3f-17d9-4b88-8965-d662ec4802bb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "73af4080-5016-4759-8e6d-3be2198c8d79", "node_type": null, "metadata": {}, "hash": "24db5f9057abc1d62e076bee199d82a41c605c179c0392c3010e3707ba0c81bc"}, "2": {"node_id": "5e69d876-a216-4a69-8181-efc445aed1e5", "node_type": null, "metadata": {}, "hash": "a7e80963e82e7582fc648361afeae0c92e7131a6718356944166691b9962a5bc"}, "3": {"node_id": "5b9a3be4-8592-4ff0-9451-0460d9ab61c8", "node_type": null, "metadata": {}, "hash": "1f91295b5e8394c2178fabbbdd8422fe277653ae8cd64b931ea034cfd1171a74"}}, "hash": "178d83235c264fcd07c2f39d718d06fb1a276d77247a874339e91b4f810c2073", "text": "of a genetic toggle switch in Escherichia coli. Nature 403, 339-342 (2000)\n\nAtkinson, M. R., Savageau, M. A., Myers, J. T. & Ninfa, A. J. Development of genetic circuitry exhibiting toggle switch or oscillatory behaviour in Escherichia coli. Cell 113, 597-607 (2003)\n\nKnight, T. F. DARPA BioComp Plasmid Distribution 1.00 of Standard Biobrick Components MIT Synthetic Biology Working Group Reports published online 22 May 2002 (doi:1721.1/21167).\n\nGraham-Rowe, D. Britain may force DNA \u2018barcodes\u2019 for GM food.New Sci. (2003).\n\nMead, C. & Conway, L. Introduction to VLSI Systems (Addison-Wesley, Reading, Massachusetts, 1980)\n\nCanton, B. Engineering the Interface Between Cellular Chassis and Integrated Biological Systems MIT Synthetic Biology Working Group Reports published online 8 August 2005 (doi:1721.1/19813).\n\nCarlson, R. The pace and proliferation of biological technologies. Biosecur. Bioterror. 1, 203-214 (2003)\n\nStemmer, W. P. et al. Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides. Gene 164, 49-53 (1995)\n\nYount, B., Curtis, K. M. & Baric, R. S. Strategy for systematic assembly of large RNA and DNA genomes: transmissible gastroenteritis virus model. J. Virol. 74, 10600-10611 (2000)\n\nTian, J. et al. Accurate multiplex gene synthesis from programmable DNA microchips. Nature 432, 1050-1054 (2004)\n\nSharp, P. A. RNA interference-2001. Genes Dev. 15, 485-490 (2001)\n\nVarmus, H. Reverse transcription. Sci. Am. 257, 56-59 (1987)\n\nKatz, L. & Burge, C. B. Widespread selection for local RNA secondary structure in coding regions of bacterial genes. Genome Res. 13, 2042-2051 (2003)\n\nZarrinpar, A., Park, S. H. & Lim, W. A. Optimization of specificity in a cellular protein interaction network by negative selection. Nature 426, 676-680 (2003)\n\nCarroll, S. B. Evolution at two levels: on genes and form. PLoS Biol. 3, e245 (2005)\n\nRutherford, S. L. & Lindquist, S. Hsp90 as a capacitor for morphological evolution. Nature 396, 336-342 (1998)\n\nvon Neumann, J. in Collected Works (ed. Taub, A. H.) Vols 1-6 (Pergamon Press, New York, 1961-1963)\n\nEndy, D., Deese, I. & Wadey, C. Adventures in synthetic biology. Nature [online] (2005); also available at http://mit.edu/endy/www/comic/.\n\nTumpey, T. et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310, 77-80 (2005)\n\nVenter, J. C. Gene Synthesis Technology: State of the Science National Science Advisory Board on Biosecurity (conference) (2005).\n\nDyson, F. The darwinian interlude. Technology Review (2005).\n\nWolfe, S. A., Grant, R. A. & Pabo, C. O. Structure of a designed dimeric zinc finger protein bound to DNA. Biochemistry 42, 13401-13409 (2003)\n\nEndy, D. Foundations for engineering biology. Nature 438, 449\u2013453 (2005). https://doi.org/10.1038/nature04342\n\nICOR: improving codon optimization with recurrent neural networks\nRishab JainAditya JainDouglas Densmore\nBMC Bioinformatics (2023)\n\nDe novo engineering of a bacterial lifestyle program\nWentao KongYuanchao QianTing Lu\nNature Chemical Biology", "start_char_idx": 29031, "end_char_idx": 32085, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5b9a3be4-8592-4ff0-9451-0460d9ab61c8": {"__data__": {"id_": "5b9a3be4-8592-4ff0-9451-0460d9ab61c8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "73af4080-5016-4759-8e6d-3be2198c8d79", "node_type": null, "metadata": {}, "hash": "24db5f9057abc1d62e076bee199d82a41c605c179c0392c3010e3707ba0c81bc"}, "2": {"node_id": "e0920a3f-17d9-4b88-8965-d662ec4802bb", "node_type": null, "metadata": {}, "hash": "178d83235c264fcd07c2f39d718d06fb1a276d77247a874339e91b4f810c2073"}}, "hash": "1f91295b5e8394c2178fabbbdd8422fe277653ae8cd64b931ea034cfd1171a74", "text": "KongYuanchao QianTing Lu\nNature Chemical Biology (2023)\n\nApplications of synthetic biology in medical and pharmaceutical fields\nXu YanXu LiuGuo-Qiang Chen\nSignal Transduction and Targeted Therapy (2023)\n\nDigital Sequence Information and the Access and Benefit-Sharing Obligation of the Convention on Biological Diversity\nFrank Irikefe AkpoviriSyarul Nataqain BaharumZinatul Ashiqin Zainol\nNanoEthics (2023)\n\nHow to grow (almost) anything: a hybrid distance learning model for global laboratory-based synthetic biology education\nEyal PerryJessica WeberDavid Kong\nNature Biotechnology (2022)\n\nSynthetic Biology\n\n\u2018Synthetic biology\u2019 is a rapidly growing field, and this week's Nature reflects that growth. Biologists use it to test models of natural systems, as discussed by David Sprinzak and Michael B. Elowitz. Drew Endy takes the engineer's approach, seeing it as an extension of technologies such as genetic engineering and biotechnology. Examples of what synthetic biology can do were on view at the first international Inter collegiate Genetically Engineered Machine competition. Synthetic biology promises much but there are risks too. In a Commentary, George Church urges the synthetic biology community to learn from mistakes made by nuclear physicists and geneticists, and to act now to develop safeguards that satisfy public concerns.", "start_char_idx": 32094, "end_char_idx": 33437, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "becfcfa7-0dda-47b8-91bc-84b5e1a8ab56": {"__data__": {"id_": "becfcfa7-0dda-47b8-91bc-84b5e1a8ab56", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e6eccb9b-6d24-4d40-8293-5c61181b2125", "node_type": null, "metadata": {}, "hash": "48509e3ba5252a539c393a5878e5d48cd7a129258e09fbbd3e49cc6c9fa58ccd"}, "3": {"node_id": "60779efd-497f-4922-9625-1d656f6b81b7", "node_type": null, "metadata": {}, "hash": "c377631c88eb78172e04d5c1096389c691e90ea6c7027466819d2f4aabdbe44d"}}, "hash": "8e4ec209de741c0c9b0afdd9eef688b8902018b6809b5dbca6ae83a8fc75b878", "text": "Welcome to Introduction to Bioengineering at Stanford University. Just a short video. What is our class about? Students completing the course will have a working understanding for how to approach the systematic engineering of living systems to benefit all people in the planet. By systematic engineering, we mean a general purpose way of thinking about biology as a technology, regardless of what application you might be interested in, such that if you gain access to this approach, no matter what you want to do in the future, you have a chance of getting underway. In slightly more detail, the goals we have for this class include the following three. To help you learn these ways of thinking about engineering living matter from the inside out, as you'll see. To empower you to explore and do bioengineering starting with DNA. We think of this like literacy. Do you know how to read and write in English or whatever language you like? Do you know how to read and write in Python or another computer programming language? There we talk about literacy or computer literacy. Do you know how to read and write DNA? That would be bioliteracy. We want to empower you to start to become literate with biology at the DNA level. Then third, for you to become more capable of leading discussions about bioengineering with others. Stated differently, hey, if you get an A plus in Introduction to Bioengineering, almost by definition, you should be able to introduce somebody else to bioengineering. That's what we mean about becoming more capable of helping others, leading discussions about bioengineering. Not just the nerdy stuff, but the really tricky stuff like the social and cultural and political and ethical aspects. That's what our class is about. But it's also motivated from a more basic foundation. I want to give you an example of how Professor Brophy and I are thinking about why our class should be organized in a particular way and how we hope to relate with you. As one example, Neil Postman was a critic, author, and educator, and he had a lot to say about education. I take what he says as provocations to help me think about what we're doing in this course. For example, how's this for drama? The basic function of education is to increase the survival prospects of the group. What should you be learning now in case an asteroid hits the Earth next year, or another pandemic shows up, or who knows what's going to happen? That's the basic function. This sounds strange. Has any teacher told you, this is why you're coming to school, in case the asteroid hits the Yucatan? Maybe, maybe not. It's just dramatic. But it's interesting to think about. Continuing on, it's one thing to survive if nothing's changing, but if the world's changing, the environment's changing, it's changing quickly, then from an education perspective, it's trickier because you've got to figure out, what are the existing knowledge do we need to make sure everybody keeps and learns? And then, what are the old ideas we need to get rid of? And then what new things do we need to learn about? So now that brings us back to bioengineering. Bioengineering is a new and emerging field. And so education in bioengineering is going to have to figure out, how do we navigate these changes and these fundamental goals? Stated differently and more practically, bioengineering matters a lot. It already matters a lot, and it's not getting less important. It's getting way more important. Therefore, as teachers, we're with you. We're not trying to make the hardest p-sets possible. They'll be challenging, but we're not at you trying to like, oh, you're not as smart. No, no, no, no, we just want you to learn as much as possible because it's going to matter. The more you can learn, the better we're all going to be. And so we want to see you as people first and to help you learn as much as possible. So hopefully you just reflect on this and have a sense of how Professor Brophy and I are thinking in our own minds as we're building the course and learning together with you. I want to switch gears and end with just one comment. And this is already in service of the third goal, to help you lead others in discussion about bioengineering. And I want to be really clear up front. I'm going to say some things that might seem like they're critical. I", "start_char_idx": 0, "end_char_idx": 4331, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "60779efd-497f-4922-9625-1d656f6b81b7": {"__data__": {"id_": "60779efd-497f-4922-9625-1d656f6b81b7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e6eccb9b-6d24-4d40-8293-5c61181b2125", "node_type": null, "metadata": {}, "hash": "48509e3ba5252a539c393a5878e5d48cd7a129258e09fbbd3e49cc6c9fa58ccd"}, "2": {"node_id": "becfcfa7-0dda-47b8-91bc-84b5e1a8ab56", "node_type": null, "metadata": {}, "hash": "8e4ec209de741c0c9b0afdd9eef688b8902018b6809b5dbca6ae83a8fc75b878"}}, "hash": "c377631c88eb78172e04d5c1096389c691e90ea6c7027466819d2f4aabdbe44d", "text": "up front. I'm going to say some things that might seem like they're critical. I don't mean to. I'm just observing and trying to give you some context to help understand the uniqueness of this course, Intro to BioE at Stanford. What you see here is rankings of graduate programs in bioengineering according to a magazine, US News and World Report, from 2019, about four years ago. What's really interesting at first glance, I'm sure everybody can see, on the left side is bioengineering and on the right side is biological engineering. How come there are two different rankings? And what's the difference between bioengineering and biological engineering? And does it matter? Well, it turns out that these rankings and the split of the rankings comes from the past. It's really a 20th century framework for how people were thinking about bioengineering. If you were a mechanical engineer or an electrical engineer and you got a call from a doctor who needed help with a patient who needed an artificial knee, or you need to make a better x-ray machine or an MRI machine, you'd find yourself working in a clinical setting to help the health enterprise, and you'd be a bioengineer. But that shorthand on the left for biomedical engineer, an existing type of engineer helping with a medical need or application. Conversely, on the right, if you were a mechanical engineer or an electrical engineer or a civil engineer, making a better tractor, making a better brewery, or making a better wastewater treatment plant, then you're taking the skills of engineering and helping people working in manufacturing, farming, and related things. And that becomes biological engineering. Stated more abstractly, these two rankings reflect the needs of the world and existing engineering disciplines being organized into institutional programs that are doing incredibly important work. Like, this is absolutely essential for excellence in both bioengineering and biological engineering. But it's this outside-in framing that is just kind of, well, just say 20th century. So with love and respect, I'm going to put a big X right there. Let's go into the 21st century. This is a watercolor painted by David Goodsell. It shows the molecules comprising part of a bacterium, E. coli. What our course is about is to start with the physics of living matter, the molecules that comprise life, from the inside out. And if we can learn how to systematically engineer biology from this starting line, then when we get out into the real world, it doesn't matter what we need to do. Any sort of application can be accommodated and addressed. And so that's what we think of as 21st century bioengineering going forward into the future. We'll come back and look at these paintings, but just to give you a clue, like that green set of lines on the top left, that's the membrane dividing the cell from its inside and outside. Hidden in that is a motor for spinning around the flagella, which is the tube heading off to the left that pushes the cell through liquid. In purple and blue are ribosomes and proteins in the cytoplasm. Look at how crowded it is. In orange and yellow, you can see DNA and RNA and replication of the genome. If we can figure out how to bioengineer from the inside out with life, then everything that life can be becomes possible for bioengineers. Until next time.", "start_char_idx": 4252, "end_char_idx": 7606, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9de9ccdb-c81d-49e1-a507-d9fad0994f42": {"__data__": {"id_": "9de9ccdb-c81d-49e1-a507-d9fad0994f42", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0dbe04b2-f662-47fa-9c46-046ae5317deb", "node_type": null, "metadata": {}, "hash": "a50b80cc1f7ac65ad0eeccb4f3212298e185ffd1aa810400d45a7dc629b16386"}}, "hash": "a50b80cc1f7ac65ad0eeccb4f3212298e185ffd1aa810400d45a7dc629b16386", "text": "Welcome to Introduction to Bioengineering at Stanford University. This is a short little tool that's great at the start of class. It's called Imagine a Bioengineer, Imagine Your Bioengineer. This tool comes from Dr. Veronica Brand, past colleague, amazing educator, super grateful for her help in developing the materials in this course and others in bioengineering. Let's get started. Again, this is a tool, an exercise you should do towards the beginning of class, and we'll do it again at the end of class if you like. Imagine a bioengineer. Now, you're going to need in a minute, pencil or pen and some scrap paper or paper, so take a moment, get that. Once you have that, the first thing to do is close your eyes, just relax, and imagine a bioengineer. It's a little bit strange because it's the beginning of class and maybe you're not sure what a bioengineer is. Nevertheless, just relax and you're like, well, what's a bioengineer? What do they look like? What are they doing? What's the scene they're in? When you stop and try and imagine a bioengineer, what comes to your mind? Take as much time as you like on this, but then once you're feeling good about it, go on to the next step and use your paper and pencil, and just draw a sketch, you know, simple stick figure, whatever, however you like to draw. Draw a sketch of the person. Where are they? What do they look like? What are they doing? What's around them? Take a few minutes, get that sketched out, and when you're ready, move on to step two. When you think about what you've imagined and what you've drawn, just write down three words, three different words that describe the bioengineer you imagined. Characteristics, anything about them that comes to your mind. Great, next step. Take a look at what you've drawn. This is an example from Veronica. Is that what a bioengineer looks like? Well, that's what she imagined. Looks like they're working at a bench. Maybe they've got safety goggles on. It's interesting. What were the words? A bioengineer is creative. Bioengineer is logical. A bioengineer is a problem solver. There's no right answer here. The exercise is just to get you to imagine what a bioengineer is at this point in the course, at the beginning of things. Next, find a friend, if you can, pair up and share your drawings. Next, compare both bioengineers that you imagined. What's the same? What's different? On a scale of zero to 100, where zero is totally different and 100 is exactly the same, how different or alike are the bioengineers that you imagined? Again, there's no wrong or right answers, just trying to orient you and begin to imagine what a bioengineer is. And that's it. However, at the end of the class, we're gonna come back and do this again. If at the start, we imagined a bioengineer, at the end of the class, your job will be to imagine your bioengineer, what you think a bioengineer is after you've taken the entire class. And I don't wanna spend too much time on it, but I'll do a quick reveal of what Veronica came up with at the end of class when she created this exercise for you. A lot more is going on and maybe a lot more interesting. We'll see what you come up with in a couple months.", "start_char_idx": 0, "end_char_idx": 3203, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8050142c-8722-4568-b4d6-f075300a8db7": {"__data__": {"id_": "8050142c-8722-4568-b4d6-f075300a8db7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b60f1b52-33f8-4ccd-8ea7-e22a9ae6d854", "node_type": null, "metadata": {}, "hash": "e8c4a82192752d93f9afb5dabe6db68361508ce8cbd906804204f6c0d3bc3269"}, "3": {"node_id": "0243a1f0-9573-41d6-82f6-87ffffb970e0", "node_type": null, "metadata": {}, "hash": "0ba352ad526ea4f3bb911a9d610fbe6bf6738e9596c3c98f3396fb43a930256e"}}, "hash": "d465e122260fab5c479f3d87e6895634775f8caf8b71733f223cabf5de47908f", "text": "Today, we're going to explore the question, why engineer biology? This question is meant not as a prescription, but really as an invitation for you to explore and reflect on what's going on. You oftentimes hear in movies, you know, just because you could do something, should you do it? And so in the spirit of that reflection, let's explore how engineering and biology come together. My name is Drew Endy. The slides are for me. Any mistakes or comments, let me know. There's my email address. Just send me a note. The thing that's so interesting about bioengineering is biology becomes apparent well before engineering. I love this movie, Growing is Forever, short little film, you can find it online. And it's a, you know, representation of what you can find in the woods around Northern California. None of this has anything to do with bioengineering, right? This is all something that exists before homo sapiens come around, humans come around and start doing things. In other words, the planet is full of life. It's full of biology. And it's amazing and wondrous and sacred and many more things you could give name to. So think about this when we think about why engineering biology. So once upon a time, until one day, some of the biology, the human part started happening to the rest of the biology. There's many ways to illustrate this. Here's one of a few examples. Take a look at these fruits and plants on the screen. The three up top, the three down below, and see if you can figure out what they are. I'm sure many of you are familiar with many, if not most, or all of these plants. Watermelon, eggplant, carrot, banana, corn, broccoli. These are the natural ancestors of these plants before they were adapted by our ancestors through a process of domestication and breeding to make the modern forms we're familiar with. So teosinte becoming maize, becoming corn, look at what's in the bottom middle. There's no cob, there's quite a small number of kernels, and so on. So one day, we started happening to biology, we humanity. Why? Well, one of the reasons is we depend on biology for many things, starting with food. So here's a fabulous meal, the first nation's fall celebration. Industrial agricultural today in the United States gets us to a lot more, right? So we're now the largest global exporter of food. This is, in other words, shaped the relationship between human and biology, because we care about what biology can make, because we increasingly depend on what biology can make. We're going to change the biology, historically through domestication of plants and animals. More recently, over the last couple hundred years, but especially over the last 100 years, the science of biology has become so interesting. For example, Barbara McClintock in the middle here, she studied maize and corn and how sometimes corn on the cob, you get different colored kernels and link this back to the idea that some genes can jump around on the chromosomes, so called jumping genes or transposons. More recently, a fourth generation DNA editing tool famously known as CRISPR was discovered and then invented, and it's just so incredibly interesting. By the way, if you want a funny little thing to remember, the scientist down below, Jennifer Doudna from Berkeley, look at her last name carefully. I bet you could impress your friends or parents just by remembering how to spell her name. Do you DNA? Hmm. Kind of cool. Now if we get bountiful manufacturing and growing and science, the next thing that follows, remember this has nothing to do with us yet, this is all before our time, what follows science is often technology. For example, this is a United States patent issued in 1980 to Stanford University. If you look at the title of the patent in the top left, process for producing biologically functional molecular chimeras. What the heck's that? What that means is you can take different molecules of DNA and cut and paste them to make a composite or chimeric molecule. This is part of the birth of genetic engineering in 1980, over 50, no, 40 years ago, right? Now once you get the ability to intentionally intervene in genetic material, see breeding and domestication, that's sculpting from the outside of the", "start_char_idx": 0, "end_char_idx": 4232, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0243a1f0-9573-41d6-82f6-87ffffb970e0": {"__data__": {"id_": "0243a1f0-9573-41d6-82f6-87ffffb970e0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b60f1b52-33f8-4ccd-8ea7-e22a9ae6d854", "node_type": null, "metadata": {}, "hash": "e8c4a82192752d93f9afb5dabe6db68361508ce8cbd906804204f6c0d3bc3269"}, "2": {"node_id": "8050142c-8722-4568-b4d6-f075300a8db7", "node_type": null, "metadata": {}, "hash": "d465e122260fab5c479f3d87e6895634775f8caf8b71733f223cabf5de47908f"}, "3": {"node_id": "a6463906-f946-419d-b291-997d71031aa1", "node_type": null, "metadata": {}, "hash": "faed98102835925a4951fa1b63c800547864a79665cdeeb74867f937b94f3537"}}, "hash": "0ba352ad526ea4f3bb911a9d610fbe6bf6738e9596c3c98f3396fb43a930256e", "text": "material, see breeding and domestication, that's sculpting from the outside of the traits of a plant or animal back in. But now we're going from the inside and trying to figure out what could happen when we make changes and then the animal show up or the plant shows up. If we can begin to do that, then we're going to have a whole other sort of approach to economic activity. And this can be represented, maybe you've heard of the gross domestic product as a measure of the economy, how much dollars there are being produced in goods and services. You could look at a subset of that and call it the genetically engineered domestic product or the GEDP. And what's shown here over time, starting in 1980, around when this patent comes out, going out to 2017 for what the data is available, you can see that the plots are going up and to the right. And so what that means is the amount of money made in the United States by genetic engineering organisms is increasing over time, or at least it has been increasing over time. And this is because of three major types of products or services. In green are genetically modified organisms, cotton or corn or soy. In red, those are biologics, those are medicines, and then in blue is industrial intermediates. Because this is kind of abstract, I'll give you examples on the next slide. But the takeaway here is, wow, suddenly in 1980, we're getting a tool for the first time we can begin to engineer biology from the DNA outwards. And almost immediately, you start to see this growth of a bioeconomy. And one thing you can think about later is like, how long does it take for the bioeconomy to double, say from $100 billion a year of revenue to $200 billion a year of revenue to $400 billion a year of revenue? Think about where that's going. It's already a huge number, by the way, but think about where it's going. But let's look a little bit more about what these different types of products and services are. So on the top right, we have an example of genetic engineering for medicine. You can take a gene that encodes a protein, insulin, and modify bacteria so that the bacteria makes the insulin for treating diabetes, as opposed to having to harvest insulin from the pig's organs. Or on the bottom left, you could see a papaya that's suffering from a virus infection, in this case, the ring spot virus, as shown in the inset. And Dennis Gonsalves and others figured out that you could genetically modify the papaya so that it could be immune or resistant to the ring spot virus. On the top left, we see this oily yellow material, I believe that's farnesine, an industrial intermediate compound. But what's interesting is where the farnesine is coming from. It's not coming from a barrel of oil or some other thing. It's coming from bioengineered yeast, which are the bluish gray circles much smaller here. And they've been engineered to take glucose or sugar in. And instead of making wine or beer, they're making this oily substance farnesine. Whoa. Bottom right, you see what looks like an animal hide, a leather or something like that. But that's not what it turns out to be. It's a replacement for those types of materials. And instead of being made from a vertebrate, a mammal, it's made from something like this, from a mushroom. And it's growing from wood chips or sawdust. Very interesting. So that's when we talk about food and medicines and industrial intermediates and materials, these are examples of what's in the bioeconomy. It's not all awesome, right? So let's just go to the other side of the coin really quick. Humanity's relationship with biology, it's booming in terms of biotechnology in the bioeconomy. But a whole bunch of things, some of which you're obviously familiar with, but others might be a little bit esoteric, are not going well at all. So everybody's experienced the pandemic. The word pandemic literally means all people. So how about we make that not happen ever more? But what about pollution? If I've got industrial agriculture, and I'm fertilizing the fields, and I have runoff through", "start_char_idx": 4162, "end_char_idx": 8236, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a6463906-f946-419d-b291-997d71031aa1": {"__data__": {"id_": "a6463906-f946-419d-b291-997d71031aa1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b60f1b52-33f8-4ccd-8ea7-e22a9ae6d854", "node_type": null, "metadata": {}, "hash": "e8c4a82192752d93f9afb5dabe6db68361508ce8cbd906804204f6c0d3bc3269"}, "2": {"node_id": "0243a1f0-9573-41d6-82f6-87ffffb970e0", "node_type": null, "metadata": {}, "hash": "0ba352ad526ea4f3bb911a9d610fbe6bf6738e9596c3c98f3396fb43a930256e"}, "3": {"node_id": "6b77a12b-b2fc-4328-8949-5d144fa93043", "node_type": null, "metadata": {}, "hash": "c42bfd9fa335dbb1b556499004b7288bf7a46077e15f03f13f5afaf985153cfb"}}, "hash": "faed98102835925a4951fa1b63c800547864a79665cdeeb74867f937b94f3537", "text": "agriculture, and I'm fertilizing the fields, and I have runoff through the rivers, and then suddenly I get a lot of nitrogen and phosphorus in the estuaries, I might get overwhelming algal growth. Or where do I grow these crops? This is an oil palm plantation on the top right. And to grow oil palms, I have to displace the jungle. And if I displace the jungle, then where are the natural creatures going to live? Probably nowhere, which is causing, top left, increasingly things to go extinct, besides So over my lifetime, the human population has doubled. But natural biodiversity seems to have gone down by a factor of two. So begs the question, if we've had this relationship with life that predates us, growing is forever, not totally clear that's a done deal. This is a shocking photograph of a wildfire in California, only about 30 miles from the Stanford campus, near Santa Cruz, California. So is growing forever. How does this then take us to Martin Luther King Jr. and his most famous speech? And so when you think about bioengineering, for me, at least, I think it's impossible to think about bioengineering without thinking about what we wish for. And just to say what this speech was not about, I bet everybody knows this, but I'm just going to say it so we know what it was not about. This very famous speech was not about, I have a degree, or I have a vaccine. The speech was not about, I have a petri dish for doing experiments, not at all. It was not, I have a bio, it was about none of the things we've been talking about, at least not yet. This speech, as we know, is I have a dream. Now, what's this have to do with bioengineering? We'll see. It turns out, from an engineer's perspective, we can think of dreams as a type of technology in and of themselves. In other words, dreams are tools. What do we mean by this? A tool has to be good for something. So what are dreams good for? Dreams can be the tool we use to make sure that we're happening to things. What does that mean? We can use dreams to organize ourselves and others. So are you happening to the future, or is the future happening to you? Are you happening to the world, or is the world happening to you? Are you happening to artificial intelligence research, or is that happening to you? Oftentimes, in the world, it feels like, because it's true, things are happening, and just everything's crashing on us, and the world's happening to us. But if we think about dreams as tools, we can use these sorts of approaches to make sure we're happening to the world. We're happening to the future we wish for. Is bioengineering happening to you, or are you happening to bioengineering? So if you want to determine your answer to that question, as opposed to just let whatever happen happens, maybe you'll find this next little section interesting. Now, dreams come. I'm not going to make this too complicated. Dreams come in a couple different flavors. The easiest to understand is the nightmare or the negative dream. It's horrible. A lot of times when we use dreams as tools, we use negative dreams because it's easier to get attention by shouting about the bad thing, the boy who cried wolf. Even though it's easier to get attention and to get people to react, the problem with the negative dream is if enough people don't believe the bad thing's real, you won't get anything to happen. Stated differently, you have to get enough people believing that the bad thing is real before you get enough action. That's going to sound really strange, but what if we've been living in a negative dream about climate change for longer than we can remember, and because it's a negative dream and not everyone believes climate change is real, it's making climate emergency inevitable. It's like a double nightmare. It's like we have a bad dream about the future, and then because of that, the bad future's even more likely to happen. Let's see if the data supports this way of thinking about it. We'll go back in time, 110 years ago", "start_char_idx": 8248, "end_char_idx": 12248, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6b77a12b-b2fc-4328-8949-5d144fa93043": {"__data__": {"id_": "6b77a12b-b2fc-4328-8949-5d144fa93043", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b60f1b52-33f8-4ccd-8ea7-e22a9ae6d854", "node_type": null, "metadata": {}, "hash": "e8c4a82192752d93f9afb5dabe6db68361508ce8cbd906804204f6c0d3bc3269"}, "2": {"node_id": "a6463906-f946-419d-b291-997d71031aa1", "node_type": null, "metadata": {}, "hash": "faed98102835925a4951fa1b63c800547864a79665cdeeb74867f937b94f3537"}, "3": {"node_id": "1370e093-be41-4dbc-9c82-c39cb96a434e", "node_type": null, "metadata": {}, "hash": "db3bccc428c71db22636bf62cb49f76ded5f62d073b46c9f22a8630200fd662c"}}, "hash": "c42bfd9fa335dbb1b556499004b7288bf7a46077e15f03f13f5afaf985153cfb", "text": "data supports this way of thinking about it. We'll go back in time, 110 years ago or so, 120 years ago. You can find in the newspapers articles about how burning coal will eventually cause the earth to boil all the oceans because it's going to become so hot. Or in popular mechanics, it's just a couple centuries, going to get way too hot. All right, I guess we knew that, this bad future, this bad story about the future, but we didn't do anything about it yet. Fast forward, 1989, 2006, Vice President Gore is very concerned about climate change, making an incredible slide deck, and then a documentary, An Inconvenient Truth, and you can see right there in the subtitle, a global warning. He's telling a story about the future based on his understanding of what's happening, and the future isn't going to be good, and he's taking a negative narrative approach to spur us into collective action. Did it work? Not obvious. Maybe not enough people believed that it's real. How about we fast forward to this decade? Here's a great book, Speed and Scale, a global action plan for solving our climate crisis now. See that? Our climate crisis, the negative thing is starting to become real, and because enough people are starting to believe, look at all these other names on this book, Bill Gates, Jeffrey, Christina, wow. Because enough people are now believing the negative thing is real, maybe we can get to collective action. Here at Stanford, we've seen that. John, the author of that book, and his wife helped underwrite a new school at Stanford, the School of Sustainability. Amazing, right? Maybe just in time. Language is so curious to me. What's interesting about the School of Sustainability is if you turn it into an acronym, what do you get? SOS. That's the signal that is broadcast when a ship is sinking. Save our souls. We're going down. So see how over 100 years by telling a negative story about the future of climate, eventually we're getting to the emergency becoming real, and now we've got the SOS signal being broadcast. Here's the good news if you're interested in bioengineering. If you ever happen to be on a ship that's sinking, I would encourage you to put on a life jacket and go to lifeboats. Life jackets, lifeboats, life. Oh, that's biology. That's the living stuff. That's bioengineering, baby. Now, enough about negative dreams. Let's talk about positive dreams. Positive dreams, if you can pull it off, have a chance of enabling collective action in advance of reality. Going to the moon is an example of a collective dream. Martin Luther King, I have a dream that's a positive, aspirational dream in advance of reality. It lets people work together before the hard work of making something really fabulous gets all figured out. It's harder to do, maybe. It's funny to think about, and the counter examples we were just giving. Instead of climate change, making climate crisis, making climate emergency, could you reframe that and say, wow, hey, everybody, we've got a climate opportunity. There is so much carbon in the atmosphere. What can we do with all this carbon in the atmosphere? Gosh, if we have a climate opportunity, I have a dream. It's called Climate Awesome. Let's all work together to make climate awesome. Because I bet each of you has grown up in a world that doesn't use this language at all and just talks about climate change and climate emergency and climate crisis, I hope these words, when flipped around, feel a little bit strange. That should be a clue to you that there's a choice to make in terms of how you architect a dream. I want you to think about this question, too, and then we'll move back to bioengineering. Is it harder to articulate a positive dream? Is it harder to make it real? If you want a clue about this, go back and read the history about the I have a dream speech that Dr. King gave and see if you can track down the link in the bottom of this photograph here of Mahalia Jackson and her role in contributing to the speech as it was presented that day. Incredible story. I'll let you follow up on as you like. Now let's bring it back to bioengineering. What are our", "start_char_idx": 12243, "end_char_idx": 16385, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1370e093-be41-4dbc-9c82-c39cb96a434e": {"__data__": {"id_": "1370e093-be41-4dbc-9c82-c39cb96a434e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b60f1b52-33f8-4ccd-8ea7-e22a9ae6d854", "node_type": null, "metadata": {}, "hash": "e8c4a82192752d93f9afb5dabe6db68361508ce8cbd906804204f6c0d3bc3269"}, "2": {"node_id": "6b77a12b-b2fc-4328-8949-5d144fa93043", "node_type": null, "metadata": {}, "hash": "c42bfd9fa335dbb1b556499004b7288bf7a46077e15f03f13f5afaf985153cfb"}}, "hash": "db3bccc428c71db22636bf62cb49f76ded5f62d073b46c9f22a8630200fd662c", "text": "up on as you like. Now let's bring it back to bioengineering. What are our positive dreams of and with biology? If you've got nothing to say to this question, no problem. Maybe you're going to do something else besides bioengineering. But if this question resonates with you at all, or if you care about the answer, then maybe that's a clue that you have something to contribute to bioengineering in the future as manifesting via bioengineering. I love this photograph of a boy. Looks like he's fishing on a creek somewhere in India, in part because not just of the boy and what he's doing, but because of what's behind the boy. It looks like a suspension bridge, but this suspension bridge is not made out of concrete and steel. This is made out of the roots of a rubber tree and is so incredibly interesting to me because it doesn't emit carbon as the concrete is curing. It actually fixes carbon and it gets stronger over time and it could be passed down from one generation to the next. It's a totally different way of building. It's a way of building called growing. What if biology was the ultimate way of manufacturing because it was nature's way of manufacturing via growing? We'll come back to that in another lecture. Do you have a positive dream of and with biology? What I can offer you really quickly is some facts. We know biology is all over the planet. It's in most places. We can quantify how much energy it captures from the sun via photosynthesis. The answer is 90 terawatts. A terawatt is 10 to the 12th watts. What's 90 terawatts? You should be asking. All of human civilization today is running on about 20 terawatts, so you know that 90 is four and a half times bigger than 20. Stated differently, if you're understanding what that means, in nature itself, there is an energy harvesting capacity sufficient to make things at about four and a half times as much as all of humanity is running on. It's like, whoa, whoa, whoa. There's a clue there. I have a dream. We should be able to flourish.", "start_char_idx": 16377, "end_char_idx": 18392, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0c8684b8-00a6-4ef3-ae0f-1b05b52d470b": {"__data__": {"id_": "0c8684b8-00a6-4ef3-ae0f-1b05b52d470b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d463771d-cec1-46e0-ba77-f8c16ceefd07", "node_type": null, "metadata": {}, "hash": "f3ca98c8fd15b79475c562a093fb97af75326885833a6590b5c94f5ec8a42914"}, "3": {"node_id": "d7e14ba6-2054-4637-b894-1908cd5c5598", "node_type": null, "metadata": {}, "hash": "4bb1e9817ab1567b2ba56bce4182bb8467971b72a827bd8b31d51f5ff46b9ae0"}}, "hash": "558b1e2823f7c8d39d44f05f2d8c97f05bd7db5930628df864d2848fee50fd1d", "text": "on this planet with everything else. Like just that 90 terawatt fact makes that seem plausible. We also know as facts that biology reproduces, it grows, the materials heal. Very functional material, right? You can make a structure, you could sequester metals, you could grow a fiber optic cable with a sponge in the ocean, right? We also know that life matters, ramifications, right? It's like very important what's happening with life, let alone anything we do with life. So, we could adjust the facts a little bit, but not too much, because the facts are the reality of the planet and life on the planet. What's up for grabs though, is anything you put on the right of this slide. So here's my offering, but it's not a prescription, like positive dream. Let's enable 10 billion people to flourish, provide for themselves, ourselves. Let's do that in a way that doesn't trash the place. Let's stabilize and recover natural biodiversity. Let's make infectious diseases obsolete and might as well make other diseases obsolete too, like take them off the table. There's a choice here in terms of how we develop biological futures. Am I a citizen of that future? Are you a citizen of that future? What about your kids? What about your grandkids? Or are they only consumers in a biotic future or subjects or objects or something? We're still. I also have a dream that by building with biology, we'll learn how natural living systems work a little bit better. You know, you could take a bicycle apart. They kind of understand a bicycle, but if you put a bicycle together, I bet you'd understand the bicycle a lot more, right? And so learning by building is a nice outcome perhaps of bioengineering. Again, what's on the left are the facts. What's on the right is an example, not a prescription. And I encourage you to discuss and debate what should be on the right of this slide. But most of all, in the context of dreams, please, if you're going down this path, go for a positive dream, right? Towards the thing that's aspirational that we can work on collectively. What's so interesting beyond, you know, the initial bioeconomy data is the fact that even though it's booming, you know, and it's like 5% of the economy already, mostly doesn't exist. I mean, like people haven't imagined most of what biology could be. Here's one of my favorite recent examples. This is work coming out of London, England and Moscow, Russia and a US company. And these are plants. Now, when you think of plants as harvesting light and fixing carbon and emitting oxygen, these plants do that, but they've been engineered. They've been bioengineered in addition to also take some of that sugar that they make and turn it back into light. So if the plants are in the dark, they glow. If you bring one of these plants home and put it on your bookshelf or your dresser and it's dark in the room at three in the morning, you'll have a nightlight. But instead of plugging the nightlight into the electrical outlet, you're watering it because it's alive, right? Like, okay, you know, what else could we imagine bioengineering with living systems? Now, back to introduction to bioengineering, you know, if you had to learn everything about everything in biology to be a bioengineer, it's not gonna be very valuable. And one of the things that's so neat about now is the science of biology has gotten us to a starting line where we think we know enough about biology to have a general purpose bioengineering discipline. Historically, let me try and make sense of it by going back in time and thinking about the beginnings of computer science. There's a neat quote that used to be on a building here on the Stanford campus from 1961. Enough is known about the diverse applications of computing for us to recognize the birth of a coherent body of technique, which I call computer science. Whether computers are used for engineering design, like medical data processing or making music or anything, the structure of computing is pretty much the same. It doesn't change, right? Now let's just update this for bioengineering. Enough is known about the diverse applications of biology for us to recognize the birth of", "start_char_idx": 0, "end_char_idx": 4179, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d7e14ba6-2054-4637-b894-1908cd5c5598": {"__data__": {"id_": "d7e14ba6-2054-4637-b894-1908cd5c5598", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d463771d-cec1-46e0-ba77-f8c16ceefd07", "node_type": null, "metadata": {}, "hash": "f3ca98c8fd15b79475c562a093fb97af75326885833a6590b5c94f5ec8a42914"}, "2": {"node_id": "0c8684b8-00a6-4ef3-ae0f-1b05b52d470b", "node_type": null, "metadata": {}, "hash": "558b1e2823f7c8d39d44f05f2d8c97f05bd7db5930628df864d2848fee50fd1d"}, "3": {"node_id": "9575f03a-6cb2-4724-885b-d745dcc629f6", "node_type": null, "metadata": {}, "hash": "4e4e08f28da8697422ae756c533025ed94c7da28b13cb7da514a14735434406f"}}, "hash": "4bb1e9817ab1567b2ba56bce4182bb8467971b72a827bd8b31d51f5ff46b9ae0", "text": "Enough is known about the diverse applications of biology for us to recognize the birth of a coherent body of technique which we call, wait for it, bioengineering. Whether living matter is used for manufacturing, making medicines, abiotic data storage, that means putting the library inside DNA, making bio art or other purposes, the structure of engineering life from the inside out is much the same. And we're gonna have to see if this is true and prove it to you and then enable you to practice it, but that's the gist of what's going on that makes bioengineering interesting in thinking about why now. I'll give you a totally different example coming from social media. You know, seemingly random tweet from almost two years ago. Synthetic biology is about to undergo a Cambrian explosion says Eric Schmidt at a meeting somewhere in Boston it looks like. Now, Eric Schmidt's well-known for being the CEO of Google when Google became a very big company. And now he's thinking about synthetic biology. What's synthetic biology? Synthetic biology is a suite of tools we'll see in another lecture relating to how people do bioengineering. And he says it's about to undergo a Cambrian explosion. Now the Cambrian explosion is relating to a point in the history of life on earth where over a period of 10 or 20 million years you got a tremendous diversification of animal and body plants. So put all this together, like what's going on here? How do we interpret this? Option one, since the Cambrian explosion took 13 to 25 million years, maybe what Eric means is that biotechnology is gonna take another 13 to 25 million years to mature. In which case, if you're in high school or college you wanna come back in 20 million years, good luck. I don't think that's what Eric means. I think what he means instead is that the underlying approaches that will unlock all the possibilities of biotechnology, those approaches are being worked out now in real time over the last 10, 20 years and this decade such that by or before 2030, you're gonna see biology become a general purpose technology just like computing became a general purpose technology. And so what that means is in terms of why bioengineering and why now, it's looking pretty interesting, looks like there's a lot at stake. We see that reflecting back from the government. So here is an executive order from the 12th of September of 2022, signed by President Biden. Let's look at the title of this. Now an executive order is the president is instructing the executive branch of the government to do certain things. This is an executive order on advancing biotechnology and biomanufacturing innovation for sustainable, safe and secure American bioeconomy. And if you just, I'd encourage you to read the whole thing or skim it if you like. The policy here is to take a whole of government approach like all hands, the entire federal government, everybody has to figure out how to advance biotechnology and biomanufacturing towards innovative solutions in health, in climate change. Oh, note the negative there. In energy, in food security, that sounds positive. In agriculture, in supply chain resilience, positive dream there. In national and economic security, mixed. Central to this policy and its outcomes are the principles of equity, ethics, safety and security, enabling access to technologies, processes and products in a manner that benefits all Americans and the global community. And that makes sure USA is winning or in the lead or at least competitive, I'm paraphrasing. Well, that's interesting. Like all hands, says the White House just a few months ago. If you go back not even as far to October 18th of 2022, the administration is this time releasing a national security memorandum, number 15 from their term, I guess. And this one's called the National Biodefense Strategy and Implementation Plan for Countering Biological Threats, Enhancing Pandemic Preparedness and Achieving Global Health Security. Within this document, my favorite part is the vision. This is akin to the dream. It reads, the United States actively and effectively assesses, prevents, prepares for, responds to and recovers from naturally occurring, accidental or deliberate. Well, deliberate, we're gonna have to come back and talk about", "start_char_idx": 4105, "end_char_idx": 8387, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9575f03a-6cb2-4724-885b-d745dcc629f6": {"__data__": {"id_": "9575f03a-6cb2-4724-885b-d745dcc629f6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d463771d-cec1-46e0-ba77-f8c16ceefd07", "node_type": null, "metadata": {}, "hash": "f3ca98c8fd15b79475c562a093fb97af75326885833a6590b5c94f5ec8a42914"}, "2": {"node_id": "d7e14ba6-2054-4637-b894-1908cd5c5598", "node_type": null, "metadata": {}, "hash": "4bb1e9817ab1567b2ba56bce4182bb8467971b72a827bd8b31d51f5ff46b9ae0"}}, "hash": "4e4e08f28da8697422ae756c533025ed94c7da28b13cb7da514a14735434406f", "text": "Well, deliberate, we're gonna have to come back and talk about that. Biological threats impacting humans, animals, plants and the environment. And, and here's the best part, creates a world free from catastrophic biological incidents. So let's just like simplify. The United States creates a world free from catastrophic biological incidents. Sounds to me like no more pandemics, right? Well, we're not there yet, but that's a nice dream, right? Maybe, interesting. In any case, here's evidence that something is afoot. Something is afoot at the biggest scale on the grandest stages. Bioengineering is contributing and becoming something unlike anything we've navigated before. Which brings us back to where it started. What does it mean to be a bioengineer? Should we be bioengineers? We're not yet anywhere as capable of the things that we see here in nature. Yet each thing we see in nature is a point of inspiration, a point of instruction, a point of empathy. It's not really a point, it's more like a web or a connection or a story or something we are still gonna figure out. So I hope these remarks give you an on-ramp for yourself to think about why bioengineer? Let me offer some very accessible questions, I hope. Do you think it was inevitable that Homo sapiens would start to adapt and change living systems? Should we keep going? Could we stop? If you look at the plot on slide six around the bioeconomy growing, could you estimate how long it takes the bioeconomy to double historically? Like how many years? And if that trend continued, how big would it be in 30 years, say 2050 or whatever time you like? One of the things about bioengineering as mentioned is mostly hasn't been imagined yet, those glowing plants or who knows what else you could think of. So you could practice inventing the future, why don't you give it a try? So here's an example prompt. In a flourishing future, there is a biotechnology related to libraries. What is it? Just go invent that future thing, a biotechnology related to libraries in a world where everything's working really well. And if you like this type of prompt, see the little words I put in parentheses, flourishing and libraries, you could change that to like in a catastrophic future, there's a biotechnology related to yogurt. What is it? Right, just feel free to play with those words and keep inventing biotechnological futures and see what you can come up with. Reflective question four. And again, reflective questions. These are not homework per se, and just things to get you to think about what we've been talking about in the slides here. If you zoom out and think more broadly, we saw that there was food, medicine, and industrial chemicals as the big three slices of the pie for the bioeconomy. Is that all there is? What if you went to this point in the future after you do some invention, could you come up with entirely new sectors of biotechnology? Which ones would you like to pioneer? Question five. Setting aside all the economic stuff and the security stuff, if you just take a step back and imagine the world you wish to live in or contribute to or both, as it has to do with biology, what do you wish for? What are your emergent dreams? Things that biology could or should become or should not become? And then zooming out still further and thinking about dreams as to, I know it's a bioengineering class, but wow, one of the things from today is dreams are tools. If you can understand that, you've got a super powerful tool in your toolkit to make things that happen or not. So thinking about that, dreams as tools, the world you live in now, what bigger picture dreams coming from outside you, coming from other people, whether they're good or bad, have nothing to do with biology, but are like defined by other people. What dreams are you experiencing that are shaping the currents and context in which you're navigating? That's it for today and can't wait for next time.", "start_char_idx": 8400, "end_char_idx": 12355, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9fc1dd50-d11d-4488-851c-2c9260fc8330": {"__data__": {"id_": "9fc1dd50-d11d-4488-851c-2c9260fc8330", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "971eabe0-9fb2-4df5-abaf-ae9c5fd856ec", "node_type": null, "metadata": {}, "hash": "dc2ba08c84196e2e6bcd51e95f92b52d52937a0210b809cc69d19241a19e489a"}, "3": {"node_id": "5ba439ab-1d57-496f-96f8-99a0b37820aa", "node_type": null, "metadata": {}, "hash": "c90a3a042f7a9a820ab1f6d8a5706f3b4fdd014aa75c393420de11d46ccf6a18"}}, "hash": "174828a9daf62b36568c6cb51f765351786f3ea05dd7e74cab98629e3e25e05f", "text": "This is a medium-sized session on how to quickly make sense of a research paper. Research papers are reports from laboratories, scientists, engineers, claiming to present a discovery or an invention that might be related to a cure for disease or some underlying development in a tool that's exciting. And if you want to be a bionaut and be capable of navigating the frontier in future bioengineering, underneath it all you've got to get to reality, which is oftentimes represented in these research papers, as opposed to newspaper stories. So let's dig in and see how it goes. This is meant to be a lightweight tool you can put in your bioengineering toolkit and keep getting better at over time. I am still getting better at using these approaches and reading research papers. You may be already awesome at this, like a chess master-level superstar of reading research papers, or maybe you've never even seen a research paper, you don't know what I'm talking about yet. Don't worry, no matter how great you are, you can become even better or even more great, greater, at reading research papers. We're going to do the short version here, and it's got four steps. Make sense of the title, find a claim in the abstract, skim the figures, think of this like a picture book, not a wall of text, and then decide what you think. So let's get into it. For example, let's say I see a headline, bacterial photography. Apparently you can take photographs with bacteria. I thought you could only take photographs with cell phones or film. Let's see if we can find a research paper involved in this space and then use that as an example. Should be exciting to see what's going on in the space of bacterial photography. As an aside, with all these slides, down at the bottom, I'm usually including a link to a website if you want to learn more about what's shown right here, so just in general. Okay, here is a research paper that is representing something to do with bacterial photography. And gosh, it looks intimidating. There's many, many pages, and it's just a wall of text. Let's figure out how to quickly read a research paper. This should be a fun example. So we'll zoom in a little bit. And the first thing we're going to do is we're going to look at the title of the paper. The title is the big, bold text at the top. A Synthetic Genetic Edge Detection Program. That's the first thing I'm going to do. I'm going to read the title, and I'm going to see if I can understand it. A Synthetic Genetic Edge Detection Program. A program. A synthetic program. A genetic program. A genetic program, like something in DNA. It's a program, like a computer program, but it's a genetic program. And it's a synthetic one. It's not a natural one. It's something that Jeffrey, Howard, Zachary, Aaron, Anselm, Edward, Chris, and Andrew, they must have bioengineered. A synthetic program. A synthetic genetic program. I'm okay with all those words. Edge detection. Obviously, I know an edge, like the edge of a cliff, and detection. Detected. But edge detection I'm not totally up to date on. So maybe I'm going to flag those words and say, before I go any further, let me just make sure I understand what edge detection is. Now, how would I quickly try and upgrade my knowledge of edge detection? You know how to do this. It's not that complicated. I'm going to go to Google or some search, and I'm going to type in the words edge detection. And oftentimes, I go right to the images. And so, for example, I see a photograph of a person, and then to the right, it looks like you can sort of see the outline of the face and the hair and the dress. Or if I go to the top middle, I see, what are those, nickels? And other, maybe dimes? And then, just to the right, this black and white image, the edges are revealed, where the coins stop, and then the various etchings or imprints on the coin, the edges of those. To the right, the hat. To the bottom left, a person. A photograph. And then, OK, I can see the outline of the person,", "start_char_idx": 0, "end_char_idx": 4008, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5ba439ab-1d57-496f-96f8-99a0b37820aa": {"__data__": {"id_": "5ba439ab-1d57-496f-96f8-99a0b37820aa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "971eabe0-9fb2-4df5-abaf-ae9c5fd856ec", "node_type": null, "metadata": {}, "hash": "dc2ba08c84196e2e6bcd51e95f92b52d52937a0210b809cc69d19241a19e489a"}, "2": {"node_id": "9fc1dd50-d11d-4488-851c-2c9260fc8330", "node_type": null, "metadata": {}, "hash": "174828a9daf62b36568c6cb51f765351786f3ea05dd7e74cab98629e3e25e05f"}, "3": {"node_id": "ea04c89a-504f-445b-b7e9-7991fd25915d", "node_type": null, "metadata": {}, "hash": "8defdf1e92fad6056cd4672261dd721e8e937b185049bd0a451ab46d3d028f93"}}, "hash": "c90a3a042f7a9a820ab1f6d8a5706f3b4fdd014aa75c393420de11d46ccf6a18", "text": "A photograph. And then, OK, I can see the outline of the person, their shirt, their tie. It looks like whenever there's a change from one boundary to the next, that's an edge. And so, edge detection is finding that transition. Anyway, I'm spending more time explaining what I'm observing than I actually do in reality when I'm trying to learn. Another thing, which is fabulous, of course, oftentimes, is Wikipedia. And sure enough, there's an entry on edge detection, and we can skim this really quickly. So, edge detection is using math to identify edges or discontinuities. And I'm just going to skip down. And the purpose here is to detect sharp changes in image brightness. This is a little bit too digital world. We're in bio world. But I get the idea. Like, if there's an image or a pattern, and suddenly, a certain property of the image or pattern is changing discreetly, that defines an edge. And so, edge detection detects such changes or transitions or discontinuities. OK, great. So, now we've got a synthetic DNA program that can detect edges in something. Where's the pattern? Well, it's bacterial photography, so maybe it's in the picture taken by the bacteria. But we'll have to see. OK, that was step one. How about step two? Can you find a strong claim in the abstract? So, the abstract in a research paper is the chunk of text before the paper itself that's supposed to be the summary, you know, executive synopsis of what's going on in the paper. And this is going to be one of the only parts of the paper that I actually read and would recommend you read. I don't read papers, actually. But the abstract we're going to read, and we're going to read it with a purpose, a ruthless purpose. We're going to try and find a strong claim in the abstract, where the authors are making a claim. I say this, right? And right there is a hint. Oftentimes, in abstracts, the best claims use first-person declarative statements. Like, I did this, we did that. So, let's read this abstract together and see what we can find as a claim. Edge detection is a signal processing algorithm common in artificial intelligence and image recognition. Okay, that's just background. We have constructed, oh, there we go. They're claiming to have done something. We have constructed a genetically encoded edge detection algorithm that programs an isogenic community of E. coli to sense an image of light, communicate to identify the light-dark edges, and visually present the result of the computation. But sounds like a claim. It's like, we have constructed, blah, blah, blah, blah, blah. Next sentence. The algorithm is implemented using multiple genetic circuits. An engineered light sensor enables cells to distinguish between light and dark regions. In the dark, cells produce a diffusible chemical signal that diffuses into light regions. Genetic logic gates are used so that only cells that sense light and the diffusible signal produce a positive output. A mathematical model constructed from first principles and parameterized with experimental measurements of the component circuits predicts the performance of the complete program. Quantitatively accurate models will facilitate the engineering of more complex biological behaviors and inform bottom-up studies of natural genetic... Oh, my God. Everything after the sentence, beginning with the word we, is nice. There's a lot there. But the main claim is, we have constructed, in that sentence. We have constructed a genetic program that gets E. coli to sense a light image and identify the edges in the so-produced image. So I'm just going to highlight that. This, I think, is the main claim for this paper. And just like with the title, is there any word in here I don't understand or I want to brush up on before I go further? We have constructed a genetically encoded edge detection algorithm. Nope, these are all good. Isogenic. Maybe I want to understand what that means exactly, because that's a mod of isogenic community of E. coli to sense... Yeah, I think I'm okay with all the other words, but I just", "start_char_idx": 3957, "end_char_idx": 8022, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ea04c89a-504f-445b-b7e9-7991fd25915d": {"__data__": {"id_": "ea04c89a-504f-445b-b7e9-7991fd25915d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "971eabe0-9fb2-4df5-abaf-ae9c5fd856ec", "node_type": null, "metadata": {}, "hash": "dc2ba08c84196e2e6bcd51e95f92b52d52937a0210b809cc69d19241a19e489a"}, "2": {"node_id": "5ba439ab-1d57-496f-96f8-99a0b37820aa", "node_type": null, "metadata": {}, "hash": "c90a3a042f7a9a820ab1f6d8a5706f3b4fdd014aa75c393420de11d46ccf6a18"}, "3": {"node_id": "7c0e4f7e-c4d3-4524-9024-7a75d2171787", "node_type": null, "metadata": {}, "hash": "e741619d1e014d6a59ab05805043f5d161b9c2842f633529c619a947af90942e"}}, "hash": "8defdf1e92fad6056cd4672261dd721e8e937b185049bd0a451ab46d3d028f93", "text": "to sense... Yeah, I think I'm okay with all the other words, but I just want to brush up on isogenic. So let me flag that. And we'll do the same thing as before. Isogenic. Dictionary. It's an adjective. Having the same or closely similar genotypes. Organisms having the same or closely similar genotypes. What does that mean? The same? Okay, the same. So, like, I don't have the same... I'm not the same as my brother. We're not twins. But closely similar. Like, are we isogenic? And then what's a genotype? Better double check that. A genotype is a noun, and it's the genetic constitution of an individual organism. So I think that's the DNA of an organism. It's genome. That's the genotype. And then an isogenic population of organisms would all have the same DNA. Or all have the same... I'm going to get rid of this closely similar, because I don't know what to make of it. But isogenic is a population of organisms all having the same DNA. So, all right. We're now at a point where we have to make a decision. This is the most important part of reading a paper. We've done our best to understand the title. We've done our best to parse the abstract and see if we can find a claim. And now we have to make a decision. If we can't understand the title, we should decide to not spend any more time with the paper. Or do not read this paper if you cannot understand the title. You'll be wasting your time. Find another paper. There's plenty of papers. In this case, great title. We figured it out. Okay to proceed. Next, do not read the paper if you cannot find a clearly stated claim in the abstract. Find another paper. The paper will waste your time if there's no claim. There's plenty of other papers. So the most important thing about practicing how to read a paper is to make sure you're not wasting your time on papers that are not easy to read. Don't waste your time. There's so many papers. Most of them are okay. And now the example again we're working with here. Very nice paper so far. We've got a title we can understand and a very strong claim in the abstract. Even when those conditions are true, even when we understand the title, even when you found a strong claim, don't read the paper. However, keep going. The reason I say don't read the paper is as soon as you sit down to read the paper, it's like sitting down on the couch with a good book and I'll see you tomorrow. We're not trying to savor the paper yet. If that's your hobby, go do that. But we're just trying to parse this paper quickly. It's actually really interesting. When you read a paper, don't ever read a paper. You're going to parse the paper. Let's see what that looks like when we keep going. Here's where it gets really fun. Think of it like a kid's book, a picture book, because that's what we're going to do next. Instead of reading the paper, we're going to look at the images in the paper because research papers often come with what are known as figures. It's like the picture book part of the research paper. We're just going to take a quick skim, flip through and look for all the figures. We're looking for evidence of the primary claim. Remember, in this paper, the primary claim is they had made a genetic edge detector. We're looking for something that is evidence of an edge detector. Here's the first picture I could find in this paper. There's a lot on this figure. There's no evidence here. This is just all schematics. Next figure. I don't know. I don't know. I'm not going to spend more time on this figure. Next figure, figure three. Mask, in vivo, in silico. I see something called an edge detector down on the bottom left. I see an image of data that looks like evidence. Then when I go and look at the figure title, figure three title. Construction of the edge detector from individual genetic circuits. It looks like they're making an edge detector here. They're showing me, they're showing us that they made an edge detector. Edge detector is down in D. If we go over to the figure legend, we go all the way down to the bottom right, we can see the text describing just to", "start_char_idx": 8018, "end_char_idx": 12104, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7c0e4f7e-c4d3-4524-9024-7a75d2171787": {"__data__": {"id_": "7c0e4f7e-c4d3-4524-9024-7a75d2171787", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "971eabe0-9fb2-4df5-abaf-ae9c5fd856ec", "node_type": null, "metadata": {}, "hash": "dc2ba08c84196e2e6bcd51e95f92b52d52937a0210b809cc69d19241a19e489a"}, "2": {"node_id": "ea04c89a-504f-445b-b7e9-7991fd25915d", "node_type": null, "metadata": {}, "hash": "8defdf1e92fad6056cd4672261dd721e8e937b185049bd0a451ab46d3d028f93"}, "3": {"node_id": "34a72aec-770e-44b8-a5e3-97b6df8da356", "node_type": null, "metadata": {}, "hash": "38c46de02ae7089f5d8326476c1dde480a812afc78cab9ef70793022b6b74b8d"}}, "hash": "e741619d1e014d6a59ab05805043f5d161b9c2842f633529c619a947af90942e", "text": "we go all the way down to the bottom right, we can see the text describing just to the left what's in figure 3D. It reads, a population of cells programmed with a complete edge detector system produces black pigment only at the boundary between light and dark regions. The model solutions are reported in Miller units on the right. Okay. Let me back up. This is a really interesting figure. This has evidence. I'm going to spend a little bit more time on it. It's at the very top. Underneath the title, it reads, various circuits are constructed. I guess these are DNA circuits, DNA code. And the effect on image processing is assayed or measured, left, and compared to mathematical models, right, predictions. The details and so on. Okay. This middle column that's in black and white, well, let's do actually the top row, the mask. I guess they're having some sort of mask that lets light through the white zone and blocks light in the black zone. And they're putting that mask above a plate, a Petri dish, full of bacteria. See that little scale bar, 1.4 centimeters down in the bottom? It looks like there's a Petri dish, a circular plate of bacteria, that's about 10 centimeters across. And when they shine light through a mask, the light only hits in the opening. And that's the white zone. And the bacteria that are in the dark make a black pigment. And what's actually happening on the bacterial plate is shown in this in vivo column in the middle. And then what they expect should be happening is shown in the right column, colored in red and blue and green and yellow. And we can see that if they just take a bacterial picture in the top, the photograph, they have a mask that's a star, and the bacteria make a capture pattern of the star. And then if you go down to the inverter, row C, they can flip the pattern. So what was black and white is now the opposite. And then if you look in the edge detector and you look closely, you can see that the darkness is strongest at the border of the star. Okay, so I spent a lot of time on this figure, in part because the figure is claiming to provide the evidence in support of the main claim, constructing the edge detector. Let's go to the any more figures? One more figure as it turns out. This also looks really interesting because the title says edge detection of complex patterns. And so here we see in the top, a mask, circle in a circle. When you shine light with that pattern on a plate, you see a circle is captured in the bacterial film, and it looks like the perimeter of the circle is the darkest region. And it looks to me like they have an intensity plot just below the circle, which is measuring how dark it is going across, say the equator of this plate. And the maximum intensity is at the borders of the circle. This looks like edge detection. Middle, the next one down. I see the mask pattern is a square on the plate. And yep, we see that the perimeter of the square has the darkest intensity. That looks like edge detection to me. What's this thing on the bottom? That looks like, what is it? A silhouette of Alfred Hitchcock. If I have a mask that's shining light onto a plate of bacteria, and the bacteria responding to the light and doing edge detection on the light-dark border, we see in the middle, yeah, look at that. You actually are capturing the silhouette and the edge detection computation of the Alfred Mr. Hitchcock. Hmm. Now look, we haven't read any of the paper except for the abstract at this point and some of the figure legends. But what do we have? We have access to the primary evidence, the experimental evidence, in support of the main claim that the authors are stating up front in their abstract. And so now we can get to step four. What do we think? Does the evidence support the main claim? Based on what I can see so far, absolutely. This is a fabulous paper. Clear claim in the abstract, and at least two of the three figures straight up show us evidence that's supporting this claim, that you could make a genetic edge detector and use that to do simple signal processing within a bacterial photograph, a choleroid. Not a polaroid,", "start_char_idx": 12097, "end_char_idx": 16234, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "34a72aec-770e-44b8-a5e3-97b6df8da356": {"__data__": {"id_": "34a72aec-770e-44b8-a5e3-97b6df8da356", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "971eabe0-9fb2-4df5-abaf-ae9c5fd856ec", "node_type": null, "metadata": {}, "hash": "dc2ba08c84196e2e6bcd51e95f92b52d52937a0210b809cc69d19241a19e489a"}, "2": {"node_id": "7c0e4f7e-c4d3-4524-9024-7a75d2171787", "node_type": null, "metadata": {}, "hash": "e741619d1e014d6a59ab05805043f5d161b9c2842f633529c619a947af90942e"}}, "hash": "38c46de02ae7089f5d8326476c1dde480a812afc78cab9ef70793022b6b74b8d", "text": "processing within a bacterial photograph, a choleroid. Not a polaroid, but an e-choleroid. Do I want to learn more is the next thing then. If the evidence doesn't support the main claim, what am I going to do? It's like, okay, this is a bad paper, but this is a great paper. Wow, what a neat paper. Do you want to learn more? Sure. If I want to learn more, then what I could do is, well, what do I want to learn more about? Do I want to learn more context? Then I might go back and read the introduction of the paper and really savor it. Maybe I just want to learn, how did they do this? I want to read the recipes. I want to go see the methods. What are the impacts of this? If that's what I care about, I might go read the discussion at the end of the paper where the authors might explain how they're thinking and why they think this matters. Related but different is, what questions or ideas do I have or do you have? Are there weaknesses in this work? What are the limitations of bacterial edge detection? What would be the next things to do? Is there future work? Is this good for anything? My dad would ask, what's this good for? And other things. But it starts with deciding what you think. Is there evidence in support of the main claim? If no, then the paper's got a problem. Go find another paper. But if yes, then what do you want to do next? And have a lot of fun with that. Reflective questions. How many bioengineering-relevant research papers do you think are published every year? 100? 1,000? A million? Here's a hint. Go check out this website, PubMed. Just do a Google search for PubMed. And I bet you will quickly find that there's, I don't know, at least 10 million, maybe 100 million. Not every year, but total. At least a million papers a year. How long does it take to read a research paper? Even with this abridged, super-turbo method, how long does it take? How long have we been going? How many papers do you think you could read or parse each year? Could you ever keep up with how much is being published? If you can take photographs with bacteria and program a biofilm to do simple computations like edge detection, what would you do next? Are there practical applications of this? Most people don't read research papers. Who has time for that? But as bionauts, you have this superpower now to connect the dots between what people are saying about bioengineering, the headlines in the newspapers with claims about curing diseases or degrading plastics or some other super innovation. Those newspapers, they're selling you a story. They're giving you the headline, which is what the people are hoping to get to you. But the research paper is where the reality lives. And so you now have this superpower of being able to connect the headline, the claim, down into the reality and then to critically evaluate whether or not that claim is real. So see if you can find a news release about a recent bioengineering breakthrough, a disease cure, an environmental solution. And if you can find that, then see if you can link that claim, that news release, back to the primary research paper. And can you parse it? The more you practice that, the more of a biocitizen you can be and you can enable those around you to be biocitizens as well. Don't believe the hype. How good are you right now at reading a research paper? I bet everybody could learn how to play chess pretty quickly, but it might take you a while to become a grandmaster at chess. How much better do you think you can get at reading bioengineering research papers?", "start_char_idx": 16229, "end_char_idx": 19780, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0306edde-6966-4bab-b44d-22e07b4e3dab": {"__data__": {"id_": "0306edde-6966-4bab-b44d-22e07b4e3dab", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c3f860a3-59d0-46a3-a1b9-353f455d3682", "node_type": null, "metadata": {}, "hash": "a1d94164625f471e9c57b86f49f07f54b8e6f326643300cdbfe8f2f73f911873"}, "3": {"node_id": "c57c6886-ab85-441c-ba63-7643aa2485f0", "node_type": null, "metadata": {}, "hash": "b54dc6714127adaba0a2bbdc67f150ec1e6eb2781d49130f06dea857d19ef7ca"}}, "hash": "9d266ec7f8a69b08ee16be8d0c42d6c13d6267394e2f69f8274e71a9f18c8ad9", "text": "We're going to explore a question. What makes living matter unique? Unique compared to what should be your next question. Well, how about rocks? What makes living matter unique compared to rocks? Rocks we know we find it all over the place. We can get good at working with rocks. We can pile up rocks to make a dam or a wall. Heck, we can even standardize rocks, make regular rocks. And if we make regular rocks, they look like blocks and we can stack them up and make this aqueduct like the one found in Segovia, Spain, almost 2000 years old. We can get even better at working with these rocky materials and grind up rocks and make synthetic artificial rock or concrete. And next thing you know, you have a viaduct like the one found in France. So what makes living matter unique compared to these types of materials or the types of materials you might find in a mobile phone? That's what this class is about. From a bioengineer's perspective, what makes living matter unique? And I'm going to offer five aspects for you to learn about and explore. The first three have to do with life as we observe it on the planet. It's most places, it's local evolved. We'll lift the lid on these three. The fourth has to do with the physics of living matter from the inside out. How does it behave in ways that are different from rocks and computers and other things that you see in engineering as a type of material? And then the fifth has to do with our time. You could be a bioengineer in the 10th century or the 15th century, but good luck with that. Thankfully, we're bioengineers in the 21st century, and that's because we have tools in the 21st century that are making bioengineering really unique in terms of how the tools relate to the material or matter we're working with. So let's take the first three and then go from there. We know our planet, it's full of life, covered with life. What does that mean though? You know, growing up, maybe you heard about biomes. Different places on earth that have different ecologies, different constellations or relationships among living systems. It's sort of taken for granted, but the main thing to remember is that life's all over the place. Now, what does that mean for a bioengineer? If our substrate for engineering is living matter and life's all over the place, then we can say, well, everywhere there's biology, there could be bioengineering. And the asterisk is there for the obvious, could doesn't mean should, but, oh, whoa, this is pretty interesting. Everywhere there's biology, there could be bioengineering. Think about how that's not even, most people have cell phones, but not everybody has a cell phone. So like biology is really embedded in all over the place in a way that's very intriguing. We know about these biomes, but let's keep pushing it. Like what are the limits of where life lives? Here's a tar lake in Trinidad, I think, you know, like literally a lake of tar. The tar is full of bacteria. What about radioactive environments? Can you get biology there? Yep. I'll give you an example of that in a minute. What about boiling water? Hot springs? Absolutely. Lots of biology and life lives in hot springs. How about, you know, a super salty environment? The Dead Sea. It's called the Dead Sea. There shouldn't be life in it. Wrong. There's life in the Dead Sea, organisms that can manage in high salt environments. In snowy places, buried in the glaciers, yep, you'll find bacteria, other things, sometimes worms. Deep in the earth, miles underground, there's life. How about on a spaceship? Did you know that scientists with the European Space Agency put simple animals on the outside of a spacecraft and they survived? These are called tardigrades or water bears. They're not super big. They're only a millimeter or so. They normally eat mosses and stuff like that, but they're very resistant to radiation. They're very resistant to drying out. They could survive on the outside of a spacecraft, not inside, on the outside of a spacecraft. We could do bioengineering on the outside of a spacecraft. What is it going to mean when we can bioengineer a creature like this, the", "start_char_idx": 0, "end_char_idx": 4144, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c57c6886-ab85-441c-ba63-7643aa2485f0": {"__data__": {"id_": "c57c6886-ab85-441c-ba63-7643aa2485f0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c3f860a3-59d0-46a3-a1b9-353f455d3682", "node_type": null, "metadata": {}, "hash": "a1d94164625f471e9c57b86f49f07f54b8e6f326643300cdbfe8f2f73f911873"}, "2": {"node_id": "0306edde-6966-4bab-b44d-22e07b4e3dab", "node_type": null, "metadata": {}, "hash": "9d266ec7f8a69b08ee16be8d0c42d6c13d6267394e2f69f8274e71a9f18c8ad9"}, "3": {"node_id": "7719dde6-cb23-40e2-90e1-9c69e67d626f", "node_type": null, "metadata": {}, "hash": "fbd6e517a8e8751f92784f609302035e63c24d81e07a58e0c8e75089463ad5f4"}}, "hash": "b54dc6714127adaba0a2bbdc67f150ec1e6eb2781d49130f06dea857d19ef7ca", "text": "What is it going to mean when we can bioengineer a creature like this, the tardigrade? Should we be doing that? Another question. So I mentioned radiation. Let's just dig into that a little bit. One way of keeping food safe is to irradiate it to get rid of the microorganisms that might otherwise spoil the food. And oftentimes that can be a good thing to do. It turns out that there's an organism that was discovered in the 20th century in 1956 by Arthur Anderson in Oregon. They were radiating tins of meat. Yet the tins of meat were spoiling after they had been sterilized by radiation because they weren't totally sterilized. Instead, the spoilage would lead to some macroscopic signal that there was a bacterial infection in the tin of meat. This organism so identified is called Deinococcus radiodurans, or D. radiodurans. It's very interesting because it can survive a hundred times or a thousand times more radiation than most other organisms. Even though its DNA is damaged, it can repair that DNA damage. It's a funny organism for microbiologists to think about. I was reading a paper and somebody called it Conan the bacteria because it's incredibly resilient and powerful in terms of surviving radiation. But who knew, right? Like even in an environment with a lot of radiation, you could have a life form. Also when we're thinking about biology being everywhere, we have to appreciate that it's moving oftentimes and causing movement in interesting ways. Could you imagine a plant pathogen that might help to nucleate raindrops or hailstones and move around through the water cycle? Well, wouldn't you know, there's a microbe called Pseudomonas syringae. And here is a micrograph looking at it on the surface of a leaf. You see the opening in the leaf there where materials are exchanged with the environment. This microbe can help with the formation of water droplets and frost, it's thought. And by helping to create ice crystals and other things, it can create damage in the leaf surface, maybe get in a little bit easier and create a localized infection in the leaf. If the leaf falls apart and deteriorates, then you'll get dust and the wind will pick it up and it'll be blown around and maybe go back through the clouds and rain down somewhere else and so on. So not only is life everywhere, but oftentimes the life in nature that's everywhere is moving naturally all over the place. All of this provides potential or opportunity for bioengineering. It's very, you know, it's like, imagine if the computers were just raining from the sky. What do we do with that? In biology, we see things like that. Next topic. Look at this photo of the leaves or wherever you are, like, please go look at a leaf, go look at a tree, go look at a bush. And I want you to ask the question, where are the leaves coming from? Do they come from a factory somewhere where leaves are made in large quantities and packed in cardboard boxes and shipped to where the tree is you're looking at? And then somebody staples or tapes the leaves to the twigs and branches? No, I guess not. Instead, what we see is that the leaves on the tree come from the tree. The tree grows the leaves from the energy, the photons that arrive from the sun, and the molecules, the carbon dioxide from the air, the water from the soil through the roots and other nutrients through the roots. Biology is building with the materials and energy that's where the biology is. This is very complementary, or you could say the opposite of an industrialized factory, a centralized manufacturing process followed by logistics and transportation. Stated differently, and I really want you to remember this next turn of phrase. Biology teaches us that all atoms are local. It's the ultimate distributed manufacturing platform as a complement to centralized industrialized factory-based manufacturing. Let's just contrast this. Since we're looking at leaves, let's look at something else that harnesses energy from the sun. This is a photograph in the California Central Valley of a photovoltaic farm. These are all solar panels. Some of these solar panels actually supply the electricity to the Stanford campus. Where do solar panels come from? Did they", "start_char_idx": 4085, "end_char_idx": 8299, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7719dde6-cb23-40e2-90e1-9c69e67d626f": {"__data__": {"id_": "7719dde6-cb23-40e2-90e1-9c69e67d626f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c3f860a3-59d0-46a3-a1b9-353f455d3682", "node_type": null, "metadata": {}, "hash": "a1d94164625f471e9c57b86f49f07f54b8e6f326643300cdbfe8f2f73f911873"}, "2": {"node_id": "c57c6886-ab85-441c-ba63-7643aa2485f0", "node_type": null, "metadata": {}, "hash": "b54dc6714127adaba0a2bbdc67f150ec1e6eb2781d49130f06dea857d19ef7ca"}, "3": {"node_id": "9defa700-8b12-4126-b38c-5e61ff36d53e", "node_type": null, "metadata": {}, "hash": "d2ab69cee0250db4417f7acfb1ad17fb02636c794a770010db8f136000021676"}}, "hash": "fbd6e517a8e8751f92784f609302035e63c24d81e07a58e0c8e75089463ad5f4", "text": "the electricity to the Stanford campus. Where do solar panels come from? Did they grow in the fields where they're now deployed? Uh-uh. They were made in a factory that makes lots of solar panels, and then they were shipped here and then deployed, and now we get electricity from them. How does that work? What does that involve? You can look at the elemental components of a solar panel, and there's silicon, okay, that's abundant. Let's look at the silver. The silver going into solar panels is accounting for about 10% of all the use of silver on earth today. Where do we get silver from? Did the silver come from the fields where the panels are deployed? No, silver comes from mines, most notably in Mexico and Peru. You can see here at a nation-state level, where are the countries on earth that are mining silver, and then obviously that silver would have to go to the panel factory, and then the panel would have to be made, and then it'd have to be shipped to California and installed. All of that is obviously very different from a leaf growing on a tree, where the photon comes to the tree, and the carbon dioxide comes to the tree. Look at it differently. A leaf is a self-assembling solar panel that grows itself and recycles itself, very, very different. What makes living matter unique? All atoms are local. Biology grows with the stuff that's local. Next, biology's evolved, and we're going to have to deal with that, so let's look at something that's not evolved like biology, a bicycle. Here's a diagram of a bicycle. I guess if you looked at a bicycle and you had a diagram like this, you could determine what absolutely every part in that bicycle is. You could learn about it. You could look at an owner's manual, a repair manual. Anything about that bicycle, we're going to be able to figure out what it is because heck, we made it, and you could learn how to take it apart and put it back together, and maybe you made a custom bicycle. In engineering, we're working with systems usually that we fully understand in an operational sense. We know what all the components are. We know we designed the system to be understandable and repairable, hopefully. That's what you would normally expect in engineering, but in biology and bioengineering with living matter, none of this is true. We are inheriting billions of years of evolved systems, and they work amazingly well, and we don't understand completely how they work. Here's a favorite example. On the left is a photograph of a mycoplasma, a simple bacterium that has the smallest number of parts needed for a life form on earth, about 500, 450 genes or parts, if you will. On the right is a representation of this where all the molecules are carefully represented based on what we understand about them. At first blush, you might go, yeah, this looks like the bicycle and the parts list. It's not that different in its motivation, but there's a profound difference, which is we don't know what all the parts do. The best studied versions of these microbes that have literally been completely read out and actually resynthesized, their entire genomes resynthesized, there's still about 70 or 80 of the 450 parts that are absolutely essential for life. All of these parts are essential for life, but 70 or 80 of them, nobody on earth knows what they do. There's no manual. There's no repair kit. We know a lot, but it's not like a bicycle. Because of that remaining mystery, when we try and be a bioengineer today, it's what I would call Edisonian. We haven't made the light bulb yet, and so you just got to tinker and test, tinker and test. This underlying ignorance, until we resolve it, is going to make bioengineering workflows research intensive to a large degree. That makes living matter unique. We've inherited these objects. It's almost like imagine if aliens appeared and they were millions of years more technically advanced or billions of years more technically advanced than us, and we inherited all their technology and it was like, how does this work? We're figuring it out. Well, it's not aliens. Actually, life on earth is billions of", "start_char_idx": 8292, "end_char_idx": 12414, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9defa700-8b12-4126-b38c-5e61ff36d53e": {"__data__": {"id_": "9defa700-8b12-4126-b38c-5e61ff36d53e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c3f860a3-59d0-46a3-a1b9-353f455d3682", "node_type": null, "metadata": {}, "hash": "a1d94164625f471e9c57b86f49f07f54b8e6f326643300cdbfe8f2f73f911873"}, "2": {"node_id": "7719dde6-cb23-40e2-90e1-9c69e67d626f", "node_type": null, "metadata": {}, "hash": "fbd6e517a8e8751f92784f609302035e63c24d81e07a58e0c8e75089463ad5f4"}, "3": {"node_id": "2f08617b-5325-48a7-b484-22f0c0f4cfa5", "node_type": null, "metadata": {}, "hash": "fa26bc59953b71e902f78ffba877dad44831294a7424728749126a9f1a167164"}}, "hash": "d2ab69cee0250db4417f7acfb1ad17fb02636c794a770010db8f136000021676", "text": "it out. Well, it's not aliens. Actually, life on earth is billions of years more advanced than our understanding of it as bioengineers today, and we're quickly filling in that understanding, but we have a lot still to catch up and we haven't gotten the basics fully worked out yet. Let's go into the fourth category, physics of living matter, and although I'm showing this macroscopic image, I want to focus our attention on the microscopic, from the atoms to the molecules to the cells, and I'm mostly wanting to contrast this, again, to other types of material like dope silicon semiconductors or rocks or steel high beams and so on. In all those other systems, the matter mostly stays put. The transistors on a computer chip aren't running around the computer chip. We'll quickly see that biology is very different from that. We can be very technical. First we can say that because living systems are comprised of atoms making molecules making cells, there's going to be what we refer to as thermal noise or random motion of molecules at the lowest scale, and that's going to cause the systems to mix themselves. Instead of transistors fixed on a computer chip and not moving around in relation to each other, the molecules comprising a cell are literally going to be spontaneously moving relative to each other and mixing themselves up all the time for free, so to speak, whether we like it or not. That's a totally different substrate to be an engineer within. The next aspect I want to focus attention on, again, just introducing, we'll have a lot more to say about it, but just introducing it to you, is obviously living, I'll say it obviously, but again, we're going to slow it down. Living systems can reproduce. They're reproducing machines. We know this when we see, you know, parent to child of any type of creature, but I don't know of another engineering domain where things routinely directly make copies, like your car is not going to make a baby car, right? The computer is not making a baby computer, right? But a yeast cell is going to make, a mother yeast cell make a daughter yeast cell routinely, right? So somehow the molecules comprising life are capable of not only carrying out their functions in the moment, but they're actually capable of making an entire copy of themselves. And because of that, we'll see a tremendous diversity of molecular functions, what I call high molecular heterogeneity. Instead of having a billion transistors that are functionally all the same, a cell might have a billion molecules, but each molecule might be doing something slightly different. And so that means the complexity of function that gets integrated into the biosystems is very intriguing, very intimidating. And it's derived, I think, from this requirement of living systems needing to be able to reproduce. Let's take a look at this with a more accessible example, not just words, let me show you an example of the first two things and a little bit of the fourth. This is a computer simulation of cytoplasm. Cytoplasm is the inside of a cell where molecules are moving about spontaneously and they interact with each other and sometimes cause or undergo chemical reactions. And those become the living processes that make a life form. And what's shown on this movie, which is about 13, 14 years old, is just a section of cytoplasm and the different colored objects are biomolecules, mostly proteins, a little bit of RNA in here. And this movement that you're looking at is slowed down relative to what's actually happening in a real live living system. How slowed down is it? Well, in a real live living system, the average time, like a bacterium, the average time between when two molecules collide with each other, let's just ballpark it and say it's a nanosecond or a billionth of a second. And so just take a look at this movie and see how long it takes for that yellow molecule over there, that green molecule over there to hit a different molecule. And once you get a sense of that timescale, think of that as a nanosecond or a billionth of a second. Right. So this movie is probably slowed down at least a trillion fold, probably actually a little bit", "start_char_idx": 12426, "end_char_idx": 16604, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2f08617b-5325-48a7-b484-22f0c0f4cfa5": {"__data__": {"id_": "2f08617b-5325-48a7-b484-22f0c0f4cfa5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c3f860a3-59d0-46a3-a1b9-353f455d3682", "node_type": null, "metadata": {}, "hash": "a1d94164625f471e9c57b86f49f07f54b8e6f326643300cdbfe8f2f73f911873"}, "2": {"node_id": "9defa700-8b12-4126-b38c-5e61ff36d53e", "node_type": null, "metadata": {}, "hash": "d2ab69cee0250db4417f7acfb1ad17fb02636c794a770010db8f136000021676"}}, "hash": "fa26bc59953b71e902f78ffba877dad44831294a7424728749126a9f1a167164", "text": "this movie is probably slowed down at least a trillion fold, probably actually a little bit more than that. So a real living system, the molecules are moving at least a trillion times faster than what's shown on this movie. Why are they moving? There's things that are not shown in this simulation, which are the water molecules that are moving and vibrating and bumping into these bigger molecules, the biomolecules and causing them to move, so-called Brownian motion. Whoa, this is again, I don't know how many times they need to say it. This is not what the computer chip looks like inside your computer, right? Like those things in the chip aren't moving around like this. And if you give this enough time, although it looks like the molecules are mostly staying in one spot locally, they can actually move all the way around. You know, it might take an average size molecule in a bacterium about a second to go from one end of the bacterium to the other, just because of this random thermal motion.", "start_char_idx": 16570, "end_char_idx": 17573, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "744bd50a-37da-4afb-a05a-44d998562bfc": {"__data__": {"id_": "744bd50a-37da-4afb-a05a-44d998562bfc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bcd7dbe4-c15c-4d37-87fd-b310d010f3fa", "node_type": null, "metadata": {}, "hash": "35a403be4bdb438e331439544406da5283522d073c4ef7ed41682a13f1a204e7"}, "3": {"node_id": "e426ca88-1144-43cc-a553-fe7fde22a7e6", "node_type": null, "metadata": {}, "hash": "7fdb4b5ce4de08462911b241f8e46d71bfe0549947102ea45e2dae7fc03e1328"}}, "hash": "f01cfe42e5ded0536727b2c0793ee344649bc59661f66f475f9e0399440b93d4", "text": "Another thing you might think about here is how full this space is. You can't even see through it. You can't see to the other side of the cell. It's chock full of molecules. Maybe it's about 20% or 30% full. What I mean by that is the volume within the cell is occupied, a significant fraction of it's occupied by molecules, 20% full or 30% full. Now you might be saying, wait a minute, wait, it's only 20% full or 30% full? That doesn't sound very full, but let's do a quick estimate. The room I'm in right here, there's the door, there's the window, there's the ceiling. What fraction of this room I'm in right now is occupied by humans, by me? We could do a quick Fermi estimate. We could say I've got a room, what is it, three meters by four meters and six meters tall, so that's 72 meters cubed. What about me? I'm two meters tall and maybe 20 centimeters by 20 centimeters, so I am 0.08 meters cubed. Let's make it 0.1 meters cubed. If the room is 72 meters, let's just make it 100 meters cubed. If I'm 0.1 meters cubed and the room is 100 meters, I'm occupying 0.1% of the room. The room's practically empty. That seems like maybe I got that wrong. Let's try a different way. Let me just stand. How many of me can I go side by side? I think it's maybe 15 in this direction, and if I go the other direction, it's eight, and then probably stack two of me in this room. You could get 240 of me in this room, and there's just one of me, so yeah, actually, the initial estimate of 0.1% seems pretty good. The other approach gives me 0.25%. Think of the room you're in right now. What fraction of the space in the room is occupied with people? My guess is it's less than a percent or two, whereas the molecules inside the cell are 10 times more densely packed. How they relate to each other, how they interact, how they get around is going to be just viscerally very different. I'm belaboring this because I'm hoping that you imagine yourself transported in this molecular milieu and begin to have empathy for what these molecules must experience. To the extent you can gain that feeling, you're going to have a better foundation for becoming a bionaut, for being a bioengineer. Last part for today, 21st century tools. This is an amazing microscopy movie from Caltech, Grant Jensen's lab. They take a bacterium, they put it in a microscope, an electron microscope, and they make slices and slices and slices of it to see where all the molecules are. Then they take all that data and they put it into a fancy computer simulation program and they make a cartoon representation of this bacterial cell. Now we get to fly inside it and look at where some of the molecules are. This is one of my favorite bacterium because what's focused on here in this section of the visualization of the microscopy data is what is called a magnetotactic array of particles. If we take just a snapshot of what this microscope can generate, what we're looking at here is a slice of a bacteria, it's about one, one and a half microns long. You can see the outer membrane, which is the outside boundary, that's abbreviated OM. The inner membrane, IM, and then you see those dark black specks towards the middle running left to right. Those are actually magnetic granules or complexes of iron that the bacteria has grown and organized into a linear array such that it has some ability to interact with magnetic fields. Did you know that there are microbes that can build magnetic arrays and interact with the Earth's magnetic field? Meanwhile, we can see all the other things inside this cell to a degree. The arrow with the letter R pointing at a little dark speck, that's a ribosome where proteins are made. The thing in the middle that looks like this medium dark bleb, PHB, I believe that to be polyhydroxybutyrate. I think of it as a strategic oil reserve or an energy reserve for this cell and so on.", "start_char_idx": 0, "end_char_idx": 3883, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e426ca88-1144-43cc-a553-fe7fde22a7e6": {"__data__": {"id_": "e426ca88-1144-43cc-a553-fe7fde22a7e6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bcd7dbe4-c15c-4d37-87fd-b310d010f3fa", "node_type": null, "metadata": {}, "hash": "35a403be4bdb438e331439544406da5283522d073c4ef7ed41682a13f1a204e7"}, "2": {"node_id": "744bd50a-37da-4afb-a05a-44d998562bfc", "node_type": null, "metadata": {}, "hash": "f01cfe42e5ded0536727b2c0793ee344649bc59661f66f475f9e0399440b93d4"}, "3": {"node_id": "40a5cd8c-c47e-4f64-b49d-e43d2e3d9620", "node_type": null, "metadata": {}, "hash": "0d6bcc8cc216a0dd0c642be477be02721d56e79c64208af3d3348c55175e2891"}}, "hash": "7fdb4b5ce4de08462911b241f8e46d71bfe0549947102ea45e2dae7fc03e1328", "text": "it as a strategic oil reserve or an energy reserve for this cell and so on. This type of microscopy only really became possible in this century and is becoming practical now. It's called cryo-electron microscopy or tomographic cryo-electron microscopy, where you use an electron microscope to take a series of images and tilt the sample such that you can make a three-dimensional reconstruction of what the cell looks like and see where the molecules are. You can learn more about it via the links and so on. I just want to give you a taste of what an incredible time to become a bioengineer where suddenly we can see where all the molecules are as they build cells. The next type of tool is computing. Now we've already looked at a type of simulation of cytoplasm, but what about the molecules? Here's a news story from July of 2022. Scientists use artificial intelligence or machine learning to make predictions for the shapes of almost every protein they could get sequences for, 200 million proteins, 200 million proteins. So I remember when this came out, we were teaching the class. Before the class started, we didn't have predictions that we could easily access for all the proteins making up biology. At the end of the class, we did because this modeling tool suddenly appeared. Let me give you one more example of a 21st century tool. And we'll use the pandemic, the SARS-CoV-2 pandemic to illustrate these tools. When the pandemic started in late 2019 and early 2020, infected people through travel started moving the pandemic all across the world. If we use Switzerland as an example, we can look at the public health records and see that the first case in Switzerland was reported on the 25th of February of 2020 and is thought to have come in over the Italian border, which is what this little photograph is showing, the border up in the top of the mountains between Italy and Switzerland. So the 25th of February, that's when the first case arrives in Switzerland. But it turns out that's not when the virus first got to Switzerland. Then what happened is the virus is first discovered in China. We can use the tool of DNA sequencing or reading out the DNA of a life form to take the genome that's a physical object and turn it into a digital representation of A's, T's, C's, and G's, the sequence of the DNA. So by using the tool of DNA sequencing, around the 10th of January of 2020, researchers in China had read out the genome of SARS-CoV-2, and then they put that information on the Internet. And once it's on the Internet, you can move it around the world at the speed of light. Almost immediately, researchers in the Swiss capital downloaded the information and then used another 21st century bioengineering tool that we'll talk a lot more about, DNA synthesis or DNA printing, to take the sequence that is specified to encode the virus and organize chemicals in the right order to remake that sequence from scratch. So in China, you go from atoms, the genome, to bits, the sequence. The sequence moves around the Internet. In Switzerland, you go from the bits and re-synthesize the genome from scratch using a DNA printer. And that DNA, once you make it, is just a template, so then you have to read it off and make RNA and then get that RNA into cells to infect the cells. And they did all that, all those things, in a laboratory, and infected cells in a laboratory and got live SARS-CoV-2 infections by or before the 13th of February of 2020. Now just compare these two dates. The pandemic arrived on the 25th of February, but bioengineering tools of reading DNA, plus the Internet, plus the bioengineering tool of writing DNA, got the virus to the Swiss capital almost two weeks before. We can transmit DNA programs by the Internet. Lots more to say about that. All right, so it's a very interesting time to be interacting with living matter because it's all over the place, because it's local, because it's evolved, because it's got incredible physics, and because we've got amazing tools emerging for measuring biology, modeling biology, and making biology. So let's end with a few questions for practice, just to help you", "start_char_idx": 3824, "end_char_idx": 7974, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "40a5cd8c-c47e-4f64-b49d-e43d2e3d9620": {"__data__": {"id_": "40a5cd8c-c47e-4f64-b49d-e43d2e3d9620", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bcd7dbe4-c15c-4d37-87fd-b310d010f3fa", "node_type": null, "metadata": {}, "hash": "35a403be4bdb438e331439544406da5283522d073c4ef7ed41682a13f1a204e7"}, "2": {"node_id": "e426ca88-1144-43cc-a553-fe7fde22a7e6", "node_type": null, "metadata": {}, "hash": "7fdb4b5ce4de08462911b241f8e46d71bfe0549947102ea45e2dae7fc03e1328"}}, "hash": "0d6bcc8cc216a0dd0c642be477be02721d56e79c64208af3d3348c55175e2891", "text": "and making biology. So let's end with a few questions for practice, just to help you reflect. What's the strangest life form you know about? Or what's the most surprising place you can find that life exists on Earth? Feel free to search online. Why do we depend on so many factories? If you go back a couple hundred years, they're not huge numbers of factories. Factories are a relatively recent thing, so why do we depend on them? Factories for making solar panels, for example. And if biology teaches us that all atoms are local and promises at least a complementary approach to making, what must be true for distributed biobased making to compete in the future with centralized, industrialized manufacturing? It's not that complicated, but it's important to think through, like, well, you know, if we really wanted to unlock this superpower biology, what would have to make that practical? From a system design and human understanding perspective, what's the difference between a bicycle and a bacteria? And again, from a system design perspective, from a human understanding perspective, can you list all the ways that a bicycle and a bacteria are different? What causes molecules inside cells to move randomly? Something to do with the water? Why is the water moving? I dare you to think about this question as deeply as you can. What tools for measuring, modeling, or making with biology can you imagine already exist? If you just said, you know, I bet bioengineers can measure this or model that, like an electrical engineer could use the ohm to describe resistivity of current flowing in a wire. We have units for measuring resistance. Could you imagine? Do we have units for measuring gene expression or, well, anyway, if you just stop and think about bioengineering, what tools would you imagine exist and write them down? And then if you could wish for some tools, you might as well write those down too. That'll be useful. I don't know if you got it, but go back a couple of slides. The internet plus bioengineering got a human pathogen to another country faster than the pandemic. Does that surprise you? Is that exciting that you can move biocode around? Is there a bionet in our future? Is it nerve wracking? Is it scary? How do you think about that? Thank you.", "start_char_idx": 7950, "end_char_idx": 10226, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c05a0bc9-aa7d-45ca-a3be-cfa10cd0806d": {"__data__": {"id_": "c05a0bc9-aa7d-45ca-a3be-cfa10cd0806d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c42ee03b-6667-4501-9a88-4af636d9cc2b", "node_type": null, "metadata": {}, "hash": "48c1b326c8c4ad4e465977cb0700d32297e6ac70b8c6591401ddb000ebd42e81"}, "3": {"node_id": "48caa830-bf9e-4aca-a414-10fa5328b91f", "node_type": null, "metadata": {}, "hash": "ac756ac95cd59f72e84949afb3a34e3d8ccdb6e81637f608a42f9107c6ace962"}}, "hash": "3026206a893850f016e747d58591eedeba0267ca097d4855c22702cdb7fab7ad", "text": "Welcome to the second week of Introduction to Bioengineering. This week we're going to talk about innovations in medicine. We're going to talk about how bioengineers can help develop new medicines and can scale the production of medicines in order to ensure that there's enough for everyone. There are four learning objectives for this week. The first is just to understand the process by which new medicines are developed. We want you to think like a bioengineer and to see if you can think of ways of developing new medicines by telling you about the process. Then we want you to describe the difference between categories of medicines. This week we're going to talk about small molecule-based medicines, protein-based medicines, and whole cell medicines. We want you to understand the difference between these medicines and the ways that bioengineers can help create new medicines of all three types. We also want you to understand the importance of protein structure in how well a protein-based medicine functions, and then to understand the tools available for measuring and predicting protein structure. Before we get into this week, I want to pose a simple question. What is a medicine? Maybe when I ask this question, you think of things like this. These are examples of drugs that you can get at the pharmacy or via prescription from your doctor. The Food and Drug Administration has a specific definition of a drug, which I'd like to go over so that we can all be on the same page as we enter this week. The Food and Drug Administration defines a medicine as a substance that's intended to be used for the diagnosis, cure, mitigation, treatment, or prevention of disease. It's something that you need to take in order to feel better or diagnose a disease. It's not a food and it's not a device. All other things can fall into the category of a medicine. Not a food, not a device. We're going to discuss three categories of medicine this week. Like I said, those are small molecule drugs. These are molecules that can enter cells very easily because they're very small or they have a low molecular weight. These molecules typically affect the function of proteins within a cell, and that is how they cause changes that treat disease. There are also protein-based medicines. These protein-based drugs are either of naturally occurring proteins or ones that have been modified. The proteins are administered to people in order to help treat disease. Lastly, the whole cell medicines are living cells that are administered to people to treat disease. Sometimes these cells are engineered in order to perform a specific function within the body, and sometimes they're just naturally occurring organisms that we don't have enough of within us at any given time. Think like probiotics, but to treat disease. Okay, so the three steps to developing new medicines that I want us to focus on are identifying potential medicines, so that's the first step in the development of something new, testing to see whether or not these medicines work, and then scaling up production. Our goal for the week is to think about how you might improve or accelerate each step, so I want you to be thinking where throughout the week I want you to be thinking like where can I look for new medicines? How do I know if this new thing that I've identified is working? Is it actually helping to cure someone's disease? How can I make enough of a medicine once I know it works? To sort of frame this discussion, we're going to have three different case studies. We're going to talk about syphilis, malaria, and diabetes and the drugs that are available to treat each of these diseases. We're going to go back in history and see when the first treatments for these diseases were developed, and as we go through this, I want you to pay attention to what observations people made in order to come up with a new treatment idea, so somebody had maybe a friend who had syphilis and they're like, what do I do to treat this person? Well, they observed something around them that led to a hypothesis about what they could use to treat their friend, and so I want you to keep track of what the observations are that led to new treatments. I also want you to pay attention", "start_char_idx": 0, "end_char_idx": 4240, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "48caa830-bf9e-4aca-a414-10fa5328b91f": {"__data__": {"id_": "48caa830-bf9e-4aca-a414-10fa5328b91f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c42ee03b-6667-4501-9a88-4af636d9cc2b", "node_type": null, "metadata": {}, "hash": "48c1b326c8c4ad4e465977cb0700d32297e6ac70b8c6591401ddb000ebd42e81"}, "2": {"node_id": "c05a0bc9-aa7d-45ca-a3be-cfa10cd0806d", "node_type": null, "metadata": {}, "hash": "3026206a893850f016e747d58591eedeba0267ca097d4855c22702cdb7fab7ad"}}, "hash": "ac756ac95cd59f72e84949afb3a34e3d8ccdb6e81637f608a42f9107c6ace962", "text": "observations are that led to new treatments. I also want you to pay attention to the methods that were used to figure out if the new medicine worked, right? It's one thing to have an idea for how to treat a disease and another for it to actually be functional, so how do we know if the medicines work and then how is production of the medicine scaled up to treat everyone in need? Those are the three steps in developing medicines explained slightly differently, and so I want you to pay attention to all three of these things as we go through the week. I'm excited to talk to you about syphilis, malaria, diabetes, and protein-based drugs, so hopefully this week is an exciting module for both you and me. All right, bye.", "start_char_idx": 4163, "end_char_idx": 4885, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "269984ef-07b1-4ab0-99c1-27ee937095f3": {"__data__": {"id_": "269984ef-07b1-4ab0-99c1-27ee937095f3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "70b83907-0f17-408f-9aa3-a41491f453a5", "node_type": null, "metadata": {}, "hash": "bd4ddcdce6351da79fee8eeff33787fe4b915ed4d2eeb1f2e338c293e4d92daf"}, "3": {"node_id": "6cbbfdb9-ebf3-4d72-bf3e-a4e48a04a431", "node_type": null, "metadata": {}, "hash": "6b2fdd8e34f1deadbda7bc98b8f6f292f57f6ef86928ce147a1e58aeabb8ab29"}}, "hash": "77cfe58203e16169adf638c289184d0ffa36a5630d23f21e7f575cf8121841e7", "text": "Today, we're gonna talk about the discovery of drugs to treat syphilis and malaria. And as we go through this lecture, what I want you to do is practice thinking like a bioengineer that's trying to develop a new medicine. I want you to observe how other people have done it in the past. As we go through these stories, think about how people identify new potential medicines, how they test to see if those medicines work, and then how they scale up production. Because these are each of the areas where bioengineering is really having an impact on new medicine development. So after we talk about how it's been done in the past, we'll talk about all of the new things that bioengineers are doing to accelerate each of these steps in medicine development. Before we get to the medicines, we're going to talk about the diseases. I wanna introduce you to malaria and syphilis. Hopefully, they're not super familiar to you yet, but malaria is a very common disease, actually, so maybe it is. Malaria is transmitted from person to person by mosquitoes, and when it is infecting you, it causes fever and chills, abdominal pain, chest pain, headache, nausea, and vomiting. And it's still really prevalent. So this is just a map of malaria infections globally in 2019. And you can see that there are areas where there's more than 400, almost half of the people have been infected with malaria. And that's just in one year. Now, in 2020, globally, that looked like 240 million cases of malaria and 627,000 deaths. So this is a very serious disease. And it's caused by a parasite. So malaria is caused by a parasite called Plasmodium falciparum, and that parasite lives for part of its life inside human red blood cells. So here we're seeing red blood cells. Those are these kind of big, light purple balls. And inside of them, or at least some of them, are malaria parasites, these darker purple stains. Now, living inside of a red blood cell is just one stage of the malaria life cycle, but it is the stage that causes symptoms. So here's the full life cycle. Like I mentioned before, malaria is transmitted from person to person by mosquitoes. So when a mosquito bites you, it pushes the person's parasite into the person's bloodstream, not on purpose, but just because the process of biting pushes some material from the mosquito into the person before they start sucking up blood. Okay, so once those parasites are in your bloodstream, they'll find their way to your liver, and there they'll get into liver cells and make copies of themselves. And then they'll butt off into vesicles and those vesicles will enable the infection of red blood cells. And like I said before, it's at this point when the malaria parasite is infecting your red blood cells that you start to have symptoms. And then eventually the red blood cells will burst and you'll get parasite in your blood that can be sucked up by a new mosquito and delivered to another person. There's an important aspect of malaria or Plasmodium falciparum's life cycle that occurs inside of the mosquito. I'm not gonna talk about it today, but I encourage you to look it up. It's really fascinating. Okay, so this is malaria. It's caused by that parasite Plasmodium falciparum. Syphilis is a sexually transmitted disease. It's caused by a bacteria and its symptoms occur in three stages. In the first stage, which occurs three to 90 days after exposure, you get a sore. That sore appears either in your mouth or on your genitals, but it's not painful. Eventually the sore heals and about four to 10 weeks later, you get a rash. And that's a full body rash. And for some people, the syphilis infection stops there. They never have another symptom and they live the rest of their life normally. But for other people, about three to 15 years after the initial infection, their syphilis disease reappears. And this time it's much more severe. Stage three syphilis affects your internal organs. It's actually", "start_char_idx": 0, "end_char_idx": 3953, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6cbbfdb9-ebf3-4d72-bf3e-a4e48a04a431": {"__data__": {"id_": "6cbbfdb9-ebf3-4d72-bf3e-a4e48a04a431", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "70b83907-0f17-408f-9aa3-a41491f453a5", "node_type": null, "metadata": {}, "hash": "bd4ddcdce6351da79fee8eeff33787fe4b915ed4d2eeb1f2e338c293e4d92daf"}, "2": {"node_id": "269984ef-07b1-4ab0-99c1-27ee937095f3", "node_type": null, "metadata": {}, "hash": "77cfe58203e16169adf638c289184d0ffa36a5630d23f21e7f575cf8121841e7"}, "3": {"node_id": "d36c1149-f10f-4955-b8f0-2b4bd3971aaf", "node_type": null, "metadata": {}, "hash": "847e7af936b5ba8cad5d045e2827c940af3809e4f0ad297f5d316facabf1b9f5"}}, "hash": "6b2fdd8e34f1deadbda7bc98b8f6f292f57f6ef86928ce147a1e58aeabb8ab29", "text": "much more severe. Stage three syphilis affects your internal organs. It's actually lethal. It causes dementia and other psychotic disorders. It will cause internal bleeding, like I said, damage to your internal organs and respiratory failure. Here's actually a photo of a skull from somebody who had syphilis. And you can see the degeneration, the holes within it that are caused by the disease. Now syphilis is caused by a bacteria called trepanoma. It's not infecting red blood cells. It actually doesn't live inside of your cells at all, but it is what causes syphilis. So I wanna ask you, after hearing about these two diseases, how would you cure them? What would you do to treat somebody who has malaria and syphilis? What would you do if it were the 1800s? Imagine there are no antibiotics. We don't know about bacteria. We don't know about plasmodium. We really don't know what's causing these diseases, but we know that people are getting sick. We know that they're dying. What would you do to try to cure these diseases? Take a minute to brainstorm. Maybe you're lost. Maybe you have an idea. Either of those are okay, but check in. See how you're thinking about this problem. All right, now what actually happened? Well, a cure for syphilis started with an observation. We're gonna talk about the cure for syphilis first, and then we'll get to cure for malaria. This observation was made at a mental hospital. He said syphilis can cause neurodegeneration, and so a lot of patients with stage three syphilis would end up in mental hospitals. And a doctor at the mental hospital noticed that syphilitic patients occasionally were cured by what he called febrile episodes. These are fevers. And so he thought to himself, maybe a fever can cure syphilis. Didn't know why that would work, but he thought it was an idea worth testing. The challenge became, if a fever can cure syphilis, how can you induce a fever? This question of how could you induce a fever is not an easy one to answer. People tried wrapping people up in blankets. They tried doing all sorts of physical things to raise their temperature. What worked really well was actually infecting patients with malaria. So you'll remember malaria induces a high fever. It's one of the symptoms of having plasmodium falciparum in your blood. And so this doctor, Dr. Wagner-Jorig, the one who made that observation in the psychiatric hospital, tested plasmodium falciparum as a treatment for syphilis. He extracted malaria parasites from a patient who currently had malaria and then infected a stage three syphilitic patient with that malaria parasite, with plasmodium falciparum. And this is risky, right? Like, what if you're wrong? What if the fever isn't strong enough to kill syphilis? What if it wasn't actually the fever at all that was causing patients in the mental hospital to recover from syphilis on occasion? But Dr. Wagner-Jorig got lucky, or rather he knew what he was doing and it worked. He won a Nobel Prize for this work, actually, for discovering the therapeutic value of malaria in the treatment of what, in this case, they're calling dementia paralytica, but is actually syphilis. So just to be really explicit about it, the treatment that Dr. Wagner-Jorig prescribed or started using to treat syphilitic patients looked like this. So if you had stage three syphilis, it's important to note here that he was only treating stage three syphilitic patients. Right, at stage two, you just have a body rash, the disease is not that lethal, and it's possible that you'll never develop stage three. But once you start showing stage three symptoms, it's pretty bad. So he would infect the stage three syphilitic patients with malaria in order to try to cure them and wait for the malaria parasite to induce a fever in person. After the fever, hopefully their syphilis, the bacteria that causes that was dead, but the malaria parasite would still", "start_char_idx": 3883, "end_char_idx": 7805, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d36c1149-f10f-4955-b8f0-2b4bd3971aaf": {"__data__": {"id_": "d36c1149-f10f-4955-b8f0-2b4bd3971aaf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "70b83907-0f17-408f-9aa3-a41491f453a5", "node_type": null, "metadata": {}, "hash": "bd4ddcdce6351da79fee8eeff33787fe4b915ed4d2eeb1f2e338c293e4d92daf"}, "2": {"node_id": "6cbbfdb9-ebf3-4d72-bf3e-a4e48a04a431", "node_type": null, "metadata": {}, "hash": "6b2fdd8e34f1deadbda7bc98b8f6f292f57f6ef86928ce147a1e58aeabb8ab29"}, "3": {"node_id": "e388c546-05f5-449f-b03c-92a154aa13e2", "node_type": null, "metadata": {}, "hash": "1e1fff46deeaf0674944c1beb310f73667ba707d476ba5df42467be6d02cbd2f"}}, "hash": "847e7af936b5ba8cad5d045e2827c940af3809e4f0ad297f5d316facabf1b9f5", "text": "the bacteria that causes that was dead, but the malaria parasite would still be very much alive within the person. And so the only reason why this was a viable treatment approach was because a cure for malaria already existed. There was something called quinine that was being used in order to treat malaria. And so once the patients spiked a fever that cured them of syphilis, he would administer quinine and cure the patient's malaria too. Okay, so here's just a slide saying that explicitly, this P. falciparum, plasmodium falciparum treatment only works if you can cure the malaria that it causes. Otherwise, you're just swapping one disease for another. You're trading syphilis for malaria, which isn't really better. Okay, so that begs the question, how did a cure for malaria get found? Malaria had been around for quite a long time and like the cure for syphilis, a cure for malaria started with an observation. The Kachua people who were living in what is presently Peru were using bark from a cinchona tree, a certain type of tree in order to treat fevers. And this was noticed by a Jesuit colonist who had come over from Italy or Spain and realized that there were, or come over from Spain where there was a lot of malaria and thought, hey, if this cinchona tree bark can be used to treat fevers, maybe it can be used to treat that fever that's going around in Spain. And so he sent a sample of the cinchona tree bark back to Spain. And then for 300 years, cinchona bark is shipped from Peru to Europe to treat malaria. It worked, I should say. And no one really knew why it was that this bark was able to cure people with malaria. They just knew that it worked. And so they have the Kachua people to thank for the cure to malaria. Okay, so notice that it's 1630 when this Jesuit apothecary first sends cinchona tree bark to Europe and that it took until 1820 to isolate quinine as the active component of bark. People didn't know for a really long time what it was about the bark that was making it a useful malaria treatment, but eventually they figured out that it contained a lot of this molecule called quinine. Once the population in Europe grew and there was more demand for quinine, more cinchona plantations were planted. And this time they were planted not in Peru, but in Indonesia, which also had a hospitable climate for this tree. So, you know, for 300 years, Peru is the source of all of this bark. And then from 1910 to around 1944, this bark is being supplied from a plantation in Indonesia. Okay, in 1944, World War, or sorry, in 1939, excuse me, World War II breaks out and the allied nations are cut off from their supply of cinchona bark. And this is a problem because of a lot of fighting and a lot of fighting in World War II was happening in malaria heavy regions and regions where there was a lot of parasite and a lot of potential for soldiers to contract malaria. But when they're cut off from this, the plantations when they're cut off from the source of this bark, they have no treatment options for malaria. So this war sparks a massive hunt for cinchona bark alternatives. People are trying really hard to synthesize quinine in the lab so that they don't need to get it from the bark of this tree, but they have no idea how to put this molecule together. And so they start doing a lot of synthetic chemistry to figure out if they can get this molecule made in the lab. But they also start screening other alternatives. So they have libraries of chemicals that serve as dyes for like the clothing industry and other textiles. And they think, okay, well, we have all of these compounds. We have all of these molecules. Maybe one of them is also effective against malaria. So scientists start digging out every chemical they can think of. They go through these large libraries to see, do we have something on hand that can treat malaria? And what they find, oh, sorry, when they're doing this screening, they're actually testing for efficacy", "start_char_idx": 7813, "end_char_idx": 11793, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e388c546-05f5-449f-b03c-92a154aa13e2": {"__data__": {"id_": "e388c546-05f5-449f-b03c-92a154aa13e2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "70b83907-0f17-408f-9aa3-a41491f453a5", "node_type": null, "metadata": {}, "hash": "bd4ddcdce6351da79fee8eeff33787fe4b915ed4d2eeb1f2e338c293e4d92daf"}, "2": {"node_id": "d36c1149-f10f-4955-b8f0-2b4bd3971aaf", "node_type": null, "metadata": {}, "hash": "847e7af936b5ba8cad5d045e2827c940af3809e4f0ad297f5d316facabf1b9f5"}, "3": {"node_id": "0c94b2cf-6ba2-4621-96bc-a0c797db27d5", "node_type": null, "metadata": {}, "hash": "5d7250e13dbc06d7d69a2358b4c84d26c477bea2d6897698e29cc882eeac004f"}}, "hash": "1e1fff46deeaf0674944c1beb310f73667ba707d476ba5df42467be6d02cbd2f", "text": "oh, sorry, when they're doing this screening, they're actually testing for efficacy against malaria in birds. Turns out birds can get a form of malaria that's very similar to the form that affects humans. And so you can see whether a potential treatment for humans might work by giving malaria-infected birds whatever compound you think might function well as a medicine. Okay, so they're testing all these different dye compounds. They're trying to modify the compounds that they have in order to make new potential medicines. And what they end up with is something called chloroquine. Chloroquine is a synthetic alternative to quinine and it becomes the dominant anti-malaria medicine, not just during the war, but actually for quite a while after. And that's in part because of resistance to quinine and in part because of the ease of synthesizing chloroquine relative to the extraction of quinine from cinchona tree bark. Okay, but eventually the malaria parasites, Plasmodium falciparum, start becoming resistant to quinine. And this is sort of similar to what's happening now with antibiotics. We see that there are bacteria that are resistant to our first line antibiotics, like penicillin, things that we would usually administer at the first sign of infection don't work on bacteria. They're starting to evolve. And so the malaria parasites at this time, starting around the 1950s, but really accelerating through the later half of the 1900s, we start to see a rise in chloroquine resistant malaria. And so this is a problem. If chloroquine is your method of choice for curing malaria and chloroquine doesn't work on an increasingly large fraction of the parasites that cause malaria, then you need to find a new treatment. And one of the places where this was very important was in China, where there was a large population of chloroquine resistant Plasmodium falciparum, where there was a lot of malaria that could not be killed with chloroquine. And so the Chinese government instructs scientists to start to hunt for an alternative to malaria. And by 1969, there are more than 240,000 compounds that have been screened for anti-malarial activity worldwide. And they haven't found stuff that's better than chloroquine and quinine. But this Chinese scientist, Tu Youyou, began screening Chinese herbs, remedies that have been used for a long time in China to treat different ailments, but have not been tested by Western scientists against malaria as a potential treatment. And so she starts screening all of these different herbs. And at this point, we can actually screen for in red blood cells in a dish. So we don't have to, she's not doing experiments with malaria infected birds. Instead, she has samples of red blood cells that are infected with malaria, which she can then treat with these different herbs by kind of grinding them up and adding them to the cells and seeing whether or not this kind of treatment cures the, or kills the parasite, but leaves the red blood cell relatively intact. So through these types of screening, she identifies artemisinin. It's a compound from a shrub called Artemisia annua that kills the malaria parasite faster and in all life cycle stages. So that's really exciting. So once she discovers this through her cell-based screens, they start clinical trials in people and discover that not only does it work well at curing malaria, it has fewer side effects than chloroquine or quinine. And so Tu Youyou gets the Nobel Prize for Medicine in 2015 for this discovery. And that's a very exciting time because we have now a new and even more effective treatment for malaria, which is still a problematic disease worldwide, but it's actually difficult to source large quantities of artemisinin. In this big shrubby plant, artemisinin content is only 0.1 to 1%. So you have to grind up a lot of the plant in order to get enough artemisinin to treat people. And it's not just that, artemisinin crops are exposed to the weather and if there's a bad crop year, then you can have less medicine and it can change the prices of this anti-malarial drug in a way that pushes it out of reach for people who might really need it.", "start_char_idx": 11786, "end_char_idx": 15954, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0c94b2cf-6ba2-4621-96bc-a0c797db27d5": {"__data__": {"id_": "0c94b2cf-6ba2-4621-96bc-a0c797db27d5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "70b83907-0f17-408f-9aa3-a41491f453a5", "node_type": null, "metadata": {}, "hash": "bd4ddcdce6351da79fee8eeff33787fe4b915ed4d2eeb1f2e338c293e4d92daf"}, "2": {"node_id": "e388c546-05f5-449f-b03c-92a154aa13e2", "node_type": null, "metadata": {}, "hash": "1e1fff46deeaf0674944c1beb310f73667ba707d476ba5df42467be6d02cbd2f"}}, "hash": "5d7250e13dbc06d7d69a2358b4c84d26c477bea2d6897698e29cc882eeac004f", "text": "drug in a way that pushes it out of reach for people who might really need it. So this is an area where bioengineers step in. They see an opportunity to produce this compound, artemisinin.", "start_char_idx": 15948, "end_char_idx": 16136, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "adc45dde-0169-4ab4-a329-d415575ad099": {"__data__": {"id_": "adc45dde-0169-4ab4-a329-d415575ad099", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c914b42c-19f9-448b-b2db-fd29d8a8c233", "node_type": null, "metadata": {}, "hash": "32e4fb2247cb198577c73ac9d6d0b0b2efc8d99eff2ea284a107fddf99ad59c4"}, "3": {"node_id": "4c3eebfe-08b0-4bd7-94f8-e745f336092e", "node_type": null, "metadata": {}, "hash": "23dc29ba282487ca9008ee206cba030f1935b762b96bab2647284d694609e005"}}, "hash": "02a90d77e6b45ad23f09fffb3ccb799937a7c953f06849a451626ea9e5f97b04", "text": "in a different way. They think, why don't we try engineering yeast to produce this compound instead? Then we can move from the field where conditions are variable to fermenters where we control everything. Okay, now how do you do that? How do you engineer a bacteria to produce this medicinal compound that's usually found in a shrub? Well, you need some background information. You have to know how the plant cells, the cells of that Artemisia annua shrub produce artemisinin. And fortunately, there had been a lot of work on plant genetics to figure out exactly which genes encoded in Artemisia annua's genome lead to the production of artemisinin. So this is just showing you all of the compounds that are intermediates as you move from acetyl-CoA, which is a part of central metabolism, all the way to artemisinin. And in bold uppercase letters are the genes encoding enzymes that are responsible for making artemisinin from acetyl-CoA. And what you'll notice on this slide is that there are a lot of steps to go from acetyl-CoA to artemisinin. And there are a lot of genes that do those chemical reactions. And so it's not going to be an easy feat to try to move all of these genes from this plant into yeast, but there's a researcher at Berkeley who really wants to try. So Professor Jay Kiesling at UC Berkeley initiates a project in his lab to express all of the enzymes necessary for artemisinin production in yeast. And he's able to achieve 25 grams per liter production of this compound in yeast just by putting these genes from the plant into yeast. And this is really exciting to people who work in bioengineering. And it's an example of new technology being used to try to change the way that medicine scale up occurs, but there's some market resistance. So there are people who are maybe not as happy with the use of genetically engineered yeast to make medicines because it's not making a whole lot at first, that titer, although pretty good, could be higher and the process of producing artemisinin in yeast could yield more artemisinin per cell. And people were excited to kind of see it there and were maybe a little disappointed at first at the yields, but also there are social factors at play here where people whose whole livelihood was to farm this shrub in order to produce artemisinin were going to potentially be put out of a job by bioengineers who had taken their whole process and moved it into a fermenter. And so there were some kinks to work out, but the kind of financial drivers, this need to produce low-cost medicines really got the Gates Foundation involved, which helped push scale up to see if we can produce 25 grams per liter of artemisinin in the lab, how much can we produce when we start moving these engineered yeast into bigger and bigger bioreactors. I am listing a bunch of news articles here, mostly because I would encourage you to read them, to see kind of how this new bioengineering invention was sort of received and how it's kind of found its way to where it is now, where artemisinin is being, sorry, yeast produced artemisinin is really being much more heavily embraced and pointed to as a great innovation in bioengineering in solving a key problem in medicine, which is scale up or contributing a solution, I should say. Okay, so those are treatments or those are the stories of the development of medicines to treat syphilis and malaria. And I just wanna put them into context for you. So remember at the beginning of this lecture, I said that I wanted you to pay attention to the steps to creating new medicines. Remember, we need to identify a potential medicine test to see if it works and then scale up production. Well, if we think of Plasmodium falciparum, the parasite that causes malaria as a new medicine, then the step, this first step, identify a potential medicine occurs when someone observes fever reducing, that a fever reduces syphilitic symptoms, right? And then that leads them to test Plasmodium falciparum as a fever inducer, right? So they", "start_char_idx": 0, "end_char_idx": 4021, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4c3eebfe-08b0-4bd7-94f8-e745f336092e": {"__data__": {"id_": "4c3eebfe-08b0-4bd7-94f8-e745f336092e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c914b42c-19f9-448b-b2db-fd29d8a8c233", "node_type": null, "metadata": {}, "hash": "32e4fb2247cb198577c73ac9d6d0b0b2efc8d99eff2ea284a107fddf99ad59c4"}, "2": {"node_id": "adc45dde-0169-4ab4-a329-d415575ad099", "node_type": null, "metadata": {}, "hash": "02a90d77e6b45ad23f09fffb3ccb799937a7c953f06849a451626ea9e5f97b04"}}, "hash": "23dc29ba282487ca9008ee206cba030f1935b762b96bab2647284d694609e005", "text": "Plasmodium falciparum as a fever inducer, right? So they think, okay, a fever could be used to treat syphilis. And I know that Plasmodium falciparum causes a pretty high fever. And so I'm going to test it as a fever inducer. The scale up in this case is sort of weird. The doctors were sourcing parasites from malaria patients. This is certainly not as widely adopted as of a practice as any of the other drugs that we talked about today, but it is how this particular treatment was sourced. So I wanted to put it in here. Maybe you can think of a better way to source Plasmodium falciparum for the treatment of syphilis. Okay, so actually I do want to just say that we don't treat syphilis with Plasmodium falciparum today. Syphilis is caused by a bacterium and we have antibiotics that can kill it. And so if you were to contract syphilis today, you would get an antibiotic from your doctor and that would cure you. Please don't seek out malaria as a treatment for a disease that's much easier to cure today than it was in the 1850s. Okay, so now let's think about cinchona bark or quinine as a new medicine. So colonialists observed the Quechua people treating fevers with cinchona bark that led them to the hypothesis that cinchona bark can be used to treat malaria because malaria also has fever as one of its symptoms. They sent cinchona bark back to Europe to be tested as a treatment against malaria. I should say the fact that cinchona bark was being, the diseases that the Quechuan people were treating with cinchona bark were not malaria. It just was fortunate that this compound happened or this bark happened to work against malaria and the other ailments that the Quechuan people were treating. I don't want you to think that they were already treating malaria. Okay, so they sent this bark back to Europe as a treatment. So that's how they were testing to see if it worked with people. And then to scale up production, they decided to create large plantations of cinchona trees. Now that is problematic and there are better ways to produce a lot of medicine. I think bioengineering can have an impact in streamlining these processes of medicinal development and scale up and can avoid situations where we feel like we need to plant very large quantities of a tree, for example, in order to get a lot of medicine. Okay, chloroquine as a new medicine. Here, the identifying a potential medicine and testing to see if it worked was being, these two steps were being done simultaneously. So here scientists are screening a large chemical library of dyes for the ability to cure birds of malaria. And so that didn't necessarily spawn from a fortunate observation, but from a directed screen. And then they scaled up production through chemical synthesis because they already knew they could synthesize this molecule. And then finally we have artemisinin as a new medicine. This was also a situation where the screen and the testing to see whether or not it works were kind of hand in hand. But I want you to think about how you might innovate in each of these areas and how the advancement of science or ability to have models of diseases and to engineer organisms to produce a lot of compounds really changed the way we search for new medicines and the way we scale up production. But just because we have new methods of doing this doesn't mean that some of those old school observational methods are worthless. It's still worth looking around you to see if there are things about the world that you observe that might be or lead to a new medicine sometime in the future.", "start_char_idx": 3965, "end_char_idx": 7547, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b1355554-c476-411f-b6be-5948a0604314": {"__data__": {"id_": "b1355554-c476-411f-b6be-5948a0604314", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "685e5eb1-7d50-4d73-b03f-fabdde0ac592", "node_type": null, "metadata": {}, "hash": "61a66fefc3701c9542ebe2c9dbb677d88158e27f6d2de0256bb2b82ffa0a43d8"}, "3": {"node_id": "dc19e830-9fd0-4513-a2db-54195b1d8da0", "node_type": null, "metadata": {}, "hash": "0fe5454728b703aeb7ef4083cffa1d89e4e2f4925bef47cadcb36817e02b09e1"}}, "hash": "6afff22d67b855c70c4eda2a92ba1097fb7ef0440bd985a1df43f3c40acea1be", "text": "All right, welcome back. Today, we're gonna talk about the discovery of insulin and protein structure prediction. So insulin is a protein that can be used to treat diabetes. It is gonna be the focus of this lecture because it's actually an incredible bioengineering success story. Insulin is the first medicine that was made using engineered bacteria. These bacteria were given the gene for human insulin and then were able to produce a bunch of this protein in fermenters. And then the protein could be extracted from the mixture of bacteria and sold to people. In fact, recombinant insulin is still the dominant form of insulin available for diabetic patients today. Now, before recombinant insulin was available, insulin was extracted from pig pancreases to treat diabetes. People would literally grind up mountains of pig pancreases in order to get enough insulin to treat everybody who needed it. And whenever I hear this story, I'm both shocked at the mountain of pig pancreases, the volume of these things that people needed to grind up in order to get insulin, and also curious, how do you figure this out? How do you look at somebody who has diabetes and think, I know what you need. You need a pig pancreas extraction in order to regulate your blood sugar. It turns out this story is pretty interesting, and it's also a nice example of an observation leading to a new treatment. So I thought I would share it with you today so you can have yet another example of somebody looking at the world around them, realizing there was an opportunity and developing it into a treatment that in this case has saved millions of lives. Okay, so the observation actually was part of an autopsy or is the results of autopsies in the mid 1800s. While looking at cadavers, people realized that the pancreas was always destroyed or somehow damaged in patients who had diabetes. Now, the reverse wasn't always true. There were some patients who had diabetes whose pancreases looked to be intact, but in general, a damaged pancreas always belonged to a person or if a person had a damaged pancreas, they always had diabetes. So this led people to the hypothesis or the idea that a pancreas was essential for blood sugar management. Diabetes is a disease where your blood sugar is out of control. So the observation led some German physicians in 1890-ish to take the pancreases out of some dogs and just sort of see what happens to them. They thought, okay, if the pancreas really is important for blood sugar regulation, then dogs without pancreases should be like people with diabetes. And this was true, except much more extreme. The dogs, once their pancreases were removed, did exhibit blood sugar regulation symptoms, but they also passed away very, very quickly. But this was enough for people to keep experimenting. This led to a second experiment where dog pancreases were extracted and then ground up and fed back to dogs. And this allowed dogs to survive for, I think on the order of like 70 days. The first dog who got ground up, pancreas did pretty well. And so they thought, oh, there is something in pancreas that is allowing or helping with blood sugar regulation. It's not the whole organ, right? It's not that the thing needs to be in the dog and functional, but it is actually something in that pancreas. It's something maybe that the pancreas is making. They weren't really sure, but they were kind of on the right track for figuring out how to treat diabetes. So they continued to do these types of experiments and were getting extractions of pig pancreases that were purer and purer. On this slide, I'm showing you sort of a brown splotch as the ground up pancreas, because that is indeed what the first descriptions of these things sound like. But over time, the scientists were able to get purer and purer extractions. And I don't mean a long time. They did this experiment with dogs in 1921. By 1922, there was the first trial of this medicine in a person. A 14-year-old named Leonard Thompson had really severe diabetes, and he", "start_char_idx": 0, "end_char_idx": 4042, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "dc19e830-9fd0-4513-a2db-54195b1d8da0": {"__data__": {"id_": "dc19e830-9fd0-4513-a2db-54195b1d8da0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "685e5eb1-7d50-4d73-b03f-fabdde0ac592", "node_type": null, "metadata": {}, "hash": "61a66fefc3701c9542ebe2c9dbb677d88158e27f6d2de0256bb2b82ffa0a43d8"}, "2": {"node_id": "b1355554-c476-411f-b6be-5948a0604314", "node_type": null, "metadata": {}, "hash": "6afff22d67b855c70c4eda2a92ba1097fb7ef0440bd985a1df43f3c40acea1be"}, "3": {"node_id": "a0a99ffa-c7a8-438d-983e-618067a1eded", "node_type": null, "metadata": {}, "hash": "bd0c222b638a881c8bbfe71ffd9e6354188543919b98d2d7d4aad369ba7bfc83"}}, "hash": "0fe5454728b703aeb7ef4083cffa1d89e4e2f4925bef47cadcb36817e02b09e1", "text": "person. A 14-year-old named Leonard Thompson had really severe diabetes, and he was the first person to be treated with a pancreatic extraction. One thing to know is that diabetes at this time, especially type 1 diabetes for children, was incredibly lethal. The only way to manage diabetes for these children was through diet, and that meant many of them were very, very skinny and that spikes in blood sugar could be fatal and often were. And so when he was treated, he was in the hospital in very rough shape, but the treatment actually allowed him to survive, which most people did not think he was going to. He also got pretty sick because the pancreatic extraction at this point still wasn't completely pure, and so he had an allergic reaction to it. But he was able to continue to receive basically insulin treatments or pancreatic extraction treatments for a while. And he lived for another 13 years, which is a huge success story. He ended up dying not of diabetes, but of pneumonia. So once this happened, it spurred the scientists and really the world to start thinking about how you could scale up production. Here is a treatment for a disease that previously had no treatment. And so everyone was eager to get their hands on some pancreatic extractions. And one of the clever things that they did was look around and say, well, how do we get a lot of pancreases? Where are there a lot of pancreases? And the answer was the butcher shop, right? People were already slaughtering animals and kind of cutting them up and using them for food. The pancreas wasn't widely consumed. People don't usually eat that organ. And so the scientists were able to get pancreases from butcher shops, and that is how you, and they actually drove up the price of pancreases, interestingly, after butchers realized that they were valuable, they started charging for them, whereas at first they were just giving them away, which is kind of funny. But yeah, so they were able to get a larger volume of pancreases from these butcher shops. And this is where you're gonna start to see those mountains like what I showed you on the previous slide of pancreases accumulating. But it's not just this that led to kind of widespread scale up of insulin production. It's actually something else too. The scientists who figured out how to do some crude extractions of pancreases and that you could give those crude extractions to diabetic patients to treat them got a patent for this process. And as soon as the patent was awarded, they sold it. They sold it for $1 to the University of Toronto. They said that insulin belongs to the world, that it is too important to try to make, too important to treat everybody who needs insulin to quibble over cash. And so they decided not to try to get rich off of this, but instead to sell the patent to the University of Toronto with the agreement that the university would help them scale up production as quickly as possible. And the university was in a unique position to be able to do that at the time. And so I think this is a really lovely example of somebody kind of choosing humanity, choosing to do what is best for everybody instead of just trying to get rich off of an innovation. Okay, so there's the patent. Eventually scientists figure out that the active ingredient in these pig pancreases is a protein. It is a protein that comes in two pieces. Insulin, the protein sequence is shown here. People had started to figure out that proteins were composed of amino acids. And so insulin was actually the first protein to ever be sequenced. Fred Sanger, who is a remarkable person who actually won several Nobel prizes, was the first person to ever sequence a protein to figure out what is the order of amino acids in this proteins. And the protein that he sequenced first was insulin, was showing kind of how important this protein has been to humanity in so many different ways. So here are the two peptides that compose insulin. There's one that's 21 amino acids long and another that's 30 amino acids long. And you can see some disulfide bonds kind of bridging the two chains of the insulin protein. But I don't love this representation of insulin. I", "start_char_idx": 3975, "end_char_idx": 8161, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a0a99ffa-c7a8-438d-983e-618067a1eded": {"__data__": {"id_": "a0a99ffa-c7a8-438d-983e-618067a1eded", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "685e5eb1-7d50-4d73-b03f-fabdde0ac592", "node_type": null, "metadata": {}, "hash": "61a66fefc3701c9542ebe2c9dbb677d88158e27f6d2de0256bb2b82ffa0a43d8"}, "2": {"node_id": "dc19e830-9fd0-4513-a2db-54195b1d8da0", "node_type": null, "metadata": {}, "hash": "0fe5454728b703aeb7ef4083cffa1d89e4e2f4925bef47cadcb36817e02b09e1"}, "3": {"node_id": "b3c3c55b-56d2-406d-9af0-9f3c92de24bf", "node_type": null, "metadata": {}, "hash": "7781947ff19470b6146d91c0e59bffb6821e9d8e930576a92d207200dc70340a"}}, "hash": "bd0c222b638a881c8bbfe71ffd9e6354188543919b98d2d7d4aad369ba7bfc83", "text": "chains of the insulin protein. But I don't love this representation of insulin. I mean, it's easy to look at, but it's actually not all that accurate. The protein is not like two little sticks bound together. It actually has a more complicated 3D structure. It's sort of folded back on itself. Even this is not quite right. And I'll show you a structure of insulin that's more accurate in the next slide. But I wanted to give you this idea that there's this three-dimensional structure to the protein that's really important. And the reason that's important is because insulin, as it's floating around in your blood when it's released by the body, will, to help with blood sugar management, will bind to receptors. And those receptors recognize not the sequence of amino acids. It doesn't go through and say, hey, is that a glycine, isoleucine, maline? It doesn't do that type of analysis. It actually just looks for the structure or is activated by a protein with the same structure as insulin. You can think of it sort of like insulin being a puzzle piece, the last puzzle piece, I guess, that's fit into a space, right? So it's a tight, really nice tight fit. So when insulin is bound by its receptor, which is on the surface of the cell, this kind of black double line is supposed to be the surface of a cell, it brings the intracellular parts of the protein together. Those become active and then can signal to the cell, like, hey, you've got a blood sugar problem. You should start to do stuff to regulate it. So this three-dimensional structure of insulin is really important. And it's not just insulin. The 3D structure of many proteins are important. So people have devised several ways of representing a protein structure. This thing that I've been showing you with the little balls, that's actually not all that common. People will use what are called ribbon structures to represent proteins. These came about because they're sort of two big or two structural building blocks. There are ribbons or, sorry, there are helices called alpha helices or beta sheets and certain sequences of proteins will form one or the other. And then these collections of alpha helices and beta sheets like fold even more into the final structure of the protein. So there are ribbon structures. There are also space-filling models. This is another way of looking at the protein. So this is actually also insulin. Everything you're seeing on this slide is insulin. These are just different ways of representing a protein structure, different ways of looking at it. This space-filling model is showing you the location of every atom in the protein. So each of these little balls is supposed to represent a different atom. Okay, so all interesting. If you see, I think, if you see things that look like this, know that those are probably proteins. People are probably trying to represent a protein or show you what the shape of that protein looks like. These things are so small that you can't really see them by eye. In fact, this is what it looks like when you try to experimentally observe a protein structure. This is X-ray crystallography. So it's taking a, so sorry, let me back up. Dorothy Mary Crowfoot Hodgkin is the first scientist to solve the structure of insulin. She used a technique called X-ray crystallography where she took a sample of pure insulin and made it into a crystal. Kind of like you can get salt crystals if you dry them out, right? If you have some salt water and it dries out, you can also get protein crystals and then you can shine X-rays through them. And the very regular structure of the protein when it's in a crystal will cause the X-rays to be, sorry, the X-ray beam to diffract and give you a pattern. And that pattern tells you where in the protein there are atoms that are deflecting the X-ray beam. So you can get a model of exactly where the atoms in a protein are located. And before there were computers that people would build what are called ball and stick models of proteins. They would actually represent the location of each atom as a ball and then they would kind of hold them together with sticks. And it was one way of looking at a structure. And so what you're looking", "start_char_idx": 8162, "end_char_idx": 12373, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b3c3c55b-56d2-406d-9af0-9f3c92de24bf": {"__data__": {"id_": "b3c3c55b-56d2-406d-9af0-9f3c92de24bf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "685e5eb1-7d50-4d73-b03f-fabdde0ac592", "node_type": null, "metadata": {}, "hash": "61a66fefc3701c9542ebe2c9dbb677d88158e27f6d2de0256bb2b82ffa0a43d8"}, "2": {"node_id": "a0a99ffa-c7a8-438d-983e-618067a1eded", "node_type": null, "metadata": {}, "hash": "bd0c222b638a881c8bbfe71ffd9e6354188543919b98d2d7d4aad369ba7bfc83"}}, "hash": "7781947ff19470b6146d91c0e59bffb6821e9d8e930576a92d207200dc70340a", "text": "sticks. And it was one way of looking at a structure. And so what you're looking at on this slide are Dorothy and also a ball and stick model of insulin. You'll notice that this ball and stick model looks different than the insulin that I had shown you on the previous slide. And that is because insulin can actually form a hexamer. So there are six copies of the kind of insulin monomer that A and B chain that I was showing you earlier in this hexamer. Each individual insulin protein is shown as a different color in this structure. And so you can see how the six of them all kind of sit together. It's really interesting, right? But why, like, what is this? Why is there this hexamer? Oh, actually, before we talk about why there's a hexamer, I wanna show you that structure prediction and protein sequence revealed a difference between human and pig insulin. We got lucky, actually, that human and pig insulin are very similar. There are only three amino acids that differ between the two proteins. But one of the amino acids that's different between pig insulin and human insulin is on the outer surface of the protein. There's an alanine here in the pig insulin and a threonine here in the human insulin. And the change from threonine to alanine actually affects how well this protein can form that hexameric complex that I was showing you on the previous slide. It doesn't form quite as well with the pig insulin. And that affects kinda how the protein behaves in the body. Okay, we'll get back to that in a little bit. Now, in 1978, recombinant DNA technology made it possible to produce human insulin in E. coli. So this is the big bioengineering advance that I told you about at the beginning. Here, you're basically taking the DNA that encodes for the human insulin gene. So this is exactly the same DNA that's in you and me. And we will put it into a plasmid, which is basically a circular piece of DNA that's maintained inside of a bacterium. The bacteria will replicate this piece of DNA the same way it replicates its own chromosomes when it divides. And so it never really loses these plasmids. By putting the human insulin gene into this piece of DNA, you can then put it into the recombinant bacterium and then put the bacterium into the fermentation tank. And the bacteria will transcribe and then translate this human insulin gene in order to make a bunch of the protein to be harvested from there. So this is sort of the process of engineering a bacterium to produce a recombinant protein. Now, understanding this insulin structure has led to new medicines. As I mentioned before, that alanine versus threonine on the outer surface of pig insulin versus human insulin affects the ability to form this hexameric complex. And that's interesting because this hexameric complex sort of serves as a storage of insulin in the body. So insulin, the protein, isn't functional. It doesn't bind its receptor and tell cells to do anything when it's in its hexameric form. It's only when the monomers break apart that they become able to interact with signaling proteins, with their receptor proteins. And so the fact that the pig insulin can't form this hexamer means that it doesn't store as well. And so more of the insulin that you deliver into a person is going to be what we call rapid acting or short acting. If you are a diabetic or you know anybody who takes insulin, you would know that there are different types of insulin. There are rapid acting insulin, kind of intermediate and long acting insulins as well. And so these are ones that will regulate, like be able to deal with a quick spike in blood sugar or would be able to regulate it over sort of a long period of time, but it takes a while to start acting. And so depending on kind of your particular pathology, you would take different types of insulin. And in these are formulations or different collections of either insulin monomers.", "start_char_idx": 12361, "end_char_idx": 16276, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "184f6b8e-6fcd-428a-9519-7969baf5384a": {"__data__": {"id_": "184f6b8e-6fcd-428a-9519-7969baf5384a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3f0eb595-68ed-4497-96ae-640aaf18e8e0", "node_type": null, "metadata": {}, "hash": "e6ee177354cefbf9be0cb0d3ffa9bd39201f086e11d17ee700ec3ebaae09e8da"}, "3": {"node_id": "13094e2a-8b61-4ece-9098-f4c899041f04", "node_type": null, "metadata": {}, "hash": "6620450116c0fd744dcca3dc037c158557bd1abdb084a03204cef3158f2c6831"}}, "hash": "8e36370fa3ba21bdc453d976f8db3558bfc2059d29f724f11506dc02acee311c", "text": "monomers, in the case of the short acting that's mostly monomers, or hexamers, or you can even get higher order complexes. In this case, the insulin is engineered to have these extra kind of protein tails on them that help stick multiple hexamers together and create something that is even more kind of long lived in the body as a complex, and so it takes longer to break off these pieces, which is why you get the longer and longer acting insulins. So I think that's a really interesting, I think it's an interesting example of us like taking an understanding of a protein structure and then pushing it, right? These long acting ones, that's not a natural protein. It's not just the insulin that you and I produce in our bodies, but it is a modified version of it that has an even different kind of function relative to the kind of standard or naturally occurring human insulin. So a really cool way to engineer some new medicine is just to change the protein structure. Okay, so since structure is so important, then the question becomes, how do we measure it? How do we predict it? If we, you know, at this point, I think you've probably heard about the Human Genome Project. We have been able to sequence humans' DNA. We can identify where there are proteins encoded in the DNA, and because we understand the genetic code, we can know exactly what those protein sequences are, but then we're stuck, right? We know something like the sequence of amino acids that are in a protein, but we don't really know just based on the sequence of amino acids what shape they fold into, and because the shape of the protein is so important for function, we don't know, or it's harder to guess, what the function of all of the human proteins in your genome are. So this desire to figure out from what's called primary sequence the structure of a protein has led to a lot of computational projects where people are trying to predict what the final folded form of the protein looks like. So this is just one approach. We're going to go over a few. I like this example because I think it's kind of easily digestible. Here, we're using what's called a multiple threading alignment and then iterative structure assembly in order to predict the structure of the protein, and so you're taking a string of amino acids, and then you're saying, okay, do I know by alignment to other proteins, by looking at other proteins, that any of these collections of amino acids would form either alpha helices or beta sheets, and if they do, then I'm just going to like stick them all together and try to fold it into something. Maybe, you know, not the most cutting-edge approach that we have to this day, but it's been effective at helping to predict the structure of some proteins. Okay, there is also an approach where you can use free energy minimization to try to fold a protein. Let me see if I can get this to play. All right, so this is a GIF that's just showing you a protein sequence, and it's looping really fast, so it's a little bit hard to see, but a protein, when it is folded correctly, will be in its lowest energy state, right? You can sort of think of it like flopping down on the couch at the end of the day. It's like the place that you are like trying to reach is like the lowest energy structure here, and that, okay, so what they do is they just sample a lot of different conformations for a protein, and then see, all right, which one of these has the lowest energy, because different structures will require more or less energy to maintain. You can think of like kind of gripping something really hard, requiring more energy. Okay, there are now sort of the cutting edge of protein structure prediction is to use a machine learning algorithm to predict a protein's structure, and a machine learning algorithm is basically trained to look at data and recognize patterns, and so you write an algorithm that is trained on a bunch of already known protein sequences and structures, and so you have to have already a large library of proteins whose structures you know because you measure them through something like x-ray crystallography or NMR, maybe another approach in the lab, and then you tell the algorithm like, okay, here are all of these protein", "start_char_idx": 0, "end_char_idx": 4247, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "13094e2a-8b61-4ece-9098-f4c899041f04": {"__data__": {"id_": "13094e2a-8b61-4ece-9098-f4c899041f04", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3f0eb595-68ed-4497-96ae-640aaf18e8e0", "node_type": null, "metadata": {}, "hash": "e6ee177354cefbf9be0cb0d3ffa9bd39201f086e11d17ee700ec3ebaae09e8da"}, "2": {"node_id": "184f6b8e-6fcd-428a-9519-7969baf5384a", "node_type": null, "metadata": {}, "hash": "8e36370fa3ba21bdc453d976f8db3558bfc2059d29f724f11506dc02acee311c"}}, "hash": "6620450116c0fd744dcca3dc037c158557bd1abdb084a03204cef3158f2c6831", "text": "lab, and then you tell the algorithm like, okay, here are all of these protein structures. Sorry, here are all of these protein sequences. Here are the structures that they fold into, and then the machine learning algorithm gets some time to kind of look at both the sequence and structure and say like, okay, I can see that every time there's an alanine valine valine that like the protein starts to fold like this, right? It can look for patterns in this data, and it has been surprisingly good at predicting the structures of proteins because now you can feed the algorithm protein sequences it's never seen before, and it will fold them into a structure, and when we check to see whether or not they're folded correctly, let's say by doing an experiment, they are quite impressive in how often they are correct, and so this machine learning algorithm that does protein structure prediction, at least the one we're talking about here, is called AlphaFold2. This is the biggest one at the moment in kind of the protein structure prediction world, and I would, oh, okay, so here's a simulation of it folding a protein. You can see it kind of figuring out also what the structure of the protein might look like. It's also sort of an iterative process, kind of like the free energy model we were looking at before. Okay, so today the AlphaFold database has two million structures in it, so I'd encourage you to go to their database and look at some of these proteins. I think it's astounding that they've been able to predict the structure of so many proteins. Last year when I gave this presentation, there were only basically one million structures in their database, so in about a year they have multiplied the number of structures available by 20, which is very big. That's a lot of proteins that we have potential structures for now, and this is just the type of data that you can see. If you go to AlphaFold, you can look, you can type in a protein name. It has suggestions for you if you don't really know where to start, and then it will show you the primary sequence of that protein and then the structure that it's predicted. I can't do it here because it's a screenshot, but you can actually like zoom in and rotate these proteins around, kind of get a really good look at them. Maybe go look at the structure of human insulin. The other thing that AlphaFold will have is how confident the model is that the structure it's predicted is correct, and so what you'll see on this one is that it's pretty sure that most of these amino acids in the middle are forming alpha helices. It's much less sure about this loop out of the end. This kind of disordered part of the protein has maybe an alpha helice in there, but the algorithm just isn't quite sure, so it's kind of interesting to see, you know, what the cutting edge of protein structure prediction is. I encourage you to go check it out if you're feeling really ambitious. You can download AlphaFold and try putting in your own protein sequences. You could make up a totally arbitrary sequence and just see like what would that protein's shape look like if I were ever to make it. I think these are really cool tools, and they can be used to, you know, advance or make advanced medicines like the insulin example I was talking about today, and I think the full impact of them we don't quite know yet what it will be. Anyway, I hope you're excited about proteins and encourage you to check this out.", "start_char_idx": 4169, "end_char_idx": 7629, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c8c6991c-4774-4be4-884b-90d9331119a6": {"__data__": {"id_": "c8c6991c-4774-4be4-884b-90d9331119a6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "18267c81-baae-42c1-95e9-78fcbf5d4339", "node_type": null, "metadata": {}, "hash": "c54af16f7611fbafc177ebdca228ff4d666034bb94df5fa265fc4e682a430a76"}, "3": {"node_id": "5ebdc624-894b-4ea3-b94e-b5c0e6d46556", "node_type": null, "metadata": {}, "hash": "83ef7d77a7d6ea67570232c615992d1fbe1e91fcca59bdb37573ff1fdd1be190"}}, "hash": "237622736ec4758cf4c882c86688dc9e37a9d83ca1d7f845862b52f8d954a98d", "text": "So now that we've talked about small molecule medicines and protein-based medicines, we're going to talk about a type of medicine that you may not have encountered before. We're going to talk about using whole living cells as medicines. And this may sound a little surprising, but there are several advantages to using whole living cells as medicines. First, cells can respond dynamically to changes in their environment, which means they can kind of adapt on the fly to disease progressions or other environmental changes. They also have some remarkable innate abilities. Here in this video, you can see a macrophage, that's a type of human immune cell, chasing after a bacteria. This cell's job is to keep infections in check in your body, and so the macrophage will chase after bacteria. And you can see it making all of these dynamic decisions, right? It changes direction. It knows when to stop when it's gotten that bacteria. And that's pretty awesome. If we could maybe help macrophage recognize or chase after bacteria that it doesn't usually do a good job with, or make other modifications to it that help it along, we can start to consider them potentially as a whole cell medicine. That's an example of something that could theoretically be a whole cell medicine. There's an additional advantage to having living cells as medicine, and that is that some of them can self-replicate. Your bottle of Tylenol never makes a copy of itself, but a whole cell will. And so these are things that can continue to grow and make more of themselves, and that in certain situations can be advantageous. Here's an example from some students out of the University of Cambridge to engineer E. coli to diagnose disease. They engineered E. coli in order to produce a protein that was so bright it turned the bacteria different colors. What you're seeing at the bottom of this slide are actually tubes full of different strains of E. coli that have been engineered to produce different, what's called chromoproteins, or colorful proteins. So you can see that the colors are really vivid, and the students thought it would be great to administer them sort of like probiotics. You'd get a little capsule full of these bacteria, and then you would swallow it, and the bacteria would break out of the capsule, and then live inside of your gut. And they wouldn't be producing this colorful protein all the time. Students thought it would be a good idea if they only produced the colorful protein in response to biomarkers that were indicative of different diseases. So for example, if the E. coli happened to encounter a salmonella, or a worm, or a stomach ulcer, then they might start expression of one of these colorful proteins. The expression of that colorful protein would then turn the person's poop a specific color, and based on the color of your poop, you would know, oh, I might have a stomach ulcer. I should probably go to the doctor and seek treatment. I think this is really fun. One of my favorite parts about this is that these colorful poops were actually made. They're plastic, but they were made for an exhibit at the New York Museum of Modern Art, and were on display for quite a while. And so it's clearly an idea that has captured a lot of people's imagination and attention. I should say, it doesn't actually exist. You can't go to the store and buy a bottle of this colorful E. coli, but that idea is out there, and increasingly the tools to make it a reality are becoming available, or are available, I should say. One of the things I want to point out about this is that it is just a diagnostic tool. The bacteria don't actually do anything to treat these diseases, but I think it's feasible to imagine having the expression of the blue protein in response to worms in your gut, for example, also initiate expression of some sort of therapeutic protein that helped to get rid of the worms, so that the bacteria were not just telling you that you might have some sort of infection, but that they would begin to help treat it as well. And so maybe you could go through an entire bout of infection with worms, or food poisoning by salmonella, and never really know, because", "start_char_idx": 0, "end_char_idx": 4182, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5ebdc624-894b-4ea3-b94e-b5c0e6d46556": {"__data__": {"id_": "5ebdc624-894b-4ea3-b94e-b5c0e6d46556", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "18267c81-baae-42c1-95e9-78fcbf5d4339", "node_type": null, "metadata": {}, "hash": "c54af16f7611fbafc177ebdca228ff4d666034bb94df5fa265fc4e682a430a76"}, "2": {"node_id": "c8c6991c-4774-4be4-884b-90d9331119a6", "node_type": null, "metadata": {}, "hash": "237622736ec4758cf4c882c86688dc9e37a9d83ca1d7f845862b52f8d954a98d"}, "3": {"node_id": "22e8a381-e726-46dd-b0d9-02c3e1a1496c", "node_type": null, "metadata": {}, "hash": "0f48e3ae2c7819dc97b0a30a4106090192cc5d8f21161a0c723326358743337f"}}, "hash": "83ef7d77a7d6ea67570232c615992d1fbe1e91fcca59bdb37573ff1fdd1be190", "text": "with worms, or food poisoning by salmonella, and never really know, because it's cleared from your system before you start to show symptoms. Now, there is actually a company that is working on engineering gut bacteria to treat diseases. This company is called Synlogic. They're based in Boston, Massachusetts, and they are engineering E. coli to treat NASH. NASH is non-alcoholic steatohepatitis, and it is a fatty liver disease, and they are proposing to treat it, excuse me, they're proposing to treat it by overexpressing specific compounds in the E. coli once it gets into your gut. And so the idea is that these bacteria would relieve the symptoms associated with NASH, which is pretty exciting. So be on the lookout for products from Synlogic. You might be seeing a bioengineered bacteria available as a medicine to treat this disease. There are some kind of more cutting edge, well, I'd say the Synlogic stuff is also cutting edge. This is a very recent paper, so recent that it's on an archive server. It's not actually published yet, out of a lab here at Stanford. And in this study, Stanford researchers used a skin bacteria called Staphylococcus epidermidis to train a mouse's immune system to recognize cancer cells as an infection and treat them the same way that macrophage was treating that bacteria, was trying to get rid of all of these cancer cells. Now, you might have heard of staph infections. Those are caused by Staphylococcus aureus. That's sort of like a sister to this bacteria. Staphylococcus epidermidis is actually a common colonizer of skin. There's probably some living on you right now. And so this bacteria is safe. It's a normal inhabitant of your skin microbiome. And by engineering it to display a little piece of a tumor, or it's called a tumor antigens, a little piece of protein that's usually found on the surface of a tumor cell, you could get the mouse's immune system to be trained to recognize that as infectious and clear it from the body. So when the Stanford researchers, Dr. Aaron Chen and Professor Michael Fischbach swabbed some of this engineered bacteria behind the ear of the mouse, of a mouse, and then gave the mouse a small tumor, they found that the tumor grew, it was not able to grow. So the control or the samples where the engineered bacteria was administrated are these OVA samples in blue. These others are controls where there was either no bacteria given, that's the naive control, and or an unmodified staph epidermidis was given, and that's this control. And in both cases, the tumor continues to grow, but when the bacteria is displaying this antigen, it does not. So it looks like this might be a way of kind of having a vaccine against cancer or a prophylactic treatment so that your immune system knows that it should be on the lookout for these specific proteins because those commonly occur on the surface of tumor cells. And so it's another nice example of using a whole cell to do this. And one of the reasons why a whole cell is, well, okay, so Aaron and Michael are going to be figuring out how all of this works. We don't know exactly how the tumors that are the T cells, the immune cells that are recognizing this staph epidermidis displayed protein are getting access to it because they're on the surface of the skin and most of the T cells are in circulation in your body. But they're going to try to figure it out. What we know at this point is that the engineered bacterium has this effect, but the individual protein applied to the skin does not. So kind of an interesting use of an engineered bacteria. The whole cell medicines don't have to just be bacteria. They actually engineer human cells too in order to treat different types of cancers. So we'll get into this in much more detail in the cancer section, but I just wanted to point out that engineered human cells actually have been used to cure cancers. These work well against lymphomas and the mechanism by which they do it again, I think we'll cover in the cancer section. So what I'll leave you with in terms of", "start_char_idx": 4119, "end_char_idx": 8176, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "22e8a381-e726-46dd-b0d9-02c3e1a1496c": {"__data__": {"id_": "22e8a381-e726-46dd-b0d9-02c3e1a1496c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "18267c81-baae-42c1-95e9-78fcbf5d4339", "node_type": null, "metadata": {}, "hash": "c54af16f7611fbafc177ebdca228ff4d666034bb94df5fa265fc4e682a430a76"}, "2": {"node_id": "5ebdc624-894b-4ea3-b94e-b5c0e6d46556", "node_type": null, "metadata": {}, "hash": "83ef7d77a7d6ea67570232c615992d1fbe1e91fcca59bdb37573ff1fdd1be190"}}, "hash": "0f48e3ae2c7819dc97b0a30a4106090192cc5d8f21161a0c723326358743337f", "text": "I think we'll cover in the cancer section. So what I'll leave you with in terms of this is just a New York Times story that talks about how the cancer treatments are very effective. They make leukemia, they can cure leukemia, but they have some patients who get these therapies do have relapse or recurrence of cancer at a later date. Some have unusual side effects with fevers and things that sort of resemble an infection. And these types of CAR T, these engineered T cell treatments, they don't work against all types of cancers. They're not good against solid tumors. And so there's still a lot more work to do to figure out how we might be able to tackle different types of cancers potentially by modifying our own cells to recognize them as a problem and start clearing them from the body. Okay. I want to challenge you to think about whether it's good or bad that all of the examples that we've talked about have been medicines for people. We're not the only living things on the planet. So what about making medicines for our friends, for our non-human friends? We're going to go through an example later in this course that's about this Panamanian golden frog. This is a frog that was last seen in the wild in 2009. It's a really small frog that is very poisonous and is usually found in the Panama cloud forests and some central rainforests in South America. And this frog is going extinct because it keeps getting infections from a fungal pathogen. And so there is an idea that maybe you could engineer the skin bacteria of this frog to fight off that infection. We'll go through how all of that works later. I just wanted to give this to you as food for thought. Maybe we could make medicines for our non-human friends to do things like help reintroduce them to the wild where there's still a lot of that fungal pathogen, but no frogs. Okay. The last thing I'll leave you with is some breaking news. This is a paper that literally came out today reporting the de novo design of luciferases using a deep, using deep learning. What does that mean? Well, luciferases are the enzymes that are responsible for light emission from things like fireflies or deep water jellyfish and other bioluminescent organisms. And these researchers, in fact, David Baker, so when you do the PSET or if you've already done, watched the video associated with the PSET, you'll be familiar with David Baker. His lab at the University of Washington was able to design an enzyme from scratch that also produces light when given the correct chemical substrate. In order to get this protein a functional new luciferase, they tested about 7,500 designs. And I know that sounds like a lot, but this protein is 117 amino acids long. And if you were to sample the entire space, the entire design space for 117 amino acid long protein, there would be 10 to the 152 different possibilities. There's basically that many different potential proteins that could be made that are 117 amino acids long. That's a lot of zeros and a completely intractable number of proteins to ever build and test. But 7,000, that's within the wheelhouse of things that we can do. So it's exciting and mind blowing that this just came out and that they are able to make a new enzyme from scratch. So who knows what's next? I'd love to hear if you have an idea of what's next. Thanks for hanging out with me during this protein and medicines week. Looking forward to our future lectures together.", "start_char_idx": 8158, "end_char_idx": 11608, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "391620cb-7dcb-4af3-8e84-7c2a8dfe2d83": {"__data__": {"id_": "391620cb-7dcb-4af3-8e84-7c2a8dfe2d83", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "216e0901-5b01-449f-a115-69c5d483f0bb", "node_type": null, "metadata": {}, "hash": "548342dabea3f2c3826c28656a914e6e04cee84350b7dc96b99eea4006407e23"}, "3": {"node_id": "0541350f-072e-4d47-9079-21cdeb46d7bb", "node_type": null, "metadata": {}, "hash": "ce46bd6d1d92d47bae1029bd728b3287764ef3bb5d94a5e6ab14d3fbd74255c6"}}, "hash": "a570afd8356de05da6665022c93637f964fcea4abed407d29419f1baf50524a7", "text": "All right, we're gonna continue this week's discussion on bioengineering innovations in medicine by talking about sourcing, screening, and scaling up production of medicines and all the ways that bioengineers can help us do this, do these things better. Okay, so first, if you wanna source new medicines, one way that you can do it is to look for new sources of medicines. Now, there are potentially new compounds that could serve as therapeutics all around us, we talked about examples previously that came from plants and then were moved into bacteria, but it's possible that bacteria are making compounds themselves that could be useful as therapeutics. It's also possible that there are things in fungi or in animals or insects that are also going to be able to have some sort of medicinal effect, right? So we can start to do extractions from these different types of organisms to look for new chemicals, and this has been pretty successful in the past at giving us new medicines. But one of the things that's challenging about this is that some organisms only make compounds when stimulated correctly, and maybe we can get at more diverse medicines by challenging the organisms. So here, what you're looking at is a leaf that's getting chewed on by some insects, and to stop the insects from chewing on them, this plant will start to produce compounds that change the taste of the leaf to the organisms. And this is only in response to them, so if you were to take an unchewed-on leaf and look for production of that compound, you wouldn't find it. So the question becomes, if there are hidden molecules inside of organisms' genomes, how do we access them? Well, one of the things that bioengineers can do is awaken natural product pathways in the lab. One way of doing this is to use, or there's one tool that's really helpful for doing this called an anti-smash tool. This will allow you to feed in a genome sequence from a bacterium, and then anti-smash will look for enzymes encoded in the genome, and then try to predict what kinds of compounds would be made when those enzymes are expressed. So this is one way of looking or predicting what types of things may be made by that bacteria, even if the bacteria isn't currently making them, right? Genes in the genome aren't all being expressed at the same time, but we can predict what would be possible for the bacteria to make by looking at the genes that are encoded in that genome. Once you know what's encoded, then you can take those genes and change the promoter and overexpress them. So here we would be taking genes from Colobacter crescentus, a weird or wild bacteria, and then moving them into E. coli, which is much easier to manipulate in the lab, and try to see if genes from Colobacter do in fact produce the compounds of interest. So that's one way of trying to access new molecules is just to take the genes, even if you don't know what they're gonna do at first, and move them into another organism. And there's been a lot of work done by people on projects like this. It's not always that easy. Sometimes you're missing enzymes in a biosynthetic pathway, and so it doesn't actually make anything new, but we're getting better at predicting which genes are involved in pathways, and then at methods of heterologously expressing them in organisms where the enzymes are most likely to function well. So you could also do some synthetic chemistry to try to get new reactions to occur in the lab. We've gotten pretty good at doing chemical reactions where you change the conditions of two molecules in order to get them to combine or otherwise react in ways that yield new molecules, but you can also use biocatalysts to initiate the generation of new types of molecules. So maybe we don't know what conditions would combine two potential chemicals together to produce some new compound or new molecule, but we have a biocatalyst that can catalyze or push forward that reaction. So by exploring what types of bacteria or proteins could be added to chemicals in order to change those chemicals, bioengineers can start to make new molecules. Here's an", "start_char_idx": 0, "end_char_idx": 4122, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0541350f-072e-4d47-9079-21cdeb46d7bb": {"__data__": {"id_": "0541350f-072e-4d47-9079-21cdeb46d7bb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "216e0901-5b01-449f-a115-69c5d483f0bb", "node_type": null, "metadata": {}, "hash": "548342dabea3f2c3826c28656a914e6e04cee84350b7dc96b99eea4006407e23"}, "2": {"node_id": "391620cb-7dcb-4af3-8e84-7c2a8dfe2d83", "node_type": null, "metadata": {}, "hash": "a570afd8356de05da6665022c93637f964fcea4abed407d29419f1baf50524a7"}, "3": {"node_id": "d905e483-6aa7-453c-b94d-ad35b9b2441c", "node_type": null, "metadata": {}, "hash": "b77ea0e4c4d18307ca0a39922268ebe008c4314a3b060f8b4ef6d1cd016df5f6"}}, "hash": "ce46bd6d1d92d47bae1029bd728b3287764ef3bb5d94a5e6ab14d3fbd74255c6", "text": "those chemicals, bioengineers can start to make new molecules. Here's an example of that type of work being done in plants. Your tryptophan, which is an amino acid, an essential amino acid, is made into a compound called brassinin in plants, usually, and these researchers, one at Stanford and one at UC Berkeley, figured out that they could make chlorobrassinin or chloro, or sorry, bromobrassinin by feeding in different types of intermediates to plants and changing the enzyme in them. So they were able to make new compounds that actually now function as, or have functionality as antifungals just by manipulating this pathway that usually appears in plants. Okay, so that's different ways of sourcing things, but once you've sourced a whole lot of molecules, the question becomes, how do you screen them to make sure that they're functional? Angela Kohler, a professor at MIT, has been pioneering this high-throughput screening method where she is able to test thousands of different compounds all at the same time. She makes these arrays in which you can look for activity of a molecule against a cell really easily. So this is just a video showing you kind of the size scale of the types of chips that she has been able to build. As you zoom in, you'll see, like, here's the small molecules that have been printed there by the robot, and then you can see whether or not they bind to a protein of interest. In this case, the idea is that binding that protein might interfere with that protein's activity, and if the protein is something that is causing problems in a disease, then by binding it, you would interfere with its activity and treat the disease. So here's one method of trying to scale up screening, right, removing from how many birds can you have in a lab for the malaria example to hundreds of thousands of things on a chip. Okay, another way that you can test things more efficiently in the lab is to have new model systems for testing. Talked about using, we talked about using birds, and we just talked about using protein-binding assays to see whether or not a drug might be effective, but there sometimes is information lost in those types of assays, and it might be better to be able to test to see whether or not a drug has an effect on a human cell and, you know, in a whole human organ. So one thing that people have tried is taking individual human cells and then changing the conditions in which you grow them in to stimulate them to form miniature versions of human organs. These miniature versions of human organs look kind of like this. These are two different brain organoids, and so these are supposed to be models of the human brain, but then you can test different types of drugs on or look at cells that are starting from, with different genetic mutations to see how it affects, you know, the structure of the organ. And I think these are pretty cool. You can see sort of the folds here starting to appear like a human brain or eye cups forming on this brain organoid. And so I think it's an exciting way of looking to see whether or not, or an exciting platform that can be used to see whether or not a drug has an impact on cells that are kind of more like their native structure or they're in a situation that's more like their native situation. Here, just for scale, is an image of actual organoids in a dish. So they're small, but they're still macroscopic, right? You're able to see these tiny organoids with your naked eye. You don't need a microscope or something like that. Okay, outside of, and while organoids are getting great and they're advancing really quickly in their complexity, and that's useful because the more complex the organ, the more likely it is to represent the whole human organ effectively, but not quite to the point where these tiny organoids are as advanced as the whole brain. And so it's still useful to be able to use animal models for research. There's been some genetic engineering of mice in order to get them to be better models of specific human diseases. So we can knock out specific genes that are homologues of things in people in order to get mice that have ailments, and then we can try to treat them with different modalities. And so here's a mouse model of obesity, a mouse model", "start_char_idx": 4061, "end_char_idx": 8327, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d905e483-6aa7-453c-b94d-ad35b9b2441c": {"__data__": {"id_": "d905e483-6aa7-453c-b94d-ad35b9b2441c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "216e0901-5b01-449f-a115-69c5d483f0bb", "node_type": null, "metadata": {}, "hash": "548342dabea3f2c3826c28656a914e6e04cee84350b7dc96b99eea4006407e23"}, "2": {"node_id": "0541350f-072e-4d47-9079-21cdeb46d7bb", "node_type": null, "metadata": {}, "hash": "ce46bd6d1d92d47bae1029bd728b3287764ef3bb5d94a5e6ab14d3fbd74255c6"}, "3": {"node_id": "24528f9b-a319-4dcd-9d06-aa89f24583f8", "node_type": null, "metadata": {}, "hash": "5c1e398d78693daa881c59cd0d3b75415690f25d045be397994102999f7c394c"}}, "hash": "b77ea0e4c4d18307ca0a39922268ebe008c4314a3b060f8b4ef6d1cd016df5f6", "text": "them with different modalities. And so here's a mouse model of obesity, a mouse model of tumor, tumor genesis, and then a mouse model even of vitiligo. And so we can start to test to see, you know, kind of how different medicines might work on mouse models that are supposed to be more similar to people. All right, so those are our ways of testing. When we talk about scale-up of production, we have been talking primarily about moving production of compounds from slow-growing or rare organisms into fast-growing organisms that are easy to grow in large quantities. This is an example from Christina Smolki's lab here at Stanford, where they were able to move the genes that encode for production of an opiate from poppy into yeast. And so there's many genes in this pathway, and it has enabled them to basically brew opiates instead of having to grow the plant and isolate the compounds from there. And so they're exploring other types of drugs that you could also make by changing enzymes in this pathway, and are hopeful that they'll find a solution for pain management at her company that they recently started. Okay, there's also a scale-up or production being done in model plants. So this might be surprising, but it can be useful to move production of a compound of interest from a slow-growing plant into a fast-growing plant. So here we're highlighting the movement of a compound called etoposide, which is usually produced by a slow-growing plant called mayapple, into Nicotiana benthamiana, which is a really rapidly-growing lab plant. So it can be exciting to think about heterologous production, not just in microbial organisms, but also in plants. We'll get a little bit into the benefits of working with plants in a minute, but I just wanted to show you an example where this has been done. Throughout all of these slides, if you want to go back and look later, links to the scientific literature are at the bottom. And so you can read the actual science paper where they engineered Nicotiana benthamiana to produce etoposide. Okay, so there are some benefits and some drawbacks to using bacteria or different hosts in order to produce medicinal compounds of interest. E. coli, which is a really commonly-engineered organism, has several benefits and disadvantages. So I just wanted to go through them really quickly so that if you're ever thinking like, hey, I would really like to make a lot of this compound, should I try to move the genes that encode for this compound into E. coli, or should I pick a different organism to try to make my new medicine? So the benefits of working with E. coli is that it grows really fast. It doubles every 20 minutes. That means it divides and makes a copy of itself every 20 minutes and grows exponentially. So you can get a lot of E. coli cells really fast if you put them into kind of warm, high-nutrient conditions. High-cell density cultures are really easily achieved. The E. coli will basically continue to divide and divide and divide until it's very, very dense. You can get up to 10 to the 13 mls of bacteria, or 10 to the 13 bacteria per milliliter of water. So just to put that into perspective, that's 10 followed by 13 zeros in one milliliter, which is a very small amount of liquid. Media for growing bacteria can be made really easily from inexpensive components, so it's easy to get a lot of this bacteria and cheap. And then transformation, or the introduction of new DNA into E. coli is also fast and quite easy. The disadvantages of working with E. coli is that you need to usually give it antibiotics in order to force it to maintain plasmids. So we talked in the last lecture about plasmids, which are little circular pieces of DNA that exist and are replicated by the E. coli. But E. coli sees this extra piece of DNA as a burden because it has to devote some of its cellular resources to making copies of this plasmid, and so it will kick it out over time unless you supply some sort of selective pressure to make the bacteria keep this plasmid. So in this case, we usually encode for an antibiotic resistance gene on a", "start_char_idx": 8319, "end_char_idx": 12418, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "24528f9b-a319-4dcd-9d06-aa89f24583f8": {"__data__": {"id_": "24528f9b-a319-4dcd-9d06-aa89f24583f8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "216e0901-5b01-449f-a115-69c5d483f0bb", "node_type": null, "metadata": {}, "hash": "548342dabea3f2c3826c28656a914e6e04cee84350b7dc96b99eea4006407e23"}, "2": {"node_id": "d905e483-6aa7-453c-b94d-ad35b9b2441c", "node_type": null, "metadata": {}, "hash": "b77ea0e4c4d18307ca0a39922268ebe008c4314a3b060f8b4ef6d1cd016df5f6"}}, "hash": "5c1e398d78693daa881c59cd0d3b75415690f25d045be397994102999f7c394c", "text": "So in this case, we usually encode for an antibiotic resistance gene on a plasmid and then grow the bacteria with antibiotics in order to force them to keep the piece of DNA that encodes for our genes of interest. That's obviously problematic to have a lot of antibiotic around, and so there are people who work with other methods of selection or methods of integrating genes that encode for your medicines into the genome of E. coli, so you don't need to do this, but typically it's faster and easier to work with plasmids, and so you do have to consider whether you wanna work with antibiotics. You can get improper protein folding in E. coli. It just has different ribosomes than humans and can fold proteins somewhat differently, and so there is a possibility that you'll make a lot of protein, but it won't be quite right for your therapeutic application. Often what happens is it just becomes this unfolded kind of globby mess inside of the E. coli cell. There's a lack of post-translational modifications, which I'll get to in a second. You can also get endotoxin contamination. E. coli is a pathogen and does produce some compounds that are detrimental to human health, so you need to make sure that you purify your medicines really well before you administer them to humans so that you don't have any of these toxins that carry over. Just the sheer fact that that exists means they're a little bit more dangerous to work with in terms of using them to produce medicines than from other hosts, which we'll get to in a minute. And then they do do some proteolytic digestion, which means they may chew up your protein of interest before you're able to extract it in the case of protein therapeutics or before those proteins are able to make whatever small molecule drug you're trying to make. So sometimes that can be a problem. It is protein sequence dependent, so it's not going to be an issue for every protein you try to express in E. coli, but it is something to consider. Okay, we're going to talk for a second about post-translational modifications now. Protein activity is defined by multiple features. We've already talked about the primary structure, which is just the amino acid sequence of a protein, then folding into what we call secondary structures. These are either alpha helices or beta sheets. Then the protein will fold even more into what's called a tertiary structure or a three-dimensional structure. And then sometimes proteins will bind to each other to form higher order complexes that we call the quaternary structure. So each of these affect the protein activity. You have to form the right structure in order for the protein to be active. But in addition to that, you can also get decorations of the proteins with other molecules. So you can get the addition of methyl groups, like a carbon and some hydrogens. You can get the addition of just hydroxylations, so oxygen and hydrogens, or you can get the addition of whole sugars. This process of adding sugar compounds to proteins is called glycosylation. And each of these modifications can affect the activity of a promoter, or sorry, of a protein. Just to put that in perspective or to give you an example, here is the structure of glucocerebrosidase. This is an enzyme that is important for, or sorry, that is sometimes deficient or defective in a disease called Gaucher's disease. And that's a type of fatty acids in liver. You get accumulation of fatty acids in liver. And in this protein structure, you can see the protein itself is being represented by one of these stick models. And then these sugars are in blue. And you can see relative to the protein how big these things are. And hopefully that kind of illustrates for you how important they can be for the protein to serve its function. They're a big part of protein and they're...", "start_char_idx": 12416, "end_char_idx": 16246, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1b519fd2-2173-4024-b130-87968de1d36a": {"__data__": {"id_": "1b519fd2-2173-4024-b130-87968de1d36a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9a527a69-dddd-4795-b429-9cb00ec7a6aa", "node_type": null, "metadata": {}, "hash": "5efd2f937f1b77f28c212c1a9d978bc48c58faebc836e6200a744a64362b5679"}, "3": {"node_id": "ba9e114e-bc74-444a-9973-17a4b1c3daf3", "node_type": null, "metadata": {}, "hash": "627d469506cdc5ab491e9ea8dbdb7d994833174b6cecfe5cac86e3de5aa5c733"}}, "hash": "7ddfb0054a9aadbf878f603835a8e33134976af5dfa49980ad8eb3f0d59ddc42", "text": "essential for it to function correctly. The reason glycosylation, so bacteria don't do any glycosylation and then glycosylation varies across organisms. So yeast, insects, plants, non-human mammals, and humans all encode different enzymes that attach sugars onto proteins. And so those will result in different glycosylation patterns and therefore it can be difficult to use something like a yeast to make a human protein therapeutic because it's possible that the yeast will add sugars onto the protein that are not the same as the sugars that a human cell would add on. And therefore the proteins coming out of yeast may have different activities than the ones coming out of human cells. Okay, so there's actually more than just, E. coli and yeasts and plants that you can express or use to produce medicines. These are some of the most common production hosts. There's E. coli that we already talked about, yeast, you can grow mammalian cell lines. And so these are cells that are isolated from mammals, sometimes humans in order and then grown in the lab. Usually they're isolated from cancer samples so that the cells can continue to grow and divide indefinitely. Cancer is overproliferation or the continued growth of cells that actually shouldn't be growing in your body. But when you take them out of the body, those cells can be useful because they continue to grow and produce a lot of cell material for you to work with. There are also insect cell lines and insect cell lines is the same idea as the mammalian cell lines. It's just the peas are derived from insects. So here, what you're looking at are a whole bunch of different pluses and minuses to working with each of these production hosts. So E. coli, like we mentioned, has no glycosylation. And then if you go down this table, you'll see that we sort of colored them by how close to human glycosylation the organism is able to produce. But there are other considerations than just glycosylation patterns, right? The mammalian cell lines can have perfect human glycosylation, but they're harder to genetically modify relative to E. coli and actually the yeast and even insect cell lines. They are relatively slow growing. There's high risk for virus contamination and they're very expensive. The medias that they grow in are much more expensive than the ones that we grow E. coli yeast or even plants in. So I encourage you to spend a little bit of time looking at this table and thinking about like which of these things are gonna be most important to you if you're trying to make a medicine of interest. It let's say you're not trying to work with a, or you're not trying to produce a protein-based therapeutic. Maybe you don't care about the glycosylation state then. And so you can work with either E. coli or yeast. It's just one example of something to consider. Now, these are the benefits and drawbacks of these types of cells or organisms unmodified. The bioengineers have been working on modifying these things in order to improve them, make them better production hosts. So yeast can actually be what's called humanized to enable production of correctly glycosylated proteins. This is how yeast would usually glycosylate proteins, but by knocking out specific enzymes from the yeast genome and then adding enzymes that are usually found in humans, you can change the glycosylation patterns and make them identical or at least much more similar to the human glycosylation patterns. And then these humanized yeast become really good production hosts for protein-based therapeutics that have to be glycosylated. Another technology advance is to get high concentrations of proteins out of CHO cells. So CHO stands for Chinese hamster ovary, the type of mammalian cell line that's really easy to work with in terms of bioproduction because it can be grown in fermenters. A lot of human cell lines have to be grown on solid substrates. So you can imagine just like a whole sheet of cells that are growing. That kind of makes sense. Most of the cells in your body are attached to one another and they're happiest when they're got something solid to hold on to. These cells seem to be okay in batch culture and you can up,", "start_char_idx": 0, "end_char_idx": 4194, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ba9e114e-bc74-444a-9973-17a4b1c3daf3": {"__data__": {"id_": "ba9e114e-bc74-444a-9973-17a4b1c3daf3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9a527a69-dddd-4795-b429-9cb00ec7a6aa", "node_type": null, "metadata": {}, "hash": "5efd2f937f1b77f28c212c1a9d978bc48c58faebc836e6200a744a64362b5679"}, "2": {"node_id": "1b519fd2-2173-4024-b130-87968de1d36a", "node_type": null, "metadata": {}, "hash": "7ddfb0054a9aadbf878f603835a8e33134976af5dfa49980ad8eb3f0d59ddc42"}}, "hash": "627d469506cdc5ab491e9ea8dbdb7d994833174b6cecfe5cac86e3de5aa5c733", "text": "hold on to. These cells seem to be okay in batch culture and you can up, but they unfortunately are not as good at producing large quantities of protein as things like yeast or E. coli. One of the things that people figured out is that if you treat CHO cells with a drug called methotrexate, a specific region of the genome where a enzyme to deal with methotrexate is encoded will start to amplify itself. The cell will actually just make many more copies of that piece of DNA. And so if the gene to deal with methotrexate is colored red here, you can put your gene of interest here. You can pretend that it's blue gene, as long as it's close enough to the methotrexate induced gene. And you can get lots of copies of your gene of interest too and drive really high expression of your protein of interest. So I think that's exciting. Okay, so I wanted to do a quick shout out to my favorite production host. I am a plant genetic engineer. And so I wanted to take a second to talk about molecular farming. One of the advantages of engineering plants to produce medicinal compounds, which actually is the thing that people do is that it's easy to scale production. So again, this would be the movement of compounds from a really slow growing plant into something that's faster growing or production of protein therapeutics that a plant wouldn't usually make at all. And so you can engineer the plant to produce them and then get a lot of seeds and use all the infrastructure that we currently have in place to farm things in order to get a large quantity of whatever compound or protein of interest you're trying to make. And the nice thing about this is you don't need really expensive reagents. You don't need really expensive gross medias in order to make a lot of the plant. But you do need to purify your protein or compound of interest out of the plant at the end, which can be time consuming. Okay, so that was kind of a crash course in all of the cool things that we've been doing in bioengineering to try to up production or sourcing, screening and scaling of medicine. But it is just a crash course. There's so much more. So I encourage you to start looking into all of the different ways that bioengineering is impacting the development of medicine. The papers that I've linked here are really good starts in that direction. But I also encourage you just to think about how medicine development can be innovated on even further. Can you think of new ways to source medicines or screen to see whether or not they're functional or scale production?", "start_char_idx": 4122, "end_char_idx": 6677, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "074f11d1-8deb-4fc7-b98b-49e8dce03f01": {"__data__": {"id_": "074f11d1-8deb-4fc7-b98b-49e8dce03f01", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1b7eed84-f5f9-42fb-ba83-14671a23490c", "node_type": null, "metadata": {}, "hash": "2f437388ce20a9ab58bd2d1a3a4b49682042f42a55eb92fd789ab4b8093963e3"}, "3": {"node_id": "9edaebc1-94a2-4eb6-9dbe-2c5a732bc7dc", "node_type": null, "metadata": {}, "hash": "d066e2aae6eea8eb27ffdf277da4c6f150ca502f7c747a8a677bef4647103f2c"}}, "hash": "36b1e5dbbfc4290dd259217f649eda1e88b5d15ecaeee591ff2a8a6f78a35381", "text": "We're going to explore first the idea of molecular diffusion, and once we get a basic understanding of that, move on to think about how we go from molecular diffusion to synthetic biological behaviors. So let's jump in and see what's going on and what we can make with it. The photo here is of a frog egg, you know, a frog, and it's just sitting there. It hasn't turned into a frog yet. And I want you to think about these questions. What is underneath how life works? Why does a frog egg turn into a frog? Why is it happening? So it turns out this image is from a movie, a historical film, an incredible film of frog development. So let's take a look and see what's happening. Again, we're starting here, looking just at a frog egg, ready to go. Here we go. We see this cell divide, it looks like, in the two... Why did that end in four cells? Wait a minute. Why is this happening? Let's go back in time. It was just sitting here. We have one big cell, and suddenly it's starting to change and do things. I don't see anything coming in from the outside, like cutting and dividing and making all of this happen. It's all happening from the inside out. Everything underneath and inside this living matter is causing all of these changes of behaviors, these cell division events. Oh, look at what's happened now. Just keeps going. Why is this happening? If we fast forward, we start to see forms and shapes appear, starting to begin to look like the body plan of an animal, and eventually we get tadpoles, and eventually a frog. But remember where all this started, right? We had a cell, and it started to spontaneously divide, and then differentiate, and turn into a tadpole and then a frog. We know that cells are comprised of biomolecules, and we know that life happens in water. The molecules within a cell are mostly suspended in water. Of course, there's other things in there too, but for now, let's just think of it as biomolecules suspended in water. On the left is an image of a simple, quote unquote, simple microorganism, not a frog. On the right, we've seen this before, is a beautiful representation, a representation of how the molecules might be organized in this cell. The green in the bottom shows us the outer membrane or shell of the cell. And then in purple, we see, I don't know if those are ribosomes for making proteins, and then maybe in yellow, we've got DNA or RNA. Not quite sure, but we could figure it out. Oh no, it looks like maybe the RNA is in this pinker color, and the yellow must be the DNA. It's so interesting, once you can see things, you can begin, what would it be? What could it be? Now these images, they're static. They don't answer the question of like, how did that egg turn into a frog? Let's keep going. Now in keeping it going, I also want to help us and challenge us to develop a deeper empathy for what it's like to be one of these molecules, what it's like to be a cell. The tool I like to use is a magic wand, and it's a certain type of magic wand. It's a magic wand that lets us make things bigger. We can use it in this case, cells are tiny, so let's use this magic wand to make a cell a lot bigger, just so we can help think about it. And when we start to imagine things moving around, hopefully we'll be more comfortable with what might be going on. So I've listed in the middle here, different types of molecules or objects we can find in cells. A water molecule, two hydrogens and one oxygen, or a base pair of DNA, an A and a T base pairing in this case, GFP is a green fluorescent protein. Maybe our cell has a little protein that's green when you excite it with a wavelength of light. A bilayer, this is lipids that make a membrane that could encapsulate the cell or regions within the cell. The ribosome, a combination of molecules that when you give it messenger RNA and other inputs, it can make proteins. A phage, phage are only in cells if they're", "start_char_idx": 0, "end_char_idx": 3913, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9edaebc1-94a2-4eb6-9dbe-2c5a732bc7dc": {"__data__": {"id_": "9edaebc1-94a2-4eb6-9dbe-2c5a732bc7dc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1b7eed84-f5f9-42fb-ba83-14671a23490c", "node_type": null, "metadata": {}, "hash": "2f437388ce20a9ab58bd2d1a3a4b49682042f42a55eb92fd789ab4b8093963e3"}, "2": {"node_id": "074f11d1-8deb-4fc7-b98b-49e8dce03f01", "node_type": null, "metadata": {}, "hash": "36b1e5dbbfc4290dd259217f649eda1e88b5d15ecaeee591ff2a8a6f78a35381"}, "3": {"node_id": "f626a660-fbd9-40ac-9670-bfd406c6183a", "node_type": null, "metadata": {}, "hash": "4bd37d9ed19937b5cc0c2531f865a4d11de9d9ed206eb736b8c5cd9eeb5ea10f"}}, "hash": "d066e2aae6eea8eb27ffdf277da4c6f150ca502f7c747a8a677bef4647103f2c", "text": "it can make proteins. A phage, phage are only in cells if they're infected. A phage is a type of virus for bacteria. The full name for phage would be bacteriophage, which means eater of bacteria. mRNA, messenger RNA, that's going to instruct the ribosome what protein to make. The genome, the DNA template that when transcribed makes the RNA that then gets transcribed. So these aren't all the types of molecules we'll find in a cell, but some ones that we'll talk about again and you should know about. Cells are tiny. So if we use a example cell, say E. coli, the bacterium that lives inside the human gut, how big are these molecules? So E. coli roughly is one millionth of a meter long. Sometimes it's a little bit bigger and it's shaped like a tube or a cylinder, about one micron or one millionth of a meter long. And that's notated by one E minus six. This means shorthand for one times 10 to the minus sixth meters, or one millionth of a meter. Okay, so how big is a water molecule? How big are all these other molecules? And you can see a water molecule is about 2.8 times 10 to the minus 10th of a meter. A nanometer would be one times 10 to the negative nine. So this is not even a nanometer. It's 28% of a nanometer, it looks like. How about a base pair of DNA? 3.4 times 10 to the minus 10th meters. What about this green fluorescent protein? Oh, it's about three nanometers or 30 tenths of a nanometer. I'm keeping everything in one times 10 to the minus 10th, just so you can compare it more easily. Proteins about this protein, a typical protein, maybe three nanometers in diameter. You know, bilayer, four nanometers or 40 tenths of a nanometer. Ribosome looks like it's approximately, you know, 20 nanometers. And the phage, 580 tenths of a nanometer or 58 nanometers. RNA, 3,000 tenths of a nanometer. The genome, 1.6 millimeters. I jumped there, right? Genome's like big, looks like it's going back. This is incredible to think about. It looks like a genome in a bacterium like E. coli is so long, it's going back and forth over a thousand times just to fit within the cell. Now it's very skinny, but watch, it's going back and forth, back and forth. And it's not necessarily organized literally like a cable, but it's like, hmm. Now, of course, these things are moving. And this is what, you know, our current discussion will end up being about. So this GFP, we can represent how quickly it's moving. And we'll make more sense in a few slides, but roughly it's moving about six microns or six times 10 to the minus ninth meters per second. Excuse me, six times 10 to the minus sixth microns per second. A micron is a millionth of a meter. All right. So see what I mean? Like cells are tiny. These numbers, they're real or approximately real. And by the way, there's a great site on the internet called bio numbers where you can get quick access to a lot of numbers like this will be useful in your back of the envelope calculations as a bioengineer. But, you know, unless you've already been operating at the scale of angstroms and nanometers in your life, it's like, it's hard to have empathy or make sense of this. So that's why I like this magic wand. So what we're going to do is we're going to take E.coli and we say, boom, boom, boom. It's a hundred million times bigger. We're going to multiply all the dimensions by a factor of 10 to the eighth or a hundred million. Not going to go a billion. That'd be too big. But like, let's see what happens when we go with a hundred million. So we're going to multiply all these dimensions by a hundred million. And we're just making a bigger cell. We're not adding more atoms, but just like magically everything's bigger so we can see what it feels like. Now, when I make", "start_char_idx": 3861, "end_char_idx": 7601, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f626a660-fbd9-40ac-9670-bfd406c6183a": {"__data__": {"id_": "f626a660-fbd9-40ac-9670-bfd406c6183a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1b7eed84-f5f9-42fb-ba83-14671a23490c", "node_type": null, "metadata": {}, "hash": "2f437388ce20a9ab58bd2d1a3a4b49682042f42a55eb92fd789ab4b8093963e3"}, "2": {"node_id": "9edaebc1-94a2-4eb6-9dbe-2c5a732bc7dc", "node_type": null, "metadata": {}, "hash": "d066e2aae6eea8eb27ffdf277da4c6f150ca502f7c747a8a677bef4647103f2c"}, "3": {"node_id": "51b8894d-47e5-4693-a08f-8d56de1464f1", "node_type": null, "metadata": {}, "hash": "21503088cdfd347dc817efcd54bb490581387983a5af2ea43e30383a8b39a0b1"}}, "hash": "4bd37d9ed19937b5cc0c2531f865a4d11de9d9ed206eb736b8c5cd9eeb5ea10f", "text": "everything's bigger so we can see what it feels like. Now, when I make something a hundred million times bigger, and originally it was a micron. Now it's about a hundred meters long, you know, like multiply one times 10 to the minus six times one times 10 to the eighth, you get a hundred. So, so now we have our magical cell and it's about a hundred meters long, which conveniently is about the size of the bioengineering building at Stanford. Which is called the Sriram Center for Bioengineering and Chemical Engineering. And so we're going to call this magically enlarged cell, a Shariki of Sriram. E Sriram. Suddenly it's like a lot easier. I don't know about you, but it's going to be a lot easier for me to think about, you know, what's going on inside this object. So water molecule is suddenly 2.8 centimeters. Oh, that feels nice. You know, it's like an inch and a base pair of DNA. It's suddenly much more accessible. It's like 3.4 centimeters roughly. And this green fluorescent protein that was so tiny before three nanometers. Ah, yeah. It's 30 centimeters. What is that? Like the size of a, of a basketball or football, approximately the bi-layer encapsulating things, you know, 40 centimeters, almost half a meter. The ribosome, the ribosome is making proteins. Yeah. It's two meters tall. It's about six feet tall. That feels friendly. Like I can deal with that. The phage, this virus that be infecting a cell is kind of intimidating. It's six meters. Wow. Interesting to think about that. You know, it's like a two-story building. The mRNA that's being translated to make a protein. It's, it's about a hundred feet long. It's like a little string, 30 meters long. The genome encoding all the DNA is 160 kilometers. And if you, not that it looks this way, but if you packed it up in the building and, and had it be like really densely configured, you know, back and forth, back and forth, back and forth, back and forth, back and forth, 1600 times, the cross-section of that bundle would be about four, four meters square. Right. So that's kind of interesting. Like it fits. It all fits within this hundred meter, hundred meter building. Now, remember things are moving, right? I mean, something is causing life to happen. That frog embryo develops. The ribosome makes proteins for the ribosome to make protein. It either has to move along messenger RNA or spool and pull the messenger RNA through it. And, and we know that it's running at about 50 nucleotides or letters on the RNA per second, depending on conditions, but like roughly that fast. And so we can do the math, like how long is the base pair. And if we're transiting, you know, uh, 50 bases a second or nucleotides a second and each base is this long. Oh yeah. You know, like that ribosome is moving at about 1.7 meters per second. That's a brisk walk, right? It's not a sprinter. It's not like the a hundred meter dash, right? You do a hundred meter dash and 10 seconds, you know, you're fast. Right. And, and so like a sprinter is running at 10 meters a second, maybe a little bit faster than that, depending how great you are. You know, so ribosomes like walking along fast walk, um, this, this green fluorescent protein is example protein. That's the size of a football, soccer ball, basketball. Yeah. Um, it's moving. It looks like 650 meters a second. I don't know how you think about that for me. That's just like, whoa. Remember the whole cell size of a building is only a hundred meters. And I've got proteins in this object, size of basketballs, and they are zooming around at almost a kilometer a second. And I think we'll have to figure this out. This is actually not like the instantaneous velocity as we'll see, but this is the average displacement over time. So in the super microscopic, it might actually appear to be going even faster. Okay. But hopefully I really invite you to explore and walk", "start_char_idx": 7598, "end_char_idx": 11490, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "51b8894d-47e5-4693-a08f-8d56de1464f1": {"__data__": {"id_": "51b8894d-47e5-4693-a08f-8d56de1464f1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1b7eed84-f5f9-42fb-ba83-14671a23490c", "node_type": null, "metadata": {}, "hash": "2f437388ce20a9ab58bd2d1a3a4b49682042f42a55eb92fd789ab4b8093963e3"}, "2": {"node_id": "f626a660-fbd9-40ac-9670-bfd406c6183a", "node_type": null, "metadata": {}, "hash": "4bd37d9ed19937b5cc0c2531f865a4d11de9d9ed206eb736b8c5cd9eeb5ea10f"}, "3": {"node_id": "c094a7e3-a2f6-42b9-8a07-dbaa9f343bb6", "node_type": null, "metadata": {}, "hash": "c7fb469fb039db68a2e7218a4f0a4d6500fe09df705e65128a760dfaa70f18ed"}}, "hash": "21503088cdfd347dc817efcd54bb490581387983a5af2ea43e30383a8b39a0b1", "text": "going even faster. Okay. But hopefully I really invite you to explore and walk around Escherichia shriram, the cell, the size of a building, um, because suddenly you can get a sense of like the relative sizes and how things are moving roughly. And how does it all fit together? Right. So fun to think about Escherichia shriram. So we've seen this video before. I want to reuse it to go inside this building and remind us of a couple of things, but also come back to the question, like what's underlying life happening. This is a computer simulation of molecules comprising cytoplasm of a bacteria, you know, like most of the molecules people know about. And the molecules, they're all biomolecules have different colors depending on what they are. And you can see they're just jostling around. They're moving around seemingly randomly. Like what's causing them to move? They have little like rocket jets. No, that we don't see any evidence of rocket jets or, you know, as somebody coming in there with a stick and like poke, poke, poke, poke, poke, lots of sticks, poking this around. Not from the outside, at least. And what's not shown here is what these molecules are suspended within. Are they in a vacuum of space? No, they're inside a cell. And we know on our planet, right, life operates mostly within water, almost exclusively. And so the invisible thing not shown here are the water molecules. And so we know this jostling is happening within a watery milieu. We'll come back and look at this video again once we understand diffusion. A little bit better. Remember what happens if you freeze a living system? Won't be living, right? If the ice crystals disrupt the structures, then it's broken forever. But yeah, you know, like things moving in water, that movement is essential for life as we know it. And so that's interesting, right? We could change how quickly things are moving by changing the temperature. In 1827, there's an important brief account. Look at the title of this. We've talked about reading research papers. Here's one from 1827. A brief account of microscopical observations made in the months of June, July, and August of 1827 of the particles contained in the pollen of plants and on the general existence of active molecules in inorganic and organic bodies by Robert Brown. This is a really important research paper, to say the least. And Mr. Brown, among other things, was apparently interested in life. And if you looked at objects derived from living systems, like the pollen of plants, he could observe that grains of pollen suspended in liquid just jostle around, are moving around by themselves, seemingly randomly. Maybe this capacity to move around spontaneously is the secret essence underlying life, that there is some life essence within living systems that causes this apparent spontaneous movement. My understanding is one of the experiments he tried was to take grains of pollen and observe their motion, as shown here, and then to take some of those samples and cook them, basically autoclave them, sterilize them, so that the grains of pollen would still be there, but they'd be dead. So that any life force or essence within them that was causing this spontaneous movement should go away, because they'd be killed, right? But they'd still be these physical grains of pollen, they'd just be killed. Interestingly enough, when you do that, they still move. Something else is causing the pollen grains to move about. Brown's work is going to be developed over time into what is recognized as Brownian diffusion, or spontaneous motion of objects suspended in water or another solution. Here are two representations of this. Again, very simple computer simulations in two dimensions, in this case. And I encourage you to look at the links below if you want to go deep on this. But for an introductory course, I just want to get a sense of what's going on. So first, let's look at the movie on the left. We are going to have particles moving around. They're moving around in a circular motion. We are going to have particles moving around. They're moving around randomly. And some of the particles have been colored yellow. And the", "start_char_idx": 11483, "end_char_idx": 15658, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c094a7e3-a2f6-42b9-8a07-dbaa9f343bb6": {"__data__": {"id_": "c094a7e3-a2f6-42b9-8a07-dbaa9f343bb6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1b7eed84-f5f9-42fb-ba83-14671a23490c", "node_type": null, "metadata": {}, "hash": "2f437388ce20a9ab58bd2d1a3a4b49682042f42a55eb92fd789ab4b8093963e3"}, "2": {"node_id": "51b8894d-47e5-4693-a08f-8d56de1464f1", "node_type": null, "metadata": {}, "hash": "21503088cdfd347dc817efcd54bb490581387983a5af2ea43e30383a8b39a0b1"}}, "hash": "c7fb469fb039db68a2e7218a4f0a4d6500fe09df705e65128a760dfaa70f18ed", "text": "They're moving around randomly. And some of the particles have been colored yellow. And the yellow particles are going to follow their traces over time to see how they're moving. And of course, the particles might run into each other, and they'll be moving around. So let's just see what happens. They're moving around pretty fast. And the traces shown in blue are kind of all over the place. It's just, I don't know, I'd describe it as random. Now, of course, if we wanted to claim they were random, we would have to really carefully validate the statistics of the trajectories. But it looks random to me. It's really fast. The movie on the right is a little bit different. We've got, it's exactly the same as the left, except one of the particles suspended in solution is big. This big yellow particle right in the middle, at least to start. And so let's run that movie.", "start_char_idx": 15632, "end_char_idx": 16504, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8611eb7c-86ff-48b2-912a-a070f28af374": {"__data__": {"id_": "8611eb7c-86ff-48b2-912a-a070f28af374", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "29fd480d-1c2c-45c8-a54b-2eccf5b43215", "node_type": null, "metadata": {}, "hash": "7f171948552e0fb9b93efea95776c58664409b15cc6f4a24a292e9b9b1a22d28"}, "3": {"node_id": "e7f86d3b-cec6-443e-8ce1-4786cbc065e2", "node_type": null, "metadata": {}, "hash": "0fef49dfe638aa35c18b6b3d4cf8af197fc5f87cf95c7b7215bd9e421c71afd1"}}, "hash": "230eaf6a8888a2cb5f58650d06929fe6cad33bdf6c2c4aa0e5630bef0259a91e", "text": "The first thing you notice is the particle that's larger is moving more slowly. The trace isn't very long, so it looks like it's going up in this case, mostly, but it's like drifting around, so it might still be random. I'd want to follow it for a longer period of time to see where it ends up and does it go in all directions, but it's being jostled around by the smaller particles and other things that might be invisible. This is a way of thinking about what Brown was observing, those pollen grains moving around. How is this going to be related and more simply organized into what we know today as Brownian motion, Brownian diffusion? The first thing we can draw upon, beyond looking at what's happening at a microscopic level, is to just think about what happens. Imagine you had a perfectly smooth dish of water, and you were able to put a drop of food coloring in the middle of the dish, and it didn't disturb the water at all, and there was no flow in the water. You're just looking over time to see how the dye and the food coloring, what would it do? What would you expect it to do? In my experience, when I've done things like this, there might be a concentrated spot of dye in the middle of the dish right when I add it, but inevitably, for reasons, the dye will spread out over time. That's what's shown in this depiction on the bottom left of this slide. The height of the surface shown in this image is the density of the dye in a two-dimensional solution. As time progresses, the intensity of the dye diminishes as the dye overall spreads out and colors the entire dish. If I wanted to think about that instead of a two-dimensional system, just something on a string or on a line in one dimension, I might have a peak of something that I add at an early time, and that peak spreads out as things diffuse over time. What's interesting here is suddenly, we just went from a microscopic representation of how things are spontaneously moving around to a bulk or aggregate representation, which means when you have many molecules interacting as a system, things behave as an ensemble set of molecules or in bulk. The bulk representations are often not dominated by noisy behavior. Instead, we see this very smooth, almost determined behavior that follows our expectations. Our expectations, again, are derived from empirical observation. I add a drop of food coloring to a dish in perfectly still water, and the dye will diffuse or disseminate and become less intense over time. Diffusing particles, we know from experience, tend to spread out over time. Diffusing particles, particles moving around spontaneously. It turns out mathematics can describe how far molecules move due to this spontaneous Brownian motion named after Mr. Brown. We're going to use some math here, and it might look a little strange at first, but it's not too complicated, so I really encourage you to, if you haven't seen it before, just play with it. It's such beautiful math. There are three equations here. From top to bottom, it represents how far molecules move due to spontaneous random motion in a one-dimensional system at the top, in a two-dimensional system at the bottom, in the middle, excuse me, and a three-dimensional system at the bottom. What do I mean by 1, 2, 3D? Imagine you had a molecule on a strand of DNA or a strand of RNA, and it was sitting there, and it could just randomly go back and forth. How far would it tend to go over time? The equation at the top is going to help us think about that. Instead, let's say I had a membrane on the cell and a molecule sitting inside the membrane or outside the membrane, and it was just randomly searching around the membrane. How far would it tend to go over time? We could use the middle equation, or let's say I have a molecule inside the cell in the middle of cytoplasm. Obviously, it's a three-dimensional space it can explore, and we can use the bottom equation for that. What do the terms mean in these equations? X-squared or R-squared is known as the mean square", "start_char_idx": 0, "end_char_idx": 4027, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e7f86d3b-cec6-443e-8ce1-4786cbc065e2": {"__data__": {"id_": "e7f86d3b-cec6-443e-8ce1-4786cbc065e2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "29fd480d-1c2c-45c8-a54b-2eccf5b43215", "node_type": null, "metadata": {}, "hash": "7f171948552e0fb9b93efea95776c58664409b15cc6f4a24a292e9b9b1a22d28"}, "2": {"node_id": "8611eb7c-86ff-48b2-912a-a070f28af374", "node_type": null, "metadata": {}, "hash": "230eaf6a8888a2cb5f58650d06929fe6cad33bdf6c2c4aa0e5630bef0259a91e"}, "3": {"node_id": "5ccd14ca-9de1-4de9-9160-33e7e8cda112", "node_type": null, "metadata": {}, "hash": "9e23d28e125d8bd11f19805e958a0b0e02b7195f98e7149efd1399e0d3c46022"}}, "hash": "0fef49dfe638aa35c18b6b3d4cf8af197fc5f87cf95c7b7215bd9e421c71afd1", "text": "in these equations? X-squared or R-squared is known as the mean square displacement, the square of the average distance traveled by a particle in one of these systems. The left side of the equations is the square of how far something is going to move on average. The letter D here on the right side of the equation is the diffusion coefficient. It's the oomph. It's like how fast is something going to be moving, we think. T is the elapsed time. To state this in simple English, if I want to know, on average, how far something is likely to travel, I am going to take the diffusion coefficient for the something, for the molecule, and the amount of time I'm willing to let go, the elapsed time, and I multiply those two terms. If I take the square root of the product, following these equations, I'll get the value to X or R, and that'll be my mean square displacement, the average distance traveled by a molecule with that diffusion coefficient and that amount of elapsed time in the system. Let's do an example. Remember green fluorescent protein. It's a protein a couple nanometers across, and it's going to exist in cytoplasm if we have the DNA encoding that protein in the cell and it gets expressed. We can look up the apparent diffusion coefficient, the value of D for this protein in typical bacterial cytoplasm in this case, and to keep it simple, the value of D, the diffusion coefficient, is 7 microns squared per second. If we wanted to ask how far will green fluorescent protein tend to move on average over some period of time, we can take this value of D and decide what system we're working with, like a 1D, 2D, or 3D system, and plug it into the equation. Let's do it for a cytoplasm. We use the 3D equation, and we get the number 6 times the diffusion coefficient of 7 microns squared per second, and let's just ask in a second how far will green fluorescent protein go, and so we just add one second in, and so we're just filling in the bottom equation with our values, and we see that the mean square displacement is 42 microns squared, which is a little bit strange. We want to turn this into just microns, or millionths of a meter, and so we need to take the square root of 42, which is about 6.5 microns. A protein of the size of green fluorescent protein, relatively typical protein in cytoplasm, everything else being equal, for bacteria, at room temperature, maybe body temperature in a second, it'll go about 6.5 microns. That's pretty interesting. Remember the cell, E. coli, is about a micron, so this thing's moving, it's moving around. The fact that molecules are moving spontaneously, because they're being jostled by the underlying invisible movement of the water molecules, is what's going to enable living systems to behave, to be alive, to spontaneously perform, and in the case of the frog embryo, start to undergo development. What's really interesting when you start to adopt this mathematical thinking, is you can ask questions, like, oh, let's say I wanted to go twice as far, how much longer would that take? You'd be like, well, if I want to go twice as far, I need twice as much time. Look at that 3D equation, any of the equations, to get the average distance traveled in units of length, you actually take the square root of the right side, so if you want to go twice as far, you actually have to wait four times as long, because you're going to take the square root of t. So that's one of the powers of moving this thinking into some mathematical representation. Let's unpack the diffusion coefficient, and once we get through this, we're going to pause, catch our breath, but I want to unpack the diffusion coefficient just to give you deeper intuition for what factors are going to influence how molecules are moving around, and so at first blush, you might have never seen this before, it might be intimidating, but it's not too complicated, so let's just play with this diffusion coefficient equation. So D is the diffusion coefficient for a molecule, each molecule could have a different diffusion", "start_char_idx": 3969, "end_char_idx": 8018, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5ccd14ca-9de1-4de9-9160-33e7e8cda112": {"__data__": {"id_": "5ccd14ca-9de1-4de9-9160-33e7e8cda112", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "29fd480d-1c2c-45c8-a54b-2eccf5b43215", "node_type": null, "metadata": {}, "hash": "7f171948552e0fb9b93efea95776c58664409b15cc6f4a24a292e9b9b1a22d28"}, "2": {"node_id": "e7f86d3b-cec6-443e-8ce1-4786cbc065e2", "node_type": null, "metadata": {}, "hash": "0fef49dfe638aa35c18b6b3d4cf8af197fc5f87cf95c7b7215bd9e421c71afd1"}, "3": {"node_id": "a2513c57-cb40-4ac1-b124-eef20af14e7b", "node_type": null, "metadata": {}, "hash": "5641a5634d001f92d6eeeb0a212a2cdd2037ba32d9ce1b437803b5515d69351b"}}, "hash": "9e23d28e125d8bd11f19805e958a0b0e02b7195f98e7149efd1399e0d3c46022", "text": "diffusion coefficient for a molecule, each molecule could have a different diffusion coefficient, we'll see in this example why there could be differences. The numerator has two terms, the first thing is called the Boltzmann constant, which if you haven't heard about, it's going to be esoteric, the second thing I bet you've heard about is just temperature, temperature of the system, and so right there we can see if temperature goes up, diffusion coefficient is going to go up, because temperature is in the numerator. Boltzmann constant is a constant, and you'll be asked in the p-set to make sure you have a feeling for what it means, but in simple language, the Boltzmann constant takes temperature and lets you relate temperature to the velocity or kinetic energy of molecules, so it's like how fast is something going to be moving, the temperature is the energy of the system, but how does that energy of the system translate to molecular motion, that's what the Boltzmann constant is going to let us do. Okay so we've talked about the numerator, again the Boltzmann constant isn't going to change, the temperature could change, if the temperature changes that's going to impact the diffusion coefficient, in the denominator we have six, okay that's a number, we have pi, that's a constant, another number, then we have viscosity, viscosity is how thick the fluid is, think of syrup for a pancake, it's like really thick, if we have a thick liquid it's going to be harder for molecules to move around, so as viscosity goes up the denominator increases, diffusivity is going to go down, that makes sense, that's viscosity, and then r is the radius of the molecule, you know, like how big is the molecule, and the bigger the molecule, well it's going to be the denominator, so the denominator goes up and diffusion coefficient goes down. It's interesting, the only thing that's specific to the molecule in this example of the diffusion coefficient is the size of the molecule, right, and then the system is defined by the viscosity of the liquid or the solvent, and the temperature of the system, right, so those are the variables, and just to summarize, diffusion follows temperature, meaning if temperature goes up, diffusion goes up, temperature goes down, diffusion goes down, if temperature goes all the way down, right, there's no diffusion, so you're not going to have a living system, so it's going to be static, right, it's going to be frozen, although technically frozen is a little bit, okay, you get the idea, the inverse of viscosity, so viscosity goes up because it's in the denominator again, diffusion is going to go down and vice versa, and diffusion follows also the inverse of molecular radius, the molecule gets bigger, diffusion is going to get slower, you know, a molecule that was four times smaller should diffuse about twice as far, right, because remember when we go to the preceding slide to get the mean square displacement, distance traveled on average, we have to go through a square root, right, so hopefully this gives you, you know, some framework to chew on and think about what's going to impact how fast molecules are moving. I want to recommend to you, if you love reading books, this incredible book, Random Walks in Biology by Howard Berg, and the link here will take you to a website where you can actually find, I believe for free, the chapters of this book, but if you can't get it, let me know and we'll get you the chapters as best we can. It's such a beautiful book about how randomness and spontaneous behavior, bottom-up in biology, manifest as beautiful biological phenomena within living systems. Okay, so now we're going to return to something we're familiar with, this representation of molecules jostling around in cytoplasm, and what I want to ask you to do is just pick a molecule. We're going to let this video loop, right, like let's pick, look at this little red", "start_char_idx": 8005, "end_char_idx": 11930, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a2513c57-cb40-4ac1-b124-eef20af14e7b": {"__data__": {"id_": "a2513c57-cb40-4ac1-b124-eef20af14e7b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "29fd480d-1c2c-45c8-a54b-2eccf5b43215", "node_type": null, "metadata": {}, "hash": "7f171948552e0fb9b93efea95776c58664409b15cc6f4a24a292e9b9b1a22d28"}, "2": {"node_id": "5ccd14ca-9de1-4de9-9160-33e7e8cda112", "node_type": null, "metadata": {}, "hash": "9e23d28e125d8bd11f19805e958a0b0e02b7195f98e7149efd1399e0d3c46022"}}, "hash": "5641a5634d001f92d6eeeb0a212a2cdd2037ba32d9ce1b437803b5515d69351b", "text": "going to let this video loop, right, like let's pick, look at this little red molecule down here. Find the tiniest molecule and just follow it around. Is what we're observing consistent with the framework we've just developed for representing spontaneous diffusion of molecules, Brownian diffusion? I look at a tiny molecule, like this tiny red molecule, it seems to be, what would I expect, it should be moving more quickly relative to the larger molecules, and that looks to be true. Where's a big molecule? Like this molecule over here on the right, it's like a Christmas molecule, it's red and green. It's not moving as quickly. Its diffusion coefficient must be lower. That makes sense. Another thing I want you to think about is whether a molecule, is it only stuck in one neighborhood for sub-region of this, or do the molecules eventually get to go everywhere? And this is trickier to see because at first blush, when I look at this video, it seems like things are really locally constrained, but if you pay closer attention, there doesn't seem to be any formal constraint keeping things in the top left versus the bottom right. Instead, over time, when it's easier to see with the smaller molecules, they're able to go everywhere. This is what's called a self-mixing system, such that over time, on average, anything can be anywhere. This idea of self-mixing, that on average, anything can be anywhere over time, for at least some of the molecules inside living systems, is going to make the engineering really different. It's not like, oh, I've got a transistor and another transistor and I've got a wire and I connect the two and they're stuck there. Of course, we are going to be able to connect some things in biology to other things, but underneath it all is this self-mixing foundation. For a lot of things, the business of life requires that everything can move around to be everywhere else on average and interact and sample or touch everything else. Very interesting. Spend enough time with this. Find the video online if you like. All these videos, make sure you're gaining empathy for what's going on with the molecules inside living systems. We're going to wrap up for now and offer these reflective questions. Which molecules move faster or slower? Why? Do things make sense to you? Given enough time, how many other molecules will any given molecule interact with? In a diffusing system, will all molecules eventually interact, i.e. collide with everything else? Thinking ahead, how are we going to get organized behavior from this underlying randomness or Brownian motion? Stated differently, what's good about this underlying spontaneous self-mixing from an engineering perspective and what's going to be a challenge? See if you can guess how that might end up.", "start_char_idx": 11926, "end_char_idx": 14712, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ae982e83-4f2e-4db7-89e5-6993a8bc1ab7": {"__data__": {"id_": "ae982e83-4f2e-4db7-89e5-6993a8bc1ab7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "26d3e909-9d51-40e0-b667-5c5fcd96ff4a", "node_type": null, "metadata": {}, "hash": "d14be8764daa51757378f9c58ca268d41fe82e86faa1585c135dacce90e4dedc"}, "3": {"node_id": "f03f2ddc-4c32-413e-855a-e078f8ed6b97", "node_type": null, "metadata": {}, "hash": "a896494b1b527af1cc34baeb2d7318ede774d7e93bf709b4d819381c237baef3"}}, "hash": "90be4cad9b57765e30bd7e1a2bcbff01ae1195b45ee4eeb639b3a551fcab9b4e", "text": "We've just learned about molecular diffusion, and now we're gonna see how it applies in bioengineering. Can we sculpt and shape and program synthetic behaviors? So let's get into it, see what we can do. Remember, in the first week of the material for bioengineering, we were talking about reading papers. So let's use that tool real quick. Here's a paper, 23 years old. Maybe it's older than most of you now, which is incredible. A synthetic oscillatory network of transcriptional regulators. Oscillatory network, an oscillating system. Transcription, that's the reading out of DNA to make RNA. Regulators, things that regulate transcription. Synthetic, we've made this oscillatory network from scratch, maybe. Michael Elowitz and Stan Liebler. Let's look at the abstract. Networks of interacting biomolecules carry out many essential functions, okay. But the design principles underlying the functioning of such intracellular networks remains poorly understood. Despite intensive efforts, including analysis and so on. Okay, remember, we're looking for the claim and oftentimes active voice, you know, okay, first person. Here, we present a complementary approach to this problem. That's not really a great claim. The design and construction of a synthetic network to implement a picture, this is a generic claim. We need something more specific. We used, okay, good. We used three transcription repressors that are not part of any natural biological clock to build an oscillating network termed the repressolator. And that's a good claim. So let's highlight that. Any other claims? The network periodically induces synthesis of a green protein as a readout of the clock. And the resulting oscillations, which are typically hours long, are slower than the cell division. Okay, interesting. So the state is transmitted. The state of the clock is transmitted, okay. And this clock displays noisy behavior, possibly because of stochastic, which means random, fluctuations of its components. Remember, in molecular diffusion, in Brownian diffusion, we have molecules moving around randomly at the individual microscopic level, and that results in bulk behavior, which can be represented more smoothly. So this is kind of an interesting statement down here as it might relate to Brownian diffusion. Inside cells, things are moving around randomly. Okay, well, let's take a look. We're not gonna spend a lot of time on this paper, but we're just gonna use it to set up a second example that'll let us explore diffusion even more. So let's jump into this paper and look for the evidence. It turns out this paper is so cool. I'd encourage you to read the whole thing, but one of the cool things about the paper is the movie you can find. So let's take a look at the movie, and we're looking for an oscillator or a clock that's been built and operating inside cells. Again, this work's done by Michael Elowitz, Mike Elowitz, now a professor at Caltech down in Pasadena, California. What we're looking at here in this movie, and you can find the movie yourself online through Vimeo or Michael's website. The links are at the bottom. What we're looking at is a microscopic movie, a time-lapse of a sheet of E. coli cells growing and dividing in a two-dimensional plane. And we're only looking at the state of the clock. So we're not just looking at the cells in normal light. We're looking at the state of the cells as measured by fluorescence, and the fluorescence is coming from a fluorescent protein. And so we're only seeing the cells showing up when the clock, let's say, is at midnight. And then when the clock's at 6 a.m. or 6 p.m., the cells are dark. And so that's the first thing. You can see that there are these patterns here of becoming very bright and very dark. The other thing, of course, that's happening in the background that makes it a little bit confusing, but we're gonna appreciate it, is that the cells are also growing and dividing. And so the way this works is at the beginning of the movie, in the very center of the screen, there's just one or two cells. And then every time they grow and divide, they make two cells, make four cells,", "start_char_idx": 0, "end_char_idx": 4152, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f03f2ddc-4c32-413e-855a-e078f8ed6b97": {"__data__": {"id_": "f03f2ddc-4c32-413e-855a-e078f8ed6b97", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "26d3e909-9d51-40e0-b667-5c5fcd96ff4a", "node_type": null, "metadata": {}, "hash": "d14be8764daa51757378f9c58ca268d41fe82e86faa1585c135dacce90e4dedc"}, "2": {"node_id": "ae982e83-4f2e-4db7-89e5-6993a8bc1ab7", "node_type": null, "metadata": {}, "hash": "90be4cad9b57765e30bd7e1a2bcbff01ae1195b45ee4eeb639b3a551fcab9b4e"}, "3": {"node_id": "f34bd321-25f9-454b-b74b-7689762c97e7", "node_type": null, "metadata": {}, "hash": "010ef8c293f2aa9405b67add1e77b52cbd6e6d932f42103dea64003b52fb4379"}}, "hash": "a896494b1b527af1cc34baeb2d7318ede774d7e93bf709b4d819381c237baef3", "text": "And then every time they grow and divide, they make two cells, make four cells, make eight cells, make 16 cells, make 32 cells, make 64 cells, right, like exponential growth of the cells. As the cells grow and divide, they push their daughter cells out and about and grow into this bigger two-dimensional colony of cells. So two things are happening here. Again, growth of the cells in a sheet from a seed cell, and then inside each cell is this synthetic genetic clock that's causing the cells to blink. This so-called repressilator. You just run this movie backwards and forwards, right? So if you look right in the middle, there's a cell that's quite bright, and now it goes dark. And if we go back in time, it becomes bright again, and then it's going dark. And you can see it. Now we're gonna run it forward in time. The cell we were just looking at, and it just divided into two bright cells, right? So that's both these processes, like the cells becoming bright and dark, but the cells are also growing and dividing. You can see off to the bottom right, there's a cell that's very bright, just become two very bright cells, and now they went dark. And then just above it, four cells are becoming bright. And now some other cells are becoming bright. What's interesting is these cells are not all doing the same thing at the same time. They're all growing, but whether they're bright or dark doesn't seem to be well correlated. Should we care about this? I think the answer is yes. And this is that second comment we found in the abstract. What's interesting is if you wind the movie all the way back to the beginning, and there's just one cell here, and you can't see it because it's dark, well, everything's the same because there's only one cell. And then here's just barely see early on in the movie, maybe there's eight cells here. They're mostly all off. But as we get to 30 cells, 60 cells, 120 cells, suddenly we see diversity or heterogeneity in the physical state of the cell. Just pause right here. Maybe 10% of the cells are very bright and 80% are off and some are in between. How did we go from one cell that's by definition genetically identical to a hundred cells still probably genetically identical? It probably hasn't been a lot of evolution or mutation here yet, but the physical state of the cell is very diverse. Where's this noise coming from? Where's this stochasticity coming from? Now, remember from last time, cells are made of molecules and the molecules inside the cells are self-mixing. They're moving around to do the thermal energy and the Brownian motion, right? And so what if in one cell where the molecules are in relation to causing the clock to move around are different than in another cell just because of how they're jostling? Or what if when one cell, it looks like the cells divide in the middle, when that barrier goes down, it's called septum formation and cytokinesis, but just think of it like a cell is growing and dividing, a barrier comes down and cuts the big cell in half into two tinier cells. What if when that barrier goes in place some molecules were on one side of the barrier versus the other side? And so even though the daughter cells are genetically identical, the physical molecules comprising their cytoplasm are different. That's probably happening, right? So maybe Brownian motion of individual molecules is contributing to this observed variation in the state of this clock. Of course, the cool thing is you can make a clock at all inside a cell, right? E. coli normally are like living in your gut. They're not running this clock making blinking lights, right? And so in the year 2000, for the first time, somebody is building a purposeful clock inside bacteria. Let's not complain that it's not keeping track of time perfectly. It's just the first time you get a oscillation like this working. It's amazing. Okay, so again, the question to reflect upon is what does this have to do? Maybe it has to do with time diffusion, at the molecular scale, maybe it's something to do with why individually genetically identical cells soon appear to be physically different. Isn't that interesting that we can get physical differences even with genetic homogeneity? Let's go on.", "start_char_idx": 4088, "end_char_idx": 8329, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f34bd321-25f9-454b-b74b-7689762c97e7": {"__data__": {"id_": "f34bd321-25f9-454b-b74b-7689762c97e7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "26d3e909-9d51-40e0-b667-5c5fcd96ff4a", "node_type": null, "metadata": {}, "hash": "d14be8764daa51757378f9c58ca268d41fe82e86faa1585c135dacce90e4dedc"}, "2": {"node_id": "f03f2ddc-4c32-413e-855a-e078f8ed6b97", "node_type": null, "metadata": {}, "hash": "a896494b1b527af1cc34baeb2d7318ede774d7e93bf709b4d819381c237baef3"}, "3": {"node_id": "7dd70d5b-5099-4dab-8458-3c51b446b3e8", "node_type": null, "metadata": {}, "hash": "1c161d438dcef7c48574fff9fdfa55a7b503cf9e077c11a9220bb03609600b00"}}, "hash": "010ef8c293f2aa9405b67add1e77b52cbd6e6d932f42103dea64003b52fb4379", "text": "interesting that we can get physical differences even with genetic homogeneity? Let's go on. That was just a warmup, so wait for it. Let's go on to a paper from 12 years later. This paper is, what, 11 years old. A sensing, we're gonna run the same method and keep leveling up that method, it's awesome. So first thing we do, we read the title. Are there any words we can't understand? Let's try. A sensing array of radically coupled genetic biopixels. What? Okay, a sensing array, an array that can sense something. Radically coupled, what is that, skateboarding? I have no idea what that means in this context. Radical, dude, no way. I have no idea what this word means in this context. Radically coupled. Genetic, okay, DNA. Biopixels, I know what a pixel is, like a pixel on a display, on a television, on a computer screen, something like that. Biopixel, must be a pixel made out of biology. Cool, all right, then we're gonna go to the abstract. I still don't know what the word radically means though in this title, that's fine. Now we're gonna read the abstract and see if we can find a claim. Although there has been considerable, this is not a claim, it's just a statement. Although there's been considerable progress in the development of engineering, a substantial challenge is the construction of robust circuits in noisy environments. So this is kind of interesting, like noisy, spontaneously mixing, diffusing, randomness. Okay, good. Such an environment, a noisy environment, leads to considerable intercellular variability in circuit behavior. If you make a DNA circuit, just like we saw in the previous work, although all the individual cells have the same genetic program in them, the cells are not doing the same thing at the same time. Right, so considerable variability. This is looking like this might be a pretty cool paper. Considerable variability in circuit behavior, which can hinder functionality at the colony level, the collective level. When you have a bunch of cells, bunch of bacteria, you call it a colony. Here, oh, here we go. Here's the claim. Here, we engineer the synchronization of thousands of oscillating colony biopixels over centimeter length scales through the use of synergistic intercellular coupling involving quorum sensing. It just, isn't this a heroic language? It's like, wow, they did all this. Involving quorum sensing within a colony and gas phase redox signaling between colonies. Maybe that has something to do with radically coupled. We use this platform to construct liquid crystal display like macroscopic clock that can be used to sense arsenic, an environmental pollutant, like polluted water via modulation of the period of oscillation. Given all this, we have set the stage, I'm paraphrasing, set the stage for the construction of low cost genetic biosensors that are capable of detecting heavy metals and pathogens in the field. By in the field, they mean in the real world. It's like, why do we have problems figuring out whether our water supplies are polluted? Maybe this paper can help us answer that question and do some other things. But what do I think is the big claim here? For me, I'm gonna highlight this statement. Like here, we engineer the synchronization of thousands of biopixels over centimeter length scales by coupling some things. All right, anything else I like in this? Yeah, we can use this to sense arsenic by modulating how the display is oscillating. Okay, again, now we found a good claim, mostly understand the title, step three, hunt for the evidence. And again, just like before in this paper, you can access through the link at the bottom. The cool thing is gonna be the video. So let's go right to the video. This work's done by Arthur Prindle and colleagues working in Jeff Hastie's lab in San Diego, California. What do we have here? Look at this blanket. I've never, have you ever seen, I've never seen something like this before. Start this over, let's go back to the beginning. Zero minutes, 40 minutes. Some things are turning blue. Other things are turning blue. Some of", "start_char_idx": 8316, "end_char_idx": 12389, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7dd70d5b-5099-4dab-8458-3c51b446b3e8": {"__data__": {"id_": "7dd70d5b-5099-4dab-8458-3c51b446b3e8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "26d3e909-9d51-40e0-b667-5c5fcd96ff4a", "node_type": null, "metadata": {}, "hash": "d14be8764daa51757378f9c58ca268d41fe82e86faa1585c135dacce90e4dedc"}, "2": {"node_id": "f34bd321-25f9-454b-b74b-7689762c97e7", "node_type": null, "metadata": {}, "hash": "010ef8c293f2aa9405b67add1e77b52cbd6e6d932f42103dea64003b52fb4379"}, "3": {"node_id": "2b9aa816-d439-4c7f-a219-c717d10011c4", "node_type": null, "metadata": {}, "hash": "19b093b4602aa7b46747f8eb843d6e944fd1d693c6d72272f7e2f2d4751b674c"}}, "hash": "1c161d438dcef7c48574fff9fdfa55a7b503cf9e077c11a9220bb03609600b00", "text": "40 minutes. Some things are turning blue. Other things are turning blue. Some of the things that are turning blue are turning off. They look like a grid of blue pixels, I guess. And now mostly everything's turning blue on and off together. I'll just let it run. Blink, blink, blink, pretty cool. Let's see if we can figure out how this works. To do that, let's build on our knowledge of diffusion. What can we infer, if anything, about the diffusion of biomolecules in this array of biopixels? The one thing I'm noticing for now is that although it doesn't start off with each pixel doing the same thing, synchronized with the others, over time, something is causing the pixels to synchronize. Now it could be that there's electrical wires that are communicating voltages behind this pixel array, but I'll just tell you, that's not what's happening here. All of this is being done with biology and biomolecules. And so the fact that the pixels start out of phase and then become synchronized suggests that there's a molecule diffusing across this entire array of pixels, sharing information with all the pixels about the state of other pixels, such that that signal is then being used to entrain or synchronize this blinking pattern among the individual pixels. So I think it's gotta be something like that, right? Like, how else would these things be blinking together? And if we knew what the length scale was, right, they mentioned centimeters, I think, then, and we know what the time scale is, we can see that clock running in the bottom left, then we can infer something about the diffusion coefficient, the apparent diffusion coefficient of this molecule, like how fast can it move around, has to be at least fast enough for it to be able to move around. Like how fast can it move around has to be at least fast enough to get across a centimeter or two within tens of minutes, it looks like. Let's take a closer look at one of the individual pixels. Maybe there's something else going on. So now we're zooming in and we're looking at just one individual pixel. This is really interesting. I see a flow from the top to the bottom. And what I see at the top is, it looks like bacteria E. coli, these rod-shaped bacteria growing and dividing. And as they're growing and dividing, like see how they're like mostly static at the top and then they get pushed down and maybe swept away at the bottom. They're growing and dividing and then they're blinking. They've got an oscillator running inside them and they're turning blue and black and blue and black. Unlike the movie we saw before with the paper from Mike Elowitz's lab in the year 2000, where individual cells very quickly were not in the same position in the clock, in this image, it looks like all the cells in this biopixel are all on at the same time or all off. At the same time, they're synchronized. It's a synchronized clock somehow. So something's gotta be doing that synchronization. What if that's another diffusing molecule? Something that is letting each cell in this image, in this movie, communicate with the other cells and say, oh, hey, it's 12 o'clock where I am. Hope it's 12 o'clock where you are. Oh yeah, it's 12 o'clock where I am. Hope it's 12 o'clock where you are. And like that's happening in parallel across all these cells. Now it's one o'clock, now it's two o'clock. Yeah, it sounds good to me. Let's stay in step with each other. Let's stay in time together. We've got synchronized clocks. Each of these cells is somehow communicating to each other. So we can infer there might be an existence of a second diffusing molecule in this system that's outside of the cells in this case. So far, all the molecules that we're thinking about to control the synchronization are outside the cell. And we know what the timescale is. And do we know what the length scale is? Well, if E. coli is about a micron, we could just, as a rod, how many E. coli lengths across the top? Maybe a hundred, right? So maybe it's a hundred microns or maybe a little bit less than", "start_char_idx": 12402, "end_char_idx": 16444, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2b9aa816-d439-4c7f-a219-c717d10011c4": {"__data__": {"id_": "2b9aa816-d439-4c7f-a219-c717d10011c4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "26d3e909-9d51-40e0-b667-5c5fcd96ff4a", "node_type": null, "metadata": {}, "hash": "d14be8764daa51757378f9c58ca268d41fe82e86faa1585c135dacce90e4dedc"}, "2": {"node_id": "7dd70d5b-5099-4dab-8458-3c51b446b3e8", "node_type": null, "metadata": {}, "hash": "1c161d438dcef7c48574fff9fdfa55a7b503cf9e077c11a9220bb03609600b00"}}, "hash": "19b093b4602aa7b46747f8eb843d6e944fd1d693c6d72272f7e2f2d4751b674c", "text": "right? So maybe it's a hundred microns or maybe a little bit less than that. So a hundred microns, what's that, 0.1 millimeters? Yeah. So, you know, 10th of a millimeter and 10s of minutes, whatever the thing is that's coordinating the behavior of the cell level clock is running on that timescale and length scale. So we could take a guess at what its diffusion coefficient is and if we could guess what its diffusion coefficient is, we could probably guess what its radius is. Remember, the diffusion coefficient is sensitive to the size of the molecule. Yeah. So you can learn a lot just by looking and then using your understanding of molecular diffusion to get a sense of what must be inside this engineered biological system, this radically coupled array of biopixels doing heavy metal detection in polluted waters or who knows. I mean, you can just like begin to figure out how it probably is working. And it's all coordinated, all powered in this case, probably by diffusion. Well, let's pull some other papers just to try and stitch this together. This is the biopixel array we started with. And if you zoom in on any given pixel, you can see that there are these little blocks or stations or crypts where individual bacterial cells are growing. And it, yeah, it looks like they say there's about 5,000 cells per biopixel. And so we probably had the length scales pretty good. And then inside each cell is a genetic program and each cell has the same genetic program. I'm gonna show it to you as a sort of cartoon version because we're really-", "start_char_idx": 16441, "end_char_idx": 17993, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "3a8dbf9c-f982-4fea-a1f2-b3f8a6bbbb67": {"__data__": {"id_": "3a8dbf9c-f982-4fea-a1f2-b3f8a6bbbb67", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8fed0da7-633e-4634-906a-951d151ed94a", "node_type": null, "metadata": {}, "hash": "d20f29914c1041738bc8331d40c49e348f0c2f50e07c5b5fdd9f4900f38791b0"}, "3": {"node_id": "a381f8a9-76fb-4fda-b1fd-bae0f2f579b8", "node_type": null, "metadata": {}, "hash": "6b64e944e7921ec0824c6fdcb2909ed83fc3545c9b395f01ef26d3233be55dce"}}, "hash": "2e8fd5f84f1fd727844b6dc300bce1ed716d1ba6cb391e972c056b9ec5701aaa", "text": "want to focus on diffusion for now. We'll get into the details of how to make these genetic programs later this week, but at a high level, you know, what this genetic program is, is there's an oscillator. I'm showing that as a pendulum, right, but it's not literally like a swinging mass or weight inside. No, it's going to be like genetically encoded proteins and other bio-gizmos. So we've got this oscillator, and then of course the cells are turning blue or not, so there must be something to make them blue. So we've got a reporter that's the light bulb that's telling us what state the clock is in, and then there's this coupling device that's somehow telling the cells within a single biopixel, you know, how to behave the same, and then telling the pixels across the array how to behave the same, right. So that's probably what's in each individual cell. Great, and there's something that's diffusing within the pixels that's coordinating the behavior of the individual cells, and there's something that's diffusing across the entire array that's coordinating the behavior of the pixels across the array. Slightly different schematic, how this looks like as a physical object. We have these crypts or, you know, like little closets, if you will, and the bacterial cells, 5,000 or so at a time, are growing and dividing. Each pixel has its own crypt. There's fresh media or food for the cells flowing through a channel. There are three walls to this crypt, and so if the cells get pushed out, they get swept away, and so that means, you know, the cells that are left are the ones that happen to be inside and didn't get pushed out. Kind of dramatic, and there's all these different pixels all over the place in this regular grid with each have their own cells, and then they're showing us that there's a blue molecule or cyan colored molecule dissolved AHL, and that's the diffusing molecule within the individual pixel that's coordinating the behavior of the cells in that pixel, and then there's another molecule, these orange circles, H2O2, hydrogen peroxide vapor, and that looks to be diffusing or moving across the pixels, so that must be what's coordinating the behavior across the whole array, and so let's look a little bit more into the details of AHL, whatever that is, and H2O2, which we know what that is. So AHL is a chemical called acyl homoserine lactone, A-H-L, A for acyl, homoserine, H for homoserine, L for lactone, so AHL for short, and this is a molecule that was found among other places in bacteria, Vibrio fischeri, if I remember right, that live in the light organ of the Pacific bobtail squid, and if that sounds interesting, you should just go look up what the Pacific bobtail squid is. It's an amazing creature, and from what I remember, when it hunts near dusk, it actually uses bacteria in a light organ to emit light to mask its shadow, so to do like more stealthy grabbing of the things it needs to eat, and to coordinate when the lights turn on, the light is made by bacteria, the bacteria coordinate their behavior by accumulating this diffusing molecule, A-H-L. Now it looks like Arthur and Jeff have repurposed this diffusing molecule to instead of, you know, being squid hunting for food, it's coordinating the synchronization of oscillations through diffusing in these biopixels, so that's A-H-L, and you can learn more about it on Wikipedia, the link here, and this is what the chemical structure looks like. It's got a carbon ring, and then a nitrogen, and then one, two, three, four, five, six more carbons, so you get a sense of it. It's about a, you know, 15, 16, you know, getting rid of, there's about 20 atom molecule. Cool, what about hydrogen peroxide, H2O2? Well, it's the water with extra oxygen, right, so that's going to be much tinier than A-H-L, right, it's only got two oxygens, right, it's it's, yeah,", "start_char_idx": 0, "end_char_idx": 3865, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a381f8a9-76fb-4fda-b1fd-bae0f2f579b8": {"__data__": {"id_": "a381f8a9-76fb-4fda-b1fd-bae0f2f579b8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8fed0da7-633e-4634-906a-951d151ed94a", "node_type": null, "metadata": {}, "hash": "d20f29914c1041738bc8331d40c49e348f0c2f50e07c5b5fdd9f4900f38791b0"}, "2": {"node_id": "3a8dbf9c-f982-4fea-a1f2-b3f8a6bbbb67", "node_type": null, "metadata": {}, "hash": "2e8fd5f84f1fd727844b6dc300bce1ed716d1ba6cb391e972c056b9ec5701aaa"}}, "hash": "6b64e944e7921ec0824c6fdcb2909ed83fc3545c9b395f01ef26d3233be55dce", "text": "right, it's only got two oxygens, right, it's it's, yeah, probably 10 times smaller in mass, and not quite 10 times smaller in radius, and it looks like it's, the A-H-L is diffusing in water, where the hydrogen peroxide is diffusing in vapor, so that's, it's probably faster, just vapor relative to water, but again, it's smaller, so it's going to be going faster regardless. Cool, so we've got this one molecule diffusing in water in the pixels, and that's coordinating the pixel behavior, the cells within the pixel behavior rather, and then this other molecule, hydrogen peroxide, diffusing across the whole array, and that's synchronizing the individual pixels in the array. Awesome, now let's go back and look and see if we understand this better. So this is an individual pixel, we see about 5,000 cells in this pixel, they're running a genetic oscillator, when the oscillator is at midnight or noon, their cells are blue, and at 6 a.m. or 6 p.m. the cells are dark. I don't mean that literally, like, that's the time on the clock, I'm just giving you a sense of, like, tracking an oscillation in a clock, and so the cells, like, want to be doing a different thing, they want to be different, they want to be noisy, but somehow this diffusing molecule is causing this oscillator to lock in, to entrain, to synchronize across all the cells. Pretty cool, we're using diffusion, a random process, to create a more regular deterministic behavior. Amazing. Now if we go and look at the whole array again, their pixels aren't behaving, they're doing their own thing. Oh, nope, they're locked in, they've entrained, this hydrogen peroxide vapor has somehow communicated across the whole array, okay, this is when we should be blue, this one should be dark, blue, dark, blue, like, that's being coordinated through the random diffusion of hydrogen peroxide. There's no electrical wiring, you know, causing all this to happen, we're getting this coordination and control through random diffusion. So let's end with a couple reflective questions. How might random diffusion of biomolecules contribute to physical diversity among genetically identical cells? Go back and think about the repressilator, and, you know, like, why did the cells become different, even though they're genetically the same? Second, how can, just reflect, how can spontaneous diffusion of molecules be used to create reliable behavior across populations of cells, like we just saw? Make sure you can puzzle with that. Here's a good one, this will be the last one. Is there an upper limit to how far random diffusion can be used to control behavior, cellular behavior? Like, the biopixel array we just saw, that was good for tens of millimeters, centimeters or so. Could you use diffusion to coordinate behavior across meters, tens of meters, kilometer, longer? What limits, remember, you now know what controls the diffusion coefficient, how far something will move per unit time. You also have a sense of how big molecules are, so is there an upper limit, a practical upper limit, for how far we could use random diffusion to coordinate behavior? Okay, great, that's all for now.", "start_char_idx": 3808, "end_char_idx": 6959, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7ef2159d-801f-4c0b-8f25-53087d9159f3": {"__data__": {"id_": "7ef2159d-801f-4c0b-8f25-53087d9159f3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "43c346ac-b7fc-47a6-8e70-96b70c4cf1b4", "node_type": null, "metadata": {}, "hash": "c3828c4a51dac4978246f3bd1aeabbbf2f0b31bd78003d52ed3940337cec6604"}, "3": {"node_id": "8db24b60-a857-4c7c-8283-76b17d221c9f", "node_type": null, "metadata": {}, "hash": "c04c38a45b334fde765f82dcf65780bda68a614e11b6274cf534ea012c5b482b"}}, "hash": "0693246b92af607048ecda04a4b4e02108392457db69b6a19e0050aead7a702e", "text": "Today we're going to talk about parts for the genetic control over biological systems. We're going to get into a little bit of the nitty-gritty of how you reprogram cells in order to have new functions. To motivate today's discussion we're going to talk about arsenic. Arsenic is a naturally occurring component of the earth's crust. It's an element and it's sometimes found at high levels in groundwater. Arsenic is highly toxic to people in its inorganic form. Contaminated water that's used for drinking, food prep, or the irrigation of food crops is a public health threat. Long-term exposure to arsenic can cause cancer or skin lesions. What you're seeing on this slide are actually the hands of a person who has been drinking arsenic contaminated water. You can see that the arsenic in the water causes skin lesions in this person's hands but that they clear up relatively quickly when they get access to safe clean drinking water that does not contain arsenic. It's important to try to figure out where there's arsenic contamination in groundwater and to prevent people from consuming that water because of the toxic effects of this element in water. There actually is arsenic in the U.S. groundwater. The slide here is showing you a map of arsenic concentrations in groundwater samples. I just want to point out that this stuff is pretty potently toxic. The National Academy of Sciences estimate that about one in 100 people drinking arsenic contaminated water, that's water that contains at least 50 parts per billion of arsenic, will get cancer assuming that they consume two liters of contaminated water per day. That kind of boils down to the lifetime risk of dying from cancer due to arsenic in tap water at about one in 500. To give you a kind of clearer picture of the map, here it is. I want you to notice that it's kind of all over the country and that it's not easy to detect arsenic in groundwater. Arsenic is odorless and tasteless. There are methods approved by the U.S. Environmental Protection Agency for detecting arsenic in water, but all of these approved methods require labs and complex equipment. The ones that I'm showing on this slide are called inductively coupled plasma mass spectrometry, gas chromatography with atomic absorption spectrometry, and then hydride generation followed by atomic absorption spectrometry. So these are techniques that are good if you're bringing samples from an area into the lab, but it's not as good if you're, for example, interested in testing your tap water at home. Most people probably don't have mass spectrometers at home and wouldn't be able to perform these types of experiments very easily. So bioengineers thought, what if we make a test for arsenic that's a little bit simpler? What if we have bacteria that report contamination by turning fluorescent green? These bacteria have been engineered by people, so this is actually something that people have made. On this part of the slide, you can see a strain engineered to sense arsenic in their water and they turn this fluorescent green color, whereas the wild type bacteria do not. I should point out that these are sensing arsenite. This is a specific form of arsenic in the water and that they are able to detect or have a significant difference between the unengineered bacteria, which are shown on this black line, and the engineered bacteria at the WHO limit of safe arsenic levels in drinking water. So the engineered bacteria are producing a significant fluorescent signal at this limit of 0.33 micromolar arsenic in water. So this is potentially something that you could use in order to detect arsenic in groundwater. You can imagine taking a sample of your water and mixing it with some of these bacteria and just waiting to see, do they turn this fluorescent green? Now, how do you engineer these bacteria to sense arsenic in the water? It's obviously not something that they do naturally, as the wild type bacteria do not turn a bright fluorescent green in response to this water contamination. Well, before we talk about that, we're going to get into key components of the central dogma. I want us to be all on the same page as to how gene expression is controlled in living organisms. The central dogma of molecular biology is just an explanation of how genetic information flows within a biological", "start_char_idx": 0, "end_char_idx": 4339, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8db24b60-a857-4c7c-8283-76b17d221c9f": {"__data__": {"id_": "8db24b60-a857-4c7c-8283-76b17d221c9f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "43c346ac-b7fc-47a6-8e70-96b70c4cf1b4", "node_type": null, "metadata": {}, "hash": "c3828c4a51dac4978246f3bd1aeabbbf2f0b31bd78003d52ed3940337cec6604"}, "2": {"node_id": "7ef2159d-801f-4c0b-8f25-53087d9159f3", "node_type": null, "metadata": {}, "hash": "0693246b92af607048ecda04a4b4e02108392457db69b6a19e0050aead7a702e"}, "3": {"node_id": "7515b8fd-a5e7-43d7-8249-fd4ada1a00c6", "node_type": null, "metadata": {}, "hash": "4227026aded388a2f9cabb9512229be465435865bc7f78115c1504d75d19c242"}}, "hash": "c04c38a45b334fde765f82dcf65780bda68a614e11b6274cf534ea012c5b482b", "text": "molecular biology is just an explanation of how genetic information flows within a biological system. It's usually stated as DNA makes RNA makes protein. Now, for the bacteria to turn green in response to arsenic, they have to make a bunch of green fluorescent protein. So they essentially need to initiate transcription of RNA that encodes for this fluorescent protein, and then translation of that RNA into the protein that then produces the visible signal that you can read out to determine how much arsenic is contaminating your water. Now, transcription is initiated at DNA sequences called promoters. Promoters are segments of DNA to which RNA polymerase and transcription factors bind to initiate the transcription of RNA at genes encoded downstream of a promoter. So on this slide, you're seeing DNA, a region of the DNA that encodes for a promoter, is highlighted in yellow. RNA polymerase, which is this kind of purple circle, binds that segment of DNA and then initiates the expression of downstream genes. You'll notice here that I have this little vent arrow in the corner. We're going to get into what these are in a minute, but there's actually a standard way of representing promoters when you're drawing out synthetic genetic designs. And for promoters, the standard way of representing them is this vent arrow. Now, in addition to promoters, you have ribosome binding sites in bacteria that control translation. So ribosome binding sites are segments on the RNA that are bound by ribosomes to translate a messenger RNA into protein. So these ribosome binding sites will bind a fragment of the ribosome called the 30S complex. The 30S complex makes very specific contact with the RNA at a region called the Shine-Delgarno. This is a consensus sequence of RNA that ribosomes in E. coli really like to bind. So they'll bind there and then they'll bind at the first codon, at a start codon that encodes for your gene of interest downstream. It's the first codon for that gene downstream. After the 30S complex binds to RNA, it will recruit the 50S subunit and those two things combine together to make a functional ribosome. Once the functional ribosome is assembled on the RNA, it will initiate the synthesis of protein. So it will go through and it will read all the codons. It will recruit tRNAs that have an amino acid linked to them and it will take the amino acid from that tRNA and add it to a growing peptide or a growing protein chain. We'll talk about how those proteins then fold up into being functional within the cell, but this is the way that we synthesize these proteins. Now in E. coli, each of these steps are really well understood and actually predictable. So there are these cool things that bioengineers have developed that allow you to calculate how much protein you might get from a given sequence of RNA. If we go back for a second, you might be able to tell that changes in the DNA or in the RNA sequence right here might influence how strongly this subunit of the ribosome binds the RNA. So if it binds really strongly, then you might get more translation because this RNA is very good at recruiting ribosomes to it in order to translate the downstream gene. But if the ribosome subunit has poor affinity for this RNA, let's say the sequence is not C-A-G-G-G-G-G-A-C, but C-A-T-T-T-G-G-A-C or something like that, that's not the optimum for ribosome binding, then the ribosome may bind less frequently to the RNA and give you less translation of the gene that's encoded by the RNA. So you get less protein at the other side. Anyway, these interactions between ribosome binding to specific RNA sequences and then recruitment of the 50S subunit are so well understood that you can make these mathematical models of ribosome binding and the initiation of translation that tell you for a given RNA sequence how much total protein you might expect to be making. So this RBS calculator was developed by a professor at Penn State University called Howard Salas, and it's actually online. I encourage you to go and check it out. Try feeding in an RNA sequence and just seeing how much protein do you think it would make. And as you change that", "start_char_idx": 4260, "end_char_idx": 8436, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "7515b8fd-a5e7-43d7-8249-fd4ada1a00c6": {"__data__": {"id_": "7515b8fd-a5e7-43d7-8249-fd4ada1a00c6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "43c346ac-b7fc-47a6-8e70-96b70c4cf1b4", "node_type": null, "metadata": {}, "hash": "c3828c4a51dac4978246f3bd1aeabbbf2f0b31bd78003d52ed3940337cec6604"}, "2": {"node_id": "8db24b60-a857-4c7c-8283-76b17d221c9f", "node_type": null, "metadata": {}, "hash": "c04c38a45b334fde765f82dcf65780bda68a614e11b6274cf534ea012c5b482b"}, "3": {"node_id": "8c236949-804a-41d5-83ec-d1342b030777", "node_type": null, "metadata": {}, "hash": "7c107265515de6dc9ae3e0b7e2bf48037a030650265763f4dfc38dd2d6910766"}}, "hash": "4227026aded388a2f9cabb9512229be465435865bc7f78115c1504d75d19c242", "text": "RNA sequence and just seeing how much protein do you think it would make. And as you change that RNA at the kind of five prime and beginning part of the transcript, how does translation or the amount of protein being made change, or at least how is it predicted to change? So I think this is cool. This is a method of being able to tune the amount of protein that's being made. And if we take a close look at the arsenic biosensor, we can see some of these things in action. So this might look a little bit complex at first, but let's start with what we are maybe most familiar with, which is GFP. So GFP is our output signal. Remember that the bacteria makes a lot of GFP in response to arsenic in the water. Expression of GFP is driven by this promoter called PARS. PARS has a binding site in it for a transcription factor called ARSR. So ARSR is a protein that's made constantly in this bacteria. That protein would usually bind to the PARS promoter sequence and prevent any activity of this promoter. You'll notice that its binding site overlaps with something that the researchers have highlighted called the minus 35. This is a segment of the promoter that's important for RNA polymerase to bind the DNA. And when the ARSR protein is sitting on the DNA at this location, it's going to prevent RNA polymerase from binding. So we should get no expression of GFP when ARSR is bound to the promoter and ARSR is produced all the time. So it should always be there preventing the expression of GFP. Now that is true, except when there's arsenic present in the cell. When arsenic is present, it actually binds to the protein and changes the protein's shape just a little bit. It gets in there enough to change the protein's ability to bind DNA. So when the arsenic is present in the system or in the cell, ARSR is not able to bind the DNA. Instead, it comes off of the DNA and now this promoter is open for RNA polymerase to come in and bind the DNA and initiate the expression of GFP. So that is how this sensor works. And in an engineered cell, we will usually have three separate things. We'll have inputs or sensors like we just showed you that initiate or change gene expression in response to various inputs that we care about. So these might be chemicals, these might be metal ions, light, heat, nucleic acids, maybe they're antigens or pathogens. And the bacterial strains or our cells even, they don't have to be bacteria, are engineered to sense these things through sort of similar mechanisms to what I just showed you with the arsenic sensor. And then they have internal logic circuits that integrate this information and initiate the expression of output genes or actuators. So these could be reporters like GFP or RFP, which is red fluorescent protein. These could be proteins that control the movement of a bacterium or control cell growth. They could initiate the expression of different chemicals or other things. These outputs or actuators are genes that cause a change in the cell's behavior. Okay. So these are sort of the different parts of an engineered cell. We, in order to communicate about what is happening within a cell, have come up with a table of glyphs to represent different elements in synthetic biology. So we already talked about the glyph or promoter, but there are also little shorthands for coding sequences or genes, for ribosome binding sites, for terminators. These are segments of DNA that stop the movement or the activity of RNA polymerase. There are also, you know, glyphs to represent primer binding sites when you're talking about amplifying specific segments of DNA. These are really helpful in allowing bioengineers to communicate with one another about what it is they've designed a organism to be able to do. You can imagine maybe sending a sequence of DNA from one person to another, but it can take a while to figure out exactly what that sequence is encoding. And instead, if you send something like this, where the promoter is represented not as the sequence, but as this bent arrow, and the gene is represented not as the sequence, but as this kind of arrow, then you can get a quick understanding of what it is that the engineer was trying to do. It may seem like a lot to think about all of these little", "start_char_idx": 8439, "end_char_idx": 12700, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8c236949-804a-41d5-83ec-d1342b030777": {"__data__": {"id_": "8c236949-804a-41d5-83ec-d1342b030777", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "43c346ac-b7fc-47a6-8e70-96b70c4cf1b4", "node_type": null, "metadata": {}, "hash": "c3828c4a51dac4978246f3bd1aeabbbf2f0b31bd78003d52ed3940337cec6604"}, "2": {"node_id": "7515b8fd-a5e7-43d7-8249-fd4ada1a00c6", "node_type": null, "metadata": {}, "hash": "4227026aded388a2f9cabb9512229be465435865bc7f78115c1504d75d19c242"}, "3": {"node_id": "93e4b592-79cb-4281-8034-00cdfb78f2c5", "node_type": null, "metadata": {}, "hash": "ff63c27f599f3e36f7d159cb1524f2272134d2ef53462ff01bfb4fdc929cc5df"}}, "hash": "7c107265515de6dc9ae3e0b7e2bf48037a030650265763f4dfc38dd2d6910766", "text": "was trying to do. It may seem like a lot to think about all of these little glyphs, but I just want you to be aware that they exist, and for you to have this reference table to come back to if at some point during the semester you get confused as to what it is we're showing on the screen. This can be a good cheat sheet, a good way for you to think or to have an idea of what's trying to be represented on the screen. Okay, so we talked a little bit about promoters and coding sequences, and one of the things about bioengineering is that there's this idea that you might be able to standardize these different parts in order to make programs that are easy to put together. Sort of the same way that you assemble Lego bricks into really complex structures, you might be able to just snap together promoters of a known strength. These are promoters that drive, you know, a kind of consistent amount of transcription, perhaps some binding sites of a known strength, proteins that have a consistent impact on the cell. So green fluorescent protein, for example, whenever it's expressed will make the cell fluorescent, and that if you characterize each of these parts well, then you can snap them together in ways that give you a predictable change in an organism's behavior. People would love to be able to assemble parts into programs, like I said, the same way that you assemble Legos, where you go from things represented as DNA to little parts, sort of like Lego bricks, to devices that are sort of sub builds, I guess you would say, maybe like a tower of stacked bricks that has a specific function that you then compile together to get a whole system that does something new. Now this is a beautiful idea for how to do engineering, right? Engineering is built on standardization. You have, you know, screws that are always the same length and same diameter, you have lots of specifications for how each piece in an engineered system would fit together. And so in biology, the equivalent is sort of each DNA segment that encodes for a part being a piece that you can snap together. And this idea is really lovely that you would be able to snap together different segments of DNA, but it doesn't always hold. You know, about 20 years of bioengineering experience have shown that it's not as simple as just having a promoter, a ribosome binding site, and a gene of interest, and a terminator all put together to give you expression of your gene of interest at a specific level. It's actually that different parts influence each other. DNA is one continuous molecule. And so the sequence of the promoter can sometimes affect the ribosome binding site's ability to recruit a ribosome, and that can affect the expression level of a gene of interest. There have been many ways in which people have figured out that each part may interact with each other to give you unpredictable effects. But bioengineers have been addressing each of those problems head on. They've actually instituted additional parts to what we were just showing you with promoters and ribosome binding sites that make the predictability of the system even better. So you might put in insulating sequences that prevent a promoter from affecting the activity of a ribosome binding site. You might put in something that actually just cuts off any residual RNA from the promoter to prevent a ribosome binding site from having its activity changed by the promoter. There are a bunch of different things that bioengineers have done in order to try to make biology more predictable. So here is sort of a modern expression cassette relative to the sort of simple way in which we often represent gene expression control in biological systems. Now this ability to predict how well gene expression can be controlled has led to circuit design automation. These are essentially computer programs in which you can specify the activity of a biological system and then the computer will go through a list of parts, these DNA parts that it has, and figure out how to combine them together in order to give you a genetic program that does exactly what you want. It'll actually spit out the DNA that you need to build and transform into a cell in order to get a cell that has the desired activity. Now these types of computer programs are still complex to build. They require a lot of parts that have been well characterized in the organism that you're trying to engineer. And so we've been able to do it for", "start_char_idx": 12720, "end_char_idx": 17177, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "93e4b592-79cb-4281-8034-00cdfb78f2c5": {"__data__": {"id_": "93e4b592-79cb-4281-8034-00cdfb78f2c5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "43c346ac-b7fc-47a6-8e70-96b70c4cf1b4", "node_type": null, "metadata": {}, "hash": "c3828c4a51dac4978246f3bd1aeabbbf2f0b31bd78003d52ed3940337cec6604"}, "2": {"node_id": "8c236949-804a-41d5-83ec-d1342b030777", "node_type": null, "metadata": {}, "hash": "7c107265515de6dc9ae3e0b7e2bf48037a030650265763f4dfc38dd2d6910766"}}, "hash": "ff63c27f599f3e36f7d159cb1524f2272134d2ef53462ff01bfb4fdc929cc5df", "text": "that you're trying to engineer. And so we've been able to do it for E. coli, for a gut bacteria called Bacteroides, and for a strain of yeast, it's actually baker's yeast called Saccharomyces cerevisiae. And so for these three cells there exist computer programs that you can use to specify a given behavior and then have it spit out a DNA sequence that should change the bacteria in a way that matches the desired behavior. Okay, so our reflective questions for the week are what DNA parts control transcription and translation? What did we talk about that gives you the ability to tune transcription and translation? How would you manipulate DNA in order to get more or less protein being made? Why are glyphs helpful for communication about bioengineering? And then what are some reasons DNA parts may not behave as modularly as Legos? And then I'd love you to think about what you would design a cell to do if you could design it to do anything.", "start_char_idx": 17169, "end_char_idx": 18118, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "70e82283-9cf8-427d-bfdb-e1c7393ac047": {"__data__": {"id_": "70e82283-9cf8-427d-bfdb-e1c7393ac047", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4e519bc3-29de-419c-9b5c-bdd4c91c2171", "node_type": null, "metadata": {}, "hash": "c3828c4a51dac4978246f3bd1aeabbbf2f0b31bd78003d52ed3940337cec6604"}, "3": {"node_id": "d6e5d46a-2200-48c1-893c-a6ce5ca80274", "node_type": null, "metadata": {}, "hash": "c04c38a45b334fde765f82dcf65780bda68a614e11b6274cf534ea012c5b482b"}}, "hash": "0693246b92af607048ecda04a4b4e02108392457db69b6a19e0050aead7a702e", "text": "Today we're going to talk about parts for the genetic control over biological systems. We're going to get into a little bit of the nitty-gritty of how you reprogram cells in order to have new functions. To motivate today's discussion we're going to talk about arsenic. Arsenic is a naturally occurring component of the earth's crust. It's an element and it's sometimes found at high levels in groundwater. Arsenic is highly toxic to people in its inorganic form. Contaminated water that's used for drinking, food prep, or the irrigation of food crops is a public health threat. Long-term exposure to arsenic can cause cancer or skin lesions. What you're seeing on this slide are actually the hands of a person who has been drinking arsenic contaminated water. You can see that the arsenic in the water causes skin lesions in this person's hands but that they clear up relatively quickly when they get access to safe clean drinking water that does not contain arsenic. It's important to try to figure out where there's arsenic contamination in groundwater and to prevent people from consuming that water because of the toxic effects of this element in water. There actually is arsenic in the U.S. groundwater. The slide here is showing you a map of arsenic concentrations in groundwater samples. I just want to point out that this stuff is pretty potently toxic. The National Academy of Sciences estimate that about one in 100 people drinking arsenic contaminated water, that's water that contains at least 50 parts per billion of arsenic, will get cancer assuming that they consume two liters of contaminated water per day. That kind of boils down to the lifetime risk of dying from cancer due to arsenic in tap water at about one in 500. To give you a kind of clearer picture of the map, here it is. I want you to notice that it's kind of all over the country and that it's not easy to detect arsenic in groundwater. Arsenic is odorless and tasteless. There are methods approved by the U.S. Environmental Protection Agency for detecting arsenic in water, but all of these approved methods require labs and complex equipment. The ones that I'm showing on this slide are called inductively coupled plasma mass spectrometry, gas chromatography with atomic absorption spectrometry, and then hydride generation followed by atomic absorption spectrometry. So these are techniques that are good if you're bringing samples from an area into the lab, but it's not as good if you're, for example, interested in testing your tap water at home. Most people probably don't have mass spectrometers at home and wouldn't be able to perform these types of experiments very easily. So bioengineers thought, what if we make a test for arsenic that's a little bit simpler? What if we have bacteria that report contamination by turning fluorescent green? These bacteria have been engineered by people, so this is actually something that people have made. On this part of the slide, you can see a strain engineered to sense arsenic in their water and they turn this fluorescent green color, whereas the wild type bacteria do not. I should point out that these are sensing arsenite. This is a specific form of arsenic in the water and that they are able to detect or have a significant difference between the unengineered bacteria, which are shown on this black line, and the engineered bacteria at the WHO limit of safe arsenic levels in drinking water. So the engineered bacteria are producing a significant fluorescent signal at this limit of 0.33 micromolar arsenic in water. So this is potentially something that you could use in order to detect arsenic in groundwater. You can imagine taking a sample of your water and mixing it with some of these bacteria and just waiting to see, do they turn this fluorescent green? Now, how do you engineer these bacteria to sense arsenic in the water? It's obviously not something that they do naturally, as the wild type bacteria do not turn a bright fluorescent green in response to this water contamination. Well, before we talk about that, we're going to get into key components of the central dogma. I want us to be all on the same page as to how gene expression is controlled in living organisms. The central dogma of molecular biology is just an explanation of how genetic information flows within a biological", "start_char_idx": 0, "end_char_idx": 4339, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d6e5d46a-2200-48c1-893c-a6ce5ca80274": {"__data__": {"id_": "d6e5d46a-2200-48c1-893c-a6ce5ca80274", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4e519bc3-29de-419c-9b5c-bdd4c91c2171", "node_type": null, "metadata": {}, "hash": "c3828c4a51dac4978246f3bd1aeabbbf2f0b31bd78003d52ed3940337cec6604"}, "2": {"node_id": "70e82283-9cf8-427d-bfdb-e1c7393ac047", "node_type": null, "metadata": {}, "hash": "0693246b92af607048ecda04a4b4e02108392457db69b6a19e0050aead7a702e"}, "3": {"node_id": "c21e9466-59b7-4fef-8323-90eeb9bce0b1", "node_type": null, "metadata": {}, "hash": "4227026aded388a2f9cabb9512229be465435865bc7f78115c1504d75d19c242"}}, "hash": "c04c38a45b334fde765f82dcf65780bda68a614e11b6274cf534ea012c5b482b", "text": "molecular biology is just an explanation of how genetic information flows within a biological system. It's usually stated as DNA makes RNA makes protein. Now, for the bacteria to turn green in response to arsenic, they have to make a bunch of green fluorescent protein. So they essentially need to initiate transcription of RNA that encodes for this fluorescent protein, and then translation of that RNA into the protein that then produces the visible signal that you can read out to determine how much arsenic is contaminating your water. Now, transcription is initiated at DNA sequences called promoters. Promoters are segments of DNA to which RNA polymerase and transcription factors bind to initiate the transcription of RNA at genes encoded downstream of a promoter. So on this slide, you're seeing DNA, a region of the DNA that encodes for a promoter, is highlighted in yellow. RNA polymerase, which is this kind of purple circle, binds that segment of DNA and then initiates the expression of downstream genes. You'll notice here that I have this little vent arrow in the corner. We're going to get into what these are in a minute, but there's actually a standard way of representing promoters when you're drawing out synthetic genetic designs. And for promoters, the standard way of representing them is this vent arrow. Now, in addition to promoters, you have ribosome binding sites in bacteria that control translation. So ribosome binding sites are segments on the RNA that are bound by ribosomes to translate a messenger RNA into protein. So these ribosome binding sites will bind a fragment of the ribosome called the 30S complex. The 30S complex makes very specific contact with the RNA at a region called the Shine-Delgarno. This is a consensus sequence of RNA that ribosomes in E. coli really like to bind. So they'll bind there and then they'll bind at the first codon, at a start codon that encodes for your gene of interest downstream. It's the first codon for that gene downstream. After the 30S complex binds to RNA, it will recruit the 50S subunit and those two things combine together to make a functional ribosome. Once the functional ribosome is assembled on the RNA, it will initiate the synthesis of protein. So it will go through and it will read all the codons. It will recruit tRNAs that have an amino acid linked to them and it will take the amino acid from that tRNA and add it to a growing peptide or a growing protein chain. We'll talk about how those proteins then fold up into being functional within the cell, but this is the way that we synthesize these proteins. Now in E. coli, each of these steps are really well understood and actually predictable. So there are these cool things that bioengineers have developed that allow you to calculate how much protein you might get from a given sequence of RNA. If we go back for a second, you might be able to tell that changes in the DNA or in the RNA sequence right here might influence how strongly this subunit of the ribosome binds the RNA. So if it binds really strongly, then you might get more translation because this RNA is very good at recruiting ribosomes to it in order to translate the downstream gene. But if the ribosome subunit has poor affinity for this RNA, let's say the sequence is not C-A-G-G-G-G-G-A-C, but C-A-T-T-T-G-G-A-C or something like that, that's not the optimum for ribosome binding, then the ribosome may bind less frequently to the RNA and give you less translation of the gene that's encoded by the RNA. So you get less protein at the other side. Anyway, these interactions between ribosome binding to specific RNA sequences and then recruitment of the 50S subunit are so well understood that you can make these mathematical models of ribosome binding and the initiation of translation that tell you for a given RNA sequence how much total protein you might expect to be making. So this RBS calculator was developed by a professor at Penn State University called Howard Salas, and it's actually online. I encourage you to go and check it out. Try feeding in an RNA sequence and just seeing how much protein do you think it would make. And as you change that", "start_char_idx": 4260, "end_char_idx": 8436, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c21e9466-59b7-4fef-8323-90eeb9bce0b1": {"__data__": {"id_": "c21e9466-59b7-4fef-8323-90eeb9bce0b1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4e519bc3-29de-419c-9b5c-bdd4c91c2171", "node_type": null, "metadata": {}, "hash": "c3828c4a51dac4978246f3bd1aeabbbf2f0b31bd78003d52ed3940337cec6604"}, "2": {"node_id": "d6e5d46a-2200-48c1-893c-a6ce5ca80274", "node_type": null, "metadata": {}, "hash": "c04c38a45b334fde765f82dcf65780bda68a614e11b6274cf534ea012c5b482b"}, "3": {"node_id": "e8b15746-d669-471b-b0fa-dea5c264e590", "node_type": null, "metadata": {}, "hash": "7c107265515de6dc9ae3e0b7e2bf48037a030650265763f4dfc38dd2d6910766"}}, "hash": "4227026aded388a2f9cabb9512229be465435865bc7f78115c1504d75d19c242", "text": "RNA sequence and just seeing how much protein do you think it would make. And as you change that RNA at the kind of five prime and beginning part of the transcript, how does translation or the amount of protein being made change, or at least how is it predicted to change? So I think this is cool. This is a method of being able to tune the amount of protein that's being made. And if we take a close look at the arsenic biosensor, we can see some of these things in action. So this might look a little bit complex at first, but let's start with what we are maybe most familiar with, which is GFP. So GFP is our output signal. Remember that the bacteria makes a lot of GFP in response to arsenic in the water. Expression of GFP is driven by this promoter called PARS. PARS has a binding site in it for a transcription factor called ARSR. So ARSR is a protein that's made constantly in this bacteria. That protein would usually bind to the PARS promoter sequence and prevent any activity of this promoter. You'll notice that its binding site overlaps with something that the researchers have highlighted called the minus 35. This is a segment of the promoter that's important for RNA polymerase to bind the DNA. And when the ARSR protein is sitting on the DNA at this location, it's going to prevent RNA polymerase from binding. So we should get no expression of GFP when ARSR is bound to the promoter and ARSR is produced all the time. So it should always be there preventing the expression of GFP. Now that is true, except when there's arsenic present in the cell. When arsenic is present, it actually binds to the protein and changes the protein's shape just a little bit. It gets in there enough to change the protein's ability to bind DNA. So when the arsenic is present in the system or in the cell, ARSR is not able to bind the DNA. Instead, it comes off of the DNA and now this promoter is open for RNA polymerase to come in and bind the DNA and initiate the expression of GFP. So that is how this sensor works. And in an engineered cell, we will usually have three separate things. We'll have inputs or sensors like we just showed you that initiate or change gene expression in response to various inputs that we care about. So these might be chemicals, these might be metal ions, light, heat, nucleic acids, maybe they're antigens or pathogens. And the bacterial strains or our cells even, they don't have to be bacteria, are engineered to sense these things through sort of similar mechanisms to what I just showed you with the arsenic sensor. And then they have internal logic circuits that integrate this information and initiate the expression of output genes or actuators. So these could be reporters like GFP or RFP, which is red fluorescent protein. These could be proteins that control the movement of a bacterium or control cell growth. They could initiate the expression of different chemicals or other things. These outputs or actuators are genes that cause a change in the cell's behavior. Okay. So these are sort of the different parts of an engineered cell. We, in order to communicate about what is happening within a cell, have come up with a table of glyphs to represent different elements in synthetic biology. So we already talked about the glyph or promoter, but there are also little shorthands for coding sequences or genes, for ribosome binding sites, for terminators. These are segments of DNA that stop the movement or the activity of RNA polymerase. There are also, you know, glyphs to represent primer binding sites when you're talking about amplifying specific segments of DNA. These are really helpful in allowing bioengineers to communicate with one another about what it is they've designed a organism to be able to do. You can imagine maybe sending a sequence of DNA from one person to another, but it can take a while to figure out exactly what that sequence is encoding. And instead, if you send something like this, where the promoter is represented not as the sequence, but as this bent arrow, and the gene is represented not as the sequence, but as this kind of arrow, then you can get a quick understanding of what it is that the engineer was trying to do. It may seem like a lot to think about all of these little", "start_char_idx": 8439, "end_char_idx": 12700, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e8b15746-d669-471b-b0fa-dea5c264e590": {"__data__": {"id_": "e8b15746-d669-471b-b0fa-dea5c264e590", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4e519bc3-29de-419c-9b5c-bdd4c91c2171", "node_type": null, "metadata": {}, "hash": "c3828c4a51dac4978246f3bd1aeabbbf2f0b31bd78003d52ed3940337cec6604"}, "2": {"node_id": "c21e9466-59b7-4fef-8323-90eeb9bce0b1", "node_type": null, "metadata": {}, "hash": "4227026aded388a2f9cabb9512229be465435865bc7f78115c1504d75d19c242"}, "3": {"node_id": "6303af92-3080-4860-bb76-a2ec847b7cc8", "node_type": null, "metadata": {}, "hash": "ff63c27f599f3e36f7d159cb1524f2272134d2ef53462ff01bfb4fdc929cc5df"}}, "hash": "7c107265515de6dc9ae3e0b7e2bf48037a030650265763f4dfc38dd2d6910766", "text": "was trying to do. It may seem like a lot to think about all of these little glyphs, but I just want you to be aware that they exist, and for you to have this reference table to come back to if at some point during the semester you get confused as to what it is we're showing on the screen. This can be a good cheat sheet, a good way for you to think or to have an idea of what's trying to be represented on the screen. Okay, so we talked a little bit about promoters and coding sequences, and one of the things about bioengineering is that there's this idea that you might be able to standardize these different parts in order to make programs that are easy to put together. Sort of the same way that you assemble Lego bricks into really complex structures, you might be able to just snap together promoters of a known strength. These are promoters that drive, you know, a kind of consistent amount of transcription, perhaps some binding sites of a known strength, proteins that have a consistent impact on the cell. So green fluorescent protein, for example, whenever it's expressed will make the cell fluorescent, and that if you characterize each of these parts well, then you can snap them together in ways that give you a predictable change in an organism's behavior. People would love to be able to assemble parts into programs, like I said, the same way that you assemble Legos, where you go from things represented as DNA to little parts, sort of like Lego bricks, to devices that are sort of sub builds, I guess you would say, maybe like a tower of stacked bricks that has a specific function that you then compile together to get a whole system that does something new. Now this is a beautiful idea for how to do engineering, right? Engineering is built on standardization. You have, you know, screws that are always the same length and same diameter, you have lots of specifications for how each piece in an engineered system would fit together. And so in biology, the equivalent is sort of each DNA segment that encodes for a part being a piece that you can snap together. And this idea is really lovely that you would be able to snap together different segments of DNA, but it doesn't always hold. You know, about 20 years of bioengineering experience have shown that it's not as simple as just having a promoter, a ribosome binding site, and a gene of interest, and a terminator all put together to give you expression of your gene of interest at a specific level. It's actually that different parts influence each other. DNA is one continuous molecule. And so the sequence of the promoter can sometimes affect the ribosome binding site's ability to recruit a ribosome, and that can affect the expression level of a gene of interest. There have been many ways in which people have figured out that each part may interact with each other to give you unpredictable effects. But bioengineers have been addressing each of those problems head on. They've actually instituted additional parts to what we were just showing you with promoters and ribosome binding sites that make the predictability of the system even better. So you might put in insulating sequences that prevent a promoter from affecting the activity of a ribosome binding site. You might put in something that actually just cuts off any residual RNA from the promoter to prevent a ribosome binding site from having its activity changed by the promoter. There are a bunch of different things that bioengineers have done in order to try to make biology more predictable. So here is sort of a modern expression cassette relative to the sort of simple way in which we often represent gene expression control in biological systems. Now this ability to predict how well gene expression can be controlled has led to circuit design automation. These are essentially computer programs in which you can specify the activity of a biological system and then the computer will go through a list of parts, these DNA parts that it has, and figure out how to combine them together in order to give you a genetic program that does exactly what you want. It'll actually spit out the DNA that you need to build and transform into a cell in order to get a cell that has the desired activity. Now these types of computer programs are still complex to build. They require a lot of parts that have been well characterized in the organism that you're trying to engineer. And so we've been able to do it for", "start_char_idx": 12720, "end_char_idx": 17177, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6303af92-3080-4860-bb76-a2ec847b7cc8": {"__data__": {"id_": "6303af92-3080-4860-bb76-a2ec847b7cc8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4e519bc3-29de-419c-9b5c-bdd4c91c2171", "node_type": null, "metadata": {}, "hash": "c3828c4a51dac4978246f3bd1aeabbbf2f0b31bd78003d52ed3940337cec6604"}, "2": {"node_id": "e8b15746-d669-471b-b0fa-dea5c264e590", "node_type": null, "metadata": {}, "hash": "7c107265515de6dc9ae3e0b7e2bf48037a030650265763f4dfc38dd2d6910766"}}, "hash": "ff63c27f599f3e36f7d159cb1524f2272134d2ef53462ff01bfb4fdc929cc5df", "text": "that you're trying to engineer. And so we've been able to do it for E. coli, for a gut bacteria called Bacteroides, and for a strain of yeast, it's actually baker's yeast called Saccharomyces cerevisiae. And so for these three cells there exist computer programs that you can use to specify a given behavior and then have it spit out a DNA sequence that should change the bacteria in a way that matches the desired behavior. Okay, so our reflective questions for the week are what DNA parts control transcription and translation? What did we talk about that gives you the ability to tune transcription and translation? How would you manipulate DNA in order to get more or less protein being made? Why are glyphs helpful for communication about bioengineering? And then what are some reasons DNA parts may not behave as modularly as Legos? And then I'd love you to think about what you would design a cell to do if you could design it to do anything.", "start_char_idx": 17169, "end_char_idx": 18118, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a333f89f-9549-4d66-acfe-0a20c418e2b8": {"__data__": {"id_": "a333f89f-9549-4d66-acfe-0a20c418e2b8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "86de31a0-3140-46a2-b800-2c9a31c3ae82", "node_type": null, "metadata": {}, "hash": "d272ff9cf3daee5345c1f9916dc7b356b7edd8f0f0f327d691346ba3797c4c57"}, "3": {"node_id": "fcb681a5-a55c-4097-8834-bb1c93f524da", "node_type": null, "metadata": {}, "hash": "94ece4c039b956b04ecc74b8e21a3f5e1f4416a57fd3f52ddc58a86116b21192"}}, "hash": "b3e533838f9452be4552787d41597b4d0bd3ccd98c909f4db15671b05d03bf0d", "text": "Okay, let's talk about synthetic genetic circuits. Synthetic genetic circuits are artificial systems made of DNA that are designed to control and regulate the behavior of living cells. They work by taking advantage of the cell's natural gene expression control machinery to turn genes on and off in response to specific stimuli. Now, the arsenic biosensor I showed you is a simple synthetic genetic circuit. It runs a simple program, which determines if arsenic then express green fluorescent protein. This type of synthetic genetic circuit is called a buffer gate and its activity can be described by the truth table shown at the bottom of the slide. Truth tables are ways of demonstrating the, or showing the activity of a synthetic genetic circuit that does logic computation. I'm gonna walk you through this truth table because we're gonna show a bunch of these in this presentation and I want you to be comfortable looking at truth tables and familiar with what it is they're trying to tell you. So this truth table, again, describes the activity of a buffer gate. In the case of the arsenic biosensor, the input is arsenic and an input value of zero denotes no arsenic present in the water that you're trying to measure arsenic concentration in. And an input value of one is a toxic level of arsenic in the water. Now, the output is expression of green fluorescent protein. So when there's no arsenic, you should also have no green fluorescent protein. But when there is arsenic present in the water, you should produce green fluorescent protein. So your output value should be one when your input value is one. Okay, so that's a truth table for a type of synthetic genetic circuit called a buffer gate. And it, again, is a really simple type of synthetic genetic circuit, but it's powerful, right? It's enabling you to produce a bacteria that responds to a contaminant in the environment and produces a visible signal. Now, what if you want to make a slightly more complicated biosensor that responds to arsenic and lead in the water? Let's say you want it to produce green fluorescent protein in response to either of those two contaminants. Well, you could use a slightly more complicated synthetic genetic circuit to achieve this goal. The type of synthetic genetic circuit I would recommend using for this is called a logical OR gate. OR gates, again, respond to two inputs. And in this case, your inputs could be arsenic and lead. So A might be arsenic, B might be lead. Your output would still be a response, or would still be expression of GFP. So you should get GFP when either arsenic or lead or both are present in the water. So by just increasing the complexity of your synthetic genetic circuit a little bit, you now get a bacterium with a broader set of capability. Now, let's say instead of just detecting arsenic or lead in the water, you actually want to remediate or remove these contaminants from the water. You could potentially express a set of enzymes that produce a chelating molecule or something that removes the arsenic, let's say, from the water. An example of a molecule that can chelate arsenic is 2,3-dimeraptopropanol. This compound has a high amount of sulfur in it. And so you maybe don't want to be creating it all the time. And you might want to only be producing this compound when there's arsenic in the water and when there's a sufficient amount of sulfur in the water because otherwise you may be making enzyme that's not able to produce the chelating molecule. So you should, in this case, probably use a logical AND gate where your two inputs are arsenic and sulfur. Again, the sulfur is there so that you can produce enough of the dimeraptopropanol in order to chelate enough arsenic to be meaningful. And you should be expressing the enzymes that make that chelating compound only when there's arsenic and sulfur in the water. So by using a logical AND gate, you can get a sort of smart remediator, a smart cell that is able to start to remediate arsenic or work on remediating arsenic only when it's there and when there are enough resources there for the bacteria to do the remediation that you want it to do. Now,", "start_char_idx": 0, "end_char_idx": 4165, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fcb681a5-a55c-4097-8834-bb1c93f524da": {"__data__": {"id_": "fcb681a5-a55c-4097-8834-bb1c93f524da", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "86de31a0-3140-46a2-b800-2c9a31c3ae82", "node_type": null, "metadata": {}, "hash": "d272ff9cf3daee5345c1f9916dc7b356b7edd8f0f0f327d691346ba3797c4c57"}, "2": {"node_id": "a333f89f-9549-4d66-acfe-0a20c418e2b8", "node_type": null, "metadata": {}, "hash": "b3e533838f9452be4552787d41597b4d0bd3ccd98c909f4db15671b05d03bf0d"}, "3": {"node_id": "21c257dd-0ca5-4966-8874-c6cafcd2fc6a", "node_type": null, "metadata": {}, "hash": "fae4b0a1b3b51f41e54f77a81e605bf738392808a4107fdc8b235323d69adacf"}}, "hash": "94ece4c039b956b04ecc74b8e21a3f5e1f4416a57fd3f52ddc58a86116b21192", "text": "there for the bacteria to do the remediation that you want it to do. Now, I just showed you a buffer gate, an OR gate and an AND gate, but there are actually even more types of logic gates that you can build into living organisms in order to control their behavior. There are 16 different two input logic gates that allow you to take two different inputs and determine what to do based on the presence of those two inputs. And you can build even higher order logic gates too, where you have, let's say, three inputs and you only produce your output gene when all three inputs are present in the environment. And so these types of logic gates are really powerful. They're only one type of synthetic genetic circuit too. I believe Professor Endy showed you some oscillators. That's a different type of dynamic synthetic genetic circuit. But what's true for all of these different synthetic genetic circuits is that there are many different ways to build them. And there are lots of biomolecules that you can take advantage of in order to construct a synthetic genetic circuit. So we're gonna talk on the next couple of slides about building logical AND gates. I'm gonna show you designs for four different type, for four different AND gates built with different types of biomolecules so you can get a sense for how bioengineers are thinking about creating synthetic genetic circuits inside of living cells. Okay, so this first AND gate is built with transcription factor and chaperone pairs. So the design of this AND gate uses two different inducible promoters. One promoter is turned on by the presence of arabinose. That's a type of sugar in the cell. And the other promoter is turned on by a type of antibiotic called tetracycline. And so when the arabinose promoter is activated, it turns on expression of a protein called SIC-A. SIC-A is a transcription factor that would bind a third promoter called P-SIC-A and initiate expression of the gene downstream of SIC-A. But SIC-A when it's produced is not folded correctly. For whatever reason, the bacteria is not able to fold it correctly. And so remember we talked about how protein structure is really important for function. Well, when it's not folded correctly, it can't bind the DNA and it can't initiate expression of the output gene, which is RFP, a red fluorescent protein. SIC-A needs a chaperone called INVF in order to fold correctly. So the second input, the tetracycline drives expression or initiates expression of INVF. This chaperone protein then helps SIC-A fold correctly. And it's only when you get both SIC-A and INVF expressed in the cell that you get a functional transcription factor that can then turn on this SIC-A promoter and initiate expression of your output gene RFP. So that's the design of this AND gate. Its activity was assayed in E. coli. And so in this graph, you can see increasing amounts of tetracycline along the bottom, and then increasing amounts of arabinose up the side. And you can get strong expression of RFP, your output gene, only when there is both a high concentration of arabinose and a high concentration of tetracycline in the E. coli cell. And so this is exciting. That means that type of AND gate built on transcription factor chaperone pairs is functional. It's not the only way to build an AND gate. You can actually take one transcription factor and split it in two and drive expression of one half of the transcription factor with one input promoter and the other half with another input promoter. So only when you then get expression in promoter A and promoter B that you get both halves of the transcription factor being made. Once both halves are made, they can bind together and activate an output promoter. And in this case, it's driving expression of a different fluorescent protein called cyan fluorescent protein. These are just different colors of fluorescent protein. The activity of this type of AND gate was assayed in a type of mammalian cell line called U2OS cells. So I think it's exciting that we're able to build AND gates with a different type of biomolecule, in this case, a split transcription factor, and in a different", "start_char_idx": 4107, "end_char_idx": 8259, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "21c257dd-0ca5-4966-8874-c6cafcd2fc6a": {"__data__": {"id_": "21c257dd-0ca5-4966-8874-c6cafcd2fc6a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "86de31a0-3140-46a2-b800-2c9a31c3ae82", "node_type": null, "metadata": {}, "hash": "d272ff9cf3daee5345c1f9916dc7b356b7edd8f0f0f327d691346ba3797c4c57"}, "2": {"node_id": "fcb681a5-a55c-4097-8834-bb1c93f524da", "node_type": null, "metadata": {}, "hash": "94ece4c039b956b04ecc74b8e21a3f5e1f4416a57fd3f52ddc58a86116b21192"}, "3": {"node_id": "9837547e-91cd-492c-88f6-0ea1c5b9625e", "node_type": null, "metadata": {}, "hash": "7ebfaede4a7b4e0f4d49b5da8f9d5799624960ddbc9267de8355233d544cd81f"}}, "hash": "fae4b0a1b3b51f41e54f77a81e605bf738392808a4107fdc8b235323d69adacf", "text": "of biomolecule, in this case, a split transcription factor, and in a different type of cell, a mammalian cell, which is very different from an E. coli bacterium. Okay, so you can also build AND gates with a special type of protein called a recombinase. Recombinases are proteins that invert segments of DNA. So the first recombinase in this AND gate design is BXB1. BXB1 expression is stimulated by a molecule called acyl homoserine lactone. So this is just a molecule you can add to the cell. When you add it to the cell, you get expression of BXB1. BXB1 then looks for its recognition sequences, which are segments of DNA in this cartoon indicated by little red arrows. When it finds the DNA that it likes, it recognizes, it will actually invert the part in the middle. And so the DNA in between these two recognition sequences is a terminator. The terminator will stop progression of RNA polymerase. So this promoter should be attracting RNA polymerase and then initiating transcription of an RNA. However, when the polymerase hits the terminator, it'll fall off and it won't be able to express the gene that's downstream, which is GFP here. So BXB1 will invert this terminator sequence and essentially allow the RNA polymerase to progress to GFP, or at least it would progress to GFP, except that this design has two terminators in it. The second terminator is flanked by recognition sequences for a different recombinase called 5C31. 5C31 expression is initiated by a antibiotic. And this is the same one as before, tetracycline. When 5C31 is expressed, it will invert the second terminator so that when you get expression of BXB1, which flips the first terminator and 5C31, which flips the second terminator, you can then get an RNA polymerase that is able to express or read through this segment of DNA and express your downstream gene GFP. So it's another way of building an AND gate inside of a living cell. This type of AND gate was tested in E. coli and found to function very well. The last type of AND gate that I'm gonna show you is built with proteins called proteases. These proteases cleave proteins. And so there's no transcriptional control in this case. A lot of, all three of the other circuits that I showed you, all three of the other AND gates were all dependent on changes in transcription in order to get changes in expression or GFP signal. In this case, we're going to have control at the level of protein stability. Okay, so a protease, again, cuts proteins at very specific sequences, very specific amino acid sequences. And the protein in this case is going to have GFP fused to a degradation tag and a Tev protease cut site, and then another protease cut site for HCV protease and another degradation tag. Now, these two degradation tags will cause GFP, the protein to be degraded really quickly. So you never see fluorescence signal in a cell, even though it's making GFP protein because the protein is so quickly chewed up. Now, the Tev protease is going to be expressed in response to your first input, and it will cut the protein just upstream of the GFP part so that it removes the degradation tag. It will essentially cut off this degradation tag. Your second input is going to be this HCV protease, and it will cut off the other degradation tag. So when you have both Tev protease and HCV protease expressed in your cell, you'll cut off both degradation tags and get a GFP signal. So in this case, you're going to be getting AND gate-like logic just by cutting a protein in specific locations. So this is just showing you fluorescence intensity in HEK293 cells. That's a type of human embryonic kidney cell line. So these are human cells. You can see strong GFP signal only when both your Tev protease and your HCV protease are expressed in the HEK cells. And so this type of AND gate is just another example of a logic gate or a genetic circuit being built with a biomolecule. What is true", "start_char_idx": 8253, "end_char_idx": 12182, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9837547e-91cd-492c-88f6-0ea1c5b9625e": {"__data__": {"id_": "9837547e-91cd-492c-88f6-0ea1c5b9625e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "86de31a0-3140-46a2-b800-2c9a31c3ae82", "node_type": null, "metadata": {}, "hash": "d272ff9cf3daee5345c1f9916dc7b356b7edd8f0f0f327d691346ba3797c4c57"}, "2": {"node_id": "21c257dd-0ca5-4966-8874-c6cafcd2fc6a", "node_type": null, "metadata": {}, "hash": "fae4b0a1b3b51f41e54f77a81e605bf738392808a4107fdc8b235323d69adacf"}, "3": {"node_id": "f83078de-19e5-4b26-8890-7794f34d9d27", "node_type": null, "metadata": {}, "hash": "3cf189881c3a827b1fd79496ba17b57ebee59bc7f9e4ffda36337dfec866c083"}}, "hash": "7ebfaede4a7b4e0f4d49b5da8f9d5799624960ddbc9267de8355233d544cd81f", "text": "gate or a genetic circuit being built with a biomolecule. What is true for all of these is actually that you can build diverse genetic circuits with the same tools. So the same kinds of protease tools can be used to build synthetic genetic circuits that perform other types of logic. This is a not AND gate. So it has actually exactly the opposite type of behavior as an AND gate where it's on in all cases, except where both Tev protease and HCV protease are expressed. There are, you know, implies, not implies, or exclusive or gates. There's all different types of logic gates that you can build using the same type of protease tools and using the same type of recombinase tools, you can build diverse types of logic gates as well. And so these different biomolecules lead to, can be used to build different types of synthetic genetic circuits. And through all of this, you may be wondering, what's a concrete example of where I would use a logic gate? Like, why would I go through the trouble of building these things? Well, one example is here. A synthetic genetic circuit can be used to increase cancer treatment specificity. So in this case, we're talking about a type of cancer treatment called a CAR-T. So these are T cells, which are immune cells that are activated to basically kill cancer cells within your body. We've engineered the T cells to recognize the cancer cells as foreign, and then start breaking them down. And the cancer, the T cell needs to be very specific and only start killing cancerous cells. Because if it starts killing other cells within your body, it can cause a lot of side effects and be potentially detrimental to your health. And so an AND gate can be implemented in order to help the T cell very specifically kill cancer cells by very specifically recognizing things that are only on the surface of cancer cells. And so by having three different input signals, the T cell is able to more specifically kill cancerous cell lines. And this graph on the right is just showing you that it's able to do this very specific targeted killing of cancer cell lines when it has a three input AND gate, or when the three input AND gate is used in T cells. We're gonna talk more about the mechanism of T cell-based or engineered T cell-based cancer therapies in our cancer week. But I just wanna show you that this type of three input AND gate can be useful for refining treatments, which is, I think, an exciting application. Okay, now tuning gene expression, changing how much transcription or translation is going on within a cell can change the behavior of a synthetic genetic circuit. Just wanna show you that with a really simple synthetic genetic circuit called a NOT gate, in this case, it is just flipping the buffer gate around. So if you have an inducible promoter, which we're denoting with this gray arrow here, that's turned on by something like tetracycline or arsenic, any of the inducible signals we showed before, instead of expressing a GFP signal, it will express a repressor. A repressor is a type of transcription factor that then turns off a promoter. And so if you turn off a promoter that's upstream of your output gene, in this case, a yellow fluorescent protein, then you'll get a transfer function or a response function that looks like this, where as you increase the amount of your input, let's say you increase the amount of arsenic present, then you will decrease the amount of observed fluorescent protein, as you increase the amount of input, you make more repressor, that repressor turns off your output. So you get something that looks like this. Now, what we care about in these types of synthetic genetic circuits are the dynamic range. What is the difference between the on state and the off state? You want a big dynamic range or a big difference between on and off for most biosensors or most synthetic genetic circuits, because if you produce, for example, just a little bit of fluorescent signal in response to arsenic, then it can be really difficult to see, is my bacteria fluorescing or is it not? Am I making, is there arsenic in the water? Is there not? Whereas if you get a really big signal, if you get a big dynamic range, a big difference between on and off", "start_char_idx": 12191, "end_char_idx": 16426, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f83078de-19e5-4b26-8890-7794f34d9d27": {"__data__": {"id_": "f83078de-19e5-4b26-8890-7794f34d9d27", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "86de31a0-3140-46a2-b800-2c9a31c3ae82", "node_type": null, "metadata": {}, "hash": "d272ff9cf3daee5345c1f9916dc7b356b7edd8f0f0f327d691346ba3797c4c57"}, "2": {"node_id": "9837547e-91cd-492c-88f6-0ea1c5b9625e", "node_type": null, "metadata": {}, "hash": "7ebfaede4a7b4e0f4d49b5da8f9d5799624960ddbc9267de8355233d544cd81f"}}, "hash": "3cf189881c3a827b1fd79496ba17b57ebee59bc7f9e4ffda36337dfec866c083", "text": "signal, if you get a big dynamic range, a big difference between on and off states, then it's much more obvious that the bacteria has detected something in the environment that it's trying to tell you about. And then the other thing we care about is just the threshold, right? This is the point at which a genetic circuit switches from being on to being off or being off to being on. This you can think of as the threshold at which like there's a, the bacteria recognizes that there's arsenic in the water and starts responding to it. You can imagine that at a really low concentration of arsenic, maybe the bacteria can't even detect it. It can't even tell. And so that threshold is just where the switch point is from being on to being off. Now, if you change different parts of this NOT gate here, then the circuit will.", "start_char_idx": 16409, "end_char_idx": 17232, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2f3aa23c-8afb-463c-9690-062f35513d50": {"__data__": {"id_": "2f3aa23c-8afb-463c-9690-062f35513d50", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5399b3a5-3d94-432c-a51a-6ce1c4574045", "node_type": null, "metadata": {}, "hash": "c389f685058607079444883419284c0ef3d6873e395508c2a1f449592bab3136"}, "3": {"node_id": "87dafef3-d727-4219-ae85-8cc563f3e7e2", "node_type": null, "metadata": {}, "hash": "1b9f84c7ec8f7b059031e61b75e57ad8f91c161070dd504bdc0b1ec68f4451a9"}}, "hash": "a96471916ae2cdae9502f298f9e0fbe94b5aefb713ba90f0c340e69f02fde813", "text": "behave differently. So for example, if you change the strength of this second promoter, this red output promoter, then you can change the kind of whole circuits output. So if this black line is the original circuit and you increase expression or the activity of this red promoter, then you can shift the entire curve up. You basically will be producing more output protein all the time, even as you try to turn it off, you'll still get more than you would have originally. And if you decrease this promoter strength, then you can shift it down. The other things you can do are change the degradation rate of the fluorescent protein, let's say in this case, if you start increasing the rate at which this protein is degraded, let's say you put one of those degradation tags on, but not a very good one, just one that's like kind of okay, you can reduce the amount of fluorescent protein that's being, that's stably produced in the cell at any time and shift this curve down. By changing the ribosome binding site, you can actually shift the curve left and right and change the thresholds. So basically what I want you to take away from this is that there are many ways that you can tune synthetic genetic circuits in order to tune the activity of the, or the behavior of your living cell, your biosensory or your remediator, whatever it is that you're trying to build, your CAR T therapy. These curves, these are not experiments. These are actually mathematical models. So we actually can predict what would be the impact of doing something like changing promoter strength. We understand enough about how biological systems are functioning in order to do this type of prediction. And so if you are a bioengineer and you're designing a synthetic genetic circuit, you might build a mathematical model first and then say, okay, like what parameters do I need in order to make the circuit function correctly? How strong of a promoter do I need? How strong of a ribosome binding site? Stuff like that can help guide the construction of synthetic genetic circuits that have different performances in living cells. Okay, the other thing I'll say is that it's not just the expression control elements that matter, but actually the part choice affects circuit performance. So I showed you two, a couple of different types of AND gates, one of which was built with transcription factors and chaperones. And in this case, if you, the AND gate that gets built is very sensitive to changes in both the chaperone and activator expression levels. And so what do I mean by that? Well, it responds dynamically to changes in these things. If you have input one and input two pulsed into your system over time. So let's say you have a bacteria and it's living for three hours, and then you add inducers, both the tetracycline and the arabinose, those were the two triggers for promoter one and promoter two to initiate or become active. So you add both of them together, then you will get expression of both your chaperone and your activator at the same time, your transcription factor. Those things will bind to the promoter and initiate expression of your output gene. And so you'll see an increase in the amount of your output over time, and then it will hit eventually a saturation. And when your chaperone and your activator, when both things are still being expressed, it will stay on. But then if you wash away the arabinose and your tetracycline, these two input molecules, eventually you'll stop making the chaperone and activator, and then expression of your output gene will turn back off. So you get this kind of dynamic response to the inputs. If you have them temporally separated, then you'll actually never see the input or the AND gate turn on, right? If first you make some activator because you have one of your inputs present, then you stop adding that molecule, and later you add the other molecule, you will get chaperone being expressed, and then later on in the cell, you'll get the activator being expressed, but they were never expressed together. They were never expressed at the same time. And so they won't be able to activate expression of your output gene. And so this type of AND gate shows you when both inputs are present at the same time, when the bacteria is", "start_char_idx": 0, "end_char_idx": 4274, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "87dafef3-d727-4219-ae85-8cc563f3e7e2": {"__data__": {"id_": "87dafef3-d727-4219-ae85-8cc563f3e7e2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5399b3a5-3d94-432c-a51a-6ce1c4574045", "node_type": null, "metadata": {}, "hash": "c389f685058607079444883419284c0ef3d6873e395508c2a1f449592bab3136"}, "2": {"node_id": "2f3aa23c-8afb-463c-9690-062f35513d50", "node_type": null, "metadata": {}, "hash": "a96471916ae2cdae9502f298f9e0fbe94b5aefb713ba90f0c340e69f02fde813"}}, "hash": "1b9f84c7ec8f7b059031e61b75e57ad8f91c161070dd504bdc0b1ec68f4451a9", "text": "AND gate shows you when both inputs are present at the same time, when the bacteria is experiencing both of them together. But this recombinase-based AND gate does something different. It makes a permanent change in the DNA. Remember, one of the recombinases will invert a terminator, and the other invertase will invert the other terminator, but these inversions, these are permanent. So they are permanently changing the DNA. So if you express, and they take a long time to initiate relative to the expression of your activator and chaperone. So if you have both promoter one and promoter two triggered at the same time, if you start expressing both recombinases at the same time, you will get expression of your output gene slowly turning on as these recombinases catalyze this inversion. But what's really interesting is that if these things are temporally separated, you will get the first invertase expressed early on. It will invert its piece of DNA, its terminator that it recognizes. And then that invertase, the promoter expressing it may shut back off. You may stop making this recombinase, but it will have already done its inversion thing So now this piece of DNA is sitting here with one terminator inverted and the other one still preventing expression of GFP. But if you put the other input into the cell, then you can get inversion of the second invertase and expression of your output gene. So this AND gate is actually reporting whether or not your two inputs were ever delivered into the cell, not whether they were delivered together. So it's just an interesting like nuance of how when like your choice in what biomolecules to use to construct synthetic genetic circuits affect the cell's behavior. And so there's this big race within synthetic biology or bioengineering to figure out what are all the different types of molecules I can use to build synthetic genetic circuits. And when I build circuits with this molecules, how do they behave? So I just wanna leave you with that thought and then I have some reflective questions. So I want you to think about like what are other biomolecules that you could use to build AND gates? Maybe these are biomolecules you've heard of in your biology courses, or maybe you're just, you know, dreaming. Maybe you're thinking like, if only there were a biomolecule that did this thing, we could build a really cool AND gate with unique dynamic responses or, you know, other unique properties. I want you to reflect for a little while on what would be an interesting biomolecule to build a logical AND gate with. Wanna think about why tuning gene expression affects circuit behavior, and then what situations you think synthetic genetic circuits could be helpful in.", "start_char_idx": 4188, "end_char_idx": 6916, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f9d820d3-7e2a-4df3-ac94-109a77ffb589": {"__data__": {"id_": "f9d820d3-7e2a-4df3-ac94-109a77ffb589", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "90618f92-da87-45f1-97fd-4d8f8dacea0e", "node_type": null, "metadata": {}, "hash": "569ab1660f4fb554b352014076bd52bb3e2d1214f8a2de8781843b5f7913aed2"}, "3": {"node_id": "28fa33e7-47ac-4dfa-bbbc-7d9b84fcacb0", "node_type": null, "metadata": {}, "hash": "666baf6918afac152c274e3ee172b11ffbfe5149dfbd74be0da7699b7ed309d3"}}, "hash": "2b40ccb966e2bfbc27dc79086ece6c79daebc810cd0f189567b83508cd2e3772", "text": "We're going to explore the idea that DNA could be developed as a programming language. We mean this in an engineering context as opposed to what exists already in nature. Could we develop a language for programming DNA? Let's stop for a minute and think about what languages are. We take it for granted. Like, oh, we're speaking, we're using a language. More abstractly, we can think of languages as systems for representing things we see, our wishes and intentions, ideas, and more. Languages themselves are a type of technology for representation and communication. For example, if we go back to the 19th century and to Cork, Ireland, we can see the work of George Boole, very curiously titled publication, The Laws of Thought, an investigation of the laws of thought, and then of which are founded the mathematical theory of logic and probability. So here's Mr. Boole as represented in the 1850s. Let's just take a little snippet of the text we can find in this book. The link to the reference is at the bottom. I encourage you to explore it. Signs of mental operations whereby we collect parts into a whole or separate a whole into its parts. Now, remember, he's thinking about thought and the laws of thought. We are not only capable of entertaining the conceptions of objects as characterized by names, qualities, or circumstances applicable to each individual of the group under consideration, but also of forming the aggregate conception of a group of objects consisting of partial groups, each of which is separately named or described. Okay, that's pretty abstract. Let's see. Okay, good examples. We use the conjunctions and, or, etc. For example, trees and minerals, barren mountains or fertile veils are examples of this kind. In the strictness, the word and or interposed between the terms descriptive of two or more classes of objects imply that those classes are distinct so that no member of one is found in another because you don't find a fertile veil in a barren mountain and vice versa. Okay, and this in all other respects, the word and or are analogous with the sign plus addition in algebra. One thing you should notice is this is really formal thought in and of itself, but hidden within it and explained is the idea that words are being developed because they're useful, they have utility. The word and is incredibly useful because it allows us to represent something about what we observe. You know, if it's warm and sunny, then I might go to the beach. And of course, Boole is famous for Boolean logic, which allows us to do operations both via language and computers, whether electrical, mechanical, or biological. So again, this is pretty esoteric, but if you go back into the formal development of languages, you can learn a lot firstly, but also you can imagine languages as these more abstract things such that, you know, we might be having class in English, or you might be communicating with a computer in Python or some other computer programming language. And I should be careful, an electrical computer programming language, as opposed to a biological computer, or maybe we could have one or more languages for programming and DNA. What are those languages going to be called? I don't know, like maybe it's your name language, right? You might be able to be the person who makes that language. So that's hopefully gives you a sense of what we're talking about. I want to share and introduce you quickly to a hero of mine. This is Professor Vassie Ware from Lehigh University in Bethlehem, Pennsylvania. Professor Ware was my professor, gosh, probably around 1992 when I was a student studying genetics. So she was my genetics professor. And I would think I was the only engineer in the class. We met really early. We met like 7.45 in the morning, but she would always bring bagels or donuts and a lot of orange juice. And I would sit there confused mostly because I didn't understand genetics, but she was such a great teacher. And I want to relate to you what it was like to be a student in that class. One of the things that would happen is she would show us pictures, structures of molecules. And we've already been looking at these. And I would sit in the back", "start_char_idx": 0, "end_char_idx": 4202, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "28fa33e7-47ac-4dfa-bbbc-7d9b84fcacb0": {"__data__": {"id_": "28fa33e7-47ac-4dfa-bbbc-7d9b84fcacb0", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "90618f92-da87-45f1-97fd-4d8f8dacea0e", "node_type": null, "metadata": {}, "hash": "569ab1660f4fb554b352014076bd52bb3e2d1214f8a2de8781843b5f7913aed2"}, "2": {"node_id": "f9d820d3-7e2a-4df3-ac94-109a77ffb589", "node_type": null, "metadata": {}, "hash": "2b40ccb966e2bfbc27dc79086ece6c79daebc810cd0f189567b83508cd2e3772"}, "3": {"node_id": "1e5be4b9-d434-4692-bcda-f468de0d2908", "node_type": null, "metadata": {}, "hash": "1678dd9bb33cd91e7cd3de01b1b49c0de068a478edbab1dd822663e903acc9ea"}}, "hash": "666baf6918afac152c274e3ee172b11ffbfe5149dfbd74be0da7699b7ed309d3", "text": "And we've already been looking at these. And I would sit in the back of the class and I'm going, what's up with this? Like, why do I need to understand the structure of this molecule? So let's just use this one as an example. What's it do? What does it do? Can you figure it out just by looking at it? And of course, there's the link down in the bottom left. If you want to go to the protein data bank and learn more about it and turn it around in a web browser, I encourage you to do that. But for now, tell me what you see here. I guess I see some orange glob and a blue glob. Those must be proteins. And this is interesting. It looks like a double helix becoming, maybe this is a double helix of DNA. And then a single strand of DNA. The DNA seems to be going through these globs. So it's like a DNA going through a protein pore. And I see a minus and a plus. That reminds me of electronics. This turns out to be a protein that can be used to sequence DNA by passing the DNA through a pore and looking at changes of current as different bases of DNA go through the pore. This is the basis of what's called nanopore sequencing, which we'll learn about later. But what's this got to do with language? As a student, I didn't want to understand how this thing worked. I just wanted Professor Ware to tell me what it did. Don't give me all this complexity of how the things work. Just tell me what it does. Let's try another example. Hey, what's this? Looks interesting. It looks kind of crazy. It's got, I don't know, what is this thing? Just tell me what it does. I don't know. Do I need to know the etymology of a word to use the word and all the details? No, I just want to know what the word is so I can use it. This is me thinking like an engineer in a somewhat naive way. Oh, OK. It's the photosynthetic super complex. Kind of important. Takes in sunlight, fixes carbon dioxide, makes sugar. All right. How about this? What's this? Of course, they're beautiful things to look at and imagine. I just want to know. I just want to use it for something. I just want to be an engineer. Oh, it's a cellulose synthase. Mix wood. What's this? I have no idea. Oh, of course. It's biodegradable plastic. You see what's happening? As soon as I know what it is, as soon as you tell me what it is, I'm excited. It's not that other people can't get excited about the structure and all the details. It's like, I just want to biodegrade plastic. How about this? What's this? SARS-2 spike protein and antibodies. All right. For preventing an infection. What's this? I see that gray box. Maybe it's another membrane thing. But I have no idea. Caspasin, a receptor for the spicy stuff. Whoa. How would I know that? Just by looking. What's this? I guess it's the same thing looking top down and on the side and the bottom. Yeah. Voltage-gated sodium channel. I could use a change in voltage to let ions go through a membrane. That'll be interesting for nerves, neurons, other things maybe. What are these things? Fold it one, fold it three. Fairy dog diesel. Citizen science designer proteins. I don't know what they do, but that's cool. Somebody made them. Citizen science. Let's zoom out and make sense of this. I could go on forever going through the entire PDB with all the structures and all the functions and just be like, hmm. But the point here around language is, could we ever organize these relationships between the functional objects themselves, the biomolecules, and their abstracted representation? Representation is such a cool word. Slow it down. Re-presentation. Re-present. So could we ever organize these relationships between the functional objects, the biomolecules, and these names, these abstracted representations like cellulose synthase, along with a grammar, rules for composing these objects into more complicated systems? If we can do that, then we might be able", "start_char_idx": 4148, "end_char_idx": 8024, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1e5be4b9-d434-4692-bcda-f468de0d2908": {"__data__": {"id_": "1e5be4b9-d434-4692-bcda-f468de0d2908", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "90618f92-da87-45f1-97fd-4d8f8dacea0e", "node_type": null, "metadata": {}, "hash": "569ab1660f4fb554b352014076bd52bb3e2d1214f8a2de8781843b5f7913aed2"}, "2": {"node_id": "28fa33e7-47ac-4dfa-bbbc-7d9b84fcacb0", "node_type": null, "metadata": {}, "hash": "666baf6918afac152c274e3ee172b11ffbfe5149dfbd74be0da7699b7ed309d3"}, "3": {"node_id": "d1727f3d-941d-4663-8f11-abb822ab3bae", "node_type": null, "metadata": {}, "hash": "701e6c68ab0de6659282de247ae1847ab2ca38bcd0c1a17f6fa2f528017b03bd"}}, "hash": "1678dd9bb33cd91e7cd3de01b1b49c0de068a478edbab1dd822663e903acc9ea", "text": "these objects into more complicated systems? If we can do that, then we might be able to develop languages for programming life. You want to think about this with pictures, with English as a language, or any human-to-human language. We're familiar with dictionaries as definitions of words. This is the relationship between the name of the word and its function. And of course, we have the rules of grammar, which give us the instructions for how to compose words reliably to make sentences and paragraphs and novels and so on. Could we develop this type of capacity, this bioengineering infrastructure, such that we could have one or more languages for relating to living systems, for expressing our wishes and intentions within the code of life? For example, wouldn't it be nice if I could say, you know, I'd like a cell that floats when it's sunny. And that's all I needed to do. And by saying that, a whole bunch of grammar and functions would compose into a low-level DNA sequence that could be made, and then we'd have a cell that floats when it's sunny. That's what it's like to have a language. We have functions and definitions and grammar we can compose, and we get what we want. Of course, you've got to be creative and do the editing and learn how to use the grammar and understand the definitions. But essentially, this is what we're going for. What might this look like? Well, I'm going to need a sunlight detector as a device, and I'm going to need a buoyancy modulator, something to control floating or sinking. And if I could just get those off the shelf, and then I could get the DNA sequences encoding those things, and I could then we'd have a cell that floats when it's sunny. And I wouldn't necessarily have to be an expert in sunlight detection, right? Somebody would have figured that out before and created the entry in the dictionary. Sure enough, students before you have been working on this more than anybody else, frankly, because they want it. They want this language and grammar. Here's an example. The Registry of Standard Biological Parts, made by students in high school and college. The website is down at the bottom where you just go to the website, college. The website is down at the bottom where you just go to parts.igem.org. Here's a part we can find in this very immature early dictionary for programming DNA. Part number I750016. I guess a computer could like that name. Here's a better name. Gas Vesicle Polycistronic Gene. This part contains 11 open reading frames or genes encoding proteins from a bacteria, Bacillus megaterium. If you express this, you make gas vesicles, tiny little protein balloons in cytoplasm that are maybe 60 nanometers across. Or if the cell was as big as the building, 100 meters, that's maybe a two meter balloon. And these organelles contain gas and therefore can control the buoyancy of the cell. To read more, check out this reference. But you can just read as much as you want on this website. Okay. And look, on this website, there's a little link. It says get part sequence. We can click that link. Now we've got the DNA sequence encoding the genes that make a tiny little protein balloon in the cytoplasm of bacteria. This is the protein balloon generator DNA. In other words, a transcription source, the reading out of this DNA can be used to modulate buoyancy. And it starts with an A, A, A, G, G, G. I don't know what's going on there. It's like, there's about 6,000 letters it looks like. You have to be an expert in this to understand what all the letters do. And that's okay. Maybe that's what you want to do. That's cool. Then I would need, what else? I need a sunlight detector. And earlier in the class, we were talking about, what was it? The edge detector based on collecting light patterns and then determining where the boundaries in those patterns are. Here's earlier work leading to that by Jeff Tabor, Chris Voigt, Andy Ellington, and some Laskaia and colleagues. The simpler version is here, just take the bacterial picture, right?", "start_char_idx": 8010, "end_char_idx": 12039, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d1727f3d-941d-4663-8f11-abb822ab3bae": {"__data__": {"id_": "d1727f3d-941d-4663-8f11-abb822ab3bae", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "90618f92-da87-45f1-97fd-4d8f8dacea0e", "node_type": null, "metadata": {}, "hash": "569ab1660f4fb554b352014076bd52bb3e2d1214f8a2de8781843b5f7913aed2"}, "2": {"node_id": "1e5be4b9-d434-4692-bcda-f468de0d2908", "node_type": null, "metadata": {}, "hash": "1678dd9bb33cd91e7cd3de01b1b49c0de068a478edbab1dd822663e903acc9ea"}, "3": {"node_id": "a4fc4f7a-be61-44d5-965d-b5cf70b91baa", "node_type": null, "metadata": {}, "hash": "1fff08a40deb86bcf686a6e6f32b66aca74801bedb376f0f26ddb45b962d31fb"}}, "hash": "701e6c68ab0de6659282de247ae1847ab2ca38bcd0c1a17f6fa2f528017b03bd", "text": "colleagues. The simpler version is here, just take the bacterial picture, right? So there's a portrait of Andy Ellington, second from the right. And I think that's the flying spaghetti monster captured in a bacterial plate. It's not a Polaroid image. They call it a coliroid for E. coli. Okay. So I've got a light sensor here. I could find that sequence. And if I put those two together and compose those pieces of DNA and then got that DNA into a bacterium, then I'd have a cell that floats when it's sunny. So that should give you an idea of if we could organize the functions of life, create a grammar, supporting composition, you'd be able to have a programming language for DNA. Let me give you another example and a sense of the formalism that underlies this type of work. And I want to be really careful. In the year 2023, this type of bioengineering idea is about 20 years old and people have been working on it sputteringly for the last couple of decades. But you cannot now go to the perfectly reliable dictionary of biological functions. You cannot now go and read the perfectly reliable grammar for composing. We're getting there, but it's such a fundamental topic that the work is ongoing and will fill in over the next decade or two completely. Let's say, for example, I wanted to make an eight-bit counter. What the heck's that? Well, one bit, zero, one. Now I have eight bits. So eight zeros and ones. And let's imagine I make this counter. Each bit is just controlled or represented by taking a piece of DNA I engineer and I can flip the DNA. So it's like the DNA is pointing to the right. That's a zero. Or if it's pointing to the left, that's a one. And just by flipping a little string of DNA back and forth, I go zero, one, zero, one, zero, one. And then if I have eight of these things, like zero, one, flip, flip, now I can count to four if I just keep adding. So that's what this little image looks like. Give me an eight-bit counter because then I could count to two to the eighth, which is 256. I could count anything I could count. I could count how many times a cell is divided. How old is the cell? How many times arsenic pollution signal has been coming in and exposing the cell of that pollutant? I just want to keep track of things. This looks like, how am I going to make this thing? It's going to be pretty complicated. What's the DNA sequence encoding a genetic eight-bit counter? If we tried to go right from this little schematic to those details, we'd be up all night and for a whole century probably up all night. So instead, what we're going to try and do is rely on the idea that we could have a formalized device framework and says, you know, I just need flippers. And, you know, the person making the eight-bit counter could just ask the flipper engineer, like, hey, I need eight flippers. And the flipper bioengineer go, here you go. Right. And now the person working on the system, this eight-bit counter or any other system, you know, would compose those devices and they'd be happy. Just like we were doing before. I want a sunlight detector and a buoyancy generator. Hey, give me those things. And, you know, the grammar and the dictionary would exist. And somebody would give you those things and you'd be on your way with your, you know, cell that's floating when it's sunny. So that's the idea here. Now, who's going to make the flippers and what are those going to be made of? They're going to be made of biological molecules, the parts themselves. And so the device engineers who are making these abstracted functions are going to have to call it, hello, anybody got some parts for flipping DNA, recombinases or integrases? Suddenly I'm using a lot of bio jargon because the details are going to matter. But if the folks who understand that are organized and well-instructed in terms of how to compose those functions to give them to device engineers, to bundle them up into simpler representations that do the functions, then you could give them to the people making", "start_char_idx": 12041, "end_char_idx": 16061, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a4fc4f7a-be61-44d5-965d-b5cf70b91baa": {"__data__": {"id_": "a4fc4f7a-be61-44d5-965d-b5cf70b91baa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "90618f92-da87-45f1-97fd-4d8f8dacea0e", "node_type": null, "metadata": {}, "hash": "569ab1660f4fb554b352014076bd52bb3e2d1214f8a2de8781843b5f7913aed2"}, "2": {"node_id": "d1727f3d-941d-4663-8f11-abb822ab3bae", "node_type": null, "metadata": {}, "hash": "701e6c68ab0de6659282de247ae1847ab2ca38bcd0c1a17f6fa2f528017b03bd"}}, "hash": "1fff08a40deb86bcf686a6e6f32b66aca74801bedb376f0f26ddb45b962d31fb", "text": "into simpler representations that do the functions, then you could give them to the people making the systems and be like, we'd have a language, right? You know, just like if I wanted to send my mom a text message or something like that on the phone, I'd be calling on some functions with my fingers. Inside this machine, there's all sorts of zeros and ones rolling. I have no idea how that works. I just know what's happening. But I get to call on these high level functions that are letting me program this computing object. Ultimately in biology, we've got to encode these parts. We've got to compose it into the DNA sequence itself. That's the genetic material, right? So this is what's called an abstraction hierarchy or a framework that lets you systematically organize layers of function. And as you compile down, you get closer and closer to the instantiation of it in actual living matter, in our case, in DNA. And you could replace what's on the top. Again, we had the example of a cell that floats when it's sunny. There could be an example of like a super spirulina smoothie organism that's making extra vitamins when it's rainy, right? Or whatever you like, right? It's like, what are the number of poems you could come up with? You have a language and grammar. It's an infinite number of poems. What are the number of computer programs you could write? It's an infinite number, right? So we're creating a framework for supporting open-ended generative construction and composition. There's a lot to learn here. And so this is just meant to be an introduction. I want to point you to a comic book. You can find the free PDF download online at the link at the bottom. And if you wanted to learn more about it, which we would encourage you to, take a look at this comic. It's available in six or seven different languages. And of course, in this week's PISA, you'll have some opportunities to practice this sort of thinking around abstracting genetic functions. So to end for now, let's offer a few questions to reflect upon. Slow down and just go back. What are languages? Human languages? Computer languages? Bio languages? What are languages? What must be true for any language to work well? In bioengineering, what do you think the biggest challenges are going to be in terms of getting to one or more languages within living systems? Is it going to be making the dictionary? Is it going to be coming up with the grammar? Is it going to be something else? How long until this is all work in progress? How long until you think anyone can learn how to program DNA? How long until we've got the equivalent of the grammar books and the dictionary for life and it works reliably? You just have to learn the language, but the language works. How much work do you think that's going to be? Do you think it's like five years, 500 years? Maybe you think it's impossible. Maybe it'll never happen. OK, that's it.", "start_char_idx": 16033, "end_char_idx": 18950, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4b14c783-3edc-4958-be8b-c0c0673c11ac": {"__data__": {"id_": "4b14c783-3edc-4958-be8b-c0c0673c11ac", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8cd49350-0a44-48cd-a337-cd75befa1bfd", "node_type": null, "metadata": {}, "hash": "a216e1563634384d70d77df9327396fe23a21d7914ec1c9fc8877bfc3bf5e9a3"}, "3": {"node_id": "304d48c4-000f-47f8-b5d1-0bf48bdbdee6", "node_type": null, "metadata": {}, "hash": "26fc2ccd73716ae094e0e9ccaa7725a1eefd071e6be8dce72c157e0b0def6b02"}}, "hash": "5ad940ecc8a12ecccdd5b9388cf4c592786959ee455d1166c82a35b144dc1ed3", "text": "Welcome to Introduction to Bioengineering at Stanford University. We're going to take a look at the polkadorks and see whether or not they got their design right. This is a fabulous example of the power of abstraction to help us debug genetic designs in synthetic biology. So, let's go on the website. I'll share my screen. Great. And we're going to type in polkadorks and no, I really mean that. Okay. And here we are. So, back in 2004, these folks want to design a dynamic repeating bacterial flash mob, just to remind us their dream, their intention, right? We're talking about abstraction, a language for programming in life. They want to have cells randomly moving around, Brownian motion maybe. They're all flipping coins. One cell comes up heads, changes color, starts broadcasting a diffusible signal shown in green. Other cells are attracted to that signal and they move up the gradient towards the source of the signal. And after a while, the party gets tiresome at the molecular to cellular scale and the system resets and everybody goes about their business and it repeats. So, that's what this thing is supposed to be doing. Okay. So, we're going to look at the device level system diagram. So, their system specification is this animated GIF. Their device level system diagram gives us a high level representation of how they think this could work. If we try to debug down at this level, like there could be problems down at the parts level or at the genetic layout level, but it's so complicated down here. We really want to focus our debugging on this abstracted intermediate level resolution, the device level. All right. So, trigger, that's a coin flipper. And if the coin flipper comes up, it kicks the signal out to this two input on switch here. And all right. And it's a two input gate into a three input switch, actually. So, we're going to have to come try and understand that. And this looks like an or gate, I guess. So, if the trigger is on or if this other signal is on, then do some things. The things it should do is make an attractant. That's the diffusible signal that causes other things to show up. And change colors. So, that's the thing we saw in the animation. So, that kind of makes sense. Now, interesting thing about this switch is a three input switch. So, it's got an off signal. And I presume this is dominant. Meaning that if the signal C coming in is high, it's going to override whatever this A or B signal is telling it to turn on R. And this on signal is responding to another diffusible molecule, homoserine lactone. Where's that coming from? It looks like every cell in the system, just at a low basal level, spontaneously producing some amount of homoserine lactone. And if that signal gets high enough, all cells will receive it. And they will start producing an off signal into this switch. Which would cause the system to reset or turn off. Okay. So, let's just, we're getting there. Let's keep going. Let's look at this attractor. If the switch is on, it's making this attractor ASP or aspartate, I guess. This is going to be something that cells will chemotax towards. And so, for that to happen, we loop back around. Aspartate is an input to all cells. And if cells receive aspartate, they respond. This is the chemotactic response. Towards aspartate. But they also receive a reinforcing signal that goes into the switch. It's like, okay, so let's just play it out. Let's see if this makes sense. Flipping coins, if one cell triggers, it starts making an attractor and it changes colors. And the attractor, if that gets received by another cell, that cell will start moving towards the party, the cell that turned on. And as it moves towards the party, the cell that turns on, the cell that received the aspartate is going to join the party and start making more aspartate. So, there's a really interesting positive feedback loop here manifesting at the population level. One cell randomly turns on, it starts making aspartate. Other cells receive that signal providing a second input B into", "start_char_idx": 0, "end_char_idx": 4048, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "304d48c4-000f-47f8-b5d1-0bf48bdbdee6": {"__data__": {"id_": "304d48c4-000f-47f8-b5d1-0bf48bdbdee6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8cd49350-0a44-48cd-a337-cd75befa1bfd", "node_type": null, "metadata": {}, "hash": "a216e1563634384d70d77df9327396fe23a21d7914ec1c9fc8877bfc3bf5e9a3"}, "2": {"node_id": "4b14c783-3edc-4958-be8b-c0c0673c11ac", "node_type": null, "metadata": {}, "hash": "5ad940ecc8a12ecccdd5b9388cf4c592786959ee455d1166c82a35b144dc1ed3"}}, "hash": "26fc2ccd73716ae094e0e9ccaa7725a1eefd071e6be8dce72c157e0b0def6b02", "text": "making aspartate. Other cells receive that signal providing a second input B into the switch that causes additional cells to start making aspartate. And so, we're just going to get this big positive feedback producing more and more aspartate that's going to recruit more and more cells to make aspartate. And all the cells receiving the aspartate signal are going to be heading up the gradient towards the aspartate. And I guess all the cells are going to change color. That's interesting. Not just the first cell is going to change color, but every cell that is jamming out to aspartate is going to start changing colors. So, it's a little bit different. Only the first cell in this animation change colors. So, the first bug in this device level diagram we can see is that all the cells are probably going to change color. Okay. So, we've got this positive feedback, but so far, it's looking pretty interesting. We're going to make this diffusible signal. The other cells are going to help make the diffusible signal. We're definitely going to get this clustering of cells towards a high concentration of aspartate, and they're all going to be red. A little bit different, but okay. So, we know we're going to get clustering. Now, how is this going to play out, this quorum sensing? So, this is getting made in the background, and when it gets high enough, then everybody's going to turn on C, like a high C signal, which is going to turn off the switch. And if we turn off the switch, then we're not going to make aspartate anymore, and we're not going to make the color anymore in the first cell. That seems pretty good. But we're still making homoserine lactone. Nothing's turning this off, and so this signal C is never going to go down. Like, this is just a constitutive source that comes out of every cell, that every cell can receive, and above some threshold concentration will turn off everything else. And so, I think this doesn't cycle. I think this only comes together with a little bit of a bug of everybody turns red, and then it does shut off, but is it going to reset and start back up? Um, I don't think so. Something would have to remove the HSL signal. Okay, so we just looked at this device level system diagram, and by thinking carefully about how the signals are flowing, and how that relates to the desired specified behavior, we can find one or two bugs that you might want to think about. Like, maybe we need a little bit of a feedback here to turn this off, so that the reset signal itself will reset, and maybe we want to think about whether or not we care. Should only one cell turn color, or should every cell in the party bring their flashlight to the raid, or something like that? But isn't it interesting? Instead of going down to this level and debugging, we can just do some high-level debugging and see if the block diagrams and the control feedbacks make sense. Cool!", "start_char_idx": 3967, "end_char_idx": 6872, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "00cd7fcf-1025-4207-bdc6-c3134a69fb44": {"__data__": {"id_": "00cd7fcf-1025-4207-bdc6-c3134a69fb44", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c774fbac-eea3-4371-b879-8fc57e21f29d", "node_type": null, "metadata": {}, "hash": "a216e1563634384d70d77df9327396fe23a21d7914ec1c9fc8877bfc3bf5e9a3"}, "3": {"node_id": "b17811f6-9e14-459c-8b77-88c8e3ca4225", "node_type": null, "metadata": {}, "hash": "26fc2ccd73716ae094e0e9ccaa7725a1eefd071e6be8dce72c157e0b0def6b02"}}, "hash": "5ad940ecc8a12ecccdd5b9388cf4c592786959ee455d1166c82a35b144dc1ed3", "text": "Welcome to Introduction to Bioengineering at Stanford University. We're going to take a look at the polkadorks and see whether or not they got their design right. This is a fabulous example of the power of abstraction to help us debug genetic designs in synthetic biology. So, let's go on the website. I'll share my screen. Great. And we're going to type in polkadorks and no, I really mean that. Okay. And here we are. So, back in 2004, these folks want to design a dynamic repeating bacterial flash mob, just to remind us their dream, their intention, right? We're talking about abstraction, a language for programming in life. They want to have cells randomly moving around, Brownian motion maybe. They're all flipping coins. One cell comes up heads, changes color, starts broadcasting a diffusible signal shown in green. Other cells are attracted to that signal and they move up the gradient towards the source of the signal. And after a while, the party gets tiresome at the molecular to cellular scale and the system resets and everybody goes about their business and it repeats. So, that's what this thing is supposed to be doing. Okay. So, we're going to look at the device level system diagram. So, their system specification is this animated GIF. Their device level system diagram gives us a high level representation of how they think this could work. If we try to debug down at this level, like there could be problems down at the parts level or at the genetic layout level, but it's so complicated down here. We really want to focus our debugging on this abstracted intermediate level resolution, the device level. All right. So, trigger, that's a coin flipper. And if the coin flipper comes up, it kicks the signal out to this two input on switch here. And all right. And it's a two input gate into a three input switch, actually. So, we're going to have to come try and understand that. And this looks like an or gate, I guess. So, if the trigger is on or if this other signal is on, then do some things. The things it should do is make an attractant. That's the diffusible signal that causes other things to show up. And change colors. So, that's the thing we saw in the animation. So, that kind of makes sense. Now, interesting thing about this switch is a three input switch. So, it's got an off signal. And I presume this is dominant. Meaning that if the signal C coming in is high, it's going to override whatever this A or B signal is telling it to turn on R. And this on signal is responding to another diffusible molecule, homoserine lactone. Where's that coming from? It looks like every cell in the system, just at a low basal level, spontaneously producing some amount of homoserine lactone. And if that signal gets high enough, all cells will receive it. And they will start producing an off signal into this switch. Which would cause the system to reset or turn off. Okay. So, let's just, we're getting there. Let's keep going. Let's look at this attractor. If the switch is on, it's making this attractor ASP or aspartate, I guess. This is going to be something that cells will chemotax towards. And so, for that to happen, we loop back around. Aspartate is an input to all cells. And if cells receive aspartate, they respond. This is the chemotactic response. Towards aspartate. But they also receive a reinforcing signal that goes into the switch. It's like, okay, so let's just play it out. Let's see if this makes sense. Flipping coins, if one cell triggers, it starts making an attractor and it changes colors. And the attractor, if that gets received by another cell, that cell will start moving towards the party, the cell that turned on. And as it moves towards the party, the cell that turns on, the cell that received the aspartate is going to join the party and start making more aspartate. So, there's a really interesting positive feedback loop here manifesting at the population level. One cell randomly turns on, it starts making aspartate. Other cells receive that signal providing a second input B into", "start_char_idx": 0, "end_char_idx": 4048, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b17811f6-9e14-459c-8b77-88c8e3ca4225": {"__data__": {"id_": "b17811f6-9e14-459c-8b77-88c8e3ca4225", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c774fbac-eea3-4371-b879-8fc57e21f29d", "node_type": null, "metadata": {}, "hash": "a216e1563634384d70d77df9327396fe23a21d7914ec1c9fc8877bfc3bf5e9a3"}, "2": {"node_id": "00cd7fcf-1025-4207-bdc6-c3134a69fb44", "node_type": null, "metadata": {}, "hash": "5ad940ecc8a12ecccdd5b9388cf4c592786959ee455d1166c82a35b144dc1ed3"}}, "hash": "26fc2ccd73716ae094e0e9ccaa7725a1eefd071e6be8dce72c157e0b0def6b02", "text": "making aspartate. Other cells receive that signal providing a second input B into the switch that causes additional cells to start making aspartate. And so, we're just going to get this big positive feedback producing more and more aspartate that's going to recruit more and more cells to make aspartate. And all the cells receiving the aspartate signal are going to be heading up the gradient towards the aspartate. And I guess all the cells are going to change color. That's interesting. Not just the first cell is going to change color, but every cell that is jamming out to aspartate is going to start changing colors. So, it's a little bit different. Only the first cell in this animation change colors. So, the first bug in this device level diagram we can see is that all the cells are probably going to change color. Okay. So, we've got this positive feedback, but so far, it's looking pretty interesting. We're going to make this diffusible signal. The other cells are going to help make the diffusible signal. We're definitely going to get this clustering of cells towards a high concentration of aspartate, and they're all going to be red. A little bit different, but okay. So, we know we're going to get clustering. Now, how is this going to play out, this quorum sensing? So, this is getting made in the background, and when it gets high enough, then everybody's going to turn on C, like a high C signal, which is going to turn off the switch. And if we turn off the switch, then we're not going to make aspartate anymore, and we're not going to make the color anymore in the first cell. That seems pretty good. But we're still making homoserine lactone. Nothing's turning this off, and so this signal C is never going to go down. Like, this is just a constitutive source that comes out of every cell, that every cell can receive, and above some threshold concentration will turn off everything else. And so, I think this doesn't cycle. I think this only comes together with a little bit of a bug of everybody turns red, and then it does shut off, but is it going to reset and start back up? Um, I don't think so. Something would have to remove the HSL signal. Okay, so we just looked at this device level system diagram, and by thinking carefully about how the signals are flowing, and how that relates to the desired specified behavior, we can find one or two bugs that you might want to think about. Like, maybe we need a little bit of a feedback here to turn this off, so that the reset signal itself will reset, and maybe we want to think about whether or not we care. Should only one cell turn color, or should every cell in the party bring their flashlight to the raid, or something like that? But isn't it interesting? Instead of going down to this level and debugging, we can just do some high-level debugging and see if the block diagrams and the control feedbacks make sense. Cool!", "start_char_idx": 3967, "end_char_idx": 6872, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1e445500-3faa-4c6e-b90f-59c6f6569949": {"__data__": {"id_": "1e445500-3faa-4c6e-b90f-59c6f6569949", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2b91a97e-5696-4dd0-9927-abbe78bac3d9", "node_type": null, "metadata": {}, "hash": "e33c399035a51d41c84daff8e4bec0284e01e1ab525947e580c6f2186bb05acb"}, "3": {"node_id": "b84f36f0-bc9c-4f2a-a9a8-5efe17f0e80a", "node_type": null, "metadata": {}, "hash": "6b7c7f490d7ea4fb10af32bb79fada82d0ad448c2299bb6d2fa3171917a58568"}}, "hash": "4644cd22122beec52a80fd632af1d2d520b6ae7001b17be4b889eeae46ff5e0c", "text": "This week we're going to talk about reading and writing DNA. We're going to go over technologies to sequence and synthesize DNA and we're also going to talk a little bit about how data or information is stored or could be stored in DNA. Now you interact with a lot of data every day. Each text that we send is 50 to 500 bytes of data. The average email is around 10 kilobytes of data. Each photo contains 1.5 to 3.5 megabytes of data. This is the data associated with tweeting or scrolling on TikTok and as a global population each of these texts and emails add up to being a pretty insane amount of data. Globally it's predicted or estimated that we send about 65 billion texts via WhatsApp every day and that's just one messaging service so the true number of texts sent each day is probably much much higher than that. Send about 300 billion emails every day which is the equivalent of 3.4 million emails getting sent every second of every day. There are about 5 billion photos taken every day and more than 700 or 17 million videos posted to TikTok every day. All of this information that we generate all of this data has to be stored somewhere. Some of it is stored locally on your phone but some of it is stored in the cloud and you know we know that this data is stored because we can go back and access it later. I can read text messages that I sent yesterday and look at pictures that I took last year. So we're you know have a data store a looming data storage problem. In 2025 it's predicted that we're going to be generating 33 zettabytes of data each day and a zettabyte is an insane amount of information. Just for reference today we usually talk about petabytes of data and a petabyte of data is a lot of data. It's the equivalent of 20 million filing cabinets completely filled with text right if you were to write really densely on a piece of paper and do that over and over and over again until you filled 20 million four-drawer filing cabinets. That's how much information is stored in a petabyte of data. It's also 13.3 years of HD video. It's just an unfathomably large amount of data and we're already at the point where we're generating multiple petabytes of data each day and a zettabyte of data is a thousand times bigger than a petabyte. There's an error in this slide I'll correct it later. So a zettabyte 33 zettabytes of data is a lot of data and the question is what do we do with all of this data? Where do we store it? Where do we keep our information as a society? Well some data is stored in storage facilities that look like this. This is actually an image of a google storage facility data storage center. You can click this link at the bottom of the slide to see a youtube video where they actually walk you through this center and what you'll see when you watch the video are rows and rows of servers where there's hard drives storing information that you can query and access from google's online interfaces. But when you're not looking at your google doc or you're not looking at your google photo it's sitting there in one of these data centers just waiting for you to access it. It's not clear exactly how much data is stored in each data center but google has several of these all over the world and it's estimated that they currently store about 10 to 15 exabytes of data and so we will need essentially to increase the amount of data that data storage capacity that we have or start to think more carefully about whether we need you know bursts of photos for every situation that we get into. Now I wanted to just think about the kind of digital data information for a minute and think about how we've stored it so that we can contrast it with how data is stored in biological systems. I want you to think for a second about how much data how many petabytes or kilobytes or bytes of data it might take in order to encode you. At the moment no one knows how to do this right we don't know how to download our consciousness or translate our consciousness into zeros and ones so that we could live forever as data in one of those google storage centers but it's an interesting thing to think about right what would it really take to encode a person as bytes of data. Well in some ways we already know right in some ways the instructions to create another one of me is in my DNA. It's in the 23", "start_char_idx": 0, "end_char_idx": 4335, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b84f36f0-bc9c-4f2a-a9a8-5efe17f0e80a": {"__data__": {"id_": "b84f36f0-bc9c-4f2a-a9a8-5efe17f0e80a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2b91a97e-5696-4dd0-9927-abbe78bac3d9", "node_type": null, "metadata": {}, "hash": "e33c399035a51d41c84daff8e4bec0284e01e1ab525947e580c6f2186bb05acb"}, "2": {"node_id": "1e445500-3faa-4c6e-b90f-59c6f6569949", "node_type": null, "metadata": {}, "hash": "4644cd22122beec52a80fd632af1d2d520b6ae7001b17be4b889eeae46ff5e0c"}, "3": {"node_id": "e4d3bc90-8249-4e00-b573-6da7986761df", "node_type": null, "metadata": {}, "hash": "691d83c74f2425d518eb5eb5bb79fc93dfea221dc2211935ad5565922058d472"}}, "hash": "6b7c7f490d7ea4fb10af32bb79fada82d0ad448c2299bb6d2fa3171917a58568", "text": "the instructions to create another one of me is in my DNA. It's in the 23 chromosomes or 3.2 gigabases of DNA. Notice it's gigabases not gigabytes in this case we're talking about a's t's c's and g's we're talking about the building blocks of DNA but inside each one of my cells are 3.2 billion of these bases of DNA and together they make the instructions for me and DNA is that's kind of incredible that's actually many orders of magnitude smaller than the amount of data that I generate on a yearly basis but DNA is an incredible storage medium right in this DNA there are about 20 to 25,000 protein coding genes so in this quarter we've talked about how you know DNA leads to RNA leads to protein that's kind of the canonical central dogma of biology and yet only our genome only encodes for 20 to 25,000 of these protein coding genes actually only about two percent of the genome codes for proteins the rest of it is other information some of that information is telling your body or your cells when to express certain genes so some of that DNA is in promoter and terminator regions that choose basically where to turn on the expression of genes here's an example where this is supposed to be a promoter driving expression of a gene that is important for muscle cell movement and this promoter would basically only be active in muscle cells so that you get efficient muscle movement you actually don't need the protein that this gene encodes in other cells within the body and so that's where some of that DNA information is taken up it's in these protein or these promoter regions these what we call regulatory regions of DNA now it might seem like that's kind of flat right there's just it just maybe doesn't take a lot to be able to encode for a person it's not all that complicated to make one if it's just 3.2 billion bases of DNA and some bases are serving to tell um your uh polymerase and ribosomes when to translate or create a protein from a gene it does not all that complicated but that's not it's not that straightforward there's actually multiple layers of regulation and multiple ways in which a single protein coding gene can produce different proteins based on what's happening in their environment one example of this is called alternative splicing so if we think about the example that i just showed you where there's this important gene for muscle movement and we you know think of it as being one gene makes one protein then there's not a lot of flexibility there we basically can decide to make that protein or not we can decide to make a little bit of it or a lot of it we're always making that protein in a world where this DNA sequence is always read um directly but sometimes um RNAs are spliced so there are in human systems and actually eukaryotes in general uh introns in between the portions of the genome that encode for the protein so an RNA actually gets spliced together into a um kind of new form from the form that a polymerase makes into what's called a splice form that is then translated into a protein and there's actually different ways that you can splice genes together to get different protein products so here these bars are supposed to show you different proteins and the RNA or the gene is shown on the left and so if the RNA if every intron in a gene is spliced out you get what's called constitutive splicing and that gives you one protein but if you get exon skipping where you splice out this entire pink region and the protein that you make doesn't have the amino acids that correlate to that pink region you can get intron uh retention so that's here where you get pieces of the intron being encoded in your protein there's also a little bit of that here and so what i'm trying to show you is that a single gene can actually encode for several different proteins so there's some overlap right a base doesn't always have the same function in every situation because these alternative splicings can occur under different environmental conditions maybe you're running and you need to make more of that protein in order to facilitate faster movement of your muscle fibers and the protein form that is usually made is not as efficient as this other protein form and so you might have alternative splicing where you start making more of this in a situation where you're running quickly just as a hypothetical example that's one way in which information is sort of layered in", "start_char_idx": 4278, "end_char_idx": 8704, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e4d3bc90-8249-4e00-b573-6da7986761df": {"__data__": {"id_": "e4d3bc90-8249-4e00-b573-6da7986761df", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2b91a97e-5696-4dd0-9927-abbe78bac3d9", "node_type": null, "metadata": {}, "hash": "e33c399035a51d41c84daff8e4bec0284e01e1ab525947e580c6f2186bb05acb"}, "2": {"node_id": "b84f36f0-bc9c-4f2a-a9a8-5efe17f0e80a", "node_type": null, "metadata": {}, "hash": "6b7c7f490d7ea4fb10af32bb79fada82d0ad448c2299bb6d2fa3171917a58568"}, "3": {"node_id": "b7d32e3b-62af-4d64-ac5f-bbd90412ecfa", "node_type": null, "metadata": {}, "hash": "3c66216ac632f89e27c1a9f78834a6b449b523a23b1d0cbc962f58c65936594c"}}, "hash": "691d83c74f2425d518eb5eb5bb79fc93dfea221dc2211935ad5565922058d472", "text": "just as a hypothetical example that's one way in which information is sort of layered in dna and it's not in electronic systems another way so okay here are different forms of the human protein tropomyosin 2 that have been identified to date and so tropomyosin 2 is an example of a protein that does kind of facilitate the movement of fibers during muscle contraction and you can see that there this if this is the full length gene with all of the introns shown as flat lines and the exon shown as boxes you can see that there are several different splice forms that get made within the human body so this one segment of dna although it looks like it's only encoding for one protein is actually encoding in this case for at least five or six different types of protein so i think that's interesting another way in which dna is an information rich carrier is because the shape of the dna actually can affect gene expression so like splicing shape is another layer in which information is encoded within dna so what do i mean by the shape of the dna well it turns out when polymerases are actively transcribing dna they lead to positive or negative super coils and positive super coils on either side of it so if you've ever played with your shoelaces and you twist them you can actually get them to coil up and that's the same type of thing that's happening with your dna as a polymerase is moving along so you can try this if you take your a cord for something and you twist it a little bit so that you have a little bit of a twist and then you pull you can get even tighter coiling right and if you keep doing that you can get these super coils to form and actually proteins like polymerases will preferentially bind to negative super coils and initiate more transcription in parts of dna that are negatively super coiled and so it's responding not just to the sequence of dna but actually to the three-dimensional shape that it's coiling into as well and so certain sequences will coil more readily than others and that's one way or another way in which more information is encoded in these in these proteins should say that there are also proteins that actively regulate the super coiling state of dna so topoisomerase 2 is an example of a protein that comes through and relaxes these super coils so it's you know heavily regulated within your cell what the shape of the dna looks like in addition to the sequence that shape is important for getting good gene expression or you know accurately running your genetic program okay so small changes in dna sequence can dramatically change the phenotype of a biological system this is claude this is an albino alligator who lives at the california academy of science i've seen him he's really cute he has a mutation in a gene that's essential for making melanin which is a pigment that would usually make claude a kind of darker brown color but because he's missing that pigment he is this nice or kind of intensely white uh alligator he's albino so what is the mutation that causes albinism well uh we have i couldn't find the genome sequence for claude but what i could find was um the sequence or analysis of albino zebrafish so this is a wild type zebrafish which has these beautiful stripes and an albino zebrafish does not have the capacity to make those striped pigments so he's not striped and this albino zebrafish has a premature stop codon in a protein that's important for melanin production that protein is called slc45a2 and my mouth little doesn't mean a lot but this stop codon means that the gene is not expressed in these zebrafish and a single gene deletion the missing one protein is causing this pretty striking phenotype here's just the genome sequence of the wild type zebrafish this is the codon that would usually encode for a glycine and when it's mutated when this first base is mutated to a t like it is in these albino fish you get a stop codon instead and so as the ribosome is reading through it reads this stop and it says oh i'm done and it stops making protein so you get a truncated form of this slc45a2 and you don't get the full protein that you need in order to make melanin in these fish so that was um a nice demonstration of how important dna sequence can be", "start_char_idx": 8690, "end_char_idx": 12937, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b7d32e3b-62af-4d64-ac5f-bbd90412ecfa": {"__data__": {"id_": "b7d32e3b-62af-4d64-ac5f-bbd90412ecfa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2b91a97e-5696-4dd0-9927-abbe78bac3d9", "node_type": null, "metadata": {}, "hash": "e33c399035a51d41c84daff8e4bec0284e01e1ab525947e580c6f2186bb05acb"}, "2": {"node_id": "e4d3bc90-8249-4e00-b573-6da7986761df", "node_type": null, "metadata": {}, "hash": "691d83c74f2425d518eb5eb5bb79fc93dfea221dc2211935ad5565922058d472"}}, "hash": "3c66216ac632f89e27c1a9f78834a6b449b523a23b1d0cbc962f58c65936594c", "text": "in these fish so that was um a nice demonstration of how important dna sequence can be and how important small changes can be in the phenotype of an organism now it's not just in the protein coding regions that changes in dna sequence can dramatically alter an organism's phenotype here's an example from tomato where the authors made or the scientists made changes in the promoter region upstream of a gene called clavata3 these mutations change how strongly clavata3 is expressed so in the wild type it's expressed pretty strongly and then as you make more and more mutations you reduce the amount of clavata3 and you get um uh different phenotypes here and so you can see the the fruit locule number or kind of the um and also the size of the fruit changes as you change the expression of this gene so this week we're going to go through dna reading and writing right how do we know that those changes in dna are underpinning those phenotypes how are we able to observe what the sequence of dna is right we can't take it out of ourselves and just like look at it there are methods for figuring out what the sequence of dna is and so we're going to go over kind of the cutting edge of dna sequencing and then we're also going to talk about how you can write completely new sequences of dna our reflective questions for the week or for this section are how much data like let's start thinking about how much data is encoded in all of the organisms you interact with um we have a lot of statistics about how much data you interact with through your phone or through the internet but how much are you interacting with biotically and then why do changes in dna alter living organisms we talked about how changes may lead to proteins no longer being expressed or to changes in how much protein is being expressed but are there other things you can think of and then what are the potential benefits of sequencing an organism's genome we'll get into this a little bit in the next lecture but i'd like you to think about it for yourself what could you learn by sequencing an organism's genome and then finally why are people interested in synthesizing new sequences of dna what are the potential advantages of being able to do that all right i'm excited to talk to you about dna technology this week and i'll meet you at the next lecture", "start_char_idx": 12924, "end_char_idx": 15255, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a5dc620d-b86d-468f-9a1b-b78ac11e7028": {"__data__": {"id_": "a5dc620d-b86d-468f-9a1b-b78ac11e7028", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d969ddda-4720-4dc5-8a53-bd7869c811e5", "node_type": null, "metadata": {}, "hash": "829088f1a8fce5996b4af4c62b0138eced9c5ac33896a6ae4b33a2ec6576f74f"}, "3": {"node_id": "c253acc0-49dc-4f11-afa9-63ac42fa04dd", "node_type": null, "metadata": {}, "hash": "643239648ad875503d82c496659822d90976c36472897efe71f8ceb8523b170c"}}, "hash": "261905c8d4ff7f329b8cec1d7326a6d0d062432ede1d776c2b1d81264d697273", "text": "So we're gonna talk about DNA sequencing technologies. To start this off, I want you to imagine that you're deep undersea, you're exploring, you're swimming around, and you see this really bright pink organism, something you've never quite seen before, swimming around, it's got lots of tentacles, maybe like a little bit of a cross between an octopus and a jellyfish, but it's glowing this glow that you've never seen before. And so you reach out towards it and you touch it, but as you touch it, it gets scared and it drops one of its tentacles and swims away quickly. Sort of the same way that a lizard might drop its tail when you grab it, it knows that if it releases whatever has got your attention then maybe it can get away faster. So you're left there in the dark now with just this tentacle, it's still glowing a little bit, and you're intrigued. You wanna know more about this organism, you wanna know whether that glow could be useful for something else. So my question to you is what can you do with that tentacle to find the source of the pink glow? Can you, is there any information in that tentacle that you can get at in order to figure out how this deep sea creature was glowing and whether or not you can engineer that same feature into other organisms? Well, if you had its genomic sequence, you could predict the genes that are encoded within its genome. Here you're just seeing a zoom in on a piece of DNA and each protein encoded in the genome will start with a start codon, something like ATG is the most common three letters that encode for a start codon, although occasionally a TTG or GTG will also be able to serve this function. And then in frame, that means a multiple of three bases downstream of this ATG will be a stop codon. There are several stop codons, TAA, this one that you're seeing here is one of them. And these are the codons that tell the ribosome, you've reached the end of a protein, you can let go now. So if you find a start codon and stop codon that are a multiple of three bases away from each other, then you've likely found a gene. So in some ways, just looking at genome sequence can allow you to predict where genes are encoded within the genome. Now, we talked a little bit about splicing in the previous lecture, and so you'll know it's not quite this simple and there are mathematical models, there are ways of trying to predict gene sequence, even genes that have introns in them that may shift the coding range or the coding window. But at a high level, this is something that's possible to do. It's possible to predict where genes might be encoded in the genome. And it's becoming increasingly possible to also predict the function of those genes. Now, before we knew a lot about proteins, we didn't really have an idea or a way of predicting what an individual protein might be doing. We would just know that it was possible that that region of the genome encoded for a protein. Now we have the really nice data from a lot of organisms that we can compare our genes to. So we can do something like a protein sequence alignment where we take a protein from our mysterious deep sea creature and we align it. We look for matches in the human genome, in the chimp genome, in a mouse or in another well-studied organism. And we see, are there any regions of those genomes that look like the region of the genome from my deep sea creature? That might tell us if there's a high match in this case, the protein sequence, that might tell us that the proteins serve a similar function. We also talked before about how structure can be more important than the sequence of the protein as it's actually the three-dimensional structure of the protein that is contributing the most towards the function. And so using something like AlphaFold, you might be able to predict the structure of a gene encoded in your deep sea creature's genome and then align the structure. See, these are two different proteins doing a structural alignment. One is in red and one is in yellow and you can see that their structures are very similar. So by doing something like this, you can have an even better", "start_char_idx": 0, "end_char_idx": 4134, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c253acc0-49dc-4f11-afa9-63ac42fa04dd": {"__data__": {"id_": "c253acc0-49dc-4f11-afa9-63ac42fa04dd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d969ddda-4720-4dc5-8a53-bd7869c811e5", "node_type": null, "metadata": {}, "hash": "829088f1a8fce5996b4af4c62b0138eced9c5ac33896a6ae4b33a2ec6576f74f"}, "2": {"node_id": "a5dc620d-b86d-468f-9a1b-b78ac11e7028", "node_type": null, "metadata": {}, "hash": "261905c8d4ff7f329b8cec1d7326a6d0d062432ede1d776c2b1d81264d697273"}, "3": {"node_id": "87adaa89-8516-4ef9-8876-81bacdec4486", "node_type": null, "metadata": {}, "hash": "07adbf73421ff91d093baa28f3b29977d4d3d3e5871068722009cb09a3b1c87d"}}, "hash": "643239648ad875503d82c496659822d90976c36472897efe71f8ceb8523b170c", "text": "their structures are very similar. So by doing something like this, you can have an even better idea that maybe these two proteins serve the same function. So with this capacity to predict what genes are in a genome and what those genes may be doing, what the proteins that they encode for may do, then it becomes really exciting to start applying DNA sequencing technologies to all kinds of organisms to start to try to figure out what are they doing? What are they capable of doing? And how are they doing it? I do wanna point out that our knowledge of gene function is still pretty limited. And so it's likely that there will be large portions, most of the genome of this organism we wouldn't necessarily understand, but we have some tools to begin to figure out what portions of a new organism's genome might be doing. Now, how do you figure out the sequence of this organism's genome? Well, if we're 1980, if it were 40 years ago, you might try DNA sequencing with the Sanger method. Sanger is essentially DNA sequencing by synthesis. This is a picture of Fred Sanger. He invented this method. And just want you to remember that usually when we synthesize DNA, we have a template strand and then we have the strand that you're building. And so you'll incorporate individual DNA bases to pair with the template strand. And so Sanger invented a method of observing what bases are getting incorporated as DNA synthesis is occurring. And by reading out which bases are getting incorporated, you would know the sequence of the template strand. Now, the thing that he... Oh, okay. So usually DNA synthesis requires deoxynucleotides. So here's the sugar backbone, the base that A, T, C, or G is just indicated by this little circle that says base here, but just imagine that there are nucleosides here. And then the sugar backbone has an OH group at one end and a triphosphate, that's what these things are, at the other end. And this oxygen or OH group interacts with the triphosphate to catalyze a reaction that leads to the attachment of this new nucleotide onto the growing DNA strand, right? So this presence of this OH group is really important for the elongation of a DNA molecule. And this is what's happening in all of your cells as your DNA replicates, this type of chemistry is occurring. But what Sanger found was that if you use a dideoxynucleotide, so something where there are no OH groups on the base, then it stops DNA synthesis. You essentially terminate the reaction. You can no longer elongate the DNA. Now, why would that be useful? Well, if you make a mixture of four different solutions and you try to run PCR, polymerase chain reaction, you try to synthesize the opposite strand of a DNA piece that you wanna sequence, and you have a mixture of dideoxynucleotides and regular nucleotides in each reaction condition, then you'll get DNA synthesis that stops at different points. So if you're synthesizing, you always synthesize from the five prime to three prime direction. So this might be the first base that you try to synthesize. And if you're in this two, if you're in this reaction condition, then you'll probably incorporate a DDTTP, a dideoxynucleotide, and stop the growing reaction. Whereas if you're in this DDCTP, you may elongate with that one base and then have a stop at C. What I wanna point out is that this contains a mixture of nucleotides that are both dideoxy and deoxynucleotide. So occasionally in even this reaction condition, you'll incorporate a T as normal in this position, and then go on to hit another T later where you incorporate a terminal nucleotide. Okay, why does this matter? Well, that means that in this reaction, you have a collection, in each reaction actually, you have a collection of DNA of different lengths. And then you can run those out on a gel using gel electrophoresis to see how long the base or the segments of DNA are. So in this case, if we had this T is supposed to indicate a reaction in which you had all four regular nucleotides and then one", "start_char_idx": 4056, "end_char_idx": 8077, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "87adaa89-8516-4ef9-8876-81bacdec4486": {"__data__": {"id_": "87adaa89-8516-4ef9-8876-81bacdec4486", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d969ddda-4720-4dc5-8a53-bd7869c811e5", "node_type": null, "metadata": {}, "hash": "829088f1a8fce5996b4af4c62b0138eced9c5ac33896a6ae4b33a2ec6576f74f"}, "2": {"node_id": "c253acc0-49dc-4f11-afa9-63ac42fa04dd", "node_type": null, "metadata": {}, "hash": "643239648ad875503d82c496659822d90976c36472897efe71f8ceb8523b170c"}, "3": {"node_id": "e9815643-171d-46c3-88de-7ee783f013ee", "node_type": null, "metadata": {}, "hash": "b469484ca4ae3754cb656ec16d286705ef16bc01e37ca5aecee51f4f049fb9df"}}, "hash": "07adbf73421ff91d093baa28f3b29977d4d3d3e5871068722009cb09a3b1c87d", "text": "to indicate a reaction in which you had all four regular nucleotides and then one dideoxynucleotide TTP. And that one, you had one really short fragment corresponding to this one base long DNA sequence, and then one kind of medium fragment corresponding to here. The A, you had a different length of molecules because it was terminating every time it reached an A. Here, you're terminating every time you reach a G, and here you're terminating every time you reach a C. So if you wanna go back and read the sequence, you would say, okay, the first base is a T, the next base is a C, the next base is a G, the next base is an A, an A, right? And you can do that because you know that the sequence of this length is only possible because we incorporated a stopping nucleotide at that location. Okay, so hopefully that's clear. I thought it was a really, or it is a very clever way of trying to read back DNA sequence because it's actually not that easy to do. And here's an example of what one of the Sanger sequencing gels actually look like. You can see how each length of DNA leads to a slightly different, or yeah, each reaction leads to a slightly different collection of DNA lengths, and you can read back out what the sequence might be. But notice, you probably have 20, 25 bases read here. And if the human genome is 3.2 billion bases long, it would take a very long time to use Sanger sequencing gels in order to sequence the entire thing. It's not to say you couldn't do it, it just might take quite a while. So people started doing things that would not require you to run a gel at the end since reading back out that gel is quite time-consuming. Actually developed these dideoxynucleotides. Remember, these are the ones that terminate the chain reaction, the elongation of DNA, that have fluorescent dyes attached to them. And so as you synthesize DNA along your template, if you incorporate one of these chain-terminating, fluorescently-labeled nucleotides, then you would end up with a piece of DNA of a specific length with a specific color dye at the end. And then you can take this big mixture. Now you don't have to do four different reactions. You can do them all together since each nucleotide has a different color. And you can run them through what's called a capillary gel. So now instead of having a big gel where you're able to visualize each lane, it's this very thin tube that's full of gel. And it still separates the DNA based on size. So the smallest pieces of DNA will run through the fastest. But as you are running the DNA through, you're actually using a laser to excite these fluorophore dyes and then detecting to see, okay, well, did I see a red dye? Did I see a green dye? Did I see a blue dye? And you know, based on the order of the dyes coming through what the sequence is. So this type of reaction gives you data that looks like this. We call these chromatograms, where each peak corresponds to the passage of a DNA of a specific length through this laser detector region, showing you that there's a piece of DNA that's this length that has this specific base. In this case, I think pink is a G incorporated in your DNA. So this has helped accelerate DNA sequencing quite a lot. Up until the last year or two, this was the most common method used by my lab and that I used all throughout graduate school to do DNA sequencing. But there are some newer, what's called next generation sequencing technologies that will allow you to do even more sequencing to get at like even the sequences of even bigger genomes. Because again, these types of reactions, they're very good up until about a thousand bases of DNA, but it would still take a really long time to sequence a human genome if you're doing it in thousand base pair chunks. Okay, so there are these next generation sequencing methods and these are what we're gonna talk about today. I think that they're all super interesting. It's really cool to see how people have figured out how to sequence DNA. We're gonna go through kind of how they each work and what the benefits and drawbacks of each method might be. So the first one that we're gonna talk about is actually a variation", "start_char_idx": 8090, "end_char_idx": 12264, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e9815643-171d-46c3-88de-7ee783f013ee": {"__data__": {"id_": "e9815643-171d-46c3-88de-7ee783f013ee", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d969ddda-4720-4dc5-8a53-bd7869c811e5", "node_type": null, "metadata": {}, "hash": "829088f1a8fce5996b4af4c62b0138eced9c5ac33896a6ae4b33a2ec6576f74f"}, "2": {"node_id": "87adaa89-8516-4ef9-8876-81bacdec4486", "node_type": null, "metadata": {}, "hash": "07adbf73421ff91d093baa28f3b29977d4d3d3e5871068722009cb09a3b1c87d"}, "3": {"node_id": "b52d16a3-356a-4722-b844-d1774e03fe86", "node_type": null, "metadata": {}, "hash": "e9dfb88dce2b4047f9eb7e035efb6fbd4c2b5f65bf766577253562f0a5df94d4"}}, "hash": "b469484ca4ae3754cb656ec16d286705ef16bc01e37ca5aecee51f4f049fb9df", "text": "method might be. So the first one that we're gonna talk about is actually a variation on sequencing by synthesis. We're calling it next generation sequencing by synthesis and this is what is used by a company called Illumina. The machines that they build actually look just like this. Okay, so Illumina sequencing is sort of similar in that you're going to be incorporating bases with a mixture of either dyes or, sorry, you're gonna be incorporating a mixture of bases, each of which has a dye on them. And these are, yeah, all done on a chip instead of in solution. So what happens is you take a bunch of genomic DNA and you shear it into pieces. You can actually agitate a solution of DNA in a way that breaks it into fairly regular pieces. Then what you do is you ligate on, you attach little short DNA sequences called adapters. These adapters all have exactly the same sequence and what they're gonna do is allow you to bind your pieces of genomic DNA to what's called a flow cell. So this is a little chip that basically has tiny pieces of DNA already stuck onto it. And those tiny pieces of DNA are complimentary to your adapter sequences of DNA. So those little adapters allow you to stick pieces of genomic DNA onto the chip. And then you do something called bridge PCR where what you're really trying to do is get clusters of DNA that's all identical right next to each other. So it's really difficult with this Illumina method to sequence a single molecule of DNA. So they do amplify it in this location. We can talk about how this kind of bridge amplification works if you're curious, but I think it's sufficient to just know that it occurs and it gives you clusters of DNA that's all identical in little locations along this chip. And then what you do is you flow through across this chip a solution of nucleotides that are each terminating, but they have a special chemistry. So they're terminating in that you can only incorporate one of these bases at a time and each one of the bases are color-coded. So you might have an A be red, a T be yellow, a C be green and a G be blue. And you can then see, as you synthesize the strand of DNA, you can take a picture of the chip and see what color occurred at the location of each of your pieces of DNA. So what do I mean by that? Okay, so like if you can think of this as going in time as we move from top to bottom. So if the first base is red then, or an A, then it's gonna appear red and then you'll wash out all of the remaining bases. You'll do what's called unblocking where you then make the base ready to receive a second base. You'll flow in a new set of nucleotides and a T might attach there and so you'll read it as yellow. You'll repeat and the next time it might be green, the next time it might be blue. And so as you image that spot over time, you'll see the color change and that correspondence to the sequence of the DNA that's at that location on the chip. This is what one of these chips look like. So this is a flow cell. It's pretty small, 75 millimeters by 25 millimeters. This is what an image of one of those flow cells look like right after you've flowed your nucleotides over it. So you can see the individual spots where there's DNA adhered to the chip and the color indicates what base was incorporated then. There are about 1.6 billion of these spots per flow cell. So you can now measure like 1.6 billion molecules of DNA clusters of DNA simultaneously. So I think that's pretty cool. Now, this is what this looks like in real time as you are, well, it's maybe a little sped up, but this is what this looks like over time as you flow in and out different chemicals, different bases, and you do that blocking, unblocking step. You have to track individual spots and see what color comes up. And so it's actually a big image processing problem to figure out how to track each of these, how to know when the color has changed to indicate a new base has been incorporated and all of that stuff. But I think it's pretty impressive. This type of sequencing method is very powerful. It can sequence a lot more DNA than the Sanger sequencing method we talked about", "start_char_idx": 12262, "end_char_idx": 16410, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b52d16a3-356a-4722-b844-d1774e03fe86": {"__data__": {"id_": "b52d16a3-356a-4722-b844-d1774e03fe86", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d969ddda-4720-4dc5-8a53-bd7869c811e5", "node_type": null, "metadata": {}, "hash": "829088f1a8fce5996b4af4c62b0138eced9c5ac33896a6ae4b33a2ec6576f74f"}, "2": {"node_id": "e9815643-171d-46c3-88de-7ee783f013ee", "node_type": null, "metadata": {}, "hash": "b469484ca4ae3754cb656ec16d286705ef16bc01e37ca5aecee51f4f049fb9df"}}, "hash": "e9dfb88dce2b4047f9eb7e035efb6fbd4c2b5f65bf766577253562f0a5df94d4", "text": "powerful. It can sequence a lot more DNA than the Sanger sequencing method we talked about before. Now, one of the problems with Illumina sequencing is that it generates short reads. So it only can read DNA sequences that are around 75 to 300 bases long. And that's okay, except 75 to 300 bases is not a lot of bases of DNA. And when you wanna figure out how the whole genome is assembled together, then you would assemble each of these little short reads into contigs. So what does that mean? That means you would basically look for regions where they overlap slightly or significantly even and say, okay, well, clearly, like these two segments of DNA, they're next to each other, they're like partially overlapping. Because when you do that shearing, you have to remember the...", "start_char_idx": 16390, "end_char_idx": 17170, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f49fa140-5cd7-42cd-bfb7-248860e7b89f": {"__data__": {"id_": "f49fa140-5cd7-42cd-bfb7-248860e7b89f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d6c177fa-cc81-4527-af07-593456035e28", "node_type": null, "metadata": {}, "hash": "7c52ac080a54ea2d0e6fdf18e80cbbadf955becca02a1bb794f5673186990a76"}, "3": {"node_id": "5458e084-2ef8-44a5-a725-1461edf91e33", "node_type": null, "metadata": {}, "hash": "05d0fdd1433f818d123f18488cef6304e6de97815af946a2e01a1e5a2ca894e2"}}, "hash": "e6ce80188e1f0c8c4b6020bddf2adfa2cbd930fe6df9803ec65d8d4bd11233d4", "text": "there are billions of molecules of identical DNA in there and each one's gonna get cut slightly differently. So you're gonna have lots of overlapping sequencing reads. But anyway, these are assembled then into what's called scaffolds where we fill in with ends. We basically say like, we're not sure what sequence is in between these two larger segments of DNA, but we believe that there is missing sequence there because sometimes regions get difficult to resolve. And we'll go into what that means on the next slide. Okay, so it can be challenging to sequence genomes with repeated sequences using this type of short read technology. When you're only getting sequencing reads that are 75 to 300 bases long, then you have a hard time figuring out whether like repeated sequences are real or not. So here's an example where you have a genome, let's say it's all mostly an orange and all of the orange is unique sequence, right? That sequence that's only appearing once in the genome, but you have this repeat region where there's a segment, maybe several hundred base pairs long, that's identical to another segment in the genome. And in between them is some unique sequence, but we don't necessarily know whether these reads here map to this repeated region or this repeated region, because you'll notice like this blue bar, for example, it's completely contained within the repeat. So it's totally possible that it is a read from this region of the genome. And so when you use an algorithm to try to figure out how to assemble the genome, it becomes really difficult to know is this, are these reads two different repeated regions within the genome or just reads covering one location? And these ones that are overlapping at the boundaries, maybe that's suggesting this boundary here. So the algorithms have a hard time, people will have a hard time figuring out how to deal with these repeated sequence, even though there is this extra DNA in the middle and there are some unique junctions here. When there's a lot of overlapping sequence, it still just becomes very difficult to know how to deal with that. And so some of that will end up as kind of trash at the end of an experiment where people will say, well, these extra reads, we didn't really know where to align them, we didn't know where to put them. So when you were going through the P set and you see like the human genome project had finished and yet we only had sequence of like 92% of the genome, some of it is because we just have regions that we didn't know how to kind of put into the context of the rest of the genome. Until recently, that has been figured out. So hopefully you'll get to, or you'll enjoy seeing that on the P set. Okay, our Illumina Next Generation Sequencing has several advantages. It's cheap, it's very accurate, it's really good at accurately conveying what base is on a molecule, those kind of clusters of identical DNA all being read at the same time means that it's pretty high fidelity and it can sequence fragmented DNA. So if you have DNA that's old, right, and already pretty broken, or you have a sample that hasn't been treated very well, maybe it was left in a hot car or you were trekking from your deep sea adventure, you had to take that DNA on a plane and get it home, things can happen that break down your DNA and Illumina is still pretty good at sequencing even fragmented DNA because it's gonna break the DNA into pieces anyway at the beginning of the library prep. Some of the disadvantages of Illumina sequencing is that it's hard to sequence repetitive regions and it can't resolve structural variants. So that becomes really difficult to do with this. Now, the next type of sequencing that we're gonna talk about is single molecule real-time sequencing. This is different. So here you're taking sequence that you want to know the sequence of and you ligate on these adapters. So you make a full DNA circle. And then at the bottom of a nano well, a very small sample size, a very small little like well in a chip, you have a single polymerase fused to the bottom. And that polymerase will incorporate or try to make a copy of this single strand of DNA. And as it does, it will incorporate fluorescent nucleotides. Then you", "start_char_idx": 0, "end_char_idx": 4237, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5458e084-2ef8-44a5-a725-1461edf91e33": {"__data__": {"id_": "5458e084-2ef8-44a5-a725-1461edf91e33", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d6c177fa-cc81-4527-af07-593456035e28", "node_type": null, "metadata": {}, "hash": "7c52ac080a54ea2d0e6fdf18e80cbbadf955becca02a1bb794f5673186990a76"}, "2": {"node_id": "f49fa140-5cd7-42cd-bfb7-248860e7b89f", "node_type": null, "metadata": {}, "hash": "e6ce80188e1f0c8c4b6020bddf2adfa2cbd930fe6df9803ec65d8d4bd11233d4"}, "3": {"node_id": "863d8eac-b462-40af-a987-2779fed1a8c4", "node_type": null, "metadata": {}, "hash": "51de7c70f832a3c27253a42c2bfc4da060e3b95f518535ccd5d06a1a1a6e48a1"}}, "hash": "05d0fdd1433f818d123f18488cef6304e6de97815af946a2e01a1e5a2ca894e2", "text": "And as it does, it will incorporate fluorescent nucleotides. Then you can use a basically imaging tool at the bottom of this micro well, you can shine a laser and then collect the light that's re-emitted from the fluorescent nucleotides. And as they're getting incorporated into the DNA, they will be the closest to the detector and therefore give the brightest fluorescent signal. And so you can use that to figure out what the sequence of DNA is of this molecule as it's being synthesized. So this is essentially another sequencing by synthesis method. Here's what something looks like where you have fluorescence intensity over time and you can see each base has a different signature. And so you would know that it's an A getting incorporated based on how intense the fluorescence signal is that you're reading at your detector over time. So that's true for each individual base and allows you to read DNA. One thing I will say is that this method is pretty low fidelity. So it's sometimes confusing to know whether it was an A or a T that got incorporated, a G or a C, they're just, it's kind of low fidelity, especially as you get fluorophores or some of these nucleotides that kind of drift down towards the detector, you can get errors in the sequencing read. And so what people usually do is run this circular DNA molecule through the polymerase over and over and over and over and over again, and then look for kind of the consensus sequence. If you read the same molecule many, many times, then you can kind of average out any error that's occurring. So that's helpful. Here's the actual size of one of these smart cells. So what's in there? Well, you have, right, this little micro well with the polymerase at the bottom, and then there are, yeah. So, and then it's placed into this chip. It's just kind of stepping through different magnifications here so you can see kind of what's happening inside of these smart cells. So it's an exciting method of being able to take long read measurements, where you can take a long molecule of DNA and sequence the whole thing instead of having to break it into those small pieces like you do for Illumina sequencing, this PacBio, this SMRT sequencing can handle long molecules. And what that's good for is actually looking for repeated sequence. So now you can actually know how many times does a repeated sequence occur in the genome? Are there locations where a region of the genome is repeated or inverted? And sometimes those repeats or inversions can influence how strongly a gene is expressed. So they're really important. And this type of sequencing read has finally allowed us to be able to look at these types of kind of complex genomic regions. Okay, so it has these advantages of being able to sequence repetitive regions and resolve structural rearrangements, but it's not compatible with fragmented DNA. Again, the advantage here is being able to sequence a long segment. If you have a really short piece of DNA would like zip through the polymerase really fast, but not be a super good use of the technology. I mean, it does have a little bit of coverage bias. So it's not perfect at all reading all bases. And then it is low accuracy. Although again, we kind of get over that low accuracy problem by sequencing the same molecule many times in a row. All right, our last technology that we're gonna talk about is nanopore sequencing. This is not sequencing by synthesis, is a little bit different. You basically have a sensor chip with an array of nanopores, little holes on them. And you then measure the current as it passes through these nanopores. What does that mean? Okay, so on this chip, there's like I said, this array of tiny holes, these nanopores, they're embedded in a membrane that's connected to a chip. You can kind of see all of that here that measures current. And the current is disrupted by the passage of DNA bases through the pore. And so here's just an animation of this kind of thing occurring. In this case, it's sort of modeling the DNA bases of different kinds as these orange balls of different sizes. And you can see the current passing through on the left. So the current's passing through at a high level until that first base or that first", "start_char_idx": 4179, "end_char_idx": 8417, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "863d8eac-b462-40af-a987-2779fed1a8c4": {"__data__": {"id_": "863d8eac-b462-40af-a987-2779fed1a8c4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d6c177fa-cc81-4527-af07-593456035e28", "node_type": null, "metadata": {}, "hash": "7c52ac080a54ea2d0e6fdf18e80cbbadf955becca02a1bb794f5673186990a76"}, "2": {"node_id": "5458e084-2ef8-44a5-a725-1461edf91e33", "node_type": null, "metadata": {}, "hash": "05d0fdd1433f818d123f18488cef6304e6de97815af946a2e01a1e5a2ca894e2"}, "3": {"node_id": "239defe6-6377-4907-abc7-d8a24b7173b8", "node_type": null, "metadata": {}, "hash": "3cde9e0e0f9ba6213518c7552d3f90c52ed407e2769b7399ce98fdeac4f77307"}}, "hash": "51de7c70f832a3c27253a42c2bfc4da060e3b95f518535ccd5d06a1a1a6e48a1", "text": "left. So the current's passing through at a high level until that first base or that first ball occurs and it dips. The second ball, which blocks more of the current, gives the bigger drop. And when it's removed, then it returns up to this baseline. And so each nucleotide interferes with the passage of ions through this pore differently and gives a unique signature. So you can sequence the DNA as it goes through. So something like that looks like this, where here's the DNA passing through the nanopore. And I apologize, that's super fast, but it's all passing through slowly and you get this signature of different currents that correspond to the different bases passing through and therefore the sequence of the DNA. Nanopore has all these great how it works videos. I totally recommend checking them out and seeing for yourself, what you think of these different technologies. And they do explain it in greater depth. So you can, please feel free to check those out. Okay, so nanowire products are really cool. They're actually quite inexpensive, right? A minion is about a thousand dollars. So it's like a handheld version of a sequencer and it includes two flow cells and a kit to help you kind of prep DNA. So for, you know, around a thousand dollars, you can sequence potentially two organisms' genomes, although they'd have to be relatively small organisms. And we'll talk about that in a second. But yeah, the prices here are much, they're pretty affordable relative to the cost of a lot of laboratory equipment. So it's been really exciting to have nanopore on the scene because it's made it easier to sequence all kinds of DNA samples. Each product, again, has a different sequencing capacity. So the flow cell sizes, the number of nanopores on each one are different. And so the more nanopores you have, the more kind of chips you put in any one machine, the bigger the genome you can sequence. And so here's people, actually wheat has a genome that's even bigger than humans. Instead of being about 3.2 billion bases, wheat is around 16. So the bread that you eat actually has more DNA in it than you. But I think it's great to have this diversity of options available at different price points to be able to sequence DNA for all kinds of needs. Okay, this is something that I'm super excited about. I haven't seen it come out yet. We did talk about it last year and it's still not out. So I'm not sure exactly when it will happen. But Nanopore Tech, Oxford Nanopore, the company that makes these types of sequencing devices has been talking about Smidge Ion. So Minion is the version of the sequencer that you can plug into your USB port on a computer. Smidge Ion is one that you can plug into your cell phone and get some sequencing to occur. And I just think it would be so fun to be able to have a little device that you plug into your phone and that you can take sequence of maybe in field or on the fly. So here are some of the advantages and disadvantages of Nanopore. It can sequence repetitive regions. It also does really long reads like the PacBio system that I showed you before. It's pretty cheap. It can resolve those structural rearrangements and it's portable. But it does have a lower accuracy than the Illumina system. And it doesn't have the advantage that PacBio does of being able to sequence multiple molecules over and over and over again. And so you are subject to potentially more mistakes in your sequencing. But if you have many copies of the same piece of DNA and they're all going through different pores, any one pore may have a problem getting a really accurate sequence read. But when you, again, kind of combine them all together, you should be able to get something that's pretty high fidelity. Okay, so at the end of all of this, you have technologies you can choose from, you have approaches you can choose from for being able to sequence the DNA of your mysterious sea creature. And I want you to think like, what can you learn? What secrets does your sea creature's genome contain? Maybe there are new pigment proteins. Maybe there's new medicinal compounds or enzymes that make new medicinal compounds encoded in the DNA. Maybe", "start_char_idx": 8403, "end_char_idx": 12586, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "239defe6-6377-4907-abc7-d8a24b7173b8": {"__data__": {"id_": "239defe6-6377-4907-abc7-d8a24b7173b8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d6c177fa-cc81-4527-af07-593456035e28", "node_type": null, "metadata": {}, "hash": "7c52ac080a54ea2d0e6fdf18e80cbbadf955becca02a1bb794f5673186990a76"}, "2": {"node_id": "863d8eac-b462-40af-a987-2779fed1a8c4", "node_type": null, "metadata": {}, "hash": "51de7c70f832a3c27253a42c2bfc4da060e3b95f518535ccd5d06a1a1a6e48a1"}}, "hash": "3cde9e0e0f9ba6213518c7552d3f90c52ed407e2769b7399ce98fdeac4f77307", "text": "compounds or enzymes that make new medicinal compounds encoded in the DNA. Maybe there's instructions for limb regeneration, losing a whole tentacle. That's not something that organisms do lightly. Usually they have a strategy to regrow that lost limb. Maybe there's new bioluminescent proteins or instructions for how to withstand high pressures. Maybe there's something else, but I think only once we sequence, will we really know a little bit more about what the potential of this organism might be. Okay, so as you were listening today, I'd like you to kind of reflect back on what would you like to sequence if you had the capacity to sequence something? What are the potential benefits of sequencing an organism's genome? What would you wish for in the next generation of sequencing technologies? I told you a little bit about the advantages and disadvantages of the ones that we already have, but are there any other things that you might wish for a DNA sequencing technology to be capable of? And then if Smidgeion became available tomorrow, would you buy one? What would you do with it? I think that's fun to think about. All right.", "start_char_idx": 12580, "end_char_idx": 13721, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4db018ba-81db-4534-9b9b-477c51bf212b": {"__data__": {"id_": "4db018ba-81db-4534-9b9b-477c51bf212b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "08c4aff6-0f02-4cda-8205-baa57b7e3a2d", "node_type": null, "metadata": {}, "hash": "58722a40f1c82c6c0e31eec737d4f97fa883eedd382e09110682e25a84942c17"}, "3": {"node_id": "506b85c2-0fb8-40bd-bbc1-54f09c1ff2da", "node_type": null, "metadata": {}, "hash": "f6b48c88ac4723a974e4c1e1c2fdf8570afc2c21c47741e184509eb1df65c0ed"}}, "hash": "d57667d6e0d745be342f8d93f54b8ac9332cf1b376b7390090e77ccbabbd8a0d", "text": "All right, now we're going to talk about DNA synthesis. I want you to imagine that you're trying to engineer E. coli to degrade plastic. You've identified a gene encoding a plastic degrading enzyme from a soil bacterium. You have the gene sequence, but no access to the bacteria itself because you found the sequence in the NIH, the National Institute for Health's sequence database. How do you get the DNA encoding this enzyme? Well, you could try to track down the soil bacterium or maybe you could try DNA synthesis. You can actually synthesize DNA from scratch. You can take the individual bases and sugars that make up DNA and stick them together to make new DNA sequences. At a high level, DNA synthesis looks like this. You add a base that is chemically blocked so that you can only add one base to a substrate. In this case, you're going to start out with a solid support, maybe a chip or a bead that this base can bind to. Then you're going to do what's called an oxidation reaction to get the base to adhere to your support and then you're going to deblock. You're going to remove the chemical group that was preventing multiple bases from getting added at once. Then you're going to add a new set of blocked bases, only one of which will be able to be incorporated because it will not have the capacity to get a new base put onto it. You'll go around this cycle several times. You'll attach the new base via oxidation. You'll unblock it and then you'll be able to add in a third base. In time, you can build up a sequence of DNA that looks like this. Now, the chemistry of DNA synthesis is actually quite special. Non-templated DNA synthesis, so this is the synthesis of completely new DNA sequences. I'm going to try to move this out of the way. Requires phosphoramidate chemistry. If this is a typical adenine nucleotide, you have your sugar backbone, you have a phosphate group, and then you have the base. This is the adenine part of the nitrogenous base. When you attach an adenine or an A base onto a growing strand of DNA, this phosphate will react with the oxygen group, this hydroxyl group on the previous base of DNA in order to make a stable bond. In this sequence, this is a short segment of DNA. You have a thiamine, a T, an adenine, an A, and then you have another adenine, this one, for example, attached onto the end and it's attached again through this phosphate and sugar reaction. A phosphoramidate is a special type of base. If you look really hard in the middle here, you can see that sugar backbone and that adenine base, but it's got a bunch of chemical modifications to it. It has what's called a variable group that protects the amine, that protects the base part essentially. You have this DMT moiety that protects the phosphate. Instead of there being a phosphate here, you have this big, bulky DMT. Then instead of the hydroxyl, you have this phosphoramidate moiety. We'll talk in a second about what that does, but it is essentially this phosphoramidate moiety and these other protecting things that allow you to add single bases at a time to a growing segment of DNA. We're going to talk first about how the seminal patent for this phosphoramidate-based DNA synthesis was filed in 1984. Similar chemistries have been used since 1984 to synthesize DNA for nearly 40 years. That phosphoramidate chemistry hasn't changed all that much. Basically, each of these things can be chemically added and removed in order to do that type of blocking and unblocking that I was talking about on the previous slide. Today, DNA synthesis is automated and miniaturized. You can, instead of adding or building up one sequence of DNA at a time, you can actually get these chips that have arrays of addressable surface clusters. That means that you can individually add bases to each spot on this chip in order to build up very specific sequences of DNA at each spot. Here's an example of what one of these chips looks like. You can synthesize around one million strands of DNA simultaneously on one of these chips. There are", "start_char_idx": 0, "end_char_idx": 4046, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "506b85c2-0fb8-40bd-bbc1-54f09c1ff2da": {"__data__": {"id_": "506b85c2-0fb8-40bd-bbc1-54f09c1ff2da", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "08c4aff6-0f02-4cda-8205-baa57b7e3a2d", "node_type": null, "metadata": {}, "hash": "58722a40f1c82c6c0e31eec737d4f97fa883eedd382e09110682e25a84942c17"}, "2": {"node_id": "4db018ba-81db-4534-9b9b-477c51bf212b", "node_type": null, "metadata": {}, "hash": "d57667d6e0d745be342f8d93f54b8ac9332cf1b376b7390090e77ccbabbd8a0d"}, "3": {"node_id": "53649073-64a3-4212-be15-410ebe793d30", "node_type": null, "metadata": {}, "hash": "7c97df361668c9a1ba591fa81239e4ec7be2c92aa5308185673a10348cc0546b"}}, "hash": "f6b48c88ac4723a974e4c1e1c2fdf8570afc2c21c47741e184509eb1df65c0ed", "text": "around one million strands of DNA simultaneously on one of these chips. There are many chip-based synthesis methods. All of them use that phosphoramidate chemistry. One example of how you can add a very specific base at a time is with a bioprinter where you're simply printing out each base at a time. Here's an example of this going through, the addition of one base and then changing of the chemistry or the environment that all of this DNA is sitting in to uncap that DNA molecule so it can receive the next base. That's basically, that's the beautiful thing about phosphoramidate synthesis, is that ability to cap and uncap. Although this is super exciting that you can synthesize DNA from scratch using this method by specifying which base you add in what order. This synthesis steps are not perfect and we're pretty limited in the length of DNA that we can synthesize. Even though we can synthesize millions of DNA sequences simultaneously, the synthesis is going to be of fragments that are around 100, maybe 50 bases in length. That's because the synthesis methods incorporate errors. On this graph, what you're seeing is as the length of the DNA that you're trying to synthesize increases, the percent of the molecules that you're trying to make that are correct goes down. If you're only synthesizing 50 base pair segments of DNA, then you have pretty good synthesis fidelity. Most of the molecules that you try to make are going to be the correct sequence, around 80 percent of them. But if you try to synthesize longer fragments of DNA, your sequence fidelity goes down. That might suggest to you that this is maybe not all that useful. 50 bases, that's not a lot of DNA. But what people do is synthesize these short fragments of DNA and then use something called overlap extension PCR in order to stitch them into larger pieces of DNA. Each of these little blue arrows is supposed to be a short segment of DNA. If you design them so that they have overlapping sequence, then you mix them all together. You can get these short pieces of synthesized DNA to bind together. Then you can use PCR and a polymerase essentially to fill in the missing gaps. Now it's templated DNA synthesis instead of untemplated. The polymerase will, with high fidelity, fill in all of these gaps. You can use that type of overlap extension PCR to build up long segments of DNA from short synthesized regions. That's exciting. The only problem is that the methods don't do well with repeated sequence. For the same reason, it's difficult to sequence repeated regions of a genome using short reads. It is difficult to synthesize repeated regions of DNA using short oligonucleotides. You may have designed oligos or short segments of DNA to match each part of a repeated sequence. DNA molecules, when they're assembling together, they don't know that you were trying to make multiple copies here. This oligonucleotide is essentially identical to this one. You may end up only getting one copy of a region of DNA in which you are trying to make three. This is just a screen grab from a DNA sequence browsing program called BenchLink. If you want, you can check these out. They're free, and I encourage you to try browsing around looking at DNA sequences. What's exciting is that the cost of doing DNA sequencing and synthesis is going down. It's actually going down at the same rate that computers are getting less expensive, which is exciting. Moore's law is an observation and a projection of a historical trend. It states that the number of transistors in a dense integrated circuit doubles every two years, even though the cost of computers is halved. What that means is that you're getting more computing power for less cost every year. If you were to align Moore's law, this exponential decrease in cost with how much DNA synthesis is cost in genome sequencing, you'll see that these DNA-based technologies are also coming down in cost very, very rapidly on the same scale. Maybe a little bit later, so we're not quite as cheap as some of the hardware computing stuff, but it's coming, and it's exciting to watch all of these", "start_char_idx": 3979, "end_char_idx": 8096, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "53649073-64a3-4212-be15-410ebe793d30": {"__data__": {"id_": "53649073-64a3-4212-be15-410ebe793d30", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "08c4aff6-0f02-4cda-8205-baa57b7e3a2d", "node_type": null, "metadata": {}, "hash": "58722a40f1c82c6c0e31eec737d4f97fa883eedd382e09110682e25a84942c17"}, "2": {"node_id": "506b85c2-0fb8-40bd-bbc1-54f09c1ff2da", "node_type": null, "metadata": {}, "hash": "f6b48c88ac4723a974e4c1e1c2fdf8570afc2c21c47741e184509eb1df65c0ed"}, "3": {"node_id": "4eddc232-e312-47fd-9997-e24bfda3fc0d", "node_type": null, "metadata": {}, "hash": "fbd563da4302445ccda0e7ab59f73e7ece331c6329f05b20d04494fef3590fb5"}}, "hash": "7c97df361668c9a1ba591fa81239e4ec7be2c92aa5308185673a10348cc0546b", "text": "computing stuff, but it's coming, and it's exciting to watch all of these new technologies get developed and to come online at a pretty low price point. One question that I think is important to raise is, is there anything that we shouldn't synthesize? Within the limits of overlap extension assembly, within the limits of how you stitch these small DNA sequences together, it's technically possible to synthesize any segment of DNA. Should we, or should we impose limitations? If we do impose limitations, who should enforce them? What would be off limits? Should we be able to synthesize the genomes of pathogens? Is there utility in doing that? If we synthesize the DNA of a virus, for example, we can put it into a bunch of human cells growing in the lab. In addition, those cells will take the instructions for making those viruses, and they will make virus. You can actually get live virus out of cells that way. In some ways, having virus in the lab is helpful because then you can study how the virus behaves. You can use it to search for treatments, but in other ways, synthesizing that viral sequence could be dangerous in the hands of somebody who wasn't interested in trying to find a cure for the whatever disease the virus causes, but is actually interested in making it more virulent, more pathogenic. So there are tough things to think about in this space. As this technology gets better and cheaper, it may become more widespread. So what do we do? Today, DNA synthesis is monitored by the International Gene Synthesis Consortium. This is a collection of primarily gene synthesis companies who have got together to develop an answer to this question of what should we synthesize and for whom. They have come up with a harmonized screening protocol to prevent the synthesis of potentially dangerous DNA. This harmonized screening protocol is essentially an agreement that all of these companies have signed on to. And they are agreeing to screen the DNA that people are requesting to have synthesized by sequence. They're basically looking to see, are you trying to synthesize part of a known pathogen? They're also screening by customer. So they do a little bit of background check and they look to see, are you on any of these lists where we probably shouldn't be supplying you with biological materials? And they also agreed to keep records. So they make note of who has synthesized what and when, so that they can go back and look for trends, potentially identifying people who have no previous criminal records, but maybe have problems that are problematic patterns that are appearing in their synthesis orders. It can also refuse. And if they do refuse to synthesize DNA for somebody, then they report problematic orders to the group as a whole. And then the protocol also has each company, many of which they're located in a bunch of different countries all over the world, comply with all of their local laws. And so this is not to supersede anything that maybe the U.S. government has put into place to regulate synthesis. But I encourage you to check out this harmonized screening protocol to take a close look at what gene sequences are deemed off limits by this group, to think about what customer attributes are deemed off limits by this group, and then who is comprising the group. One of the things that I think is really interesting about the IGSC is that it is voluntary. And so not every gene synthesis needs to be a part of it. And that's problematic because even if these companies have come up with a good protocol for screening potentially hazardous sequences, if not everyone is doing it, then there are still mechanisms by which you could synthesize something that maybe wouldn't be beneficial to humanity or the planet. Okay, that's kind of a sad note to end on, but I would like you to instead, or in addition, I guess, think about what you can do with DNA synthesis. So we did talk about how with DNA synthesis, you might be able to synthesize an enzyme from a soil bacterium that is supposed to degrade plastics, but there might be other ways to tackle the plastic degradation problem with DNA synthesis. For example, if you use one of", "start_char_idx": 8104, "end_char_idx": 12283, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4eddc232-e312-47fd-9997-e24bfda3fc0d": {"__data__": {"id_": "4eddc232-e312-47fd-9997-e24bfda3fc0d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "08c4aff6-0f02-4cda-8205-baa57b7e3a2d", "node_type": null, "metadata": {}, "hash": "58722a40f1c82c6c0e31eec737d4f97fa883eedd382e09110682e25a84942c17"}, "2": {"node_id": "53649073-64a3-4212-be15-410ebe793d30", "node_type": null, "metadata": {}, "hash": "7c97df361668c9a1ba591fa81239e4ec7be2c92aa5308185673a10348cc0546b"}}, "hash": "fbd563da4302445ccda0e7ab59f73e7ece331c6329f05b20d04494fef3590fb5", "text": "plastic degradation problem with DNA synthesis. For example, if you use one of those deep learning approaches to design a completely new enzyme, then you need to make it somehow, right? You need to make the DNA that encodes for that enzyme. And so you can use a combination of that deep learning algorithm and the synthesis technologies to bring these new proteins into existence, which is really quite cool. Another thing you might be able to do is screen through genomes to look for PETAs, like plastic degrading enzyme homologs that may also have some capacity to degrade plastics. And maybe even better than the one that the soil bacterium you had originally found had, or than the deep learning approach. So there's different, and sorry, the metagenomic data, that just means that there's DNA in a database somewhere, there's sequence information, but there's no physical DNA anymore. Like people don't have that, but they do have the sequence. And so you can kind of revive or reaccess DNA that you only have the information about using something like synthesis. Okay. So I hope you're inspired to look into DNA synthesis a little bit more closely. I want you to think a little bit more about the harmonized screening protocol and whether or not you think companies should work on developing at-home DNA synthesizers, sort of like the smidge ion, but for writing DNA. Is that a good idea? Does that open accessibility or does that make biosecurity risks? Where are the lines in these places? And how do we think about drawing them if they don't already exist? What sequence would you synthesize if you were to make DNA? The potential is here. And so let's start thinking about it together.", "start_char_idx": 12266, "end_char_idx": 13961, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f439deee-c13b-4205-93cb-60459eae36f3": {"__data__": {"id_": "f439deee-c13b-4205-93cb-60459eae36f3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c82a1ed2-6632-430b-b417-210bd6948512", "node_type": null, "metadata": {}, "hash": "e53215b94047c6970219afe86f93cfdfb61d8780b862018aeed817fa37571123"}, "3": {"node_id": "29ddf5fd-85b8-427a-98e2-a78d732c88c8", "node_type": null, "metadata": {}, "hash": "c1ed29546abf68681af444c0e310899531ab3e40f75abf40379b7224b4d07b12"}}, "hash": "2320a524b902fa6d16e22ab11b04e8b827da7c759b7c27d9d46c08002ce865f8", "text": "We're going to talk about navigating change in the context of emerging technologies underlying bioengineering, and along the way we'll have this interesting topic, abiotic data storage. So let's get right into it. Pixar is a world-famous animation studio. They're such a success, they must have always been a success, right? Not so fast. How did Pixar navigate the change that was relevant to them when they were just beginning? What's really interesting is you can read about this story, and I'm just pulling two paragraphs from a very neat article published 10 years ago with one of the people who helped get Pixar going, Alvy Ray Smith. And so let's just read this bit of text to see what we can learn. When we moved to California, we got close to making a computer-animated movie again in the mid-1980s, 1985. It's the second time they're trying to do something. It's going to be an interesting movie about a monkey with godlike powers. Something's missing from anyway. We had somebody who would pay for it, and we had a story, and the marketing looked good, and we're going to do a screen test, and we had an animator who sketched out the studies, the monkey and a glass dragon, and okay. Second paragraph. But when it came time to harden the deal and run the numbers for the contracts, meaning who's going to do what for what money, I discovered to my dismay that the computers were still too slow. The projected production cost was too high and the computation time way too long. What's he talking about? Well, they have a computer-animated movie, and so they have the idea for what the movie should be, but actually making the movie itself is going to use computers to render the images. Remember, this is 1985, plus or minus, or thereabouts, and so the computers weren't powerful enough. It was the second time they had this experience. Apparently, they tried this earlier, and they couldn't do it, and they tried it again in the mid-1980s, and we had to back out of the deal. It was too expensive. Computers were too slow. This time, they write, we knew enough to correctly apply Moore's law. We had to wait another five years to start making the first movie, and sure enough, five years later, Disney approached us to make Toy Story. What's interesting here is Pixar didn't start out as a huge success. In fact, it looks like they tried to make a movie, they failed, and then they were about to try again, but they learned from their first failure, we better check how slow computers are, how fast computers are, how much they cost, and they're like, oh, we can't do it again. Almost made a second mistake, but at least now you have two data points. We can't do it, but anybody with two points knows that you can make a line. If you can make a line, then maybe you can extrapolate or project that line into the future. It's so interesting, and I really love this example because what you see today existing as the big successes, it didn't start that way. Oftentimes, in the starting of things, you have to learn and fail and learn and then figure out what's possible and when things are possible. Well, this is for computing and movies. What's this got to do with bioengineering? Let's use this as an example to dig a little deeper and extract the mechanisms by which we might figure out how to understand what's going on and extrapolate into the future and decide what type of bionaut or bioengineer we want to be. To stick with the Pixar example, how much cheaper did using computers to render animations get between 1985 and 1990? Because that's where this little anecdote ends. What information would we need to answer this question? The most important thing is framing the question because once you frame the question, you're like, how do I figure this out? You can just go ask anybody you know, what's happening with computers? Once you start asking questions like that, you'll start to get answers like, well, what is happening with computers? In the case of computers, one of the most famous trends that's relevant and is cited in this example is shown here, so-called Moore's law after one of the founders of Intel, Gordon Moore. And so this is a plot over time.", "start_char_idx": 0, "end_char_idx": 4182, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "29ddf5fd-85b8-427a-98e2-a78d732c88c8": {"__data__": {"id_": "29ddf5fd-85b8-427a-98e2-a78d732c88c8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c82a1ed2-6632-430b-b417-210bd6948512", "node_type": null, "metadata": {}, "hash": "e53215b94047c6970219afe86f93cfdfb61d8780b862018aeed817fa37571123"}, "2": {"node_id": "f439deee-c13b-4205-93cb-60459eae36f3", "node_type": null, "metadata": {}, "hash": "2320a524b902fa6d16e22ab11b04e8b827da7c759b7c27d9d46c08002ce865f8"}, "3": {"node_id": "ec7c26c5-6ef3-40f8-87e6-94e6381ce7bb", "node_type": null, "metadata": {}, "hash": "884f11d0cf4047a3af12309469f9d5953d3bfe7e5e72758383b30cd9b38f00bb"}}, "hash": "c1ed29546abf68681af444c0e310899531ab3e40f75abf40379b7224b4d07b12", "text": "one of the founders of Intel, Gordon Moore. And so this is a plot over time. It's a line. It looks like starting around 1970 and going to 2011. So that 40-year period, that's the x-axis. And then the y-axis is transistor count. And it's basically how many transistors are on a computer chip. And the points on this line are different types of computers or computer cores or microprocessors. And if you look carefully at the y-axis, you see that it's a logarithmic y-axis. It's going up by a factor of 10, a factor of 10, a factor of 10. It's an exponential axis. So a straight line with a logarithmic y-axis means exponential growth. Computers are doubling in power about every two years as measured by the number of transistors on a computer chip. This is what the Pixar founders were learning about when they say Moore's law. And so in 1985, not fast enough, but if we wait two and a half years, the computers might be twice as good after two years, twice as four times as good, almost eight times as good, maybe six times as good. It's like almost 10 times as good, right? In five years, like three doublings is two times, two times two is eight, eight times more powerful. So every three to four years, your computer's getting 10 times more powerful. That's the slope of this. Now they had learned from their two experiences that computers were following the increase in computing power is following this trend. So like around this time, they thought we'd be able to afford making this computer animated movie. Sergeant. Yes, sir. Establish a recon post downstairs. So by the time we get to this in the theaters, right, it looks like a big success, but the big success is derived from decisions that were being made back in 1980, 1985. For Toy Story to arrive in theaters in 1995, the Pixar team had to be making smart decisions in the 1980s. Begs the question, what smart decisions should we, should you, as you know, like there's going to be a lot of bioengineers. They're just going to be following instructions, but who's going to be the bionaut? Who's going to be the bold bioengineering leader? And if you want to be in that second category, it's like, what smart decisions should you be making when, including today, about the right time for doing different types of bioengineering projects and possibilities? So that's what this is about. That's a warmup. I like thinking about this through the perspective of surfing. If you've never seen surfing, here's what it looks like. This is next to San Francisco in California. When you see somebody surfing, the drama of surfing is what captures your attention. But for today's class, I really want you to think about where are these waves coming from and what's making the shape of the wave and how they're changing over time. There's some engine somewhere far away, a storm that's causing a trend, this swell, and then the wind and the topology of the ocean bottom and the tide are other physical factors that shape the wave. But the key thing is to understand that there's some engine somewhere, some trend that's creating this pulsing set of waves. It's like there's some trend that's creating changes in computing power. There's some trend that's going to be changing the capacities of bioengineering power, which we'll get to in a minute, and we've been talking about earlier this week already. But if you can see these trends, then you can see that they're generating these pulses, these waves. You can understand where the wave's going to be. Then you can decide where you want to be with respect to where the wave's going to be, and then you can surf the trends. It allows you, if you understand what's going on, to say, do I want to position myself there and when do I want to position? Maybe you do, maybe you don't. The most important thing with surfing is not getting out there surfing per se. It's like understanding where the wave's going to be and then reading what's going on and then making a decision about where to position yourself. That's the gist of it from just a totally different perspective. Turning this back to", "start_char_idx": 4122, "end_char_idx": 8217, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ec7c26c5-6ef3-40f8-87e6-94e6381ce7bb": {"__data__": {"id_": "ec7c26c5-6ef3-40f8-87e6-94e6381ce7bb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c82a1ed2-6632-430b-b417-210bd6948512", "node_type": null, "metadata": {}, "hash": "e53215b94047c6970219afe86f93cfdfb61d8780b862018aeed817fa37571123"}, "2": {"node_id": "29ddf5fd-85b8-427a-98e2-a78d732c88c8", "node_type": null, "metadata": {}, "hash": "c1ed29546abf68681af444c0e310899531ab3e40f75abf40379b7224b4d07b12"}, "3": {"node_id": "f4f7ddac-3a7e-403f-a290-012bb65ff987", "node_type": null, "metadata": {}, "hash": "d086a899c4079b0edfa260ed553304e6e24bce54fe8af7c1739294d74372be5d"}}, "hash": "884f11d0cf4047a3af12309469f9d5953d3bfe7e5e72758383b30cd9b38f00bb", "text": "the gist of it from just a totally different perspective. Turning this back to bioengineering, title of the slide, what are the emerging trends beyond computing that are or will likely impact the practice or impacts of bioengineering, if any? Here's something that helps us understand changes with respect to the tools we've been looking at this week. We're going to talk about sequencing of DNA and synthesis of DNA and trends related to that. Of course, you want to understand how these tools work, but if you want to be a bionaut, you have to understand how these tools are turning into trends, meaning change in DNA sequencing and DNA writing capacities over time. To get to that, we need to find clues. The best way to find clues is just go look for clues. I know that sounds really trivial and maybe esoteric, but I'm just going to give you some examples. As we go through these examples, I'm going to pose some questions so that you can practice and gain confidence with like, how do I find what the trends are? Here is a totally esoteric document from 1996, Cellular Computing, Summer Study. At the top, you can see this symbol on the top right, DARPA. You should ask, what is DARPA? You can find a Wikipedia article. I'd encourage you to read it. DARPA is a U.S. federal agency whose mission is to create and prevent surprise, technical surprise. It was started by the United States Congress in response to the Soviet Union launching Sputnik. That was so alarming, having another nation state surprise us with this object orbiting the earth and sending out little radio signals. It's like, we don't want that to ever happen again. How do we avoid that? We must create our own purpose, mission-driven organization to make sure we're never surprised by another country's technology. The only way to do that is to make sure we have the most innovative technologies. That's one way of describing what DARPA is about. Maybe you could learn more. Maybe one or more of you will be DARPA program managers. I bet and expect one or more of you might be the DARPA director in the future. Wouldn't that be interesting? Anyway, let's go back to the study. You can track down the study and download the whole thing for free from the MIT library. There's this incredible plot. It's such a simple bar graph in the middle of the study. It says sequence genomes. It's got three bars on the graph. Then it's got 95, 96, 97. Those are the years 1995, 1996, and 1997. The y-axis is number of microorganisms. This is a representation of how many genomes have been sequenced for microorganisms on the entirety of the earth in the history of human civilization. The answer in the year 1995 is zero. Then in the year 1996, the answer is two. That's when they had their study. I guess they must have been guessing about how many would be sequenced the next year. They're saying, this could be 10. It's like, we have zero genome sequenced in 1999, even though Sanger sequencing, as we learned, was invented in the 70s. It wasn't applied to bacterial genomes yet. It had only been applied to some virus genomes. Zero, and then it goes to two, and then it goes to 10. I love how they take three data points and make this unbelievable slide title. Biochemical knowledge is undergoing explosive growth. That's a bold statement. You know what? They weren't wrong. They're right on target. If you keep reading in this document, there's other things. It's like, you know, DNA has very dense molecular memory. You could store a hundred thousand bits per cell within this spatial feature. One of the places you can find trends and learn about the future is to find new organizations whose mission is to understand trends and invent the future, DARPA being one of them. Look right here again. 25 years ago, people are learning about the trend in sequencing. It's undergoing explosive improvement in capacity. Now we can quantify this in more detail. This is a work done by Rob Carlson. What Rob is doing is, time again, on the x-axis, we're familiar with this from Moore's law. In fact, Moore's law is", "start_char_idx": 8214, "end_char_idx": 12287, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f4f7ddac-3a7e-403f-a290-012bb65ff987": {"__data__": {"id_": "f4f7ddac-3a7e-403f-a290-012bb65ff987", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c82a1ed2-6632-430b-b417-210bd6948512", "node_type": null, "metadata": {}, "hash": "e53215b94047c6970219afe86f93cfdfb61d8780b862018aeed817fa37571123"}, "2": {"node_id": "ec7c26c5-6ef3-40f8-87e6-94e6381ce7bb", "node_type": null, "metadata": {}, "hash": "884f11d0cf4047a3af12309469f9d5953d3bfe7e5e72758383b30cd9b38f00bb"}, "3": {"node_id": "fefe3df9-9a4c-452d-9802-68885fc6e173", "node_type": null, "metadata": {}, "hash": "fe219ccdb76df08ac67e5299eb6174de43170ae69e93a88f94fb71b70d09fd75"}}, "hash": "d086a899c4079b0edfa260ed553304e6e24bce54fe8af7c1739294d74372be5d", "text": "we're familiar with this from Moore's law. In fact, Moore's law is re-plotted on here on the blue line. And so we see transistors per chip on the y-axis, but we also see the red and yellow line. And these have different y-axes. These are the number of bases of DNA, or nucleotides, that a person could read or sequence in a day. So that's the red line. How many nucleotides could one human being sequence in a day, given the technologies of that time? So in 1985, it's looking like it's somewhere between 10,000 and 100,000. One times 10 to the fourth, one times 10 to the fifth, right here. So call it 20,000 a day. But you fast forward to 2005 and it's gone up and it's somewhere between 1 million and 10 million. And if we jump ahead, now it's somewhere between 10 billion and 100 billion. Well, so that's an exponential increase in DNA reading capacity. And it's trending actually and accelerating, if you will, faster than Moore's law. So in other words, DNA sequencing over your entire lifetime, more or less, has gotten more powerful, faster than computers have been getting better. And then the yellow trend is less mature, but it's writing DNA, DNA synthesis. So in 1990, a person maybe could synthesize 100 nucleotides in a day. And by 2005, you could synthesize a million nucleotides in a day, depending if you had access to the latest tools. Wow. So we saw what happened with computing, just one example, computing getting better. And then suddenly we've got computer animated movies, but now underneath bioengineering, if DNA is central to all of 21st century bioengineering and everything it can do, the two tools that are right upon DNA, touching DNA, DNA reading and DNA writing, they're moving out like gangbusters and following trends as profoundly changing as computers were. Well, what's this going to mean? Let's use some examples. Surprise. And I don't really mean surprise, because if you can really start to get into these trends, none of this should be surprising. You're anticipating this as we're learning to surf along these trends of DNA read, write about 10 years ago, 11 years ago, some colleagues wrote a book and then they use DNA synthesis to encode their book in DNA. So they took an entire book, you know, which is a analog object, but of course you can represent the book as a digital file that you might download to read on a tablet reader. But if you have as a digital file, zeros and ones, if you could map the zeros and ones to ACs, TGs, we'll talk about that later. Then you could synthesize DNA, storing the information of zeros and ones. And so instead of having a physical copy of your book or a digital file on your tablet or laptop, you could have a test tube and inside the test tube is synthesized DNA. It's not alive. And instead of it being an open reading frame for a protein or anything to do with biology, it's just data. So that was done for the first time over 10 years ago. And as soon as you start to think about data storage, like archival data storage, how big a market is that? It turns out way big. And so then you can ask the question like, what if the people who want to store data have a much bigger demand for DNA synthesis than the people who want to do bioengineering? Because just more data to store than DNA to tinker with for solving a disease or something. Once you start to see something, you just keep seeing, it's like, it was like, I just saw that car. And now suddenly you see 10 other instances of the same model car. Once you start, people are putting information in the DNA. You just find more and more examples. So that video from the musical group, OK Go, suddenly there's this example coming from Microsoft and the University of Washington up in Seattle. And they're taking a high definition music video from the band OK Go. And also the Universal Declaration of Human Rights in more than 100 languages, and the top 100 books from Project Gutenberg, and the Crop Trust Global Seed Database. And they're putting all of that data into synthesized DNA that can sit in a test tube somewhere. 200 megabytes of data just got", "start_char_idx": 12298, "end_char_idx": 16399, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fefe3df9-9a4c-452d-9802-68885fc6e173": {"__data__": {"id_": "fefe3df9-9a4c-452d-9802-68885fc6e173", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c82a1ed2-6632-430b-b417-210bd6948512", "node_type": null, "metadata": {}, "hash": "e53215b94047c6970219afe86f93cfdfb61d8780b862018aeed817fa37571123"}, "2": {"node_id": "f4f7ddac-3a7e-403f-a290-012bb65ff987", "node_type": null, "metadata": {}, "hash": "d086a899c4079b0edfa260ed553304e6e24bce54fe8af7c1739294d74372be5d"}}, "hash": "fe219ccdb76df08ac67e5299eb6174de43170ae69e93a88f94fb71b70d09fd75", "text": "DNA that can sit in a test tube somewhere. 200 megabytes of data just got pushed into DNA synthesis. And now you've got a test tube with microscopically small DNA molecules encoding the music video for the band, the Universal Declaration of Human Rights. What? Is it surprising? Once you're seeing the world in this way, it's like, oh no, I expect more of this might be happening. People are going to put more and more data in the DNA. And now you just keep looking. In the year 2017, the Library of Congress, the US Library of Congress, is holding a workshop. What do the librarians think about DNA data storage? Well, let's have a meeting about designing storage architectures for digital collections. This happened in the fall in Washington, D.C. at the Library of Congress. And we can track this down and see what the agenda is. And it's like, OK, Seagate government solutions. That sounds very good, but conventional. Tape manufacturer consolidation. That's what I think about. I think about tape reels and storing data on tape. But if we keep looking at the agenda for this meeting, the next day on September 19th, we see alternative media and the future. And there's all these speakers and then alternative media in the future. And here we go. Karen Strauss, who was the researcher on the preceding slide from the University of Washington and Microsoft Research, DNA Research, and Hwajin Park, DNA Storage Update. Whoa. So between the year 2012 and 2017, in 2012, the first book goes into DNA, you could say almost as a stunt, but like a research project. Within five years, the Library of Congress is like, we should be talking about putting the Library of Congress in the DNA. Is that the future? Right. And we're finding this just by scratching the surface and like, who is thinking about what these trends are and when the right time to do some bioengineering might be. Now, I want to switch gears for a moment. We'll come back and talk about surfing in a couple of different ways. But I want to dig into why DNA might be the ultimate digital data storage format and how to put data into DNA. And the reason is subtle, but in my opinion, truly profound. Yes, DNA is tiny. So you've got a carbon ring and then you could put two bases on the DNA. And so for five carbons, you could store two bits of data. We'll get to that. So it's super high density, like a thousand times greater than most things. DNA, if you keep it in a dry place and don't change the temperature or irradiate it, it's pretty stable.", "start_char_idx": 16381, "end_char_idx": 18895, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "dc3eb136-10c8-4243-a0af-e7f54d6c322a": {"__data__": {"id_": "dc3eb136-10c8-4243-a0af-e7f54d6c322a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "87724d6e-064b-4946-953c-75b95b8de25b", "node_type": null, "metadata": {}, "hash": "acd643f122b454ae0ace667f4b5106ded5afa57f30123696d56110a5be840725"}, "3": {"node_id": "4076f231-110d-4a3d-a268-26812d3e5d3f", "node_type": null, "metadata": {}, "hash": "16c1e734d6152236efa447696e268e724c452232e15c1137eefe2500810d4358"}}, "hash": "d6fa77ef066b3e28f67e189ae83d1f42490b287c447dfcdf3f3c59b8934cb0e1", "text": "So it lasts for hundreds of years, thousands of years. But the kicker is really the property on the right. When I talk to librarians, they had to teach me this. They're very skeptical about putting their most important information, the library, into digital archives, because the technology of digital archives has been changing so quickly. And if you're a librarian, you want to make sure your library is around in 100 years or 500 years. Would you feel comfortable putting it into a compact disc or a DVD or a USB stick? These technologies don't even last that long. But for them, they also have to think about the people visiting the library in 100 years. Are they going to know how to use a USB drive? How many people know how to use an 8-track tape still? How many people? Do you have an 8-track tape player where you are? That was state of the art just a few decades ago. Now imagine what's going to be the technology that's relevant for digital storage in 100 years. The cool thing about DNA from the librarian's perspective, and again, they had to teach me this, is people are in love with themselves. We're in love with ourselves. And we have DNA inside us, and we like reading out our DNA. And so if you can move your library into DNA, you can have confidence that if people are still around, if Homo sapiens still exist, that it's very likely they'll be DNA sequencers. They'll be readers for reading out the tape, right? And so that's the subtle but profound reason. It doesn't matter how immature it is right now. Well, if you can get your library into DNA and make that technology better over time, you can guarantee that the readers will exist and people who know how to use the DNA readers will exist in 100 years, 500 years, for as long as people exist, right? So it's the ultimate obsolescence insurance policy, DNA is not going to go obsolete from the perspective of Homo sapiens. So puzzle with that in your mind until you understand it, but like that was something that was a really big aha for me. How to store DNA, data in DNA, simplest way to think about it is if I'm going from bits, zeros and ones, then I could just say, well, you know, a zero is going to be represented by an A or T, right? And if I see an A or T, or if I put an A or T on a DNA strand, that's a zero. If I have a one, I want to put it on DNA, a C or a G, right? So that's a simple one to two transcoding. It's not the most data dense. You could obviously store two bits of data in each position on DNA because there's four options, right? So you could store a zero zero into an A and a zero one into a T and a one zero into a C and a one one into a G and so on. So these are pretty straightforward, simple transcoding. There are other things you can do, which instead of using binary digits in the DNA, you could say, well, we want to make sure that when we get to the sequence of DNA encoding the data, that the base that's being used is always changing, right? And so we're going to use a ternary digit code where the base that follows depends on the preceding base. And you can see if you can work through how to do that. But there's an infinite number of ways to go from information into DNA. One thing I should say very plainly is you don't have to go through binary digits or bits, right? Let's say you wanted to encode music into DNA, like a piece of piano music. You could just say, well, here is the sheet music and the notes on the sheet music and the octaves. And I'm just going to directly give different notes in the sheet music, different sequences or letters of DNA. So I just want to take care. You don't have to do DNA data storage by going through binary, right? Infinite options, right? And part of the puzzle you've got in front of you is to consider imagining one or more of these. One thing I want to highlight, which is subtle, is why not just go with full data density of two bits to one position? And the answer comes down to reliability of reading and writing. And as we've heard, these tools for reading and writing of DNA are amazing, but they're not always perfect. And we can make things easier for the tools if", "start_char_idx": 0, "end_char_idx": 4137, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4076f231-110d-4a3d-a268-26812d3e5d3f": {"__data__": {"id_": "4076f231-110d-4a3d-a268-26812d3e5d3f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "87724d6e-064b-4946-953c-75b95b8de25b", "node_type": null, "metadata": {}, "hash": "acd643f122b454ae0ace667f4b5106ded5afa57f30123696d56110a5be840725"}, "2": {"node_id": "dc3eb136-10c8-4243-a0af-e7f54d6c322a", "node_type": null, "metadata": {}, "hash": "d6fa77ef066b3e28f67e189ae83d1f42490b287c447dfcdf3f3c59b8934cb0e1"}, "3": {"node_id": "24176a38-ac1d-4748-8356-338621794216", "node_type": null, "metadata": {}, "hash": "05d598f90cabd0ac9e5e056a443b5dc5b29a2e06bd88ab9e32cd79ccfcf5ccb8"}}, "hash": "16c1e734d6152236efa447696e268e724c452232e15c1137eefe2500810d4358", "text": "but they're not always perfect. And we can make things easier for the tools if we, for example, are always making sure that the letter is changing A, C, T, G from one to the next. Why might that be the case? Well, when you do the actual reading out off of one of these machines, you might get a peak that says, oh, the base right here is an A. And if you have a lot of A's in a row, the machines is going to be saying like, ah. And you're going to have to be parsing that signal really carefully if it's possible at all to discriminate between, was that two A's or three A's? Was that five A's or six A's? But if instead you're trying to read out a sequence that's A, C, T, G, C, T, where each position is always different, you'll get a very discreetly different signal. And so it makes the reading more accurate. So we can choose data storage codes that make it easier to do read and write. Whether you should do that or not is going to depend on other variables in a particular application. And just to close on this, if you want to learn more and if you want to see more evidence for what's going on, suddenly there's the DNA Storage Alliance, the DNA Data Storage Alliance with this website. And look at all these organizations that are now clustering around this topic to try and figure out how to invent this version of bioengineering future. Were you expecting in bioengineering suddenly it's about libraries and librarians and archival data storage? I wasn't, at least not until I started thinking about this DNA read-write trend and how it might impact things beyond living systems directly. What else? What else might we expect seeing these trends? What else could be happening? I'll give you some other examples. When DNA sequencing got cheap enough, it turned out that it changed how health care could be provided for pregnant women. For example, our youngest child is six years old. And when Christina, my wife, was pregnant with our second child, we had a new experience at the hospital. They took a blood draw, and in the blood of healthy pregnant women, there's DNA circulating from the fetus. And that's normal. And you can use DNA sequencing to read out that DNA and determine what's going on with the fetus genetically. So 10 weeks into our second pregnancy, we knew that our second child would be a boy because Christina, my wife, had Y chromosome DNA from the fetus, male chromosome DNA, in her blood. This is before you can see what's going on with ultrasound or another method. With our first child, this technology didn't exist in the hospital here. So it's like, oh, there's two data points. What's going on? This is called cell-free DNA or non-invasive prenatal screening. It's a technology that can displace amniocentesis or more invasive ways of collecting samples from a fetus. Well, here's something at the opposite end of the spectrum. Maybe you live in a neighborhood and you're worried about dogs pooping everywhere. What if you could register your dog and its DNA and have some, by the way, I don't know if this is a good idea or not, it's called poo prints. What if you could use DNA sequencing to determine who wasn't cleaning up after their dog? Well, that's something that becomes possible apparently when DNA sequencing becomes accessible and affordable enough. Here's another example. It's like, okay, somebody used a 3D printer to print a bunny rabbit, but they didn't use just a normal 3D print material. They actually, in the material that they were using to do the 3D printing, the polymers, they included glass beads and inside the glass beads were synthetic DNA. And the synthetic DNA was encoding the data for the computer file to 3D print the rabbit. Stated differently, this abiotic plastic object has a DNA genome, which is the computer instructions for 3D printing this object. And so because of that, you could cut off a little bit of the rabbits here, recover the DNA, sequence it, get the computer file and use that to print more rabbits. And so they're showing in the bottom, this life cycle of", "start_char_idx": 4074, "end_char_idx": 8123, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "24176a38-ac1d-4748-8356-338621794216": {"__data__": {"id_": "24176a38-ac1d-4748-8356-338621794216", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "87724d6e-064b-4946-953c-75b95b8de25b", "node_type": null, "metadata": {}, "hash": "acd643f122b454ae0ace667f4b5106ded5afa57f30123696d56110a5be840725"}, "2": {"node_id": "4076f231-110d-4a3d-a268-26812d3e5d3f", "node_type": null, "metadata": {}, "hash": "16c1e734d6152236efa447696e268e724c452232e15c1137eefe2500810d4358"}, "3": {"node_id": "6dcbc230-3487-472d-9cd2-594c5a9474ea", "node_type": null, "metadata": {}, "hash": "f5497c2a9022cce6ff35558f8185706bdc9d81ad43fa0d2d0ce626d682097ee0"}}, "hash": "05d598f90cabd0ac9e5e056a443b5dc5b29a2e06bd88ab9e32cd79ccfcf5ccb8", "text": "print more rabbits. And so they're showing in the bottom, this life cycle of an abiotic object that has its own instructions for reproducing itself encoded in DNA. DNA, it's not in a living system, it's in a glass bead and just like make more rabbits. They call this a DNA of things storage architecture to create materials with embedded memory. They put movie recordings in DNA encoded in the lenses of glasses. You could put all the information needed to rebuild civilization into DNA and then put that DNA in glass beads and embed that in your refrigerator handle. Such that if there was ever an apocalypse, you'd like, okay, we're going to reboot civilization by recovering the information from our refrigerator. You put arbitrary information and arbitrary objects. Is this surprising? First time you hear it, but not if you orient within this context of DNA read-write are getting better and better. Here's another example, Anika Bio. They're using synthetic DNA to basically do provenance tracking. Where did this thing come from? How's my food supply chain doing? If I have a whole bunch of lettuce and some of the lettuce has a pathogen that's causing people to get sick, do I have to recall all of it? What if I could spray different sequences at different points of collection such that I have finer granularity around the sourcing and logistics of where things are coming and going from such that I could more surgically only remove the 1% of the lettuce that's problematic. That's an interesting idea. Wonder how that's going. What changes might bioengineers realize via DNA? We've seen now that there are trends, meaning changes over time with respect to DNA read and write capacity. Given these trends, maybe you should start tracking them. Maybe you could have a little plot next to your desk at home or above your bed. What's the DNA trend? My prediction would be over your entire life, there are going to be ongoing changes and improvements to DNA read-write tools. I view DNA as the polymer of the century from a technology and economic perspective. If you're tracking these trends, then you can be not just a bioengineer, but a bio-not and position yourself to decide, just like Albie Ray Smith. When was the right time to do Pixar? I don't know what the Pixar's are going to be for bioengineering yet, but I know some somebody's going to figure them out and maybe it's going to be you. If you can follow these trends, it can help you decide what to do and when you want and what change you might want to make. I want to end with a little snippet. We've been talking about quantitative change. It's getting a little bit cheaper, a little bit more powerful over time, but sometimes there's qualitative change. It's much harder to think about qualitative change. The qualitative change I want to focus your attention on is what happens when you combine DNA sequencing and DNA synthesis. DNA sequencing lets me take an organism or a piece of DNA at some point in its history and turn it into digital information, the letters, ATCG, that I can act on through computers and computer networks. Sequencing lets me go from atoms to bits. Synthesis lets me go from bits to atoms. I can take that information, I can reinstantiate the genetic material, whether that goes into a living system or a library. When you put sequencing and synthesis together, the language is going to sound funny, but it's the simplest way of saying it. We're making genetic material and genetic information interconvertible or fungible. You can go from bits to atoms and atoms to bits and back and forth and back and forth. That's just shockingly new. Prior to these two tools coming together, all of life on earth exists like you see in this little sketch I made at the top, from one generation to the next. You came from your parents, I came from my parents. If you have kids, they'll come from you. And that's normal, that's natural. But suddenly, through DNA ReadWrite, we're creating a potential break in that lineage, that chain. It's a very profound, underlying, qualitative change that's opening up. I'll give you two more slides just to help you think about what I mean by qualitative change.", "start_char_idx": 8125, "end_char_idx": 12313, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6dcbc230-3487-472d-9cd2-594c5a9474ea": {"__data__": {"id_": "6dcbc230-3487-472d-9cd2-594c5a9474ea", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "87724d6e-064b-4946-953c-75b95b8de25b", "node_type": null, "metadata": {}, "hash": "acd643f122b454ae0ace667f4b5106ded5afa57f30123696d56110a5be840725"}, "2": {"node_id": "24176a38-ac1d-4748-8356-338621794216", "node_type": null, "metadata": {}, "hash": "05d598f90cabd0ac9e5e056a443b5dc5b29a2e06bd88ab9e32cd79ccfcf5ccb8"}}, "hash": "f5497c2a9022cce6ff35558f8185706bdc9d81ad43fa0d2d0ce626d682097ee0", "text": "give you two more slides just to help you think about what I mean by qualitative change. I'll use an example of music first, and then we'll go back to bioengineering. So it used to be the only way to hear music was to have an instrument and to play it, like this gentleman is playing his interesting instrument here. Later on, we learned how to record music, and the movie here is showing a microscopic close-up of a vinyl record, and how you can store stereo signals in a V-shaped trough. You can see the needle going back and forth in the left and right channels. Later on, we figured out how to turn analog storage into digital storage, things like compact discs, and that's what's shown in the bottom right. And then suddenly, this thing called Napster happened, which let you take the digital files and move them around via the internet, so that you no longer needed to have the physical media. Now, Napster becomes other things like Spotify or Tidal or whatever's popular today. But it's in this fourth quadrant, this top right quadrant, where the qualitative change gets to be revealed. And suddenly, music is available anywhere in real-time streaming through the internet. It's like, huh. So let's end with this. Here we see a person relating to perfume. What is perfume? Perfume, where do we get perfume? Plants and other chemicals are collected and mixed together in a perfume factory, and the perfume is placed in a bottle, and then somebody buys the bottle and then dabs the perfume over themselves, depending on how they want to smell and when, and that's what perfume's all about. How does qualitative bioengineering change related to DNA read-write? How might that impact perfume? Just as one tiny example. Well, what if there was a website called iFumes? On the website, you could download DNA code for 99 cents a pop, and the DNA code was for the biosynthetic pathways making different molecules that smell in different ways, odorants. And you'd go to iFumes, you'd pay, you'd download the DNA code, you'd build that DNA, and then you'd slather that DNA on your skin, transfecting the microbes on your skin, your epidermal ecosystems, so that now they'd be reprogrammed to make living perfumes. That's an example, it's a fantastical example for today of what it might mean to navigate qualitative change associated with bioengineering. So hopefully there's a lot more for you to think about, and maybe start with like, what did he just say? Did he really mean it? By the way, I really meant it. So let's wrap up. Do you feel like you're happening to the future, or is the future happening to you? When was the last time someone or something just futured all over you, without asking your permission? Who was it? Was it Elon Musk? Did Elon Musk just future all over me today? I don't know. Right? But how do you feel about this? Second, how can you develop and use understanding of trends, technical trends or otherwise, to give yourself the option of happening to the future, positioning yourself as the waves are breaking? Where do you want to be? How good do you think bioengineers can get at reading and writing DNA? What do you think the DNA read-write tech of 2030, 2040, 2050, over your lifetime, what do you think it's going to look like? And like, as important, what's it going to feel like if you were using it? You can store information in DNA by converting bits and then to DNA. But as I mentioned in passing, you could just encode whatever information you want through some special codecs, you know, directly DNA without going through bits first. It might be music, might be a drawing, you know, like have fun with thinking about that and trying that out. Why might you, why might you skip the bits and just go right to the basics? Regardless, thinking back to the why DNA slide, remind yourself, like, why is DNA so ripe as a substrate for data storage if you're a librarian? Okay, that's it.", "start_char_idx": 12288, "end_char_idx": 16210, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5ae1e491-f920-4d5b-98f2-95297851c440": {"__data__": {"id_": "5ae1e491-f920-4d5b-98f2-95297851c440", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2cc2148e-386e-4858-988f-a0b2f9913f96", "node_type": null, "metadata": {}, "hash": "03a185f23441bc08d2b1d3ac9f4977c967da3d45c19ed751c8a5a7b9a3bf2ba5"}, "3": {"node_id": "fcbd2ef8-e4ab-41f0-be3e-318470c535c7", "node_type": null, "metadata": {}, "hash": "8ec97deeeb81117018711b23ca5b970740e55a00835d0c93fa21428f7fc8958a"}}, "hash": "801c58426432e0b16398cd4d1fa592af70824b6844c375f050e6a5798a8b5427", "text": "This week, we're going to go all the way from mutations and evolution to next generation genetically modified organisms, including food. So let's get started right away. We'll even touch upon things like variants and who knows what else. Mutation, bug, or feature? Of course we know about mutants, right? I read about this thing in the Marvel Universe. Mutants are humans born with a genetic trait called the... What? Why are mutants born with an X gene? Would you bioengineer people to have the X gene? What about mutants not in the Marvel Universe? How about the reality, the real universe? Well, in nature, you can think about what happens as an organism makes another organism, makes another when a parent has a child, has a grandchild, has a great grandchild, and so on and so forth. Whether this be Homo sapiens, a human, or a bacteria, or a plant, what happens when one generation begets or reproduces and makes the next generation, and so on and so forth. Underlying this process can be spontaneous changes in the genetic material, which we'll talk about in detail. The genetic material could be DNA for you and me, or it could be RNA, like the coronavirus. If there are spontaneous changes in the genetic material encoding the living systems, then maybe the living systems can change themselves. And so mutations are spontaneously or randomly arising changes in the genetic material encoding living systems. A lot of mutations, because they don't matter, at least not immediately, some mutations have no immediate impact on the so-called phenotype, the form or behavior of the so-mutated organism. Oftentimes you might refer to these mutations as silent, shh, silent mutations. They don't seem to do anything. But of course the genetic material is changing, so it might do something later. Other mutations have profound and obvious changes. Here's an example I found from a neat biology class. Got a cat on the left, looks like it's a lion, no, it's a tiger. It's got stripes, it's got orange fur. In the middle is a mutant, still got stripes, but the fur is no longer orange. Nothing has changed in the animal's genetic material, such that the pigmentation of the fur is different. On the far right, we see another mutant, it's albino. There's no stripes, no color of any form, right? So some mutations have obvious changes. That's in nature, but how about in bioengineering? Well, in bioengineering, if we're clever, we can create systems where there are random changes bioengineered into what the living system's doing. And then if we do that right, we might get very interesting tuning or engineering of the resulting properties of the living systems. It's kind of unbelievable how much you can do with this. I'll give you just one example here. Look at this incredibly colorful image. Believe it or not, you're looking at neurons in the hippocampus of a mouse brain. That's why I've got the brain, the cartoon character on the right. And scientists have put DNA into the individual neurons designed to produce different colors in different neurons, but what color any individual neuron makes is not hard-coded. It's not prescribed. It's the result of a random process where through clever bioengineering, there are spontaneous or random changes in the DNA at very high frequency as this brain is developing. And thus as a result, each individual neuron gets a different dosing of different colors and you get this beautiful image where you can clearly discriminate between one neuron and the next as the brain's wiring up. This is called a brain bow. And it's just such an amazing demonstration of how you can use clever bioengineering and random genetic process to produce diversity, in this case, the diversity of colors to help us see how the brain's wired up. And really, if you're excited about this, check out the URL down there and learn more about it. The brain bow. Okay, well, back to basics. Where do mutations come from in nature or stated differently? Like, why do they happen? They have to happen? I want to start exploring this question with the macroscopic. Let's imagine you went to a museum, you brought some", "start_char_idx": 0, "end_char_idx": 4140, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fcbd2ef8-e4ab-41f0-be3e-318470c535c7": {"__data__": {"id_": "fcbd2ef8-e4ab-41f0-be3e-318470c535c7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2cc2148e-386e-4858-988f-a0b2f9913f96", "node_type": null, "metadata": {}, "hash": "03a185f23441bc08d2b1d3ac9f4977c967da3d45c19ed751c8a5a7b9a3bf2ba5"}, "2": {"node_id": "5ae1e491-f920-4d5b-98f2-95297851c440", "node_type": null, "metadata": {}, "hash": "801c58426432e0b16398cd4d1fa592af70824b6844c375f050e6a5798a8b5427"}, "3": {"node_id": "d0086d60-c0a6-499e-82a7-b1312a74e3fa", "node_type": null, "metadata": {}, "hash": "0c973f8ce719a82d45dfa35cb6a5d7f9079b1f0e8a39ea754cfc8768edf6b827"}}, "hash": "8ec97deeeb81117018711b23ca5b970740e55a00835d0c93fa21428f7fc8958a", "text": "the macroscopic. Let's imagine you went to a museum, you brought some paint and some canvas, and you wanted to copy a painting in the museum. It's a little bit strange, but maybe you could do it, like this person here. This person is looking at something and then through a physical process of painting, making a copy of the first painting. We can think about this and just say, well, what's going to happen here? Maybe we could say the following. Whenever one object is copied by a physical process, there's a chance that the resulting copy will not be exactly the same due to one or more random differences. You know, like trying to copy it, but maybe I couldn't figure out exactly how the hair was on the person in the first painting. I did my best, so maybe I couldn't decode the first painting. So even if I was a perfect painter, I wasn't quite sure what I was seeing. Or maybe I could perfectly interpret the first painting, but my hands were a little shaky. Oops, made a mistake on the ear. So whenever you have a physical process that's copying something, there's a chance, random chance that you might get a change in the offspring, if you will. I want to test you and test your thinking by giving you just a case study of copying. Okay, so let's take a look. Or take a listen, in this case. So here's a song that's a number one hit from the late 1960s in the United States in a genre called bubblegum pop. I don't know if I'd recommend it, but let's listen to the hit. I don't know if I'd recommend it, but let's listen to the hit. Now here's a copy of this song by Bob Farley and the Wailers, just a little bit after. So is the second song a mutation of the first song? Of course, oh, it's a cover song, right? The original and then a cover song. But going back to the preceding slide, is Bob Farley and the Wailers version, which I prefer, nothing against the original, but this sounds more interesting, is it a mutant? Think about that. For me, I'd say no, because the resulting copy is not produced via a random process. A mutant of the first song would be you're making the physical copy directly and maybe got a note wrong or something changed, but it wasn't this purposeful, conscious, intentional derivative or cover. So take care when things are getting copied. Sometimes they're mutants and sometimes they're just cover songs, right? So trick slide here, but think about it. Okay, let's bring this back to biology and bioengineering. Here we've got a whole slide full of A's, T's, C's, and G's. Can you guess what it is? How many letters are on here? One, two, three, four, five, six, 29,000, almost 30,000. It's amazing how many letters you can get on one slide. Turns out this is a DNA representation of SARS-CoV-2, the coronavirus, which is normally the T's would be used because it's RNA, but this is the DNA version. Here's the whole genome. If you got infected with SARS-CoV-2, this is a thing that's reproducing inside of you at least an abstracted representation as the genetic sequence. I want you to, right now, start, get a piece of paper and quickly copy the sequence. Go. Are you done? Did you make any mistakes? Of course, it's impossible for you to physically copy it using Pencer, but somehow when we think about mutation in biology, at the core of it is random changes in nucleic acid sequences. I hope if you seriously confronted the challenge of quickly copy the sequence, that's what the molecules of life are going to have to do with perfection if we didn't want random changes, if we didn't want mutation. Hopefully, you're beginning to get a sense of how ridiculously difficult or challenging it's going to be to copy these strands of genetic material with zero random changes. Let's look at the molecules that actually copy the SARS-CoV-2 genome, at least a representation of it. This is something we've seen before in terms of structural biology. In this case, we're looking at", "start_char_idx": 4083, "end_char_idx": 8006, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d0086d60-c0a6-499e-82a7-b1312a74e3fa": {"__data__": {"id_": "d0086d60-c0a6-499e-82a7-b1312a74e3fa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2cc2148e-386e-4858-988f-a0b2f9913f96", "node_type": null, "metadata": {}, "hash": "03a185f23441bc08d2b1d3ac9f4977c967da3d45c19ed751c8a5a7b9a3bf2ba5"}, "2": {"node_id": "fcbd2ef8-e4ab-41f0-be3e-318470c535c7", "node_type": null, "metadata": {}, "hash": "8ec97deeeb81117018711b23ca5b970740e55a00835d0c93fa21428f7fc8958a"}, "3": {"node_id": "da7396c2-56f6-4c94-b042-4c7f67b63a0f", "node_type": null, "metadata": {}, "hash": "90ec36819bf96db6a61bbfcc3ac7a3fa05f66036f8e521faa07634a6b5edbaa1"}}, "hash": "0c973f8ce719a82d45dfa35cb6a5d7f9079b1f0e8a39ea754cfc8768edf6b827", "text": "something we've seen before in terms of structural biology. In this case, we're looking at what's called the RNA-dependent RNA polymerase. Normally, when you think about copying of genetic material, we're thinking about copying of DNA, so you have a DNA polymerase, but some viruses have their genetic material stored as RNA, not DNA. To copy RNA, you need an RNA-dependent RNA polymerase, which is a mouthful, I'll admit. What we're looking at here around the outside of this core barrel are the proteins that comprise the RNA-copying machinery that are going to replicate this entire sequence. Hopefully, if we wanted it to have no mutations, they're not going to make a single mistake when they copy all this sequence. Right down the middle of this, in red and blue, is a representation of an RNA being copied. Then we're just going to rotate the whole thing 90 degrees. Now you can see the RNA that's being copied, the template is in blue, and then the duplication or second copy of the genome is being made in red and coming out from right to left. How this machine is actually working, this is just a static image and all the atoms are kind of hidden away in these ribbon diagrams, but somehow this is the business. This is the molecular machine that's copying the virus genome that's causing the pandemic. Let's look at an example of a DNA-copying machine and see if we can develop a little bit more empathy for what must be happening inside a cell. Again, just on background, SARS copying itself is RNA copying RNA. This example, a beautiful animation from Drew Barry and colleagues, is a DNA copying DNA. What's shown here is a strand of DNA coming in on the left and then two strands of DNA proceeding off to the right. The spaceship-looking thing, of course it's a molecular complex, that's the set of molecules, the DNA polymerase, that's copying the DNA. Here's the business side of it, where you've got a single strand of DNA coming in and a double strand of DNA going out to the right. Right here, we're seeing the individual bases being copied somehow, an A being matched up with a T, a C with a G, a G with a C, a T with an A. You can get a sense of it, but of course this is super slowed down. In reality, all of this is happening in a human cell. Maybe it's moving at 50 letters a second. In a bacteria or virus, it could be 1,000 letters a second. For this to work, randomly the bases are appearing and the poor polymerase has to decide, I need a G, is that a G or a C? It can't look, it's somehow electrostatics in physics. Is this process going to be a perfect process? No. I can hardly copy anything when I'm thinking as hard as possible about it without making a mistake. How are these molecular systems going to copy millions of base pairs, tens of thousands of base pairs without making, it's just not going to happen. It's actually remarkable they're as accurate as they are. They might make a mistake one in 10,000, one in a million, one in a billion, depending on how much proofreading and error correction there is. All of this is done at the molecular level, but the key thing is this copying process, as good as it is, isn't going to be perfect. Because it's not perfect, there's going to be random mistakes throughout what's going on. What happens if a polymerase, a DNA polymerase or an RNA dependent RNA polymerase makes a mistake? Depends. A lot of the time it's silent, so it doesn't make an appearance on the broader stage. But if it has an impact, if it impacts phenotype, if it impacts what actually happens functionally at the limit, by the way, it's not if it makes a mistake, remember it's when a polymerase makes a random error. You don't know where in the sequence it's going to be, but it's going to be there randomly. So what happens? Well, it depends. At the limit, it's not silent. The opposite of it is like, it's on the news, right? And we've all", "start_char_idx": 7989, "end_char_idx": 11886, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "da7396c2-56f6-4c94-b042-4c7f67b63a0f": {"__data__": {"id_": "da7396c2-56f6-4c94-b042-4c7f67b63a0f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2cc2148e-386e-4858-988f-a0b2f9913f96", "node_type": null, "metadata": {}, "hash": "03a185f23441bc08d2b1d3ac9f4977c967da3d45c19ed751c8a5a7b9a3bf2ba5"}, "2": {"node_id": "d0086d60-c0a6-499e-82a7-b1312a74e3fa", "node_type": null, "metadata": {}, "hash": "0c973f8ce719a82d45dfa35cb6a5d7f9079b1f0e8a39ea754cfc8768edf6b827"}, "3": {"node_id": "a29ad700-8c5f-4e04-b345-de4cafc1b99c", "node_type": null, "metadata": {}, "hash": "6884d79ca1303a9c63300ff394e4924b937a07a7e7039c3c3b76100e926d70e4"}}, "hash": "90ec36819bf96db6a61bbfcc3ac7a3fa05f66036f8e521faa07634a6b5edbaa1", "text": "The opposite of it is like, it's on the news, right? And we've all been living through the consequences of these random mutations, some of which are not silent. And they have, in the case of the SARS-CoV-2 pandemic, significant impact on how the pandemic's progressing. Variants, you know, the Omicron variant, the Delta variant. This language we're seeing in the news is traceable back to the physical process of copying nucleic acids. And the fact that that copying process, as good as it is, is imperfect. And so we get spontaneous changes that result in mutations. And some of the mutations have significant consequences for how the virus infects. And that's a variant, right? So now hopefully you're a little bit more motivated. It's not just the X-Men, it's like, oh, it's the pandemic. You know, it's what evolution does. So let's see if we can make sense of this. And remember, we're practicing throughout the course, parsing the research literature. This one's going to be a challenging one, right? So let's look at the title first. This is a paper that came out in February of 2022. So this paper is 13 months old, right? SARS-CoV-2, okay. Omicron variant. I've heard Omicron. It's a variant. I guess that means it's a mutant. Well, it's a mutant that matters, so it's a variant. And then antibody evasion. Antibodies are part of the immune system. Evasion, something's evading part of the immune system. And cryo-EM, jargon, structure of spike protein ACE2 complex. Spike proteins are part of the virus particle. ACE2 is the part of your cells that normally would regulate blood pressure, I think. But it happens to be the part of the surface of your cell that the virus binds to and comes in on. It's so interesting. So now let's go to the abstract. The newly reported Omicron variant is poised to replace the Delta variant as the most prevalent SARS-CoV-2 strain variant across the world. Cryo-electron. Okay. So that's cryo-EM microscopy. Right. Got it. A microscope. A fancy microscope. Analyzing the structure or shape of the Omicron variant spike protein. So how the mutants cause the spike protein to have a different shape. An analysis of how the shape changes the complex with the human angiotensin-converting agent, aka ACE2. Again, the receptor that the virus binds to that's normally doing blood pressure stuff, but in this case it's how the virus gets into our cells. Reveals salt bridges. Sounds like I drive a car over a salt bridge. Can't be what that's about. Hydrogen bonds, mutated residues. Mutated residues. Ah, mutants are appearing. Good. Mutated residues, arginine-493, serine-496, arginine-498. Whoa. I told you this was going to be a hard abstract. I'm just going to stop here and I'm like, this looks interesting. A microscope is revealing how things are physically shaped in relation to each other and there's mutated residues. Things like serine-496. All right. We're going to come back to this, but I want to just pause and make sure everybody's following what's going on between the spike protein and this thing called ACE2. This is just a, not from this paper, but just on background, you know, what's the life cycle and how does SARS-CoV-2 work and transmit? You know, so if you're getting a SARS-CoV-2 particle coming into your body, on the virus particle itself, on the outside are these things called the spike proteins. And for the particle to do anything, those spike proteins have to interact with a specific molecule on the surface of some of your cells. This is called the receptor and the specific receptor that the SARS-CoV-2 spike protein interacts with is called ACE2 or ACE2, right? This thing I've been mentioning as something to do with regulating blood pressure, I guess. All right. So", "start_char_idx": 11910, "end_char_idx": 15655, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a29ad700-8c5f-4e04-b345-de4cafc1b99c": {"__data__": {"id_": "a29ad700-8c5f-4e04-b345-de4cafc1b99c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2cc2148e-386e-4858-988f-a0b2f9913f96", "node_type": null, "metadata": {}, "hash": "03a185f23441bc08d2b1d3ac9f4977c967da3d45c19ed751c8a5a7b9a3bf2ba5"}, "2": {"node_id": "da7396c2-56f6-4c94-b042-4c7f67b63a0f", "node_type": null, "metadata": {}, "hash": "90ec36819bf96db6a61bbfcc3ac7a3fa05f66036f8e521faa07634a6b5edbaa1"}}, "hash": "6884d79ca1303a9c63300ff394e4924b937a07a7e7039c3c3b76100e926d70e4", "text": "as something to do with regulating blood pressure, I guess. All right. So that's just what's going on. And if you had a mutant that is changing the structure of the spike protein, then you might expect it could change how the spike protein interacts with the receptor. And since a lot of the antibodies that your immune system might produce, you know, are basically trying to prevent this binding event, the antibodies are going to be interacting with the spike protein too. And so if the spike protein mutates, then an antibody that might be giving you immunity from infection, perhaps generated by a vaccine or a prior infection, that antibody might not recognize the mutated spike protein and a variant that can escape and cause reinfection. So in other words, your vaccine might not protect you from the latest variants. That's what it's all coming from, from the mutations. All right. So let's go back to this paper and we can find this figure in the paper and it's like, oh my gosh, this is complicated.", "start_char_idx": 15635, "end_char_idx": 16644, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "87755d0d-37c7-464a-81ef-55a04e57fb7b": {"__data__": {"id_": "87755d0d-37c7-464a-81ef-55a04e57fb7b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "85380493-c4a7-4d2c-aad1-2c0293382887", "node_type": null, "metadata": {}, "hash": "6fa8f0d8ec367c21ab9b43329874a31b87e727323af60d53ae64fa676ac989fc"}, "3": {"node_id": "5f1c789f-09d9-49a7-a87a-98035c896d3c", "node_type": null, "metadata": {}, "hash": "00019f653317c71b072f2e37cfbcf1651d6e2ccf1c88ad81b5e83e2f2956141f"}}, "hash": "b606c4400e2e44ce5a39658d1a8de8d8eaa76cfd50ecd7214c8ee998d2ba8590", "text": "Um, you know, but I, I see things like, um, what was it, 496 serine, I'm going to go back and double check. What was that about? Yeah. Like mutated residue, serine 496. So just remember that mutated residue, serine 496. So what this is depicting is just looking at the physical structure that they're measuring on their fancy microscope and where the mutants are on the structure of the spike protein, right? So I see the number 496 and I see the letter S and you know, that's what the physical structure looks like and where that mutant is, it's somewhere, I guess it's out on the tip of the spike protein where it's going to be interacting with the receptor. And so, you know, that's, that's that, you know, that's the region that the antibody might bind to. So, but what is, what is 496S mean? And more specifically, if we go back and look at this, it's like, it's not 496S it's a G496S. So whoa, where did all this jargon come from? How are we going to decode it? So let's see if we can figure this out. I'm going to use the Gettysburg address to quickly explain what the heck things like G496S mean. So there's Abraham Lincoln with his top hat. What an amazing photo. And if you know the Gettysburg address, you know, it starts with the four score and seven years ago. So the first thing we're going to do is we're going to put a number, we're just going to number the letters in order. So the first letter's an F, and so that's a one. The second letter's an O, that's at position two. The third letter's a U, that's at position three, and so on. And so this set of words has 25 different letters, and we can say, you know, there's an A at position 23, and so on. Okay, good. Now I'm going to propose some changes, or mutants, right, but just changes. So for example, the letter C that is historically at position six, let's change that to a P. Or the letter Y that's historically at position 18, we're going to change that to a B. And the letter A that's at position 20, you know, right here, we're going to change that to an E. So if we make all these changes, we'll get a different set of words. Let's see, what would those be? Let's make these changes. Instead of four score and seven years ago, we make these three changes, and we get, aha, four spore and seven beers ago. So when we see C6P, we're taking the original letter C at position six, and replacing it with the letter P, and so on. And that's what's happening in the spike protein, but with a different alphabet that we're going to have to introduce on the next slide. But quickly now, you can hopefully see this type of jargon and how it works. It's a coding system for taking one letter and turning it into a different letter at a particular position. So what's the language? What's the coding table? G496S. What does that mean? It's not going to be the letters of the English alphabet. These letters refer to the single letter abbreviation of the amino acids, the 20 amino acids that make up proteins. From alanine, which is abbreviated with the single letter A, or the three letter ala, you know, arginine, asparagine, aspartic acid, cysteine, glutamine, all the way down to tyrosine, which is abbreviated with the single letter Y. That's awkward. Well, that's because T was already used, you know, just above for threonine. Anyway, these 20 letters refer to the 20 different amino acids that comprise proteins. So G496 is, well, we had a G, which was a glycine, and we're going to turn it into an S, which is a serine. And we're going to do that at position 496 in the spike protein. Just to restate that and write it out, at position 496 in the polypeptide chain of the spike protein, we're going to replace the original G, or glycine, with an S, or serine. And so I was able to find the spike protein sequence online at the website at the bottom.", "start_char_idx": 0, "end_char_idx": 3823, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5f1c789f-09d9-49a7-a87a-98035c896d3c": {"__data__": {"id_": "5f1c789f-09d9-49a7-a87a-98035c896d3c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "85380493-c4a7-4d2c-aad1-2c0293382887", "node_type": null, "metadata": {}, "hash": "6fa8f0d8ec367c21ab9b43329874a31b87e727323af60d53ae64fa676ac989fc"}, "2": {"node_id": "87755d0d-37c7-464a-81ef-55a04e57fb7b", "node_type": null, "metadata": {}, "hash": "b606c4400e2e44ce5a39658d1a8de8d8eaa76cfd50ecd7214c8ee998d2ba8590"}}, "hash": "00019f653317c71b072f2e37cfbcf1651d6e2ccf1c88ad81b5e83e2f2956141f", "text": "so I was able to find the spike protein sequence online at the website at the bottom. And here are the single letter abbreviations for all the amino acids making up the SARS-CoV-2 spike protein, starting with an M and ending with a T. And if we find the G, 496 letters into this thing, G496S means we're replacing that G with an S, and that's it. So this is the G496S mutation, or variant, found in the mutated spike protein that's taken over the pandemic. Now, to be careful, these changes in the protein sequence are not mutations per se, they're the result of an underlying mutation in the nucleic acid sequence. So what do we mean by that? RNA or DNA encodes triplets that are then decoded by the ribosome and the tRNA to make proteins. And there's a lookup table, the famous genetic code, that tells you how to do the decoding. So each triplet in RNA, in this case, will result in one of the 20 amino acids or a start or stop sequence. And so glycine, for example, or G, is encoded by any of these four triplet codons would get you a glycine amino acid, GGU, GGC, GGA, GGG. And if we have a mutation that's resulting in a serine, we can see that there are four options for serine over here, UCU and so on, but also two more options for serine over here, AGU and AGC. So if I had a random error in an RNA copying process that caused a glycine on a protein to become a serine, I'm probably, well, I've got to be moving from one of these four, but to jump all the way over here to one of these four serines, I'd have to change more than one letter. Whereas, if I just want to pop up here, like GGU, that's a glycine. If I just change the G to an A on the RNA, I'll get AGU. So just a G to A substitution will move me up this codon table in a mutation, if you will, from a glycine encoding codon to a serine encoding codon. So probably what's happening during the evolution of this particular variant in SARS is, in the protein, it's originally encoded by either GGU or GGC, and it's most likely becoming either AGU or AGC. So this funny notation is at the protein level, the mutations themselves are at the nucleic acid level, and you've got to decode it through the codon table here. So that's a lot. I'm going to pause there. Reflective questions. What are mutations? Random changes that you remember. Why do they happen? Any physical copying process is likely to be imperfect in ways that are random. Is it possible to stop this from occurring? Not absolutely. You can do a lot of correction, but that's going to require energy. And so depending on how much energy you have, why do mutations matter? Are mutations always bad? If we can't stop mutations from happening, can we stop them from mattering? Sure, if you stop replication by squelching a pandemic, you won't get the mutations, it just won't be enough replication. But there might be other ways to stop mutations from matter. But hidden within this question is a whole bunch of policy topics you can think about, like how urgent is it to get people vaccinated? Could you invent a game or experience if you were talking with somebody who had no idea what mutations were? What experience could you invent for them that might help them develop empathy for this puzzle of why do mutations occur in the first place? How's that related to physical copying? One of my favorite ways of exploring this, for example, in a classroom is to get 10 people in a line and give the first person a written phrase to whisper to the next person and cheer everybody on to as quickly as possible, get that phrase whispered all the way down the line of people. And the best thing to do is to have another line of people and compete to see who get there first without making any mistakes in what the saying or phrase is. But I'm sure you can come up with other ways of helping people think about where do mutations come from.", "start_char_idx": 3738, "end_char_idx": 7603, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "18546f5a-9fd5-4635-9914-28b7aef75e9a": {"__data__": {"id_": "18546f5a-9fd5-4635-9914-28b7aef75e9a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6d8cb138-f981-4deb-820c-639c01fb026f", "node_type": null, "metadata": {}, "hash": "6fa8f0d8ec367c21ab9b43329874a31b87e727323af60d53ae64fa676ac989fc"}, "3": {"node_id": "5041258c-3dc2-4db9-9747-b310ea24de15", "node_type": null, "metadata": {}, "hash": "00019f653317c71b072f2e37cfbcf1651d6e2ccf1c88ad81b5e83e2f2956141f"}}, "hash": "b606c4400e2e44ce5a39658d1a8de8d8eaa76cfd50ecd7214c8ee998d2ba8590", "text": "Um, you know, but I, I see things like, um, what was it, 496 serine, I'm going to go back and double check. What was that about? Yeah. Like mutated residue, serine 496. So just remember that mutated residue, serine 496. So what this is depicting is just looking at the physical structure that they're measuring on their fancy microscope and where the mutants are on the structure of the spike protein, right? So I see the number 496 and I see the letter S and you know, that's what the physical structure looks like and where that mutant is, it's somewhere, I guess it's out on the tip of the spike protein where it's going to be interacting with the receptor. And so, you know, that's, that's that, you know, that's the region that the antibody might bind to. So, but what is, what is 496S mean? And more specifically, if we go back and look at this, it's like, it's not 496S it's a G496S. So whoa, where did all this jargon come from? How are we going to decode it? So let's see if we can figure this out. I'm going to use the Gettysburg address to quickly explain what the heck things like G496S mean. So there's Abraham Lincoln with his top hat. What an amazing photo. And if you know the Gettysburg address, you know, it starts with the four score and seven years ago. So the first thing we're going to do is we're going to put a number, we're just going to number the letters in order. So the first letter's an F, and so that's a one. The second letter's an O, that's at position two. The third letter's a U, that's at position three, and so on. And so this set of words has 25 different letters, and we can say, you know, there's an A at position 23, and so on. Okay, good. Now I'm going to propose some changes, or mutants, right, but just changes. So for example, the letter C that is historically at position six, let's change that to a P. Or the letter Y that's historically at position 18, we're going to change that to a B. And the letter A that's at position 20, you know, right here, we're going to change that to an E. So if we make all these changes, we'll get a different set of words. Let's see, what would those be? Let's make these changes. Instead of four score and seven years ago, we make these three changes, and we get, aha, four spore and seven beers ago. So when we see C6P, we're taking the original letter C at position six, and replacing it with the letter P, and so on. And that's what's happening in the spike protein, but with a different alphabet that we're going to have to introduce on the next slide. But quickly now, you can hopefully see this type of jargon and how it works. It's a coding system for taking one letter and turning it into a different letter at a particular position. So what's the language? What's the coding table? G496S. What does that mean? It's not going to be the letters of the English alphabet. These letters refer to the single letter abbreviation of the amino acids, the 20 amino acids that make up proteins. From alanine, which is abbreviated with the single letter A, or the three letter ala, you know, arginine, asparagine, aspartic acid, cysteine, glutamine, all the way down to tyrosine, which is abbreviated with the single letter Y. That's awkward. Well, that's because T was already used, you know, just above for threonine. Anyway, these 20 letters refer to the 20 different amino acids that comprise proteins. So G496 is, well, we had a G, which was a glycine, and we're going to turn it into an S, which is a serine. And we're going to do that at position 496 in the spike protein. Just to restate that and write it out, at position 496 in the polypeptide chain of the spike protein, we're going to replace the original G, or glycine, with an S, or serine. And so I was able to find the spike protein sequence online at the website at the bottom.", "start_char_idx": 0, "end_char_idx": 3823, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5041258c-3dc2-4db9-9747-b310ea24de15": {"__data__": {"id_": "5041258c-3dc2-4db9-9747-b310ea24de15", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6d8cb138-f981-4deb-820c-639c01fb026f", "node_type": null, "metadata": {}, "hash": "6fa8f0d8ec367c21ab9b43329874a31b87e727323af60d53ae64fa676ac989fc"}, "2": {"node_id": "18546f5a-9fd5-4635-9914-28b7aef75e9a", "node_type": null, "metadata": {}, "hash": "b606c4400e2e44ce5a39658d1a8de8d8eaa76cfd50ecd7214c8ee998d2ba8590"}}, "hash": "00019f653317c71b072f2e37cfbcf1651d6e2ccf1c88ad81b5e83e2f2956141f", "text": "so I was able to find the spike protein sequence online at the website at the bottom. And here are the single letter abbreviations for all the amino acids making up the SARS-CoV-2 spike protein, starting with an M and ending with a T. And if we find the G, 496 letters into this thing, G496S means we're replacing that G with an S, and that's it. So this is the G496S mutation, or variant, found in the mutated spike protein that's taken over the pandemic. Now, to be careful, these changes in the protein sequence are not mutations per se, they're the result of an underlying mutation in the nucleic acid sequence. So what do we mean by that? RNA or DNA encodes triplets that are then decoded by the ribosome and the tRNA to make proteins. And there's a lookup table, the famous genetic code, that tells you how to do the decoding. So each triplet in RNA, in this case, will result in one of the 20 amino acids or a start or stop sequence. And so glycine, for example, or G, is encoded by any of these four triplet codons would get you a glycine amino acid, GGU, GGC, GGA, GGG. And if we have a mutation that's resulting in a serine, we can see that there are four options for serine over here, UCU and so on, but also two more options for serine over here, AGU and AGC. So if I had a random error in an RNA copying process that caused a glycine on a protein to become a serine, I'm probably, well, I've got to be moving from one of these four, but to jump all the way over here to one of these four serines, I'd have to change more than one letter. Whereas, if I just want to pop up here, like GGU, that's a glycine. If I just change the G to an A on the RNA, I'll get AGU. So just a G to A substitution will move me up this codon table in a mutation, if you will, from a glycine encoding codon to a serine encoding codon. So probably what's happening during the evolution of this particular variant in SARS is, in the protein, it's originally encoded by either GGU or GGC, and it's most likely becoming either AGU or AGC. So this funny notation is at the protein level, the mutations themselves are at the nucleic acid level, and you've got to decode it through the codon table here. So that's a lot. I'm going to pause there. Reflective questions. What are mutations? Random changes that you remember. Why do they happen? Any physical copying process is likely to be imperfect in ways that are random. Is it possible to stop this from occurring? Not absolutely. You can do a lot of correction, but that's going to require energy. And so depending on how much energy you have, why do mutations matter? Are mutations always bad? If we can't stop mutations from happening, can we stop them from mattering? Sure, if you stop replication by squelching a pandemic, you won't get the mutations, it just won't be enough replication. But there might be other ways to stop mutations from matter. But hidden within this question is a whole bunch of policy topics you can think about, like how urgent is it to get people vaccinated? Could you invent a game or experience if you were talking with somebody who had no idea what mutations were? What experience could you invent for them that might help them develop empathy for this puzzle of why do mutations occur in the first place? How's that related to physical copying? One of my favorite ways of exploring this, for example, in a classroom is to get 10 people in a line and give the first person a written phrase to whisper to the next person and cheer everybody on to as quickly as possible, get that phrase whispered all the way down the line of people. And the best thing to do is to have another line of people and compete to see who get there first without making any mistakes in what the saying or phrase is. But I'm sure you can come up with other ways of helping people think about where do mutations come from.", "start_char_idx": 3738, "end_char_idx": 7603, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "63d487e3-aa6b-4af4-b569-cbb0e225b8cb": {"__data__": {"id_": "63d487e3-aa6b-4af4-b569-cbb0e225b8cb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "103bb39e-40c2-4130-aa26-363b570cd31a", "node_type": null, "metadata": {}, "hash": "2161ad529087cf084a1ea9f3c910a0071acc06e515dbaa3c2316dd6d7f56e45b"}, "3": {"node_id": "fde57304-2ecb-4e4b-98e2-b6b2c08f5864", "node_type": null, "metadata": {}, "hash": "01431dce29938606cd721541fc81228bec4a50cae788d18849e06a0e01dc0e80"}}, "hash": "0f9d1ebaa1d01286ec0b7eacf9e129899cd8b345635f910ff202f7e4cc47f09b", "text": "This week, we're going to talk about nutrition and food crop biotechnology. I want to start by posing a question to you. What innovations do you think have saved the most human lives? Do you think it's something like seatbelts or chemotherapeutic drugs that help treat cancer? What invention have humans come up with that have saved the most lives? Take a second to think about it. Why is that the invention that you've chosen? How many lives do you think it saved? Now keep that in the back of your head because the answer to this question might surprise you. It's actually synthetic fertilizers. These synthetic fertilizers actually don't help people directly at all. They're applied to plants and they help plants become more productive. They help plants produce more food for people. The invention of synthetic fertilizers helped increase the global food production so significantly that it's estimated that about 2.7 billion people who might otherwise have starved were able to thrive because of synthetic fertilizers. I think that's kind of an astounding number and really exciting to see something related to food and crop health at the top of this list. Right after synthetic fertilizers are blood groups. So you might know what blood type you are. Maybe you're A positive. Maybe you're B negative or O negative. Regardless of what blood type you are, the identification of what blood type you are helps doctors figure out what type of blood you can receive if you need a blood transfusion and who might be good matches for things like organs should you need a transplant. So before we understood blood groups, things like blood transfusions were much less likely to succeed. And so the identification of blood groups also has saved over a billion human lives. Now, just after blood groups is smallpox vaccine. And then right after that is actually wheat, a special type of wheat, which we will also talk about in this lecture, kind of went hand in hand with synthetic fertilizers in increasing the amount of food that we produce and therefore saving lots of human lives by making sure that people had enough nutrition. Now, a nutritionally balanced diet is important for a healthy life. You need enough protein, vitamins, fats, minerals, and carbohydrates in order for your body to have fuel and all of the building blocks it needs to keep itself running day to day. If you consume too much of one thing and not enough of another, you can put your metabolism and put your body sort of out of whack and that can lead to health problems. So it's important to make sure that your diet is composed of enough of the things that you need in order for your body to be working correctly. Now, one really important part of your body's functioning correctly is protein. The protein that we eat is actually digested into amino acids and then remade into new proteins. What do I mean by that? Well, if you were to eat beef or chicken or some other source of protein, maybe soybeans, your digestive system will actually take the proteins that are found in cow muscle or soybean seeds and it will break it down into its individual parts, into amino acids. And then the cells in your body will actually recycle those amino acids into making new protein. And if you don't have enough amino acids, then you can't make all the proteins that your cells need in order to function correctly. Maybe you don't have enough amino acids to make polymerases, to drive the expression of genes in your genome. Maybe you don't make enough of ribosomes to translate RNAs into new proteins, right? It's really important to have all of these building blocks in sufficient quantity for your cells to function correctly. Now, kind of amazingly, your body can actually synthesize 11 of the 20 amino acids that are the building blocks of proteins. That means that they can actually make the molecules from scratch inside of your cells. And that's pretty cool. That means that you actually don't need to consume a lot of protein that has alanines in it, for example, because your body is capable of making them. But there are essential amino acids, and these cannot be synthesized within the body. So you actually have to eat enough protein that has these amino acids within them in order to have a sufficient source of these amino acids", "start_char_idx": 0, "end_char_idx": 4308, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "fde57304-2ecb-4e4b-98e2-b6b2c08f5864": {"__data__": {"id_": "fde57304-2ecb-4e4b-98e2-b6b2c08f5864", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "103bb39e-40c2-4130-aa26-363b570cd31a", "node_type": null, "metadata": {}, "hash": "2161ad529087cf084a1ea9f3c910a0071acc06e515dbaa3c2316dd6d7f56e45b"}, "2": {"node_id": "63d487e3-aa6b-4af4-b569-cbb0e225b8cb", "node_type": null, "metadata": {}, "hash": "0f9d1ebaa1d01286ec0b7eacf9e129899cd8b345635f910ff202f7e4cc47f09b"}, "3": {"node_id": "ac4db4a3-aa1e-4b11-84c1-bff7877a4302", "node_type": null, "metadata": {}, "hash": "eba184b4772207234208a560ad687efa0b139709707a069af30d48bf429b7897"}}, "hash": "01431dce29938606cd721541fc81228bec4a50cae788d18849e06a0e01dc0e80", "text": "these amino acids within them in order to have a sufficient source of these amino acids to get incorporated into new proteins. So here are the eight or nine, excuse me, that are essential amino acids. And these three at the bottom, valine, leucine, and isoleucine, these are proteins that are really essential for you to consume in high quantity. They account for 30 to 40% of the essential amino acids that you need to consume. So when we look for protein sources, we want to look for things that are high in valine, leucine, and isoleucine. So although all amino acids are required for body growth, these essential amino acids are really important to get in your diet because you can't make them and you need to have them. So each food that you eat has a unique profile of amino acids, right? Rice is obviously like a different organism than cow. It's also different from the fish. And each of these organisms have their own kind of proteins that they require to function. And so they will have like different compositions. Compositions. So you need to consume the right types of dietary proteins in order for you to get enough of the proteins you need. What do I mean by that? Okay, well, often people eat rice and beans together. And although that is nice because they taste good together, that's also pretty practical. Rice is a pretty complete protein. It has the essential, almost all of the essential amino acids that you need, but it's a little bit low in lysine. It's pretty high in methionine, which is helpful, but it doesn't have quite enough lysine to be sufficient for being the only type of food that you consume. You would eventually need to eat something else to get enough lysine. Now, beans, on the other hand, are high in lysine, but low in methionine. So the two complement each other really nicely because if you eat both of them together, then you get enough of the essential amino acids that you need to function well. Quinoa, on the other hand, is what's called a complete protein. So it has all of the amino acids or essential amino acids that you need to consume in your diet at sufficiently high quantities that you can consume just quinoa, for example, and get all of the protein that you need in order to function. Animal products are similarly complete proteins and are a good source of all of these things. Now, even in animals, some of these amino acids are consumed. Now, we're so a big building block, a major part of an amino acid is actually nitrogen. And so nitrogen is in your food actually comes from the air. So nitrogen is fixed from a gaseous form into ammonia, which plants can then uptake and incorporate into their seeds. So for rice, that would be into the grain or into other parts of the plant in order for the plant to be able to make protein. And that conversion of atmospheric nitrogen into a form that the plant can use to build proteins is actually converted by bacteria. These bacteria, we will talk about a lot, but it's kind of interesting that they're the ones pulling nitrogen out of the atmosphere and turning it into a form that then plants use to make proteins that then animals eat. And then we eventually consume either in the form directly of animal meat or other animal products. So all of the nitrogen that's in your food is actually coming from the air, or it was at one point. Now, plants form unique relationships with bacteria in order to get this nitrogen. Some plants form symbiotic root nodules. So they actually make little homes for bacteria to live within their roots. The bacteria, when they live within these root nodules, will fix nitrogen. They'll actually take in nitrogen gas, and then they will deliver ammonia or a form of nitrogen that the plants can use to the plant cells. And in return, they'll get sugar from the plant. Remember, the plant is fixing carbon dioxide into sugars that can then be consumed by other organisms. So there's this really nice symbiotic relationship between plants and bacteria where the bacteria giving the plants nitrogen and the plants are giving the bacteria sugar. But not all plants form these root nodules. Some of them just associate with bacteria. So there will be", "start_char_idx": 4237, "end_char_idx": 8425, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ac4db4a3-aa1e-4b11-84c1-bff7877a4302": {"__data__": {"id_": "ac4db4a3-aa1e-4b11-84c1-bff7877a4302", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "103bb39e-40c2-4130-aa26-363b570cd31a", "node_type": null, "metadata": {}, "hash": "2161ad529087cf084a1ea9f3c910a0071acc06e515dbaa3c2316dd6d7f56e45b"}, "2": {"node_id": "fde57304-2ecb-4e4b-98e2-b6b2c08f5864", "node_type": null, "metadata": {}, "hash": "01431dce29938606cd721541fc81228bec4a50cae788d18849e06a0e01dc0e80"}, "3": {"node_id": "1c186c8a-58d8-4e86-bcf0-8efb865ac00b", "node_type": null, "metadata": {}, "hash": "6c7a31f390389ba8dbf6d83a7d9a47d705cf028ffc6580f4fd22c976dcd5523a"}}, "hash": "eba184b4772207234208a560ad687efa0b139709707a069af30d48bf429b7897", "text": "these root nodules. Some of them just associate with bacteria. So there will be bacteria living on the surface of the root system, and those bacteria sometimes fix nitrogen mostly for themselves, but they will fix excess occasionally, and the plant will benefit from having those bacteria nearby because they'll be able to get nitrogen from them. They're also free-living nitrogen bacteria, which are present more in bulk soil. There's some of them flying kind of around in air. They ride air currents, and they are fixing nitrogen, again, primarily for themselves, but other organisms can take advantage of the fixed nitrogen that the bacteria are producing. When, for example, the bacteria dies, other organisms can take advantage of the nitrogen that they've fixed. Now, here is what these root nodules look like. I think they're pretty amazing. All of these things that look like little beans, they're actually stuffed full of bacteria that are fixing nitrogen for the plant. The way these nodules form, it's actually quite interesting. It's a very intricate relationship between the plant and the bacteria where there are these tiny root hair structures on the surface of these roots. They're really small, and so they're difficult to see in the pictures that we have here. A bacteria will release some chemical signals that the root then recognizes, and the root will send back chemical signals to the bacteria. That will cause an infection thread to form, basically a little channel in which a bacteria can enter into the plant. Once they're inside of a deeper layer of the plant root, they'll begin to replicate and then differentiate into what's called a bacteroid. This is a version of the bacteria that is optimal for fixing nitrogen and receiving carbon directly from the plant. I'll show you, I think, on the next slide what this looks like. These bacteroids are sometimes elongated versions of the bacteria. They tend to lose their own cell wall and permeate their cell membrane. They become one with the plant cell, but they are distinct enough that they are still capable of fixing nitrogen and of receiving sugars from the plant. They enter a new cellular state. They don't look as much like bacteria as they did before. Even though they do that, this video should play, there are many of the bacteria that form these root nodules are actually capable of living on their own. Here is just a video where a researcher cut open one of these root nodules, started again in the beginning, and then squeezed it. You can see this looks like really fine powder exuding from the root nodule. They squeeze it. You can see it puff out. That's all bacteria. Some bacteria, even when they're in this bacteroid state, retain the ability to reform their cell wall and then start to live independently again. If you cut them open, you can actually culture some of these bacteria, which is really interesting. This nodulation, this is a very specialized process that only occurs in some plants. It is common in legumes. That means it's common in things like peas and peanuts and beans of different kinds. Many other plants, for example, potatoes and rice, don't form associations with nitrogen fixing bacteria and can't get a lot of nitrogen from this type of interaction. They're stuck getting fixed nitrogen at lower quantities than the legume species and having to find other ways of getting nitrogen. One solution that was recently discovered in maize is this mucilage. These are actually brace roots from maize. Here's a maize plant. It produces these brace roots, which are truncated roots that are coming out above ground. They will produce a lot of mucilage. This clear stuff that you see here, that's not water. That's something that the roots have exuded. That mucilage will actually trap nitrogen fixing bacteria that happen to be traveling through the air. Then it will drip them down into the soil by their root systems so that the nitrogen fixing bacteria will then be making nitrogen in a place that the plant can access. I think that's actually a pretty cool example of maize, which is not able to form root nodules, figuring out how to get nitrogen for itself. Now, not every variety of maize does this. In fact, most of the ones that we grow commercially", "start_char_idx": 8432, "end_char_idx": 12704, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1c186c8a-58d8-4e86-bcf0-8efb865ac00b": {"__data__": {"id_": "1c186c8a-58d8-4e86-bcf0-8efb865ac00b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "103bb39e-40c2-4130-aa26-363b570cd31a", "node_type": null, "metadata": {}, "hash": "2161ad529087cf084a1ea9f3c910a0071acc06e515dbaa3c2316dd6d7f56e45b"}, "2": {"node_id": "ac4db4a3-aa1e-4b11-84c1-bff7877a4302", "node_type": null, "metadata": {}, "hash": "eba184b4772207234208a560ad687efa0b139709707a069af30d48bf429b7897"}, "3": {"node_id": "0fbda229-3938-4573-a11a-98f6f458fafc", "node_type": null, "metadata": {}, "hash": "cd2cfa9fc9af062041da4823fdbe51e128d48b9a99e149209478ec2aa37aa913"}}, "hash": "6c7a31f390389ba8dbf6d83a7d9a47d705cf028ffc6580f4fd22c976dcd5523a", "text": "of maize does this. In fact, most of the ones that we grow commercially don't have this capability, but it's an interesting example of a wild relative of the maize we usually eat being able to form an association with nitrogen fixing bacteria. Here's where we get to synthetic fertilizer. In 1910, the Haber-Posch process was invented for chemically fixing nitrogen gas. Instead of relying on bacteria to fix atmospheric nitrogen into a form that's what we call bioavailable or able to be used by plants and people to build proteins, they were fixing the nitrogen gas through a chemical process. Here's just an outline of what this process looks like. You can read the Wikipedia page about the Haber-Posch process if you're curious about these steps, kind of like this simplified view of the Haber-Posch process better, where you're taking nitrogen gas and hydrogen gas and you are mixing them together and applying a lot of heat in order to get ammonia or the fixed version of nitrogen to be made. This process is very energy intensive, but it's also very powerful because this fixed nitrogen is what we then apply to plants as chemical fertilizer in order to get them to grow. Now the plants are no longer dependent on the microbes growing in or around them in order to be able to produce proteins and get quite productive, get quite big. They can rely on chemical fertilizers supplied by people. Now, these chemists, Fritz Haber and Carl Bosch won Nobel Prizes in chemistry for developing this, for developing the Haber-Posch process. So the invention of this nitrogen fertilizer dramatically increases food production. The world population has grown very significantly, right? We're more than 7 billion people in the world right now, close to 8 billion, in fact. But the world population without synthetic fertilizer is predicted to have been much lower, about half the population, because we would not have been able to feed as many people without this synthetic fertilizer. So this red line shows you where we would be without this synthetic fertilizer, and the gray line is just showing the proportion of the world population that is able to be fed because we have invented these synthetic fertilizers. And they were, again, invented right here around 1910. So a really powerful invention. But like I mentioned before, it wasn't just fertilizer. There was a simultaneous invention of semi-dwarf food crops that enabled fertilizer to boost crop yields. So here's a picture on the left of semi-dwarf wheat. This wheat is shorter than conventional wheat. It has sort of a sturdier stem. The cells, individual cells within the plant actually don't get quite as big, and so you get a more compact structure. And that's really helpful because as you apply fertilizer to these plants, they will both get taller. But the semi-dwarf plant won't get so tall that it's a problem, whereas the conventional wheat plants or the conventional plants of even rice or barley will get so tall that they'll lodge. And that means they'll fall over in response to kind of gusty winds, stormy conditions. And when the plants fall over like this, it becomes very difficult for them to set seed and for farmers to harvest the grain. And so lodging usually results in large losses of agricultural product. So these semi-dwarf plants were really key to farmers being able to utilize the fertilizer because they could apply fertilizer to these plants and get an increase in grain yield instead of just more straw biomass. So I like to point out the invention of this semi-dwarf wheat because I don't think it's quite as famous, though agronomist Norman Borlaug, who is the person that developed semi-dwarf wheat, actually won a Nobel Prize for his efforts as well. He won it, I think, 30 years after the Haber and Bosch Nobel Prize was given out. So kind of exciting. And now there are problems with applying lots of nitrogen fertilizer to farms. You can get runoff. So if you apply more fertilizer to a farm than the", "start_char_idx": 12713, "end_char_idx": 16709, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0fbda229-3938-4573-a11a-98f6f458fafc": {"__data__": {"id_": "0fbda229-3938-4573-a11a-98f6f458fafc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "103bb39e-40c2-4130-aa26-363b570cd31a", "node_type": null, "metadata": {}, "hash": "2161ad529087cf084a1ea9f3c910a0071acc06e515dbaa3c2316dd6d7f56e45b"}, "2": {"node_id": "1c186c8a-58d8-4e86-bcf0-8efb865ac00b", "node_type": null, "metadata": {}, "hash": "6c7a31f390389ba8dbf6d83a7d9a47d705cf028ffc6580f4fd22c976dcd5523a"}}, "hash": "cd2cfa9fc9af062041da4823fdbe51e128d48b9a99e149209478ec2aa37aa913", "text": "You can get runoff. So if you apply more fertilizer to a farm than the plants actually need, then the excess nitrogen can end up in waterways where organisms that would are essentially limited in growth by the amount of nitrogen. Remember, like all nitrogen has to get fixed from this gaseous form by some sort of microbe. And there aren't a lot of those nitrogen fixing bacteria naturally in the world. So if you supply a lot of synthetic fertilizer, you can get big blooms of organisms. In this case, this is an algae growing in a lake. And the algae actually grow so vigorously that they use up a lot of oxygen in the lake and that kills off a lot of other things, like a lot of other fish and animals that require oxygen within the water to survive. And so excess nitrogen running off of farms can be really problematic for ecosystems near farms and even actually pretty far away from them, as these these chemicals can travel pretty far. OK, so can we move away from synthetic fertilizer? This is a question that people have been asking and trying to figure out.", "start_char_idx": 16697, "end_char_idx": 17764, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "aac3782e-57e5-40a8-9111-f1a50b2455ed": {"__data__": {"id_": "aac3782e-57e5-40a8-9111-f1a50b2455ed", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1ed3d51f-981e-4705-a19c-a6b6595a682e", "node_type": null, "metadata": {}, "hash": "462c4b3570e5c5bca4dc91914eaaa3a9c168e047c1f4bbf015f7db9dbc035199"}, "3": {"node_id": "c83e851d-ffe1-4ce4-93a9-2800ed0984c2", "node_type": null, "metadata": {}, "hash": "c6195021f32ebf1b72262e614ef0a8954238fb244f97e216396d3ba6af5f3eb5"}}, "hash": "23b89dca8fe69d6e2ebcef87328f145489881193145627971f039ef37b27bdfe", "text": "an answer to for at least the last 10 or 15 years. In 2012, the Gates Foundation started funding efforts to genetically engineer cereal crops to produce their own nitrogen. So cereal crops are things like wheat, barley, rye, rice, maize, and these are plants that cannot form root nodules. They cannot form those symbiotic associations with nitrogen-fixing bacteria, and so they are pretty reliant on synthetic fertilizers in order to get enough nitrogen in order to produce grain at the quantities that we're used to them producing at. Now, we could just stop applying nitrogen fertilizer to these plants, but we would drastically reduce the amount of food that we're able to produce globally, and so it would be, you know, a big problem for the human population if we did that. So another solution is just to figure out how can we modify these plants to be able to produce their own nitrogen. There's been some progress towards trying to do this. It's a really challenging goal. It's really hard to get cereal crops to fix their own nitrogen or to form associations with nitrogen-fixing bacteria. So scientists have taken on different approaches towards trying to get nitrogen-fixing cereals created. This effort is to try to get barley to associate with rhizobacteria, which is the type of bacteria that would form root nodules on legumes, on bean plants, but they don't talk to each other. Remember, the first step in forming a root nodule was a chemical communication between the bacteria and the plant root cells, and the barley plants just don't talk to the rhizobacteria correctly. They actually just don't make the right chemicals in order to attract the bacteria, and so these scientists have been able to engineer plants to produce a chemical that nitrogen-fixing bacteria recognize and respond to. Here's the chemical that they're producing, and on these plates below, you can see in black and white a little barley plant that has bacteria applied to them, and the bacteria are engineered to luminesce, to produce a little bit of light, when they detect this compound. Usually they would detect this compound and begin some of the nodule formation steps, but just as a visual signal of where they are in this process, the scientists also added the capacity for them to make light, and what you can see is that when the bacteria are put onto barley plants that have been engineered to produce this compound, they do in fact produce light, but when the bacteria are put onto wild type plants or unengineered plants, they do not, and so this is a nice demonstration that the plants have been successfully engineered to produce this compound, which is a good first step towards getting this kind of trans-kingdom signaling, the signaling between the plant and the bacteria, to happen between a plant variety that would not usually talk to this bacteria and the nitrogen fixer. So it's an exciting first step. There's obviously quite a long way to go, but I encourage you to kind of keep your eye out for stuff like this as, you know, over the next 10 years we hope that these types of solutions just mature and become even more kind of complex and close to the nitrogen fixation that's happening in legumes. Okay, an alternative approach is not to worry about root nodules, but just to make free-living nitrogen-fixing bacteria more productive. Remember there are some bacteria that just live on the surface or in the bulk, on the surface of roots or in bulk soil, and those do fix some nitrogen, and maybe if you just engineer them to fix a lot more nitrogen, then you don't need to form those really specialized root nodules, you can just get enough nitrogen being made by these free-living organisms for the plant to survive. So a pair of engineers at Stanford, this is Professor Beth Satley and her graduate student Tim Schnabel, were able to engineer a strain of Azospirillum to fix more nitrogen, and this is a free-living bacteria, but it doesn't produce a whole lot of nitrogen unless it itself needs nitrogen, and so they were able to kind of deregulate its nitrogen fixing. And they're", "start_char_idx": 0, "end_char_idx": 4103, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "c83e851d-ffe1-4ce4-93a9-2800ed0984c2": {"__data__": {"id_": "c83e851d-ffe1-4ce4-93a9-2800ed0984c2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1ed3d51f-981e-4705-a19c-a6b6595a682e", "node_type": null, "metadata": {}, "hash": "462c4b3570e5c5bca4dc91914eaaa3a9c168e047c1f4bbf015f7db9dbc035199"}, "2": {"node_id": "aac3782e-57e5-40a8-9111-f1a50b2455ed", "node_type": null, "metadata": {}, "hash": "23b89dca8fe69d6e2ebcef87328f145489881193145627971f039ef37b27bdfe"}, "3": {"node_id": "5dc6b10a-20b2-4e5b-9677-f76ed0feb21c", "node_type": null, "metadata": {}, "hash": "d5fa17af02f07e3d97da429fe91ad9379129441a65f5308a1be48700f9010b4a"}}, "hash": "c6195021f32ebf1b72262e614ef0a8954238fb244f97e216396d3ba6af5f3eb5", "text": "so they were able to kind of deregulate its nitrogen fixing. And they're hoping that they will have a product that is something farmers can buy that consists of a bunch of these engineered bacteria that are grown up in some sort of fermentation in a lab and then freeze-dried and delivered to farms where they are put out into fields. The bacteria would then revive, they would rehydrate, and they would start to replicate, and so they'd make copies of themselves and then start to fix nitrogen for the plant. So the company that Tim started is called Switch BioWorks, and this is their goal. It's a really exciting goal to see nitrogen fertilizer use be offset by this biological solution. They're not the first ones to have thought of something like this. Pivot Bio is a Bay Area company that is also looking to replace synthetic fertilizer with engineered bacteria. They have a slightly different approach to how they engineer the bacteria, but the end goal is very similar. Now they do have some data that show that their product, which is called Proven, is able to help plants grow better with less fertilizer. So you kind of offset some of the fertilizer with this Proven product, this bacterial-based product. But in Navasca field trials, which were released pretty recently, the Proven benefits are limited. It looks like adding the engineered bacteria didn't really help the plants grow any better, and so it's unclear exactly what happened. But one common thing with engineered bacteria is that they don't live for very long out in the environment. You can engineer bacteria in the lab to do some pretty amazing things, but as soon as those bacteria are put into a competitive environment where there are, you know, hundreds or thousands of microbes competing with your engineered bacteria for resources, then your engineered bacteria may not survive. It may not be able to continue to do things like fix nitrogen once they're out in the wild if they're having to continue to compete just to survive. So it would be nice to see in some of these trials measurements of how much bacteria were, you know, in the soil at the end of growing seasons, and to see these repeated. These were all done in Nebraska and all with corn, and so it would be nice to see some kind of other data for these types of products because, at least in the PivotBio team's trials, they did seem to work. So it's, you know, important for us to figure out, like, how all of these biotechnological solutions are working, how well they're working, and what kind of situations they're best for. Okay, one kind of off-the-wall solution is just to engineer the plants to self-fertilize by fixing their own nitrogen. So instead of figuring out how to get them to associate with bacteria more tightly to, like, form root nodules or how to get the free-living bacteria to fix more nitrogen, maybe just engineer the plant to produce nitrogen itself. Now that sounds like a good idea, except these nitrogen fixation pathways, the enzymes that fix nitrogen, are very complicated. Here are two examples of gene clusters from bacteria that encode for nitrogen-fixing enzymes, and each of these little arrows is a gene, and you can see that there are lots of them involved in this process, and so figuring out which ones you need to move into a plant in order to get the plant to fix nitrogen is not easy. People have taken some first steps at this and have been able to get some nitrogen-fixing enzyme components into plant cells and verify that they are functional. They've not yet gotten full nitrogen fixing to happen in plant cells. I think this is actually in yeast, so in eukaryotic cells, but they're on their way, and that's really exciting because it would be great to just have the plants fix nitrogen, and that could solve a lot of those nitrogen runoff problems too. If the plant is just making what it needs in terms of nitrogen to grow, then you would worry a lot less about there being too much in the field, and then that nitrogen getting into other ecosystems and disrupting them, so kind of cool. All right, so that was your crash course introduction to plant biotechnology and some sort of human nutrition. I want you", "start_char_idx": 4044, "end_char_idx": 8249, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5dc6b10a-20b2-4e5b-9677-f76ed0feb21c": {"__data__": {"id_": "5dc6b10a-20b2-4e5b-9677-f76ed0feb21c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1ed3d51f-981e-4705-a19c-a6b6595a682e", "node_type": null, "metadata": {}, "hash": "462c4b3570e5c5bca4dc91914eaaa3a9c168e047c1f4bbf015f7db9dbc035199"}, "2": {"node_id": "c83e851d-ffe1-4ce4-93a9-2800ed0984c2", "node_type": null, "metadata": {}, "hash": "c6195021f32ebf1b72262e614ef0a8954238fb244f97e216396d3ba6af5f3eb5"}}, "hash": "d5fa17af02f07e3d97da429fe91ad9379129441a65f5308a1be48700f9010b4a", "text": "your crash course introduction to plant biotechnology and some sort of human nutrition. I want you to think about where the protein in your diet comes from. Can you access information about what the amino acid composition of the foods you really like to eat might look like, and can you tell, are you getting enough of the essential amino acids that your body needs to survive? I encourage you to kind of think closely about your diet and what you might change if you find that you're not getting the right amino acids for optimum performance. Do you view the invention of synthetic fertilizer as good or bad? We talked about some pretty significant benefits and some pretty significant drawbacks to this type of invention. I'd like to know what you think about it, and then what role did semi-dwarf plants play in the green revolution or in this massive increase in food production that happened in the mid-1900s, and then which biotechnological method of reducing synthetic fertilizer use are you most excited about? We talked about three different ones today. Maybe you're more excited about one than another, or maybe you have your own idea of how we can solve these synthetic fertilizer problems. Okay, see you in the next lecture.", "start_char_idx": 8211, "end_char_idx": 9447, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "abaee270-e759-4ad1-90b0-23817060b571": {"__data__": {"id_": "abaee270-e759-4ad1-90b0-23817060b571", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "99740c43-5487-407e-b6af-7bc8db6b74ef", "node_type": null, "metadata": {}, "hash": "e82df2d04d2d90aed3d6662b58a9b5ef23af66a8f68fc492d910537fe0b4e71c"}, "3": {"node_id": "95038553-3f67-4a30-81a2-ddf557b1cce8", "node_type": null, "metadata": {}, "hash": "db343a4d93aeb8ad680c595d963a0cc722b35d09cf8bb8a4305a5d83fb76e047"}}, "hash": "6de41d56a13479e9846ce854d93426f8c6fdaec18328482fa27ab809b0d647be", "text": "Okay, now we're going to talk about next generation genetically modified organisms, and specifically this lecture is still about food. What is bioengineered food? In 2021, the US FDA started to require a bioengineering label on specific food products. That label might look something like this, where there's a circle and it says derived from bioengineering or bioengineered. There might also be something small on the back of your food products, maybe right next to the nutrition facts could be a small statement that says something like contains a bioengineered food ingredient. Now if you see these things on food in the grocery store, and I encourage you to check the next time you're there, or maybe to look in your own pantry and see do you have foods that are derived from bioengineering, I want you to think, what does that mean? Do you know what that means? According to the US FDA, a food that contains genetic material that has been modified through in vitro recombinant DNA techniques, and for which the modification could not otherwise be obtained through conventional breeding or found in nature is a bioengineered food. Now that's kind of a mouthful and so in this lecture we're going to break down what that means. We're going to talk about all the different ways that food crops can be improved and what counts as bioengineering, at least according to the US FDA. Okay, so here's sort of the overview. Crops are genetically modified in many different ways, and we're going to go through each of them and talk about sort of the benefits, disadvantages, and regulation related to each one. So the first crop improvement strategy that we're going to talk about is traditional breeding. This is crossing plants and then selecting offspring with desired traits. So if you have one plant that produces a lot of seeds and another that produces really big seeds, you might cross them together in order to get a plant that has a lot of really big seeds. This type of breeding approach is something that humans have been using for thousands of years. They've been observing crops with desirable phenotypes and crossing them together. And when they do this, you can affect just a few genes within the plant genome or you can change entire genomes, right? You're remixing the genetic material of the plants as you cross them together. There's no safety testing required for this type of crop improvement, and there's no regulations. You know, in this week, we've been talking about directed evolution, domestication, or the traditional breeding of crops to improve them is essentially a very long directed evolution experiment. And through this type of approach, people have really changed the crops that we know and love today. These are ancestors of watermelons. You can see how much of the inside of the watermelon is actually rind and how much of it is just devoted to seeds. And humans in time have selected over and over again for watermelons with more of that sweet pink flesh and fewer and fewer seeds and rinds to get the varieties that we have today. Same type of thing has happened for bananas. Here's a wild ancestor of banana, again, it's just chock full of seeds. And then maize, the wild ancestor of maize is actually something called teosinte, which has, you know, much smaller and harder seeds than the maize that we grow as sweet corn today. So this cool kind of very long directed evolution experiment is still something that we use today in order to try to improve crop varieties. There are advanced methods for breeding today that allow you to kind of genotype plants when they are small, either as seeds or seedlings in order to figure out if they maybe have the mutations from each parent that you're interested in. We sort of figured out for some traits, which genes are important for them, and then can direct breeding through genetics instead of waiting for the whole plant to grow up. But the point really is that you can just cross plants together and get improved varieties over time. Another strategy is mutagenesis, another way to get a new crop variety or to change it. And in mutagenesis, you expose seeds to chemicals or radiation in order to make DNA damages in order to acquire random changes in the genome. Chemicals and radiation can damage DNA and then as your cells or the cells of the plant try to repair those breaks in DNA,", "start_char_idx": 0, "end_char_idx": 4371, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "95038553-3f67-4a30-81a2-ddf557b1cce8": {"__data__": {"id_": "95038553-3f67-4a30-81a2-ddf557b1cce8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "99740c43-5487-407e-b6af-7bc8db6b74ef", "node_type": null, "metadata": {}, "hash": "e82df2d04d2d90aed3d6662b58a9b5ef23af66a8f68fc492d910537fe0b4e71c"}, "2": {"node_id": "abaee270-e759-4ad1-90b0-23817060b571", "node_type": null, "metadata": {}, "hash": "6de41d56a13479e9846ce854d93426f8c6fdaec18328482fa27ab809b0d647be"}, "3": {"node_id": "1ab70d1d-ffd6-4cfb-9446-18ba41361e1c", "node_type": null, "metadata": {}, "hash": "fca63dba8b231b7dcde622a7540985930b8b2afa7331304f8c6d8255b7487446"}}, "hash": "db343a4d93aeb8ad680c595d963a0cc722b35d09cf8bb8a4305a5d83fb76e047", "text": "DNA and then as your cells or the cells of the plant try to repair those breaks in DNA, they may not repair them perfectly and you get changes in the genome. When you apply chemical or radiation mutagenesis, you usually affect hundreds to thousands of genes all at the same time. It's really difficult to just dial in the amount of radiation in order to get a single mutation in the backbone or in the genome of your plant. And often actually that's not that helpful because this is a random mutagenesis method. It would take a really long time if you were to apply low doses of radiation that change one DNA base at a time. Instead you want to change a bunch of things all at the same time to increase the likelihood that you change a phenotype that you care about. So ruby grapefruits are actually an example of plants that have been developed using chemical mutagenesis. Maybe it was chemical, maybe it was radiation mutagenesis. It doesn't matter. Basically farmers realized through one plant growing in a field that grapefruits were able to produce this ruby color. There was one plant that acquired a mutation just serendipitously and it made ruby red fruits. And the farmers who saw this thought that that would be a really valuable trait, that would make them stand apart from other grapefruit sellers in the market. And so they started applying mutagens to their grapefruit seeds in order to try to get more plants that also had this ruby phenotype. And so they were successful. There are actually several different varieties of grapefruit that now all have this kind of really sweet and beautiful ruby red color. This type of mutagenesis does not require safety testing and there's no regulation on it. So you may be eating lots of plants who have been developed using a mutagenesis strategy. There is a strategy called RNA interference. This is a method for turning off specific genes. The way it works is that you transform your plants. You introduce small RNAs into the plants that then bind to a gene of interest, to the RNA of the gene of interest, and then target that RNA for degradation. So double-stranded RNA inside of a plant cell is very unstable and often gets degraded really quickly. So if you introduce small RNAs that match a messenger RNA, then you can get it degraded. The example that I'm showing here is of a small RNA that targets virus RNA, so that the plant cells are protected from a viral pathogen. That's actually because papaya were engineered to be resistant to a ring spot virus using this method. Almost all of the papaya that you eat is of the genetically modified variety. They are producing a small RNA that targets this ring spot virus and prevents it from making the whole plant sick. When you introduce RNAs like this into the plant genome, you can affect one to tens of genes all at the same time. These short RNAs are short enough that it's possible that they would target several different genes in the plant genome, although often they are quite specific. There is safety testing required for this type of thing, and it's highly regulated, so this would count as a bioengineered food because there is no way of naturally getting these short RNAs into plant cells, so they would count as a recombinant DNA technology. There's straight-up transgenics. This is where you insert selected genes into the genome that are not RNAs. These small RNAs are one class of transgenic plants. We separated them out just to be able to talk about the papaya ring spot virus example, but in practice, these two things are quite similar. The most famous examples of genetically modified plants being made with a recombinant DNA method are the Roundup Ready or herbicide-tolerant plants that have a single herbicide-resistant gene overexpressed, and that makes the transgenic plants resistant to the herbicide, so you can spray this herbicide all over the field and your transgenic or genetically modified plants will still grow, but weeds and other things that you don't want to be growing won't. The other really famous examples are like Bt cotton and Bt corn. Bt stands for Bacillus thuringiensis. It's actually a type of soil bacterium that usually produces a small toxin that is only toxic to a larval stage of insect or like a wormy type of insect, and", "start_char_idx": 4303, "end_char_idx": 8592, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "1ab70d1d-ffd6-4cfb-9446-18ba41361e1c": {"__data__": {"id_": "1ab70d1d-ffd6-4cfb-9446-18ba41361e1c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "99740c43-5487-407e-b6af-7bc8db6b74ef", "node_type": null, "metadata": {}, "hash": "e82df2d04d2d90aed3d6662b58a9b5ef23af66a8f68fc492d910537fe0b4e71c"}, "2": {"node_id": "95038553-3f67-4a30-81a2-ddf557b1cce8", "node_type": null, "metadata": {}, "hash": "db343a4d93aeb8ad680c595d963a0cc722b35d09cf8bb8a4305a5d83fb76e047"}, "3": {"node_id": "f5587619-42ba-4ab9-8349-b4bffcc1a52d", "node_type": null, "metadata": {}, "hash": "71fef0c212d4d95381e8e2a5cc6cf9aa6f099fa993ad8318c6c6c14e3c657539"}}, "hash": "fca63dba8b231b7dcde622a7540985930b8b2afa7331304f8c6d8255b7487446", "text": "to a larval stage of insect or like a wormy type of insect, and when you put the gene encoding this toxin into the plant genome, then the plants can produce this short peptide that kills like these cotton bollworms or other types of pests and protects the plant essentially from these predators, and so these are nice because then you don't have to spray the plants with any type of pesticide. Instead, the plant is producing a little bit of this soil bacteria's genes to prevent predation from pests. Okay, so this usually affects less than 10 genes, but it does require safety testing and is highly regulated because the US FDA again terms this type of modification of plants as a genetically modified organism. Okay, the last crop improvement strategy is gene editing. You can use proteins like CRISPR-Cas proteins in order to make really targeted deletions from the genome. The way CRISPR works is it's essentially a protein that likes to cut DNA that is targeted to specific DNA sequences using a short guide RNA, and when that guide RNA finds a region of the genome that it matches, then the Cas protein, Cas9 in this case, sits down and cuts the DNA there. After a cut is made, the cell usually tries to repair the DNA but will make deletions in trying to repair it. So this all is an example in tomato where the authors were trying to increase the amount of vitamin D that the tomato produced by deleting an enzyme in a biosynthetic pathway. Then in this case, they're deleting this DR2 enzyme, and by deleting this part of the pathway, they can increase flux through the pathway towards vitamin D. So interestingly, this type of deletion, even though it's highly designed, you do transform in or you deliver in this Cas9 protein and these guide RNAs, because you're only deleting portions of the genome, this is not regulated, at least in the United States. So there's no safety testing required and there's no regulation of it here. In Europe, it's a different story. This type of modification would still count as a genetically modified organism, and there these would all be prohibited from sale. So sort of interesting, there is a spectrum of methods by which you can modify plants, and those methods are all regulated somewhat differently. Now how do you get DNA into plants? This is a question that I would have had if I were in your shoes, like, okay, that sounds interesting, but like, how do you actually get DNA into plants? The answer to this question actually lies at the center of this crown gall tumor. Inside of this kind of weird plant tumor is actually a little bacterium. It's a bacteria called Agrobacterium tumifacens, and this bacteria is kind of amazing. It actually takes a portion of its genome and pumps it into the plant cells. So this kind of red region down here, excuse me, gets copied and then moved into the plant cell. The bacteria actually makes this little protein-like needle to poke a plant cell, and then through the middle of this needle, they pump in DNA and they pump in some proteins. These proteins help shuttle the DNA into the nucleus, and then once the DNA from the bacteria gets into the nucleus, it actually integrates itself into the plant's genome. Now Agrobacterium usually delivers instructions to the plant cell to deprogram it. So it will tell it, okay, stop being a, like a bark cell, for example, stop being a, you know, vascular cell inside of the middle of a plant stem. Instead, you should just turn into a sugar factory, make me a lot of sugar. And the plant cell doesn't necessarily know that this DNA came from a bacterium, and so it will start expressing the genes encoded on that DNA, and it will turn itself into a sugar factory that replicates over and over and over again and forms this big kind of tumor-like structure. So in the middle here, you can see all of these like very clever, very happy bacteria eating lots of plant sugars. Okay, but you can actually use Agrobacterium to deliver DNA into plant cells in order to make transgenic plants. So we can take that little", "start_char_idx": 8612, "end_char_idx": 12662, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f5587619-42ba-4ab9-8349-b4bffcc1a52d": {"__data__": {"id_": "f5587619-42ba-4ab9-8349-b4bffcc1a52d", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "99740c43-5487-407e-b6af-7bc8db6b74ef", "node_type": null, "metadata": {}, "hash": "e82df2d04d2d90aed3d6662b58a9b5ef23af66a8f68fc492d910537fe0b4e71c"}, "2": {"node_id": "1ab70d1d-ffd6-4cfb-9446-18ba41361e1c", "node_type": null, "metadata": {}, "hash": "fca63dba8b231b7dcde622a7540985930b8b2afa7331304f8c6d8255b7487446"}}, "hash": "71fef0c212d4d95381e8e2a5cc6cf9aa6f099fa993ad8318c6c6c14e3c657539", "text": "DNA into plant cells in order to make transgenic plants. So we can take that little segment of DNA that usually gets transferred, and we can recode it. We can actually remove the genes that tell the plant to become a little sugar producing factory, and we can put in instructions for other things like produce a fluorescent protein or, you know, produce a BT toxin, something like that. One of the easiest ways to actually get transgenic plants is to take the plants and then dip the flowers into a solution of Agrobacterium. In this solution of Agrobacterium, the bacteria will donate DNA or conjugate DNA into the egg cells within the flower. Those egg cells will then get fertilized by pollen and become seeds, develop into seeds, and some of those seeds will then be transgenic. They'll then carry the what's called tDNA or transferred DNA that was given to it by the bacteria. So here's just examples of what the seeds of this plant, which is Arabidopsis thaliana, look like under white light. And then you can see we delivered into them this red fluorescent protein, and the seeds then glow when they have that red fluorescent protein. OK, but floral dip, this method does not work on all plants. Arabidopsis thaliana, this model plant, makes tens of thousands of seeds. Within just like a single pot of plants. But something like tomato makes maybe hundreds of seeds, maybe less per plant. And so if you're not able to deliver DNA efficiently into each egg cell, then the likelihood you would get transformed seeds is pretty low. There's also issues with just like the shape of the flower and the access that the bacteria have to the egg cells within the flower. And so it seems to not work in every plant variety. So what do you do? How do you make a transgenic tomato if you can't just dip the tomato flowers into a solution of bacteria? Well, you can take advantage of the fact that plant cells can usually de-differentiate into what's called callus. So here's a little piece of a leaf that has been treated with hormones that cause some of the leaf cells to de-differentiate into callus. So this callus are basically like undifferentiated plant cells. You can think of them sort of like plant stem cells, which you can then treat with a different series of hormones to get this callus to re-differentiate into leaves and then re-differentiate or produce roots. And so you can go from callus undifferentiated cells into whole plants. Now, why is that useful? Well, you can take callus and you can incubate it with agrobacterium and agrobacterium will again conjugate DNA into the plant cells that it comes into contact with. Then you can take that callus and you can put it onto selective plates. So here, if the agrobacterium is delivering DNA that encodes for your genes of interest, maybe your fluorescent proteins, maybe something else, it may also encode for an herbicide resistance gene or another selectable marker. And you can put the callus onto plates that contain the herbicide and only the ones that are transgenic, only the calli that have received DNA from agrobacterium will continue to grow. Everything else will turn sort of black and die. But those ones that grew, you know that they contain DNA from the agrobacterium. You can then take that callus and you can put it onto new media plates, onto other plant hormones to start to get shoots and then roots to form and you can actually regenerate a whole plant. So that's the process by which people make transgenic plants. You can, instead of using agrobacterium, use something called a gene gun to inject little gold particles that are covered in DNA into the cells of the plant and then do the same type of selection and regeneration methods. It's not as popular because these gene guns are quite expensive.", "start_char_idx": 12629, "end_char_idx": 16416, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "47c59203-6b25-4890-b2fa-75cada4a5c62": {"__data__": {"id_": "47c59203-6b25-4890-b2fa-75cada4a5c62", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e11470ea-6fff-4c68-872d-22efa4ba7278", "node_type": null, "metadata": {}, "hash": "c508df1558feb1cbf3d5b70c627e5960fc2a325c9bec67c7997e54954dc4a0e4"}, "3": {"node_id": "5f6edfe4-dc85-4641-80a5-516d5c2af3fe", "node_type": null, "metadata": {}, "hash": "d5320aa59c7fa2b91eb21894b1ceb493c4c2fe2156d25740855dcabfccc5c629"}}, "hash": "66559baf84b01057dd629e815886c854037a53e1999028c1be89ec319864fc87", "text": "and usually you end up with many, many copies of your transgenes inside each plant cell. And so people don't like that because you have a little bit less control using a gene gun than you do with the agrobacterium. You can also deliver DNA into plants using carbon nanotubes. So there's like a little tiny tube of carbon that you can attach DNA onto and then deliver into plant cells just using very little amount of force. You can get these things to permeate plant cells and then the cells will express fluorescent protein. So here's a GFP in four different plant varieties after having it delivered with these little carbon nanotubes. So that's kind of fun and exciting. One of my favorite methods for producing transgenic plants is really new. I would say it's not all that widely used yet but it's an exciting idea that you might be able to get plant transformation without having to go through this regeneration step because it's actually at this step where the transformation of many plants fails. You may be able to get callus that's resistant showing that you got your DNA into the plant cells but you might not be able to get new shoots or roots to form because you don't have exactly the right conditions. And then you can never make these transgenic plants. So if you can avoid that regeneration step then you might be able to make transgenic plants of different varieties or the very least you wouldn't require so much specialized equipment to put the callus into exactly the right conditions in order to get the transgenic plants you want. Okay, so sorry, this is a picture of a plant's meristem. This is the portion of the plant that is actively growing. It is the part of it that will produce flowers and seeds. If you are to cut it off the plant would determine a different location to have a new meristem grow. It will basically not like that you have cut it off and it will try again. If you prune things, this is often what you're doing. You're cutting off this meristem. Now there were some authors, some scientists at the University of Minnesota who figured out that if you cut off the meristem then deliver a agrobacterium like which conjugates DNA into the cells along with a couple of developmental regulators some proteins that stimulate meristem development. You can actually get a new meristem to form that contains your edited genomic DNA. So here the authors were trying to, they delivered DNA encoding Cas9 that CRISPR-Cas system targeting phytoene desaturase which is an enzyme that's important for chlorophyll development. And if you knock it out, you get these really white plants. And so what they showed is that, yeah you can cut off the meristem and then new shoots will form that are edited and you can collect seeds from them and those seeds will be edited and you can make new modified plants without having to go through the tissue culture. So I thought this was really fun and I wanted to share with you how that was done. But where is all of this leading? I promised you that we would talk about the next generation of bioengineered or GMO plants. And what I think is that these plants will have more precise control over gene expression for more nuanced phenotypes. So the first generation of GMO plants had single genes expressed through the entire plant. So this might be that BT gene expressed in every cell within the plant in order to make the entire plant resistant to the insects that were trying to eat it or it might be the herbicide resistance gene expressed in every cell within the plant in order to get the whole plant resistant to that herbicide. And that's great for features like pest resistance or herbicide tolerance. But I think the next generation of plants is going to have genetic programs introduced to them to control gene expression in very specific cell types at very specific times in development. And I think that people are going to be doing this in order to make stress resilient crop varieties. The new challenge is really to see if we can grow crops in increasingly hostile climates and being able to tune the activity or change the activity of specific parts of the plant can be really important for that. You don't need the whole plant to start like, okay. So if there's drought, for example, you might want the root system to elongate to start getting deeper. And that might allow it to reach water in layers of soil that", "start_char_idx": 0, "end_char_idx": 4400, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5f6edfe4-dc85-4641-80a5-516d5c2af3fe": {"__data__": {"id_": "5f6edfe4-dc85-4641-80a5-516d5c2af3fe", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e11470ea-6fff-4c68-872d-22efa4ba7278", "node_type": null, "metadata": {}, "hash": "c508df1558feb1cbf3d5b70c627e5960fc2a325c9bec67c7997e54954dc4a0e4"}, "2": {"node_id": "47c59203-6b25-4890-b2fa-75cada4a5c62", "node_type": null, "metadata": {}, "hash": "66559baf84b01057dd629e815886c854037a53e1999028c1be89ec319864fc87"}}, "hash": "d5320aa59c7fa2b91eb21894b1ceb493c4c2fe2156d25740855dcabfccc5c629", "text": "start getting deeper. And that might allow it to reach water in layers of soil that have not yet dried out. But you want that only to happen in the root systems. The plant is devoting resources to its root system to get it to elongate. If you have that elongation program running, for example, in the above ground portion of the plant too, now you have two things that are fighting each other, right? The shoot system's trying to grow and the root system is trying to grow and maybe there won't be enough resources for both to be able to do that. And you'll never reach the water in those deeper layers of soil during the drought. So it would be great to be able to control gene expression in specific portions of the plant to really do some kind of fine tuning of plant resilience. And we're starting to get the capacity to be able to do this. This is an example from my lab, just showing you how precise control over spatial patterns of gene expression across a plant can be important for engineering specific features of a plant. So what you're looking at are three different Arabidopsis plants. Arabidopsis is our model system. It's a really small and easy to work with plant and it's easy to transform. A wild type or unmodified Arabidopsis has a long primary root that grows down in the direction of gravity. All these root branches that also grow down in the direction of gravity. And if you were to zoom in on this root system, you'd see that it's covered in these tiny root hairs, which are really important for water and nutrient acquisition. Now, if you express a mutant developmental regulator from a promoter that's active in lots of different cell types throughout the plant, you can change the development of the plant pretty severely. So this engineered plant has no lateral roots. It also has a shorter primary root. That primary root has a hard time sensing gravity, which you can tell because it no longer grows straight down. It doesn't have any root hairs and it's got several structural changes in the shoot as well. And one of the reasons that there are all these different impacts is because this gene is expressed in all these different tissues throughout the plant. Now, if we take this same gene and we only express it in one cell type in these what's called xylem pole paracycle cells, these specific cell types within the plant root system, then we can make a targeted change in the plant's structure. So here the plant does not produce any lateral roots, but it's otherwise identical to the wild type plant. So with this precise control over gene expression, we can make a precise change in the structure of the plant. We can actually take it one step farther than that and tune the number of root branches that the plants make. So with different synthetic genetic systems, with different gene expression levels, essentially in a tissue specific manner, we can control the density of root branches. And now we're wondering, okay, can we tune root structure for optimal growth in a specific environment? So we're not the only people by any stretch who work on this type of precise plant genetic engineering, and we're excited to see where it goes. After this lesson, I'd like you to think about the USDA, or sorry, the FDA's definition of a bioengineered plant or a genetically modified organism. Do you think that they're drawing the line in the right place? Do you think it makes sense to have regulation that's based on the process by which you have developed an improved crop variety? Or is there some other metric that you would prefer to see labels on or about on your food in the grocery store? Do you look for GMO or non-GMO labels when purchasing food? Why or why not? Did anything surprise you about the way transgenic plants are created? And then would you feel differently about GMO plants created to withstand climate change versus those engineered to produce pesticide? Or are those both the same to you? Is a GMO always a GMO or does it matter kind of what the purpose was for producing that plant? I would love to know what you think of these GMOs. And if you feel like sharing your answer to these questions with me, I'd love to get an email from you. Hope you enjoy the rest of the week. Bye.", "start_char_idx": 4317, "end_char_idx": 8556, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "91d01f93-9e3d-4bf9-9bd2-cb31118d4f79": {"__data__": {"id_": "91d01f93-9e3d-4bf9-9bd2-cb31118d4f79", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "37e0d9be-2edc-412b-b35f-ad6724c9cc3d", "node_type": null, "metadata": {}, "hash": "c508df1558feb1cbf3d5b70c627e5960fc2a325c9bec67c7997e54954dc4a0e4"}, "3": {"node_id": "5f0c7dee-04c8-4045-b7b5-2ed35278a8a3", "node_type": null, "metadata": {}, "hash": "d5320aa59c7fa2b91eb21894b1ceb493c4c2fe2156d25740855dcabfccc5c629"}}, "hash": "66559baf84b01057dd629e815886c854037a53e1999028c1be89ec319864fc87", "text": "and usually you end up with many, many copies of your transgenes inside each plant cell. And so people don't like that because you have a little bit less control using a gene gun than you do with the agrobacterium. You can also deliver DNA into plants using carbon nanotubes. So there's like a little tiny tube of carbon that you can attach DNA onto and then deliver into plant cells just using very little amount of force. You can get these things to permeate plant cells and then the cells will express fluorescent protein. So here's a GFP in four different plant varieties after having it delivered with these little carbon nanotubes. So that's kind of fun and exciting. One of my favorite methods for producing transgenic plants is really new. I would say it's not all that widely used yet but it's an exciting idea that you might be able to get plant transformation without having to go through this regeneration step because it's actually at this step where the transformation of many plants fails. You may be able to get callus that's resistant showing that you got your DNA into the plant cells but you might not be able to get new shoots or roots to form because you don't have exactly the right conditions. And then you can never make these transgenic plants. So if you can avoid that regeneration step then you might be able to make transgenic plants of different varieties or the very least you wouldn't require so much specialized equipment to put the callus into exactly the right conditions in order to get the transgenic plants you want. Okay, so sorry, this is a picture of a plant's meristem. This is the portion of the plant that is actively growing. It is the part of it that will produce flowers and seeds. If you are to cut it off the plant would determine a different location to have a new meristem grow. It will basically not like that you have cut it off and it will try again. If you prune things, this is often what you're doing. You're cutting off this meristem. Now there were some authors, some scientists at the University of Minnesota who figured out that if you cut off the meristem then deliver a agrobacterium like which conjugates DNA into the cells along with a couple of developmental regulators some proteins that stimulate meristem development. You can actually get a new meristem to form that contains your edited genomic DNA. So here the authors were trying to, they delivered DNA encoding Cas9 that CRISPR-Cas system targeting phytoene desaturase which is an enzyme that's important for chlorophyll development. And if you knock it out, you get these really white plants. And so what they showed is that, yeah you can cut off the meristem and then new shoots will form that are edited and you can collect seeds from them and those seeds will be edited and you can make new modified plants without having to go through the tissue culture. So I thought this was really fun and I wanted to share with you how that was done. But where is all of this leading? I promised you that we would talk about the next generation of bioengineered or GMO plants. And what I think is that these plants will have more precise control over gene expression for more nuanced phenotypes. So the first generation of GMO plants had single genes expressed through the entire plant. So this might be that BT gene expressed in every cell within the plant in order to make the entire plant resistant to the insects that were trying to eat it or it might be the herbicide resistance gene expressed in every cell within the plant in order to get the whole plant resistant to that herbicide. And that's great for features like pest resistance or herbicide tolerance. But I think the next generation of plants is going to have genetic programs introduced to them to control gene expression in very specific cell types at very specific times in development. And I think that people are going to be doing this in order to make stress resilient crop varieties. The new challenge is really to see if we can grow crops in increasingly hostile climates and being able to tune the activity or change the activity of specific parts of the plant can be really important for that. You don't need the whole plant to start like, okay. So if there's drought, for example, you might want the root system to elongate to start getting deeper. And that might allow it to reach water in layers of soil that", "start_char_idx": 0, "end_char_idx": 4400, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5f0c7dee-04c8-4045-b7b5-2ed35278a8a3": {"__data__": {"id_": "5f0c7dee-04c8-4045-b7b5-2ed35278a8a3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "37e0d9be-2edc-412b-b35f-ad6724c9cc3d", "node_type": null, "metadata": {}, "hash": "c508df1558feb1cbf3d5b70c627e5960fc2a325c9bec67c7997e54954dc4a0e4"}, "2": {"node_id": "91d01f93-9e3d-4bf9-9bd2-cb31118d4f79", "node_type": null, "metadata": {}, "hash": "66559baf84b01057dd629e815886c854037a53e1999028c1be89ec319864fc87"}}, "hash": "d5320aa59c7fa2b91eb21894b1ceb493c4c2fe2156d25740855dcabfccc5c629", "text": "start getting deeper. And that might allow it to reach water in layers of soil that have not yet dried out. But you want that only to happen in the root systems. The plant is devoting resources to its root system to get it to elongate. If you have that elongation program running, for example, in the above ground portion of the plant too, now you have two things that are fighting each other, right? The shoot system's trying to grow and the root system is trying to grow and maybe there won't be enough resources for both to be able to do that. And you'll never reach the water in those deeper layers of soil during the drought. So it would be great to be able to control gene expression in specific portions of the plant to really do some kind of fine tuning of plant resilience. And we're starting to get the capacity to be able to do this. This is an example from my lab, just showing you how precise control over spatial patterns of gene expression across a plant can be important for engineering specific features of a plant. So what you're looking at are three different Arabidopsis plants. Arabidopsis is our model system. It's a really small and easy to work with plant and it's easy to transform. A wild type or unmodified Arabidopsis has a long primary root that grows down in the direction of gravity. All these root branches that also grow down in the direction of gravity. And if you were to zoom in on this root system, you'd see that it's covered in these tiny root hairs, which are really important for water and nutrient acquisition. Now, if you express a mutant developmental regulator from a promoter that's active in lots of different cell types throughout the plant, you can change the development of the plant pretty severely. So this engineered plant has no lateral roots. It also has a shorter primary root. That primary root has a hard time sensing gravity, which you can tell because it no longer grows straight down. It doesn't have any root hairs and it's got several structural changes in the shoot as well. And one of the reasons that there are all these different impacts is because this gene is expressed in all these different tissues throughout the plant. Now, if we take this same gene and we only express it in one cell type in these what's called xylem pole paracycle cells, these specific cell types within the plant root system, then we can make a targeted change in the plant's structure. So here the plant does not produce any lateral roots, but it's otherwise identical to the wild type plant. So with this precise control over gene expression, we can make a precise change in the structure of the plant. We can actually take it one step farther than that and tune the number of root branches that the plants make. So with different synthetic genetic systems, with different gene expression levels, essentially in a tissue specific manner, we can control the density of root branches. And now we're wondering, okay, can we tune root structure for optimal growth in a specific environment? So we're not the only people by any stretch who work on this type of precise plant genetic engineering, and we're excited to see where it goes. After this lesson, I'd like you to think about the USDA, or sorry, the FDA's definition of a bioengineered plant or a genetically modified organism. Do you think that they're drawing the line in the right place? Do you think it makes sense to have regulation that's based on the process by which you have developed an improved crop variety? Or is there some other metric that you would prefer to see labels on or about on your food in the grocery store? Do you look for GMO or non-GMO labels when purchasing food? Why or why not? Did anything surprise you about the way transgenic plants are created? And then would you feel differently about GMO plants created to withstand climate change versus those engineered to produce pesticide? Or are those both the same to you? Is a GMO always a GMO or does it matter kind of what the purpose was for producing that plant? I would love to know what you think of these GMOs. And if you feel like sharing your answer to these questions with me, I'd love to get an email from you. Hope you enjoy the rest of the week. Bye.", "start_char_idx": 4317, "end_char_idx": 8556, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e1568e93-ce08-4b5b-b176-0098d8b620d2": {"__data__": {"id_": "e1568e93-ce08-4b5b-b176-0098d8b620d2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "87a13fee-c559-408f-9ff7-ab37ea9e2517", "node_type": null, "metadata": {}, "hash": "6ffb667aea7988efd9d60e5ee6ea012b97fcc9107a2ebf8f37d4ec5251ea7b67"}, "3": {"node_id": "24d4a904-90a7-48e3-99bb-cfce73c337d2", "node_type": null, "metadata": {}, "hash": "5d83b646d9b7b5d3b342d790a0fe8897922651c80e695247050841b3c4ce8317"}}, "hash": "370c2a18c00fc2a3c66aaa216199c1b70a9935aec456f1db468b5ddded8b68d2", "text": "We're going to talk about tools for seeing biology. This will set us up to think about biodiversity and other things, but this is really just about tools for seeing biology. So let's get into it. Earlier in class, we talked about living matter and what makes it unique from a bioengineer's perspective. I want to focus on the last thing that we introduced, and it has to do with tools and tools of our time, 21st century tools. And when we think about seeing, seeing is a tool related to measurement or observing. So we're going to highlight that and really think about what we're doing in terms of observing or seeing or measuring biology. Earlier we saw an example, incredible video from Grant Jensen's laboratory at Caltech in Pasadena, California, using an electron microscope to create a representation to see what's going on in a bacterial cell. This is one of my favorite examples because this bacteria, if you remember, actually grows magnets or magnetic crystals in an array that helps the bacteria react to magnetic fields. So it's a magnetotactic bacteria. And so somehow we go from this microscopic organism to a fancy computer graphic that lets us see what's happening in the biology. And of course, if you're thinking about being an engineer, imagine being an engineer with a system where you can't see anything. You could do it, but it'd be tricky, be much easier to be an engineer if you can see what's going on. So that's why we care about seeing and observing and tools that let us see. Now, so far, it might not make any sense at all how these sorts of images are generated. So we're going to dig into that. The technique has a fancy name, electrocryotomography, which is basically cold temperature electron microscopy with a tilting sample tomography. So cold temperature, that's cryo, electro, electron microscopy, tomography, tilting sample. And if you go down to Pasadena, they're happy to welcome you at Caltech to their CryoEM facility, cold temperature electron microscopy facility. And within that facility, according to their website, you see an instrument that looks like this, looks complicated, looks big, looks expensive. You know, these instruments, these CryoEM machines fill up a room. They cost a million bucks, maybe 10 million bucks for one microscope, $10 million, $7 million. Whoa. How do they work? We're going to observe a sample using an electron microscope. We'll explain that in a little bit. And the sample is going to have to be in a vacuum. So the electrons in the electron microscope get right to the sample. Now if I put something in a vacuum and it's alive, like how would you do if you were in outer space? If you were like in a spaceship, you're like, I'm out of here. And you didn't have a space suit on, you just like went out of the spaceship and you're in the vacuum. My guess is you already know that you wouldn't do well, but why is that? Well, if in outer space, the pressure is low, there's a vacuum. Think about what happens to water when you put water in a vacuum, you lower the boiling temperature of water. The water will start to boil at lower and lower temperatures, the lower the vacuum. In space, of course, water is just going to boil off. If you're alive, living things have water inside them. So if an electron microscope, the sample's in a vacuum, that it's like, how are you going to do in outer space? You're going to, you're going to like, are you going to explode? No, not really. You're going to burst though. And so you don't want that to happen because you can't really see what the thing looks like if it blows up, if it bursts, right? The thing that's full of water in a vacuum, quote, explodes or burst. To solve that problem, one approach is to freeze it, right? And so you could freeze the living sample quickly to fix the water so that the water can't evaporate into the vacuum. It will eventually, but not in the same way. And so the way this works is to use something really", "start_char_idx": 0, "end_char_idx": 3962, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "24d4a904-90a7-48e3-99bb-cfce73c337d2": {"__data__": {"id_": "24d4a904-90a7-48e3-99bb-cfce73c337d2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "87a13fee-c559-408f-9ff7-ab37ea9e2517", "node_type": null, "metadata": {}, "hash": "6ffb667aea7988efd9d60e5ee6ea012b97fcc9107a2ebf8f37d4ec5251ea7b67"}, "2": {"node_id": "e1568e93-ce08-4b5b-b176-0098d8b620d2", "node_type": null, "metadata": {}, "hash": "370c2a18c00fc2a3c66aaa216199c1b70a9935aec456f1db468b5ddded8b68d2"}, "3": {"node_id": "d23b5fa2-c982-4a9f-bb7f-4cca942bf869", "node_type": null, "metadata": {}, "hash": "7bfab3203cf0c61a045e5dd7142ee9a44f6ed13c5a11eb38437148399b814d72"}}, "hash": "5d83b646d9b7b5d3b342d790a0fe8897922651c80e695247050841b3c4ce8317", "text": "but not in the same way. And so the way this works is to use something really cold, something cryogenic, hence cryo electron microscopy. Cryo is any temperature below negative 153 Celsius. Well, liquid nitrogen, that's convenient. You know, if you cool down nitrogen and so it's a liquid, it's 100, negative 195 Celsius. Basically what you do oftentimes is you'll first put your sample very quickly. You know, for example, if you grow an ice crystal slowly, if you let it form slowly, you'll get big crystals. You don't want that to happen because that'll disrupt the sample too. So if you're going to freeze your living sample, you've got to go like a plunge, flash freeze. And so the first thing you do oftentimes is you don't go right into liquid nitrogen. You go into liquid ethane, which isn't quite as cold, but can absorb more heat. And so it's a faster way of cooling something down to quickly freeze it until you do a quick like plunge or dunk in the liquid ethane and then move it over to nitrogen, liquid nitrogen, then put it in. Wow, sounds complicated. But okay, so just give you a sense of like how the Jensen lab is creating these microscopic amazing images of cells. Now the next thing is we're going to tilt the sample, right? So if you're looking at something, you're like, look at your hand right now. What you're seeing is the light reflecting back off your hand. And you've got two eyes, so let's cover one eye, right? And now we're seeing the light. And your hand is a pseudo two-dimensional object, right? Even though you know your hand's a three-dimensional object, right? And so if we wanted to create an image of a three-dimensional object, but we can only see it in two dimensions, well, one thing we could do is we could move where we are with relation to the object. And it's like, oh yeah, if I look at my hand from this perspective, I get a different image, right? But in this microscope, instead of moving the microscope around, we're just going to tilt the sample, that's tomography. And by tilting the sample, we'll be able to get images from different perspectives or slices. That's what's shown here. And if we collect all of those images and keep track of them, then we can use a computer or software to infer and reconstruct what the three-dimensional object looks like. That's called tomographic reconstruction. This is used in microscopy and some types of medical imaging, right? But it gives you a sense of... So now we have this fancy word electro, cryo, tomography, cold temperature electron microscopy with a tilting sample. And we have a sense of what's going on, but let's dig in a little deeper just to make sure we have a good foundation for how seeing things relates to bioengineering. And to do this, we've got to remind ourselves like, how do we see things in the first place? Like if I'm looking at an apple, how come I can see an apple on an apple tree outside? That's because there's sunlight and the sun is emitting various forms of radiation, for example, visible light. And that light has different wavelengths. When it encounters an object, some of that light can be absorbed by the object, reflected by the object, refracted or passed through the object. And if light's, for example, reflected by an object, it can go into my eyes or your eyes, right? And in your retina, different wavelengths will be detected. So an apple, for example, will absorb visible light except for the red, and then that gets reflected and, oh, an apple's red, or it's a green apple, you know, it's reflecting the green and absorbing the rest. So radiation hits an object and can pass through and so on. So that's how we're seeing things. This radiation comes in different wavelengths. So let's think about how wavelengths determine what we observe and why we might be interested in, as bioengineers, an electron microscope in addition to a visible light microscope. So here's a really cool video that helps us understand how the wavelength of light is related to the resolution of what we can observe. Now what's resolution? It's resolving", "start_char_idx": 3902, "end_char_idx": 7979, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d23b5fa2-c982-4a9f-bb7f-4cca942bf869": {"__data__": {"id_": "d23b5fa2-c982-4a9f-bb7f-4cca942bf869", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "87a13fee-c559-408f-9ff7-ab37ea9e2517", "node_type": null, "metadata": {}, "hash": "6ffb667aea7988efd9d60e5ee6ea012b97fcc9107a2ebf8f37d4ec5251ea7b67"}, "2": {"node_id": "24d4a904-90a7-48e3-99bb-cfce73c337d2", "node_type": null, "metadata": {}, "hash": "5d83b646d9b7b5d3b342d790a0fe8897922651c80e695247050841b3c4ce8317"}, "3": {"node_id": "a55b5ead-c163-4763-8f42-e192b2cd9ec1", "node_type": null, "metadata": {}, "hash": "2b558c4cf73b0b825a6a8f87eac9e8755e4a5e6af832c1227ea96ce2e9ce29b3"}}, "hash": "7bfab3203cf0c61a045e5dd7142ee9a44f6ed13c5a11eb38437148399b814d72", "text": "to the resolution of what we can observe. Now what's resolution? It's resolving things, right? So if I'm looking at two objects, do I see them as two separate objects that I can clearly, you know, separate from one another, or, and I can't, if I can't tell them apart, then I can't resolve them, right? So like how far apart do two things need to be in order for me to see them as being two separate things? So this is a really neat video to illustrate the point. I've got an object that is just a pattern of lines and the lines are some distance apart. And right now, because we have a whole bunch of different wavelengths of visible light looking at this microscopic object, we can see the lines as being different from each other. But in this clever example, what's going to happen is we're going to use green light, right? So suddenly we're only looking at this object using green light, which has a wavelength and we can still see it, right? We go to red, it's a little bit harder to see, right? Red wavelength is a little bit longer than green, not by much, what is it, like a hundred nanometers longer in the wavelength. And because of that, it's much harder to resolve or tell apart the lines here, right? And the further out we go into the red, like suddenly we can't, it's the same object. The object's not changed. The only thing that's changed is the wavelength of light we're looking to observe the object and whether or not we can tell apart features within the object. And so as the wavelength has gotten longer, we're not able to resolve the fine details in the same way, all right? So there's this relationship between the radiation and the wavelength of the radiation and how it reacts with the object and how we observe it. And the longer the wavelength, the bigger things have to be, the farther apart things have to be for us to see them as apart. Conversely, the smaller the wavelength, the shorter the wavelength, in other words, the better resolution we're going to get. So the nice thing about wavelengths is there's plenty of wavelengths. And in bioengineering, the most relevant wavelengths right now, at least, are the visible wavelengths, which are shown here. And so if we use a light microscope, what we mean by that is visible light microscope, we'll be able to resolve objects that are a couple hundred nanometers in resolution. And here you see red is a little bit longer than green. And so that's why green in the example, cleverly set up example, was able to see the tiny distances between the lines. But we were talking earlier about an electron microscope. So different type of radiation and so a different wavelength. And what's so interesting is the wavelength on an electron microscope is going to be way down here. And if you come down to the bottom of the slide, you can see that these wavelengths, if the visible wavelengths are somewhere between, say, a virus particle and a whole cell, that means the visible wavelengths on a light microscope are going to let us see microorganisms and some of the structures inside microorganisms. But now if we jump down here, several orders of magnitude shorter wavelengths to electron microscope wavelengths, come down here, it's like, oh, those wavelengths are between the size of a molecule and the nucleus of an atom. Thus, we should be able to resolve objects and structures that are much closer together. All right. So let's look at another video of an electron microscope. Again, we'll stick with the Jensen Lab, amazing group, super inspiring researchers. And let let them walk us through how they can help us see what's happening in a living cell. All right. The first thing we're going to look at is the sample frozen in one of these fancy microscopes and it being tilted and the images being captured. So you can see the tilting, there's a bacterial cell in the middle and it's being tilted back and forth. Isn't that incredible? Let's look at that again. You might notice all these dark dots all around. Those are typically gold dots, like physical particles of gold or something that the electron microscope, the electrons", "start_char_idx": 7974, "end_char_idx": 12091, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "a55b5ead-c163-4763-8f42-e192b2cd9ec1": {"__data__": {"id_": "a55b5ead-c163-4763-8f42-e192b2cd9ec1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "87a13fee-c559-408f-9ff7-ab37ea9e2517", "node_type": null, "metadata": {}, "hash": "6ffb667aea7988efd9d60e5ee6ea012b97fcc9107a2ebf8f37d4ec5251ea7b67"}, "2": {"node_id": "d23b5fa2-c982-4a9f-bb7f-4cca942bf869", "node_type": null, "metadata": {}, "hash": "7bfab3203cf0c61a045e5dd7142ee9a44f6ed13c5a11eb38437148399b814d72"}, "3": {"node_id": "2afc6927-fa37-4256-b9c0-6f16a6e60a21", "node_type": null, "metadata": {}, "hash": "430f862ca63989cf21542b09b3205721f5e7181cb9b7105cefb51463ae00ff53"}}, "hash": "2b558c4cf73b0b825a6a8f87eac9e8755e4a5e6af832c1227ea96ce2e9ce29b3", "text": "like physical particles of gold or something that the electron microscope, the electrons will really interact with. And so it's very easy to tell what's there. And these are registers or markers that the computer software can use in the tomographic reconstruction to help understand where things are in three-dimensional space and create a more accurate three-dimensional reconstruction of the cell. So those are purposely added to the sample when it's frozen to create a set of marks or indices that make it easier to do the 3D reconstruction. So that's the tomography part. Now we're going to do computational reconstruction. So let's see what that looks like. Instead of tilting, we're just representing it as an up-down series of slices. And so now it looks like this is what the microscope's seeing, but this is actually a computational reconstruction of all the tilts to give you a stack of slices from the raw data. Now that we've constructed this three-dimensional representation from the tilted slices, we're going to start to identify biological aspects of the cell about the membranes encompassing the cell. We've got an outer and inner membrane. We're going to identify those structures in purple and blue. Remember this is an electron microscope that's got resolution between nuclei and molecules. And so, you know, it looks like if you just look at the image, it's like, oh, it looks kind of grainy. But we're going to zoom in and pick up on the detailed resolution of the microscope. So within this membrane, oh, we've got some petite glycan, right? We've got these structures of atoms that are part of the membrane system surrounding the cell. The nucleoid, as a bacteria, you're not going to have a nucleus, but you're going to have a region where the chromosome is condensed or localized. And so you can be, that's the DNA in other words, and you can begin to say, well, what does that look like? Where's that? Right. And here they're highlighting that and using the computer to identify that. The flagella is something that's typically sticking out of the cell and pushes the cell through the environment. It pushes the cell by spinning around, to spin around, it has to have a motor. The motor is made of proteins. And here's what that looks like. By the way, you have microscopic motors inside cells, pushing cells around, right? Like that sounds like engineering. If you're going to be moving around, you need to have a sensor array to know where you want to go. You're going to be sensing chemicals. And so here are the things on the surface of the cell that are interacting with molecules in the environment. And depending on what's interacting with the receptors on the cell surface, you're going to control your motor, moving the flagella, pushing you around or tumbling. Maybe you have to have things coming in and out of the cell, pores and other stuff, right? So it's pretty cool, right? It's just absolutely amazing. These microscopic objects made of molecules that turn out to be cells have all these different parts and using electron beams and a fancy electron microscope, we can take a look at what these things look like. And once you get a sense of what they look like, it feels a lot easier to be a bioengineer. You know, it's like, do we want this thing over there? What if we changed it? What would that look like? Right? Ribosomes. Oh yeah. Those are the things that make proteins. What are they in the cell? Oh, they're around, you know, where the DNA is and we can count how many there are and so on and so forth. So, so you get the idea. So I just want to take a deep dive into something that sounds really complicated and totally esoteric, which valid, but hopefully you have a sense of, well, this is what 21st century bioengineering is enabled by, right? Okay, good. However, what are some of the limitations of this microscope? First off, it's really expensive. I don't have one of these, you know, people on my team, they get to use it, but we have to go like beg or borrow for access and it's like really grateful we can use", "start_char_idx": 12083, "end_char_idx": 16156, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2afc6927-fa37-4256-b9c0-6f16a6e60a21": {"__data__": {"id_": "2afc6927-fa37-4256-b9c0-6f16a6e60a21", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "87a13fee-c559-408f-9ff7-ab37ea9e2517", "node_type": null, "metadata": {}, "hash": "6ffb667aea7988efd9d60e5ee6ea012b97fcc9107a2ebf8f37d4ec5251ea7b67"}, "2": {"node_id": "a55b5ead-c163-4763-8f42-e192b2cd9ec1", "node_type": null, "metadata": {}, "hash": "2b558c4cf73b0b825a6a8f87eac9e8755e4a5e6af832c1227ea96ce2e9ce29b3"}}, "hash": "430f862ca63989cf21542b09b3205721f5e7181cb9b7105cefb51463ae00ff53", "text": "to go like beg or borrow for access and it's like really grateful we can use it. It's like, whoa, who can afford a $10 million microscope? Hardly nobody. So be nice if this costs like $10, would that be possible? Another thing is, well, this is frozen and so it's not really alive. I'm like seeing everything in one fixed time and so I'm not really sure how it works. I just like, I can see it, like, but what's really behaving? It'd be like having a photograph of people playing soccer and you're like, how does soccer work? If you could just see one image and you don't get to see the players running around, right? It'd be like, do you really understand soccer? If you could just see one image on the field, I'd rather have something that's not frozen, but I have to freeze it.", "start_char_idx": 16156, "end_char_idx": 16936, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "818fff00-7cf2-4411-b9df-dd7125fa71bd": {"__data__": {"id_": "818fff00-7cf2-4411-b9df-dd7125fa71bd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6ff5dfbd-4a2f-4a75-8936-486d9c797d3c", "node_type": null, "metadata": {}, "hash": "f092827fe45bd70cd86a04c5fce4da33bd76a6c82b5030c8bd7eb5472608c82a"}, "3": {"node_id": "5710083f-e829-4223-b149-006b8e2cc37a", "node_type": null, "metadata": {}, "hash": "93420653353514a0d5aae2a991483dfe00d3e49b6eb63dac487cf4b8bb8290c0"}}, "hash": "40ef7c1f9909ef24b7584c061f42200a561c553c99ab67e9566455727c8e12b7", "text": "Otherwise, the living cell is going to get blown up when it's in a vacuum. So how do I get a non-destructive image? And the other thing I didn't talk about is this electron beam that's coming in. That's a form of energy. And it's basically going to be cooking or damaging the sample. And so I've got to be careful about how much energy I'm putting into the sample. Otherwise, I'll destroy it as I'm trying to see it. And so I'd like to have an affordable microscope like this. I'd like it to be non-destructive, doesn't require freezing, doesn't use too much energy. And I want to see this living thing. And also, if you remember from our diffusion conversations, these molecules, when they're moving, we know how fast they're moving. The time between molecular collisions is about a nanosecond, which means I need a non-destructive microscope with this level of resolution that's observing the entire cell with gigahertz frequencies, like a billion times a second. So give me that. Now, if you give me that, now we're talking. Now we're bioengineering. But of course, that type of microscope doesn't exist yet. Parts of it may be physically impossible to make. You should talk to your physics friends. Hey, could you give me a cryo-electron tomographic microscope that's got gigahertz sampling rates and is non-destructive? And they're just going to go, what? But keep asking that. What do I mean by this? I want to zoom out for a second. One of the unique and incredible things about 21st century bioengineering is it's an emerging engineering discipline, which means, what do we mean by emerging? We have an opportunity to advance the discipline, not just by doing useful things for patients and the planet, but also by improving our tools, making better tools for bioengineering. Ever better tools and approaches are essential to advancing bioengineering. So this type of work in and of itself, tool development, tool improvement, is part of bioengineering. What am I talking about? Well, on the middle of the slide, you see a simple schematic, design, build, test. No matter what type of engineer you might be, you'd be a mechanical engineer making a car, or a civil engineer making a bridge, or a chemical engineer making a refinery, or an electrical engineer making a computer, you name it. No matter what type of engineer you are, once you've decided you know what you want to make, you've got to design the system, then you've got to build the system, and then you've got to test the system. Is it working? When we talk about making better tools, we're talking about improving the ability to design, build, test. And any improvement you make in this cycle is just going to have a sustained impact on the engineering workflows. Like a good engineer is able to make a useful system that people can rely on. A great engineer makes engineering easier. And one of the ways you make engineering easier for everybody is you improve the tools. So we've already talked about in this class a type of tool called DNA synthesis. Well, that's an improvement because it could allow you to accelerate the step from design to build. We've talked about the idea of testing, and measurement, and standards. We've talked about the idea of abstraction for managing complexity. These are, over the last 20 years, types of categories of improvements. But more simply and abstractly, better tools for measurement, better tools for seeing, better microscopes, better bioengineering, better tools for modeling, representing cells, representing molecules, better bioengineering, better tools for making, better DNA synthesis, better tissue printing, which we'll get to, better bioengineering. So I just want to pause and zoom out and talk about this particular aspect of 21st century bioengineering, which is 21st century tools. And the culture that celebrates, and supports, and rewards tool developers. You're probably now thinking I sound like a broken record on this topic. The reason is it's very difficult in bioengineering to work on improving tools. It's not that it's technically difficult to make better tools. It's that it's culturally difficult to focus attention on making better", "start_char_idx": 0, "end_char_idx": 4175, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5710083f-e829-4223-b149-006b8e2cc37a": {"__data__": {"id_": "5710083f-e829-4223-b149-006b8e2cc37a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6ff5dfbd-4a2f-4a75-8936-486d9c797d3c", "node_type": null, "metadata": {}, "hash": "f092827fe45bd70cd86a04c5fce4da33bd76a6c82b5030c8bd7eb5472608c82a"}, "2": {"node_id": "818fff00-7cf2-4411-b9df-dd7125fa71bd", "node_type": null, "metadata": {}, "hash": "40ef7c1f9909ef24b7584c061f42200a561c553c99ab67e9566455727c8e12b7"}, "3": {"node_id": "0fb2014c-0d4d-42c4-8a73-2c7ac73de9f1", "node_type": null, "metadata": {}, "hash": "304fb10c2a8f6ba47f7c9c0768e642c3969ccfd9f9829835566243a75efadafd"}}, "hash": "93420653353514a0d5aae2a991483dfe00d3e49b6eb63dac487cf4b8bb8290c0", "text": "make better tools. It's that it's culturally difficult to focus attention on making better tools. Because I bet every one of you is first interested in bioengineering, not from a tool perspective, but because you care about somebody who's sick, or you care about an endangered species, or climate change, or something wrong with the world. And you want to solve a problem that's an immediate problem, and it's totally valid and important. I love that connection. Never give that up. But bioengineering is so powerful for solving these problems. It means that bioengineers tend to be exclusively focused on solving the problems right now. And it's very difficult to get attention and support So you know what? Instead of solving this disease, I'd like to make it easier for all disease to be solved. And to do that, I need to work on tools. Do you see what I mean? So foundational science and foundational tool development is very tricky to protect and celebrate as an activity. That's why I'm spending a little bit more time than usual on this one slide. Hopefully you get it. Now, to wrap up this, I want to transition back to light microscopy and talk a little bit about how tools are not the same. And I'm using funny language, like tools are not tools. What I mean by that is it depends on the form that the tool takes. The particular form that a tool takes impacts who can use the tool where for what purpose. Here's an example in the 1960s, 1970s of a computer, an IBM mainframe computer, an industrial computer. The people who could use this computer were people who could afford computers in big rooms. And certain people could do that. Shortly thereafter, around the same time, a different type of computer showed up. The personal computer, just across the creek from where I'm recording this lecture, Menlo Park. It's still a computer, but it's not the same thing. A computer is not a computer. It depends on the form of the computer. What's interesting here is that the personal computer as a revolution is not a revolution in the physics of transistors. It's a revolution because of the word personal. It changed who could compute where for what purpose. Tools are not tools. A computer is not a computer. A microscope is not a microscope. A DNA sequencer is not a DNA sequencer, and so on. It depends on who can do it where for what purpose. What do I mean by that? A microscope is not a microscope. You know, what if a microscope, instead of costing a million dollars, costs $1? Instead of being this fancy instrument in a room, what if it was paper? What if you could step on it? What if you could use it as a bookmark? What if everybody had a microscope? A personal microscope. Well, guess what? Here it is. Well, guess what? Here it is. The Foldscope. The Foldscope is an origami microscope. And each of you will get one, and you'll have to build it. And then you get to use it. Now, this microscope is an optical microscope. And so visible light will be the source of radiation that you use to see things. And so that means the lowest wavelength is gonna be about 400 nanometers, right? So you'll be able to see things on the order of a micron, a little bit less than a micron, and a little bit bigger than that. This is a tool within the context of the P-SET we'll encourage you to use to help you understand yourself. We're gonna send you out into the world to look for biological things. And by doing that, you'll have some choices to make about what types of things you're looking for and why. It gives you experience with thinking about tools and improving tools. By going out and looking at biology outside of a laboratory, we're gonna encourage you to think about nature and natural biodiversity and all the life that pre-exists us on Earth. As bioengineers, it's incredibly important to have empathy for the planet and the life that we inherit, so to speak. It's not ours, but it's arrived before us. What do I mean by that? You know, in computer science, all of computer science has been invented in the last century or so. The software that's on GitHub, all the code, it's like a year to a decade to", "start_char_idx": 4099, "end_char_idx": 8226, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0fb2014c-0d4d-42c4-8a73-2c7ac73de9f1": {"__data__": {"id_": "0fb2014c-0d4d-42c4-8a73-2c7ac73de9f1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6ff5dfbd-4a2f-4a75-8936-486d9c797d3c", "node_type": null, "metadata": {}, "hash": "f092827fe45bd70cd86a04c5fce4da33bd76a6c82b5030c8bd7eb5472608c82a"}, "2": {"node_id": "5710083f-e829-4223-b149-006b8e2cc37a", "node_type": null, "metadata": {}, "hash": "93420653353514a0d5aae2a991483dfe00d3e49b6eb63dac487cf4b8bb8290c0"}}, "hash": "304fb10c2a8f6ba47f7c9c0768e642c3969ccfd9f9829835566243a75efadafd", "text": "on GitHub, all the code, it's like a year to a decade to a couple decades old. And I'm talking about biocode. If I'm talking about DNA code found on Earth, oh, you know, that's like a million years old, a billion years old, right? So it's like back to nature, like, whoa. One of the amazing things about bioengineering is we're encountering this evolved code base. And then of course, hashtag bioquality. What if everybody had a microscope? The Foldscope is an invention of Stanford bioengineer Manu Prakash and his team. And it's so interesting in and of itself, I'd encourage you to take a look at Manu's website and see what's going on there and why they're doing it. Okay, so to wrap up, here are some questions to think about. What is resolution with respect to seeing? What determines the resolution limit of what you can observe? How could microscopes be made better? I gave you my perspective with respect to cryo-electron tomography. What do you think? I love this question. I still wrestle with this question all the time. At the molecular to cellular scale, is biology complicated only because we can't see it easily? Remember that idea of like a cell made as big as a building? If we just see what's going on and observe everything, like suddenly it would just make sense and we'd be bioengineering like, ta-da, it's all working really well. Or is biology at this scale molecules making cells? Is it somehow intrinsically complicated? Even when we could see it with perfect resolution, with perfect sampling rates. Even if you gave me a camcorder, video recorder that let me see how molecules are making cells with like perfect, perfect resolution, perfect. Would it still be complicated? I'm not so sure, honestly. I think it might actually not be that complicated. But what do you think? Thus, why is developing better tools important for bioengineering? And also, why is it hard? Why is it hard to organize resources to make better tools? If you go to your local, here's an idea. Write the person in your district for the US House of Representatives and say, I think it's important for making better tools for bioengineering and here's why. And see what they write back. Why is it hard to make that argument? Last question, wherever you are, look at different forms of technology. Maybe it's a screwdriver, maybe it's a computer, maybe it's a bicycle, maybe it's a car, maybe it's a food processor, a microwave, or an oven, or a stove, or a refrigerator. Like what are some examples of different forms of technology? Challenge yourself to see, a refrigerator is not a refrigerator, it depends on the refrigerator. A bicycle is not a bicycle, it depends on the bicycle. Start to see technology not only as a label, but from the perspective of who can use it where for what purpose. And if you can see that extra dimensionality of technology, you'll be so equipped to understand how different forms of bioengineering tools will impact who gets to be a bioengineer. Thanks so much, can't wait until next time.", "start_char_idx": 8247, "end_char_idx": 11268, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "693e9899-8695-4938-9cfa-b4d9cb2fed1a": {"__data__": {"id_": "693e9899-8695-4938-9cfa-b4d9cb2fed1a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b3e92f83-c6e9-48a1-917b-f90368028926", "node_type": null, "metadata": {}, "hash": "66d200b5a358ca8118a8f6f494eedb6e2de6d8d320f3e2062e95ed28fabc6514"}, "3": {"node_id": "0d8b786c-b5f8-4501-8a4a-f265cb7512aa", "node_type": null, "metadata": {}, "hash": "715db60618ddd7435c850e1b7694fc98b2ff97451fa319c65d43817e148da584"}}, "hash": "a965930f9ae7318d11d020b8de247e239d412fc6cb3b394b17aee347bc441bad", "text": "We're going to talk about biodiversity, species loss, and bioengineering. So far in the course, we've mostly been motivated not just by learning about living matter and bioengineering, but the applications, and primarily people, health, or medicine. Truly a profound area that motivates bioengineering learning and practice. It turns out, though, the molecules of life, they don't really care what the use is. Maybe if we got good at bioengineering proteins, we could make medicines not only for people, but the planet. So let's think about the health of the planet, what we call planet health. And one, as we'll learn, dimension of planet health is how is the rest of life on Earth beyond Homo sapiens doing? So that's what this set of slides is about. Let's get going. For example, here's a creature commonly known as the horseshoe crab. You can find these in the Atlantic Ocean, parts of the Pacific Ocean, elsewhere on Earth. This species is thought to not have changed very much. For almost half a billion years, it's, quote, older than the dinosaurs, and shows up on the beaches every now and then. Such an interesting creature. In nature, living things are related to one another, the web of life. And so here we see a horseshoe crab in relation to the red knots, a bird that migrates. If you look at the world map down below in the bottom right, this bird is migrating and oftentimes it'll stop and feed on what's available, including things related to the horseshoe crab. So that's a relationship between species. Let's ask a more personal question. What's the relationship between our species, Homo sapiens, and Limulus polyphemus, the horseshoe crab? Here's a photograph from the early 20th century in Delaware Bay, Pennsylvania, New Jersey, that part of the eastern seaboard of the United States. And you can see that the fellows here are stacking up lots and lots and lots and lots and lots and lots of horseshoe crabs, and then taking them away on trolley carts or train cars. It looks like they're using this for fertilizer, so you could do farming. What's this going to do to the horseshoe crab? It's going to reduce the population of horseshoe crabs. Now to make this story more interesting, I have to introduce something related to people health. It turns out that planet health and people health are going to be connected. So even if you care about medicine and health and only people, you end up needing to care about nature. So check this out. There's in human medicine an issue where you get a fever, and one type of fever is derived from a pyrogen, something that generates pyro, you know, pyromania, pyrogen, a fever-causing agent. A type of pyrogen, one type is an endotoxin, which is part of a bacteria. And so if you get a bacterial infection, you might get a fever in part because you might have endotoxins or pyrogens. In medicine, not only is that an issue, but if we use bioengineering to make medicines, then we might want to make sure we're purifying our medicines from any endotoxins. Or if we have something that is being made to be injected into people, it could even just be a syringe with a needle, or it could be a saline solution. We want to make sure that there's no endotoxins in those things either, right? Because if there's an endotoxin, then a person might be very sensitive to that, get a fever or worse. All right, so just on background, there's endotoxins, some endotoxins are derived from certain types of bacteria. And so we have to make sure anything we're using in medicine, you know, doesn't have an endotoxin associated with it. Well, what's this got to do with the horseshoe crab? All right, thanks for your patience. We want to make sure the things that we're putting in the people in medicine don't have pyrogens or endotoxins. It used to be that the way you'd figure this out is you'd take a little bit of your injectable, and not all of it, right, and you'd test it on rabbits. And", "start_char_idx": 0, "end_char_idx": 3941, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "0d8b786c-b5f8-4501-8a4a-f265cb7512aa": {"__data__": {"id_": "0d8b786c-b5f8-4501-8a4a-f265cb7512aa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b3e92f83-c6e9-48a1-917b-f90368028926", "node_type": null, "metadata": {}, "hash": "66d200b5a358ca8118a8f6f494eedb6e2de6d8d320f3e2062e95ed28fabc6514"}, "2": {"node_id": "693e9899-8695-4938-9cfa-b4d9cb2fed1a", "node_type": null, "metadata": {}, "hash": "a965930f9ae7318d11d020b8de247e239d412fc6cb3b394b17aee347bc441bad"}, "3": {"node_id": "963d8af9-d4af-4975-9aeb-2963913b1ebd", "node_type": null, "metadata": {}, "hash": "40cb5ceb5b9d80c9517dba76a034f051b1a731bf2937d65cfd160fe0322076a8"}}, "hash": "715db60618ddd7435c850e1b7694fc98b2ff97451fa319c65d43817e148da584", "text": "and not all of it, right, and you'd test it on rabbits. And so you'd have these poor rabbits in a situation like this, and you'd give them an injection of what you wanted to see whether it had an endotoxin or not. And if the rabbit got a fever or worse, you're like, oh, no, no, that's not safe to put in humans. So it's called the rabbit pyrogen test, or you still haven't gotten back to the horseshoe crab. Well, this fellow, Jack Levin, in the 1960s, was studying the blood of horseshoe crabs. And horseshoe crabs, they have to worry about infections, too. And so it turns out they don't have a human immune system. They have their own sort of way of dealing with microbial infections, obviously. And it has to do with something in their blood. And within their blood, they have the capacity to aggregate or coagulate around anything that might be a bacteria or related to bacteria like an endotoxin. And Jack and colleagues figured out that if you extracted this factor found in horseshoe crab blood, instead of taking a sample of your vaccine or saline solution and injecting it into rabbits, you could just mix it up with this horseshoe crab blood extract and see whether or not you got this coagulation or observable property. And so this becomes known as the Limulus test, Limulus for the horseshoe crab, and a test, a way of determining whether or not IV fluids or pacemakers or injectable drugs have endotoxins in them. All right, so anything going into a human patient needs to be tested to make sure it doesn't have endotoxins. And we're going to use horseshoe crab blood to do this test, the Limulus test. Where's the horseshoe crab blood come from? Remember that photograph of fertilizers, it's coming from the horseshoe crabs. And so, for example, there are harvesting facilities, this one is in South Carolina, where you can see the horseshoe crabs, they've been captured through fishing or harvesting from the ocean, and some of their blood is being removed. Their blood's blue, again, I guess the blood that's red has iron in it, but blue is going to have copper in it, that's pretty cool. And the horseshoe crabs are still alive, they have some of their blood drained, it's collected in these bottles, and you just see the statistics, half a million animals collected a year. Don't take all their blood because they die, take a third to a half. This blood is worth $60,000 a gallon, like 10,000 times more valuable than milk. And how would you do if somebody took a third of your blood, or you lost a third of your blood? You might die, right? And so not all the animals survive this process, there's a significant mortality rate. This is also that we have medicines that are safe to inject. What's the impact of this on the population of horseshoe crabs? It's threatening their existence. So on the right, you can see a little schematic, and it's got this interesting notation in the bottom. What's the conservation status of this species, the Atlantic Ocean horseshoe crab? The further to the right on the scale it is, the less worried we are about this organism going extinct. All the way to the left, the organism is extinct. What does extinct mean? It's not found alive on planet Earth anymore. Like the passenger pigeon went extinct, the dodo went extinct, the dinosaurs went extinct. That's what's on the left. And so anything moving towards the left is at risk of being increasingly threatened, vulnerable, becoming extinct. And so this one looks like it's not too bad, but it's threatened. The more we're using medicines, the more we're going to have to collect horseshoe crabs to get their blood, and so it's probably trending to the left. Here's another way of looking at that, conservation status. So we just go back to the horseshoe crab again, it's VU, or vulnerable. And so it's like heading towards extinction. I'm using", "start_char_idx": 3895, "end_char_idx": 7750, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "963d8af9-d4af-4975-9aeb-2963913b1ebd": {"__data__": {"id_": "963d8af9-d4af-4975-9aeb-2963913b1ebd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b3e92f83-c6e9-48a1-917b-f90368028926", "node_type": null, "metadata": {}, "hash": "66d200b5a358ca8118a8f6f494eedb6e2de6d8d320f3e2062e95ed28fabc6514"}, "2": {"node_id": "0d8b786c-b5f8-4501-8a4a-f265cb7512aa", "node_type": null, "metadata": {}, "hash": "715db60618ddd7435c850e1b7694fc98b2ff97451fa319c65d43817e148da584"}, "3": {"node_id": "05caf1ff-530f-440d-b419-1447e82ff532", "node_type": null, "metadata": {}, "hash": "7fdd0a7281dd12a36e48789ac92f633a4f9a1ab7f847c31538e9490eb1911326"}}, "hash": "40cb5ceb5b9d80c9517dba76a034f051b1a731bf2937d65cfd160fe0322076a8", "text": "or vulnerable. And so it's like heading towards extinction. I'm using the example of the horseshoe crabs, it's just so amazing. But obviously there's many species on the planet, and our relationship, Homo sapiens' relationship with the rest of life is just increasingly depleting natural stocks or changing what's going on. And so there's significant threats to natural biodiversity or straight up extinction induced by human beings. We'll have more to say about that in a minute. One of the places you can learn about this is an organization. When I started out bioengineering, I didn't know about this organization. It had been around, I just never heard about it because as a bioengineer, I only knew about people health and the National Institutes of Health and going to the doctor and trying to help medicine be better. But there's a whole other set of things going on related to planet health. And one of the groups that works on this quite a lot is called the IUCN, or the International Union for the Conservation of Nature. And if you go to their website, they maintain something called the Red List. The Red List is basically the endangered species list for not just the United States, but for Earth. And so I encourage you to go to this and take a look and see which ones you like and what's going on with it. They represent that almost 40,000 species are threatened with extinction. And you can see how it's distributed. We haven't seen all the species, so there's more species threatened with extinction. These are just the ones we know about. The IUCN is a very interesting organization, it turns out. They're 70-some years old. They're based in Switzerland. They have 1,400 members, but the members aren't people. The members are organizations. So they're an organization of organizations. So a nation could be a member of the IUCN. Or a civil society organization, not-for-profit, could be a member of the IUCN. What's also very interesting is the IUCN maintains a permanent observer status with the United Nations in New York. So you think about who's representing what country in the United Nations, and then suddenly the IUCN shows up and is like, we're representing nature? Isn't that such an interesting organization? I was able to travel to Switzerland, go east of Geneva on the train, and visit their headquarters in a town called Galande. And within their headquarters, you can see their library. And although their Red List of Endangered Species is on the internet now, if you actually visit, the Red List historically was kept track of on a card catalog, like those old library card catalog things. And I have to share with you how it felt when I pulled out the drawer and would start to thumb through the catalog of species and how the species were doing. And it had been typed out on a manual typewriter, you know, species name found in this part of the world, and it's endangered, or then endangered got crossed out and somebody typed extinct. And it was such a profound heaviness, because it forced me to understand that somebody who cared so much about these creatures to make such a card catalog in the first place, because they love these creatures, and then to have to come back and type in all capital letters on the typewriter extinct. It's just a shockingly profound experience. Well, let's think about what's going on a little bit more systematically from an engineer's perspective, from a bioengineer's perspective. So here's a representation of the population of Homo sapiens on Earth. By the way, this slide, which I'm borrowing, you know, from a corporation, says population of the Earth. We Homo sapiens love Homo sapiens so much that we don't even bother to say, like, population of humans on the Earth. It's just population of the Earth. So going back 300 years, and, you know, like, number of Homo sapiens is 2 billion around 1927, and then it's just clocking up, three and a half billion in 1970 when I'm born. And so there's like over twice as many Homo sapiens as when I was born. That's interesting. On the left of this plot, I'm showing some examples of photographs from around Stanford. So the left one on the bottom is", "start_char_idx": 7739, "end_char_idx": 11909, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "05caf1ff-530f-440d-b419-1447e82ff532": {"__data__": {"id_": "05caf1ff-530f-440d-b419-1447e82ff532", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b3e92f83-c6e9-48a1-917b-f90368028926", "node_type": null, "metadata": {}, "hash": "66d200b5a358ca8118a8f6f494eedb6e2de6d8d320f3e2062e95ed28fabc6514"}, "2": {"node_id": "963d8af9-d4af-4975-9aeb-2963913b1ebd", "node_type": null, "metadata": {}, "hash": "40cb5ceb5b9d80c9517dba76a034f051b1a731bf2937d65cfd160fe0322076a8"}, "3": {"node_id": "e081b850-e694-4694-bfa1-198347b7c91a", "node_type": null, "metadata": {}, "hash": "fcd7d53c1b38497810fb2d5bff66a43b9ba51693413f0bfb26a3989f59ab8001"}}, "hash": "7fdd0a7281dd12a36e48789ac92f633a4f9a1ab7f847c31538e9490eb1911326", "text": "some examples of photographs from around Stanford. So the left one on the bottom is Redwood City Lumber Company, you know, 1870, 1880 or thereabouts. There's a town very near Stanford, California called Redwood City, and it was given that name because that's where, once you cut down the redwood trees and turn that into lumber for construction, you'd ship it on boats, right, out into the San Francisco Bay to get to where it needed to be. So that's why it's called Redwood City. We're cutting down redwood trees. The symbol, the animal on the California state flag is the California grizzly bear. That animal was last seen in the wild in California in 1924, extinct in California in the wild. The engineering school at Stanford, where I work, we were started just the next year. We didn't go up Sand Hill Road to raise venture capital to start an internet company. You went up Sand Hill Road to go into woods to cut down redwood trees, right? So that's what engineering was about. In a way, that's what engineering is still about. It's like making things that insulate and protect people from the vagaries of nature. And ever since then, a lot more of us, right, because engineering in that role has been very successful. But what's it doing to everything else? Well, everything that's not humans is having a different set of circumstances, right? Here's George the snail, the last of his species, dead at 14. Now it's extinct. That was 2019. We see this is happening over and over and over again. So here's an article from colleagues at Stanford thinking about the environmental sciences. The title of this article reads, Accelerated Modern Human Induced Species Losses, Entering the Sixth Mass Extinction. By sixth mass extinction, you know, they're talking about through the entire history of life on earth, there have been five previous times where most of life went extinct. And those were not caused by human beings, like the asteroid, then the dinosaurs going extinct, like that's one of the mass extinctions. But there's a sixth extinction, they argue. They write, since 1900 alone, 69 mammal species are believed to have gone extinct, along with about 400 other vertebrates. Evidence for species lost among other types of creatures is more difficult to come by, but we don't think it's doing better. And then why is this happening? Well, we're changing habitat, more land being used not for forest or jungle, but for farming. We're having invasive species show up that eat all the natural species. Industrialization and carbon emissions are changing the environment. Some of the things we're doing release toxins that don't just harm us, harm other things. Let's look at this a little bit more. So here's an example of a palm oil plantation. You can see in the middle of the slide, the biology looks very regular. These are oil palms, and they're used to make palm oil, which goes into food. If you have pancake mix from the supermarket, check out the ingredient list, you'll see palm oil. It's very useful for making nice pancakes. Also goes into many other consumer products. Well, to grow palm oil via oil palms, we've got to get rid of everything else that's growing there, this forest or jungle. Now think about all the other things that live here, and when you get rid of that environment, how many of them are going to live in the oil palms? Not as many. That might be orangutans and other creatures, as this is what we mean by changing land use, loss of habitat. What do we mean by invasive species? Here is a tree snake that used to not be on the island of Guam, and then through shipping and other sorts of human activities, suddenly it's there. And so it's going to eat the birds on Guam and other things that were native to Guam. If we think about carbon emissions and industrialization, that leads us to changes in the acidification of the ocean that causes bleaching of coral systems. Over 90% of the Great Barrier Reef in Australia is suffering from bleaching, says this story. More abstractly, we can quantify this, and remember I was saying the human population doubled between 1970 and today, approximately. It's more than doubled now, three and a half to eight billion.", "start_char_idx": 11900, "end_char_idx": 16099, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e081b850-e694-4694-bfa1-198347b7c91a": {"__data__": {"id_": "e081b850-e694-4694-bfa1-198347b7c91a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b3e92f83-c6e9-48a1-917b-f90368028926", "node_type": null, "metadata": {}, "hash": "66d200b5a358ca8118a8f6f494eedb6e2de6d8d320f3e2062e95ed28fabc6514"}, "2": {"node_id": "05caf1ff-530f-440d-b419-1447e82ff532", "node_type": null, "metadata": {}, "hash": "7fdd0a7281dd12a36e48789ac92f633a4f9a1ab7f847c31538e9490eb1911326"}}, "hash": "fcd7d53c1b38497810fb2d5bff66a43b9ba51693413f0bfb26a3989f59ab8001", "text": "approximately. It's more than doubled now, three and a half to eight billion. Here's one index of natural biodiversity, all the other human things, and it's gone from a value, a scaled value of one, to about half. So stated differently, over my lifetime, the population of Homo sapiens has doubled, and the biodiversity of everything else has gone down by half. And there's definitely correlation, but from the preceding slides, we can see there's some causation as well. And wait, it's getting worse. For example, if you have a coronavirus pandemic that shuts down tourism, then maybe people who don't have other ways of earning a livelihood have to kill the things that the tourists would come, but there's no tourists coming because they're on lockdown. So let's just kill the endangered animals to get their rhino horns. Let's just pause. What do you think? Should bioengineers care about natural biodiversity? Should bioengineers care about planet health? Well, hopefully you already have some examples. If we didn't have horseshoe crabs, we wouldn't be able to test for endotoxins without hurting rabbits, so it'd be good to keep the horseshoe crabs around, right? But is that the only reason, or are there other reasons? And I really want to encourage you to wrestle with this question. One of my answers is every natural creature, every lineage on earth, every beautiful thing that predates us and exists, it's made of molecules, and molecules are gizmos. And maybe some of those gizmos are useful for bioengineering. Now, that's a utility-based argument. I could give you a moral argument, but just like any bioengineer who actually wants to build with biology, who doesn't understand that each natural creature is a true organism.", "start_char_idx": 16091, "end_char_idx": 17831, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "8c314373-158c-4809-aa1e-e62cac28267a": {"__data__": {"id_": "8c314373-158c-4809-aa1e-e62cac28267a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9ea37fd5-c81e-48a5-bd3c-bae82986e816", "node_type": null, "metadata": {}, "hash": "308907ce0542535898b3a474ff2ce05ceaf999e49bbfbba4710ba28a688655b7"}, "3": {"node_id": "764a415e-1965-43e7-9e14-8bd22b8d4570", "node_type": null, "metadata": {}, "hash": "121490ac21ac68392a1a016d53da9bb425e7566d660574959049d418c92585e0"}}, "hash": "6ae2d5ee87044c16931c3cbf8429a3483d26113a2a02fed0f710cd2c8499e10f", "text": "treasure trove, a library of useful molecules that who knows what they do, we know what some of what they do, but they could do many more. It's like a Lego kit we haven't fully understood yet. Any bioengineer who like wants to build with biology, well, you just have to be crazy not to want to keep things from going extinct because it's where we're going to get all our gizmos. That's my utility argument. I'm very happy to make a more argument, just like natural biodiversity is good, species are good in and of themselves. But let me give you an example of utility, different from the Limulus pyrogen test. This is a quote antifreeze protein. Now they've been renamed, I think they're called ice structuring proteins now, but this is a protein isolated from the cold water ocean pelt that is capable of modifying how water freezes. And what's very interesting about this protein is it allows these ocean pelt creatures to exist in waters that are colder than freezing, like antifreeze, but it's not antifreeze that kills you, you know, a poison. It's a protein based antifreeze. It's an ice structuring protein. What's this good for? Ice cream. If you want to have really smooth ice cream, you got to use a lot of fat. You know, like you leave your ice cream in the freezer and the freezer, it freezer burn over time, right? As the freezer is modulating its temperature a little bit to keep frost from forming and that freeze thawing, you know, has these ice crystals growing. And so, you know, the best way to avoid that historically is just have really fatty ice cream, right? Because that fat will keep the ice crystals from growing. That's good ice cream, but it's bad for you if you have heart disease or problems with cholesterol in your blood, perhaps. What if we could take, instead of adding more fat to the ice cream, just add in some of this fish protein by doing some bioengineering and making lots of that protein in a fermenter, purifying it, adding it to the ice cream. And now we have low fat ice cream that doesn't grow ice crystals in your freezer. No freezer burn. All right. Like who knew? Better ice cream? You're welcome, says the ocean pal. Isn't that amazing? Every natural living creature is full of molecules, some of which we know what they do. And the more we know about what they do, the more we can use them to do other things that can be useful too. Again, I don't want to make the argument in favor of bioengineers caring for natural biodiversity only on the basis of utility. I think there's other ways of making this argument too. And so in general, let's think about how bioengineers make decisions, whether it's for biodiversity, biosafety, biosecurity, we'll get to those things later in the course. But like generally, bioengineers are always confronting decisions, whether this is the right thing to be doing or the wrong thing to be doing. And you're encountering that decision all the time in your life already. And underlying how you make these decisions is an idea, the moral compass. And so I'd encourage you to reflect a little bit about like, how do I decide whether or not something's the right thing to do or the wrong thing to do? We're expecting to get that question in bioengineering, but of course it's here because biology matters so much. Anybody interacting with biology as an engineer is going to encounter these types of questions all the time. You need a moral compass, in other words, to be a good bioengineer. Let's look at some more examples of what's going on. This one I find incredible. This returns to the passing comment I made about snakes as an invasive species in Guam. The brown tree snake has plagued Guam for years, destroying native wildlife, eating birds' eggs, biting residents, and knocking out electricity. Unlike many snakes, brown tree snakes eat prey they did not kill themselves and are vulnerable to acetaminophen. Taking advantage of these two weaknesses, scientists decided to airdrop dead mice laced with acetaminophen and attach them to streamers in areas near Guam's sprawling Anderson", "start_char_idx": 0, "end_char_idx": 4075, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "764a415e-1965-43e7-9e14-8bd22b8d4570": {"__data__": {"id_": "764a415e-1965-43e7-9e14-8bd22b8d4570", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9ea37fd5-c81e-48a5-bd3c-bae82986e816", "node_type": null, "metadata": {}, "hash": "308907ce0542535898b3a474ff2ce05ceaf999e49bbfbba4710ba28a688655b7"}, "2": {"node_id": "8c314373-158c-4809-aa1e-e62cac28267a", "node_type": null, "metadata": {}, "hash": "6ae2d5ee87044c16931c3cbf8429a3483d26113a2a02fed0f710cd2c8499e10f"}, "3": {"node_id": "71f26691-4420-4346-9629-2f4360782977", "node_type": null, "metadata": {}, "hash": "918a87da067193cc98f1ac3cc992c2dd77317a30b3c46c14187e9f4f73b8e10c"}}, "hash": "121490ac21ac68392a1a016d53da9bb425e7566d660574959049d418c92585e0", "text": "with acetaminophen and attach them to streamers in areas near Guam's sprawling Anderson Air Force Base. The dead mice will be dropped by hand, one by one, from helicopters. Mice with streamers will be caught in the branches in the forest foliage where the snakes live and feed. So I'm not sure if you caught all that. There's an invasive snake in Guam. It's preying on the natural species and the trees. We're going to try and get rid of this by having dead mouse paratroopers that have, I think, Tylenol tablets associated with them. The snakes are going to eat the dead mice and then bleed out, basically, if I understand what's going on. We've got this dead mouse with Tylenol tablets or acetaminophen taped to a streamer such that it gets caught in the branches so the snakes will eat it. What an incredible story. What an interesting way of trying to remove an invasive species. Is it going to work? It might help a little bit. I don't think it'll solve the problem completely, but hopefully it's like, could we do better? Do bioengineers have other tools, we might imagine, that could help with invasive species? Here's another example. This video can be a little bit disturbing, so take care. In this example, we've got an invasive species, which is a mouse, on islands where native birds are being born. Albatross, the big wingspan bird that glides long distances, soars long distances across the ocean. The invasive mice are starving and hungry, so they're just going to eat the young albatross alive in the nest. Imagine being eaten alive by a mouse. Where did the mice come from? The mice weren't normally on the islands. They got there by swimming from another island or more likely on a ship that landed or something like that. So how could we ever solve that problem? It turns out there's a very compelling organization, islandconservation.org, it's a charity, the entire mission is preventing extinction by removing invasive species from islands. So I'd encourage you to think about how could they go about this? How could you get mice that weren't normally on islands and are eating all the interesting reptiles and birds, eggs and young creatures, causing them to go extinct? How could you get rid of the rats and the mice that shouldn't be there? Well, you could use toxicants, put down poisons, like poisonous food, baited food. Or you could put down lots of mouse traps, rat traps. Or you could put down cats, a biological drug, something that eats mice and rats. Or maybe you could do some bioengineering. Maybe you could have a bioengineered mouse that if you introduce your bioengineered mouse onto the island, it would breed with the other mice and cause all the mice to go extinct. All right, so we've got options. And then I just want to jump down to this row here. Is the option socially acceptable? Like, is putting down poison food on an island socially acceptable? No, it's controversial. Why? Because something besides the mice might eat it and be hurt. Is putting down a bunch of rat traps controversial? Yep, it is. Because maybe it's painful to the rats, or maybe it doesn't work completely. What about adding cats? That's controversial, because now we're just adding another invasive species to get rid of the first one. How are we getting rid of the cats? We're going to add dogs. And how are we getting rid of the dogs? I don't know. What about bioengineering a mouse to breed with invasive mice and cause the entire mouse population to go extinct? That'd be nice, because I only have to get one of those mice. But what if that mouse gets off the island, and then mice everywhere go extinct? That doesn't sound like a good idea. What's really interesting about the social acceptability role is every option is controversial. Oh, wait, there's one more option. Don't do anything. Just let all the native species go extinct. Well, of course, that's controversial, because we don't want things to go extinct. At least I don't. So, oh, so interesting. Every option is", "start_char_idx": 4001, "end_char_idx": 8001, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "71f26691-4420-4346-9629-2f4360782977": {"__data__": {"id_": "71f26691-4420-4346-9629-2f4360782977", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9ea37fd5-c81e-48a5-bd3c-bae82986e816", "node_type": null, "metadata": {}, "hash": "308907ce0542535898b3a474ff2ce05ceaf999e49bbfbba4710ba28a688655b7"}, "2": {"node_id": "764a415e-1965-43e7-9e14-8bd22b8d4570", "node_type": null, "metadata": {}, "hash": "121490ac21ac68392a1a016d53da9bb425e7566d660574959049d418c92585e0"}}, "hash": "918a87da067193cc98f1ac3cc992c2dd77317a30b3c46c14187e9f4f73b8e10c", "text": "extinct. At least I don't. So, oh, so interesting. Every option is controversial. That's an opportunity. Could you make an option that wasn't controversial? Could you bioengineer something better? Which one, if you couldn't, would you choose of these? So, just to zoom out and summarize, we've introduced the idea of planet health. We've framed some initial puzzles around, are there any things bioengineers could do related to changes in land use, related to things like species in places where they aren't historically found, related to climate change and its impact on the environment, coral bleaching, related to pollution? Should we ignore what's going on? Should we react? Should we change what we're doing to prevent some of these things from happening in the first place? Or is there something you can imagine still different to do? Hopefully, at this point, when you stop to think about it, it's like, oh, yeah. And there's a lot of bioengineering opportunity related to planet health. And note that we've only talked about biodiversity so far. There's other aspects of planet health, too. Also, think about this in the context of the future you wish for. What do you want to be true in the year 2030, 2040, 2050 regarding planet health? Remember, we were talking about Pixar starting to do things in the 1980s to get to Toy Story in the 1990s. That same type of thinking of being an anticipatory leader applies for planet health, along with tools and tool development and people health, all of bioengineering. So, don't forget that part of what you're learning. Oh, yeah, by the way, if we're too late, if something went extinct, could we bioengineer it back? Reflective questions, and then we're done. What's happening to life on Earth beyond Homo sapiens? What is biodiversity? How is it measured? How do we know what's going on? Who's keeping track? Should bioengineers care about any of this? Maybe we should just care about people. Like, we're working at the hospital, and we're helping, and that's it, right? Or do you feel different? What are some of the most important bioengineering opportunities related to biodiversity and its conservation? What bioengineering knowledge and tools might help? Think of all the things you've learned so far, or the things you can imagine would be useful, but you haven't learned about yet.", "start_char_idx": 8010, "end_char_idx": 10352, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ce98c793-a083-469f-b2c5-e08f9aa48da3": {"__data__": {"id_": "ce98c793-a083-469f-b2c5-e08f9aa48da3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f8889e75-d27e-4f61-b0b6-ff36cab61945", "node_type": null, "metadata": {}, "hash": "47feec6313d6bc6c9468d61e497a37273b5f245396819b488e1f19d3f335b5fe"}, "3": {"node_id": "84ed673b-1d18-4bff-8e69-0252ebd0ffa8", "node_type": null, "metadata": {}, "hash": "ab31cd94d94d72acb12b6a88ebcae6e8aa687c4986ad63ffd0efa92cdf0e9b75"}}, "hash": "e7c4b84b4f1bbb78d07fa6405dc812caaad1b6bd5b877fe9bba89cda5072fd35", "text": "Welcome to Introduction to Bioengineering. We're going to talk about medicines for endangered frogs in this lecture. We want to consider whether or not we can use bioengineering to make medicines for endangered species. Our test case today is going to be this golden frog called Aetopolis setesci. And it is about three and a half to 4.8 centimeters long. So it's a really small frog. And it was last seen in the wild in the Panamanian cloud forests and central rainforests in Central America. It was seen in 2009 in these places but hasn't been seen in the wild since then. These frogs are adorable. They communicate to predators that they're poisonous through their bright yellow skin color, but they communicate to other frogs through this behavior called semaphore or waving, sort of flag waving. And they do this in order to kind of discuss mating and all kinds of other sort of territorial behaviors. It's a really cute little frog. And it went extinct in the wild because of a combination of habitat loss and a fungal disease called chytrid mycosis. Chytrid mycosis is caused by the chytrid fungus. And in the last 30 years, this fungus that causes chytrid mycosis has been linked to the decline or extinction of more than 200 species of frogs and salamanders throughout the world. This fungus infects the outer skin layers of the frog, which usually frogs use to hydrate and control their body temperatures and to regulate minerals and nutrients. The infection makes the skin thicker and less permeable to air and to other electrolytes, causing imbalances and a loss of muscle control. Eventually it causes heart failure and death. It's spread from frog to frog by contact. And so it's very difficult to prevent the spread of this fungal disease once it's in a specific location. Here's the life cycle of this fungus, this chytrid fungus. It has little spores that can actually move in the water and swim towards frogs. Once it reaches a frog, it burrows into the skin and then matures and starts to release new spores, kind of causing this infection to spread along the skin. This is the stage that causes that skin thickening. And infected frogs will usually die about 120 days after infection, so it's also pretty rapid. Now this chytrid fungus spread really quickly through Central America. It was first discovered up in Costa Rica in 1987, and by 2006 had swept all the way across Panama, causing the decline of those amphibious species that we were just talking about. Now, incredibly, not all frogs and salamanders, not all amphibians are sensitive to this chytrid fungus. Some seem to be resistant to chytrid mycosis. Here's two examples of a salamander and a frog species that are resistant. And in studying these amphibians, scientists have figured out that they produce antifungal compounds on their skin that seem to protect them from disease. So here's some examples of these antifungal compounds that have been found on the surfaces of these amphibians, and they're at pretty high concentrations. They can actually suppress the growth of the chytrid fungus. So researchers thought that, you know, maybe it was not the frogs themselves that were producing these compounds, but their skin bacteria. There's a lot of sharing of production of compounds between a host organism and the microbes that live in and around them. And it turns out that they were correct in some cases. So one of the bacterium that colonizes these red-bellied salamanders is called Dantheobacterium levidum, and this bacterium produces an antifungal compound called violicin. What they found was that when frogs were colonized with this bacteria, well, this is not the Panamanian golden frog, it's a different type of frog that is a natural host for this bacterium. When they are colonized with the bacteria and challenged with the fungus that causes chytrid mycosis, the frogs are able to clear the infection and they all survive. However, if they treat the frogs with antibiotics to remove the bacteria from their skin, then infecting", "start_char_idx": 0, "end_char_idx": 4030, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "84ed673b-1d18-4bff-8e69-0252ebd0ffa8": {"__data__": {"id_": "84ed673b-1d18-4bff-8e69-0252ebd0ffa8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f8889e75-d27e-4f61-b0b6-ff36cab61945", "node_type": null, "metadata": {}, "hash": "47feec6313d6bc6c9468d61e497a37273b5f245396819b488e1f19d3f335b5fe"}, "2": {"node_id": "ce98c793-a083-469f-b2c5-e08f9aa48da3", "node_type": null, "metadata": {}, "hash": "e7c4b84b4f1bbb78d07fa6405dc812caaad1b6bd5b877fe9bba89cda5072fd35"}, "3": {"node_id": "5987bcd2-04aa-40c4-8949-a25177e9db7a", "node_type": null, "metadata": {}, "hash": "bbe1bb6a5040008d5e5498fa220e4ddf8fceefd274b08774c6e9d6d43e82458c"}}, "hash": "ab31cd94d94d72acb12b6a88ebcae6e8aa687c4986ad63ffd0efa92cdf0e9b75", "text": "the frogs with antibiotics to remove the bacteria from their skin, then infecting them with the chytrid fungus causes the frogs to succumb to the fungal disease and die. So this is a good example of showing that it's actually this frog skin bacteria that is protecting them from this chytrid fungus. Now, the golden frog does not have this type of bacteria living on its skin, but researchers thought that it might be possible to just introduce that bacteria to the frog, right? Maybe they don't have this one naturally growing on their skin, but they could introduce it and maybe protect the frog from disease. Now, unfortunately, adding the bacteria to these Panamanian golden frogs did not protect them from chytrid mycosis. When they challenged the frogs that either had the bacteria put on their skin or did not have the bacteria put on their skin with this chytrid fungus, which is represented as BD here, the frogs showed no difference in survival. So the bacterium were not able to help the frogs. And one of the hypotheses for why these bacteria did not help the frogs was because that they were not well-suited for survival on these golden frogs' skin. They had evolved over many, many years to live on the backs of these other types of frogs and salamanders. And so on the skin of this golden frog, the bacteria couldn't survive. So, oh, and this is just showing actual quantification of the bacterium over time. And it does not, in fact, survive for very long on the surface of the skin. Okay, so this is where some of the bioengineering comes into effect. Dr. Matthew Becker and Brian Bratwick at the Smithsonian Conservation Biology Institute reached out to my PhD advisor, who's a bioengineer at MIT, Professor Christopher Voigt, to ask if we could help them engineer one of the bacteria that is usually found on the skin of these Panamanian golden frogs to produce the antifungal compound violicin. The thought was that if one of the bacteria that usually survives on the skin was producing these compounds, then those bacteria would be able to survive for a much longer period of time and protect the frogs from disease. So we decided to try and help them. And I'm gonna walk you through the different bioengineering steps that we undertook in order to try to make a probiotic for this endangered frog species. I should point out that even though these frogs were extinct in the wild, there were still colonies of them at a couple of zoos around the world. And so there are still potentially frogs that could be reintroduced to the wild, but we want to make sure that if we reintroduce them that they are resistant to the fungus and not all going to die immediately upon going back into the Panamanian rainforest. Okay, so the first step to figuring out or creating this probiotic for these frogs is to figure out which of the bacteria that usually colonize their skin we can grow in the lab. If we want to be able to engineer these bacteria, we need to be able to culture them in the lab. And so we swabbed the frogs, or rather Matt Becker and Brian Katowicz swabbed the frogs and then sent us samples of all of the skin bacteria that they could culture. So we had this nice collection of around 11 or 12 skin bacteria that we could grow in the lab. And then we needed to figure out which of the bacteria were resistant to antibiotics. So in order to engineer this bacteria, we will need to introduce new DNA into the bacteria. And when we introduce new segments of DNA to the bacteria, we usually also introduce an antibiotic resistance gene. The co-introduction of the antibiotic resistance gene and the pathway for violacin, the biosynthetic pathway, means that we can select for bacteria that have this new piece of DNA by introducing antibiotics to the media where we're growing the bacteria. So the idea is that only the ones that have our new piece of DNA will be able to survive in the antibiotic. Now that type of approach works really well, but it has to start with the bacteria that is sensitive to the antibiotic that you're trying to use. If the bacteria is already resistant, then it", "start_char_idx": 3962, "end_char_idx": 8077, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5987bcd2-04aa-40c4-8949-a25177e9db7a": {"__data__": {"id_": "5987bcd2-04aa-40c4-8949-a25177e9db7a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f8889e75-d27e-4f61-b0b6-ff36cab61945", "node_type": null, "metadata": {}, "hash": "47feec6313d6bc6c9468d61e497a37273b5f245396819b488e1f19d3f335b5fe"}, "2": {"node_id": "84ed673b-1d18-4bff-8e69-0252ebd0ffa8", "node_type": null, "metadata": {}, "hash": "ab31cd94d94d72acb12b6a88ebcae6e8aa687c4986ad63ffd0efa92cdf0e9b75"}, "3": {"node_id": "cb8cf659-62c7-45ad-9b31-0f25b6239658", "node_type": null, "metadata": {}, "hash": "ac3aaad2e8659a817697726d9ae5999b7abab82da74d90f444515cb2fbc6417c"}}, "hash": "bbe1bb6a5040008d5e5498fa220e4ddf8fceefd274b08774c6e9d6d43e82458c", "text": "that you're trying to use. If the bacteria is already resistant, then it won't matter if you apply or introduce new DNA and apply antibiotics to select for the bacteria. All of them will grow regardless of whether they have your DNA or not. Okay, so we tested a couple of different antibiotics and a couple of concentrations for each antibiotic to figure out which ones they were sensitive to. And some bacteria like these Chrysiobacterium were resistant to all of the different antibiotics that we tested. So we wouldn't be able to engineer these bacteria very easily using that method that I talked about where you introduce your pathway along with an antibiotic resistance marker. So we chose not to pursue engineering this Chrysiobacterium, but the others in the set had antibiotics that they were sensitive to and we could therefore try to engineer. Okay, so we figured out what antibiotics we could potentially use. Then we needed to design a segment of DNA that encodes for biosynthetic enzymes for Violacin. So we know what enzymes are essential in this Janthiobacterium. That's the bacteria that naturally produces Violacin. We know what enzymes are essential within them for creating Violacin from the amino acid tryptophan. It is a five enzyme pathway. And we designed a synthetic piece of DNA where all five of these enzymes are placed downstream of an inducible promoter. So this promoter just becomes active in response to a small molecule. So we can choose when to turn on production of Violacin and when to keep it off. Now, we also needed to identify a method of introducing DNA into these bacteria. For bacteria that are commonly engineered like E.coli, there are lots of different methods of introducing DNA into the bacteria. But for undomesticated or wild strains of bacteria, this step can actually be really challenging. What we chose to use is this tri-parental mating method where we have an E.coli strain that has a plasmid that encodes for a type three secretion system. This, or sorry, type four secretion system. And this has a bunch of proteins that encode for essentially a needle that will stick the E.coli to other cells that it comes into contact with. And through that needle, it can actually pump DNA. So this E.coli strain is mixed with an E.coli donor. This E.coli donor strain has either a GFP or our Violacin biosynthetic pathway on it. And when it is mixed with the helper, it actually receives this helper plasmid that encodes for that type four secretion system. And then it will poke into our recipient cells and deliver, in this case, the plasmid that encodes for our GFP gene or our Violacin biosynthetic pathway. We made two different versions of this plasmid, one with GFP and one with Violacin just to make the process of figuring out how to transform the bacteria easier. But yeah, so by mixing the skin bacteria with these two E.coli strains, we can introduce new DNA into this skin bacterium. When we transform the pathway that has the entire Violacin biosynthetic, or when we transform the DNA that encodes the entire Violacin biosynthetic pathway, we can get purple bacteria. This Violacin compound is purple, and then we can use LC-MS in order to figure out whether or not the bacteria are producing exactly the compound of interest. So if our standard purified Violacin gives us a specific signature in our chromatography, then our Violacin extract from these bacteria will give us the same one if they are producing the compounds that we're interested in. So using these methods, we were able to confirm that the skin bacteria can produce Violacin. And then we picked a location within the genome in order to integrate the Violacin pathway. So we didn't want to have the DNA floating around as a circle within the skin strain. In this case, we're calling the frog skin strain 63F. This is just our shorthand for the strain. And we picked a location within the genome to integrate it that was next to some tRNAs, but not in any essential genes. So by integrating it", "start_char_idx": 8087, "end_char_idx": 12108, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "cb8cf659-62c7-45ad-9b31-0f25b6239658": {"__data__": {"id_": "cb8cf659-62c7-45ad-9b31-0f25b6239658", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f8889e75-d27e-4f61-b0b6-ff36cab61945", "node_type": null, "metadata": {}, "hash": "47feec6313d6bc6c9468d61e497a37273b5f245396819b488e1f19d3f335b5fe"}, "2": {"node_id": "5987bcd2-04aa-40c4-8949-a25177e9db7a", "node_type": null, "metadata": {}, "hash": "bbe1bb6a5040008d5e5498fa220e4ddf8fceefd274b08774c6e9d6d43e82458c"}}, "hash": "ac3aaad2e8659a817697726d9ae5999b7abab82da74d90f444515cb2fbc6417c", "text": "next to some tRNAs, but not in any essential genes. So by integrating it into the genome, we can confirm that the DNA sticks around, even if the bacteria is not exposed to the antibiotic that is kind of selecting for just the bacteria that contain our new piece of DNA. Okay, so once we have the strain engineered, we can compare it to the wild type strain. So we want to make sure that introducing Violacin biosynthesis into the skin strain does not interfere with its growth. So we measured how quickly the bacteria grow in two different types of media. One that's like a rich media that provides everything that the bacteria need to grow at a high concentration. And one that's a more minimal media that is, we hope, more closely related to the environment the bacteria will experience on the skin, the frog's skin. And in both situations, we see that the engineered bacteria, which is shown as the purple bar, and the wild type bacteria, which is shown as the yellow bar, grow at about the same rate. And then in competition experiments where we mix the strain at either a one-to-one ratio or a one-to-10 ratio, we see that our engineered bacteria is able to persist. And so it does well, not just growing by itself, but growing in competition with the unengineered bacteria. So we determined after these steps that these strains were ready to be tested on the skin of the bacteria, or sorry, of the frog. So we shipped them from MIT down to the Smithsonian Conservation Institute where Matt Becker applied them to the skin of the frogs to see if they could help, if the engineered bacteria could help the frogs survive exposure to this chytrid fungus. And unfortunately, what we found was that the engineered bacteria did not protect the frogs from disease compared to control frogs, which did not have exposure to the chytrid fungus. The strains with our engineered bacteria or without it behaved the same. So all of them, the engineered bacteria were unable to protect the frogs from disease. What we found was that even though we engineered these strains which were native to this frog to produce Felicin, that when we looked for them four days after the introduction of the bacteria to the frog skin, we didn't find any of the bacteria. That's what this white bar is showing you right here. And that was surprising because the unengineered version of this strain did survive on the frog skin for many days, but somehow introducing this Felicin pathway, engineering the strain made it less competitive on the frog skin and it was not able to survive for very long, which is probably why it was unable to protect the frog from this chytrid fungus. So unfortunately, this is a story where our attempts to engineer a probiotic for these frogs that would help it survive and hopefully allow us to reintroduce these endangered species back into the wild was not successful, but it was just our first attempt at this. And so our reflective questions are mostly centered around whether or not we can improve this type of approach in order to actually make probiotics for endangered species. So the questions I want you to think about are, is it a good idea to engineer probiotics for endangered animals? Do you think this is an approach that we should even be pursuing? To ponder why the engineered bacteria did not protect the frogs from disease, told you that they didn't persist for very long on the skin, but could there be other reasons why these engineered bacteria were unsuccessful? What could we do in order to improve the probiotic? And then are there other strategies we should consider taking to save the frogs? So I hope that this has sort of expanded your perspective on bioengineering and the types of organisms that we can engineer solutions for, health solutions for, and that it also shows you that we have a ways to go before we are able to make really productive or beneficial probiotics for organisms that we don't know and understand quite as well as people. All right, thanks.", "start_char_idx": 12096, "end_char_idx": 16096, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "4abb23eb-b9ae-4d65-b5ee-8892ac8c51cf": {"__data__": {"id_": "4abb23eb-b9ae-4d65-b5ee-8892ac8c51cf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "24ad982c-47d1-455c-952d-a31ae43a2c78", "node_type": null, "metadata": {}, "hash": "a0ae25e54f66c0236eefc3ffa7c7b7df476622fd3b5ff72653ac87599bdbb5f4"}, "3": {"node_id": "b490697e-511d-4a71-aa09-3a660cc77090", "node_type": null, "metadata": {}, "hash": "819ddd2556eea6362ea6c7d55c457007abf6832f3e7f32a4204332ea40fc3322"}}, "hash": "835364ccfe27560b05bbff73fdd2fcf02322866dabf553b54ccd5903ab5e31cc", "text": "Hi, welcome back to Introduction to Bioengineering. We talk about cancer this week because it's a leading cause of death in the United States. As people age, cancer, the likelihood that they contract and die from cancer increases. On this graph, you can see age of people in the U.S. and the cause of death for people of that age. And what I hope is clear is that cancer becomes more prevalent as you get older. I think this graph is really interesting to look at and I encourage you to come back to it to sort of think about, you know, how old are you and what are the things that are most likely to bring about your demise if you were to pass away soon. I want to point out that data is from 2017 and that there have been changes in cause of death across age groups in the U.S. in recent years. Those are mostly due to the COVID-19 pandemic and rise in opioid abuse in the U.S. And so some of this will have shifted around a little bit, but the kind of growing incidence of cancer with age and the high fraction of people that it kills, you know, this is around 30% of people 55 and older, is still very significant. Okay, cancer is a relatively new phenomenon. If you look at causes of death in Boston in 1812, so about 200 years ago, you'll see that five out of about a thousand people have cancer recorded as their cause of death. A lot more people are dying from tuberculosis or diarrhea, all kinds of other maladies, fevers of different types. And one of the reasons why people are dying of cancer is because of what was shown on this previous slide. You have to live to be a certain age in order to have your likelihood of cancer increase significantly. So that's part of it. People's life expectancies were not as long, 200 years ago. They may also not have recognized certain things as being cancer. And so you may have passed away because you got a fever, but the underlying condition that was leading you to be susceptible to a new type of death, for example, could have been a cancer. So an increase in our ability to diagnose cancer and then a lengthening in lifespans has brought about more and more cases of cancer in time. Now, what is cancer? Simply put, cancer is a disease in which some of the body's cells go uncontrollably and other parts of the body. On this slide, you're seeing a dividing breast cancer cell all the way on the left-hand side. You can see the DNA here in blue and the tubulin, which is sort of organized during this process of division. The green is mitochondria, the kind of energy powerhouses of the cell. And you can see just that it's more or less a normal cell, but it's dividing. And then on the right, you're seeing mammograms, which are essentially x-ray imaging of a patient who has very early stage breast cancer that's indicated by this little box. And what you'll notice is that it's more or less normal, but it's the cells in this area that have started to divide when they shouldn't. Now, I think an easy question to ask the point is, aren't cells supposed to grow, right? Why are the dangerous cells in your body are dividing? But although cells in your body are supposed to grow, they usually grow or multiply in order to fulfill a need. For example, they may replace old cells, but when they grow and multiply when they should, then they start to form tumors or little lumps of tissue that can either be cancerous or not cancerous. And whether you're cancerous or not is really just a measure of how fast you're growing, how sort of dangerous you are to the rest of the body. Now, cancerous tumors can spread into nearby tissues and can travel into distant parts of the body to form new tumors. This traveling into distant parts of the body is a process called metastasis and cancers become lethal when they interfere with the functions of organs and cells in your body. So you can actually live for a pretty long time with a tumor as long as it's not interfering with the function of the organ that it's growing in. So for example, lung cancer in this image, you're seeing stage four lung cancer. So this is pretty advanced. The tumor is this sort of whitish region you can see inside lung. If it were not", "start_char_idx": 0, "end_char_idx": 4164, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b490697e-511d-4a71-aa09-3a660cc77090": {"__data__": {"id_": "b490697e-511d-4a71-aa09-3a660cc77090", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "24ad982c-47d1-455c-952d-a31ae43a2c78", "node_type": null, "metadata": {}, "hash": "a0ae25e54f66c0236eefc3ffa7c7b7df476622fd3b5ff72653ac87599bdbb5f4"}, "2": {"node_id": "4abb23eb-b9ae-4d65-b5ee-8892ac8c51cf", "node_type": null, "metadata": {}, "hash": "835364ccfe27560b05bbff73fdd2fcf02322866dabf553b54ccd5903ab5e31cc"}, "3": {"node_id": "9c170077-5710-4100-8fe6-b7fc617f5103", "node_type": null, "metadata": {}, "hash": "e30ea9de3d99db0c800219f17f7cea6e25f433b54e94af4f0e0613f6731b175a"}}, "hash": "819ddd2556eea6362ea6c7d55c457007abf6832f3e7f32a4204332ea40fc3322", "text": "is this sort of whitish region you can see inside lung. If it were not interfering with lung function at all, if you were able to breathe normally, even with this big mass of cells growing inside of your lungs, it wouldn't be that dangerous. The problem is that these cancer cells often interfere with the function of the organ. So in this case, interfere with your ability to breathe, which is lethal, right? And if some of those cells break up from your lungs and travel via your blood system to other portions of your body, then you can get cancers or tumors forming in new locations that may be even less amenable to the growth of new cells. There are more than a hundred types of cancer. Cancers are usually aimed for the organs or tissues where they're from. So this could be lung cancer, brain cancer, etc. They may also be described by the type of cell that formed them. So they could be epithelial cells, squamous cells. Sometimes you'll hear a combination of both tissue that they're from and the cell type they're forming. And if you want to, you can go to this link at the bottom of the page and scroll through all of the different types of cancers that currently categorize or kind of break cancers up into. So you can read about each of them and I encourage you to do so. It's kind of astounding how many different types of cancer there are and differently they behave. There are two sort of broad categories that we're going to break down cancer into in this lecture. There are solid tumors. So this solid map of cancer cells, the breast cancer tumor that you saw on a previous slide, that's an example of a solid tumor. But you can also have liquid tumors. These occur in blood, bone marrow, or lymph nodes. And these are usually the product of a cell that is normally found in blood or lymph fluid growing uncontrollably. So in this case on the slide, you're seeing an example of where these white blood cells are replicating and taking over the blood. Essentially you're getting too many of them and that is what is liquid tumor. And it's different solid tumor and that is in circulation kind of throughout your body all the time. Here's just an example of a biopsy, blood biopsy, and you can actually see the sort of cancerous patient's blood sample has a few of these white blood cells in it. And then the cancerous person who has leukemia sample has a lot more of them. And they're just colored dark in this case because of the stain that's applied to the white blood cells or the blood in total before it's imaged on a microscope to make the blood cells easier to see. They're not actually that dark most of the time. Okay, so if those are the types of cancer we're going to talk about, solid tumors and liquid tumors, then a good question is what causes cancer, right? We know that it's an overproliferation of cells, but the cancer, like what causes them to overproliferate, right? Cancer is caused by changes in DNA, often in gene coding regions, but not with. So sometimes you get a gene that gets mutated and that makes the gene either non-functional or hyper-functional, and we'll talk about what that means in a second. So mutations that turn on oncogenes or inactivate tumor suppressors are the most dangerous. These are the ones that are most likely to cause cancer. Now, these are two different jargon words that I threw at you, and so let's define them. Oncogenes are genes that promote uncontrolled cell division and growth when they're institutively activated. So these are genes that stimulate your cells to grow and divide. Usually these genes are very tightly controlled. They're only addressed when you need to make a new cell to fill a function within the body, for example, to replace a dead or dying cell. But when they're turned on institutively, which means all the time, then you can get cells that they constantly need to be growing and therefore start to create little tumors. So mutation in an oncogene is one that will activate it. HER2 and KRAS are just examples of genes that are commonly to be turned on. These are oncogenes in cancers. Tumor suppressors, on the other hand, are genes that would usually slow", "start_char_idx": 4109, "end_char_idx": 8269, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "9c170077-5710-4100-8fe6-b7fc617f5103": {"__data__": {"id_": "9c170077-5710-4100-8fe6-b7fc617f5103", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "24ad982c-47d1-455c-952d-a31ae43a2c78", "node_type": null, "metadata": {}, "hash": "a0ae25e54f66c0236eefc3ffa7c7b7df476622fd3b5ff72653ac87599bdbb5f4"}, "2": {"node_id": "b490697e-511d-4a71-aa09-3a660cc77090", "node_type": null, "metadata": {}, "hash": "819ddd2556eea6362ea6c7d55c457007abf6832f3e7f32a4204332ea40fc3322"}, "3": {"node_id": "485fd1f9-1cb7-4db7-b9e5-9d8b16f068f5", "node_type": null, "metadata": {}, "hash": "c6aac06f4ceb8086b93a95053c3beb5e9eb345a3369710172858034c51dd20c0"}}, "hash": "e30ea9de3d99db0c800219f17f7cea6e25f433b54e94af4f0e0613f6731b175a", "text": "Tumor suppressors, on the other hand, are genes that would usually slow or stop cell growth. These are inactivated in cancers. So in a normal cell, a tumor suppressor gene is intact. And in a cancerous cell, you may have damage to your DNA that bleeds or somehow inactivates one of these tumor suppressors. And without the tumor suppressor, without the expression of something like P50 to stop cell growth, you start to get uncontrolled cell growth and formation of the tumor. So mutations to oncogenes or tumor suppressors are what can lead to cancers. Here's an example of a very famous tumor suppressor. So you may or may not have heard of BRCA1. BRCA1 is a DNA repair protein that's expressed in breast and other tissues. The protein structure is shown on the slide right here. So this is a ribbon diagram showing you sort of the alpha helices or DNA binding regions of the protein and some business end of it. The protein is involved in error-free repair of DNA double-strand breaks. So your DNA gets broken all the time. Different things that you encounter in the environment can cause damage to your DNA. UV light is a good example of something that can cause damage to your DNA. This BRCA1 protein will come in and fix that damage, and it will fix it without errors, which is really important because that means you're not getting mutations in genes within your genome, wherever this BRCA1 protein is expressed. Now, BRCA1 is serving this DNA repair function in breast tissue and in ovarian tissue and pancreatic tissue to a smaller degree. And when it mutated, then you get more DNA damage in these tissues. So if you have a mutation in BRCA1, which occurs commonly actually in the human population, this is something that can be passed from generation to generation, from mother to child or from father to child. And when you hit a damaged BRCA1 copy, then your risk of getting breast cancer in women goes up 50% to 65%. Or a risk of getting pancreatic cancer is around 1% to 3%. Your risk of getting ovarian cancer is 40% to 65%. That's greater than a coin toss for both breast cancer and ovarian cancer. So it's pretty severe. It's really significant that people have figured out that this one gene is so important for cancer risk. Now, the discovery of BRCA1 has led to some really interesting behavior, some interesting prophylactic measures. So this just means sort of preemptive measures to try to prevent the patient from getting cancer. In this case, what you're seeing is actually Angela Jolie, a rather famous actress who elected to have a double mastectomy. So she had both of her breasts cut off because she discovered that she actually carried a broken copy of BRCA1, which meant that her risk of getting cancer was incredibly high. And she chose to remove the breast tissue to remove the chance she might one day get breast cancer because she had this lack of a functional BRCA1 gene. And actually her decision to do this, she published, or she was very vocal about, she published an opinion piece in the New York Times and talked about it on a number of daytime talk shows and actually led to a number of other women getting screened for BRCA1 mutations. They wanted to know, do I carry also a dysfunctional copy of the protein? And for women who found a mutation in their genome, in this BRCA1 gene, they were also electing mastectomies and hysterectomies, which is the removal of their ovaries. And she spurred this sort of increase in prophylactic mastectomies is called Angelina, actually, as people sort of tell their doctors, oh, I heard this actress talking about her decision to have a mastectomy because I want to know if I have this same mutation. So it's sort of interesting that this is one approach to avoiding, albeit a very extreme one, is one that people are pursuing. Now, BRCA1 has got some interesting history beyond just Angelina Jolie. A biotech company called Myriad Genetics first located BRCA1 gene on the human genome or human chromosome number 17 in the late 1990s. They actually established the first clinical lab to commercialize genetic testing. So they've established first", "start_char_idx": 8266, "end_char_idx": 12394, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "485fd1f9-1cb7-4db7-b9e5-9d8b16f068f5": {"__data__": {"id_": "485fd1f9-1cb7-4db7-b9e5-9d8b16f068f5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "24ad982c-47d1-455c-952d-a31ae43a2c78", "node_type": null, "metadata": {}, "hash": "a0ae25e54f66c0236eefc3ffa7c7b7df476622fd3b5ff72653ac87599bdbb5f4"}, "2": {"node_id": "9c170077-5710-4100-8fe6-b7fc617f5103", "node_type": null, "metadata": {}, "hash": "e30ea9de3d99db0c800219f17f7cea6e25f433b54e94af4f0e0613f6731b175a"}}, "hash": "c6aac06f4ceb8086b93a95053c3beb5e9eb345a3369710172858034c51dd20c0", "text": "They actually established the first clinical lab to commercialize genetic testing. So they've established first genetic test that you could get prescribed by your doctor, and they saved countless lives by informing women about their BRCA1 risk. But they also patent the BRCA1 gene sequence and cancer-promoting mutations. So they patent the sequence of the fully functional gene and a version of the gene that would activate it that are commonly found in people. And this patent prevents other companies from running BRCA1 to diagnostic tests from looking for this same gene. So it's great for Myriad Genetics. Now they have essentially a monopoly on this type of test. It's not so good for patients because the cost of getting one of these tests becomes really high. Myriad Genetics can essentially charge whatever they want. They have competition and patients can't get second opinion. So if Myriad Genetics comes back and says, no, you're fine, you don't have this BRCA1 mutation, but a patient sees so much familial history of breast cancer or ovarian cancer, and they want a second opinion, there's no place to get them. And so this actually causes a legal battle. And genetics is sued by the Association for Molecular Pathology. And this, this course case goes all the way to the Supreme Court. And this court rules actually against the molecular Myriad Genetics, excuse me. They decide that you cannot patent a DNA segment, which is really fascinating. Actually, it has some interesting ramifications on the current kind of state of diagnostics in the country and of biotech. Here is a quote from the majority opinion, which was written by Chief Justice Clarence Thomas in 2013. He said, a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated. However, cDNA is patentable because it is not naturally occurring. So that's interesting. They really decide you cannot patent BRCA1 or it's naturally occurring mutant for mutant versions. And so that opened up other companies to be able to make BRCA1 genetic tests and sort of do the same thing that Myriad Genetics has been doing. But they leave the door open for patenting cDNAs. So cDNA is complementary DNA. It's DNA that's made in the lab in vitro from RNA. So you start with an RNA message and you build DNA that is essentially the complement of the RNA. And those sequences you can patent. So while this did throw Myriad Genetics' business model into a bit of turmoil and actually make it really difficult for the company to continue to develop new genetic tests and profit from them, it didn't completely scruff innovation in biotech or in diagnostics altogether as people worked to figure out how to kind of avoid running out of the Supreme Court and work with cDNA in order to get patentable genetic material. Here's a picture of the Supreme Court in 2013 if you're curious about the people who made the decision about cDNA and whether or not humans can patent naturally occurring DNA. Okay, so if genetic changes can underlie cancer, then a good question is what causes genetic changes. You can inherit specific genetic sequences from your parents. That's sort of how the BRCA1 mutation is passed from generation to generation. UV light though and chemicals, smoking, these things in your environment can also cause damage to your DNA. Viruses and then even just the process of cell division can also cause damage to your DNA. And because each of these exposures increase with age, you get more and more DNA mutations as you age and that is part of why your cancer risk goes up as you age. So here's just a cartoon example showing a child who has had very limited exposure to harsh chemicals, to viruses, has had less cell division because he just hasn't grown that much. And as this child ages, they may encounter more and more DNA damaging agents in their environment and start", "start_char_idx": 12343, "end_char_idx": 16247, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "354d3032-6499-4dc3-850a-274f6bfac20c": {"__data__": {"id_": "354d3032-6499-4dc3-850a-274f6bfac20c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c1075af5-68cf-4abd-9166-1b8cdb36eadd", "node_type": null, "metadata": {}, "hash": "65008acddc65e127f0090c7d7c884aec16df264bc5de470aa1803f424780acef"}, "3": {"node_id": "6fe5b514-8788-4c8c-b9bb-e92bdef9d8eb", "node_type": null, "metadata": {}, "hash": "a7965f3be15ad7983701849fef8f26918a6384bbaa5c19ec2726bd5263cc97f6"}}, "hash": "66d7cc542874ddef122b8251d18603dcc39ade540787950020f6861f670d808a", "text": "to get accumulate some mutations and that process just accelerates as the person ages. And so your risk of cancer later in life is greater because you have had so much more exposure to things that may be damaging your DNA. Now, how we detect cancer is a really big question in the field because we know that early detection typically results in higher survival risk. Here are statistics for non-small cell lung cancer or stomach cancer and pancreatic cancer showing that if you catch the cancer in stage one or two, your chances of survival are much higher than if you catch them at stage three or four, literally half to maybe even a third or a quarter of the survival rate if you catch it earlier than if you catch it earlier. So it's really advantageous to figure out whether or not you have cancer as early as possible. Now brings us to a whole thing that we're going to have here on how cancer is diagnosed. So no single test diagnose cancer because there are so many different types of cancer. So it's really challenging to have one test that can tell you whether or not you have cancer at all. It may be able to tell you whether you have breast cancer or not, but it probably can't simultaneously detect a lymphoma or another type of cancer. So cancers are found via screening tests. You may show up to the doctor and say, I'm not feeling very well. And the doctor rules out a bunch of very specific or acute causes of whatever pain you're feeling. You have stomach pain. They may test you for different types of pathogens to see if you've picked up food poisoning somewhere, look for problems with your kidneys or appendix. Maybe you have kidney stones, but they can rule all of that out. They might start to run tests that look specifically for cancer. Another way you may at cancer testing done is just by age related screening. So for women after the age of 40, you start to get mammograms done, which are those types of x-ray tests we showed earlier looking for breast cancer or cancerous cells within your breast tissue. There's a similar type of screening that's done for men for prostate cancer, for people of both ages, they get screened for colon cancer vehicle colonoscopies after I think the age of 55. But unless you're falling into one of these categories where you either have symptoms or you're of a certain age that you would require screening, it's unlikely that you're going to get a lot of cancer screening early in life. Now, what do these screens look like? Or what are these tests look like? You can get a blood chemistry test. This looks at sugars and salts, different components of your blood, just to see how well your kidneys, liver, things that should be filtering the blood are working. And if you see, you know, very strange results from a blood chemistry test that may tell you like, oh, the kidneys are not working that well. Maybe we should do a follow-up test of some kind to see if there's something wrong with the kidneys. This may be an imaging-based test. And we'll talk about what those are in just a minute. Another pretty straightforward and routine type of test would be a complete blood cell count. This just looks for red and white blood cells. It counts basically how many of each type you have. They can be used to diagnose things like leukemias. Remember the slide I showed you earlier where there were these microscopy images showing you lots and lots of white blood cells in a person's blood sample. That would be a way of diagnosing a leukemia, basically saying there are more white blood cells here than we would expect. You may also have more white blood cells if you have an active infection and those cells are trying to fight off that infection. And so you do sort of have to decouple some of the blood cell count information from other things that may be making you sick, right? Like a high white blood cell count may not just be because of cancer. So you sort of have to use these things with all of the knowledge you have about a patient. Okay, you can do cytogenic analysis. You can basically look, take a sample and look at people's DNA and see if there are changes in chromosomes. Are there any broken, missing or rearranged? This could be that cancer is likely because these changes in chromosomes where pieces are obviously broken, missing or arranged are so severe that it could very well lead to", "start_char_idx": 0, "end_char_idx": 4367, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6fe5b514-8788-4c8c-b9bb-e92bdef9d8eb": {"__data__": {"id_": "6fe5b514-8788-4c8c-b9bb-e92bdef9d8eb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c1075af5-68cf-4abd-9166-1b8cdb36eadd", "node_type": null, "metadata": {}, "hash": "65008acddc65e127f0090c7d7c884aec16df264bc5de470aa1803f424780acef"}, "2": {"node_id": "354d3032-6499-4dc3-850a-274f6bfac20c", "node_type": null, "metadata": {}, "hash": "66d7cc542874ddef122b8251d18603dcc39ade540787950020f6861f670d808a"}, "3": {"node_id": "e65461c4-d1ed-4d26-9013-c16773a0da8e", "node_type": null, "metadata": {}, "hash": "8fdb325028f994a7f223022946d3f17264c923d22c5c302dbd995a5213e1e0f9"}}, "hash": "a7965f3be15ad7983701849fef8f26918a6384bbaa5c19ec2726bd5263cc97f6", "text": "pieces are obviously broken, missing or arranged are so severe that it could very well lead to cancer. You could get immunophenotyping. This is where you take the tissue and you try to stain it with different antibodies and those antibodies will identify specific proteins typically on the surface of cells. And you can use the protein content on the surface of the cell to diagnose and stage or monitor blood cancers. So certain blood cancers will have a high concentration of very specific surface markers. And so you can know what type of cancer you have by what type of antigens stick to the surface of your blood cells. You can do what's called sputum cytology. And so this is just, sputum is sort of like what you would cough up from your lungs. And if you analyze that, you can look at sort of what cells are getting coughed up from your lungs. If you have cancer, you may get an unusually high number of cells and cells just it sort of cellular mass or sputum. So that's one way of searching for, in this case, a lung cancer. You could look for tumor markers. So these could be proteins or other substances that are typically made in higher amounts by cancer cells than normal cells. So you, if you see a high number of tumor markers and a blood test, then you would assume or, or it is possible that you would cancerous cells somewhere in your body producing all of these proteins and substances. You can analyze urine. This is a way of potentially diagnosing kidney or urethral cancers. And if any of these sort of bodily fluids tests come back positive, you may follow it up with some based tests. So you can use CT scans. These are essentially a series of x-rays that create 3D images in the body. You can look for things like colorectal cancer or lung cancer this way. Often you'll ingest contrast agents that sort of help with these scans to make it clear where within your body cancer cells are active. You can get MRIs, which use radio waves to image the inside of a body. This can also be used to find solid tumors. You can use PET scans. This is another one where you would ingest a contrast agent before getting a PET scan. And it shows you where glucose is taken up in the body. And if you're ingesting, or if you're using a lot of glucose in one location, that's expected. And it might be that you have cancer cells there because cancer cells will consume a lot of sugar, a lot of glucose in order to grow quickly. That's another way of searching for cancer in the body. And then you may get a biopsy where a little bit of tissue is actually cut out of a tumor and it is analyzed under a microscope to see kind of hallmarks of disordered growth. And you can actually stain tissue that you collect from a biopsy to look for cell surface markers using antibodies, sort of in the same way that we were talking about these immunophenotyping tests before. These biopsies can help people stage and diagnose different types of cancers, not just blood cancers, because you're really taking samples from solid tumors in this case. Okay, so here's all of these different tests. And they're all good. They complement each other in different ways to be able to identify lots of different types of cancers. But can we do better than that? That's something that bioengineers have been asking for a while and trying to figure out an answer to. Because if we can get better early detection of cancer, we can increase the odds that people survive. So what about a better blood test? Here's an example that I really like in part because it's pushed forward by a professor here at Stanford. This is work out of Steve Quake's group. And here they're using cell-free DNA to try to detect pancreatic cancer at one of its very earliest stages. Now, what is cell-free DNA? It turns out it is exactly what it sounds like. It's actually DNA floating around in your blood that is not within a cell. How does it get there? Well, if it's a tumor, then there may be a lot of unhealthy cells and unhealthy cells because they're trying to grow so fast, maybe losing and releasing DNA from your insides, just kind of letting it out. And that DNA can very", "start_char_idx": 4290, "end_char_idx": 8432, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e65461c4-d1ed-4d26-9013-c16773a0da8e": {"__data__": {"id_": "e65461c4-d1ed-4d26-9013-c16773a0da8e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c1075af5-68cf-4abd-9166-1b8cdb36eadd", "node_type": null, "metadata": {}, "hash": "65008acddc65e127f0090c7d7c884aec16df264bc5de470aa1803f424780acef"}, "2": {"node_id": "6fe5b514-8788-4c8c-b9bb-e92bdef9d8eb", "node_type": null, "metadata": {}, "hash": "a7965f3be15ad7983701849fef8f26918a6384bbaa5c19ec2726bd5263cc97f6"}, "3": {"node_id": "b6f0456d-79ad-4b02-a825-b91b0ce03725", "node_type": null, "metadata": {}, "hash": "7289d39bf7cb84082ac640d931199f9030b50dd637ba1e6f5ce2e921cededf89"}}, "hash": "8fdb325028f994a7f223022946d3f17264c923d22c5c302dbd995a5213e1e0f9", "text": "DNA from your insides, just kind of letting it out. And that DNA can very easily enter your bloodstream and end up circulating. And so you can collect a blood sample and actually look at just the DNA that is not housed within cells. You can, by centrifugation, separate whole cells from just DNA. And then you can sequence that free DNA and you can see, you know, is there anything unusual that I'm seeing in this free DNA? Because you will get some free DNA coming from healthy cells as well. What they found is that there's a lot of hydroxymethylcysteine, I'm sorry, cytosine signatures on cancer cells that are missing from pancreatic cells. And so if you do sequencing of cell free DNA and you look specifically for this type of modification and you don't see very much of it, then it's likely that you actually have a pancreatic cancer developing within the body, which is pretty amazing because pancreatic cancer is actually one of these cancers that is most frequently detected very late. It does not cause a lot of symptoms and by the time patients are losing weight and feeling ill, they often have very rest pancreatic cancer with typically months left to live. And so something where you can diagnose pancreatic cancer from a blood test would be really powerful because it could mean that you could get routine screening for this type of cancer, you know, well before you have any type of symptom. Okay, so actually this type of screening is being done commercially and not necessarily for pancreatic cancer in this case because this 5-methylcysteine, or sorry, cytosine modification is a newly identified signature for pancreatic cancer cells, but there are other cell free DNA markers that you can look for and this company is selling tests that will allow you to search for 50 different cancers with a blood test. Here's just a workflow for how this type of thing works. We have patients that they collect blood samples from in the clinical trials where they were trying to establish that this type of screen test work, they would randomize essentially these samples and some of them as a control that are just stored for future testing, but other ones are run through their kind of proprietary test to see whether or not the patient's blood contains DNA that would indicate that they had a specific type of cancer and then they would refer patients who had a positive test to, you know, might have cancer to further diagnosis and assess to see whether or not their tests were correct and they were good enough to get approval to be sold. These tests run about a thousand dollars per test, so for a thousand dollars you can get tested for three different cancers all at one and the idea is that you would do this on healthy patients to screen for cancers that they don't even know that they have for things that are not really causing any symptoms. So I think that's really powerful and can be very impactful if we can really screen people regularly for cancers in an in-base way, that would be great. Is a thousand dollars, at a thousand dollars a test, how frequently do you want to do this? I'm not sure, it's actually something I would love for you guys to ponder and consider. Okay, what else can you do for early cancer detection? I showed you this image already and what I think is really fascinating about this is actually in this early image, these are the same patients taken at different time points and you can see that hopefully there's actually almost nothing in this red box, right? I would not certainly have looked at that and said that looks like a cancerous mass, especially as it looks pretty similar to other parts of breast tissue. Later, after the breast cancer develops, you can more clearly see that there is a tumor growing there. The innovation here is actually from a professor out of MIT's lab. She's using image-based deep learning models, so machine learning models, to predict breast cancer up to five years in advance. So you can take these images, they've been trained, this model has been trained on the seed breast cancer images at different stages and the machine learning model can now pick out areas that might look up like they're totally normal but that are likely to develop into cancer in the future. It can help women get earlier diagnosis for breast cancer or just know that there may be problematic areas to follow up on and potentially get screening more regularly", "start_char_idx": 8452, "end_char_idx": 12877, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b6f0456d-79ad-4b02-a825-b91b0ce03725": {"__data__": {"id_": "b6f0456d-79ad-4b02-a825-b91b0ce03725", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c1075af5-68cf-4abd-9166-1b8cdb36eadd", "node_type": null, "metadata": {}, "hash": "65008acddc65e127f0090c7d7c884aec16df264bc5de470aa1803f424780acef"}, "2": {"node_id": "e65461c4-d1ed-4d26-9013-c16773a0da8e", "node_type": null, "metadata": {}, "hash": "8fdb325028f994a7f223022946d3f17264c923d22c5c302dbd995a5213e1e0f9"}}, "hash": "7289d39bf7cb84082ac640d931199f9030b50dd637ba1e6f5ce2e921cededf89", "text": "there may be problematic areas to follow up on and potentially get screening more regularly than they have otherwise. A pretty cool use of machine learning for cancer diagnosis. Okay, cancer treatments. How do we actually treat cancer? How can we do this better than we're currently doing it? Here's an example from another Stanford bioengineering professor's lab. This is Professor Jennifer Cochran. They recently engineered a novel cytokine ligand in order to increase or rather slow down cancer cell growth in mice. So what they did was engineer this cytokine CLF1 in order to have tighter affinity for one of its binding partners. You can be sort of the kind of complex assay that they had up in order to do that is cartooned right here where the cytokine ligand would be bound by different proteins. Usually use fluorescently tied antibodies to detect whether or not the ligand was bound and you can run these flow cytometry plots. Try to see whether mutations that you make this protein increase binding affinity or not. You can read a lot of details about it in this paper if you're curious. I guess the thing I would like to show you is just that the engineered version of this CLCF1 when administered to mice actually helped keep the tumors that mice had from growing and so they were able to have a much lower tumor volume relative to mice that were not treated with this engineered peptide. So here's a really nice of trying to slow down growth that works really well in mice. Will be interesting to see as they move it to people whether or not this new cancer treatment, this protein-based cancer treatment would be effective. Okay, so probably the biggest thing in cancer treatment right now is something called CAR-T therapy. CAR-T stands for chimeric antigen receptor T-cell therapy. This type of therapy actually weaponizes your own immune system to fight cancer for you. It's quite clever and a little bit complicated. I'm going to do my best to walk you through this. In CAR-T therapy, a patient gets a blood draw and they remove T-cells, a certain type of immune cell from the person's body and then they engineer these T-cells who have chimeric antigen receptors. So T-cells are usually the cells that can sniff out and destroy invading cells within the body and they do so because they have little antigen receptors on their surface and those tell the T-cell when they, those bind to things and when they bind to things they tell the T-cell, hey I found something that shouldn't be here, you should destroy it. And so the CAR-T is an engineered T-cell that has had a new engineered into it. You actually get genes encoding this new receptor into the T-cell now and those new receptors recognize cancer cells. They recognize protein that are prolific or abundant on cancer cells. Now this isn't easy to do because again, cancer cells are sort of the same as your own cell in the body. They just have gotten a little out of hand. They're replicating too much. They're dividing too much. So they have a lot of same surface markers, a lot of the same proteins on their surface as healthy cells. It just, they have a higher abundance, certain types of markers on their surface, certain proteins on their surface than healthy cells do. And so CAR-T therapy takes advantage of this and says, well, maybe these T-cells will kill some healthy cells in the process, but they will mostly cancer cells. So the chimeric anti-receptors, these sort of cancer-recognizing proteins that are put onto the surface of the T-cell,", "start_char_idx": 12845, "end_char_idx": 16375, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d6747943-9398-44c0-aac7-99ef809c5847": {"__data__": {"id_": "d6747943-9398-44c0-aac7-99ef809c5847", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "823bc112-1294-4fe6-b2f5-3faf64dfbe18", "node_type": null, "metadata": {}, "hash": "ba6bc6fe32b95e208b5c24bcafdc10e97f336e41d3177c6939b9bc040c0855bc"}, "3": {"node_id": "6133f04f-cff1-43d7-9429-027ae1d0720a", "node_type": null, "metadata": {}, "hash": "79d0dc8222bb11d95d85632386423dbb8724d79e174f05cdc826e340edb129ac"}}, "hash": "0bb029cd428ea95a67956a2082bdb5071b9ef2d5bbb04def3b3a8b200693cbab", "text": "and have been very specifically picked out in order to help maximize killing of cancer cells and minimize killing of healthy cells. So the T cell is, it is what's called expanded in vitro. So it's just stimulated to grow itself that you get millions of these T cells. And then they're infused back into the patient who we originally took the T cell from. So your own cells are getting taken out of your body, engineered, and then put back. And when they're put back into the body, they should find cancerous cells within your body, use the chimeric antigen receptors to bind to them and to start to kill them. And incredibly, this stuff works. This is an article celebrating the 10-year anniversary of a child's first CAR T therapy. There was a six-year-old woman named Emily who had an acute lymphocytic leukemia, and she was treated with CAR T therapy and has survived. She is now 16 and still cancer-free thanks to this type of therapy, which is pretty amazing because she had had many unsuccessful rounds of chemotherapy and her disease was progressing so rapidly that she was ineligible for bone marrow transplants and other things that are often used to treat leukemias. This was really a last line of defense for her. It was a brand new technology at the time, and it is pretty amazing that it has worked so well. Since Emily, lots and lots of people have received CAR T therapy, and it's been great. It actually helped cure cancer in lots of people worldwide, but it's so contributing. So CAR T therapy is incredibly expensive. It costs anywhere from $500,000 to around a million dollars per patient that gets treated. It's expensive because of the types of manipulations and treatments involved. So for each patient, you need to collect T cells, you need to run biopsies to sort of see how their cancers are progressing. You need to actually engineer those T cells so that they have antigen receptors being expressed from them. You need to reintroduce these CAR T cells into the patient and they are monitored after infusion quite a while instead of staying in the hospital for a while. They get imaging studies and medicines kind of all the time in order to ensure this CAR T therapy is going well. There's actually a whole page dedicated to navigating the financial aspects of CAR T therapy. You can actually read that down here. I thought that was interesting. There's also, when this was first coming out, a lot of stories in the news about how expensive this therapy actually is. But what we pay for care, it's sort of a difficult thing to put a dollar amount on. I think most people would pay a lot to save their only child or their young child if they had the means to be able to do so. But who really has the means to pay a million dollars for a therapy, right? So just an interesting aspect of CAR T, there are many insurance companies that do cover this type of thing now, but it is an active area of debate to figure out how to bring cost of therapies that have been expensive to develop down in price and to make them actually impactful because if they are too expensive, it really won't have the reach that it could. In addition, I want to emphasize how incredible I think CAR T therapies are, but then also give you a little side of this. I think it's an important part of being well-versed in bioengineering is to really not just think about how good certain things are, but also what are the challenges that we're still facing with some of these new technologies. With CAR T therapy, there's still a lot for us to learn. We're about 13 years now after the first CAR T treatments, and since then, researchers have found instances of cancer relapse. It's only about one-fifth to one-third of patients that go into complete remission, so they never ever have a relapse, which is still pretty good, better than a lot of cancer therapies, but not perfect. We have identified patients for whom the therapy just does not work, and as far as I know, they still don't really understand what it is that leads this type of therapy to work really well for some patients and less well for others. They found instances where CD8 cells, so this is the type of T cell that's usually being engineered to express these chimeric antigen", "start_char_idx": 0, "end_char_idx": 4242, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "6133f04f-cff1-43d7-9429-027ae1d0720a": {"__data__": {"id_": "6133f04f-cff1-43d7-9429-027ae1d0720a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "823bc112-1294-4fe6-b2f5-3faf64dfbe18", "node_type": null, "metadata": {}, "hash": "ba6bc6fe32b95e208b5c24bcafdc10e97f336e41d3177c6939b9bc040c0855bc"}, "2": {"node_id": "d6747943-9398-44c0-aac7-99ef809c5847", "node_type": null, "metadata": {}, "hash": "0bb029cd428ea95a67956a2082bdb5071b9ef2d5bbb04def3b3a8b200693cbab"}, "3": {"node_id": "bbe5ca41-84f9-4aa3-9e2b-c9510899515e", "node_type": null, "metadata": {}, "hash": "3218bae10526ae184c19a8a6cc6f8636314b52974590c4e64dd2da70d39b4fd1"}}, "hash": "79d0dc8222bb11d95d85632386423dbb8724d79e174f05cdc826e340edb129ac", "text": "is the type of T cell that's usually being engineered to express these chimeric antigen receptors, turn into CD4 cells, which is a different type of T cell. CD4 cells are more like helper cells that sort of assist in the killing of things, whereas CD8 cells are called killer T cells because they're the ones that are actively destroying and invading the body, so it's sort of a mystery to what it is that's causing CD8 cells to turn into CD4 cells. After the CAR T therapies eliminated cancer from a patient's body, is it just that that's how immune systems sort of naturally progress? What is going on there? It's sort of an interesting area of research for people to dive into and continue to explore. In some patients, there are serious signs for CAR T therapy. You can get high fever, have slipped into comas, get really low blood pressure. Typically, these are acute and resolve pretty quickly, but there have been a couple of instances where patients have not survived demonstration of CAR T therapy, and that is still not very well understood, and is another thing to figure out for the type of treatment. It's rare, but it does happen. Okay, and then CAR T therapies are not successful in solid tumors. Ah, okay, so we'll get back to the solid tumors in a second. Now, CAR T therapy has been under kind of constant technological innovation. People are constantly trying to make this stuff better, and there have been some really incredible things that have been done to try to improve CAR T therapies. I'm just going to talk about two of them today, but I encourage you to dig into the literature to find out more interest in CAR T therapy. So, here's an example where researchers have improved CAR T therapy specificity. So, I mentioned that tumor cells are not that different from healthy cells, because they are essentially derived from your healthy cells. So, they are you. They're just sort of your cells out of control, and they may have more copies of specific proteins on their surface than a normal cell, but it's the same protein that's on the surface, and so if a CAR T cell recognizes this specific surface protein, then it may go about killing a bunch of normal cells in addition to killing tumor cells if it has a linear relationship with oxygen recognition and killing, so that's sort of shown here. This engineered CAR T cell would kill both this normal cell and the T cell, and so Rogelio Hernandez-Lopez, who is also a professor of bioengineering at Stanford, developed an approach to change sort of the sensitivity of the CAR T cell to the amount of antigen displayed on the surface of a cell, and so the way this is supposed to work is that at kind of low concentrations of surface markers on these cells, you would get no CAR T cell killing, and only if there was a high concentration of the surface marker, which would indicate that this is actually a tumor, so what you get like the, which is essentially killing of that cell. Okay, how does this actually work? Here's a little schematic for how this type of CAR T cell kind of ultra-sensitive switch works. I'm not actually going to go through it in this lecture, but it's here if you want to think about how this might work. There's a low affinity switch, a high affinity switch, and one kind of leads to the other, and that's the way that they engineered this ultra-sensitivity. Some data I want to show you where they tried putting two different types of tumors into mice. One is a very slow-growing non HER2 tumor, and so HER2 is an example of one of these antigens that may be on the surface of a normal cell at a low concentration and on the surface of a tumor cell or cancerous cell at a high concentration, and when mice who have these different types of tumors on their flanks are injected with CAR T cells with their ultra-sensitive switch, they are able to completely stop tumor growth of the tumor that has a high concentration of HER2 and really not attenuate the growth of the others all that much. It's just trying to show you that this type of CAR T cell is able to very specifically pick out cell types in the body based on the amount of SIRK protein that they're showing. This is kind", "start_char_idx": 4170, "end_char_idx": 8355, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "bbe5ca41-84f9-4aa3-9e2b-c9510899515e": {"__data__": {"id_": "bbe5ca41-84f9-4aa3-9e2b-c9510899515e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "823bc112-1294-4fe6-b2f5-3faf64dfbe18", "node_type": null, "metadata": {}, "hash": "ba6bc6fe32b95e208b5c24bcafdc10e97f336e41d3177c6939b9bc040c0855bc"}, "2": {"node_id": "6133f04f-cff1-43d7-9429-027ae1d0720a", "node_type": null, "metadata": {}, "hash": "79d0dc8222bb11d95d85632386423dbb8724d79e174f05cdc826e340edb129ac"}, "3": {"node_id": "02650291-184b-4a68-b8e5-5f211912159a", "node_type": null, "metadata": {}, "hash": "b3ae47d058d04ed877add8ecb60410ff055351ae6840081606bd09f62fe756ba"}}, "hash": "3218bae10526ae184c19a8a6cc6f8636314b52974590c4e64dd2da70d39b4fd1", "text": "the body based on the amount of SIRK protein that they're showing. This is kind of an extreme example where both of the cell types they're monitoring are in fact human tumors put into mice, but it is showing you that the kind of SIRK that they enter into these T cells is actually working. The T cell is now able to pick out, based on the concentration of HER2 on the surface of the cell, whether or not it should kill the cell or not. Okay, so that's Rogelio's work. I highly recommend you check this out. The other thing I want to talk about are solid tumors because solid tumors, as I mentioned, are difficult to treat with CAR T therapy. In contrast to blood and lymph cancers, things that are called liquid tumors, which move through blood vessels, it is difficult to access the cancerous cells in a solid tumor. You can imagine if this mixture of cells is floating around in blood and mixed with a bunch of T cells, the T cells could easily add all of these extra lymph cells and destroy them, all of these cancerous cells. But if the cancer cells are within the solid mass of tumors or of a tumor, then it can be difficult for the T cells to get in there and start killing off the cancer cells. And that's a problem because many different cancers come from solid tumors, right? Here's a PET scan showing you a lung cancer. Here's a brain cancer, colon cancer, liver cancer. All of these are very T types of cancers and they're all solid tumors and not currently treatable with CAR T therapy. Okay, so why is it? Well, it turns out that typically the tumor microenvironment, sort of the conditions in a solid tumor, suppress T cell activation. That's what this little red bar is trying to show you. And that includes cytokine production, which can help sort of stimulate T cell activation. And so the bioengineers have bypassed the suppression by engineering synthetic I2 circuits into T cells that are activated independently. So the tumor therefore is not, so how do I explain this? The surface marker that would usually be recognized by the T cell would be the triggering event to activate the T cell. But because the tumor microenvironment is sort of suppressing this inactivity and preventing this IL2 production, which feeds back and sort of helps reinforce activation of this T cell, you don't get T cell activation. Here they've decoupled the two. And so now when the T cell recognizes surface marker that it's interested in, it produces its own interleukin-2 and that kind of helps reinforce T cell activation. And this T cell kind of ignores the signals that the tumor is sending to stop its activity. And what you can see in these images on the right are that CAR T cells would normally get kind of stuck, sort of black dots along the top at the surface of a solid tumor, which is here. Whereas when they have their engineered CAR T cells with this interleukin-2 circuit, they, you get in the CAR T cells into the solid tumor, and you can see them already sort of destroying this tumor environment. Also exciting. So this is work done by Professor Kyle Daniels. He is a new professor at Stanford and is continuing to push forward CAR T therapy in exciting ways. Okay. So those are the two kind of CAR T advances I wanted to highlight for you guys today. And, you know, where is this going next? Well, there are so many different types of new CAR T therapy modifications being developed and tested to improve this technology, to make it better for solid tumors, to make it more specific and have side effects. And so, you know, I would encourage you to check this out. I wanted to put up this picture of a naked mole rat because I think they're cute and they're fascinating because these rodents actually don't get cancer. And so there's something that people have been interested in studying, have been studying for quite a while to figure out, like, why is it that these rodents don't get cancer? And can we steal any tricks from them? People have figured out relatively recently is that one of the reasons why mole rats don't get cancer probably has to do with a special hyalurone in their extracellular matrix.", "start_char_idx": 8364, "end_char_idx": 12494, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "02650291-184b-4a68-b8e5-5f211912159a": {"__data__": {"id_": "02650291-184b-4a68-b8e5-5f211912159a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "823bc112-1294-4fe6-b2f5-3faf64dfbe18", "node_type": null, "metadata": {}, "hash": "ba6bc6fe32b95e208b5c24bcafdc10e97f336e41d3177c6939b9bc040c0855bc"}, "2": {"node_id": "bbe5ca41-84f9-4aa3-9e2b-c9510899515e", "node_type": null, "metadata": {}, "hash": "3218bae10526ae184c19a8a6cc6f8636314b52974590c4e64dd2da70d39b4fd1"}}, "hash": "b3ae47d058d04ed877add8ecb60410ff055351ae6840081606bd09f62fe756ba", "text": "cancer probably has to do with a special hyalurone in their extracellular matrix. This kind of sugar is something that they think helps with the elasticity of the naked mole rat skin. But when they interfere with production of this compound in the naked mole rat, they actually do start to get tumors forming. And so it's thought that maybe the molecule or really the kind of structure of the extracellular matrix is important for tumor or cancer cell development and progression. And so there are questions about whether this molecule could help humans avoid cancer. There's a lot of research being done with naked mole rats. In addition to carotenoids and new methods of diagnosing cancer and new, you know, protein-based treatments, all kinds of stuff, there really is a ton of work being done on cancer and all these different types. And so I encourage you to dig deep and see, you know, what interests you in cancer and in bioengineering specifically. Okay, here are reflective questions for today. How often would you want to be screened for cancer? Let's say that you had access to these tests, $1,000 per test for 50 plus cancer. Is that something reasonable? Would you do it every year, five years, every 10? If you only did it every 10 years, is that still effective? I just want you to think about the current state of cancer screening and cancer diagnosis and what you wish to change about it or what you think about it now. I think it's kind of incredible that we can engineer our own immune cells to take cancer, but what other diseases would we fight with this capacity to engine T-cells, to reprogram them, to find something that they wouldn't usually find in your body and just spit? Where would you look in the naked mole rat to learn the secrets of its cancer-free life? I don't really know the answer to this, but it would be fun for you to contemplate it. I only scanned the six CAR-T engineering here, so I want to encourage you now to go learn more about it. You can read links to some of the news articles we had here if you want to know more about Emily, that young girl who had CAR-T therapy when she was six, or if you want to know more about the kind of costs of CAR-T therapy, if you want to know more about the technologies, you can read the links to the scientific papers that are there. Whatever you found to be most interesting, I highly encourage you to dig deep on it and to learn more. All right, thanks so much.", "start_char_idx": 12478, "end_char_idx": 14926, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "47931fe8-deb8-4f76-b5c4-f727e574ae07": {"__data__": {"id_": "47931fe8-deb8-4f76-b5c4-f727e574ae07", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8d5ad962-585b-4050-8998-b68b7d4f356a", "node_type": null, "metadata": {}, "hash": "b2590ee8505ecc733641c1caffe1221a2efe27b5f0490a346a313e38fb56d33e"}, "3": {"node_id": "725b54c8-090f-46fb-9fcf-5b7d1d3ceb73", "node_type": null, "metadata": {}, "hash": "9451852d1a18723b55c74375f00c8a317baba0a90c79d63c90a4e507dfa56cd3"}}, "hash": "e7a02214b9c8382ccc198f0481935a00aabebdfabd9a1dffc37ac3ad8469d7e0", "text": "Welcome to Introduction to Bioengineering at Stanford University. This is a brief video introducing the class project, the BioNaut project. Let's get into it. Remember, the goal for this course, Intro to BioE, is to become a BioNaut. Bios life, not a sailor. We're sailing into the biotic future as we learn what bioengineering can be in the 21st century. And this involves becoming somebody who understands what do living systems do? How do we work with them? How do we partner with them? Can you talk about this with others? Are you familiar with the tools that bioengineers use, at least as a beginner? And could you decide what to work on? A BioNaut is someone who can not just go along for the ride, but steer the ship. What should we be thinking about doing? What are the big problems? What are the tiny problems? What are your problems? What are her problems, his problems, their problems? So this last part of our goal for you in becoming a BioNaut is to start to put it together. Start to imagine what bioengineering could do where you are. All right, let's get into it. Step-by-step, this project will take you through the process of imagining what you might wish for, and then thinking about whether or not it's a good thing to do. First, we're going to work on brainstorming bioengineering opportunities. Second, there's this funny word, framestorming. We're going to framestorm better opportunities or ideas and teach you how to do that. Third, you're going to have so many ideas. It might be a good idea to ask, is it legal? Are you going to get in trouble if you did it or not? And also, is it ethical or unethical? Maybe those are the same things. Maybe they're not the same things. We'll give you a tool to think about that. Thus far, your ideas will be pretty simple in their description. We use a tool called design criteria so that you can develop a richer specification of what's involved in your bioengineering project. Finally, once you've started to decide what to work on and what you are super excited about, we'll pull out one last tool, the futures wheel, so that you can better understand the impacts, the direct impacts, the second-order impacts, the third-order impacts, and so on. And from that, do one last check in terms of whether or not you think your project's really a good idea or not, or if you need to make some final adjustments. This will then lead to a final decision about whether or not you think your project should go ahead. Now, you're not going to do the project. Your job here is just to specify what the project would be. Overall, the goal here, again, is to describe a compelling bioengineering project of your own choosing. We're not going to give it to you. You have to come up with it. That's the whole point of being a Bionaut, that you are truly excited about and you can share with others. That's the primary goal. Along the way, there's a hidden secondary goal, which is to give you improved literacy. Maybe you've already heard about brainstorming, but we're going to level up your brainstorming. But most of the tools, I bet you haven't seen before, and literacy and practice with generally useful tools for deciding what to do. These are tools that are useful in bioengineering, but if you go into business, if you go to the theater, whatever you do, these will be useful tools that you're getting through the class project. Enjoy that, too. Let's take them one at a time. What I'm going to do here is I'm not going to spend all the time you need to spend on the tools. I'm just going to give you a taste of it. Then when you look at the project module assignment, we've embedded links to websites and resources, YouTube videos and this and that, five minutes here, eight minutes there, would really encourage you and are expecting you to watch those videos, practice the materials before you apply the tools. I'll just give you a taste of each tool. The first tool is brainstorming. Again, you've probably heard about brainstorming or at least familiar with the word. I want you to think about it, though, like chess. Maybe you", "start_char_idx": 0, "end_char_idx": 4091, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "725b54c8-090f-46fb-9fcf-5b7d1d3ceb73": {"__data__": {"id_": "725b54c8-090f-46fb-9fcf-5b7d1d3ceb73", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8d5ad962-585b-4050-8998-b68b7d4f356a", "node_type": null, "metadata": {}, "hash": "b2590ee8505ecc733641c1caffe1221a2efe27b5f0490a346a313e38fb56d33e"}, "2": {"node_id": "47931fe8-deb8-4f76-b5c4-f727e574ae07", "node_type": null, "metadata": {}, "hash": "e7a02214b9c8382ccc198f0481935a00aabebdfabd9a1dffc37ac3ad8469d7e0"}, "3": {"node_id": "d29b08c4-3165-4509-b5fc-69167c2df5b4", "node_type": null, "metadata": {}, "hash": "4e252c5d0a079bebfdcabe342e174d44c0406f20f253fa9e301860d7bee8c835"}}, "hash": "9451852d1a18723b55c74375f00c8a317baba0a90c79d63c90a4e507dfa56cd3", "text": "with the word. I want you to think about it, though, like chess. Maybe you know how to set up a chess board. That's pretty good. Maybe you even know how to play chess, but you're probably not, maybe some of you, but I guess most of you are not chess grandmasters. You're not among the best people in the world at playing chess. Even if you know how to set up a brainstorm, maybe you're not a grandmaster of brainstorming. In that spirit, please pay attention to what's going on here. In other words, never miss an opportunity to be fabulous. Okay. Brainstorming fundamentals. This comes from the d.school at Stanford, where I have a lot of fun and do some teaching as well. The first thing about brainstorming, these are like rules of brainstorming, which is a little bit paradoxical, but they're rules, so you have a good brainstorm or a great brainstorm. You want to do this with others and this part of the project you can do with others and we're asking you to do with others. When you're brainstorming, you don't want to judge what somebody says. It's like, oh, that's a stupid idea. If you say that, brainstorm is going to crash. Suspend critique. There'll be plenty of time to figure out whether it was a good or bad idea later. Once you get that out of the way, now you can go for wild ideas and encourage it. It's like something sounds totally crazy. Just keep going. Oftentimes, the next thing that comes up will be really important or good. Work together. Build on the ideas of others. Listen to what other people are saying and add on to it. My favorite turn of phrase when I'm brainstorming is like, yes, end. Yes, end. Like, oh, my gosh, this is amazing. Yes, end. It's like, oh, we're going to put a potato on the moon. Yes, end. It'll be French fries the next time we go there. It doesn't make any sense. Just yes, end as a tool will help you build on the ideas of others. It's amazing. Go for volume. Not loudest volume, like not up to 11, but go for as many ideals as possible. If we're going to challenge you in this part of the project, wait for it, to come up with 100 bioengineering project ideas. And we mean it. Go for quantity. Once you get into the flow, be no problem. When you're working in a group, listen and participate to maintain a single thread of a conversation, momentum as a group. Don't break the group up into side conversations. Don't go it alone. Just get for the headline of the idea, right? Capture the idea and don't give a whole essay on your idea. Well, yes, I'm thinking of this interesting new thermometer that's made out of plastic and has a particular color that I think might go well with my drapes. And it's like, no, no, no, no. It's like, oh, we're making an upside down thermometer. Cool. Yes. And what if we, you see what I mean? Lastly, you need to write down what the headline ideas are as you go. And everybody participating together in a brainstorm must have their own pencil or marker if you're using a whiteboard. You don't want one person to have to listen and write down everybody's ideas because they couldn't participate otherwise. So you can work in parallel in terms of recording the ideas all on one big giant sheet of paper on a chalkboard or a whiteboard, but everybody has to be able to write independently. Okay. And just as a reminder, practice using the turn of phrase when you're in a brainstorm. When somebody says something, listen to it and go, yes. And what about this? Right. Unbelievably, these are magic words in a brainstorm. I guarantee if you only practice using yes and, your brainstorming will become 10 times better. Okay. Now, next tool. Brainstorming. The amazing author, Ursula K. Le Guin has a nice quote. There are no right answers to wrong questions. So if you have a project idea and your project idea sounds pretty cool to you, but it's not", "start_char_idx": 4032, "end_char_idx": 7869, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "d29b08c4-3165-4509-b5fc-69167c2df5b4": {"__data__": {"id_": "d29b08c4-3165-4509-b5fc-69167c2df5b4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8d5ad962-585b-4050-8998-b68b7d4f356a", "node_type": null, "metadata": {}, "hash": "b2590ee8505ecc733641c1caffe1221a2efe27b5f0490a346a313e38fb56d33e"}, "2": {"node_id": "725b54c8-090f-46fb-9fcf-5b7d1d3ceb73", "node_type": null, "metadata": {}, "hash": "9451852d1a18723b55c74375f00c8a317baba0a90c79d63c90a4e507dfa56cd3"}, "3": {"node_id": "25440e66-f9c5-47b7-a8b2-4f916352bd33", "node_type": null, "metadata": {}, "hash": "05580cb51e01db0e665982fbbb6ab613884522b6cd5ee34b532cdc7522213f84"}}, "hash": "4e252c5d0a079bebfdcabe342e174d44c0406f20f253fa9e301860d7bee8c835", "text": "a project idea and your project idea sounds pretty cool to you, but it's not framed as well as it could be, you could spend a huge amount of time and in the real world, a huge amount of resources working on the wrong problem, working to answer the wrong question. And so, framestorming is the second tool we're going to give you. And this tool is to help you double check and really actively question whether or not you're asking the right question or you could ask a better question. This comes from a colleague, Tina Seelig. In brainstorming, you're given a prompt and you come up with a lot of ideas. In framestorming, you're questioning the question. Right. And Tina likes to say, you got to framestorm before you brainstorm. In our case, we're going to take your brainstorm, as you'll see, and you'll pick your topics or questions and then we'll framestorm just a subset because you're going to have so many ideas. It'll work. Trust me. Let me give you a simple example to think about. Hey, everybody, let's plan a birthday party for Sally. What should we do for Sally's birthday? Brainstorm. Right. And so, if we brainstorm on what should we do for Sally's birthday, we'll get all these amazing ideas for what to do for Sally's birthday. Brainstorming, we go, hmm, let's brainstorm how we could have a celebration for Sally. Let's have, what should we do for a party for Sally? I just got rid of birthday. If we brainstormed on that question, we get a different set of answers than what should we do for Sally's birthday? What should we do to have a party for Sally? Slightly different questions, totally different outcomes from the brainstorm. So, that's what that's what framestorming is about. Keep it wild and weird. Let me give you an example. We're questioning the question. We're going to brainstorm the question, in other words. So, maybe some of your project ideas had to do with cancer and fighting cancer. How can we fight cancer? Right. This is an example of skin cancer. How can we fight cancer? But what if we said, you know, instead, like, how can we, let's brainstorm the question. Instead of how can we fight cancer, let's just brainstorm. How can we prevent cancer? How can we tease cancer? How can we love cancer? How can we tickle cancer? Remember, there's no bad idea in brainstorming, and we're brainstorming the question here. How can we tickle cancer? How can we stop cancer? How can we share cancer? How can we lick cancer? It doesn't make any sense, but I shouldn't have said that because we're brainstorming. You know, how can we blog cancer? Oh, that's interesting. How could we blockchain cancer? Could I use the blockchain to create an advocacy group in support of a particular type of skin cancer? Like, oh, right. It's like, whoa. So, we're brainstorming the question. Instead of locking in on how can we fight skin cancer, you could keep going. Of course, you could have a hundred different ideas here, and then you go, which one of these is really unique, potentially powerful, has never been asked before, lets me pioneer an entirely new Bionaut idea, an opportunity. So, I really, I love all these tools we're introducing you to, but brainstorming is really one of my favorites because it lets you question the question, and if you really embrace brainstorming, I guarantee you will find new ways of thinking about important problems that nobody's uncovered before. That's brainstorming. Okay, next. And this might be like, well, how could this issue arise in bioengineering? You don't know, but it's good to have this tool in case it does, right? So, what do we mean by legal ethical? You can map actions into four quadrants. The ones on the top, they're legal. The ones on the bottom are illegal. The ones on the left are ethical. The ones on the right are unethical. So, I could be in the top left quadrant and I'm doing something, it's legal and ethical. I'm in the bottom right quadrant, it's illegal and unethical. If I'm in either top left or bottom right quadrant, it's", "start_char_idx": 7868, "end_char_idx": 11887, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "25440e66-f9c5-47b7-a8b2-4f916352bd33": {"__data__": {"id_": "25440e66-f9c5-47b7-a8b2-4f916352bd33", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8d5ad962-585b-4050-8998-b68b7d4f356a", "node_type": null, "metadata": {}, "hash": "b2590ee8505ecc733641c1caffe1221a2efe27b5f0490a346a313e38fb56d33e"}, "2": {"node_id": "d29b08c4-3165-4509-b5fc-69167c2df5b4", "node_type": null, "metadata": {}, "hash": "4e252c5d0a079bebfdcabe342e174d44c0406f20f253fa9e301860d7bee8c835"}, "3": {"node_id": "2eec2970-4623-4c74-bbbf-c3a209896641", "node_type": null, "metadata": {}, "hash": "e7808c166800a0082f1f285754188d29a1c5a91c1f0ce8d9e9fd7d34712564ad"}}, "hash": "05580cb51e01db0e665982fbbb6ab613884522b6cd5ee34b532cdc7522213f84", "text": "illegal and unethical. If I'm in either top left or bottom right quadrant, it's kind of obvious what I should be doing. Like, if I'm in the top left, go for it. If I'm in the bottom right, don't do it. But what if it's legal yet unethical? Should I do that? Or what if it's illegal but ethical? Should I do it? And so, the top right and bottom left are like a little bit interesting. And then of course, opportunities might lie over the boundaries. So, let's see some examples. A pediatrician taking care of a kid. That's legal, that's ethical. All right, pretty easy, right? Somebody robbing somebody else with a handgun. That's illegal in most places, so far as I know, and it's certainly unethical, so far as I'm concerned. Cheating on your boyfriend or girlfriend or partner. It's probably legal, but I wouldn't call it ethical. I'd call that unethical, right? Rosa Parks riding on a bus. Illegal at the time, but easy to argue it was ethical. Smoking in school. Depends where you are. Might be legal, might be illegal. What about secondhand smoke that might harm somebody who's not a smoker? Probably, in my mind, makes this unethical. So, it gives you a sense of legal, ethical. When you come up with your project ideas, we're going to ask you to just check. You know, where in this quadrant space does your project idea land? And by the way, at first blush, it's like, yeah, come on, I just want to cure cancer. Okay, probably that's legal, ethical, depending on your idea. But since you're brainstorming and going for hundreds of ideas, my guess is some of them might not all be in the top left, right? And that's okay. We just want to understand and think about how things might deploy if it were to get to the real world. All right, legal, ethical, all good. Next, design criteria. So, once you have your ideas and you're selecting, like, the finalist or the final one, it's important to elaborate on the details of what the thing should be as it manifests in the real world. And I'm going to give you a really simple example here. You'll typically want to have a half dozen or so entries in each of these four areas. But let's do a simple one just for the sake of time. So, let's say we wanted to make a glowing plant. We're going to bioengineer glowing plants. We've already talked about them. You've seen videos of them. They're wonderful. But, like, imagine we were starting out on that project. So, the first thing about the design criteria is, what must this project have? What must your project have? Well, we're making glowing plants. So, the glowing plants must glow. It's not negotiable. They have to produce light. All right. And we could write some other things about what must they do. The next thing is, what should they do? You know, should have. Important features of these plants. To start, I might say, like, my glowing plants should look like normal plants. Sounds reasonable. Again, you could have a lot of entries here. Sounds reasonable. Again, you could have a lot of entries here. The next category in design criteria is could. Could have. Optional features. You know, must have. Not negotiable. Could have options. Like, I got some options on my car. Well, maybe we could have the option of having the glow turn on or off in response to darkness or light. You know, so the plants are only making light when it's dark in the room or only making light when it's dark outside. The last category of the design criteria, super important, what won't your project have? Not negotiable. It won't have whatever you put in this box. Like, not on the table. So, for example, I might say, my glowing plants will not share their genes with other creatures. I don't want to if I have a glowing plant in my house, I don't want my dog to start glowing. Right? Like, not negotiable. I don't want a glowing dog from my glowing plant, at least. So, that's design criteria. We'll ask you to complete this. And again, with more", "start_char_idx": 11884, "end_char_idx": 15825, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "2eec2970-4623-4c74-bbbf-c3a209896641": {"__data__": {"id_": "2eec2970-4623-4c74-bbbf-c3a209896641", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8d5ad962-585b-4050-8998-b68b7d4f356a", "node_type": null, "metadata": {}, "hash": "b2590ee8505ecc733641c1caffe1221a2efe27b5f0490a346a313e38fb56d33e"}, "2": {"node_id": "25440e66-f9c5-47b7-a8b2-4f916352bd33", "node_type": null, "metadata": {}, "hash": "05580cb51e01db0e665982fbbb6ab613884522b6cd5ee34b532cdc7522213f84"}}, "hash": "e7808c166800a0082f1f285754188d29a1c5a91c1f0ce8d9e9fd7d34712564ad", "text": "that's design criteria. We'll ask you to complete this. And again, with more entries, more detail, just want to give you a quick taste here. Finally, futures wheel. This is a tool you can use to evaluate the consequences of success. Imagine your project is real. It's all over the place in the world. Right? As a product, a service, or some change. What futures wheel lets you do is says, okay, if this change happens in the world, what are the first order consequences as a result of that change in orange? And then, what are the consequences of those consequences? Using your imagination. Like, what are the second order consequences? And then, once you get to that second layer or wheel of consequences, you can keep going. What are the third order consequences? And so on. So, given a change, use your imagination, say, well, what's this going to do in the world? And if those things happen, what's going to happen because of that? And so on and so forth. Futures wheel. Sounds pretty simple. What's really interesting about this is suddenly you can find things happening that maybe you wouldn't have expected. And if you can imagine what those things might be, wait for it. Now you can loop back to design criteria and say, would I like to change any of my design criteria so that I'm promoting the consequences I like while minimizing or mitigating or stopping the consequences I don't like? Right? This is an all-open loop. These are tools that are meant to be used in conjunction with one another. Great. Let's look at a couple examples. Right? So, we've all experienced the coronavirus outbreak back in 2019. And a first order consequence of that is that we saw that schools shut down and companies shut down and other institutions shut down. And because of that, there was a second order consequence of people staying at home, you know, doing whatever they do at home. And because of that, we saw a third order consequence of digital platform companies increasing their growth and standing in society. Like Zoom suddenly became a thing. Right? Because of the pandemic, there was a first order consequence of hospitals being overwhelmed and supply chains and nurses and doctors.", "start_char_idx": 15815, "end_char_idx": 18002, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ad60890b-2625-4e4c-a380-d3384e5d4b67": {"__data__": {"id_": "ad60890b-2625-4e4c-a380-d3384e5d4b67", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "53bd4554-9e4a-490e-a410-bbdbc26f5130", "node_type": null, "metadata": {}, "hash": "7542ab2756817e53fef1ca7cc447d301f9f279cb9b950e7b8b1508ea1ee2adba"}, "3": {"node_id": "10a6cd87-4ef5-473a-80e2-773a4edbb8a5", "node_type": null, "metadata": {}, "hash": "77a92a00532a8c12796937ac0c43a680612c8d34ffe4a09135aba78f322e8aa3"}}, "hash": "46a4e3bb728a7465d39f88cf4ee77872a768a769d3e88c6e938b7c36c8c0c29b", "text": "doctors being super stressed and dying. We saw a second order consequence of hoarding potential black markets around masks and other things. We saw a different second order consequence of challenges to governmental systems at every level, local, regional, national controversies. We saw changes in political leadership due to failures in elections to get reelected. We saw a third order consequence of stresses and trust of the government and other institutions. We potential imagined a fourth order consequence of future social unrest and challenges to democracy and international relations. You get the idea. Let's come back and do this with glowing plants. Okay, so imagine my Bionet project idea to make a glowing plant, cha-ching. And now I wanna know what impacts it's gonna have on the world. So I can think about these impacts and decide if I wanna change any of them. Right, so glowing plants, first order impacts. Hey, you know, my kids are impressed. I bring a glowing plant home. They're like, wow, dad, that's pretty cool. Next C, I'm gonna have a water dependent nightlights. Don't plug it in, gotta water it. I love glowing gardens. All right. Wow, glowing plants, they're cool. Maybe I get more funding from the government or from investors for plant biotech R&D. All right. And if that's true, you know, like maybe I get actually, no, no, even just the glowing plants itself, this is a first order impact. It's a better tool for plant R&D. I can use the glow to tell me whether genes are on or off in certain tissue types. So like glowing as a print statement or an output statement to let me understand plants, like super cool tool for plant R&D research. There's more first order consequences. Let's just get a sense of it. All right. So let's see. New category at flower shows. That's a first order impact. So if people who compete in flower shows start to create new categories around glowing plants, a second order impact is gonna be more colors of glowing. And then the third order impact would be like glowing rainbow gardens. And let's see, more flower show stuff. So who participates in flower shows? I don't have time for that. Maybe there'll be greater GMO acceptance among retirees. Like I might enjoy a flower show if I ever retire. And if that's happening, you know, maybe this all comes together and instead of like fall foliage in Vermont or wherever, where the leaves change color, maybe we have nighttime foliage where there's different glows of plants. It's not in the fall, it's in the spring and the summer. So you go out at night and people's hillsides and forests are all different colors lit up at night. All right. Okay, better tools for plant biotech R&D, more climate resilient crops, better operational understanding of plants. Finally, we get nitrogen fixing crops for crops that aren't naturally legumes or things like that. These are all second order consequences. Well, then third order consequences or impacts would be reduced starvation risk, increased population before, more profits for seed corpse. Is that good or bad? Depends. What if we could have plants that grow things? If we have full understanding of plants, like I'd like to have a pitcher plant that's just a coffee cup. You know, it's like, why do I have to make coffee cups in a factory to just grow coffee cups or grow, you know, thermoses? Could we have, oh no, like nitrogen fixing plants and operational understanding of plants. Maybe we can get plant based weapons. Could I engineer an apple tree or like a grapefruit plant to make a grenade, you know, where the plants are doing biosynthesis of high energy compounds. And then the fruit is a grenade fruit, like, whoa, like suddenly growing plants. And like, I might get military munitions grown off of, okay, well, let's come back off that one. Nitrogen fixing, but like, okay, here's the thing. If you wanted this, what would you do in your design criteria to make this outcome more likely? Plant-based weapons, grenade fruit. Or if you didn't want this, what would be in", "start_char_idx": 0, "end_char_idx": 4045, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "10a6cd87-4ef5-473a-80e2-773a4edbb8a5": {"__data__": {"id_": "10a6cd87-4ef5-473a-80e2-773a4edbb8a5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "53bd4554-9e4a-490e-a410-bbdbc26f5130", "node_type": null, "metadata": {}, "hash": "7542ab2756817e53fef1ca7cc447d301f9f279cb9b950e7b8b1508ea1ee2adba"}, "2": {"node_id": "ad60890b-2625-4e4c-a380-d3384e5d4b67", "node_type": null, "metadata": {}, "hash": "46a4e3bb728a7465d39f88cf4ee77872a768a769d3e88c6e938b7c36c8c0c29b"}}, "hash": "77a92a00532a8c12796937ac0c43a680612c8d34ffe4a09135aba78f322e8aa3", "text": "weapons, grenade fruit. Or if you didn't want this, what would be in your won't line in the design criteria? See what I mean? See why this gets really interesting? All right, lower CO2 emissions, all right. Okay, let's go back. Glowing gardens. I cannot wait to plant glowing plants in my lawn, in my garden. Oh, maybe that's going to confuse the insects. They're going to be like up all night or who knows. And maybe there'll be some horizontal gene transfer. Other creatures will get the glowing cassette. And now suddenly, like, not just my garden is glowing, but other things are glowing, like the forest or the birds and insects that are eating the plants or parts of the plants. And if I have confused insects, then maybe I have collapsing ecosystems. It's like, maybe I need to, like, what do I, do I want this or not? What do I do down here? Water-dependent light lights, lower electric bills, but more water spills, more shopping, because I saved money on my utility bill, but more water spills. I have to do more laundry or ruin clothes. And what does that cost? If my kids are impressed, oh, no, they're going to have higher expectations. You know, they're going to look at that movie, Avatar. It's like, well, you know, that's like, that's just a movie. I have glowing plants in real life. So then James Cameron, who made Avatar, is going to have to like double down. He's going to have to go and imagine something even crazier than Pandora and so on. All right. You get the idea. Future's Wheel, pretty cool. And the point here is to imagine first, second, third, fourth order impacts. Keep going until you get tired, basically. But most importantly, don't just stop at that. Think about what you want and what you don't want from these impacts and then redesign your project. All right. Reflective questions. The thing about this BioNet project is we really are not telling you what to do. It's up to you where you are to decide the most important, fun, compelling thing that you'd like to imagine bioengineers can do. And so the first reflective question is, is it hard? Give it a blank slate. How do you feel about it? Have you been asked to do this sort of thing before? Leaders are asked this all the time. So we cannot wait to see what you come up with and to see that you're practicing these tools because having these five tools and using them once, you just keep going for the rest of your life. But stop for a moment and think about how you feel about it. Was it challenging? Was it easy? You know, why? What tools of the five helped you get going the most? Which tools do you feel like you understand? Which tools would you like to practice some more? Remember in the assignment itself, there are links to more information, YouTube videos, websites. I'm still learning about all these tools, right? Like I know how to brainstorm. I can get better at brainstorming. I'm definitely about the world's best brainstormer. How often, when you're coming up with a project idea, should you stop to consider the impacts, real or potential, of what you are or might be doing? Should you think about this at all? Or should you check at every step or something in between? That's it. Can't wait to see what your projects are.", "start_char_idx": 3977, "end_char_idx": 7214, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ebf94cfa-7a0a-4fab-b377-1e956a88e06b": {"__data__": {"id_": "ebf94cfa-7a0a-4fab-b377-1e956a88e06b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "27fbe2c8-e129-4395-a5a5-778eb7354f3e", "node_type": null, "metadata": {}, "hash": "dd72093905aa920bc96a1854f61dcb3fc52c1d274556e8c61d30d2383d393710"}, "3": {"node_id": "b4bb383e-d719-4d2a-ac03-b0abf1845785", "node_type": null, "metadata": {}, "hash": "0cd32e1a2911b4e1ae990166f6e76ac17cfd0905c751f0b0b3e64df9c8df1e17"}}, "hash": "c56e7810cbfb14c2eefb66563ae864ecce987fe9fdcc09f033ece1912146beb2", "text": "We're going to talk about the bio-economy. So zooming out and not thinking about the details of molecules, but how this manifests in economic practice and relationships. Let's jump in. Economy, what's that? Well, you could say it's the wealth or resources of a region, or more particularly, the making of things, the consumption of things, the goods and services. And so when we put bio in front of economy, it's how does bio-making and bio-consumption relate to the goods and services we enjoy or depend upon? In the modern sense, the thinking here is not that old. Here's a paper that was published in 2007 by Rob Carlson. Rob used to be my old housemate, believe it or not. He writes, laying the foundations for a bio-economy. And in the abstract, we see he says, biotech is becoming an important part of the economy. Now, biotech, of course, gets invented around 1980. And so when he writes in 2007, this is 27 years in, maybe 30 years in. And within a generation after the invention of genetic engineering, biotech is contributing 1% to the gross domestic product, this proxy for all economic activity in the United States. So 1% of everything, right? 1% including finance revenue and manufacturing revenue of cars. And biotech's already 1%, this back in 2007. And what's interesting is he's like, it's growing. It's growing fast, 20% growth. That's incredible growth, right? It's like doubling in just a few years. If you grow 20% every year, suddenly you've got twice as much. All right, what else does Rob say? Oh, I love this. This is fun language. He writes, welcome to the paleobiotic age. Just as today, we look back somewhat wistfully on our quaint paleolithic, literally old stone ancestors, our descendants, the people who come after us, they're gonna see us as the paleobiotic people, that we hardly understood biology and biotechnology at all. It's only 1% of the economy. Maybe it's gonna become 90% of the economy. We're paleobiotic people. I love that word. And what is the bioeconomy? How big is it? And he estimates it's somewhere between 350 to a trillion dollars a year and so on. All right. And if you go back in time to 2007, one of the reasons Rob's framing and paper were so important is it helped displace recent earlier experiences. So this image here shows an effort to decontaminate, it looks like the Congress in Washington, DC, in response to a marathrax, the sending of anthrax spores as a pathogen to members of Congress and others. And there are about 24 casualties due to these very famous attacks that immediately followed the planes being hijacked. What do I mean? More specifically, the way people thought about biotechnology following the anthrax attacks, culturally, the narrative was dominated by fear and bioterror. And so when Rob shows up with others, as we'll see, and starts talking about the bioeconomy, people are like, oh, thank goodness. We might want economic growth. We might want jobs and money, right? And so might bioeconomy be culturally more powerful than bioterror? It turns out it was. And so another incredibly important piece of work was led by Mary Maxson working in the Obama White House. She's a biologist, a geneticist who'd studied yeast previously, but then enters public service and working in the Obama White House drafts, leads the drafting of what was then called the National Bioeconomy Blueprint. And, you know, goes on to write things like, a bioeconomy is one based on the use of research and innovation and the biological sciences to create economic activity and public benefit. The bioeconomy is all around us, new drugs, new diagnostics for improved health, higher yielding food crops, better biofuels that reduce dependency on petroleum and so on, just to name a few, they write. And the public benefit gained here is enormous. It's feeling pretty good. This is 11 years ago. But there's a problem. And it was a political cultural problem. Although the White House is drafting a bioeconomy blueprint, we", "start_char_idx": 0, "end_char_idx": 3985, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "b4bb383e-d719-4d2a-ac03-b0abf1845785": {"__data__": {"id_": "b4bb383e-d719-4d2a-ac03-b0abf1845785", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "27fbe2c8-e129-4395-a5a5-778eb7354f3e", "node_type": null, "metadata": {}, "hash": "dd72093905aa920bc96a1854f61dcb3fc52c1d274556e8c61d30d2383d393710"}, "2": {"node_id": "ebf94cfa-7a0a-4fab-b377-1e956a88e06b", "node_type": null, "metadata": {}, "hash": "c56e7810cbfb14c2eefb66563ae864ecce987fe9fdcc09f033ece1912146beb2"}, "3": {"node_id": "f2aa6b1c-1ae4-47d5-944f-113f26a67784", "node_type": null, "metadata": {}, "hash": "6ab2163dd9a356ba897f69cbc308c40ed407bb8228db32289fc64e58a495af33"}}, "hash": "0cd32e1a2911b4e1ae990166f6e76ac17cfd0905c751f0b0b3e64df9c8df1e17", "text": "political cultural problem. Although the White House is drafting a bioeconomy blueprint, we weren't able to put into practice executive orders or legislation to dramatically advance the blueprint. Instead, what we encountered was concerns about biotechnology, concerns about GMOs, valid concerns. And so in other words, instead of boosting the bioeconomy back in 2012, we got a little bit of a pushback and people concerned about the environment and organic food and so on appropriately raised questions about what future we might be building with our bioeconomy. And so we didn't see actions taken at the highest levels of government just over a decade ago. Rob appears not too much later, 2016, and he's estimating this time, how big is the bioeconomy really and how much is it growing? And it's like, okay, we've got industrial stuff. These are polymers and monomers, things that make carpets by brewing ingredients. We've got biologics, which is a placeholder for medicines and then crops. And you can see these sectors in 1980, there's $0 billion a year of revenue and genetic engineering is just getting going and then up, up, up, up, up and away. And it's doubling with interesting pacing every five years or so. Okay. And so, again, why are we talking about bioeconomy? If you're becoming a bionaut and are gonna be doing things in the world, whether you're making goods or services, you're gonna be entering into the bioeconomy directly or indirectly. So we might wanna understand it. That's just to remind us what the motivation is here. Here's another cut at what Rob's representing. It's interesting. The biggest economic sector for biotechnology back in 2017 is food, agriculture. And the second biggest is industrial intermediates and medicines and health, which is what people think about first most of the time. It's actually a big sector, but it's the third biggest, right? So that's interesting to see. Okay. And this is just for the United States, right? So globally, it's gonna be bigger still. So let's see what's happening again. Let's try again at the White House. So here we are in 2019 with the White House then, Dr. Megan Palmer, Dr. Mark Sallet, and myself. And we're there for the 2019 Summit on America's Bioeconomy. And you can see a description here. The link down below. You can read the whole report. Bioeconomy represents the infrastructure, innovation, products, technology, and data derived from biologically related processes and science that drive economic growth, improve public health, agriculture, and security. Bioeconomy outputs are incredibly diverse and feature applications limitless in terms of application and value. New ways to treat cancer, novel manufacturing methods for medicines, plastics, materials, consumer products, pests and diseases, and so on and so forth. DNA-based information storage. Well, all the things we've been talking about in class. Looks like they got it right. Now it's 2% of the GDP, almost $400 billion a year. We weren't able just in 2019 to get an executive order signed by the president. We didn't see it at the highest levels of government. Just like in 2012, we were close. We were close again, but no deal. But what if we really could grow almost anything? And so while we didn't yet see the government going all in on biotechnology and bioengineering and the bioeconomy, we saw the private sector start to pick up on this even more. And so here's a report from McKinsey, the consulting shop, and they dropped this in 2020 or thereabouts, the biorevolution. There's gonna be four areas for innovation, molecular, systems, biomachines, and biocomputing. And the scope of the impact of innovation in these fundamental research layers is ridiculous. 60% of the physical stuff we need and consume in our society could be grown as opposed to refined and derived from fossil inputs or other manufacturing methods. We foresee addressing almost half of the world's diseases through a biorevolution. And this is talking about the next 10, 20 years. And there's a lot of R&D opportunity. What are they talking about in a little bit more detail?", "start_char_idx": 3907, "end_char_idx": 8023, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "f2aa6b1c-1ae4-47d5-944f-113f26a67784": {"__data__": {"id_": "f2aa6b1c-1ae4-47d5-944f-113f26a67784", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "27fbe2c8-e129-4395-a5a5-778eb7354f3e", "node_type": null, "metadata": {}, "hash": "dd72093905aa920bc96a1854f61dcb3fc52c1d274556e8c61d30d2383d393710"}, "2": {"node_id": "b4bb383e-d719-4d2a-ac03-b0abf1845785", "node_type": null, "metadata": {}, "hash": "0cd32e1a2911b4e1ae990166f6e76ac17cfd0905c751f0b0b3e64df9c8df1e17"}, "3": {"node_id": "5d4433de-3bb9-4c4d-a37e-470e46c75a6a", "node_type": null, "metadata": {}, "hash": "c5db734ac6f0098c3cba4be51d7c28d0577c8cd5748c16c565e59ec4586141d6"}}, "hash": "6ab2163dd9a356ba897f69cbc308c40ed407bb8228db32289fc64e58a495af33", "text": "of R&D opportunity. What are they talking about in a little bit more detail? Biomaterial production, personalized precision services and medicines, engineered organisms, higher productivity, biomachine interfaces and computing. It's gonna impact agriculture, health, energy, consumers, instead of being a couple of hundred billion dollars a year domestically, it's gonna be two to $4 trillion a year. It's a double digit percentage of the economy. It's growing, right? We're not just growing in terms of what we do with biology, like the economic impact of bioengineering is growing. And not only are there like transformational capacities across many different application areas, there's a lot of problems. There are a lot of risks, things to manage. It could be misused. It's hard to get agreement. There's privacy concerns. It might not be fairly distributed. Not everybody can benefit from the bioeconomy. You might not be able to control it in terms of crossing borders and policing, right? So you can look at that the right side and probably add other concerns. I just want you to know that all these risks are opportunities for somebody to figure out how to mitigate the risk or solve the problem, right? So there's tremendous growth in opportunity and support for the bioeconomy. Of course, now we're also experiencing a pandemic, right? And so the SARS-CoV-2 experience is informing everybody's thinking. The private sector continues to grow. Here's some students who took over the New York Stock Exchange for a day and it looks like they put a T-Rex on the front. And below that, as they're listing their company on the Stock Exchange, they say, grow everything, right? So they're gonna give that a try. Finally, in September of 2022, we see an executive order signed by the president of the United States of America. And let's just read it a little bit. Executive order on advancing biotechnology and biomanufacturing innovation for a sustainable, safe, and secure American bioeconomy. And one of the lead public servants who helped get this across the finish line is Dr. Michelle Rosso. Here, Megan Palmer, past colleague, was part of the event as well. And so the executive order mechanism is interesting because it's literally the president ordering the executive branch of the government to do stuff, right? And so they're fun to read. It's like, by the authority vested in me as president, I order the following, right? Section one, policy. It's the policy of my administration to coordinate a whole-of-government approach to advance biotech, biomanufacturing towards innovative solutions and all the things we've been talking about in this class. Health, climate, energy, food security, agriculture, supply chains, national and economic security, central to this policy and its outcomes are the principles of fairness, doing the right thing, safety, and security. All right. And again, the link, if you wanna read the whole thing and see what's going on, is at the bottom of the slide. Finally, right? Like, finally, we see at the highest level of government, like, bioeconomy's gonna matter, which is proxy for jobs and money derived from bioengineering biotechnology. It only took us four administrations, but here we are, right? And so, you know, what does this look like? You can track down on YouTube the recording of the event. I dropped some links in here. Like, check it out. I double-dog dare you to go to the second link at the timestamp, 15 minutes, and listen to what the director of the National Science Foundation has to say about bioengineering, right? But this is the room and you've got the science advisor to the president, the chair of the National Economic Council, the advisory advisor, Chairman Warner from the Senate Intelligence Committee. Anyway, like, all of government approach, like, we're gonna figure this out, right? Okay. And so, the rest of the world starts to react. Here's John Cumbers writing for Forbes, White House unveils strategy to grow trillion-dollar U.S. bioeconomy. The bioeconomy is booming and it's gonna get a lot bigger, and", "start_char_idx": 8040, "end_char_idx": 12130, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "5d4433de-3bb9-4c4d-a37e-470e46c75a6a": {"__data__": {"id_": "5d4433de-3bb9-4c4d-a37e-470e46c75a6a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "27fbe2c8-e129-4395-a5a5-778eb7354f3e", "node_type": null, "metadata": {}, "hash": "dd72093905aa920bc96a1854f61dcb3fc52c1d274556e8c61d30d2383d393710"}, "2": {"node_id": "f2aa6b1c-1ae4-47d5-944f-113f26a67784", "node_type": null, "metadata": {}, "hash": "6ab2163dd9a356ba897f69cbc308c40ed407bb8228db32289fc64e58a495af33"}, "3": {"node_id": "ec1a0ccd-1a92-427c-b890-a704e121f820", "node_type": null, "metadata": {}, "hash": "5aafada92d88b32dcd2924918ab9b38c3c5eeb8163c0caadcd627b202daebdb2"}}, "hash": "c5db734ac6f0098c3cba4be51d7c28d0577c8cd5748c16c565e59ec4586141d6", "text": "The bioeconomy is booming and it's gonna get a lot bigger, and let's go, right? Like, he used Dali and artificial intelligence to make a pseudo-watercolor painting of what the bioeconomy looks like. Let you decide what you think of that artwork. Also in this article, it's pretty interesting. Dragon Lady has a comment that she drops at the bottom. A nice article. The one thing that's gonna be a problem with this plan is that our education system isn't educating the future generations to think, to innovate, to create, to push the envelope and to develop new technologies that are safe and sustainable. Ha-ha, but here you are, right? So, Dragon Lady doesn't know about you and what we're doing through this class together. I love this comment. We're on it, right? So, remember, when you become a bionaut, maybe you can pay it forward and teach still more people about what biotechnology is about and why they might wanna be part of it or at least express how they feel about it. Okay, fine. It's great at a high level, but it's like White House, this and that. At this point, you should be saying, what about me, right? Like, what do 21st century bioengineers do? And it's like, are there really jobs? And like, what are they? And is there a job for me? Right, so these are all the more important questions, right? Cause we're all just individuals and we've gotta figure this out for ourselves. Our course has this theme of enabling you to become a bionaut, navigating and leading into the biotechnology frontier and beyond, right? Like an astronaut going into space, but much more interesting, we're going into the future of biotechnology together, right, so bionauts assemble. What we wanted to do is talk to people in the real world about what it's like to be a bionaut. And what we want to do is talk to people in the real world and ask them what type of bioengineers they are. And so just for this class, with the team here, we have arranged for nine people to be interviewed, the folks shown here. And we've asked each of them about things like, well, what type of bioengineer are you? And how did you find your way into the biotic future as a bionaut? Let me tell you just a little bit about some of these people. But as of today, the recordings of the interviews are all online on YouTube. And as part of the PSET, we'll ask you to at least dig into three of them to see what you can learn. So let me just give you some postcards to help you get oriented and motivate why you want to track down these interviews. First, Sophia. She is the co-founder and chief of culture for a company called MycoWorks. She used to be a dancer, an artist, a performer, but now she's a leader of this company called MycoWorks, Myco for mushrooms. And so you can see a picture here with her CEO and the New York Times is asking the question, are mushrooms the future of leather? And what MycoWorks does is they use mushrooms that grow on wood chips to make a mushroom skin that you can peel off and put through a tanning process and make a replacement for animal leather. So what if you could grow a replacement for leather in a couple of weeks with no cows involved, right? And you can see this picture down in the bottom left, there's Sophia in the middle in red and they're down in Union County, South Carolina creating a new factory, a million square foot factory that's gonna provide 400 jobs in that community to scale up the manufacturing of mycological leather, right? So maybe you want to check out the interview she was a performer, a dancer, now she's the chief of culture for MycoWorks. Another person, Ben Novick, lead scientist and program manager at Revive and Restore. Revive and Restore is a charity whose mission is to bring bioengineering technologies to every other species besides Homo sapiens. There's so many people working on human health, what about the health of other creatures on the planet? And so one of the projects Ben leads, believe it or not, is to work on de-extincting or reviving the passenger pigeon one of the most abundant", "start_char_idx": 12143, "end_char_idx": 16198, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "ec1a0ccd-1a92-427c-b890-a704e121f820": {"__data__": {"id_": "ec1a0ccd-1a92-427c-b890-a704e121f820", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "27fbe2c8-e129-4395-a5a5-778eb7354f3e", "node_type": null, "metadata": {}, "hash": "dd72093905aa920bc96a1854f61dcb3fc52c1d274556e8c61d30d2383d393710"}, "2": {"node_id": "5d4433de-3bb9-4c4d-a37e-470e46c75a6a", "node_type": null, "metadata": {}, "hash": "c5db734ac6f0098c3cba4be51d7c28d0577c8cd5748c16c565e59ec4586141d6"}}, "hash": "5aafada92d88b32dcd2924918ab9b38c3c5eeb8163c0caadcd627b202daebdb2", "text": "or reviving the passenger pigeon one of the most abundant birds in the history of North America. It went extinct about a century ago from over hunting and loss of habitat. Could we bring that back to life and responsibly release it into the wild? That's what Ben does. So maybe you want to listen to Ben's interview. How about Ahmed, Ahmed Best? Amazing friend and teacher for me. He's an actor, he's a storyteller, he's an Afro-futurist. What do I mean? Well, he played a character in Star Wars. Or if you watch The Mandalorian, he came back as a master Jedi. And I don't want to like, spoiler alert, well, he like saved baby Grogu. Or with his colleague, Dr. Lonnie Brooks from Cal State East Bay, runs a program called Afro Rhythms, Afro Rhythms from the Future about democratizing the future through storytelling with respect to diversity of cultures. What type of bioengineer is Ahmed, right? Maybe you should check that one out. How about Carrie McInter? Special agent for the FBI, the Federal Bureau of Investigations, an emergency trauma nurse. What type of bioengineer is Carrie? Well, she thinks about economic espionage, nation states spying on each other, companies spying on each other, bioengineering innovations in the United States. Are they safe and secure to benefit Americans and others? Or what if bioengineering technologies could be misused to create more bioterror? How are we going to deal with counter-proliferation and biosecurity? And other matters involving people and keeping people-", "start_char_idx": 16192, "end_char_idx": 17704, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e7a18b09-5e05-472f-9fd3-19ae204de705": {"__data__": {"id_": "e7a18b09-5e05-472f-9fd3-19ae204de705", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "deebf027-27d2-47f0-8869-b4dd099c55bc", "node_type": null, "metadata": {}, "hash": "fa82bfdea73b768adc13b63577a9a5eb9b2fc7f60353f3a322e85d59c0508c49"}, "3": {"node_id": "e21613ce-28e5-4126-a97c-fb100f34571a", "node_type": null, "metadata": {}, "hash": "ebdaf80234e586865dd11799b1a32a8ca9bd90d748360938feb284afbc22d32d"}}, "hash": "627945186c30bb71346404d3e7fc72fbb7f77f2741d2c365076a23b245519e70", "text": "safe right trafficking and and so on right check out her interview or tia lyles williams founder and ceo of lucas pie bio lucas and pie are the names of her uh grandmothers combined into one name she named her company after her grandmothers um as i understand it and at lucas pie bio which is based in philadelphia or just outside philadelphia and pennsylvania their mission is to make the manufacturing of biotherapies more affordable while growing the bioeconomy and strengthening health care offerings within underserved communities um you can see a sketch of the manufacturing facility her team is is developing and operating in pennsylvania check out what what they have to say um another example barbara jonkosa she's a biotech professor and program director at miracosta college a community college in northern san diego in california and so the college runs a biomanufacturing program where people can learn how to help with biomanufacturing there's a lot of good jobs in a growing economy around manufacturing and if bioeconomy based manufacturing is growing there'll be more jobs there not only are there jobs in biomanufacturing but there's jobs in teaching people about biomanufacturing right so maybe your biotic future as you're learning about bioengineering is to help other people learn about bioengineering one of the things i wanted to do in selecting just a subset of these bio not interviews to highlight them is to give you a like what you might be surprised by a vastly increased uh diversity of of bioengineering futures right it's not just the nerdy stuff with the making of molecules and the designing of the cells it's all the other stuff that the society needs to have a rich and vibrant bioeconomy right the storytelling the law enforcement the education and so on right it's also very interesting to see who can become a leader of a bioengineering operation like sofia's story as a performer and artist suddenly becoming an executive in a mushroom manufacturing company there's no shortage of needs or opportunities in other words and i want to challenge you to think about this forever frankly by just giving you one more postcard this is what are known as the united nations sustainability development goals things that we would like collectively to see made real so that the world would be better like let's get rid of poverty let's get rid of hunger let's make sure everybody has good health and well-being everybody has the option of accessing a quality education that there's gender equality that there's clean water and sanitation for all affordable and so on and so forth right there's 17 different goals here each of these goals is full of opportunities for bioengineers and bionauts and so as a challenge like take a look at these 17 and see if you can just sketch out a bioengineering idea or a bioeconomy opportunity that might if developed help realize one of these goals it's a lot but it means there's a lot of opportunity it also means that most of what bioengineers could do hasn't been imagined yet and so sometimes if not most of the time yeah you could find a job posting and apply for a job but even more powerful is to invent the job once you understand what bioengineering can do that nobody else has understood before you just get to invent your job and suddenly you're writing job postings for other people once you figure that out the last part of this lecture is a warning not to be dramatic but it's really interesting to understand both the power and limitation of economic thinking and so this is a type of friendly warning and i'm so excited to share these next three slides with you because it's just profoundly interesting to stop and think about what the limits of economic thinking are and what lessons we can take from the recent past that might inform each of us and all of us together to shape the bioeconomy we really want right so first beware the label of economy right here's an interesting new york times story from 1999 1999 see what's going on there right and one of the articles is titled computer age gains respect of economists 1999 right for years even as the computer revolutionized the workplace productivity as measured by output stagnated barely advancing one percent a year so it's easy to see why economists didn't care very much about computers you got to be kidding me it's 1999 you know like i was building computer models of virus infection for my phd thesis and", "start_char_idx": 0, "end_char_idx": 4450, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "e21613ce-28e5-4126-a97c-fb100f34571a": {"__data__": {"id_": "e21613ce-28e5-4126-a97c-fb100f34571a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "deebf027-27d2-47f0-8869-b4dd099c55bc", "node_type": null, "metadata": {}, "hash": "fa82bfdea73b768adc13b63577a9a5eb9b2fc7f60353f3a322e85d59c0508c49"}, "2": {"node_id": "e7a18b09-5e05-472f-9fd3-19ae204de705", "node_type": null, "metadata": {}, "hash": "627945186c30bb71346404d3e7fc72fbb7f77f2741d2c365076a23b245519e70"}, "3": {"node_id": "aba609f2-3914-4104-93a1-1792afa729cf", "node_type": null, "metadata": {}, "hash": "43bf0e45ab620651bbe84c20f80bdd24e8a1fa9d4c7ee33ddbca18fe3e1d9810"}}, "hash": "ebdaf80234e586865dd11799b1a32a8ca9bd90d748360938feb284afbc22d32d", "text": "you know like i was building computer models of virus infection for my phd thesis and shipping that i graduated with my p in 1998 like like a year later finally like computers gained respect of economists right so so like so much interesting stuff was happening in reality well before the economic impact of computing was manifesting right another thing to to note is when you adopt an economic narrative a lot of people then manage for incrementalism like oh let's grow the economy one percent or four percent you know like not very much is going to change it's just going to get a little bit bigger imagine going back in time 50 years to 1973 and it's like we're going to grow the information economy we need more mainframe computers we need four percent more ibm like nothing against ibm but that's not what it's all about it's going to be about uh the arpanet becoming the internet and the personal computer like qualitative disruptive opportunity right so like don't don't let economy become proxy for reality because it's going to favor incremental thinking second warning don't let the economy become a proxy for society i love this example john maynard keynes probably the top economist in the united kingdom in the 20th century so he writes this very interesting essay 1930 right uh 93 years ago the economic possibilities for our grandchildren now what's going on in 1930 from history you remember this is the great depression and so he opens his essay by saying in the middle of the great depression we are suffering just now from a bad attack of economic pessimism well that's funny language for the great depression right um anyway he then goes on to say immediately i believe it's widely mistaken interpretation that the economy is crashing and burning all the way down right we're suffering he writes not from the rheumatics of old age from arthritis but from growing pains of over rapid change um and the painfulness of adjustment from one economic period to the next um he goes on to write right like in the middle of the depression he goes on to write what he imagines life will be like in a hundred years for the grandkids that's you and me like we're the grandkids and and so he says over the long term the economy's going to grow the structural transformations undergirding economic growth are profound i'm so confident in this i'm willing to predict a century of economic growth so the economy is going to be four to eight times as high as it is today compared to 1930 um we're going to solve the economic problem in other words he writes we're going to have so much money that nobody's going to worry about money bold bold bold bold bet john um well he makes a mistake and the mistake he makes is he underestimates the economic growth we actually got today we actually have more money than keynes predicted as i understand it but wait you might say if that's true um is it also the case that nobody has to worry about money no right um there is plenty of money for everybody but not everybody has plenty of money so something was missing in other words from the argument that keynes was putting forward at least in terms of the implementation of what followed we did get the economic growth but we didn't get a society in which everybody has plenty of money hmm don't let economy become a proxy for society in other words make sure we're getting the economy we want as you are bio not and the economy becomes a bioeconomy okay last one and this one's fun and strange and even more esoteric intern yet why did the soviet union fail to build a national computer network i told you it's going to be esoteric but hang on people knew in the 1960s that networking and information technology is going to become important and so there was a decision to make in the 1970s about what to do and different governments made different decisions the united kingdom the british government didn't want to invest in basic research anymore said they'd already figured out networking as was proven in the labs in the 1960s and they wanted to go right to commercialization and economic growth like grow the economy right now with the tools of the 1960s and so they missed out on packet switching networking or tcp ip and and tried to and so they missed out on packet switching networking or tcp ip and and tried to translate too early in the united states we figured out packet switching networking and through public funding built out the early form of the internet known as", "start_char_idx": 4381, "end_char_idx": 8858, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "aba609f2-3914-4104-93a1-1792afa729cf": {"__data__": {"id_": "aba609f2-3914-4104-93a1-1792afa729cf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "deebf027-27d2-47f0-8869-b4dd099c55bc", "node_type": null, "metadata": {}, "hash": "fa82bfdea73b768adc13b63577a9a5eb9b2fc7f60353f3a322e85d59c0508c49"}, "2": {"node_id": "e21613ce-28e5-4126-a97c-fb100f34571a", "node_type": null, "metadata": {}, "hash": "ebdaf80234e586865dd11799b1a32a8ca9bd90d748360938feb284afbc22d32d"}}, "hash": "43bf0e45ab620651bbe84c20f80bdd24e8a1fa9d4c7ee33ddbca18fe3e1d9810", "text": "packet switching networking and through public funding built out the early form of the internet known as the arpanet and we did this through uh uh you know public investment and with the backing of the the defense department and then basically gave away those technologies to industry so that the civilian sector could build out the full internet which we understand today which is letting us have this class operating as it is okay sounds pretty good like a little bit of public support in the right next-gen tech unleashed huge qualitative infrastructure improvements and structural transformation of all of our civilization through the internet the soviet union is interesting they understood the power of the network their motivation was economic growth you can hear the leaders of the soviet union at the time brag about how they're going to bury the west in economic growth the shouting and and claiming at the united nations and the way they're going to do this is to have computers control and optimize how the economy is operating and sounds pretty good except the people in the soviet union who had responsibility and therefore power for different sectors of the economy didn't want to give up their power their political power and standing to the computers and so they sabotaged the technology and therefore failed to get a national computer network so the lesson here is if you motivate something only through the lens of economic growth you might ironically fail to get the full power of the technology implemented that's the internet internet example if you motivate something only through economic growth you might not get equity or fairness that's the keynesian example and if you motivate something through economic growth you might not appreciate the qualitatively new disruptive opportunity right so beware even though the economic framing is powerful and transcending fear and unlocking tremendous opportunity for jobs and money and innovation you can't let it be the only thing driving the bus when you build your biotic future so let's reflect really quick what ultimately limits the bioeconomy like why is mckinsey saying it's only four trillion a year why isn't it 40 now should the 21st century bioeconomy be different from the 12th century by economy like the economy used to be 100 biological before we had any technology by definition right so so we want to make sure if we're building a bioeconomy it's progressive and future-facing how are we going to how we're going to figure that out and make sure that happens obviously there's a lot of economic opportunity already but compared to what it's going to be what would you guess is the percentage of jobs in bioengineering that haven't yet been invented that the job postings that nobody's written yet i would guess it's at least half maybe 90 hasn't been imagined yet but what do you think could you invent a new job type in response to one of the un's sustainability development goals speaking of a new job like pick one of the 17 and invent a job you might be inventing the job for yourself or your friend or your cousin and then finally why is it important like beware economic thinking as powerful as is why is it important if not essential to not only think about things through the lens of economy", "start_char_idx": 8824, "end_char_idx": 12108, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "277cfaa5-adec-4de8-89bb-f882cd8963be": {"__data__": {"id_": "277cfaa5-adec-4de8-89bb-f882cd8963be", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2b13c655-fad3-45df-93ab-7fda4e85ca44", "node_type": null, "metadata": {}, "hash": "55d6825b7174aa66fd4fe71706f58352ce163284a3cd9a80d17dd0d4700a95bc"}, "3": {"node_id": "459bd1ac-bdc4-4c5d-a1fb-a6ba3f29581b", "node_type": null, "metadata": {}, "hash": "93a39149ec7ae4d1dce7b4752a862d21b5b44220759a798637663d86664f692e"}}, "hash": "884f216f82c2a46e66a9fb5b1f7df713b1b6054f6096be809f9996529943b523", "text": "---\ntitle: \"Syllabus 2018\"\npermalink: /docs/syllabus/\nlast_modified_at: 2018-11-25T22:21:33-05:00\ntoc: true\n---\n\n## BIOE/ENGR.80 - Spring 2018\n\n**_Introduction to Bioengineering (Engineering Living Matter)_**\n\nStudents successfully completing BIOE/ENGR.80 should have a working understanding for how to approach the systematic engineering of living systems to benefit all people and the planet. More specifically, our three main goals for the quarter are (1) to help you learn ways of thinking about engineering living matter, (2) to empower you to explore and do bioengineering starting from DNA, and (3) for you to become more capable of learning and explaining bioengineering to yourself and others, including discussing the broader ramifications of engineering the living world.  \n\n### When \n\n1 April to 5 June 2019\n\nMWF, 1:30-2:20p\u2028, Lectures & Activities\n\n### Where \n\nClassroom (most Mondays and some Wednesdays): Building 320 Room 105\n\nActivity Space (many Wednesdays & most Fridays): Shriram Center Rooms 112 & 132\n\n### Final Exam\n\nSelf-proctored three hour written exam due by XXX on XXX June 2019\n\n### Instructors\n\nProf. Drew Endy; Office Hours Mon 4p & Wed 4p @ Shriram 252; [endy@stanford.edu](mailto:endy@stanford.edu)\n\nProf. Jan Liphardt; Office Hours Mon 10a & Fri 3p @ Shriram 005; [jan.liphardt@stanford.edu](mailto:jan.liphardt@stanford.edu)\n\n### Education Fellow\n\nDr. Siavash Ahrar; Office Hours Mon 3p @ Tressider & Fri 3p @ Shriram Tea Room; [sahrar@stanford.edu](mailto:sahrar@stanford.edu)\n\n### Head Teaching Assistant\n\nRolando Cruz Perez; Office Hours Mon 3p @ Tressider; [rcperez@stanford.edu](mailto:rcperez@stanford.edu)\n\n### Teaching Assistants\n\nNamrata Anand; Office Hours Tues 9a @ Huang Engr. Center; [namrataa](mailto:namrataa@stanford.edu)[@stanford.edu](mailto:namrataa@stanford.edu)\n\nAlyssa Ferris; Office Hours Thurs 4p @ Shriram Tea Room; [acferris@stanford.edu](mailto:acferris@stanford.edu)\n\nNina Horowitz; Office Hours Mon 7p @ Old Union; [nina92](mailto:nina92@stanford.edu)[@stanford.edu](mailto:nina92@stanford.edu)\n\nNelson Hall; Office Hours Tues 5p @ Shriram Tea Room; [rnhall](mailto:rnhall@stanford.edu)[@stanford.edu](mailto:rnhall@stanford.edu)\n\n### Grading\n\nIn-Class Puzzles (15%); 1-2 per week; lowest 2 dropped including absences; based on pre-class materials\n\nProblem Sets (70%); lowest 1 dropped including absences\n\nFinal Exam (15%); 3 design problems\n\n### Key Dates\n\n1 April 2019; first class\n\n24 May 2019; deadline to request change of grading basis or withdraw\n\n5 June 2019; last class\n\n### Honor Code\n\nWe expect you will uphold Stanford's Honor Code. Discussion among peers and with the teaching staff is strongly encouraged. All submitted work must be completed individually unless explicitly noted otherwise.\n\n### Week 1\n**Why are you here? Why engineer biology? What's unique about living matter?**\n\nMon \t1 April\t\t320-105\tHello; course mechanics; initial questions; opening tour\n\nWed \t3 April\t\tSC 112/132\tFuture impacts of bioengineering\n\nFri \t5 April\t\tSC 112/132\tMake your foldscope; embrace nature **(PSET 1)**\n\n### Week 2\t\t\n**How do design, build, and test tools work to support", "start_char_idx": 0, "end_char_idx": 3142, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}, "459bd1ac-bdc4-4c5d-a1fb-a6ba3f29581b": {"__data__": {"id_": "459bd1ac-bdc4-4c5d-a1fb-a6ba3f29581b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2b13c655-fad3-45df-93ab-7fda4e85ca44", "node_type": null, "metadata": {}, "hash": "55d6825b7174aa66fd4fe71706f58352ce163284a3cd9a80d17dd0d4700a95bc"}, "2": {"node_id": "277cfaa5-adec-4de8-89bb-f882cd8963be", "node_type": null, "metadata": {}, "hash": "884f216f82c2a46e66a9fb5b1f7df713b1b6054f6096be809f9996529943b523"}}, "hash": "93a39149ec7ae4d1dce7b4752a862d21b5b44220759a798637663d86664f692e", "text": "Week 2\t\t\n**How do design, build, and test tools work to support bioengineering?**\n\nMon \t8 April\t\t320-105\tHow do engineers engineer with, of, and for biology?\n\nWed \t10 April\t320-105\tHow will engineers engineer biology?\n\nFri \t12 April\tSC 112/132\tGet your GOOP tube; express DNA **(PSET 2)**\n\n### Week 3\t\t\n**What arises from DNA read/write trends that will matter for the rest of our lives?**\n\nMon \t15 April\t320-105\tHow much better can DNA synthesis get? So what?\n\nWed \t17 April\tSC 112/132\tWhat happens as genetic material becomes equivalent to information?\n\nFri \t19 April\tSC 112/132\tWhat can't be encoded in DNA? **(PSET 3)**\n\n### Week 4\t\t\n**If we can construct a genome then why can't we build an organism?**\n\nMon \t22 April\t320-105\tHow to parse a research paper on the frontiers of bioengineering\n\nWed \t24 April\t320-105\tWhy is humpty dumpty more than just a nursery rhyme?\n\nFri \t26 April \tSC 112/132\tMeet your microbes **(PSET 4)**\n\n### Week 5\t\t\n**Something from \"nothing.\" Why do molecules move? How do patterns grow?**\n\nMon \t29 April\t320-105\tMolecular diffusion, what is it and why does it matter to bioengr.?\n\nWed \t1 May\t\t320-105\tPatterns via development; e.g., could you grow an arm?\n\nFri \t3 May\t\tSC 112/132\tDancing droplets; \"programming\" autonomous objects **(PSET 5)**\n\n### Week 6\t\t\n**Abstraction as a tool for managing complexity in bioengineering**\n\nMon \t6 May\t\t320-105\tHow to implement Boolean logic in DNA \n\nWed \t8 May\t\t320-105\tHow to architect arbitrary genetic systems \n\nFri \t10 May\t\tSC 112/132 GOOP revisited; genetic sensors, logic, actuators **(PSET 6)**\n\n### Week 7\t\t\n**Evolution as an algorithm; Evolution as a service**\n\nMon \t13 May\t\t320-105\tWhat is evolution from an engineering perspective?\n\nWed \t15 May\t\t320-105\tHow to use and change evolution \n\nFri \t17 May\t\tSC 112/132\tPlague; offense versus defense **(PSET 7)**\n\n### Week 8\t\t\n**Citizenship & Humanity --  Flourishing**\n\nMon \t20 May\t\t320-105\tWhy do people work to solve problems via bioengineering? \n\nWed \t22 May\t\t320-105\tHow much can we make with biology? \n\nFri \t24 May\t\tSC 112/132\tMaking with mushrooms **(PSET 8)**\n\n### Week 9\t\t\n**Citizenship & Humanity -- Doom & Dystopia?**\n\nMon \t27 May \t\t**NO CLASS (Memorial Day)**\n\nWed \t29 May\t\t320-105\tWhy don't we have modern biological weapons?\n\nFri \t31 May\t\tSC 112/132\tHow many people should learn bioengineering? **(PSET 9)**\n\n### Week 10\t\t\n**Summary Sendoff**\n\nMon \t3 June \t\t320-105\tWhat is bioengineering from a technical perspective?\n\nWed \t5 June\t\t320-105\tWhat is bioengineering from a cultural perspective?", "start_char_idx": 3079, "end_char_idx": 5607, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n"}, "__type__": "1"}}, "docstore/ref_doc_info": {"1b3b6816-1958-458c-8149-78fdc732e3ed": {"node_ids": ["d88111c5-5c2d-4ca7-869c-50631e5383a3", "3a4bd5c4-d905-41af-8099-571093f86255"], "metadata": {"page_label": "1", "file_name": "1_PhoenixVirus.pdf"}}, "d765e96f-17af-4a9c-8058-b8b9b9d6de43": {"node_ids": ["7ed9d7be-60b1-4c85-80c3-90882184e672", "b20a0218-a06a-49a3-9bbf-67f59a81e2c8"], "metadata": {"page_label": "2", "file_name": "1_PhoenixVirus.pdf"}}, "b7955333-7e0f-451d-a6d3-3aacbbfb34c6": {"node_ids": ["e09fb4c5-4d77-460e-8d82-c8dd7cbb9372", "419b6a02-1175-4c13-9f0f-c21710064c21"], "metadata": {"page_label": "3", "file_name": "1_PhoenixVirus.pdf"}}, "b77b174e-6c7d-4c0b-8c62-66003c42a5bf": {"node_ids": ["1f814178-2bdd-4f90-88b7-55ca606a272e", "a64ee598-7107-4ad5-8c57-d4e297c86b63"], "metadata": {"page_label": "4", "file_name": "1_PhoenixVirus.pdf"}}, "070446a3-3da9-42f0-954c-a635b168ddd7": {"node_ids": ["0ec52f52-02e5-49c7-80c2-d76e4f9d2f4e", "03bbb1c3-07eb-453e-8428-ddc3faae2e7b"], "metadata": {"page_label": "5", "file_name": "1_PhoenixVirus.pdf"}}, "e91e3e68-57cf-4e78-ac15-9b987f356d6c": {"node_ids": ["c2f5e7d0-dd26-45f7-b93a-ddc1f7e72fc9", "914451a0-36d2-4930-be45-c1ee3537756a"], "metadata": {"page_label": "6", "file_name": "1_PhoenixVirus.pdf"}}, "e8f2fe11-fb74-4d04-95b5-b10985c269aa": {"node_ids": ["a3850e14-a154-4959-8959-b373b6945410", "5ac68af3-5d43-4b4e-9b04-7c188c75a24e", "57e3bd1e-137a-475d-9903-129736fe13a1"], "metadata": {"page_label": "7", "file_name": "1_PhoenixVirus.pdf"}}, "431a22b7-b77a-49e3-b468-da4406cd9369": {"node_ids": ["38ba013a-6609-4a0c-845d-9bad70fca7e2", "91a1ac69-e01f-4cf1-97f1-b20f55216de1", "7822fe13-ccb6-4615-aa22-defc698bf8b5"], "metadata": {"page_label": "8", "file_name": "1_PhoenixVirus.pdf"}}, "9ee5af03-ad45-4d50-badb-990e0c2a9fdd": {"node_ids": ["03edea06-c124-407c-abad-7b173c36d1bf", "421b8b40-b015-436a-bee0-cce6db83fd58", "e19f52dc-0427-4d13-9142-cf1265c38a5b", "a2c4c8de-ebeb-407c-b16b-ca2aaa323899"], "metadata": {"page_label": "9", "file_name": "1_PhoenixVirus.pdf"}}, "c0b96265-ec2e-495a-a56e-5d30cb2be073": {"node_ids": ["2ef1cba7-494e-4372-b09d-4477f20768bd"], "metadata": {"page_label": "10", "file_name": "1_PhoenixVirus.pdf"}}, "58038d3c-d0cb-4127-b0a6-c6c43d4e3e61": {"node_ids": ["b7d331f8-0996-4965-a7cc-51e38e45bb9d"], "metadata": {"page_label": "1", "file_name": "3_Covid.pdf"}}, "c8f396ef-0baa-4633-9b38-a0eb9a243cee": {"node_ids": ["52eb706a-16b9-4ad3-a32d-309ff00212c6"], "metadata": {"page_label": "2", "file_name": "3_Covid.pdf"}}, "7ef34fde-d145-4415-a33a-c810b2b0a5bb": {"node_ids": ["b51a406d-d29a-4573-a6db-ea49cf8b096d"], "metadata": {"page_label": "3", "file_name": "3_Covid.pdf"}}, "47f8485b-9dcd-4b69-87bb-8fd38f8f4b01": {"node_ids": ["80e0a98d-2999-4d0a-a6ac-7a0eed28a745"], "metadata": {"page_label": "4", "file_name": "3_Covid.pdf"}}, "ab00847a-2717-4357-a270-8c37399d3c3e": {"node_ids": ["7a70b390-e152-453f-939b-c9abd4ef4de9"], "metadata": {"page_label": "5", "file_name": "3_Covid.pdf"}}, "e506c5dc-b575-4b7f-b2bb-6a5405548aac": {"node_ids": ["c584229e-aeda-4a04-b52d-e8d3b73e52e9"], "metadata": {"page_label": "6", "file_name": "3_Covid.pdf"}}, "825498ea-067a-47a3-be1a-ff41fd529cde": {"node_ids": ["aa2c6917-796d-4808-8bd8-bfb35d4b4d79"], "metadata": {"page_label": "7", "file_name": "3_Covid.pdf"}}, "31b57863-aad5-4d81-8864-cfffe5731a95": {"node_ids": ["0aeb9b04-bf9b-4e59-8f90-b4e427ac34b1"], "metadata": {"page_label": "8", "file_name": "3_Covid.pdf"}}, "b42026b7-52ac-4c0d-9323-569519f16406": {"node_ids": ["168962aa-34c0-4d80-b3e1-d5a2bee2f615"], "metadata": {"page_label": "9", "file_name": "3_Covid.pdf"}}, "32f6faf4-f7b0-4b0b-b7ab-fa52e7b01eb2": {"node_ids": ["ea439a48-6c02-45a4-8e67-14c10dbfcc01"], "metadata": {"page_label": "10", "file_name": "3_Covid.pdf"}}, "cac5159c-9ab7-41ee-9f10-ca69789a719f": {"node_ids": ["48d17c72-bc9e-4ea8-9f86-e2188a8102c8"], "metadata": {"page_label": "11", "file_name": "3_Covid.pdf"}}, "86d31c25-af43-4738-8006-7731b59af8cd": {"node_ids": ["9cb2cfc3-2ab8-4b29-a0e1-4253dbac5f55"], "metadata": {"page_label": "12", "file_name": "3_Covid.pdf"}}, "9a1339b5-f26d-4c46-a509-9b1d4b9ccb77": {"node_ids": ["85b83824-3ce3-4c3e-9492-3cf97e4632b8"], "metadata": {"page_label": "13", "file_name": "3_Covid.pdf"}}, "ae16cc8a-f01d-4f92-9cec-074f198aface": {"node_ids": ["20312873-d71f-4e69-a174-fbf4cf841258"], "metadata": {"page_label": "14", "file_name": "3_Covid.pdf"}}, "c470acc8-f010-45e5-9eff-29457f42fadf": {"node_ids": ["d27c9f49-1eb1-42d1-9227-fbd9d211652a"], "metadata": {"page_label": "15", "file_name": "3_Covid.pdf"}}, "95e1795d-5fe8-470e-81a9-fcd21e8dedb4": {"node_ids": ["77363321-b770-412e-81da-48d61c19b271"], "metadata": {"page_label": "16", "file_name": "3_Covid.pdf"}}, "0d2b8727-73a6-4b72-b6e4-2049b1d0a154": {"node_ids": ["0542ecdf-d6dd-4f01-ae5d-bc3537611bdf"], "metadata": {"page_label": "17", "file_name": "3_Covid.pdf"}}, "5b6bbc65-d3e4-44ef-a3c4-288f9e62e3d3": {"node_ids": ["25a0cda0-7632-4bf1-9fdc-914bb6b30d59"], "metadata": {"page_label": "18", "file_name": "3_Covid.pdf"}}, "a21ae520-db05-4339-b8e5-d73dc7be5643": {"node_ids": ["228cc1ac-9712-41ee-b88d-54f2bd75f557"], "metadata": {"page_label": "19", "file_name": "3_Covid.pdf"}}, "780c1fca-724d-4026-b189-cbfc52c97dcb": {"node_ids": ["bef68375-5c6c-4e27-ab3b-ad87f3ce27cb"], "metadata": {"page_label": "20", "file_name": "3_Covid.pdf"}}, "2ebfab61-a517-4ee6-bae8-546e2001f300": {"node_ids": ["f8175b62-fb63-4373-bd35-fdc183f3e5f9"], "metadata": {"page_label": "21", "file_name": "3_Covid.pdf"}}, "c66fca50-a58e-4dd5-a417-14f48fea9cc6": {"node_ids": ["79e5377f-3b53-4848-a76c-15836734bef1"], "metadata": {"page_label": "22", "file_name": "3_Covid.pdf"}}, "b2f16060-1afa-40f8-932a-bb865d50af76": {"node_ids": ["b050465a-a261-4913-878e-3ab98495483a"], "metadata": {"page_label": "23", "file_name": "3_Covid.pdf"}}, "2b72f4e9-f9bb-4d2e-920f-8e06d4dd5010": {"node_ids": ["da507684-d356-4a0c-9523-c3ffcb393e99"], "metadata": {"page_label": "24", "file_name": "3_Covid.pdf"}}, "19f554eb-964b-4b07-a5d2-4f3cf82a24b0": {"node_ids": ["98b91c68-6590-49fe-bb09-c101b27f41b5"], "metadata": {"page_label": "25", "file_name": "3_Covid.pdf"}}, "6854c36d-a946-4d8e-a11b-bebf003f9ec5": {"node_ids": ["86cbddaf-dd13-4727-aef8-532a00209c68"], "metadata": {"page_label": "26", "file_name": "3_Covid.pdf"}}, "a4a87fe2-1f30-415a-9677-847e034f0666": {"node_ids": ["130da3d8-1cfb-4f63-a0ae-90c45e8335f9"], "metadata": {"page_label": "27", "file_name": "3_Covid.pdf"}}, "e59f91fa-2038-442f-8de6-23891af8efa3": {"node_ids": ["9d096cb7-bc83-4a73-a4e2-08b05082c628"], "metadata": {"page_label": "28", "file_name": "3_Covid.pdf"}}, "f3bc2f24-8dd8-4784-9ef5-17e958b016a3": {"node_ids": ["0f57c95a-1d01-49d4-9e7f-9ccf2ad2b0ae"], "metadata": {"page_label": "29", "file_name": "3_Covid.pdf"}}, "042268cc-9263-43f8-a77d-62af53d7870a": {"node_ids": ["f8971cf5-726d-4310-9e4d-061a8a5f1682", "81a599ce-1371-4f66-9309-ef753cb94d57"], "metadata": {"page_label": "39", "file_name": "4_DNA_of_things.pdf"}}, "383c7093-d630-4481-841f-852df9cf73b3": {"node_ids": ["4a7282e4-2418-4bee-9550-dc279c89e654", "bfc4245f-5581-4203-8ddb-7c808b396d38"], "metadata": {"page_label": "40", "file_name": "4_DNA_of_things.pdf"}}, "29358fce-80f0-4b9e-9c8e-9234fb2e4bd5": {"node_ids": ["cdf182f7-a25b-40eb-8f34-79edebf4bac1", "8aa55827-446c-40d2-a135-0be6b9660789"], "metadata": {"page_label": "41", "file_name": "4_DNA_of_things.pdf"}}, "86981af9-7c65-4b79-b0e7-352378ac6265": {"node_ids": ["5e4a93e9-9a49-4ec3-8226-1b725f6d27bf", "cf005b2f-9063-42fe-a0ef-e4e1add9531b"], "metadata": {"page_label": "42", "file_name": "4_DNA_of_things.pdf"}}, "bd179acc-67b8-499f-b779-94b4ed1b18ea": {"node_ids": ["9cfb6122-36b5-4648-b10e-f448ef9b716e", "0a8d94e5-665f-4b6f-b2f4-b556c1423aa8", "a99a5f2e-8f6d-4f97-8536-07018a7c7ab4"], "metadata": {"page_label": "43", "file_name": "4_DNA_of_things.pdf"}}, "1bdce6de-3906-429d-83c6-8a2539dc7c57": {"node_ids": ["6a08adf3-1408-4008-9aa1-0906db922c83", "10495a0d-57cc-42eb-9a04-0ec2e12ab6e6", "7c9de5bd-7411-45f4-bd2f-d1857163a7a7", "b6e5ba86-17eb-4e63-a97b-0ed865d9d0b8"], "metadata": {"page_label": "44", "file_name": "4_DNA_of_things.pdf"}}, "73d0cfbd-e0e7-4e6e-85d9-60a25cc4a1ac": {"node_ids": ["71fc69a0-ce96-4466-8553-639b0af29f7a"], "metadata": {"page_label": "45", "file_name": "4_DNA_of_things.pdf"}}, "040e8e55-1b5e-423b-a61e-78b07c315c43": {"node_ids": ["70a96f1a-9292-4f55-8236-7078e612a96c", "6ae90039-22e3-4f19-a45e-8ca3ad90e0d7"], "metadata": {"page_label": "1", "file_name": "5_COVID_Medicine.pdf"}}, "2bfe3106-e487-4947-ac3c-9593794b4ec4": {"node_ids": ["457f887c-421e-432f-a504-2f0d15e83052", "ec10494a-8d7a-478c-868a-579082577571"], "metadata": {"page_label": "2", "file_name": "5_COVID_Medicine.pdf"}}, "9f9e7857-8573-46b4-809f-39d62f873ae1": {"node_ids": ["c271753a-766b-40d1-985b-ab14a37c4555", "530410eb-fa93-46cd-9048-9db79d3e8387", "d6ff58f3-4120-47d6-8e97-696bbf6475e6"], "metadata": {"page_label": "3", "file_name": "5_COVID_Medicine.pdf"}}, "476b5ee2-fa3c-475c-acde-2a856ca49598": {"node_ids": ["f4ce544d-c2d3-41d7-a447-61ae5996c356", "c09b6a39-d94b-41cb-a1d2-fdf6f41e42a8", "c6a902ce-ae8e-49be-b11e-d34edb665935"], "metadata": {"page_label": "4", "file_name": "5_COVID_Medicine.pdf"}}, "aa35fe49-aa28-429c-a281-d4ff86262064": {"node_ids": ["71fa0849-1390-468e-bbcf-1b9f5be80beb", "697c33a6-d80d-459c-ac10-0e1ba69cdc9e"], "metadata": {"page_label": "5", "file_name": "5_COVID_Medicine.pdf"}}, "fc107e44-0f72-4a91-8a46-92f5643f6459": {"node_ids": ["0669bcbd-659c-4385-a744-c6a16128ef1d", "9c60ef29-f1fd-4628-919f-7757f702d2d8"], "metadata": {"page_label": "6", "file_name": "5_COVID_Medicine.pdf"}}, "4ab30247-e869-407d-a643-01b3be87b5fc": {"node_ids": ["09534c82-703c-44db-8e39-de05e7b252d2", "002ba8ec-84c4-4cc4-ac2e-9257c16d01bf", "64b9eb5d-1218-4501-8388-943f19a57f75"], "metadata": {"page_label": "7", "file_name": "5_COVID_Medicine.pdf"}}, "030b6d96-a642-4a88-982b-45434086a4ad": {"node_ids": ["6e6418f7-9754-4aa3-8ca4-30864191f408", "19112842-e366-4f3d-8b58-c4bc05705217"], "metadata": {"page_label": "8", "file_name": "5_COVID_Medicine.pdf"}}, "42889750-f2fa-4c3f-b9ce-32e8dad2b00c": {"node_ids": ["ed90a57d-ea06-45c7-a4ee-86d518a2732f", "8a604d14-4e9a-4b11-8372-55320c813a84"], "metadata": {"page_label": "9", "file_name": "5_COVID_Medicine.pdf"}}, "95591b9d-3ef3-475d-a93c-1fba79f156e5": {"node_ids": ["e7d29b03-6830-4b88-b8d0-030434ec2ef2", "0351036d-6a80-4cf7-b9c4-6ec7cd46c65f", "d1ad78a3-8f30-4d3e-8812-837966c9971a"], "metadata": {"page_label": "10", "file_name": "5_COVID_Medicine.pdf"}}, "33da8422-6e5d-46da-9f8d-61ca983eb55e": {"node_ids": ["f15e74fb-4d33-4809-9933-5143d50d9002", "395fa888-85c3-4f26-a8ca-367756b1644e", "6ef2dfc1-e86e-4653-af67-6f56dea89a53", "a8ca9e5c-7419-4773-a605-d97a651f73cf", "edc0108c-3ea9-440a-9a86-a2d16c680724"], "metadata": {"page_label": "11", "file_name": "5_COVID_Medicine.pdf"}}, "964807da-f9b7-494f-9a11-4cd7c7c2594e": {"node_ids": ["1343b8e5-3f04-43b3-9cbc-395cb074ad5f", "b648d7ea-9149-458d-838c-050ed68be90b", "3abf83c4-5435-4f9d-afcf-1980a45e3f9f", "e3224ff9-c9c6-431c-ba7e-1bcc1dbdbf02", "6dab25d3-e35e-4c29-adc8-55ec0c26c866"], "metadata": {"page_label": "12", "file_name": "5_COVID_Medicine.pdf"}}, "42343088-7b3d-49e5-b163-cf8e7c21fa09": {"node_ids": ["4c94fac8-c7ab-434b-b526-cd9752eee1cb", "701448be-994d-42dc-8342-f5f29cdaf514"], "metadata": {"page_label": "13", "file_name": "5_COVID_Medicine.pdf"}}, "632b7795-822b-41ac-936e-93ae876a7cf1": {"node_ids": ["b1c8e77a-c3b5-4c48-a94e-f8eff1982f51"], "metadata": {"page_label": "14", "file_name": "5_COVID_Medicine.pdf"}}, "16f8ca8f-fd14-40b1-a292-9fcd5c355da5": {"node_ids": ["bbb23c7e-2d78-4169-959e-7265c16ef7cb"], "metadata": {"page_label": "15", "file_name": "5_COVID_Medicine.pdf"}}, "e2941bf5-0505-4abb-a1ba-4a5eb057ea6f": {"node_ids": ["aafb88d5-8fee-4551-a5ee-eb0a1f946965"], "metadata": {"page_label": "16", "file_name": "5_COVID_Medicine.pdf"}}, "840d3bf8-8a0e-4576-aead-dafa00fbe7a2": {"node_ids": ["9829d300-e571-4447-bd65-9f0e4f0d8495"], "metadata": {"page_label": "17", "file_name": "5_COVID_Medicine.pdf"}}, "c11986ca-e7a9-473c-bdb5-39b5ea6357d1": {"node_ids": ["ec6d8172-61a3-4422-8309-bcfc182f4640"], "metadata": {"page_label": "18", "file_name": "5_COVID_Medicine.pdf"}}, "465f8c44-113e-4abd-92ff-0edf5721d2f2": {"node_ids": ["97d74e34-4890-4ab4-9e79-d84a3e759c4f"], "metadata": {"page_label": "19", "file_name": "5_COVID_Medicine.pdf"}}, "a9ab4941-7cb5-41e2-9ba0-bce4729b3024": {"node_ids": ["892ecbdc-d1fe-45c0-88a2-379273c21e52"], "metadata": {"page_label": "20", "file_name": "5_COVID_Medicine.pdf"}}, "86c8d4eb-296b-4eb0-8807-cc4440408207": {"node_ids": ["56c54bf5-7980-4e4d-9f68-e52914443dd9"], "metadata": {"page_label": "21", "file_name": "5_COVID_Medicine.pdf"}}, "c96ff112-0157-46d1-afc7-062945cee5e8": {"node_ids": ["53402e72-f71a-4ced-9c46-ff64d523dedb", "9c0b2ebb-12fd-4c04-b898-8c3289a526df", "a56aaed1-27a8-4bbc-9762-e108a04fa6f2"], "metadata": {"page_label": "3698", "file_name": "6_Bacterial_Lithography.pdf"}}, "ce9f5616-877a-44e5-8cb0-b4482925c8c2": {"node_ids": ["3105db04-163f-4bf0-a988-7f2ca81ca815", "7e75b686-87c7-44d5-a3dd-2cbf17eb321f"], "metadata": {"page_label": "3699", "file_name": "6_Bacterial_Lithography.pdf"}}, "7774eaf7-da5c-46eb-b4d8-ce492199a35d": {"node_ids": ["35a6b9ca-7179-4509-b09f-d217c75a36c0", "c012bfef-2960-4cb7-8e34-47995ef8ec49", "debde025-9bd9-4f58-a0c2-8fc4abebdf80"], "metadata": {"page_label": "3700", "file_name": "6_Bacterial_Lithography.pdf"}}, "f6c30827-2624-471c-9232-2255e5419ef0": {"node_ids": ["177c2108-7b45-475c-bc09-a5e9eeef807d", "3c780846-ade5-4f1f-b807-62cb9daa67e8", "b86dd750-0abe-461a-abf2-4031b04f2d78"], "metadata": {"page_label": "3701", "file_name": "6_Bacterial_Lithography.pdf"}}, "cee73198-a1e9-45f2-886f-9438a1bd4941": {"node_ids": ["594addd9-4526-41bc-8cb9-8f817f45f594", "de043ff6-a667-45d4-bbc4-f59fe216fa2a", "ef41ebd1-72e9-4c82-8d88-9ebf2c502ecd"], "metadata": {"page_label": "3702", "file_name": "6_Bacterial_Lithography.pdf"}}, "1c5a8482-67dd-4f6f-ad77-0347e49cbd87": {"node_ids": ["0f166413-6027-43c7-8302-a7229b23273d", "d735a31b-8d83-44b9-af23-6904d1cc9313", "3eb61476-9ed0-4c41-be89-c5008536f6c5", "627cff98-0935-460c-9c2c-86091d8fc95c"], "metadata": {"page_label": "3703", "file_name": "6_Bacterial_Lithography.pdf"}}, "0c6386b0-e9fa-45fc-9979-461bcb548ca7": {"node_ids": ["d443a53b-e2c1-4ea5-bf06-78e9e220ddbb", "38022e6d-f4c4-40b7-b696-0c01bdcf7b82"], "metadata": {"page_label": "78", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}}, "2a9fffc5-cb4d-4256-bf15-3ae118b45cc6": {"node_ids": ["0bd6f479-1ed4-4c7d-bb87-2fcadf02f8f4", "326f48af-3c8b-498d-8ba8-7eb9b0687d88"], "metadata": {"page_label": "79", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}}, "bf4ed3e7-72df-4708-b175-cfe7b30c6df6": {"node_ids": ["7e51c9a9-a114-4f7a-b47d-05fcdfccd3be", "778b8b0d-0771-4ce5-89aa-a1f6954f483d"], "metadata": {"page_label": "80", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}}, "7d793112-63e0-4df1-a230-2a88b2814a91": {"node_ids": ["7a504931-95d1-4c33-96f7-93655e7371a4", "d594a625-15f7-426d-a964-06a4c405e80e", "6ed7d1f8-06b4-4202-8442-8fb6a861e809"], "metadata": {"page_label": "81", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}}, "da1ae84b-def8-4b78-bc8c-3d7e923d352d": {"node_ids": ["15b86604-a610-46df-95e9-f4f391bac995", "b3faf751-82a0-4ed9-ac47-40c0d5d99d0d", "95081197-c928-47b0-872c-a1a76b4fa6df"], "metadata": {"page_label": "82", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}}, "b2a8144f-e260-41ce-9862-13cb8a4f9d1b": {"node_ids": ["cff898c1-49b3-471c-8436-77ef467f0a0e"], "metadata": {"page_label": "83", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}}, "6d517ac0-ad80-48de-9fb0-6d941c193baf": {"node_ids": ["5ee2f055-d432-49c6-a2b4-816efc6f18e4", "6383e10c-3f31-4a32-b4a7-ab1b65e1cd3a", "93783ed7-dea3-4ba8-b9dd-0b6403ddec51"], "metadata": {"page_label": "OM1", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}}, "d5999fc5-6e91-4b03-a590-22bbb863d842": {"node_ids": ["16c72702-0871-4a87-ad4d-9f26c7329045", "47b8cce7-5baf-4743-a1e0-854e8523c399", "4a63da66-e883-40d9-89d2-58b2431546cf"], "metadata": {"page_label": "OM2", "file_name": "A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.pdf"}}, "1af20325-881e-40df-aa99-7173fcbc25c7": {"node_ids": ["0a9f933a-93c1-4b31-a179-f17d05d92bdf", "feb8aa93-a1cf-4250-9a9a-b0d99c584026"], "metadata": {"page_label": "1", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}}, "f09b998a-1082-4b58-afec-3686b619651f": {"node_ids": ["754b8b70-29ff-4a25-99eb-97e0a9383ff3", "f15684df-522b-42b9-8490-1f0219d2c30c"], "metadata": {"page_label": "2", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}}, "10e3b110-c6bd-4324-aeaf-8389002f32ed": {"node_ids": ["09b00673-3361-47a6-afa9-10be2001c91e", "3e092ae2-3e8a-4cec-be85-263c0c831924"], "metadata": {"page_label": "3", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}}, "1dbe0886-2bdb-4948-893a-8e1289135704": {"node_ids": ["30286db6-3820-4c30-896b-24a15d0bad99", "ae2d3c06-526a-445c-a533-0183b92ec72e"], "metadata": {"page_label": "4", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}}, "4b8a3c67-6899-4add-b562-df68a9d3ec82": {"node_ids": ["ceb39412-e202-44ec-b691-f59091b70308", "4dc9194d-24bf-4b02-aa7f-88362cd168da"], "metadata": {"page_label": "5", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}}, "8e5b980b-174d-4b0a-b125-fc1edbc3e3f1": {"node_ids": ["07341d95-7cd2-4c7d-8535-ad8d7922a35d", "b14a46f7-90a2-4a98-9a90-dae4a681d3e4"], "metadata": {"page_label": "6", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}}, "1da45cb7-ec01-418b-9699-1d611a9eb1ea": {"node_ids": ["3a3df280-effb-488a-9877-348fc9eb5675", "e0f4f9c9-3fc4-4f00-93cd-f13e28621d60", "ea160cf8-1bb7-4ea0-9668-65cc0062314d"], "metadata": {"page_label": "7", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}}, "c4d62c21-fd18-44c7-8cae-887634363ed4": {"node_ids": ["b2b1abc5-e4a4-4fc3-90e7-a092a00250fb", "c3891d57-6330-4e6c-ad04-bbc8ee57b996", "692cab3c-7b0c-49b6-a137-0f8b7e11c60b"], "metadata": {"page_label": "8", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}}, "9c07f040-46fc-410b-a8c6-3ffd10943c0f": {"node_ids": ["41f86849-1423-4f47-843d-3a4189de53b4", "9ed0940b-daf0-437b-b813-fea55fcbac5a", "835b5bac-2732-4be4-95f4-d9b21d41d39e", "2ae4bccc-0ecd-490b-b71f-011c5e3e7beb"], "metadata": {"page_label": "9", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}}, "d3eda07a-cfaa-4dc5-8564-4909ff605fe4": {"node_ids": ["fcee602a-d1a8-4768-b530-579010d93ddb"], "metadata": {"page_label": "10", "file_name": "Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements.pdf"}}, "923a94ef-af9f-42ac-b099-640e707f6931": {"node_ids": ["e951c7c0-aea0-4a8b-a86c-e4210701c0c8", "ea555bc5-96f4-499c-ae8f-dea28f846e18", "4611531f-7be8-42ab-b0bd-724b85e40363", "8d3e7748-e1ec-4c66-aea5-3df8ab4258e4", "30ed782e-28bd-470e-afaa-3c722c82d995", "4131791d-6d8a-4620-a6e7-eb9d5a21d5cf", "d1d42f18-6022-409a-85b0-f996a77f8477", "e8ec6d48-4535-4668-b392-e0d1bad9680a"], "metadata": {}}, "6ca606fd-0454-4a3c-8f6e-a99d1368dab4": {"node_ids": ["c952cc82-ca2c-480f-8db2-1304a9099ccf", "9046d928-4cc2-41c6-a747-da6856fbe30c", "280cf2df-4e33-4e8b-b2a7-e09fbf21dfe0", "efca8c91-0add-4ef7-bf3d-737c4f8319a7", "46d74122-a40d-429b-a7dd-a289dc0bd2aa", "645b24d2-e0ce-43a9-9e08-b3bcfc0e5f75", "2cefc23a-55c6-4ca7-9337-572cf128bf49"], "metadata": {}}, "0cedf0fa-abc8-4f72-b929-bb6af80badc5": {"node_ids": ["9c9c9e3e-72a1-4bc0-a733-ba77d7eae0d8", "eee3b41f-2b36-431f-9239-cc7b5db9b33b", "332e7a22-5ed5-420d-a269-89a7221df196", "7cc8e856-a0fd-4655-ba46-303968bdd965", "c318d636-18e3-4f3d-ab84-26eb05c26352", "c678010c-fe8e-47a0-b15c-834f84e9c30d", "3a144196-f49d-48fa-9472-a206a7b637db", "4737476f-7377-408b-ad53-3d3c71b408b3"], "metadata": {}}, "3e6bd924-2c5f-459f-9318-9420a9e33ba3": {"node_ids": ["6f2c9210-3779-4b74-9279-2560073d8734", "835a6315-1e1c-40e0-9cb5-119335cf01d4", "5311c2f1-b538-44e3-9a3e-b07d609207d7"], "metadata": {"page_label": "1", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}}, "66fefaef-6ba7-4df7-81ff-c072fe119879": {"node_ids": ["f588c98b-61fb-4b05-b4a4-ecf270bcbc89", "93a5025b-9233-4750-b5a6-9011c81d15d6"], "metadata": {"page_label": "2", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}}, "bfde1ebb-63ba-4ac6-8622-c91fe12c3a89": {"node_ids": ["1f98cb1d-b748-4579-91b0-ac0d4536ee17", "95de104c-cd78-4f43-9edc-530a9abceebe"], "metadata": {"page_label": "3", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}}, "322a8bcf-c775-4b29-8426-bdfeaf0ad72b": {"node_ids": ["53629363-3e58-4e13-a368-82f7ef1565d2", "84318884-e5d5-4892-bb4b-d704a3f4d452", "fd5e26a7-bbbd-4404-884b-6a51055b8954"], "metadata": {"page_label": "4", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}}, "43f9ca28-4532-4a92-9c07-59013df56d1a": {"node_ids": ["00166eef-598f-4437-95e1-b9402d28c055", "67393e03-69fb-4a8f-a671-07d440da96c8", "e75788aa-d349-4147-912e-1ca0666c14b0"], "metadata": {"page_label": "5", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}}, "877bbf1f-5106-4894-a5e1-3285b410d669": {"node_ids": ["4a7a7e3f-997b-407f-9028-66c5aa865cd4", "bc209971-7e4e-45c3-ba1e-463ad943adf6", "7d13c077-5950-4f2b-ab27-94831f0c9f8b", "f7a1d006-8fa7-4b9c-8c94-d0a5eba3c810", "ec1ee651-4b0c-47b7-9f98-0fdcacda9311"], "metadata": {"page_label": "6", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}}, "52764204-8803-47f3-ad26-052cfabc7f84": {"node_ids": ["b272c3e0-9341-4072-9fea-6a1e71531d70", "1930f2b0-29d3-4b06-9846-619eaf1207f4", "1776d018-bd97-44ce-9ec2-42e827e10b31", "a91f861a-ba1e-48c6-ab49-ce861b1925b4"], "metadata": {"page_label": "7", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}}, "36132048-5b84-4c1f-9209-2abff9297b0b": {"node_ids": ["d6891c34-5c10-4b73-bad8-3764f7d150e9", "44f15c74-ff06-4684-bd29-179f36f1e075", "8d94b934-4534-41e3-b277-15b52285367c", "2ed823d7-d9d2-4399-8257-b987af381099"], "metadata": {"page_label": "8", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}}, "11bbdfb9-b55b-420b-893e-42c5b2be6732": {"node_ids": ["beebd843-d8bd-4fd8-9476-662122f8326e", "ffa77d7d-e5ed-4a05-9319-a59768aaf549"], "metadata": {"page_label": "9", "file_name": "High-level semi-synthetic production of the potent antimalarial artemisinin.pdf"}}, "564be214-2fe9-4681-84be-93f26b887790": {"node_ids": ["0a9fee56-a758-44ff-ade0-b89d8bd83863", "6b106609-5372-4d2a-a375-d0dc224cf81e"], "metadata": {}}, "a07c1f81-e112-4d24-b379-3173bda1f275": {"node_ids": ["ea066f63-8af9-43e5-968e-0e4212d94a71", "45a5b192-fb73-4765-81e0-46ee07af9845", "2486d01e-60e9-4a64-b240-cb67eeed7690", "84cad516-4adb-45aa-9ce0-d241ed187470", "0c6ab53d-cabd-4b4d-b7e8-ba6ffe96aee7", "5edf3f53-8c1a-484d-9172-b7f4f482fa4a", "6f69f89c-9cd8-4aaf-a35d-5de457acae66", "8a2fb072-28cd-4006-9676-89a8eb8434bb", "a6f3cd15-fb77-4b97-9d4b-a5492ca8770c"], "metadata": {}}, "24d748fb-a338-4061-b032-0466ee6697e8": {"node_ids": ["b128157d-9f1a-4199-8dbd-4e4b35385ff8", "8d0e1396-8165-431d-b0ac-2f58a0952892", "5d44643a-88e5-4095-975e-0f373e9b38fe", "9e9cecca-6015-44bd-96cf-3deb12ac24cc", "3c2c4feb-38aa-4df3-9050-10c1c7da9c64", "d00a2be3-59f8-40ab-a2ad-d0f056b35294", "352c27a2-6598-434e-9c3b-4d75d2c9989c", "7f10eeb0-701d-4d63-9b9c-f29d74424d7e"], "metadata": {}}, "96613642-e63d-4b1e-8252-ecb4d4e26853": {"node_ids": ["f1d6febf-03aa-4ef0-9507-02a8c1bb6f0e", "5ce8fa17-089a-4270-8ede-7b08fc823da5", "9dd45a83-1df4-48ad-a252-ee84ecab1741", "5abc2c8e-e5b8-43c6-b732-985766fc22fb", "ffecce29-2cc7-474a-b89c-ad8e750e8111", "929d9da9-c77e-4d30-9866-f5da79d36830", "4a84a8a3-0b30-498f-af20-1bfe7b1fd16d", "64084fbc-0d40-4ce2-bf17-f5dcd7232297", "6ee6fab6-6f36-4f8a-907e-97225c01d8f0"], "metadata": {}}, "aafa609a-4cb3-42f7-8637-aa761dc4f733": {"node_ids": ["dd8aa3f5-cec3-4794-807d-10e726bf074c", "d7d40529-0952-4823-99b7-b571aecfd62b", "16317337-af6a-47f3-9966-c28247926065", "e247ef33-5c3f-4884-a641-b9849175f7f0", "c19dffdf-2bf6-4350-9f08-54a3a709f677"], "metadata": {}}, "2edfb660-1efa-4517-b3d7-2c7c42053af2": {"node_ids": ["660755ea-048e-41a4-b58d-ea38c2776a26", "8b9bec50-67ce-4940-a5be-b99a7a838eaf", "1fa23db0-433f-47b4-91fd-2fc81a00a227", "96f4fe87-4e21-4088-8381-6279675def54", "5937a12d-c359-47dc-b0e8-7d42ef8f6d69", "0063b3ea-0801-4263-9c56-75cca5255a7b", "99423ed5-0c4e-40d0-ac63-d76dd2ecaadd", "16529f6c-0a09-4e13-8fbd-9a602de72665", "eeeb62d0-d13a-4581-84e2-e5fee3a5aaa5"], "metadata": {}}, "4029a4e4-3c05-41b1-aab2-3512cb045dbd": {"node_ids": ["4f1ff419-1c3b-4a6b-925f-e5a1062f2be1", "f9c3f23d-e0c4-4758-a2ac-37eaf8f61d91", "67a91526-3d60-4a7b-a97f-4740da4a7fd7", "bde6d71c-aed5-49d6-9b79-796edda986cc", "96e63029-1f71-42fe-818c-58017536a9b5", "0a34bd99-0674-4038-b979-d20aa5c00460", "36442997-87ec-4cb2-b348-77450a7d15bd", "283d0512-492c-4e90-9b45-e2f585ccdf1a", "ce33a154-1d5a-43a8-ab28-897485fb0942", "df42b3a9-20b8-4ec0-876f-9fc355bc1e02"], "metadata": {}}, "4d4d8996-38b7-4922-a5a3-8d460bdcccdd": {"node_ids": ["ea639285-da04-477f-baf9-537e9d2196f7"], "metadata": {}}, "22a72e50-3350-486e-897a-d10f1865f945": {"node_ids": ["0a46df26-0faa-4880-9cb0-a018de3ab880"], "metadata": {}}, "47f3f53c-3ea9-42d0-80da-1817d6feef8e": {"node_ids": ["ba4865c4-44fb-41a3-b835-5dd528115af3"], "metadata": {}}, "f80344a4-f951-44f4-b562-cf9c2eafcd14": {"node_ids": ["ede47257-aa3d-4826-b5b1-ed154d6ca766"], "metadata": {}}, "9985ffb1-0998-483b-8b2d-b3bf7665cc35": {"node_ids": ["933ae657-3341-4562-be4c-d3e5f9a17aab"], "metadata": {}}, "65c43e63-3cad-4eea-8e2e-2eefdd741572": {"node_ids": ["b0e470e9-c52c-4b2e-bd79-b1d2bece0655"], "metadata": {}}, "46715ff1-001c-42a3-b1c7-c5f9aafdcdba": {"node_ids": ["71ff9a68-a58e-480d-9cb9-7ba7bf4a5608"], "metadata": {}}, "065fd747-9054-4a38-aea8-0afc053c9abe": {"node_ids": ["d7e4d261-5579-4cf2-b2c6-c0a67c07b2f4"], "metadata": {}}, "ba303aa1-ca51-4ca1-ab01-b46b11269478": {"node_ids": ["ae5931d9-818f-4a26-91f3-a133fe31128b"], "metadata": {}}, "eb6c427c-364e-4849-8a79-0e46f568a1f9": {"node_ids": ["ab86afae-c3bc-4c8e-ac98-215c4efe1662"], "metadata": {}}, "a69db317-69d6-4df8-87d3-3b67e5ef98ee": {"node_ids": ["fda80048-74b1-45b2-93f9-5a3a02f895f2"], "metadata": {}}, "557ebe60-20be-48ca-9271-cf6bd9e97759": {"node_ids": ["5b92a4e0-4b8c-4138-b2f7-9bb16179456e"], "metadata": {}}, "0c365bc2-bcc0-40d8-8359-312d7db0ea2c": {"node_ids": ["f80d0539-2eaa-477f-a6a2-3d03911209c7"], "metadata": {}}, "11760da2-6cb5-44a1-b8cb-24ec0da66b81": {"node_ids": ["4ce29ceb-24c0-4b1d-a98d-be9dae95d663"], "metadata": {}}, "2cd72a0a-e948-4ff7-9f40-dbc3b9d4ea8b": {"node_ids": ["80625897-7eec-4d3c-9d2f-a61ac33a9975"], "metadata": {}}, "2231a9a6-e601-4296-ada5-8372b6438bca": {"node_ids": ["f8a1a392-b154-44f9-8bae-129585e85a3c"], "metadata": {}}, "454d8df7-3e4e-48db-afa0-93c1996ca420": {"node_ids": ["68abbf8e-d10b-405f-86c5-c8b768f25f12"], "metadata": {}}, "08b94b43-9af2-497c-bb3f-ebe575c982a7": {"node_ids": ["0e04afd8-0560-48ae-9243-bb105902157e"], "metadata": {}}, "fc50f281-55d5-4bca-8c0e-b00942990a56": {"node_ids": ["d8c8d4a2-75c9-4cc6-8972-2ea9ec05b57e"], "metadata": {}}, "7b190dc8-87f9-4544-ae07-5279ce3046df": {"node_ids": ["d819f5ef-910f-497c-8d79-f30abea08677"], "metadata": {}}, "d7dd4540-5a15-48fc-b18c-11de029555bf": {"node_ids": ["7b29d162-82a2-4187-9091-d23cee72e09f"], "metadata": {}}, "1fab887a-2cc2-448b-9138-3857e0701c2a": {"node_ids": ["037e4d8c-80e8-4e17-b8a1-a51ebdd4467e"], "metadata": {}}, "8636484c-e14b-44dd-a251-e385c4fc294b": {"node_ids": ["69afcf26-b0f3-487b-b5dc-f088976df4e0"], "metadata": {}}, "62bbae2d-2a78-4e00-9e92-693cdbb875c3": {"node_ids": ["547b89ac-a120-46ee-9499-6189be3d72e7"], "metadata": {}}, "c73013c9-4787-41d0-9d00-34488ecc060d": {"node_ids": ["3b93d38c-c0db-466d-92f9-00c12ba4f80a"], "metadata": {}}, "fc3608e5-730c-4c90-b7d1-7929f0c13535": {"node_ids": ["35dbaa95-d457-477d-a828-db6329496d1e"], "metadata": {}}, "4f11f617-4d24-45ad-b7d3-8d85bb8ce0ec": {"node_ids": ["afc91496-fabd-4eea-83ca-3cf28945f4e3"], "metadata": {}}, "164c284c-7d6e-406a-ab4a-01fe063f918a": {"node_ids": ["1931b393-296f-49d7-96a6-470cca4f8435"], "metadata": {}}, "7551b48e-58a2-4aa1-9488-450efbb970bc": {"node_ids": ["8acd034d-14ef-4902-8b6c-6c612d3afe8e"], "metadata": {}}, "6eb7cbf9-595d-4db0-9b59-a948ae86bc15": {"node_ids": ["217514ac-0302-4024-be7c-5c9c129f10fb"], "metadata": {}}, "4edb0ee4-816a-491d-b66e-d989f8566872": {"node_ids": ["f9e5e153-602d-4b20-be33-63c5a27df942"], "metadata": {}}, "0830e9d3-f18c-471f-8483-3041ab118bf3": {"node_ids": ["5aebc125-9b5b-4cdc-9bb7-652a1baf1189"], "metadata": {}}, "6805abe0-1bef-47af-8148-626d40fda5a9": {"node_ids": ["74136630-c072-42e6-a157-1f74252eaf71"], "metadata": {}}, "b9740561-4cd0-4c2d-b92b-a2889e1c4ee9": {"node_ids": ["91b2c7cd-cdf3-4435-92ea-ca40473b5075"], "metadata": {}}, "3023d401-35be-42ca-b3cb-cbf86baa1b62": {"node_ids": ["4a4ebe49-5c0d-47b9-8636-8704494eb3d6"], "metadata": {}}, "abd74dc6-fe7d-4741-9b1c-86cf92e9dabf": {"node_ids": ["88f72e55-2042-4efd-8841-8e883a11aa05"], "metadata": {}}, "4f3b0d9b-3d9c-4ecf-94d8-82ff1cae6797": {"node_ids": ["e0ba8016-d0d1-4755-ab00-0dabef4c6e16"], "metadata": {}}, "45404661-bab7-4afc-b84f-ad80c34e64ef": {"node_ids": ["f3a92e71-4b5c-4585-b284-c141bcf3d68f"], "metadata": {}}, "7141c8aa-45df-4258-857b-3f22bede7a91": {"node_ids": ["3e99523d-5c41-42e2-b34e-49ca61162bcc"], "metadata": {}}, "d1ad9bc5-6a79-4608-b573-62003c3ac7ea": {"node_ids": ["2ba61e40-2efb-490e-b098-5e104b25402e"], "metadata": {}}, "af45694e-1feb-4877-bb4e-50acd4f43140": {"node_ids": ["00adc7df-e795-43b3-9281-3038e36fc896"], "metadata": {}}, "523b1e56-c39b-4a4a-8a56-ccd03adb8d44": {"node_ids": ["b8841d32-bfa2-498e-a6d2-2cc15e813f53"], "metadata": {}}, "82e70b4e-1015-49a6-b739-e34dd8156fab": {"node_ids": ["5bf5ec7a-fac5-4130-a024-2404ca9d4755"], "metadata": {}}, "86778868-7bb3-4f49-9a26-c78b2494eade": {"node_ids": ["8995be51-bc15-44fb-b62c-b7f3329ff100"], "metadata": {}}, "f4f60c32-d5f9-44d4-b601-312e24eff0b7": {"node_ids": ["0b2ebfac-3563-44bc-8800-e0fd2deefe6c"], "metadata": {}}, "d60fb424-3065-4c56-97b2-f1cbd9afde27": {"node_ids": ["67556386-09dd-4bd5-9b39-10802a53e8e0"], "metadata": {}}, "be98ff6f-3e0b-4d15-b1e0-45cf596f670e": {"node_ids": ["926d310a-3165-4ce6-99c7-db589da8c99f"], "metadata": {}}, "d618ac31-f76b-4fb9-9f01-aeb7219e1f8c": {"node_ids": ["f120ad7b-51ac-4619-8cbb-7391534f5c18"], "metadata": {}}, "a9c80840-7405-4c0d-8877-02e68e887912": {"node_ids": ["af72457b-c4c8-4ad6-9b38-cb9d41939956"], "metadata": {}}, "d17a71fa-869f-4b81-98d3-ff8349298260": {"node_ids": ["a651bbec-9897-478d-a598-7aa2d99b79ef"], "metadata": {}}, "73e33618-683d-4bc7-9faf-051ffc48cc4b": {"node_ids": ["13275b11-c875-48c3-8737-a36bb3a43668"], "metadata": {}}, "320656b7-73a3-4842-b9c3-168530bde414": {"node_ids": ["a6baf061-15fc-4a0c-aa59-1a9e919e880a", "14463634-2918-4934-aa20-bbc7e8fec7b1"], "metadata": {}}, "e9428e8d-3031-4b47-ab08-aca218f40ef6": {"node_ids": ["945ff3e4-4a48-4595-9ca0-00f596c38f37"], "metadata": {}}, "20ad4412-10a8-4773-ac3d-ac540932b472": {"node_ids": ["de4a92f0-e385-4258-8f07-8cf05dc11a33"], "metadata": {}}, "121b4028-703c-44b1-9338-f482f68f9e35": {"node_ids": ["910029f0-9e4a-487a-9bb3-9be05d353706"], "metadata": {}}, "3bc50e88-cce7-4421-805d-9e3007b2187e": {"node_ids": ["52763446-f37b-4c10-8f3c-7e3f1aff0e0b"], "metadata": {}}, "d0646bfb-0b1d-4b34-b0df-5d5a7945cea2": {"node_ids": ["e350a3a4-7d4f-4971-b7da-2921f83ab1f2"], "metadata": {}}, "00706bb0-b713-4b31-be38-a28d086dd506": {"node_ids": ["e03cc3c3-c480-45f8-8d4a-a349fe103c89"], "metadata": {}}, "5582fb45-e245-45e8-a48a-ef2e232df2ed": {"node_ids": ["299cdbad-23bb-4048-b8ff-4bac8d6bb318"], "metadata": {}}, "1350de92-7f10-40f9-9c9e-febcc0126be8": {"node_ids": ["b75cfa21-4137-4e47-8fa6-e5ab52c15b86"], "metadata": {}}, "6590eeee-6173-4372-8040-49481b4dcd11": {"node_ids": ["d25f949c-b3f8-40a7-80d7-64aa92f76caa", "384e8ffc-ab56-4f74-b8ae-2ed822ee3b98"], "metadata": {}}, "267fddab-aaeb-4434-b1ca-f4883a1d767d": {"node_ids": ["afe77b60-4255-4a25-8ed1-f526ff848693"], "metadata": {}}, "61a98377-5bf1-4862-a502-94a14a74c755": {"node_ids": ["91cfe710-79e6-4a28-9f6c-3f7cd5b6d353"], "metadata": {}}, "aeb2cb41-13b7-44f1-b621-cf924cc08d97": {"node_ids": ["335b5e7c-00e5-42f9-a3a3-cd2d9cfb78cd"], "metadata": {}}, "3769e52b-d842-45ac-8b7a-3c33f489dfef": {"node_ids": ["526e119b-9ca6-4d6f-92a1-3bb8e3c85683"], "metadata": {}}, "16fe3a9d-d8bb-4065-9958-448ae109fc6b": {"node_ids": ["265564f4-fb91-410f-9567-6b3eb05d4a09"], "metadata": {}}, "30f5fc87-1a02-46f0-80e8-51751b8f5215": {"node_ids": ["0eceda12-9049-4396-a1b1-8d495580b8dd"], "metadata": {}}, "d0c6b54c-3a08-49ee-bb80-d5364fb49707": {"node_ids": ["2dcab1ec-8af2-44f5-a1ad-a8bca77eca2e"], "metadata": {}}, "fe9b8670-2917-4f81-b168-34eb07a0a8b5": {"node_ids": ["a42feef0-0d08-4fc2-9af6-3a7b5a6c826e"], "metadata": {}}, "cb162009-3a11-4c0a-aae3-23b0ec30497c": {"node_ids": ["5c2f61bd-f4ab-4bfa-873b-e247a07a1fdc"], "metadata": {}}, "75d77322-5d9e-40d0-adcd-324b2274e3f0": {"node_ids": ["c0966a18-53c6-46c8-b5a4-ed0965af8f06"], "metadata": {}}, "3f498d54-3613-4c3c-aae9-1d2d8887754f": {"node_ids": ["66abc75b-1312-45de-ab81-19fd54d49ab3"], "metadata": {}}, "55793051-95e5-4bc3-8f97-b1a7430c48cd": {"node_ids": ["600ce937-46d3-4b4a-9a87-aba1f4e14d70"], "metadata": {}}, "76aa9e20-2532-45e3-8834-c6bf10f1c929": {"node_ids": ["f973e596-e39e-4f06-a675-9553a560d491"], "metadata": {}}, "c920ead1-8e97-4ee1-a373-bd138608e3f4": {"node_ids": ["928aa4d8-f827-46e5-a260-5824d5da7538"], "metadata": {}}, "706afe10-1d21-41e7-a56a-a9714dfa220d": {"node_ids": ["ba2f78bb-ffdf-4aee-8673-57fcc0246a3e"], "metadata": {}}, "a7fc0c2c-cfaf-4a3a-bb82-593ec92ba62b": {"node_ids": ["28f391d7-b209-44e1-b3eb-e9a373688552"], "metadata": {}}, "1ff26edc-6068-4418-87a6-5f6954af649e": {"node_ids": ["d9db22eb-bf05-4b6a-b9ac-19ab505a6a3f"], "metadata": {}}, "50af3b9a-9078-4af7-9d3a-fcafc326ca7e": {"node_ids": ["0d291464-a5cb-45d3-aea0-a3d4fcf715e8"], "metadata": {}}, "dcf0a36f-cf81-405c-8222-597a4ab35fff": {"node_ids": ["6a1bb986-4981-41a5-8013-1c0ea2d830be"], "metadata": {}}, "2c4eee77-7889-4fd0-9b3c-5cf27e31e117": {"node_ids": ["23ac4044-81e5-4ae2-9e15-ad50dc9f9a62"], "metadata": {}}, "b8040aff-46eb-4b9d-b564-38e42aa53bfc": {"node_ids": ["9621eae2-edde-49ab-9404-5473ab25f901"], "metadata": {}}, "03a32e3a-9ec1-4327-99bf-588d27b47a52": {"node_ids": ["ab3b63f2-7083-4428-b7b8-219dbecba0ec"], "metadata": {}}, "40048bb9-df3b-4ec7-bb92-de8f0695610c": {"node_ids": ["3b00b9e9-3fa9-4767-abda-3f5bedc2fca1"], "metadata": {}}, "b5077bf6-30b9-41af-9bf3-761cee8b9bad": {"node_ids": ["74e668d9-6710-47ed-bd9e-ef1aeabca33c"], "metadata": {}}, "8174bae9-4522-4adc-bc8b-192a8f06cb11": {"node_ids": ["431de908-7ca4-46fe-93d7-5287dc3677ae"], "metadata": {}}, "80e1dba3-3e11-4412-b88f-283d539a6a80": {"node_ids": ["49a6317d-f8b8-45de-b0e5-0f7faaa41b45"], "metadata": {}}, "b2ac548d-5e76-40a5-b2b3-987488dcba02": {"node_ids": ["faf54093-7e8a-4628-97f7-f034f0dcc6f0"], "metadata": {}}, "183de8bd-164f-43d1-ab3b-15a1589f21f5": {"node_ids": ["81304499-aa85-4a57-b325-6d9a6478211c"], "metadata": {}}, "36d87278-720a-4186-8abc-502e01c4c92c": {"node_ids": ["4ce45d0e-5e6d-4f56-93b2-166e4a4cca9d"], "metadata": {}}, "c6a3cd14-4f5d-4453-97d5-2c412c6b872f": {"node_ids": ["bf8b70de-44fc-4838-974c-0c4822b65e14"], "metadata": {}}, "50bf6623-bca6-47b7-bafd-bcba7cd025dd": {"node_ids": ["6ff5a90b-45e3-4777-805c-d8377ea4c098"], "metadata": {}}, "51184f76-ff7d-4635-a3fe-782c187e98ca": {"node_ids": ["39d97ab4-a99d-463b-a950-eacfe53dd664"], "metadata": {}}, "ed366a82-5a01-474e-9658-ea4995f6816f": {"node_ids": ["42f114aa-529c-47e7-adc9-07910d150a62"], "metadata": {}}, "e03429d5-b5b0-41f1-8298-da426c6d8cb1": {"node_ids": ["d3515af2-41fd-4f90-9415-8a3e37d92e24"], "metadata": {}}, "592ef5db-5488-4678-bdcf-a395d808d1e7": {"node_ids": ["7fe85003-e71f-496c-8ac2-7adf9a52086b"], "metadata": {}}, "08e01526-25ca-40a7-b3dc-dcff6052c0bc": {"node_ids": ["3b8fa743-65f5-49dd-99cf-fd8cef6445b2"], "metadata": {}}, "d40a7492-e2e2-4de8-9478-08d112579e1e": {"node_ids": ["8edfccdb-292f-43e0-bf79-83180b6b59b0"], "metadata": {}}, "76092514-2027-4582-b797-e282c30074c5": {"node_ids": ["3739e152-4112-49cf-bff2-25ace0bbad70"], "metadata": {}}, "e84abbec-d22f-41ea-9b98-807ba9ecc40a": {"node_ids": ["9eb98e97-1386-4a6a-a52d-29169a2849d1"], "metadata": {}}, "18b64455-6332-49ab-9827-1f0737061d77": {"node_ids": ["753f5604-f539-4b4b-b959-a54cf7ac9cbf"], "metadata": {}}, "ba275713-5ed4-4998-ae30-e6c7c907d010": {"node_ids": ["39a99b8b-7b07-465d-9ddf-bb1409012fa2"], "metadata": {}}, "c29cde0f-500a-436d-b4cf-ba2cea602e2b": {"node_ids": ["51750201-7ff4-451f-bf12-45ea13fedc6b"], "metadata": {}}, "aefbd97e-0df7-492f-8b63-46cce30bbc67": {"node_ids": ["ca94cb58-b2bb-4582-a65b-0d2c632f5904"], "metadata": {}}, "68bbc07e-2bff-444b-9669-da38603e38c3": {"node_ids": ["b9ca5db3-cc71-43ce-9f25-378f5a4e7efc"], "metadata": {}}, "1d329a1e-0703-4833-99fb-677b52c7c2df": {"node_ids": ["1cb2a82a-f5ab-45bd-9c0b-24bb350f57cc"], "metadata": {}}, "f5f941f3-33c1-4129-b048-86958c4ce59f": {"node_ids": ["ca72572a-d14e-49c0-9281-14cc6bc32135"], "metadata": {}}, "bd32f1cc-9490-4fdf-a7f9-af9c8727de96": {"node_ids": ["a00bb63b-0ca0-4562-8a6a-02adbc8994b2"], "metadata": {}}, "889cd50e-629c-4ca0-a8d5-0fd3e5725da8": {"node_ids": ["88adc248-6f71-434e-8ef6-7e3f3e62b82a"], "metadata": {}}, "e4211359-7d89-4f16-a277-172fc2824132": {"node_ids": ["67288be1-b886-4cd8-ba98-f6bd551db859"], "metadata": {}}, "e18d9d14-5d55-4e48-9694-9c345ca4c553": {"node_ids": ["9d6881f0-6667-4c21-94a7-9c63003f9cc7"], "metadata": {}}, "091ec803-2613-4a04-bd73-56767fd6700d": {"node_ids": ["eb1868ee-381d-4a49-b76e-8f7e8da02e01"], "metadata": {}}, "30a60ecd-2d11-43ae-b311-b812c138845d": {"node_ids": ["8ac18525-2496-4838-87c2-154537173ca3"], "metadata": {}}, "665f4910-425a-4a19-80e3-3ee30f9af373": {"node_ids": ["19faec39-55ed-4d84-95bf-027d54d4f2dd"], "metadata": {}}, "8a98ee00-4caf-4f06-ae25-e4dbc0edd485": {"node_ids": ["f0d53255-0bbd-404d-aba1-614f7a016feb"], "metadata": {}}, "751589dd-2e81-4c07-9036-3f2bd12521c8": {"node_ids": ["36dc1a2c-82e0-4305-8493-805b3ec5dc4f"], "metadata": {}}, "abd0c72c-4a87-47ca-bd66-66ba21d56103": {"node_ids": ["235f43b5-181a-4c46-946f-6157d339d318"], "metadata": {}}, "39d1ae6e-aa3d-499c-9e51-56bb223f7d48": {"node_ids": ["f08699df-cfb2-400a-981b-391444220f25"], "metadata": {}}, "1f4943a8-9181-4030-aed5-6d8c2537c119": {"node_ids": ["56e114b6-a3d8-4eca-8e8d-6979e368370e"], "metadata": {}}, "d7f47c7f-3166-4fd7-be4a-0536779e410f": {"node_ids": ["a9e9655c-f5a8-44a7-a033-2d8e4e25b1f5"], "metadata": {}}, "5c855c94-1d62-4907-84c6-71f7a45fa42a": {"node_ids": ["e5077f7c-6d27-4fd7-82c5-0a2fc5bbbb6e"], "metadata": {}}, "c75d8b1d-2bd0-4d16-97c2-86ddee171fcb": {"node_ids": ["a861ccb5-a594-4f13-b903-bfc332ab5505", "d5eb1fe6-7042-43e3-b692-52210be9acb2"], "metadata": {}}, "403c7a90-f672-476a-805a-30ffcffc9ac4": {"node_ids": ["b533ce53-6263-43bf-a3a8-1000d24f8971"], "metadata": {}}, "4c7d94f0-0b39-4907-adf6-198ca9f103ef": {"node_ids": ["e177f1a3-1c67-4f53-9a45-6ffddfa14ba6"], "metadata": {}}, "fd7c1274-1898-4c64-be35-3330e31dbd2d": {"node_ids": ["95c1194f-f587-4497-b357-2489eb58e3be"], "metadata": {}}, "53ec4ed4-b3c8-4993-a3bb-b1d829bcbbc5": {"node_ids": ["a88973d1-4a1d-4e13-9c84-a9012b798772"], "metadata": {}}, "6ed45376-0993-4862-80ff-81bbc9430f32": {"node_ids": ["69163d6d-5721-4ced-bc83-d7e6a1e5ff0e"], "metadata": {}}, "662e1f61-bdc1-4564-b941-fd74ebfd115d": {"node_ids": ["1ea99c6e-a7a9-47e4-b0a9-98ed10e4c8e5"], "metadata": {}}, "27799c77-1c88-4b19-913a-be1a43e96d5e": {"node_ids": ["979c9a0c-7fb8-47eb-8c63-5f929e43f5a2"], "metadata": {}}, "31932e3a-b7b8-41ec-8d9d-5733fd7da724": {"node_ids": ["1b34bdc3-53d9-468b-9087-8156159ee081"], "metadata": {}}, "84e7383c-40d5-443a-94a7-5a7bcf59e66c": {"node_ids": ["dbffbdc5-d447-4b7b-92f9-352fd7cfacc6"], "metadata": {}}, "2fe1d8c2-5a5c-4ead-91b0-051b3b1c6c9e": {"node_ids": ["f0ae845c-eb81-43da-a725-0f7492261826"], "metadata": {}}, "8bfcac68-b6a3-4f3f-aa57-c4871b18cd8e": {"node_ids": ["dfcbeaf4-e847-43c5-84ad-44cd8fe34ca2"], "metadata": {}}, "1de97efb-4656-4e94-95e6-478e452fe11b": {"node_ids": ["cf102e4f-0665-40d4-9659-fda6aa99fbd3"], "metadata": {}}, "a49a2160-6510-49d7-a44e-318221aa98eb": {"node_ids": ["25a5b9be-ca88-4ffb-b1db-229a6f0ca12e"], "metadata": {}}, "2fe85357-3333-462e-8bfb-86fd13130c4c": {"node_ids": ["3cd1e1b2-13fa-4f7d-8575-9fc605ff3268"], "metadata": {}}, "2761301d-6f02-4aa5-be7a-e8f7ef1c9123": {"node_ids": ["ff19db76-d9e9-49db-aef8-0945b94ea412"], "metadata": {}}, "5b01e8da-cdf8-498c-97be-d7fec3306a22": {"node_ids": ["760cf1b0-416f-4022-bba0-7fa4f8c83eb1"], "metadata": {}}, "84db34e3-f7a7-40ea-aa21-a25df08d2118": {"node_ids": ["3f3bd525-02b4-493f-a792-502ef3bdc737"], "metadata": {}}, "8c64ef8d-0cef-4420-b875-ed74ca20af63": {"node_ids": ["efa85554-8b85-44cd-b46c-5cead059591a"], "metadata": {}}, "e1bc2c2b-2118-407b-bdbe-c5cebae82411": {"node_ids": ["f4241ec7-b9fb-4ff3-8c1f-7eff3436ac02"], "metadata": {}}, "6faff7ed-f9fe-416d-b93b-66ff57602eea": {"node_ids": ["fc925d48-7a94-413c-b7c0-284bd3b65ec2"], "metadata": {}}, "5d51fdf4-b97f-4932-9aeb-12a44a11ad9e": {"node_ids": ["8550ecc3-10be-47af-b379-a581cb908df9"], "metadata": {}}, "7b1bcf56-e8a1-4d60-858d-873a215c8797": {"node_ids": ["451854f1-a9f9-4328-a8a7-d226f6b388e0"], "metadata": {}}, "6f5f8819-8c97-4618-8c22-231e7a63b9e9": {"node_ids": ["2dc3e64d-7418-4a7f-bcec-022df3923f8e"], "metadata": {}}, "6a9f4369-38b1-4b58-96c9-53477b30e0d0": {"node_ids": ["5752e04a-09ea-4a59-a33c-55ad523ac00b"], "metadata": {}}, "0976cd84-8c3b-44fe-b76c-79d43a093462": {"node_ids": ["5916a9c6-7cd1-4921-9698-237d1ee568e9"], "metadata": {}}, "1632a9d5-d901-414b-9f23-4d288dcbe667": {"node_ids": ["37397fbc-e0f3-4db6-9442-2c976661e7a7"], "metadata": {}}, "cbc9625c-b832-4841-9f4a-79d7ef4eb00a": {"node_ids": ["12e0c405-2466-4d23-b7f7-0ea28c98e1d7"], "metadata": {}}, "53c38a42-adeb-4cba-9f02-fce031194822": {"node_ids": ["2f10864b-b493-4ab9-863f-d5ef10c5cc0f"], "metadata": {}}, "ab3afd9f-61b9-4672-a80f-7929b53381a5": {"node_ids": ["f8de43e2-0837-4fee-9cf0-e0119786e8e1"], "metadata": {}}, "8562775b-0cc5-4cfe-b91b-c570ebd28d69": {"node_ids": ["703cbfaf-bca3-4485-9868-0d5127984e32"], "metadata": {}}, "0f7cc04c-c62f-4a04-8b8e-5fcafe22108f": {"node_ids": ["cb404a40-6e9e-4dcd-b998-a2aa9c4f98e0"], "metadata": {}}, "6181ad41-099c-4f46-bc34-22c438fb9110": {"node_ids": ["6d910027-5cdc-42d6-913a-f12a30e4b91b"], "metadata": {}}, "6bc4fb2e-ff80-4ba2-9cdb-c4b48fb96cc8": {"node_ids": ["f99014cf-b613-40e1-82fd-a0c8e9728068"], "metadata": {}}, "219dd4f0-169b-4eb3-aed1-a1c071bd2e81": {"node_ids": ["d4fffb0a-1351-4761-b023-1c6b0b19082d"], "metadata": {}}, "8bdd227f-6d71-496d-beea-90ccbaf24cd1": {"node_ids": ["3fb366e6-ee1f-4b2e-9780-8ee059c8d139"], "metadata": {}}, "6bcc1e8c-952b-4fe2-a07c-60f677d54836": {"node_ids": ["c188c748-f7bd-4642-82cc-6fc14a674992"], "metadata": {}}, "814542d0-a943-45c8-8b7f-17312ea9f32c": {"node_ids": ["a2059d8b-ed25-4a40-ac5f-683610fbc349"], "metadata": {}}, "d94d010b-1367-42f0-86a1-a31e8489c1d1": {"node_ids": ["3087930b-1e6e-4fef-a911-6bd6639b8166"], "metadata": {}}, "56b566c1-7e01-4dad-8f70-08e80810707c": {"node_ids": ["4a2bb702-e7a6-4051-ad15-f5de720411e8"], "metadata": {}}, "93f90cd7-76ce-468e-9609-829ed002d25a": {"node_ids": ["fde02f39-122b-4659-b015-cdd88952b979"], "metadata": {}}, "c87ef109-5034-45a5-817b-5b7089cf2be8": {"node_ids": ["6cd1d26e-7baf-4750-b787-a94b0d1f44c0"], "metadata": {}}, "98a71733-3765-4d3f-941f-0d0c73e1436a": {"node_ids": ["998824e0-c58c-4486-bfd9-d59833b68c54"], "metadata": {}}, "026288bc-f373-4e0f-a2fc-fff67d7d0d65": {"node_ids": ["12f6a891-3671-4ab3-885f-87ac1b63fe11"], "metadata": {}}, "0fa70009-c74f-452a-827d-e23cef0a4264": {"node_ids": ["a66036bc-2b0d-4e66-97a8-bb08e113c087"], "metadata": {}}, "a22d8d37-6647-4f99-905a-802fb2dada39": {"node_ids": ["724c90cf-2ad0-4781-b684-cb29c7892327"], "metadata": {}}, "3f4f69cc-dbda-4249-8138-4b543a63dbe9": {"node_ids": ["f93180f4-09c3-41b3-b553-ed3a29ac7027"], "metadata": {}}, "b037187b-168e-47a0-a234-40424e837049": {"node_ids": ["6cf8a60b-6975-495c-8949-5971fc6582e0"], "metadata": {}}, "e190678b-93a7-4aba-bc84-dc2e3d026831": {"node_ids": ["2a58c021-9886-4791-ba83-d7924108955b"], "metadata": {}}, "67dde4f9-e0a7-4bb0-b2d9-cacb212fad75": {"node_ids": ["da53c304-2bbf-4f7f-8142-ea573a71a157"], "metadata": {}}, "e672f2b1-52e9-466d-b00e-8971b3239a2e": {"node_ids": ["693daaea-aa59-4eab-ba1e-a62ffd6d773e"], "metadata": {}}, "cb1885e7-5557-4608-9163-5cf17eb20ac2": {"node_ids": ["ab4a228e-3073-4453-bd4d-4101169cd9ee"], "metadata": {}}, "48e2f4cc-40df-435b-b25d-966a29140255": {"node_ids": ["b6239cb8-38b7-4cbb-9561-9ebd848418aa"], "metadata": {}}, "8c924ce5-dbc9-47cc-85fa-b5415399c7bb": {"node_ids": ["e3b3ae4f-afee-450d-a113-7ef3370ec372"], "metadata": {}}, "fa9d4ee3-efef-4660-969f-0e664b9e7965": {"node_ids": ["162404ad-a136-4c43-bc17-6c3e0779acb3"], "metadata": {}}, "8b664315-0da8-477f-b771-ded25b832a1f": {"node_ids": ["0ad1bee6-bda9-4d64-9f1a-2c0f6d91b1b9"], "metadata": {}}, "43d0a6c4-1751-43c4-9a86-0081f573b732": {"node_ids": ["7936686d-e216-40c2-8060-6c4395245639"], "metadata": {}}, "08ca0299-2d3b-4d06-a6e4-e38785018b19": {"node_ids": ["3d1b75b6-db29-4951-aa6f-a9062c38e1d1"], "metadata": {}}, "41760108-e91e-4910-a3b0-abd0a5074054": {"node_ids": ["43574f83-da1d-4bed-b832-840be1f0c44f"], "metadata": {}}, "b4fd54f1-65b3-4753-b6bb-ba929903a383": {"node_ids": ["d94fa6c4-5ab2-42a4-9261-6444b8b7cbb6"], "metadata": {}}, "5091eaca-5116-4288-a894-e579c77ce2f2": {"node_ids": ["6116d24f-d37e-450b-adc5-b0da78848a78"], "metadata": {}}, "b495504f-99f2-4f00-8289-e132287648eb": {"node_ids": ["8dd463ec-c44b-4494-990e-13a29e55132a", "52018ce0-2f4e-453b-a81f-2a2a24accea9"], "metadata": {}}, "ce38c990-8ff4-48cc-ad74-b1716523ee85": {"node_ids": ["07674c8f-96eb-48fc-af03-4652c649af05"], "metadata": {}}, "54ab014f-1bc1-4451-967a-3a09aa3d6682": {"node_ids": ["7a467993-8164-4434-834f-a26527bed0ed"], "metadata": {}}, "1e93cd10-201f-4094-bbce-8f55d589895c": {"node_ids": ["c3984da4-6798-49f9-b181-049000963206"], "metadata": {}}, "d8a38b2a-6d9d-4ab1-9448-8bc2d106f785": {"node_ids": ["5f1293be-9034-492d-a954-c9c165d6ab2f"], "metadata": {}}, "c54999e7-a083-46f1-8977-cba0591d7b82": {"node_ids": ["5e7a5dd8-19b3-4f19-88ab-1b86fa7bfca3"], "metadata": {}}, "08ba7508-b6cc-4a57-9273-e78e7bc33d38": {"node_ids": ["517dbeb2-2672-4324-991a-918a22b7b3cb"], "metadata": {}}, "3ca03a1f-4216-4d0d-a111-7f9ac455d319": {"node_ids": ["e120fec8-1074-430f-bf4f-a10ddd946a88"], "metadata": {}}, "9c0dc66a-4a2f-4e60-bc3b-55ffa499c387": {"node_ids": ["eec26144-b4e2-49fd-87e6-6b11519585ca"], "metadata": {}}, "e49a5757-2aaa-42ca-9ecc-92280809f8f9": {"node_ids": ["a1f90c99-e4bf-4cd0-870c-6c8192953a5e"], "metadata": {}}, "4b99f63e-c492-4cb2-b40e-72d8d78aa5e3": {"node_ids": ["ec6406b3-0f36-4f7b-8ca7-8137a363cc61"], "metadata": {}}, "a68ed2a5-faa4-4695-ad41-30c66ac6865e": {"node_ids": ["34e7d15a-d9e6-4d73-a5bf-5c99ada6e793"], "metadata": {}}, "871c5359-e2cf-45f5-b029-325a1695579c": {"node_ids": ["e17aae44-dad8-4f49-bd63-bc92f421185c"], "metadata": {}}, "0c17d98a-ad42-406e-ba96-b074716ece41": {"node_ids": ["e1dee07a-8a97-420a-95da-36762653bd04"], "metadata": {}}, "396f56a4-7757-4959-adaf-5ce628011ea2": {"node_ids": ["29c0a0c3-c270-4e19-9038-2884cb8c1bbe"], "metadata": {}}, "28cb1650-ce1b-4752-bf3b-5374d5a0c862": {"node_ids": ["5e2536c0-e3a1-46be-aeb9-9333ef5234af"], "metadata": {}}, "b16f0d93-7d87-4f19-9ab2-efdc2f07508a": {"node_ids": ["dcb83664-0098-48d4-91f0-2434118747c0"], "metadata": {}}, "36606f32-0c53-471f-9449-c6c88bd25c55": {"node_ids": ["6cb78328-cbcd-4dc8-aa7a-8b080b17c331"], "metadata": {}}, "de452f0f-b7ca-4fef-9cb2-d1100b0820e1": {"node_ids": ["d527b497-fe27-4005-ae0c-e464617ea9b5"], "metadata": {}}, "f96687e2-8b36-42ed-89aa-043031f280fb": {"node_ids": ["a181c69c-f0ab-4594-ad98-b845148eb48a"], "metadata": {}}, "114209dd-c3f0-4c23-952a-2eb3841c4e0f": {"node_ids": ["b2838f06-7ebc-4ddf-83a3-171011bb15bf"], "metadata": {}}, "c92d7b7d-d307-40c5-9463-4201f68950c7": {"node_ids": ["bf56bd92-3eb8-468c-a837-b738466906b4"], "metadata": {}}, "bb6c8e65-ce9c-4bcb-89f3-3fcbc085e6d9": {"node_ids": ["54eb5e22-7122-4475-87cf-8a02fbbd084a"], "metadata": {}}, "199dc43a-fa99-416f-9f9a-dca34492d54b": {"node_ids": ["e957f483-d986-4571-a571-18169bbae733"], "metadata": {}}, "a194c74a-dee7-4eb3-b608-20799ce20975": {"node_ids": ["92ab99f4-0247-4551-9193-600249d217a9"], "metadata": {}}, "5c480dc4-f289-4b8d-a582-b69db29fcbc6": {"node_ids": ["72efe6de-19af-4447-aae2-495fd629c2ac", "28dc8eba-27fc-4085-b0fb-70338b9fb5db"], "metadata": {}}, "be16816a-89f7-4570-adb0-cb6bc4aa1929": {"node_ids": ["f767fc25-451a-4b9c-86d2-dccbfa9426ef"], "metadata": {}}, "eed48874-0ca6-4536-b38d-3ac2b5459f23": {"node_ids": ["3020b8bb-de31-4d16-8094-a2416d352d5f"], "metadata": {}}, "bcaee994-c85e-4a0b-b683-c8650ef622bd": {"node_ids": ["0d4e5db9-ae9b-437a-8795-f9bcc90e0b84"], "metadata": {}}, "fd74c8ba-c371-4b34-a41b-11dcd76beec1": {"node_ids": ["1ee037e6-5c10-44f7-be67-2f47d502b3a2"], "metadata": {}}, "aa1dc9d5-9637-4cad-8683-0d3b78b6a5f3": {"node_ids": ["8b41760e-e087-4f6c-accb-4799186f769b"], "metadata": {}}, "29fed515-9919-45b0-b19f-c438861dd2c1": {"node_ids": ["7315d2d8-ee17-4929-9fe5-0cee967aa820"], "metadata": {}}, "06ba733b-9eb8-48f4-a13d-2712d158fbbc": {"node_ids": ["b1145a33-5999-40ca-b7aa-4a355b78c23e"], "metadata": {}}, "508f3977-f5b5-4d30-b48a-cd0b28b9648c": {"node_ids": ["2a3cd050-c677-4408-9eb3-5fb0ae196566"], "metadata": {}}, "a6c54a9a-220e-4a7e-b4ba-db36984ed438": {"node_ids": ["525ddb01-fabb-4e5b-90fa-4b356e8b6cb9"], "metadata": {}}, "75145522-13df-486d-9407-fcb25dbc61c9": {"node_ids": ["132e1696-ae47-49cd-b1bd-63dd983a194a"], "metadata": {}}, "249e5398-ad37-4e63-b758-6ad6581a4ec1": {"node_ids": ["2ad2424d-e85f-4020-a7a9-1f895b06b6f9"], "metadata": {}}, "1393e96d-5672-4c1f-964c-1bf711a54242": {"node_ids": ["9111114d-7007-4495-a3c4-ce006224eddd"], "metadata": {"page_label": "1", "file_name": "200419_biomolecules_deck.pdf"}}, "b5efe434-5d4a-4b07-863a-78270ede227a": {"node_ids": ["a56b2916-5c93-4b6b-973d-ddfefb3193bc"], "metadata": {"page_label": "2", "file_name": "200419_biomolecules_deck.pdf"}}, "b68f706a-4896-4b7e-ab61-53d9c369c487": {"node_ids": ["b7e4e73b-7d6e-48bc-8a1d-5281b21c1871"], "metadata": {"page_label": "3", "file_name": "200419_biomolecules_deck.pdf"}}, "d5fcdfed-41f5-4f2d-a2e2-1089c0fac632": {"node_ids": ["a67b9481-40d3-491d-8dc3-08d81038bda5"], "metadata": {"page_label": "4", "file_name": "200419_biomolecules_deck.pdf"}}, "cb1d5f08-8e88-4fa9-aba4-8f8914f57612": {"node_ids": ["ad2a2470-bfda-48db-829c-91683ef020c1"], "metadata": {"page_label": "5", "file_name": "200419_biomolecules_deck.pdf"}}, "2f875451-b71b-41f1-abab-d58e1f8b87f7": {"node_ids": ["4bdb01bf-ea29-454e-939f-8e29a7f01a8a"], "metadata": {"page_label": "6", "file_name": "200419_biomolecules_deck.pdf"}}, "56154760-10c7-47a4-8a8c-1d1b2e68a24c": {"node_ids": ["e643902d-e70e-40f8-a8cc-d2f18d100f8c"], "metadata": {"page_label": "7", "file_name": "200419_biomolecules_deck.pdf"}}, "372234ac-74c6-4632-ac11-6d73f036cd2c": {"node_ids": ["8dcd3a28-54f3-490d-8633-42d5710f2567"], "metadata": {"page_label": "8", "file_name": "200419_biomolecules_deck.pdf"}}, "e6d60321-b32b-46a7-9192-011c10f3b05a": {"node_ids": ["a82075c7-fff8-4e83-bfbf-0c87bd40d5b2"], "metadata": {"page_label": "9", "file_name": "200419_biomolecules_deck.pdf"}}, "7eac9f2b-9698-48b3-b65f-869b28114dd3": {"node_ids": ["b55cc126-485e-4c16-931b-5bf403ca028f"], "metadata": {"page_label": "10", "file_name": "200419_biomolecules_deck.pdf"}}, "030c4b85-035d-4b57-a196-dec5b10f3dc2": {"node_ids": ["fbeb3bd7-a905-4c0f-84f1-ad921ad4d0e6"], "metadata": {"page_label": "11", "file_name": "200419_biomolecules_deck.pdf"}}, "02c64c2b-2d3a-4ff4-b647-6582aa1bd20d": {"node_ids": ["b1a3237d-02ad-48d4-b09d-f99136b973a0"], "metadata": {"page_label": "12", "file_name": "200419_biomolecules_deck.pdf"}}, "bbf1da6a-2921-4a4e-955c-33ce1ef6f3ec": {"node_ids": ["b0daa1ac-5efc-4614-b793-42178c895d39"], "metadata": {"page_label": "13", "file_name": "200419_biomolecules_deck.pdf"}}, "2ddd6854-53df-486c-b20c-9061691d57e6": {"node_ids": ["f2a9382d-a200-4481-a4c6-ac2ee0c47eca"], "metadata": {"page_label": "14", "file_name": "200419_biomolecules_deck.pdf"}}, "b35bf376-96d7-457a-8501-d8ab87a56741": {"node_ids": ["f34bb0c3-1819-425e-8c67-2201da1338cb"], "metadata": {"page_label": "15", "file_name": "200419_biomolecules_deck.pdf"}}, "7cea3a13-0def-4e49-bbed-d0df8dc4e13e": {"node_ids": ["232ef1e8-2993-4040-9432-ea652369d380"], "metadata": {"page_label": "16", "file_name": "200419_biomolecules_deck.pdf"}}, "4b32e8ce-2449-497e-8b28-3b08c60d4005": {"node_ids": ["a289e731-9deb-490f-a9b9-f8d1f46c842d"], "metadata": {"page_label": "17", "file_name": "200419_biomolecules_deck.pdf"}}, "2b3e6e4e-593b-4b70-9fc4-ff01a1cf338f": {"node_ids": ["a9118504-f382-41da-aea4-7ced17e70074"], "metadata": {"page_label": "18", "file_name": "200419_biomolecules_deck.pdf"}}, "2b2be256-a302-4ad1-97cd-3bf2f4e7157a": {"node_ids": ["c2bd5547-c7af-425d-be59-b8c5449cae32"], "metadata": {"page_label": "19", "file_name": "200419_biomolecules_deck.pdf"}}, "9906c64e-7aa8-42cd-8ea6-4df35ba83ca9": {"node_ids": ["3183e05d-a528-49b2-82c0-3bf1abf030ce"], "metadata": {"page_label": "20", "file_name": "200419_biomolecules_deck.pdf"}}, "b34325f6-4d87-4ee5-918a-ab92adba3181": {"node_ids": ["306648fa-2bd9-4d0e-9cf1-74d4759c769b"], "metadata": {"page_label": "21", "file_name": "200419_biomolecules_deck.pdf"}}, "e6494872-b79c-43bd-ad90-496a4276dc0f": {"node_ids": ["ce6f1050-e242-4dec-9595-5c8ce24aed2c"], "metadata": {"page_label": "22", "file_name": "200419_biomolecules_deck.pdf"}}, "1699a1e2-f7eb-4715-91b2-76171e32e8d9": {"node_ids": ["2fcd8041-02e6-4e96-a35d-801c2169a81b"], "metadata": {"page_label": "23", "file_name": "200419_biomolecules_deck.pdf"}}, "2e89285d-cd67-438a-a1c6-cd37dad1ddaa": {"node_ids": ["45e0528a-2bb9-40aa-9fa3-b6e6b04fdad8"], "metadata": {"page_label": "24", "file_name": "200419_biomolecules_deck.pdf"}}, "2177da75-a3c9-4dd7-91c7-396eff74e80e": {"node_ids": ["f83ea746-90c3-44b0-ab22-c56b782a20b6"], "metadata": {"page_label": "25", "file_name": "200419_biomolecules_deck.pdf"}}, "8acc95f1-80e7-4628-8f6e-f3a072acf140": {"node_ids": ["189947f0-7d6b-4918-9666-58c239ebb017"], "metadata": {"page_label": "26", "file_name": "200419_biomolecules_deck.pdf"}}, "faed7418-4f49-477d-9c3e-6735993d8d1c": {"node_ids": ["366ff943-1a55-4abf-a2ca-0da61dc257bd"], "metadata": {"page_label": "27", "file_name": "200419_biomolecules_deck.pdf"}}, "aba80f52-0638-4bcd-ae24-ef59f7531a5a": {"node_ids": ["fabaa199-2b29-4304-9293-ca23965ee003"], "metadata": {"page_label": "28", "file_name": "200419_biomolecules_deck.pdf"}}, "0364ed87-108a-43a2-8955-ff5f81d645c9": {"node_ids": ["b46ce821-b02b-477d-b474-3f1e16ae68e9"], "metadata": {"page_label": "29", "file_name": "200419_biomolecules_deck.pdf"}}, "ebf888b7-020e-4ebc-8c44-4fa407b3ad71": {"node_ids": ["977039c1-b9e7-4a92-b6d1-9549604bcaad"], "metadata": {"page_label": "30", "file_name": "200419_biomolecules_deck.pdf"}}, "c035b128-3007-4740-bdbd-52378a31b460": {"node_ids": ["6308d5d2-4f2b-4a87-806e-171df07e67df"], "metadata": {"page_label": "31", "file_name": "200419_biomolecules_deck.pdf"}}, "d257ddfa-46b0-4265-ba8d-1e0ca181ff05": {"node_ids": ["1e0c8a40-7b35-4c2f-894e-9d35dc21e1a9"], "metadata": {"page_label": "32", "file_name": "200419_biomolecules_deck.pdf"}}, "4aa28399-d79d-4307-9ac0-887ee43f9917": {"node_ids": ["6b0f32a0-8e23-4d08-a6dc-48f0e5aa6ba1"], "metadata": {"page_label": "33", "file_name": "200419_biomolecules_deck.pdf"}}, "f4b1972e-8a52-466f-8256-3cc01a6214d3": {"node_ids": ["ee97dd64-c214-4a0a-b67d-0748c3fde2d1"], "metadata": {"page_label": "1", "file_name": "Engr_BioE_80_PSET1.pdf"}}, "61654af1-2de7-4da1-b49f-1e66dc467aaa": {"node_ids": ["a4ea7b18-8d35-4489-b26c-244e1dea05ab"], "metadata": {"page_label": "2", "file_name": "Engr_BioE_80_PSET1.pdf"}}, "8c3ae60d-c0bc-4932-ac62-f612bfe01745": {"node_ids": ["cb946c0a-3453-46ac-b1c0-64a9413d77ad"], "metadata": {"page_label": "3", "file_name": "Engr_BioE_80_PSET1.pdf"}}, "502271a1-a919-4ec7-affa-60086b96a7ab": {"node_ids": ["5d23be60-5a7a-4422-b4b3-590f23ce0b23"], "metadata": {"page_label": "4", "file_name": "Engr_BioE_80_PSET1.pdf"}}, "a66bc89b-3d68-4032-9d33-844381ab7fc9": {"node_ids": ["5ed3e715-fff0-4ff2-bb7e-550a051678f1"], "metadata": {"page_label": "5", "file_name": "Engr_BioE_80_PSET1.pdf"}}, "af3149a5-22ae-4a37-ba9f-0daa7bbc7c9a": {"node_ids": ["c0468e9c-d9f3-4bd4-b8bb-8c05b63370f0"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "a927777f-51d0-4918-8821-d113c1d616d7": {"node_ids": ["83f76be8-5781-45a3-bcca-9e75f840e5d5"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "db0c8ecf-f252-41fd-bf90-2a2f2f45d1b4": {"node_ids": ["f808eb8a-9d9f-4b9a-b123-90fb64f37d1a"], "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "9d2c51f3-1f65-43c3-848d-7b8c9aaaae30": {"node_ids": ["7c14baa3-cf9f-4b7b-bd9a-de0e8c933b80"], "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "de77d731-5d31-480e-9b02-e0a148e6f2fa": {"node_ids": ["bfb98fbd-69f8-4a74-9bfc-1d5f3779a1b5"], "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "c0a248b4-1429-412f-85a2-7cfb4f97a35b": {"node_ids": ["ac60a717-41fd-4e23-9a9c-8b3861548e85"], "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "8a8e756c-7d2f-4aef-acde-8abe31a85285": {"node_ids": ["fa6a722a-90a2-4baf-9482-68e72cdba3b9"], "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "7aae59f0-f6c5-4c31-b9d6-1818fe4caae7": {"node_ids": ["fb5d495d-c999-4156-9d54-92b088813f42"], "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "c3f6d652-1d3a-4011-8345-7b43154d447b": {"node_ids": ["fa973945-4a4d-45b5-a690-4ccab4f2ee91"], "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "214c2c80-da52-4e5e-9eca-340ef182e59b": {"node_ids": ["342ae22d-56c2-4f88-b8fa-645ef98e84cf"], "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "0a5a8146-d989-43db-bd13-071849a61dc8": {"node_ids": ["f4097ff7-e5e2-4a95-ad80-a7b71922fbb0"], "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "12a1ccb9-4cd9-401e-b78a-284992d075b3": {"node_ids": ["2ae0d4e8-0e4b-4a0c-9174-030aea9bad7c"], "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "14633116-3be4-49c1-ac2a-af6833fb77e8": {"node_ids": ["7eb22c98-9365-42a0-94a4-5a5490a82774"], "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "384ee793-8cfc-4eef-bb78-2279591ec169": {"node_ids": ["b97cf4d7-39b5-4b33-aa25-2a3787dd278a"], "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "8eacd4ca-96bd-4d7a-ae66-84fcfa82fecf": {"node_ids": ["1384580d-2dca-437c-8a6e-ae3f49fa47d4"], "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "4cfc7e19-b986-47ac-8230-1fe5c89a1d7c": {"node_ids": ["a3e6426d-3c71-4323-9449-ced0a6857fe7"], "metadata": {"page_label": "27", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "f5decd1b-4ffa-446c-8671-1cb14dd17f5d": {"node_ids": ["e5542335-5114-4da7-bea6-e1acba868855"], "metadata": {"page_label": "29", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "45ee9676-4042-413c-a5c2-9739ae78450c": {"node_ids": ["ec884725-99c2-43fa-ba57-cc1125ab4593"], "metadata": {"page_label": "30", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "aa63fe36-66ab-4604-a512-1a24bf9efddf": {"node_ids": ["058a97e4-77f5-44fc-babc-e3ba976fc8fb"], "metadata": {"page_label": "31", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "7e66a00c-9e2b-43ba-9963-7d9dc0c0e8f0": {"node_ids": ["5d6692b1-5bc8-4ef6-83fe-b6386f60c7d1"], "metadata": {"page_label": "32", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "091195b6-77f7-4c41-9a95-d2e7458e1454": {"node_ids": ["c300f158-5d99-4fc2-b681-d41e3d26b222"], "metadata": {"page_label": "33", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "b5c8f1fa-1d35-4434-aef9-5a73150765fc": {"node_ids": ["54447828-fb03-4280-8f44-cff96ea6b8c8"], "metadata": {"page_label": "34", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "8d8847a0-8a60-4d44-a48c-cfe9a329fced": {"node_ids": ["fc064960-13bd-4e43-a7de-84295a9e1336"], "metadata": {"page_label": "35", "file_name": "Stanford_BIOE80_Day10_27April20.pdf"}}, "847cc523-ad0a-430e-9a4d-10c322d69765": {"node_ids": ["9ecc34e4-d4c2-42ea-9044-2ed4b4532ebe"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "c43957d4-d1c4-483d-9617-f253fd4ce501": {"node_ids": ["c0d8ce06-93ba-44a1-a160-b53a3ee45f2c"], "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "8cc7038e-4a92-4545-9eae-b44d918c4034": {"node_ids": ["08cddb51-3849-4cea-aaf4-c0da244d1053"], "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "2ba33c6f-138c-497a-8c34-2e26dcee99d8": {"node_ids": ["1183b9b3-19f3-4429-93a4-c7f3c1e31590"], "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "b6e75d96-528d-4876-98cb-3bb412d062e3": {"node_ids": ["1c7b442b-2145-4df4-844c-80476f5a3c3e"], "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "2add9834-e099-46b5-92e6-1bf112a8c8e2": {"node_ids": ["b32e5894-f76a-4de6-9a31-182d73c787e1"], "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "558b39a2-a42c-49c9-8965-e91aeefb5e8c": {"node_ids": ["15f7d3da-a0d5-41bd-9199-de4c90444ef9"], "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "5b3cd6cc-74ab-4144-bd11-836d4294b1a1": {"node_ids": ["08bca4d2-56a8-4342-97ac-2b24f0d780e6"], "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "76dd1dd1-a980-469c-929d-45be7af573fb": {"node_ids": ["50949945-c3b3-4eab-888d-2678fd288602"], "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "536ed06a-1bf1-4332-ab44-6a24ca0a70ab": {"node_ids": ["8561daae-3c82-4130-9618-5e68d14d35ec"], "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "7056acff-81fd-4c47-ac1d-aa3d44039b2d": {"node_ids": ["8852690d-563a-4a1c-a387-543081112713"], "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "a5f75fd9-5e62-454d-a1e0-c530dda55998": {"node_ids": ["e2622b0e-c5f4-43b8-9d08-3fbde9ef4c2f"], "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "f89f877f-a5d2-4a17-9e73-55b60b4c07e5": {"node_ids": ["466b73ef-2ef1-4d7e-a903-5949c4f03dfb"], "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "f4773fad-1731-4484-9bfe-6c969b86c51f": {"node_ids": ["5bb8219a-03ce-4699-b13d-ddaf870c96a3"], "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "dad44534-f2f8-4299-8541-aac67e0adebb": {"node_ids": ["93fc4c02-6c4e-4bb2-8383-6c74a5511f65"], "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "dee24cd6-e25a-4e11-95cc-d1dd600fb258": {"node_ids": ["0a829309-4572-4c18-9f2b-879a527394f1"], "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "7910c92b-e77a-4593-8e8e-c052461c22ff": {"node_ids": ["e417585b-1cca-459f-9fca-4669ede2b095"], "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "4fb31344-41d5-491a-b3af-3c8cfb080810": {"node_ids": ["af597769-f624-48bf-9104-560849b54ccc"], "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "28eb9a33-5d63-4346-8782-6cc4c110c7ef": {"node_ids": ["42720fb3-d2f7-4d1f-aa80-1ac0b3608158"], "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "a381e99d-428e-4584-b1d8-1f38875bb39d": {"node_ids": ["7e5a0b44-f57d-4ec8-914c-be80a6141d00"], "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "cfebc3f6-a515-426c-9fbe-8664a8d0a0f7": {"node_ids": ["cb9e95d1-1e47-4320-b97a-60eb34180a79"], "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "73c156b3-4447-40cf-a167-5f3a9c734ba9": {"node_ids": ["d5e11156-e53e-4dd6-bfe5-ecf30222e4da"], "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "0521c137-7569-46fb-a7f5-ec9863101883": {"node_ids": ["2821b06f-8e6b-475d-9da1-310ef9af7cd9"], "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day11_29April20.pdf"}}, "59d266c8-e7ee-40b0-9bab-23daf7d679cc": {"node_ids": ["c2ee4bd6-dbbf-4991-99ba-0f8c5efe2485"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "93e4e1d4-2431-490e-9736-b0ee0c6a03d3": {"node_ids": ["9c2b8f81-ff0b-4942-a01f-ecea43702233"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "64b1958f-904f-4b8a-a68a-d910a22ec84f": {"node_ids": ["d4f58d19-7c2c-4dcb-9f46-bf4556991918"], "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "98736360-5799-4d99-a700-7eeef2383c98": {"node_ids": ["2fae1aab-9948-49b7-a9b6-ef8ddbfb7c21"], "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "7e08d210-08ca-4beb-a8c3-3164760a1faf": {"node_ids": ["27a7d603-f229-475d-87fc-07388bf0438b"], "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "ff8420b1-db58-417b-a095-401a8ae6ceda": {"node_ids": ["962660d0-984d-48fe-942e-6cdd7ae29d0a"], "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "22f664b1-429f-464a-9ab5-8efd85bbe601": {"node_ids": ["19b0f0fb-067f-4a17-bf45-3cebd85574a7"], "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "e35c7e90-66e4-4f57-928e-807d4e44f915": {"node_ids": ["7fa03572-a33a-461c-8089-b191bdb97781"], "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "54866c51-7519-4431-9896-e77009cc1bd6": {"node_ids": ["47c39ab0-6e60-4512-8e2f-57f85979a3b8"], "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "6e0cbbfa-923c-44db-83df-1be863618107": {"node_ids": ["49cf98e2-1feb-4ef5-b6b2-4b28af9cab5f"], "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "dc39979f-ab7f-4685-a505-4cb71d028e8d": {"node_ids": ["594bbe8e-8a41-4439-a579-faa90d873f41"], "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "95bb94e0-96b5-48fc-b902-5519599b1622": {"node_ids": ["c21d5739-2da0-4606-b6af-6b563d1a22c2"], "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "262c71ad-8937-4d67-ae60-2a027cdcbc8b": {"node_ids": ["c0cd86a2-d5b2-444c-ba15-74535398736e"], "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "18cb0e6d-7b31-4119-9d26-eba95623c599": {"node_ids": ["7580d9ef-63e6-4060-aa4f-f37202224077"], "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "b3203d08-981c-4ff2-b907-6a89028ef19b": {"node_ids": ["704129c3-ac87-4153-ba50-8cfe4ecce372"], "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "601b2877-bd45-4a3a-9ea4-72e2c8a63667": {"node_ids": ["adf64a4d-8604-4f78-b045-8df47fd981a8"], "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "bb4c07d3-82e0-4e31-b4fa-c472c09ddd56": {"node_ids": ["96772174-818c-4356-90e7-76bd0c7acc09"], "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "89c917ad-9b8b-4b12-b468-535274738573": {"node_ids": ["f6bc4646-1d26-49f9-870b-c3672966511c"], "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "c2e3a3c4-f216-45f6-a45c-292a3e326572": {"node_ids": ["dd52a6fc-a68d-4e9c-8fc8-4c57c46027d4"], "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "d0cf6711-65cc-4616-828b-6fb8297d7735": {"node_ids": ["b826317b-ad42-4f91-b10f-ae277e698e9d", "95dfbc90-cff5-4825-8126-7fe9734ea14e"], "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "e40940b5-496b-4c8a-b343-991dc5e15c1d": {"node_ids": ["dfb0dfc3-fe73-4206-b304-0b11ae68fe97"], "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "0b707e58-b244-48a8-acae-3951a8a07440": {"node_ids": ["d4a3cdf8-4635-4977-8f22-f5316353a1b6"], "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "c0d6491f-4e66-4870-916f-39ccd91893de": {"node_ids": ["524633a4-370f-4299-8797-0d49b51adef6"], "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day13_4May20.pdf"}}, "8e244258-ce82-48e4-ab09-b4985835d6ff": {"node_ids": ["f2d9d198-36a0-42f2-9626-c05220a56a23"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}}, "05a21a83-38b5-4631-8527-b1e1be17a6a7": {"node_ids": ["10a13c11-5674-4ec9-9d79-4571487c4345"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}}, "8b07e036-a70a-4f5d-a8e1-bfe9c64c33dd": {"node_ids": ["a2be7ffc-1b58-4756-bc92-e4a6b51ac21a"], "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}}, "f123db96-bde5-4cf4-bf62-59c8ebabcfa2": {"node_ids": ["10764762-bd24-42ea-bad6-3c66ed5d9a48"], "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}}, "b9b4f284-6b1f-44be-8e63-1789dd16d0b0": {"node_ids": ["b4a5fe1a-6153-4e11-91a6-aca748d54048"], "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}}, "7ec26ca4-978d-428d-8853-3c19af52e1dc": {"node_ids": ["9e4c2221-66c4-467b-bb9e-02f3af6173a0"], "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}}, "3fb390ab-5fe8-4517-ba8b-1aaf75651131": {"node_ids": ["ed64d3fc-08cf-4768-9129-8cad3602c35b"], "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}}, "12d59e46-b053-4d4d-a2ef-9b55e9637041": {"node_ids": ["d41a65c8-8fcf-4c7c-abfb-498c8e4cd5aa"], "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}}, "25996ae0-abbc-4a3e-94ed-2be6180ab372": {"node_ids": ["d8361ba6-42d7-406a-a3dd-283334f73b4e"], "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}}, "e958eaac-faff-4d6d-b39a-de6b38bec378": {"node_ids": ["b6da2fc8-3880-4cc2-9671-2ffd416e06a7"], "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}}, "e191e3d9-7ea5-4785-9d54-de14eaa891b1": {"node_ids": ["a232b068-7f5c-4f65-bd46-2c77b1d9f059"], "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}}, "20ba0f61-f859-4ee7-bb7c-43c8f133e7ea": {"node_ids": ["f35a511a-f5c3-4ff0-92a7-5ff211288cf5"], "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}}, "a328156d-2d2d-463f-83f7-89897fdd01b6": {"node_ids": ["fccedcba-ada4-49b5-9023-357f9c1446b9"], "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}}, "8b82c6ff-cfe1-43dd-bf17-47e22b82d1e7": {"node_ids": ["ce7b68fe-8fd8-49a7-8163-96f379212c70"], "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}}, "5ab9ab3a-ea89-4cf4-98be-79809b993d4d": {"node_ids": ["2617fae3-a51e-406a-9e31-1b7de76824cd"], "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}}, "74343b6a-befb-4945-83cd-8624afc21a78": {"node_ids": ["a5ca573b-4663-4278-a22d-4ea3c17c9b57"], "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}}, "49773c2e-553c-438a-83e3-9ee8bff9dd02": {"node_ids": ["a151a985-1f96-4900-b4d7-9dcf034bdab7"], "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day13_4May20_Sequencing.pdf"}}, "c8895567-d7d3-41f0-af4d-323e66ca12a5": {"node_ids": ["364712e9-39c8-45eb-80a1-1ab7a2d1d4d1"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "b7cd3b05-b387-4e47-bd73-6332868d2f71": {"node_ids": ["8e590a6f-ba5d-4613-91e7-64c095596c33"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "80c09984-4352-4c08-9c7d-3849fe2af964": {"node_ids": ["930cb0cd-dd9c-4cd5-9f7f-e242d6839570"], "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "2644ea91-18a5-492e-a493-618e2b18453c": {"node_ids": ["52b4edfe-cccc-454b-830e-a12ba4a99ea1"], "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "c9251f5f-1c6d-4e16-9134-2c2ac3c139b0": {"node_ids": ["bc9f0df5-2eab-4138-9c5e-8e4100e6adc0"], "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "b7906c76-a271-4abd-8076-4718b552463c": {"node_ids": ["109f0e51-71bc-4ebc-ba5a-e2319f3bb773"], "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "83d64e1e-4dc1-44c6-ae1f-e10e751821c8": {"node_ids": ["9c2cce78-4759-4872-b117-933e7b398dbf"], "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "8ccecdc0-a929-4abe-8711-764bcce21d46": {"node_ids": ["e39e42ea-a156-4776-a7a1-c059a2accfe7"], "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "1c5ae921-d2d4-4638-bcea-3268b4f399a7": {"node_ids": ["d8b5f0f2-b7bb-4a6b-9a9f-52d914f23d5b"], "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "5b8f5770-46f0-4457-84ff-e4fead8b5ea8": {"node_ids": ["b7547afa-2f98-470f-a76f-23374157fa3f"], "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "65609a37-f6f0-4cbf-af03-0560605f4151": {"node_ids": ["859f5d15-8c4a-4150-9cd1-47834beae28a"], "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "06485463-bed3-463d-9461-a3115a18a41c": {"node_ids": ["f2a63b53-3014-45a8-8d69-3f80a932522f"], "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "da5f1789-484f-4b37-a625-7224e9af9bc1": {"node_ids": ["74e041a6-8e4f-4441-9fe7-e24717d60a8e"], "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "0c190c38-2aca-4303-9904-a9d9e2aff4ad": {"node_ids": ["580d0859-9c51-419a-ad3d-e2ab68417e36"], "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "3fa27da2-95c6-4e2f-9908-8ad616c2ac93": {"node_ids": ["e9ee20f1-391b-40e6-b1b4-73377ae0a521"], "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "2b9c6b40-8ef1-4f1e-b712-a6618e6b2700": {"node_ids": ["29a35073-a96d-4407-995d-398957872cd1"], "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "25806191-6fae-4531-bc02-c0cc86cdf675": {"node_ids": ["4f066b06-1897-48f0-bb02-10a5941b8a00"], "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "4de1f6e0-fea2-4c63-8530-7f994b1dab01": {"node_ids": ["8e4b1be8-d201-42ad-8b26-4fdba9bafd01"], "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "e3c1da99-58cc-44f6-973f-ec416ff41ecb": {"node_ids": ["a0500740-20c2-4149-97a5-b5ae11417d78"], "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "843db1e8-313f-4dcd-8a38-11fe49895ed2": {"node_ids": ["dea23ae2-1f8d-40a8-b9f7-23804a8fef7b"], "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "9b56996e-92f8-47a9-a2bb-aa13b6224d50": {"node_ids": ["a0368a94-525b-4c1b-9ed0-504971c7be55"], "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "f36e38dd-553c-4e0d-ac75-a5d7b713e845": {"node_ids": ["5efe383b-5b46-41ba-a015-0b926de97775"], "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "55162cc9-88dd-4f82-8993-ecde20fc8218": {"node_ids": ["943aa60e-b93d-40db-9249-83c64b26cac6"], "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "c612144b-a346-49a7-9f89-812486da452d": {"node_ids": ["46776e83-1fee-4526-81ac-4944be38ba54"], "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "55bf603a-fd80-4849-89d7-9cde89fc6608": {"node_ids": ["05254788-00b6-4611-87da-eb96cc536352"], "metadata": {"page_label": "28", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "8a50997a-ce41-40a4-af4b-51b7c36cd5d4": {"node_ids": ["31832931-b874-44f8-8210-ecfcba1db792"], "metadata": {"page_label": "29", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "fd0096f8-c08c-4a89-9c46-4be58dd57aaf": {"node_ids": ["7932b02b-7e76-43c2-b3c5-7e740aaeba49"], "metadata": {"page_label": "30", "file_name": "Stanford_BIOE80_Day14_6May20.pdf"}}, "95c8c2e0-91c4-48e2-be73-551fe0c0faf4": {"node_ids": ["aceef56b-786c-442a-b654-f7aa36576798"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}}, "e1458d9e-6811-4473-ba70-8d3f74ffedda": {"node_ids": ["c77571bc-ab79-4d50-9d7a-c896600f31b3"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}}, "563b72de-8eb3-4255-a09c-e178e130a693": {"node_ids": ["72a289b7-6157-47ab-af06-04e4aad155e8"], "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}}, "7eeb2edb-fe43-4036-836d-7eef45d0310f": {"node_ids": ["f4daf9a6-e3fb-48dd-8b8b-2d39b579d758"], "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}}, "f5cc37e0-8d0c-4e05-9497-9c8b22631e6e": {"node_ids": ["e9e05026-871f-49d8-8f89-dd6339e5fc06"], "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}}, "ca777b81-be46-4861-a040-2822409932fb": {"node_ids": ["5e780672-7164-4ed3-9d9a-bedf6561a105"], "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}}, "1ca83fb1-02b6-4557-8ebc-2a2b07acceb0": {"node_ids": ["0497ea76-86cf-411a-9b0c-34c997f34e6d"], "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}}, "9c40b014-3149-41c4-99c4-fb5908945fcd": {"node_ids": ["1e4dca50-ec02-41ad-b048-e1c71c53508d"], "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day15_8May20.pdf"}}, "7cbc7b66-a5f4-40bb-8507-e2c6ef1a1798": {"node_ids": ["1b4f3ba4-edcb-4c8d-b488-8a6f99eb78f4"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}}, "d13f967e-a94f-4f32-9efb-297fed8be716": {"node_ids": ["7e9aa9ab-fc1f-4611-9c4c-bfcce0afd3e8"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}}, "3e450db7-6cce-456c-a366-296cc11772f7": {"node_ids": ["07456e60-5c6e-4dfb-aacc-c4f7976ccdec"], "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}}, "72f72bd8-581e-4857-bfcf-0d91ea609926": {"node_ids": ["9da110c3-f9d5-4dac-81e1-15ffebc73678"], "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}}, "a4ddecbc-db0a-4788-b640-2b0c48ab3dd1": {"node_ids": ["1bc25ce4-f0aa-4c0a-b604-bb314a15fa73"], "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}}, "31be2bfa-63db-47ee-98bd-d895e19d1f79": {"node_ids": ["a5137f03-03f9-4c9e-bf99-1534cbd42abf"], "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}}, "3eeb9251-1278-4cba-bca6-1228f5ef77a4": {"node_ids": ["5a3afb0c-dcd3-4e0b-add1-879e1ee86cb2"], "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}}, "85d9eaac-aece-4fb1-b21f-3fed29f5b1f9": {"node_ids": ["75031268-fe31-40a5-9cf0-ab51fb50ce36"], "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}}, "e1ac18f8-8c2b-4df6-a9e9-df3add5dff8d": {"node_ids": ["2093ff83-57a0-4cfb-a33f-b7d292576828"], "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}}, "b43afcef-a70c-4de2-91bf-045894da8b85": {"node_ids": ["a04f252e-044c-4bfd-9b18-3b813645f5b5"], "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}}, "68a515dc-0738-48af-b90e-865a07583aa1": {"node_ids": ["2e772f81-9bc3-45bd-a270-ca251b0c7b77"], "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}}, "adda00cd-fd82-47bb-ab6f-65f8106c5cd6": {"node_ids": ["a899541c-31f4-4f35-ba52-15a92d1728ca"], "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}}, "537c8940-b879-437c-af8c-e60eab39e36c": {"node_ids": ["af4d4531-602f-400d-a7a4-c4a6dba858ed"], "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day16_11May20.pdf"}}, "dd866226-6628-438f-9b32-fa5540433fcf": {"node_ids": ["059f2bb3-657e-4996-9c20-8a3ead9c7e9d"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}}, "3e535bc6-a0b6-4cc1-b23b-941a8f71cbca": {"node_ids": ["bf0e753e-2220-4fc4-814f-6e26dc7d00e3"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}}, "6326781e-f2ad-4de6-8ddc-f8896584e187": {"node_ids": ["ccc0ad08-e978-4763-b521-0eeb119a5433"], "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}}, "5a52e576-ecca-46e5-abe8-afc9f8eaf98d": {"node_ids": ["d7ea3afc-6947-465c-bc7f-8d5a670fb4cb"], "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}}, "8b0ee7db-f668-4ab9-b6f8-5eacef6ce66f": {"node_ids": ["36e5b6fa-a7b9-481d-96bc-3557b9f29bc5"], "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}}, "e95ead9b-daef-43d5-a7c4-f65903599fdd": {"node_ids": ["e940c6e3-653b-46f1-86d5-5d43179e2fb7"], "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}}, "c0f99a7c-927e-4f3b-bf34-a7955338e211": {"node_ids": ["570bdca0-3dc5-43f1-affc-f1187bbbb0d9"], "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}}, "11c68c32-5e28-409c-a38c-d23ed01226b0": {"node_ids": ["fa56dd15-b2e8-4aa2-a91c-c3bfc8effc73"], "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}}, "5137f702-1993-4c47-865c-54be5a4e01aa": {"node_ids": ["05c11f84-da7b-495d-ac9c-3174f892815a"], "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}}, "f1197c4f-56cf-42b3-ae02-2edbaa4c12f3": {"node_ids": ["92157c07-439c-4062-be9b-b8d3b250f703"], "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}}, "8d1ca404-b26c-4e93-901a-5fd42e281f1b": {"node_ids": ["9b8cffa0-7d61-442d-add0-7ed6fd167c78"], "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}}, "8fc7f01f-eac6-4d4a-bc14-efd63530f1e6": {"node_ids": ["a629a532-730f-467a-b7a7-72b3e699abcf"], "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}}, "be20f6dd-0544-4400-81e9-90c49b9e1c87": {"node_ids": ["8d877530-15d5-4c4c-8102-676e80e9041d"], "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day17_13May20.pdf"}}, "8c38fd15-c3b7-4aa2-a5c3-43f232285574": {"node_ids": ["35e5b796-1e58-4c78-9788-f0fffe02488f"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}}, "9fbcc2bd-481f-4a49-94d1-a8fc053fde3c": {"node_ids": ["d866e2d8-1346-4793-a4aa-8e5f2afcd480"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}}, "fbca77c3-84fe-4cc6-9bd5-cde8b169a07d": {"node_ids": ["c4a2fcc3-d771-4b07-8078-55ff279f835d"], "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}}, "93f70f2d-ccfe-4e5a-87bd-4c8e04a2cc60": {"node_ids": ["57dc438a-5746-4463-a2af-e3530221da08"], "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}}, "4c95681c-666d-4d0b-a70e-58ad7f7d0c2e": {"node_ids": ["01161378-09c7-4e3f-aa3d-dcf61e0599a9"], "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}}, "ab2759f0-3cdf-4eed-9b89-034c5a4df81b": {"node_ids": ["c95fcfa7-06d0-41e2-8385-0efbb1887855"], "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}}, "b55ee70e-c31d-488b-ac5c-a58989c8a7d3": {"node_ids": ["7ef83312-a150-44e5-b712-dd12be58d0e6"], "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}}, "3a8bcb25-4f13-4666-818c-ef35089ac60c": {"node_ids": ["72446381-df80-4ae6-a3c5-70742f5f9251"], "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}}, "cbc32d79-dc69-4a2e-8c63-c9024836d8e1": {"node_ids": ["fe3dd61e-0e93-4dfb-8859-c49bdb2750ad"], "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}}, "b0b8a719-144f-4c58-91a4-3cdd04719217": {"node_ids": ["cefbde89-fc99-49a6-85ca-c221ed00235e"], "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}}, "b5e73bf4-899d-4b93-86e4-d06a64514f30": {"node_ids": ["34cfbc64-e909-4b85-8f38-df8974e96468"], "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}}, "1d58fd78-3f25-41f1-b741-fbe5daf17545": {"node_ids": ["b2b5db5d-6194-4952-955a-dd4bab48c19e"], "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}}, "be4c64c7-2ac6-4ff6-8315-424cadd800d0": {"node_ids": ["cc23551e-21c4-4128-8312-f5d3c86c7e98"], "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}}, "2b1c3246-6cd1-460d-9f84-97eae6be59a8": {"node_ids": ["edcceba6-ada1-44ff-b3c0-954b6ebe5eff"], "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}}, "cc35bbe2-2f71-4bf7-805a-7aa04ccf3cec": {"node_ids": ["f5c19990-3452-4ef3-960d-eddd193e0f81"], "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}}, "8f244968-058a-4b28-96c8-54231b836c86": {"node_ids": ["3b64ecad-15ff-4f20-87b5-798fec51a8ba"], "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}}, "a3cda906-642e-4693-b653-91e0e0930d44": {"node_ids": ["5ecb1289-3517-4bda-a9d9-324d49d1e090"], "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}}, "5d1aac2c-5dd0-400c-af4a-691963a335eb": {"node_ids": ["28ef66a9-f638-47d6-a8f1-791cf8f5eda1"], "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}}, "b246a1ef-6c8d-412b-b7a6-8ebbbc2fa4fa": {"node_ids": ["0f9562c4-e24c-42c4-9acd-7aa7d4fb878b"], "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day18_15May20.pdf"}}, "48bb9627-0e93-4f1e-a663-882cbc8b48f1": {"node_ids": ["7275e3a8-866a-417a-84e7-299188adf5bb"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "96ca9ee5-accc-4efb-a58b-cbea598e1853": {"node_ids": ["fa9efaa9-4b09-4721-98ad-5ce2784a0dad"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "bfb93aa3-909f-43da-8b36-35068775b2d5": {"node_ids": ["ec43a3d0-9dc4-4be1-b2b1-cbaf90932cec"], "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "7ae3b18b-3148-48a1-93ff-f59a957801bf": {"node_ids": ["aadd0e4b-ab37-4ec9-85a1-1f00514439d4"], "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "bd069c61-8ffa-44a6-833a-376b260d943f": {"node_ids": ["afc239eb-e9a2-4b74-a2f8-7521e64db9e3"], "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "19d4a083-81f2-41cb-849b-0dfcdb2ba363": {"node_ids": ["a0fd4cd5-b198-4182-9b53-37323ecded8c"], "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "326f35aa-b7fb-4b59-9e5f-686bf8da67cb": {"node_ids": ["c8182f1e-7184-484a-97f5-b8136a46f03c"], "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "b3a984a1-cc76-4ebd-a2dd-b859dec5e178": {"node_ids": ["a91d4993-3b9a-46ae-af45-b226ff9e4189"], "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "340602bd-fd52-4c47-a88a-f60b2a334379": {"node_ids": ["593e6482-2548-4455-9052-2c7243c6c2d1"], "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "6cf3666e-c874-4a61-a829-fd4870acf4ad": {"node_ids": ["cb7fe02f-2084-463a-b900-ab5fb7282e55"], "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "ffed7e98-724f-4ecd-abd5-82c1c936fca1": {"node_ids": ["b715ce9b-d232-4d4d-99bc-95c3a2fdacc7"], "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "25350984-feb6-4e1c-8866-ee5a7d062813": {"node_ids": ["fb80ed35-825a-492f-a748-a8458d94a5e5"], "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "0dbc89fb-1ed2-47b4-acd0-2fa69a22ab72": {"node_ids": ["b472e735-ce31-43fe-9efe-6b086b8e8593"], "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "cbfe7b95-bc81-40fc-9ac3-367c16bf4b08": {"node_ids": ["39f7f34b-3cc7-4a0f-9014-0961df352474"], "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "40edf429-a462-41d0-b55f-5889cc3fdda1": {"node_ids": ["1c7b4eee-ede3-49da-a1b5-53b6fb19dbc5"], "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "e4ef913b-8fb2-43e1-8799-9372b7c41da2": {"node_ids": ["3bd3cacf-6ee3-43bb-8ae3-35ab8760c9a7"], "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "0db4f992-e1b5-4b2d-bb66-e2d857638072": {"node_ids": ["29bd2599-ad0a-49d1-8d47-031341511b0a"], "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "5028cfdc-74f2-46d6-967b-f91496342667": {"node_ids": ["1e9fec63-e3fc-41bc-ade7-8abd03e9b406"], "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "4e2426af-23d9-4557-94ba-7c70b1075ea9": {"node_ids": ["61595e0b-bf98-47fa-b271-490ef7b1a2fa"], "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "6baca1f2-5328-406d-8e50-faac2a4f3b23": {"node_ids": ["0a79cc6d-7432-4ffe-b2f3-418479d9c9a4", "997e2e07-8cb2-47ef-9bc3-46ff8c0b13d3"], "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "df728331-6a32-4c9b-b5e1-ff7abe42926a": {"node_ids": ["5d55b35b-4c36-499a-ac78-0e2dae56dbde"], "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "5400fae0-5fc5-4e30-ae1f-83d44dd5dd06": {"node_ids": ["fad7ec60-2d03-4a9e-9c06-434889973b52"], "metadata": {"page_label": "27", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "3a902a5e-83a1-4fbd-b444-4d2816941a25": {"node_ids": ["9995d704-a341-4b54-9e54-c93f1de21d74"], "metadata": {"page_label": "28", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "dfe82da8-b5ee-470d-a706-d81394c80778": {"node_ids": ["df532cd8-936a-47ec-9464-c8c48ac2f010"], "metadata": {"page_label": "29", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "d984e73d-8443-4308-b6eb-ddc9c4475b3d": {"node_ids": ["32310663-18b5-4101-956a-4ef25fc9bc5a"], "metadata": {"page_label": "31", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "414e7d21-4569-4522-94cf-c6a7a4f97765": {"node_ids": ["f00e6f06-28d8-4eb6-ad66-df98a5959f35"], "metadata": {"page_label": "32", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "74ed164e-b9dd-470c-a775-382f3165dec8": {"node_ids": ["15e1bc63-62e7-4a70-b2f7-3c07e36901d0"], "metadata": {"page_label": "33", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "e593b6e7-c1db-482c-9523-d3b18c67dea0": {"node_ids": ["ec6f7101-2cfa-4663-9de4-f52a76f1cf65"], "metadata": {"page_label": "34", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "56c936d7-0c72-4d5f-99c9-90851dfd3c4b": {"node_ids": ["cfc1b58a-2a3e-43fd-99cf-a25f5e799f75"], "metadata": {"page_label": "35", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "82aeaad1-c8bf-43d2-82dc-446c5beba1b8": {"node_ids": ["048a7971-7832-40cb-af48-846f1baa681e"], "metadata": {"page_label": "36", "file_name": "Stanford_BIOE80_Day1_06April20.pdf"}}, "dfccef0c-5266-48d4-9ac0-cba82680f8e2": {"node_ids": ["689f7407-4fbe-476f-99db-f4a564b130f9"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}}, "d8f011d6-bdd1-4296-91d3-2212fd530a42": {"node_ids": ["2f878312-5dd0-49f6-b331-9022466b864e"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}}, "61347e8b-48c7-4264-9306-9c7c54ba86d3": {"node_ids": ["238ec9e9-5dbd-408c-81f8-491d6e9ad33d"], "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}}, "80342e07-82a4-430f-b4d4-659d7582b928": {"node_ids": ["a4f39c2e-f564-4b33-9a09-0e0900fac1d0"], "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}}, "69b2d8eb-c43f-41cd-9936-c7591d645dde": {"node_ids": ["99d359e9-69c1-43dd-b96d-480f958166da"], "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}}, "f3f8b529-843d-4e57-be0b-999636c81b66": {"node_ids": ["3ba100a0-44b6-43c2-aeeb-00ceabcd5ef9"], "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}}, "aeb8ba79-baba-4ff6-af11-0b792ece2cd8": {"node_ids": ["ab7fd245-e601-4a24-a0b8-def54ebd9210"], "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}}, "0d9e8793-6891-4aa7-9231-8f0425b74ada": {"node_ids": ["175642c0-4626-4118-a744-305d372f9fe3"], "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}}, "c516e149-81fe-4c9d-b33b-1cd9405d2a7f": {"node_ids": ["e0a0efa0-5b9e-4882-b549-ad60f1eca4cf"], "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}}, "4bd96e82-36b4-4fa4-aeb3-73b90edde45e": {"node_ids": ["1dcb0171-24f2-4b02-a7de-6fb004bb7f9f"], "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}}, "b7872f07-08fb-41f6-bb4b-01043cdc3776": {"node_ids": ["789d0713-1183-4351-ba77-c953fe2a1db2"], "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}}, "70118c48-8006-4642-bdbc-650a44838811": {"node_ids": ["d5d3a7f4-5aa2-4104-af7e-65512d0a9611"], "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}}, "f5ab21c7-4a41-4218-83e8-8d9d0a0a9720": {"node_ids": ["4e6f42da-3bf1-4aca-92d3-e4829cdd2ef5"], "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}}, "b9435c82-af16-419a-b1a4-d8dde3b52a61": {"node_ids": ["183f8f70-4808-4829-83a0-384890479e57"], "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}}, "695e7042-7851-47be-9245-39cbb6e62990": {"node_ids": ["9df3a1be-5cb8-41ae-857a-4ca3874a1fcc"], "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}}, "2f40d532-aa3b-4cec-9c92-b9b86ab2761a": {"node_ids": ["2ca5fd7e-f431-442c-a080-e7b0e7aacb4a"], "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}}, "ad2a7a4c-d6c0-4249-9727-20cedbfec3ad": {"node_ids": ["ab409f11-bc92-4a6b-bf15-dfc6c034299e"], "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day22_27May20.pdf"}}, "f4a588de-9a68-4282-9e49-24f8e0684dc9": {"node_ids": ["3dfe89c7-ce20-49e6-8cac-d3775bb68220"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}}, "7622fc68-037a-429a-8112-e6c7981b4385": {"node_ids": ["8ce5a58f-0e32-4be8-8b82-438f794750f8"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}}, "cfc0b404-7185-4d74-9a7f-c3779acdf1d0": {"node_ids": ["b0904091-99d2-4d1b-a59e-36d83819c48c"], "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}}, "6d4adbf4-53ae-48f8-afa7-cb29e2b56221": {"node_ids": ["c5824f60-7629-4259-bf52-a475329a1eb3"], "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}}, "f5171a67-45ed-4f46-87fa-e735da6bf8f5": {"node_ids": ["3e824c69-1d60-4623-8f9c-98e57f83839a"], "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}}, "ab886341-ca4a-488f-b6c4-b8566cccb408": {"node_ids": ["96a05e0b-24ae-40a9-8246-d029a7fb792a"], "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}}, "e5142296-fb57-4d5d-8471-8a2429789238": {"node_ids": ["8a46a8b3-7569-42ac-8ffa-268ab0c68b91"], "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}}, "88a79746-b3b1-4930-8de0-ef14e7bac47b": {"node_ids": ["0e9aee42-605b-41e8-aea3-1a2907092db6"], "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}}, "fefeb2e4-fa50-409b-b273-9a55d090854c": {"node_ids": ["46e9c00b-1fd0-4cc7-b086-d271bfcdb8ad"], "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}}, "dabfb1ec-1fec-423e-9e17-6a4a84193b0b": {"node_ids": ["e7958613-e73b-426e-9cc8-a0daea64c468"], "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}}, "47d534d4-569f-4124-9961-a543051103ae": {"node_ids": ["49a5b01c-eb79-4cf7-a53f-6f174629191c"], "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}}, "9213abc8-699d-4d6a-b9b5-3c0d30d9c5e9": {"node_ids": ["a8315963-f5c3-4921-b1fb-e1c3c85d06a9"], "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}}, "bd124f09-adbe-436d-9c99-1a05470cc56d": {"node_ids": ["a2399b5d-5707-4db9-8dfe-4fdae3981326"], "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}}, "334260e0-0bc2-4ef8-8466-e6c09bf5c427": {"node_ids": ["ee7f5154-c2e6-4a4e-87c5-8c2b1e39b3c3"], "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}}, "a02d10cf-7961-4714-bca0-c2f0057e0be7": {"node_ids": ["0f6dd000-5b1b-464b-a845-dd3eccfb6be6"], "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}}, "9ddabf22-f972-4a1a-87ea-f255e5d173f6": {"node_ids": ["7a1c1630-b72a-48d5-baf3-338ec7dcf53b"], "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}}, "14dfcf1c-bfe0-435c-b92f-4d541b041a13": {"node_ids": ["3bf1aa97-37d3-4994-9dd8-d13e884ce487"], "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}}, "aea476da-fc3b-4f90-973c-6ca78b1f3f4e": {"node_ids": ["3271bb74-d320-4319-b1bf-aa97724fb697"], "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}}, "d80db5c4-9be7-49c9-b200-ef5ee39ae91f": {"node_ids": ["231b76ca-87f9-4c38-bdf4-f2e4a390f8cf"], "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}}, "f6ec7068-4cb1-4aeb-a6f6-3e063d9ecf22": {"node_ids": ["70873e6c-2c82-4328-8249-277958021442"], "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day23_29May20.pdf"}}, "eb69c7c3-889f-40d7-90a1-803c125e3873": {"node_ids": ["e7911243-ec7c-44ab-a314-2ed64ded7910"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}}, "296186c2-9202-48c5-b70c-3294eaa81af6": {"node_ids": ["786219fa-d603-49bd-9527-0c901cbf5fd5"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}}, "cfda448e-23be-4c3d-a72d-943b7ea328f7": {"node_ids": ["270db915-93a4-4aab-9a3a-091112acaf8b"], "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}}, "2a86203e-4954-4c9a-bf58-886c2274a6f2": {"node_ids": ["53f57b99-b6ff-4d9a-89b3-ee6cb358ac82"], "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}}, "65382a9d-f1b6-4134-9420-99e6e3515f21": {"node_ids": ["e4ed45f1-3a53-4927-a26c-79070a591d8f"], "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}}, "7c81ecd3-1852-4c8e-9e59-52c4cc960c88": {"node_ids": ["decafcd9-a7ad-42af-b737-646cbcb31992"], "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}}, "d13da3cb-9445-4e9f-bc4f-4086d3094aef": {"node_ids": ["8c34cecd-595f-4fc8-9270-26719b594f91"], "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}}, "f3e2be62-9905-4c69-bb8e-e82dacfb0172": {"node_ids": ["5d0d9326-2550-4a4d-89e9-c70e2fc39a8f"], "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}}, "fd117434-8cee-451c-ae80-6cdafb89ab36": {"node_ids": ["cee5bec1-7ae2-4523-8370-b0e3acb635d4"], "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}}, "46fab903-bd65-4bed-89fa-4215915b5a98": {"node_ids": ["4c926c00-6f3d-4aaa-a306-98c7a214b943"], "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}}, "53388152-0495-4488-b81f-a4f44c519302": {"node_ids": ["de2c544f-368b-4d19-879b-930644291fe0"], "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}}, "969aa1b9-3650-4098-80cc-d4ff65a472c0": {"node_ids": ["b34d8286-f02b-4765-aec4-e91982f1f0f1"], "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}}, "602a1312-e439-4400-9e75-7ebd57787044": {"node_ids": ["a98b9bf7-8fe5-41bc-a325-1073f7d138bb"], "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}}, "6081da8e-5f59-4c95-8879-f2d8e6fdf693": {"node_ids": ["af1e9418-850b-4839-b21a-ad775d4b9ac8"], "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}}, "09902bf0-884b-42b0-855b-0814e8e38eb3": {"node_ids": ["5614989e-d57a-41a0-bbdf-95ba30b37926"], "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}}, "4e5a221c-86af-4c7f-8ab6-fcc8923bbec8": {"node_ids": ["f2e206dd-63d8-4640-92a5-407f2680c750"], "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}}, "b3de2038-fb5d-4cf4-92fb-c52b2d5053b5": {"node_ids": ["34b6c13b-019f-4b87-836c-23d06bdbef7d"], "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}}, "5d6094d6-5229-4fda-8bdf-5b54ba3281ad": {"node_ids": ["f4cf3d1b-566c-4952-a176-f3166da36fd6"], "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}}, "a375168c-7ef6-43d7-baec-d629602c2e61": {"node_ids": ["8d0cee87-b5a2-4417-b4fc-7558ffb81dc8"], "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}}, "a873d01a-f583-45a5-9b1c-0acb4b421302": {"node_ids": ["cba00c07-eaa7-41a0-bf39-df29f8eddab8"], "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day24_1June20.pdf"}}, "d4968a66-01e4-411f-ba47-88438d7131bd": {"node_ids": ["96c30dcc-d977-4855-ab19-9c693d625c97"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}}, "f198b2e5-6c47-4fec-8bd5-0f38a5b74b0b": {"node_ids": ["2b21fc6f-9259-48c3-b76d-71ecdc31ad80"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}}, "5b853828-4e4e-460a-9d9c-adb26ecd020d": {"node_ids": ["aa1b965b-7594-447d-8739-1fa0921944b4"], "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}}, "9e7d6bd3-f4d7-4f43-9080-fcd97e581879": {"node_ids": ["209b87ca-d3f4-4855-8c70-c3d0459a60d3"], "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}}, "de7af606-e05a-429e-82f6-46659b800759": {"node_ids": ["8702b66e-8c54-4c62-94d2-fc03909384a6"], "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}}, "48e56db1-a34f-47b0-85f7-f8e0d4a498c7": {"node_ids": ["d2c7809d-15d0-4810-bf2b-658e29f54d77"], "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}}, "8ec066e6-b23f-4efe-a5c0-1c29405acbd8": {"node_ids": ["f8b5e776-a7c7-44c6-b6b9-0b88ca2414ea"], "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}}, "eac67285-dde7-410e-a8bf-9ed7417ab0fd": {"node_ids": ["af706123-e945-4102-aac6-8d5c5acc0fb2"], "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}}, "240c6a92-ffb9-4379-8cc3-62c3b9bb6797": {"node_ids": ["8e28b912-eb4f-44ee-98b6-c730092acf71"], "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}}, "7184ef01-821b-4940-8b97-77f57740fe36": {"node_ids": ["f338f187-d88b-4867-b03f-cec8eb12f316"], "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}}, "e9575dc0-b5d3-47ed-a1b1-53bd518d6b4d": {"node_ids": ["5bea6282-f6b4-401e-9664-710e05e3116d"], "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}}, "168da124-b2a2-46a4-a21c-6756a475ad72": {"node_ids": ["787dc2a2-10f3-4b51-9d45-68138174030a"], "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}}, "6372dea5-5c91-4cbc-b6c2-99db1f1ad824": {"node_ids": ["5ec06432-240a-4da9-8143-a0cd8d1a0c85"], "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}}, "eed29472-a58a-4c50-bc20-6c10b3cf4b06": {"node_ids": ["29ce71a9-59b5-4343-b873-662254de2f78"], "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}}, "e9618c84-17fb-4d63-afde-315af3ee7994": {"node_ids": ["1ba84ce9-5faf-450e-979b-b658ad6114d8"], "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}}, "766d11d7-0ee7-44ce-b991-66b9b044c35c": {"node_ids": ["643c4898-3826-4ded-8a19-b9834a6d6b34"], "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}}, "96e540cb-c8be-4391-b8db-a6e7362b8bed": {"node_ids": ["a828ceab-c5c5-425e-ad47-179c14f6d5b4"], "metadata": {"page_label": "27", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}}, "093142eb-5b44-41bd-a7e0-0fb9c67094fb": {"node_ids": ["2e7055be-c0fd-46b1-accb-70dea0636a63"], "metadata": {"page_label": "28", "file_name": "Stanford_BIOE80_Day25_3June20.pdf"}}, "3c18afb4-9eea-4a32-ac32-fbe38fbe01cf": {"node_ids": ["c5bfdf2f-0b87-4b46-9af3-33b88b64f94f"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}}, "47bf9623-b0cc-4780-b5f7-98913aa5676d": {"node_ids": ["8d762f62-ac38-4d08-8471-fe070575324f"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}}, "47275007-5bd9-4bd2-a364-a46daf657f56": {"node_ids": ["eb6cfab6-bd4c-406f-8bcd-f324d90a7350"], "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}}, "f16e9867-3d7f-4ab4-b0a4-730aa8ff021b": {"node_ids": ["a8659176-32d2-49b1-bc2d-ec694be160fd"], "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}}, "8efc1757-450a-4101-85a8-6a8ac8a7cdc8": {"node_ids": ["c4e78711-331a-4361-8601-23fb9360a85f"], "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}}, "b6eb5b1a-cf86-4208-af68-778b22528b3c": {"node_ids": ["e347eb9d-6f30-445d-a891-1bc827ec9a39"], "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}}, "17ce5a05-7749-4cad-94d0-e2a035a07589": {"node_ids": ["0709621f-d709-460b-91cf-cced4007ec7a"], "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}}, "865dfd3d-082a-4c13-ba8c-d3f94173a2e5": {"node_ids": ["c287223f-b131-4946-930f-f79a72e07312"], "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}}, "41b42745-8e37-4c18-b9bb-f5546abc7ca8": {"node_ids": ["4c0c6d47-e60d-4e66-aa81-475d109c75ad"], "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}}, "2c4b01fb-9624-4039-a5c3-b9601afc5505": {"node_ids": ["17776516-d1c3-4f70-8502-47dbef9b7724"], "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}}, "fcd73603-c506-4c9f-b171-88e41786b6fc": {"node_ids": ["7d04c8bb-9181-4a53-bbb5-29fdc992a8eb"], "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}}, "ace1e287-3f72-420a-925d-cb07dcffeb41": {"node_ids": ["56e906c8-6ace-486c-bf8a-17fbcf8d44b0"], "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}}, "886dbe1a-cc89-4f6e-b87c-3cccc957e758": {"node_ids": ["0e2df1af-42da-49b6-aab1-ae19252779ed"], "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}}, "a15f0fdc-e685-4859-a340-c571e43268f6": {"node_ids": ["d874027f-1aa8-4661-bef6-5bde8274ac6e"], "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}}, "8c6065d3-4518-4f9a-aac9-65c10b8e7326": {"node_ids": ["2b81d68a-82dd-475a-8456-0d21ce25cae7"], "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}}, "eaff0afd-454f-45ee-b410-8a34b92ac9d1": {"node_ids": ["c64671a2-d2de-4c6f-acef-7e4086cde925"], "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}}, "c2c818c3-94f1-4d70-b757-e0308d0e6047": {"node_ids": ["f141558e-a89e-4cd6-96f8-f4b718da8a9a"], "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}}, "f39ad70b-4517-4cea-9847-c4c7b96bb20c": {"node_ids": ["b1900855-520d-4e59-a351-5586feea8160"], "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day26_5June20.pdf"}}, "0b3d603b-6f5c-452d-9e94-5d690fc02fcb": {"node_ids": ["35fdc611-628f-4d1c-a1de-d891d598b4ca"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}}, "e16dd13f-d22a-4924-a5cd-e5fc41c962ae": {"node_ids": ["231b0a85-6f66-4535-ab14-f0e174d595b5"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}}, "c531c61b-6774-4e5f-af49-dcc479bf860e": {"node_ids": ["be6199aa-d4a8-47d9-a876-01b02a8383b9"], "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}}, "5c89ec9e-8fe5-4fe6-8191-d55b40abb5d1": {"node_ids": ["c5a7f2bf-a06b-4225-a62c-20fccbea926c"], "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}}, "e97a6fee-0257-45a0-996b-e4003e08f436": {"node_ids": ["0376581d-45ca-455d-9379-5ecec6925d35"], "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}}, "7b91c120-fd51-473a-8679-845e77d25a69": {"node_ids": ["80bcdd99-2e69-4e1a-bc6b-2f573bc2df9d"], "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}}, "af3394b1-e0ad-4c6f-8797-05f32e48917c": {"node_ids": ["e2d3a483-0e37-4d4b-939d-493ac2c03a17"], "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}}, "7211b10d-5d49-428b-a6ac-c8e52e775ede": {"node_ids": ["d3fdda39-c5de-4db1-8b1e-d2145af877b1"], "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}}, "6bbf4b1e-91d7-4e0e-8415-43a3e9facda7": {"node_ids": ["833692a4-8100-4efb-9a4c-7056060e3a7f"], "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}}, "ed92c2c6-1d2b-4944-a66c-a3f178c78963": {"node_ids": ["d9fda1a9-9628-4d4b-9de6-b658243a0736"], "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day28_12June20.pdf"}}, "6395f535-202c-40ae-af13-5cd0750064de": {"node_ids": ["11fcf3af-6add-4d95-a300-416a2c445acd"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "25251940-a9aa-4a44-be2a-d6d182a6643c": {"node_ids": ["0698bd11-935e-4ba2-acfb-ac38311abe5a"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "c488adb3-85df-415f-b162-2059539bd9e1": {"node_ids": ["650d2d2f-d372-45ab-b589-fb68418f9bd8"], "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "41620ec0-17d6-491d-b92e-f2feb3f5dafc": {"node_ids": ["af222551-8ce6-461f-bab7-7c67511a34b6"], "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "77362737-2019-4275-b843-391f0f66c833": {"node_ids": ["9454e10f-7ead-4d88-ac36-144d9a8d7e52"], "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "d4f9f3d6-5264-403b-8ed9-b3f55debc262": {"node_ids": ["201a64ab-b912-41bf-99e7-4509de01a59d"], "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "d0124cc1-a30a-4d11-b057-b5cb518082ce": {"node_ids": ["e1dff4df-3a33-4aba-b06a-ec7af357dde9"], "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "08ec5caf-db44-40e2-aa24-02749acf641f": {"node_ids": ["f7a084b9-063b-409f-b607-e755f72e31fe"], "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "9464a974-34ee-4592-9db7-80cee722a664": {"node_ids": ["e4f297b2-fef4-4f0e-abc5-628924830d1d"], "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "81957cd5-b59d-4b41-bea7-cdce65fa0f74": {"node_ids": ["e5ba6a66-5a69-4aa3-8ff0-a7532a9fffa3"], "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "978509c9-644c-4cce-8779-41b73b77d6df": {"node_ids": ["98cbd58e-da25-4501-8260-d01964be8381"], "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "8a4cee62-34ff-489a-b469-9008fdac7c6f": {"node_ids": ["305980e2-5d57-426c-9434-5eaf483ed047"], "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "10bb66b5-b2ae-4876-a56b-73b97d570b8e": {"node_ids": ["cfa2bb4a-16d7-499b-845b-b6bc3cabe96a"], "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "2581dd4a-8231-4db4-a147-21247e3535e5": {"node_ids": ["23ddf73b-7d49-4ed3-9770-b062a7fbafea"], "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "3053c4a2-649f-4da0-8b26-58906bb1e2aa": {"node_ids": ["4cc89f8b-43b1-4519-9045-5016aa95c4ec"], "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "768e62b1-4fd0-47cf-868f-29f51dddc810": {"node_ids": ["cc6bef92-7b63-4e78-ad4e-6c65a82717cb"], "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "f2fce29c-72c4-471c-9f2c-7aa2905e4800": {"node_ids": ["263d9f44-1efa-4a9e-9d7c-61a7f9990f43"], "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "1a331528-9e76-438a-9b25-fecde62bfd6b": {"node_ids": ["0f446209-c32c-4fda-8f2b-deea19440081"], "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "64fdaecc-2262-45c5-837f-b1c02a2b04ec": {"node_ids": ["87975171-4a91-4bc4-bc90-16bf6f4a2222"], "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "bfa27bcb-2237-40a5-b9b8-66e737ad0bf3": {"node_ids": ["7520ba72-4be4-420a-b59e-316e61182481"], "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "0438edf7-54b4-45fc-92ca-3e10b8691fd5": {"node_ids": ["074883ab-2928-42f9-9b33-3c25018f1741"], "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "c1545690-c03d-429a-9824-919d39e1bb8b": {"node_ids": ["f4738d78-56f8-4815-90f5-4b367c4353e1"], "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "500dd663-ab10-49a3-ba66-1e29de46d7b8": {"node_ids": ["d955fbfe-9da1-4085-9435-a5982590fec3"], "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "19155338-de8b-47be-9b4f-923dbbd478f9": {"node_ids": ["aa9173f8-801f-4b06-9bd4-8362c00e996a"], "metadata": {"page_label": "27", "file_name": "Stanford_BIOE80_Day2_08April20.pdf"}}, "8bfae649-ca7a-447e-b5ea-b4626bbc3cd8": {"node_ids": ["e8567626-3484-4ac1-95ae-ee8f0abc4b62"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}}, "9aa7c006-17e3-45fd-8f1a-3baa73580c3b": {"node_ids": ["5c466c4c-97a9-4ee2-8816-3b6f4e758a82"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}}, "78881e17-c525-4eba-970f-7a041e68e21a": {"node_ids": ["aba408d5-ac12-40a2-b823-7c3ccb8fd5ec"], "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}}, "3376a34d-1a3f-45fb-9da2-184d1178df59": {"node_ids": ["f9171d4d-e27d-4ae9-9134-67609a4224a1"], "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}}, "a9568b26-ee9b-4411-87f9-2ec374d23452": {"node_ids": ["53786129-583f-4c93-b873-012fcd616dba"], "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}}, "d6232089-f1fa-4846-99ab-d09259c97e72": {"node_ids": ["18137675-f1dd-40f4-8b35-f6706b353ee8"], "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}}, "6462ee0d-7760-434c-a7ad-bb2ab830e4cd": {"node_ids": ["6e1aebe7-e0f7-4695-9b44-8414928ecc18"], "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}}, "26ccd585-ed8c-4540-b663-ca78d36b32b5": {"node_ids": ["497efb4d-a759-4ba6-b2c2-7b192205b2a8"], "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}}, "0872a95f-a12d-454b-8fb5-8fa8a8745c32": {"node_ids": ["6b9f7abe-174d-480c-acca-85c9c4d0ace4"], "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}}, "6954f9ca-a7ec-493a-be4d-db893e3fb581": {"node_ids": ["c0c227d1-cec8-45be-b95f-0ea75b94a5df"], "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}}, "01f8ccf6-c17b-444b-b86b-16ca2bd4519a": {"node_ids": ["6c494515-3af4-4f76-8349-36d62b63c072"], "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}}, "b0573aee-04b4-4eb9-8aff-1b831ea7adee": {"node_ids": ["f8414fc6-d65d-4c4a-992d-67510fa066e7"], "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}}, "04273a0d-2536-4665-9838-ba4be1315332": {"node_ids": ["05327225-a34f-42d9-a578-aba7c65d5074"], "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}}, "cb9b74d6-c457-41ab-a698-be9e5117e15e": {"node_ids": ["3e239478-c7aa-49d8-8698-417595883121"], "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day4_13April20.pdf"}}, "abe218d5-7fbd-46bd-a5ea-4ae4541ccf0a": {"node_ids": ["104d9cb6-83f6-4c8c-8c08-6db97fb6a85b"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "395498b6-3b64-48e8-a76f-7570241b9d7c": {"node_ids": ["9d43e97a-feca-4c17-b52d-3b2b6ca5b7a0"], "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "e22252c5-29e4-4c97-ab69-4d724bf10dda": {"node_ids": ["413a90a1-f253-4827-b283-9247329ad9e6"], "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "d68ce0ac-4b94-4063-bb5e-1b26b9549a34": {"node_ids": ["7edf93b9-48fe-4f62-b7a7-28b6bdb2aab3"], "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "f0bf4a6b-0bc9-4657-a02b-5f9928d52d02": {"node_ids": ["79794603-0892-49d5-9c3e-10e4e2cebd15"], "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "f4d8fdda-7afb-42a4-b263-315c6759a080": {"node_ids": ["7451e935-9d04-41a2-a84b-c6449ed72809"], "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "d3c06c8f-28b9-4ad2-9a41-3ea8061b8bb8": {"node_ids": ["bdf99cfc-f558-4d79-a3f8-0b73ce4a93ec"], "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "5a9186a3-c5b2-421e-bad9-52037ff8f147": {"node_ids": ["5279ccad-e861-4718-8206-12395116270a"], "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "414c19d2-8dc2-430c-96da-8392067048f1": {"node_ids": ["06b89863-1436-4597-a041-b380801f74f1"], "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "e634a94d-f01a-40c1-97a9-b40e98f81cc9": {"node_ids": ["0b64ccb6-91b9-4e8d-b385-55c9dd01cdf6"], "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "da6b46e2-a30f-42c9-b5df-409135888d47": {"node_ids": ["ea76787f-43af-4055-86da-e1b6754468ca"], "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "16fd00d8-ae5e-4807-877a-2779a8b43f3a": {"node_ids": ["804fb2e2-48c2-43b7-8b45-a6234b18926e"], "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "37ad5fb6-fd88-4971-8d40-64f08ff770b3": {"node_ids": ["95f44770-de1d-48fc-8f2f-1664a00417b4"], "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "c5da2eea-0177-43bd-ab5f-96b6c181450d": {"node_ids": ["27015a00-d915-494e-8ef2-f0ca78eb2c79"], "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "9843dc54-2c66-4950-ae83-07365b0620c7": {"node_ids": ["5b60a166-cf63-4fdf-a385-33d12691b997"], "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "8539a61a-f8fd-4077-8507-154b939fd6b5": {"node_ids": ["a6848844-92e1-4451-8d10-2b808b05504e"], "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "445010af-be61-47fa-96e3-7e3311ae92e5": {"node_ids": ["25693c24-7cb9-424a-8ce8-264c489b5887"], "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "78f83326-329d-4bba-9954-2e47fe4cdbde": {"node_ids": ["39101dfe-3ca4-482a-8c22-d0162dd3f1e5"], "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "ced2e015-d42d-44a6-9896-5d7d5b6b035e": {"node_ids": ["f00ad10b-c03b-48ab-9c95-0b97f1cd28b7"], "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "28f49267-5c6f-40a5-96c2-761c97e54565": {"node_ids": ["4fa5e6b7-dfff-4977-8269-e9b61908841b"], "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "27d7d2e1-8b17-40b0-bc1a-6bf7d1d99f29": {"node_ids": ["7a97ece0-372e-4199-b059-a7440ea2cc34"], "metadata": {"page_label": "27", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "16196aef-a89a-4129-a589-8a59cacbe57b": {"node_ids": ["4f219c82-8d76-4444-b55c-364efed94728"], "metadata": {"page_label": "28", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "2828cf88-22b2-4f21-b1ec-e3b687d57b4b": {"node_ids": ["014365ab-f9ee-4603-b821-0cda078428f4"], "metadata": {"page_label": "29", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "dda42b98-4673-4f4c-b0a4-eb142ee475ae": {"node_ids": ["9d44dd46-a4bc-4271-97db-13d254ce694b"], "metadata": {"page_label": "30", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "7b5f1e27-ce57-404b-b178-75462eac1191": {"node_ids": ["65502f8d-7c5a-4f3f-be8e-010147f09366"], "metadata": {"page_label": "31", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "b30cca01-bca3-4cd6-8b28-ef040cdef698": {"node_ids": ["6a12453e-eb58-445a-8b79-805d81253dfd"], "metadata": {"page_label": "32", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "3d41d941-e12f-4b03-8278-95934e666eef": {"node_ids": ["a326da56-f86b-43a5-9fd7-00e7f557f46f"], "metadata": {"page_label": "33", "file_name": "Stanford_BIOE80_Day5_15April20.pdf"}}, "0222e3b8-2e99-409d-9dc9-325350e1368c": {"node_ids": ["7ca740ad-e2f8-4b0d-875d-e4138b0cb3a0"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}}, "da724003-f946-4e97-aab5-6723bf41167b": {"node_ids": ["0b3eff4e-e048-4b88-9395-6f48afeaa67e"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}}, "6a23ed58-8ff0-44eb-84a5-86be2329939e": {"node_ids": ["7b476d46-d041-427c-bb29-9f47f9f5d29c"], "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}}, "bb70d6a9-956a-42c7-a90e-340138353d6b": {"node_ids": ["6db9ff3c-3614-4652-9752-1f3b3bb29049"], "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}}, "c338b85b-5910-460f-8985-baf44b386a50": {"node_ids": ["cf3113a9-ae5a-476c-804c-9aacab526913"], "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}}, "0cc39450-ffee-4e2a-a6fb-0cf4205ed138": {"node_ids": ["73cff873-8026-4bc1-a874-a82d3b155412"], "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}}, "fa97cbc6-dca5-4588-b3e2-5ac343963e64": {"node_ids": ["e612b570-77b6-4976-ba42-dbeb750dba06"], "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}}, "e429dcd4-fc5f-47d4-afc5-091d24ecf087": {"node_ids": ["f139d746-8a5d-4e11-9f17-1061bb5f1147"], "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}}, "9c5d9557-dc8f-4f83-a3e5-6482850caa45": {"node_ids": ["80247227-393d-469d-b2b5-ca4c6973aa10"], "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}}, "096f6d0f-a1b9-4d89-a030-b614f13b0928": {"node_ids": ["c186fbcf-baed-4224-9fd6-2b0ad9f57efd", "02e19e6a-bb63-4d71-a33d-8f5e21a65654", "3e8e1c22-e135-4c56-9af2-1faadcd33940"], "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}}, "0221f21f-533e-499e-8a6c-9ab3371aba6c": {"node_ids": ["3fad2f19-46d1-4dbc-9c9e-3b2c1f480e4d"], "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}}, "408c9afc-ae19-442e-b34e-6f4a968be1e9": {"node_ids": ["9e1c85f5-9f5b-4f54-a43e-414b57b289d3"], "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}}, "7b198585-0651-4d18-9ad1-2c18c5384b89": {"node_ids": ["5e95e6de-faed-446f-8903-adc75c4a2e65"], "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}}, "9030a411-2fe7-490e-bf54-98da9e614fea": {"node_ids": ["179f412f-6314-45f7-8c50-6295f11efb67"], "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day6_17April20.pdf"}}, "15ed4db5-c25c-4510-b40a-b888c83dde49": {"node_ids": ["73d90f82-4eac-4ba2-a3d3-ace3c78d2437"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}}, "7e9ce147-1d7d-46b0-926c-8d6c5b3236fc": {"node_ids": ["9b360ade-5e78-4247-90fa-fb06d11c8afa"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}}, "5076c786-4113-46e6-af09-3c1065253e6b": {"node_ids": ["9ae0081c-a23e-4ff8-9396-333ac53752bc"], "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}}, "7b116cc3-b924-4681-80a0-6f2942899ae0": {"node_ids": ["d44a3be0-62ca-4398-8d96-5663689ab7bb"], "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}}, "c3da7ba5-9756-4bbc-88a9-04f2b9c1d47c": {"node_ids": ["4f4db405-36df-478e-bb34-2b9dbbb4db19"], "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}}, "6e3ef52f-d2a2-435c-a94e-e183aff702dc": {"node_ids": ["1819545b-84b5-4352-a907-4033433ddb4d"], "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}}, "ad883cdb-5bc4-4b28-9b53-d45eae2c3dac": {"node_ids": ["326e2c56-4094-4678-a914-ad50f4a6ddcc"], "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}}, "6544ec01-8856-411c-87c3-c9fdff15b75a": {"node_ids": ["b397fecb-f4e5-4db7-8ede-52cc116d9bae"], "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}}, "97adca19-548a-4ca8-8bdb-139e790d4474": {"node_ids": ["3c8f6f71-f61d-428e-98e2-ff40229d5197"], "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}}, "8d03a7f9-e960-4642-9e43-7e040e6cf608": {"node_ids": ["a21cbc0e-599d-46c3-8e1e-1d708ebc2284"], "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}}, "80fdd1b4-fd4a-482c-b6bc-21072484a0aa": {"node_ids": ["fb552bba-cf38-4dc5-9ed5-3cc1758e6e7f"], "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day7_20April20.pdf"}}, "ba0f64b0-60c7-4bb6-9eae-f330517d1527": {"node_ids": ["6bd82d4f-c603-469c-99ad-65b207169256"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "66236342-c64b-42a4-bd6a-21375720f8d2": {"node_ids": ["1653a7f3-0422-44ae-8c65-a5e0845a9c7f"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "d1183035-04d1-4881-bbce-bdcc1f90d454": {"node_ids": ["f2f2c470-9e4c-4163-a3ac-52b07d62c2c7"], "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "d1d821a4-265f-424d-a1e9-ba9cd96749ef": {"node_ids": ["fa3ad50d-aa0b-4ada-8eec-d8ca6882f263", "0915bb2c-0a10-4aa9-9c1d-0651ef0ec0f0", "59c90a06-351e-4525-9283-c0eda045c29b"], "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "809252d7-09c1-45b4-8e0c-cd17abed0bc3": {"node_ids": ["fa7c69b7-e356-4ea7-94d6-c1a643f2dd2a"], "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "3efc3db5-f691-49b1-915a-d33eb89b5584": {"node_ids": ["73912734-e13e-4bbe-a30d-9dcf1db91563"], "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "3d7fb24b-545c-4805-b50e-cb64f3eefdb6": {"node_ids": ["ca45094f-cb2e-41cc-9270-3a487fc0637b"], "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "d5d8e73b-cdbb-4bb4-bd44-5d5061357f0b": {"node_ids": ["8e2ce759-1fd1-475b-84bd-4e16e2674df0", "21ac7a76-22b8-41bd-a1d9-59fc31ff944d", "d6f5c387-1516-40bc-90cd-8548ce468b16"], "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "ea015b4e-e9df-469c-8e4a-2540fd0ce2e2": {"node_ids": ["ad38e77d-e63b-4cce-962d-560a43e7da1a", "e2704c23-a290-4d79-8de3-c2757ba9f213", "c31913ef-e258-4037-bbe0-e848bc864b90"], "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "c0b9c18a-d7e8-41b4-9208-cd94722c46d0": {"node_ids": ["56742981-38be-4dcf-90fa-98533897779e"], "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "56536342-369d-4ac0-9b53-6a7d41ef9093": {"node_ids": ["0d0156fe-6c03-40e8-9489-c6edbbb72c19"], "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "94c39ae4-911b-486c-afb6-ce3b469ab99e": {"node_ids": ["d3cccacb-d0aa-4f54-9d35-d51a6f0e5b74"], "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "6fa2d6e4-5d6d-4b07-a521-2eb3ec602aca": {"node_ids": ["805cb416-9e03-408f-a2a7-708e174b719e"], "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "6c6f8500-d42c-4ffd-9880-6bf8efb96eb5": {"node_ids": ["7287c845-6be4-4d0e-b36d-68b2b3875699"], "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "2b2afbcf-c5d2-4f9c-a31c-b0623cfa21a7": {"node_ids": ["8dffb8bf-71f5-412d-9531-a16981cc0e86"], "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "9a87e606-489f-4eca-8b52-5930f9294ecd": {"node_ids": ["43848eed-d46d-44be-ace9-4af55a03b0f2"], "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "f3819c57-c2ad-4fdf-9ee5-1a9cebc0094a": {"node_ids": ["6b3cc094-9dbc-4987-b06d-4482d4fa4187"], "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "126e3063-fd17-40b2-9763-eb9ca89dd3ce": {"node_ids": ["3e610083-4be7-4ec2-b526-c86c0f2866dc"], "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "4fd7aef3-8287-4b77-86e3-e302dd2e0e1d": {"node_ids": ["9af7bbcc-5cf0-420d-8925-0a0974b5c077"], "metadata": {"page_label": "21", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "179f7de7-3417-4759-aea1-5af23e617098": {"node_ids": ["7e808ec4-48c7-418c-9d1a-c6d7347df526"], "metadata": {"page_label": "22", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "b4c15fdd-cade-41fa-898f-8ce1b3698eda": {"node_ids": ["3cf6053b-7f68-4d51-b512-baab4d24abdd"], "metadata": {"page_label": "23", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "c348d70a-c948-4bbb-adfa-cd8d0584c6bc": {"node_ids": ["172c7029-52b2-4eca-a63e-160e141a45d0"], "metadata": {"page_label": "24", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "90f05822-ff9e-4dd6-a16f-74811208cea9": {"node_ids": ["ea62c283-6ca9-4350-84b6-139597832f11"], "metadata": {"page_label": "25", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "c2cb36ea-501c-4d7a-94d8-57e04e2abccb": {"node_ids": ["2b478724-1f73-4db3-a6c9-1e2fc3177fa8"], "metadata": {"page_label": "26", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "bad1e53b-3f75-49da-9933-9dfa87803513": {"node_ids": ["7c5b19ec-2c2f-4b2a-aa11-83af1ebb7380"], "metadata": {"page_label": "27", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "641565d9-5d94-42d9-8bf5-71065e432027": {"node_ids": ["35b90f3d-cdc3-4b29-829d-761368747c7e"], "metadata": {"page_label": "28", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "9e355033-4d36-4402-9ae1-91586cae39c5": {"node_ids": ["b907b3c6-c073-42a6-ac1d-d060bf159ab2"], "metadata": {"page_label": "29", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "d844d938-d107-4133-8b6d-943c8f6882e1": {"node_ids": ["99cf3815-df30-4adf-ab85-b18527495274"], "metadata": {"page_label": "30", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "466948df-3193-49dd-aef9-5660f2d1b2f4": {"node_ids": ["ae12aafc-485a-4270-8cb6-7a6f99cc358f"], "metadata": {"page_label": "31", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "d4ebb80b-57c2-4212-ae89-b7d03fed5808": {"node_ids": ["36535690-c3f3-4b18-be8d-6ef47c81284a"], "metadata": {"page_label": "32", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "e986b28b-65f2-440c-9164-d1771d720e5b": {"node_ids": ["c6ae5842-961a-4e9e-a470-2430b4aa338d"], "metadata": {"page_label": "33", "file_name": "Stanford_BIOE80_Day8_22April20.pdf"}}, "b45fa1d8-31d2-4ace-9dbf-2985acbcc01e": {"node_ids": ["bc1441a6-9e2a-48a1-8112-65ef2f2b0daf"], "metadata": {"page_label": "1", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}}, "b0a102fd-edb9-4528-8813-817a66edb6ce": {"node_ids": ["fa4ff336-1a89-4e53-9026-c99c559ad65c"], "metadata": {"page_label": "2", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}}, "0d9ab629-dc3a-46f4-a4f1-b274c1d61ecc": {"node_ids": ["ad927f5d-f066-4176-9c71-b426db155b63"], "metadata": {"page_label": "3", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}}, "bbb4e867-9c55-45b4-89a8-110d3cd81088": {"node_ids": ["ddadac37-e15e-4cc4-bbb8-e5edc94962c3"], "metadata": {"page_label": "4", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}}, "f76b4f24-17e7-49e3-af96-50f841fa4053": {"node_ids": ["28e52fc1-9b5b-4e3d-898d-b2dd09d58bbd"], "metadata": {"page_label": "5", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}}, "8b6161e9-28be-420c-9df5-e2cb8f3ddb00": {"node_ids": ["ce0cdc89-a26e-4b32-8bc7-c2f5e118814e"], "metadata": {"page_label": "6", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}}, "6aaba0e6-6fc2-4137-9d93-f9e28f1a8f96": {"node_ids": ["296495c7-b609-4d02-abb6-a7ae55a0e686"], "metadata": {"page_label": "7", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}}, "8144624d-fe3b-430f-9b0b-cb7f09d22a3f": {"node_ids": ["2cd52b86-6fc6-4267-b032-284ac54f2bc5"], "metadata": {"page_label": "8", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}}, "dbbd87a3-3925-4eda-b0b4-f6b5997aa555": {"node_ids": ["33bca0c6-2906-448f-9b36-dcb088d7324d"], "metadata": {"page_label": "9", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}}, "be11db4e-3d43-4fe4-b75b-d6fd466fd959": {"node_ids": ["d122aad4-558e-41f4-9dda-0cc293924b38"], "metadata": {"page_label": "10", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}}, "dce594c8-8c6f-46dd-ab57-c708e6af7f54": {"node_ids": ["55718dab-2871-4de2-9ac3-ef0eb30823c5"], "metadata": {"page_label": "11", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}}, "6fd743f9-6b2a-4993-a587-d1ebc3371876": {"node_ids": ["bcd1e528-6eb0-484e-b615-6e544246eac5"], "metadata": {"page_label": "12", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}}, "73585aa2-0aa6-4c2b-a2cb-d3a7054912ea": {"node_ids": ["f5d9bf1e-e570-460c-9c14-93f169ec21fe"], "metadata": {"page_label": "13", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}}, "1092826d-70a7-47fc-b815-a0fec2eca5a2": {"node_ids": ["33485320-eaea-44cf-93ee-2bcb91262453"], "metadata": {"page_label": "14", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}}, "a5dcb2cd-9355-4083-8ce6-cdc64275d3b2": {"node_ids": ["d9a0c41b-f874-4282-be09-8c0a144cb90d"], "metadata": {"page_label": "15", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}}, "38d2a0d1-c1e5-4181-a4c6-2483b114b7c4": {"node_ids": ["fc2c4993-3de8-4c3b-91a5-6399b0d501b7"], "metadata": {"page_label": "16", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}}, "4d8006dc-bf0b-4e97-81fe-43f3818136f4": {"node_ids": ["d9cdb572-14db-411d-b9f4-73d5d60af6fb"], "metadata": {"page_label": "17", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}}, "ec1a898c-61f2-4f2d-aa85-9924745205c9": {"node_ids": ["34078a83-8527-4793-9161-e88fb1b446cd"], "metadata": {"page_label": "18", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}}, "998a3f32-8c34-4aac-82ce-5e09116d7dc3": {"node_ids": ["8e173b85-7fcf-448f-8945-38ea7f373dab"], "metadata": {"page_label": "19", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}}, "b0eb98a7-8078-4088-9626-0f0a1a73d54a": {"node_ids": ["e5b05fb9-dc6e-4f95-a156-97b3de323d01"], "metadata": {"page_label": "20", "file_name": "Stanford_BIOE80_Day9_24April20.pdf"}}, "8ac6b4ec-6c2c-4ce7-a6f3-09940035431a": {"node_ids": ["4dc97208-bea2-4a78-9841-29ef78f7260f"], "metadata": {"page_label": "1", "file_name": "w3ps.pdf"}}, "11193413-5dfa-49ed-b554-659fb978048f": {"node_ids": ["9d8d3384-d30b-4823-8f86-7f615b3c725a"], "metadata": {"page_label": "2", "file_name": "w3ps.pdf"}}, "ba6ae197-583e-41a3-acaa-e34f13ecd4a8": {"node_ids": ["b44c52cc-9444-4da4-a9bb-fc25b0a86e45"], "metadata": {"page_label": "3", "file_name": "w3ps.pdf"}}, "a86d8f41-431b-418a-876e-738034e77aa2": {"node_ids": ["12ea6f5d-c178-44b8-8c1e-aba71d4e718b"], "metadata": {"page_label": "4", "file_name": "w3ps.pdf"}}, "087c9eb8-b802-478b-a328-100010ddae24": {"node_ids": ["8118a288-8659-4620-ba33-666b97a3cb56"], "metadata": {"page_label": "5", "file_name": "w3ps.pdf"}}, "64c87987-c398-47fd-bdea-9ecb541e4b90": {"node_ids": ["6d6a2116-40c6-43d3-a908-837714912ed9", "9bc9b730-2649-45ac-b008-0b74f44c5c9e"], "metadata": {}}, "0507fe5c-5eb7-4339-88b6-c0851636e608": {"node_ids": ["ae4edda3-09d7-465d-9a98-18995fd68954", "d6aed060-8f63-4d62-a893-6fe3e0e50feb", "3985d5b7-45ad-4fb1-a5e3-905b8d881841", "2273510c-3b45-485e-aa6d-1fb84a4dfa8e"], "metadata": {}}, "f869ac5d-b608-49e6-b0ed-9106387e6c41": {"node_ids": ["202b0011-9f12-4828-b7e7-351693fcd282", "c0297a94-d151-40fb-891d-6df53182ecab", "e8a86fe0-30a4-49c8-9412-446acf5b604d", "7ebe1b2f-427e-456d-9d40-3cff421955a8", "0f2db9c3-2f91-443f-88f1-2b0d16896797"], "metadata": {}}, "4030aae3-0365-443e-a794-e358776dd6f3": {"node_ids": ["054e0d4f-70d4-40d3-ad36-7470bd64a9cf", "645efdf3-f569-468e-a48b-2927439533a7", "f0d3ec22-99c1-473a-be4a-23d3a4c69192", "40809ff8-cdf4-4867-aa6d-7b1b2678b9a7", "00240aa9-6b8e-46dc-8d0e-a06189100603"], "metadata": {}}, "941ae92a-ee2d-40a9-9000-7b2e00b061f6": {"node_ids": ["3fe71f0b-3204-4378-a7f3-d2dc305bf1ba", "fc59229f-ac16-43e0-a0e1-7a1a41db7881", "fe20bc37-aad7-4c0e-910f-e8f60e181fe5", "a4e3b13c-82b6-46f4-8b6b-c344fe41d9b0"], "metadata": {}}, "5bd77dd5-0f77-412c-a16e-8fe9bcbd4f25": {"node_ids": ["d09bea1b-2b0e-4317-8539-871ebeeef697", "63bf84cc-6bb7-4880-9da2-a97913db3808", "c8a846f2-eb26-4021-8703-a413ba958dbd", "9de35603-4cf4-4939-9bec-7d9360547d30"], "metadata": {}}, "21c5150f-ba65-4463-b9a4-7b6cc46774d1": {"node_ids": ["af5587a6-2593-4bae-a1ee-5782ba363497", "18398298-b91a-4ea2-b7b0-f494e0e7babe", "fd241010-c07a-4b07-9399-d6a9d3fdcb11", "0b8a87e9-0ef2-416b-981a-a36595da67be", "42ab1fd4-ae05-48a2-bb36-7deef6db7bbc", "8c9d0eab-2868-415f-b693-62327b8eb53f"], "metadata": {}}, "acabbdc1-3dac-4cb0-a745-98ee92a31da5": {"node_ids": ["eabb7bdd-f29d-47d0-98ff-e74dc16139a9", "1753cbf6-6289-4dd5-8cc1-ec396c4e7998", "57c742fc-029c-4a52-ac80-9bf123e909f5", "6ca95c29-59d9-4177-aba8-976cba88b82d"], "metadata": {}}, "880f2ccc-ce11-4f02-b940-ad9e5fbed360": {"node_ids": ["50ad5d94-7afb-433b-9d21-528ed8b432a6"], "metadata": {}}, "c2286310-5d5e-456f-bc5f-07dd356f904f": {"node_ids": ["8477a745-994c-4891-8706-e8cc46d58265", "a301b8b7-9fdd-44ba-affc-b1de97c7c404", "2ad05135-f727-4fe8-aa0e-067d950d0fce"], "metadata": {}}, "b79e56cc-1fc9-4282-a83e-d131ee3df67a": {"node_ids": ["ae62338e-bd16-4de9-9f42-3fcabfe435b1", "49e36f9c-baad-4000-870f-8636af293ce5", "ac8f5290-543f-4c15-b42e-523d5168341d", "4793a604-c914-470b-94a3-26f2175d1902", "fabd75d6-8aac-434c-80d5-3a1616424456"], "metadata": {}}, "8fa06bdf-3135-4003-9bfd-fbe0dd9501e5": {"node_ids": ["19f8625c-c143-4001-8bba-4b54b49b596d", "0cecde41-e8bc-432b-aed0-2b0091456b56", "4feae115-4bd7-48b3-bfd2-2298e7460ee4", "e00a6891-4adf-48bb-8728-2ed6e8978622", "e341310d-56b1-4fcd-ad0f-39d4d77bcbc2", "33563af5-af3d-4204-a53b-24c90e45019b"], "metadata": {}}, "8cbd348c-8e10-494e-b9a9-a36551bb66ca": {"node_ids": ["4833f9f3-6a2a-45e0-bc29-77cd084ce264", "f6e45b3c-5d26-4c74-b74c-4380b8fd2fb3", "630e35a9-f078-476c-a3b1-81f91bd4df25", "b176a171-2e73-470c-b496-c03252252a63"], "metadata": {}}, "6b692a4f-0b81-48ac-842b-07859deb3301": {"node_ids": ["e881883f-2b12-450a-a6e2-e089dd7bcb2c", "a965164f-649c-489e-b828-24f27b52242f", "be874afb-a9a4-4e8a-925c-4fb98912acef", "feb6da34-b679-4bf1-97e8-12e8068995e1"], "metadata": {}}, "da06ef5a-6c94-43a2-9347-b7d0f6280998": {"node_ids": ["94b73e2c-db77-4fe7-88ed-fe3675652aab", "3e60d765-da5b-472a-a5b8-7d6892f092b9", "b0df5462-4e19-41d0-9582-29730f587456", "40d2dbad-fde0-490d-889e-ffa50bb1ee1e", "ebdc86de-e786-46c2-92af-2ee95a78ed5c", "8eda9e10-5a28-4399-83b6-bc34e233e286"], "metadata": {}}, "12171429-7444-4e97-b551-1ea5eed30f87": {"node_ids": ["225f51d1-82ac-472c-9009-31722b15eecb", "0d1eba7e-2175-4f27-befd-39e4b87d9e94", "691fc26a-704f-437d-89b4-ef01fc7c93ae", "3d21d032-9889-4ff8-8c7f-0b9226a888fe", "485d5279-275c-4438-8e7e-c592032baeab", "abd93524-e851-4886-be1f-933c2b83bc7f", "87d84eb6-9091-4b08-9905-90d1f2f1b539"], "metadata": {}}, "73af4080-5016-4759-8e6d-3be2198c8d79": {"node_ids": ["76b4e163-8ba7-4e42-8876-f388dfb49388", "760438f2-9c61-435c-8579-363639e9d235", "59a87990-7c5b-48c7-b4ab-86cf6c106250", "b96afea9-d62b-4fb8-9d11-c5c3a7424d8f", "28232525-2e59-4d84-b615-2d94881df3f5", "3984616d-c373-425b-9ebb-ce6f79bce0cb", "5e69d876-a216-4a69-8181-efc445aed1e5", "e0920a3f-17d9-4b88-8965-d662ec4802bb", "5b9a3be4-8592-4ff0-9451-0460d9ab61c8"], "metadata": {}}, "e6eccb9b-6d24-4d40-8293-5c61181b2125": {"node_ids": ["becfcfa7-0dda-47b8-91bc-84b5e1a8ab56", "60779efd-497f-4922-9625-1d656f6b81b7"], "metadata": {}}, "0dbe04b2-f662-47fa-9c46-046ae5317deb": {"node_ids": ["9de9ccdb-c81d-49e1-a507-d9fad0994f42"], "metadata": {}}, "b60f1b52-33f8-4ccd-8ea7-e22a9ae6d854": {"node_ids": ["8050142c-8722-4568-b4d6-f075300a8db7", "0243a1f0-9573-41d6-82f6-87ffffb970e0", "a6463906-f946-419d-b291-997d71031aa1", "6b77a12b-b2fc-4328-8949-5d144fa93043", "1370e093-be41-4dbc-9c82-c39cb96a434e"], "metadata": {}}, "d463771d-cec1-46e0-ba77-f8c16ceefd07": {"node_ids": ["0c8684b8-00a6-4ef3-ae0f-1b05b52d470b", "d7e14ba6-2054-4637-b894-1908cd5c5598", "9575f03a-6cb2-4724-885b-d745dcc629f6"], "metadata": {}}, "971eabe0-9fb2-4df5-abaf-ae9c5fd856ec": {"node_ids": ["9fc1dd50-d11d-4488-851c-2c9260fc8330", "5ba439ab-1d57-496f-96f8-99a0b37820aa", "ea04c89a-504f-445b-b7e9-7991fd25915d", "7c0e4f7e-c4d3-4524-9024-7a75d2171787", "34a72aec-770e-44b8-a5e3-97b6df8da356"], "metadata": {}}, "c3f860a3-59d0-46a3-a1b9-353f455d3682": {"node_ids": ["0306edde-6966-4bab-b44d-22e07b4e3dab", "c57c6886-ab85-441c-ba63-7643aa2485f0", "7719dde6-cb23-40e2-90e1-9c69e67d626f", "9defa700-8b12-4126-b38c-5e61ff36d53e", "2f08617b-5325-48a7-b484-22f0c0f4cfa5"], "metadata": {}}, "bcd7dbe4-c15c-4d37-87fd-b310d010f3fa": {"node_ids": ["744bd50a-37da-4afb-a05a-44d998562bfc", "e426ca88-1144-43cc-a553-fe7fde22a7e6", "40a5cd8c-c47e-4f64-b49d-e43d2e3d9620"], "metadata": {}}, "c42ee03b-6667-4501-9a88-4af636d9cc2b": {"node_ids": ["c05a0bc9-aa7d-45ca-a3be-cfa10cd0806d", "48caa830-bf9e-4aca-a414-10fa5328b91f"], "metadata": {}}, "70b83907-0f17-408f-9aa3-a41491f453a5": {"node_ids": ["269984ef-07b1-4ab0-99c1-27ee937095f3", "6cbbfdb9-ebf3-4d72-bf3e-a4e48a04a431", "d36c1149-f10f-4955-b8f0-2b4bd3971aaf", "e388c546-05f5-449f-b03c-92a154aa13e2", "0c94b2cf-6ba2-4621-96bc-a0c797db27d5"], "metadata": {}}, "c914b42c-19f9-448b-b2db-fd29d8a8c233": {"node_ids": ["adc45dde-0169-4ab4-a329-d415575ad099", "4c3eebfe-08b0-4bd7-94f8-e745f336092e"], "metadata": {}}, "685e5eb1-7d50-4d73-b03f-fabdde0ac592": {"node_ids": ["b1355554-c476-411f-b6be-5948a0604314", "dc19e830-9fd0-4513-a2db-54195b1d8da0", "a0a99ffa-c7a8-438d-983e-618067a1eded", "b3c3c55b-56d2-406d-9af0-9f3c92de24bf"], "metadata": {}}, "3f0eb595-68ed-4497-96ae-640aaf18e8e0": {"node_ids": ["184f6b8e-6fcd-428a-9519-7969baf5384a", "13094e2a-8b61-4ece-9098-f4c899041f04"], "metadata": {}}, "18267c81-baae-42c1-95e9-78fcbf5d4339": {"node_ids": ["c8c6991c-4774-4be4-884b-90d9331119a6", "5ebdc624-894b-4ea3-b94e-b5c0e6d46556", "22e8a381-e726-46dd-b0d9-02c3e1a1496c"], "metadata": {}}, "216e0901-5b01-449f-a115-69c5d483f0bb": {"node_ids": ["391620cb-7dcb-4af3-8e84-7c2a8dfe2d83", "0541350f-072e-4d47-9079-21cdeb46d7bb", "d905e483-6aa7-453c-b94d-ad35b9b2441c", "24528f9b-a319-4dcd-9d06-aa89f24583f8"], "metadata": {}}, "9a527a69-dddd-4795-b429-9cb00ec7a6aa": {"node_ids": ["1b519fd2-2173-4024-b130-87968de1d36a", "ba9e114e-bc74-444a-9973-17a4b1c3daf3"], "metadata": {}}, "1b7eed84-f5f9-42fb-ba83-14671a23490c": {"node_ids": ["074f11d1-8deb-4fc7-b98b-49e8dce03f01", "9edaebc1-94a2-4eb6-9dbe-2c5a732bc7dc", "f626a660-fbd9-40ac-9670-bfd406c6183a", "51b8894d-47e5-4693-a08f-8d56de1464f1", "c094a7e3-a2f6-42b9-8a07-dbaa9f343bb6"], "metadata": {}}, "29fd480d-1c2c-45c8-a54b-2eccf5b43215": {"node_ids": ["8611eb7c-86ff-48b2-912a-a070f28af374", "e7f86d3b-cec6-443e-8ce1-4786cbc065e2", "5ccd14ca-9de1-4de9-9160-33e7e8cda112", "a2513c57-cb40-4ac1-b124-eef20af14e7b"], "metadata": {}}, "26d3e909-9d51-40e0-b667-5c5fcd96ff4a": {"node_ids": ["ae982e83-4f2e-4db7-89e5-6993a8bc1ab7", "f03f2ddc-4c32-413e-855a-e078f8ed6b97", "f34bd321-25f9-454b-b74b-7689762c97e7", "7dd70d5b-5099-4dab-8458-3c51b446b3e8", "2b9aa816-d439-4c7f-a219-c717d10011c4"], "metadata": {}}, "8fed0da7-633e-4634-906a-951d151ed94a": {"node_ids": ["3a8dbf9c-f982-4fea-a1f2-b3f8a6bbbb67", "a381f8a9-76fb-4fda-b1fd-bae0f2f579b8"], "metadata": {}}, "43c346ac-b7fc-47a6-8e70-96b70c4cf1b4": {"node_ids": ["7ef2159d-801f-4c0b-8f25-53087d9159f3", "8db24b60-a857-4c7c-8283-76b17d221c9f", "7515b8fd-a5e7-43d7-8249-fd4ada1a00c6", "8c236949-804a-41d5-83ec-d1342b030777", "93e4b592-79cb-4281-8034-00cdfb78f2c5"], "metadata": {}}, "4e519bc3-29de-419c-9b5c-bdd4c91c2171": {"node_ids": ["70e82283-9cf8-427d-bfdb-e1c7393ac047", "d6e5d46a-2200-48c1-893c-a6ce5ca80274", "c21e9466-59b7-4fef-8323-90eeb9bce0b1", "e8b15746-d669-471b-b0fa-dea5c264e590", "6303af92-3080-4860-bb76-a2ec847b7cc8"], "metadata": {}}, "86de31a0-3140-46a2-b800-2c9a31c3ae82": {"node_ids": ["a333f89f-9549-4d66-acfe-0a20c418e2b8", "fcb681a5-a55c-4097-8834-bb1c93f524da", "21c257dd-0ca5-4966-8874-c6cafcd2fc6a", "9837547e-91cd-492c-88f6-0ea1c5b9625e", "f83078de-19e5-4b26-8890-7794f34d9d27"], "metadata": {}}, "5399b3a5-3d94-432c-a51a-6ce1c4574045": {"node_ids": ["2f3aa23c-8afb-463c-9690-062f35513d50", "87dafef3-d727-4219-ae85-8cc563f3e7e2"], "metadata": {}}, "90618f92-da87-45f1-97fd-4d8f8dacea0e": {"node_ids": ["f9d820d3-7e2a-4df3-ac94-109a77ffb589", "28fa33e7-47ac-4dfa-bbbc-7d9b84fcacb0", "1e5be4b9-d434-4692-bcda-f468de0d2908", "d1727f3d-941d-4663-8f11-abb822ab3bae", "a4fc4f7a-be61-44d5-965d-b5cf70b91baa"], "metadata": {}}, "8cd49350-0a44-48cd-a337-cd75befa1bfd": {"node_ids": ["4b14c783-3edc-4958-be8b-c0c0673c11ac", "304d48c4-000f-47f8-b5d1-0bf48bdbdee6"], "metadata": {}}, "c774fbac-eea3-4371-b879-8fc57e21f29d": {"node_ids": ["00cd7fcf-1025-4207-bdc6-c3134a69fb44", "b17811f6-9e14-459c-8b77-88c8e3ca4225"], "metadata": {}}, "2b91a97e-5696-4dd0-9927-abbe78bac3d9": {"node_ids": ["1e445500-3faa-4c6e-b90f-59c6f6569949", "b84f36f0-bc9c-4f2a-a9a8-5efe17f0e80a", "e4d3bc90-8249-4e00-b573-6da7986761df", "b7d32e3b-62af-4d64-ac5f-bbd90412ecfa"], "metadata": {}}, "d969ddda-4720-4dc5-8a53-bd7869c811e5": {"node_ids": ["a5dc620d-b86d-468f-9a1b-b78ac11e7028", "c253acc0-49dc-4f11-afa9-63ac42fa04dd", "87adaa89-8516-4ef9-8876-81bacdec4486", "e9815643-171d-46c3-88de-7ee783f013ee", "b52d16a3-356a-4722-b844-d1774e03fe86"], "metadata": {}}, "d6c177fa-cc81-4527-af07-593456035e28": {"node_ids": ["f49fa140-5cd7-42cd-bfb7-248860e7b89f", "5458e084-2ef8-44a5-a725-1461edf91e33", "863d8eac-b462-40af-a987-2779fed1a8c4", "239defe6-6377-4907-abc7-d8a24b7173b8"], "metadata": {}}, "08c4aff6-0f02-4cda-8205-baa57b7e3a2d": {"node_ids": ["4db018ba-81db-4534-9b9b-477c51bf212b", "506b85c2-0fb8-40bd-bbc1-54f09c1ff2da", "53649073-64a3-4212-be15-410ebe793d30", "4eddc232-e312-47fd-9997-e24bfda3fc0d"], "metadata": {}}, "c82a1ed2-6632-430b-b417-210bd6948512": {"node_ids": ["f439deee-c13b-4205-93cb-60459eae36f3", "29ddf5fd-85b8-427a-98e2-a78d732c88c8", "ec7c26c5-6ef3-40f8-87e6-94e6381ce7bb", "f4f7ddac-3a7e-403f-a290-012bb65ff987", "fefe3df9-9a4c-452d-9802-68885fc6e173"], "metadata": {}}, "87724d6e-064b-4946-953c-75b95b8de25b": {"node_ids": ["dc3eb136-10c8-4243-a0af-e7f54d6c322a", "4076f231-110d-4a3d-a268-26812d3e5d3f", "24176a38-ac1d-4748-8356-338621794216", "6dcbc230-3487-472d-9cd2-594c5a9474ea"], "metadata": {}}, "2cc2148e-386e-4858-988f-a0b2f9913f96": {"node_ids": ["5ae1e491-f920-4d5b-98f2-95297851c440", "fcbd2ef8-e4ab-41f0-be3e-318470c535c7", "d0086d60-c0a6-499e-82a7-b1312a74e3fa", "da7396c2-56f6-4c94-b042-4c7f67b63a0f", "a29ad700-8c5f-4e04-b345-de4cafc1b99c"], "metadata": {}}, "85380493-c4a7-4d2c-aad1-2c0293382887": {"node_ids": ["87755d0d-37c7-464a-81ef-55a04e57fb7b", "5f1c789f-09d9-49a7-a87a-98035c896d3c"], "metadata": {}}, "6d8cb138-f981-4deb-820c-639c01fb026f": {"node_ids": ["18546f5a-9fd5-4635-9914-28b7aef75e9a", "5041258c-3dc2-4db9-9747-b310ea24de15"], "metadata": {}}, "103bb39e-40c2-4130-aa26-363b570cd31a": {"node_ids": ["63d487e3-aa6b-4af4-b569-cbb0e225b8cb", "fde57304-2ecb-4e4b-98e2-b6b2c08f5864", "ac4db4a3-aa1e-4b11-84c1-bff7877a4302", "1c186c8a-58d8-4e86-bcf0-8efb865ac00b", "0fbda229-3938-4573-a11a-98f6f458fafc"], "metadata": {}}, "1ed3d51f-981e-4705-a19c-a6b6595a682e": {"node_ids": ["aac3782e-57e5-40a8-9111-f1a50b2455ed", "c83e851d-ffe1-4ce4-93a9-2800ed0984c2", "5dc6b10a-20b2-4e5b-9677-f76ed0feb21c"], "metadata": {}}, "99740c43-5487-407e-b6af-7bc8db6b74ef": {"node_ids": ["abaee270-e759-4ad1-90b0-23817060b571", "95038553-3f67-4a30-81a2-ddf557b1cce8", "1ab70d1d-ffd6-4cfb-9446-18ba41361e1c", "f5587619-42ba-4ab9-8349-b4bffcc1a52d"], "metadata": {}}, "e11470ea-6fff-4c68-872d-22efa4ba7278": {"node_ids": ["47c59203-6b25-4890-b2fa-75cada4a5c62", "5f6edfe4-dc85-4641-80a5-516d5c2af3fe"], "metadata": {}}, "37e0d9be-2edc-412b-b35f-ad6724c9cc3d": {"node_ids": ["91d01f93-9e3d-4bf9-9bd2-cb31118d4f79", "5f0c7dee-04c8-4045-b7b5-2ed35278a8a3"], "metadata": {}}, "87a13fee-c559-408f-9ff7-ab37ea9e2517": {"node_ids": ["e1568e93-ce08-4b5b-b176-0098d8b620d2", "24d4a904-90a7-48e3-99bb-cfce73c337d2", "d23b5fa2-c982-4a9f-bb7f-4cca942bf869", "a55b5ead-c163-4763-8f42-e192b2cd9ec1", "2afc6927-fa37-4256-b9c0-6f16a6e60a21"], "metadata": {}}, "6ff5dfbd-4a2f-4a75-8936-486d9c797d3c": {"node_ids": ["818fff00-7cf2-4411-b9df-dd7125fa71bd", "5710083f-e829-4223-b149-006b8e2cc37a", "0fb2014c-0d4d-42c4-8a73-2c7ac73de9f1"], "metadata": {}}, "b3e92f83-c6e9-48a1-917b-f90368028926": {"node_ids": ["693e9899-8695-4938-9cfa-b4d9cb2fed1a", "0d8b786c-b5f8-4501-8a4a-f265cb7512aa", "963d8af9-d4af-4975-9aeb-2963913b1ebd", "05caf1ff-530f-440d-b419-1447e82ff532", "e081b850-e694-4694-bfa1-198347b7c91a"], "metadata": {}}, "9ea37fd5-c81e-48a5-bd3c-bae82986e816": {"node_ids": ["8c314373-158c-4809-aa1e-e62cac28267a", "764a415e-1965-43e7-9e14-8bd22b8d4570", "71f26691-4420-4346-9629-2f4360782977"], "metadata": {}}, "f8889e75-d27e-4f61-b0b6-ff36cab61945": {"node_ids": ["ce98c793-a083-469f-b2c5-e08f9aa48da3", "84ed673b-1d18-4bff-8e69-0252ebd0ffa8", "5987bcd2-04aa-40c4-8949-a25177e9db7a", "cb8cf659-62c7-45ad-9b31-0f25b6239658"], "metadata": {}}, "24ad982c-47d1-455c-952d-a31ae43a2c78": {"node_ids": ["4abb23eb-b9ae-4d65-b5ee-8892ac8c51cf", "b490697e-511d-4a71-aa09-3a660cc77090", "9c170077-5710-4100-8fe6-b7fc617f5103", "485fd1f9-1cb7-4db7-b9e5-9d8b16f068f5"], "metadata": {}}, "c1075af5-68cf-4abd-9166-1b8cdb36eadd": {"node_ids": ["354d3032-6499-4dc3-850a-274f6bfac20c", "6fe5b514-8788-4c8c-b9bb-e92bdef9d8eb", "e65461c4-d1ed-4d26-9013-c16773a0da8e", "b6f0456d-79ad-4b02-a825-b91b0ce03725"], "metadata": {}}, "823bc112-1294-4fe6-b2f5-3faf64dfbe18": {"node_ids": ["d6747943-9398-44c0-aac7-99ef809c5847", "6133f04f-cff1-43d7-9429-027ae1d0720a", "bbe5ca41-84f9-4aa3-9e2b-c9510899515e", "02650291-184b-4a68-b8e5-5f211912159a"], "metadata": {}}, "8d5ad962-585b-4050-8998-b68b7d4f356a": {"node_ids": ["47931fe8-deb8-4f76-b5c4-f727e574ae07", "725b54c8-090f-46fb-9fcf-5b7d1d3ceb73", "d29b08c4-3165-4509-b5fc-69167c2df5b4", "25440e66-f9c5-47b7-a8b2-4f916352bd33", "2eec2970-4623-4c74-bbbf-c3a209896641"], "metadata": {}}, "53bd4554-9e4a-490e-a410-bbdbc26f5130": {"node_ids": ["ad60890b-2625-4e4c-a380-d3384e5d4b67", "10a6cd87-4ef5-473a-80e2-773a4edbb8a5"], "metadata": {}}, "27fbe2c8-e129-4395-a5a5-778eb7354f3e": {"node_ids": ["ebf94cfa-7a0a-4fab-b377-1e956a88e06b", "b4bb383e-d719-4d2a-ac03-b0abf1845785", "f2aa6b1c-1ae4-47d5-944f-113f26a67784", "5d4433de-3bb9-4c4d-a37e-470e46c75a6a", "ec1a0ccd-1a92-427c-b890-a704e121f820"], "metadata": {}}, "deebf027-27d2-47f0-8869-b4dd099c55bc": {"node_ids": ["e7a18b09-5e05-472f-9fd3-19ae204de705", "e21613ce-28e5-4126-a97c-fb100f34571a", "aba609f2-3914-4104-93a1-1792afa729cf"], "metadata": {}}, "2b13c655-fad3-45df-93ab-7fda4e85ca44": {"node_ids": ["277cfaa5-adec-4de8-89bb-f882cd8963be", "459bd1ac-bdc4-4c5d-a1fb-a6ba3f29581b"], "metadata": {}}}}